<?xml version="1.0" ?>
<document id="amazon_go">
  <sentence id="s0" text="These findings underscore the specificity of protective effects observed here in models of Parkinson's disease, and previously in Huntington's disease, and support the development of SIRT2 inhibitors as potential therapeutics for the two neurodegenerative diseases.">
    <entity charOffset="183-188" id="s0.e0" ontology_id="22933" text="SIRT2" type="GENE"/>
    <entity charOffset="238-264" id="s0.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s0.e0" e2="s0.e1" id="s0.p0" relation="true"/>
  </sentence>
  <sentence id="s1" text="The interaction required the tumor necrosis factor receptor-associated factor domain of USP7 and the central region of UVSSA and was disrupted by an amino acid substitution in the tumor necrosis factor receptor-associated factor-binding motif of UVSSA.">
    <entity charOffset="29-34" id="s1.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="119-124" id="s1.e1" ontology_id="57654" text="UVSSA" type="GENE"/>
    <pair e1="s1.e0" e2="s1.e1" id="s1.p0" relation="true"/>
  </sentence>
  <sentence id="s2" text="A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. BRCA1, BRCA2) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. BRIP1, RAD51C/D, MSH6); and multiple common but low penetrance susceptibility alleles identified by GWAS.">
    <entity charOffset="225-230" id="s2.e0" ontology_id="672" text="BRCA1" type="GENE"/>
    <entity charOffset="295-301" id="s2.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2.e0" e2="s2.e1" id="s2.p0" relation="true"/>
  </sentence>
  <sentence id="s3" text="A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. BRCA1, BRCA2) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. BRIP1, RAD51C/D, MSH6); and multiple common but low penetrance susceptibility alleles identified by GWAS.">
    <entity charOffset="232-237" id="s3.e0" ontology_id="675" text="BRCA2" type="GENE"/>
    <entity charOffset="295-301" id="s3.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3.e0" e2="s3.e1" id="s3.p0" relation="true"/>
  </sentence>
  <sentence id="s4" text="A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. BRCA1, BRCA2) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. BRIP1, RAD51C/D, MSH6); and multiple common but low penetrance susceptibility alleles identified by GWAS.">
    <entity charOffset="295-301" id="s4.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="361-366" id="s4.e1" ontology_id="64979" text="BRIP1" type="GENE"/>
    <pair e1="s4.e0" e2="s4.e1" id="s4.p0" relation="true"/>
  </sentence>
  <sentence id="s5" text="A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. BRCA1, BRCA2) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. BRIP1, RAD51C/D, MSH6); and multiple common but low penetrance susceptibility alleles identified by GWAS.">
    <entity charOffset="295-301" id="s5.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="378-382" id="s5.e1" ontology_id="2956" text="MSH6" type="GENE"/>
    <pair e1="s5.e0" e2="s5.e1" id="s5.p0" relation="true"/>
  </sentence>
  <sentence id="s6" text="Among the proteins enriched in LO, cytokeratin 18 (CK18) was one of the most abundant (within the top 5th percentile) and was used to develop an assay to detect LO in the circulation and tissues of mice and patients with prostate cancer.">
    <entity charOffset="198-202" id="s6.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="230-236" id="s6.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s6.e0" e2="s6.e1" id="s6.p0" relation="true"/>
  </sentence>
  <sentence id="s7" text="Germline SMARCE1 mutations have been described in hereditary forms of this disease and more recently in small syndromic and sporadic CCM series.">
    <entity charOffset="9-16" id="s7.e0" ontology_id="6605" text="SMARCE1" type="GENE"/>
    <entity charOffset="124-132" id="s7.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s7.e0" e2="s7.e1" id="s7.p0" relation="true"/>
  </sentence>
  <sentence id="s8" text="The diagnostic value of SMARCE1 in distinguishing between CCM and other meningioma variants has not been yet established.">
    <entity charOffset="24-31" id="s8.e0" ontology_id="6605" text="SMARCE1" type="GENE"/>
    <entity charOffset="72-82" id="s8.e1" ontology_id="HP_0002858" text="meningioma" type="HP"/>
    <pair e1="s8.e0" e2="s8.e1" id="s8.p0" relation="true"/>
  </sentence>
  <sentence id="s9" text="Nuclear respiratory factor 1 (NRF1) transcription factor has recently been shown to control breast cancer progression.">
    <entity charOffset="30-34" id="s9.e0" ontology_id="4779" text="NRF1" type="GENE"/>
    <entity charOffset="99-105" id="s9.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s9.e0" e2="s9.e1" id="s9.p0" relation="true"/>
  </sentence>
  <sentence id="s10" text="However, mechanistic aspects by which NRF1 may contribute to susceptibility to different breast tumor subtypes are still not fully understood.">
    <entity charOffset="38-42" id="s10.e0" ontology_id="4779" text="NRF1" type="GENE"/>
    <entity charOffset="96-101" id="s10.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s10.e0" e2="s10.e1" id="s10.p0" relation="true"/>
  </sentence>
  <sentence id="s11" text="Since transcriptional control of NRF1 seems to be dependent on epidermal growth factor receptor signaling, herein, we investigated the role of NRF1 in estrogen receptor/progesterone receptor negative, but human epidermal growth factor receptor 2-positive (ER/PR -ve HER2 +ve) breast cancer.">
    <entity charOffset="33-37" id="s11.e0" ontology_id="4779" text="NRF1" type="GENE"/>
    <entity charOffset="283-289" id="s11.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s11.e0" e2="s11.e1" id="s11.p0" relation="true"/>
  </sentence>
  <sentence id="s12" text="Since transcriptional control of NRF1 seems to be dependent on epidermal growth factor receptor signaling, herein, we investigated the role of NRF1 in estrogen receptor/progesterone receptor negative, but human epidermal growth factor receptor 2-positive (ER/PR -ve HER2 +ve) breast cancer.">
    <entity charOffset="266-270" id="s12.e0" ontology_id="2064" text="HER2" type="GENE"/>
    <entity charOffset="283-289" id="s12.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s12.e0" e2="s12.e1" id="s12.p0" relation="true"/>
  </sentence>
  <sentence id="s13" text="This was consistent with our observation of higher NRF1 protein expression in the experimental model of HER2+ breast cancer brain metastasis.">
    <entity charOffset="51-55" id="s13.e0" ontology_id="4779" text="NRF1" type="GENE"/>
    <entity charOffset="117-123" id="s13.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s13.e0" e2="s13.e1" id="s13.p0" relation="true"/>
  </sentence>
  <sentence id="s14" text="This was consistent with our observation of higher NRF1 protein expression in the experimental model of HER2+ breast cancer brain metastasis.">
    <entity charOffset="104-108" id="s14.e0" ontology_id="2064" text="HER2" type="GENE"/>
    <entity charOffset="117-123" id="s14.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s14.e0" e2="s14.e1" id="s14.p0" relation="true"/>
  </sentence>
  <sentence id="s15" text="To identify network-based pathways involved in the susceptibility to the ER/PR-ve HER2+ve breast cancer subtype, the NRF1 transcriptional regulatory genome-wide landscape was analyzed using the approach consisting of a systematic integration of ChIP DNA-seq, RNA-Microarray, NRF1 protein-DNA motif binding, signal pathway analysis, and Bayesian machine learning.">
    <entity charOffset="83-87" id="s15.e0" ontology_id="2064" text="HER2" type="GENE"/>
    <entity charOffset="99-105" id="s15.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s15.e0" e2="s15.e1" id="s15.p0" relation="true"/>
  </sentence>
  <sentence id="s16" text="To identify network-based pathways involved in the susceptibility to the ER/PR-ve HER2+ve breast cancer subtype, the NRF1 transcriptional regulatory genome-wide landscape was analyzed using the approach consisting of a systematic integration of ChIP DNA-seq, RNA-Microarray, NRF1 protein-DNA motif binding, signal pathway analysis, and Bayesian machine learning.">
    <entity charOffset="99-105" id="s16.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="119-123" id="s16.e1" ontology_id="4779" text="NRF1" type="GENE"/>
    <pair e1="s16.e0" e2="s16.e1" id="s16.p0" relation="true"/>
  </sentence>
  <sentence id="s17" text="Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including EGFR, IGFR, and E2F1, are under transcriptional control of NRF1.">
    <entity charOffset="50-54" id="s17.e0" ontology_id="2064" text="HER2" type="GENE"/>
    <entity charOffset="63-69" id="s17.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s17.e0" e2="s17.e1" id="s17.p0" relation="true"/>
  </sentence>
  <sentence id="s18" text="Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including EGFR, IGFR, and E2F1, are under transcriptional control of NRF1.">
    <entity charOffset="63-69" id="s18.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="161-165" id="s18.e1" ontology_id="4779" text="NRF1" type="GENE"/>
    <pair e1="s18.e0" e2="s18.e1" id="s18.p0" relation="true"/>
  </sentence>
  <sentence id="s19" text="Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including EGFR, IGFR, and E2F1, are under transcriptional control of NRF1.">
    <entity charOffset="63-69" id="s19.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="108-112" id="s19.e1" ontology_id="3480" text="IGFR" type="GENE"/>
    <pair e1="s19.e0" e2="s19.e1" id="s19.p0" relation="true"/>
  </sentence>
  <sentence id="s20" text="Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including EGFR, IGFR, and E2F1, are under transcriptional control of NRF1.">
    <entity charOffset="63-69" id="s20.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="118-122" id="s20.e1" ontology_id="1869" text="E2F1" type="GENE"/>
    <pair e1="s20.e0" e2="s20.e1" id="s20.p0" relation="true"/>
  </sentence>
  <sentence id="s21" text="By pathway analysis, key breast cancer hallmark genes of epithelial-mesenchymal transition, stemness, cell apoptosis, cell cycle regulation, chromosomal integrity, and DNA damage/repair were highly enriched with NRF1 motifs.">
    <entity charOffset="32-38" id="s21.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="212-216" id="s21.e1" ontology_id="4779" text="NRF1" type="GENE"/>
    <pair e1="s21.e0" e2="s21.e1" id="s21.p0" relation="true"/>
  </sentence>
  <sentence id="s22" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="76-80" id="s22.e0" ontology_id="4779" text="NRF1" type="GENE"/>
    <entity charOffset="470-476" id="s22.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s22.e0" e2="s22.e1" id="s22.p0" relation="true"/>
  </sentence>
  <sentence id="s23" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="136-141" id="s23.e0" ontology_id="2260" text="FGFR1" type="GENE"/>
    <entity charOffset="470-476" id="s23.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s23.e0" e2="s23.e1" id="s23.p0" relation="false"/>
  </sentence>
  <sentence id="s24" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="143-148" id="s24.e0" ontology_id="3480" text="IGF1R" type="GENE"/>
    <entity charOffset="470-476" id="s24.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s24.e0" e2="s24.e1" id="s24.p0" relation="false"/>
  </sentence>
  <sentence id="s25" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="183-187" id="s25.e0" ontology_id="1869" text="E2F1" type="GENE"/>
    <entity charOffset="470-476" id="s25.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s25.e0" e2="s25.e1" id="s25.p0" relation="true"/>
  </sentence>
  <sentence id="s26" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="214-218" id="s26.e0" ontology_id="2885" text="GRB2" type="GENE"/>
    <entity charOffset="470-476" id="s26.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s26.e0" e2="s26.e1" id="s26.p0" relation="true"/>
  </sentence>
  <sentence id="s27" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="220-225" id="s27.e0" ontology_id="5594" text="MAPK1" type="GENE"/>
    <entity charOffset="470-476" id="s27.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s27.e0" e2="s27.e1" id="s27.p0" relation="true"/>
  </sentence>
  <sentence id="s28" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="227-231" id="s28.e0" ontology_id="5290" text="PI3K" type="GENE"/>
    <entity charOffset="470-476" id="s28.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s28.e0" e2="s28.e1" id="s28.p0" relation="true"/>
  </sentence>
  <sentence id="s29" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="259-265" id="s29.e0" ontology_id="5293" text="PIK3CD" type="GENE"/>
    <entity charOffset="470-476" id="s29.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s29.e0" e2="s29.e1" id="s29.p0" relation="true"/>
  </sentence>
  <sentence id="s30" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="267-273" id="s30.e0" ontology_id="5295" text="PIK3R1" type="GENE"/>
    <entity charOffset="470-476" id="s30.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s30.e0" e2="s30.e1" id="s30.p0" relation="true"/>
  </sentence>
  <sentence id="s31" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="275-281" id="s31.e0" ontology_id="8503" text="PIK3R3" type="GENE"/>
    <entity charOffset="470-476" id="s31.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s31.e0" e2="s31.e1" id="s31.p0" relation="true"/>
  </sentence>
  <sentence id="s32" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="283-290" id="s32.e0" ontology_id="6199" text="RPS6KB2" type="GENE"/>
    <entity charOffset="470-476" id="s32.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s32.e0" e2="s32.e1" id="s32.p0" relation="true"/>
  </sentence>
  <sentence id="s33" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="350-354" id="s33.e0" ontology_id="1643" text="DDB2" type="GENE"/>
    <entity charOffset="470-476" id="s33.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s33.e0" e2="s33.e1" id="s33.p0" relation="true"/>
  </sentence>
  <sentence id="s34" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="470-476" id="s34.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="505-509" id="s34.e1" ontology_id="2064" text="HER2" type="GENE"/>
    <pair e1="s34.e0" e2="s34.e1" id="s34.p0" relation="true"/>
  </sentence>
  <sentence id="s35" text="Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.">
    <entity charOffset="85-91" id="s35.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="134-138" id="s35.e1" ontology_id="4779" text="NRF1" type="GENE"/>
    <pair e1="s35.e0" e2="s35.e1" id="s35.p0" relation="true"/>
  </sentence>
  <sentence id="s36" text="Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.">
    <entity charOffset="85-91" id="s36.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="245-250" id="s36.e1" ontology_id="2260" text="FGFR1" type="GENE"/>
    <pair e1="s36.e0" e2="s36.e1" id="s36.p0" relation="true"/>
  </sentence>
  <sentence id="s37" text="Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.">
    <entity charOffset="85-91" id="s37.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="236-240" id="s37.e1" ontology_id="1869" text="E2F1" type="GENE"/>
    <pair e1="s37.e0" e2="s37.e1" id="s37.p0" relation="false"/>
  </sentence>
  <sentence id="s38" text="Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.">
    <entity charOffset="85-91" id="s38.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="198-203" id="s38.e1" ontology_id="2932" text="GSK3B" type="GENE"/>
    <pair e1="s38.e0" e2="s38.e1" id="s38.p0" relation="true"/>
  </sentence>
  <sentence id="s39" text="In summary, our findings suggest novel roles of NRF1 and its regulatory networks in susceptibility to the ER/PR-ve HER2+ve aggressive breast cancer subtype.">
    <entity charOffset="48-52" id="s39.e0" ontology_id="4779" text="NRF1" type="GENE"/>
    <entity charOffset="143-149" id="s39.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s39.e0" e2="s39.e1" id="s39.p0" relation="true"/>
  </sentence>
  <sentence id="s40" text="In summary, our findings suggest novel roles of NRF1 and its regulatory networks in susceptibility to the ER/PR-ve HER2+ve aggressive breast cancer subtype.">
    <entity charOffset="116-120" id="s40.e0" ontology_id="2064" text="HER2" type="GENE"/>
    <entity charOffset="143-149" id="s40.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s40.e0" e2="s40.e1" id="s40.p0" relation="true"/>
  </sentence>
  <sentence id="s41" text="Clinical confirmation of our machine learned Bayesian networks will have significant impact on our understanding of the role of NRF1 as a valuable biomarker for breast cancer diagnosis and prognosis as well as provide strong rationale for future studies to develop NRF1 signaling-based therapeutics to target HER2+ breast cancer">
    <entity charOffset="168-174" id="s41.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="309-313" id="s41.e1" ontology_id="2064" text="HER2" type="GENE"/>
    <pair e1="s41.e0" e2="s41.e1" id="s41.p0" relation="true"/>
  </sentence>
  <sentence id="s42" text="Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was LYST (10%), which may represent a novel cancer gene in chordoma.Chordoma is a rare often incurable malignant bone tumour.">
    <entity charOffset="106-110" id="s42.e0" ontology_id="1130" text="LYST" type="GENE"/>
    <entity charOffset="220-226" id="s42.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s42.e0" e2="s42.e1" id="s42.p0" relation="true"/>
  </sentence>
  <sentence id="s43" text="Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was LYST (10%), which may represent a novel cancer gene in chordoma.Chordoma is a rare often incurable malignant bone tumour.">
    <entity charOffset="106-110" id="s43.e0" ontology_id="1130" text="LYST" type="GENE"/>
    <entity charOffset="161-169" id="s43.e1" ontology_id="HP_0010762" text="chordoma" type="HP"/>
    <pair e1="s43.e0" e2="s43.e1" id="s43.p0" relation="true"/>
  </sentence>
  <sentence id="s44" text="Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was LYST (10%), which may represent a novel cancer gene in chordoma.Chordoma is a rare often incurable malignant bone tumour.">
    <entity charOffset="106-110" id="s44.e0" ontology_id="1130" text="LYST" type="GENE"/>
    <entity charOffset="146-152" id="s44.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s44.e0" e2="s44.e1" id="s44.p0" relation="true"/>
  </sentence>
  <sentence id="s45" text="Here, the authors investigate driver mutations of sporadic chordoma in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in LYST, a potential novel cancer gene in chordoma">
    <entity charOffset="50-58" id="s45.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="200-204" id="s45.e1" ontology_id="1130" text="LYST" type="GENE"/>
    <pair e1="s45.e0" e2="s45.e1" id="s45.p0" relation="true"/>
  </sentence>
  <sentence id="s46" text="Here, the authors investigate driver mutations of sporadic chordoma in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in LYST, a potential novel cancer gene in chordoma">
    <entity charOffset="59-67" id="s46.e0" ontology_id="HP_0010762" text="chordoma" type="HP"/>
    <entity charOffset="200-204" id="s46.e1" ontology_id="1130" text="LYST" type="GENE"/>
    <pair e1="s46.e0" e2="s46.e1" id="s46.p0" relation="true"/>
  </sentence>
  <sentence id="s47" text="Here, the authors investigate driver mutations of sporadic chordoma in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in LYST, a potential novel cancer gene in chordoma">
    <entity charOffset="200-204" id="s47.e0" ontology_id="1130" text="LYST" type="GENE"/>
    <entity charOffset="224-230" id="s47.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s47.e0" e2="s47.e1" id="s47.p0" relation="true"/>
  </sentence>
  <sentence id="s48" text="Studies in humans with autosomal recessive CARD9 deficiency have indicated a highly specific role for this molecule in the activation of antifungal immune responses in the central nervous system, the oral mucosa, and the skin.">
    <entity charOffset="23-42" id="s48.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="43-48" id="s48.e1" ontology_id="64170" text="CARD9" type="GENE"/>
    <pair e1="s48.e0" e2="s48.e1" id="s48.p0" relation="true"/>
  </sentence>
  <sentence id="s49" text="Studies in humans with autosomal recessive CARD9 deficiency have indicated a highly specific role for this molecule in the activation of antifungal immune responses in the central nervous system, the oral mucosa, and the skin.">
    <entity charOffset="43-48" id="s49.e0" ontology_id="64170" text="CARD9" type="GENE"/>
    <entity charOffset="172-179" id="s49.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s49.e0" e2="s49.e1" id="s49.p0" relation="true"/>
  </sentence>
  <sentence id="s50" text="Moreover, CARD9-dependent functions have recently been indicated to modulate the development of autoimmunity, inflammatory bowel diseases, and cancer.">
    <entity charOffset="10-15" id="s50.e0" ontology_id="64170" text="CARD9" type="GENE"/>
    <entity charOffset="143-149" id="s50.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s50.e0" e2="s50.e1" id="s50.p0" relation="true"/>
  </sentence>
  <sentence id="s51" text="Mutations in peripherin 2 (PRPH2), also known as retinal degeneration slow/RDS, lead to various retinal degenerations including retinitis pigmentosa (RP) and macular/pattern dystrophy (MD/PD).">
    <entity charOffset="27-32" id="s51.e0" ontology_id="5961" text="PRPH2" type="GENE"/>
    <entity charOffset="49-69" id="s51.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s51.e0" e2="s51.e1" id="s51.p0" relation="true"/>
  </sentence>
  <sentence id="s52" text="We asked whether ROM1 could modify the phenotype of a PRPH2 mutation associated with a high degree of intrafamilial phenotypic heterogeneity: Y141C.">
    <entity charOffset="17-21" id="s52.e0" ontology_id="6094" text="ROM1" type="GENE"/>
    <entity charOffset="127-140" id="s52.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s52.e0" e2="s52.e1" id="s52.p0" relation="true"/>
  </sentence>
  <sentence id="s53" text="We asked whether ROM1 could modify the phenotype of a PRPH2 mutation associated with a high degree of intrafamilial phenotypic heterogeneity: Y141C.">
    <entity charOffset="54-59" id="s53.e0" ontology_id="5961" text="PRPH2" type="GENE"/>
    <entity charOffset="127-140" id="s53.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s53.e0" e2="s53.e1" id="s53.p0" relation="true"/>
  </sentence>
  <sentence id="s54" text="Familial amyloid polyneuropathy (FAP) is a rare autosomal dominant disorder characterized by amyloid accumulation in the peripheral nerves and other organs, including the heart, kidney, and eyes.">
    <entity charOffset="33-36" id="s54.e0" ontology_id="2191" text="FAP" type="GENE"/>
    <entity charOffset="121-131" id="s54.e1" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <pair e1="s54.e0" e2="s54.e1" id="s54.p0" relation="true"/>
  </sentence>
  <sentence id="s55" text="Forty unique IFNGR1 mutations have been reported and they exert either an autosomal dominant or an autosomal recessive effect.">
    <entity charOffset="13-16" id="s55.e0" ontology_id="3439" text="IFN" type="GENE"/>
    <entity charOffset="99-118" id="s55.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s55.e0" e2="s55.e1" id="s55.p0" relation="true"/>
  </sentence>
  <sentence id="s56" text="MTP deficiency should be considered in patients with the combination of peripheral neuropathy and recurrent rhabdomyolysis">
    <entity charOffset="0-3" id="s56.e0" ontology_id="4547" text="MTP" type="GENE"/>
    <entity charOffset="83-93" id="s56.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s56.e0" e2="s56.e1" id="s56.p0" relation="true"/>
  </sentence>
  <sentence id="s57" text="Phenotypically, bs mice exhibit nuclear cataracts and male infertility; genetic analyses assigned the bs locus to mouse chromosome 2.">
    <entity charOffset="19-23" id="s57.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="40-49" id="s57.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s57.e0" e2="s57.e1" id="s57.p0" relation="true"/>
  </sentence>
  <sentence id="s58" text="Based on the function of TBC1D20 as a RABGAP and the bs cataract and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and RAB18.">
    <entity charOffset="25-32" id="s58.e0" ontology_id="128637" text="TBC1D20" type="GENE"/>
    <entity charOffset="56-64" id="s58.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s58.e0" e2="s58.e1" id="s58.p0" relation="true"/>
  </sentence>
  <sentence id="s59" text="Based on the function of TBC1D20 as a RABGAP and the bs cataract and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and RAB18.">
    <entity charOffset="41-44" id="s59.e0" ontology_id="5921" text="GAP" type="GENE"/>
    <entity charOffset="56-64" id="s59.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s59.e0" e2="s59.e1" id="s59.p0" relation="true"/>
  </sentence>
  <sentence id="s60" text="Based on the function of TBC1D20 as a RABGAP and the bs cataract and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and RAB18.">
    <entity charOffset="56-64" id="s60.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="330-334" id="s60.e1" ontology_id="5861" text="RAB1" type="GENE"/>
    <pair e1="s60.e0" e2="s60.e1" id="s60.p0" relation="true"/>
  </sentence>
  <sentence id="s61" text="An oncogenic role for CHD4, a NuRD component, is defined for initiating and supporting tumor suppressor gene (TSG) silencing in human colorectal cancer.">
    <entity charOffset="22-26" id="s61.e0" ontology_id="1108" text="CHD4" type="GENE"/>
    <entity charOffset="87-92" id="s61.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s61.e0" e2="s61.e1" id="s61.p0" relation="true"/>
  </sentence>
  <sentence id="s62" text="An oncogenic role for CHD4, a NuRD component, is defined for initiating and supporting tumor suppressor gene (TSG) silencing in human colorectal cancer.">
    <entity charOffset="22-26" id="s62.e0" ontology_id="1108" text="CHD4" type="GENE"/>
    <entity charOffset="145-151" id="s62.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s62.e0" e2="s62.e1" id="s62.p0" relation="true"/>
  </sentence>
  <sentence id="s63" text="An oncogenic role for CHD4, a NuRD component, is defined for initiating and supporting tumor suppressor gene (TSG) silencing in human colorectal cancer.">
    <entity charOffset="87-92" id="s63.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="110-113" id="s63.e1" ontology_id="57045" text="TSG" type="GENE"/>
    <pair e1="s63.e0" e2="s63.e1" id="s63.p0" relation="true"/>
  </sentence>
  <sentence id="s64" text="CHD4 knockdown activates silenced TSGs, revealing their role for blunting colorectal cancer cell proliferation, invasion, and metastases.">
    <entity charOffset="0-4" id="s64.e0" ontology_id="1108" text="CHD4" type="GENE"/>
    <entity charOffset="85-91" id="s64.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s64.e0" e2="s64.e1" id="s64.p0" relation="true"/>
  </sentence>
  <sentence id="s65" text="X-linked Myopathy with Excessive Autophagy (XMEA) affects proximal muscles of the lower extremities and follows a progressive course reminiscent of muscular dystrophy.">
    <entity charOffset="44-48" id="s65.e0" ontology_id="203547" text="XMEA" type="GENE"/>
    <entity charOffset="148-166" id="s65.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s65.e0" e2="s65.e1" id="s65.p0" relation="true"/>
  </sentence>
  <sentence id="s66" text="Rescue of KLHL9 expression induced proteasomal degradation of C/EBP proteins, abrogated the mesenchymal signature, and reduced tumor viability in vitro and in vivo.">
    <entity charOffset="10-15" id="s66.e0" ontology_id="55958" text="KLHL9" type="GENE"/>
    <entity charOffset="127-132" id="s66.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s66.e0" e2="s66.e1" id="s66.p0" relation="true"/>
  </sentence>
  <sentence id="s67" text="The fatty acid (FA) composition of red blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer type or therapy.">
    <entity charOffset="4-7" id="s67.e0" ontology_id="948" text="fat" type="GENE"/>
    <entity charOffset="82-88" id="s67.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s67.e0" e2="s67.e1" id="s67.p0" relation="true"/>
  </sentence>
  <sentence id="s68" text="The fatty acid (FA) composition of red blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer type or therapy.">
    <entity charOffset="4-7" id="s68.e0" ontology_id="948" text="fat" type="GENE"/>
    <entity charOffset="110-115" id="s68.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s68.e0" e2="s68.e1" id="s68.p0" relation="true"/>
  </sentence>
  <sentence id="s69" text="The fatty acid (FA) composition of red blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer type or therapy.">
    <entity charOffset="110-115" id="s69.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="152-156" id="s69.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s69.e0" e2="s69.e1" id="s69.p0" relation="true"/>
  </sentence>
  <sentence id="s70" text="To date, researchers have discovered that Nrf2 deletion results in high susceptibility and severity of insults in various models of respiratory diseases, including bronchopulmonary dysplasia (BPD), respiratory infections, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, idiopathic pulmonary fibrosis (IPF), and lung cancer.">
    <entity charOffset="305-309" id="s70.e0" ontology_id="372" text="COPD" type="GENE"/>
    <entity charOffset="366-372" id="s70.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s70.e0" e2="s70.e1" id="s70.p0" relation="true"/>
  </sentence>
  <sentence id="s71" text="Ano1 is a Ca(2+) activated Cl(-) channel that is related to head and neck cancer, often caused by human papilloma virus (HPV) infection.">
    <entity charOffset="0-4" id="s71.e0" ontology_id="55107" text="Ano1" type="GENE"/>
    <entity charOffset="74-80" id="s71.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s71.e0" e2="s71.e1" id="s71.p0" relation="true"/>
  </sentence>
  <sentence id="s72" text="Ano1 is a Ca(2+) activated Cl(-) channel that is related to head and neck cancer, often caused by human papilloma virus (HPV) infection.">
    <entity charOffset="0-4" id="s72.e0" ontology_id="55107" text="Ano1" type="GENE"/>
    <entity charOffset="104-113" id="s72.e1" ontology_id="HP_0012740" text="papilloma" type="HP"/>
    <pair e1="s72.e0" e2="s72.e1" id="s72.p0" relation="true"/>
  </sentence>
  <sentence id="s73" text="Because TMC8 is required to lower cytosolic Zn(2+) concentrations by the Zn(2+) transporter ZnT-1, we hypothesize that HPV infections and cancer caused by mutations in TMC8 are related to upregulated Zn(2+)/Ca(2+) signaling and activation of Ano1.">
    <entity charOffset="8-11" id="s73.e0" ontology_id="3703" text="TMC" type="GENE"/>
    <entity charOffset="138-144" id="s73.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s73.e0" e2="s73.e1" id="s73.p0" relation="true"/>
  </sentence>
  <sentence id="s74" text="Because TMC8 is required to lower cytosolic Zn(2+) concentrations by the Zn(2+) transporter ZnT-1, we hypothesize that HPV infections and cancer caused by mutations in TMC8 are related to upregulated Zn(2+)/Ca(2+) signaling and activation of Ano1.">
    <entity charOffset="138-144" id="s74.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="242-246" id="s74.e1" ontology_id="55107" text="Ano1" type="GENE"/>
    <pair e1="s74.e0" e2="s74.e1" id="s74.p0" relation="true"/>
  </sentence>
  <sentence id="s75" text="VLCFA-containing lipids accumulate in X-ALD patients, although the effect of ABCD1-deficiency on each lipid species in the central nervous system has not been fully characterized.">
    <entity charOffset="77-82" id="s75.e0" ontology_id="215" text="ABCD1" type="GENE"/>
    <entity charOffset="123-130" id="s75.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s75.e0" e2="s75.e1" id="s75.p0" relation="true"/>
  </sentence>
  <sentence id="s76" text="We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor 2 subunit (CHRNB2) found in patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).">
    <entity charOffset="212-221" id="s76.e0" ontology_id="HP_0025301" text="nocturnal" type="HP"/>
    <entity charOffset="230-234" id="s76.e1" ontology_id="84335" text="lobe" type="GENE"/>
    <pair e1="s76.e0" e2="s76.e1" id="s76.p0" relation="false"/>
  </sentence>
  <sentence id="s77" text="Our analyses identified 15 CpG sites within the APC 1A promoter that were significantly hypermethylated and 14 CpG loci within the NFATC1 gene body that were significantly hypomethylated (pLIS&amp;lt;1  10&lt;sup&gt;-5&lt;/sup&gt; ) in the tumours of active smokers.">
    <entity charOffset="131-137" id="s77.e0" ontology_id="4772" text="NFATC1" type="GENE"/>
    <entity charOffset="227-233" id="s77.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s77.e0" e2="s77.e1" id="s77.p0" relation="true"/>
  </sentence>
  <sentence id="s78" text="The APC 1A promoter was hypermethylated in 7 of 36 tumours from never-smokers (19%), 12 of 47 tumours from former smokers (26%), and 8 of 13 tumours from active smokers (62%).">
    <entity charOffset="4-7" id="s78.e0" ontology_id="324" text="APC" type="GENE"/>
    <entity charOffset="51-57" id="s78.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s78.e0" e2="s78.e1" id="s78.p0" relation="true"/>
  </sentence>
  <sentence id="s79" text="On the other hand, intraperitoneal administration of PQQ exerted protective effects on rats that had received rotenone injection into the medial forebrain bundle through decreasing the apomorphine-evoked rotation, inhibiting neuronal loss and TH down-regulation in SNc, increasing the antioxidative ability, and regulating intracellular expressions of Ndufs1 and Ndufs 4.">
    <entity charOffset="225-238" id="s79.e0" ontology_id="HP_0002529" text="neuronal loss" type="HP"/>
    <entity charOffset="352-358" id="s79.e1" ontology_id="4719" text="Ndufs1" type="GENE"/>
    <pair e1="s79.e0" e2="s79.e1" id="s79.p0" relation="true"/>
  </sentence>
  <sentence id="s80" text="In vitro and invivo (a subcutaneous BALB/c nude mouse model) studies showed that exosomal ZIP4 can significantly promote pancreatic cancer growth.">
    <entity charOffset="91-95" id="s80.e0" ontology_id="55630" text="ZIP4" type="GENE"/>
    <entity charOffset="133-139" id="s80.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s80.e0" e2="s80.e1" id="s80.p0" relation="true"/>
  </sentence>
  <sentence id="s81" text="By combining meta-analysis results and identification of two unrelated HCM patients with homozygous CSRP3 truncating variants, we suggest that the association of CSRP3 as a validated HCM-causing gene require additional studies and those CSRP3 variants could result in HCM with an autosomal recessive inheritance rather than with an autosomal dominant transmission as usually reported on HCM (OMIM 612124)">
    <entity charOffset="100-105" id="s81.e0" ontology_id="8048" text="CSRP3" type="GENE"/>
    <entity charOffset="300-311" id="s81.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s81.e0" e2="s81.e1" id="s81.p0" relation="true"/>
  </sentence>
  <sentence id="s82" text="However, the prognostic value of ALDH5A1 in ovarian cancer remains unclear.">
    <entity charOffset="33-40" id="s82.e0" ontology_id="7915" text="ALDH5A1" type="GENE"/>
    <entity charOffset="52-58" id="s82.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s82.e0" e2="s82.e1" id="s82.p0" relation="false"/>
  </sentence>
  <sentence id="s83" text="In survival analyses, we found that ALDH5A1 was positively linked to prognosis in patients with OC, particularly in those with serous ovarian cancer (SOC).">
    <entity charOffset="142-148" id="s83.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="150-153" id="s83.e1" ontology_id="91544" text="SOC" type="GENE"/>
    <pair e1="s83.e0" e2="s83.e1" id="s83.p0" relation="true"/>
  </sentence>
  <sentence id="s84" text="Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma (CMT4B2, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.">
    <entity charOffset="28-32" id="s84.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="102-115" id="s84.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s84.e0" e2="s84.e1" id="s84.p0" relation="true"/>
  </sentence>
  <sentence id="s85" text="Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma (CMT4B2, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.">
    <entity charOffset="54-62" id="s85.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="64-70" id="s85.e1" ontology_id="81846" text="CMT4B2" type="GENE"/>
    <pair e1="s85.e0" e2="s85.e1" id="s85.p0" relation="true"/>
  </sentence>
  <sentence id="s86" text="Alterations of its normal function may contribute to two different phenotypes: juvenile amyotrophic lateral sclerosis (ALS 16) and distal hereditary motor neuropathies (dHMN).">
    <entity charOffset="119-122" id="s86.e0" ontology_id="3483" text="ALS" type="GENE"/>
    <entity charOffset="131-137" id="s86.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s86.e0" e2="s86.e1" id="s86.p0" relation="true"/>
  </sentence>
  <sentence id="s87" text="Direct sequencing revealed a G to T transition (c.886G&amp;gt;T) in exon 9 of the fourpointone, ezrin, radixin, moesin domaincontaining 7 (FRMD7) gene, which resulted in a conservative substitution of glycine to cysteine at codon 296 (p.G296C), leading to idiopathic congenital nystagmus in the two affected brothers.">
    <entity charOffset="138-143" id="s87.e0" ontology_id="90167" text="FRMD7" type="GENE"/>
    <entity charOffset="277-286" id="s87.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s87.e0" e2="s87.e1" id="s87.p0" relation="true"/>
  </sentence>
  <sentence id="s88" text="A moderate to severe reduction (&amp;gt;50%) in PRODH activity resulting from recessive deletions and/or missense mutations has been shown to cause type 1 hyperprolinemia (HPI).">
    <entity charOffset="44-49" id="s88.e0" ontology_id="5625" text="PRODH" type="GENE"/>
    <entity charOffset="151-166" id="s88.e1" ontology_id="HP_0008358" text="hyperprolinemia" type="HP"/>
    <pair e1="s88.e0" e2="s88.e1" id="s88.p0" relation="true"/>
  </sentence>
  <sentence id="s89" text="Here we studied the frequency of a recurrent small 22q11.2 deletion encompassing PRODH and the neighboring DGCR6 gene in three case-control studies, one comprising HPI patients (n=83), and the other two comprising autism spectrum disorder (ASD) patients (total of n=2800), analyzed with high-resolution microarrays.">
    <entity charOffset="81-86" id="s89.e0" ontology_id="5625" text="PRODH" type="GENE"/>
    <entity charOffset="216-222" id="s89.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s89.e0" e2="s89.e1" id="s89.p0" relation="true"/>
  </sentence>
  <sentence id="s90" text="Here we studied the frequency of a recurrent small 22q11.2 deletion encompassing PRODH and the neighboring DGCR6 gene in three case-control studies, one comprising HPI patients (n=83), and the other two comprising autism spectrum disorder (ASD) patients (total of n=2800), analyzed with high-resolution microarrays.">
    <entity charOffset="107-112" id="s90.e0" ontology_id="8214" text="DGCR6" type="GENE"/>
    <entity charOffset="216-222" id="s90.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s90.e0" e2="s90.e1" id="s90.p0" relation="true"/>
  </sentence>
  <sentence id="s91" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.">
    <entity charOffset="79-97" id="s91.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="106-112" id="s91.e1" ontology_id="11005" text="SPINK5" type="GENE"/>
    <pair e1="s91.e0" e2="s91.e1" id="s91.p0" relation="true"/>
  </sentence>
  <sentence id="s92" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.">
    <entity charOffset="79-97" id="s92.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="114-119" id="s92.e1" ontology_id="2068" text="ERCC2" type="GENE"/>
    <pair e1="s92.e0" e2="s92.e1" id="s92.p0" relation="true"/>
  </sentence>
  <sentence id="s93" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.">
    <entity charOffset="79-97" id="s93.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="128-134" id="s93.e1" ontology_id="404672" text="GTF2H5" type="GENE"/>
    <pair e1="s93.e0" e2="s93.e1" id="s93.p0" relation="true"/>
  </sentence>
  <sentence id="s94" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.">
    <entity charOffset="79-97" id="s94.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="136-142" id="s94.e1" ontology_id="136647" text="MPLKIP" type="GENE"/>
    <pair e1="s94.e0" e2="s94.e1" id="s94.p0" relation="true"/>
  </sentence>
  <sentence id="s95" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.">
    <entity charOffset="79-97" id="s95.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="150-155" id="s95.e1" ontology_id="9076" text="CLDN1" type="GENE"/>
    <pair e1="s95.e0" e2="s95.e1" id="s95.p0" relation="true"/>
  </sentence>
  <sentence id="s96" text="A GARP complex mutation analogous to a VPS53 allele causing progressive cerebello-cerebral atrophy type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.">
    <entity charOffset="82-98" id="s96.e0" ontology_id="HP_0002059" text="cerebral atrophy" type="HP"/>
    <entity charOffset="99-103" id="s96.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s96.e0" e2="s96.e1" id="s96.p0" relation="true"/>
  </sentence>
  <sentence id="s97" text="Through whole-exome sequencing in six unrelated nonconsanguineous families having a sporadic case of intellectual disability, we identified six novel de novo truncating mutations in CHAMP1: c.1880C&amp;gt;G p.(Ser627*), c.1489C&amp;gt;T; p.(Arg497*), c.1876_1877delAG; p.(Ser626Leufs*4), c.1043G&amp;gt;A; p.(Trp348*), c.1002G&amp;gt;A; p.(Trp334*), and c.958_959delCC; p.(Pro320*).">
    <entity charOffset="101-124" id="s97.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="182-188" id="s97.e1" ontology_id="283489" text="CHAMP1" type="GENE"/>
    <pair e1="s97.e0" e2="s97.e1" id="s97.p0" relation="true"/>
  </sentence>
  <sentence id="s98" text="These data suggest a pathogenic mechanism of the CHAMP1-associated intellectual disability syndrome mediated by direct interacting partners of CHAMP1, several of which are involved in chromo/kinetochore-related disorders.">
    <entity charOffset="49-55" id="s98.e0" ontology_id="283489" text="CHAMP1" type="GENE"/>
    <entity charOffset="67-90" id="s98.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s98.e0" e2="s98.e1" id="s98.p0" relation="true"/>
  </sentence>
  <sentence id="s99" text="These findings implicate for the first time perturbed TGF- signaling in the genesis of retinal dystrophies, support the study of related morphogenetic genes for comparable roles in retinal disease and may offer additional therapeutic opportunities for genetically heterogeneous disorders presently only treatable with gene therapy">
    <entity charOffset="77-84" id="s99.e0" ontology_id="27022" text="genesis" type="GENE"/>
    <entity charOffset="265-278" id="s99.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s99.e0" e2="s99.e1" id="s99.p0" relation="true"/>
  </sentence>
  <sentence id="s100" text="Brain malformations described in association with 22q11.2 deletion syndrome include polymicrogyria, cerebellar hypoplasia, megacisterna magna, and agenesis of the corpus callosum (ACC), although these are rare.">
    <entity charOffset="147-178" id="s100.e0" ontology_id="HP_0001274" text="agenesis of the corpus callosum" type="HP"/>
    <entity charOffset="180-183" id="s100.e1" ontology_id="31" text="ACC" type="GENE"/>
    <pair e1="s100.e0" e2="s100.e1" id="s100.p0" relation="true"/>
  </sentence>
  <sentence id="s101" text="Preclinical studies have demonstrated that EMP2 is associated with disease prognosis in a number of human cancers, including glioblastoma.">
    <entity charOffset="43-47" id="s101.e0" ontology_id="2013" text="EMP2" type="GENE"/>
    <entity charOffset="125-137" id="s101.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s101.e0" e2="s101.e1" id="s101.p0" relation="true"/>
  </sentence>
  <sentence id="s102" text="Preclinical studies have demonstrated that EMP2 is associated with disease prognosis in a number of human cancers, including glioblastoma.">
    <entity charOffset="43-47" id="s102.e0" ontology_id="2013" text="EMP2" type="GENE"/>
    <entity charOffset="106-112" id="s102.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s102.e0" e2="s102.e1" id="s102.p0" relation="true"/>
  </sentence>
  <sentence id="s103" text="Translational research suggests that EMP2 may be targeted with antibodies to improve tumor control and survival in a variety of murine models and cancer types.">
    <entity charOffset="37-41" id="s103.e0" ontology_id="2013" text="EMP2" type="GENE"/>
    <entity charOffset="85-90" id="s103.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s103.e0" e2="s103.e1" id="s103.p0" relation="true"/>
  </sentence>
  <sentence id="s104" text="In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, LFNG, HES7) and autosomal dominant (TBX6) inheritance.">
    <entity charOffset="103-122" id="s104.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="137-141" id="s104.e1" ontology_id="3955" text="LFNG" type="GENE"/>
    <pair e1="s104.e0" e2="s104.e1" id="s104.p0" relation="true"/>
  </sentence>
  <sentence id="s105" text="In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, LFNG, HES7) and autosomal dominant (TBX6) inheritance.">
    <entity charOffset="103-122" id="s105.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="143-147" id="s105.e1" ontology_id="84667" text="HES7" type="GENE"/>
    <pair e1="s105.e0" e2="s105.e1" id="s105.p0" relation="true"/>
  </sentence>
  <sentence id="s106" text="A previously reported CLCN2 gene for epilepsy was excluded as the disease-causing gene in the family by mutational analysis of all exons and exon-intron boundaries of CLCN2 and by haplotype analysis.">
    <entity charOffset="22-27" id="s106.e0" ontology_id="1181" text="CLCN2" type="GENE"/>
    <entity charOffset="37-45" id="s106.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s106.e0" e2="s106.e1" id="s106.p0" relation="true"/>
  </sentence>
  <sentence id="s107" text="Herein, we newly identified that truncated form of CHL1 is produced and released from lung tumor tissue in a mouse model expressing human EML4-ALK fusion gene.">
    <entity charOffset="51-55" id="s107.e0" ontology_id="1663" text="CHL1" type="GENE"/>
    <entity charOffset="91-96" id="s107.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s107.e0" e2="s107.e1" id="s107.p0" relation="true"/>
  </sentence>
  <sentence id="s108" text="Considering these results, the measurement of circulating CHL1 level may contribute to assess a tumor progression in human lung tumor patients">
    <entity charOffset="58-62" id="s108.e0" ontology_id="1663" text="CHL1" type="GENE"/>
    <entity charOffset="96-101" id="s108.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s108.e0" e2="s108.e1" id="s108.p0" relation="true"/>
  </sentence>
  <sentence id="s109" text="Tricho-hepato-enteric syndrome (SD/THE) and Multiple intestinal atresia with combined immune deficiency (MIA-CID) are autosomal recessive disorders that present immunological and gastrointestinal features.">
    <entity charOffset="105-108" id="s109.e0" ontology_id="8190" text="MIA" type="GENE"/>
    <entity charOffset="118-137" id="s109.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s109.e0" e2="s109.e1" id="s109.p0" relation="true"/>
  </sentence>
  <sentence id="s110" text="There are two different phenotypes of patients with TTC7A mutations: the severe form, caused by null mutations and leading to the classical MIA-CID; and the mild form, caused by missense mutations and leading to predominant features of VEO-IBD, less severe immunological involvement and hair abnormalities.">
    <entity charOffset="140-143" id="s110.e0" ontology_id="8190" text="MIA" type="GENE"/>
    <entity charOffset="287-305" id="s110.e1" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <pair e1="s110.e0" e2="s110.e1" id="s110.p0" relation="false"/>
  </sentence>
  <sentence id="s111" text="We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="30-35" id="s111.e0" ontology_id="57217" text="TTC7A" type="GENE"/>
    <entity charOffset="172-190" id="s111.e1" ontology_id="HP_0011100" text="intestinal atresia" type="HP"/>
    <pair e1="s111.e0" e2="s111.e1" id="s111.p0" relation="true"/>
  </sentence>
  <sentence id="s112" text="We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="30-35" id="s112.e0" ontology_id="57217" text="TTC7A" type="GENE"/>
    <entity charOffset="290-309" id="s112.e1" ontology_id="HP_0001392" text="liver abnormalities" type="HP"/>
    <pair e1="s112.e0" e2="s112.e1" id="s112.p0" relation="true"/>
  </sentence>
  <sentence id="s113" text="We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="30-35" id="s113.e0" ontology_id="57217" text="TTC7A" type="GENE"/>
    <entity charOffset="338-359" id="s113.e1" ontology_id="HP_0004313" text="hypogammaglobulinemia" type="HP"/>
    <pair e1="s113.e0" e2="s113.e1" id="s113.p0" relation="true"/>
  </sentence>
  <sentence id="s114" text="We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="163-166" id="s114.e0" ontology_id="8190" text="MIA" type="GENE"/>
    <entity charOffset="172-190" id="s114.e1" ontology_id="HP_0011100" text="intestinal atresia" type="HP"/>
    <pair e1="s114.e0" e2="s114.e1" id="s114.p0" relation="false"/>
  </sentence>
  <sentence id="s115" text="We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="163-166" id="s115.e0" ontology_id="8190" text="MIA" type="GENE"/>
    <entity charOffset="290-309" id="s115.e1" ontology_id="HP_0001392" text="liver abnormalities" type="HP"/>
    <pair e1="s115.e0" e2="s115.e1" id="s115.p0" relation="true"/>
  </sentence>
  <sentence id="s116" text="We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="163-166" id="s116.e0" ontology_id="8190" text="MIA" type="GENE"/>
    <entity charOffset="338-359" id="s116.e1" ontology_id="HP_0004313" text="hypogammaglobulinemia" type="HP"/>
    <pair e1="s116.e0" e2="s116.e1" id="s116.p0" relation="false"/>
  </sentence>
  <sentence id="s117" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="20-23" id="s117.e0" ontology_id="238" text="ALK" type="GENE"/>
    <entity charOffset="37-50" id="s117.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s117.e0" e2="s117.e1" id="s117.p0" relation="true"/>
  </sentence>
  <sentence id="s118" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="20-23" id="s118.e0" ontology_id="238" text="ALK" type="GENE"/>
    <entity charOffset="70-81" id="s118.e1" ontology_id="HP_0009592" text="astrocytoma" type="HP"/>
    <pair e1="s118.e0" e2="s118.e1" id="s118.p0" relation="false"/>
  </sentence>
  <sentence id="s119" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="20-23" id="s119.e0" ontology_id="238" text="ALK" type="GENE"/>
    <entity charOffset="217-233" id="s119.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s119.e0" e2="s119.e1" id="s119.p0" relation="true"/>
  </sentence>
  <sentence id="s120" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="37-50" id="s120.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="195-199" id="s120.e1" ontology_id="5077" text="PAX3" type="GENE"/>
    <pair e1="s120.e0" e2="s120.e1" id="s120.p0" relation="true"/>
  </sentence>
  <sentence id="s121" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="70-81" id="s121.e0" ontology_id="HP_0009592" text="astrocytoma" type="HP"/>
    <entity charOffset="195-199" id="s121.e1" ontology_id="5077" text="PAX3" type="GENE"/>
    <pair e1="s121.e0" e2="s121.e1" id="s121.p0" relation="false"/>
  </sentence>
  <sentence id="s122" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="102-106" id="s122.e0" ontology_id="673" text="BRAF" type="GENE"/>
    <entity charOffset="217-233" id="s122.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s122.e0" e2="s122.e1" id="s122.p0" relation="false"/>
  </sentence>
  <sentence id="s123" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="195-199" id="s123.e0" ontology_id="5077" text="PAX3" type="GENE"/>
    <entity charOffset="217-233" id="s123.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s123.e0" e2="s123.e1" id="s123.p0" relation="true"/>
  </sentence>
  <sentence id="s124" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="200-204" id="s124.e0" ontology_id="2736" text="GLI2" type="GENE"/>
    <entity charOffset="217-233" id="s124.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s124.e0" e2="s124.e1" id="s124.p0" relation="true"/>
  </sentence>
  <sentence id="s125" text="A MMP9 inhibitor significantly inhibited cell invasion and migration in ALDOA-HIF-1 axis-induced lung cancer.">
    <entity charOffset="2-6" id="s125.e0" ontology_id="4318" text="MMP9" type="GENE"/>
    <entity charOffset="103-109" id="s125.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s125.e0" e2="s125.e1" id="s125.p0" relation="true"/>
  </sentence>
  <sentence id="s126" text="In summary, our results reveal the molecular mechanism of Aldolase A in promoting lung cancer metastasis via PHD-mediated stabilization of HIF-1 and the subsequent activation of MMP9.">
    <entity charOffset="87-93" id="s126.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="179-183" id="s126.e1" ontology_id="4318" text="MMP9" type="GENE"/>
    <pair e1="s126.e0" e2="s126.e1" id="s126.p0" relation="true"/>
  </sentence>
  <sentence id="s127" text="The ALDOA-HIF-1 axis may provide a new therapeutic target for metastatic lung cancer treatment">
    <entity charOffset="4-9" id="s127.e0" ontology_id="226" text="ALDOA" type="GENE"/>
    <entity charOffset="79-85" id="s127.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s127.e0" e2="s127.e1" id="s127.p0" relation="true"/>
  </sentence>
  <sentence id="s128" text="We report a case of 2-year old child who presented with small bone osteomyelitis involving bilateral feet and was later diagnosed to have autosomal recessive CGD due to mutation in NCF1 gene">
    <entity charOffset="138-157" id="s128.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="181-185" id="s128.e1" ontology_id="653361" text="NCF1" type="GENE"/>
    <pair e1="s128.e0" e2="s128.e1" id="s128.p0" relation="true"/>
  </sentence>
  <sentence id="s129" text="Chromosomal studies for Individual 1 identified an X-chromosome deletion due to a de novo pericentric inversion; the inversion breakpoint was associated with deletion of the 5'UTR of the USP9X, a gene which has been implicated in a syndromic intellectual disability affecting females.">
    <entity charOffset="187-192" id="s129.e0" ontology_id="8239" text="USP9X" type="GENE"/>
    <entity charOffset="242-265" id="s129.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s129.e0" e2="s129.e1" id="s129.p0" relation="true"/>
  </sentence>
  <sentence id="s130" text="Haploinsufficiency of USP9X in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.">
    <entity charOffset="22-27" id="s130.e0" ontology_id="8239" text="USP9X" type="GENE"/>
    <entity charOffset="171-182" id="s130.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s130.e0" e2="s130.e1" id="s130.p0" relation="true"/>
  </sentence>
  <sentence id="s131" text="Haploinsufficiency of USP9X in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.">
    <entity charOffset="22-27" id="s131.e0" ontology_id="8239" text="USP9X" type="GENE"/>
    <entity charOffset="124-133" id="s131.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s131.e0" e2="s131.e1" id="s131.p0" relation="true"/>
  </sentence>
  <sentence id="s132" text="Haploinsufficiency of USP9X in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.">
    <entity charOffset="22-27" id="s132.e0" ontology_id="8239" text="USP9X" type="GENE"/>
    <entity charOffset="135-155" id="s132.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s132.e0" e2="s132.e1" id="s132.p0" relation="true"/>
  </sentence>
  <sentence id="s133" text="Haploinsufficiency of USP9X in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.">
    <entity charOffset="22-27" id="s133.e0" ontology_id="8239" text="USP9X" type="GENE"/>
    <entity charOffset="157-169" id="s133.e1" ontology_id="HP_0002023" text="anal atresia" type="HP"/>
    <pair e1="s133.e0" e2="s133.e1" id="s133.p0" relation="true"/>
  </sentence>
  <sentence id="s134" text="We present the cloning and characterization of a novel gene, CRG-L2 (Cancer related gene-Liver 2), which displays high expression in murine and human hepatocellular carcinomas.">
    <entity charOffset="61-67" id="s134.e0" ontology_id="342035" text="CRG-L2" type="GENE"/>
    <entity charOffset="150-174" id="s134.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s134.e0" e2="s134.e1" id="s134.p0" relation="true"/>
  </sentence>
  <sentence id="s135" text="Using in situ hybridization, we show that CRG-L2 mRNA levels are increased early during the development of liver tumors in C3H/HeJ mice, and that in normal tissues CRG-L2 mRNA is restricted to the murine testis and human placenta.">
    <entity charOffset="42-48" id="s135.e0" ontology_id="342035" text="CRG-L2" type="GENE"/>
    <entity charOffset="113-119" id="s135.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s135.e0" e2="s135.e1" id="s135.p0" relation="true"/>
  </sentence>
  <sentence id="s136" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="103-110" id="s136.e0" ontology_id="6399" text="TRAPPC2" type="GENE"/>
    <entity charOffset="167-189" id="s136.e1" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <pair e1="s136.e0" e2="s136.e1" id="s136.p0" relation="true"/>
  </sentence>
  <sentence id="s137" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="112-119" id="s137.e0" ontology_id="83696" text="TRAPPC9" type="GENE"/>
    <entity charOffset="191-214" id="s137.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s137.e0" e2="s137.e1" id="s137.p0" relation="true"/>
  </sentence>
  <sentence id="s138" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="112-119" id="s138.e0" ontology_id="83696" text="TRAPPC9" type="GENE"/>
    <entity charOffset="167-189" id="s138.e1" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <pair e1="s138.e0" e2="s138.e1" id="s138.p0" relation="true"/>
  </sentence>
  <sentence id="s139" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="112-119" id="s139.e0" ontology_id="83696" text="TRAPPC9" type="GENE"/>
    <entity charOffset="216-233" id="s139.e1" ontology_id="HP_0002167" text="speech impairment" type="HP"/>
    <pair e1="s139.e0" e2="s139.e1" id="s139.p0" relation="true"/>
  </sentence>
  <sentence id="s140" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="112-119" id="s140.e0" ontology_id="83696" text="TRAPPC9" type="GENE"/>
    <entity charOffset="238-257" id="s140.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s140.e0" e2="s140.e1" id="s140.p0" relation="true"/>
  </sentence>
  <sentence id="s141" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="124-132" id="s141.e0" ontology_id="60684" text="TRAPPC11" type="GENE"/>
    <entity charOffset="191-214" id="s141.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s141.e0" e2="s141.e1" id="s141.p0" relation="true"/>
  </sentence>
  <sentence id="s142" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="124-132" id="s142.e0" ontology_id="60684" text="TRAPPC11" type="GENE"/>
    <entity charOffset="216-233" id="s142.e1" ontology_id="HP_0002167" text="speech impairment" type="HP"/>
    <pair e1="s142.e0" e2="s142.e1" id="s142.p0" relation="true"/>
  </sentence>
  <sentence id="s143" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="124-132" id="s143.e0" ontology_id="60684" text="TRAPPC11" type="GENE"/>
    <entity charOffset="238-257" id="s143.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s143.e0" e2="s143.e1" id="s143.p0" relation="true"/>
  </sentence>
  <sentence id="s144" text="Through biological and in silico analyses, our study suggests an association between SIX1/EYA1 mutations and cardiovascular malformations, SIX1/EYA1 mutations might be partially responsible for CTDs">
    <entity charOffset="85-89" id="s144.e0" ontology_id="6495" text="SIX1" type="GENE"/>
    <entity charOffset="109-137" id="s144.e1" ontology_id="HP_0030680" text="cardiovascular malformations" type="HP"/>
    <pair e1="s144.e0" e2="s144.e1" id="s144.p0" relation="true"/>
  </sentence>
  <sentence id="s145" text="Through biological and in silico analyses, our study suggests an association between SIX1/EYA1 mutations and cardiovascular malformations, SIX1/EYA1 mutations might be partially responsible for CTDs">
    <entity charOffset="90-94" id="s145.e0" ontology_id="2138" text="EYA1" type="GENE"/>
    <entity charOffset="109-137" id="s145.e1" ontology_id="HP_0030680" text="cardiovascular malformations" type="HP"/>
    <pair e1="s145.e0" e2="s145.e1" id="s145.p0" relation="true"/>
  </sentence>
  <sentence id="s146" text="The pattern of inheritance is autosomal recessive, and a causative mutation is evident in the CTDP1 gene.">
    <entity charOffset="30-49" id="s146.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="94-99" id="s146.e1" ontology_id="9150" text="CTDP1" type="GENE"/>
    <pair e1="s146.e0" e2="s146.e1" id="s146.p0" relation="true"/>
  </sentence>
  <sentence id="s147" text="Here we report that RANK-c transcript is expressed in 3.2% of cases in The Cancer Genome Atlas breast cancer cohort evenly between ER-positive and ER-negative cases.">
    <entity charOffset="20-24" id="s147.e0" ontology_id="8792" text="RANK" type="GENE"/>
    <entity charOffset="102-108" id="s147.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s147.e0" e2="s147.e1" id="s147.p0" relation="true"/>
  </sentence>
  <sentence id="s148" text="Nevertheless, the ratio of RANK to RANK-c (RANK/RANK-c) is increased in ER-negative breast cancer cell lines compared to ER-positive breast cancer cell lines.">
    <entity charOffset="27-31" id="s148.e0" ontology_id="8792" text="RANK" type="GENE"/>
    <entity charOffset="91-97" id="s148.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s148.e0" e2="s148.e1" id="s148.p0" relation="true"/>
  </sentence>
  <sentence id="s149" text="The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.">
    <entity charOffset="4-8" id="s149.e0" ontology_id="8792" text="RANK" type="GENE"/>
    <entity charOffset="46-60" id="s149.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s149.e0" e2="s149.e1" id="s149.p0" relation="true"/>
  </sentence>
  <sentence id="s150" text="The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.">
    <entity charOffset="34-40" id="s150.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="84-86" id="s150.e1" ontology_id="23114" text="NF" type="GENE"/>
    <pair e1="s150.e0" e2="s150.e1" id="s150.p0" relation="true"/>
  </sentence>
  <sentence id="s151" text="The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.">
    <entity charOffset="34-40" id="s151.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="185-190" id="s151.e1" ontology_id="10010" text="TRAF2" type="GENE"/>
    <pair e1="s151.e0" e2="s151.e1" id="s151.p0" relation="true"/>
  </sentence>
  <sentence id="s152" text="The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.">
    <entity charOffset="46-60" id="s152.e0" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <entity charOffset="84-86" id="s152.e1" ontology_id="23114" text="NF" type="GENE"/>
    <pair e1="s152.e0" e2="s152.e1" id="s152.p0" relation="true"/>
  </sentence>
  <sentence id="s153" text="Additional protein interaction characterization revealed epidermal growth factor receptor (EGFR) as a novel interacting partner for RANK-c in breast cancer cells with a negative effect on EGFR phosphorylation and EGF-dependent downstream signaling pathway activation.">
    <entity charOffset="91-95" id="s153.e0" ontology_id="1956" text="EGFR" type="GENE"/>
    <entity charOffset="149-155" id="s153.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s153.e0" e2="s153.e1" id="s153.p0" relation="true"/>
  </sentence>
  <sentence id="s154" text="Our findings further elucidate the complex molecular biology of the RANKL/RANK system in breast cancer and provide preliminary data for RANK-c as a possible marker for disease progression and aggressiveness">
    <entity charOffset="68-72" id="s154.e0" ontology_id="8792" text="RANK" type="GENE"/>
    <entity charOffset="96-102" id="s154.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s154.e0" e2="s154.e1" id="s154.p0" relation="true"/>
  </sentence>
  <sentence id="s155" text="De novo loss of function (LOF) mutations in the ASXL3 gene cause Bainbridge-Ropers syndrome, a severe form of intellectual disability (ID) and developmental delay, but there is evidence that they also occur in healthy individuals.">
    <entity charOffset="48-53" id="s155.e0" ontology_id="80816" text="ASXL3" type="GENE"/>
    <entity charOffset="110-133" id="s155.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s155.e0" e2="s155.e1" id="s155.p0" relation="true"/>
  </sentence>
  <sentence id="s156" text="De novo loss of function (LOF) mutations in the ASXL3 gene cause Bainbridge-Ropers syndrome, a severe form of intellectual disability (ID) and developmental delay, but there is evidence that they also occur in healthy individuals.">
    <entity charOffset="48-53" id="s156.e0" ontology_id="80816" text="ASXL3" type="GENE"/>
    <entity charOffset="143-162" id="s156.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s156.e0" e2="s156.e1" id="s156.p0" relation="true"/>
  </sentence>
  <sentence id="s157" text="We established a genetic diagnosis in six families with autosomal recessive HSP (SPG11 in three families and TFG/SPG57, SACS and ALS2 in one family each).">
    <entity charOffset="56-75" id="s157.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="81-86" id="s157.e1" ontology_id="80208" text="SPG11" type="GENE"/>
    <pair e1="s157.e0" e2="s157.e1" id="s157.p0" relation="true"/>
  </sentence>
  <sentence id="s158" text="We established a genetic diagnosis in six families with autosomal recessive HSP (SPG11 in three families and TFG/SPG57, SACS and ALS2 in one family each).">
    <entity charOffset="56-75" id="s158.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="109-112" id="s158.e1" ontology_id="10342" text="TFG" type="GENE"/>
    <pair e1="s158.e0" e2="s158.e1" id="s158.p0" relation="true"/>
  </sentence>
  <sentence id="s159" text="We established a genetic diagnosis in six families with autosomal recessive HSP (SPG11 in three families and TFG/SPG57, SACS and ALS2 in one family each).">
    <entity charOffset="56-75" id="s159.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="113-118" id="s159.e1" ontology_id="10342" text="SPG57" type="GENE"/>
    <pair e1="s159.e0" e2="s159.e1" id="s159.p0" relation="true"/>
  </sentence>
  <sentence id="s160" text="We established a genetic diagnosis in six families with autosomal recessive HSP (SPG11 in three families and TFG/SPG57, SACS and ALS2 in one family each).">
    <entity charOffset="56-75" id="s160.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="120-124" id="s160.e1" ontology_id="26278" text="SACS" type="GENE"/>
    <pair e1="s160.e0" e2="s160.e1" id="s160.p0" relation="true"/>
  </sentence>
  <sentence id="s161" text="We established a genetic diagnosis in six families with autosomal recessive HSP (SPG11 in three families and TFG/SPG57, SACS and ALS2 in one family each).">
    <entity charOffset="56-75" id="s161.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="129-133" id="s161.e1" ontology_id="57679" text="ALS2" type="GENE"/>
    <pair e1="s161.e0" e2="s161.e1" id="s161.p0" relation="true"/>
  </sentence>
  <sentence id="s162" text="Patients did not present with visual impairment as observed in a previously reported SPG57 family (c.316C&amp;gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in TFG complex formation/function and a possible phenotype correlation to variant location.">
    <entity charOffset="30-47" id="s162.e0" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <entity charOffset="85-90" id="s162.e1" ontology_id="10342" text="SPG57" type="GENE"/>
    <pair e1="s162.e0" e2="s162.e1" id="s162.p0" relation="true"/>
  </sentence>
  <sentence id="s163" text="In addition to a FOXG1 mutation in a patient with all core features of the congenital variant of RTT, we identified a missense (p.Ser240Thr) in CDKL5 in a patient who appeared to be seizure free.">
    <entity charOffset="17-22" id="s163.e0" ontology_id="2290" text="FOXG1" type="GENE"/>
    <entity charOffset="182-189" id="s163.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s163.e0" e2="s163.e1" id="s163.p0" relation="true"/>
  </sentence>
  <sentence id="s164" text="In addition to a FOXG1 mutation in a patient with all core features of the congenital variant of RTT, we identified a missense (p.Ser240Thr) in CDKL5 in a patient who appeared to be seizure free.">
    <entity charOffset="97-100" id="s164.e0" ontology_id="4204" text="RTT" type="GENE"/>
    <entity charOffset="182-189" id="s164.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s164.e0" e2="s164.e1" id="s164.p0" relation="true"/>
  </sentence>
  <sentence id="s165" text="In addition to a FOXG1 mutation in a patient with all core features of the congenital variant of RTT, we identified a missense (p.Ser240Thr) in CDKL5 in a patient who appeared to be seizure free.">
    <entity charOffset="144-149" id="s165.e0" ontology_id="6792" text="CDKL5" type="GENE"/>
    <entity charOffset="182-189" id="s165.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s165.e0" e2="s165.e1" id="s165.p0" relation="true"/>
  </sentence>
  <sentence id="s166" text="Finally, exome sequencing enabled us to characterize a heterozygous de novo missense (p.Val408Ala) in KCNA2 encoding the potassium channel Kv 1.2 in a girl with infantile-onset seizures variant of RTT.">
    <entity charOffset="102-107" id="s166.e0" ontology_id="3737" text="KCNA2" type="GENE"/>
    <entity charOffset="177-184" id="s166.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s166.e0" e2="s166.e1" id="s166.p0" relation="true"/>
  </sentence>
  <sentence id="s167" text="Finally, exome sequencing enabled us to characterize a heterozygous de novo missense (p.Val408Ala) in KCNA2 encoding the potassium channel Kv 1.2 in a girl with infantile-onset seizures variant of RTT.">
    <entity charOffset="177-184" id="s167.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="197-200" id="s167.e1" ontology_id="4204" text="RTT" type="GENE"/>
    <pair e1="s167.e0" e2="s167.e1" id="s167.p0" relation="true"/>
  </sentence>
  <sentence id="s168" text="Previous studies have demonstrated that COX15 mutations are associated with typical LS as well as fatal infantile hypertrophic cardiomyopathy.">
    <entity charOffset="40-45" id="s168.e0" ontology_id="1355" text="COX15" type="GENE"/>
    <entity charOffset="127-141" id="s168.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s168.e0" e2="s168.e1" id="s168.p0" relation="true"/>
  </sentence>
  <sentence id="s169" text="Furthermore, targeted knockout of Slc7a14 in mice results in retinal degeneration with abnormal ERG response.">
    <entity charOffset="34-41" id="s169.e0" ontology_id="57709" text="Slc7a14" type="GENE"/>
    <entity charOffset="61-81" id="s169.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s169.e0" e2="s169.e1" id="s169.p0" relation="true"/>
  </sentence>
  <sentence id="s170" text="Furthermore, targeted knockout of Slc7a14 in mice results in retinal degeneration with abnormal ERG response.">
    <entity charOffset="45-49" id="s170.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="61-81" id="s170.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s170.e0" e2="s170.e1" id="s170.p0" relation="true"/>
  </sentence>
  <sentence id="s171" text="Furthermore, targeted knockout of Slc7a14 in mice results in retinal degeneration with abnormal ERG response.">
    <entity charOffset="61-81" id="s171.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="96-99" id="s171.e1" ontology_id="2078" text="ERG" type="GENE"/>
    <pair e1="s171.e0" e2="s171.e1" id="s171.p0" relation="true"/>
  </sentence>
  <sentence id="s172" text="These findings suggested that HtrA3 is an important adaptor in hypoxic regions that drives endometrial cancer development">
    <entity charOffset="30-35" id="s172.e0" ontology_id="726" text="HtrA3" type="GENE"/>
    <entity charOffset="103-109" id="s172.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s172.e0" e2="s172.e1" id="s172.p0" relation="true"/>
  </sentence>
  <sentence id="s173" text="Here, we report that the expression of the INTU gene is aberrantly elevated in human basal cell carcinoma (BCC), coinciding with increased primary cilia formation and activated hedgehog (Hh) signaling.">
    <entity charOffset="43-47" id="s173.e0" ontology_id="27152" text="INTU" type="GENE"/>
    <entity charOffset="85-105" id="s173.e1" ontology_id="HP_0002671" text="basal cell carcinoma" type="HP"/>
    <pair e1="s173.e0" e2="s173.e1" id="s173.p0" relation="true"/>
  </sentence>
  <sentence id="s174" text="The role of c-Myc (a target gene of let-7) and the Lin28-let-7-c-Myc pathway in the growth and malignancy of thyroid cancer is unclear.">
    <entity charOffset="12-17" id="s174.e0" ontology_id="4609" text="c-Myc" type="GENE"/>
    <entity charOffset="117-123" id="s174.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s174.e0" e2="s174.e1" id="s174.p0" relation="true"/>
  </sentence>
  <sentence id="s175" text="The role of c-Myc (a target gene of let-7) and the Lin28-let-7-c-Myc pathway in the growth and malignancy of thyroid cancer is unclear.">
    <entity charOffset="51-56" id="s175.e0" ontology_id="79727" text="Lin28" type="GENE"/>
    <entity charOffset="117-123" id="s175.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s175.e0" e2="s175.e1" id="s175.p0" relation="true"/>
  </sentence>
  <sentence id="s176" text="The purpose of the present study was to evaluate the expression of Lin28A, let-7a, and c-Myc in human papillary thyroid carcinoma (PTC) and to investigate their potential mechanisms in the progression of PTC.">
    <entity charOffset="67-72" id="s176.e0" ontology_id="79727" text="Lin28" type="GENE"/>
    <entity charOffset="102-129" id="s176.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s176.e0" e2="s176.e1" id="s176.p0" relation="true"/>
  </sentence>
  <sentence id="s177" text="Clinically, Lin28A was linked to a higher tumor/node/metastasis stage and the presence of lymph node metastases.">
    <entity charOffset="12-17" id="s177.e0" ontology_id="79727" text="Lin28" type="GENE"/>
    <entity charOffset="42-47" id="s177.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s177.e0" e2="s177.e1" id="s177.p0" relation="true"/>
  </sentence>
  <sentence id="s178" text="CONCLUSIONS The Lin28A/let-7a/c-Myc pathway is involved in cancer growth and malignant behavior in PTC and is a potential target for therapeutic intervention in this disease">
    <entity charOffset="16-21" id="s178.e0" ontology_id="79727" text="Lin28" type="GENE"/>
    <entity charOffset="59-65" id="s178.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s178.e0" e2="s178.e1" id="s178.p0" relation="true"/>
  </sentence>
  <sentence id="s179" text="CONCLUSIONS The Lin28A/let-7a/c-Myc pathway is involved in cancer growth and malignant behavior in PTC and is a potential target for therapeutic intervention in this disease">
    <entity charOffset="30-35" id="s179.e0" ontology_id="4609" text="c-Myc" type="GENE"/>
    <entity charOffset="59-65" id="s179.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s179.e0" e2="s179.e1" id="s179.p0" relation="true"/>
  </sentence>
  <sentence id="s180" text="CONCLUSIONS The Lin28A/let-7a/c-Myc pathway is involved in cancer growth and malignant behavior in PTC and is a potential target for therapeutic intervention in this disease">
    <entity charOffset="59-65" id="s180.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="99-102" id="s180.e1" ontology_id="8030" text="PTC" type="GENE"/>
    <pair e1="s180.e0" e2="s180.e1" id="s180.p0" relation="true"/>
  </sentence>
  <sentence id="s181" text="Mutations in MYH2 are associated with skeletal myopathies, characterized by ophthalmoplegia.">
    <entity charOffset="13-16" id="s181.e0" ontology_id="4595" text="MYH" type="GENE"/>
    <entity charOffset="38-57" id="s181.e1" ontology_id="HP_0003756" text="skeletal myopathies" type="HP"/>
    <pair e1="s181.e0" e2="s181.e1" id="s181.p0" relation="true"/>
  </sentence>
  <sentence id="s182" text="Mutations in MYH2 are associated with skeletal myopathies, characterized by ophthalmoplegia.">
    <entity charOffset="13-16" id="s182.e0" ontology_id="4595" text="MYH" type="GENE"/>
    <entity charOffset="76-91" id="s182.e1" ontology_id="HP_0000602" text="ophthalmoplegia" type="HP"/>
    <pair e1="s182.e0" e2="s182.e1" id="s182.p0" relation="true"/>
  </sentence>
  <sentence id="s183" text="Mutations in MYH3 and MYH8 are associated with distal arthrogryposis syndromes.">
    <entity charOffset="13-16" id="s183.e0" ontology_id="4595" text="MYH" type="GENE"/>
    <entity charOffset="47-53" id="s183.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s183.e0" e2="s183.e1" id="s183.p0" relation="true"/>
  </sentence>
  <sentence id="s184" text="Mutations in MYH3 and MYH8 are associated with distal arthrogryposis syndromes.">
    <entity charOffset="13-16" id="s184.e0" ontology_id="4595" text="MYH" type="GENE"/>
    <entity charOffset="54-68" id="s184.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s184.e0" e2="s184.e1" id="s184.p0" relation="true"/>
  </sentence>
  <sentence id="s185" text="Mutations in MYH7 are associated with not only skeletal muscle diseases, such as Laing distal myopathy and myosin storage myopathy, but also hypertrophic cardiomyopathy.">
    <entity charOffset="13-16" id="s185.e0" ontology_id="4595" text="MYH" type="GENE"/>
    <entity charOffset="87-93" id="s185.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s185.e0" e2="s185.e1" id="s185.p0" relation="true"/>
  </sentence>
  <sentence id="s186" text="Mutations in MYH7 are associated with not only skeletal muscle diseases, such as Laing distal myopathy and myosin storage myopathy, but also hypertrophic cardiomyopathy.">
    <entity charOffset="13-16" id="s186.e0" ontology_id="4595" text="MYH" type="GENE"/>
    <entity charOffset="94-102" id="s186.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s186.e0" e2="s186.e1" id="s186.p0" relation="true"/>
  </sentence>
  <sentence id="s187" text="On these bases, we investigated whether the ligation of ER by a selective agonist, the 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN), could impact HL tumor growth.">
    <entity charOffset="140-146" id="s187.e0" ontology_id="55364" text="impact" type="GENE"/>
    <entity charOffset="150-155" id="s187.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s187.e0" e2="s187.e1" id="s187.p0" relation="true"/>
  </sentence>
  <sentence id="s188" text="In nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice engrafted with HL cells, ER activation by DPN was able to reduce lymphoma growth up to 60% and this associated with the induction of tumor cell autophagy.">
    <entity charOffset="64-68" id="s188.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="203-208" id="s188.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s188.e0" e2="s188.e1" id="s188.p0" relation="false"/>
  </sentence>
  <sentence id="s189" text="After ER activation, both DRAM2 and protein 1 light chain 3 (LC3), a key actor in the autophagosome formation, strictly interacted each other and localized at mitochondrial level.Altogether these results suggest that targeting ER with selective agonists might affect HL cell proliferation and tumor growth via a mechanism that brings into play DRAM2-dependent autophagic cascade">
    <entity charOffset="27-32" id="s189.e0" ontology_id="128338" text="DRAM2" type="GENE"/>
    <entity charOffset="295-300" id="s189.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s189.e0" e2="s189.e1" id="s189.p0" relation="true"/>
  </sentence>
  <sentence id="s190" text="The oncogenic potential of ASS1 in terms of prognosis and cancer metastasis in arginine prototrophic gastric cancer (GC) remains unclear at present.">
    <entity charOffset="27-31" id="s190.e0" ontology_id="445" text="ASS1" type="GENE"/>
    <entity charOffset="58-64" id="s190.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s190.e0" e2="s190.e1" id="s190.p0" relation="true"/>
  </sentence>
  <sentence id="s191" text="ASS1 was highly expressed in GC and positively correlated with GC aggressiveness and poor outcome.">
    <entity charOffset="0-4" id="s191.e0" ontology_id="445" text="ASS1" type="GENE"/>
    <entity charOffset="66-80" id="s191.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s191.e0" e2="s191.e1" id="s191.p0" relation="true"/>
  </sentence>
  <sentence id="s192" text="Depletion of ASS1 led to inhibition of tumor growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active -catenin, Snail, and Twist.">
    <entity charOffset="13-17" id="s192.e0" ontology_id="445" text="ASS1" type="GENE"/>
    <entity charOffset="39-44" id="s192.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s192.e0" e2="s192.e1" id="s192.p0" relation="true"/>
  </sentence>
  <sentence id="s193" text="Ectopic expression of ASS1 in GC cells reversed these effects and protected cancer cells from chemotherapy drug-induced apoptosis via activation of the AKT-mammalian target of rapamycin signaling pathway.">
    <entity charOffset="22-26" id="s193.e0" ontology_id="445" text="ASS1" type="GENE"/>
    <entity charOffset="76-82" id="s193.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s193.e0" e2="s193.e1" id="s193.p0" relation="true"/>
  </sentence>
  <sentence id="s194" text="Ectopic expression of ASS1 in GC cells reversed these effects and protected cancer cells from chemotherapy drug-induced apoptosis via activation of the AKT-mammalian target of rapamycin signaling pathway.">
    <entity charOffset="76-82" id="s194.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="152-155" id="s194.e1" ontology_id="207" text="AKT" type="GENE"/>
    <pair e1="s194.e0" e2="s194.e1" id="s194.p0" relation="true"/>
  </sentence>
  <sentence id="s195" text="Finally, we show that inhibition of SMYD2 cooperates with standard chemotherapy to treat PDAC cells and tumors.">
    <entity charOffset="36-41" id="s195.e0" ontology_id="56950" text="SMYD2" type="GENE"/>
    <entity charOffset="104-110" id="s195.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s195.e0" e2="s195.e1" id="s195.p0" relation="true"/>
  </sentence>
  <sentence id="s196" text="These findings uncover a pivotal role for SMYD2 in promoting pancreatic cancer.">
    <entity charOffset="42-47" id="s196.e0" ontology_id="56950" text="SMYD2" type="GENE"/>
    <entity charOffset="72-78" id="s196.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s196.e0" e2="s196.e1" id="s196.p0" relation="true"/>
  </sentence>
  <sentence id="s197" text="Phase 2 occurs postnatally through adult stages with bone marrow production of granulocyte precursors and positive selection of mutants due to chronic G-CSF therapy to reverse the severe neutropenia.">
    <entity charOffset="151-156" id="s197.e0" ontology_id="1440" text="G-CSF" type="GENE"/>
    <entity charOffset="187-198" id="s197.e1" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <pair e1="s197.e0" e2="s197.e1" id="s197.p0" relation="true"/>
  </sentence>
  <sentence id="s198" text="Therefore, we conducted genotyping for 17 SNPs of six NER core genes (&lt;i&gt;XPA, XPC, XPG, ERCC1, ERCC2&lt;/i&gt;, and &lt;i&gt;ERCC4&lt;/i&gt;) in 89 ovarian cancer cases and 356 cancer-free controls.">
    <entity charOffset="54-57" id="s198.e0" ontology_id="7376" text="NER" type="GENE"/>
    <entity charOffset="138-144" id="s198.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s198.e0" e2="s198.e1" id="s198.p0" relation="true"/>
  </sentence>
  <sentence id="s199" text="Therefore, we conducted genotyping for 17 SNPs of six NER core genes (&lt;i&gt;XPA, XPC, XPG, ERCC1, ERCC2&lt;/i&gt;, and &lt;i&gt;ERCC4&lt;/i&gt;) in 89 ovarian cancer cases and 356 cancer-free controls.">
    <entity charOffset="78-81" id="s199.e0" ontology_id="7508" text="XPC" type="GENE"/>
    <entity charOffset="138-144" id="s199.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s199.e0" e2="s199.e1" id="s199.p0" relation="true"/>
  </sentence>
  <sentence id="s200" text="The result showed that both &lt;i&gt;ERCC1&lt;/i&gt; rs11615 and &lt;i&gt;XPC&lt;/i&gt; rs2228000 were significantly associated with reduced risk of ovarian cancer under dominant genetic model (adjusted OR = 0.35, 95% CI = 0.20-0.61, &lt;i&gt;P&lt;/i&gt;=0.0002 and adjusted OR = 0.49, 95% CI = 0.30-0.81, &lt;i&gt;P&lt;/i&gt;=0.005 respectively).">
    <entity charOffset="31-36" id="s200.e0" ontology_id="2067" text="ERCC1" type="GENE"/>
    <entity charOffset="133-139" id="s200.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s200.e0" e2="s200.e1" id="s200.p0" relation="true"/>
  </sentence>
  <sentence id="s201" text="The result showed that both &lt;i&gt;ERCC1&lt;/i&gt; rs11615 and &lt;i&gt;XPC&lt;/i&gt; rs2228000 were significantly associated with reduced risk of ovarian cancer under dominant genetic model (adjusted OR = 0.35, 95% CI = 0.20-0.61, &lt;i&gt;P&lt;/i&gt;=0.0002 and adjusted OR = 0.49, 95% CI = 0.30-0.81, &lt;i&gt;P&lt;/i&gt;=0.005 respectively).">
    <entity charOffset="56-59" id="s201.e0" ontology_id="7508" text="XPC" type="GENE"/>
    <entity charOffset="133-139" id="s201.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s201.e0" e2="s201.e1" id="s201.p0" relation="true"/>
  </sentence>
  <sentence id="s202" text="In addition, &lt;i&gt;XPC&lt;/i&gt; rs2228001 and &lt;i&gt;ERCC2&lt;/i&gt; rs238406 had statistically significant association with the increased risk of ovarian cancer under dominant genetic model (adjusted OR = 1.72, 95% CI = 1.02-2.92, &lt;i&gt;P&lt;/i&gt;=0.043 and adjusted OR = 2.07, 95% CI = 1.07-4.01, &lt;i&gt;P&lt;/i&gt;=0.032 respectively).">
    <entity charOffset="16-19" id="s202.e0" ontology_id="7508" text="XPC" type="GENE"/>
    <entity charOffset="137-143" id="s202.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s202.e0" e2="s202.e1" id="s202.p0" relation="true"/>
  </sentence>
  <sentence id="s203" text="&lt;i&gt;ERCC1&lt;/i&gt; rs3212986 were related with the increased risk of ovarian cancer under recessive model (adjusted OR = 2.40, 95% CI = 1.30-4.44, &lt;i&gt;P&lt;/i&gt;=0.005).">
    <entity charOffset="3-8" id="s203.e0" ontology_id="2067" text="ERCC1" type="GENE"/>
    <entity charOffset="71-77" id="s203.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s203.e0" e2="s203.e1" id="s203.p0" relation="true"/>
  </sentence>
  <sentence id="s204" text="In conclusion, our results indicated that &lt;i&gt;ERCC1, XPC&lt;/i&gt; and &lt;i&gt;ERCC2&lt;/i&gt; might influence ovarian cancer susceptibility.">
    <entity charOffset="45-50" id="s204.e0" ontology_id="2067" text="ERCC1" type="GENE"/>
    <entity charOffset="101-107" id="s204.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s204.e0" e2="s204.e1" id="s204.p0" relation="true"/>
  </sentence>
  <sentence id="s205" text="In conclusion, our results indicated that &lt;i&gt;ERCC1, XPC&lt;/i&gt; and &lt;i&gt;ERCC2&lt;/i&gt; might influence ovarian cancer susceptibility.">
    <entity charOffset="52-55" id="s205.e0" ontology_id="7508" text="XPC" type="GENE"/>
    <entity charOffset="101-107" id="s205.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s205.e0" e2="s205.e1" id="s205.p0" relation="true"/>
  </sentence>
  <sentence id="s206" text="Historically classified as a subtype of hepatocellular carcinoma (HCC), FLC has a unique clinical, histological, and molecular presentation.">
    <entity charOffset="40-64" id="s206.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="66-69" id="s206.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s206.e0" e2="s206.e1" id="s206.p0" relation="true"/>
  </sentence>
  <sentence id="s207" text="High TROP2 expression plays an important role in promoting tumor development and aggressiveness, which is correlated with reduced patient survival.">
    <entity charOffset="5-10" id="s207.e0" ontology_id="4070" text="TROP2" type="GENE"/>
    <entity charOffset="59-64" id="s207.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s207.e0" e2="s207.e1" id="s207.p0" relation="true"/>
  </sentence>
  <sentence id="s208" text="High TROP2 expression plays an important role in promoting tumor development and aggressiveness, which is correlated with reduced patient survival.">
    <entity charOffset="5-10" id="s208.e0" ontology_id="4070" text="TROP2" type="GENE"/>
    <entity charOffset="81-95" id="s208.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s208.e0" e2="s208.e1" id="s208.p0" relation="true"/>
  </sentence>
  <sentence id="s209" text="Here we took advantage of a transgenic mouse line expressing an RDS mutant (R172W) known to cause macular degeneration (MD) in humans.">
    <entity charOffset="64-67" id="s209.e0" ontology_id="5961" text="RDS" type="GENE"/>
    <entity charOffset="98-118" id="s209.e1" ontology_id="HP_0000608" text="macular degeneration" type="HP"/>
    <pair e1="s209.e0" e2="s209.e1" id="s209.p0" relation="true"/>
  </sentence>
  <sentence id="s210" text="Mucopolysaccharidosis (MPS) type I is a rare autosomal recessive disease caused by a deficiency of the lysosomal enzyme -L-iduronidase.">
    <entity charOffset="28-32" id="s210.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="45-64" id="s210.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s210.e0" e2="s210.e1" id="s210.p0" relation="true"/>
  </sentence>
  <sentence id="s211" text="Next, we took epicardial fat samples from patients with valvular heart disease and non- coronary artery disease.">
    <entity charOffset="25-28" id="s211.e0" ontology_id="948" text="fat" type="GENE"/>
    <entity charOffset="56-78" id="s211.e1" ontology_id="HP_0001654" text="valvular heart disease" type="HP"/>
    <pair e1="s211.e0" e2="s211.e1" id="s211.p0" relation="true"/>
  </sentence>
  <sentence id="s212" text="The aim this study was to investigate the prevalence of single nucleotide polymorphisms in LEP gene (LEP 3'UTR A/C, -2548G/A) and LEPR (K109R and Q223R) and their association with Leptin level and obesity.">
    <entity charOffset="91-94" id="s212.e0" ontology_id="3952" text="LEP" type="GENE"/>
    <entity charOffset="198-205" id="s212.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s212.e0" e2="s212.e1" id="s212.p0" relation="true"/>
  </sentence>
  <sentence id="s213" text="The K109R polymorphism was associated with obesity (P=.025) and seems to significantly decrease the LEP levels (P&amp;lt;.001).">
    <entity charOffset="43-50" id="s213.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="102-105" id="s213.e1" ontology_id="3952" text="LEP" type="GENE"/>
    <pair e1="s213.e0" e2="s213.e1" id="s213.p0" relation="true"/>
  </sentence>
  <sentence id="s214" text="De novo variants of ASH1L, which encodes a histone methyltransferase, have been reported in a few patients with intellectual disability and autistic features.">
    <entity charOffset="20-25" id="s214.e0" ontology_id="55870" text="ASH1L" type="GENE"/>
    <entity charOffset="112-135" id="s214.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s214.e0" e2="s214.e1" id="s214.p0" relation="true"/>
  </sentence>
  <sentence id="s215" text="Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in ASH1L in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, sleep apnea, and scoliosis.">
    <entity charOffset="118-123" id="s215.e0" ontology_id="55870" text="ASH1L" type="GENE"/>
    <entity charOffset="190-209" id="s215.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s215.e0" e2="s215.e1" id="s215.p0" relation="true"/>
  </sentence>
  <sentence id="s216" text="Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in ASH1L in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, sleep apnea, and scoliosis.">
    <entity charOffset="118-123" id="s216.e0" ontology_id="55870" text="ASH1L" type="GENE"/>
    <entity charOffset="276-287" id="s216.e1" ontology_id="HP_0010535" text="sleep apnea" type="HP"/>
    <pair e1="s216.e0" e2="s216.e1" id="s216.p0" relation="true"/>
  </sentence>
  <sentence id="s217" text="Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in ASH1L in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, sleep apnea, and scoliosis.">
    <entity charOffset="118-123" id="s217.e0" ontology_id="55870" text="ASH1L" type="GENE"/>
    <entity charOffset="293-302" id="s217.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s217.e0" e2="s217.e1" id="s217.p0" relation="true"/>
  </sentence>
  <sentence id="s218" text="Our report provides further evidence to support loss-of-function alterations of ASH1L as causative for an emergent neurodevelopmental syndrome characterized by MCA, intellectual disability, and behavioral problems, and further delineates this genetic disorder">
    <entity charOffset="80-85" id="s218.e0" ontology_id="55870" text="ASH1L" type="GENE"/>
    <entity charOffset="165-188" id="s218.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s218.e0" e2="s218.e1" id="s218.p0" relation="true"/>
  </sentence>
  <sentence id="s219" text="Our report provides further evidence to support loss-of-function alterations of ASH1L as causative for an emergent neurodevelopmental syndrome characterized by MCA, intellectual disability, and behavioral problems, and further delineates this genetic disorder">
    <entity charOffset="80-85" id="s219.e0" ontology_id="55870" text="ASH1L" type="GENE"/>
    <entity charOffset="194-213" id="s219.e1" ontology_id="HP_0000708" text="behavioral problems" type="HP"/>
    <pair e1="s219.e0" e2="s219.e1" id="s219.p0" relation="true"/>
  </sentence>
  <sentence id="s220" text="Here, we investigated the biological functions and clinical significance of TRIM44 in human esophageal cancer (HEC).">
    <entity charOffset="103-109" id="s220.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="111-114" id="s220.e1" ontology_id="10403" text="HEC" type="GENE"/>
    <pair e1="s220.e0" e2="s220.e1" id="s220.p0" relation="true"/>
  </sentence>
  <sentence id="s221" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="139-147" id="s221.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="159-164" id="s221.e1" ontology_id="4629" text="MYH11" type="GENE"/>
    <pair e1="s221.e0" e2="s221.e1" id="s221.p0" relation="true"/>
  </sentence>
  <sentence id="s222" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="139-147" id="s222.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="214-218" id="s222.e1" ontology_id="4638" text="MYLK" type="GENE"/>
    <pair e1="s222.e0" e2="s222.e1" id="s222.p0" relation="false"/>
  </sentence>
  <sentence id="s223" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="139-147" id="s223.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="227-232" id="s223.e1" ontology_id="8740" text="light" type="GENE"/>
    <pair e1="s223.e0" e2="s223.e1" id="s223.p0" relation="true"/>
  </sentence>
  <sentence id="s224" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="139-147" id="s224.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="240-243" id="s224.e1" ontology_id="23209" text="MLC" type="GENE"/>
    <pair e1="s224.e0" e2="s224.e1" id="s224.p0" relation="false"/>
  </sentence>
  <sentence id="s225" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="159-164" id="s225.e0" ontology_id="4629" text="MYH11" type="GENE"/>
    <entity charOffset="253-272" id="s225.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s225.e0" e2="s225.e1" id="s225.p0" relation="true"/>
  </sentence>
  <sentence id="s226" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="159-164" id="s226.e0" ontology_id="4629" text="MYH11" type="GENE"/>
    <entity charOffset="273-284" id="s226.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s226.e0" e2="s226.e1" id="s226.p0" relation="true"/>
  </sentence>
  <sentence id="s227" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="190-195" id="s227.e0" ontology_id="25802" text="LMOD1" type="GENE"/>
    <entity charOffset="253-272" id="s227.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s227.e0" e2="s227.e1" id="s227.p0" relation="false"/>
  </sentence>
  <sentence id="s228" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="190-195" id="s228.e0" ontology_id="25802" text="LMOD1" type="GENE"/>
    <entity charOffset="273-284" id="s228.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s228.e0" e2="s228.e1" id="s228.p0" relation="true"/>
  </sentence>
  <sentence id="s229" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="214-218" id="s229.e0" ontology_id="4638" text="MYLK" type="GENE"/>
    <entity charOffset="253-272" id="s229.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s229.e0" e2="s229.e1" id="s229.p0" relation="true"/>
  </sentence>
  <sentence id="s230" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="214-218" id="s230.e0" ontology_id="4638" text="MYLK" type="GENE"/>
    <entity charOffset="273-284" id="s230.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s230.e0" e2="s230.e1" id="s230.p0" relation="true"/>
  </sentence>
  <sentence id="s231" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="240-243" id="s231.e0" ontology_id="23209" text="MLC" type="GENE"/>
    <entity charOffset="253-272" id="s231.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s231.e0" e2="s231.e1" id="s231.p0" relation="true"/>
  </sentence>
  <sentence id="s232" text="Two sisters with c.137T&amp;gt;C (p.Leu46Pro) PIGY variants had multi-system disease including dysmorphism, seizures, severe developmental delay, cataracts and early death.">
    <entity charOffset="42-46" id="s232.e0" ontology_id="84992" text="PIGY" type="GENE"/>
    <entity charOffset="104-112" id="s232.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s232.e0" e2="s232.e1" id="s232.p0" relation="true"/>
  </sentence>
  <sentence id="s233" text="Two sisters with c.137T&amp;gt;C (p.Leu46Pro) PIGY variants had multi-system disease including dysmorphism, seizures, severe developmental delay, cataracts and early death.">
    <entity charOffset="42-46" id="s233.e0" ontology_id="84992" text="PIGY" type="GENE"/>
    <entity charOffset="121-140" id="s233.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s233.e0" e2="s233.e1" id="s233.p0" relation="true"/>
  </sentence>
  <sentence id="s234" text="Two sisters with c.137T&amp;gt;C (p.Leu46Pro) PIGY variants had multi-system disease including dysmorphism, seizures, severe developmental delay, cataracts and early death.">
    <entity charOffset="42-46" id="s234.e0" ontology_id="84992" text="PIGY" type="GENE"/>
    <entity charOffset="142-151" id="s234.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s234.e0" e2="s234.e1" id="s234.p0" relation="true"/>
  </sentence>
  <sentence id="s235" text="Mutations in the homeobox gene SHOX cause SHOX deficiency, a condition with clinical manifestations ranging from short stature without dysmorphic signs to severe mesomelic skeletal dysplasia.">
    <entity charOffset="31-35" id="s235.e0" ontology_id="6473" text="SHOX" type="GENE"/>
    <entity charOffset="113-126" id="s235.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s235.e0" e2="s235.e1" id="s235.p0" relation="true"/>
  </sentence>
  <sentence id="s236" text="Mutations in the homeobox gene SHOX cause SHOX deficiency, a condition with clinical manifestations ranging from short stature without dysmorphic signs to severe mesomelic skeletal dysplasia.">
    <entity charOffset="31-35" id="s236.e0" ontology_id="6473" text="SHOX" type="GENE"/>
    <entity charOffset="172-190" id="s236.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s236.e0" e2="s236.e1" id="s236.p0" relation="true"/>
  </sentence>
  <sentence id="s237" text="Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, ACSL4, GNMT, IFI27, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (HCC).">
    <entity charOffset="226-231" id="s237.e0" ontology_id="2182" text="ACSL4" type="GENE"/>
    <entity charOffset="415-439" id="s237.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s237.e0" e2="s237.e1" id="s237.p0" relation="true"/>
  </sentence>
  <sentence id="s238" text="Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, ACSL4, GNMT, IFI27, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (HCC).">
    <entity charOffset="233-237" id="s238.e0" ontology_id="27232" text="GNMT" type="GENE"/>
    <entity charOffset="415-439" id="s238.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s238.e0" e2="s238.e1" id="s238.p0" relation="true"/>
  </sentence>
  <sentence id="s239" text="Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, ACSL4, GNMT, IFI27, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (HCC).">
    <entity charOffset="239-244" id="s239.e0" ontology_id="3429" text="IFI27" type="GENE"/>
    <entity charOffset="415-439" id="s239.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s239.e0" e2="s239.e1" id="s239.p0" relation="true"/>
  </sentence>
  <sentence id="s240" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="100-106" id="s240.e0" ontology_id="478" text="ATP1A3" type="GENE"/>
    <entity charOffset="213-226" id="s240.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s240.e0" e2="s240.e1" id="s240.p0" relation="true"/>
  </sentence>
  <sentence id="s241" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="191-200" id="s241.e0" ontology_id="HP_0001284" text="areflexia" type="HP"/>
    <entity charOffset="202-205" id="s241.e1" ontology_id="23481" text="pes" type="GENE"/>
    <pair e1="s241.e0" e2="s241.e1" id="s241.p0" relation="true"/>
  </sentence>
  <sentence id="s242" text="Although mammalian MEGF10 is expressed in the central nervous system as well as in skeletal muscle, patients carrying mutations in MEGF10 do not show symptoms of central nervous system dysfunction.">
    <entity charOffset="19-25" id="s242.e0" ontology_id="84466" text="MEGF10" type="GENE"/>
    <entity charOffset="46-53" id="s242.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s242.e0" e2="s242.e1" id="s242.p0" relation="true"/>
  </sentence>
  <sentence id="s243" text="The present study screened pathogenic genes, ectodysplasinA (EDA) and lamin A/C (LMNA), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.">
    <entity charOffset="62-65" id="s243.e0" ontology_id="1896" text="EDA" type="GENE"/>
    <entity charOffset="127-145" id="s243.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s243.e0" e2="s243.e1" id="s243.p0" relation="true"/>
  </sentence>
  <sentence id="s244" text="The present study screened pathogenic genes, ectodysplasinA (EDA) and lamin A/C (LMNA), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.">
    <entity charOffset="82-86" id="s244.e0" ontology_id="4000" text="LMNA" type="GENE"/>
    <entity charOffset="127-145" id="s244.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s244.e0" e2="s244.e1" id="s244.p0" relation="true"/>
  </sentence>
  <sentence id="s245" text="The present study screened pathogenic genes, ectodysplasinA (EDA) and lamin A/C (LMNA), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.">
    <entity charOffset="82-86" id="s245.e0" ontology_id="4000" text="LMNA" type="GENE"/>
    <entity charOffset="193-211" id="s245.e1" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <pair e1="s245.e0" e2="s245.e1" id="s245.p0" relation="true"/>
  </sentence>
  <sentence id="s246" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="122-126" id="s246.e0" ontology_id="1428" text="CRYM" type="GENE"/>
    <entity charOffset="274-292" id="s246.e1" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <pair e1="s246.e0" e2="s246.e1" id="s246.p0" relation="true"/>
  </sentence>
  <sentence id="s247" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="122-126" id="s247.e0" ontology_id="1428" text="CRYM" type="GENE"/>
    <entity charOffset="241-249" id="s247.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s247.e0" e2="s247.e1" id="s247.p0" relation="true"/>
  </sentence>
  <sentence id="s248" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="122-126" id="s248.e0" ontology_id="1428" text="CRYM" type="GENE"/>
    <entity charOffset="251-263" id="s248.e1" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <pair e1="s248.e0" e2="s248.e1" id="s248.p0" relation="false"/>
  </sentence>
  <sentence id="s249" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="181-189" id="s249.e0" ontology_id="22930" text="RAB3GAP1" type="GENE"/>
    <entity charOffset="274-292" id="s249.e1" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <pair e1="s249.e0" e2="s249.e1" id="s249.p0" relation="true"/>
  </sentence>
  <sentence id="s250" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="181-189" id="s250.e0" ontology_id="22930" text="RAB3GAP1" type="GENE"/>
    <entity charOffset="241-249" id="s250.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s250.e0" e2="s250.e1" id="s250.p0" relation="true"/>
  </sentence>
  <sentence id="s251" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="218-224" id="s251.e0" ontology_id="80326" text="WNT10A" type="GENE"/>
    <entity charOffset="274-292" id="s251.e1" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <pair e1="s251.e0" e2="s251.e1" id="s251.p0" relation="true"/>
  </sentence>
  <sentence id="s252" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="218-224" id="s252.e0" ontology_id="80326" text="WNT10A" type="GENE"/>
    <entity charOffset="241-249" id="s252.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s252.e0" e2="s252.e1" id="s252.p0" relation="true"/>
  </sentence>
  <sentence id="s253" text="Crizotinib is a small orally-administered ALK inhibitor for patients with non-small cell lung cancer with EML4-ALK rearrangement (echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase).">
    <entity charOffset="94-100" id="s253.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="106-110" id="s253.e1" ontology_id="27436" text="EML4" type="GENE"/>
    <pair e1="s253.e0" e2="s253.e1" id="s253.p0" relation="true"/>
  </sentence>
  <sentence id="s254" text="Lactate dehydrogenase A (LDHA), a key enzyme in glycolysis, is highly expressed in a variety of tumors and catalyzes pyruvate to lactate.">
    <entity charOffset="25-29" id="s254.e0" ontology_id="3939" text="LDHA" type="GENE"/>
    <entity charOffset="96-101" id="s254.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s254.e0" e2="s254.e1" id="s254.p0" relation="true"/>
  </sentence>
  <sentence id="s255" text="In the present study, we first analyzed the association and clinical significance of p53 and LDHA in breast cancer expressing wild-type p53 (wt-p53) and found that LDHA mRNA levels are negatively correlated with wt-p53 but not with mutation p53 mRNA levels, and low p53 and high LDHA expression are significantly associated with poor overall survival rates.">
    <entity charOffset="93-97" id="s255.e0" ontology_id="3939" text="LDHA" type="GENE"/>
    <entity charOffset="108-114" id="s255.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s255.e0" e2="s255.e1" id="s255.p0" relation="true"/>
  </sentence>
  <sentence id="s256" text="Moreover, a series of LDHA gain-of-function and rescore experiments were carried out in breast cancer MCF7 cells expressing endogenous wt-p53, showing that ectopic expression of p53 decreases aerobic glycolysis, cell proliferation, migration, invasion and tumor formation of breast cancer cells and that restoration of the expression of LDHA in p53-overexpressing cells could abolish the suppressive effect of p53 on aerobic glycolysis and other malignant phenotypes.">
    <entity charOffset="22-26" id="s256.e0" ontology_id="3939" text="LDHA" type="GENE"/>
    <entity charOffset="95-101" id="s256.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s256.e0" e2="s256.e1" id="s256.p0" relation="true"/>
  </sentence>
  <sentence id="s257" text="In conclusion, our findings showed that repression of LDHA induced by wt-p53 blocks tumor growth and invasion through downregulation of aerobic glycolysis in breast cancer, providing new insights into the mechanism by which p53 contributes to the development and progression of breast cancer">
    <entity charOffset="54-58" id="s257.e0" ontology_id="3939" text="LDHA" type="GENE"/>
    <entity charOffset="84-89" id="s257.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s257.e0" e2="s257.e1" id="s257.p0" relation="true"/>
  </sentence>
  <sentence id="s258" text="In conclusion, our findings showed that repression of LDHA induced by wt-p53 blocks tumor growth and invasion through downregulation of aerobic glycolysis in breast cancer, providing new insights into the mechanism by which p53 contributes to the development and progression of breast cancer">
    <entity charOffset="54-58" id="s258.e0" ontology_id="3939" text="LDHA" type="GENE"/>
    <entity charOffset="165-171" id="s258.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s258.e0" e2="s258.e1" id="s258.p0" relation="true"/>
  </sentence>
  <sentence id="s259" text="However, the significance of Brf1 overexpression in human breast cancer (HBC) remains to be investigated.">
    <entity charOffset="29-33" id="s259.e0" ontology_id="677" text="Brf1" type="GENE"/>
    <entity charOffset="65-71" id="s259.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s259.e0" e2="s259.e1" id="s259.p0" relation="true"/>
  </sentence>
  <sentence id="s260" text="Inhibition of ER by its siRNA or tamoxifen reduces cellular levels of Brf1 and Pol III gene expression and decreases the rate of colony formation of breast cancer cells.">
    <entity charOffset="71-75" id="s260.e0" ontology_id="677" text="Brf1" type="GENE"/>
    <entity charOffset="157-163" id="s260.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s260.e0" e2="s260.e1" id="s260.p0" relation="true"/>
  </sentence>
  <sentence id="s261" text="The most important finding is the recurrently mutated gene, ASXL3, which has never been reported in parathyroid tumors before.">
    <entity charOffset="60-65" id="s261.e0" ontology_id="80816" text="ASXL3" type="GENE"/>
    <entity charOffset="112-117" id="s261.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s261.e0" e2="s261.e1" id="s261.p0" relation="true"/>
  </sentence>
  <sentence id="s262" text="Moreover, we identified two different somatic mutations in the CDC73 gene and one somatic mutation in the EZH2 gene.">
    <entity charOffset="38-54" id="s262.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="63-68" id="s262.e1" ontology_id="79577" text="CDC73" type="GENE"/>
    <pair e1="s262.e0" e2="s262.e1" id="s262.p0" relation="true"/>
  </sentence>
  <sentence id="s263" text="Moreover, we identified two different somatic mutations in the CDC73 gene and one somatic mutation in the EZH2 gene.">
    <entity charOffset="38-54" id="s263.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="106-110" id="s263.e1" ontology_id="2146" text="EZH2" type="GENE"/>
    <pair e1="s263.e0" e2="s263.e1" id="s263.p0" relation="true"/>
  </sentence>
  <sentence id="s264" text="The Y54X mutation in the CDC73 gene was previously identified in parathyroid carcinomas, which proved that parathyroid adenomas and carcinomas might possess similar molecular signatures.">
    <entity charOffset="25-30" id="s264.e0" ontology_id="79577" text="CDC73" type="GENE"/>
    <entity charOffset="65-87" id="s264.e1" ontology_id="HP_0006780" text="parathyroid carcinomas" type="HP"/>
    <pair e1="s264.e0" e2="s264.e1" id="s264.p0" relation="true"/>
  </sentence>
  <sentence id="s265" text="The congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms.">
    <entity charOffset="37-40" id="s265.e0" ontology_id="23607" text="CMS" type="GENE"/>
    <entity charOffset="46-59" id="s265.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s265.e0" e2="s265.e1" id="s265.p0" relation="true"/>
  </sentence>
  <sentence id="s266" text="In a patient with Leigh-like syndrome presenting with leukodystrophy and severe epilepsy, we identified a homozygous splice site mutation in COX8A, which codes for the ubiquitously expressed isoform of subunit VIII, the smallest nuclear-encoded subunit of complex IV.">
    <entity charOffset="80-88" id="s266.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="141-146" id="s266.e1" ontology_id="1351" text="COX8A" type="GENE"/>
    <pair e1="s266.e0" e2="s266.e1" id="s266.p0" relation="true"/>
  </sentence>
  <sentence id="s267" text="The purpose of this study is to investigate whether NTS can modulate the osteoclastogenesis induced by RANKL or cancer cells.">
    <entity charOffset="52-55" id="s267.e0" ontology_id="4922" text="NTS" type="GENE"/>
    <entity charOffset="112-118" id="s267.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s267.e0" e2="s267.e1" id="s267.p0" relation="true"/>
  </sentence>
  <sentence id="s268" text="The purpose of this study is to investigate whether NTS can modulate the osteoclastogenesis induced by RANKL or cancer cells.">
    <entity charOffset="103-108" id="s268.e0" ontology_id="8600" text="RANKL" type="GENE"/>
    <entity charOffset="112-118" id="s268.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s268.e0" e2="s268.e1" id="s268.p0" relation="true"/>
  </sentence>
  <sentence id="s269" text="We found that NTS inhibits RANKL- or cancer cell-mediated osteoclastogenesis via blockade of TRAF6 and NF-B activation.">
    <entity charOffset="14-17" id="s269.e0" ontology_id="4922" text="NTS" type="GENE"/>
    <entity charOffset="37-43" id="s269.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s269.e0" e2="s269.e1" id="s269.p0" relation="true"/>
  </sentence>
  <sentence id="s270" text="We found that NTS inhibits RANKL- or cancer cell-mediated osteoclastogenesis via blockade of TRAF6 and NF-B activation.">
    <entity charOffset="37-43" id="s270.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="93-98" id="s270.e1" ontology_id="7189" text="TRAF6" type="GENE"/>
    <pair e1="s270.e0" e2="s270.e1" id="s270.p0" relation="true"/>
  </sentence>
  <sentence id="s271" text="We found that NTS inhibits RANKL- or cancer cell-mediated osteoclastogenesis via blockade of TRAF6 and NF-B activation.">
    <entity charOffset="37-43" id="s271.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="103-105" id="s271.e1" ontology_id="23114" text="NF" type="GENE"/>
    <pair e1="s271.e0" e2="s271.e1" id="s271.p0" relation="true"/>
  </sentence>
  <sentence id="s272" text="Almost all are inherited in autosomal recessive patterns with a few exceptions such as the X-linked ALG13.">
    <entity charOffset="28-47" id="s272.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="100-105" id="s272.e1" ontology_id="79868" text="ALG13" type="GENE"/>
    <pair e1="s272.e0" e2="s272.e1" id="s272.p0" relation="true"/>
  </sentence>
  <sentence id="s273" text="Here, we show that tamoxifen, a well-known drug used against breast cancer, rescues the phenotype of Mtm1-deficient mice.">
    <entity charOffset="68-74" id="s273.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="101-105" id="s273.e1" ontology_id="4534" text="Mtm1" type="GENE"/>
    <pair e1="s273.e0" e2="s273.e1" id="s273.p0" relation="true"/>
  </sentence>
  <sentence id="s274" text="Congenital dyserythropoietic anemia type I (CDAI) is a rare autosomal recessive disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.">
    <entity charOffset="36-40" id="s274.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="60-79" id="s274.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s274.e0" e2="s274.e1" id="s274.p0" relation="true"/>
  </sentence>
  <sentence id="s275" text="Congenital dyserythropoietic anemia type I (CDAI) is a rare autosomal recessive disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.">
    <entity charOffset="44-48" id="s275.e0" ontology_id="146059" text="CDAI" type="GENE"/>
    <entity charOffset="60-79" id="s275.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s275.e0" e2="s275.e1" id="s275.p0" relation="true"/>
  </sentence>
  <sentence id="s276" text="Congenital dyserythropoietic anemia type I (CDAI) is a rare autosomal recessive disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.">
    <entity charOffset="44-48" id="s276.e0" ontology_id="146059" text="CDAI" type="GENE"/>
    <entity charOffset="124-150" id="s276.e1" ontology_id="HP_0010972" text="ineffective erythropoiesis" type="HP"/>
    <pair e1="s276.e0" e2="s276.e1" id="s276.p0" relation="true"/>
  </sentence>
  <sentence id="s277" text="HGK is also involved in cancer cell migration.">
    <entity charOffset="0-3" id="s277.e0" ontology_id="9448" text="HGK" type="GENE"/>
    <entity charOffset="24-30" id="s277.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s277.e0" e2="s277.e1" id="s277.p0" relation="true"/>
  </sentence>
  <sentence id="s278" text="Subsequently, the top 12 highly mutated genes were selected for validation by polymerase chain reaction and DNA sequencing in an expanded sample set including FLC, sporadic lung cancer, and healthy population.">
    <entity charOffset="145-148" id="s278.e0" ontology_id="6418" text="set" type="GENE"/>
    <entity charOffset="164-172" id="s278.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s278.e0" e2="s278.e1" id="s278.p0" relation="true"/>
  </sentence>
  <sentence id="s279" text="Subsequently, the top 12 highly mutated genes were selected for validation by polymerase chain reaction and DNA sequencing in an expanded sample set including FLC, sporadic lung cancer, and healthy population.">
    <entity charOffset="145-148" id="s279.e0" ontology_id="6418" text="set" type="GENE"/>
    <entity charOffset="178-184" id="s279.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s279.e0" e2="s279.e1" id="s279.p0" relation="true"/>
  </sentence>
  <sentence id="s280" text="Mutations of the five genes (ARHGEF5, ANKRD20A2, ZNF595, ZNF812, MYO18B) may be potential germline mutations of lung cancer.">
    <entity charOffset="29-36" id="s280.e0" ontology_id="7984" text="ARHGEF5" type="GENE"/>
    <entity charOffset="117-123" id="s280.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s280.e0" e2="s280.e1" id="s280.p0" relation="true"/>
  </sentence>
  <sentence id="s281" text="Mutations of the five genes (ARHGEF5, ANKRD20A2, ZNF595, ZNF812, MYO18B) may be potential germline mutations of lung cancer.">
    <entity charOffset="49-55" id="s281.e0" ontology_id="152687" text="ZNF595" type="GENE"/>
    <entity charOffset="117-123" id="s281.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s281.e0" e2="s281.e1" id="s281.p0" relation="true"/>
  </sentence>
  <sentence id="s282" text="Mutations of the five genes (ARHGEF5, ANKRD20A2, ZNF595, ZNF812, MYO18B) may be potential germline mutations of lung cancer.">
    <entity charOffset="65-71" id="s282.e0" ontology_id="84700" text="MYO18B" type="GENE"/>
    <entity charOffset="117-123" id="s282.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s282.e0" e2="s282.e1" id="s282.p0" relation="true"/>
  </sentence>
  <sentence id="s283" text="We also analyzed specific mutations within the 12 genes and found that some specific mutations within the MUC12, FOXD4L3 and FOXD4L5 genes showed higher frequencies in the samples of FLC and/or lung cancer tissue, compared with the healthy population.">
    <entity charOffset="106-111" id="s283.e0" ontology_id="10071" text="MUC12" type="GENE"/>
    <entity charOffset="199-205" id="s283.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s283.e0" e2="s283.e1" id="s283.p0" relation="true"/>
  </sentence>
  <sentence id="s284" text="We also analyzed specific mutations within the 12 genes and found that some specific mutations within the MUC12, FOXD4L3 and FOXD4L5 genes showed higher frequencies in the samples of FLC and/or lung cancer tissue, compared with the healthy population.">
    <entity charOffset="113-120" id="s284.e0" ontology_id="286380" text="FOXD4L3" type="GENE"/>
    <entity charOffset="199-205" id="s284.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s284.e0" e2="s284.e1" id="s284.p0" relation="true"/>
  </sentence>
  <sentence id="s285" text="We also analyzed specific mutations within the 12 genes and found that some specific mutations within the MUC12, FOXD4L3 and FOXD4L5 genes showed higher frequencies in the samples of FLC and/or lung cancer tissue, compared with the healthy population.">
    <entity charOffset="125-132" id="s285.e0" ontology_id="653427" text="FOXD4L5" type="GENE"/>
    <entity charOffset="199-205" id="s285.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s285.e0" e2="s285.e1" id="s285.p0" relation="true"/>
  </sentence>
  <sentence id="s286" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s286.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="157-161" id="s286.e1" ontology_id="25806" text="VAX2" type="GENE"/>
    <pair e1="s286.e0" e2="s286.e1" id="s286.p0" relation="true"/>
  </sentence>
  <sentence id="s287" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s287.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="290-295" id="s287.e1" ontology_id="3645" text="INSRR" type="GENE"/>
    <pair e1="s287.e0" e2="s287.e1" id="s287.p0" relation="true"/>
  </sentence>
  <sentence id="s288" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s288.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="297-303" id="s288.e1" ontology_id="63978" text="PRDM14" type="GENE"/>
    <pair e1="s288.e0" e2="s288.e1" id="s288.p0" relation="true"/>
  </sentence>
  <sentence id="s289" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s289.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="305-309" id="s289.e1" ontology_id="30813" text="VSX1" type="GENE"/>
    <pair e1="s289.e0" e2="s289.e1" id="s289.p0" relation="true"/>
  </sentence>
  <sentence id="s290" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s290.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="311-317" id="s290.e1" ontology_id="7021" text="TFAP2b" type="GENE"/>
    <pair e1="s290.e0" e2="s290.e1" id="s290.p0" relation="false"/>
  </sentence>
  <sentence id="s291" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s291.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="319-324" id="s291.e1" ontology_id="5396" text="PRRX1" type="GENE"/>
    <pair e1="s291.e0" e2="s291.e1" id="s291.p0" relation="true"/>
  </sentence>
  <sentence id="s292" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s292.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="330-338" id="s292.e1" ontology_id="8361" text="HIST1H4F" type="GENE"/>
    <pair e1="s292.e0" e2="s292.e1" id="s292.p0" relation="true"/>
  </sentence>
  <sentence id="s293" text="In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of EGFR in patient HNSCC samples.">
    <entity charOffset="33-38" id="s293.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="183-187" id="s293.e1" ontology_id="1956" text="EGFR" type="GENE"/>
    <pair e1="s293.e0" e2="s293.e1" id="s293.p0" relation="true"/>
  </sentence>
  <sentence id="s294" text="In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of EGFR in patient HNSCC samples.">
    <entity charOffset="33-38" id="s294.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="87-92" id="s294.e1" ontology_id="595" text="CCND1" type="GENE"/>
    <pair e1="s294.e0" e2="s294.e1" id="s294.p0" relation="true"/>
  </sentence>
  <sentence id="s295" text="In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of EGFR in patient HNSCC samples.">
    <entity charOffset="33-38" id="s295.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="93-97" id="s295.e1" ontology_id="1021" text="CDK6" type="GENE"/>
    <pair e1="s295.e0" e2="s295.e1" id="s295.p0" relation="true"/>
  </sentence>
  <sentence id="s296" text="In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of EGFR in patient HNSCC samples.">
    <entity charOffset="50-64" id="s296.e0" ontology_id="HP_0009919" text="retinoblastoma" type="HP"/>
    <entity charOffset="87-92" id="s296.e1" ontology_id="595" text="CCND1" type="GENE"/>
    <pair e1="s296.e0" e2="s296.e1" id="s296.p0" relation="true"/>
  </sentence>
  <sentence id="s297" text="In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of EGFR in patient HNSCC samples.">
    <entity charOffset="50-64" id="s297.e0" ontology_id="HP_0009919" text="retinoblastoma" type="HP"/>
    <entity charOffset="93-97" id="s297.e1" ontology_id="1021" text="CDK6" type="GENE"/>
    <pair e1="s297.e0" e2="s297.e1" id="s297.p0" relation="true"/>
  </sentence>
  <sentence id="s298" text="EEF1A2 gene is highly expressed in the central nervous system and Eef1a2 knockout mice show the neuronal degeneration.">
    <entity charOffset="0-6" id="s298.e0" ontology_id="1917" text="EEF1A2" type="GENE"/>
    <entity charOffset="39-46" id="s298.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s298.e0" e2="s298.e1" id="s298.p0" relation="true"/>
  </sentence>
  <sentence id="s299" text="EEF1A2 gene is highly expressed in the central nervous system and Eef1a2 knockout mice show the neuronal degeneration.">
    <entity charOffset="39-46" id="s299.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="82-86" id="s299.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s299.e0" e2="s299.e1" id="s299.p0" relation="true"/>
  </sentence>
  <sentence id="s300" text="Here, we report that the expression of microRNA-493 (miR-493) is decreased in HCC cell lines and in tumor tissues.">
    <entity charOffset="53-56" id="s300.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="100-105" id="s300.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s300.e0" e2="s300.e1" id="s300.p0" relation="true"/>
  </sentence>
  <sentence id="s301" text="Overexpression of miR-493 in HCC cells dramatically inhibited cell proliferation and colony-formation in vitro and inhibited tumor formation of HCC cell xenografts in vivo.">
    <entity charOffset="18-21" id="s301.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="125-130" id="s301.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s301.e0" e2="s301.e1" id="s301.p0" relation="true"/>
  </sentence>
  <sentence id="s302" text="Novel targets ANTXR1 and RSPO2 were confirmed to be suppressed by miR-493 directly, and overexpression of ANTXR1 and RSPO2 could restore tumorigenesis in miR-493 treated HCC cell.">
    <entity charOffset="14-20" id="s302.e0" ontology_id="84168" text="ANTXR1" type="GENE"/>
    <entity charOffset="137-142" id="s302.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s302.e0" e2="s302.e1" id="s302.p0" relation="true"/>
  </sentence>
  <sentence id="s303" text="Novel targets ANTXR1 and RSPO2 were confirmed to be suppressed by miR-493 directly, and overexpression of ANTXR1 and RSPO2 could restore tumorigenesis in miR-493 treated HCC cell.">
    <entity charOffset="66-69" id="s303.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="137-142" id="s303.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s303.e0" e2="s303.e1" id="s303.p0" relation="true"/>
  </sentence>
  <sentence id="s304" text="Moreover, Wnt/-catenin signaling pathway, which was reported to be activated by ANTXR1 and RSPO2, was also inhibited by miR-493 overexpression and might be involved in anti-tumor function of miR-493.">
    <entity charOffset="92-97" id="s304.e0" ontology_id="340419" text="RSPO2" type="GENE"/>
    <entity charOffset="174-179" id="s304.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s304.e0" e2="s304.e1" id="s304.p0" relation="true"/>
  </sentence>
  <sentence id="s305" text="Moreover, Wnt/-catenin signaling pathway, which was reported to be activated by ANTXR1 and RSPO2, was also inhibited by miR-493 overexpression and might be involved in anti-tumor function of miR-493.">
    <entity charOffset="121-124" id="s305.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="174-179" id="s305.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s305.e0" e2="s305.e1" id="s305.p0" relation="true"/>
  </sentence>
  <sentence id="s306" text="We present a young boy whose mild ataxia and abnormal eye movements repeatedly deteriorated with fever, making him unable to sit or walk during fever episodes.">
    <entity charOffset="45-67" id="s306.e0" ontology_id="HP_0000496" text="abnormal eye movements" type="HP"/>
    <entity charOffset="125-128" id="s306.e1" ontology_id="55733" text="sit" type="GENE"/>
    <pair e1="s306.e0" e2="s306.e1" id="s306.p0" relation="true"/>
  </sentence>
  <sentence id="s307" text="This family demonstrates phenotypic variability of FGF14 deletions (SCA 27), fever sensitivity of ataxia and the added value of SNP-array analysis in making a diagnosis">
    <entity charOffset="51-56" id="s307.e0" ontology_id="2259" text="FGF14" type="GENE"/>
    <entity charOffset="98-104" id="s307.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s307.e0" e2="s307.e1" id="s307.p0" relation="true"/>
  </sentence>
  <sentence id="s308" text="The disease family of muscular dystrophy-dystroglycanopathy (MDDG) contains a spectrum of severe to mild disorders, designated as MDDG type A to C.">
    <entity charOffset="22-40" id="s308.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="135-139" id="s308.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s308.e0" e2="s308.e1" id="s308.p0" relation="true"/>
  </sentence>
  <sentence id="s309" text="Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="13-18" id="s309.e0" ontology_id="10585" text="POMT1" type="GENE"/>
    <entity charOffset="140-160" id="s309.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s309.e0" e2="s309.e1" id="s309.p0" relation="true"/>
  </sentence>
  <sentence id="s310" text="Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="27-34" id="s310.e0" ontology_id="55624" text="POMGNT1" type="GENE"/>
    <entity charOffset="140-160" id="s310.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s310.e0" e2="s310.e1" id="s310.p0" relation="true"/>
  </sentence>
  <sentence id="s311" text="Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="36-40" id="s311.e0" ontology_id="2218" text="FKTN" type="GENE"/>
    <entity charOffset="140-160" id="s311.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s311.e0" e2="s311.e1" id="s311.p0" relation="true"/>
  </sentence>
  <sentence id="s312" text="Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="72-78" id="s312.e0" ontology_id="1282" text="COL4A1" type="GENE"/>
    <entity charOffset="140-160" id="s312.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s312.e0" e2="s312.e1" id="s312.p0" relation="true"/>
  </sentence>
  <sentence id="s313" text="Patients with WWS frequently demonstrate a complete lack of psychomotor development, severe eye malformations, cobblestone lissencephaly and a hypoplastic cerebellum and brainstem, seizures, hydrocephalus and poor prognosis.">
    <entity charOffset="14-17" id="s313.e0" ontology_id="55906" text="WWS" type="GENE"/>
    <entity charOffset="181-189" id="s313.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s313.e0" e2="s313.e1" id="s313.p0" relation="true"/>
  </sentence>
  <sentence id="s314" text="Patients with WWS frequently demonstrate a complete lack of psychomotor development, severe eye malformations, cobblestone lissencephaly and a hypoplastic cerebellum and brainstem, seizures, hydrocephalus and poor prognosis.">
    <entity charOffset="14-17" id="s314.e0" ontology_id="55906" text="WWS" type="GENE"/>
    <entity charOffset="191-204" id="s314.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s314.e0" e2="s314.e1" id="s314.p0" relation="true"/>
  </sentence>
  <sentence id="s315" text="We also demonstrate that tumor-associated MSCs induce the expression of genes associated with an aggressive phenotype in primary lung cancer cells and selectively promote their dissemination rather than local growth.">
    <entity charOffset="25-30" id="s315.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="42-45" id="s315.e1" ontology_id="9242" text="MSC" type="GENE"/>
    <pair e1="s315.e0" e2="s315.e1" id="s315.p0" relation="true"/>
  </sentence>
  <sentence id="s316" text="Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (SLC12A6).">
    <entity charOffset="427-437" id="s316.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="643-650" id="s316.e1" ontology_id="9990" text="SLC12A6" type="GENE"/>
    <pair e1="s316.e0" e2="s316.e1" id="s316.p0" relation="true"/>
  </sentence>
  <sentence id="s317" text="By analysing prostate cancer bone metastases using high density microarrays, we found a common genomic copy number loss at 6q16.1-16.2, containing the FBXL4 gene, which was confirmed in larger series of bone metastases by fluorescence in situ hybridisation (FISH).">
    <entity charOffset="22-28" id="s317.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="151-156" id="s317.e1" ontology_id="26235" text="FBXL4" type="GENE"/>
    <pair e1="s317.e0" e2="s317.e1" id="s317.p0" relation="true"/>
  </sentence>
  <sentence id="s318" text="Loss of FBXL4 was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (PSA) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.">
    <entity charOffset="8-13" id="s318.e0" ontology_id="26235" text="FBXL4" type="GENE"/>
    <entity charOffset="43-50" id="s318.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s318.e0" e2="s318.e1" id="s318.p0" relation="true"/>
  </sentence>
  <sentence id="s319" text="Loss of FBXL4 was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (PSA) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.">
    <entity charOffset="43-50" id="s319.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="177-180" id="s319.e1" ontology_id="3818" text="PSA" type="GENE"/>
    <pair e1="s319.e0" e2="s319.e1" id="s319.p0" relation="true"/>
  </sentence>
  <sentence id="s320" text="We also demonstrated that FBXL4 deletion is detectable in circulating tumour cells (CTCs), making it a potential prognostic biomarker by 'liquid biopsy'.">
    <entity charOffset="26-31" id="s320.e0" ontology_id="26235" text="FBXL4" type="GENE"/>
    <entity charOffset="70-76" id="s320.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s320.e0" e2="s320.e1" id="s320.p0" relation="true"/>
  </sentence>
  <sentence id="s321" text="In vitro analysis showed that FBXL4 plays a role in regulating the migration and invasion of prostate cancer cells.">
    <entity charOffset="30-35" id="s321.e0" ontology_id="26235" text="FBXL4" type="GENE"/>
    <entity charOffset="102-108" id="s321.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s321.e0" e2="s321.e1" id="s321.p0" relation="true"/>
  </sentence>
  <sentence id="s322" text="Therefore, FBXL4 could be a potential novel prostate cancer suppressor gene, which may prevent cancer progression and metastasis through controlling cell invasion">
    <entity charOffset="11-16" id="s322.e0" ontology_id="26235" text="FBXL4" type="GENE"/>
    <entity charOffset="53-59" id="s322.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s322.e0" e2="s322.e1" id="s322.p0" relation="true"/>
  </sentence>
  <sentence id="s323" text="The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="34-42" id="s323.e0" ontology_id="5270" text="SERPINE2" type="GENE"/>
    <entity charOffset="76-81" id="s323.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s323.e0" e2="s323.e1" id="s323.p0" relation="true"/>
  </sentence>
  <sentence id="s324" text="The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="61-66" id="s324.e0" ontology_id="22821" text="RASA3" type="GENE"/>
    <entity charOffset="76-81" id="s324.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s324.e0" e2="s324.e1" id="s324.p0" relation="true"/>
  </sentence>
  <sentence id="s325" text="The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="76-81" id="s325.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="88-93" id="s325.e1" ontology_id="5468" text="PPARG" type="GENE"/>
    <pair e1="s325.e0" e2="s325.e1" id="s325.p0" relation="true"/>
  </sentence>
  <sentence id="s326" text="The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="76-81" id="s326.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="101-105" id="s326.e1" ontology_id="1510" text="CTSE" type="GENE"/>
    <pair e1="s326.e0" e2="s326.e1" id="s326.p0" relation="true"/>
  </sentence>
  <sentence id="s327" text="In the present study, western blotting was used to verified the expression of Tlymphocyte CaSR and pathway proteins, including phosphorylated extracellular signalregulated kinase (PERK)1/2 and phosphorylated cJun Nterminal kinase (PJNK), and used cytometric bead array to detect the secretion of interleukin (IL)4, IL6, IL10 and tumor necrosis factor (TNF) in AMI onset, the results demonstrated that they were all increased.">
    <entity charOffset="91-95" id="s327.e0" ontology_id="846" text="CaSR" type="GENE"/>
    <entity charOffset="338-343" id="s327.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s327.e0" e2="s327.e1" id="s327.p0" relation="false"/>
  </sentence>
  <sentence id="s328" text="We used the Illumina HumanMethylation450 BeadChip microarray to test whether white blood cell DNA, an easily accessible source of DNA, exhibits site-specific changes in DNA methylation in blood of diagnosed HCC patients (post-diagnostic, 24 cases, 24 controls) and in prospectively collected blood specimens of HCC patients who were cancer-free at blood collection (pre-diagnostic, 21 cases, 21 controls).">
    <entity charOffset="207-210" id="s328.e0" ontology_id="84668" text="HCC" type="GENE"/>
    <entity charOffset="333-339" id="s328.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s328.e0" e2="s328.e1" id="s328.p0" relation="false"/>
  </sentence>
  <sentence id="s329" text="Our findings highlight the significance of recalibrating tumor cell metabolism by fine-tuning nucleotide and NAD synthesis in tumor growth.&lt;b&gt;Significance:&lt;/b&gt; Our findings elucidate an instrumental function of AMPK in direct regulation of nucleic acid and NAD synthesis in tumor cells in response to energy stress.">
    <entity charOffset="57-62" id="s329.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="211-215" id="s329.e1" ontology_id="5563" text="AMPK" type="GENE"/>
    <pair e1="s329.e0" e2="s329.e1" id="s329.p0" relation="false"/>
  </sentence>
  <sentence id="s330" text="Mutations in two genes, &lt;i&gt;PKD1&lt;/i&gt; and &lt;i&gt;PKD2&lt;/i&gt;, account for most cases of autosomal dominant polycystic kidney disease, one of the most common monogenetic disorders.">
    <entity charOffset="27-31" id="s330.e0" ontology_id="5310" text="PKD1" type="GENE"/>
    <entity charOffset="109-123" id="s330.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s330.e0" e2="s330.e1" id="s330.p0" relation="true"/>
  </sentence>
  <sentence id="s331" text="Mutations in two genes, &lt;i&gt;PKD1&lt;/i&gt; and &lt;i&gt;PKD2&lt;/i&gt;, account for most cases of autosomal dominant polycystic kidney disease, one of the most common monogenetic disorders.">
    <entity charOffset="43-47" id="s331.e0" ontology_id="25865" text="PKD2" type="GENE"/>
    <entity charOffset="109-123" id="s331.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s331.e0" e2="s331.e1" id="s331.p0" relation="false"/>
  </sentence>
  <sentence id="s332" text="Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K).">
    <entity charOffset="156-175" id="s332.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="177-182" id="s332.e1" ontology_id="54332" text="CMT4A" type="GENE"/>
    <pair e1="s332.e0" e2="s332.e1" id="s332.p0" relation="true"/>
  </sentence>
  <sentence id="s333" text="Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K).">
    <entity charOffset="156-175" id="s333.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="187-189" id="s333.e1" ontology_id="231" text="AR" type="GENE"/>
    <pair e1="s333.e0" e2="s333.e1" id="s333.p0" relation="true"/>
  </sentence>
  <sentence id="s334" text="Three families (families 1, 2 and 3) were found to have an autosomal recessive (AR) pattern of inheritance while family 4 displayed an autosomal dominant (AD) mode of inheritance.">
    <entity charOffset="59-78" id="s334.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="80-82" id="s334.e1" ontology_id="231" text="AR" type="GENE"/>
    <pair e1="s334.e0" e2="s334.e1" id="s334.p0" relation="true"/>
  </sentence>
  <sentence id="s335" text="Three families (families 1, 2 and 3) were found to have an autosomal recessive (AR) pattern of inheritance while family 4 displayed an autosomal dominant (AD) mode of inheritance.">
    <entity charOffset="80-82" id="s335.e0" ontology_id="231" text="AR" type="GENE"/>
    <entity charOffset="159-178" id="s335.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s335.e0" e2="s335.e1" id="s335.p0" relation="true"/>
  </sentence>
  <sentence id="s336" text="Electro-physiologic studies revealed an axonal type of neuropathy (AR-CMT2K and AD-CMT2K) in all affected individuals.">
    <entity charOffset="55-65" id="s336.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="67-69" id="s336.e1" ontology_id="231" text="AR" type="GENE"/>
    <pair e1="s336.e0" e2="s336.e1" id="s336.p0" relation="true"/>
  </sentence>
  <sentence id="s337" text="Delayed bone age and seizure disorders were overrepresented in the TTDN1 group (P=0.009 and P=0.024, respectively), whereas some characteristic TTD clinical, laboratory, and imaging findings were absent.">
    <entity charOffset="21-28" id="s337.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="67-70" id="s337.e1" ontology_id="404672" text="TTD" type="GENE"/>
    <pair e1="s337.e0" e2="s337.e1" id="s337.p0" relation="true"/>
  </sentence>
  <sentence id="s338" text="We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of STAR syndrome, a suspected ciliopathy.">
    <entity charOffset="266-274" id="s338.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="383-387" id="s338.e1" ontology_id="2984" text="STAR" type="GENE"/>
    <pair e1="s338.e0" e2="s338.e1" id="s338.p0" relation="false"/>
  </sentence>
  <sentence id="s339" text="We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of STAR syndrome, a suspected ciliopathy.">
    <entity charOffset="298-317" id="s339.e0" ontology_id="HP_0003468" text="vertebral anomalies" type="HP"/>
    <entity charOffset="383-387" id="s339.e1" ontology_id="2984" text="STAR" type="GENE"/>
    <pair e1="s339.e0" e2="s339.e1" id="s339.p0" relation="true"/>
  </sentence>
  <sentence id="s340" text="We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of STAR syndrome, a suspected ciliopathy.">
    <entity charOffset="349-367" id="s340.e0" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <entity charOffset="383-387" id="s340.e1" ontology_id="2984" text="STAR" type="GENE"/>
    <pair e1="s340.e0" e2="s340.e1" id="s340.p0" relation="true"/>
  </sentence>
  <sentence id="s341" text="Affected individuals presented with prenatal-onset spinal muscular atrophy (SMA), multiple congenital contractures (arthrogryposis multiplex congenita), respiratory distress, and congenital bone fractures.">
    <entity charOffset="76-79" id="s341.e0" ontology_id="6606" text="SMA" type="GENE"/>
    <entity charOffset="102-114" id="s341.e1" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <pair e1="s341.e0" e2="s341.e1" id="s341.p0" relation="true"/>
  </sentence>
  <sentence id="s342" text="Molecular mechanisms of SWS pathogenesis are initiated by the somatic mutation in GNAQ.">
    <entity charOffset="24-27" id="s342.e0" ontology_id="10908" text="SWS" type="GENE"/>
    <entity charOffset="62-78" id="s342.e1" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <pair e1="s342.e0" e2="s342.e1" id="s342.p0" relation="true"/>
  </sentence>
  <sentence id="s343" text="Solid tumors developed and total tumor mass and the number of tumors were characterized.">
    <entity charOffset="6-11" id="s343.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="39-43" id="s343.e1" ontology_id="2200" text="mass" type="GENE"/>
    <pair e1="s343.e0" e2="s343.e1" id="s343.p0" relation="false"/>
  </sentence>
  <sentence id="s344" text="The vIL-6 gene had no significant impact on tumor mass, but significantly more tumors were detected when vIL-6 was present.">
    <entity charOffset="4-7" id="s344.e0" ontology_id="7429" text="vIL" type="GENE"/>
    <entity charOffset="44-49" id="s344.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s344.e0" e2="s344.e1" id="s344.p0" relation="true"/>
  </sentence>
  <sentence id="s345" text="Significant differences in expression of B cell markers in cells from extracted tumors were detected based upon the presence of vIL-6.">
    <entity charOffset="80-85" id="s345.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="128-131" id="s345.e1" ontology_id="7429" text="vIL" type="GENE"/>
    <pair e1="s345.e0" e2="s345.e1" id="s345.p0" relation="true"/>
  </sentence>
  <sentence id="s346" text="B cell markers in tumor cells were also compared to the same cell type in culture, prior to xenotransplantation; B cell markers were mostly downregulated during tumor formation and these changes did not differ based upon the presence of vIL-6.">
    <entity charOffset="18-23" id="s346.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="237-240" id="s346.e1" ontology_id="7429" text="vIL" type="GENE"/>
    <pair e1="s346.e0" e2="s346.e1" id="s346.p0" relation="true"/>
  </sentence>
  <sentence id="s347" text="These data indicate that vIL-6 plays a role in KSHV tumor formation in B cells in vivo.">
    <entity charOffset="25-28" id="s347.e0" ontology_id="7429" text="vIL" type="GENE"/>
    <entity charOffset="52-57" id="s347.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s347.e0" e2="s347.e1" id="s347.p0" relation="true"/>
  </sentence>
  <sentence id="s348" text="Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that cdGAP, an adhesion-localized Rac1 and Cdc42 specific GTPase activating protein, is necessary for U2OS osteosarcoma cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness.">
    <entity charOffset="99-104" id="s348.e0" ontology_id="57514" text="cdGAP" type="GENE"/>
    <entity charOffset="201-213" id="s348.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s348.e0" e2="s348.e1" id="s348.p0" relation="true"/>
  </sentence>
  <sentence id="s349" text="Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that cdGAP, an adhesion-localized Rac1 and Cdc42 specific GTPase activating protein, is necessary for U2OS osteosarcoma cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness.">
    <entity charOffset="128-132" id="s349.e0" ontology_id="5879" text="Rac1" type="GENE"/>
    <entity charOffset="201-213" id="s349.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s349.e0" e2="s349.e1" id="s349.p0" relation="true"/>
  </sentence>
  <sentence id="s350" text="Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that cdGAP, an adhesion-localized Rac1 and Cdc42 specific GTPase activating protein, is necessary for U2OS osteosarcoma cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness.">
    <entity charOffset="137-142" id="s350.e0" ontology_id="998" text="Cdc42" type="GENE"/>
    <entity charOffset="201-213" id="s350.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s350.e0" e2="s350.e1" id="s350.p0" relation="true"/>
  </sentence>
  <sentence id="s351" text="Mutation of aspartic acid 378 of hnRNPDL to either asparagine or histidine has been associated with limb girdle muscular dystrophy.">
    <entity charOffset="33-40" id="s351.e0" ontology_id="9987" text="hnRNPDL" type="GENE"/>
    <entity charOffset="100-130" id="s351.e1" ontology_id="HP_0006785" text="limb girdle muscular dystrophy" type="HP"/>
    <pair e1="s351.e0" e2="s351.e1" id="s351.p0" relation="true"/>
  </sentence>
  <sentence id="s352" text="According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of PAIP2B but not NAGK, MCEE or DYSF was significantly lower in pancreatic tumors than in normal adjacent tissues.">
    <entity charOffset="109-115" id="s352.e0" ontology_id="400961" text="PAIP2B" type="GENE"/>
    <entity charOffset="181-187" id="s352.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s352.e0" e2="s352.e1" id="s352.p0" relation="true"/>
  </sentence>
  <sentence id="s353" text="According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of PAIP2B but not NAGK, MCEE or DYSF was significantly lower in pancreatic tumors than in normal adjacent tissues.">
    <entity charOffset="130-134" id="s353.e0" ontology_id="84693" text="MCEE" type="GENE"/>
    <entity charOffset="181-187" id="s353.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s353.e0" e2="s353.e1" id="s353.p0" relation="true"/>
  </sentence>
  <sentence id="s354" text="According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of PAIP2B but not NAGK, MCEE or DYSF was significantly lower in pancreatic tumors than in normal adjacent tissues.">
    <entity charOffset="138-142" id="s354.e0" ontology_id="8291" text="DYSF" type="GENE"/>
    <entity charOffset="181-187" id="s354.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s354.e0" e2="s354.e1" id="s354.p0" relation="true"/>
  </sentence>
  <sentence id="s355" text="Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation.">
    <entity charOffset="8-15" id="s355.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="93-98" id="s355.e1" ontology_id="2130" text="EWSR1" type="GENE"/>
    <pair e1="s355.e0" e2="s355.e1" id="s355.p0" relation="true"/>
  </sentence>
  <sentence id="s356" text="Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation.">
    <entity charOffset="8-15" id="s356.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="99-103" id="s356.e1" ontology_id="2314" text="FLI1" type="GENE"/>
    <pair e1="s356.e0" e2="s356.e1" id="s356.p0" relation="false"/>
  </sentence>
  <sentence id="s357" text="Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation.">
    <entity charOffset="45-50" id="s357.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="93-98" id="s357.e1" ontology_id="2130" text="EWSR1" type="GENE"/>
    <pair e1="s357.e0" e2="s357.e1" id="s357.p0" relation="true"/>
  </sentence>
  <sentence id="s358" text="Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation.">
    <entity charOffset="45-50" id="s358.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="99-103" id="s358.e1" ontology_id="2314" text="FLI1" type="GENE"/>
    <pair e1="s358.e0" e2="s358.e1" id="s358.p0" relation="true"/>
  </sentence>
  <sentence id="s359" text="However, the major driver mutations in USP8 wild-type tumors remain elusive.">
    <entity charOffset="39-43" id="s359.e0" ontology_id="9101" text="USP8" type="GENE"/>
    <entity charOffset="54-60" id="s359.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s359.e0" e2="s359.e1" id="s359.p0" relation="true"/>
  </sentence>
  <sentence id="s360" text="FGD is a heterogeneous disorder for which causal mutations have been identified in MC2R, MRAP, MCM4 and TXNRD2.">
    <entity charOffset="9-22" id="s360.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="89-93" id="s360.e1" ontology_id="56246" text="MRAP" type="GENE"/>
    <pair e1="s360.e0" e2="s360.e1" id="s360.p0" relation="true"/>
  </sentence>
  <sentence id="s361" text="This study doubles the number of known mutations for this disorder, confirms that truncating mutations in C2orf37 are the only known cause of WSS, and suggests that mutations in this gene do not contribute significantly to cases presenting with isolated elements of WSS such as deafness and dystonia.">
    <entity charOffset="106-113" id="s361.e0" ontology_id="80067" text="C2orf37" type="GENE"/>
    <entity charOffset="278-286" id="s361.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s361.e0" e2="s361.e1" id="s361.p0" relation="false"/>
  </sentence>
  <sentence id="s362" text="This study doubles the number of known mutations for this disorder, confirms that truncating mutations in C2orf37 are the only known cause of WSS, and suggests that mutations in this gene do not contribute significantly to cases presenting with isolated elements of WSS such as deafness and dystonia.">
    <entity charOffset="106-113" id="s362.e0" ontology_id="80067" text="C2orf37" type="GENE"/>
    <entity charOffset="291-299" id="s362.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s362.e0" e2="s362.e1" id="s362.p0" relation="true"/>
  </sentence>
  <sentence id="s363" text="While the down regulation of PrKD1 by DNA methylation in gastric cancer and by nuclear beta-catenin in colon cancer has been shown, the regulatory mechanisms in other cancers are unknown.">
    <entity charOffset="29-34" id="s363.e0" ontology_id="5587" text="PrKD1" type="GENE"/>
    <entity charOffset="65-71" id="s363.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s363.e0" e2="s363.e1" id="s363.p0" relation="true"/>
  </sentence>
  <sentence id="s364" text="While the down regulation of PrKD1 by DNA methylation in gastric cancer and by nuclear beta-catenin in colon cancer has been shown, the regulatory mechanisms in other cancers are unknown.">
    <entity charOffset="65-71" id="s364.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="87-99" id="s364.e1" ontology_id="1499" text="beta-catenin" type="GENE"/>
    <pair e1="s364.e0" e2="s364.e1" id="s364.p0" relation="true"/>
  </sentence>
  <sentence id="s365" text="Because we had demonstrated that PrKD1 is the only known kinase to phosphorylate threonine 120 (T120) of beta-catenin in prostate cancer resulting in increased nuclear beta-catenin, we explored the role of beta-catenin in gene regulation of &lt;i&gt;PrKD1&lt;/i&gt;.">
    <entity charOffset="105-117" id="s365.e0" ontology_id="1499" text="beta-catenin" type="GENE"/>
    <entity charOffset="130-136" id="s365.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s365.e0" e2="s365.e1" id="s365.p0" relation="true"/>
  </sentence>
  <sentence id="s366" text="&lt;i&gt;In silico&lt;/i&gt; human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate cancer correlated inversely with the expression of MAX, but not MYC, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates &lt;i&gt;PrKD1&lt;/i&gt; gene expression.">
    <entity charOffset="81-86" id="s366.e0" ontology_id="5587" text="PrKD1" type="GENE"/>
    <entity charOffset="110-116" id="s366.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s366.e0" e2="s366.e1" id="s366.p0" relation="true"/>
  </sentence>
  <sentence id="s367" text="&lt;i&gt;In silico&lt;/i&gt; human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate cancer correlated inversely with the expression of MAX, but not MYC, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates &lt;i&gt;PrKD1&lt;/i&gt; gene expression.">
    <entity charOffset="110-116" id="s367.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="174-177" id="s367.e1" ontology_id="4609" text="MYC" type="GENE"/>
    <pair e1="s367.e0" e2="s367.e1" id="s367.p0" relation="true"/>
  </sentence>
  <sentence id="s368" text="&lt;i&gt;In silico&lt;/i&gt; human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate cancer correlated inversely with the expression of MAX, but not MYC, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates &lt;i&gt;PrKD1&lt;/i&gt; gene expression.">
    <entity charOffset="110-116" id="s368.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="161-164" id="s368.e1" ontology_id="4149" text="MAX" type="GENE"/>
    <pair e1="s368.e0" e2="s368.e1" id="s368.p0" relation="true"/>
  </sentence>
  <sentence id="s369" text="Small series of cases have documented the co-occurrence of ganglioneuroma with a pheochromocytoma (Pheo)/paraganglioma (PGL) component.">
    <entity charOffset="105-118" id="s369.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="120-123" id="s369.e1" ontology_id="6392" text="PGL" type="GENE"/>
    <pair e1="s369.e0" e2="s369.e1" id="s369.p0" relation="true"/>
  </sentence>
  <sentence id="s370" text="One patient had a retroperitoneal composite PGL-ganglioneuroma in the setting of neurofibromatosis type 1.">
    <entity charOffset="44-47" id="s370.e0" ontology_id="6392" text="PGL" type="GENE"/>
    <entity charOffset="81-98" id="s370.e1" ontology_id="HP_0001067" text="neurofibromatosis" type="HP"/>
    <pair e1="s370.e0" e2="s370.e1" id="s370.p0" relation="true"/>
  </sentence>
  <sentence id="s371" text="In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (ZNF688), early B cell factor 2 (EBF2), crystallin, alpha B (CRYAB) and tumor necrosis factor receptor superfamily member 13C (TNFRSF13C).">
    <entity charOffset="167-172" id="s371.e0" ontology_id="1410" text="CRYAB" type="GENE"/>
    <entity charOffset="178-183" id="s371.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s371.e0" e2="s371.e1" id="s371.p0" relation="true"/>
  </sentence>
  <sentence id="s372" text="In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (ZNF688), early B cell factor 2 (EBF2), crystallin, alpha B (CRYAB) and tumor necrosis factor receptor superfamily member 13C (TNFRSF13C).">
    <entity charOffset="178-183" id="s372.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="233-242" id="s372.e1" ontology_id="115650" text="TNFRSF13C" type="GENE"/>
    <pair e1="s372.e0" e2="s372.e1" id="s372.p0" relation="true"/>
  </sentence>
  <sentence id="s373" text="Chromosome conformation capture analysis showed that iCHAV2 interacts with the ZNF365 and NRBF2 (more than 600 kb away) promoters in normal and cancerous breast epithelial cells.">
    <entity charOffset="79-85" id="s373.e0" ontology_id="22891" text="ZNF365" type="GENE"/>
    <entity charOffset="144-150" id="s373.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s373.e0" e2="s373.e1" id="s373.p0" relation="true"/>
  </sentence>
  <sentence id="s374" text="Chromosome conformation capture analysis showed that iCHAV2 interacts with the ZNF365 and NRBF2 (more than 600 kb away) promoters in normal and cancerous breast epithelial cells.">
    <entity charOffset="90-95" id="s374.e0" ontology_id="29982" text="NRBF2" type="GENE"/>
    <entity charOffset="144-150" id="s374.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s374.e0" e2="s374.e1" id="s374.p0" relation="true"/>
  </sentence>
  <sentence id="s375" text="Luciferase assays did not identify SNPs that affect transactivation of ZNF365, but identified a protective haplotype in iCHAV2, associated with silencing of the NRBF2 promoter, implicating this gene in the etiology of breast cancer.">
    <entity charOffset="161-166" id="s375.e0" ontology_id="29982" text="NRBF2" type="GENE"/>
    <entity charOffset="225-231" id="s375.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s375.e0" e2="s375.e1" id="s375.p0" relation="true"/>
  </sentence>
  <sentence id="s376" text="The continuum of epithelial changes in the process of serous neoplasia including p53 signature, STIL, STIC and invasive carcinoma was identified in 8 cases of pelvic HGSC.">
    <entity charOffset="61-70" id="s376.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="96-100" id="s376.e1" ontology_id="6491" text="STIL" type="GENE"/>
    <pair e1="s376.e0" e2="s376.e1" id="s376.p0" relation="true"/>
  </sentence>
  <sentence id="s377" text="Humanization of SCID pigs would thus provide a valuable model system for researchers to study interactions between human tumor and human immune cells.">
    <entity charOffset="21-25" id="s377.e0" ontology_id="94005" text="pigs" type="GENE"/>
    <entity charOffset="121-126" id="s377.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s377.e0" e2="s377.e1" id="s377.p0" relation="true"/>
  </sentence>
  <sentence id="s378" text="Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).">
    <entity charOffset="25-28" id="s378.e0" ontology_id="2729" text="GCS" type="GENE"/>
    <entity charOffset="209-224" id="s378.e1" ontology_id="HP_0002154" text="hyperglycinemia" type="HP"/>
    <pair e1="s378.e0" e2="s378.e1" id="s378.p0" relation="true"/>
  </sentence>
  <sentence id="s379" text="Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).">
    <entity charOffset="111-115" id="s379.e0" ontology_id="2731" text="GLDC" type="GENE"/>
    <entity charOffset="167-181" id="s379.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s379.e0" e2="s379.e1" id="s379.p0" relation="true"/>
  </sentence>
  <sentence id="s380" text="Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).">
    <entity charOffset="117-120" id="s380.e0" ontology_id="275" text="AMT" type="GENE"/>
    <entity charOffset="167-181" id="s380.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s380.e0" e2="s380.e1" id="s380.p0" relation="true"/>
  </sentence>
  <sentence id="s381" text="Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).">
    <entity charOffset="117-120" id="s381.e0" ontology_id="275" text="AMT" type="GENE"/>
    <entity charOffset="209-224" id="s381.e1" ontology_id="HP_0002154" text="hyperglycinemia" type="HP"/>
    <pair e1="s381.e0" e2="s381.e1" id="s381.p0" relation="true"/>
  </sentence>
  <sentence id="s382" text="Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).">
    <entity charOffset="167-181" id="s382.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="226-229" id="s382.e1" ontology_id="275" text="NKH" type="GENE"/>
    <pair e1="s382.e0" e2="s382.e1" id="s382.p0" relation="true"/>
  </sentence>
  <sentence id="s383" text="Limb-girdle muscular dystrophy type 2D (LGMD2D) is a rare autosomal-recessive disease, affecting striated muscle, due to mutation of SGCA, the gene coding for -sarcoglycan.">
    <entity charOffset="12-30" id="s383.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="133-137" id="s383.e1" ontology_id="6442" text="SGCA" type="GENE"/>
    <pair e1="s383.e0" e2="s383.e1" id="s383.p0" relation="true"/>
  </sentence>
  <sentence id="s384" text="Corneal dystrophies may have a simple autosomal dominant, autosomal recessive or X-linked recessive Mendelian mode of inheritance.">
    <entity charOffset="31-37" id="s384.e0" ontology_id="9516" text="simple" type="GENE"/>
    <entity charOffset="58-77" id="s384.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s384.e0" e2="s384.e1" id="s384.p0" relation="true"/>
  </sentence>
  <sentence id="s385" text="Corneal dystrophies may have a simple autosomal dominant, autosomal recessive or X-linked recessive Mendelian mode of inheritance.">
    <entity charOffset="31-37" id="s385.e0" ontology_id="9516" text="simple" type="GENE"/>
    <entity charOffset="110-129" id="s385.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s385.e0" e2="s385.e1" id="s385.p0" relation="true"/>
  </sentence>
  <sentence id="s386" text="Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s386.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="61-66" id="s386.e1" ontology_id="4166" text="CHST6" type="GENE"/>
    <pair e1="s386.e0" e2="s386.e1" id="s386.p0" relation="true"/>
  </sentence>
  <sentence id="s387" text="Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s387.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="68-72" id="s387.e1" ontology_id="3850" text="KRT3" type="GENE"/>
    <pair e1="s387.e0" e2="s387.e1" id="s387.p0" relation="true"/>
  </sentence>
  <sentence id="s388" text="Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s388.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="89-96" id="s388.e1" ontology_id="83959" text="SLC4A11" type="GENE"/>
    <pair e1="s388.e0" e2="s388.e1" id="s388.p0" relation="true"/>
  </sentence>
  <sentence id="s389" text="Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s389.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="98-105" id="s389.e1" ontology_id="4070" text="TACSTD2" type="GENE"/>
    <pair e1="s389.e0" e2="s389.e1" id="s389.p0" relation="true"/>
  </sentence>
  <sentence id="s390" text="Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s390.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="107-112" id="s390.e1" ontology_id="7045" text="TGFBI" type="GENE"/>
    <pair e1="s390.e0" e2="s390.e1" id="s390.p0" relation="true"/>
  </sentence>
  <sentence id="s391" text="Herein, we investigated the role of LTBP3 in the distinct processes involved in cancer metastasis.">
    <entity charOffset="36-41" id="s391.e0" ontology_id="4054" text="LTBP3" type="GENE"/>
    <entity charOffset="80-86" id="s391.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s391.e0" e2="s391.e1" id="s391.p0" relation="true"/>
  </sentence>
  <sentence id="s392" text="By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.">
    <entity charOffset="21-26" id="s392.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="229-234" id="s392.e1" ontology_id="4054" text="LTBP3" type="GENE"/>
    <pair e1="s392.e0" e2="s392.e1" id="s392.p0" relation="true"/>
  </sentence>
  <sentence id="s393" text="By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.">
    <entity charOffset="124-136" id="s393.e0" ontology_id="HP_0100244" text="fibrosarcoma" type="HP"/>
    <entity charOffset="229-234" id="s393.e1" ontology_id="4054" text="LTBP3" type="GENE"/>
    <pair e1="s393.e0" e2="s393.e1" id="s393.p0" relation="true"/>
  </sentence>
  <sentence id="s394" text="A similar compensatory approach rescued the dampened intravasation of LTBP3-deficient HEp-3 cells, suggesting that LTBP3 regulates the induction of the intravasation-supporting angiogenic vasculature within developing primary tumors.">
    <entity charOffset="70-75" id="s394.e0" ontology_id="4054" text="LTBP3" type="GENE"/>
    <entity charOffset="226-231" id="s394.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s394.e0" e2="s394.e1" id="s394.p0" relation="true"/>
  </sentence>
  <sentence id="s395" text="Using our recently developed microtumor model, we confirmed that LTBP3 loss resulted in the development of intratumoral vessels with an abnormal microarchitecture incompatible with efficient intravasation of HEp-3 carcinoma cells.">
    <entity charOffset="34-39" id="s395.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="65-70" id="s395.e1" ontology_id="4054" text="LTBP3" type="GENE"/>
    <pair e1="s395.e0" e2="s395.e1" id="s395.p0" relation="true"/>
  </sentence>
  <sentence id="s396" text="Collectively, these findings demonstrate that LTBP3 represents a novel oncotarget that has distinctive functions in the regulation of angiogenesis-dependent tumor cell intravasation, a critical process during early cancer dissemination.">
    <entity charOffset="46-51" id="s396.e0" ontology_id="4054" text="LTBP3" type="GENE"/>
    <entity charOffset="215-221" id="s396.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s396.e0" e2="s396.e1" id="s396.p0" relation="true"/>
  </sentence>
  <sentence id="s397" text="Collectively, these findings demonstrate that LTBP3 represents a novel oncotarget that has distinctive functions in the regulation of angiogenesis-dependent tumor cell intravasation, a critical process during early cancer dissemination.">
    <entity charOffset="46-51" id="s397.e0" ontology_id="4054" text="LTBP3" type="GENE"/>
    <entity charOffset="157-162" id="s397.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s397.e0" e2="s397.e1" id="s397.p0" relation="true"/>
  </sentence>
  <sentence id="s398" text="Our experimental data are also consistent with the survival prognostic value of LTBP3 expression in early-stage head and neck squamous cell carcinomas, further indicating a specific role for LTBP3 in cancer progression toward metastatic disease">
    <entity charOffset="80-85" id="s398.e0" ontology_id="4054" text="LTBP3" type="GENE"/>
    <entity charOffset="200-206" id="s398.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s398.e0" e2="s398.e1" id="s398.p0" relation="true"/>
  </sentence>
  <sentence id="s399" text="Our experimental data are also consistent with the survival prognostic value of LTBP3 expression in early-stage head and neck squamous cell carcinomas, further indicating a specific role for LTBP3 in cancer progression toward metastatic disease">
    <entity charOffset="80-85" id="s399.e0" ontology_id="4054" text="LTBP3" type="GENE"/>
    <entity charOffset="140-150" id="s399.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s399.e0" e2="s399.e1" id="s399.p0" relation="true"/>
  </sentence>
  <sentence id="s400" text="All tumors were positive for AE1-AE3, CK18, PAX 8, antimitochondrial antigen, and SDHB.">
    <entity charOffset="4-10" id="s400.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="82-85" id="s400.e1" ontology_id="1757" text="SDH" type="GENE"/>
    <pair e1="s400.e0" e2="s400.e1" id="s400.p0" relation="true"/>
  </sentence>
  <sentence id="s401" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="142-148" id="s401.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="229-232" id="s401.e1" ontology_id="1757" text="SDH" type="GENE"/>
    <pair e1="s401.e0" e2="s401.e1" id="s401.p0" relation="true"/>
  </sentence>
  <sentence id="s402" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="142-148" id="s402.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="204-207" id="s402.e1" ontology_id="7515" text="RCC" type="GENE"/>
    <pair e1="s402.e0" e2="s402.e1" id="s402.p0" relation="true"/>
  </sentence>
  <sentence id="s403" text="Cone-rod degeneration (CRD) belongs to the disease spectrum of retinal degenerations, a group of hereditary disorders characterized by an extreme clinical and genetic heterogeneity.">
    <entity charOffset="5-8" id="s403.e0" ontology_id="9735" text="rod" type="GENE"/>
    <entity charOffset="63-84" id="s403.e1" ontology_id="HP_0000546" text="retinal degenerations" type="HP"/>
    <pair e1="s403.e0" e2="s403.e1" id="s403.p0" relation="true"/>
  </sentence>
  <sentence id="s404" text="Cone-rod degeneration (CRD) belongs to the disease spectrum of retinal degenerations, a group of hereditary disorders characterized by an extreme clinical and genetic heterogeneity.">
    <entity charOffset="23-26" id="s404.e0" ontology_id="1406" text="CRD" type="GENE"/>
    <entity charOffset="63-84" id="s404.e1" ontology_id="HP_0000546" text="retinal degenerations" type="HP"/>
    <pair e1="s404.e0" e2="s404.e1" id="s404.p0" relation="true"/>
  </sentence>
  <sentence id="s405" text="Interaction studies also showed that CEP78 binds to FAM161A, another ciliary protein associated with retinal degeneration.">
    <entity charOffset="37-42" id="s405.e0" ontology_id="84131" text="CEP78" type="GENE"/>
    <entity charOffset="101-121" id="s405.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s405.e0" e2="s405.e1" id="s405.p0" relation="true"/>
  </sentence>
  <sentence id="s406" text="Interaction studies also showed that CEP78 binds to FAM161A, another ciliary protein associated with retinal degeneration.">
    <entity charOffset="52-59" id="s406.e0" ontology_id="84140" text="FAM161A" type="GENE"/>
    <entity charOffset="101-121" id="s406.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s406.e0" e2="s406.e1" id="s406.p0" relation="true"/>
  </sentence>
  <sentence id="s407" text="Altogether, our data strongly suggest that mutations in CEP78 cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.">
    <entity charOffset="56-61" id="s407.e0" ontology_id="84131" text="CEP78" type="GENE"/>
    <entity charOffset="233-250" id="s407.e1" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <pair e1="s407.e0" e2="s407.e1" id="s407.p0" relation="true"/>
  </sentence>
  <sentence id="s408" text="B1 induced readthrough at all three nonsense codons in cultured cancer cells with &lt;i&gt;TP53&lt;/i&gt; (tumor protein p53) mutations, in cells from patients with nonsense mutations in the &lt;i&gt;TPP1&lt;/i&gt; (tripeptidyl peptidase 1), &lt;i&gt;DMD&lt;/i&gt; (dystrophin), &lt;i&gt;SMARCAL1&lt;/i&gt; (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1), and &lt;i&gt;COL7A1&lt;/i&gt; (collagen type VII alpha 1 chain) genes, and in an in vivo tumor xenograft model.">
    <entity charOffset="95-100" id="s408.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="385-389" id="s408.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s408.e0" e2="s408.e1" id="s408.p0" relation="true"/>
  </sentence>
  <sentence id="s409" text="Two common &lt;i&gt;POLG&lt;/i&gt; mutations usually found &lt;i&gt;in cis&lt;/i&gt; in patients primarily with progressive external ophthalmoplegia generate T251I and P587L amino acid substitutions.">
    <entity charOffset="14-18" id="s409.e0" ontology_id="5428" text="POLG" type="GENE"/>
    <entity charOffset="88-99" id="s409.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s409.e0" e2="s409.e1" id="s409.p0" relation="true"/>
  </sentence>
  <sentence id="s410" text="Somatic missense mutations in the Ser/Thr protein phosphatase 2A (PP2A) A scaffold subunit gene PPP2R1A are among the few genomic alterations that occur frequently in serous endometrial carcinoma (EC) and carcinosarcoma, two clinically aggressive subtypes of uterine cancer with few therapeutic options.">
    <entity charOffset="97-104" id="s410.e0" ontology_id="5518" text="PPP2R1A" type="GENE"/>
    <entity charOffset="175-196" id="s410.e1" ontology_id="HP_0012114" text="endometrial carcinoma" type="HP"/>
    <pair e1="s410.e0" e2="s410.e1" id="s410.p0" relation="true"/>
  </sentence>
  <sentence id="s411" text="Somatic missense mutations in the Ser/Thr protein phosphatase 2A (PP2A) A scaffold subunit gene PPP2R1A are among the few genomic alterations that occur frequently in serous endometrial carcinoma (EC) and carcinosarcoma, two clinically aggressive subtypes of uterine cancer with few therapeutic options.">
    <entity charOffset="97-104" id="s411.e0" ontology_id="5518" text="PPP2R1A" type="GENE"/>
    <entity charOffset="268-274" id="s411.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s411.e0" e2="s411.e1" id="s411.p0" relation="true"/>
  </sentence>
  <sentence id="s412" text="Accordingly, overexpression of the A mutants in EC cells harboring wild-type PPP2R1A increased anchorage-independent growth and tumor formation, and triggered hyperphosphorylation of oncogenic PP2A-B56/B' substrates in the GSK3, Akt, and mTOR/p70S6K signaling pathways.">
    <entity charOffset="78-85" id="s412.e0" ontology_id="5518" text="PPP2R1A" type="GENE"/>
    <entity charOffset="129-134" id="s412.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s412.e0" e2="s412.e1" id="s412.p0" relation="true"/>
  </sentence>
  <sentence id="s413" text="By pooling genetic findings across multiple studies, we have identified six individuals with severe developmental delay (6/6), refractory seizures (5/6), and similar dysmorphic features (3/6), each harboring a de novo mutation in PPP3CA.">
    <entity charOffset="100-119" id="s413.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="230-236" id="s413.e1" ontology_id="5530" text="PPP3CA" type="GENE"/>
    <pair e1="s413.e0" e2="s413.e1" id="s413.p0" relation="true"/>
  </sentence>
  <sentence id="s414" text="Based on these findings, we securely implicate PPP3CA in early-onset refractory epilepsy and further support the emerging role for synaptic dysregulation in epilepsy">
    <entity charOffset="47-53" id="s414.e0" ontology_id="5530" text="PPP3CA" type="GENE"/>
    <entity charOffset="80-88" id="s414.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s414.e0" e2="s414.e1" id="s414.p0" relation="true"/>
  </sentence>
  <sentence id="s415" text="Biotin Thiamine responsive Basal Ganglia Disease (BTBGD) is a rare treatable autosomal recessive metabolic disorder caused by mutations in SLC19A3 gene.">
    <entity charOffset="77-96" id="s415.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="139-146" id="s415.e1" ontology_id="80704" text="SLC19A3" type="GENE"/>
    <pair e1="s415.e0" e2="s415.e1" id="s415.p0" relation="true"/>
  </sentence>
  <sentence id="s416" text="Furthermore, we show that increased FAR2 expression in human patients is associated with diabetic nephropathy, lupus nephritis, and IgA nephropathy.">
    <entity charOffset="36-40" id="s416.e0" ontology_id="55711" text="FAR2" type="GENE"/>
    <entity charOffset="98-109" id="s416.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s416.e0" e2="s416.e1" id="s416.p0" relation="true"/>
  </sentence>
  <sentence id="s417" text="Here, we conducted whole-exome sequencing of patients with optic atrophy and other neurological signs of mitochondriopathy and identified 17 individuals from 13 unrelated families with recessive mutations in FDXR, encoding the mitochondrial membrane-associated flavoprotein ferrodoxin reductase required for electron transport from NADPH to cytochrome P450.">
    <entity charOffset="59-72" id="s417.e0" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <entity charOffset="208-212" id="s417.e1" ontology_id="2232" text="FDXR" type="GENE"/>
    <pair e1="s417.e0" e2="s417.e1" id="s417.p0" relation="true"/>
  </sentence>
  <sentence id="s418" text="Taken together, these data provide the first demonstration that germline, hypomorphic mutations in FDXR cause a novel mitochondriopathy and optic atrophy in humans">
    <entity charOffset="99-103" id="s418.e0" ontology_id="2232" text="FDXR" type="GENE"/>
    <entity charOffset="140-153" id="s418.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s418.e0" e2="s418.e1" id="s418.p0" relation="true"/>
  </sentence>
  <sentence id="s419" text="Mutations in the DNAJB2 gene lead to inherited neuropathies such as Charcot-Marie-Tooth type-2, distal hereditary motor neuropathies, spinal muscular atrophy with parkinsonism and the later stages can resemble amyotrophic lateral sclerosis.">
    <entity charOffset="17-23" id="s419.e0" ontology_id="3300" text="DNAJB2" type="GENE"/>
    <entity charOffset="163-175" id="s419.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s419.e0" e2="s419.e1" id="s419.p0" relation="true"/>
  </sentence>
  <sentence id="s420" text="In humans, mutations in CISD2 result in Wolfram syndrome 2, a disease in which the patients display juvenile diabetes, neuropsychiatric disorders and defective platelet aggregation.">
    <entity charOffset="24-29" id="s420.e0" ontology_id="493856" text="CISD2" type="GENE"/>
    <entity charOffset="150-180" id="s420.e1" ontology_id="HP_0003540" text="defective platelet aggregation" type="HP"/>
    <pair e1="s420.e0" e2="s420.e1" id="s420.p0" relation="true"/>
  </sentence>
  <sentence id="s421" text="The pathogenesis of hepatocellular carcinoma (HCC) is poorly understood, but recent advances in genomics have increased our understanding of the mechanisms by which hepatitis B virus, hepatitis C virus, alcohol, fatty liver disease, and other environmental factors, such as aflatoxin, cause liver cancer.">
    <entity charOffset="20-44" id="s421.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="46-49" id="s421.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s421.e0" e2="s421.e1" id="s421.p0" relation="true"/>
  </sentence>
  <sentence id="s422" text="Using exome sequencing, we identified dominant mutations in DNM1L on chromosome 12p11.21 in three large families with isolated optic atrophy, including the two families that defined the OPA5 locus on chromosome 19q12.1-13.1, the existence of which is denied by the present study.">
    <entity charOffset="60-65" id="s422.e0" ontology_id="10059" text="DNM1L" type="GENE"/>
    <entity charOffset="127-140" id="s422.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s422.e0" e2="s422.e1" id="s422.p0" relation="true"/>
  </sentence>
  <sentence id="s423" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).">
    <entity charOffset="99-118" id="s423.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="133-138" id="s423.e1" ontology_id="10491" text="CRTAP" type="GENE"/>
    <pair e1="s423.e0" e2="s423.e1" id="s423.p0" relation="true"/>
  </sentence>
  <sentence id="s424" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).">
    <entity charOffset="99-118" id="s424.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="140-146" id="s424.e1" ontology_id="64175" text="LEPRE1" type="GENE"/>
    <pair e1="s424.e0" e2="s424.e1" id="s424.p0" relation="true"/>
  </sentence>
  <sentence id="s425" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).">
    <entity charOffset="99-118" id="s425.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="148-152" id="s425.e1" ontology_id="5479" text="PPIB" type="GENE"/>
    <pair e1="s425.e0" e2="s425.e1" id="s425.p0" relation="true"/>
  </sentence>
  <sentence id="s426" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).">
    <entity charOffset="99-118" id="s426.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="172-176" id="s426.e1" ontology_id="649" text="BMP1" type="GENE"/>
    <pair e1="s426.e0" e2="s426.e1" id="s426.p0" relation="true"/>
  </sentence>
  <sentence id="s427" text="Our case-control study investigates the possible association between seven DPYD gene polymophisms (rs1801267, rs72547602, rs1801160, rs3918290, rs1801159, rs1801158, rs1801265) and risk of colorectal cancer (CRC).">
    <entity charOffset="75-79" id="s427.e0" ontology_id="1806" text="DPYD" type="GENE"/>
    <entity charOffset="200-206" id="s427.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s427.e0" e2="s427.e1" id="s427.p0" relation="true"/>
  </sentence>
  <sentence id="s428" text="The present study suggests that the SNP rs1801160 and the &amp;quot;IISt&amp;quot; haplotype in the DPYD gene may also have a role in colorectal cancer risk">
    <entity charOffset="92-96" id="s428.e0" ontology_id="1806" text="DPYD" type="GENE"/>
    <entity charOffset="137-143" id="s428.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s428.e0" e2="s428.e1" id="s428.p0" relation="true"/>
  </sentence>
  <sentence id="s429" text="We previously identified a set of the most frequently mutated cytoskeleton- and extracellular matrix-related proteins (CECMPs) in numerous cancer datasets.">
    <entity charOffset="27-30" id="s429.e0" ontology_id="6418" text="set" type="GENE"/>
    <entity charOffset="139-145" id="s429.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s429.e0" e2="s429.e1" id="s429.p0" relation="true"/>
  </sentence>
  <sentence id="s430" text="We report a case of a 33 month-old male referred for developmental delay that was found to have an Xp21.2 duplication containing IL1RAPL1 and multiple midline brain malformations">
    <entity charOffset="53-72" id="s430.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="129-137" id="s430.e1" ontology_id="11141" text="IL1RAPL1" type="GENE"/>
    <pair e1="s430.e0" e2="s430.e1" id="s430.p0" relation="true"/>
  </sentence>
  <sentence id="s431" text="JBTS is genetically heterogeneous, however mutations in CEP290 are a common underlying cause.">
    <entity charOffset="20-33" id="s431.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="56-62" id="s431.e1" ontology_id="80184" text="CEP290" type="GENE"/>
    <pair e1="s431.e0" e2="s431.e1" id="s431.p0" relation="true"/>
  </sentence>
  <sentence id="s432" text="We report a case with novel AARS2 gene mutations with developed striking cerebellar atrophy and leukoencephalopathy, which helps to further understand the clinical and genetic heterogeneity of AARS2-L">
    <entity charOffset="28-33" id="s432.e0" ontology_id="57505" text="AARS2" type="GENE"/>
    <entity charOffset="96-115" id="s432.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s432.e0" e2="s432.e1" id="s432.p0" relation="true"/>
  </sentence>
  <sentence id="s433" text="We report a case with novel AARS2 gene mutations with developed striking cerebellar atrophy and leukoencephalopathy, which helps to further understand the clinical and genetic heterogeneity of AARS2-L">
    <entity charOffset="28-33" id="s433.e0" ontology_id="57505" text="AARS2" type="GENE"/>
    <entity charOffset="73-91" id="s433.e1" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <pair e1="s433.e0" e2="s433.e1" id="s433.p0" relation="true"/>
  </sentence>
  <sentence id="s434" text="Mutations in NOTCH3 causes cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a hereditary cerebrovascular disease that leads to ischemic strokes and dementia, but in which migraine is often present, sometimes long before the onset of other symptoms.">
    <entity charOffset="13-19" id="s434.e0" ontology_id="4854" text="NOTCH3" type="GENE"/>
    <entity charOffset="98-117" id="s434.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s434.e0" e2="s434.e1" id="s434.p0" relation="true"/>
  </sentence>
  <sentence id="s435" text="A variable-length poly-T variant in intron 6 of the TOMM40 gene, rs10524523, is associated with risk and age-of-onset of sporadic (late-onset) Alzheimer's disease.">
    <entity charOffset="52-58" id="s435.e0" ontology_id="10452" text="TOMM40" type="GENE"/>
    <entity charOffset="121-129" id="s435.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s435.e0" e2="s435.e1" id="s435.p0" relation="true"/>
  </sentence>
  <sentence id="s436" text="Here we report a patient with a congenital syndrome consisting of severe global developmental delay, microcephaly, heart defects, failure to thrive and liver disease with a previously unreported homozygous NM_015352.1: c.485C&amp;gt;T variant (p.Ser162Leu) in POFUT1 detected by exome sequencing.">
    <entity charOffset="80-99" id="s436.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="256-262" id="s436.e1" ontology_id="23509" text="POFUT1" type="GENE"/>
    <pair e1="s436.e0" e2="s436.e1" id="s436.p0" relation="true"/>
  </sentence>
  <sentence id="s437" text="Here we report a patient with a congenital syndrome consisting of severe global developmental delay, microcephaly, heart defects, failure to thrive and liver disease with a previously unreported homozygous NM_015352.1: c.485C&amp;gt;T variant (p.Ser162Leu) in POFUT1 detected by exome sequencing.">
    <entity charOffset="101-113" id="s437.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="256-262" id="s437.e1" ontology_id="23509" text="POFUT1" type="GENE"/>
    <pair e1="s437.e0" e2="s437.e1" id="s437.p0" relation="true"/>
  </sentence>
  <sentence id="s438" text="These results suggest that this N-glycan of POFUT1 is not required for its proper enzymatic function, and that the p.Ser162Leu mutation of POFUT1 likely causes global developmental delay, microcephaly with vascular and cardiac defects">
    <entity charOffset="44-50" id="s438.e0" ontology_id="23509" text="POFUT1" type="GENE"/>
    <entity charOffset="167-186" id="s438.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s438.e0" e2="s438.e1" id="s438.p0" relation="true"/>
  </sentence>
  <sentence id="s439" text="These results suggest that this N-glycan of POFUT1 is not required for its proper enzymatic function, and that the p.Ser162Leu mutation of POFUT1 likely causes global developmental delay, microcephaly with vascular and cardiac defects">
    <entity charOffset="44-50" id="s439.e0" ontology_id="23509" text="POFUT1" type="GENE"/>
    <entity charOffset="188-200" id="s439.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s439.e0" e2="s439.e1" id="s439.p0" relation="true"/>
  </sentence>
  <sentence id="s440" text="Abnormal prion proteins are responsible for several fatal neurodegenerative diseases in humans and in animals, including Creutzfeldt-Jakob disease (CJD), Gerstmann-Strussler-Scheinker disease, and fatal familial insomnia.">
    <entity charOffset="58-84" id="s440.e0" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <entity charOffset="148-151" id="s440.e1" ontology_id="5621" text="CJD" type="GENE"/>
    <pair e1="s440.e0" e2="s440.e1" id="s440.p0" relation="true"/>
  </sentence>
  <sentence id="s441" text="In addition, different prion mutations were suggested to play a possible role in additional phenotypes, such as Alzheimer's type pathology, spongiform encephalopathy, or frontotemporal dementia.">
    <entity charOffset="97-101" id="s441.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="151-165" id="s441.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s441.e0" e2="s441.e1" id="s441.p0" relation="true"/>
  </sentence>
  <sentence id="s442" text="In addition, different prion mutations were suggested to play a possible role in additional phenotypes, such as Alzheimer's type pathology, spongiform encephalopathy, or frontotemporal dementia.">
    <entity charOffset="97-101" id="s442.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="170-193" id="s442.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s442.e0" e2="s442.e1" id="s442.p0" relation="false"/>
  </sentence>
  <sentence id="s443" text="FINDINGS We observed a significantly increased trend (nptrend = 0.0320) in the proportion of methylated p16 ink4a in cervical samples during cancer development.">
    <entity charOffset="108-113" id="s443.e0" ontology_id="1029" text="ink4a" type="GENE"/>
    <entity charOffset="141-147" id="s443.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s443.e0" e2="s443.e1" id="s443.p0" relation="true"/>
  </sentence>
  <sentence id="s444" text="MAIN CONCLUSIONS There was an increase in methylation of the p16 ink4a promoter from pre-neoplastic lesions to cancer.">
    <entity charOffset="65-70" id="s444.e0" ontology_id="1029" text="ink4a" type="GENE"/>
    <entity charOffset="111-117" id="s444.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s444.e0" e2="s444.e1" id="s444.p0" relation="true"/>
  </sentence>
  <sentence id="s445" text="Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (PKD), paroxysmal nonkinesigenic dyskinesia (PNKD), and episodic ataxia type 1 or 2.">
    <entity charOffset="113-116" id="s445.e0" ontology_id="5587" text="PKD" type="GENE"/>
    <entity charOffset="168-176" id="s445.e1" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <pair e1="s445.e0" e2="s445.e1" id="s445.p0" relation="true"/>
  </sentence>
  <sentence id="s446" text="Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (PKD), paroxysmal nonkinesigenic dyskinesia (PNKD), and episodic ataxia type 1 or 2.">
    <entity charOffset="157-161" id="s446.e0" ontology_id="25953" text="PNKD" type="GENE"/>
    <entity charOffset="168-176" id="s446.e1" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <pair e1="s446.e0" e2="s446.e1" id="s446.p0" relation="true"/>
  </sentence>
  <sentence id="s447" text="Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (PKD), paroxysmal nonkinesigenic dyskinesia (PNKD), and episodic ataxia type 1 or 2.">
    <entity charOffset="157-161" id="s447.e0" ontology_id="25953" text="PNKD" type="GENE"/>
    <entity charOffset="177-183" id="s447.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s447.e0" e2="s447.e1" id="s447.p0" relation="true"/>
  </sentence>
  <sentence id="s448" text="Antiepileptic drugs remain the treatment of choice for PKD and episodic ataxia type 1, benzodiazepines are often useful for PNKD, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology">
    <entity charOffset="63-71" id="s448.e0" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <entity charOffset="124-128" id="s448.e1" ontology_id="25953" text="PNKD" type="GENE"/>
    <pair e1="s448.e0" e2="s448.e1" id="s448.p0" relation="true"/>
  </sentence>
  <sentence id="s449" text="Antiepileptic drugs remain the treatment of choice for PKD and episodic ataxia type 1, benzodiazepines are often useful for PNKD, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology">
    <entity charOffset="63-71" id="s449.e0" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <entity charOffset="79-83" id="s449.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s449.e0" e2="s449.e1" id="s449.p0" relation="true"/>
  </sentence>
  <sentence id="s450" text="Chemical inhibition of epigenetic regulatory proteins BrdT and Brd4 is emerging as a promising therapeutic strategy in contraception, cancer, and heart disease.">
    <entity charOffset="54-58" id="s450.e0" ontology_id="676" text="BrdT" type="GENE"/>
    <entity charOffset="134-140" id="s450.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s450.e0" e2="s450.e1" id="s450.p0" relation="true"/>
  </sentence>
  <sentence id="s451" text="The remaining cases, clinically similar to XLA, are autosomal recessive agammaglobulinemia (ARA).">
    <entity charOffset="43-46" id="s451.e0" ontology_id="695" text="XLA" type="GENE"/>
    <entity charOffset="52-71" id="s451.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s451.e0" e2="s451.e1" id="s451.p0" relation="true"/>
  </sentence>
  <sentence id="s452" text="However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between PlgT/T mice and wild-type mice.">
    <entity charOffset="93-111" id="s452.e0" ontology_id="HP_0002204" text="pulmonary embolism" type="HP"/>
    <entity charOffset="217-220" id="s452.e1" ontology_id="5340" text="Plg" type="GENE"/>
    <pair e1="s452.e0" e2="s452.e1" id="s452.p0" relation="true"/>
  </sentence>
  <sentence id="s453" text="Coexistence in mice of PlgT/T and Pros1E/E did not affect pulmonary embolism symptoms, compared with those in Pros1E/E mice.">
    <entity charOffset="23-26" id="s453.e0" ontology_id="5340" text="Plg" type="GENE"/>
    <entity charOffset="58-76" id="s453.e1" ontology_id="HP_0002204" text="pulmonary embolism" type="HP"/>
    <pair e1="s453.e0" e2="s453.e1" id="s453.p0" relation="true"/>
  </sentence>
  <sentence id="s454" text="Moreover, LMP2 R/C+C/C genotype was associated with increased tumor invasion depth (p = 0.041).">
    <entity charOffset="10-14" id="s454.e0" ontology_id="5698" text="LMP2" type="GENE"/>
    <entity charOffset="62-67" id="s454.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s454.e0" e2="s454.e1" id="s454.p0" relation="true"/>
  </sentence>
  <sentence id="s455" text="To our knowledge, no study investigates the association of genetic variant distributions of WW domain-containing oxidoreductase (WWOX) gene with development of invasive cancer, clinicopathologic variables and patient survival in uterine cervical cancer for Taiwanese women.">
    <entity charOffset="129-133" id="s455.e0" ontology_id="51741" text="WWOX" type="GENE"/>
    <entity charOffset="169-175" id="s455.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s455.e0" e2="s455.e1" id="s455.p0" relation="true"/>
  </sentence>
  <sentence id="s456" text="We therefore conducted this study to explore the clinical involvements of WWOX single nucleotide polymorphisms (SNPs) in cervical cancer.">
    <entity charOffset="74-78" id="s456.e0" ontology_id="51741" text="WWOX" type="GENE"/>
    <entity charOffset="130-136" id="s456.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s456.e0" e2="s456.e1" id="s456.p0" relation="true"/>
  </sentence>
  <sentence id="s457" text="The results revealed that only WWOX SNP rs3764340 was associated between patients with cervical invasive cancer and normal controls among 5 WWOX genetic variants.">
    <entity charOffset="31-35" id="s457.e0" ontology_id="51741" text="WWOX" type="GENE"/>
    <entity charOffset="105-111" id="s457.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s457.e0" e2="s457.e1" id="s457.p0" relation="true"/>
  </sentence>
  <sentence id="s458" text="In conclusion, Taiwanese women with CG/GG in WWOX SNP rs3764340 are susceptible to cervical invasive cancer.">
    <entity charOffset="45-49" id="s458.e0" ontology_id="51741" text="WWOX" type="GENE"/>
    <entity charOffset="101-107" id="s458.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s458.e0" e2="s458.e1" id="s458.p0" relation="true"/>
  </sentence>
  <sentence id="s459" text="PCD is characterized by clinical variability and extensive genetic heterogeneity, associated with different cilia ultrastructural defects and mutations identified in &amp;gt;20 genes.">
    <entity charOffset="0-3" id="s459.e0" ontology_id="352909" text="PCD" type="GENE"/>
    <entity charOffset="67-80" id="s459.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s459.e0" e2="s459.e1" id="s459.p0" relation="true"/>
  </sentence>
  <sentence id="s460" text="We will also discuss emerging paradigms of the molecular and cellular pathophysiology of disease-causing ephrinB2-EphB4-RASA1 mutations, including the potential role of somatic mosaicism.">
    <entity charOffset="120-125" id="s460.e0" ontology_id="5921" text="RASA1" type="GENE"/>
    <entity charOffset="169-186" id="s460.e1" ontology_id="HP_0001442" text="somatic mosaicism" type="HP"/>
    <pair e1="s460.e0" e2="s460.e1" id="s460.p0" relation="true"/>
  </sentence>
  <sentence id="s461" text="We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-42" id="s461.e0" ontology_id="6904" text="TBCD" type="GENE"/>
    <entity charOffset="289-305" id="s461.e1" ontology_id="HP_0002120" text="cortical atrophy" type="HP"/>
    <pair e1="s461.e0" e2="s461.e1" id="s461.p0" relation="true"/>
  </sentence>
  <sentence id="s462" text="We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-42" id="s462.e0" ontology_id="6904" text="TBCD" type="GENE"/>
    <entity charOffset="334-346" id="s462.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s462.e0" e2="s462.e1" id="s462.p0" relation="true"/>
  </sentence>
  <sentence id="s463" text="We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-42" id="s463.e0" ontology_id="6904" text="TBCD" type="GENE"/>
    <entity charOffset="370-389" id="s463.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s463.e0" e2="s463.e1" id="s463.p0" relation="true"/>
  </sentence>
  <sentence id="s464" text="We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-42" id="s464.e0" ontology_id="6904" text="TBCD" type="GENE"/>
    <entity charOffset="391-414" id="s464.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s464.e0" e2="s464.e1" id="s464.p0" relation="true"/>
  </sentence>
  <sentence id="s465" text="We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-42" id="s465.e0" ontology_id="6904" text="TBCD" type="GENE"/>
    <entity charOffset="416-424" id="s465.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s465.e0" e2="s465.e1" id="s465.p0" relation="true"/>
  </sentence>
  <sentence id="s466" text="We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-42" id="s466.e0" ontology_id="6904" text="TBCD" type="GENE"/>
    <entity charOffset="426-439" id="s466.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s466.e0" e2="s466.e1" id="s466.p0" relation="true"/>
  </sentence>
  <sentence id="s467" text="We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-42" id="s467.e0" ontology_id="6904" text="TBCD" type="GENE"/>
    <entity charOffset="445-465" id="s467.e1" ontology_id="HP_0002510" text="spastic quadriplegia" type="HP"/>
    <pair e1="s467.e0" e2="s467.e1" id="s467.p0" relation="true"/>
  </sentence>
  <sentence id="s468" text="Finally, it was observed that 4 hub genes were highly expressed in gastric cancer tissue compared with paracarcinoma tissue in the 12patients; the increased TSPAN4 was significant (&amp;gt;5fold).">
    <entity charOffset="75-81" id="s468.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="159-165" id="s468.e1" ontology_id="7106" text="TSPAN4" type="GENE"/>
    <pair e1="s468.e0" e2="s468.e1" id="s468.p0" relation="true"/>
  </sentence>
  <sentence id="s469" text="To address this, we performed exome sequencing and copy number variant analysis on 1511 frozen human brains with a diagnosis of Alzheimer's disease (AD, n = 289), frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS, n = 252), Creutzfeldt-Jakob disease (CJD, n = 239), Parkinson's disease (PD, n = 39), dementia with Lewy bodies (DLB, n = 58), other neurodegenerative, vascular, or neurogenetic disorders (n = 266), and controls with no significant neuropathology (n = 368).">
    <entity charOffset="163-186" id="s469.e0" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <entity charOffset="264-267" id="s469.e1" ontology_id="5621" text="CJD" type="GENE"/>
    <pair e1="s469.e0" e2="s469.e1" id="s469.p0" relation="true"/>
  </sentence>
  <sentence id="s470" text="CSD is clinically and genetically heterogeneous.">
    <entity charOffset="0-3" id="s470.e0" ontology_id="51380" text="CSD" type="GENE"/>
    <entity charOffset="34-47" id="s470.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s470.e0" e2="s470.e1" id="s470.p0" relation="true"/>
  </sentence>
  <sentence id="s471" text="It is autosomal recessively inherited, and caused by SPINT2 mutations.">
    <entity charOffset="6-25" id="s471.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="53-59" id="s471.e1" ontology_id="10653" text="SPINT2" type="GENE"/>
    <pair e1="s471.e0" e2="s471.e1" id="s471.p0" relation="true"/>
  </sentence>
  <sentence id="s472" text="The nonsyndromic form of CSD can be caused by dominant activating mutations in GUCY2C, encoding intestinal receptor guanylate cyclase C (GC-C), and by autosomal recessive SLC9A3 loss-of-function mutations.">
    <entity charOffset="79-85" id="s472.e0" ontology_id="2984" text="GUCY2C" type="GENE"/>
    <entity charOffset="151-170" id="s472.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s472.e0" e2="s472.e1" id="s472.p0" relation="true"/>
  </sentence>
  <sentence id="s473" text="The nonsyndromic form of CSD can be caused by dominant activating mutations in GUCY2C, encoding intestinal receptor guanylate cyclase C (GC-C), and by autosomal recessive SLC9A3 loss-of-function mutations.">
    <entity charOffset="151-170" id="s473.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="171-177" id="s473.e1" ontology_id="6550" text="SLC9A3" type="GENE"/>
    <pair e1="s473.e0" e2="s473.e1" id="s473.p0" relation="true"/>
  </sentence>
  <sentence id="s474" text="In this sense, evidence from both clinical and experimental studies indicates that EPO may reverse diabetic neuropathy through an antioxidant action by decreasing pro-inflammatory cytokines, restoring Na+/K+-ATPase activity, and blocking the generation of pro-apoptotic proteins.">
    <entity charOffset="83-86" id="s474.e0" ontology_id="8288" text="EPO" type="GENE"/>
    <entity charOffset="108-118" id="s474.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s474.e0" e2="s474.e1" id="s474.p0" relation="true"/>
  </sentence>
  <sentence id="s475" text="Rac1, one of the best characterized Rho GTPases, is an established effector of receptors and an important node in signaling networks crucial for tumorigenesis and metastasis.">
    <entity charOffset="0-4" id="s475.e0" ontology_id="5879" text="Rac1" type="GENE"/>
    <entity charOffset="145-150" id="s475.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s475.e0" e2="s475.e1" id="s475.p0" relation="true"/>
  </sentence>
  <sentence id="s476" text="Rac1 hyperactivation is common in human cancer and could be the consequence of overexpression, abnormal upstream inputs, deregulated degradation, and/or anomalous intracellular localization.">
    <entity charOffset="0-4" id="s476.e0" ontology_id="5879" text="Rac1" type="GENE"/>
    <entity charOffset="40-46" id="s476.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s476.e0" e2="s476.e1" id="s476.p0" relation="true"/>
  </sentence>
  <sentence id="s477" text="More recently, cancer-associated gain-of-function mutations in Rac1 have been identified which contribute to tumor phenotypes and confer resistance to targeted therapies.">
    <entity charOffset="15-21" id="s477.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="63-67" id="s477.e1" ontology_id="5879" text="Rac1" type="GENE"/>
    <pair e1="s477.e0" e2="s477.e1" id="s477.p0" relation="true"/>
  </sentence>
  <sentence id="s478" text="More recently, cancer-associated gain-of-function mutations in Rac1 have been identified which contribute to tumor phenotypes and confer resistance to targeted therapies.">
    <entity charOffset="63-67" id="s478.e0" ontology_id="5879" text="Rac1" type="GENE"/>
    <entity charOffset="109-114" id="s478.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s478.e0" e2="s478.e1" id="s478.p0" relation="true"/>
  </sentence>
  <sentence id="s479" text="Translating our extensive knowledge in Rac pathway biochemistry into a clinical setting still remains a major challenge; nonetheless, remarkable opportunities for cancer therapeutics arise from promising lead compounds targeting Rac and its effectors">
    <entity charOffset="39-42" id="s479.e0" ontology_id="207" text="Rac" type="GENE"/>
    <entity charOffset="163-169" id="s479.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s479.e0" e2="s479.e1" id="s479.p0" relation="true"/>
  </sentence>
  <sentence id="s480" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="86-92" id="s480.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="172-175" id="s480.e1" ontology_id="472" text="ATM" type="GENE"/>
    <pair e1="s480.e0" e2="s480.e1" id="s480.p0" relation="true"/>
  </sentence>
  <sentence id="s481" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="86-92" id="s481.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="177-184" id="s481.e1" ontology_id="5519" text="PPP2R1B" type="GENE"/>
    <pair e1="s481.e0" e2="s481.e1" id="s481.p0" relation="true"/>
  </sentence>
  <sentence id="s482" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="86-92" id="s482.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="195-200" id="s482.e1" ontology_id="23705" text="CADM1" type="GENE"/>
    <pair e1="s482.e0" e2="s482.e1" id="s482.p0" relation="true"/>
  </sentence>
  <sentence id="s483" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="186-190" id="s483.e0" ontology_id="6392" text="SDHD" type="GENE"/>
    <entity charOffset="229-238" id="s483.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s483.e0" e2="s483.e1" id="s483.p0" relation="true"/>
  </sentence>
  <sentence id="s484" text="The alterations of ATM and CADM1 are associated with the progression of tumor from CIN to Stage I/II, thus implying their role in early invasiveness.">
    <entity charOffset="19-22" id="s484.e0" ontology_id="472" text="ATM" type="GENE"/>
    <entity charOffset="72-77" id="s484.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s484.e0" e2="s484.e1" id="s484.p0" relation="true"/>
  </sentence>
  <sentence id="s485" text="High mobility group box 3 (HMGB3), a member of the high-mobility group box (HMGB) family, was reported to be over-expressed in gastric carcinoma and bladder cancer.">
    <entity charOffset="27-32" id="s485.e0" ontology_id="3149" text="HMGB3" type="GENE"/>
    <entity charOffset="157-163" id="s485.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s485.e0" e2="s485.e1" id="s485.p0" relation="true"/>
  </sentence>
  <sentence id="s486" text="qRT-PCR results showed that high expression of HMGB3 had positive correlation with serosal invasion, lymph metastasis, and tumor-node-metastasis (TNM) stage in CRC patient.">
    <entity charOffset="47-52" id="s486.e0" ontology_id="3149" text="HMGB3" type="GENE"/>
    <entity charOffset="123-128" id="s486.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s486.e0" e2="s486.e1" id="s486.p0" relation="true"/>
  </sentence>
  <sentence id="s487" text="Transcriptomic analysis revealed significant alterations in a number of genes associated with autism, such as adsl, mbd5, shank3, and tsc1b.">
    <entity charOffset="94-100" id="s487.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="110-114" id="s487.e1" ontology_id="158" text="adsl" type="GENE"/>
    <pair e1="s487.e0" e2="s487.e1" id="s487.p0" relation="true"/>
  </sentence>
  <sentence id="s488" text="Transcriptomic analysis revealed significant alterations in a number of genes associated with autism, such as adsl, mbd5, shank3, and tsc1b.">
    <entity charOffset="94-100" id="s488.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="116-120" id="s488.e1" ontology_id="55777" text="mbd5" type="GENE"/>
    <pair e1="s488.e0" e2="s488.e1" id="s488.p0" relation="true"/>
  </sentence>
  <sentence id="s489" text="Typical HHT clinical features are mucocutaneous telangiectases, arteriovenous malformations, spontaneous and recurrent epistaxis, as well as gastrointestinal bleedings.">
    <entity charOffset="8-11" id="s489.e0" ontology_id="94" text="HHT" type="GENE"/>
    <entity charOffset="64-91" id="s489.e1" ontology_id="HP_0100026" text="arteriovenous malformations" type="HP"/>
    <pair e1="s489.e0" e2="s489.e1" id="s489.p0" relation="true"/>
  </sentence>
  <sentence id="s490" text="Alzheimer's disease (AD) is a serious neurodegenerative disease, and microRNAs (miRNAs) have been linked to its pathogenesis.">
    <entity charOffset="38-63" id="s490.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="80-83" id="s490.e1" ontology_id="220972" text="miR" type="GENE"/>
    <pair e1="s490.e0" e2="s490.e1" id="s490.p0" relation="true"/>
  </sentence>
  <sentence id="s491" text="Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (IFN), tumor necrosis factor (TNF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) are implicated in the pathology of rheumatoid arthritis (RA).">
    <entity charOffset="105-110" id="s491.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="128-131" id="s491.e1" ontology_id="7124" text="TNF" type="GENE"/>
    <pair e1="s491.e0" e2="s491.e1" id="s491.p0" relation="true"/>
  </sentence>
  <sentence id="s492" text="RESULTS Circ-CFH expression was significantly upregulated in glioma tissue and was correlated with tumor grade.">
    <entity charOffset="13-16" id="s492.e0" ontology_id="3075" text="CFH" type="GENE"/>
    <entity charOffset="99-104" id="s492.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s492.e0" e2="s492.e1" id="s492.p0" relation="true"/>
  </sentence>
  <sentence id="s493" text="Eight different SRD5A2 mutations were detected in 15 patients with posterior hypospadias (60%, 15/25), including six previously described mutations (p.Q6X, Q71X, p.L20P, p.G203S, p.R227Q, and p.R246Q) and two novel mutations (p.G196R and p.L73Pfs&lt;sup&gt;&lt;/sup&gt;17).">
    <entity charOffset="16-22" id="s493.e0" ontology_id="6716" text="SRD5A2" type="GENE"/>
    <entity charOffset="77-88" id="s493.e1" ontology_id="HP_0000047" text="hypospadias" type="HP"/>
    <pair e1="s493.e0" e2="s493.e1" id="s493.p0" relation="true"/>
  </sentence>
  <sentence id="s494" text="Patients with adult-onset NCL may present with slowly progressive ataxia, persistent photosensitivity, and seizures without dementia or extrapyramidal findings.">
    <entity charOffset="26-29" id="s494.e0" ontology_id="4691" text="NCL" type="GENE"/>
    <entity charOffset="66-72" id="s494.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s494.e0" e2="s494.e1" id="s494.p0" relation="true"/>
  </sentence>
  <sentence id="s495" text="Recently, it has been demonstrated that, mutations of LRTOMT are associated with profound nonsyndromic hearing impairment at the DFNB63 locus.">
    <entity charOffset="54-60" id="s495.e0" ontology_id="220074" text="LRTOMT" type="GENE"/>
    <entity charOffset="103-121" id="s495.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s495.e0" e2="s495.e1" id="s495.p0" relation="true"/>
  </sentence>
  <sentence id="s496" text="Recently, it has been demonstrated that, mutations of LRTOMT are associated with profound nonsyndromic hearing impairment at the DFNB63 locus.">
    <entity charOffset="81-89" id="s496.e0" ontology_id="HP_0012829" text="profound" type="HP"/>
    <entity charOffset="129-135" id="s496.e1" ontology_id="220074" text="DFNB63" type="GENE"/>
    <pair e1="s496.e0" e2="s496.e1" id="s496.p0" relation="true"/>
  </sentence>
  <sentence id="s497" text="The objective of this study is to evaluate the carrier frequency of c.242G&amp;gt;A mutation in LRTOMT gene and define the contribution of this gene in the etiology of deafness in Moroccan population.">
    <entity charOffset="92-98" id="s497.e0" ontology_id="220074" text="LRTOMT" type="GENE"/>
    <entity charOffset="164-172" id="s497.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s497.e0" e2="s497.e1" id="s497.p0" relation="true"/>
  </sentence>
  <sentence id="s498" text="Our results show that after the GJB2 gene mutation in LRTOMT gene is the second cause of congenital hearing impairment in Moroccan patients.">
    <entity charOffset="32-36" id="s498.e0" ontology_id="2706" text="GJB2" type="GENE"/>
    <entity charOffset="100-118" id="s498.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s498.e0" e2="s498.e1" id="s498.p0" relation="true"/>
  </sentence>
  <sentence id="s499" text="Our results show that after the GJB2 gene mutation in LRTOMT gene is the second cause of congenital hearing impairment in Moroccan patients.">
    <entity charOffset="54-60" id="s499.e0" ontology_id="220074" text="LRTOMT" type="GENE"/>
    <entity charOffset="100-118" id="s499.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s499.e0" e2="s499.e1" id="s499.p0" relation="true"/>
  </sentence>
  <sentence id="s500" text="However, BMP-9 is a big protein expensive to produce that can hardly access the central nervous system.">
    <entity charOffset="9-14" id="s500.e0" ontology_id="2658" text="BMP-9" type="GENE"/>
    <entity charOffset="80-87" id="s500.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s500.e0" e2="s500.e1" id="s500.p0" relation="true"/>
  </sentence>
  <sentence id="s501" text="Since it is known that the native protein, BMP-9, can act in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, EGF, IGF-2 or NGF on the cholinergic differentiation of human neuroblastoma cells SH-SY5Y.">
    <entity charOffset="43-48" id="s501.e0" ontology_id="2658" text="BMP-9" type="GENE"/>
    <entity charOffset="272-285" id="s501.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s501.e0" e2="s501.e1" id="s501.p0" relation="true"/>
  </sentence>
  <sentence id="s502" text="Since it is known that the native protein, BMP-9, can act in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, EGF, IGF-2 or NGF on the cholinergic differentiation of human neuroblastoma cells SH-SY5Y.">
    <entity charOffset="210-213" id="s502.e0" ontology_id="1950" text="EGF" type="GENE"/>
    <entity charOffset="272-285" id="s502.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s502.e0" e2="s502.e1" id="s502.p0" relation="true"/>
  </sentence>
  <sentence id="s503" text="Since it is known that the native protein, BMP-9, can act in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, EGF, IGF-2 or NGF on the cholinergic differentiation of human neuroblastoma cells SH-SY5Y.">
    <entity charOffset="224-227" id="s503.e0" ontology_id="4803" text="NGF" type="GENE"/>
    <entity charOffset="272-285" id="s503.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s503.e0" e2="s503.e1" id="s503.p0" relation="true"/>
  </sentence>
  <sentence id="s504" text="After diagnosis of granular cell tumour by core needle biopsy, the masses were excised with histopathological and immunohistochemical analysis of both specimens confirming the presence of non-malignant granular cell tumours.">
    <entity charOffset="33-39" id="s504.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="67-71" id="s504.e1" ontology_id="2200" text="mass" type="GENE"/>
    <pair e1="s504.e0" e2="s504.e1" id="s504.p0" relation="true"/>
  </sentence>
  <sentence id="s505" text="Here we describe two unrelated individuals with infantile-onset epilepsy and abnormalities of brain morphology, harboring de novo variants that affect adjacent amino acids in a beta-tubulin gene TUBB2A.">
    <entity charOffset="64-72" id="s505.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="195-201" id="s505.e1" ontology_id="7280" text="TUBB2A" type="GENE"/>
    <pair e1="s505.e0" e2="s505.e1" id="s505.p0" relation="true"/>
  </sentence>
  <sentence id="s506" text="However, sequencing of large human cohorts reveals a cumulative frequency of additional rare CaM mutations that raise the possibility of CaM variants not exclusively causing severe cardiac arrhythmias.">
    <entity charOffset="93-96" id="s506.e0" ontology_id="889" text="CaM" type="GENE"/>
    <entity charOffset="181-200" id="s506.e1" ontology_id="HP_0011675" text="cardiac arrhythmias" type="HP"/>
    <pair e1="s506.e0" e2="s506.e1" id="s506.p0" relation="true"/>
  </sentence>
  <sentence id="s507" text="As rare polymorphisms have been described in IKBKG and polygenic inheritance remains an option in the presented case, this study emphasizes the need for thorough functional and genetic evaluation when encountering and interpreting suspected disease-causing NEMO-ID variants">
    <entity charOffset="45-50" id="s507.e0" ontology_id="8517" text="IKBKG" type="GENE"/>
    <entity charOffset="55-76" id="s507.e1" ontology_id="HP_0010982" text="polygenic inheritance" type="HP"/>
    <pair e1="s507.e0" e2="s507.e1" id="s507.p0" relation="true"/>
  </sentence>
  <sentence id="s508" text="BEN is a primary, chronic tubulointerstitial nephritis characterized with chronic anemia, absence of edema, xantoderma, normal blood pressure and normal findings on the fundus oculi.">
    <entity charOffset="0-3" id="s508.e0" ontology_id="9569" text="BEN" type="GENE"/>
    <entity charOffset="26-54" id="s508.e1" ontology_id="HP_0001970" text="tubulointerstitial nephritis" type="HP"/>
    <pair e1="s508.e0" e2="s508.e1" id="s508.p0" relation="true"/>
  </sentence>
  <sentence id="s509" text="The overexpression of PARIS selectively leads to the loss of dopaminergic neurons (DN) and mitochondrial abnormalities in the substantia nigra (SN) of Parkinson's disease (PD) models.">
    <entity charOffset="22-27" id="s509.e0" ontology_id="155061" text="PARIS" type="GENE"/>
    <entity charOffset="91-104" id="s509.e1" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <pair e1="s509.e0" e2="s509.e1" id="s509.p0" relation="true"/>
  </sentence>
  <sentence id="s510" text="The overexpression of PARIS selectively leads to the loss of dopaminergic neurons (DN) and mitochondrial abnormalities in the substantia nigra (SN) of Parkinson's disease (PD) models.">
    <entity charOffset="91-104" id="s510.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="144-146" id="s510.e1" ontology_id="7857" text="SN" type="GENE"/>
    <pair e1="s510.e0" e2="s510.e1" id="s510.p0" relation="true"/>
  </sentence>
  <sentence id="s511" text="Familial hypercholesterolemia is usually due to loss-of-function mutations in LDLR, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: APOB, PCSK9 and LDLRAP1.">
    <entity charOffset="9-29" id="s511.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="78-82" id="s511.e1" ontology_id="3949" text="LDLR" type="GENE"/>
    <pair e1="s511.e0" e2="s511.e1" id="s511.p0" relation="true"/>
  </sentence>
  <sentence id="s512" text="Familial hypercholesterolemia is usually due to loss-of-function mutations in LDLR, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: APOB, PCSK9 and LDLRAP1.">
    <entity charOffset="9-29" id="s512.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="202-206" id="s512.e1" ontology_id="338" text="APOB" type="GENE"/>
    <pair e1="s512.e0" e2="s512.e1" id="s512.p0" relation="true"/>
  </sentence>
  <sentence id="s513" text="Familial hypercholesterolemia is usually due to loss-of-function mutations in LDLR, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: APOB, PCSK9 and LDLRAP1.">
    <entity charOffset="9-29" id="s513.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="208-213" id="s513.e1" ontology_id="255738" text="PCSK9" type="GENE"/>
    <pair e1="s513.e0" e2="s513.e1" id="s513.p0" relation="true"/>
  </sentence>
  <sentence id="s514" text="Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, APOC2, APOA5, LMF1, GPIHBP1).">
    <entity charOffset="10-30" id="s514.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="139-144" id="s514.e1" ontology_id="344" text="APOC2" type="GENE"/>
    <pair e1="s514.e0" e2="s514.e1" id="s514.p0" relation="true"/>
  </sentence>
  <sentence id="s515" text="Conversely familial hypobetalipoproteinemia is caused by inactivation of the PCSK9 gene which increases the number of LDL receptors and decreases plasma cholesterol.">
    <entity charOffset="20-43" id="s515.e0" ontology_id="HP_0003563" text="hypobetalipoproteinemia" type="HP"/>
    <entity charOffset="77-82" id="s515.e1" ontology_id="255738" text="PCSK9" type="GENE"/>
    <pair e1="s515.e0" e2="s515.e1" id="s515.p0" relation="true"/>
  </sentence>
  <sentence id="s516" text="Consistent with this pattern of activity, polr1c and polr1d homozygous mutant zebrafish exhibit cartilage hypoplasia and cranioskeletal anomalies characteristic of humans with Treacher Collins syndrome.">
    <entity charOffset="42-48" id="s516.e0" ontology_id="9533" text="polr1c" type="GENE"/>
    <entity charOffset="127-145" id="s516.e1" ontology_id="HP_0000924" text="skeletal anomalies" type="HP"/>
    <pair e1="s516.e0" e2="s516.e1" id="s516.p0" relation="true"/>
  </sentence>
  <sentence id="s517" text="More importantly, we show that genetic inhibition of tp53 can suppress neuroepithelial cell death and ameliorate the skeletal anomalies in polr1c and polr1d mutants, providing a potential avenue to prevent the pathogenesis of Treacher Collins syndrome.">
    <entity charOffset="117-135" id="s517.e0" ontology_id="HP_0000924" text="skeletal anomalies" type="HP"/>
    <entity charOffset="139-145" id="s517.e1" ontology_id="9533" text="polr1c" type="GENE"/>
    <pair e1="s517.e0" e2="s517.e1" id="s517.p0" relation="true"/>
  </sentence>
  <sentence id="s518" text="More importantly, we show that genetic inhibition of tp53 can suppress neuroepithelial cell death and ameliorate the skeletal anomalies in polr1c and polr1d mutants, providing a potential avenue to prevent the pathogenesis of Treacher Collins syndrome.">
    <entity charOffset="117-135" id="s518.e0" ontology_id="HP_0000924" text="skeletal anomalies" type="HP"/>
    <entity charOffset="150-156" id="s518.e1" ontology_id="51082" text="polr1d" type="GENE"/>
    <pair e1="s518.e0" e2="s518.e1" id="s518.p0" relation="true"/>
  </sentence>
  <sentence id="s519" text="Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) STAT3 deficiency, the only disorder corresponding to the original definition of HIES, and autosomal recessive (AR) DOCK8 and PGM3 deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.">
    <entity charOffset="215-234" id="s519.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="240-245" id="s519.e1" ontology_id="81704" text="DOCK8" type="GENE"/>
    <pair e1="s519.e0" e2="s519.e1" id="s519.p0" relation="true"/>
  </sentence>
  <sentence id="s520" text="Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) STAT3 deficiency, the only disorder corresponding to the original definition of HIES, and autosomal recessive (AR) DOCK8 and PGM3 deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.">
    <entity charOffset="215-234" id="s520.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="250-254" id="s520.e1" ontology_id="5238" text="PGM3" type="GENE"/>
    <pair e1="s520.e0" e2="s520.e1" id="s520.p0" relation="true"/>
  </sentence>
  <sentence id="s521" text="We evaluated the genetic impact of the amyotrophic lateral sclerosis (ALS) risk gene never in mitosis gene a-related kinase 1 (NEK1) in a Belgian cohort of 278 patients with ALS (n= 245) or ALS with frontotemporal dementia (ALS-FTD, n= 33) and 609 control individuals.">
    <entity charOffset="127-131" id="s521.e0" ontology_id="4750" text="NEK1" type="GENE"/>
    <entity charOffset="200-223" id="s521.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s521.e0" e2="s521.e1" id="s521.p0" relation="true"/>
  </sentence>
  <sentence id="s522" text="In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal tip) in whom two novel FREM1 mutations (c.305A&amp;gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.">
    <entity charOffset="115-128" id="s522.e0" ontology_id="HP_0000316" text="hypertelorism" type="HP"/>
    <entity charOffset="204-209" id="s522.e1" ontology_id="158326" text="FREM1" type="GENE"/>
    <pair e1="s522.e0" e2="s522.e1" id="s522.p0" relation="true"/>
  </sentence>
  <sentence id="s523" text="In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal tip) in whom two novel FREM1 mutations (c.305A&amp;gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.">
    <entity charOffset="115-128" id="s523.e0" ontology_id="HP_0000316" text="hypertelorism" type="HP"/>
    <entity charOffset="181-184" id="s523.e1" ontology_id="81533" text="tip" type="GENE"/>
    <pair e1="s523.e0" e2="s523.e1" id="s523.p0" relation="false"/>
  </sentence>
  <sentence id="s524" text="In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal tip) in whom two novel FREM1 mutations (c.305A&amp;gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.">
    <entity charOffset="141-153" id="s524.e0" ontology_id="HP_0000528" text="anophthalmia" type="HP"/>
    <entity charOffset="204-209" id="s524.e1" ontology_id="158326" text="FREM1" type="GENE"/>
    <pair e1="s524.e0" e2="s524.e1" id="s524.p0" relation="true"/>
  </sentence>
  <sentence id="s525" text="In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal tip) in whom two novel FREM1 mutations (c.305A&amp;gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.">
    <entity charOffset="141-153" id="s525.e0" ontology_id="HP_0000528" text="anophthalmia" type="HP"/>
    <entity charOffset="181-184" id="s525.e1" ontology_id="81533" text="tip" type="GENE"/>
    <pair e1="s525.e0" e2="s525.e1" id="s525.p0" relation="false"/>
  </sentence>
  <sentence id="s526" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="215-220" id="s526.e0" ontology_id="701" text="BUB1B" type="GENE"/>
    <entity charOffset="551-556" id="s526.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s526.e0" e2="s526.e1" id="s526.p0" relation="true"/>
  </sentence>
  <sentence id="s527" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="222-226" id="s527.e0" ontology_id="9787" text="HURP" type="GENE"/>
    <entity charOffset="551-556" id="s527.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s527.e0" e2="s527.e1" id="s527.p0" relation="true"/>
  </sentence>
  <sentence id="s528" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="222-226" id="s528.e0" ontology_id="9787" text="HURP" type="GENE"/>
    <entity charOffset="431-441" id="s528.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s528.e0" e2="s528.e1" id="s528.p0" relation="false"/>
  </sentence>
  <sentence id="s529" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="228-232" id="s529.e0" ontology_id="4751" text="NEK2" type="GENE"/>
    <entity charOffset="551-556" id="s529.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s529.e0" e2="s529.e1" id="s529.p0" relation="true"/>
  </sentence>
  <sentence id="s530" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="239-245" id="s530.e0" ontology_id="51438" text="damage" type="GENE"/>
    <entity charOffset="431-441" id="s530.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s530.e0" e2="s530.e1" id="s530.p0" relation="false"/>
  </sentence>
  <sentence id="s531" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="254-257" id="s531.e0" ontology_id="55872" text="PBK" type="GENE"/>
    <entity charOffset="551-556" id="s531.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s531.e0" e2="s531.e1" id="s531.p0" relation="true"/>
  </sentence>
  <sentence id="s532" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="294-298" id="s532.e0" ontology_id="546" text="ATRX" type="GENE"/>
    <entity charOffset="551-556" id="s532.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s532.e0" e2="s532.e1" id="s532.p0" relation="true"/>
  </sentence>
  <sentence id="s533" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="294-298" id="s533.e0" ontology_id="546" text="ATRX" type="GENE"/>
    <entity charOffset="431-441" id="s533.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s533.e0" e2="s533.e1" id="s533.p0" relation="true"/>
  </sentence>
  <sentence id="s534" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="380-384" id="s534.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="431-441" id="s534.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s534.e0" e2="s534.e1" id="s534.p0" relation="true"/>
  </sentence>
  <sentence id="s535" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="100-104" id="s535.e0" ontology_id="9787" text="HURP" type="GENE"/>
    <entity charOffset="275-285" id="s535.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s535.e0" e2="s535.e1" id="s535.p0" relation="true"/>
  </sentence>
  <sentence id="s536" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="106-110" id="s536.e0" ontology_id="4751" text="NEK2" type="GENE"/>
    <entity charOffset="275-285" id="s536.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s536.e0" e2="s536.e1" id="s536.p0" relation="true"/>
  </sentence>
  <sentence id="s537" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="134-137" id="s537.e0" ontology_id="55872" text="PBK" type="GENE"/>
    <entity charOffset="275-285" id="s537.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s537.e0" e2="s537.e1" id="s537.p0" relation="false"/>
  </sentence>
  <sentence id="s538" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="173-177" id="s538.e0" ontology_id="1616" text="DAXX" type="GENE"/>
    <entity charOffset="275-285" id="s538.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s538.e0" e2="s538.e1" id="s538.p0" relation="true"/>
  </sentence>
  <sentence id="s539" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="190-202" id="s539.e0" ontology_id="1499" text="beta-catenin" type="GENE"/>
    <entity charOffset="275-285" id="s539.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s539.e0" e2="s539.e1" id="s539.p0" relation="true"/>
  </sentence>
  <sentence id="s540" text="Angioinvasion defined as tumor cells invading through a vessel wall and intravascular tumor cells admixed with thrombus proved to be the best prognostic parameter, predicting adverse outcome in the entire cohort as well as within low-grade ACCs.">
    <entity charOffset="25-30" id="s540.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="137-141" id="s540.e1" ontology_id="7439" text="best" type="GENE"/>
    <pair e1="s540.e0" e2="s540.e1" id="s540.p0" relation="true"/>
  </sentence>
  <sentence id="s541" text="Low mitotic tumor grade, Weiss score, global loss of DAXX expression, and high phospho-mTOR expression correlated with disease-free survival, but Weiss score and biomarkers failed to predict adverse outcome in low-grade disease.">
    <entity charOffset="12-17" id="s541.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="53-57" id="s541.e1" ontology_id="1616" text="DAXX" type="GENE"/>
    <pair e1="s541.e0" e2="s541.e1" id="s541.p0" relation="true"/>
  </sentence>
  <sentence id="s542" text="Low mitotic tumor grade, Weiss score, global loss of DAXX expression, and high phospho-mTOR expression correlated with disease-free survival, but Weiss score and biomarkers failed to predict adverse outcome in low-grade disease.">
    <entity charOffset="12-17" id="s542.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="87-91" id="s542.e1" ontology_id="2475" text="mTOR" type="GENE"/>
    <pair e1="s542.e0" e2="s542.e1" id="s542.p0" relation="true"/>
  </sentence>
  <sentence id="s543" text="For diagnosis of central nervous system degeneration in adolescents with bulbar symptoms, great attention should be paid to JALS">
    <entity charOffset="17-52" id="s543.e0" ontology_id="HP_0007009" text="central nervous system degeneration" type="HP"/>
    <entity charOffset="90-95" id="s543.e1" ontology_id="122042" text="great" type="GENE"/>
    <pair e1="s543.e0" e2="s543.e1" id="s543.p0" relation="true"/>
  </sentence>
  <sentence id="s544" text="Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly.">
    <entity charOffset="14-18" id="s544.e0" ontology_id="10166" text="ORC1" type="GENE"/>
    <entity charOffset="69-82" id="s544.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s544.e0" e2="s544.e1" id="s544.p0" relation="true"/>
  </sentence>
  <sentence id="s545" text="Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly.">
    <entity charOffset="14-18" id="s545.e0" ontology_id="10166" text="ORC1" type="GENE"/>
    <entity charOffset="87-99" id="s545.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s545.e0" e2="s545.e1" id="s545.p0" relation="true"/>
  </sentence>
  <sentence id="s546" text="Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly.">
    <entity charOffset="23-27" id="s546.e0" ontology_id="5000" text="ORC4" type="GENE"/>
    <entity charOffset="69-82" id="s546.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s546.e0" e2="s546.e1" id="s546.p0" relation="true"/>
  </sentence>
  <sentence id="s547" text="Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly.">
    <entity charOffset="23-27" id="s547.e0" ontology_id="5000" text="ORC4" type="GENE"/>
    <entity charOffset="87-99" id="s547.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s547.e0" e2="s547.e1" id="s547.p0" relation="true"/>
  </sentence>
  <sentence id="s548" text="Mutations in ST3GAL5, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset seizure disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits.">
    <entity charOffset="114-121" id="s548.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="193-201" id="s548.e1" ontology_id="2583" text="B4GALNT1" type="GENE"/>
    <pair e1="s548.e0" e2="s548.e1" id="s548.p0" relation="false"/>
  </sentence>
  <sentence id="s549" text="Possible candidate genes in 6q14 for intellectual disability might be FILIP1, MYO6, HTR1B, and SNX14">
    <entity charOffset="37-60" id="s549.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="70-76" id="s549.e1" ontology_id="27145" text="FILIP1" type="GENE"/>
    <pair e1="s549.e0" e2="s549.e1" id="s549.p0" relation="true"/>
  </sentence>
  <sentence id="s550" text="Possible candidate genes in 6q14 for intellectual disability might be FILIP1, MYO6, HTR1B, and SNX14">
    <entity charOffset="37-60" id="s550.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="84-89" id="s550.e1" ontology_id="3351" text="HTR1B" type="GENE"/>
    <pair e1="s550.e0" e2="s550.e1" id="s550.p0" relation="true"/>
  </sentence>
  <sentence id="s551" text="CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.">
    <entity charOffset="0-4" id="s551.e0" ontology_id="10273" text="CHIP" type="GENE"/>
    <entity charOffset="48-73" id="s551.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s551.e0" e2="s551.e1" id="s551.p0" relation="true"/>
  </sentence>
  <sentence id="s552" text="CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.">
    <entity charOffset="0-4" id="s552.e0" ontology_id="10273" text="CHIP" type="GENE"/>
    <entity charOffset="130-136" id="s552.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s552.e0" e2="s552.e1" id="s552.p0" relation="true"/>
  </sentence>
  <sentence id="s553" text="CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.">
    <entity charOffset="130-136" id="s553.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="157-161" id="s553.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s553.e0" e2="s553.e1" id="s553.p0" relation="true"/>
  </sentence>
  <sentence id="s554" text="In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast cancer (BC) in a Chinese population.We genotyped SENP1 (rs61918808), SENP2 (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.">
    <entity charOffset="164-170" id="s554.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="252-257" id="s554.e1" ontology_id="57337" text="SENP7" type="GENE"/>
    <pair e1="s554.e0" e2="s554.e1" id="s554.p0" relation="true"/>
  </sentence>
  <sentence id="s555" text="Lucitanib is a small molecule inhibitor of vascular endothelial growth factor (VEGF) receptors 1 to 3 (VEGFR1 to 3), platelet derived growth factor / (PDGFR/) and FGFR1-3 tyrosine kinases and has demonstrated activity in a phase I/II clinical study, with objective RECIST responses in breast cancer patients with FGFR1 or FGF3/4/19 gene amplification, as well as in patients anticipated to benefit from anti-angiogenic agents.">
    <entity charOffset="79-83" id="s555.e0" ontology_id="7422" text="VEGF" type="GENE"/>
    <entity charOffset="296-302" id="s555.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s555.e0" e2="s555.e1" id="s555.p0" relation="true"/>
  </sentence>
  <sentence id="s556" text="We report here the in vitro and in vivo antitumor activity of lucitanib in experimental models with or without FGFR1/2 amplification or mutations.">
    <entity charOffset="44-49" id="s556.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="111-116" id="s556.e1" ontology_id="2260" text="FGFR1" type="GENE"/>
    <pair e1="s556.e0" e2="s556.e1" id="s556.p0" relation="true"/>
  </sentence>
  <sentence id="s557" text="In cell assays, lucitanib potently inhibited the growth of tumor cell lines with amplified FGFR1 or mutated/amplified FGFR2.">
    <entity charOffset="59-64" id="s557.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="118-123" id="s557.e1" ontology_id="2263" text="FGFR2" type="GENE"/>
    <pair e1="s557.e0" e2="s557.e1" id="s557.p0" relation="true"/>
  </sentence>
  <sentence id="s558" text="Notably, in two lung cancer models with FGFR1 amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of VEGF and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.">
    <entity charOffset="21-27" id="s558.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="143-147" id="s558.e1" ontology_id="7422" text="VEGF" type="GENE"/>
    <pair e1="s558.e0" e2="s558.e1" id="s558.p0" relation="true"/>
  </sentence>
  <sentence id="s559" text="Notably, in two lung cancer models with FGFR1 amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of VEGF and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.">
    <entity charOffset="21-27" id="s559.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="40-45" id="s559.e1" ontology_id="2260" text="FGFR1" type="GENE"/>
    <pair e1="s559.e0" e2="s559.e1" id="s559.p0" relation="true"/>
  </sentence>
  <sentence id="s560" text="Notably, in two lung cancer models with FGFR1 amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of VEGF and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.">
    <entity charOffset="69-74" id="s560.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="143-147" id="s560.e1" ontology_id="7422" text="VEGF" type="GENE"/>
    <pair e1="s560.e0" e2="s560.e1" id="s560.p0" relation="true"/>
  </sentence>
  <sentence id="s561" text="Similar antitumor activity was observed in FGFR2 wild-type and amplified or mutated xenograft models.">
    <entity charOffset="12-17" id="s561.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="43-48" id="s561.e1" ontology_id="2263" text="FGFR2" type="GENE"/>
    <pair e1="s561.e0" e2="s561.e1" id="s561.p0" relation="true"/>
  </sentence>
  <sentence id="s562" text="However, the inherent susceptibility of these tissues to SCO1 mutations and the clinical heterogeneity observed across SCO1 pedigrees remain poorly understood phenomena.">
    <entity charOffset="57-61" id="s562.e0" ontology_id="6341" text="SCO1" type="GENE"/>
    <entity charOffset="89-102" id="s562.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s562.e0" e2="s562.e1" id="s562.p0" relation="true"/>
  </sentence>
  <sentence id="s563" text="CTR1 was similarly mislocalized to the cytosol in the heart of knockin mice carrying a homozygous G115S substitution in Sco1, which in humans causes a hypertrophic cardiomyopathy.">
    <entity charOffset="0-4" id="s563.e0" ontology_id="1317" text="CTR1" type="GENE"/>
    <entity charOffset="164-178" id="s563.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s563.e0" e2="s563.e1" id="s563.p0" relation="true"/>
  </sentence>
  <sentence id="s564" text="CTR1 was similarly mislocalized to the cytosol in the heart of knockin mice carrying a homozygous G115S substitution in Sco1, which in humans causes a hypertrophic cardiomyopathy.">
    <entity charOffset="120-124" id="s564.e0" ontology_id="6341" text="Sco1" type="GENE"/>
    <entity charOffset="164-178" id="s564.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s564.e0" e2="s564.e1" id="s564.p0" relation="true"/>
  </sentence>
  <sentence id="s565" text="Increasing evidence has shown that WT1-interacting protein (WTIP) plays important roles both physiologically and pathologically in humans; however, the role of WTIP in cancer is unknown.">
    <entity charOffset="35-38" id="s565.e0" ontology_id="7490" text="WT1" type="GENE"/>
    <entity charOffset="168-174" id="s565.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s565.e0" e2="s565.e1" id="s565.p0" relation="true"/>
  </sentence>
  <sentence id="s566" text="We report that WTIP is a tumor suppressor in human NSCLC.">
    <entity charOffset="15-19" id="s566.e0" ontology_id="126374" text="WTIP" type="GENE"/>
    <entity charOffset="25-30" id="s566.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s566.e0" e2="s566.e1" id="s566.p0" relation="true"/>
  </sentence>
  <sentence id="s567" text="Moreover, ectopic overexpression of WTIP dramatically inhibits cell proliferation and tumorigenesis invitro and invivo; conversely, depletion of WTIP expression shows the opposite effects.">
    <entity charOffset="36-40" id="s567.e0" ontology_id="126374" text="WTIP" type="GENE"/>
    <entity charOffset="86-91" id="s567.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s567.e0" e2="s567.e1" id="s567.p0" relation="true"/>
  </sentence>
  <sentence id="s568" text="This review goes over recent scientific progress in understanding the molecular mechanisms governing pruritus, the cross-talk between the immune and nervous systems that regulate itch, and central nervous pathways and projections affected by itch.">
    <entity charOffset="179-183" id="s568.e0" ontology_id="83737" text="itch" type="GENE"/>
    <entity charOffset="189-196" id="s568.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s568.e0" e2="s568.e1" id="s568.p0" relation="true"/>
  </sentence>
  <sentence id="s569" text="Here, we have described a homozygous missense variant (c.602C&amp;gt;T, p.S201F) in POPDC1, identified by whole-exome sequencing, in a family of 4 with cardiac arrhythmia and limb-girdle muscular dystrophy (LGMD).">
    <entity charOffset="80-86" id="s569.e0" ontology_id="11149" text="POPDC1" type="GENE"/>
    <entity charOffset="148-166" id="s569.e1" ontology_id="HP_0011675" text="cardiac arrhythmia" type="HP"/>
    <pair e1="s569.e0" e2="s569.e1" id="s569.p0" relation="true"/>
  </sentence>
  <sentence id="s570" text="Our study therefore identifies POPDC1 as a disease gene causing a very rare autosomal recessive cardiac arrhythmia and LGMD, expanding the genetic causes of this heterogeneous group of inherited rare diseases">
    <entity charOffset="31-37" id="s570.e0" ontology_id="11149" text="POPDC1" type="GENE"/>
    <entity charOffset="76-95" id="s570.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s570.e0" e2="s570.e1" id="s570.p0" relation="true"/>
  </sentence>
  <sentence id="s571" text="Our study therefore identifies POPDC1 as a disease gene causing a very rare autosomal recessive cardiac arrhythmia and LGMD, expanding the genetic causes of this heterogeneous group of inherited rare diseases">
    <entity charOffset="31-37" id="s571.e0" ontology_id="11149" text="POPDC1" type="GENE"/>
    <entity charOffset="96-114" id="s571.e1" ontology_id="HP_0011675" text="cardiac arrhythmia" type="HP"/>
    <pair e1="s571.e0" e2="s571.e1" id="s571.p0" relation="true"/>
  </sentence>
  <sentence id="s572" text="Our study therefore identifies POPDC1 as a disease gene causing a very rare autosomal recessive cardiac arrhythmia and LGMD, expanding the genetic causes of this heterogeneous group of inherited rare diseases">
    <entity charOffset="31-37" id="s572.e0" ontology_id="11149" text="POPDC1" type="GENE"/>
    <entity charOffset="162-175" id="s572.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s572.e0" e2="s572.e1" id="s572.p0" relation="true"/>
  </sentence>
  <sentence id="s573" text="To test whether this gene can confer a wide variety of psychiatric disorders, we carried out a case-control association analysis of three tagging single-nucleotide polymorphisms (rs2074896, rs2074897, and rs2074898) in the NDUFS7 gene by sequencing 330 Han Chinese patients with schizophrenia and 330 well-matched healthy controls.">
    <entity charOffset="223-229" id="s573.e0" ontology_id="374291" text="NDUFS7" type="GENE"/>
    <entity charOffset="279-292" id="s573.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s573.e0" e2="s573.e1" id="s573.p0" relation="true"/>
  </sentence>
  <sentence id="s574" text="Tumor growth in xenografts as well as EGFR signaling were assessed in HCT116 cells expressing IL17RD with either a mutant 3' untranslated region (UTR) or wild-type (WT) 3'UTR.&lt;b&gt;Results:&lt;/b&gt; miR-31, miR-34a, miR-106b, and miR-193a-3p were significantly dysregulated in ulcerative colitis-neoplasia and adjacent tissue.">
    <entity charOffset="38-42" id="s574.e0" ontology_id="1956" text="EGFR" type="GENE"/>
    <entity charOffset="288-297" id="s574.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s574.e0" e2="s574.e1" id="s574.p0" relation="true"/>
  </sentence>
  <sentence id="s575" text="Tumor growth in xenografts as well as EGFR signaling were assessed in HCT116 cells expressing IL17RD with either a mutant 3' untranslated region (UTR) or wild-type (WT) 3'UTR.&lt;b&gt;Results:&lt;/b&gt; miR-31, miR-34a, miR-106b, and miR-193a-3p were significantly dysregulated in ulcerative colitis-neoplasia and adjacent tissue.">
    <entity charOffset="191-194" id="s575.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="288-297" id="s575.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s575.e0" e2="s575.e1" id="s575.p0" relation="true"/>
  </sentence>
  <sentence id="s576" text="Changes in methylation of miR-193a or expression of pri-miR-193a were not observed in ulcerative colitis cancer.">
    <entity charOffset="26-29" id="s576.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="105-111" id="s576.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s576.e0" e2="s576.e1" id="s576.p0" relation="true"/>
  </sentence>
  <sentence id="s577" text="IL17RD expression was increased in ulcerative colitis cancers, and miR-193a-3p treatment decreased growth and EGFR signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.&lt;b&gt;Conclusions:&lt;/b&gt; miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.">
    <entity charOffset="54-60" id="s577.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-70" id="s577.e1" ontology_id="220972" text="miR" type="GENE"/>
    <pair e1="s577.e0" e2="s577.e1" id="s577.p0" relation="true"/>
  </sentence>
  <sentence id="s578" text="IL17RD expression was increased in ulcerative colitis cancers, and miR-193a-3p treatment decreased growth and EGFR signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.&lt;b&gt;Conclusions:&lt;/b&gt; miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.">
    <entity charOffset="67-70" id="s578.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="319-328" id="s578.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s578.e0" e2="s578.e1" id="s578.p0" relation="true"/>
  </sentence>
  <sentence id="s579" text="Several studies have demonstrated that N-butyldeoxynojirimycin (NB-DNJ, also known as miglustat), an inhibitor of the enzyme glucosylceramide synthase (GCS), successfully delays the onset of motor deficits, improves longevity, and rescues some of the cerebellar abnormalities (e.g., Purkinje cell death) seen in another lysosomal disease known as Niemann-Pick type C (NPC).">
    <entity charOffset="251-275" id="s579.e0" ontology_id="HP_0001317" text="cerebellar abnormalities" type="HP"/>
    <entity charOffset="360-364" id="s579.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s579.e0" e2="s579.e1" id="s579.p0" relation="true"/>
  </sentence>
  <sentence id="s580" text="Herein, we designed a retro-inverso isomer of &lt;sup&gt;L&lt;/sup&gt;c(LyP-1), termed &lt;sup&gt;D&lt;/sup&gt;c(LyP-1), expecting to inspire brain metastatic tumor targeted drug delivery.">
    <entity charOffset="60-63" id="s580.e0" ontology_id="4068" text="LyP" type="GENE"/>
    <entity charOffset="135-140" id="s580.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s580.e0" e2="s580.e1" id="s580.p0" relation="true"/>
  </sentence>
  <sentence id="s581" text="Further, &lt;sup&gt;L&lt;/sup&gt;c(LyP-1) modified PEG-PLA micelles displayed much higher in vivo distribution in brain metastatic tumor than &lt;sup&gt;D&lt;/sup&gt;c(LyP-1).">
    <entity charOffset="23-26" id="s581.e0" ontology_id="4068" text="LyP" type="GENE"/>
    <entity charOffset="119-124" id="s581.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s581.e0" e2="s581.e1" id="s581.p0" relation="true"/>
  </sentence>
  <sentence id="s582" text="All results suggested that &lt;sup&gt;L&lt;/sup&gt;c(LyP-1) had a better performance than &lt;sup&gt;D&lt;/sup&gt;c(LyP-1) in brain metastatic tumor-targeted drug delivery">
    <entity charOffset="41-44" id="s582.e0" ontology_id="4068" text="LyP" type="GENE"/>
    <entity charOffset="119-124" id="s582.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s582.e0" e2="s582.e1" id="s582.p0" relation="true"/>
  </sentence>
  <sentence id="s583" text="A majority of the familial breast cancer cases are not explained by mutations in the best-known high susceptibility genes BRCA1 and BRCA2.">
    <entity charOffset="34-40" id="s583.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="122-127" id="s583.e1" ontology_id="672" text="BRCA1" type="GENE"/>
    <pair e1="s583.e0" e2="s583.e1" id="s583.p0" relation="true"/>
  </sentence>
  <sentence id="s584" text="VSX1 remains as the best characterised keratoconus gene but only accounts for rare cases.">
    <entity charOffset="20-24" id="s584.e0" ontology_id="7439" text="best" type="GENE"/>
    <entity charOffset="39-50" id="s584.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s584.e0" e2="s584.e1" id="s584.p0" relation="true"/>
  </sentence>
  <sentence id="s585" text="Family-based studies have recently led to the identification of the MIR184 gene for keratoconus with cataract and to the DOCK9 gene in a family with isolated keratoconus.">
    <entity charOffset="84-95" id="s585.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="121-126" id="s585.e1" ontology_id="23348" text="DOCK9" type="GENE"/>
    <pair e1="s585.e0" e2="s585.e1" id="s585.p0" relation="true"/>
  </sentence>
  <sentence id="s586" text="Family-based studies have recently led to the identification of the MIR184 gene for keratoconus with cataract and to the DOCK9 gene in a family with isolated keratoconus.">
    <entity charOffset="101-109" id="s586.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="121-126" id="s586.e1" ontology_id="23348" text="DOCK9" type="GENE"/>
    <pair e1="s586.e0" e2="s586.e1" id="s586.p0" relation="false"/>
  </sentence>
  <sentence id="s587" text="Similarly, recent genome-wide association studies in case-controlled cohorts have identified common variations in and around HGF, RAB3GAP1 and LOX as candidate risk factors for keratoconus.">
    <entity charOffset="125-128" id="s587.e0" ontology_id="3569" text="HGF" type="GENE"/>
    <entity charOffset="177-188" id="s587.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s587.e0" e2="s587.e1" id="s587.p0" relation="true"/>
  </sentence>
  <sentence id="s588" text="Similarly, recent genome-wide association studies in case-controlled cohorts have identified common variations in and around HGF, RAB3GAP1 and LOX as candidate risk factors for keratoconus.">
    <entity charOffset="130-138" id="s588.e0" ontology_id="22930" text="RAB3GAP1" type="GENE"/>
    <entity charOffset="177-188" id="s588.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s588.e0" e2="s588.e1" id="s588.p0" relation="true"/>
  </sentence>
  <sentence id="s589" text="Similarly, recent genome-wide association studies in case-controlled cohorts have identified common variations in and around HGF, RAB3GAP1 and LOX as candidate risk factors for keratoconus.">
    <entity charOffset="143-146" id="s589.e0" ontology_id="4015" text="LOX" type="GENE"/>
    <entity charOffset="177-188" id="s589.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s589.e0" e2="s589.e1" id="s589.p0" relation="true"/>
  </sentence>
  <sentence id="s590" text="PRMT7 plays important roles in the regulation of gene expression, splicing, DNA damage, paternal imprinting, cancer and metastasis.">
    <entity charOffset="0-5" id="s590.e0" ontology_id="54496" text="PRMT7" type="GENE"/>
    <entity charOffset="109-115" id="s590.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s590.e0" e2="s590.e1" id="s590.p0" relation="true"/>
  </sentence>
  <sentence id="s591" text="An early intervention using biomarkers to predict acute myocardial infarction (AMI) will effectively reduce global heart attack incidence, particularly among high-risk patients with type 2 diabetes mellitus (T2DM).">
    <entity charOffset="56-77" id="s591.e0" ontology_id="HP_0001658" text="myocardial infarction" type="HP"/>
    <entity charOffset="182-186" id="s591.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s591.e0" e2="s591.e1" id="s591.p0" relation="true"/>
  </sentence>
  <sentence id="s592" text="The brains of &lt;i&gt;Ube3b&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex.">
    <entity charOffset="17-22" id="s592.e0" ontology_id="89910" text="Ube3b" type="GENE"/>
    <entity charOffset="85-104" id="s592.e1" ontology_id="HP_0002119" text="enlarged ventricles" type="HP"/>
    <pair e1="s592.e0" e2="s592.e1" id="s592.p0" relation="true"/>
  </sentence>
  <sentence id="s593" text="The brains of &lt;i&gt;Ube3b&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex.">
    <entity charOffset="41-45" id="s593.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="50-83" id="s593.e1" ontology_id="HP_0002079" text="hypoplasia of the corpus callosum" type="HP"/>
    <pair e1="s593.e0" e2="s593.e1" id="s593.p0" relation="true"/>
  </sentence>
  <sentence id="s594" text="A heterozygous mutation (c.643C&amp;gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene MCT12 (also known as SLC16A12) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.">
    <entity charOffset="99-104" id="s594.e0" ontology_id="387700" text="MCT12" type="GENE"/>
    <entity charOffset="239-250" id="s594.e1" ontology_id="HP_0000482" text="microcornea" type="HP"/>
    <pair e1="s594.e0" e2="s594.e1" id="s594.p0" relation="true"/>
  </sentence>
  <sentence id="s595" text="A heterozygous mutation (c.643C&amp;gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene MCT12 (also known as SLC16A12) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.">
    <entity charOffset="120-128" id="s595.e0" ontology_id="387700" text="SLC16A12" type="GENE"/>
    <entity charOffset="228-237" id="s595.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s595.e0" e2="s595.e1" id="s595.p0" relation="true"/>
  </sentence>
  <sentence id="s596" text="A heterozygous mutation (c.643C&amp;gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene MCT12 (also known as SLC16A12) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.">
    <entity charOffset="120-128" id="s596.e0" ontology_id="387700" text="SLC16A12" type="GENE"/>
    <entity charOffset="239-250" id="s596.e1" ontology_id="HP_0000482" text="microcornea" type="HP"/>
    <pair e1="s596.e0" e2="s596.e1" id="s596.p0" relation="true"/>
  </sentence>
  <sentence id="s597" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s597.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="319-323" id="s597.e1" ontology_id="5896" text="Rag1" type="GENE"/>
    <pair e1="s597.e0" e2="s597.e1" id="s597.p0" relation="true"/>
  </sentence>
  <sentence id="s598" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s598.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="325-329" id="s598.e1" ontology_id="5897" text="Rag2" type="GENE"/>
    <pair e1="s598.e0" e2="s598.e1" id="s598.p0" relation="true"/>
  </sentence>
  <sentence id="s599" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s599.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="337-343" id="s599.e1" ontology_id="7441" text="Vpreb1" type="GENE"/>
    <pair e1="s599.e0" e2="s599.e1" id="s599.p0" relation="true"/>
  </sentence>
  <sentence id="s600" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s600.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="345-351" id="s600.e1" ontology_id="29802" text="Vpreb3" type="GENE"/>
    <pair e1="s600.e0" e2="s600.e1" id="s600.p0" relation="true"/>
  </sentence>
  <sentence id="s601" text="Dysfunction of SNORD115-PBRM1 connecting with SMARCA2 as well as other proven schizophrenia-associated genes might explain why traditionally catatonia has been classified with schizophrenia.">
    <entity charOffset="24-29" id="s601.e0" ontology_id="55193" text="PBRM1" type="GENE"/>
    <entity charOffset="78-91" id="s601.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s601.e0" e2="s601.e1" id="s601.p0" relation="true"/>
  </sentence>
  <sentence id="s602" text="Dysfunction of SNORD115-PBRM1 connecting with SMARCA2 as well as other proven schizophrenia-associated genes might explain why traditionally catatonia has been classified with schizophrenia.">
    <entity charOffset="46-53" id="s602.e0" ontology_id="6595" text="SMARCA2" type="GENE"/>
    <entity charOffset="78-91" id="s602.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s602.e0" e2="s602.e1" id="s602.p0" relation="false"/>
  </sentence>
  <sentence id="s603" text="SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene.">
    <entity charOffset="9-13" id="s603.e0" ontology_id="6872" text="TAF1" type="GENE"/>
    <entity charOffset="206-218" id="s603.e1" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <pair e1="s603.e0" e2="s603.e1" id="s603.p0" relation="true"/>
  </sentence>
  <sentence id="s604" text="SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene.">
    <entity charOffset="24-28" id="s604.e0" ontology_id="8818" text="DPM2" type="GENE"/>
    <entity charOffset="206-218" id="s604.e1" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <pair e1="s604.e0" e2="s604.e1" id="s604.p0" relation="false"/>
  </sentence>
  <sentence id="s605" text="SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene.">
    <entity charOffset="206-218" id="s605.e0" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <entity charOffset="257-263" id="s605.e1" ontology_id="85358" text="SHANK3" type="GENE"/>
    <pair e1="s605.e0" e2="s605.e1" id="s605.p0" relation="true"/>
  </sentence>
  <sentence id="s606" text="Here we characterize Plk4-dependent cancer cell migration and invasion as well as local invasion and metastasis of cancer xenografts.">
    <entity charOffset="21-25" id="s606.e0" ontology_id="10733" text="Plk4" type="GENE"/>
    <entity charOffset="36-42" id="s606.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s606.e0" e2="s606.e1" id="s606.p0" relation="true"/>
  </sentence>
  <sentence id="s607" text="Plk4 depletion suppressed cancer invasion and induced an epithelial phenotype in poorly differentiated breast cancer cells.">
    <entity charOffset="0-4" id="s607.e0" ontology_id="10733" text="Plk4" type="GENE"/>
    <entity charOffset="26-32" id="s607.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s607.e0" e2="s607.e1" id="s607.p0" relation="true"/>
  </sentence>
  <sentence id="s608" text="In an unbiased BioID screen for Plk4 interactors, we identified members of the Arp2/3 complex and confirmed a physical and functional interaction between Plk4 and Arp2 in mediating Plk4-driven cancer cell movement.">
    <entity charOffset="32-36" id="s608.e0" ontology_id="10733" text="Plk4" type="GENE"/>
    <entity charOffset="193-199" id="s608.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s608.e0" e2="s608.e1" id="s608.p0" relation="true"/>
  </sentence>
  <sentence id="s609" text="In an unbiased BioID screen for Plk4 interactors, we identified members of the Arp2/3 complex and confirmed a physical and functional interaction between Plk4 and Arp2 in mediating Plk4-driven cancer cell movement.">
    <entity charOffset="79-83" id="s609.e0" ontology_id="10097" text="Arp2" type="GENE"/>
    <entity charOffset="193-199" id="s609.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s609.e0" e2="s609.e1" id="s609.p0" relation="true"/>
  </sentence>
  <sentence id="s610" text="Our results validate Plk4 as a therapeutic target in cancer patients and reveal a new role for Plk4 in regulating Arp2/3-mediated actin cytoskeletal rearrangement.">
    <entity charOffset="21-25" id="s610.e0" ontology_id="10733" text="Plk4" type="GENE"/>
    <entity charOffset="53-59" id="s610.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s610.e0" e2="s610.e1" id="s610.p0" relation="true"/>
  </sentence>
  <sentence id="s611" text="Our data, for the first time, functionally link Jalili syndrome gene CNNM4 to LCA gene IQCB1, providing important insights into the molecular pathogenic mechanism of retinal dystrophy in Jalili syndrome">
    <entity charOffset="69-74" id="s611.e0" ontology_id="26504" text="CNNM4" type="GENE"/>
    <entity charOffset="166-183" id="s611.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s611.e0" e2="s611.e1" id="s611.p0" relation="true"/>
  </sentence>
  <sentence id="s612" text="Our data, for the first time, functionally link Jalili syndrome gene CNNM4 to LCA gene IQCB1, providing important insights into the molecular pathogenic mechanism of retinal dystrophy in Jalili syndrome">
    <entity charOffset="87-92" id="s612.e0" ontology_id="9657" text="IQCB1" type="GENE"/>
    <entity charOffset="166-183" id="s612.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s612.e0" e2="s612.e1" id="s612.p0" relation="true"/>
  </sentence>
  <sentence id="s613" text="Renpenning syndrome is a group of X-linked intellectual disability syndromes caused by mutations in human polyglutamine-binding protein 1 (PQBP1) gene.">
    <entity charOffset="43-66" id="s613.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="139-144" id="s613.e1" ontology_id="10084" text="PQBP1" type="GENE"/>
    <pair e1="s613.e0" e2="s613.e1" id="s613.p0" relation="true"/>
  </sentence>
  <sentence id="s614" text="Small intestine neuroendocrine tumors (SI-NETs) represent the most common histotype among small intestine neoplasms, and metastatic disease is usually present at diagnosis.">
    <entity charOffset="31-37" id="s614.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="42-46" id="s614.e1" ontology_id="11005" text="NETs" type="GENE"/>
    <pair e1="s614.e0" e2="s614.e1" id="s614.p0" relation="false"/>
  </sentence>
  <sentence id="s615" text="Small intestine neuroendocrine tumors (SI-NETs) represent the most common histotype among small intestine neoplasms, and metastatic disease is usually present at diagnosis.">
    <entity charOffset="39-41" id="s615.e0" ontology_id="6490" text="SI" type="GENE"/>
    <entity charOffset="106-115" id="s615.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s615.e0" e2="s615.e1" id="s615.p0" relation="false"/>
  </sentence>
  <sentence id="s616" text="Small intestine neuroendocrine tumors (SI-NETs) represent the most common histotype among small intestine neoplasms, and metastatic disease is usually present at diagnosis.">
    <entity charOffset="42-46" id="s616.e0" ontology_id="11005" text="NETs" type="GENE"/>
    <entity charOffset="106-115" id="s616.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s616.e0" e2="s616.e1" id="s616.p0" relation="true"/>
  </sentence>
  <sentence id="s617" text="A retrospective series of 52 sporadic primary surgically resected SI-NETs, which were metastatic at diagnosis, was analyzed by high-coverage target sequencing (HCTS) for the mutational status of 57 genes and copy number status of 40 genes selected from recently published genome sequencing data.">
    <entity charOffset="29-37" id="s617.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="66-68" id="s617.e1" ontology_id="6490" text="SI" type="GENE"/>
    <pair e1="s617.e0" e2="s617.e1" id="s617.p0" relation="true"/>
  </sentence>
  <sentence id="s618" text="Recurrent copy number variations are important events in SI-NET and SRC may represent a novel prognostic biomarker for this tumor type">
    <entity charOffset="57-59" id="s618.e0" ontology_id="6490" text="SI" type="GENE"/>
    <entity charOffset="124-129" id="s618.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s618.e0" e2="s618.e1" id="s618.p0" relation="true"/>
  </sentence>
  <sentence id="s619" text="Recurrent copy number variations are important events in SI-NET and SRC may represent a novel prognostic biomarker for this tumor type">
    <entity charOffset="60-63" id="s619.e0" ontology_id="2004" text="NET" type="GENE"/>
    <entity charOffset="124-129" id="s619.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s619.e0" e2="s619.e1" id="s619.p0" relation="true"/>
  </sentence>
  <sentence id="s620" text="Recurrent copy number variations are important events in SI-NET and SRC may represent a novel prognostic biomarker for this tumor type">
    <entity charOffset="68-71" id="s620.e0" ontology_id="6714" text="SRC" type="GENE"/>
    <entity charOffset="124-129" id="s620.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s620.e0" e2="s620.e1" id="s620.p0" relation="true"/>
  </sentence>
  <sentence id="s621" text="In this study, we examine the role of proton-sensing ovarian cancer G protein-coupled receptor 1 (OGR1) in extracellular acidification-induced regulation of cyclooxygenase (COX)-2 induction, PGI(2) production, MAPK phosphatase (MKP)-1 expression, and plasminogen activator inhibitor (PAI)-1 expression and proliferation in human aortic smooth muscle cells (AoSMCs).">
    <entity charOffset="61-67" id="s621.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="173-176" id="s621.e1" ontology_id="1351" text="COX" type="GENE"/>
    <pair e1="s621.e0" e2="s621.e1" id="s621.p0" relation="true"/>
  </sentence>
  <sentence id="s622" text="Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting IL-17-mediated immunity, such as &lt;i&gt;STAT3, AIRE, RORC, CARD9, IL12B&lt;/i&gt;, and &lt;i&gt;IL12RB1&lt;/i&gt;, or gain of function (GOF) mutations in &lt;i&gt;STAT1&lt;/i&gt;.">
    <entity charOffset="8-33" id="s622.e0" ontology_id="HP_0002728" text="mucocutaneous candidiasis" type="HP"/>
    <entity charOffset="93-98" id="s622.e1" ontology_id="3605" text="IL-17" type="GENE"/>
    <pair e1="s622.e0" e2="s622.e1" id="s622.p0" relation="true"/>
  </sentence>
  <sentence id="s623" text="Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting IL-17-mediated immunity, such as &lt;i&gt;STAT3, AIRE, RORC, CARD9, IL12B&lt;/i&gt;, and &lt;i&gt;IL12RB1&lt;/i&gt;, or gain of function (GOF) mutations in &lt;i&gt;STAT1&lt;/i&gt;.">
    <entity charOffset="8-33" id="s623.e0" ontology_id="HP_0002728" text="mucocutaneous candidiasis" type="HP"/>
    <entity charOffset="136-140" id="s623.e1" ontology_id="326" text="AIRE" type="GENE"/>
    <pair e1="s623.e0" e2="s623.e1" id="s623.p0" relation="true"/>
  </sentence>
  <sentence id="s624" text="Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting IL-17-mediated immunity, such as &lt;i&gt;STAT3, AIRE, RORC, CARD9, IL12B&lt;/i&gt;, and &lt;i&gt;IL12RB1&lt;/i&gt;, or gain of function (GOF) mutations in &lt;i&gt;STAT1&lt;/i&gt;.">
    <entity charOffset="8-33" id="s624.e0" ontology_id="HP_0002728" text="mucocutaneous candidiasis" type="HP"/>
    <entity charOffset="142-146" id="s624.e1" ontology_id="6097" text="RORC" type="GENE"/>
    <pair e1="s624.e0" e2="s624.e1" id="s624.p0" relation="true"/>
  </sentence>
  <sentence id="s625" text="Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting IL-17-mediated immunity, such as &lt;i&gt;STAT3, AIRE, RORC, CARD9, IL12B&lt;/i&gt;, and &lt;i&gt;IL12RB1&lt;/i&gt;, or gain of function (GOF) mutations in &lt;i&gt;STAT1&lt;/i&gt;.">
    <entity charOffset="8-33" id="s625.e0" ontology_id="HP_0002728" text="mucocutaneous candidiasis" type="HP"/>
    <entity charOffset="148-153" id="s625.e1" ontology_id="64170" text="CARD9" type="GENE"/>
    <pair e1="s625.e0" e2="s625.e1" id="s625.p0" relation="true"/>
  </sentence>
  <sentence id="s626" text="Genomic imbalance of lung cancer was determined by the array comparative genomic hybridization (aCGH), and common gCNVs at these imbalance regions were genotyped in lung cancer-based and COPD-based retrospective studies.">
    <entity charOffset="26-32" id="s626.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="187-191" id="s626.e1" ontology_id="372" text="COPD" type="GENE"/>
    <pair e1="s626.e0" e2="s626.e1" id="s626.p0" relation="true"/>
  </sentence>
  <sentence id="s627" text="The CNVR_3425.1, overlapping the chr16q24.1 with genomic imbalance, was significantly associated with increased risks of lung cancer (OR = 1.76; 95% CI = 1.46-2.11) and COPD (OR = 1.98; 95% CI = 1.57-2.51).">
    <entity charOffset="126-132" id="s627.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="169-173" id="s627.e1" ontology_id="372" text="COPD" type="GENE"/>
    <pair e1="s627.e0" e2="s627.e1" id="s627.p0" relation="true"/>
  </sentence>
  <sentence id="s628" text="The increase copy of CNVR_3425.1 forms a new additional truncated FOXF1 adjacent non-coding developmental regulatory RNA (FENDRR) sequences comparing the gene promoter and perturbs the transcriptional factors (TFs) binding to the original FENDRR promoter and further downregulates FENDRR, a long intergenic non-coding RNA (lincRNA) that functions to inhibit lung cancer by affecting expressions of an abundant number of genes, including the tumor suppressor FOXF1.">
    <entity charOffset="66-71" id="s628.e0" ontology_id="2294" text="FOXF1" type="GENE"/>
    <entity charOffset="441-446" id="s628.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s628.e0" e2="s628.e1" id="s628.p0" relation="true"/>
  </sentence>
  <sentence id="s629" text="The increase copy of CNVR_3425.1 forms a new additional truncated FOXF1 adjacent non-coding developmental regulatory RNA (FENDRR) sequences comparing the gene promoter and perturbs the transcriptional factors (TFs) binding to the original FENDRR promoter and further downregulates FENDRR, a long intergenic non-coding RNA (lincRNA) that functions to inhibit lung cancer by affecting expressions of an abundant number of genes, including the tumor suppressor FOXF1.">
    <entity charOffset="66-71" id="s629.e0" ontology_id="2294" text="FOXF1" type="GENE"/>
    <entity charOffset="363-369" id="s629.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s629.e0" e2="s629.e1" id="s629.p0" relation="true"/>
  </sentence>
  <sentence id="s630" text="In a meta-analysis of our previous GWAS and the replication studies, which included a total of 7,141 prostate cancer cases and 11,804 controls from a single ancestry group, three new loci reached genome-wide significance on chromosomes 11q12 (rs1938781; P = 1.10  10(-10); FAM111A-FAM111B), 10q26 (rs2252004; P = 1.98  10(-8)) and 3p11.2 (rs2055109; P = 3.94  10(-8)).">
    <entity charOffset="110-116" id="s630.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="274-281" id="s630.e1" ontology_id="63901" text="FAM111A" type="GENE"/>
    <pair e1="s630.e0" e2="s630.e1" id="s630.p0" relation="true"/>
  </sentence>
  <sentence id="s631" text="Single nucleotide polymorphisms (SNPs) in WRAP53 have been associated with risk of cancer, which strengthens the role of WRAP53 in the pathogenesis of human malignancies.">
    <entity charOffset="42-48" id="s631.e0" ontology_id="55135" text="WRAP53" type="GENE"/>
    <entity charOffset="83-89" id="s631.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s631.e0" e2="s631.e1" id="s631.p0" relation="true"/>
  </sentence>
  <sentence id="s632" text="In fact, WRAP53 has been considered as a candidate cancer susceptibility gene.">
    <entity charOffset="3-7" id="s632.e0" ontology_id="11198" text="fact" type="GENE"/>
    <entity charOffset="51-57" id="s632.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s632.e0" e2="s632.e1" id="s632.p0" relation="true"/>
  </sentence>
  <sentence id="s633" text="Accordingly, we performed a study to examine the association of a frequent genetic variation in WRAP53, rs2287499 (C/G), with breast cancer risk and prognosis among Iranian-Azeri population.">
    <entity charOffset="96-102" id="s633.e0" ontology_id="55135" text="WRAP53" type="GENE"/>
    <entity charOffset="133-139" id="s633.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s633.e0" e2="s633.e1" id="s633.p0" relation="true"/>
  </sentence>
  <sentence id="s634" text="Here, we utilized the CRISPR-Cas9 system to generate Kcnj13 mutant mice by zygote injection to verify the pathogenic role of human KCNJ13, mutations of which are thought to cause Leber congenital amaurosis (LCA), an early-onset form of blindness.">
    <entity charOffset="53-59" id="s634.e0" ontology_id="3769" text="Kcnj13" type="GENE"/>
    <entity charOffset="236-245" id="s634.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s634.e0" e2="s634.e1" id="s634.p0" relation="true"/>
  </sentence>
  <sentence id="s635" text="Here, we utilized the CRISPR-Cas9 system to generate Kcnj13 mutant mice by zygote injection to verify the pathogenic role of human KCNJ13, mutations of which are thought to cause Leber congenital amaurosis (LCA), an early-onset form of blindness.">
    <entity charOffset="131-137" id="s635.e0" ontology_id="3769" text="KCNJ13" type="GENE"/>
    <entity charOffset="236-245" id="s635.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s635.e0" e2="s635.e1" id="s635.p0" relation="true"/>
  </sentence>
  <sentence id="s636" text="Here, we utilized the CRISPR-Cas9 system to generate Kcnj13 mutant mice by zygote injection to verify the pathogenic role of human KCNJ13, mutations of which are thought to cause Leber congenital amaurosis (LCA), an early-onset form of blindness.">
    <entity charOffset="207-210" id="s636.e0" ontology_id="1211" text="LCA" type="GENE"/>
    <entity charOffset="236-245" id="s636.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s636.e0" e2="s636.e1" id="s636.p0" relation="true"/>
  </sentence>
  <sentence id="s637" text="Reproductive aging phenotypes, including age at menarche (AM) and age at natural menopause (ANM), are well-established risk factors for breast cancer.">
    <entity charOffset="92-95" id="s637.e0" ontology_id="7138" text="ANM" type="GENE"/>
    <entity charOffset="143-149" id="s637.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s637.e0" e2="s637.e1" id="s637.p0" relation="true"/>
  </sentence>
  <sentence id="s638" text="Using data from the Women's Circle of Health Study (WCHS) of 1,307 European-American (EA) and 1,365 African-American (AA) breast cancer cases and controls, we aimed to replicate 53 earlier GWAS variants for AM and ANM in AA and EA groups and to perform analyses on total and net reproductive lifespan (TRLS; NRLS).">
    <entity charOffset="129-135" id="s638.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="275-278" id="s638.e1" ontology_id="2004" text="net" type="GENE"/>
    <pair e1="s638.e0" e2="s638.e1" id="s638.p0" relation="true"/>
  </sentence>
  <sentence id="s639" text="In this study, we identified a splice-site mutation (c.637+1G&amp;gt;T) in Ca(2+)-binding protein 2 (CABP2) in three consanguineous Iranian families affected by moderate-to-severe hearing loss.">
    <entity charOffset="97-102" id="s639.e0" ontology_id="51475" text="CABP2" type="GENE"/>
    <entity charOffset="176-188" id="s639.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s639.e0" e2="s639.e1" id="s639.p0" relation="true"/>
  </sentence>
  <sentence id="s640" text="In 2005, CLTC clients were significantly more likely to have chronic conditions, including hypertension, chronic obstructive pulmonary disease, Alzheimer's disease, arthritis, diabetes, and renal failure (all p &amp;lt; 0.05).">
    <entity charOffset="9-13" id="s640.e0" ontology_id="1213" text="CLTC" type="GENE"/>
    <entity charOffset="91-103" id="s640.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s640.e0" e2="s640.e1" id="s640.p0" relation="true"/>
  </sentence>
  <sentence id="s641" text="MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin Fat 4 (FAT4), and large tumor suppressors 2 (LATS2), at both the mRNA and protein level.">
    <entity charOffset="130-133" id="s641.e0" ontology_id="948" text="Fat" type="GENE"/>
    <entity charOffset="154-159" id="s641.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s641.e0" e2="s641.e1" id="s641.p0" relation="true"/>
  </sentence>
  <sentence id="s642" text="MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin Fat 4 (FAT4), and large tumor suppressors 2 (LATS2), at both the mRNA and protein level.">
    <entity charOffset="137-141" id="s642.e0" ontology_id="79633" text="FAT4" type="GENE"/>
    <entity charOffset="154-159" id="s642.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s642.e0" e2="s642.e1" id="s642.p0" relation="false"/>
  </sentence>
  <sentence id="s643" text="MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin Fat 4 (FAT4), and large tumor suppressors 2 (LATS2), at both the mRNA and protein level.">
    <entity charOffset="154-159" id="s643.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="175-180" id="s643.e1" ontology_id="26524" text="LATS2" type="GENE"/>
    <pair e1="s643.e0" e2="s643.e1" id="s643.p0" relation="true"/>
  </sentence>
  <sentence id="s644" text="Leber hereditary optic neuropathy (LHON) and dominant optic atrophy (DOA), the most common forms of hereditary optic neuropathy, are easily confused, and it is difficult to distinguish one from the other in the clinic, especially in young children.">
    <entity charOffset="35-39" id="s644.e0" ontology_id="100873240" text="LHON" type="GENE"/>
    <entity charOffset="54-67" id="s644.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s644.e0" e2="s644.e1" id="s644.p0" relation="true"/>
  </sentence>
  <sentence id="s645" text="Overall, our study proposes that TRPS1 acts as a central hub in the control of cell cycle and proliferation during cancer development.">
    <entity charOffset="33-38" id="s645.e0" ontology_id="7227" text="TRPS1" type="GENE"/>
    <entity charOffset="115-121" id="s645.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s645.e0" e2="s645.e1" id="s645.p0" relation="true"/>
  </sentence>
  <sentence id="s646" text="We report four individuals from three unrelated families who have homozygous missense or compound heterozygous truncating mutations in UNC80 and persistent hypotonia, encephalopathy, growth failure, and severe intellectual disability.">
    <entity charOffset="135-140" id="s646.e0" ontology_id="285175" text="UNC80" type="GENE"/>
    <entity charOffset="210-233" id="s646.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s646.e0" e2="s646.e1" id="s646.p0" relation="true"/>
  </sentence>
  <sentence id="s647" text="The primary objective of the study was to estimate the maximum tolerated dose (MTD) and/or recommended phase II dose (RP2D) of oral alpelisib in patients with advanced solid tumors who had progressed despite standard therapy.">
    <entity charOffset="79-82" id="s647.e0" ontology_id="4493" text="MTD" type="GENE"/>
    <entity charOffset="174-180" id="s647.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s647.e0" e2="s647.e1" id="s647.p0" relation="true"/>
  </sentence>
  <sentence id="s648" text="Dihydropyrimidinase (DHP) deficiency is an autosomal recessive disease caused by mutations in the DPYS gene.">
    <entity charOffset="43-62" id="s648.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="98-102" id="s648.e1" ontology_id="1807" text="DPYS" type="GENE"/>
    <pair e1="s648.e0" e2="s648.e1" id="s648.p0" relation="true"/>
  </sentence>
  <sentence id="s649" text="Here, we report bi-allelic pathogenic SPTBN4 variants (three homozygous and two compound heterozygous) that cause a severe neurological syndrome that includes congenital hypotonia, intellectual disability, and motor axonal and auditory neuropathy.">
    <entity charOffset="38-44" id="s649.e0" ontology_id="57731" text="SPTBN4" type="GENE"/>
    <entity charOffset="181-204" id="s649.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s649.e0" e2="s649.e1" id="s649.p0" relation="true"/>
  </sentence>
  <sentence id="s650" text="Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and intellectual disability, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper lip, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.">
    <entity charOffset="151-165" id="s650.e0" ontology_id="HP_0000520" text="prominent eyes" type="HP"/>
    <entity charOffset="205-208" id="s650.e1" ontology_id="23049" text="lip" type="GENE"/>
    <pair e1="s650.e0" e2="s650.e1" id="s650.p0" relation="true"/>
  </sentence>
  <sentence id="s651" text="Mutations in LIAS have been identified that result in a variant form of nonketotic hyperglycinemia with early-onset convulsions combined with a defect in mitochondrial energy metabolism with encephalopathy and cardiomyopathy.">
    <entity charOffset="13-17" id="s651.e0" ontology_id="11019" text="LIAS" type="GENE"/>
    <entity charOffset="191-205" id="s651.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s651.e0" e2="s651.e1" id="s651.p0" relation="true"/>
  </sentence>
  <sentence id="s652" text="Mutations in LIAS have been identified that result in a variant form of nonketotic hyperglycinemia with early-onset convulsions combined with a defect in mitochondrial energy metabolism with encephalopathy and cardiomyopathy.">
    <entity charOffset="13-17" id="s652.e0" ontology_id="11019" text="LIAS" type="GENE"/>
    <entity charOffset="210-224" id="s652.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s652.e0" e2="s652.e1" id="s652.p0" relation="true"/>
  </sentence>
  <sentence id="s653" text="However, activated T cells and B cells secrete pro-osteoclastogenic factors including receptor activator of Nuclear factor-kappaB (NF-kB) ligand (RANKL), Interleukin (IL)-17A, and tumor necrosis factor (TNF)- promoting bone loss in inflammatory states such as rheumatoid arthritis.">
    <entity charOffset="146-151" id="s653.e0" ontology_id="8600" text="RANKL" type="GENE"/>
    <entity charOffset="180-185" id="s653.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s653.e0" e2="s653.e1" id="s653.p0" relation="false"/>
  </sentence>
  <sentence id="s654" text="However, activated T cells and B cells secrete pro-osteoclastogenic factors including receptor activator of Nuclear factor-kappaB (NF-kB) ligand (RANKL), Interleukin (IL)-17A, and tumor necrosis factor (TNF)- promoting bone loss in inflammatory states such as rheumatoid arthritis.">
    <entity charOffset="180-185" id="s654.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="203-206" id="s654.e1" ontology_id="7124" text="TNF" type="GENE"/>
    <pair e1="s654.e0" e2="s654.e1" id="s654.p0" relation="true"/>
  </sentence>
  <sentence id="s655" text="T cell-produced TNF and IL-17A further contribute to bone loss in hyperparathyroidism, while T cell production of the anabolic Wingless integration site (Wnt) ligand, Wnt10b, promotes bone formation in response to anabolic parathyroid hormone and the immunomodulatory costimulation inhibitor cytotoxic T lymphocyte-associated protein-4-IgG (abatacept).">
    <entity charOffset="16-19" id="s655.e0" ontology_id="7124" text="TNF" type="GENE"/>
    <entity charOffset="66-85" id="s655.e1" ontology_id="HP_0000843" text="hyperparathyroidism" type="HP"/>
    <pair e1="s655.e0" e2="s655.e1" id="s655.p0" relation="true"/>
  </sentence>
  <sentence id="s656" text="A recent genome-wide association study (GWAS) linked hypercalciuria and kidney stones to a claudin-14 (CLDN14) risk haplotype.">
    <entity charOffset="53-67" id="s656.e0" ontology_id="HP_0002150" text="hypercalciuria" type="HP"/>
    <entity charOffset="103-109" id="s656.e1" ontology_id="23562" text="CLDN14" type="GENE"/>
    <pair e1="s656.e0" e2="s656.e1" id="s656.p0" relation="true"/>
  </sentence>
  <sentence id="s657" text="Usher syndrome (USH) is the most common cause of inherited deaf-blindness, manifested as USH1, USH2 and USH3 clinical types.">
    <entity charOffset="64-73" id="s657.e0" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <entity charOffset="104-108" id="s657.e1" ontology_id="7401" text="USH3" type="GENE"/>
    <pair e1="s657.e0" e2="s657.e1" id="s657.p0" relation="true"/>
  </sentence>
  <sentence id="s658" text="Feingold syndrome is a skeletal dysplasia caused by loss-of-function mutations of either MYCN (type 1) or MIR17HG that encodes miR-17-92 microRNAs (type 2).">
    <entity charOffset="23-41" id="s658.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="95-99" id="s658.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s658.e0" e2="s658.e1" id="s658.p0" relation="false"/>
  </sentence>
  <sentence id="s659" text="Feingold syndrome is a skeletal dysplasia caused by loss-of-function mutations of either MYCN (type 1) or MIR17HG that encodes miR-17-92 microRNAs (type 2).">
    <entity charOffset="23-41" id="s659.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="127-130" id="s659.e1" ontology_id="220972" text="miR" type="GENE"/>
    <pair e1="s659.e0" e2="s659.e1" id="s659.p0" relation="true"/>
  </sentence>
  <sentence id="s660" text="A single family with an autosomal recessive form of OFCS and a homozygous missense mutation in PAX1 gene has been described.">
    <entity charOffset="24-43" id="s660.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="95-99" id="s660.e1" ontology_id="5075" text="PAX1" type="GENE"/>
    <pair e1="s660.e0" e2="s660.e1" id="s660.p0" relation="true"/>
  </sentence>
  <sentence id="s661" text="This report provides evidence that bi-allelic null PAX1 mutations may lead to a multi-system autosomal recessive disorders, where SCID might represent the main feature">
    <entity charOffset="51-55" id="s661.e0" ontology_id="5075" text="PAX1" type="GENE"/>
    <entity charOffset="93-112" id="s661.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s661.e0" e2="s661.e1" id="s661.p0" relation="true"/>
  </sentence>
  <sentence id="s662" text="uPA may enhance the migratory and invasive capabilities of endometrial tumor cells by the phosphorylation of ERK1/2, Akt and p38 molecules.">
    <entity charOffset="0-3" id="s662.e0" ontology_id="5328" text="uPA" type="GENE"/>
    <entity charOffset="71-76" id="s662.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s662.e0" e2="s662.e1" id="s662.p0" relation="true"/>
  </sentence>
  <sentence id="s663" text="uPA is a dysregulated gene involved in the tumorigenesis, bio-pathological features and outcomes of EEC. uPA may be a potential molecule and target for the detection and treatment of EEC.">
    <entity charOffset="0-3" id="s663.e0" ontology_id="5328" text="uPA" type="GENE"/>
    <entity charOffset="43-48" id="s663.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s663.e0" e2="s663.e1" id="s663.p0" relation="true"/>
  </sentence>
  <sentence id="s664" text="By demonstrating that MT-bound Tau inhibits the Eg5 kinesin and cell mitosis, our work provides a new framework to consider the role of Tau in neurodegenerative diseases.">
    <entity charOffset="31-34" id="s664.e0" ontology_id="4137" text="Tau" type="GENE"/>
    <entity charOffset="143-169" id="s664.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s664.e0" e2="s664.e1" id="s664.p0" relation="true"/>
  </sentence>
  <sentence id="s665" text="Homozygozity mapping and exome sequencing in 62 isolated individuals with early-onset parkinsonism and confirmed consanguinity followed by data mining in the exomes of 1,348 PD-affected individuals identified, in three isolated subjects, homozygous or compound heterozygous truncating mutations in vacuolar protein sorting 13C (VPS13C).">
    <entity charOffset="86-98" id="s665.e0" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <entity charOffset="328-334" id="s665.e1" ontology_id="54832" text="VPS13C" type="GENE"/>
    <pair e1="s665.e0" e2="s665.e1" id="s665.p0" relation="true"/>
  </sentence>
  <sentence id="s666" text="This work suggests that loss of function of VPS13C is a cause of autosomal-recessive early-onset parkinsonism with a distinctive phenotype of rapid and severe progression">
    <entity charOffset="44-50" id="s666.e0" ontology_id="54832" text="VPS13C" type="GENE"/>
    <entity charOffset="97-109" id="s666.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s666.e0" e2="s666.e1" id="s666.p0" relation="true"/>
  </sentence>
  <sentence id="s667" text="Human genetic evidence demonstrates that WNT1 mutations cause osteogenesis imperfecta (OI) and early-onset osteoporosis, implicating WNT1 as a major regulator of bone metabolism.">
    <entity charOffset="41-45" id="s667.e0" ontology_id="7471" text="WNT1" type="GENE"/>
    <entity charOffset="107-119" id="s667.e1" ontology_id="HP_0000939" text="osteoporosis" type="HP"/>
    <pair e1="s667.e0" e2="s667.e1" id="s667.p0" relation="true"/>
  </sentence>
  <sentence id="s668" text="Agonistic antibodies, which bind specifically to death receptor 5 (DR5), can trigger apoptosis in tumor cells through the extrinsic pathway.">
    <entity charOffset="67-70" id="s668.e0" ontology_id="8795" text="DR5" type="GENE"/>
    <entity charOffset="98-103" id="s668.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s668.e0" e2="s668.e1" id="s668.p0" relation="true"/>
  </sentence>
  <sentence id="s669" text="After screening for agonism in a cell-viability assay in vitro, a novel DR5-specific scFv antibody TR2-3 was isolated, which inhibited COLO205 and MDA-MB-231 tumor cell growth without any cross-linking agents.">
    <entity charOffset="72-75" id="s669.e0" ontology_id="8795" text="DR5" type="GENE"/>
    <entity charOffset="158-163" id="s669.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s669.e0" e2="s669.e1" id="s669.p0" relation="true"/>
  </sentence>
  <sentence id="s670" text="After screening for agonism in a cell-viability assay in vitro, a novel DR5-specific scFv antibody TR2-3 was isolated, which inhibited COLO205 and MDA-MB-231 tumor cell growth without any cross-linking agents.">
    <entity charOffset="99-102" id="s670.e0" ontology_id="7181" text="TR2" type="GENE"/>
    <entity charOffset="158-163" id="s670.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s670.e0" e2="s670.e1" id="s670.p0" relation="true"/>
  </sentence>
  <sentence id="s671" text="The activity of TR2-3 in inducing apoptosis in cancer cells was evaluated by using an Annexin V-PE apoptosis detection kit in combination with flow cytometry and the Hoechst 33342 and propidium iodide double staining analysis.">
    <entity charOffset="16-19" id="s671.e0" ontology_id="7181" text="TR2" type="GENE"/>
    <entity charOffset="47-53" id="s671.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s671.e0" e2="s671.e1" id="s671.p0" relation="true"/>
  </sentence>
  <sentence id="s672" text="The activity of TR2-3 in inducing apoptosis in cancer cells was evaluated by using an Annexin V-PE apoptosis detection kit in combination with flow cytometry and the Hoechst 33342 and propidium iodide double staining analysis.">
    <entity charOffset="47-53" id="s672.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="119-122" id="s672.e1" ontology_id="3815" text="kit" type="GENE"/>
    <pair e1="s672.e0" e2="s672.e1" id="s672.p0" relation="false"/>
  </sentence>
  <sentence id="s673" text="Furthermore, TR2-3 suppressed the tumor growth significantly in the xenograft model.">
    <entity charOffset="13-16" id="s673.e0" ontology_id="7181" text="TR2" type="GENE"/>
    <entity charOffset="34-39" id="s673.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s673.e0" e2="s673.e1" id="s673.p0" relation="true"/>
  </sentence>
  <sentence id="s674" text="Defects in ISC biogenesis lead to multiple mitochondrial dysfunction syndromes including: ISCA2 with infantile onset leukodystrophy.">
    <entity charOffset="43-68" id="s674.e0" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <entity charOffset="90-95" id="s674.e1" ontology_id="122961" text="ISCA2" type="GENE"/>
    <pair e1="s674.e0" e2="s674.e1" id="s674.p0" relation="true"/>
  </sentence>
  <sentence id="s675" text="Within the last decade, the Bromodomain and Extra-Terminal domain family (BET) of proteins have emerged as promising drug targets in diverse clinical indications including oncology, auto-immune disease, heart failure, and male contraception.">
    <entity charOffset="74-77" id="s675.e0" ontology_id="92737" text="BET" type="GENE"/>
    <entity charOffset="203-216" id="s675.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s675.e0" e2="s675.e1" id="s675.p0" relation="true"/>
  </sentence>
  <sentence id="s676" text="Mutations in bestrophin-1 (BEST1) are associated with distinct retinopathies, notably three forms with autosomal dominant inheritance and one condition with an autosomal recessive mode of transmission.">
    <entity charOffset="27-32" id="s676.e0" ontology_id="7439" text="BEST1" type="GENE"/>
    <entity charOffset="160-179" id="s676.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s676.e0" e2="s676.e1" id="s676.p0" relation="true"/>
  </sentence>
  <sentence id="s677" text="Although heterozygous missense mutations in BEST1 reveal dominant-negative effects in patients with autosomal dominant Best disease (BD), heterozygous mutations associated with autosomal recessive bestrophinopathy (ARB) display no disease phenotype.">
    <entity charOffset="44-49" id="s677.e0" ontology_id="7439" text="BEST1" type="GENE"/>
    <entity charOffset="177-196" id="s677.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s677.e0" e2="s677.e1" id="s677.p0" relation="true"/>
  </sentence>
  <sentence id="s678" text="Although heterozygous missense mutations in BEST1 reveal dominant-negative effects in patients with autosomal dominant Best disease (BD), heterozygous mutations associated with autosomal recessive bestrophinopathy (ARB) display no disease phenotype.">
    <entity charOffset="119-123" id="s678.e0" ontology_id="7439" text="Best" type="GENE"/>
    <entity charOffset="177-196" id="s678.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s678.e0" e2="s678.e1" id="s678.p0" relation="true"/>
  </sentence>
  <sentence id="s679" text="However, the role of &lt;i&gt;RTEL1&lt;/i&gt; mutations in other bone marrow failure (BMF) syndromes and myeloid neoplasms, and the contribution of monoallelic &lt;i&gt;RTEL1&lt;/i&gt; mutations to disease development are not well defined.">
    <entity charOffset="74-77" id="s679.e0" ontology_id="90427" text="BMF" type="GENE"/>
    <entity charOffset="101-110" id="s679.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s679.e0" e2="s679.e1" id="s679.p0" relation="true"/>
  </sentence>
  <sentence id="s680" text="We screened 516 patients for germline mutations in telomere-associated genes by next-generation sequencing in 2 independent cohorts; one constituting unselected patients with idiopathic BMF, unexplained cytopenia, or myeloid neoplasms (n = 457) and a second cohort comprising selected patients on the basis of the suspicion of constitutional/familial BMF (n = 59).">
    <entity charOffset="186-189" id="s680.e0" ontology_id="90427" text="BMF" type="GENE"/>
    <entity charOffset="225-234" id="s680.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s680.e0" e2="s680.e1" id="s680.p0" relation="false"/>
  </sentence>
  <sentence id="s681" text="The results show that LEPREL1 plays an important role in eye development and homozygous loss-of-function mutation of this gene can cause severely high myopia and early-onset cataract.">
    <entity charOffset="22-29" id="s681.e0" ontology_id="55214" text="LEPREL1" type="GENE"/>
    <entity charOffset="151-157" id="s681.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s681.e0" e2="s681.e1" id="s681.p0" relation="true"/>
  </sentence>
  <sentence id="s682" text="The results show that LEPREL1 plays an important role in eye development and homozygous loss-of-function mutation of this gene can cause severely high myopia and early-onset cataract.">
    <entity charOffset="22-29" id="s682.e0" ontology_id="55214" text="LEPREL1" type="GENE"/>
    <entity charOffset="174-182" id="s682.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s682.e0" e2="s682.e1" id="s682.p0" relation="true"/>
  </sentence>
  <sentence id="s683" text="Hereditary sensory and autonomic neuropathy 1 (HSAN1) is an autosomal dominant disorder that can be caused by variants in SPTLC1 or SPTLC2, encoding subunits of serine palmitoyl-CoA transferase.">
    <entity charOffset="33-43" id="s683.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="47-52" id="s683.e1" ontology_id="10558" text="HSAN1" type="GENE"/>
    <pair e1="s683.e0" e2="s683.e1" id="s683.p0" relation="true"/>
  </sentence>
  <sentence id="s684" text="Hereditary sensory and autonomic neuropathy 1 (HSAN1) is an autosomal dominant disorder that can be caused by variants in SPTLC1 or SPTLC2, encoding subunits of serine palmitoyl-CoA transferase.">
    <entity charOffset="33-43" id="s684.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="122-128" id="s684.e1" ontology_id="10558" text="SPTLC1" type="GENE"/>
    <pair e1="s684.e0" e2="s684.e1" id="s684.p0" relation="true"/>
  </sentence>
  <sentence id="s685" text="Hereditary sensory and autonomic neuropathy 1 (HSAN1) is an autosomal dominant disorder that can be caused by variants in SPTLC1 or SPTLC2, encoding subunits of serine palmitoyl-CoA transferase.">
    <entity charOffset="33-43" id="s685.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="132-138" id="s685.e1" ontology_id="9517" text="SPTLC2" type="GENE"/>
    <pair e1="s685.e0" e2="s685.e1" id="s685.p0" relation="true"/>
  </sentence>
  <sentence id="s686" text="Sequencing of SPTLC2 should be considered in all patients presenting with mild late-onset sensory-predominant small or large fiber neuropathy.">
    <entity charOffset="14-20" id="s686.e0" ontology_id="9517" text="SPTLC2" type="GENE"/>
    <entity charOffset="131-141" id="s686.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s686.e0" e2="s686.e1" id="s686.p0" relation="true"/>
  </sentence>
  <sentence id="s687" text="In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in TENM3 (previously named ODZ3) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.">
    <entity charOffset="101-106" id="s687.e0" ontology_id="55714" text="TENM3" type="GENE"/>
    <entity charOffset="174-183" id="s687.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s687.e0" e2="s687.e1" id="s687.p0" relation="true"/>
  </sentence>
  <sentence id="s688" text="In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in TENM3 (previously named ODZ3) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.">
    <entity charOffset="125-129" id="s688.e0" ontology_id="10178" text="ODZ3" type="GENE"/>
    <entity charOffset="197-211" id="s688.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s688.e0" e2="s688.e1" id="s688.p0" relation="true"/>
  </sentence>
  <sentence id="s689" text="In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in TENM3 (previously named ODZ3) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.">
    <entity charOffset="125-129" id="s689.e0" ontology_id="10178" text="ODZ3" type="GENE"/>
    <entity charOffset="174-183" id="s689.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s689.e0" e2="s689.e1" id="s689.p0" relation="true"/>
  </sentence>
  <sentence id="s690" text="Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous microphthalmia and developmental delay in whom genetic studies identified a homozygous TENM3 splicing mutation c.2968-2A&amp;gt;T (p.Val990Cysfs*13).">
    <entity charOffset="87-96" id="s690.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="197-202" id="s690.e1" ontology_id="55714" text="TENM3" type="GENE"/>
    <pair e1="s690.e0" e2="s690.e1" id="s690.p0" relation="true"/>
  </sentence>
  <sentence id="s691" text="This report supports the association of TENM3 mutations with colobomatous microphthalmia and expands the phenotypic spectrum associated with mutations in this gene.">
    <entity charOffset="40-45" id="s691.e0" ontology_id="55714" text="TENM3" type="GENE"/>
    <entity charOffset="74-88" id="s691.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s691.e0" e2="s691.e1" id="s691.p0" relation="true"/>
  </sentence>
  <sentence id="s692" text="Elucidating the exact relationship between these two enzymes when they methylate two distinct sites of the same substrate may aid in developing therapeutics aimed at reducing PRMT5/7 activity in cancer and other diseases">
    <entity charOffset="175-180" id="s692.e0" ontology_id="10419" text="PRMT5" type="GENE"/>
    <entity charOffset="195-201" id="s692.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s692.e0" e2="s692.e1" id="s692.p0" relation="true"/>
  </sentence>
  <sentence id="s693" text="Isobutyryl-CoA dehydrogenase deficiency (IBDHD) is a rare autosomal recessive metabolic disorder related to valine catabolism and results from variants in ACAD8.">
    <entity charOffset="58-77" id="s693.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="155-160" id="s693.e1" ontology_id="27034" text="ACAD8" type="GENE"/>
    <pair e1="s693.e0" e2="s693.e1" id="s693.p0" relation="true"/>
  </sentence>
  <sentence id="s694" text="Identification of this mutation reveals the allelic heterogeneity of RDH5 in patients with RP phenotype.">
    <entity charOffset="52-65" id="s694.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="69-73" id="s694.e1" ontology_id="5959" text="RDH5" type="GENE"/>
    <pair e1="s694.e0" e2="s694.e1" id="s694.p0" relation="true"/>
  </sentence>
  <sentence id="s695" text="UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-5" id="s695.e0" ontology_id="7319" text="UBE2A" type="GENE"/>
    <entity charOffset="54-77" id="s695.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s695.e0" e2="s695.e1" id="s695.p0" relation="true"/>
  </sentence>
  <sentence id="s696" text="UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-5" id="s696.e0" ontology_id="7319" text="UBE2A" type="GENE"/>
    <entity charOffset="152-181" id="s696.e1" ontology_id="HP_0000336" text="prominent supraorbital ridges" type="HP"/>
    <pair e1="s696.e0" e2="s696.e1" id="s696.p0" relation="true"/>
  </sentence>
  <sentence id="s697" text="UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-5" id="s697.e0" ontology_id="7319" text="UBE2A" type="GENE"/>
    <entity charOffset="229-239" id="s697.e1" ontology_id="HP_0000154" text="wide mouth" type="HP"/>
    <pair e1="s697.e0" e2="s697.e1" id="s697.p0" relation="true"/>
  </sentence>
  <sentence id="s698" text="UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-5" id="s698.e0" ontology_id="7319" text="UBE2A" type="GENE"/>
    <entity charOffset="277-287" id="s698.e1" ontology_id="HP_0000054" text="micropenis" type="HP"/>
    <pair e1="s698.e0" e2="s698.e1" id="s698.p0" relation="true"/>
  </sentence>
  <sentence id="s699" text="Erythrokeratodermia variabilis et progressiva (EKVP) is a genodermatosis with clinical and genetic heterogeneity, most often transmitted in an autosomal dominant manner, caused by mutations in GJB3 and GJB4 genes encoding connexins (Cx)31 and 30.3, respectively.">
    <entity charOffset="99-112" id="s699.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="193-197" id="s699.e1" ontology_id="2707" text="GJB3" type="GENE"/>
    <pair e1="s699.e0" e2="s699.e1" id="s699.p0" relation="true"/>
  </sentence>
  <sentence id="s700" text="The deregulation of its expression or activity contributes to leukemia, in which Spi1 can be either an oncogene or a tumor suppressor.">
    <entity charOffset="81-85" id="s700.e0" ontology_id="6688" text="Spi1" type="GENE"/>
    <entity charOffset="117-122" id="s700.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s700.e0" e2="s700.e1" id="s700.p0" relation="true"/>
  </sentence>
  <sentence id="s701" text="Herein we explored whether cellular senescence, an anti-tumoral pathway that restrains cell proliferation, is a mechanism by which Spi1 limits hematopoietic cell expansion, and thus prevents the development of leukemia.">
    <entity charOffset="56-61" id="s701.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="131-135" id="s701.e1" ontology_id="6688" text="Spi1" type="GENE"/>
    <pair e1="s701.e0" e2="s701.e1" id="s701.p0" relation="true"/>
  </sentence>
  <sentence id="s702" text="In humans, heterozygous mutations in NKX2.5 result in congenital heart defects (CHDs).">
    <entity charOffset="37-43" id="s702.e0" ontology_id="1482" text="NKX2.5" type="GENE"/>
    <entity charOffset="54-78" id="s702.e1" ontology_id="HP_0001627" text="congenital heart defects" type="HP"/>
    <pair e1="s702.e0" e2="s702.e1" id="s702.p0" relation="true"/>
  </sentence>
  <sentence id="s703" text="Finally, we show that a combination of 2 miRNAs (miR-190b and miR-516a-5p) exhibiting altered expression in TamR cell lines were predictive of treatment outcome in a cohort of ER+ breast cancer patients receiving adjuvant tamoxifen mono-therapy.">
    <entity charOffset="41-44" id="s703.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="187-193" id="s703.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s703.e0" e2="s703.e1" id="s703.p0" relation="true"/>
  </sentence>
  <sentence id="s704" text="Up to this time, only heterozygous mutations of COL9A3 gene have been reported in human and related to: (1) multiple epiphyseal dysplasia type 3, (2) susceptibility to an intervertebral disc disease, and (3) hearing loss.">
    <entity charOffset="48-54" id="s704.e0" ontology_id="1299" text="COL9A3" type="GENE"/>
    <entity charOffset="208-220" id="s704.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s704.e0" e2="s704.e1" id="s704.p0" relation="true"/>
  </sentence>
  <sentence id="s705" text="Here, we describe the first autosomal recessive Stickler family due to loss of function mutations (c.1176_1198del, p.Gln393Cysfs*25) of COL9A3 gene.">
    <entity charOffset="28-47" id="s705.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="136-142" id="s705.e1" ontology_id="1299" text="COL9A3" type="GENE"/>
    <pair e1="s705.e0" e2="s705.e1" id="s705.p0" relation="true"/>
  </sentence>
  <sentence id="s706" text="In this study, we applied this strategy to identify novel gene interactions in KRAS-mutant cancer cells.">
    <entity charOffset="79-83" id="s706.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="91-97" id="s706.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s706.e0" e2="s706.e1" id="s706.p0" relation="true"/>
  </sentence>
  <sentence id="s707" text="Silencing of FAK or LAMB3 recapitulated the synthetic lethal effects of miR-1298 expression in KRAS-driven cancer cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.">
    <entity charOffset="13-16" id="s707.e0" ontology_id="5747" text="FAK" type="GENE"/>
    <entity charOffset="107-113" id="s707.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s707.e0" e2="s707.e1" id="s707.p0" relation="true"/>
  </sentence>
  <sentence id="s708" text="Silencing of FAK or LAMB3 recapitulated the synthetic lethal effects of miR-1298 expression in KRAS-driven cancer cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.">
    <entity charOffset="95-99" id="s708.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="107-113" id="s708.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s708.e0" e2="s708.e1" id="s708.p0" relation="true"/>
  </sentence>
  <sentence id="s709" text="In clinical specimens, elevated LAMB3 expression correlated with poorer survival in lung cancer patients with an oncogenic KRAS gene signature, suggesting a novel candidate biomarker in this disease setting.">
    <entity charOffset="32-37" id="s709.e0" ontology_id="3914" text="LAMB3" type="GENE"/>
    <entity charOffset="89-95" id="s709.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s709.e0" e2="s709.e1" id="s709.p0" relation="true"/>
  </sentence>
  <sentence id="s710" text="Our results define a novel regulatory pathway in KRAS-driven cancers, which offers a potential therapeutic target for their eradication.">
    <entity charOffset="49-53" id="s710.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="61-67" id="s710.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s710.e0" e2="s710.e1" id="s710.p0" relation="true"/>
  </sentence>
  <sentence id="s711" text="To our knowledge, this is one of the first reports on isolated mild ventricular hypertrophy due to ACAD9 mutation in a family with moderate symptoms during adolescence.">
    <entity charOffset="68-91" id="s711.e0" ontology_id="HP_0001714" text="ventricular hypertrophy" type="HP"/>
    <entity charOffset="99-104" id="s711.e1" ontology_id="28976" text="ACAD9" type="GENE"/>
    <pair e1="s711.e0" e2="s711.e1" id="s711.p0" relation="true"/>
  </sentence>
  <sentence id="s712" text="Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.">
    <entity charOffset="27-34" id="s712.e0" ontology_id="64207" text="IRF2BPL" type="GENE"/>
    <entity charOffset="104-133" id="s712.e1" ontology_id="HP_0002376" text="neurodevelopmental regression" type="HP"/>
    <pair e1="s712.e0" e2="s712.e1" id="s712.p0" relation="true"/>
  </sentence>
  <sentence id="s713" text="Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.">
    <entity charOffset="27-34" id="s713.e0" ontology_id="64207" text="IRF2BPL" type="GENE"/>
    <entity charOffset="146-157" id="s713.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s713.e0" e2="s713.e1" id="s713.p0" relation="true"/>
  </sentence>
  <sentence id="s714" text="Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.">
    <entity charOffset="27-34" id="s714.e0" ontology_id="64207" text="IRF2BPL" type="GENE"/>
    <entity charOffset="158-164" id="s714.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s714.e0" e2="s714.e1" id="s714.p0" relation="true"/>
  </sentence>
  <sentence id="s715" text="Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.">
    <entity charOffset="27-34" id="s715.e0" ontology_id="64207" text="IRF2BPL" type="GENE"/>
    <entity charOffset="166-174" id="s715.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s715.e0" e2="s715.e1" id="s715.p0" relation="true"/>
  </sentence>
  <sentence id="s716" text="Mutations in PLA2G6 (PARK14) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.">
    <entity charOffset="13-19" id="s716.e0" ontology_id="8398" text="PLA2G6" type="GENE"/>
    <entity charOffset="84-103" id="s716.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s716.e0" e2="s716.e1" id="s716.p0" relation="true"/>
  </sentence>
  <sentence id="s717" text="Mutations in PLA2G6 (PARK14) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.">
    <entity charOffset="21-27" id="s717.e0" ontology_id="8398" text="PARK14" type="GENE"/>
    <entity charOffset="84-103" id="s717.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s717.e0" e2="s717.e1" id="s717.p0" relation="true"/>
  </sentence>
  <sentence id="s718" text="Mutations in PLA2G6 (PARK14) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.">
    <entity charOffset="21-27" id="s718.e0" ontology_id="8398" text="PARK14" type="GENE"/>
    <entity charOffset="142-154" id="s718.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s718.e0" e2="s718.e1" id="s718.p0" relation="true"/>
  </sentence>
  <sentence id="s719" text="Association between autism and single-nucleotide polymorphisms in SLC25A12 has been reported in various studies.">
    <entity charOffset="20-26" id="s719.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="66-74" id="s719.e1" ontology_id="8604" text="SLC25A12" type="GENE"/>
    <pair e1="s719.e0" e2="s719.e1" id="s719.p0" relation="true"/>
  </sentence>
  <sentence id="s720" text="Our findings suggest that SLC25A12 overexpression may be involved in the pathophysiology of autism, modifying neuronal networks in specific subregions, such as the dorsolateral prefrontal cortex and fusiform gyrus, at both pre- and postnatal stages">
    <entity charOffset="26-34" id="s720.e0" ontology_id="8604" text="SLC25A12" type="GENE"/>
    <entity charOffset="92-98" id="s720.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s720.e0" e2="s720.e1" id="s720.p0" relation="true"/>
  </sentence>
  <sentence id="s721" text="Episodic ataxia type 2 (EA2) is an autosomal dominant disorder associated with attacks of ataxia that are typically precipitated by stress, ethanol, caffeine or exercise.">
    <entity charOffset="9-15" id="s721.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="24-27" id="s721.e1" ontology_id="773" text="EA2" type="GENE"/>
    <pair e1="s721.e0" e2="s721.e1" id="s721.p0" relation="true"/>
  </sentence>
  <sentence id="s722" text="In 128 female patients of the recruited UCC cohort, patients who carried at least one deletion allele of &lt;i&gt;DRD2&lt;/i&gt; rs1799732 showed a higher incidence of having an invasive stage (AOR=2.585, 95% CI: 1.066~6.264, &lt;i&gt;p&lt;/i&gt;=0.032) and a large tumor (AOR=2.778, 95% CI: 1.146~6.735, &lt;i&gt;p&lt;/i&gt;=0.021).">
    <entity charOffset="108-112" id="s722.e0" ontology_id="1813" text="DRD2" type="GENE"/>
    <entity charOffset="242-247" id="s722.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s722.e0" e2="s722.e1" id="s722.p0" relation="true"/>
  </sentence>
  <sentence id="s723" text="Further analyses of The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets revealed correlations of the expression of DRD2 with an invasive tumor, tumor metastasis, and the lower survival rate in patients with UCC.">
    <entity charOffset="137-141" id="s723.e0" ontology_id="1813" text="DRD2" type="GENE"/>
    <entity charOffset="159-164" id="s723.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s723.e0" e2="s723.e1" id="s723.p0" relation="true"/>
  </sentence>
  <sentence id="s724" text="Of 35,242 men who completed the baseline dietary and supplemental questionnaire, 832 men developed invasive prostate cancers between October 2000 and December 2004.">
    <entity charOffset="10-13" id="s724.e0" ontology_id="8178" text="men" type="GENE"/>
    <entity charOffset="117-123" id="s724.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s724.e0" e2="s724.e1" id="s724.p0" relation="true"/>
  </sentence>
  <sentence id="s725" text="Although genes that are essential for cortical developmental expansion have been identified from the genetics of human primary microcephaly (a disorder associated with reduced brain size and intellectual disability) &lt;sup&gt;1&lt;/sup&gt; , studies of these genes in mice, which have a smooth cortex that is one thousand times smaller than the cortex of humans, have provided limited insight.">
    <entity charOffset="191-214" id="s725.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="257-261" id="s725.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s725.e0" e2="s725.e1" id="s725.p0" relation="false"/>
  </sentence>
  <sentence id="s726" text="Mutations in abnormal spindle-like microcephaly-associated (ASPM), the most common recessive microcephaly gene, reduce cortical volume by at least 50% in humans&lt;sup&gt;2-4&lt;/sup&gt;, but have little effect on the brains of mice&lt;sup&gt;5-9&lt;/sup&gt;; this probably reflects evolutionarily divergent functions of ASPM&lt;sup&gt;10,11&lt;/sup&gt;.">
    <entity charOffset="35-47" id="s726.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="60-64" id="s726.e1" ontology_id="259266" text="ASPM" type="GENE"/>
    <pair e1="s726.e0" e2="s726.e1" id="s726.p0" relation="true"/>
  </sentence>
  <sentence id="s727" text="Although there are nearly 100 different causative genes identified for nonsyndromic hearing loss (NSHL), Sanger sequencing-based DNA diagnostics usually only analyses three, namely, GJB2, SLC26A4, and OTOF.">
    <entity charOffset="84-96" id="s727.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="182-186" id="s727.e1" ontology_id="2706" text="GJB2" type="GENE"/>
    <pair e1="s727.e0" e2="s727.e1" id="s727.p0" relation="true"/>
  </sentence>
  <sentence id="s728" text="Although there are nearly 100 different causative genes identified for nonsyndromic hearing loss (NSHL), Sanger sequencing-based DNA diagnostics usually only analyses three, namely, GJB2, SLC26A4, and OTOF.">
    <entity charOffset="84-96" id="s728.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="188-195" id="s728.e1" ontology_id="5172" text="SLC26A4" type="GENE"/>
    <pair e1="s728.e0" e2="s728.e1" id="s728.p0" relation="true"/>
  </sentence>
  <sentence id="s729" text="&lt;i&gt;VEGFC&lt;/i&gt;, which is a gene encoding the ligand for the vascular endothelial growth factor receptor 3 (VEGFR3/FLT4) and important for lymph vessel development during lymphangiogenesis, has been associated with a specific subtype of primary lymphedema.">
    <entity charOffset="3-8" id="s729.e0" ontology_id="7424" text="VEGFC" type="GENE"/>
    <entity charOffset="247-252" id="s729.e1" ontology_id="HP_0000969" text="edema" type="HP"/>
    <pair e1="s729.e0" e2="s729.e1" id="s729.p0" relation="true"/>
  </sentence>
  <sentence id="s730" text="Through Sanger sequencing of a proband with bilateral congenital pedal edema resembling Milroy disease, we identified a novel mutation (NM_005429.2; c.361+5G&amp;gt;A) in &lt;i&gt;VEGFC&lt;/i&gt;.">
    <entity charOffset="44-53" id="s730.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="170-175" id="s730.e1" ontology_id="7424" text="VEGFC" type="GENE"/>
    <pair e1="s730.e0" e2="s730.e1" id="s730.p0" relation="true"/>
  </sentence>
  <sentence id="s731" text="Through Sanger sequencing of a proband with bilateral congenital pedal edema resembling Milroy disease, we identified a novel mutation (NM_005429.2; c.361+5G&amp;gt;A) in &lt;i&gt;VEGFC&lt;/i&gt;.">
    <entity charOffset="71-76" id="s731.e0" ontology_id="HP_0000969" text="edema" type="HP"/>
    <entity charOffset="170-175" id="s731.e1" ontology_id="7424" text="VEGFC" type="GENE"/>
    <pair e1="s731.e0" e2="s731.e1" id="s731.p0" relation="true"/>
  </sentence>
  <sentence id="s732" text="However, the role of FUZ in tumor biology remains poorly studied.">
    <entity charOffset="21-24" id="s732.e0" ontology_id="80199" text="FUZ" type="GENE"/>
    <entity charOffset="28-33" id="s732.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s732.e0" e2="s732.e1" id="s732.p0" relation="true"/>
  </sentence>
  <sentence id="s733" text="Our purpose of this study is to discover the physiological effects and mechanism of FUZ in non-small-cell lung cancer (NSCLC) in vitro.">
    <entity charOffset="84-87" id="s733.e0" ontology_id="80199" text="FUZ" type="GENE"/>
    <entity charOffset="111-117" id="s733.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s733.e0" e2="s733.e1" id="s733.p0" relation="true"/>
  </sentence>
  <sentence id="s734" text="The Wnt/beta-catenin pathway can be activated in both benign and malignant tumors by &lt;i&gt;CTNNB1&lt;/i&gt; mutations and by &lt;i&gt;ZNRF3&lt;/i&gt; inactivation in adrenal cancer (ACC).">
    <entity charOffset="75-81" id="s734.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="161-164" id="s734.e1" ontology_id="31" text="ACC" type="GENE"/>
    <pair e1="s734.e0" e2="s734.e1" id="s734.p0" relation="true"/>
  </sentence>
  <sentence id="s735" text="The Wnt/beta-catenin pathway can be activated in both benign and malignant tumors by &lt;i&gt;CTNNB1&lt;/i&gt; mutations and by &lt;i&gt;ZNRF3&lt;/i&gt; inactivation in adrenal cancer (ACC).">
    <entity charOffset="153-159" id="s735.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="161-164" id="s735.e1" ontology_id="31" text="ACC" type="GENE"/>
    <pair e1="s735.e0" e2="s735.e1" id="s735.p0" relation="true"/>
  </sentence>
  <sentence id="s736" text="Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.">
    <entity charOffset="23-29" id="s736.e0" ontology_id="286077" text="FAM83H" type="GENE"/>
    <entity charOffset="114-138" id="s736.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s736.e0" e2="s736.e1" id="s736.p0" relation="true"/>
  </sentence>
  <sentence id="s737" text="Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.">
    <entity charOffset="23-29" id="s737.e0" ontology_id="286077" text="FAM83H" type="GENE"/>
    <entity charOffset="33-38" id="s737.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s737.e0" e2="s737.e1" id="s737.p0" relation="true"/>
  </sentence>
  <sentence id="s738" text="Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.">
    <entity charOffset="33-38" id="s738.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="140-143" id="s738.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s738.e0" e2="s738.e1" id="s738.p0" relation="true"/>
  </sentence>
  <sentence id="s739" text="Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.">
    <entity charOffset="107-110" id="s739.e0" ontology_id="4609" text="MYC" type="GENE"/>
    <entity charOffset="114-138" id="s739.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s739.e0" e2="s739.e1" id="s739.p0" relation="true"/>
  </sentence>
  <sentence id="s740" text="Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.">
    <entity charOffset="114-138" id="s740.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="140-143" id="s740.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s740.e0" e2="s740.e1" id="s740.p0" relation="true"/>
  </sentence>
  <sentence id="s741" text="The expression of FAM83H is elevated in liver cancer cells, and nuclear expression of FAM83H predicted shorter survival of HCC patients.">
    <entity charOffset="18-24" id="s741.e0" ontology_id="286077" text="FAM83H" type="GENE"/>
    <entity charOffset="46-52" id="s741.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s741.e0" e2="s741.e1" id="s741.p0" relation="true"/>
  </sentence>
  <sentence id="s742" text="The expression of FAM83H is elevated in liver cancer cells, and nuclear expression of FAM83H predicted shorter survival of HCC patients.">
    <entity charOffset="46-52" id="s742.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="123-126" id="s742.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s742.e0" e2="s742.e1" id="s742.p0" relation="true"/>
  </sentence>
  <sentence id="s743" text="In hepatic tumor cells derived from Tet-O-MYC mice, the expression of mRNA and protein of FAM83H were dependent on MYC expression.">
    <entity charOffset="11-16" id="s743.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="90-96" id="s743.e1" ontology_id="286077" text="FAM83H" type="GENE"/>
    <pair e1="s743.e0" e2="s743.e1" id="s743.p0" relation="true"/>
  </sentence>
  <sentence id="s744" text="In conclusion, we present an oncogenic role of FAM83H in liver cancer, which is closely associated with the oncogene MYC.">
    <entity charOffset="47-53" id="s744.e0" ontology_id="286077" text="FAM83H" type="GENE"/>
    <entity charOffset="63-69" id="s744.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s744.e0" e2="s744.e1" id="s744.p0" relation="true"/>
  </sentence>
  <sentence id="s745" text="Our findings are both important for the differential diagnosis of patients with urea cycle disorders and also broaden the differential diagnosis of hyperammonemia associated with 3-methylglutaconic aciduria, which was earlier only reported in TMEM70 and SERAC1 defect">
    <entity charOffset="148-162" id="s745.e0" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <entity charOffset="243-249" id="s745.e1" ontology_id="54968" text="TMEM70" type="GENE"/>
    <pair e1="s745.e0" e2="s745.e1" id="s745.p0" relation="true"/>
  </sentence>
  <sentence id="s746" text="Our findings are both important for the differential diagnosis of patients with urea cycle disorders and also broaden the differential diagnosis of hyperammonemia associated with 3-methylglutaconic aciduria, which was earlier only reported in TMEM70 and SERAC1 defect">
    <entity charOffset="148-162" id="s746.e0" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <entity charOffset="254-260" id="s746.e1" ontology_id="84947" text="SERAC1" type="GENE"/>
    <pair e1="s746.e0" e2="s746.e1" id="s746.p0" relation="true"/>
  </sentence>
  <sentence id="s747" text="miR498 overexpression induced cell cycle arrest and apoptosis while it suppressed epithelialmesenchymal transition (EMT) in liver cancer cells.">
    <entity charOffset="118-121" id="s747.e0" ontology_id="3702" text="EMT" type="GENE"/>
    <entity charOffset="132-138" id="s747.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s747.e0" e2="s747.e1" id="s747.p0" relation="true"/>
  </sentence>
  <sentence id="s748" text="Furthermore, ZEB2 knockdown recapitulated the inhibitory effects of miR498 overexpression in liver cancer cells.">
    <entity charOffset="13-17" id="s748.e0" ontology_id="9839" text="ZEB2" type="GENE"/>
    <entity charOffset="100-106" id="s748.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s748.e0" e2="s748.e1" id="s748.p0" relation="true"/>
  </sentence>
  <sentence id="s749" text="Thus, we demonstrated that miR498 suppresses the growth and metastasis of liver cancer cells, partly at least, by directly targeting ZEB2, suggesting that miR498 may serve as a potential biomarker for the diagnosis and therapy of liver cancer">
    <entity charOffset="81-87" id="s749.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="134-138" id="s749.e1" ontology_id="9839" text="ZEB2" type="GENE"/>
    <pair e1="s749.e0" e2="s749.e1" id="s749.p0" relation="true"/>
  </sentence>
  <sentence id="s750" text="Both patients presented the cardinal features of the disease including microcephaly, congenital cataract and postnatal growth failure.">
    <entity charOffset="28-36" id="s750.e0" ontology_id="22900" text="cardinal" type="GENE"/>
    <entity charOffset="71-83" id="s750.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s750.e0" e2="s750.e1" id="s750.p0" relation="true"/>
  </sentence>
  <sentence id="s751" text="Structural, biophysical, and mutagenesis analyses revealed that cancer-associated mutations disrupt the SRP68-SRP72 interaction and their co-localization with ER in mammalian cells.">
    <entity charOffset="64-70" id="s751.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="104-107" id="s751.e1" ontology_id="10911" text="SRP" type="GENE"/>
    <pair e1="s751.e0" e2="s751.e1" id="s751.p0" relation="true"/>
  </sentence>
  <sentence id="s752" text="These inhibitors, coupled with targeted knockdown of Hhat and Porcn, reveal the essential functions of fatty acylation of secreted morphogens in a wide variety of human tumors">
    <entity charOffset="53-57" id="s752.e0" ontology_id="55733" text="Hhat" type="GENE"/>
    <entity charOffset="169-174" id="s752.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s752.e0" e2="s752.e1" id="s752.p0" relation="true"/>
  </sentence>
  <sentence id="s753" text="These inhibitors, coupled with targeted knockdown of Hhat and Porcn, reveal the essential functions of fatty acylation of secreted morphogens in a wide variety of human tumors">
    <entity charOffset="62-67" id="s753.e0" ontology_id="64840" text="Porcn" type="GENE"/>
    <entity charOffset="169-174" id="s753.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s753.e0" e2="s753.e1" id="s753.p0" relation="true"/>
  </sentence>
  <sentence id="s754" text="RNF170 is an endoplasmic reticulum membrane ubiquitin ligase that contributes to the ubiquitination of activated inositol 1,4,5-trisphosphate (IP3) receptors, and also, when point mutated (arginine to cysteine at position 199), causes autosomal dominant sensory ataxia (ADSA), a disease characterized by neurodegeneration in the posterior columns of the spinal cord.">
    <entity charOffset="0-6" id="s754.e0" ontology_id="81790" text="RNF170" type="GENE"/>
    <entity charOffset="262-268" id="s754.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s754.e0" e2="s754.e1" id="s754.p0" relation="true"/>
  </sentence>
  <sentence id="s755" text="Six syndromes of familial hyperparathyroidism are compared: 1) Familial hypocalciuric hypercalcemia (FHH) expresses primary hyperparathyroidism (PHPT) beginning at birth with lifelong hypercalcemia.">
    <entity charOffset="26-45" id="s755.e0" ontology_id="HP_0000843" text="hyperparathyroidism" type="HP"/>
    <entity charOffset="101-104" id="s755.e1" ontology_id="846" text="FHH" type="GENE"/>
    <pair e1="s755.e0" e2="s755.e1" id="s755.p0" relation="true"/>
  </sentence>
  <sentence id="s756" text="Six syndromes of familial hyperparathyroidism are compared: 1) Familial hypocalciuric hypercalcemia (FHH) expresses primary hyperparathyroidism (PHPT) beginning at birth with lifelong hypercalcemia.">
    <entity charOffset="86-99" id="s756.e0" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <entity charOffset="101-104" id="s756.e1" ontology_id="846" text="FHH" type="GENE"/>
    <pair e1="s756.e0" e2="s756.e1" id="s756.p0" relation="true"/>
  </sentence>
  <sentence id="s757" text="It usually reflects biallelic inactivation of the &lt;i&gt;CASR.&lt;/i&gt; 3) Multiple endocrine neoplasia type 1 (MEN1) is most frequently expressed as PHPT with asymmetric enlargement of 3-4 parathyroids.">
    <entity charOffset="85-94" id="s757.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="103-107" id="s757.e1" ontology_id="4221" text="MEN1" type="GENE"/>
    <pair e1="s757.e0" e2="s757.e1" id="s757.p0" relation="true"/>
  </sentence>
  <sentence id="s758" text="4) Multiple endocrine neoplasia type 2A from &lt;i&gt;RET&lt;/i&gt; activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and pheochromocytoma are more prominent.">
    <entity charOffset="32-36" id="s758.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="104-123" id="s758.e1" ontology_id="HP_0000843" text="hyperparathyroidism" type="HP"/>
    <pair e1="s758.e0" e2="s758.e1" id="s758.p0" relation="true"/>
  </sentence>
  <sentence id="s759" text="PKP1 and PKP3 immunoreactivity was inversely correlated with tumor histological grade and was observed only in tumors that did not metastasize.">
    <entity charOffset="0-4" id="s759.e0" ontology_id="5317" text="PKP1" type="GENE"/>
    <entity charOffset="61-66" id="s759.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s759.e0" e2="s759.e1" id="s759.p0" relation="true"/>
  </sentence>
  <sentence id="s760" text="PKP1 and PKP3 immunoreactivity was inversely correlated with tumor histological grade and was observed only in tumors that did not metastasize.">
    <entity charOffset="9-13" id="s760.e0" ontology_id="11187" text="PKP3" type="GENE"/>
    <entity charOffset="61-66" id="s760.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s760.e0" e2="s760.e1" id="s760.p0" relation="true"/>
  </sentence>
  <sentence id="s761" text="Interestingly, patients with tumors in which PKP1 and PKP3 immunoreactivity was reduced or absent exhibited local recurrences or metastases, or both, as well as poor survival.">
    <entity charOffset="29-34" id="s761.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="45-49" id="s761.e1" ontology_id="5317" text="PKP1" type="GENE"/>
    <pair e1="s761.e0" e2="s761.e1" id="s761.p0" relation="true"/>
  </sentence>
  <sentence id="s762" text="Interestingly, patients with tumors in which PKP1 and PKP3 immunoreactivity was reduced or absent exhibited local recurrences or metastases, or both, as well as poor survival.">
    <entity charOffset="29-34" id="s762.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="54-58" id="s762.e1" ontology_id="11187" text="PKP3" type="GENE"/>
    <pair e1="s762.e0" e2="s762.e1" id="s762.p0" relation="true"/>
  </sentence>
  <sentence id="s763" text="Although the 4 PKPs displayed different levels and patterns of subcellular distribution in tumors, there was a positive correlation between immunoreactivity for PKP2 and PKP3, as well as for PKP2 and p0071, suggesting possible functional similarities associated with differentiation, tumor growth, and disease prognosis.">
    <entity charOffset="91-96" id="s763.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="170-174" id="s763.e1" ontology_id="11187" text="PKP3" type="GENE"/>
    <pair e1="s763.e0" e2="s763.e1" id="s763.p0" relation="true"/>
  </sentence>
  <sentence id="s764" text="Plant homeo domain finger protein 8 (PHF8), as an oncogene, has been highlighted in cancer development and progression.">
    <entity charOffset="37-41" id="s764.e0" ontology_id="23133" text="PHF8" type="GENE"/>
    <entity charOffset="84-90" id="s764.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s764.e0" e2="s764.e1" id="s764.p0" relation="true"/>
  </sentence>
  <sentence id="s765" text="The results demonstrated that the expression of PHF8 was significantly increased in tumor tissues from patients with CRC and was correlated with tumornodemetastasis stage.">
    <entity charOffset="48-52" id="s765.e0" ontology_id="23133" text="PHF8" type="GENE"/>
    <entity charOffset="84-89" id="s765.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s765.e0" e2="s765.e1" id="s765.p0" relation="true"/>
  </sentence>
  <sentence id="s766" text="Invitro and invivo experiments revealed that PHF8 accelerated cancer cell growth and migration, confirming the oncogenic role of PHF8 in human CRC.">
    <entity charOffset="47-51" id="s766.e0" ontology_id="23133" text="PHF8" type="GENE"/>
    <entity charOffset="64-70" id="s766.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s766.e0" e2="s766.e1" id="s766.p0" relation="true"/>
  </sentence>
  <sentence id="s767" text="While a distinct set of processes drive metastasis when compared to tumorigenesis, it is yet unclear if genetic alterations in metabolic pathways are associated with metastatic progression of human cancers.">
    <entity charOffset="17-20" id="s767.e0" ontology_id="6418" text="set" type="GENE"/>
    <entity charOffset="198-204" id="s767.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s767.e0" e2="s767.e1" id="s767.p0" relation="false"/>
  </sentence>
  <sentence id="s768" text="Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (PPARA, PPARD, MLXIPL) genes were enriched in metastatic tumors.">
    <entity charOffset="113-118" id="s768.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="193-197" id="s768.e1" ontology_id="9997" text="SCO2" type="GENE"/>
    <pair e1="s768.e0" e2="s768.e1" id="s768.p0" relation="true"/>
  </sentence>
  <sentence id="s769" text="Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (PPARA, PPARD, MLXIPL) genes were enriched in metastatic tumors.">
    <entity charOffset="113-118" id="s769.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="218-222" id="s769.e1" ontology_id="857" text="CAV1" type="GENE"/>
    <pair e1="s769.e0" e2="s769.e1" id="s769.p0" relation="true"/>
  </sentence>
  <sentence id="s770" text="Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (PPARA, PPARD, MLXIPL) genes were enriched in metastatic tumors.">
    <entity charOffset="113-118" id="s770.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="261-267" id="s770.e1" ontology_id="51085" text="MLXIPL" type="GENE"/>
    <pair e1="s770.e0" e2="s770.e1" id="s770.p0" relation="false"/>
  </sentence>
  <sentence id="s771" text="Using gene expression profiles, we established a gene-signature (CAV1, CD36, MLXIPL, CPT1C, CYP2E1) that strongly associated with epithelial-mesenchymal program across multiple cancers.">
    <entity charOffset="65-69" id="s771.e0" ontology_id="857" text="CAV1" type="GENE"/>
    <entity charOffset="177-183" id="s771.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s771.e0" e2="s771.e1" id="s771.p0" relation="true"/>
  </sentence>
  <sentence id="s772" text="Using gene expression profiles, we established a gene-signature (CAV1, CD36, MLXIPL, CPT1C, CYP2E1) that strongly associated with epithelial-mesenchymal program across multiple cancers.">
    <entity charOffset="77-83" id="s772.e0" ontology_id="51085" text="MLXIPL" type="GENE"/>
    <entity charOffset="177-183" id="s772.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s772.e0" e2="s772.e1" id="s772.p0" relation="true"/>
  </sentence>
  <sentence id="s773" text="Using gene expression profiles, we established a gene-signature (CAV1, CD36, MLXIPL, CPT1C, CYP2E1) that strongly associated with epithelial-mesenchymal program across multiple cancers.">
    <entity charOffset="85-90" id="s773.e0" ontology_id="126129" text="CPT1C" type="GENE"/>
    <entity charOffset="177-183" id="s773.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s773.e0" e2="s773.e1" id="s773.p0" relation="true"/>
  </sentence>
  <sentence id="s774" text="Using gene expression profiles, we established a gene-signature (CAV1, CD36, MLXIPL, CPT1C, CYP2E1) that strongly associated with epithelial-mesenchymal program across multiple cancers.">
    <entity charOffset="92-98" id="s774.e0" ontology_id="1571" text="CYP2E1" type="GENE"/>
    <entity charOffset="177-183" id="s774.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s774.e0" e2="s774.e1" id="s774.p0" relation="true"/>
  </sentence>
  <sentence id="s775" text="This includes unaffected women who have completed their family and have RAD51C, RAD51D, or BRIP1 gene mutations; first-degree relatives of women with invasive epithelial ovarian cancer; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.">
    <entity charOffset="72-78" id="s775.e0" ontology_id="5889" text="RAD51C" type="GENE"/>
    <entity charOffset="178-184" id="s775.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s775.e0" e2="s775.e1" id="s775.p0" relation="true"/>
  </sentence>
  <sentence id="s776" text="This includes unaffected women who have completed their family and have RAD51C, RAD51D, or BRIP1 gene mutations; first-degree relatives of women with invasive epithelial ovarian cancer; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.">
    <entity charOffset="91-96" id="s776.e0" ontology_id="64979" text="BRIP1" type="GENE"/>
    <entity charOffset="178-184" id="s776.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s776.e0" e2="s776.e1" id="s776.p0" relation="true"/>
  </sentence>
  <sentence id="s777" text="In those with BRCA1, RAD51C/RAD51D/MMR mutations and the occasional families with a history of ovarian cancer in their 40s, surgery needs to be considered at younger than 45.">
    <entity charOffset="14-19" id="s777.e0" ontology_id="672" text="BRCA1" type="GENE"/>
    <entity charOffset="103-109" id="s777.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s777.e0" e2="s777.e1" id="s777.p0" relation="true"/>
  </sentence>
  <sentence id="s778" text="In those with BRCA1, RAD51C/RAD51D/MMR mutations and the occasional families with a history of ovarian cancer in their 40s, surgery needs to be considered at younger than 45.">
    <entity charOffset="21-27" id="s778.e0" ontology_id="5889" text="RAD51C" type="GENE"/>
    <entity charOffset="103-109" id="s778.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s778.e0" e2="s778.e1" id="s778.p0" relation="true"/>
  </sentence>
  <sentence id="s779" text="In those with BRCA1, RAD51C/RAD51D/MMR mutations and the occasional families with a history of ovarian cancer in their 40s, surgery needs to be considered at younger than 45.">
    <entity charOffset="28-34" id="s779.e0" ontology_id="5892" text="RAD51D" type="GENE"/>
    <entity charOffset="103-109" id="s779.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s779.e0" e2="s779.e1" id="s779.p0" relation="true"/>
  </sentence>
  <sentence id="s780" text="MAGEL2 mutations, first reported to be the cause of the Prader-Willi like syndrome with autism by Schaaf et al. (2013) Nature Genetics, 45: 1405-1408 show the wide range of phenotypic spectrum from lethal arthrogryposis multiplex congenital to autism spectrum disorder (ASD) and mild intellectual disability (ID).">
    <entity charOffset="0-6" id="s780.e0" ontology_id="54551" text="MAGEL2" type="GENE"/>
    <entity charOffset="205-219" id="s780.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s780.e0" e2="s780.e1" id="s780.p0" relation="true"/>
  </sentence>
  <sentence id="s781" text="MAGEL2 mutations, first reported to be the cause of the Prader-Willi like syndrome with autism by Schaaf et al. (2013) Nature Genetics, 45: 1405-1408 show the wide range of phenotypic spectrum from lethal arthrogryposis multiplex congenital to autism spectrum disorder (ASD) and mild intellectual disability (ID).">
    <entity charOffset="0-6" id="s781.e0" ontology_id="54551" text="MAGEL2" type="GENE"/>
    <entity charOffset="284-307" id="s781.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s781.e0" e2="s781.e1" id="s781.p0" relation="true"/>
  </sentence>
  <sentence id="s782" text="Our results indicate that MAGEL2 mutations cause multiple congenital anomalies and intellectual disability accompanied by arthrogryposis multiplex congenita and various endocrinologic abnormalities, supporting that the view that clinical phenotypes of MAGEL2 mutations are variable">
    <entity charOffset="26-32" id="s782.e0" ontology_id="54551" text="MAGEL2" type="GENE"/>
    <entity charOffset="122-136" id="s782.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s782.e0" e2="s782.e1" id="s782.p0" relation="true"/>
  </sentence>
  <sentence id="s783" text="Moreover, we demonstrated that ERG and FLI1 expression is downregulated in ECs within tumors by soluble factors enriched in the tumor microenvironment.">
    <entity charOffset="31-34" id="s783.e0" ontology_id="2078" text="ERG" type="GENE"/>
    <entity charOffset="86-91" id="s783.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s783.e0" e2="s783.e1" id="s783.p0" relation="true"/>
  </sentence>
  <sentence id="s784" text="Moreover, we demonstrated that ERG and FLI1 expression is downregulated in ECs within tumors by soluble factors enriched in the tumor microenvironment.">
    <entity charOffset="39-43" id="s784.e0" ontology_id="2313" text="FLI1" type="GENE"/>
    <entity charOffset="86-91" id="s784.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s784.e0" e2="s784.e1" id="s784.p0" relation="true"/>
  </sentence>
  <sentence id="s785" text="The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (MDS) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.">
    <entity charOffset="62-75" id="s785.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="131-134" id="s785.e1" ontology_id="5048" text="MDS" type="GENE"/>
    <pair e1="s785.e0" e2="s785.e1" id="s785.p0" relation="true"/>
  </sentence>
  <sentence id="s786" text="The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (MDS) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.">
    <entity charOffset="131-134" id="s786.e0" ontology_id="5048" text="MDS" type="GENE"/>
    <entity charOffset="254-269" id="s786.e1" ontology_id="HP_0000602" text="ophthalmoplegia" type="HP"/>
    <pair e1="s786.e0" e2="s786.e1" id="s786.p0" relation="true"/>
  </sentence>
  <sentence id="s787" text="The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (MDS) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.">
    <entity charOffset="131-134" id="s787.e0" ontology_id="5048" text="MDS" type="GENE"/>
    <entity charOffset="278-288" id="s787.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s787.e0" e2="s787.e1" id="s787.p0" relation="true"/>
  </sentence>
  <sentence id="s788" text="Although some causative genes have been identified, little progress has been made in identifying genes in which low-penetrance susceptibility variants occur in the majority of sporadic CHM cases.">
    <entity charOffset="176-184" id="s788.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="185-188" id="s788.e1" ontology_id="1121" text="CHM" type="GENE"/>
    <pair e1="s788.e0" e2="s788.e1" id="s788.p0" relation="true"/>
  </sentence>
  <sentence id="s789" text="To identify common genetic variants associated with sporadic non-syndromic CHM in Han Chinese populations, we performed a multistage genome-wide association study (GWAS) in a total of 4,225 CHM cases and 5,112 non-CHM controls.">
    <entity charOffset="52-60" id="s789.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="75-78" id="s789.e1" ontology_id="1121" text="CHM" type="GENE"/>
    <pair e1="s789.e0" e2="s789.e1" id="s789.p0" relation="true"/>
  </sentence>
  <sentence id="s790" text="Similar changes of GPNMB and G0S2 expression were present in a human liposarcoma database.">
    <entity charOffset="19-24" id="s790.e0" ontology_id="10457" text="GPNMB" type="GENE"/>
    <entity charOffset="69-80" id="s790.e1" ontology_id="HP_0012034" text="liposarcoma" type="HP"/>
    <pair e1="s790.e0" e2="s790.e1" id="s790.p0" relation="true"/>
  </sentence>
  <sentence id="s791" text="These results show that a previously-unknown, fully penetrant epistatic interaction between Pnpla2 and Lipe can cause liposarcoma in mice.">
    <entity charOffset="92-98" id="s791.e0" ontology_id="57104" text="Pnpla2" type="GENE"/>
    <entity charOffset="118-129" id="s791.e1" ontology_id="HP_0012034" text="liposarcoma" type="HP"/>
    <pair e1="s791.e0" e2="s791.e1" id="s791.p0" relation="true"/>
  </sentence>
  <sentence id="s792" text="These results show that a previously-unknown, fully penetrant epistatic interaction between Pnpla2 and Lipe can cause liposarcoma in mice.">
    <entity charOffset="103-107" id="s792.e0" ontology_id="3991" text="Lipe" type="GENE"/>
    <entity charOffset="118-129" id="s792.e1" ontology_id="HP_0012034" text="liposarcoma" type="HP"/>
    <pair e1="s792.e0" e2="s792.e1" id="s792.p0" relation="true"/>
  </sentence>
  <sentence id="s793" text="Among others, an immature subpopulation of self-renewing and therapy-resistant tumor cells-often referred to as glioblastoma stem-like cells (GSCs)-has been shown to contribute to disease recurrence.">
    <entity charOffset="79-84" id="s793.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="148-151" id="s793.e1" ontology_id="3036" text="has" type="GENE"/>
    <pair e1="s793.e0" e2="s793.e1" id="s793.p0" relation="true"/>
  </sentence>
  <sentence id="s794" text="Among others, an immature subpopulation of self-renewing and therapy-resistant tumor cells-often referred to as glioblastoma stem-like cells (GSCs)-has been shown to contribute to disease recurrence.">
    <entity charOffset="112-124" id="s794.e0" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <entity charOffset="142-145" id="s794.e1" ontology_id="145258" text="GSC" type="GENE"/>
    <pair e1="s794.e0" e2="s794.e1" id="s794.p0" relation="true"/>
  </sentence>
  <sentence id="s795" text="In summary, we identified novel immunogenic proteins, which frequently induce tumor-specific Tcell responses in GBM patients and were also detected in vitro in therapy-resistant quiescent, slow-cycling GSCs.">
    <entity charOffset="78-83" id="s795.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="203-206" id="s795.e1" ontology_id="145258" text="GSC" type="GENE"/>
    <pair e1="s795.e0" e2="s795.e1" id="s795.p0" relation="true"/>
  </sentence>
  <sentence id="s796" text="Inhibitors of molecules of the transforming growth factor- superfamily have been shown recently to target ineffective erythropoiesis and ameliorate anemia both in animal models of myelodysplastic syndrome and in RARS patients.">
    <entity charOffset="107-133" id="s796.e0" ontology_id="HP_0010972" text="ineffective erythropoiesis" type="HP"/>
    <entity charOffset="213-217" id="s796.e1" ontology_id="5917" text="RARS" type="GENE"/>
    <pair e1="s796.e0" e2="s796.e1" id="s796.p0" relation="true"/>
  </sentence>
  <sentence id="s797" text="MATERIAL AND METHODS Human neuroblastoma SH-SY5Y cells were treated for 24 h with increasing concentrations of aggregated A (5, 15, 25, and 45 mol) with or without the ACAT1 siRNA pretreatment.">
    <entity charOffset="27-40" id="s797.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="175-179" id="s797.e1" ontology_id="38" text="ACAT" type="GENE"/>
    <pair e1="s797.e0" e2="s797.e1" id="s797.p0" relation="false"/>
  </sentence>
  <sentence id="s798" text="After exclusive analysis of 10 common variations of three hearing loss-related genes, GJB2, mtDNA12srRNA and SLC26A4, a novel truncated variant of SMPX, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.">
    <entity charOffset="58-70" id="s798.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="86-90" id="s798.e1" ontology_id="2706" text="GJB2" type="GENE"/>
    <pair e1="s798.e0" e2="s798.e1" id="s798.p0" relation="true"/>
  </sentence>
  <sentence id="s799" text="After exclusive analysis of 10 common variations of three hearing loss-related genes, GJB2, mtDNA12srRNA and SLC26A4, a novel truncated variant of SMPX, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.">
    <entity charOffset="58-70" id="s799.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="109-116" id="s799.e1" ontology_id="5172" text="SLC26A4" type="GENE"/>
    <pair e1="s799.e0" e2="s799.e1" id="s799.p0" relation="true"/>
  </sentence>
  <sentence id="s800" text="Considering the pivotal role of VDR signaling in the colon epithelium both physiologically and pathologically, the correlation between H19 and VDR signaling may have an important role in the development of colon cancer.">
    <entity charOffset="32-35" id="s800.e0" ontology_id="7421" text="VDR" type="GENE"/>
    <entity charOffset="212-218" id="s800.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s800.e0" e2="s800.e1" id="s800.p0" relation="true"/>
  </sentence>
  <sentence id="s801" text="Screening the PANK2 gene in the patients as well as their unaffected family members revealed a functional single nucleotide variation, perfectly segregating in the patient's family in an autosomal recessive mode of inheritance.">
    <entity charOffset="14-19" id="s801.e0" ontology_id="80025" text="PANK2" type="GENE"/>
    <entity charOffset="187-206" id="s801.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s801.e0" e2="s801.e1" id="s801.p0" relation="true"/>
  </sentence>
  <sentence id="s802" text="Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.">
    <entity charOffset="6-9" id="s802.e0" ontology_id="10318" text="van" type="GENE"/>
    <entity charOffset="33-52" id="s802.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s802.e0" e2="s802.e1" id="s802.p0" relation="true"/>
  </sentence>
  <sentence id="s803" text="Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.">
    <entity charOffset="6-9" id="s803.e0" ontology_id="10318" text="van" type="GENE"/>
    <entity charOffset="172-188" id="s803.e1" ontology_id="HP_0002164" text="dysplastic nails" type="HP"/>
    <pair e1="s803.e0" e2="s803.e1" id="s803.p0" relation="true"/>
  </sentence>
  <sentence id="s804" text="Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.">
    <entity charOffset="33-52" id="s804.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="244-247" id="s804.e1" ontology_id="50807" text="PAP" type="GENE"/>
    <pair e1="s804.e0" e2="s804.e1" id="s804.p0" relation="true"/>
  </sentence>
  <sentence id="s805" text="Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.">
    <entity charOffset="159-170" id="s805.e0" ontology_id="HP_0009826" text="short limbs" type="HP"/>
    <entity charOffset="244-247" id="s805.e1" ontology_id="50807" text="PAP" type="GENE"/>
    <pair e1="s805.e0" e2="s805.e1" id="s805.p0" relation="true"/>
  </sentence>
  <sentence id="s806" text="Neurturin (NRTN) provides trophic support to neurons and is considered a therapeutic agent for neurodegenerative diseases, such as Parkinson's disease.">
    <entity charOffset="11-15" id="s806.e0" ontology_id="4902" text="NRTN" type="GENE"/>
    <entity charOffset="95-121" id="s806.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s806.e0" e2="s806.e1" id="s806.p0" relation="true"/>
  </sentence>
  <sentence id="s807" text="Polymorphisms in the genes encoding carbamoyl-phosphate synthase 1 (CPS1) and N-acetylglutamate synthase (NAGS) were recently reported to be risk factors for the development of hyperammonemia during valproic acid-based therapy.">
    <entity charOffset="106-110" id="s807.e0" ontology_id="162417" text="NAGS" type="GENE"/>
    <entity charOffset="177-191" id="s807.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s807.e0" e2="s807.e1" id="s807.p0" relation="true"/>
  </sentence>
  <sentence id="s808" text="This study aimed to examine the influence of patient characteristics, including polymorphisms in CPS1 4217C&amp;gt;A and NAGS -3064C&amp;gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.">
    <entity charOffset="97-101" id="s808.e0" ontology_id="1589" text="CPS1" type="GENE"/>
    <entity charOffset="194-202" id="s808.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s808.e0" e2="s808.e1" id="s808.p0" relation="true"/>
  </sentence>
  <sentence id="s809" text="This study aimed to examine the influence of patient characteristics, including polymorphisms in CPS1 4217C&amp;gt;A and NAGS -3064C&amp;gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.">
    <entity charOffset="97-101" id="s809.e0" ontology_id="1589" text="CPS1" type="GENE"/>
    <entity charOffset="157-171" id="s809.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s809.e0" e2="s809.e1" id="s809.p0" relation="true"/>
  </sentence>
  <sentence id="s810" text="This study aimed to examine the influence of patient characteristics, including polymorphisms in CPS1 4217C&amp;gt;A and NAGS -3064C&amp;gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.">
    <entity charOffset="117-121" id="s810.e0" ontology_id="162417" text="NAGS" type="GENE"/>
    <entity charOffset="194-202" id="s810.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s810.e0" e2="s810.e1" id="s810.p0" relation="true"/>
  </sentence>
  <sentence id="s811" text="This study aimed to examine the influence of patient characteristics, including polymorphisms in CPS1 4217C&amp;gt;A and NAGS -3064C&amp;gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.">
    <entity charOffset="117-121" id="s811.e0" ontology_id="162417" text="NAGS" type="GENE"/>
    <entity charOffset="157-171" id="s811.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s811.e0" e2="s811.e1" id="s811.p0" relation="true"/>
  </sentence>
  <sentence id="s812" text="With regard to the CPS1 4217C&amp;gt;A polymorphism, we did not observe a significant association with the development of hyperammonemia.">
    <entity charOffset="19-23" id="s812.e0" ontology_id="1589" text="CPS1" type="GENE"/>
    <entity charOffset="118-132" id="s812.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s812.e0" e2="s812.e1" id="s812.p0" relation="false"/>
  </sentence>
  <sentence id="s813" text="COG5-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, intellectual disability of variable degree, seizures, acquired microcephaly, sensory defects and autistic behavior.">
    <entity charOffset="0-4" id="s813.e0" ontology_id="10466" text="COG5" type="GENE"/>
    <entity charOffset="130-138" id="s813.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s813.e0" e2="s813.e1" id="s813.p0" relation="true"/>
  </sentence>
  <sentence id="s814" text="COG5-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, intellectual disability of variable degree, seizures, acquired microcephaly, sensory defects and autistic behavior.">
    <entity charOffset="0-4" id="s814.e0" ontology_id="10466" text="COG5" type="GENE"/>
    <entity charOffset="149-161" id="s814.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s814.e0" e2="s814.e1" id="s814.p0" relation="true"/>
  </sentence>
  <sentence id="s815" text="Surgical tumor specimens were collected for immunohistochemical staining to evaluate B7-H5 expression.">
    <entity charOffset="9-14" id="s815.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="88-90" id="s815.e1" ontology_id="2260" text="H5" type="GENE"/>
    <pair e1="s815.e0" e2="s815.e1" id="s815.p0" relation="true"/>
  </sentence>
  <sentence id="s816" text="Surgical tumor specimens were collected for immunohistochemical staining to evaluate B7-H5 expression.">
    <entity charOffset="9-14" id="s816.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="85-87" id="s816.e1" ontology_id="10233" text="B7" type="GENE"/>
    <pair e1="s816.e0" e2="s816.e1" id="s816.p0" relation="true"/>
  </sentence>
  <sentence id="s817" text="When co-cultured with T cells, pancreatic cancer PC cells with high B7-H5 expression induced a more potent immune reaction, indicated by elevated cytokine release and increased proliferation of T lymphocytes compared with cells exhibiting low B7-H5 expression.">
    <entity charOffset="42-48" id="s817.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="71-73" id="s817.e1" ontology_id="2260" text="H5" type="GENE"/>
    <pair e1="s817.e0" e2="s817.e1" id="s817.p0" relation="true"/>
  </sentence>
  <sentence id="s818" text="When co-cultured with T cells, pancreatic cancer PC cells with high B7-H5 expression induced a more potent immune reaction, indicated by elevated cytokine release and increased proliferation of T lymphocytes compared with cells exhibiting low B7-H5 expression.">
    <entity charOffset="42-48" id="s818.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="68-70" id="s818.e1" ontology_id="10233" text="B7" type="GENE"/>
    <pair e1="s818.e0" e2="s818.e1" id="s818.p0" relation="true"/>
  </sentence>
  <sentence id="s819" text="Of the 136 PDAC tumor tissues, 93 (68.38%) were strong and 43 (31.62%) were weak B7-H5 expression.">
    <entity charOffset="16-21" id="s819.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="84-86" id="s819.e1" ontology_id="2260" text="H5" type="GENE"/>
    <pair e1="s819.e0" e2="s819.e1" id="s819.p0" relation="true"/>
  </sentence>
  <sentence id="s820" text="Of the 136 PDAC tumor tissues, 93 (68.38%) were strong and 43 (31.62%) were weak B7-H5 expression.">
    <entity charOffset="16-21" id="s820.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="81-83" id="s820.e1" ontology_id="10233" text="B7" type="GENE"/>
    <pair e1="s820.e0" e2="s820.e1" id="s820.p0" relation="true"/>
  </sentence>
  <sentence id="s821" text="Eleven (79%) and five (36%) of fourteen keratinizing squamous cell carcinomas tested contained TP53 and CDKN2A mutations, respectively.">
    <entity charOffset="53-77" id="s821.e0" ontology_id="HP_0002860" text="squamous cell carcinomas" type="HP"/>
    <entity charOffset="104-110" id="s821.e1" ontology_id="1029" text="CDKN2A" type="GENE"/>
    <pair e1="s821.e0" e2="s821.e1" id="s821.p0" relation="true"/>
  </sentence>
  <sentence id="s822" text="The findings indicate that although PIK3CA mutations are found in &amp;lt;10% of vulvar squamous cell carcinomas, they may be specific for a particular pathway involving atypical verruciform lesions, which could function as either a direct precursor or a risk factor for vulvar squamous cell carcinoma.">
    <entity charOffset="36-42" id="s822.e0" ontology_id="5290" text="PIK3CA" type="GENE"/>
    <entity charOffset="84-108" id="s822.e1" ontology_id="HP_0002860" text="squamous cell carcinomas" type="HP"/>
    <pair e1="s822.e0" e2="s822.e1" id="s822.p0" relation="true"/>
  </sentence>
  <sentence id="s823" text="The findings indicate that although PIK3CA mutations are found in &amp;lt;10% of vulvar squamous cell carcinomas, they may be specific for a particular pathway involving atypical verruciform lesions, which could function as either a direct precursor or a risk factor for vulvar squamous cell carcinoma.">
    <entity charOffset="36-42" id="s823.e0" ontology_id="5290" text="PIK3CA" type="GENE"/>
    <entity charOffset="274-297" id="s823.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s823.e0" e2="s823.e1" id="s823.p0" relation="true"/>
  </sentence>
  <sentence id="s824" text="Whether they function as direct precursors to a less common form of squamous cell carcinoma will require further study, but carcinomas associated with these lesions might warrant testing for PIK3CA mutations to address this question">
    <entity charOffset="68-91" id="s824.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="191-197" id="s824.e1" ontology_id="5290" text="PIK3CA" type="GENE"/>
    <pair e1="s824.e0" e2="s824.e1" id="s824.p0" relation="true"/>
  </sentence>
  <sentence id="s825" text="Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness.">
    <entity charOffset="25-30" id="s825.e0" ontology_id="7401" text="USH3A" type="GENE"/>
    <entity charOffset="136-156" id="s825.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s825.e0" e2="s825.e1" id="s825.p0" relation="true"/>
  </sentence>
  <sentence id="s826" text="Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness.">
    <entity charOffset="25-30" id="s826.e0" ontology_id="7401" text="USH3A" type="GENE"/>
    <entity charOffset="175-183" id="s826.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s826.e0" e2="s826.e1" id="s826.p0" relation="true"/>
  </sentence>
  <sentence id="s827" text="Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness.">
    <entity charOffset="100-105" id="s827.e0" ontology_id="7401" text="CLRN1" type="GENE"/>
    <entity charOffset="136-156" id="s827.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s827.e0" e2="s827.e1" id="s827.p0" relation="true"/>
  </sentence>
  <sentence id="s828" text="Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness.">
    <entity charOffset="100-105" id="s828.e0" ontology_id="7401" text="CLRN1" type="GENE"/>
    <entity charOffset="175-183" id="s828.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s828.e0" e2="s828.e1" id="s828.p0" relation="true"/>
  </sentence>
  <sentence id="s829" text="Here, we report a reduction of histone deacetylase 3 (HDAC3) protein amounts in eutopic endometrium of infertile women with endometriosis compared to a control group.">
    <entity charOffset="54-59" id="s829.e0" ontology_id="8841" text="HDAC3" type="GENE"/>
    <entity charOffset="124-137" id="s829.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s829.e0" e2="s829.e1" id="s829.p0" relation="true"/>
  </sentence>
  <sentence id="s830" text="Reduction of &lt;i&gt;HDAC3&lt;/i&gt; abrogated decidualization in a primary culture of human endometrial stromal cells (hESCs) similar to that observed in infertile patients with endometriosis.">
    <entity charOffset="16-21" id="s830.e0" ontology_id="8841" text="HDAC3" type="GENE"/>
    <entity charOffset="168-181" id="s830.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s830.e0" e2="s830.e1" id="s830.p0" relation="true"/>
  </sentence>
  <sentence id="s831" text="Collectively, we found attenuation of HDAC3 and overexpression of collagen type I in the eutopic endometrium of infertile patients with endometriosis.">
    <entity charOffset="38-43" id="s831.e0" ontology_id="8841" text="HDAC3" type="GENE"/>
    <entity charOffset="136-149" id="s831.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s831.e0" e2="s831.e1" id="s831.p0" relation="true"/>
  </sentence>
  <sentence id="s832" text="Collectively, we found attenuation of HDAC3 and overexpression of collagen type I in the eutopic endometrium of infertile patients with endometriosis.">
    <entity charOffset="75-79" id="s832.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="136-149" id="s832.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s832.e0" e2="s832.e1" id="s832.p0" relation="true"/>
  </sentence>
  <sentence id="s833" text="Germline de novo truncating variants in ASXL1 and ASXL3 have been respectively implicated in causing Bohring-Opitz and Bainbridge-Ropers syndromes, which result in overlapping features of severe intellectual disability and dysmorphic features.">
    <entity charOffset="40-45" id="s833.e0" ontology_id="171023" text="ASXL1" type="GENE"/>
    <entity charOffset="195-218" id="s833.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s833.e0" e2="s833.e1" id="s833.p0" relation="true"/>
  </sentence>
  <sentence id="s834" text="Germline de novo truncating variants in ASXL1 and ASXL3 have been respectively implicated in causing Bohring-Opitz and Bainbridge-Ropers syndromes, which result in overlapping features of severe intellectual disability and dysmorphic features.">
    <entity charOffset="50-55" id="s834.e0" ontology_id="80816" text="ASXL3" type="GENE"/>
    <entity charOffset="195-218" id="s834.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s834.e0" e2="s834.e1" id="s834.p0" relation="true"/>
  </sentence>
  <sentence id="s835" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="118-123" id="s835.e0" ontology_id="55252" text="ASXL2" type="GENE"/>
    <entity charOffset="189-201" id="s835.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s835.e0" e2="s835.e1" id="s835.p0" relation="true"/>
  </sentence>
  <sentence id="s836" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="118-123" id="s836.e0" ontology_id="55252" text="ASXL2" type="GENE"/>
    <entity charOffset="272-297" id="s836.e1" ontology_id="HP_0001249" text="intellectual disabilities" type="HP"/>
    <pair e1="s836.e0" e2="s836.e1" id="s836.p0" relation="true"/>
  </sentence>
  <sentence id="s837" text="Therefore, hypertrophic cardiomyopathy and tubulopathy may not be considered as constant features of MRPS22.">
    <entity charOffset="24-38" id="s837.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="101-107" id="s837.e1" ontology_id="56945" text="MRPS22" type="GENE"/>
    <pair e1="s837.e0" e2="s837.e1" id="s837.p0" relation="true"/>
  </sentence>
  <sentence id="s838" text="These changes were accompanied by cortical atrophy as well as increased expression of angiogenesis-related genes such as &lt;i&gt;Vegfa&lt;/i&gt;, &lt;i&gt;Serpine1&lt;/i&gt;, and &lt;i&gt;Plau&lt;/i&gt; in CD31-positive endothelial cells.">
    <entity charOffset="34-50" id="s838.e0" ontology_id="HP_0002120" text="cortical atrophy" type="HP"/>
    <entity charOffset="171-175" id="s838.e1" ontology_id="5175" text="CD31" type="GENE"/>
    <pair e1="s838.e0" e2="s838.e1" id="s838.p0" relation="true"/>
  </sentence>
  <sentence id="s839" text="Moreover, overexpression of mutant but not normal CCDC174 in neuroblastoma cells caused rapid apoptosis.">
    <entity charOffset="50-57" id="s839.e0" ontology_id="51244" text="CCDC174" type="GENE"/>
    <entity charOffset="61-74" id="s839.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s839.e0" e2="s839.e1" id="s839.p0" relation="true"/>
  </sentence>
  <sentence id="s840" text="ACTB-GLI1 fusions have been reported as the pathognomonic genetic abnormality defining an unusual subset of actin-positive, perivascular myoid tumors, known as &amp;quot;pericytoma with the t(7;12) translocation.&amp;quot; In addition, GLI1 oncogenic activation through a related MALAT1-GLI1 gene fusion has been recently reported in 2 unrelated gastric tumors, namely plexiform fibromyxoma and gastroblastoma.">
    <entity charOffset="0-4" id="s840.e0" ontology_id="60" text="ACTB" type="GENE"/>
    <entity charOffset="143-149" id="s840.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s840.e0" e2="s840.e1" id="s840.p0" relation="true"/>
  </sentence>
  <sentence id="s841" text="ACTB-GLI1 fusions have been reported as the pathognomonic genetic abnormality defining an unusual subset of actin-positive, perivascular myoid tumors, known as &amp;quot;pericytoma with the t(7;12) translocation.&amp;quot; In addition, GLI1 oncogenic activation through a related MALAT1-GLI1 gene fusion has been recently reported in 2 unrelated gastric tumors, namely plexiform fibromyxoma and gastroblastoma.">
    <entity charOffset="5-9" id="s841.e0" ontology_id="2735" text="GLI1" type="GENE"/>
    <entity charOffset="143-149" id="s841.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s841.e0" e2="s841.e1" id="s841.p0" relation="true"/>
  </sentence>
  <sentence id="s842" text="Our findings open new opportunities for targeted therapy, as tumors with GLI1 oncogenic activation, and subsequent PTCH1 overexpression, might be sensitive to sonic hedgehog pathway inhibitors">
    <entity charOffset="61-67" id="s842.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="115-120" id="s842.e1" ontology_id="5727" text="PTCH1" type="GENE"/>
    <pair e1="s842.e0" e2="s842.e1" id="s842.p0" relation="false"/>
  </sentence>
  <sentence id="s843" text="Only overexpression of LAT induced a reduction of brain proliferating cells and concomitant microcephaly.">
    <entity charOffset="23-26" id="s843.e0" ontology_id="83985" text="LAT" type="GENE"/>
    <entity charOffset="92-104" id="s843.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s843.e0" e2="s843.e1" id="s843.p0" relation="true"/>
  </sentence>
  <sentence id="s844" text="Moreover, oncogenic activation of MYC and/or loss of a MYC antagonist, results in an imbalance in the activity of the network as a whole, leading to tumor initiation, progression and maintenance">
    <entity charOffset="34-37" id="s844.e0" ontology_id="4609" text="MYC" type="GENE"/>
    <entity charOffset="149-154" id="s844.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s844.e0" e2="s844.e1" id="s844.p0" relation="true"/>
  </sentence>
  <sentence id="s845" text="As a result, 14 SNPs had a significant odds ratio (OR) for lung cancer risk with P FDR &amp;lt; 0.05, of which rs3115672 in MSH5 (OR = 1.20, 95% CI = 1.14-1.27) and rs114596632 in GTF2H4 (OR = 1.19, 95% CI = 1.12-1.25) at 6q21.33 were the most statistically significant (P combined = 3.9910(-11) and P combined = 5.4010(-10), respectively).">
    <entity charOffset="64-70" id="s845.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="120-124" id="s845.e1" ontology_id="4439" text="MSH5" type="GENE"/>
    <pair e1="s845.e0" e2="s845.e1" id="s845.p0" relation="true"/>
  </sentence>
  <sentence id="s846" text="As a result, 14 SNPs had a significant odds ratio (OR) for lung cancer risk with P FDR &amp;lt; 0.05, of which rs3115672 in MSH5 (OR = 1.20, 95% CI = 1.14-1.27) and rs114596632 in GTF2H4 (OR = 1.19, 95% CI = 1.12-1.25) at 6q21.33 were the most statistically significant (P combined = 3.9910(-11) and P combined = 5.4010(-10), respectively).">
    <entity charOffset="64-70" id="s846.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="176-182" id="s846.e1" ontology_id="2968" text="GTF2H4" type="GENE"/>
    <pair e1="s846.e0" e2="s846.e1" id="s846.p0" relation="true"/>
  </sentence>
  <sentence id="s847" text="We herein report the case of a 59-year-old man with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed seizures.">
    <entity charOffset="92-96" id="s847.e0" ontology_id="9211" text="LGI1" type="GENE"/>
    <entity charOffset="107-119" id="s847.e1" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <pair e1="s847.e0" e2="s847.e1" id="s847.p0" relation="true"/>
  </sentence>
  <sentence id="s848" text="We herein report the case of a 59-year-old man with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed seizures.">
    <entity charOffset="92-96" id="s848.e0" ontology_id="9211" text="LGI1" type="GENE"/>
    <entity charOffset="234-242" id="s848.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s848.e0" e2="s848.e1" id="s848.p0" relation="false"/>
  </sentence>
  <sentence id="s849" text="Taken together, these findings indicate that anti-LGI1 encephalitis may present as slowly progressive cognitive impairment mimicking dementia and that fluctuating MRI striatal lesions may be a characteristic radiological finding of this disorder">
    <entity charOffset="50-54" id="s849.e0" ontology_id="9211" text="LGI1" type="GENE"/>
    <entity charOffset="55-67" id="s849.e1" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <pair e1="s849.e0" e2="s849.e1" id="s849.p0" relation="true"/>
  </sentence>
  <sentence id="s850" text="In order to address these questions, we searched for alterations in PLCB4, GNAI3, and EDN1 in patients with typical Auriculocondylar syndrome (n=3), Pierre Robin sequence-plus (n=3), micrognathia with additional craniofacial malformations (n=4), or non-specific auricular dysplasia (n=1), which could represent subtypes of Auriculocondylar syndrome.">
    <entity charOffset="86-90" id="s850.e0" ontology_id="1906" text="EDN1" type="GENE"/>
    <entity charOffset="187-199" id="s850.e1" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <pair e1="s850.e0" e2="s850.e1" id="s850.p0" relation="true"/>
  </sentence>
  <sentence id="s851" text="Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.&lt;b&gt;Results:&lt;/b&gt; One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in &lt;i&gt;IDH1&lt;/i&gt; A variant in &lt;i&gt;GOT2&lt;/i&gt;, c.357A&amp;gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.">
    <entity charOffset="137-143" id="s851.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="239-243" id="s851.e1" ontology_id="2806" text="GOT2" type="GENE"/>
    <pair e1="s851.e0" e2="s851.e1" id="s851.p0" relation="true"/>
  </sentence>
  <sentence id="s852" text="Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.&lt;b&gt;Results:&lt;/b&gt; One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in &lt;i&gt;IDH1&lt;/i&gt; A variant in &lt;i&gt;GOT2&lt;/i&gt;, c.357A&amp;gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.">
    <entity charOffset="171-177" id="s852.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="239-243" id="s852.e1" ontology_id="2806" text="GOT2" type="GENE"/>
    <pair e1="s852.e0" e2="s852.e1" id="s852.p0" relation="true"/>
  </sentence>
  <sentence id="s853" text="Array methylation-based analysis uncovered a somatic epigenetic mutation in &lt;i&gt;SDHC&lt;/i&gt; in a patient with multiple pheochromocytomas and a gastrointestinal stromal tumor.">
    <entity charOffset="79-82" id="s853.e0" ontology_id="1757" text="SDH" type="GENE"/>
    <entity charOffset="115-132" id="s853.e1" ontology_id="HP_0002666" text="pheochromocytomas" type="HP"/>
    <pair e1="s853.e0" e2="s853.e1" id="s853.p0" relation="true"/>
  </sentence>
  <sentence id="s854" text="Array methylation-based analysis uncovered a somatic epigenetic mutation in &lt;i&gt;SDHC&lt;/i&gt; in a patient with multiple pheochromocytomas and a gastrointestinal stromal tumor.">
    <entity charOffset="79-82" id="s854.e0" ontology_id="1757" text="SDH" type="GENE"/>
    <entity charOffset="164-169" id="s854.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s854.e0" e2="s854.e1" id="s854.p0" relation="true"/>
  </sentence>
  <sentence id="s855" text="As proof of concept, we applied CRAFT to epilepsy and predicted the tyrosine kinase receptor Csf1R as a potential therapeutic target.">
    <entity charOffset="41-49" id="s855.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="93-98" id="s855.e1" ontology_id="1436" text="Csf1R" type="GENE"/>
    <pair e1="s855.e0" e2="s855.e1" id="s855.p0" relation="true"/>
  </sentence>
  <sentence id="s856" text="The predicted effect of Csf1R blockade in attenuating epilepsy seizures was validated in three pre-clinical models of epilepsy.">
    <entity charOffset="24-29" id="s856.e0" ontology_id="1436" text="Csf1R" type="GENE"/>
    <entity charOffset="54-62" id="s856.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s856.e0" e2="s856.e1" id="s856.p0" relation="true"/>
  </sentence>
  <sentence id="s857" text="The predicted effect of Csf1R blockade in attenuating epilepsy seizures was validated in three pre-clinical models of epilepsy.">
    <entity charOffset="24-29" id="s857.e0" ontology_id="1436" text="Csf1R" type="GENE"/>
    <entity charOffset="63-71" id="s857.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s857.e0" e2="s857.e1" id="s857.p0" relation="true"/>
  </sentence>
  <sentence id="s858" text="Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH, OMIM 225790), also known as Fowler syndrome, is a rare autosomal recessive disorder, caused by mutations in FLVCR2.">
    <entity charOffset="31-46" id="s858.e0" ontology_id="HP_0002324" text="hydranencephaly" type="HP"/>
    <entity charOffset="184-190" id="s858.e1" ontology_id="55640" text="FLVCR2" type="GENE"/>
    <pair e1="s858.e0" e2="s858.e1" id="s858.p0" relation="true"/>
  </sentence>
  <sentence id="s859" text="Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH, OMIM 225790), also known as Fowler syndrome, is a rare autosomal recessive disorder, caused by mutations in FLVCR2.">
    <entity charOffset="47-59" id="s859.e0" ontology_id="HP_0000238" text="hydrocephaly" type="HP"/>
    <entity charOffset="184-190" id="s859.e1" ontology_id="55640" text="FLVCR2" type="GENE"/>
    <pair e1="s859.e0" e2="s859.e1" id="s859.p0" relation="true"/>
  </sentence>
  <sentence id="s860" text="Interestingly, the other branch of the original family was found to segregate anophthalmia/syndactyly with a novel homozygous SMOC1 variant.">
    <entity charOffset="78-90" id="s860.e0" ontology_id="HP_0000528" text="anophthalmia" type="HP"/>
    <entity charOffset="126-131" id="s860.e1" ontology_id="64093" text="SMOC1" type="GENE"/>
    <pair e1="s860.e0" e2="s860.e1" id="s860.p0" relation="true"/>
  </sentence>
  <sentence id="s861" text="Interestingly, the other branch of the original family was found to segregate anophthalmia/syndactyly with a novel homozygous SMOC1 variant.">
    <entity charOffset="91-101" id="s861.e0" ontology_id="HP_0001159" text="syndactyly" type="HP"/>
    <entity charOffset="126-131" id="s861.e1" ontology_id="64093" text="SMOC1" type="GENE"/>
    <pair e1="s861.e0" e2="s861.e1" id="s861.p0" relation="true"/>
  </sentence>
  <sentence id="s862" text="A branch-site mutation in the human gene encoding assembly factor NUBPL has recently been associated with mitochondrial encephalopathy and complex I deficiency in seven independent cases.">
    <entity charOffset="66-71" id="s862.e0" ontology_id="80224" text="NUBPL" type="GENE"/>
    <entity charOffset="120-134" id="s862.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s862.e0" e2="s862.e1" id="s862.p0" relation="true"/>
  </sentence>
  <sentence id="s863" text="As a mitotic kinesin, kinesin family member 14 (KIF14) has been reported to serve oncogenic roles in a variety of malignancies; however, its functional role and regulatory mechanisms in colorectal cancer (CRC) remain unclear.">
    <entity charOffset="48-53" id="s863.e0" ontology_id="9928" text="KIF14" type="GENE"/>
    <entity charOffset="197-203" id="s863.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s863.e0" e2="s863.e1" id="s863.p0" relation="true"/>
  </sentence>
  <sentence id="s864" text="In the present study, KIF14 was observed to be markedly overexpressed in CRC, and this upregulation was associated with tumor size and marker of proliferation Ki-67 immunostaining scores.">
    <entity charOffset="22-27" id="s864.e0" ontology_id="9928" text="KIF14" type="GENE"/>
    <entity charOffset="120-125" id="s864.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s864.e0" e2="s864.e1" id="s864.p0" relation="true"/>
  </sentence>
  <sentence id="s865" text="In the present study, KIF14 was observed to be markedly overexpressed in CRC, and this upregulation was associated with tumor size and marker of proliferation Ki-67 immunostaining scores.">
    <entity charOffset="120-125" id="s865.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="159-161" id="s865.e1" ontology_id="10197" text="Ki" type="GENE"/>
    <pair e1="s865.e0" e2="s865.e1" id="s865.p0" relation="false"/>
  </sentence>
  <sentence id="s866" text="Collectively, the findings of the present study demonstrated the oncogenic role of KIF14 in colorectal tumorigenesis, and also revealed a complexity of regulatory mechanisms mediating KIF14 overexpression, which may provide insight for developing novel treatments for patients with CRC">
    <entity charOffset="83-88" id="s866.e0" ontology_id="9928" text="KIF14" type="GENE"/>
    <entity charOffset="103-108" id="s866.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s866.e0" e2="s866.e1" id="s866.p0" relation="true"/>
  </sentence>
  <sentence id="s867" text="Common genetic variants contribute to the observed variation in breast cancer risk for BRCA2 mutation carriers; those known to date have all been found through population-based genome-wide association studies (GWAS).">
    <entity charOffset="71-77" id="s867.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="87-92" id="s867.e1" ontology_id="675" text="BRCA2" type="GENE"/>
    <pair e1="s867.e0" e2="s867.e1" id="s867.p0" relation="true"/>
  </sentence>
  <sentence id="s868" text="DNA samples from 3,881 breast cancer affected and 4,330 unaffected BRCA2 mutation carriers from 47 studies belonging to the Consortium of Investigators of Modifiers of BRCA1/2 were genotyped and available for analysis.">
    <entity charOffset="30-36" id="s868.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-72" id="s868.e1" ontology_id="675" text="BRCA2" type="GENE"/>
    <pair e1="s868.e0" e2="s868.e1" id="s868.p0" relation="true"/>
  </sentence>
  <sentence id="s869" text="We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including FGFR2, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.">
    <entity charOffset="41-47" id="s869.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="80-85" id="s869.e1" ontology_id="675" text="BRCA2" type="GENE"/>
    <pair e1="s869.e0" e2="s869.e1" id="s869.p0" relation="true"/>
  </sentence>
  <sentence id="s870" text="We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including FGFR2, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.">
    <entity charOffset="41-47" id="s870.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="146-152" id="s870.e1" ontology_id="4214" text="MAP3K1" type="GENE"/>
    <pair e1="s870.e0" e2="s870.e1" id="s870.p0" relation="true"/>
  </sentence>
  <sentence id="s871" text="We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including FGFR2, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.">
    <entity charOffset="41-47" id="s871.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="168-173" id="s871.e1" ontology_id="5744" text="PTHLH" type="GENE"/>
    <pair e1="s871.e0" e2="s871.e1" id="s871.p0" relation="true"/>
  </sentence>
  <sentence id="s872" text="This SNP was not associated with breast cancer risk either in the general population or in BRCA1 mutation carriers.">
    <entity charOffset="40-46" id="s872.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="91-96" id="s872.e1" ontology_id="672" text="BRCA1" type="GENE"/>
    <pair e1="s872.e0" e2="s872.e1" id="s872.p0" relation="true"/>
  </sentence>
  <sentence id="s873" text="The locus lies within a region containing TFAP2A, which encodes a transcriptional activation protein that interacts with several tumor suppressor genes.">
    <entity charOffset="42-48" id="s873.e0" ontology_id="7020" text="TFAP2A" type="GENE"/>
    <entity charOffset="129-134" id="s873.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s873.e0" e2="s873.e1" id="s873.p0" relation="true"/>
  </sentence>
  <sentence id="s874" text="However autosomal recessive inheritance with mutation in the SLC34A2 gene is suspected">
    <entity charOffset="8-39" id="s874.e0" ontology_id="HP_0000007" text="autosomal recessive inheritance" type="HP"/>
    <entity charOffset="61-68" id="s874.e1" ontology_id="10568" text="SLC34A2" type="GENE"/>
    <pair e1="s874.e0" e2="s874.e1" id="s874.p0" relation="true"/>
  </sentence>
  <sentence id="s875" text="In this review, we focus on skeletal conditions belonging to the ciliopathy group: the short rib-polydactyly group (SRPs) that includes Verma-Naumoff syndrome (SRP type III), Majewski syndrome (SRP type II), Jeune syndrome (ATD), as well as Ellis-van Creveld syndrome (EVC), the Sensenbrenner syndrome, and, finally, Weyers acrofacial dysostosis.">
    <entity charOffset="97-108" id="s875.e0" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <entity charOffset="116-119" id="s875.e1" ontology_id="10911" text="SRP" type="GENE"/>
    <pair e1="s875.e0" e2="s875.e1" id="s875.p0" relation="true"/>
  </sentence>
  <sentence id="s876" text="Through the examination of 48 candidate genes known to be responsible for autosomal recessive SPG, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the DDHD1 gene encoding phosphatidic acid-preferring phospholipase A1 (PA-PLA1).">
    <entity charOffset="74-93" id="s876.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="94-97" id="s876.e1" ontology_id="55764" text="SPG" type="GENE"/>
    <pair e1="s876.e0" e2="s876.e1" id="s876.p0" relation="true"/>
  </sentence>
  <sentence id="s877" text="Through the examination of 48 candidate genes known to be responsible for autosomal recessive SPG, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the DDHD1 gene encoding phosphatidic acid-preferring phospholipase A1 (PA-PLA1).">
    <entity charOffset="74-93" id="s877.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="197-202" id="s877.e1" ontology_id="80821" text="DDHD1" type="GENE"/>
    <pair e1="s877.e0" e2="s877.e1" id="s877.p0" relation="true"/>
  </sentence>
  <sentence id="s878" text="Sonic Hedgehog (SHH) signaling at primary cilia drives the proliferation and progression of a subset of medulloblastomas, the most common malignant paediatric brain tumor.">
    <entity charOffset="16-19" id="s878.e0" ontology_id="6469" text="SHH" type="GENE"/>
    <entity charOffset="104-120" id="s878.e1" ontology_id="HP_0002885" text="medulloblastomas" type="HP"/>
    <pair e1="s878.e0" e2="s878.e1" id="s878.p0" relation="true"/>
  </sentence>
  <sentence id="s879" text="Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="16-22" id="s879.e0" ontology_id="23203" text="INPP5E" type="GENE"/>
    <entity charOffset="178-183" id="s879.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s879.e0" e2="s879.e1" id="s879.p0" relation="true"/>
  </sentence>
  <sentence id="s880" text="Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="16-22" id="s880.e0" ontology_id="23203" text="INPP5E" type="GENE"/>
    <entity charOffset="53-68" id="s880.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s880.e0" e2="s880.e1" id="s880.p0" relation="true"/>
  </sentence>
  <sentence id="s881" text="Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="32-35" id="s881.e0" ontology_id="6469" text="SHH" type="GENE"/>
    <entity charOffset="53-68" id="s881.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s881.e0" e2="s881.e1" id="s881.p0" relation="true"/>
  </sentence>
  <sentence id="s882" text="Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="53-68" id="s882.e0" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <entity charOffset="120-123" id="s882.e1" ontology_id="5266" text="PI3" type="GENE"/>
    <pair e1="s882.e0" e2="s882.e1" id="s882.p0" relation="true"/>
  </sentence>
  <sentence id="s883" text="Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="120-123" id="s883.e0" ontology_id="5266" text="PI3" type="GENE"/>
    <entity charOffset="178-183" id="s883.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s883.e0" e2="s883.e1" id="s883.p0" relation="true"/>
  </sentence>
  <sentence id="s884" text="Conditional deletion of Inpp5e in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced SHH signaling and promoted tumor cell cilia loss.">
    <entity charOffset="24-30" id="s884.e0" ontology_id="23203" text="Inpp5e" type="GENE"/>
    <entity charOffset="115-120" id="s884.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s884.e0" e2="s884.e1" id="s884.p0" relation="true"/>
  </sentence>
  <sentence id="s885" text="Conditional deletion of Inpp5e in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced SHH signaling and promoted tumor cell cilia loss.">
    <entity charOffset="115-120" id="s885.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="173-176" id="s885.e1" ontology_id="6469" text="SHH" type="GENE"/>
    <pair e1="s885.e0" e2="s885.e1" id="s885.p0" relation="true"/>
  </sentence>
  <sentence id="s886" text="The number of PtdIns(3,4,5)P&lt;sub&gt;3&lt;/sub&gt;/pAKT/pGSK3-positive cilia was increased in cultured Inpp5e-null tumor cells relative to controls.">
    <entity charOffset="94-100" id="s886.e0" ontology_id="23203" text="Inpp5e" type="GENE"/>
    <entity charOffset="106-111" id="s886.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s886.e0" e2="s886.e1" id="s886.p0" relation="true"/>
  </sentence>
  <sentence id="s887" text="PI3-kinase inhibition or expression of wild-type, but not catalytically inactive HA-INPP5E partially rescued cilia loss in Inpp5e-null tumor cells in vitro.">
    <entity charOffset="0-3" id="s887.e0" ontology_id="5266" text="PI3" type="GENE"/>
    <entity charOffset="135-140" id="s887.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s887.e0" e2="s887.e1" id="s887.p0" relation="true"/>
  </sentence>
  <sentence id="s888" text="PI3-kinase inhibition or expression of wild-type, but not catalytically inactive HA-INPP5E partially rescued cilia loss in Inpp5e-null tumor cells in vitro.">
    <entity charOffset="123-129" id="s888.e0" ontology_id="23203" text="Inpp5e" type="GENE"/>
    <entity charOffset="135-140" id="s888.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s888.e0" e2="s888.e1" id="s888.p0" relation="true"/>
  </sentence>
  <sentence id="s889" text="INPP5E mRNA and copy number were reduced in human SHH medulloblastoma compared to other molecular subtypes and consistent with the murine model, reduced INPP5E was associated with improved overall survival.">
    <entity charOffset="0-6" id="s889.e0" ontology_id="23203" text="INPP5E" type="GENE"/>
    <entity charOffset="54-69" id="s889.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s889.e0" e2="s889.e1" id="s889.p0" relation="true"/>
  </sentence>
  <sentence id="s890" text="INPP5E mRNA and copy number were reduced in human SHH medulloblastoma compared to other molecular subtypes and consistent with the murine model, reduced INPP5E was associated with improved overall survival.">
    <entity charOffset="50-53" id="s890.e0" ontology_id="6469" text="SHH" type="GENE"/>
    <entity charOffset="54-69" id="s890.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s890.e0" e2="s890.e1" id="s890.p0" relation="true"/>
  </sentence>
  <sentence id="s891" text="Therefore our study identifies a compartmentalized PtdIns(3,4,5)P&lt;sub&gt;3&lt;/sub&gt;/AKT/GSK3 signaling axis at cilia in SHH-dependent medulloblastoma that is regulated by INPP5E to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression">
    <entity charOffset="129-144" id="s891.e0" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <entity charOffset="166-172" id="s891.e1" ontology_id="23203" text="INPP5E" type="GENE"/>
    <pair e1="s891.e0" e2="s891.e1" id="s891.p0" relation="true"/>
  </sentence>
  <sentence id="s892" text="Kank1, an important member of the Kank gene family, plays an important role in the development of many malignant tumors.">
    <entity charOffset="0-4" id="s892.e0" ontology_id="23189" text="Kank" type="GENE"/>
    <entity charOffset="113-119" id="s892.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s892.e0" e2="s892.e1" id="s892.p0" relation="true"/>
  </sentence>
  <sentence id="s893" text="As a brand new tumor-suppressor gene, the expression of Kank1 gene has been revealed to be downregulated or absent in many malignant tumors.">
    <entity charOffset="15-20" id="s893.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="56-60" id="s893.e1" ontology_id="23189" text="Kank" type="GENE"/>
    <pair e1="s893.e0" e2="s893.e1" id="s893.p0" relation="true"/>
  </sentence>
  <sentence id="s894" text="Concurrently, invivo nude mice experiments also confirmed that upregulation of Kank1 expression led to reduced tumor formation in nude mice and significantly reduced tumor volume.">
    <entity charOffset="22-26" id="s894.e0" ontology_id="54820" text="nude" type="GENE"/>
    <entity charOffset="112-117" id="s894.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s894.e0" e2="s894.e1" id="s894.p0" relation="true"/>
  </sentence>
  <sentence id="s895" text="Concurrently, invivo nude mice experiments also confirmed that upregulation of Kank1 expression led to reduced tumor formation in nude mice and significantly reduced tumor volume.">
    <entity charOffset="80-84" id="s895.e0" ontology_id="23189" text="Kank" type="GENE"/>
    <entity charOffset="112-117" id="s895.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s895.e0" e2="s895.e1" id="s895.p0" relation="true"/>
  </sentence>
  <sentence id="s896" text="These results revealed that upregulation of the Kankl gene inhibited the progression of lung cancer both invitro and invivo, and its mechanism was closely related to cell apoptosis as well as tumor invasion and metastasis">
    <entity charOffset="48-52" id="s896.e0" ontology_id="23189" text="Kank" type="GENE"/>
    <entity charOffset="194-199" id="s896.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s896.e0" e2="s896.e1" id="s896.p0" relation="true"/>
  </sentence>
  <sentence id="s897" text="These results revealed that upregulation of the Kankl gene inhibited the progression of lung cancer both invitro and invivo, and its mechanism was closely related to cell apoptosis as well as tumor invasion and metastasis">
    <entity charOffset="48-52" id="s897.e0" ontology_id="23189" text="Kank" type="GENE"/>
    <entity charOffset="93-99" id="s897.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s897.e0" e2="s897.e1" id="s897.p0" relation="true"/>
  </sentence>
  <sentence id="s898" text="Recently, loss-of-function mutations in BCAP31 were reported in association with severe developmental delay, deafness and dystonia.">
    <entity charOffset="40-46" id="s898.e0" ontology_id="10134" text="BCAP31" type="GENE"/>
    <entity charOffset="88-107" id="s898.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s898.e0" e2="s898.e1" id="s898.p0" relation="true"/>
  </sentence>
  <sentence id="s899" text="Recently, loss-of-function mutations in BCAP31 were reported in association with severe developmental delay, deafness and dystonia.">
    <entity charOffset="40-46" id="s899.e0" ontology_id="10134" text="BCAP31" type="GENE"/>
    <entity charOffset="109-117" id="s899.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s899.e0" e2="s899.e1" id="s899.p0" relation="false"/>
  </sentence>
  <sentence id="s900" text="Remarkably, a patient with an isolated deletion at the 3'-end of SLC6A8 had a similar severe phenotype as seen in BCAP31 deficiency but without deafness.">
    <entity charOffset="65-71" id="s900.e0" ontology_id="6535" text="SLC6A8" type="GENE"/>
    <entity charOffset="144-152" id="s900.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s900.e0" e2="s900.e1" id="s900.p0" relation="true"/>
  </sentence>
  <sentence id="s901" text="Remarkably, a patient with an isolated deletion at the 3'-end of SLC6A8 had a similar severe phenotype as seen in BCAP31 deficiency but without deafness.">
    <entity charOffset="114-120" id="s901.e0" ontology_id="10134" text="BCAP31" type="GENE"/>
    <entity charOffset="144-152" id="s901.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s901.e0" e2="s901.e1" id="s901.p0" relation="true"/>
  </sentence>
  <sentence id="s902" text="Friedreich's ataxia (FRDA), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (GAA) repeat in the FXN gene is known to inhibit the expression of frataxin protein.">
    <entity charOffset="13-19" id="s902.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="21-25" id="s902.e1" ontology_id="2395" text="FRDA" type="GENE"/>
    <pair e1="s902.e0" e2="s902.e1" id="s902.p0" relation="true"/>
  </sentence>
  <sentence id="s903" text="Friedreich's ataxia (FRDA), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (GAA) repeat in the FXN gene is known to inhibit the expression of frataxin protein.">
    <entity charOffset="13-19" id="s903.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="131-134" id="s903.e1" ontology_id="2548" text="GAA" type="GENE"/>
    <pair e1="s903.e0" e2="s903.e1" id="s903.p0" relation="true"/>
  </sentence>
  <sentence id="s904" text="Friedreich's ataxia (FRDA), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (GAA) repeat in the FXN gene is known to inhibit the expression of frataxin protein.">
    <entity charOffset="13-19" id="s904.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="150-153" id="s904.e1" ontology_id="2395" text="FXN" type="GENE"/>
    <pair e1="s904.e0" e2="s904.e1" id="s904.p0" relation="true"/>
  </sentence>
  <sentence id="s905" text="Dendritic cell (DC)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (WT1) peptides have shown great therapeutic efficacy in these diseases.">
    <entity charOffset="83-89" id="s905.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="146-149" id="s905.e1" ontology_id="7490" text="WT1" type="GENE"/>
    <pair e1="s905.e0" e2="s905.e1" id="s905.p0" relation="true"/>
  </sentence>
  <sentence id="s906" text="Dendritic cell (DC)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (WT1) peptides have shown great therapeutic efficacy in these diseases.">
    <entity charOffset="129-134" id="s906.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="146-149" id="s906.e1" ontology_id="7490" text="WT1" type="GENE"/>
    <pair e1="s906.e0" e2="s906.e1" id="s906.p0" relation="true"/>
  </sentence>
  <sentence id="s907" text="In this paper, we report the results of a phase I/II study of a DC-based vaccination for advanced breast, ovarian, and gastric cancers, and we offer evidence that patients can be effectively vaccinated with autologous DCs pulsed with WT1 peptide.">
    <entity charOffset="119-134" id="s907.e0" ontology_id="HP_0012126" text="gastric cancers" type="HP"/>
    <entity charOffset="234-237" id="s907.e1" ontology_id="7490" text="WT1" type="GENE"/>
    <pair e1="s907.e0" e2="s907.e1" id="s907.p0" relation="true"/>
  </sentence>
  <sentence id="s908" text="Here, we show that fine-mapping of pancreatic and testicular cancer GWAS within one of these loci (Region 2 in CLPTM1L) focuses the signal to nine highly correlated SNPs.">
    <entity charOffset="61-67" id="s908.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="111-118" id="s908.e1" ontology_id="81037" text="CLPTM1L" type="GENE"/>
    <pair e1="s908.e0" e2="s908.e1" id="s908.p0" relation="true"/>
  </sentence>
  <sentence id="s909" text="Therefore, these results indicated that miR-129-5p functioned as a tumor suppressor in GC and may be a potential target of GC treatment">
    <entity charOffset="40-43" id="s909.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="67-72" id="s909.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s909.e0" e2="s909.e1" id="s909.p0" relation="true"/>
  </sentence>
  <sentence id="s910" text="Elevated serum PTH concentrations in primary and secondary hyperparathyroidism have been associated with bone disease, hypertension, and in some studies, cardiovascular mortality.">
    <entity charOffset="15-18" id="s910.e0" ontology_id="5741" text="PTH" type="GENE"/>
    <entity charOffset="59-78" id="s910.e1" ontology_id="HP_0000843" text="hyperparathyroidism" type="HP"/>
    <pair e1="s910.e0" e2="s910.e1" id="s910.p0" relation="true"/>
  </sentence>
  <sentence id="s911" text="&lt;b&gt;Methods&lt;/b&gt;: Analysis of publicly available microarray data of oral SCC revealed that AMACR was significantly upregulated in tumor tissue compared with normal mucosa.">
    <entity charOffset="89-94" id="s911.e0" ontology_id="23600" text="AMACR" type="GENE"/>
    <entity charOffset="128-133" id="s911.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s911.e0" e2="s911.e1" id="s911.p0" relation="true"/>
  </sentence>
  <sentence id="s912" text="Uveal melanomas are molecularly distinct from cutaneous melanomas and lack mutations in BRAF, NRAS, KIT, and NF1.">
    <entity charOffset="46-65" id="s912.e0" ontology_id="HP_0012056" text="cutaneous melanomas" type="HP"/>
    <entity charOffset="94-98" id="s912.e1" ontology_id="4893" text="NRAS" type="GENE"/>
    <pair e1="s912.e0" e2="s912.e1" id="s912.p0" relation="true"/>
  </sentence>
  <sentence id="s913" text="Uveal melanomas are molecularly distinct from cutaneous melanomas and lack mutations in BRAF, NRAS, KIT, and NF1.">
    <entity charOffset="46-65" id="s913.e0" ontology_id="HP_0012056" text="cutaneous melanomas" type="HP"/>
    <entity charOffset="100-103" id="s913.e1" ontology_id="3815" text="KIT" type="GENE"/>
    <pair e1="s913.e0" e2="s913.e1" id="s913.p0" relation="true"/>
  </sentence>
  <sentence id="s914" text="Using a proteomics screen, we now show that the mitochondrial unfoldase-peptidase complex ClpXP associates with the oncoprotein survivin and the respiratory chain Complex II subunit succinate dehydrogenase B (SDHB) in mitochondria of tumor cells.">
    <entity charOffset="90-94" id="s914.e0" ontology_id="10845" text="ClpX" type="GENE"/>
    <entity charOffset="234-239" id="s914.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s914.e0" e2="s914.e1" id="s914.p0" relation="true"/>
  </sentence>
  <sentence id="s915" text="Using a proteomics screen, we now show that the mitochondrial unfoldase-peptidase complex ClpXP associates with the oncoprotein survivin and the respiratory chain Complex II subunit succinate dehydrogenase B (SDHB) in mitochondria of tumor cells.">
    <entity charOffset="128-136" id="s915.e0" ontology_id="332" text="survivin" type="GENE"/>
    <entity charOffset="234-239" id="s915.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s915.e0" e2="s915.e1" id="s915.p0" relation="true"/>
  </sentence>
  <sentence id="s916" text="Using a proteomics screen, we now show that the mitochondrial unfoldase-peptidase complex ClpXP associates with the oncoprotein survivin and the respiratory chain Complex II subunit succinate dehydrogenase B (SDHB) in mitochondria of tumor cells.">
    <entity charOffset="209-213" id="s916.e0" ontology_id="6390" text="SDHB" type="GENE"/>
    <entity charOffset="234-239" id="s916.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s916.e0" e2="s916.e1" id="s916.p0" relation="true"/>
  </sentence>
  <sentence id="s917" text="Deregulated mitochondrial respiration induced by ClpXP targeting causes oxidative stress, which in turn reduces tumor cell proliferation, suppresses cell motility, and abolishes metastatic dissemination in vivo.">
    <entity charOffset="49-53" id="s917.e0" ontology_id="10845" text="ClpX" type="GENE"/>
    <entity charOffset="112-117" id="s917.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s917.e0" e2="s917.e1" id="s917.p0" relation="true"/>
  </sentence>
  <sentence id="s918" text="ClpP is universally overexpressed in primary and metastatic human cancer, correlating with shortened patient survival.">
    <entity charOffset="0-4" id="s918.e0" ontology_id="8192" text="ClpP" type="GENE"/>
    <entity charOffset="66-72" id="s918.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s918.e0" e2="s918.e1" id="s918.p0" relation="true"/>
  </sentence>
  <sentence id="s919" text="Therefore, tumors exploit ClpXP-directed proteostasis to maintain mitochondrial bioenergetics, buffer oxidative stress, and enable metastatic competence.">
    <entity charOffset="11-16" id="s919.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="26-30" id="s919.e1" ontology_id="10845" text="ClpX" type="GENE"/>
    <pair e1="s919.e0" e2="s919.e1" id="s919.p0" relation="true"/>
  </sentence>
  <sentence id="s920" text="The gene responsible for an autosomal recessive Pelizaeus-Merzbacher-like disease called HLD5 is named fam126a (also known as hyccin or drctnnb1a).">
    <entity charOffset="28-47" id="s920.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="103-110" id="s920.e1" ontology_id="84668" text="fam126a" type="GENE"/>
    <pair e1="s920.e0" e2="s920.e1" id="s920.p0" relation="true"/>
  </sentence>
  <sentence id="s921" text="The gene responsible for an autosomal recessive Pelizaeus-Merzbacher-like disease called HLD5 is named fam126a (also known as hyccin or drctnnb1a).">
    <entity charOffset="28-47" id="s921.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="126-132" id="s921.e1" ontology_id="84668" text="hyccin" type="GENE"/>
    <pair e1="s921.e0" e2="s921.e1" id="s921.p0" relation="true"/>
  </sentence>
  <sentence id="s922" text="The gene responsible for an autosomal recessive Pelizaeus-Merzbacher-like disease called HLD5 is named fam126a (also known as hyccin or drctnnb1a).">
    <entity charOffset="28-47" id="s922.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="136-145" id="s922.e1" ontology_id="84668" text="drctnnb1a" type="GENE"/>
    <pair e1="s922.e0" e2="s922.e1" id="s922.p0" relation="true"/>
  </sentence>
  <sentence id="s923" text="After targeting to endothelial differentiation gene (Edg) family LPA receptors (LPA1, LPA2, LPA3) and non-Edg family LPA receptors (LPA4, LPA5, LPA6), LPA mediates physiological and pathological processes such as embryonic development, angiogenesis, tumor progression, fibrogenesis, wound healing, ischemia/reperfusion injury, and inflammatory reactions.">
    <entity charOffset="65-68" id="s923.e0" ontology_id="4018" text="LPA" type="GENE"/>
    <entity charOffset="250-255" id="s923.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s923.e0" e2="s923.e1" id="s923.p0" relation="true"/>
  </sentence>
  <sentence id="s924" text="Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="11-16" id="s924.e0" ontology_id="8309" text="ACOX2" type="GENE"/>
    <entity charOffset="111-117" id="s924.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s924.e0" e2="s924.e1" id="s924.p0" relation="true"/>
  </sentence>
  <sentence id="s925" text="Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="32-36" id="s925.e0" ontology_id="5723" text="PSPH" type="GENE"/>
    <entity charOffset="111-117" id="s925.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s925.e0" e2="s925.e1" id="s925.p0" relation="true"/>
  </sentence>
  <sentence id="s926" text="Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="44-48" id="s926.e0" ontology_id="7298" text="TYMS" type="GENE"/>
    <entity charOffset="111-117" id="s926.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s926.e0" e2="s926.e1" id="s926.p0" relation="true"/>
  </sentence>
  <sentence id="s927" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).">
    <entity charOffset="19-25" id="s927.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="151-156" id="s927.e1" ontology_id="8309" text="ACOX2" type="GENE"/>
    <pair e1="s927.e0" e2="s927.e1" id="s927.p0" relation="true"/>
  </sentence>
  <sentence id="s928" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).">
    <entity charOffset="19-25" id="s928.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="158-162" id="s928.e1" ontology_id="4582" text="MUC1" type="GENE"/>
    <pair e1="s928.e0" e2="s928.e1" id="s928.p0" relation="true"/>
  </sentence>
  <sentence id="s929" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).">
    <entity charOffset="19-25" id="s929.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="79-85" id="s929.e1" ontology_id="1415" text="CRYBB2" type="GENE"/>
    <pair e1="s929.e0" e2="s929.e1" id="s929.p0" relation="true"/>
  </sentence>
  <sentence id="s930" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).">
    <entity charOffset="19-25" id="s930.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="87-91" id="s930.e1" ontology_id="5723" text="PSPH" type="GENE"/>
    <pair e1="s930.e0" e2="s930.e1" id="s930.p0" relation="true"/>
  </sentence>
  <sentence id="s931" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).">
    <entity charOffset="19-25" id="s931.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="93-97" id="s931.e1" ontology_id="6713" text="SQLE" type="GENE"/>
    <pair e1="s931.e0" e2="s931.e1" id="s931.p0" relation="true"/>
  </sentence>
  <sentence id="s932" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).">
    <entity charOffset="19-25" id="s932.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="99-103" id="s932.e1" ontology_id="7298" text="TYMS" type="GENE"/>
    <pair e1="s932.e0" e2="s932.e1" id="s932.p0" relation="true"/>
  </sentence>
  <sentence id="s933" text="Some of these differences (CRYBB2 and PSPH) may exist from the earliest stages of tumor development, or may even precede malignancy">
    <entity charOffset="27-33" id="s933.e0" ontology_id="1415" text="CRYBB2" type="GENE"/>
    <entity charOffset="82-87" id="s933.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s933.e0" e2="s933.e1" id="s933.p0" relation="true"/>
  </sentence>
  <sentence id="s934" text="Some of these differences (CRYBB2 and PSPH) may exist from the earliest stages of tumor development, or may even precede malignancy">
    <entity charOffset="38-42" id="s934.e0" ontology_id="5723" text="PSPH" type="GENE"/>
    <entity charOffset="82-87" id="s934.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s934.e0" e2="s934.e1" id="s934.p0" relation="true"/>
  </sentence>
  <sentence id="s935" text="Helicaselike transcription factor (HLTF) has been identified as a tumor suppressor gene.">
    <entity charOffset="36-40" id="s935.e0" ontology_id="6596" text="HLTF" type="GENE"/>
    <entity charOffset="67-72" id="s935.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s935.e0" e2="s935.e1" id="s935.p0" relation="true"/>
  </sentence>
  <sentence id="s936" text="The hypermethylation of HTLF is frequently observed in various types of cancer, including colorectal cancer(CRC).">
    <entity charOffset="24-28" id="s936.e0" ontology_id="3344" text="HTLF" type="GENE"/>
    <entity charOffset="72-78" id="s936.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s936.e0" e2="s936.e1" id="s936.p0" relation="true"/>
  </sentence>
  <sentence id="s937" text="Through epigenomic study of a colon cancer cell line pair (HCT116 and DKO), we identified &lt;i&gt;JPH3&lt;/i&gt; as a methylated novel tumor suppressor gene (TSG) candidate at 16q24.">
    <entity charOffset="124-129" id="s937.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="147-150" id="s937.e1" ontology_id="57045" text="TSG" type="GENE"/>
    <pair e1="s937.e0" e2="s937.e1" id="s937.p0" relation="true"/>
  </sentence>
  <sentence id="s938" text="Thus, &lt;i&gt;JPH3&lt;/i&gt; was identified as a novel TSG methylated in colorectal and gastric tumors which promotes mitochondrial-mediated apoptosis, also as a potential metastasis and survival biomarker for digestive cancers">
    <entity charOffset="44-47" id="s938.e0" ontology_id="57045" text="TSG" type="GENE"/>
    <entity charOffset="85-90" id="s938.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s938.e0" e2="s938.e1" id="s938.p0" relation="true"/>
  </sentence>
  <sentence id="s939" text="The aim of this study was to determine the association between Rab3IP and gastric cancer, in addition to its functional role in this disease.">
    <entity charOffset="63-69" id="s939.e0" ontology_id="117177" text="Rab3IP" type="GENE"/>
    <entity charOffset="82-88" id="s939.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s939.e0" e2="s939.e1" id="s939.p0" relation="true"/>
  </sentence>
  <sentence id="s940" text="In addition, we verified the co-expression of and interplay between Rab3IP and SSX2 during gastric cancer progression.">
    <entity charOffset="68-74" id="s940.e0" ontology_id="117177" text="Rab3IP" type="GENE"/>
    <entity charOffset="99-105" id="s940.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s940.e0" e2="s940.e1" id="s940.p0" relation="true"/>
  </sentence>
  <sentence id="s941" text="Thus, these findings elucidated the central role of Rab3IP in inducing an invasive phenotype in gastric cancer cells, in addition to its involvement in EMT.">
    <entity charOffset="52-58" id="s941.e0" ontology_id="117177" text="Rab3IP" type="GENE"/>
    <entity charOffset="104-110" id="s941.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s941.e0" e2="s941.e1" id="s941.p0" relation="true"/>
  </sentence>
  <sentence id="s942" text="Thus, these findings elucidated the central role of Rab3IP in inducing an invasive phenotype in gastric cancer cells, in addition to its involvement in EMT.">
    <entity charOffset="104-110" id="s942.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="152-155" id="s942.e1" ontology_id="3702" text="EMT" type="GENE"/>
    <pair e1="s942.e0" e2="s942.e1" id="s942.p0" relation="true"/>
  </sentence>
  <sentence id="s943" text="At least 36 different forms of ADCA are known, 20 autosomal-recessive, two X-linked, and several forms of ataxia associated with mitochondrial defects are known to date.">
    <entity charOffset="31-35" id="s943.e0" ontology_id="5173" text="ADCA" type="GENE"/>
    <entity charOffset="106-112" id="s943.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s943.e0" e2="s943.e1" id="s943.p0" relation="true"/>
  </sentence>
  <sentence id="s944" text="Exome and targeted sequencing has recently identified four new genes causing ataxia: TGM6, ANO10, SYT14, and rundataxin.">
    <entity charOffset="77-83" id="s944.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="85-89" id="s944.e1" ontology_id="343641" text="TGM6" type="GENE"/>
    <pair e1="s944.e0" e2="s944.e1" id="s944.p0" relation="true"/>
  </sentence>
  <sentence id="s945" text="Only a few genes, including SMARCA4, SMO, ZNF44 and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.">
    <entity charOffset="28-35" id="s945.e0" ontology_id="6597" text="SMARCA4" type="GENE"/>
    <entity charOffset="175-180" id="s945.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s945.e0" e2="s945.e1" id="s945.p0" relation="true"/>
  </sentence>
  <sentence id="s946" text="Only a few genes, including SMARCA4, SMO, ZNF44 and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.">
    <entity charOffset="42-47" id="s946.e0" ontology_id="51710" text="ZNF44" type="GENE"/>
    <entity charOffset="175-180" id="s946.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s946.e0" e2="s946.e1" id="s946.p0" relation="true"/>
  </sentence>
  <sentence id="s947" text="We detected 11 novel mutations in &lt;i&gt;GJA3&lt;/i&gt;, &lt;i&gt;GJA8&lt;/i&gt;, &lt;i&gt;CRYAA&lt;/i&gt;, &lt;i&gt;CRYBB2&lt;/i&gt;, &lt;i&gt;CRYGS&lt;/i&gt;, &lt;i&gt;CRYGA&lt;/i&gt;, &lt;i&gt;GCNT2&lt;/i&gt;, &lt;i&gt;CRYGA&lt;/i&gt;, and &lt;i&gt;MIP&lt;/i&gt;; and three previously reported cataract-causing mutations in &lt;i&gt;GJA8&lt;/i&gt;, &lt;i&gt;CRYAA&lt;/i&gt;, and &lt;i&gt;CRYBB2&lt;/i&gt; The most commonly mutated genes were those coding for gap junctions and crystallin proteins.">
    <entity charOffset="191-199" id="s947.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="320-323" id="s947.e1" ontology_id="5921" text="gap" type="GENE"/>
    <pair e1="s947.e0" e2="s947.e1" id="s947.p0" relation="true"/>
  </sentence>
  <sentence id="s948" text="Candidate markers were identified by bisulfite conversion-based genome-wide methylation screening of lung tissue from lung cancer, fibrotic ILD, and COPD. cfDNA from 400l serum (n=204) served to test the diagnostic performance of these markers.">
    <entity charOffset="123-129" id="s948.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="149-153" id="s948.e1" ontology_id="372" text="COPD" type="GENE"/>
    <pair e1="s948.e0" e2="s948.e1" id="s948.p0" relation="true"/>
  </sentence>
  <sentence id="s949" text="Hepatocellular carcinoma related protein 1 (HCRP1), which is essential for internalization and degradation of ubiquitinated membrane receptors, is downregulated in several tumors and strongly affects the outcomes of cancer patients.">
    <entity charOffset="44-49" id="s949.e0" ontology_id="137492" text="HCRP1" type="GENE"/>
    <entity charOffset="172-178" id="s949.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s949.e0" e2="s949.e1" id="s949.p0" relation="true"/>
  </sentence>
  <sentence id="s950" text="Hepatocellular carcinoma related protein 1 (HCRP1), which is essential for internalization and degradation of ubiquitinated membrane receptors, is downregulated in several tumors and strongly affects the outcomes of cancer patients.">
    <entity charOffset="44-49" id="s950.e0" ontology_id="137492" text="HCRP1" type="GENE"/>
    <entity charOffset="216-222" id="s950.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s950.e0" e2="s950.e1" id="s950.p0" relation="true"/>
  </sentence>
  <sentence id="s951" text="It is reported the expression of HCRP1 is inversely related to epidermal growth factor receptor (EGFR) in breast cancer and lead to resistance to cetuximab in ovarian cancer.">
    <entity charOffset="33-38" id="s951.e0" ontology_id="137492" text="HCRP1" type="GENE"/>
    <entity charOffset="113-119" id="s951.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s951.e0" e2="s951.e1" id="s951.p0" relation="true"/>
  </sentence>
  <sentence id="s952" text="HCRP1 expression was significantly related to age (P=0.017), pathological grade (P=0.003), tumor encapsulation (P=0.037), recurrence (P=0.039) and death (P=0.015), but unrelated to cirrhosis (P=0.216), tumor size (P=0.273), and distant metastasis (P=0.554).">
    <entity charOffset="0-5" id="s952.e0" ontology_id="137492" text="HCRP1" type="GENE"/>
    <entity charOffset="91-96" id="s952.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s952.e0" e2="s952.e1" id="s952.p0" relation="true"/>
  </sentence>
  <sentence id="s953" text="Metabolic syndrome (MeS) is associated with increased PCa aggressiveness and recurrence.">
    <entity charOffset="54-57" id="s953.e0" ontology_id="28982" text="PCa" type="GENE"/>
    <entity charOffset="58-72" id="s953.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s953.e0" e2="s953.e1" id="s953.p0" relation="true"/>
  </sentence>
  <sentence id="s954" text="Moreover, CLCA2 depletion in PCa cells injected subcutaneously in MeS mice increased the circulating tumor cells foci compared to control.">
    <entity charOffset="10-15" id="s954.e0" ontology_id="9635" text="CLCA2" type="GENE"/>
    <entity charOffset="101-106" id="s954.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s954.e0" e2="s954.e1" id="s954.p0" relation="true"/>
  </sentence>
  <sentence id="s955" text="Recently, mutations of DNAJC12 gene were reported to be associated with early-onset parkinsonism, progressive neurodevelopmental delay, and dystonia in several unrelated pedigrees.">
    <entity charOffset="23-30" id="s955.e0" ontology_id="56521" text="DNAJC12" type="GENE"/>
    <entity charOffset="84-96" id="s955.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s955.e0" e2="s955.e1" id="s955.p0" relation="true"/>
  </sentence>
  <sentence id="s956" text="Recently, mutations of DNAJC12 gene were reported to be associated with early-onset parkinsonism, progressive neurodevelopmental delay, and dystonia in several unrelated pedigrees.">
    <entity charOffset="23-30" id="s956.e0" ontology_id="56521" text="DNAJC12" type="GENE"/>
    <entity charOffset="110-134" id="s956.e1" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <pair e1="s956.e0" e2="s956.e1" id="s956.p0" relation="true"/>
  </sentence>
  <sentence id="s957" text="This study aimed to evaluate DNAJC12 coding mutations in sporadic Chinese Han patients with Parkinson's disease (PD) and test whether an age-of-onset effect exists.">
    <entity charOffset="29-36" id="s957.e0" ontology_id="56521" text="DNAJC12" type="GENE"/>
    <entity charOffset="57-65" id="s957.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s957.e0" e2="s957.e1" id="s957.p0" relation="true"/>
  </sentence>
  <sentence id="s958" text="Biallelic UNC80 mutations cause infantile hypotonia with psychomotor retardation and characteristic facies 2 (IHPRF2), which is characterized by hypotonia, developmental delay (DD)/intellectual disability (ID), intrauterine growth retardation, postnatal growth retardation and characteristic facial features.">
    <entity charOffset="10-15" id="s958.e0" ontology_id="285175" text="UNC80" type="GENE"/>
    <entity charOffset="156-175" id="s958.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s958.e0" e2="s958.e1" id="s958.p0" relation="true"/>
  </sentence>
  <sentence id="s959" text="Furthermore, we herein summarize the genotypes and phenotypes of patients with UNC80 mutations reported in the literature, revealing that IHPRF2 is a phenotypically heterogeneous disease.">
    <entity charOffset="79-84" id="s959.e0" ontology_id="285175" text="UNC80" type="GENE"/>
    <entity charOffset="165-178" id="s959.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s959.e0" e2="s959.e1" id="s959.p0" relation="true"/>
  </sentence>
  <sentence id="s960" text="Common facial dysmorphisms include a thin upper lip, a tented upper lip, a triangular face, strabismus and microcephaly.">
    <entity charOffset="48-51" id="s960.e0" ontology_id="23049" text="lip" type="GENE"/>
    <entity charOffset="75-90" id="s960.e1" ontology_id="HP_0000325" text="triangular face" type="HP"/>
    <pair e1="s960.e0" e2="s960.e1" id="s960.p0" relation="true"/>
  </sentence>
  <sentence id="s961" text="PRKCG has also been identified as an important node in ataxia gene networks more broadly, but the functional role of PKC in other forms of ataxia remains unexplored, and the mechanisms by which PKC isozymes regulate Purkinje neuron health are not well understood.">
    <entity charOffset="0-5" id="s961.e0" ontology_id="5582" text="PRKCG" type="GENE"/>
    <entity charOffset="55-61" id="s961.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s961.e0" e2="s961.e1" id="s961.p0" relation="true"/>
  </sentence>
  <sentence id="s962" text="Recent advances in whole exome sequencing technology show promise for further elucidation of disease causing variants as in the recent identification of rare variants within ZNF644 segregating with pathological myopia.">
    <entity charOffset="174-180" id="s962.e0" ontology_id="84146" text="ZNF644" type="GENE"/>
    <entity charOffset="211-217" id="s962.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s962.e0" e2="s962.e1" id="s962.p0" relation="true"/>
  </sentence>
  <sentence id="s963" text="We evaluated the molecular heterogeneity of sCRC tumors based on simultaneous assessment of the overall GEP of both coding mRNA and non-coding RNA genes in primary sCRC tumor samples from 23 consecutive patients and their paired liver metastases.">
    <entity charOffset="27-40" id="s963.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="104-107" id="s963.e1" ontology_id="2768" text="GEP" type="GENE"/>
    <pair e1="s963.e0" e2="s963.e1" id="s963.p0" relation="true"/>
  </sentence>
  <sentence id="s964" text="We evaluated the molecular heterogeneity of sCRC tumors based on simultaneous assessment of the overall GEP of both coding mRNA and non-coding RNA genes in primary sCRC tumor samples from 23 consecutive patients and their paired liver metastases.">
    <entity charOffset="104-107" id="s964.e0" ontology_id="2768" text="GEP" type="GENE"/>
    <entity charOffset="169-174" id="s964.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s964.e0" e2="s964.e1" id="s964.p0" relation="true"/>
  </sentence>
  <sentence id="s965" text="RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="20-25" id="s965.e0" ontology_id="4090" text="SMAD5" type="GENE"/>
    <entity charOffset="131-136" id="s965.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s965.e0" e2="s965.e1" id="s965.p0" relation="true"/>
  </sentence>
  <sentence id="s966" text="RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="34-40" id="s966.e0" ontology_id="657" text="BMPR1A" type="GENE"/>
    <entity charOffset="131-136" id="s966.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s966.e0" e2="s966.e1" id="s966.p0" relation="false"/>
  </sentence>
  <sentence id="s967" text="RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="42-47" id="s967.e0" ontology_id="4092" text="SMAD7" type="GENE"/>
    <entity charOffset="131-136" id="s967.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s967.e0" e2="s967.e1" id="s967.p0" relation="true"/>
  </sentence>
  <sentence id="s968" text="The incidence rate of hepatocellular carcinoma (HCC) is rising.">
    <entity charOffset="22-46" id="s968.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="48-51" id="s968.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s968.e0" e2="s968.e1" id="s968.p0" relation="true"/>
  </sentence>
  <sentence id="s969" text="Activation of inflammatory pathways is known to accompany development of obesity-induced non-alcoholic fatty liver disease (NAFLD), insulin resistance and type 2 diabetes.">
    <entity charOffset="73-80" id="s969.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="155-159" id="s969.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s969.e0" e2="s969.e1" id="s969.p0" relation="true"/>
  </sentence>
  <sentence id="s970" text="Hearing impairment (HI) caused by mutations in the connexin-26 gene (GJB2) accounts for the majority of cases with inherited, nonsyndromic sensorineural hearing loss.">
    <entity charOffset="69-73" id="s970.e0" ontology_id="2706" text="GJB2" type="GENE"/>
    <entity charOffset="153-165" id="s970.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s970.e0" e2="s970.e1" id="s970.p0" relation="true"/>
  </sentence>
  <sentence id="s971" text="This study describes the first use of PGD for GJB2 associated non-syndromic deafness in Iran.">
    <entity charOffset="38-41" id="s971.e0" ontology_id="5226" text="PGD" type="GENE"/>
    <entity charOffset="76-84" id="s971.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s971.e0" e2="s971.e1" id="s971.p0" relation="true"/>
  </sentence>
  <sentence id="s972" text="This study describes the first use of PGD for GJB2 associated non-syndromic deafness in Iran.">
    <entity charOffset="46-50" id="s972.e0" ontology_id="2706" text="GJB2" type="GENE"/>
    <entity charOffset="76-84" id="s972.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s972.e0" e2="s972.e1" id="s972.p0" relation="true"/>
  </sentence>
  <sentence id="s973" text="GJB2 donor splicing site IVS1+1G&amp;amp;gt;A mutation analysis was performed using Sanger sequencing for a total of 71 Iranian families with at least 1 deaf child diagnosed with non-syndromic deafness.">
    <entity charOffset="0-4" id="s973.e0" ontology_id="2706" text="GJB2" type="GENE"/>
    <entity charOffset="189-197" id="s973.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s973.e0" e2="s973.e1" id="s973.p0" relation="true"/>
  </sentence>
  <sentence id="s974" text="Recent studies have linked mutations in the SLC24A4 (NCKX4) and SLC24A5 (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively.">
    <entity charOffset="64-71" id="s974.e0" ontology_id="283652" text="SLC24A5" type="GENE"/>
    <entity charOffset="151-159" id="s974.e1" ontology_id="HP_0001022" text="albinism" type="HP"/>
    <pair e1="s974.e0" e2="s974.e1" id="s974.p0" relation="true"/>
  </sentence>
  <sentence id="s975" text="We also analyzed two mutations in a Drosophila NCKX gene that have been reported to result in an increased susceptibility for seizures, and found that both resulted in mutant proteins with significantly reduced but observable NCKX activity.">
    <entity charOffset="47-51" id="s975.e0" ontology_id="9187" text="NCKX" type="GENE"/>
    <entity charOffset="126-134" id="s975.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s975.e0" e2="s975.e1" id="s975.p0" relation="true"/>
  </sentence>
  <sentence id="s976" text="Via its bipartite zona pellucida module (ZP-N/ZP-C), UMOD forms extracellular filaments that regulate kidney electrolyte balance and innate immunity, as well as protect against renal stones.">
    <entity charOffset="53-57" id="s976.e0" ontology_id="7369" text="UMOD" type="GENE"/>
    <entity charOffset="177-189" id="s976.e1" ontology_id="HP_0000787" text="renal stones" type="HP"/>
    <pair e1="s976.e0" e2="s976.e1" id="s976.p0" relation="true"/>
  </sentence>
  <sentence id="s977" text="This phenotype is associated with increased cytosine methylation heterogeneity, but not with increased AICDA-mediated somatic mutation burden.">
    <entity charOffset="65-78" id="s977.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="103-108" id="s977.e1" ontology_id="57379" text="AICDA" type="GENE"/>
    <pair e1="s977.e0" e2="s977.e1" id="s977.p0" relation="false"/>
  </sentence>
  <sentence id="s978" text="This phenotype is associated with increased cytosine methylation heterogeneity, but not with increased AICDA-mediated somatic mutation burden.">
    <entity charOffset="103-108" id="s978.e0" ontology_id="57379" text="AICDA" type="GENE"/>
    <entity charOffset="118-134" id="s978.e1" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <pair e1="s978.e0" e2="s978.e1" id="s978.p0" relation="true"/>
  </sentence>
  <sentence id="s979" text="Reciprocally, the cytosine methylation heterogeneity characteristic of normal GC B cells is lost upon AICDA depletion.">
    <entity charOffset="39-52" id="s979.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="102-107" id="s979.e1" ontology_id="57379" text="AICDA" type="GENE"/>
    <pair e1="s979.e0" e2="s979.e1" id="s979.p0" relation="true"/>
  </sentence>
  <sentence id="s980" text="These observations are relevant to human patients, since DLBCLs with high AICDA expression manifest increased methylation heterogeneity vs. AICDA-low DLBCLs.">
    <entity charOffset="74-79" id="s980.e0" ontology_id="57379" text="AICDA" type="GENE"/>
    <entity charOffset="122-135" id="s980.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s980.e0" e2="s980.e1" id="s980.p0" relation="true"/>
  </sentence>
  <sentence id="s981" text="Our results identify AICDA as a driver of epigenetic heterogeneity in B-cell lymphomas with potential significance for other tumors with aberrant expression of cytidine deaminases">
    <entity charOffset="21-26" id="s981.e0" ontology_id="57379" text="AICDA" type="GENE"/>
    <entity charOffset="53-66" id="s981.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s981.e0" e2="s981.e1" id="s981.p0" relation="true"/>
  </sentence>
  <sentence id="s982" text="Our results identify AICDA as a driver of epigenetic heterogeneity in B-cell lymphomas with potential significance for other tumors with aberrant expression of cytidine deaminases">
    <entity charOffset="21-26" id="s982.e0" ontology_id="57379" text="AICDA" type="GENE"/>
    <entity charOffset="125-131" id="s982.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s982.e0" e2="s982.e1" id="s982.p0" relation="true"/>
  </sentence>
  <sentence id="s983" text="Thus, it is clear that a more complex genetic network of cancer-associated genes than previously hypothesized is involved in BCC carcinogenesis, with a potential impact on the development of new molecular targeted therapies.">
    <entity charOffset="57-63" id="s983.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="162-168" id="s983.e1" ontology_id="55364" text="impact" type="GENE"/>
    <pair e1="s983.e0" e2="s983.e1" id="s983.p0" relation="true"/>
  </sentence>
  <sentence id="s984" text="Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia.">
    <entity charOffset="40-46" id="s984.e0" ontology_id="9780" text="PIEZO1" type="GENE"/>
    <entity charOffset="58-77" id="s984.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s984.e0" e2="s984.e1" id="s984.p0" relation="true"/>
  </sentence>
  <sentence id="s985" text="Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis).">
    <entity charOffset="40-46" id="s985.e0" ontology_id="9780" text="PIEZO1" type="GENE"/>
    <entity charOffset="81-97" id="s985.e1" ontology_id="HP_0001878" text="hemolytic anemia" type="HP"/>
    <pair e1="s985.e0" e2="s985.e1" id="s985.p0" relation="true"/>
  </sentence>
  <sentence id="s986" text="Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.">
    <entity charOffset="40-46" id="s986.e0" ontology_id="63895" text="PIEZO2" type="GENE"/>
    <entity charOffset="61-80" id="s986.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s986.e0" e2="s986.e1" id="s986.p0" relation="true"/>
  </sentence>
  <sentence id="s987" text="Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.">
    <entity charOffset="40-46" id="s987.e0" ontology_id="63895" text="PIEZO2" type="GENE"/>
    <entity charOffset="147-161" id="s987.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s987.e0" e2="s987.e1" id="s987.p0" relation="true"/>
  </sentence>
  <sentence id="s988" text="Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.">
    <entity charOffset="40-46" id="s988.e0" ontology_id="63895" text="PIEZO2" type="GENE"/>
    <entity charOffset="167-176" id="s988.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s988.e0" e2="s988.e1" id="s988.p0" relation="true"/>
  </sentence>
  <sentence id="s989" text="Results Our cohort consisted mostly of children and displayed a wide phenotypic variability in the presenting symptoms ranging from hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development.">
    <entity charOffset="145-153" id="s989.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="168-171" id="s989.e1" ontology_id="2022" text="end" type="GENE"/>
    <pair e1="s989.e0" e2="s989.e1" id="s989.p0" relation="true"/>
  </sentence>
  <sentence id="s990" text="In our study, we aim to investigate whether variants of KCNA1, KCNA2, and KCNV2 genes influence susceptibility to genetic generalized epilepsies (GGEs) and the efficacy of AEDs.">
    <entity charOffset="56-61" id="s990.e0" ontology_id="3736" text="KCNA1" type="GENE"/>
    <entity charOffset="134-144" id="s990.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s990.e0" e2="s990.e1" id="s990.p0" relation="true"/>
  </sentence>
  <sentence id="s991" text="In our study, we aim to investigate whether variants of KCNA1, KCNA2, and KCNV2 genes influence susceptibility to genetic generalized epilepsies (GGEs) and the efficacy of AEDs.">
    <entity charOffset="63-68" id="s991.e0" ontology_id="3737" text="KCNA2" type="GENE"/>
    <entity charOffset="134-144" id="s991.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s991.e0" e2="s991.e1" id="s991.p0" relation="true"/>
  </sentence>
  <sentence id="s992" text="In the present study, we sought to identify the factors involved in the RAR&amp;amp;alpha;-mediated transcriptional regulation of the tumor suppressor gene and the tissue factor pathway inhibitor 2 (TFPI2) in hepatocellular carcinoma (HCC).">
    <entity charOffset="195-200" id="s992.e0" ontology_id="7980" text="TFPI2" type="GENE"/>
    <entity charOffset="205-229" id="s992.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s992.e0" e2="s992.e1" id="s992.p0" relation="true"/>
  </sentence>
  <sentence id="s993" text="The musculo-aponeurotic fibrosarcoma oncogene homolog B (MAFB) significantly enhanced the activation of the TFPI2 promoter via RAR&amp;amp;alpha; while MAFF inhibited it.">
    <entity charOffset="24-36" id="s993.e0" ontology_id="HP_0100244" text="fibrosarcoma" type="HP"/>
    <entity charOffset="108-113" id="s993.e1" ontology_id="7980" text="TFPI2" type="GENE"/>
    <pair e1="s993.e0" e2="s993.e1" id="s993.p0" relation="true"/>
  </sentence>
  <sentence id="s994" text="The musculo-aponeurotic fibrosarcoma oncogene homolog B (MAFB) significantly enhanced the activation of the TFPI2 promoter via RAR&amp;amp;alpha; while MAFF inhibited it.">
    <entity charOffset="24-36" id="s994.e0" ontology_id="HP_0100244" text="fibrosarcoma" type="HP"/>
    <entity charOffset="148-152" id="s994.e1" ontology_id="23764" text="MAFF" type="GENE"/>
    <pair e1="s994.e0" e2="s994.e1" id="s994.p0" relation="true"/>
  </sentence>
  <sentence id="s995" text="These results suggest that MAFB and MAFF play critical roles in the antitumor effects of retinoids by regulating the expression of retinoid target genes such as TFPI2 and can be promising for developing therapies to combat HCC invasion">
    <entity charOffset="36-40" id="s995.e0" ontology_id="23764" text="MAFF" type="GENE"/>
    <entity charOffset="72-77" id="s995.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s995.e0" e2="s995.e1" id="s995.p0" relation="true"/>
  </sentence>
  <sentence id="s996" text="Naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells adhere to tumor slices in proportion to the abundance of CCL18-producing macrophages.">
    <entity charOffset="40-45" id="s996.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="87-92" id="s996.e1" ontology_id="6362" text="CCL18" type="GENE"/>
    <pair e1="s996.e0" e2="s996.e1" id="s996.p0" relation="true"/>
  </sentence>
  <sentence id="s997" text="Moreover, adoptively transferred human naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells infiltrate human breast cancer orthotopic xenografts in a CCL18-dependent manner.">
    <entity charOffset="93-99" id="s997.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="127-132" id="s997.e1" ontology_id="6362" text="CCL18" type="GENE"/>
    <pair e1="s997.e0" e2="s997.e1" id="s997.p0" relation="true"/>
  </sentence>
  <sentence id="s998" text="In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells into tumor by knocking down the expression of PITPNM3, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
    <entity charOffset="16-22" id="s998.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="157-164" id="s998.e1" ontology_id="83394" text="PITPNM3" type="GENE"/>
    <pair e1="s998.e0" e2="s998.e1" id="s998.p0" relation="true"/>
  </sentence>
  <sentence id="s999" text="In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells into tumor by knocking down the expression of PITPNM3, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
    <entity charOffset="16-22" id="s999.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="168-173" id="s999.e1" ontology_id="6362" text="CCL18" type="GENE"/>
    <pair e1="s999.e0" e2="s999.e1" id="s999.p0" relation="true"/>
  </sentence>
  <sentence id="s1000" text="In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells into tumor by knocking down the expression of PITPNM3, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
    <entity charOffset="47-51" id="s1000.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="116-121" id="s1000.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1000.e0" e2="s1000.e1" id="s1000.p0" relation="false"/>
  </sentence>
  <sentence id="s1001" text="Inhibiting naive CD4&lt;sup&gt;+&lt;/sup&gt; T cell recruitment into tumors by interfering with PITPNM3 recognition of CCL18 may be an attractive strategy for anticancer immunotherapy">
    <entity charOffset="57-62" id="s1001.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="107-112" id="s1001.e1" ontology_id="6362" text="CCL18" type="GENE"/>
    <pair e1="s1001.e0" e2="s1001.e1" id="s1001.p0" relation="true"/>
  </sentence>
  <sentence id="s1002" text="Inhibiting naive CD4&lt;sup&gt;+&lt;/sup&gt; T cell recruitment into tumors by interfering with PITPNM3 recognition of CCL18 may be an attractive strategy for anticancer immunotherapy">
    <entity charOffset="84-91" id="s1002.e0" ontology_id="83394" text="PITPNM3" type="GENE"/>
    <entity charOffset="151-157" id="s1002.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1002.e0" e2="s1002.e1" id="s1002.p0" relation="true"/>
  </sentence>
  <sentence id="s1003" text="Inhibiting naive CD4&lt;sup&gt;+&lt;/sup&gt; T cell recruitment into tumors by interfering with PITPNM3 recognition of CCL18 may be an attractive strategy for anticancer immunotherapy">
    <entity charOffset="107-112" id="s1003.e0" ontology_id="6362" text="CCL18" type="GENE"/>
    <entity charOffset="151-157" id="s1003.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1003.e0" e2="s1003.e1" id="s1003.p0" relation="true"/>
  </sentence>
  <sentence id="s1004" text="Fungal immunomodulatory protein from &lt;i&gt;Nectria haematococca&lt;/i&gt; (FIP-nha) has potential as a lung cancer therapeutic; as such, illuminating its anti-tumor mechanism is expected to facilitate novel treatment options.">
    <entity charOffset="66-69" id="s1004.e0" ontology_id="7392" text="FIP" type="GENE"/>
    <entity charOffset="99-105" id="s1004.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1004.e0" e2="s1004.e1" id="s1004.p0" relation="true"/>
  </sentence>
  <sentence id="s1005" text="Thus, we comprehensively revealed the anti-tumor mechanism of FIP-nha, which inhibits tumor growth by modulating PI3K/Akt-regulated cell cycle arrest, autophagy, and apoptosis, and provided the basis for further application of fungal immunomodulatory proteins, especially FIP-nha">
    <entity charOffset="43-48" id="s1005.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="62-65" id="s1005.e1" ontology_id="7392" text="FIP" type="GENE"/>
    <pair e1="s1005.e0" e2="s1005.e1" id="s1005.p0" relation="true"/>
  </sentence>
  <sentence id="s1006" text="Thus, we comprehensively revealed the anti-tumor mechanism of FIP-nha, which inhibits tumor growth by modulating PI3K/Akt-regulated cell cycle arrest, autophagy, and apoptosis, and provided the basis for further application of fungal immunomodulatory proteins, especially FIP-nha">
    <entity charOffset="43-48" id="s1006.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="118-121" id="s1006.e1" ontology_id="207" text="Akt" type="GENE"/>
    <pair e1="s1006.e0" e2="s1006.e1" id="s1006.p0" relation="true"/>
  </sentence>
  <sentence id="s1007" text="High mobility group A2 (HMGA2) plays a crucial role in the development of cancer.">
    <entity charOffset="24-29" id="s1007.e0" ontology_id="8091" text="HMGA2" type="GENE"/>
    <entity charOffset="74-80" id="s1007.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1007.e0" e2="s1007.e1" id="s1007.p0" relation="true"/>
  </sentence>
  <sentence id="s1008" text="However, the mechanism by which HMGA2 promotes the growth of hepatocellular carcinoma (HCC) remains unclear.">
    <entity charOffset="32-37" id="s1008.e0" ontology_id="8091" text="HMGA2" type="GENE"/>
    <entity charOffset="61-85" id="s1008.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1008.e0" e2="s1008.e1" id="s1008.p0" relation="true"/>
  </sentence>
  <sentence id="s1009" text="However, the mechanism by which HMGA2 promotes the growth of hepatocellular carcinoma (HCC) remains unclear.">
    <entity charOffset="61-85" id="s1009.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="87-90" id="s1009.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s1009.e0" e2="s1009.e1" id="s1009.p0" relation="true"/>
  </sentence>
  <sentence id="s1010" text="To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.">
    <entity charOffset="80-85" id="s1010.e0" ontology_id="672" text="BRCA1" type="GENE"/>
    <entity charOffset="208-213" id="s1010.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1010.e0" e2="s1010.e1" id="s1010.p0" relation="true"/>
  </sentence>
  <sentence id="s1011" text="To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.">
    <entity charOffset="86-91" id="s1011.e0" ontology_id="675" text="BRCA2" type="GENE"/>
    <entity charOffset="208-213" id="s1011.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1011.e0" e2="s1011.e1" id="s1011.p0" relation="true"/>
  </sentence>
  <sentence id="s1012" text="To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.">
    <entity charOffset="208-213" id="s1012.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="251-257" id="s1012.e1" ontology_id="5889" text="RAD51C" type="GENE"/>
    <pair e1="s1012.e0" e2="s1012.e1" id="s1012.p0" relation="true"/>
  </sentence>
  <sentence id="s1013" text="To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.">
    <entity charOffset="208-213" id="s1013.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="259-262" id="s1013.e1" ontology_id="472" text="ATM" type="GENE"/>
    <pair e1="s1013.e0" e2="s1013.e1" id="s1013.p0" relation="true"/>
  </sentence>
  <sentence id="s1014" text="To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.">
    <entity charOffset="208-213" id="s1014.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="276-280" id="s1014.e1" ontology_id="4292" text="MLH1" type="GENE"/>
    <pair e1="s1014.e0" e2="s1014.e1" id="s1014.p0" relation="true"/>
  </sentence>
  <sentence id="s1015" text="To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.">
    <entity charOffset="208-213" id="s1015.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="320-324" id="s1015.e1" ontology_id="2099" text="ESR1" type="GENE"/>
    <pair e1="s1015.e0" e2="s1015.e1" id="s1015.p0" relation="true"/>
  </sentence>
  <sentence id="s1016" text="This report describes for the first time a patient with SEPT5 deficiency presenting with cortical dysplasia (polymicrogyria), developmental delay, and platelet secretion defect">
    <entity charOffset="56-61" id="s1016.e0" ontology_id="5413" text="SEPT5" type="GENE"/>
    <entity charOffset="89-107" id="s1016.e1" ontology_id="HP_0002539" text="cortical dysplasia" type="HP"/>
    <pair e1="s1016.e0" e2="s1016.e1" id="s1016.p0" relation="true"/>
  </sentence>
  <sentence id="s1017" text="This report describes for the first time a patient with SEPT5 deficiency presenting with cortical dysplasia (polymicrogyria), developmental delay, and platelet secretion defect">
    <entity charOffset="56-61" id="s1017.e0" ontology_id="5413" text="SEPT5" type="GENE"/>
    <entity charOffset="126-145" id="s1017.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1017.e0" e2="s1017.e1" id="s1017.p0" relation="true"/>
  </sentence>
  <sentence id="s1018" text="E168d2 mice carry a frameshift mutation in the CRX activation domain, Glu168del2, which is associated with severe dominant CoRD or LCA in humans.">
    <entity charOffset="7-11" id="s1018.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="107-113" id="s1018.e1" ontology_id="HP_0012828" text="severe" type="HP"/>
    <pair e1="s1018.e0" e2="s1018.e1" id="s1018.p0" relation="true"/>
  </sentence>
  <sentence id="s1019" text="E168d2 mice carry a frameshift mutation in the CRX activation domain, Glu168del2, which is associated with severe dominant CoRD or LCA in humans.">
    <entity charOffset="47-50" id="s1019.e0" ontology_id="1406" text="CRX" type="GENE"/>
    <entity charOffset="107-113" id="s1019.e1" ontology_id="HP_0012828" text="severe" type="HP"/>
    <pair e1="s1019.e0" e2="s1019.e1" id="s1019.p0" relation="true"/>
  </sentence>
  <sentence id="s1020" text="E168d2 mice carry a frameshift mutation in the CRX activation domain, Glu168del2, which is associated with severe dominant CoRD or LCA in humans.">
    <entity charOffset="107-113" id="s1020.e0" ontology_id="HP_0012828" text="severe" type="HP"/>
    <entity charOffset="131-134" id="s1020.e1" ontology_id="1211" text="LCA" type="GENE"/>
    <pair e1="s1020.e0" e2="s1020.e1" id="s1020.p0" relation="false"/>
  </sentence>
  <sentence id="s1021" text="We also show expression of ARNT2 within the central nervous system, including the hypothalamus, as well as the renal tract during human embryonic development.">
    <entity charOffset="27-32" id="s1021.e0" ontology_id="9915" text="ARNT2" type="GENE"/>
    <entity charOffset="44-51" id="s1021.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s1021.e0" e2="s1021.e1" id="s1021.p0" relation="true"/>
  </sentence>
  <sentence id="s1022" text="The progressive neurological abnormalities, congenital hypopituitarism and post-retinal visual pathway dysfunction in affected individuals demonstrates for the first time the essential role of ARNT2 in the development of the hypothalamo-pituitary axis, post-natal brain growth, and visual and renal function in humans.">
    <entity charOffset="55-70" id="s1022.e0" ontology_id="HP_0040075" text="hypopituitarism" type="HP"/>
    <entity charOffset="193-198" id="s1022.e1" ontology_id="9915" text="ARNT2" type="GENE"/>
    <pair e1="s1022.e0" e2="s1022.e1" id="s1022.p0" relation="true"/>
  </sentence>
  <sentence id="s1023" text="Recently a homozygous mutation, Gly372Ser, in the TIMM50 gene, was reported in an abstract form, in three sibs who suffered from intractable epilepsy and developmental delay accompanied by 3-methylglutaconic aciduria.">
    <entity charOffset="50-56" id="s1023.e0" ontology_id="92609" text="TIMM50" type="GENE"/>
    <entity charOffset="141-149" id="s1023.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1023.e0" e2="s1023.e1" id="s1023.p0" relation="true"/>
  </sentence>
  <sentence id="s1024" text="Recently a homozygous mutation, Gly372Ser, in the TIMM50 gene, was reported in an abstract form, in three sibs who suffered from intractable epilepsy and developmental delay accompanied by 3-methylglutaconic aciduria.">
    <entity charOffset="50-56" id="s1024.e0" ontology_id="92609" text="TIMM50" type="GENE"/>
    <entity charOffset="154-173" id="s1024.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1024.e0" e2="s1024.e1" id="s1024.p0" relation="true"/>
  </sentence>
  <sentence id="s1025" text="Given the phenotypic similarity, we conclude that missense mutations in TIMM50 are likely manifesting by severe intellectual disability and epilepsy accompanied by 3-methylglutaconic aciduria and variable mitochondrial complex V deficiency.">
    <entity charOffset="72-78" id="s1025.e0" ontology_id="92609" text="TIMM50" type="GENE"/>
    <entity charOffset="140-148" id="s1025.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1025.e0" e2="s1025.e1" id="s1025.p0" relation="true"/>
  </sentence>
  <sentence id="s1026" text="Given the phenotypic similarity, we conclude that missense mutations in TIMM50 are likely manifesting by severe intellectual disability and epilepsy accompanied by 3-methylglutaconic aciduria and variable mitochondrial complex V deficiency.">
    <entity charOffset="72-78" id="s1026.e0" ontology_id="92609" text="TIMM50" type="GENE"/>
    <entity charOffset="112-135" id="s1026.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1026.e0" e2="s1026.e1" id="s1026.p0" relation="true"/>
  </sentence>
  <sentence id="s1027" text="Biallelic mutations in the SBF1 gene have been identified in one family with demyelinating Charcot-Marie-Tooth disease (CMT4B3) and two families with axonal neuropathy and additional neurological and skeletal features.">
    <entity charOffset="27-31" id="s1027.e0" ontology_id="6305" text="SBF1" type="GENE"/>
    <entity charOffset="157-167" id="s1027.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1027.e0" e2="s1027.e1" id="s1027.p0" relation="true"/>
  </sentence>
  <sentence id="s1028" text="Here we describe novel sequence variants in SBF1 (c.1168C&amp;gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, hearing loss, facial weakness and bulbar features.">
    <entity charOffset="44-48" id="s1028.e0" ontology_id="6305" text="SBF1" type="GENE"/>
    <entity charOffset="155-165" id="s1028.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1028.e0" e2="s1028.e1" id="s1028.p0" relation="true"/>
  </sentence>
  <sentence id="s1029" text="Here we describe novel sequence variants in SBF1 (c.1168C&amp;gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, hearing loss, facial weakness and bulbar features.">
    <entity charOffset="44-48" id="s1029.e0" ontology_id="6305" text="SBF1" type="GENE"/>
    <entity charOffset="167-179" id="s1029.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1029.e0" e2="s1029.e1" id="s1029.p0" relation="true"/>
  </sentence>
  <sentence id="s1030" text="Our findings suggest that SBF1 mutations may cause a syndromic form of autosomal recessive axonal neuropathy (AR-CMT2) in addition to CMT4B3">
    <entity charOffset="26-30" id="s1030.e0" ontology_id="6305" text="SBF1" type="GENE"/>
    <entity charOffset="98-108" id="s1030.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1030.e0" e2="s1030.e1" id="s1030.p0" relation="false"/>
  </sentence>
  <sentence id="s1031" text="Our findings suggest that SBF1 mutations may cause a syndromic form of autosomal recessive axonal neuropathy (AR-CMT2) in addition to CMT4B3">
    <entity charOffset="26-30" id="s1031.e0" ontology_id="6305" text="SBF1" type="GENE"/>
    <entity charOffset="71-90" id="s1031.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1031.e0" e2="s1031.e1" id="s1031.p0" relation="true"/>
  </sentence>
  <sentence id="s1032" text="Having used a similar strategy for the in silico evaluation of 150 mutations of &lt;i&gt;CYP21A2&lt;/i&gt;, the disease-causing gene in congenital adrenal hyperplasia, we now provide a full structural explanation for the clinical severity of AME resulting from each known &lt;i&gt;HSD11B2&lt;/i&gt; missense mutation.">
    <entity charOffset="135-154" id="s1032.e0" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <entity charOffset="263-270" id="s1032.e1" ontology_id="3291" text="HSD11B2" type="GENE"/>
    <pair e1="s1032.e0" e2="s1032.e1" id="s1032.p0" relation="true"/>
  </sentence>
  <sentence id="s1033" text="Metaplastic breast carcinoma is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (EMT).">
    <entity charOffset="12-28" id="s1033.e0" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <entity charOffset="145-148" id="s1033.e1" ontology_id="3702" text="EMT" type="GENE"/>
    <pair e1="s1033.e0" e2="s1033.e1" id="s1033.p0" relation="true"/>
  </sentence>
  <sentence id="s1034" text="Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma.">
    <entity charOffset="18-22" id="s1034.e0" ontology_id="8838" text="CCN6" type="GENE"/>
    <entity charOffset="186-202" id="s1034.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1034.e0" e2="s1034.e1" id="s1034.p0" relation="true"/>
  </sentence>
  <sentence id="s1035" text="Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma.">
    <entity charOffset="24-29" id="s1035.e0" ontology_id="8838" text="WISP3" type="GENE"/>
    <entity charOffset="186-202" id="s1035.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1035.e0" e2="s1035.e1" id="s1035.p0" relation="true"/>
  </sentence>
  <sentence id="s1036" text="Ccn6&lt;sup&gt;fl/fl&lt;/sup&gt;;MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide EMT, histologically similar to human metaplastic breast carcinomas.">
    <entity charOffset="0-4" id="s1036.e0" ontology_id="8838" text="Ccn6" type="GENE"/>
    <entity charOffset="148-164" id="s1036.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1036.e0" e2="s1036.e1" id="s1036.p0" relation="true"/>
  </sentence>
  <sentence id="s1037" text="High expression of Chemokine receptor 4 (CXCR4) is important in tumor invasion, metastasis, drug-resistance and maintenance of stemness in non-small cell lung cancer (NSCLC).">
    <entity charOffset="41-46" id="s1037.e0" ontology_id="7852" text="CXCR4" type="GENE"/>
    <entity charOffset="64-69" id="s1037.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1037.e0" e2="s1037.e1" id="s1037.p0" relation="true"/>
  </sentence>
  <sentence id="s1038" text="We therefore studied the molecular characteristics of drug-resistant CXCR4-positive cells on epithelial-mesenchymal transition (EMT) for the future identification of the tumor cells with the properties of both EMT and stemness.">
    <entity charOffset="69-74" id="s1038.e0" ontology_id="7852" text="CXCR4" type="GENE"/>
    <entity charOffset="170-175" id="s1038.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1038.e0" e2="s1038.e1" id="s1038.p0" relation="true"/>
  </sentence>
  <sentence id="s1039" text="Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disorder resulting from reduced expression of the protein frataxin (FXN).">
    <entity charOffset="13-19" id="s1039.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="21-25" id="s1039.e1" ontology_id="2395" text="FRDA" type="GENE"/>
    <pair e1="s1039.e0" e2="s1039.e1" id="s1039.p0" relation="true"/>
  </sentence>
  <sentence id="s1040" text="Here, we demonstrate that transgenic targeting of OGG1 to mitochondria confers significant protection from diet-induced obesity, insulin resistance, and adipose tissue inflammation.">
    <entity charOffset="50-54" id="s1040.e0" ontology_id="4968" text="OGG1" type="GENE"/>
    <entity charOffset="120-127" id="s1040.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1040.e0" e2="s1040.e1" id="s1040.p0" relation="true"/>
  </sentence>
  <sentence id="s1041" text="TRAPPC9 gene mutations have been linked recently to autosomal recessive mental retardation 13 (MRT13; MIM#613192) with only eight families reported world-wide.">
    <entity charOffset="0-7" id="s1041.e0" ontology_id="83696" text="TRAPPC9" type="GENE"/>
    <entity charOffset="52-71" id="s1041.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1041.e0" e2="s1041.e1" id="s1041.p0" relation="true"/>
  </sentence>
  <sentence id="s1042" text="Mutations in TRAPPC9 should be considered in non-syndromic autosomal recessive intellectual disability with severe speech disorder">
    <entity charOffset="13-20" id="s1042.e0" ontology_id="83696" text="TRAPPC9" type="GENE"/>
    <entity charOffset="59-78" id="s1042.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1042.e0" e2="s1042.e1" id="s1042.p0" relation="true"/>
  </sentence>
  <sentence id="s1043" text="Mutations in TRAPPC9 should be considered in non-syndromic autosomal recessive intellectual disability with severe speech disorder">
    <entity charOffset="13-20" id="s1043.e0" ontology_id="83696" text="TRAPPC9" type="GENE"/>
    <entity charOffset="79-102" id="s1043.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1043.e0" e2="s1043.e1" id="s1043.p0" relation="true"/>
  </sentence>
  <sentence id="s1044" text="Rare forms of autosomal-dominant Charcot-Marie-Tooth disease (AD-CMT) may be associated with mutations in Fibulin-5 (FBLN5) as AD-CMT is genetically heterogeneous.">
    <entity charOffset="117-122" id="s1044.e0" ontology_id="10516" text="FBLN5" type="GENE"/>
    <entity charOffset="149-162" id="s1044.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1044.e0" e2="s1044.e1" id="s1044.p0" relation="true"/>
  </sentence>
  <sentence id="s1045" text="The incidence of thyroid cancer has increased the past few decades, the most frequent type has been identified to be the papillary thyroid carcinoma (PTC).">
    <entity charOffset="25-31" id="s1045.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="86-90" id="s1045.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s1045.e0" e2="s1045.e1" id="s1045.p0" relation="true"/>
  </sentence>
  <sentence id="s1046" text="The incidence of thyroid cancer has increased the past few decades, the most frequent type has been identified to be the papillary thyroid carcinoma (PTC).">
    <entity charOffset="25-31" id="s1046.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="150-153" id="s1046.e1" ontology_id="8030" text="PTC" type="GENE"/>
    <pair e1="s1046.e0" e2="s1046.e1" id="s1046.p0" relation="true"/>
  </sentence>
  <sentence id="s1047" text="The incidence of thyroid cancer has increased the past few decades, the most frequent type has been identified to be the papillary thyroid carcinoma (PTC).">
    <entity charOffset="86-90" id="s1047.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="121-148" id="s1047.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s1047.e0" e2="s1047.e1" id="s1047.p0" relation="true"/>
  </sentence>
  <sentence id="s1048" text="Overexpression of LARP7 inhibited the proliferation and increased the radioiodine uptake ability of PTC cells invitro and inhibited the tumor growth invivo.">
    <entity charOffset="18-22" id="s1048.e0" ontology_id="23367" text="LARP" type="GENE"/>
    <entity charOffset="137-142" id="s1048.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1048.e0" e2="s1048.e1" id="s1048.p0" relation="true"/>
  </sentence>
  <sentence id="s1049" text="Overexpression of LARP7 inhibited the proliferation and increased the radioiodine uptake ability of PTC cells invitro and inhibited the tumor growth invivo.">
    <entity charOffset="100-103" id="s1049.e0" ontology_id="8030" text="PTC" type="GENE"/>
    <entity charOffset="137-142" id="s1049.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1049.e0" e2="s1049.e1" id="s1049.p0" relation="true"/>
  </sentence>
  <sentence id="s1050" text="In conclusion, LARP7 may act as a tumor suppressor in PTC by inhibiting the SHH signaling pathway and may be a promising therapeutic target in patients with PTC">
    <entity charOffset="15-19" id="s1050.e0" ontology_id="23367" text="LARP" type="GENE"/>
    <entity charOffset="34-39" id="s1050.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1050.e0" e2="s1050.e1" id="s1050.p0" relation="true"/>
  </sentence>
  <sentence id="s1051" text="In conclusion, LARP7 may act as a tumor suppressor in PTC by inhibiting the SHH signaling pathway and may be a promising therapeutic target in patients with PTC">
    <entity charOffset="34-39" id="s1051.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="54-57" id="s1051.e1" ontology_id="8030" text="PTC" type="GENE"/>
    <pair e1="s1051.e0" e2="s1051.e1" id="s1051.p0" relation="true"/>
  </sentence>
  <sentence id="s1052" text="In conclusion, LARP7 may act as a tumor suppressor in PTC by inhibiting the SHH signaling pathway and may be a promising therapeutic target in patients with PTC">
    <entity charOffset="34-39" id="s1052.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="76-79" id="s1052.e1" ontology_id="6469" text="SHH" type="GENE"/>
    <pair e1="s1052.e0" e2="s1052.e1" id="s1052.p0" relation="true"/>
  </sentence>
  <sentence id="s1053" text="The tumor cells with immunoreactivity to CK7, CK19, Cam5.2, COX2, EMA, BCL-2, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.">
    <entity charOffset="4-9" id="s1053.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="60-64" id="s1053.e1" ontology_id="140909" text="COX2" type="GENE"/>
    <pair e1="s1053.e0" e2="s1053.e1" id="s1053.p0" relation="true"/>
  </sentence>
  <sentence id="s1054" text="The tumor cells with immunoreactivity to CK7, CK19, Cam5.2, COX2, EMA, BCL-2, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.">
    <entity charOffset="4-9" id="s1054.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="66-69" id="s1054.e1" ontology_id="2108" text="EMA" type="GENE"/>
    <pair e1="s1054.e0" e2="s1054.e1" id="s1054.p0" relation="true"/>
  </sentence>
  <sentence id="s1055" text="Sheldon-Hall syndrome (SHS) is the most common of the distal arthrogryposes (DAs), a group of disorders characterized by congenital non-progressive contractures.">
    <entity charOffset="23-26" id="s1055.e0" ontology_id="10084" text="SHS" type="GENE"/>
    <entity charOffset="148-160" id="s1055.e1" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <pair e1="s1055.e0" e2="s1055.e1" id="s1055.p0" relation="true"/>
  </sentence>
  <sentence id="s1056" text="Sheldon-Hall syndrome (SHS) is the most common of the distal arthrogryposes (DAs), a group of disorders characterized by congenital non-progressive contractures.">
    <entity charOffset="23-26" id="s1056.e0" ontology_id="10084" text="SHS" type="GENE"/>
    <entity charOffset="54-60" id="s1056.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s1056.e0" e2="s1056.e1" id="s1056.p0" relation="true"/>
  </sentence>
  <sentence id="s1057" text="Patients with SHS present with contractures of the limbs and a distinctive triangular facies with prominent nasolabial folds.">
    <entity charOffset="14-17" id="s1057.e0" ontology_id="10084" text="SHS" type="GENE"/>
    <entity charOffset="31-43" id="s1057.e1" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <pair e1="s1057.e0" e2="s1057.e1" id="s1057.p0" relation="true"/>
  </sentence>
  <sentence id="s1058" text="MYH3 plays a pivotal role in fetal muscle development and mutations in this gene are associated with Freeman-Sheldon syndrome, distal arthrogryposis 8 (DA8), and autosomal dominant spondylocarpotarsal synostosis.">
    <entity charOffset="0-4" id="s1058.e0" ontology_id="4621" text="MYH3" type="GENE"/>
    <entity charOffset="127-133" id="s1058.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s1058.e0" e2="s1058.e1" id="s1058.p0" relation="true"/>
  </sentence>
  <sentence id="s1059" text="MYH3 plays a pivotal role in fetal muscle development and mutations in this gene are associated with Freeman-Sheldon syndrome, distal arthrogryposis 8 (DA8), and autosomal dominant spondylocarpotarsal synostosis.">
    <entity charOffset="0-4" id="s1059.e0" ontology_id="4621" text="MYH3" type="GENE"/>
    <entity charOffset="134-148" id="s1059.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s1059.e0" e2="s1059.e1" id="s1059.p0" relation="true"/>
  </sentence>
  <sentence id="s1060" text="We report the case of a boy with a novel pathogenic MYH3 mutation, presenting with the classical clinical features of SHS in association with unilateral carpal bone fusion and multiple vertebral fusions.">
    <entity charOffset="52-56" id="s1060.e0" ontology_id="4621" text="MYH3" type="GENE"/>
    <entity charOffset="185-202" id="s1060.e1" ontology_id="HP_0002948" text="vertebral fusions" type="HP"/>
    <pair e1="s1060.e0" e2="s1060.e1" id="s1060.p0" relation="true"/>
  </sentence>
  <sentence id="s1061" text="In a bone metastasis model, mice treated with ZOL+US had osteolytic lesions that were 58% smaller than those of ZOL-treated animals as well as a reduced skeletal tumor burden.">
    <entity charOffset="28-32" id="s1061.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="162-167" id="s1061.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1061.e0" e2="s1061.e1" id="s1061.p0" relation="true"/>
  </sentence>
  <sentence id="s1062" text="Additionally, US forced the penetration of ZOL within tumors, as demonstrated by the intratumoral accumulation of unprenylated Rap1A, a surrogate marker of ZOL antitumor activity.">
    <entity charOffset="54-59" id="s1062.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="127-132" id="s1062.e1" ontology_id="5906" text="Rap1A" type="GENE"/>
    <pair e1="s1062.e0" e2="s1062.e1" id="s1062.p0" relation="true"/>
  </sentence>
  <sentence id="s1063" text="Among these, heterozygous mutations in NOBOX, a homeobox gene encoding a transcription factor expressed specifically by oocyte and granulosa cells within the ovary, have been reported in 6% of women with sporadic POI.">
    <entity charOffset="39-44" id="s1063.e0" ontology_id="135935" text="NOBOX" type="GENE"/>
    <entity charOffset="205-213" id="s1063.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1063.e0" e2="s1063.e1" id="s1063.p0" relation="true"/>
  </sentence>
  <sentence id="s1064" text="Mutations in CASK cause a wide spectrum of phenotypes in humans ranging from mild X-linked intellectual disability to a severe microcephaly (MC) and pontocerebellar hypoplasia syndrome.">
    <entity charOffset="13-17" id="s1064.e0" ontology_id="8573" text="CASK" type="GENE"/>
    <entity charOffset="127-139" id="s1064.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1064.e0" e2="s1064.e1" id="s1064.p0" relation="true"/>
  </sentence>
  <sentence id="s1065" text="We identified integrin 7 (ITGA7) as a major laminin receptor in GSCs and in primary high-grade glioma specimens.">
    <entity charOffset="27-32" id="s1065.e0" ontology_id="3679" text="ITGA7" type="GENE"/>
    <entity charOffset="96-102" id="s1065.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1065.e0" e2="s1065.e1" id="s1065.p0" relation="true"/>
  </sentence>
  <sentence id="s1066" text="Analyses of mRNA profiles in comprehensive datasets revealed that high ITGA7 expression negatively correlated with survival of patients with both low- and high-grade glioma.">
    <entity charOffset="71-76" id="s1066.e0" ontology_id="3679" text="ITGA7" type="GENE"/>
    <entity charOffset="166-172" id="s1066.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1066.e0" e2="s1066.e1" id="s1066.p0" relation="true"/>
  </sentence>
  <sentence id="s1067" text="We also found that targeting of ITGA7 by RNAi or blocking mAbs impaired laminin-induced signaling, and it led to a significant delay in tumor engraftment plus a strong reduction in tumor size and invasion.">
    <entity charOffset="32-37" id="s1067.e0" ontology_id="3679" text="ITGA7" type="GENE"/>
    <entity charOffset="136-141" id="s1067.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1067.e0" e2="s1067.e1" id="s1067.p0" relation="true"/>
  </sentence>
  <sentence id="s1068" text="Our data, therefore, highlight ITGA7 as a glioblastoma biomarker and candidate therapeutic target">
    <entity charOffset="31-36" id="s1068.e0" ontology_id="3679" text="ITGA7" type="GENE"/>
    <entity charOffset="42-54" id="s1068.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s1068.e0" e2="s1068.e1" id="s1068.p0" relation="true"/>
  </sentence>
  <sentence id="s1069" text="The presynaptic cytomatrix protein Piccolo, encoded by PCLO, is frequently mutated and amplified in esophageal squamous cell carcinoma (ESCC), but its exact roles in ESCC remain unclear.">
    <entity charOffset="55-59" id="s1069.e0" ontology_id="27445" text="PCLO" type="GENE"/>
    <entity charOffset="111-134" id="s1069.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s1069.e0" e2="s1069.e1" id="s1069.p0" relation="true"/>
  </sentence>
  <sentence id="s1070" text="These results demonstrate that Piccolo contributes to tumor aggressiveness in ESCC, likely by stabilizing EGFR and promoting EGFR-dependent signaling.">
    <entity charOffset="54-59" id="s1070.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="106-110" id="s1070.e1" ontology_id="1956" text="EGFR" type="GENE"/>
    <pair e1="s1070.e0" e2="s1070.e1" id="s1070.p0" relation="true"/>
  </sentence>
  <sentence id="s1071" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s1071.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="272-276" id="s1071.e1" ontology_id="6647" text="SOD1" type="GENE"/>
    <pair e1="s1071.e0" e2="s1071.e1" id="s1071.p0" relation="true"/>
  </sentence>
  <sentence id="s1072" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s1072.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="152-156" id="s1072.e1" ontology_id="10849" text="CAST" type="GENE"/>
    <pair e1="s1072.e0" e2="s1072.e1" id="s1072.p0" relation="true"/>
  </sentence>
  <sentence id="s1073" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s1073.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="158-164" id="s1073.e1" ontology_id="1285" text="COL4A3" type="GENE"/>
    <pair e1="s1073.e0" e2="s1073.e1" id="s1073.p0" relation="true"/>
  </sentence>
  <sentence id="s1074" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s1074.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="182-187" id="s1074.e1" ontology_id="2308" text="FOXO1" type="GENE"/>
    <pair e1="s1074.e0" e2="s1074.e1" id="s1074.p0" relation="true"/>
  </sentence>
  <sentence id="s1075" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s1075.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="189-195" id="s1075.e1" ontology_id="64778" text="FNDC3B" type="GENE"/>
    <pair e1="s1075.e0" e2="s1075.e1" id="s1075.p0" relation="true"/>
  </sentence>
  <sentence id="s1076" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s1076.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="220-226" id="s1076.e1" ontology_id="83943" text="IMMP2L" type="GENE"/>
    <pair e1="s1076.e0" e2="s1076.e1" id="s1076.p0" relation="true"/>
  </sentence>
  <sentence id="s1077" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s1077.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="228-232" id="s1077.e1" ontology_id="84708" text="MPDZ" type="GENE"/>
    <pair e1="s1077.e0" e2="s1077.e1" id="s1077.p0" relation="true"/>
  </sentence>
  <sentence id="s1078" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s1078.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="234-238" id="s1078.e1" ontology_id="4781" text="NFIB" type="GENE"/>
    <pair e1="s1078.e0" e2="s1078.e1" id="s1078.p0" relation="true"/>
  </sentence>
  <sentence id="s1079" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s1079.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="250-255" id="s1079.e1" ontology_id="5888" text="RAD51" type="GENE"/>
    <pair e1="s1079.e0" e2="s1079.e1" id="s1079.p0" relation="true"/>
  </sentence>
  <sentence id="s1080" text="In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="44-48" id="s1080.e0" ontology_id="11011" text="TLK2" type="GENE"/>
    <entity charOffset="111-117" id="s1080.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1080.e0" e2="s1080.e1" id="s1080.p0" relation="true"/>
  </sentence>
  <sentence id="s1081" text="In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="54-60" id="s1081.e0" ontology_id="79677" text="SMC6L1" type="GENE"/>
    <entity charOffset="111-117" id="s1081.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1081.e0" e2="s1081.e1" id="s1081.p0" relation="false"/>
  </sentence>
  <sentence id="s1082" text="In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="111-117" id="s1082.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="124-128" id="s1082.e1" ontology_id="990" text="CDC6" type="GENE"/>
    <pair e1="s1082.e0" e2="s1082.e1" id="s1082.p0" relation="true"/>
  </sentence>
  <sentence id="s1083" text="In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="111-117" id="s1083.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="130-135" id="s1083.e1" ontology_id="996" text="CDC27" type="GENE"/>
    <pair e1="s1083.e0" e2="s1083.e1" id="s1083.p0" relation="true"/>
  </sentence>
  <sentence id="s1084" text="In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="111-117" id="s1084.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="137-142" id="s1084.e1" ontology_id="6612" text="SUMO3" type="GENE"/>
    <pair e1="s1084.e0" e2="s1084.e1" id="s1084.p0" relation="true"/>
  </sentence>
  <sentence id="s1085" text="In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="111-117" id="s1085.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="144-150" id="s1085.e1" ontology_id="11186" text="RASSF1" type="GENE"/>
    <pair e1="s1085.e0" e2="s1085.e1" id="s1085.p0" relation="true"/>
  </sentence>
  <sentence id="s1086" text="In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="111-117" id="s1086.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="152-156" id="s1086.e1" ontology_id="3796" text="KIF2" type="GENE"/>
    <pair e1="s1086.e0" e2="s1086.e1" id="s1086.p0" relation="true"/>
  </sentence>
  <sentence id="s1087" text="In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="111-117" id="s1087.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="162-168" id="s1087.e1" ontology_id="8556" text="CDC14A" type="GENE"/>
    <pair e1="s1087.e0" e2="s1087.e1" id="s1087.p0" relation="true"/>
  </sentence>
  <sentence id="s1088" text="In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="111-117" id="s1088.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="225-232" id="s1088.e1" ontology_id="3692" text="EIF3S10" type="GENE"/>
    <pair e1="s1088.e0" e2="s1088.e1" id="s1088.p0" relation="true"/>
  </sentence>
  <sentence id="s1089" text="In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="111-117" id="s1089.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="237-243" id="s1089.e1" ontology_id="993" text="CDC25A" type="GENE"/>
    <pair e1="s1089.e0" e2="s1089.e1" id="s1089.p0" relation="true"/>
  </sentence>
  <sentence id="s1090" text="The severe generalized lipodystrophy in this patient with progeroid features has not previously been described in other patients with MFS and FBN1 mutations.">
    <entity charOffset="11-36" id="s1090.e0" ontology_id="HP_0009064" text="generalized lipodystrophy" type="HP"/>
    <entity charOffset="142-146" id="s1090.e1" ontology_id="2200" text="FBN1" type="GENE"/>
    <pair e1="s1090.e0" e2="s1090.e1" id="s1090.p0" relation="true"/>
  </sentence>
  <sentence id="s1091" text="Also as pro-angiogenic inducer, the role of HMGB1 in different redox states has never been defined in tumour angiogenesis.">
    <entity charOffset="44-49" id="s1091.e0" ontology_id="3146" text="HMGB1" type="GENE"/>
    <entity charOffset="102-108" id="s1091.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1091.e0" e2="s1091.e1" id="s1091.p0" relation="true"/>
  </sentence>
  <sentence id="s1092" text="HMGB1 orchestrates the key events of tumour angiogenesis, migration of ECs and their induction to secrete VEGF-A, by adopting distinct redox states.">
    <entity charOffset="0-5" id="s1092.e0" ontology_id="3146" text="HMGB1" type="GENE"/>
    <entity charOffset="37-43" id="s1092.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1092.e0" e2="s1092.e1" id="s1092.p0" relation="true"/>
  </sentence>
  <sentence id="s1093" text="HMGB1 orchestrates the key events of tumour angiogenesis, migration of ECs and their induction to secrete VEGF-A, by adopting distinct redox states.">
    <entity charOffset="37-43" id="s1093.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="106-112" id="s1093.e1" ontology_id="7422" text="VEGF-A" type="GENE"/>
    <pair e1="s1093.e0" e2="s1093.e1" id="s1093.p0" relation="true"/>
  </sentence>
  <sentence id="s1094" text="Together, our findings suggest that in CRC TIAM1 suppresses tumor progression by regulating YAP/TAZ activity">
    <entity charOffset="60-65" id="s1094.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="96-99" id="s1094.e1" ontology_id="25937" text="TAZ" type="GENE"/>
    <pair e1="s1094.e0" e2="s1094.e1" id="s1094.p0" relation="true"/>
  </sentence>
  <sentence id="s1095" text="Together, our findings suggest that in CRC TIAM1 suppresses tumor progression by regulating YAP/TAZ activity">
    <entity charOffset="60-65" id="s1095.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="92-95" id="s1095.e1" ontology_id="55249" text="YAP" type="GENE"/>
    <pair e1="s1095.e0" e2="s1095.e1" id="s1095.p0" relation="true"/>
  </sentence>
  <sentence id="s1096" text="A case with GAMT deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.">
    <entity charOffset="12-16" id="s1096.e0" ontology_id="2593" text="GAMT" type="GENE"/>
    <entity charOffset="74-98" id="s1096.e1" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <pair e1="s1096.e0" e2="s1096.e1" id="s1096.p0" relation="true"/>
  </sentence>
  <sentence id="s1097" text="A case with GAMT deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.">
    <entity charOffset="12-16" id="s1097.e0" ontology_id="2593" text="GAMT" type="GENE"/>
    <entity charOffset="115-138" id="s1097.e1" ontology_id="HP_0000708" text="behavioral disturbances" type="HP"/>
    <pair e1="s1097.e0" e2="s1097.e1" id="s1097.p0" relation="true"/>
  </sentence>
  <sentence id="s1098" text="The accuracy of this mouse model was emphasized by the finding that various central nervous system and noncentral nervous system tissues from PD patients manifested similar GM1 deficiency as the B4galnt1&lt;sup&gt;+/-&lt;/sup&gt; mouse.">
    <entity charOffset="76-83" id="s1098.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="195-203" id="s1098.e1" ontology_id="2583" text="B4galnt1" type="GENE"/>
    <pair e1="s1098.e0" e2="s1098.e1" id="s1098.p0" relation="true"/>
  </sentence>
  <sentence id="s1099" text="By 3 months, zonular fibers invariably ruptured and mice developed ectopia lentis, a hallmark of Marfan syndrome.">
    <entity charOffset="52-56" id="s1099.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="67-81" id="s1099.e1" ontology_id="HP_0001083" text="ectopia lentis" type="HP"/>
    <pair e1="s1099.e0" e2="s1099.e1" id="s1099.p0" relation="false"/>
  </sentence>
  <sentence id="s1100" text="Downregulation of -actinin-1 in E-cadherin expressing basal-like breast cancer cells demonstrate that -actinin-1-assembled actin fibers destabilize E-cadherin-based adhesions.">
    <entity charOffset="35-43" id="s1100.e0" ontology_id="1015" text="cadherin" type="GENE"/>
    <entity charOffset="73-79" id="s1100.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1100.e0" e2="s1100.e1" id="s1100.p0" relation="true"/>
  </sentence>
  <sentence id="s1101" text="Taken together, these results indicate that increased -actinin-1 expression destabilizes E-cadherin-based adhesions, which is likely to promote the migratory potential of breast cancer cells.">
    <entity charOffset="92-100" id="s1101.e0" ontology_id="1015" text="cadherin" type="GENE"/>
    <entity charOffset="179-185" id="s1101.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1101.e0" e2="s1101.e1" id="s1101.p0" relation="true"/>
  </sentence>
  <sentence id="s1102" text="Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans.">
    <entity charOffset="14-18" id="s1102.e0" ontology_id="51744" text="nail" type="GENE"/>
    <entity charOffset="19-39" id="s1102.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s1102.e0" e2="s1102.e1" id="s1102.p0" relation="true"/>
  </sentence>
  <sentence id="s1103" text="Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans.">
    <entity charOffset="19-39" id="s1103.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="115-121" id="s1103.e1" ontology_id="3229" text="HOXC13" type="GENE"/>
    <pair e1="s1103.e0" e2="s1103.e1" id="s1103.p0" relation="true"/>
  </sentence>
  <sentence id="s1104" text="Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans.">
    <entity charOffset="57-76" id="s1104.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="115-121" id="s1104.e1" ontology_id="3229" text="HOXC13" type="GENE"/>
    <pair e1="s1104.e0" e2="s1104.e1" id="s1104.p0" relation="true"/>
  </sentence>
  <sentence id="s1105" text="Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans.">
    <entity charOffset="115-121" id="s1105.e0" ontology_id="3229" text="HOXC13" type="GENE"/>
    <entity charOffset="146-159" id="s1105.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s1105.e0" e2="s1105.e1" id="s1105.p0" relation="true"/>
  </sentence>
  <sentence id="s1106" text="Unlike patients with ECTD-9, Hoxc13-mutated mice and pigs do not faithfully recapitulate the phenotype of hypotrichosis, so there is a limited understanding of the molecular mechanism of Hoxc13-mediated hypotrichosis in animal models and clinically.">
    <entity charOffset="29-35" id="s1106.e0" ontology_id="3229" text="Hoxc13" type="GENE"/>
    <entity charOffset="106-119" id="s1106.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s1106.e0" e2="s1106.e1" id="s1106.p0" relation="true"/>
  </sentence>
  <sentence id="s1107" text="Therefore, our findings demonstrate that Hoxc13&lt;sup&gt;-/-&lt;/sup&gt; rabbits can be used as a model for human ECTD-9, especially to understand the pathologic mechanism of hypotrichosis.">
    <entity charOffset="41-47" id="s1107.e0" ontology_id="3229" text="Hoxc13" type="GENE"/>
    <entity charOffset="164-177" id="s1107.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s1107.e0" e2="s1107.e1" id="s1107.p0" relation="true"/>
  </sentence>
  <sentence id="s1108" text="Moreover, the disrupted balance between HFs and SGs, especially in the Hoxc13&lt;sup&gt;-/-&lt;/sup&gt; rabbits, can be used as an ideal animal model for dermatology ailments, such as acne and hypotrichosis, in preclinical studies.-Deng, J., Chen, M., Liu, Z., Song, Y., Sui, T., Lai, L., Li, Z.">
    <entity charOffset="48-51" id="s1108.e0" ontology_id="2200" text="SGs" type="GENE"/>
    <entity charOffset="181-194" id="s1108.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s1108.e0" e2="s1108.e1" id="s1108.p0" relation="true"/>
  </sentence>
  <sentence id="s1109" text="Moreover, the disrupted balance between HFs and SGs, especially in the Hoxc13&lt;sup&gt;-/-&lt;/sup&gt; rabbits, can be used as an ideal animal model for dermatology ailments, such as acne and hypotrichosis, in preclinical studies.-Deng, J., Chen, M., Liu, Z., Song, Y., Sui, T., Lai, L., Li, Z.">
    <entity charOffset="71-77" id="s1109.e0" ontology_id="3229" text="Hoxc13" type="GENE"/>
    <entity charOffset="181-194" id="s1109.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s1109.e0" e2="s1109.e1" id="s1109.p0" relation="true"/>
  </sentence>
  <sentence id="s1110" text="Context Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.">
    <entity charOffset="27-36" id="s1110.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="45-49" id="s1110.e1" ontology_id="4221" text="MEN1" type="GENE"/>
    <pair e1="s1110.e0" e2="s1110.e1" id="s1110.p0" relation="true"/>
  </sentence>
  <sentence id="s1111" text="Context Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.">
    <entity charOffset="37-41" id="s1111.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="111-116" id="s1111.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1111.e0" e2="s1111.e1" id="s1111.p0" relation="false"/>
  </sentence>
  <sentence id="s1112" text="When her brother was found to harbor the same MEN1 mutation as our proband and, around the same time, their father was diagnosed with a neuroendocrine carcinoma, this tumor was investigated for the MEN1 mutation as well.">
    <entity charOffset="46-50" id="s1112.e0" ontology_id="4221" text="MEN1" type="GENE"/>
    <entity charOffset="167-172" id="s1112.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1112.e0" e2="s1112.e1" id="s1112.p0" relation="true"/>
  </sentence>
  <sentence id="s1113" text="In the histologic biopsy of this tumor, the same MEN1 mutation was detected as previously found in his children.">
    <entity charOffset="33-38" id="s1113.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="49-53" id="s1113.e1" ontology_id="4221" text="MEN1" type="GENE"/>
    <pair e1="s1113.e0" e2="s1113.e1" id="s1113.p0" relation="true"/>
  </sentence>
  <sentence id="s1114" text="Based on the array data, we concluded that the deletion was limited to the MEN1 gene and that the father had both germline and somatic mosaicism for MEN1.">
    <entity charOffset="75-79" id="s1114.e0" ontology_id="4221" text="MEN1" type="GENE"/>
    <entity charOffset="127-144" id="s1114.e1" ontology_id="HP_0001442" text="somatic mosaicism" type="HP"/>
    <pair e1="s1114.e0" e2="s1114.e1" id="s1114.p0" relation="true"/>
  </sentence>
  <sentence id="s1115" text="Conclusions To our knowledge, this is the first reported family with combined germline and somatic mosaicism for MEN1.">
    <entity charOffset="91-108" id="s1115.e0" ontology_id="HP_0001442" text="somatic mosaicism" type="HP"/>
    <entity charOffset="113-117" id="s1115.e1" ontology_id="4221" text="MEN1" type="GENE"/>
    <pair e1="s1115.e0" e2="s1115.e1" id="s1115.p0" relation="true"/>
  </sentence>
  <sentence id="s1116" text="Genetic sequencing confirmed a homozygous R565Q missense mutation in the catalytic domain of PDE6C, a cone-specific phototransduction enzyme associated with achromatopsia in humans.">
    <entity charOffset="93-98" id="s1116.e0" ontology_id="5146" text="PDE6C" type="GENE"/>
    <entity charOffset="157-170" id="s1116.e1" ontology_id="HP_0011516" text="achromatopsia" type="HP"/>
    <pair e1="s1116.e0" e2="s1116.e1" id="s1116.p0" relation="true"/>
  </sentence>
  <sentence id="s1117" text="Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of increased bone density, we identified mutations in TBXAS1, which encodes thromboxane synthase (TXAS).">
    <entity charOffset="103-125" id="s1117.e0" ontology_id="HP_0011001" text="increased bone density" type="HP"/>
    <entity charOffset="154-160" id="s1117.e1" ontology_id="6916" text="TBXAS1" type="GENE"/>
    <pair e1="s1117.e0" e2="s1117.e1" id="s1117.p0" relation="true"/>
  </sentence>
  <sentence id="s1118" text="Three affected individuals from a small Bedouin clan presented with failure to thrive, hyponatremic dehydration and hyperkalemia with isolated sweat salt wasting.">
    <entity charOffset="48-52" id="s1118.e0" ontology_id="58484" text="clan" type="GENE"/>
    <entity charOffset="68-85" id="s1118.e1" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <pair e1="s1118.e0" e2="s1118.e1" id="s1118.p0" relation="false"/>
  </sentence>
  <sentence id="s1119" text="Various genes (eg, SPG7, SYNE1, PNPLA6) traditionally rooted in either the ataxia or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.">
    <entity charOffset="32-38" id="s1119.e0" ontology_id="10908" text="PNPLA6" type="GENE"/>
    <entity charOffset="75-81" id="s1119.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1119.e0" e2="s1119.e1" id="s1119.p0" relation="true"/>
  </sentence>
  <sentence id="s1120" text="Other genes such as GBA2 and KIF1C were almost simultaneously published as both a hereditary spastic paraplegia and an ataxia gene.">
    <entity charOffset="20-24" id="s1120.e0" ontology_id="57704" text="GBA2" type="GENE"/>
    <entity charOffset="119-125" id="s1120.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1120.e0" e2="s1120.e1" id="s1120.p0" relation="true"/>
  </sentence>
  <sentence id="s1121" text="Other genes such as GBA2 and KIF1C were almost simultaneously published as both a hereditary spastic paraplegia and an ataxia gene.">
    <entity charOffset="29-34" id="s1121.e0" ontology_id="10749" text="KIF1C" type="GENE"/>
    <entity charOffset="119-125" id="s1121.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1121.e0" e2="s1121.e1" id="s1121.p0" relation="true"/>
  </sentence>
  <sentence id="s1122" text="We found that NOTCH1 regulates TP53 expression from NOTCH1 knockdown oral cancer cells.">
    <entity charOffset="14-20" id="s1122.e0" ontology_id="4851" text="NOTCH1" type="GENE"/>
    <entity charOffset="74-80" id="s1122.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1122.e0" e2="s1122.e1" id="s1122.p0" relation="true"/>
  </sentence>
  <sentence id="s1123" text="Gainoffunction CTTNB1 mutations are detected in bladder cancer, colorectal cancer, gastric cancer, liver cancer, lung cancer, pancreatic cancer, prostate cancer and uterine cancer, whereas lossoffunction CTNNB1 mutations are also detected in human cancer.">
    <entity charOffset="58-64" id="s1123.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="208-214" id="s1123.e1" ontology_id="1499" text="CTNNB1" type="GENE"/>
    <pair e1="s1123.e0" e2="s1123.e1" id="s1123.p0" relation="true"/>
  </sentence>
  <sentence id="s1124" text="Eradicating H.pylori and HCV is the optimal approach for the firstline prevention of gastric cancer and hepatocellular carcinoma (HCC), respectively.">
    <entity charOffset="95-101" id="s1124.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="132-135" id="s1124.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s1124.e0" e2="s1124.e1" id="s1124.p0" relation="true"/>
  </sentence>
  <sentence id="s1125" text="Eradicating H.pylori and HCV is the optimal approach for the firstline prevention of gastric cancer and hepatocellular carcinoma (HCC), respectively.">
    <entity charOffset="106-130" id="s1125.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="132-135" id="s1125.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s1125.e0" e2="s1125.e1" id="s1125.p0" relation="false"/>
  </sentence>
  <sentence id="s1126" text="RFT1-congenital disorder of glycosylation (CDG) syndrome, a recessive N-glycosylation disorder caused by mutation in the RFT1 gene, is a very rare subtype of CDG syndrome associated with deafness, developmental delay, and non-specific epilepsy.">
    <entity charOffset="0-4" id="s1126.e0" ontology_id="91869" text="RFT1" type="GENE"/>
    <entity charOffset="187-195" id="s1126.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1126.e0" e2="s1126.e1" id="s1126.p0" relation="true"/>
  </sentence>
  <sentence id="s1127" text="RFT1-congenital disorder of glycosylation (CDG) syndrome, a recessive N-glycosylation disorder caused by mutation in the RFT1 gene, is a very rare subtype of CDG syndrome associated with deafness, developmental delay, and non-specific epilepsy.">
    <entity charOffset="0-4" id="s1127.e0" ontology_id="91869" text="RFT1" type="GENE"/>
    <entity charOffset="235-243" id="s1127.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1127.e0" e2="s1127.e1" id="s1127.p0" relation="true"/>
  </sentence>
  <sentence id="s1128" text="Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (TMPRSS2) and genes from the ETS transcription factor family, most commonly ERG and ETV1, result in alteration that responsible for oncogenic activity in prostate cancer (PC).">
    <entity charOffset="85-92" id="s1128.e0" ontology_id="7113" text="TMPRSS2" type="GENE"/>
    <entity charOffset="247-253" id="s1128.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1128.e0" e2="s1128.e1" id="s1128.p0" relation="true"/>
  </sentence>
  <sentence id="s1129" text="Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (TMPRSS2) and genes from the ETS transcription factor family, most commonly ERG and ETV1, result in alteration that responsible for oncogenic activity in prostate cancer (PC).">
    <entity charOffset="168-172" id="s1129.e0" ontology_id="2115" text="ETV1" type="GENE"/>
    <entity charOffset="247-253" id="s1129.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1129.e0" e2="s1129.e1" id="s1129.p0" relation="true"/>
  </sentence>
  <sentence id="s1130" text="Furthermore, cardiovascular risk factors such hyperthyroidism, hypertension and redox homeostasis have been identified to modulate PITX2 driven gene regulatory networks.">
    <entity charOffset="63-75" id="s1130.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="131-136" id="s1130.e1" ontology_id="5308" text="PITX2" type="GENE"/>
    <pair e1="s1130.e0" e2="s1130.e1" id="s1130.p0" relation="true"/>
  </sentence>
  <sentence id="s1131" text="We provide herein a state-of-the-art review of the genetic bases of atrial fibrillation, our current understanding of the genetic regulatory networks involved in AF and its plausible usage for searching novel therapeutic targets">
    <entity charOffset="33-36" id="s1131.e0" ontology_id="181" text="art" type="GENE"/>
    <entity charOffset="68-87" id="s1131.e1" ontology_id="HP_0005110" text="atrial fibrillation" type="HP"/>
    <pair e1="s1131.e0" e2="s1131.e1" id="s1131.p0" relation="true"/>
  </sentence>
  <sentence id="s1132" text="The tumor was afterwards identified as a dMMR melanoma for an exclusive loss of Msh6 expression on IHC (Figure 1).">
    <entity charOffset="4-9" id="s1132.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="80-84" id="s1132.e1" ontology_id="2956" text="Msh6" type="GENE"/>
    <pair e1="s1132.e0" e2="s1132.e1" id="s1132.p0" relation="true"/>
  </sentence>
  <sentence id="s1133" text="We describe a female proband with primordial dwarfism, skeletal dysplasia, facial dysmorphism, extreme dyslipidaemic insulin resistance and fatty liver associated with a novel homozygous frameshift mutation in POC1A, predicted to affect two of the three protein products of the gene.">
    <entity charOffset="75-93" id="s1133.e0" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <entity charOffset="210-215" id="s1133.e1" ontology_id="25886" text="POC1A" type="GENE"/>
    <pair e1="s1133.e0" e2="s1133.e1" id="s1133.p0" relation="true"/>
  </sentence>
  <sentence id="s1134" text="Biallelic loss-of-function mutations in the RNA-binding protein EIF4A3 cause Richieri-Costa-Pereira syndrome (RCPS), an autosomal recessive condition mainly characterized by craniofacial and limb malformations.">
    <entity charOffset="64-70" id="s1134.e0" ontology_id="9775" text="EIF4A3" type="GENE"/>
    <entity charOffset="120-139" id="s1134.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1134.e0" e2="s1134.e1" id="s1134.p0" relation="true"/>
  </sentence>
  <sentence id="s1135" text="Eif4a3 haploinsufficient embryos presented altered mandibular process fusion and micrognathia, thus recapitulating the most penetrant phenotypes of the syndrome.">
    <entity charOffset="0-6" id="s1135.e0" ontology_id="9775" text="Eif4a3" type="GENE"/>
    <entity charOffset="81-93" id="s1135.e1" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <pair e1="s1135.e0" e2="s1135.e1" id="s1135.p0" relation="true"/>
  </sentence>
  <sentence id="s1136" text="Salivary gland tumor (SGT) is a rare tumor type, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity.">
    <entity charOffset="15-20" id="s1136.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="22-25" id="s1136.e1" ontology_id="6449" text="SGT" type="GENE"/>
    <pair e1="s1136.e0" e2="s1136.e1" id="s1136.p0" relation="true"/>
  </sentence>
  <sentence id="s1137" text="Salivary gland tumor (SGT) is a rare tumor type, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity.">
    <entity charOffset="22-25" id="s1137.e0" ontology_id="6449" text="SGT" type="GENE"/>
    <entity charOffset="116-129" id="s1137.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1137.e0" e2="s1137.e1" id="s1137.p0" relation="true"/>
  </sentence>
  <sentence id="s1138" text="We have deleted two major tumor suppressors, Pten, a negative regulator of the PI3K pathway, and Smad4, the central signaling mediator of TGF pathway, in the murine salivary gland.">
    <entity charOffset="26-31" id="s1138.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="45-49" id="s1138.e1" ontology_id="5728" text="Pten" type="GENE"/>
    <pair e1="s1138.e0" e2="s1138.e1" id="s1138.p0" relation="true"/>
  </sentence>
  <sentence id="s1139" text="We have deleted two major tumor suppressors, Pten, a negative regulator of the PI3K pathway, and Smad4, the central signaling mediator of TGF pathway, in the murine salivary gland.">
    <entity charOffset="26-31" id="s1139.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="97-102" id="s1139.e1" ontology_id="4089" text="Smad4" type="GENE"/>
    <pair e1="s1139.e0" e2="s1139.e1" id="s1139.p0" relation="true"/>
  </sentence>
  <sentence id="s1140" text="Our results have shown that deletion of either Pten or Smad4 in murine salivary gland resulted in pleomorphic adenomas, the most common tumor in human SGT patients.">
    <entity charOffset="47-51" id="s1140.e0" ontology_id="5728" text="Pten" type="GENE"/>
    <entity charOffset="136-141" id="s1140.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1140.e0" e2="s1140.e1" id="s1140.p0" relation="true"/>
  </sentence>
  <sentence id="s1141" text="Our results have shown that deletion of either Pten or Smad4 in murine salivary gland resulted in pleomorphic adenomas, the most common tumor in human SGT patients.">
    <entity charOffset="55-60" id="s1141.e0" ontology_id="4089" text="Smad4" type="GENE"/>
    <entity charOffset="136-141" id="s1141.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1141.e0" e2="s1141.e1" id="s1141.p0" relation="true"/>
  </sentence>
  <sentence id="s1142" text="We measured the expression of autophagy genes in peripheral blood mononuclear cells of 20 patients with Huntington's disease (HD), 20 with spinocerebellar ataxia type 2 (SCA2), and 20 healthy individuals.">
    <entity charOffset="155-161" id="s1142.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="162-166" id="s1142.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s1142.e0" e2="s1142.e1" id="s1142.p0" relation="true"/>
  </sentence>
  <sentence id="s1143" text="We measured the expression of autophagy genes in peripheral blood mononuclear cells of 20 patients with Huntington's disease (HD), 20 with spinocerebellar ataxia type 2 (SCA2), and 20 healthy individuals.">
    <entity charOffset="155-161" id="s1143.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="170-174" id="s1143.e1" ontology_id="6311" text="SCA2" type="GENE"/>
    <pair e1="s1143.e0" e2="s1143.e1" id="s1143.p0" relation="true"/>
  </sentence>
  <sentence id="s1144" text="In total, 53 women with primarily inoperable or inflammatory breast cancer who were treated with NACT were included in the study.">
    <entity charOffset="68-74" id="s1144.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="97-101" id="s1144.e1" ontology_id="284111" text="NACT" type="GENE"/>
    <pair e1="s1144.e0" e2="s1144.e1" id="s1144.p0" relation="true"/>
  </sentence>
  <sentence id="s1145" text="Pre-NACT core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (Trx), and peroxiredoxin I (Prx I).">
    <entity charOffset="48-53" id="s1145.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="211-214" id="s1145.e1" ontology_id="7295" text="Trx" type="GENE"/>
    <pair e1="s1145.e0" e2="s1145.e1" id="s1145.p0" relation="true"/>
  </sentence>
  <sentence id="s1146" text="Pre-NACT core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (Trx), and peroxiredoxin I (Prx I).">
    <entity charOffset="48-53" id="s1146.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="238-241" id="s1146.e1" ontology_id="25824" text="Prx" type="GENE"/>
    <pair e1="s1146.e0" e2="s1146.e1" id="s1146.p0" relation="true"/>
  </sentence>
  <sentence id="s1147" text="Higher pre-NACT nuclear Prx I expression predicted smaller size of a resected tumor (&lt;i&gt;p&lt;/i&gt; = 0.00052; &lt;i&gt;r&lt;/i&gt; = -0.550), and higher pre-NACT cytoplasmic Prx I expression predicted a lower amount of evacuated nodal metastasis (&lt;i&gt;p&lt;/i&gt; = 0.0024; &lt;i&gt;r&lt;/i&gt; = -0.472).">
    <entity charOffset="24-27" id="s1147.e0" ontology_id="25824" text="Prx" type="GENE"/>
    <entity charOffset="78-83" id="s1147.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1147.e0" e2="s1147.e1" id="s1147.p0" relation="true"/>
  </sentence>
  <sentence id="s1148" text="This study was undertaken to investigate the prevalence of sequence variants in LCA5 in patients with Leber congenital amaurosis (LCA), early-onset retinal dystrophy (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.">
    <entity charOffset="80-84" id="s1148.e0" ontology_id="167691" text="LCA5" type="GENE"/>
    <entity charOffset="148-165" id="s1148.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s1148.e0" e2="s1148.e1" id="s1148.p0" relation="true"/>
  </sentence>
  <sentence id="s1149" text="This study was undertaken to investigate the prevalence of sequence variants in LCA5 in patients with Leber congenital amaurosis (LCA), early-onset retinal dystrophy (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.">
    <entity charOffset="80-84" id="s1149.e0" ontology_id="167691" text="LCA5" type="GENE"/>
    <entity charOffset="178-197" id="s1149.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1149.e0" e2="s1149.e1" id="s1149.p0" relation="true"/>
  </sentence>
  <sentence id="s1150" text="In this review we discuss recent advances in our knowledge of the MPC, and we argue that it may offer a promising target in diseases like cancer and type 2 diabetes.">
    <entity charOffset="138-144" id="s1150.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="149-153" id="s1150.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s1150.e0" e2="s1150.e1" id="s1150.p0" relation="true"/>
  </sentence>
  <sentence id="s1151" text="Clinical variables, including age, International Neuroblastoma Staging System (INSS) stage, tumor size and site, histology, and MYCN status were retrospectively analyzed, and EFS was chosen as the endpoint.The median age of patients was 8.2 months and average follow-up period was 40.28.6 months.">
    <entity charOffset="92-97" id="s1151.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="128-132" id="s1151.e1" ontology_id="4613" text="MYCN" type="GENE"/>
    <pair e1="s1151.e0" e2="s1151.e1" id="s1151.p0" relation="true"/>
  </sentence>
  <sentence id="s1152" text="Cox multifactor regression analysis revealed that age, histology and MYCN status had significant prognostic effect on event-free survival (EFS) rate for neuroblastoma patients underwent surgical treatment.In our study, we identified a series of prognostic factors including age, histology, and MYCN status predicting the prognosis of neuroblastoma patients after surgical treatment">
    <entity charOffset="69-73" id="s1152.e0" ontology_id="4613" text="MYCN" type="GENE"/>
    <entity charOffset="153-166" id="s1152.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1152.e0" e2="s1152.e1" id="s1152.p0" relation="true"/>
  </sentence>
  <sentence id="s1153" text="Cox multifactor regression analysis revealed that age, histology and MYCN status had significant prognostic effect on event-free survival (EFS) rate for neuroblastoma patients underwent surgical treatment.In our study, we identified a series of prognostic factors including age, histology, and MYCN status predicting the prognosis of neuroblastoma patients after surgical treatment">
    <entity charOffset="139-142" id="s1153.e0" ontology_id="10278" text="EFS" type="GENE"/>
    <entity charOffset="153-166" id="s1153.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1153.e0" e2="s1153.e1" id="s1153.p0" relation="true"/>
  </sentence>
  <sentence id="s1154" text="Leber congenital amaurosis (LCA) and juvenile retinitis pigmentosa (RP) are severe hereditary diseases that causes visual impairment in infants and children.">
    <entity charOffset="68-70" id="s1154.e0" ontology_id="100287745" text="RP" type="GENE"/>
    <entity charOffset="115-132" id="s1154.e1" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <pair e1="s1154.e0" e2="s1154.e1" id="s1154.p0" relation="true"/>
  </sentence>
  <sentence id="s1155" text="Disease associated KIF1A mutations have been associated with motor and sensory dysfunctions as well as non-syndromic intellectual disability in humans.">
    <entity charOffset="19-24" id="s1155.e0" ontology_id="547" text="KIF1A" type="GENE"/>
    <entity charOffset="117-140" id="s1155.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1155.e0" e2="s1155.e1" id="s1155.p0" relation="true"/>
  </sentence>
  <sentence id="s1156" text="Individuals with biallelic TRIP13 or BUB1B mutations have a high risk of embryonal tumors, and here we show that their cells display severe SAC impairment.">
    <entity charOffset="27-33" id="s1156.e0" ontology_id="9319" text="TRIP13" type="GENE"/>
    <entity charOffset="83-88" id="s1156.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1156.e0" e2="s1156.e1" id="s1156.p0" relation="true"/>
  </sentence>
  <sentence id="s1157" text="Individuals with biallelic TRIP13 or BUB1B mutations have a high risk of embryonal tumors, and here we show that their cells display severe SAC impairment.">
    <entity charOffset="37-42" id="s1157.e0" ontology_id="701" text="BUB1B" type="GENE"/>
    <entity charOffset="83-88" id="s1157.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1157.e0" e2="s1157.e1" id="s1157.p0" relation="true"/>
  </sentence>
  <sentence id="s1158" text="Individuals with biallelic TRIP13 or BUB1B mutations have a high risk of embryonal tumors, and here we show that their cells display severe SAC impairment.">
    <entity charOffset="83-88" id="s1158.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="140-143" id="s1158.e1" ontology_id="55811" text="SAC" type="GENE"/>
    <pair e1="s1158.e0" e2="s1158.e1" id="s1158.p0" relation="true"/>
  </sentence>
  <sentence id="s1159" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s1159.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="372-378" id="s1159.e1" ontology_id="1293" text="COL6A3" type="GENE"/>
    <pair e1="s1159.e0" e2="s1159.e1" id="s1159.p0" relation="true"/>
  </sentence>
  <sentence id="s1160" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s1160.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="404-411" id="s1160.e1" ontology_id="64421" text="DCLRE1C" type="GENE"/>
    <pair e1="s1160.e0" e2="s1160.e1" id="s1160.p0" relation="true"/>
  </sentence>
  <sentence id="s1161" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s1161.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="413-418" id="s1161.e1" ontology_id="58492" text="ZNF77" type="GENE"/>
    <pair e1="s1161.e0" e2="s1161.e1" id="s1161.p0" relation="true"/>
  </sentence>
  <sentence id="s1162" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s1162.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="483-486" id="s1162.e1" ontology_id="10537" text="UBD" type="GENE"/>
    <pair e1="s1162.e0" e2="s1162.e1" id="s1162.p0" relation="false"/>
  </sentence>
  <sentence id="s1163" text="We identified a new susceptibility locus for bladder cancer at 5q12.3, located in the intron of CWC27 (rs2042329), that was significantly associated with disease risk (OR = 1.40; P = 4.61  10(-11)).">
    <entity charOffset="53-59" id="s1163.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="96-101" id="s1163.e1" ontology_id="10283" text="CWC27" type="GENE"/>
    <pair e1="s1163.e0" e2="s1163.e1" id="s1163.p0" relation="true"/>
  </sentence>
  <sentence id="s1164" text="To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, MT-RNR1, and SLC26A4 genes.">
    <entity charOffset="58-66" id="s1164.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="196-200" id="s1164.e1" ontology_id="2706" text="GJB2" type="GENE"/>
    <pair e1="s1164.e0" e2="s1164.e1" id="s1164.p0" relation="false"/>
  </sentence>
  <sentence id="s1165" text="To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, MT-RNR1, and SLC26A4 genes.">
    <entity charOffset="58-66" id="s1165.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="215-222" id="s1165.e1" ontology_id="5172" text="SLC26A4" type="GENE"/>
    <pair e1="s1165.e0" e2="s1165.e1" id="s1165.p0" relation="true"/>
  </sentence>
  <sentence id="s1166" text="We report ten new patients from eight unrelated kindreds with DGKE nephropathy.">
    <entity charOffset="62-66" id="s1166.e0" ontology_id="8526" text="DGKE" type="GENE"/>
    <entity charOffset="67-78" id="s1166.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s1166.e0" e2="s1166.e1" id="s1166.p0" relation="true"/>
  </sentence>
  <sentence id="s1167" text="In conclusion, we did not observe a clear genotype-phenotype correlation in patients with DGKE nephropathy, suggesting additional factors mediating phenotypic heterogeneity.">
    <entity charOffset="90-94" id="s1167.e0" ontology_id="8526" text="DGKE" type="GENE"/>
    <entity charOffset="95-106" id="s1167.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s1167.e0" e2="s1167.e1" id="s1167.p0" relation="true"/>
  </sentence>
  <sentence id="s1168" text="In conclusion, we did not observe a clear genotype-phenotype correlation in patients with DGKE nephropathy, suggesting additional factors mediating phenotypic heterogeneity.">
    <entity charOffset="90-94" id="s1168.e0" ontology_id="8526" text="DGKE" type="GENE"/>
    <entity charOffset="159-172" id="s1168.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1168.e0" e2="s1168.e1" id="s1168.p0" relation="true"/>
  </sentence>
  <sentence id="s1169" text="The patient together with her younger brother was diagnosed at the age of 5 years with familial congenital hypopituitarism, due to homozygous mutation c.150delA in PROP1 gene.">
    <entity charOffset="107-122" id="s1169.e0" ontology_id="HP_0040075" text="hypopituitarism" type="HP"/>
    <entity charOffset="164-169" id="s1169.e1" ontology_id="5626" text="PROP1" type="GENE"/>
    <pair e1="s1169.e0" e2="s1169.e1" id="s1169.p0" relation="true"/>
  </sentence>
  <sentence id="s1170" text="The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="4-8" id="s1170.e0" ontology_id="6910" text="TBX5" type="GENE"/>
    <entity charOffset="94-111" id="s1170.e1" ontology_id="HP_0011662" text="tricuspid atresia" type="HP"/>
    <pair e1="s1170.e0" e2="s1170.e1" id="s1170.p0" relation="true"/>
  </sentence>
  <sentence id="s1171" text="The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="4-8" id="s1171.e0" ontology_id="6910" text="TBX5" type="GENE"/>
    <entity charOffset="276-306" id="s1171.e1" ontology_id="HP_0006695" text="atrioventricular septal defect" type="HP"/>
    <pair e1="s1171.e0" e2="s1171.e1" id="s1171.p0" relation="false"/>
  </sentence>
  <sentence id="s1172" text="The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="4-8" id="s1172.e0" ontology_id="6910" text="TBX5" type="GENE"/>
    <entity charOffset="311-328" id="s1172.e1" ontology_id="HP_0001263" text="psychomotor delay" type="HP"/>
    <pair e1="s1172.e0" e2="s1172.e1" id="s1172.p0" relation="true"/>
  </sentence>
  <sentence id="s1173" text="The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="94-111" id="s1173.e0" ontology_id="HP_0011662" text="tricuspid atresia" type="HP"/>
    <entity charOffset="150-155" id="s1173.e1" ontology_id="2626" text="GATA4" type="GENE"/>
    <pair e1="s1173.e0" e2="s1173.e1" id="s1173.p0" relation="true"/>
  </sentence>
  <sentence id="s1174" text="The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="150-155" id="s1174.e0" ontology_id="2626" text="GATA4" type="GENE"/>
    <entity charOffset="276-306" id="s1174.e1" ontology_id="HP_0006695" text="atrioventricular septal defect" type="HP"/>
    <pair e1="s1174.e0" e2="s1174.e1" id="s1174.p0" relation="false"/>
  </sentence>
  <sentence id="s1175" text="The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="150-155" id="s1175.e0" ontology_id="2626" text="GATA4" type="GENE"/>
    <entity charOffset="311-328" id="s1175.e1" ontology_id="HP_0001263" text="psychomotor delay" type="HP"/>
    <pair e1="s1175.e0" e2="s1175.e1" id="s1175.p0" relation="false"/>
  </sentence>
  <sentence id="s1176" text="Oxidative stress, which is induced by reactive oxygen species (ROS), causes cellular damage which contributes to the pathogenesis of neurodegenerative diseases.">
    <entity charOffset="85-91" id="s1176.e0" ontology_id="51438" text="damage" type="GENE"/>
    <entity charOffset="133-159" id="s1176.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s1176.e0" e2="s1176.e1" id="s1176.p0" relation="true"/>
  </sentence>
  <sentence id="s1177" text="In the present study, our results indicated that SPOP expression was significantly downregulated in HCC and was associated with tumor size, differentiation and metastasis.">
    <entity charOffset="49-53" id="s1177.e0" ontology_id="8405" text="SPOP" type="GENE"/>
    <entity charOffset="128-133" id="s1177.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1177.e0" e2="s1177.e1" id="s1177.p0" relation="true"/>
  </sentence>
  <sentence id="s1178" text="We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the great arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous Megf8.">
    <entity charOffset="51-68" id="s1178.e0" ontology_id="HP_0001999" text="dysmorphic facies" type="HP"/>
    <entity charOffset="273-278" id="s1178.e1" ontology_id="1954" text="Megf8" type="GENE"/>
    <pair e1="s1178.e0" e2="s1178.e1" id="s1178.p0" relation="true"/>
  </sentence>
  <sentence id="s1179" text="We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the great arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous Megf8.">
    <entity charOffset="124-136" id="s1179.e0" ontology_id="HP_0001651" text="dextrocardia" type="HP"/>
    <entity charOffset="273-278" id="s1179.e1" ontology_id="1954" text="Megf8" type="GENE"/>
    <pair e1="s1179.e0" e2="s1179.e1" id="s1179.p0" relation="true"/>
  </sentence>
  <sentence id="s1180" text="We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the great arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous Megf8.">
    <entity charOffset="186-207" id="s1180.e0" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <entity charOffset="273-278" id="s1180.e1" ontology_id="1954" text="Megf8" type="GENE"/>
    <pair e1="s1180.e0" e2="s1180.e1" id="s1180.p0" relation="true"/>
  </sentence>
  <sentence id="s1181" text="Patients with mutations in ZNF711 all present with mild to moderate ID and poor speech accompanied by additional features in some patients, including autistic features and mild facial dysmorphisms, suggesting that ZNF711 mutations cause non-syndromic ID">
    <entity charOffset="27-33" id="s1181.e0" ontology_id="7552" text="ZNF711" type="GENE"/>
    <entity charOffset="51-55" id="s1181.e1" ontology_id="HP_0012825" text="mild" type="HP"/>
    <pair e1="s1181.e0" e2="s1181.e1" id="s1181.p0" relation="true"/>
  </sentence>
  <sentence id="s1182" text="Patients with mutations in ZNF711 all present with mild to moderate ID and poor speech accompanied by additional features in some patients, including autistic features and mild facial dysmorphisms, suggesting that ZNF711 mutations cause non-syndromic ID">
    <entity charOffset="27-33" id="s1182.e0" ontology_id="7552" text="ZNF711" type="GENE"/>
    <entity charOffset="177-196" id="s1182.e1" ontology_id="HP_0001999" text="facial dysmorphisms" type="HP"/>
    <pair e1="s1182.e0" e2="s1182.e1" id="s1182.p0" relation="true"/>
  </sentence>
  <sentence id="s1183" text="Our study confirms linkage of a variant clinical form of hair-nail ectodermal dysplasia to chromosome 12 without any mutation in the coding sequences of the KRTHB5 gene.">
    <entity charOffset="62-66" id="s1183.e0" ontology_id="51744" text="nail" type="GENE"/>
    <entity charOffset="67-87" id="s1183.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s1183.e0" e2="s1183.e1" id="s1183.p0" relation="true"/>
  </sentence>
  <sentence id="s1184" text="Our study confirms linkage of a variant clinical form of hair-nail ectodermal dysplasia to chromosome 12 without any mutation in the coding sequences of the KRTHB5 gene.">
    <entity charOffset="67-87" id="s1184.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="157-163" id="s1184.e1" ontology_id="3891" text="KRTHB5" type="GENE"/>
    <pair e1="s1184.e0" e2="s1184.e1" id="s1184.p0" relation="true"/>
  </sentence>
  <sentence id="s1185" text="The expression of uncarboxylated MGP (ucMGP), carboxylated MGP (cMGP), matrix metalloproteinase (MMP)13, collagen type X, collagen type II, tumor necrosis factor (TNF) and interleukin (IL)1 were detected by ELISA, immunohistochemistry, reverse transcriptionquantitative polymerase chain reaction and western blotting.">
    <entity charOffset="33-36" id="s1185.e0" ontology_id="4256" text="MGP" type="GENE"/>
    <entity charOffset="141-146" id="s1185.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1185.e0" e2="s1185.e1" id="s1185.p0" relation="true"/>
  </sentence>
  <sentence id="s1186" text="The expression of uncarboxylated MGP (ucMGP), carboxylated MGP (cMGP), matrix metalloproteinase (MMP)13, collagen type X, collagen type II, tumor necrosis factor (TNF) and interleukin (IL)1 were detected by ELISA, immunohistochemistry, reverse transcriptionquantitative polymerase chain reaction and western blotting.">
    <entity charOffset="115-119" id="s1186.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="141-146" id="s1186.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1186.e0" e2="s1186.e1" id="s1186.p0" relation="true"/>
  </sentence>
  <sentence id="s1187" text="The expression of uncarboxylated MGP (ucMGP), carboxylated MGP (cMGP), matrix metalloproteinase (MMP)13, collagen type X, collagen type II, tumor necrosis factor (TNF) and interleukin (IL)1 were detected by ELISA, immunohistochemistry, reverse transcriptionquantitative polymerase chain reaction and western blotting.">
    <entity charOffset="141-146" id="s1187.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="164-167" id="s1187.e1" ontology_id="7124" text="TNF" type="GENE"/>
    <pair e1="s1187.e0" e2="s1187.e1" id="s1187.p0" relation="false"/>
  </sentence>
  <sentence id="s1188" text="MicroRNA-9 (miR-9) dysregulation is implicated in a variety of human malignancies including hepatocellular carcinoma (HCC), but its role remains contradictory.">
    <entity charOffset="92-116" id="s1188.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="118-121" id="s1188.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s1188.e0" e2="s1188.e1" id="s1188.p0" relation="true"/>
  </sentence>
  <sentence id="s1189" text="In this study, we explored the expression and methylation status of miR-9 in HCC samples, as well as the tumor-related functions of miR-9 in vitro.">
    <entity charOffset="77-80" id="s1189.e0" ontology_id="84668" text="HCC" type="GENE"/>
    <entity charOffset="105-110" id="s1189.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1189.e0" e2="s1189.e1" id="s1189.p0" relation="true"/>
  </sentence>
  <sentence id="s1190" text="Our study suggests that miR-9 functions as a tumor suppressor in HCC progression by inhibiting a series of target genes, including the newly validated miR-9/IGF2BP1/AKT&amp;amp;ERK axis, thus providing potential therapeutic targets and novel prognostic biomarkers for HCC patients.">
    <entity charOffset="45-50" id="s1190.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="65-68" id="s1190.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s1190.e0" e2="s1190.e1" id="s1190.p0" relation="true"/>
  </sentence>
  <sentence id="s1191" text="Atypical teratoid/rhabdoid tumors (AT/RT) and renal/extrarenal malignant rhabdoid tumors of childhood, epithelioid sarcoma and small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) represent the most commonly recognized SWI/SNF-driven neoplasms.">
    <entity charOffset="27-33" id="s1191.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="176-180" id="s1191.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s1191.e0" e2="s1191.e1" id="s1191.p0" relation="true"/>
  </sentence>
  <sentence id="s1192" text="Atypical teratoid/rhabdoid tumors (AT/RT) and renal/extrarenal malignant rhabdoid tumors of childhood, epithelioid sarcoma and small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) represent the most commonly recognized SWI/SNF-driven neoplasms.">
    <entity charOffset="176-180" id="s1192.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="244-253" id="s1192.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s1192.e0" e2="s1192.e1" id="s1192.p0" relation="true"/>
  </sentence>
  <sentence id="s1193" text="Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely SMARCA4) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).">
    <entity charOffset="128-135" id="s1193.e0" ontology_id="6597" text="SMARCA4" type="GENE"/>
    <entity charOffset="241-246" id="s1193.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1193.e0" e2="s1193.e1" id="s1193.p0" relation="true"/>
  </sentence>
  <sentence id="s1194" text="However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to SMARCB1) and multiple meningiomas (linked to SMARCE1) as well as others.">
    <entity charOffset="97-103" id="s1194.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="162-169" id="s1194.e1" ontology_id="6598" text="SMARCB1" type="GENE"/>
    <pair e1="s1194.e0" e2="s1194.e1" id="s1194.p0" relation="true"/>
  </sentence>
  <sentence id="s1195" text="However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to SMARCB1) and multiple meningiomas (linked to SMARCE1) as well as others.">
    <entity charOffset="97-103" id="s1195.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="207-214" id="s1195.e1" ontology_id="6605" text="SMARCE1" type="GENE"/>
    <pair e1="s1195.e0" e2="s1195.e1" id="s1195.p0" relation="true"/>
  </sentence>
  <sentence id="s1196" text="However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to SMARCB1) and multiple meningiomas (linked to SMARCE1) as well as others.">
    <entity charOffset="162-169" id="s1196.e0" ontology_id="6598" text="SMARCB1" type="GENE"/>
    <entity charOffset="184-195" id="s1196.e1" ontology_id="HP_0002858" text="meningiomas" type="HP"/>
    <pair e1="s1196.e0" e2="s1196.e1" id="s1196.p0" relation="true"/>
  </sentence>
  <sentence id="s1197" text="We found that hypermethylation of TRIM36 and reduced gene expression was prevalent in several types of human cancers.">
    <entity charOffset="34-40" id="s1197.e0" ontology_id="55521" text="TRIM36" type="GENE"/>
    <entity charOffset="109-115" id="s1197.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1197.e0" e2="s1197.e1" id="s1197.p0" relation="true"/>
  </sentence>
  <sentence id="s1198" text="The tumorigenesis and metastasis of tumors are associated with human collagen triple helix repeats containing 1 (CTHRC1).">
    <entity charOffset="36-42" id="s1198.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="113-119" id="s1198.e1" ontology_id="115908" text="CTHRC1" type="GENE"/>
    <pair e1="s1198.e0" e2="s1198.e1" id="s1198.p0" relation="true"/>
  </sentence>
  <sentence id="s1199" text="We used bivariate and multivariate analyses to examine the variations in the rates of TMA complications according to sex, age, race, and comorbid conditions, including nonpalpable pedal pulses, end-stage renal disease, coronary artery disease, hypertension, smoking status, and preoperative albumin &amp;lt;3.5mg/dL.">
    <entity charOffset="117-120" id="s1199.e0" ontology_id="55558" text="sex" type="GENE"/>
    <entity charOffset="244-256" id="s1199.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s1199.e0" e2="s1199.e1" id="s1199.p0" relation="false"/>
  </sentence>
  <sentence id="s1200" text="BACKGROUND The present study explored the expression of coiled-coil domain-containing 34 (CCDC34) in cervical cancer (CC) and its prognostic value.">
    <entity charOffset="90-96" id="s1200.e0" ontology_id="91057" text="CCDC34" type="GENE"/>
    <entity charOffset="110-116" id="s1200.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1200.e0" e2="s1200.e1" id="s1200.p0" relation="true"/>
  </sentence>
  <sentence id="s1201" text="MATERIAL AND METHODS GEPIA and Oncomine cancer databases were mined to predict the CCDC34 differential expression level between a CC group and a normal group.">
    <entity charOffset="40-46" id="s1201.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="83-89" id="s1201.e1" ontology_id="91057" text="CCDC34" type="GENE"/>
    <pair e1="s1201.e0" e2="s1201.e1" id="s1201.p0" relation="true"/>
  </sentence>
  <sentence id="s1202" text="CD31 and vascular endothelial growth factor (VEGF) were stained to reflect tumor angiogenesis in 67 CC tissues.">
    <entity charOffset="45-49" id="s1202.e0" ontology_id="7422" text="VEGF" type="GENE"/>
    <entity charOffset="75-80" id="s1202.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1202.e0" e2="s1202.e1" id="s1202.p0" relation="true"/>
  </sentence>
  <sentence id="s1203" text="RESULTS Both GEPIA and Oncomine cancer databases mining results revealed that CCDC34 was more highly expressed in the CC group than in the normal group (all P&amp;lt;0.05).">
    <entity charOffset="32-38" id="s1203.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="78-84" id="s1203.e1" ontology_id="91057" text="CCDC34" type="GENE"/>
    <pair e1="s1203.e0" e2="s1203.e1" id="s1203.p0" relation="true"/>
  </sentence>
  <sentence id="s1204" text="CONCLUSIONS High expression of CCDC34 is an independent unfavorable prognostic parameter for OS and DFS of CC patients, which was strongly associated with tumor angiogenesis">
    <entity charOffset="31-37" id="s1204.e0" ontology_id="91057" text="CCDC34" type="GENE"/>
    <entity charOffset="155-160" id="s1204.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1204.e0" e2="s1204.e1" id="s1204.p0" relation="true"/>
  </sentence>
  <sentence id="s1205" text="Over the past decade, the genetic basis of several forms of autosomal recessive SCD cases has been solved with the identification of four causative genes (DLL3, MESP2, LFNG and HES7).">
    <entity charOffset="60-79" id="s1205.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="155-159" id="s1205.e1" ontology_id="10683" text="DLL3" type="GENE"/>
    <pair e1="s1205.e0" e2="s1205.e1" id="s1205.p0" relation="true"/>
  </sentence>
  <sentence id="s1206" text="Over the past decade, the genetic basis of several forms of autosomal recessive SCD cases has been solved with the identification of four causative genes (DLL3, MESP2, LFNG and HES7).">
    <entity charOffset="60-79" id="s1206.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="161-166" id="s1206.e1" ontology_id="145873" text="MESP2" type="GENE"/>
    <pair e1="s1206.e0" e2="s1206.e1" id="s1206.p0" relation="true"/>
  </sentence>
  <sentence id="s1207" text="Over the past decade, the genetic basis of several forms of autosomal recessive SCD cases has been solved with the identification of four causative genes (DLL3, MESP2, LFNG and HES7).">
    <entity charOffset="60-79" id="s1207.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="168-172" id="s1207.e1" ontology_id="3955" text="LFNG" type="GENE"/>
    <pair e1="s1207.e0" e2="s1207.e1" id="s1207.p0" relation="true"/>
  </sentence>
  <sentence id="s1208" text="Over the past decade, the genetic basis of several forms of autosomal recessive SCD cases has been solved with the identification of four causative genes (DLL3, MESP2, LFNG and HES7).">
    <entity charOffset="60-79" id="s1208.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="177-181" id="s1208.e1" ontology_id="84667" text="HES7" type="GENE"/>
    <pair e1="s1208.e0" e2="s1208.e1" id="s1208.p0" relation="true"/>
  </sentence>
  <sentence id="s1209" text="Corneal changes in aniridia-related keratopathy (ARK) include peripheral pannus and epithelial abnormalities, which eventually result in corneal opacity and contribute to visual loss.">
    <entity charOffset="49-52" id="s1209.e0" ontology_id="558" text="ARK" type="GENE"/>
    <entity charOffset="171-182" id="s1209.e1" ontology_id="HP_0000572" text="visual loss" type="HP"/>
    <pair e1="s1209.e0" e2="s1209.e1" id="s1209.p0" relation="true"/>
  </sentence>
  <sentence id="s1210" text="The corneal abnormalities of Pax6+/- mice provide an excellent model for the corneal changes seen in PAX6+/- humans.">
    <entity charOffset="4-25" id="s1210.e0" ontology_id="HP_0000481" text="corneal abnormalities" type="HP"/>
    <entity charOffset="101-105" id="s1210.e1" ontology_id="5080" text="PAX6" type="GENE"/>
    <pair e1="s1210.e0" e2="s1210.e1" id="s1210.p0" relation="true"/>
  </sentence>
  <sentence id="s1211" text="The corneal abnormalities of Pax6+/- mice provide an excellent model for the corneal changes seen in PAX6+/- humans.">
    <entity charOffset="4-25" id="s1211.e0" ontology_id="HP_0000481" text="corneal abnormalities" type="HP"/>
    <entity charOffset="29-33" id="s1211.e1" ontology_id="5080" text="Pax6" type="GENE"/>
    <pair e1="s1211.e0" e2="s1211.e1" id="s1211.p0" relation="true"/>
  </sentence>
  <sentence id="s1212" text="Great progress has been achieved in the study of the role of TGF- signaling in triggering epithelial-mesenchymal transition (EMT) in a variety of cancers; however, the regulation of TGF- signaling during EMT in mammary tumor metastasis has not been completely defined.">
    <entity charOffset="126-129" id="s1212.e0" ontology_id="3702" text="EMT" type="GENE"/>
    <entity charOffset="221-226" id="s1212.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1212.e0" e2="s1212.e1" id="s1212.p0" relation="true"/>
  </sentence>
  <sentence id="s1213" text="In the present study, we demonstrated that OVOL2, a zinc finger transcription factor, inhibits TGF- signaling-induced EMT in mouse and human mammary tumor cells, as well as in mouse tumor models.">
    <entity charOffset="43-48" id="s1213.e0" ontology_id="58495" text="OVOL2" type="GENE"/>
    <entity charOffset="150-155" id="s1213.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1213.e0" e2="s1213.e1" id="s1213.p0" relation="true"/>
  </sentence>
  <sentence id="s1214" text="In the present study, we demonstrated that OVOL2, a zinc finger transcription factor, inhibits TGF- signaling-induced EMT in mouse and human mammary tumor cells, as well as in mouse tumor models.">
    <entity charOffset="119-122" id="s1214.e0" ontology_id="3702" text="EMT" type="GENE"/>
    <entity charOffset="150-155" id="s1214.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1214.e0" e2="s1214.e1" id="s1214.p0" relation="true"/>
  </sentence>
  <sentence id="s1215" text="Data from the Oncomine databases indicated a strong negative relationship between OVOL2 expression and breast cancer progression.">
    <entity charOffset="82-87" id="s1215.e0" ontology_id="58495" text="OVOL2" type="GENE"/>
    <entity charOffset="110-116" id="s1215.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1215.e0" e2="s1215.e1" id="s1215.p0" relation="true"/>
  </sentence>
  <sentence id="s1216" text="The modulation of these molecular processes may represent a strategy for inhibiting breast cancer invasion by restoring OVOL2 expression">
    <entity charOffset="91-97" id="s1216.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="120-125" id="s1216.e1" ontology_id="58495" text="OVOL2" type="GENE"/>
    <pair e1="s1216.e0" e2="s1216.e1" id="s1216.p0" relation="true"/>
  </sentence>
  <sentence id="s1217" text="Interestingly, heterogeneous nuclear RNA (hnRNA) for insulin and INS-IGF2, both originating from the INS promoter, were essentially undetectable in T1D pancreata, arguing for a silent INSpromoter.">
    <entity charOffset="15-28" id="s1217.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="65-68" id="s1217.e1" ontology_id="3630" text="INS" type="GENE"/>
    <pair e1="s1217.e0" e2="s1217.e1" id="s1217.p0" relation="true"/>
  </sentence>
  <sentence id="s1218" text="Mutations in LEPREL1, the gene encoding prolyl 3-hydroxylase-2 (P3H2), have recently been identified in individuals with recessively inherited nonsyndromic severe myopia.">
    <entity charOffset="13-20" id="s1218.e0" ontology_id="55214" text="LEPREL1" type="GENE"/>
    <entity charOffset="163-169" id="s1218.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1218.e0" e2="s1218.e1" id="s1218.p0" relation="true"/>
  </sentence>
  <sentence id="s1219" text="Here we demonstrate that the prostate cancer cell lines LNCaP and LAPC4 display markedly different sensitivity to docetaxel with AR activation, and RNA-seq analysis of these cell lines identified KDM5D (lysine-specific demethylase 5D) encoded on the Y chromosome as a potential mediator of this sensitivity.">
    <entity charOffset="38-44" id="s1219.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="196-201" id="s1219.e1" ontology_id="8284" text="KDM5D" type="GENE"/>
    <pair e1="s1219.e0" e2="s1219.e1" id="s1219.p0" relation="true"/>
  </sentence>
  <sentence id="s1220" text="Although AEBP1 immunoreactivity was almost absent in neurons containing neurofibrillary tangles, AEBP1 was highly expressed in neurons with pretangles and in the tau-immunopositive, dystrophic neurites of senile plaques.">
    <entity charOffset="9-14" id="s1220.e0" ontology_id="165" text="AEBP1" type="GENE"/>
    <entity charOffset="72-95" id="s1220.e1" ontology_id="HP_0002185" text="neurofibrillary tangles" type="HP"/>
    <pair e1="s1220.e0" e2="s1220.e1" id="s1220.p0" relation="true"/>
  </sentence>
  <sentence id="s1221" text="The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (SPATA2), tumour necrosis factor alpha-induced protein 3 (TNFAIP3), TNFAIP3-interacting protein 1 (TNIP1) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.">
    <entity charOffset="63-69" id="s1221.e0" ontology_id="9825" text="SPATA2" type="GENE"/>
    <entity charOffset="72-78" id="s1221.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1221.e0" e2="s1221.e1" id="s1221.p0" relation="false"/>
  </sentence>
  <sentence id="s1222" text="The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (SPATA2), tumour necrosis factor alpha-induced protein 3 (TNFAIP3), TNFAIP3-interacting protein 1 (TNIP1) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.">
    <entity charOffset="72-78" id="s1222.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="120-127" id="s1222.e1" ontology_id="7128" text="TNFAIP3" type="GENE"/>
    <pair e1="s1222.e0" e2="s1222.e1" id="s1222.p0" relation="true"/>
  </sentence>
  <sentence id="s1223" text="The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (SPATA2), tumour necrosis factor alpha-induced protein 3 (TNFAIP3), TNFAIP3-interacting protein 1 (TNIP1) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.">
    <entity charOffset="72-78" id="s1223.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="161-166" id="s1223.e1" ontology_id="10318" text="TNIP1" type="GENE"/>
    <pair e1="s1223.e0" e2="s1223.e1" id="s1223.p0" relation="true"/>
  </sentence>
  <sentence id="s1224" text="Differentiated embryo chondrocyte expressed gene1 (Dec1), a crucial cell differentiation mediator and apoptosis inhibitor, is abundantly expressed in various types of human cancer and is associated with malignant tumor progression.">
    <entity charOffset="52-56" id="s1224.e0" ontology_id="8553" text="Dec1" type="GENE"/>
    <entity charOffset="174-180" id="s1224.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1224.e0" e2="s1224.e1" id="s1224.p0" relation="true"/>
  </sentence>
  <sentence id="s1225" text="Differentiated embryo chondrocyte expressed gene1 (Dec1), a crucial cell differentiation mediator and apoptosis inhibitor, is abundantly expressed in various types of human cancer and is associated with malignant tumor progression.">
    <entity charOffset="52-56" id="s1225.e0" ontology_id="8553" text="Dec1" type="GENE"/>
    <entity charOffset="214-219" id="s1225.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1225.e0" e2="s1225.e1" id="s1225.p0" relation="true"/>
  </sentence>
  <sentence id="s1226" text="As poor differentiation and low apoptosis are closely associated with poor survival rates and a poor response to radio/chemotherapy in patients with cancer, the prognostic value of Dec1 expression was examined in the present study and its correlation with response to temozolomide (TMZ) chemotherapy was analyzed in patients with glioma.">
    <entity charOffset="181-185" id="s1226.e0" ontology_id="8553" text="Dec1" type="GENE"/>
    <entity charOffset="330-336" id="s1226.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1226.e0" e2="s1226.e1" id="s1226.p0" relation="true"/>
  </sentence>
  <sentence id="s1227" text="Dec1 expression was analyzed by immunohistochemistry in 157 samples of newly diagnosed glioma and 63 recurrent glioblastoma cases that relapsed during TMZ chemotherapy.">
    <entity charOffset="0-4" id="s1227.e0" ontology_id="8553" text="Dec1" type="GENE"/>
    <entity charOffset="87-93" id="s1227.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1227.e0" e2="s1227.e1" id="s1227.p0" relation="true"/>
  </sentence>
  <sentence id="s1228" text="Dec1 expression was also compared with the apoptosis index determined by TdTmediated dUTP nick endinglabeling assay in recurrent glioblastomas.">
    <entity charOffset="0-4" id="s1228.e0" ontology_id="8553" text="Dec1" type="GENE"/>
    <entity charOffset="131-143" id="s1228.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s1228.e0" e2="s1228.e1" id="s1228.p0" relation="true"/>
  </sentence>
  <sentence id="s1229" text="The antiglioma effect of TMZ in nude mice xenografts with Dec1 expression was examined invivo.">
    <entity charOffset="8-14" id="s1229.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="58-62" id="s1229.e1" ontology_id="8553" text="Dec1" type="GENE"/>
    <pair e1="s1229.e0" e2="s1229.e1" id="s1229.p0" relation="true"/>
  </sentence>
  <sentence id="s1230" text="High expression of Dec1, which was significantly associated with high pathological tumor grade and poor response to TMZ chemotherapy, was demonstrated to be an unfavorable independent prognostic factor and predicted poor survival in patients with newly diagnosed glioma.">
    <entity charOffset="19-23" id="s1230.e0" ontology_id="8553" text="Dec1" type="GENE"/>
    <entity charOffset="83-88" id="s1230.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1230.e0" e2="s1230.e1" id="s1230.p0" relation="true"/>
  </sentence>
  <sentence id="s1231" text="In patients with recurrent glioblastoma, there was a negative correlation between Dec1 expression and the apoptotic index.">
    <entity charOffset="27-39" id="s1231.e0" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <entity charOffset="82-86" id="s1231.e1" ontology_id="8553" text="Dec1" type="GENE"/>
    <pair e1="s1231.e0" e2="s1231.e1" id="s1231.p0" relation="true"/>
  </sentence>
  <sentence id="s1232" text="Carney triad (CT) is a very rare disease with synchronous or metachronous occurrence of at least three different tumor entities; gastric gastrointestinal stromal tumor (GIST), paraganglioma (PGL), and pulmonary chondroma.">
    <entity charOffset="113-118" id="s1232.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="191-194" id="s1232.e1" ontology_id="6392" text="PGL" type="GENE"/>
    <pair e1="s1232.e0" e2="s1232.e1" id="s1232.p0" relation="true"/>
  </sentence>
  <sentence id="s1233" text="Another disease that shares two of the tumor components of CT, namely GIST and PGL is the Carney-Stratakis syndrome (CSS) or dyad.">
    <entity charOffset="39-44" id="s1233.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="79-82" id="s1233.e1" ontology_id="6392" text="PGL" type="GENE"/>
    <pair e1="s1233.e0" e2="s1233.e1" id="s1233.p0" relation="true"/>
  </sentence>
  <sentence id="s1234" text="There is only partial overlap between the two conditions (there are a few patients with CT that have SDH subunit mutations) but both lead to increased methylation of the entire genome in the tumors associated with them.">
    <entity charOffset="101-104" id="s1234.e0" ontology_id="1757" text="SDH" type="GENE"/>
    <entity charOffset="191-196" id="s1234.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1234.e0" e2="s1234.e1" id="s1234.p0" relation="true"/>
  </sentence>
  <sentence id="s1235" text="Other tumors (outside CT and CSS) that have SDH deficiency are associated with increased methylation of the entire genome, but only in CT there is site-specific methylation of the SDHC gene.">
    <entity charOffset="6-11" id="s1235.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="44-47" id="s1235.e1" ontology_id="1757" text="SDH" type="GENE"/>
    <pair e1="s1235.e0" e2="s1235.e1" id="s1235.p0" relation="true"/>
  </sentence>
  <sentence id="s1236" text="Indeed, patients with PCBD1 mutations were shown to suffer hypomagnesemia and MODY5-like diabetes.">
    <entity charOffset="22-27" id="s1236.e0" ontology_id="5092" text="PCBD1" type="GENE"/>
    <entity charOffset="59-73" id="s1236.e1" ontology_id="HP_0002917" text="hypomagnesemia" type="HP"/>
    <pair e1="s1236.e0" e2="s1236.e1" id="s1236.p0" relation="true"/>
  </sentence>
  <sentence id="s1237" text="Indeed, patients with PCBD1 mutations were shown to suffer hypomagnesemia and MODY5-like diabetes.">
    <entity charOffset="59-73" id="s1237.e0" ontology_id="HP_0002917" text="hypomagnesemia" type="HP"/>
    <entity charOffset="78-83" id="s1237.e1" ontology_id="6928" text="MODY5" type="GENE"/>
    <pair e1="s1237.e0" e2="s1237.e1" id="s1237.p0" relation="true"/>
  </sentence>
  <sentence id="s1238" text="Mutations in CNNM2 were shown to cause hypomagnesemia, seizures and intellectual disability.">
    <entity charOffset="13-18" id="s1238.e0" ontology_id="54805" text="CNNM2" type="GENE"/>
    <entity charOffset="39-53" id="s1238.e1" ontology_id="HP_0002917" text="hypomagnesemia" type="HP"/>
    <pair e1="s1238.e0" e2="s1238.e1" id="s1238.p0" relation="true"/>
  </sentence>
  <sentence id="s1239" text="Mutations in CNNM2 were shown to cause hypomagnesemia, seizures and intellectual disability.">
    <entity charOffset="13-18" id="s1239.e0" ontology_id="54805" text="CNNM2" type="GENE"/>
    <entity charOffset="68-91" id="s1239.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1239.e0" e2="s1239.e1" id="s1239.p0" relation="true"/>
  </sentence>
  <sentence id="s1240" text="In 2009, four families with a distal duplication of Xq28 not including MECP2 and mediated by low-copy repeats (LCRs) designated &amp;quot;K&amp;quot; and &amp;quot;L&amp;quot; were reported with intellectual disability and epilepsy.">
    <entity charOffset="71-76" id="s1240.e0" ontology_id="4204" text="MECP2" type="GENE"/>
    <entity charOffset="179-202" id="s1240.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1240.e0" e2="s1240.e1" id="s1240.p0" relation="true"/>
  </sentence>
  <sentence id="s1241" text="In 2009, four families with a distal duplication of Xq28 not including MECP2 and mediated by low-copy repeats (LCRs) designated &amp;quot;K&amp;quot; and &amp;quot;L&amp;quot; were reported with intellectual disability and epilepsy.">
    <entity charOffset="71-76" id="s1241.e0" ontology_id="4204" text="MECP2" type="GENE"/>
    <entity charOffset="207-215" id="s1241.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1241.e0" e2="s1241.e1" id="s1241.p0" relation="true"/>
  </sentence>
  <sentence id="s1242" text="BCOR immunohistochemical staining was performed on archival tissue from 28 high-grade endometrial stromal sarcomas with classic morphology (20 YWHAE-NUTM2, 5 ZC3H7B-BCOR, 3 BCOR-ZC3H7B), 3 high-grade endometrial stromal sarcomas with unusual morphology and unknown gene rearrangement status, 66 low-grade endometrial stromal sarcomas, 21 endometrial stromal nodules, 38 uterine leiomyosarcomas, and 19 uterine leiomyomas.">
    <entity charOffset="106-113" id="s1242.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="143-148" id="s1242.e1" ontology_id="7531" text="YWHAE" type="GENE"/>
    <pair e1="s1242.e0" e2="s1242.e1" id="s1242.p0" relation="true"/>
  </sentence>
  <sentence id="s1243" text="BCOR immunohistochemical staining was performed on archival tissue from 28 high-grade endometrial stromal sarcomas with classic morphology (20 YWHAE-NUTM2, 5 ZC3H7B-BCOR, 3 BCOR-ZC3H7B), 3 high-grade endometrial stromal sarcomas with unusual morphology and unknown gene rearrangement status, 66 low-grade endometrial stromal sarcomas, 21 endometrial stromal nodules, 38 uterine leiomyosarcomas, and 19 uterine leiomyomas.">
    <entity charOffset="106-113" id="s1243.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="158-164" id="s1243.e1" ontology_id="23264" text="ZC3H7B" type="GENE"/>
    <pair e1="s1243.e0" e2="s1243.e1" id="s1243.p0" relation="true"/>
  </sentence>
  <sentence id="s1244" text="Strong diffuse nuclear BCOR staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="23-27" id="s1244.e0" ontology_id="54880" text="BCOR" type="GENE"/>
    <entity charOffset="178-185" id="s1244.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1244.e0" e2="s1244.e1" id="s1244.p0" relation="true"/>
  </sentence>
  <sentence id="s1245" text="Strong diffuse nuclear BCOR staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="135-140" id="s1245.e0" ontology_id="7531" text="YWHAE" type="GENE"/>
    <entity charOffset="178-185" id="s1245.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1245.e0" e2="s1245.e1" id="s1245.p0" relation="true"/>
  </sentence>
  <sentence id="s1246" text="Strong diffuse nuclear BCOR staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="178-185" id="s1246.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="260-264" id="s1246.e1" ontology_id="9644" text="FISH" type="GENE"/>
    <pair e1="s1246.e0" e2="s1246.e1" id="s1246.p0" relation="true"/>
  </sentence>
  <sentence id="s1247" text="Strong diffuse nuclear BCOR staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="260-264" id="s1247.e0" ontology_id="9644" text="FISH" type="GENE"/>
    <entity charOffset="309-315" id="s1247.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1247.e0" e2="s1247.e1" id="s1247.p0" relation="true"/>
  </sentence>
  <sentence id="s1248" text="Diffuse BCOR staining was strong in three and weak in one BCOR-rearranged high-grade endometrial stromal sarcoma while absent in the remaining four BCOR-rearranged tumors.">
    <entity charOffset="8-12" id="s1248.e0" ontology_id="54880" text="BCOR" type="GENE"/>
    <entity charOffset="105-112" id="s1248.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1248.e0" e2="s1248.e1" id="s1248.p0" relation="true"/>
  </sentence>
  <sentence id="s1249" text="Diffuse BCOR staining was strong in three and weak in one BCOR-rearranged high-grade endometrial stromal sarcoma while absent in the remaining four BCOR-rearranged tumors.">
    <entity charOffset="8-12" id="s1249.e0" ontology_id="54880" text="BCOR" type="GENE"/>
    <entity charOffset="164-170" id="s1249.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1249.e0" e2="s1249.e1" id="s1249.p0" relation="false"/>
  </sentence>
  <sentence id="s1250" text="BCOR staining was weakly positive in &amp;lt;5% of tumor cells in 4 of 66 (6%) low-grade endometrial stromal sarcomas and 1 of 18 (6%) endometrial stromal nodules and weakly to moderately positive in &amp;lt;5-40% of tumor cells in 6 of 31 (19%) leiomyosarcomas.">
    <entity charOffset="0-4" id="s1250.e0" ontology_id="54880" text="BCOR" type="GENE"/>
    <entity charOffset="47-52" id="s1250.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1250.e0" e2="s1250.e1" id="s1250.p0" relation="true"/>
  </sentence>
  <sentence id="s1251" text="No BCOR staining was seen in the remaining low-grade endometrial stromal sarcomas, endometrial stromal nodules, leiomyosarcomas, or any of the leiomyomas.">
    <entity charOffset="3-7" id="s1251.e0" ontology_id="54880" text="BCOR" type="GENE"/>
    <entity charOffset="73-80" id="s1251.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1251.e0" e2="s1251.e1" id="s1251.p0" relation="true"/>
  </sentence>
  <sentence id="s1252" text="BCOR immunohistochemical staining is a highly sensitive marker for YWHAE-NUTM2 high-grade endometrial stromal sarcoma with both classic and unusual morphology and identifies a subset of high-grade endometrial stromal sarcoma with BCOR alterations, including BCOR rearrangement and internal tandem duplication">
    <entity charOffset="67-72" id="s1252.e0" ontology_id="7531" text="YWHAE" type="GENE"/>
    <entity charOffset="110-117" id="s1252.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1252.e0" e2="s1252.e1" id="s1252.p0" relation="true"/>
  </sentence>
  <sentence id="s1253" text="Furthermore, Ptrh2 expression is altered in skeletal muscle of classical congenital muscular dystrophy mouse models.">
    <entity charOffset="13-18" id="s1253.e0" ontology_id="51651" text="Ptrh2" type="GENE"/>
    <entity charOffset="84-102" id="s1253.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s1253.e0" e2="s1253.e1" id="s1253.p0" relation="true"/>
  </sentence>
  <sentence id="s1254" text="Ptrh2 levels were up-regulated in dystrophin deficient mdx muscle, which correlates with the elevated levels of the 71 integrin observed in mdx muscle and Duchenne muscular dystrophy patients.">
    <entity charOffset="0-5" id="s1254.e0" ontology_id="51651" text="Ptrh2" type="GENE"/>
    <entity charOffset="166-184" id="s1254.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s1254.e0" e2="s1254.e1" id="s1254.p0" relation="true"/>
  </sentence>
  <sentence id="s1255" text="Two pairwise genetic interactions (B cell lymphocyte kinase (BLK) rs13277113,B cell scaffold protein with ankyrin repeats 1 (BANK1) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (MMEL1)/ tumor necrosis factor receptor superfamily member 14 (TNFRSF14) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.">
    <entity charOffset="61-64" id="s1255.e0" ontology_id="640" text="BLK" type="GENE"/>
    <entity charOffset="206-211" id="s1255.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1255.e0" e2="s1255.e1" id="s1255.p0" relation="false"/>
  </sentence>
  <sentence id="s1256" text="Two pairwise genetic interactions (B cell lymphocyte kinase (BLK) rs13277113,B cell scaffold protein with ankyrin repeats 1 (BANK1) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (MMEL1)/ tumor necrosis factor receptor superfamily member 14 (TNFRSF14) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.">
    <entity charOffset="125-130" id="s1256.e0" ontology_id="55024" text="BANK1" type="GENE"/>
    <entity charOffset="206-211" id="s1256.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1256.e0" e2="s1256.e1" id="s1256.p0" relation="true"/>
  </sentence>
  <sentence id="s1257" text="Two pairwise genetic interactions (B cell lymphocyte kinase (BLK) rs13277113,B cell scaffold protein with ankyrin repeats 1 (BANK1) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (MMEL1)/ tumor necrosis factor receptor superfamily member 14 (TNFRSF14) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.">
    <entity charOffset="198-203" id="s1257.e0" ontology_id="79258" text="MMEL1" type="GENE"/>
    <entity charOffset="206-211" id="s1257.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1257.e0" e2="s1257.e1" id="s1257.p0" relation="true"/>
  </sentence>
  <sentence id="s1258" text="Two pairwise genetic interactions (B cell lymphocyte kinase (BLK) rs13277113,B cell scaffold protein with ankyrin repeats 1 (BANK1) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (MMEL1)/ tumor necrosis factor receptor superfamily member 14 (TNFRSF14) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.">
    <entity charOffset="206-211" id="s1258.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="260-268" id="s1258.e1" ontology_id="8764" text="TNFRSF14" type="GENE"/>
    <pair e1="s1258.e0" e2="s1258.e1" id="s1258.p0" relation="true"/>
  </sentence>
  <sentence id="s1259" text="The tumor necrosis factor (TNF) family ligand ectodysplasin A (EDA) is produced as 2 full-length splice variants, EDA1 and EDA2, that bind to EDA receptor (EDAR) and X-linked EDA receptor (XEDAR/EDA2R), respectively.">
    <entity charOffset="4-9" id="s1259.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="27-30" id="s1259.e1" ontology_id="7124" text="TNF" type="GENE"/>
    <pair e1="s1259.e0" e2="s1259.e1" id="s1259.p0" relation="true"/>
  </sentence>
  <sentence id="s1260" text="The tumor necrosis factor (TNF) family ligand ectodysplasin A (EDA) is produced as 2 full-length splice variants, EDA1 and EDA2, that bind to EDA receptor (EDAR) and X-linked EDA receptor (XEDAR/EDA2R), respectively.">
    <entity charOffset="4-9" id="s1260.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="63-66" id="s1260.e1" ontology_id="1896" text="EDA" type="GENE"/>
    <pair e1="s1260.e0" e2="s1260.e1" id="s1260.p0" relation="true"/>
  </sentence>
  <sentence id="s1261" text="Inactivating mutations in Eda or Edar cause hypohidrotic ectodermal dysplasia (HED), a condition characterized by malformations of the teeth, hair and glands, with milder deficiencies affecting only the teeth.">
    <entity charOffset="57-77" id="s1261.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="79-82" id="s1261.e1" ontology_id="1896" text="HED" type="GENE"/>
    <pair e1="s1261.e0" e2="s1261.e1" id="s1261.p0" relation="true"/>
  </sentence>
  <sentence id="s1262" text="Citrin deficiency is an autosomal recessive metabolic disorder, which is caused by pathogenic mutations in the SLC25A13 gene on chromosome 7q21.3, as the causative gene that encodes the liver type aspartate/glutamate carrier isoform 2 (AGC2).">
    <entity charOffset="24-43" id="s1262.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="192-196" id="s1262.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s1262.e0" e2="s1262.e1" id="s1262.p0" relation="true"/>
  </sentence>
  <sentence id="s1263" text="Smad4 has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (RCC) remained to be elusive.">
    <entity charOffset="0-5" id="s1263.e0" ontology_id="4089" text="Smad4" type="GENE"/>
    <entity charOffset="112-132" id="s1263.e1" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <pair e1="s1263.e0" e2="s1263.e1" id="s1263.p0" relation="true"/>
  </sentence>
  <sentence id="s1264" text="Smad4 has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (RCC) remained to be elusive.">
    <entity charOffset="40-45" id="s1264.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="134-137" id="s1264.e1" ontology_id="7515" text="RCC" type="GENE"/>
    <pair e1="s1264.e0" e2="s1264.e1" id="s1264.p0" relation="true"/>
  </sentence>
  <sentence id="s1265" text="Smad4 has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (RCC) remained to be elusive.">
    <entity charOffset="112-132" id="s1265.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="134-137" id="s1265.e1" ontology_id="7515" text="RCC" type="GENE"/>
    <pair e1="s1265.e0" e2="s1265.e1" id="s1265.p0" relation="true"/>
  </sentence>
  <sentence id="s1266" text="Hereditary sensory and autonomic neuropathies (HSAN) type II are characterized by autosomal recessive inheritance, onset at birth and self-mutilating behavior.">
    <entity charOffset="53-57" id="s1266.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="82-101" id="s1266.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1266.e0" e2="s1266.e1" id="s1266.p0" relation="true"/>
  </sentence>
  <sentence id="s1267" text="Tubulin alpha 8 (TUBA8) is highly abundant in murine liver tumors suggesting a role in hepatocellular carcinoma (HCC).">
    <entity charOffset="17-22" id="s1267.e0" ontology_id="51807" text="TUBA8" type="GENE"/>
    <entity charOffset="87-111" id="s1267.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1267.e0" e2="s1267.e1" id="s1267.p0" relation="true"/>
  </sentence>
  <sentence id="s1268" text="Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.">
    <entity charOffset="23-26" id="s1268.e0" ontology_id="583" text="BBS" type="GENE"/>
    <entity charOffset="88-95" id="s1268.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1268.e0" e2="s1268.e1" id="s1268.p0" relation="true"/>
  </sentence>
  <sentence id="s1269" text="Our results indicate that BBS in Japan is genetically heterogeneous and at least partly shares genetic features with BBS in other countries.">
    <entity charOffset="26-29" id="s1269.e0" ontology_id="583" text="BBS" type="GENE"/>
    <entity charOffset="54-67" id="s1269.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1269.e0" e2="s1269.e1" id="s1269.p0" relation="false"/>
  </sentence>
  <sentence id="s1270" text="The review then discusses the diseases associated with ClC2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.">
    <entity charOffset="55-58" id="s1270.e0" ontology_id="23529" text="ClC" type="GENE"/>
    <entity charOffset="132-141" id="s1270.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s1270.e0" e2="s1270.e1" id="s1270.p0" relation="true"/>
  </sentence>
  <sentence id="s1271" text="The review then discusses the diseases associated with ClC2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.">
    <entity charOffset="55-58" id="s1271.e0" ontology_id="23529" text="ClC" type="GENE"/>
    <entity charOffset="171-182" id="s1271.e1" ontology_id="HP_0000027" text="azoospermia" type="HP"/>
    <pair e1="s1271.e0" e2="s1271.e1" id="s1271.p0" relation="true"/>
  </sentence>
  <sentence id="s1272" text="The review then discusses the diseases associated with ClC2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.">
    <entity charOffset="55-58" id="s1272.e0" ontology_id="23529" text="ClC" type="GENE"/>
    <entity charOffset="189-195" id="s1272.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1272.e0" e2="s1272.e1" id="s1272.p0" relation="true"/>
  </sentence>
  <sentence id="s1273" text="The review then discusses the diseases associated with ClC2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.">
    <entity charOffset="55-58" id="s1273.e0" ontology_id="23529" text="ClC" type="GENE"/>
    <entity charOffset="305-313" id="s1273.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1273.e0" e2="s1273.e1" id="s1273.p0" relation="true"/>
  </sentence>
  <sentence id="s1274" text="Primary pigmented nodular adrenocortical disease (PPNAD) is the rarest form of ACTH-independent CS, and can be associated with endocrine and nonendocrine tumors, forming the Carney complex (CNC).">
    <entity charOffset="79-83" id="s1274.e0" ontology_id="5443" text="ACTH" type="GENE"/>
    <entity charOffset="154-160" id="s1274.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1274.e0" e2="s1274.e1" id="s1274.p0" relation="true"/>
  </sentence>
  <sentence id="s1275" text="The increased levels of SELENBP1 and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (BTG1), human leukocyte antigen DRB1 (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (HNRPA3), and serine/arginine-rich splicing factor 1 (SFRS1) genes have also been reported.">
    <entity charOffset="152-156" id="s1275.e0" ontology_id="694" text="BTG1" type="GENE"/>
    <entity charOffset="200-213" id="s1275.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1275.e0" e2="s1275.e1" id="s1275.p0" relation="true"/>
  </sentence>
  <sentence id="s1276" text="The increased levels of SELENBP1 and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (BTG1), human leukocyte antigen DRB1 (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (HNRPA3), and serine/arginine-rich splicing factor 1 (SFRS1) genes have also been reported.">
    <entity charOffset="183-187" id="s1276.e0" ontology_id="129831" text="DRB1" type="GENE"/>
    <entity charOffset="200-213" id="s1276.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1276.e0" e2="s1276.e1" id="s1276.p0" relation="false"/>
  </sentence>
  <sentence id="s1277" text="The increased levels of SELENBP1 and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (BTG1), human leukocyte antigen DRB1 (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (HNRPA3), and serine/arginine-rich splicing factor 1 (SFRS1) genes have also been reported.">
    <entity charOffset="200-213" id="s1277.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="244-250" id="s1277.e1" ontology_id="220988" text="HNRPA3" type="GENE"/>
    <pair e1="s1277.e0" e2="s1277.e1" id="s1277.p0" relation="true"/>
  </sentence>
  <sentence id="s1278" text="The increased levels of SELENBP1 and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (BTG1), human leukocyte antigen DRB1 (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (HNRPA3), and serine/arginine-rich splicing factor 1 (SFRS1) genes have also been reported.">
    <entity charOffset="200-213" id="s1278.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="297-302" id="s1278.e1" ontology_id="6426" text="SFRS1" type="GENE"/>
    <pair e1="s1278.e0" e2="s1278.e1" id="s1278.p0" relation="true"/>
  </sentence>
  <sentence id="s1279" text="Recently, hepaCAM was reported to be implicated in cancer development, and many researchers investigated its biological function in the tumorigenesis of various cancers.">
    <entity charOffset="10-17" id="s1279.e0" ontology_id="220296" text="hepaCAM" type="GENE"/>
    <entity charOffset="51-57" id="s1279.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1279.e0" e2="s1279.e1" id="s1279.p0" relation="true"/>
  </sentence>
  <sentence id="s1280" text="However, what kind of role hepaCAM plays in colorectal cancer (CRC) remains unknown.">
    <entity charOffset="27-34" id="s1280.e0" ontology_id="220296" text="hepaCAM" type="GENE"/>
    <entity charOffset="55-61" id="s1280.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1280.e0" e2="s1280.e1" id="s1280.p0" relation="true"/>
  </sentence>
  <sentence id="s1281" text="Furthermore, the tumorigenesis assay showed that increased expression of hepaCAM suppressed CRC tumor growth and metastasis in vivo.">
    <entity charOffset="17-22" id="s1281.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="73-80" id="s1281.e1" ontology_id="220296" text="hepaCAM" type="GENE"/>
    <pair e1="s1281.e0" e2="s1281.e1" id="s1281.p0" relation="true"/>
  </sentence>
  <sentence id="s1282" text="Substitution of endogenous PGAM2 with an acetylation mimetic mutant K100Q reduces cellular NADPH production and inhibits cell proliferation and tumor growth.">
    <entity charOffset="27-32" id="s1282.e0" ontology_id="5224" text="PGAM2" type="GENE"/>
    <entity charOffset="144-149" id="s1282.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1282.e0" e2="s1282.e1" id="s1282.p0" relation="true"/>
  </sentence>
  <sentence id="s1283" text="These results reveal a mechanism of PGAM2 regulation and NADPH homeostasis in response to oxidative stress that impacts cell proliferation and tumor growth">
    <entity charOffset="36-41" id="s1283.e0" ontology_id="5224" text="PGAM2" type="GENE"/>
    <entity charOffset="143-148" id="s1283.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1283.e0" e2="s1283.e1" id="s1283.p0" relation="true"/>
  </sentence>
  <sentence id="s1284" text="The aberrant glucose metabolism is one of the hallmarks of cancer cells, and as a branch of glucose metabolism, hexosamine biosynthesis pathway (HBP) has been reported to play a critical role in the insulin resistance and progression of cancer.">
    <entity charOffset="59-65" id="s1284.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="145-148" id="s1284.e1" ontology_id="566" text="HBP" type="GENE"/>
    <pair e1="s1284.e0" e2="s1284.e1" id="s1284.p0" relation="true"/>
  </sentence>
  <sentence id="s1285" text="Glutamine:fructose-6-phosphate amidotransferase (GFAT1) is the rate-limiting enzyme of the HBP; nevertheless, the prognostic value of GFAT1 in pancreatic cancer remains elusive.">
    <entity charOffset="49-54" id="s1285.e0" ontology_id="2673" text="GFAT1" type="GENE"/>
    <entity charOffset="154-160" id="s1285.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1285.e0" e2="s1285.e1" id="s1285.p0" relation="false"/>
  </sentence>
  <sentence id="s1286" text="Glutamine:fructose-6-phosphate amidotransferase (GFAT1) is the rate-limiting enzyme of the HBP; nevertheless, the prognostic value of GFAT1 in pancreatic cancer remains elusive.">
    <entity charOffset="91-94" id="s1286.e0" ontology_id="566" text="HBP" type="GENE"/>
    <entity charOffset="154-160" id="s1286.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1286.e0" e2="s1286.e1" id="s1286.p0" relation="true"/>
  </sentence>
  <sentence id="s1287" text="In this study, we found that the expression of GFAT1 was increased in pancreatic cancer samples compared to peri-tumor tissues.">
    <entity charOffset="47-52" id="s1287.e0" ontology_id="2673" text="GFAT1" type="GENE"/>
    <entity charOffset="113-118" id="s1287.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1287.e0" e2="s1287.e1" id="s1287.p0" relation="true"/>
  </sentence>
  <sentence id="s1288" text="GFAT1 was identified as an independent prognosticator for OS, and combining GFAT1 expression with pTNM stage generated a predictive nomogram, which showed better prognostic efficiency for OS in patients with pancreatic cancer.">
    <entity charOffset="0-5" id="s1288.e0" ontology_id="2673" text="GFAT1" type="GENE"/>
    <entity charOffset="219-225" id="s1288.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1288.e0" e2="s1288.e1" id="s1288.p0" relation="true"/>
  </sentence>
  <sentence id="s1289" text="In summary, high GFAT1 expression is identified as an independent predictor of adverse clinical outcome in our small number of pancreatic cancer patients, and the practical prognostic nomogram model may help clinicians in decision making and the design of clinical studies">
    <entity charOffset="17-22" id="s1289.e0" ontology_id="2673" text="GFAT1" type="GENE"/>
    <entity charOffset="138-144" id="s1289.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1289.e0" e2="s1289.e1" id="s1289.p0" relation="true"/>
  </sentence>
  <sentence id="s1290" text="There was a significantly higher expression level of FOXP1 in the tumour than in the adjacent normal tissue (0.0052  0.0021 vs 0.0027  0.0018, P &amp;lt; 0.001).">
    <entity charOffset="53-58" id="s1290.e0" ontology_id="27086" text="FOXP1" type="GENE"/>
    <entity charOffset="66-72" id="s1290.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1290.e0" e2="s1290.e1" id="s1290.p0" relation="true"/>
  </sentence>
  <sentence id="s1291" text="Patients with genotype AA were found to have remarkably higher FOXP1 expression in the tumour than those with genotype CC (P = 0.01).">
    <entity charOffset="63-68" id="s1291.e0" ontology_id="27086" text="FOXP1" type="GENE"/>
    <entity charOffset="87-93" id="s1291.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1291.e0" e2="s1291.e1" id="s1291.p0" relation="true"/>
  </sentence>
  <sentence id="s1292" text="The search for clinically relevant molecular markers in classical Hodgkin lymphoma (cHL) is hampered by the histopathological complexity of the disease, resulting from the admixture of a small number of neoplastic Hodgkin and Reed-Sternberg (H-RS) cells with an abundant and heterogeneous microenvironment.">
    <entity charOffset="244-246" id="s1292.e0" ontology_id="5308" text="RS" type="GENE"/>
    <entity charOffset="275-288" id="s1292.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1292.e0" e2="s1292.e1" id="s1292.p0" relation="true"/>
  </sentence>
  <sentence id="s1293" text="We reinforce the potential of CASP3 as an interesting target to be explored in adult and pediatric cHL, and alert for its dual biological role in H-RS cells and tumor microenvironment">
    <entity charOffset="30-35" id="s1293.e0" ontology_id="836" text="CASP3" type="GENE"/>
    <entity charOffset="161-166" id="s1293.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1293.e0" e2="s1293.e1" id="s1293.p0" relation="true"/>
  </sentence>
  <sentence id="s1294" text="BACKGROUND The aim of this study was to investigate the prognostic relevance of CEP55 in lung cancer (LC).">
    <entity charOffset="80-85" id="s1294.e0" ontology_id="55165" text="CEP55" type="GENE"/>
    <entity charOffset="94-100" id="s1294.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1294.e0" e2="s1294.e1" id="s1294.p0" relation="true"/>
  </sentence>
  <sentence id="s1295" text="Among the available genomic studies, the key findings in Africa were variants in GATA4 (P193H), MTHFR 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (TOF), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.">
    <entity charOffset="81-86" id="s1295.e0" ontology_id="2626" text="GATA4" type="GENE"/>
    <entity charOffset="152-172" id="s1295.e1" ontology_id="HP_0001631" text="atrial septal defect" type="HP"/>
    <pair e1="s1295.e0" e2="s1295.e1" id="s1295.p0" relation="true"/>
  </sentence>
  <sentence id="s1296" text="Among the available genomic studies, the key findings in Africa were variants in GATA4 (P193H), MTHFR 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (TOF), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.">
    <entity charOffset="81-86" id="s1296.e0" ontology_id="2626" text="GATA4" type="GENE"/>
    <entity charOffset="174-199" id="s1296.e1" ontology_id="HP_0001629" text="ventricular septal defect" type="HP"/>
    <pair e1="s1296.e0" e2="s1296.e1" id="s1296.p0" relation="true"/>
  </sentence>
  <sentence id="s1297" text="Among the available genomic studies, the key findings in Africa were variants in GATA4 (P193H), MTHFR 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (TOF), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.">
    <entity charOffset="96-101" id="s1297.e0" ontology_id="4524" text="MTHFR" type="GENE"/>
    <entity charOffset="152-172" id="s1297.e1" ontology_id="HP_0001631" text="atrial septal defect" type="HP"/>
    <pair e1="s1297.e0" e2="s1297.e1" id="s1297.p0" relation="true"/>
  </sentence>
  <sentence id="s1298" text="Among the available genomic studies, the key findings in Africa were variants in GATA4 (P193H), MTHFR 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (TOF), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.">
    <entity charOffset="96-101" id="s1298.e0" ontology_id="4524" text="MTHFR" type="GENE"/>
    <entity charOffset="174-199" id="s1298.e1" ontology_id="HP_0001629" text="ventricular septal defect" type="HP"/>
    <pair e1="s1298.e0" e2="s1298.e1" id="s1298.p0" relation="true"/>
  </sentence>
  <sentence id="s1299" text="Kruppel-like factor 9 (KLF9), a transcription factor, is critical for the inhibition of growth and development of tumors, whereas its effects in pancreatic cancer remains unclear.">
    <entity charOffset="23-27" id="s1299.e0" ontology_id="687" text="KLF9" type="GENE"/>
    <entity charOffset="114-120" id="s1299.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1299.e0" e2="s1299.e1" id="s1299.p0" relation="true"/>
  </sentence>
  <sentence id="s1300" text="Kruppel-like factor 9 (KLF9), a transcription factor, is critical for the inhibition of growth and development of tumors, whereas its effects in pancreatic cancer remains unclear.">
    <entity charOffset="23-27" id="s1300.e0" ontology_id="687" text="KLF9" type="GENE"/>
    <entity charOffset="156-162" id="s1300.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1300.e0" e2="s1300.e1" id="s1300.p0" relation="true"/>
  </sentence>
  <sentence id="s1301" text="The levels of KLF9 expression in adjacent tissues and pancreatic cancer tissues were detected using immunohistochemistry.">
    <entity charOffset="14-18" id="s1301.e0" ontology_id="687" text="KLF9" type="GENE"/>
    <entity charOffset="65-71" id="s1301.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1301.e0" e2="s1301.e1" id="s1301.p0" relation="true"/>
  </sentence>
  <sentence id="s1302" text="Using flow cytometric analysis and CCK-8, we evaluated the effects of KLF9 expression on cell apoptosis, the cell cycle and proliferation of pancreatic cancer cells.">
    <entity charOffset="35-38" id="s1302.e0" ontology_id="885" text="CCK" type="GENE"/>
    <entity charOffset="152-158" id="s1302.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1302.e0" e2="s1302.e1" id="s1302.p0" relation="true"/>
  </sentence>
  <sentence id="s1303" text="Using flow cytometric analysis and CCK-8, we evaluated the effects of KLF9 expression on cell apoptosis, the cell cycle and proliferation of pancreatic cancer cells.">
    <entity charOffset="70-74" id="s1303.e0" ontology_id="687" text="KLF9" type="GENE"/>
    <entity charOffset="152-158" id="s1303.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1303.e0" e2="s1303.e1" id="s1303.p0" relation="true"/>
  </sentence>
  <sentence id="s1304" text="Our results revealed that in both tissue samples and cell lines (particularly in BxPC-3 and PANC-1 cells) of pancreatic cancer, KLF9 exhibited relatively lower expression.">
    <entity charOffset="120-126" id="s1304.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="128-132" id="s1304.e1" ontology_id="687" text="KLF9" type="GENE"/>
    <pair e1="s1304.e0" e2="s1304.e1" id="s1304.p0" relation="true"/>
  </sentence>
  <sentence id="s1305" text="In PANC-1 and BxPC-3 cells, KLF9 overexpression decreased the proliferation of pancreatic cancer cells, induced apoptosis, blocked the cell cycle at the Sphase, and inhibited the migration and invasion of tumor cells.">
    <entity charOffset="28-32" id="s1305.e0" ontology_id="687" text="KLF9" type="GENE"/>
    <entity charOffset="206-211" id="s1305.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1305.e0" e2="s1305.e1" id="s1305.p0" relation="true"/>
  </sentence>
  <sentence id="s1306" text="As in MOPDII patients, disruption of pericentrin (Pcnt) in mice caused a number of abnormalities including microcephaly, aberrant hemodynamics analyzed by in utero echocardiography, and cardiovascular anomalies; the latter being associated with mortality, as in the human condition.">
    <entity charOffset="50-54" id="s1306.e0" ontology_id="5116" text="Pcnt" type="GENE"/>
    <entity charOffset="107-119" id="s1306.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1306.e0" e2="s1306.e1" id="s1306.p0" relation="true"/>
  </sentence>
  <sentence id="s1307" text="In order to determine the role of Flii during carcinogenesis, squamous cell carcinomas (SCCs) were induced in Flii heterozygous (Flii+/-), wild-type and Flii overexpressing (FliiTg/Tg) mice by intradermal injection of 3-methylcholanthrene (MCA).">
    <entity charOffset="34-38" id="s1307.e0" ontology_id="2314" text="Flii" type="GENE"/>
    <entity charOffset="62-86" id="s1307.e1" ontology_id="HP_0002860" text="squamous cell carcinomas" type="HP"/>
    <pair e1="s1307.e0" e2="s1307.e1" id="s1307.p0" relation="true"/>
  </sentence>
  <sentence id="s1308" text="Flii was highly expressed in human SCC biopsies particularly by the invading cells at the tumor edge.">
    <entity charOffset="0-4" id="s1308.e0" ontology_id="2314" text="Flii" type="GENE"/>
    <entity charOffset="90-95" id="s1308.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1308.e0" e2="s1308.e1" id="s1308.p0" relation="false"/>
  </sentence>
  <sentence id="s1309" text="In contrast Flii+/- mice had significantly smaller tumors that were less invasive.">
    <entity charOffset="12-16" id="s1309.e0" ontology_id="2314" text="Flii" type="GENE"/>
    <entity charOffset="51-56" id="s1309.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1309.e0" e2="s1309.e1" id="s1309.p0" relation="true"/>
  </sentence>
  <sentence id="s1310" text="Intradermal injection of Flii neutralizing antibodies during SCC initiation and progression significantly reduced the size of the tumors and, in vitro, decreased cellular sphere formation and invasion.">
    <entity charOffset="25-29" id="s1310.e0" ontology_id="2314" text="Flii" type="GENE"/>
    <entity charOffset="130-135" id="s1310.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1310.e0" e2="s1310.e1" id="s1310.p0" relation="true"/>
  </sentence>
  <sentence id="s1311" text="Analysis of the tumors from the Flii overexpressing mice showed reduced caspase I and annexin V expression suggesting Flii may negatively regulate apoptosis within these tumors.">
    <entity charOffset="16-21" id="s1311.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="32-36" id="s1311.e1" ontology_id="2314" text="Flii" type="GENE"/>
    <pair e1="s1311.e0" e2="s1311.e1" id="s1311.p0" relation="true"/>
  </sentence>
  <sentence id="s1312" text="These studies therefore suggest that Flii enhances SCC tumor progression by decreasing apoptosis and enhancing tumor cell invasion.">
    <entity charOffset="37-41" id="s1312.e0" ontology_id="2314" text="Flii" type="GENE"/>
    <entity charOffset="55-60" id="s1312.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1312.e0" e2="s1312.e1" id="s1312.p0" relation="true"/>
  </sentence>
  <sentence id="s1313" text="These studies therefore suggest that Flii enhances SCC tumor progression by decreasing apoptosis and enhancing tumor cell invasion.">
    <entity charOffset="51-54" id="s1313.e0" ontology_id="6317" text="SCC" type="GENE"/>
    <entity charOffset="55-60" id="s1313.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1313.e0" e2="s1313.e1" id="s1313.p0" relation="true"/>
  </sentence>
  <sentence id="s1314" text="Since RAPSN-associated limb-girdle type CMS was only manifested in AK9 homozygous variant carriers, the disease phenotype was of digenic inheritance, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.">
    <entity charOffset="6-11" id="s1314.e0" ontology_id="5913" text="RAPSN" type="GENE"/>
    <entity charOffset="129-148" id="s1314.e1" ontology_id="HP_0010984" text="digenic inheritance" type="HP"/>
    <pair e1="s1314.e0" e2="s1314.e1" id="s1314.p0" relation="true"/>
  </sentence>
  <sentence id="s1315" text="Since RAPSN-associated limb-girdle type CMS was only manifested in AK9 homozygous variant carriers, the disease phenotype was of digenic inheritance, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.">
    <entity charOffset="40-43" id="s1315.e0" ontology_id="23607" text="CMS" type="GENE"/>
    <entity charOffset="129-148" id="s1315.e1" ontology_id="HP_0010984" text="digenic inheritance" type="HP"/>
    <pair e1="s1315.e0" e2="s1315.e1" id="s1315.p0" relation="true"/>
  </sentence>
  <sentence id="s1316" text="Since RAPSN-associated limb-girdle type CMS was only manifested in AK9 homozygous variant carriers, the disease phenotype was of digenic inheritance, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.">
    <entity charOffset="67-70" id="s1316.e0" ontology_id="221264" text="AK9" type="GENE"/>
    <entity charOffset="129-148" id="s1316.e1" ontology_id="HP_0010984" text="digenic inheritance" type="HP"/>
    <pair e1="s1316.e0" e2="s1316.e1" id="s1316.p0" relation="true"/>
  </sentence>
  <sentence id="s1317" text="Mutations in both proteins cause lens cataract and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of filensin (BFSP1) and CP49 (BFSP2) in the lens.">
    <entity charOffset="38-46" id="s1317.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="195-200" id="s1317.e1" ontology_id="631" text="BFSP1" type="GENE"/>
    <pair e1="s1317.e0" e2="s1317.e1" id="s1317.p0" relation="true"/>
  </sentence>
  <sentence id="s1318" text="Mutations in both proteins cause lens cataract and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of filensin (BFSP1) and CP49 (BFSP2) in the lens.">
    <entity charOffset="38-46" id="s1318.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="212-217" id="s1318.e1" ontology_id="8419" text="BFSP2" type="GENE"/>
    <pair e1="s1318.e0" e2="s1318.e1" id="s1318.p0" relation="true"/>
  </sentence>
  <sentence id="s1319" text="Mutations in both proteins cause lens cataract and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of filensin (BFSP1) and CP49 (BFSP2) in the lens.">
    <entity charOffset="38-46" id="s1319.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="185-193" id="s1319.e1" ontology_id="631" text="filensin" type="GENE"/>
    <pair e1="s1319.e0" e2="s1319.e1" id="s1319.p0" relation="true"/>
  </sentence>
  <sentence id="s1320" text="With the first filensin (BFSP1) mutation now having been reported to cause a recessive cataract phenotype, there is the suggestion that the mutation could predispose heterozygote carriers to the early onset of age-related nuclear cataract.">
    <entity charOffset="25-30" id="s1320.e0" ontology_id="631" text="BFSP1" type="GENE"/>
    <entity charOffset="87-95" id="s1320.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s1320.e0" e2="s1320.e1" id="s1320.p0" relation="false"/>
  </sentence>
  <sentence id="s1321" text="A TERE1-TBL2 complex likely functions in oxidative/nitrosative stress, lipid metabolism, and SXR signaling pathways in its role as a tumor suppressor">
    <entity charOffset="2-7" id="s1321.e0" ontology_id="29914" text="TERE1" type="GENE"/>
    <entity charOffset="133-138" id="s1321.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1321.e0" e2="s1321.e1" id="s1321.p0" relation="true"/>
  </sentence>
  <sentence id="s1322" text="A TERE1-TBL2 complex likely functions in oxidative/nitrosative stress, lipid metabolism, and SXR signaling pathways in its role as a tumor suppressor">
    <entity charOffset="8-12" id="s1322.e0" ontology_id="26608" text="TBL2" type="GENE"/>
    <entity charOffset="133-138" id="s1322.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1322.e0" e2="s1322.e1" id="s1322.p0" relation="true"/>
  </sentence>
  <sentence id="s1323" text="A TERE1-TBL2 complex likely functions in oxidative/nitrosative stress, lipid metabolism, and SXR signaling pathways in its role as a tumor suppressor">
    <entity charOffset="93-96" id="s1323.e0" ontology_id="8856" text="SXR" type="GENE"/>
    <entity charOffset="133-138" id="s1323.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1323.e0" e2="s1323.e1" id="s1323.p0" relation="true"/>
  </sentence>
  <sentence id="s1324" text="Here, we show that ethanol treatment (100 mM) promotes ROS production and oxidative stress in cancer-associated fibroblasts, which is sufficient to induce myofibroblastic differentiation.">
    <entity charOffset="55-58" id="s1324.e0" ontology_id="6098" text="ROS" type="GENE"/>
    <entity charOffset="94-100" id="s1324.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1324.e0" e2="s1324.e1" id="s1324.p0" relation="true"/>
  </sentence>
  <sentence id="s1325" text="Remarkably, our results also show that antioxidants [such as N-acetyl cysteine (NAC)] can effectively reverse or prevent ethanol-induced oxidative stress in cancer-associated fibroblasts, suggesting a novel strategy for cancer prevention.">
    <entity charOffset="80-83" id="s1325.e0" ontology_id="22861" text="NAC" type="GENE"/>
    <entity charOffset="157-163" id="s1325.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1325.e0" e2="s1325.e1" id="s1325.p0" relation="true"/>
  </sentence>
  <sentence id="s1326" text="DNA damage causes SPINK1 expression by engaging NF-B and C/EBP, while paracrine SPINK1 promotes cancer cell aggressiveness particularly chemoresistance.">
    <entity charOffset="4-10" id="s1326.e0" ontology_id="51438" text="damage" type="GENE"/>
    <entity charOffset="97-103" id="s1326.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1326.e0" e2="s1326.e1" id="s1326.p0" relation="true"/>
  </sentence>
  <sentence id="s1327" text="DNA damage causes SPINK1 expression by engaging NF-B and C/EBP, while paracrine SPINK1 promotes cancer cell aggressiveness particularly chemoresistance.">
    <entity charOffset="18-24" id="s1327.e0" ontology_id="6690" text="SPINK1" type="GENE"/>
    <entity charOffset="97-103" id="s1327.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1327.e0" e2="s1327.e1" id="s1327.p0" relation="true"/>
  </sentence>
  <sentence id="s1328" text="DNA damage causes SPINK1 expression by engaging NF-B and C/EBP, while paracrine SPINK1 promotes cancer cell aggressiveness particularly chemoresistance.">
    <entity charOffset="48-50" id="s1328.e0" ontology_id="23114" text="NF" type="GENE"/>
    <entity charOffset="97-103" id="s1328.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1328.e0" e2="s1328.e1" id="s1328.p0" relation="true"/>
  </sentence>
  <sentence id="s1329" text="Strikingly, SPINK1 reprograms the expression profile of cancer cells, causing prominent epithelial-endothelial transition (EET), a phenotypic switch mediated by EGFR signaling but hitherto rarely reported for a SASP factor.">
    <entity charOffset="56-62" id="s1329.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="161-165" id="s1329.e1" ontology_id="1956" text="EGFR" type="GENE"/>
    <pair e1="s1329.e0" e2="s1329.e1" id="s1329.p0" relation="true"/>
  </sentence>
  <sentence id="s1330" text="In vivo, SPINK1 is expressed in the stroma of solid tumours and is routinely detectable in peripheral blood of cancer patients after chemotherapy.">
    <entity charOffset="9-15" id="s1330.e0" ontology_id="6690" text="SPINK1" type="GENE"/>
    <entity charOffset="111-117" id="s1330.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1330.e0" e2="s1330.e1" id="s1330.p0" relation="true"/>
  </sentence>
  <sentence id="s1331" text="Cytochrome P450 3A5 (CYP3A5) metabolizes these compounds in tumors of the exocrine-like subtype, and pharmacological or short hairpin RNA (shRNA)-mediated CYP3A5 inhibition sensitizes tumor cells to these drugs.">
    <entity charOffset="21-27" id="s1331.e0" ontology_id="1577" text="CYP3A5" type="GENE"/>
    <entity charOffset="60-66" id="s1331.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1331.e0" e2="s1331.e1" id="s1331.p0" relation="true"/>
  </sentence>
  <sentence id="s1332" text="Cytochrome P450 3A5 (CYP3A5) metabolizes these compounds in tumors of the exocrine-like subtype, and pharmacological or short hairpin RNA (shRNA)-mediated CYP3A5 inhibition sensitizes tumor cells to these drugs.">
    <entity charOffset="21-27" id="s1332.e0" ontology_id="1577" text="CYP3A5" type="GENE"/>
    <entity charOffset="184-189" id="s1332.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1332.e0" e2="s1332.e1" id="s1332.p0" relation="true"/>
  </sentence>
  <sentence id="s1333" text="Activating mutations in the KIT or PDGFRA receptor tyrosine kinases are hallmarks of gastrointestinal stromal tumor (GIST).">
    <entity charOffset="28-31" id="s1333.e0" ontology_id="3815" text="KIT" type="GENE"/>
    <entity charOffset="110-115" id="s1333.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1333.e0" e2="s1333.e1" id="s1333.p0" relation="true"/>
  </sentence>
  <sentence id="s1334" text="Activating mutations in the KIT or PDGFRA receptor tyrosine kinases are hallmarks of gastrointestinal stromal tumor (GIST).">
    <entity charOffset="35-41" id="s1334.e0" ontology_id="5156" text="PDGFRA" type="GENE"/>
    <entity charOffset="110-115" id="s1334.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1334.e0" e2="s1334.e1" id="s1334.p0" relation="true"/>
  </sentence>
  <sentence id="s1335" text="Inactivating NF1 mutations were present in 46% of melanomas expressing wild-type BRAF and RAS, occurred in older patients and showed a distinct pattern of co-mutation with other RASopathy genes, particularly RASA2.">
    <entity charOffset="50-59" id="s1335.e0" ontology_id="HP_0002861" text="melanomas" type="HP"/>
    <entity charOffset="81-85" id="s1335.e1" ontology_id="673" text="BRAF" type="GENE"/>
    <pair e1="s1335.e0" e2="s1335.e1" id="s1335.p0" relation="true"/>
  </sentence>
  <sentence id="s1336" text="A novel hereditary disorder encompassing high blood Mn levels, dystonia, polycythemia, distinctive T1 hyperintense signals in the basal ganglia on magnetic resonance imaging (MRI) brain, and chronic liver disease was recently described.">
    <entity charOffset="73-85" id="s1336.e0" ontology_id="HP_0001901" text="polycythemia" type="HP"/>
    <entity charOffset="99-101" id="s1336.e1" ontology_id="921" text="T1" type="GENE"/>
    <pair e1="s1336.e0" e2="s1336.e1" id="s1336.p0" relation="true"/>
  </sentence>
  <sentence id="s1337" text="The older brother presented with progressive gait difficulties, hypotonia, intermittent dystonia, polycythemia, and characteristic T1-hyperintense lesions on MRI brain.">
    <entity charOffset="88-96" id="s1337.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="131-133" id="s1337.e1" ontology_id="921" text="T1" type="GENE"/>
    <pair e1="s1337.e0" e2="s1337.e1" id="s1337.p0" relation="true"/>
  </sentence>
  <sentence id="s1338" text="The older brother presented with progressive gait difficulties, hypotonia, intermittent dystonia, polycythemia, and characteristic T1-hyperintense lesions on MRI brain.">
    <entity charOffset="98-110" id="s1338.e0" ontology_id="HP_0001901" text="polycythemia" type="HP"/>
    <entity charOffset="131-133" id="s1338.e1" ontology_id="921" text="T1" type="GENE"/>
    <pair e1="s1338.e0" e2="s1338.e1" id="s1338.p0" relation="true"/>
  </sentence>
  <sentence id="s1339" text="A growing body of clinical literature emphasizes the impact of cerebral edema in early brain injury following aneurysmal subarachnoid hemorrhage (aSAH).">
    <entity charOffset="53-59" id="s1339.e0" ontology_id="55364" text="impact" type="GENE"/>
    <entity charOffset="63-77" id="s1339.e1" ontology_id="HP_0002181" text="cerebral edema" type="HP"/>
    <pair e1="s1339.e0" e2="s1339.e1" id="s1339.p0" relation="true"/>
  </sentence>
  <sentence id="s1340" text="Although cerebral edema is not a universal feature of aSAH, it portends a poor clinical course, with quantitative analysis revealing a direct correlation between cerebral edema and poor outcome, including mortality and cognitive deficits.">
    <entity charOffset="9-23" id="s1340.e0" ontology_id="HP_0002181" text="cerebral edema" type="HP"/>
    <entity charOffset="54-58" id="s1340.e1" ontology_id="427" text="aSAH" type="GENE"/>
    <pair e1="s1340.e0" e2="s1340.e1" id="s1340.p0" relation="true"/>
  </sentence>
  <sentence id="s1341" text="Here, we review these cellular and molecular mechanisms of global cerebral edema formation in aSAH.">
    <entity charOffset="66-80" id="s1341.e0" ontology_id="HP_0002181" text="cerebral edema" type="HP"/>
    <entity charOffset="94-98" id="s1341.e1" ontology_id="427" text="aSAH" type="GENE"/>
    <pair e1="s1341.e0" e2="s1341.e1" id="s1341.p0" relation="true"/>
  </sentence>
  <sentence id="s1342" text="Given the importance of edema to the outcome of patients with aSAH and its status as a highly modifiable pathological process, a better understanding of cerebral edema in aSAH promises to hasten the development of medical therapies to improve outcomes in this frequently devastating disease">
    <entity charOffset="24-29" id="s1342.e0" ontology_id="HP_0000969" text="edema" type="HP"/>
    <entity charOffset="62-66" id="s1342.e1" ontology_id="427" text="aSAH" type="GENE"/>
    <pair e1="s1342.e0" e2="s1342.e1" id="s1342.p0" relation="true"/>
  </sentence>
  <sentence id="s1343" text="Schizophrenia (SZ) and autism spectrum disorders (ASD) are highly heritable neuropsychiatric disorders, although environmental factors, such as maternal immune activation (MIA), play a role as well.">
    <entity charOffset="23-29" id="s1343.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="172-175" id="s1343.e1" ontology_id="8190" text="MIA" type="GENE"/>
    <pair e1="s1343.e0" e2="s1343.e1" id="s1343.p0" relation="true"/>
  </sentence>
  <sentence id="s1344" text="Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.">
    <entity charOffset="20-25" id="s1344.e0" ontology_id="1639" text="DCTN1" type="GENE"/>
    <entity charOffset="54-62" id="s1344.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1344.e0" e2="s1344.e1" id="s1344.p0" relation="true"/>
  </sentence>
  <sentence id="s1345" text="Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.">
    <entity charOffset="54-62" id="s1345.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="63-66" id="s1345.e1" ontology_id="3483" text="ALS" type="GENE"/>
    <pair e1="s1345.e0" e2="s1345.e1" id="s1345.p0" relation="true"/>
  </sentence>
  <sentence id="s1346" text="Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.">
    <entity charOffset="54-62" id="s1346.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="84-88" id="s1346.e1" ontology_id="6647" text="SOD1" type="GENE"/>
    <pair e1="s1346.e0" e2="s1346.e1" id="s1346.p0" relation="true"/>
  </sentence>
  <sentence id="s1347" text="Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.">
    <entity charOffset="54-62" id="s1347.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="90-96" id="s1347.e1" ontology_id="23435" text="TARDBP" type="GENE"/>
    <pair e1="s1347.e0" e2="s1347.e1" id="s1347.p0" relation="true"/>
  </sentence>
  <sentence id="s1348" text="Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.">
    <entity charOffset="54-62" id="s1348.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="98-101" id="s1348.e1" ontology_id="2521" text="FUS" type="GENE"/>
    <pair e1="s1348.e0" e2="s1348.e1" id="s1348.p0" relation="true"/>
  </sentence>
  <sentence id="s1349" text="Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.">
    <entity charOffset="54-62" id="s1349.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="107-114" id="s1349.e1" ontology_id="203228" text="C9orf72" type="GENE"/>
    <pair e1="s1349.e0" e2="s1349.e1" id="s1349.p0" relation="true"/>
  </sentence>
  <sentence id="s1350" text="Subsequent mutation analyses identified tumor-associated calcium signal transducer 2 (TACSTD2; former name, M1S1) as the gene responsible for GDLD.">
    <entity charOffset="40-45" id="s1350.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="86-93" id="s1350.e1" ontology_id="4070" text="TACSTD2" type="GENE"/>
    <pair e1="s1350.e0" e2="s1350.e1" id="s1350.p0" relation="true"/>
  </sentence>
  <sentence id="s1351" text="BACKGROUND The distribution of fat mass and obesity-associated gene (FTO) genes rs9939609 and rs1421085 in obese and normal ethnic Mongolians was analyzed to investigate the association of FTO gene polymorphisms with obesity and metabolic syndrome in ethnic Mongolians.">
    <entity charOffset="35-39" id="s1351.e0" ontology_id="2200" text="mass" type="GENE"/>
    <entity charOffset="44-51" id="s1351.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1351.e0" e2="s1351.e1" id="s1351.p0" relation="true"/>
  </sentence>
  <sentence id="s1352" text="RESULTS Body mass, body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-hip ratio (WHR), SBP, DBP, FPG, triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were higher, while HDL-C was lower in the obesity group compared with controls.">
    <entity charOffset="13-17" id="s1352.e0" ontology_id="2200" text="mass" type="GENE"/>
    <entity charOffset="263-270" id="s1352.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1352.e0" e2="s1352.e1" id="s1352.p0" relation="true"/>
  </sentence>
  <sentence id="s1353" text="RESULTS Body mass, body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-hip ratio (WHR), SBP, DBP, FPG, triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were higher, while HDL-C was lower in the obesity group compared with controls.">
    <entity charOffset="120-123" id="s1353.e0" ontology_id="2638" text="DBP" type="GENE"/>
    <entity charOffset="263-270" id="s1353.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1353.e0" e2="s1353.e1" id="s1353.p0" relation="true"/>
  </sentence>
  <sentence id="s1354" text="It has been reported that N-myc downstream regulated gene 1 (NDRG1) is related to the prognosis of non-small cell lung cancer (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.">
    <entity charOffset="119-125" id="s1354.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="155-160" id="s1354.e1" ontology_id="4609" text="c-Myc" type="GENE"/>
    <pair e1="s1354.e0" e2="s1354.e1" id="s1354.p0" relation="true"/>
  </sentence>
  <sentence id="s1355" text="However, the relationship of NDRG1 to prognosis or c-Myc expression in lung adenocarcinoma has not been well clarified.">
    <entity charOffset="29-34" id="s1355.e0" ontology_id="10397" text="NDRG1" type="GENE"/>
    <entity charOffset="71-90" id="s1355.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1355.e0" e2="s1355.e1" id="s1355.p0" relation="true"/>
  </sentence>
  <sentence id="s1356" text="However, the relationship of NDRG1 to prognosis or c-Myc expression in lung adenocarcinoma has not been well clarified.">
    <entity charOffset="51-56" id="s1356.e0" ontology_id="4609" text="c-Myc" type="GENE"/>
    <entity charOffset="71-90" id="s1356.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1356.e0" e2="s1356.e1" id="s1356.p0" relation="true"/>
  </sentence>
  <sentence id="s1357" text="The present study was designed to investigate the prognostic significance of NDRG1 and/or c-Myc expression in lung adenocarcinoma using immunohistochemistry with a tissue microarray.">
    <entity charOffset="77-82" id="s1357.e0" ontology_id="10397" text="NDRG1" type="GENE"/>
    <entity charOffset="110-129" id="s1357.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1357.e0" e2="s1357.e1" id="s1357.p0" relation="true"/>
  </sentence>
  <sentence id="s1358" text="The present study was designed to investigate the prognostic significance of NDRG1 and/or c-Myc expression in lung adenocarcinoma using immunohistochemistry with a tissue microarray.">
    <entity charOffset="90-95" id="s1358.e0" ontology_id="4609" text="c-Myc" type="GENE"/>
    <entity charOffset="110-129" id="s1358.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1358.e0" e2="s1358.e1" id="s1358.p0" relation="true"/>
  </sentence>
  <sentence id="s1359" text="We examined 184 lung adenocarcinomas and observed low expression of NDRG1 in adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA), whereas high expression of NDRG1 was seen in invasive adenocarcinoma.">
    <entity charOffset="16-35" id="s1359.e0" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <entity charOffset="68-73" id="s1359.e1" ontology_id="10397" text="NDRG1" type="GENE"/>
    <pair e1="s1359.e0" e2="s1359.e1" id="s1359.p0" relation="true"/>
  </sentence>
  <sentence id="s1360" text="We examined 184 lung adenocarcinomas and observed low expression of NDRG1 in adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA), whereas high expression of NDRG1 was seen in invasive adenocarcinoma.">
    <entity charOffset="16-35" id="s1360.e0" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <entity charOffset="101-104" id="s1360.e1" ontology_id="231" text="AIS" type="GENE"/>
    <pair e1="s1360.e0" e2="s1360.e1" id="s1360.p0" relation="true"/>
  </sentence>
  <sentence id="s1361" text="We demonstrated that &lt;i&gt;linc-ADAL&lt;/i&gt; interacts with heterogeneous nuclear ribonucleoprotein U (hnRNPU) and insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) at distinct subcellular locations to regulate adipocyte differentiation and lipogenesis">
    <entity charOffset="53-66" id="s1361.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="161-168" id="s1361.e1" ontology_id="10644" text="IGF2BP2" type="GENE"/>
    <pair e1="s1361.e0" e2="s1361.e1" id="s1361.p0" relation="false"/>
  </sentence>
  <sentence id="s1362" text="myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.">
    <entity charOffset="36-41" id="s1362.e0" ontology_id="134430" text="WDR36" type="GENE"/>
    <entity charOffset="90-98" id="s1362.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s1362.e0" e2="s1362.e1" id="s1362.p0" relation="true"/>
  </sentence>
  <sentence id="s1363" text="myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.">
    <entity charOffset="90-98" id="s1363.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="110-116" id="s1363.e1" ontology_id="1545" text="CYP1B1" type="GENE"/>
    <pair e1="s1363.e0" e2="s1363.e1" id="s1363.p0" relation="true"/>
  </sentence>
  <sentence id="s1364" text="myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.">
    <entity charOffset="90-98" id="s1364.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="121-126" id="s1364.e1" ontology_id="4053" text="LTBP2" type="GENE"/>
    <pair e1="s1364.e0" e2="s1364.e1" id="s1364.p0" relation="true"/>
  </sentence>
  <sentence id="s1365" text="We found previously that the candidate tumor suppressor CLCA2 is expressed in differentiated, growth-arrested mammary epithelial cells but is downregulated during tumor progression and EMT.">
    <entity charOffset="39-44" id="s1365.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="56-61" id="s1365.e1" ontology_id="9635" text="CLCA2" type="GENE"/>
    <pair e1="s1365.e0" e2="s1365.e1" id="s1365.p0" relation="true"/>
  </sentence>
  <sentence id="s1366" text="We show here that another member of the CLCA gene family, CLCA4, is expressed in mammary epithelial cells and is similarly downregulated in breast tumors and in breast cancer cell lines.">
    <entity charOffset="58-63" id="s1366.e0" ontology_id="22802" text="CLCA4" type="GENE"/>
    <entity charOffset="147-152" id="s1366.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1366.e0" e2="s1366.e1" id="s1366.p0" relation="true"/>
  </sentence>
  <sentence id="s1367" text="Mice genetically deficient in DDB2 exhibited increased susceptibility to colon tumor development in a manner associated with higher abundance of the Wnt receptor-expressing cells and greater activation of the downstream Wnt pathway.">
    <entity charOffset="30-34" id="s1367.e0" ontology_id="1643" text="DDB2" type="GENE"/>
    <entity charOffset="79-84" id="s1367.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1367.e0" e2="s1367.e1" id="s1367.p0" relation="true"/>
  </sentence>
  <sentence id="s1368" text="A variant in BAK1 (rs210138) was positively associated with GCT (OR [95% CI]: 1.70 [1.32, 2.18]), with a strong estimated effect for testis tumors (OR [95% CI]: 3.31 [1.89, 5.79]).">
    <entity charOffset="13-17" id="s1368.e0" ontology_id="578" text="BAK1" type="GENE"/>
    <entity charOffset="140-146" id="s1368.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1368.e0" e2="s1368.e1" id="s1368.p0" relation="true"/>
  </sentence>
  <sentence id="s1369" text="A variant in BAK1 (rs210138) was positively associated with GCT (OR [95% CI]: 1.70 [1.32, 2.18]), with a strong estimated effect for testis tumors (OR [95% CI]: 3.31 [1.89, 5.79]).">
    <entity charOffset="60-63" id="s1369.e0" ontology_id="25797" text="GCT" type="GENE"/>
    <entity charOffset="140-146" id="s1369.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1369.e0" e2="s1369.e1" id="s1369.p0" relation="true"/>
  </sentence>
  <sentence id="s1370" text="Mutations in SPRTN cause premature ageing and liver cancer in humans and mice; thus, defective DPC repair has great clinical ramifications.">
    <entity charOffset="13-18" id="s1370.e0" ontology_id="83932" text="SPRTN" type="GENE"/>
    <entity charOffset="52-58" id="s1370.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1370.e0" e2="s1370.e1" id="s1370.p0" relation="true"/>
  </sentence>
  <sentence id="s1371" text="In humans, PNKP mutations underlie the neurological disease known as MCSZ, but these individuals are not predisposed for cancer, implying effective alternative repair pathways in dividing cells.">
    <entity charOffset="11-15" id="s1371.e0" ontology_id="11284" text="PNKP" type="GENE"/>
    <entity charOffset="121-127" id="s1371.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1371.e0" e2="s1371.e1" id="s1371.p0" relation="true"/>
  </sentence>
  <sentence id="s1372" text="MAX which was involved in small cell lung cancer pathway was a hub gene unique to T2D (OR=1.2, P=0.006) but not in CAD.">
    <entity charOffset="42-48" id="s1372.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="115-118" id="s1372.e1" ontology_id="1677" text="CAD" type="GENE"/>
    <pair e1="s1372.e0" e2="s1372.e1" id="s1372.p0" relation="true"/>
  </sentence>
  <sentence id="s1373" text="We hypothesized that de novo mutations (DNMs) in synaptic genes explain an important fraction of sporadic NSID cases.">
    <entity charOffset="40-43" id="s1373.e0" ontology_id="1759" text="DNM" type="GENE"/>
    <entity charOffset="97-105" id="s1373.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1373.e0" e2="s1373.e1" id="s1373.p0" relation="true"/>
  </sentence>
  <sentence id="s1374" text="Sequencing these four genes in 50 additional sporadic cases of NSID identified a second DNM in GRIN1 (c.1679_1681dup/p.Ser560dup).">
    <entity charOffset="45-53" id="s1374.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="88-91" id="s1374.e1" ontology_id="1759" text="DNM" type="GENE"/>
    <pair e1="s1374.e0" e2="s1374.e1" id="s1374.p0" relation="true"/>
  </sentence>
  <sentence id="s1375" text="Sequencing these four genes in 50 additional sporadic cases of NSID identified a second DNM in GRIN1 (c.1679_1681dup/p.Ser560dup).">
    <entity charOffset="45-53" id="s1375.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="95-100" id="s1375.e1" ontology_id="114787" text="GRIN1" type="GENE"/>
    <pair e1="s1375.e0" e2="s1375.e1" id="s1375.p0" relation="true"/>
  </sentence>
  <sentence id="s1376" text="Whole-exome or targeted exome sequencing of 183 unrelated familial and/or severe CAKUT-affected case subjects, including 54 fetuses with BKA, led to the identification of 16 heterozygous variants in GREB1L (growth regulation by estrogen in breast cancer 1-like), a gene reported as a target of retinoic acid signaling.">
    <entity charOffset="199-205" id="s1376.e0" ontology_id="80000" text="GREB1L" type="GENE"/>
    <entity charOffset="247-253" id="s1376.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1376.e0" e2="s1376.e1" id="s1376.p0" relation="true"/>
  </sentence>
  <sentence id="s1377" text="One upregulated candidate named transmembrane protein 98 (TMEM98) was found to be overexpressed in 80 of 118 (67.80%) of patients with hepatocellular carcinoma.">
    <entity charOffset="58-64" id="s1377.e0" ontology_id="26022" text="TMEM98" type="GENE"/>
    <entity charOffset="135-159" id="s1377.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1377.e0" e2="s1377.e1" id="s1377.p0" relation="true"/>
  </sentence>
  <sentence id="s1378" text="TMEM98 mRNA in tumor tissues was significantly higher than nontumor tissues of patients with hepatocellular carcinoma (P &amp;lt; 0.0001).">
    <entity charOffset="0-6" id="s1378.e0" ontology_id="26022" text="TMEM98" type="GENE"/>
    <entity charOffset="93-117" id="s1378.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1378.e0" e2="s1378.e1" id="s1378.p0" relation="true"/>
  </sentence>
  <sentence id="s1379" text="Upregulation of TMEM98 was significantly correlated with advanced tumor stage (P = 0.048), high incidence of early tumor recurrence (P = 0.005), poor overall survival (P = 0.029), and poor disease-free survival (P = 0.011) of patients with hepatocellular carcinoma after hepatectomy.">
    <entity charOffset="16-22" id="s1379.e0" ontology_id="26022" text="TMEM98" type="GENE"/>
    <entity charOffset="240-264" id="s1379.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1379.e0" e2="s1379.e1" id="s1379.p0" relation="true"/>
  </sentence>
  <sentence id="s1380" text="Upregulation of TMEM98 was significantly correlated with advanced tumor stage (P = 0.048), high incidence of early tumor recurrence (P = 0.005), poor overall survival (P = 0.029), and poor disease-free survival (P = 0.011) of patients with hepatocellular carcinoma after hepatectomy.">
    <entity charOffset="16-22" id="s1380.e0" ontology_id="26022" text="TMEM98" type="GENE"/>
    <entity charOffset="66-71" id="s1380.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1380.e0" e2="s1380.e1" id="s1380.p0" relation="true"/>
  </sentence>
  <sentence id="s1381" text="Importantly, upregulation of TMEM98 mRNA in patients with hepatocellular carcinoma who received transarterial chemoembolization (TACE) treatment was significantly higher than in patients without TACE treatment (P = 0.046).">
    <entity charOffset="29-35" id="s1381.e0" ontology_id="26022" text="TMEM98" type="GENE"/>
    <entity charOffset="58-82" id="s1381.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1381.e0" e2="s1381.e1" id="s1381.p0" relation="true"/>
  </sentence>
  <sentence id="s1382" text="In vitro and in vivo studies showed that suppression of TMEM98 in chemoresistant hepatocellular carcinoma cells restored their chemosensitivity, while forced overexpression of TMEM98 enhanced their chemoresistance.">
    <entity charOffset="56-62" id="s1382.e0" ontology_id="26022" text="TMEM98" type="GENE"/>
    <entity charOffset="81-105" id="s1382.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1382.e0" e2="s1382.e1" id="s1382.p0" relation="true"/>
  </sentence>
  <sentence id="s1383" text="The mechanism of TMEM98 in conferring chemoresistance of hepatocellular carcinoma might be possibly through activation of the AKT pathway and deactivation of p53.">
    <entity charOffset="17-23" id="s1383.e0" ontology_id="26022" text="TMEM98" type="GENE"/>
    <entity charOffset="57-81" id="s1383.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1383.e0" e2="s1383.e1" id="s1383.p0" relation="true"/>
  </sentence>
  <sentence id="s1384" text="This study aims to determine the association between FGF10 (rs4415084 C&amp;gt;T), FGFR2 (rs2981582 C&amp;gt;T) and MAP3K1 (rs889312 A&amp;gt;C) gene polymorphisms and breast cancer, to analyse the discriminative ability of each SNP and to test the accuracy of the predictive breast cancer risk model which includes all SNPs.">
    <entity charOffset="53-58" id="s1384.e0" ontology_id="2255" text="FGF10" type="GENE"/>
    <entity charOffset="163-169" id="s1384.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1384.e0" e2="s1384.e1" id="s1384.p0" relation="true"/>
  </sentence>
  <sentence id="s1385" text="This study aims to determine the association between FGF10 (rs4415084 C&amp;gt;T), FGFR2 (rs2981582 C&amp;gt;T) and MAP3K1 (rs889312 A&amp;gt;C) gene polymorphisms and breast cancer, to analyse the discriminative ability of each SNP and to test the accuracy of the predictive breast cancer risk model which includes all SNPs.">
    <entity charOffset="79-84" id="s1385.e0" ontology_id="2263" text="FGFR2" type="GENE"/>
    <entity charOffset="163-169" id="s1385.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1385.e0" e2="s1385.e1" id="s1385.p0" relation="true"/>
  </sentence>
  <sentence id="s1386" text="This study aims to determine the association between FGF10 (rs4415084 C&amp;gt;T), FGFR2 (rs2981582 C&amp;gt;T) and MAP3K1 (rs889312 A&amp;gt;C) gene polymorphisms and breast cancer, to analyse the discriminative ability of each SNP and to test the accuracy of the predictive breast cancer risk model which includes all SNPs.">
    <entity charOffset="108-114" id="s1386.e0" ontology_id="4214" text="MAP3K1" type="GENE"/>
    <entity charOffset="163-169" id="s1386.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1386.e0" e2="s1386.e1" id="s1386.p0" relation="true"/>
  </sentence>
  <sentence id="s1387" text="The Random Forest algorithm selected FGFR2, MAP3K1 and age as important breast cancer predictors.">
    <entity charOffset="37-42" id="s1387.e0" ontology_id="2263" text="FGFR2" type="GENE"/>
    <entity charOffset="79-85" id="s1387.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1387.e0" e2="s1387.e1" id="s1387.p0" relation="true"/>
  </sentence>
  <sentence id="s1388" text="&lt;i&gt;In vivo&lt;/i&gt; tumorigenic studies confirmed that miR-612 overexpression retarded the growth of A375 xenograft tumors, which was coupled with a decline in the percentage of Ki-67-positive proliferating cells.">
    <entity charOffset="50-53" id="s1388.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="111-117" id="s1388.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1388.e0" e2="s1388.e1" id="s1388.p0" relation="true"/>
  </sentence>
  <sentence id="s1389" text="&lt;i&gt;In vivo&lt;/i&gt; tumorigenic studies confirmed that miR-612 overexpression retarded the growth of A375 xenograft tumors, which was coupled with a decline in the percentage of Ki-67-positive proliferating cells.">
    <entity charOffset="111-117" id="s1389.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="173-175" id="s1389.e1" ontology_id="10197" text="Ki" type="GENE"/>
    <pair e1="s1389.e0" e2="s1389.e1" id="s1389.p0" relation="true"/>
  </sentence>
  <sentence id="s1390" text="Homozygous RSPO1 mutations cause a syndrome of 46,XX disorder of sexual development (DSD), palmoplantar keratoderma (PPK), and predisposition to squamous cell carcinoma.">
    <entity charOffset="11-16" id="s1390.e0" ontology_id="284654" text="RSPO1" type="GENE"/>
    <entity charOffset="91-115" id="s1390.e1" ontology_id="HP_0000982" text="palmoplantar keratoderma" type="HP"/>
    <pair e1="s1390.e0" e2="s1390.e1" id="s1390.p0" relation="true"/>
  </sentence>
  <sentence id="s1391" text="Both have PPK and hearing impairment and carried a novel homozygous mutation c.332G&amp;gt;A (p.Cys111Tyr) located in the highly conserved furin-like cysteine-rich domain-2 (FU-CRD2).">
    <entity charOffset="18-36" id="s1391.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="135-140" id="s1391.e1" ontology_id="5045" text="furin" type="GENE"/>
    <pair e1="s1391.e0" e2="s1391.e1" id="s1391.p0" relation="false"/>
  </sentence>
  <sentence id="s1392" text="Both have PPK and hearing impairment and carried a novel homozygous mutation c.332G&amp;gt;A (p.Cys111Tyr) located in the highly conserved furin-like cysteine-rich domain-2 (FU-CRD2).">
    <entity charOffset="18-36" id="s1392.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="170-172" id="s1392.e1" ontology_id="27148" text="FU" type="GENE"/>
    <pair e1="s1392.e0" e2="s1392.e1" id="s1392.p0" relation="true"/>
  </sentence>
  <sentence id="s1393" text="Two additional mutations linked to different forms of retinal dystrophies were identified in two families: a known frameshift deletion in RPGR, a gene responsible for X-linked retinitis pigmentosa and p.Ser163Arg in C1QTNF5 associated with Late-Onset Retinal Degeneration.">
    <entity charOffset="54-73" id="s1393.e0" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <entity charOffset="138-142" id="s1393.e1" ontology_id="6103" text="RPGR" type="GENE"/>
    <pair e1="s1393.e0" e2="s1393.e1" id="s1393.p0" relation="true"/>
  </sentence>
  <sentence id="s1394" text="Two additional mutations linked to different forms of retinal dystrophies were identified in two families: a known frameshift deletion in RPGR, a gene responsible for X-linked retinitis pigmentosa and p.Ser163Arg in C1QTNF5 associated with Late-Onset Retinal Degeneration.">
    <entity charOffset="54-73" id="s1394.e0" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <entity charOffset="216-223" id="s1394.e1" ontology_id="83552" text="C1QTNF5" type="GENE"/>
    <pair e1="s1394.e0" e2="s1394.e1" id="s1394.p0" relation="true"/>
  </sentence>
  <sentence id="s1395" text="ME attenuated the influence of APOB rs512535 and TNFA rs361525 on obesity risk in FMP.">
    <entity charOffset="31-35" id="s1395.e0" ontology_id="338" text="APOB" type="GENE"/>
    <entity charOffset="66-73" id="s1395.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1395.e0" e2="s1395.e1" id="s1395.p0" relation="true"/>
  </sentence>
  <sentence id="s1396" text="We report associations for 6 out of 23 SNPs and for the GRS, which confer obesity risk, a novel finding for Mexican-Mestizo physically active population.">
    <entity charOffset="56-59" id="s1396.e0" ontology_id="597" text="GRS" type="GENE"/>
    <entity charOffset="74-81" id="s1396.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1396.e0" e2="s1396.e1" id="s1396.p0" relation="true"/>
  </sentence>
  <sentence id="s1397" text="The revision was based on data accumulated since the 2008 WHO classification of MDS, much of which relates to new molecular genetic information about these neoplasms.">
    <entity charOffset="80-83" id="s1397.e0" ontology_id="5048" text="MDS" type="GENE"/>
    <entity charOffset="156-165" id="s1397.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s1397.e0" e2="s1397.e1" id="s1397.p0" relation="true"/>
  </sentence>
  <sentence id="s1398" text="In gastrointestinal tumors, FEZF1 plays an oncogenic role through DNA demethylation.">
    <entity charOffset="20-26" id="s1398.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="28-33" id="s1398.e1" ontology_id="389549" text="FEZF1" type="GENE"/>
    <pair e1="s1398.e0" e2="s1398.e1" id="s1398.p0" relation="true"/>
  </sentence>
  <sentence id="s1399" text="However, the role of FEZF1 in the prognosis of human glioma prognosis remains unclear.">
    <entity charOffset="21-26" id="s1399.e0" ontology_id="389549" text="FEZF1" type="GENE"/>
    <entity charOffset="53-59" id="s1399.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1399.e0" e2="s1399.e1" id="s1399.p0" relation="true"/>
  </sentence>
  <sentence id="s1400" text="In this research, we discovered that FEZF1 was significantly increased in glioma tissues in contrast to normal brain tissues (NBTs; P&amp;lt;0.05).">
    <entity charOffset="37-42" id="s1400.e0" ontology_id="389549" text="FEZF1" type="GENE"/>
    <entity charOffset="74-80" id="s1400.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1400.e0" e2="s1400.e1" id="s1400.p0" relation="true"/>
  </sentence>
  <sentence id="s1401" text="In an in vitro experiment, FEZF1 can promote the proliferation, migration, and invasion of glioma cells and inhibit cell apoptosis by activating Akt-ERK pathway.">
    <entity charOffset="27-32" id="s1401.e0" ontology_id="389549" text="FEZF1" type="GENE"/>
    <entity charOffset="91-97" id="s1401.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1401.e0" e2="s1401.e1" id="s1401.p0" relation="true"/>
  </sentence>
  <sentence id="s1402" text="In an in vitro experiment, FEZF1 can promote the proliferation, migration, and invasion of glioma cells and inhibit cell apoptosis by activating Akt-ERK pathway.">
    <entity charOffset="91-97" id="s1402.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="145-148" id="s1402.e1" ontology_id="207" text="Akt" type="GENE"/>
    <pair e1="s1402.e0" e2="s1402.e1" id="s1402.p0" relation="true"/>
  </sentence>
  <sentence id="s1403" text="In A549 lung cancer cells, which endogenously express CXCR1, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.">
    <entity charOffset="13-19" id="s1403.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="78-83" id="s1403.e1" ontology_id="7905" text="REEP5" type="GENE"/>
    <pair e1="s1403.e0" e2="s1403.e1" id="s1403.p0" relation="true"/>
  </sentence>
  <sentence id="s1404" text="In A549 lung cancer cells, which endogenously express CXCR1, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.">
    <entity charOffset="13-19" id="s1404.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="88-93" id="s1404.e1" ontology_id="92840" text="REEP6" type="GENE"/>
    <pair e1="s1404.e0" e2="s1404.e1" id="s1404.p0" relation="true"/>
  </sentence>
  <sentence id="s1405" text="In A549 lung cancer cells, which endogenously express CXCR1, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.">
    <entity charOffset="13-19" id="s1405.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="154-158" id="s1405.e1" ontology_id="3576" text="IL-8" type="GENE"/>
    <pair e1="s1405.e0" e2="s1405.e1" id="s1405.p0" relation="true"/>
  </sentence>
  <sentence id="s1406" text="In A549 lung cancer cells, which endogenously express CXCR1, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.">
    <entity charOffset="13-19" id="s1406.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="170-173" id="s1406.e1" ontology_id="2048" text="ERK" type="GENE"/>
    <pair e1="s1406.e0" e2="s1406.e1" id="s1406.p0" relation="true"/>
  </sentence>
  <sentence id="s1407" text="Hypohidrotic ectodermal dysplasia (HED) results from mutation of the EDA, EDAR or EDARADD genes and is characterized by reduced or absent eccrine sweat glands, hair follicles and teeth, and defective formation of salivary, mammary and craniofacial glands.">
    <entity charOffset="13-33" id="s1407.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="69-72" id="s1407.e1" ontology_id="1896" text="EDA" type="GENE"/>
    <pair e1="s1407.e0" e2="s1407.e1" id="s1407.p0" relation="true"/>
  </sentence>
  <sentence id="s1408" text="No other novel mutation or this deletion was detected in POFUT1 in a second DDD family and a sporadic DDD case by Sanger Sequencing.">
    <entity charOffset="57-63" id="s1408.e0" ontology_id="23509" text="POFUT1" type="GENE"/>
    <entity charOffset="93-101" id="s1408.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1408.e0" e2="s1408.e1" id="s1408.p0" relation="true"/>
  </sentence>
  <sentence id="s1409" text="Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="11-15" id="s1409.e0" ontology_id="10518" text="CIB2" type="GENE"/>
    <entity charOffset="168-176" id="s1409.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s1409.e0" e2="s1409.e1" id="s1409.p0" relation="true"/>
  </sentence>
  <sentence id="s1410" text="Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="95-103" id="s1410.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="105-111" id="s1410.e1" ontology_id="10518" text="DFNB48" type="GENE"/>
    <pair e1="s1410.e0" e2="s1410.e1" id="s1410.p0" relation="false"/>
  </sentence>
  <sentence id="s1411" text="Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="105-111" id="s1411.e0" ontology_id="10518" text="DFNB48" type="GENE"/>
    <entity charOffset="207-216" id="s1411.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s1411.e0" e2="s1411.e1" id="s1411.p0" relation="true"/>
  </sentence>
  <sentence id="s1412" text="Also, the generated &lt;i&gt;CIB2&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; mice display an early onset profound deafness and have normal balance and retinal functions.">
    <entity charOffset="23-27" id="s1412.e0" ontology_id="10518" text="CIB2" type="GENE"/>
    <entity charOffset="83-91" id="s1412.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1412.e0" e2="s1412.e1" id="s1412.p0" relation="true"/>
  </sentence>
  <sentence id="s1413" text="Also, the generated &lt;i&gt;CIB2&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; mice display an early onset profound deafness and have normal balance and retinal functions.">
    <entity charOffset="23-27" id="s1413.e0" ontology_id="10518" text="CIB2" type="GENE"/>
    <entity charOffset="74-82" id="s1413.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s1413.e0" e2="s1413.e1" id="s1413.p0" relation="true"/>
  </sentence>
  <sentence id="s1414" text="Also, the generated &lt;i&gt;CIB2&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; mice display an early onset profound deafness and have normal balance and retinal functions.">
    <entity charOffset="46-50" id="s1414.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="83-91" id="s1414.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1414.e0" e2="s1414.e1" id="s1414.p0" relation="true"/>
  </sentence>
  <sentence id="s1415" text="This essential role of CIB2 in mechanotransduction and cell survival that, we show, is restricted to the cochlea, probably accounts for the presence in &lt;i&gt;CIB2&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; mice and &lt;i&gt;CIB2&lt;/i&gt; patients, unlike in Usher syndrome, of isolated hearing loss without balance and vision deficits">
    <entity charOffset="23-27" id="s1415.e0" ontology_id="10518" text="CIB2" type="GENE"/>
    <entity charOffset="247-259" id="s1415.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1415.e0" e2="s1415.e1" id="s1415.p0" relation="true"/>
  </sentence>
  <sentence id="s1416" text="Sonic hedgehog (SHH) signaling is an important promotor of desmoplasia, a critical feature in pancreatic cancer stromal reactions involving the activation of pancreatic stellate cells(PSCs).">
    <entity charOffset="16-19" id="s1416.e0" ontology_id="6469" text="SHH" type="GENE"/>
    <entity charOffset="105-111" id="s1416.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1416.e0" e2="s1416.e1" id="s1416.p0" relation="true"/>
  </sentence>
  <sentence id="s1417" text="The present study investigated the association between Gremlin1 and SHH, and the effect of Gremlin1 in pancreatic cancer.">
    <entity charOffset="69-72" id="s1417.e0" ontology_id="6469" text="SHH" type="GENE"/>
    <entity charOffset="116-122" id="s1417.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1417.e0" e2="s1417.e1" id="s1417.p0" relation="false"/>
  </sentence>
  <sentence id="s1418" text="Primary human PSCs and pancreatic cancer cell lines were exposed to SHH, cyclopamine, GLI family zinc finger-1(Gli-1) small interfering RNA (siRNA), and Gremlin1 siRNA to examine their associations and effects using an MTT assay, reverse transcription-quantitative polymerase chain reaction analysis, western blot analysis, and migration or invasion assays.">
    <entity charOffset="34-40" id="s1418.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="86-89" id="s1418.e1" ontology_id="2735" text="GLI" type="GENE"/>
    <pair e1="s1418.e0" e2="s1418.e1" id="s1418.p0" relation="true"/>
  </sentence>
  <sentence id="s1419" text="In summary, for the first time, we generated a ush2a knockout zebrafish line with auditory disorder and retinal degeneration which mimicked the symptoms of patients, and revealed that disruption of fibronectin assembly may be one of the factors underlying RP.">
    <entity charOffset="47-52" id="s1419.e0" ontology_id="7399" text="ush2a" type="GENE"/>
    <entity charOffset="104-124" id="s1419.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1419.e0" e2="s1419.e1" id="s1419.p0" relation="true"/>
  </sentence>
  <sentence id="s1420" text="The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in TOP3A, characterized by muscle-restricted mtDNA deletions and chronic progressive external ophthalmoplegia (CPEO) plus syndrome.">
    <entity charOffset="129-134" id="s1420.e0" ontology_id="7156" text="TOP3A" type="GENE"/>
    <entity charOffset="191-198" id="s1420.e1" ontology_id="HP_0011010" text="chronic" type="HP"/>
    <pair e1="s1420.e0" e2="s1420.e1" id="s1420.p0" relation="true"/>
  </sentence>
  <sentence id="s1421" text="The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in TOP3A, characterized by muscle-restricted mtDNA deletions and chronic progressive external ophthalmoplegia (CPEO) plus syndrome.">
    <entity charOffset="129-134" id="s1421.e0" ontology_id="7156" text="TOP3A" type="GENE"/>
    <entity charOffset="220-235" id="s1421.e1" ontology_id="HP_0000602" text="ophthalmoplegia" type="HP"/>
    <pair e1="s1421.e0" e2="s1421.e1" id="s1421.p0" relation="true"/>
  </sentence>
  <sentence id="s1422" text="Cilia play essential roles in normal human development and health; cilia dysfunction results in diseases such as primary ciliary dyskinesia (PCD).">
    <entity charOffset="121-139" id="s1422.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="141-144" id="s1422.e1" ontology_id="352909" text="PCD" type="GENE"/>
    <pair e1="s1422.e0" e2="s1422.e1" id="s1422.p0" relation="true"/>
  </sentence>
  <sentence id="s1423" text="We present the native 3D structures of normal and PCD-causing RSPH1-mutant human respiratory cilia in unprecedented detail; this allows comparisons of cilia structure across evolutionarily distant species and reveals the previously unknown primary defect and the heterogeneous secondary defects in RSPH1-mutant cilia.">
    <entity charOffset="50-53" id="s1423.e0" ontology_id="352909" text="PCD" type="GENE"/>
    <entity charOffset="263-276" id="s1423.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1423.e0" e2="s1423.e1" id="s1423.p0" relation="true"/>
  </sentence>
  <sentence id="s1424" text="Our data provide evidence for structural and functional heterogeneity in radial spokes, suggest a mechanism for the milder RSPH1 PCD phenotype and demonstrate that cryo-electron tomography can be applied to human disease by directly imaging patient samples.">
    <entity charOffset="56-69" id="s1424.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="129-132" id="s1424.e1" ontology_id="352909" text="PCD" type="GENE"/>
    <pair e1="s1424.e0" e2="s1424.e1" id="s1424.p0" relation="true"/>
  </sentence>
  <sentence id="s1425" text="Biallelic mutations in the YARS2 gene encoding mitochondrial tyrosyl-tRNA synthetase cause myopathy, lactic acidosis, and sideroblastic anemia 2 (MLASA2), a type of mitochondrial disease.">
    <entity charOffset="27-32" id="s1425.e0" ontology_id="51067" text="YARS2" type="GENE"/>
    <entity charOffset="101-116" id="s1425.e1" ontology_id="HP_0003128" text="lactic acidosis" type="HP"/>
    <pair e1="s1425.e0" e2="s1425.e1" id="s1425.p0" relation="true"/>
  </sentence>
  <sentence id="s1426" text="We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, hyperactivity, learning and visual-spatial difficulties, relative microcephaly, long face, stellate iris pattern, and periorbital fullness.">
    <entity charOffset="105-118" id="s1426.e0" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <entity charOffset="140-147" id="s1426.e1" ontology_id="219793" text="spatial" type="GENE"/>
    <pair e1="s1426.e0" e2="s1426.e1" id="s1426.p0" relation="true"/>
  </sentence>
  <sentence id="s1427" text="We show that an inhaled PI3K inhibitor improves survival rates following S. pneumoniae infection in wild-type mice and in mice with activated PI3K.">
    <entity charOffset="77-86" id="s1427.e0" ontology_id="HP_0002090" text="pneumonia" type="HP"/>
    <entity charOffset="111-115" id="s1427.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s1427.e0" e2="s1427.e1" id="s1427.p0" relation="true"/>
  </sentence>
  <sentence id="s1428" text="PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (ABHD12).">
    <entity charOffset="23-35" id="s1428.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="220-226" id="s1428.e1" ontology_id="26090" text="ABHD12" type="GENE"/>
    <pair e1="s1428.e0" e2="s1428.e1" id="s1428.p0" relation="true"/>
  </sentence>
  <sentence id="s1429" text="PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (ABHD12).">
    <entity charOffset="37-43" id="s1429.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="220-226" id="s1429.e1" ontology_id="26090" text="ABHD12" type="GENE"/>
    <pair e1="s1429.e0" e2="s1429.e1" id="s1429.p0" relation="true"/>
  </sentence>
  <sentence id="s1430" text="PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (ABHD12).">
    <entity charOffset="71-80" id="s1430.e0" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <entity charOffset="220-226" id="s1430.e1" ontology_id="26090" text="ABHD12" type="GENE"/>
    <pair e1="s1430.e0" e2="s1430.e1" id="s1430.p0" relation="true"/>
  </sentence>
  <sentence id="s1431" text="PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (ABHD12).">
    <entity charOffset="126-151" id="s1431.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="220-226" id="s1431.e1" ontology_id="26090" text="ABHD12" type="GENE"/>
    <pair e1="s1431.e0" e2="s1431.e1" id="s1431.p0" relation="true"/>
  </sentence>
  <sentence id="s1432" text="The DNA damage checkpoints provide an anti-cancer barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (CaP).">
    <entity charOffset="8-14" id="s1432.e0" ontology_id="51438" text="damage" type="GENE"/>
    <entity charOffset="43-49" id="s1432.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1432.e0" e2="s1432.e1" id="s1432.p0" relation="true"/>
  </sentence>
  <sentence id="s1433" text="The DNA damage checkpoints provide an anti-cancer barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (CaP).">
    <entity charOffset="43-49" id="s1433.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="148-151" id="s1433.e1" ontology_id="23476" text="CaP" type="GENE"/>
    <pair e1="s1433.e0" e2="s1433.e1" id="s1433.p0" relation="true"/>
  </sentence>
  <sentence id="s1434" text="Furthermore, targeting DNA repair defects by PARP1 inhibitors (PARPi) as a cancer treatment strategy is emerging yet requires suitable predictive biomarkers.">
    <entity charOffset="45-50" id="s1434.e0" ontology_id="142" text="PARP1" type="GENE"/>
    <entity charOffset="75-81" id="s1434.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1434.e0" e2="s1434.e1" id="s1434.p0" relation="true"/>
  </sentence>
  <sentence id="s1435" text="To address these issues, we performed immunohistochemical analysis of multiple markers of DNA damage signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial neoplasia to CaP, complemented by genetic analyses of TMPRSS2-ERG rearrangement and NQO1, an anti-oxidant factor and p53 protector.">
    <entity charOffset="268-277" id="s1435.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="281-284" id="s1435.e1" ontology_id="23476" text="CaP" type="GENE"/>
    <pair e1="s1435.e0" e2="s1435.e1" id="s1435.p0" relation="true"/>
  </sentence>
  <sentence id="s1436" text="To address these issues, we performed immunohistochemical analysis of multiple markers of DNA damage signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial neoplasia to CaP, complemented by genetic analyses of TMPRSS2-ERG rearrangement and NQO1, an anti-oxidant factor and p53 protector.">
    <entity charOffset="268-277" id="s1436.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="352-356" id="s1436.e1" ontology_id="1728" text="NQO1" type="GENE"/>
    <pair e1="s1436.e0" e2="s1436.e1" id="s1436.p0" relation="true"/>
  </sentence>
  <sentence id="s1437" text="The DNA damage checkpoint barrier (H2AX, pATM, p53) mechanism was activated during CaP tumorigenesis, albeit less and with delayed culmination compared to other cancers, possibly reflecting lower replication stress (slow proliferation despite cases of Rb loss and cyclin D1 overexpression) and progressive loss of ATM activator NKX3.1.">
    <entity charOffset="43-46" id="s1437.e0" ontology_id="472" text="ATM" type="GENE"/>
    <entity charOffset="162-168" id="s1437.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1437.e0" e2="s1437.e1" id="s1437.p0" relation="false"/>
  </sentence>
  <sentence id="s1438" text="The DNA damage checkpoint barrier (H2AX, pATM, p53) mechanism was activated during CaP tumorigenesis, albeit less and with delayed culmination compared to other cancers, possibly reflecting lower replication stress (slow proliferation despite cases of Rb loss and cyclin D1 overexpression) and progressive loss of ATM activator NKX3.1.">
    <entity charOffset="84-87" id="s1438.e0" ontology_id="23476" text="CaP" type="GENE"/>
    <entity charOffset="162-168" id="s1438.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1438.e0" e2="s1438.e1" id="s1438.p0" relation="true"/>
  </sentence>
  <sentence id="s1439" text="NQO1 genotypes of 390 men did not indicate predisposition to CaP, yet loss of NQO1 in CaP suggested potential progression-opposing tumour suppressor role.">
    <entity charOffset="0-4" id="s1439.e0" ontology_id="1728" text="NQO1" type="GENE"/>
    <entity charOffset="131-137" id="s1439.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1439.e0" e2="s1439.e1" id="s1439.p0" relation="true"/>
  </sentence>
  <sentence id="s1440" text="TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.">
    <entity charOffset="30-34" id="s1440.e0" ontology_id="5728" text="PTEN" type="GENE"/>
    <entity charOffset="101-114" id="s1440.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1440.e0" e2="s1440.e1" id="s1440.p0" relation="true"/>
  </sentence>
  <sentence id="s1441" text="TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.">
    <entity charOffset="101-114" id="s1441.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="205-208" id="s1441.e1" ontology_id="23476" text="CaP" type="GENE"/>
    <pair e1="s1441.e0" e2="s1441.e1" id="s1441.p0" relation="true"/>
  </sentence>
  <sentence id="s1442" text="TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.">
    <entity charOffset="101-114" id="s1442.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="160-164" id="s1442.e1" ontology_id="10459" text="Rev7" type="GENE"/>
    <pair e1="s1442.e0" e2="s1442.e1" id="s1442.p0" relation="true"/>
  </sentence>
  <sentence id="s1443" text="These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, TCF4 rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.">
    <entity charOffset="68-72" id="s1443.e0" ontology_id="1312" text="COMT" type="GENE"/>
    <entity charOffset="262-275" id="s1443.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1443.e0" e2="s1443.e1" id="s1443.p0" relation="true"/>
  </sentence>
  <sentence id="s1444" text="These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, TCF4 rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.">
    <entity charOffset="102-107" id="s1444.e0" ontology_id="2899" text="GRIK3" type="GENE"/>
    <entity charOffset="262-275" id="s1444.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1444.e0" e2="s1444.e1" id="s1444.p0" relation="true"/>
  </sentence>
  <sentence id="s1445" text="These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, TCF4 rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.">
    <entity charOffset="139-144" id="s1445.e0" ontology_id="5625" text="PRODH" type="GENE"/>
    <entity charOffset="262-275" id="s1445.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1445.e0" e2="s1445.e1" id="s1445.p0" relation="true"/>
  </sentence>
  <sentence id="s1446" text="BRCT-repeat inhibitor of hTERT expression (BRIT1) is involved in the invasion of tumors.">
    <entity charOffset="43-48" id="s1446.e0" ontology_id="79648" text="BRIT1" type="GENE"/>
    <entity charOffset="81-87" id="s1446.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1446.e0" e2="s1446.e1" id="s1446.p0" relation="true"/>
  </sentence>
  <sentence id="s1447" text="Here, we hypothesize that repression of transcriptional activity of forkhead box O1 (FoxO1) via histone deacetylase inhibitors (HDACi) ameliorates hyperglycemia in T2DM rats">
    <entity charOffset="85-90" id="s1447.e0" ontology_id="2308" text="FoxO1" type="GENE"/>
    <entity charOffset="147-160" id="s1447.e1" ontology_id="HP_0003074" text="hyperglycemia" type="HP"/>
    <pair e1="s1447.e0" e2="s1447.e1" id="s1447.p0" relation="true"/>
  </sentence>
  <sentence id="s1448" text="Here, we report that biallelic mutations in NCAPD2, NCAPH, or NCAPD3, encoding subunits of these complexes, cause microcephaly.">
    <entity charOffset="44-50" id="s1448.e0" ontology_id="9918" text="NCAPD2" type="GENE"/>
    <entity charOffset="114-126" id="s1448.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1448.e0" e2="s1448.e1" id="s1448.p0" relation="true"/>
  </sentence>
  <sentence id="s1449" text="Here, we report that biallelic mutations in NCAPD2, NCAPH, or NCAPD3, encoding subunits of these complexes, cause microcephaly.">
    <entity charOffset="52-57" id="s1449.e0" ontology_id="23397" text="NCAPH" type="GENE"/>
    <entity charOffset="114-126" id="s1449.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1449.e0" e2="s1449.e1" id="s1449.p0" relation="true"/>
  </sentence>
  <sentence id="s1450" text="Here, we report that biallelic mutations in NCAPD2, NCAPH, or NCAPD3, encoding subunits of these complexes, cause microcephaly.">
    <entity charOffset="62-68" id="s1450.e0" ontology_id="23310" text="NCAPD3" type="GENE"/>
    <entity charOffset="114-126" id="s1450.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1450.e0" e2="s1450.e1" id="s1450.p0" relation="true"/>
  </sentence>
  <sentence id="s1451" text="Here, we show that high levels of the actin cytoskeleton-associated protein WIP (WASP-interacting protein) correlates with tumor growth, both of which are linked to the tumor-initiating cell phenotype.">
    <entity charOffset="76-79" id="s1451.e0" ontology_id="7456" text="WIP" type="GENE"/>
    <entity charOffset="123-128" id="s1451.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1451.e0" e2="s1451.e1" id="s1451.p0" relation="true"/>
  </sentence>
  <sentence id="s1452" text="We find that WIP controls tumor growth by boosting signals that stabilize the YAP/TAZ complex via a mechanism mediated by the endocytic/endosomal system.">
    <entity charOffset="3-7" id="s1452.e0" ontology_id="81501" text="find" type="GENE"/>
    <entity charOffset="26-31" id="s1452.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1452.e0" e2="s1452.e1" id="s1452.p0" relation="false"/>
  </sentence>
  <sentence id="s1453" text="Here, we showed that the homeostatic synaptic downscaling is absent in the hippocampal neurons of Fmr1 KO mice, the mouse model of the most common inherited autism, fragile X syndrome (FXS).">
    <entity charOffset="98-102" id="s1453.e0" ontology_id="2332" text="Fmr1" type="GENE"/>
    <entity charOffset="157-163" id="s1453.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s1453.e0" e2="s1453.e1" id="s1453.p0" relation="true"/>
  </sentence>
  <sentence id="s1454" text="Here, we showed that the homeostatic synaptic downscaling is absent in the hippocampal neurons of Fmr1 KO mice, the mouse model of the most common inherited autism, fragile X syndrome (FXS).">
    <entity charOffset="106-110" id="s1454.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="157-163" id="s1454.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s1454.e0" e2="s1454.e1" id="s1454.p0" relation="false"/>
  </sentence>
  <sentence id="s1455" text="We found that the impaired homeostatic synaptic downscaling in Fmr1 KO neurons is caused by loss-of-function dephosphorylation of an epilepsy-associated ubiquitin E3 ligase, neural precursor cell expressed developmentally down-regulated gene 4-2, Nedd4-2.">
    <entity charOffset="63-67" id="s1455.e0" ontology_id="2332" text="Fmr1" type="GENE"/>
    <entity charOffset="133-141" id="s1455.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1455.e0" e2="s1455.e1" id="s1455.p0" relation="true"/>
  </sentence>
  <sentence id="s1456" text="Such dephosphorylation of Nedd4-2 is surprisingly caused by abnormally stable tumor suppressor p53 and subsequently destabilized kinase Akt.">
    <entity charOffset="26-33" id="s1456.e0" ontology_id="23327" text="Nedd4-2" type="GENE"/>
    <entity charOffset="78-83" id="s1456.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1456.e0" e2="s1456.e1" id="s1456.p0" relation="true"/>
  </sentence>
  <sentence id="s1457" text="Ellis-van Creveld (EVC) syndrome is a rare autosomal recessive disorder characterized by hypoplastic nails, polydactyly, and achondroplasia.">
    <entity charOffset="19-22" id="s1457.e0" ontology_id="2121" text="EVC" type="GENE"/>
    <entity charOffset="89-106" id="s1457.e1" ontology_id="HP_0001792" text="hypoplastic nails" type="HP"/>
    <pair e1="s1457.e0" e2="s1457.e1" id="s1457.p0" relation="true"/>
  </sentence>
  <sentence id="s1458" text="Ellis-van Creveld (EVC) syndrome is a rare autosomal recessive disorder characterized by hypoplastic nails, polydactyly, and achondroplasia.">
    <entity charOffset="19-22" id="s1458.e0" ontology_id="2121" text="EVC" type="GENE"/>
    <entity charOffset="108-119" id="s1458.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s1458.e0" e2="s1458.e1" id="s1458.p0" relation="true"/>
  </sentence>
  <sentence id="s1459" text="This is, to our knowledge, a most severe phenotype of EVC syndrome, illustrating that the specific pattern of EVC2 compound heterozygous mutations may cause severe developmental delay and intestinal malfunction.">
    <entity charOffset="54-57" id="s1459.e0" ontology_id="2121" text="EVC" type="GENE"/>
    <entity charOffset="164-183" id="s1459.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1459.e0" e2="s1459.e1" id="s1459.p0" relation="true"/>
  </sentence>
  <sentence id="s1460" text="Moreover, we show that over-expression of PNPLA8 dramatically decreases hepatic steatosis through increased autophagy in hepatocytes of HFD-fed mice.">
    <entity charOffset="42-48" id="s1460.e0" ontology_id="50640" text="PNPLA8" type="GENE"/>
    <entity charOffset="80-89" id="s1460.e1" ontology_id="HP_0001397" text="steatosis" type="HP"/>
    <pair e1="s1460.e0" e2="s1460.e1" id="s1460.p0" relation="true"/>
  </sentence>
  <sentence id="s1461" text="Humans who carry HNF1B mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.">
    <entity charOffset="17-22" id="s1461.e0" ontology_id="6928" text="HNF1B" type="GENE"/>
    <entity charOffset="150-164" id="s1461.e1" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <pair e1="s1461.e0" e2="s1461.e1" id="s1461.p0" relation="true"/>
  </sentence>
  <sentence id="s1462" text="Humans who carry HNF1B mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.">
    <entity charOffset="17-22" id="s1462.e0" ontology_id="6928" text="HNF1B" type="GENE"/>
    <entity charOffset="166-182" id="s1462.e1" ontology_id="HP_0000089" text="renal hypoplasia" type="HP"/>
    <pair e1="s1462.e0" e2="s1462.e1" id="s1462.p0" relation="true"/>
  </sentence>
  <sentence id="s1463" text="Humans who carry HNF1B mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.">
    <entity charOffset="17-22" id="s1463.e0" ontology_id="6928" text="HNF1B" type="GENE"/>
    <entity charOffset="188-215" id="s1463.e1" ontology_id="HP_0005576" text="renal interstitial fibrosis" type="HP"/>
    <pair e1="s1463.e0" e2="s1463.e1" id="s1463.p0" relation="true"/>
  </sentence>
  <sentence id="s1464" text="Mutations in 18 genes that encode components of GPI-anchor biogenesis result in a phenotypic spectrum that includes learning disability, epilepsy, microcephaly, congenital malformations and mild dysmorphic features.">
    <entity charOffset="48-51" id="s1464.e0" ontology_id="10007" text="GPI" type="GENE"/>
    <entity charOffset="137-145" id="s1464.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1464.e0" e2="s1464.e1" id="s1464.p0" relation="true"/>
  </sentence>
  <sentence id="s1465" text="Mutations in 18 genes that encode components of GPI-anchor biogenesis result in a phenotypic spectrum that includes learning disability, epilepsy, microcephaly, congenital malformations and mild dysmorphic features.">
    <entity charOffset="48-51" id="s1465.e0" ontology_id="10007" text="GPI" type="GENE"/>
    <entity charOffset="147-159" id="s1465.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1465.e0" e2="s1465.e1" id="s1465.p0" relation="true"/>
  </sentence>
  <sentence id="s1466" text="Since the original description of the IARS2-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.">
    <entity charOffset="38-43" id="s1466.e0" ontology_id="55699" text="IARS2" type="GENE"/>
    <entity charOffset="52-61" id="s1466.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s1466.e0" e2="s1466.e1" id="s1466.p0" relation="true"/>
  </sentence>
  <sentence id="s1467" text="Since the original description of the IARS2-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.">
    <entity charOffset="38-43" id="s1467.e0" ontology_id="55699" text="IARS2" type="GENE"/>
    <entity charOffset="124-136" id="s1467.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1467.e0" e2="s1467.e1" id="s1467.p0" relation="true"/>
  </sentence>
  <sentence id="s1468" text="Since the original description of the IARS2-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.">
    <entity charOffset="38-43" id="s1468.e0" ontology_id="55699" text="IARS2" type="GENE"/>
    <entity charOffset="138-156" id="s1468.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s1468.e0" e2="s1468.e1" id="s1468.p0" relation="true"/>
  </sentence>
  <sentence id="s1469" text="Here, we report on a female Danish patient with a novel homozygous IARS2 mutation, p.Gly874Arg, who presented at birth with bilateral hip dislocation and short stature.">
    <entity charOffset="67-72" id="s1469.e0" ontology_id="55699" text="IARS2" type="GENE"/>
    <entity charOffset="154-167" id="s1469.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s1469.e0" e2="s1469.e1" id="s1469.p0" relation="true"/>
  </sentence>
  <sentence id="s1470" text="At 3 months, additional dysmorphic features were noted and at 18 months her radiographic skeletal abnormalities were suggestive of an underlying spondyloepimetaphyseal dysplasia (SEMD).">
    <entity charOffset="89-111" id="s1470.e0" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <entity charOffset="179-183" id="s1470.e1" ontology_id="10371" text="SEMD" type="GENE"/>
    <pair e1="s1470.e0" e2="s1470.e1" id="s1470.p0" relation="true"/>
  </sentence>
  <sentence id="s1471" text="At 3 months, additional dysmorphic features were noted and at 18 months her radiographic skeletal abnormalities were suggestive of an underlying spondyloepimetaphyseal dysplasia (SEMD).">
    <entity charOffset="145-177" id="s1471.e0" ontology_id="HP_0002651" text="spondyloepimetaphyseal dysplasia" type="HP"/>
    <entity charOffset="179-183" id="s1471.e1" ontology_id="10371" text="SEMD" type="GENE"/>
    <pair e1="s1471.e0" e2="s1471.e1" id="s1471.p0" relation="true"/>
  </sentence>
  <sentence id="s1472" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1472.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="162-167" id="s1472.e1" ontology_id="54332" text="GDAP1" type="GENE"/>
    <pair e1="s1472.e0" e2="s1472.e1" id="s1472.p0" relation="true"/>
  </sentence>
  <sentence id="s1473" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1473.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="169-174" id="s1473.e1" ontology_id="8898" text="MTMR2" type="GENE"/>
    <pair e1="s1473.e0" e2="s1473.e1" id="s1473.p0" relation="true"/>
  </sentence>
  <sentence id="s1474" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1474.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="176-180" id="s1474.e1" ontology_id="81846" text="SBF2" type="GENE"/>
    <pair e1="s1474.e0" e2="s1474.e1" id="s1474.p0" relation="true"/>
  </sentence>
  <sentence id="s1475" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1475.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="182-187" id="s1475.e1" ontology_id="10397" text="NDRG1" type="GENE"/>
    <pair e1="s1475.e0" e2="s1475.e1" id="s1475.p0" relation="true"/>
  </sentence>
  <sentence id="s1476" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1476.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="203-206" id="s1476.e1" ontology_id="25824" text="PRX" type="GENE"/>
    <pair e1="s1476.e0" e2="s1476.e1" id="s1476.p0" relation="false"/>
  </sentence>
  <sentence id="s1477" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1477.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="208-212" id="s1477.e1" ontology_id="121512" text="FGD4" type="GENE"/>
    <pair e1="s1477.e0" e2="s1477.e1" id="s1477.p0" relation="true"/>
  </sentence>
  <sentence id="s1478" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1478.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="218-222" id="s1478.e1" ontology_id="9896" text="FIG4" type="GENE"/>
    <pair e1="s1478.e0" e2="s1478.e1" id="s1478.p0" relation="true"/>
  </sentence>
  <sentence id="s1479" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1479.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="280-284" id="s1479.e1" ontology_id="4000" text="LMNA" type="GENE"/>
    <pair e1="s1479.e0" e2="s1479.e1" id="s1479.p0" relation="false"/>
  </sentence>
  <sentence id="s1480" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1480.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="293-298" id="s1480.e1" ontology_id="3094" text="HINT1" type="GENE"/>
    <pair e1="s1480.e0" e2="s1480.e1" id="s1480.p0" relation="true"/>
  </sentence>
  <sentence id="s1481" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1481.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="307-313" id="s1481.e1" ontology_id="90678" text="LRSAM1" type="GENE"/>
    <pair e1="s1481.e0" e2="s1481.e1" id="s1481.p0" relation="true"/>
  </sentence>
  <sentence id="s1482" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1482.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="321-326" id="s1482.e1" ontology_id="3315" text="HSPB1" type="GENE"/>
    <pair e1="s1482.e0" e2="s1482.e1" id="s1482.p0" relation="true"/>
  </sentence>
  <sentence id="s1483" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1483.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="331-335" id="s1483.e1" ontology_id="9927" text="MFN2" type="GENE"/>
    <pair e1="s1483.e0" e2="s1483.e1" id="s1483.p0" relation="false"/>
  </sentence>
  <sentence id="s1484" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1484.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="162-167" id="s1484.e1" ontology_id="54332" text="GDAP1" type="GENE"/>
    <pair e1="s1484.e0" e2="s1484.e1" id="s1484.p0" relation="true"/>
  </sentence>
  <sentence id="s1485" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1485.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="169-174" id="s1485.e1" ontology_id="8898" text="MTMR2" type="GENE"/>
    <pair e1="s1485.e0" e2="s1485.e1" id="s1485.p0" relation="false"/>
  </sentence>
  <sentence id="s1486" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1486.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="182-187" id="s1486.e1" ontology_id="10397" text="NDRG1" type="GENE"/>
    <pair e1="s1486.e0" e2="s1486.e1" id="s1486.p0" relation="true"/>
  </sentence>
  <sentence id="s1487" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1487.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="203-206" id="s1487.e1" ontology_id="25824" text="PRX" type="GENE"/>
    <pair e1="s1487.e0" e2="s1487.e1" id="s1487.p0" relation="true"/>
  </sentence>
  <sentence id="s1488" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1488.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="269-273" id="s1488.e1" ontology_id="54332" text="CMT4" type="GENE"/>
    <pair e1="s1488.e0" e2="s1488.e1" id="s1488.p0" relation="false"/>
  </sentence>
  <sentence id="s1489" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1489.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="286-291" id="s1489.e1" ontology_id="55090" text="MED25" type="GENE"/>
    <pair e1="s1489.e0" e2="s1489.e1" id="s1489.p0" relation="true"/>
  </sentence>
  <sentence id="s1490" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1490.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="293-298" id="s1490.e1" ontology_id="3094" text="HINT1" type="GENE"/>
    <pair e1="s1490.e0" e2="s1490.e1" id="s1490.p0" relation="true"/>
  </sentence>
  <sentence id="s1491" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1491.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="307-313" id="s1491.e1" ontology_id="90678" text="LRSAM1" type="GENE"/>
    <pair e1="s1491.e0" e2="s1491.e1" id="s1491.p0" relation="true"/>
  </sentence>
  <sentence id="s1492" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1492.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="331-335" id="s1492.e1" ontology_id="9927" text="MFN2" type="GENE"/>
    <pair e1="s1492.e0" e2="s1492.e1" id="s1492.p0" relation="true"/>
  </sentence>
  <sentence id="s1493" text="Alterations in &lt;i&gt;MEK1/2&lt;/i&gt; occur in cancers, both in the treatment-nave state and following targeted therapies, most notably BRAF and MEK inhibitors in &lt;i&gt;BRAF&lt;/i&gt;-V600E-mutant melanoma and colorectal cancer.">
    <entity charOffset="38-44" id="s1493.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="128-132" id="s1493.e1" ontology_id="673" text="BRAF" type="GENE"/>
    <pair e1="s1493.e0" e2="s1493.e1" id="s1493.p0" relation="true"/>
  </sentence>
  <sentence id="s1494" text="This work highlights the importance of classifying mutations based on structural and phenotypic consequences, both in terms of pathway signaling output and response to pharmacologic inhibition.&lt;b&gt;Implications:&lt;/b&gt; This study suggests that alternate modes of target inhibition, such as ERK inhibition, will be required to effectively treat tumors harboring these MEK1/2-resistant alleles.">
    <entity charOffset="285-288" id="s1494.e0" ontology_id="2048" text="ERK" type="GENE"/>
    <entity charOffset="339-345" id="s1494.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1494.e0" e2="s1494.e1" id="s1494.p0" relation="true"/>
  </sentence>
  <sentence id="s1495" text="We recently demonstrated that SIRT1 is upregulated in melanoma and its inhibition by a small-molecule, tenovin-1, inhibits cell proliferation and clonogenic survival of melanoma cells, possibly via activating p53.">
    <entity charOffset="30-35" id="s1495.e0" ontology_id="23411" text="SIRT1" type="GENE"/>
    <entity charOffset="54-62" id="s1495.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1495.e0" e2="s1495.e1" id="s1495.p0" relation="true"/>
  </sentence>
  <sentence id="s1496" text="Here, we employed a gel free quantitative proteomics approach to identify the downstream effectors and targets of SIRT1 in melanoma.">
    <entity charOffset="114-119" id="s1496.e0" ontology_id="23411" text="SIRT1" type="GENE"/>
    <entity charOffset="123-131" id="s1496.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1496.e0" e2="s1496.e1" id="s1496.p0" relation="true"/>
  </sentence>
  <sentence id="s1497" text="The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of SIRT1 resulted in a downregulation of BUB3, BUB1 and BUBR1 in multiple melanoma cell lines.">
    <entity charOffset="72-77" id="s1497.e0" ontology_id="23411" text="SIRT1" type="GENE"/>
    <entity charOffset="143-151" id="s1497.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1497.e0" e2="s1497.e1" id="s1497.p0" relation="true"/>
  </sentence>
  <sentence id="s1498" text="The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of SIRT1 resulted in a downregulation of BUB3, BUB1 and BUBR1 in multiple melanoma cell lines.">
    <entity charOffset="110-114" id="s1498.e0" ontology_id="9184" text="BUB3" type="GENE"/>
    <entity charOffset="143-151" id="s1498.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1498.e0" e2="s1498.e1" id="s1498.p0" relation="true"/>
  </sentence>
  <sentence id="s1499" text="The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of SIRT1 resulted in a downregulation of BUB3, BUB1 and BUBR1 in multiple melanoma cell lines.">
    <entity charOffset="116-120" id="s1499.e0" ontology_id="699" text="BUB1" type="GENE"/>
    <entity charOffset="143-151" id="s1499.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1499.e0" e2="s1499.e1" id="s1499.p0" relation="false"/>
  </sentence>
  <sentence id="s1500" text="The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of SIRT1 resulted in a downregulation of BUB3, BUB1 and BUBR1 in multiple melanoma cell lines.">
    <entity charOffset="125-130" id="s1500.e0" ontology_id="701" text="BUBR1" type="GENE"/>
    <entity charOffset="143-151" id="s1500.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1500.e0" e2="s1500.e1" id="s1500.p0" relation="true"/>
  </sentence>
  <sentence id="s1501" text="This study targeted a novel tumor-associated antigen, ring finger protein 43 (RNF43).">
    <entity charOffset="28-33" id="s1501.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="78-83" id="s1501.e1" ontology_id="54894" text="RNF43" type="GENE"/>
    <pair e1="s1501.e0" e2="s1501.e1" id="s1501.p0" relation="true"/>
  </sentence>
  <sentence id="s1502" text="Eligible patients were resistant to standard therapy, HLA-A*24:02- or A*02:01-positive and exhibiting high RNF43 expression in their tumor cells.">
    <entity charOffset="107-112" id="s1502.e0" ontology_id="54894" text="RNF43" type="GENE"/>
    <entity charOffset="133-138" id="s1502.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1502.e0" e2="s1502.e1" id="s1502.p0" relation="true"/>
  </sentence>
  <sentence id="s1503" text="Our results confirm two previous reports indicating that loss of function of a single allele of SLC6A1 causes epilepsy.">
    <entity charOffset="96-102" id="s1503.e0" ontology_id="6529" text="SLC6A1" type="GENE"/>
    <entity charOffset="110-118" id="s1503.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1503.e0" e2="s1503.e1" id="s1503.p0" relation="true"/>
  </sentence>
  <sentence id="s1504" text="The aim of this cross-sectional study was to evaluate the functioning and HR-QoL determinants in 67 patients with anti-MAG neuropathy in terms of the International Classification of Functioning, Disability, and Health (ICF).">
    <entity charOffset="119-122" id="s1504.e0" ontology_id="2068" text="MAG" type="GENE"/>
    <entity charOffset="123-133" id="s1504.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1504.e0" e2="s1504.e1" id="s1504.p0" relation="true"/>
  </sentence>
  <sentence id="s1505" text="Furthermore, neurorehabilitation interventions aimed at improving balance and walking performance, fatigue management, and specific pain relief therapy should be considered to ameliorate participation in social life and HR-QoL in anti-MAG neuropathy patients">
    <entity charOffset="220-222" id="s1505.e0" ontology_id="55806" text="HR" type="GENE"/>
    <entity charOffset="239-249" id="s1505.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1505.e0" e2="s1505.e1" id="s1505.p0" relation="true"/>
  </sentence>
  <sentence id="s1506" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1506.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="63-67" id="s1506.e1" ontology_id="59352" text="LGR6" type="GENE"/>
    <pair e1="s1506.e0" e2="s1506.e1" id="s1506.p0" relation="true"/>
  </sentence>
  <sentence id="s1507" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1507.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="69-73" id="s1507.e1" ontology_id="4194" text="MDM4" type="GENE"/>
    <pair e1="s1507.e0" e2="s1507.e1" id="s1507.p0" relation="true"/>
  </sentence>
  <sentence id="s1508" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1508.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="75-80" id="s1508.e1" ontology_id="841" text="CASP8" type="GENE"/>
    <pair e1="s1508.e0" e2="s1508.e1" id="s1508.p0" relation="true"/>
  </sentence>
  <sentence id="s1509" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1509.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="119-123" id="s1509.e1" ontology_id="27324" text="TOX3" type="GENE"/>
    <pair e1="s1509.e0" e2="s1509.e1" id="s1509.p0" relation="true"/>
  </sentence>
  <sentence id="s1510" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1510.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="245-250" id="s1510.e1" ontology_id="5195" text="PEX14" type="GENE"/>
    <pair e1="s1510.e0" e2="s1510.e1" id="s1510.p0" relation="true"/>
  </sentence>
  <sentence id="s1511" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1511.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="268-274" id="s1511.e1" ontology_id="11086" text="ADAM29" type="GENE"/>
    <pair e1="s1511.e0" e2="s1511.e1" id="s1511.p0" relation="true"/>
  </sentence>
  <sentence id="s1512" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1512.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="337-342" id="s1512.e1" ontology_id="675" text="BRCA2" type="GENE"/>
    <pair e1="s1512.e0" e2="s1512.e1" id="s1512.p0" relation="true"/>
  </sentence>
  <sentence id="s1513" text="The downstream pathways of Nodal-Foxh1 play a critical role not only in L-R determination in the lateral plate mesoderm but also in myocardial specification and differentiation in the AHF, suggesting that TGA is a phenotype in heterotaxia as well as the primary developmental defect of the AHF.">
    <entity charOffset="27-32" id="s1513.e0" ontology_id="4838" text="Nodal" type="GENE"/>
    <entity charOffset="227-238" id="s1513.e1" ontology_id="HP_0030853" text="heterotaxia" type="HP"/>
    <pair e1="s1513.e0" e2="s1513.e1" id="s1513.p0" relation="true"/>
  </sentence>
  <sentence id="s1514" text="DNA samples from eight families with autosomal recessive retinal dystrophies were subjected to genome wide homozygosity mapping (seven by SNP arrays and one by STR markers) and genes comprised within the detected homozygous regions were analyzed by Sanger sequencing.">
    <entity charOffset="37-56" id="s1514.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="160-163" id="s1514.e1" ontology_id="6779" text="STR" type="GENE"/>
    <pair e1="s1514.e0" e2="s1514.e1" id="s1514.p0" relation="true"/>
  </sentence>
  <sentence id="s1515" text="However, Pdha1&lt;sup&gt;f/Y;&lt;/sup&gt; Cnp&lt;sup&gt;Cre/+&lt;/sup&gt; mice showed reduced fiber density and signs of axonal degeneration in both sciatic and optic nerves from 6 months of age.">
    <entity charOffset="50-54" id="s1515.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="97-116" id="s1515.e1" ontology_id="HP_0040078" text="axonal degeneration" type="HP"/>
    <pair e1="s1515.e0" e2="s1515.e1" id="s1515.p0" relation="true"/>
  </sentence>
  <sentence id="s1516" text="Disabling mutations in the FGD1 gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately short stature, facial, skeletal and urogenital anomalies, and in a number of cases, mild mental retardation.">
    <entity charOffset="27-31" id="s1516.e0" ontology_id="2245" text="FGD1" type="GENE"/>
    <entity charOffset="181-194" id="s1516.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s1516.e0" e2="s1516.e1" id="s1516.p0" relation="true"/>
  </sentence>
  <sentence id="s1517" text="Disabling mutations in the FGD1 gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately short stature, facial, skeletal and urogenital anomalies, and in a number of cases, mild mental retardation.">
    <entity charOffset="27-31" id="s1517.e0" ontology_id="2245" text="FGD1" type="GENE"/>
    <entity charOffset="217-237" id="s1517.e1" ontology_id="HP_0000119" text="urogenital anomalies" type="HP"/>
    <pair e1="s1517.e0" e2="s1517.e1" id="s1517.p0" relation="true"/>
  </sentence>
  <sentence id="s1518" text="Disabling mutations in the FGD1 gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately short stature, facial, skeletal and urogenital anomalies, and in a number of cases, mild mental retardation.">
    <entity charOffset="27-31" id="s1518.e0" ontology_id="2245" text="FGD1" type="GENE"/>
    <entity charOffset="265-269" id="s1518.e1" ontology_id="HP_0012825" text="mild" type="HP"/>
    <pair e1="s1518.e0" e2="s1518.e1" id="s1518.p0" relation="true"/>
  </sentence>
  <sentence id="s1519" text="Two recent studies unveiled new potential functions of FGD1, in particular, its involvement in the regulation of the formation and function of invadopodia and podosomes, which are cellular structures devoted to degradation of the extracellular matrix in tumour and endothelial cells.">
    <entity charOffset="55-59" id="s1519.e0" ontology_id="2245" text="FGD1" type="GENE"/>
    <entity charOffset="254-260" id="s1519.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1519.e0" e2="s1519.e1" id="s1519.p0" relation="true"/>
  </sentence>
  <sentence id="s1520" text="Moreover, we found ITGA3 expression correlated with several clinicopathological features, including tumor size, lymph node metastasis, and the TNM stage.">
    <entity charOffset="19-24" id="s1520.e0" ontology_id="3675" text="ITGA3" type="GENE"/>
    <entity charOffset="100-105" id="s1520.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1520.e0" e2="s1520.e1" id="s1520.p0" relation="true"/>
  </sentence>
  <sentence id="s1521" text="By analyzing public data sets of gene expression in human breast cancers we observed that increased levels of transcripts encoding the planar cell polarity (PCP) proteins SCRIB and VANGL1 correlate with increased risk of patient relapse.">
    <entity charOffset="65-71" id="s1521.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="157-160" id="s1521.e1" ontology_id="54858" text="PCP" type="GENE"/>
    <pair e1="s1521.e0" e2="s1521.e1" id="s1521.p0" relation="true"/>
  </sentence>
  <sentence id="s1522" text="To investigate SCRIB-associated proteins that might participate in the responses of breast cancer cells to altered levels of SCRIB, we used mass spectrometry and confocal microscopy.">
    <entity charOffset="91-97" id="s1522.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="140-144" id="s1522.e1" ontology_id="2200" text="mass" type="GENE"/>
    <pair e1="s1522.e0" e2="s1522.e1" id="s1522.p0" relation="true"/>
  </sentence>
  <sentence id="s1523" text="Focusing on NOS1AP, we observed that NOS1AP colocalizes with both SCRIB and VANGL1 along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells.">
    <entity charOffset="12-18" id="s1523.e0" ontology_id="9722" text="NOS1AP" type="GENE"/>
    <entity charOffset="131-137" id="s1523.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1523.e0" e2="s1523.e1" id="s1523.p0" relation="true"/>
  </sentence>
  <sentence id="s1524" text="Focusing on NOS1AP, we observed that NOS1AP colocalizes with both SCRIB and VANGL1 along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells.">
    <entity charOffset="66-71" id="s1524.e0" ontology_id="23513" text="SCRIB" type="GENE"/>
    <entity charOffset="131-137" id="s1524.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1524.e0" e2="s1524.e1" id="s1524.p0" relation="true"/>
  </sentence>
  <sentence id="s1525" text="We investigated the effects of shRNA-mediated knockdown of NOS1AP and SCRIB in vitro, and found that reducing NOS1AP and SCRIB slows breast cancer cell migration and prevents the establishment of leading-trailing polarity.">
    <entity charOffset="59-65" id="s1525.e0" ontology_id="9722" text="NOS1AP" type="GENE"/>
    <entity charOffset="140-146" id="s1525.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1525.e0" e2="s1525.e1" id="s1525.p0" relation="true"/>
  </sentence>
  <sentence id="s1526" text="We investigated the effects of shRNA-mediated knockdown of NOS1AP and SCRIB in vitro, and found that reducing NOS1AP and SCRIB slows breast cancer cell migration and prevents the establishment of leading-trailing polarity.">
    <entity charOffset="70-75" id="s1526.e0" ontology_id="23513" text="SCRIB" type="GENE"/>
    <entity charOffset="140-146" id="s1526.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1526.e0" e2="s1526.e1" id="s1526.p0" relation="true"/>
  </sentence>
  <sentence id="s1527" text="The tumor-node-metastasis (TNM) classification, the presence of a mucinous component, and signet ring cells are well-known criteria for identifying patients at a high risk for recurrence and determining the therapeutic approach for early-stage colon cancer (eCC).">
    <entity charOffset="27-30" id="s1527.e0" ontology_id="10178" text="TNM" type="GENE"/>
    <entity charOffset="250-256" id="s1527.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1527.e0" e2="s1527.e1" id="s1527.p0" relation="true"/>
  </sentence>
  <sentence id="s1528" text="The aims of the present study were to evaluate the relation of dysregulated MACC1, c-MET, and NM23-H1 expression with the histopathological features of tumors in recurrence formation in eCC cases.">
    <entity charOffset="76-81" id="s1528.e0" ontology_id="346389" text="MACC1" type="GENE"/>
    <entity charOffset="152-157" id="s1528.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1528.e0" e2="s1528.e1" id="s1528.p0" relation="true"/>
  </sentence>
  <sentence id="s1529" text="The aims of the present study were to evaluate the relation of dysregulated MACC1, c-MET, and NM23-H1 expression with the histopathological features of tumors in recurrence formation in eCC cases.">
    <entity charOffset="85-88" id="s1529.e0" ontology_id="79811" text="MET" type="GENE"/>
    <entity charOffset="152-157" id="s1529.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1529.e0" e2="s1529.e1" id="s1529.p0" relation="true"/>
  </sentence>
  <sentence id="s1530" text="The aims of the present study were to evaluate the relation of dysregulated MACC1, c-MET, and NM23-H1 expression with the histopathological features of tumors in recurrence formation in eCC cases.">
    <entity charOffset="94-98" id="s1530.e0" ontology_id="4830" text="NM23" type="GENE"/>
    <entity charOffset="152-157" id="s1530.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1530.e0" e2="s1530.e1" id="s1530.p0" relation="true"/>
  </sentence>
  <sentence id="s1531" text="The relationship between the altered expression of MACC1, c-MET, and NM23-H1 and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed.">
    <entity charOffset="51-56" id="s1531.e0" ontology_id="346389" text="MACC1" type="GENE"/>
    <entity charOffset="149-154" id="s1531.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1531.e0" e2="s1531.e1" id="s1531.p0" relation="true"/>
  </sentence>
  <sentence id="s1532" text="The relationship between the altered expression of MACC1, c-MET, and NM23-H1 and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed.">
    <entity charOffset="60-63" id="s1532.e0" ontology_id="79811" text="MET" type="GENE"/>
    <entity charOffset="149-154" id="s1532.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1532.e0" e2="s1532.e1" id="s1532.p0" relation="true"/>
  </sentence>
  <sentence id="s1533" text="The relationship between the altered expression of MACC1, c-MET, and NM23-H1 and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed.">
    <entity charOffset="74-76" id="s1533.e0" ontology_id="25932" text="H1" type="GENE"/>
    <entity charOffset="149-154" id="s1533.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1533.e0" e2="s1533.e1" id="s1533.p0" relation="true"/>
  </sentence>
  <sentence id="s1534" text="In addition, the coexistence of high MACC1 and low NM23-H1 expression and tumor budding was associated with short OS (p&amp;lt;0.001).">
    <entity charOffset="37-42" id="s1534.e0" ontology_id="346389" text="MACC1" type="GENE"/>
    <entity charOffset="74-79" id="s1534.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1534.e0" e2="s1534.e1" id="s1534.p0" relation="true"/>
  </sentence>
  <sentence id="s1535" text="In addition, the coexistence of high MACC1 and low NM23-H1 expression and tumor budding was associated with short OS (p&amp;lt;0.001).">
    <entity charOffset="51-55" id="s1535.e0" ontology_id="4830" text="NM23" type="GENE"/>
    <entity charOffset="74-79" id="s1535.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1535.e0" e2="s1535.e1" id="s1535.p0" relation="true"/>
  </sentence>
  <sentence id="s1536" text="We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="48-50" id="s1536.e0" ontology_id="25932" text="H1" type="GENE"/>
    <entity charOffset="87-92" id="s1536.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1536.e0" e2="s1536.e1" id="s1536.p0" relation="true"/>
  </sentence>
  <sentence id="s1537" text="We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="48-50" id="s1537.e0" ontology_id="25932" text="H1" type="GENE"/>
    <entity charOffset="222-228" id="s1537.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1537.e0" e2="s1537.e1" id="s1537.p0" relation="false"/>
  </sentence>
  <sentence id="s1538" text="The purpose of this study was to explore the use of iterative decomposition of water and fat with echo asymmetry and least-squares estimation Carr-Purcell-Meiboom-Gill (IDEAL-CPMG) to simultaneously measure skeletal muscle apparent fat fraction and water T&lt;sub&gt;2&lt;/sub&gt; (T&lt;sub&gt;2,w&lt;/sub&gt;) in patients with Duchenne muscular dystrophy (DMD).">
    <entity charOffset="313-331" id="s1538.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="333-336" id="s1538.e1" ontology_id="1756" text="DMD" type="GENE"/>
    <pair e1="s1538.e0" e2="s1538.e1" id="s1538.p0" relation="true"/>
  </sentence>
  <sentence id="s1539" text="In summary, the regulatory role of Mfsd2a deepens our knowledge of the function of the BBB, potentially contributing to the effective drug delivery in the treatments for neurodegenerative diseases, brain tumors, and life-threatening infections in the CNS.">
    <entity charOffset="35-41" id="s1539.e0" ontology_id="84879" text="Mfsd2a" type="GENE"/>
    <entity charOffset="170-196" id="s1539.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s1539.e0" e2="s1539.e1" id="s1539.p0" relation="true"/>
  </sentence>
  <sentence id="s1540" text="In summary, the regulatory role of Mfsd2a deepens our knowledge of the function of the BBB, potentially contributing to the effective drug delivery in the treatments for neurodegenerative diseases, brain tumors, and life-threatening infections in the CNS.">
    <entity charOffset="35-41" id="s1540.e0" ontology_id="84879" text="Mfsd2a" type="GENE"/>
    <entity charOffset="204-210" id="s1540.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1540.e0" e2="s1540.e1" id="s1540.p0" relation="true"/>
  </sentence>
  <sentence id="s1541" text="Patients carrying homozygous WNT1 mutations have more frequent fractures while heterozygous carriers of the mutation in WNT1 gene are also found to have early onset osteoporosis.">
    <entity charOffset="29-33" id="s1541.e0" ontology_id="7471" text="WNT1" type="GENE"/>
    <entity charOffset="165-177" id="s1541.e1" ontology_id="HP_0000939" text="osteoporosis" type="HP"/>
    <pair e1="s1541.e0" e2="s1541.e1" id="s1541.p0" relation="true"/>
  </sentence>
  <sentence id="s1542" text="Hemangioblastomas (HBs) are uncommon tumors characterized by the presence of inactivating alterations in the von Hippel-Lindau (VHL) gene in inherited cases and by infrequent somatic mutation in sporadic entities.">
    <entity charOffset="37-43" id="s1542.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="128-131" id="s1542.e1" ontology_id="7428" text="VHL" type="GENE"/>
    <pair e1="s1542.e0" e2="s1542.e1" id="s1542.p0" relation="true"/>
  </sentence>
  <sentence id="s1543" text="Hemangioblastomas (HBs) are uncommon tumors characterized by the presence of inactivating alterations in the von Hippel-Lindau (VHL) gene in inherited cases and by infrequent somatic mutation in sporadic entities.">
    <entity charOffset="128-131" id="s1543.e0" ontology_id="7428" text="VHL" type="GENE"/>
    <entity charOffset="175-191" id="s1543.e1" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <pair e1="s1543.e0" e2="s1543.e1" id="s1543.p0" relation="true"/>
  </sentence>
  <sentence id="s1544" text="Hemangioblastomas (HBs) are uncommon tumors characterized by the presence of inactivating alterations in the von Hippel-Lindau (VHL) gene in inherited cases and by infrequent somatic mutation in sporadic entities.">
    <entity charOffset="128-131" id="s1544.e0" ontology_id="7428" text="VHL" type="GENE"/>
    <entity charOffset="195-203" id="s1544.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1544.e0" e2="s1544.e1" id="s1544.p0" relation="true"/>
  </sentence>
  <sentence id="s1545" text="Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.">
    <entity charOffset="70-77" id="s1545.e0" ontology_id="285429" text="DCAF4L1" type="GENE"/>
    <entity charOffset="90-98" id="s1545.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1545.e0" e2="s1545.e1" id="s1545.p0" relation="true"/>
  </sentence>
  <sentence id="s1546" text="Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.">
    <entity charOffset="83-86" id="s1546.e0" ontology_id="7428" text="VHL" type="GENE"/>
    <entity charOffset="90-98" id="s1546.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1546.e0" e2="s1546.e1" id="s1546.p0" relation="true"/>
  </sentence>
  <sentence id="s1547" text="Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.">
    <entity charOffset="90-98" id="s1547.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="108-114" id="s1547.e1" ontology_id="730051" text="ZNF814" type="GENE"/>
    <pair e1="s1547.e0" e2="s1547.e1" id="s1547.p0" relation="true"/>
  </sentence>
  <sentence id="s1548" text="Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.">
    <entity charOffset="90-98" id="s1548.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="129-132" id="s1548.e1" ontology_id="5411" text="PNN" type="GENE"/>
    <pair e1="s1548.e0" e2="s1548.e1" id="s1548.p0" relation="true"/>
  </sentence>
  <sentence id="s1549" text="Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.">
    <entity charOffset="90-98" id="s1549.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="138-142" id="s1549.e1" ontology_id="4589" text="MUC7" type="GENE"/>
    <pair e1="s1549.e0" e2="s1549.e1" id="s1549.p0" relation="true"/>
  </sentence>
  <sentence id="s1550" text="Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.">
    <entity charOffset="22-27" id="s1550.e0" ontology_id="283310" text="OTOGL" type="GENE"/>
    <entity charOffset="94-102" id="s1550.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1550.e0" e2="s1550.e1" id="s1550.p0" relation="true"/>
  </sentence>
  <sentence id="s1551" text="Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.">
    <entity charOffset="29-34" id="s1551.e0" ontology_id="5332" text="PLCB4" type="GENE"/>
    <entity charOffset="94-102" id="s1551.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1551.e0" e2="s1551.e1" id="s1551.p0" relation="true"/>
  </sentence>
  <sentence id="s1552" text="Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.">
    <entity charOffset="36-40" id="s1552.e0" ontology_id="8796" text="SCEL" type="GENE"/>
    <entity charOffset="94-102" id="s1552.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1552.e0" e2="s1552.e1" id="s1552.p0" relation="true"/>
  </sentence>
  <sentence id="s1553" text="Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.">
    <entity charOffset="42-47" id="s1553.e0" ontology_id="79875" text="THSD4" type="GENE"/>
    <entity charOffset="94-102" id="s1553.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1553.e0" e2="s1553.e1" id="s1553.p0" relation="true"/>
  </sentence>
  <sentence id="s1554" text="Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.">
    <entity charOffset="94-102" id="s1554.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="135-140" id="s1554.e1" ontology_id="23460" text="ABCA6" type="GENE"/>
    <pair e1="s1554.e0" e2="s1554.e1" id="s1554.p0" relation="true"/>
  </sentence>
  <sentence id="s1555" text="Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.">
    <entity charOffset="94-102" id="s1555.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="153-158" id="s1555.e1" ontology_id="3908" text="LAMA2" type="GENE"/>
    <pair e1="s1555.e0" e2="s1555.e1" id="s1555.p0" relation="false"/>
  </sentence>
  <sentence id="s1556" text="Congenital heart defects represent a characteristic part of several genetic syndromes associated with chromosomal abnormalities such as 22q11.2 deletion syndrome; many genes located in this locus, mainly TBX1, are candidate genes for congenital heart defects.">
    <entity charOffset="204-208" id="s1556.e0" ontology_id="6899" text="TBX1" type="GENE"/>
    <entity charOffset="234-258" id="s1556.e1" ontology_id="HP_0001627" text="congenital heart defects" type="HP"/>
    <pair e1="s1556.e0" e2="s1556.e1" id="s1556.p0" relation="true"/>
  </sentence>
  <sentence id="s1557" text="Functional assays revealed that ectopic expression of miR-144-5p and miR-144-3p significantly blocked the malignant abilities of LUSQ cells, eg, cancer cell proliferation, migration, and invasion.">
    <entity charOffset="54-57" id="s1557.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="145-151" id="s1557.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1557.e0" e2="s1557.e1" id="s1557.p0" relation="true"/>
  </sentence>
  <sentence id="s1558" text="NSUN2 is a RNA methyltransferase that has been shown to be implicated in development of human cancer.">
    <entity charOffset="0-5" id="s1558.e0" ontology_id="54888" text="NSUN2" type="GENE"/>
    <entity charOffset="94-100" id="s1558.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1558.e0" e2="s1558.e1" id="s1558.p0" relation="true"/>
  </sentence>
  <sentence id="s1559" text="However, the functional role of NSUN2, mechanism of NSUN2 overexpression and its association with clinicopathologic features in breast cancer remain unclear.">
    <entity charOffset="32-37" id="s1559.e0" ontology_id="54888" text="NSUN2" type="GENE"/>
    <entity charOffset="135-141" id="s1559.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1559.e0" e2="s1559.e1" id="s1559.p0" relation="true"/>
  </sentence>
  <sentence id="s1560" text="To investigate alterations in the expression and functional role of NSUN2 in breast cancer, NSUN2 expression was assessed in breast cancer cells and tissues obtained from cancers at different American Joint Committee on Cancer (AJCC) stages, and its functions were investigated using breast cancer cells.">
    <entity charOffset="68-73" id="s1560.e0" ontology_id="54888" text="NSUN2" type="GENE"/>
    <entity charOffset="84-90" id="s1560.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1560.e0" e2="s1560.e1" id="s1560.p0" relation="true"/>
  </sentence>
  <sentence id="s1561" text="Our results demonstrated that the overall expression of NSUN2 significantly correlated with clinical stage (P=0.027), tumor classification (P=0.012), pathological differentiation (P=0.023), as well as with the expression levels of estrogen receptor (P&amp;lt;0.001), progesterone receptor (P=0.001), and Ki-67 (P&amp;lt;0.001).">
    <entity charOffset="118-123" id="s1561.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="300-302" id="s1561.e1" ontology_id="10197" text="Ki" type="GENE"/>
    <pair e1="s1561.e0" e2="s1561.e1" id="s1561.p0" relation="true"/>
  </sentence>
  <sentence id="s1562" text="Our findings provide a unique insight into the roles and effects of NSUN2 overexpression in breast cancer cells, and highlight the necessity of the investigation of novel therapeutic targets, such as NSUN2, for the improvement of breast cancer treatments">
    <entity charOffset="68-73" id="s1562.e0" ontology_id="54888" text="NSUN2" type="GENE"/>
    <entity charOffset="99-105" id="s1562.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1562.e0" e2="s1562.e1" id="s1562.p0" relation="true"/>
  </sentence>
  <sentence id="s1563" text="Here we present a novel Mks1(tm1a(EUCOMM)Wtsi) knockout mouse which accurately recapitulates the human condition, consistently developing pre-axial polydactyly, complex posterior fossa defects (including the Dandy-Walker malformation), and renal cystic dysplasia.">
    <entity charOffset="24-28" id="s1563.e0" ontology_id="54903" text="Mks1" type="GENE"/>
    <entity charOffset="142-147" id="s1563.e1" ontology_id="HP_0025287" text="axial" type="HP"/>
    <pair e1="s1563.e0" e2="s1563.e1" id="s1563.p0" relation="true"/>
  </sentence>
  <sentence id="s1564" text="Here we present a novel Mks1(tm1a(EUCOMM)Wtsi) knockout mouse which accurately recapitulates the human condition, consistently developing pre-axial polydactyly, complex posterior fossa defects (including the Dandy-Walker malformation), and renal cystic dysplasia.">
    <entity charOffset="24-28" id="s1564.e0" ontology_id="54903" text="Mks1" type="GENE"/>
    <entity charOffset="148-159" id="s1564.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s1564.e0" e2="s1564.e1" id="s1564.p0" relation="true"/>
  </sentence>
  <sentence id="s1565" text="To investigate the presence of specific chromosomal and gene alterations, BAP1 protein expression, and their relationship with distant progression free survival (DPFS), we analyzed tumor samples from 63 UM patients (40 men and 23 women, with a median age of 64 years), who underwent eye enucleation by a single cancer ophthalmologist from December 2005 to June 2016.">
    <entity charOffset="74-78" id="s1565.e0" ontology_id="154043" text="BAP1" type="GENE"/>
    <entity charOffset="181-186" id="s1565.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1565.e0" e2="s1565.e1" id="s1565.p0" relation="true"/>
  </sentence>
  <sentence id="s1566" text="CDK5RAP2 gene encodes a centrosomal protein, highly expressed in fetal brain and essentially indispensable for its normal development, as biallelic mutations in it lead to primary microcephaly (MCPH).">
    <entity charOffset="0-8" id="s1566.e0" ontology_id="55755" text="CDK5RAP2" type="GENE"/>
    <entity charOffset="180-192" id="s1566.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1566.e0" e2="s1566.e1" id="s1566.p0" relation="true"/>
  </sentence>
  <sentence id="s1567" text="The heterogeneity test, sensitivity analysis, and publication bias test was performed by Review Manager 5.3 software.Overall, 22 case-control studies with 5049 cases and 4157 controls were included in this meta-analysis, which contained 20 studies of MTHFR C677T polymorphism, 12 studies of MTHFR A1298C polymorphism and 4 studies of MTRR A66G polymorphism.">
    <entity charOffset="4-17" id="s1567.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="251-256" id="s1567.e1" ontology_id="4524" text="MTHFR" type="GENE"/>
    <pair e1="s1567.e0" e2="s1567.e1" id="s1567.p0" relation="true"/>
  </sentence>
  <sentence id="s1568" text="In light of more and more evidence point to the importance of Kindlin family members in normal development and human diseases especially in cancers, we aim to portrait the profile of Kindlins in the regulation of embryonic development and cancer progression.">
    <entity charOffset="3-8" id="s1568.e0" ontology_id="8740" text="light" type="GENE"/>
    <entity charOffset="140-146" id="s1568.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1568.e0" e2="s1568.e1" id="s1568.p0" relation="true"/>
  </sentence>
  <sentence id="s1569" text="Overall, this first report of a germline molecular defect in SFTPA1 unveils the key role of SP-A1 in the occurrence of several chronic respiratory diseases, ranging from severe respiratory insufficiency occurring early in life to the association of lung fibrosis and cancer in adult patients.">
    <entity charOffset="61-67" id="s1569.e0" ontology_id="653509" text="SFTPA1" type="GENE"/>
    <entity charOffset="267-273" id="s1569.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1569.e0" e2="s1569.e1" id="s1569.p0" relation="true"/>
  </sentence>
  <sentence id="s1570" text="Recently mutations in the CASPR/CNTN1 complex have been associated with similar severe phenotypes and CNTNAP1 gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.">
    <entity charOffset="26-31" id="s1570.e0" ontology_id="8506" text="CASPR" type="GENE"/>
    <entity charOffset="204-218" id="s1570.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s1570.e0" e2="s1570.e1" id="s1570.p0" relation="true"/>
  </sentence>
  <sentence id="s1571" text="Recently mutations in the CASPR/CNTN1 complex have been associated with similar severe phenotypes and CNTNAP1 gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.">
    <entity charOffset="26-31" id="s1571.e0" ontology_id="8506" text="CASPR" type="GENE"/>
    <entity charOffset="189-203" id="s1571.e1" ontology_id="HP_0003577" text="prenatal onset" type="HP"/>
    <pair e1="s1571.e0" e2="s1571.e1" id="s1571.p0" relation="false"/>
  </sentence>
  <sentence id="s1572" text="Recently mutations in the CASPR/CNTN1 complex have been associated with similar severe phenotypes and CNTNAP1 gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.">
    <entity charOffset="102-109" id="s1572.e0" ontology_id="8506" text="CNTNAP1" type="GENE"/>
    <entity charOffset="204-218" id="s1572.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s1572.e0" e2="s1572.e1" id="s1572.p0" relation="true"/>
  </sentence>
  <sentence id="s1573" text="Recently mutations in the CASPR/CNTN1 complex have been associated with similar severe phenotypes and CNTNAP1 gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.">
    <entity charOffset="102-109" id="s1573.e0" ontology_id="8506" text="CNTNAP1" type="GENE"/>
    <entity charOffset="189-203" id="s1573.e1" ontology_id="HP_0003577" text="prenatal onset" type="HP"/>
    <pair e1="s1573.e0" e2="s1573.e1" id="s1573.p0" relation="true"/>
  </sentence>
  <sentence id="s1574" text="The major categories of pancreatic neuroendocrine tumor (PanNET) are well-differentiated NET and poorly differentiated neuroendocrine carcinoma.">
    <entity charOffset="50-55" id="s1574.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="60-63" id="s1574.e1" ontology_id="2004" text="NET" type="GENE"/>
    <pair e1="s1574.e0" e2="s1574.e1" id="s1574.p0" relation="true"/>
  </sentence>
  <sentence id="s1575" text="Sequencing of these tumors has identified multiple important genes in the pathogenesis of PanNETs, such as DAXX/ATRX, MEN1, TP53, RB, and mTOR pathway genes.">
    <entity charOffset="20-25" id="s1575.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="93-96" id="s1575.e1" ontology_id="2004" text="NET" type="GENE"/>
    <pair e1="s1575.e0" e2="s1575.e1" id="s1575.p0" relation="true"/>
  </sentence>
  <sentence id="s1576" text="Sequencing of these tumors has identified multiple important genes in the pathogenesis of PanNETs, such as DAXX/ATRX, MEN1, TP53, RB, and mTOR pathway genes.">
    <entity charOffset="20-25" id="s1576.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="107-111" id="s1576.e1" ontology_id="1616" text="DAXX" type="GENE"/>
    <pair e1="s1576.e0" e2="s1576.e1" id="s1576.p0" relation="true"/>
  </sentence>
  <sentence id="s1577" text="Sequencing of these tumors has identified multiple important genes in the pathogenesis of PanNETs, such as DAXX/ATRX, MEN1, TP53, RB, and mTOR pathway genes.">
    <entity charOffset="20-25" id="s1577.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="118-122" id="s1577.e1" ontology_id="4221" text="MEN1" type="GENE"/>
    <pair e1="s1577.e0" e2="s1577.e1" id="s1577.p0" relation="true"/>
  </sentence>
  <sentence id="s1578" text="Sequencing of these tumors has identified multiple important genes in the pathogenesis of PanNETs, such as DAXX/ATRX, MEN1, TP53, RB, and mTOR pathway genes.">
    <entity charOffset="20-25" id="s1578.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="138-142" id="s1578.e1" ontology_id="2475" text="mTOR" type="GENE"/>
    <pair e1="s1578.e0" e2="s1578.e1" id="s1578.p0" relation="true"/>
  </sentence>
  <sentence id="s1579" text="Our data support that high-grade progression in PanNETs may be the result of the progressive accumulation of genetic changes (CNVs and point mutational changes) within the body of the tumor.">
    <entity charOffset="51-54" id="s1579.e0" ontology_id="2004" text="NET" type="GENE"/>
    <entity charOffset="184-189" id="s1579.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1579.e0" e2="s1579.e1" id="s1579.p0" relation="true"/>
  </sentence>
  <sentence id="s1580" text="Importantly, KLF4 inhibitor Kenpaullone sensitizes breast cancer cells and xenograft tumors to Paclitaxel and improves therapeutic effects.">
    <entity charOffset="13-17" id="s1580.e0" ontology_id="9314" text="KLF4" type="GENE"/>
    <entity charOffset="85-91" id="s1580.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1580.e0" e2="s1580.e1" id="s1580.p0" relation="true"/>
  </sentence>
  <sentence id="s1581" text="To identify tumor suppressor genes (TSGs) silenced by hypermethylation and discover new epigenetic biomarkers for early cancer detection.">
    <entity charOffset="36-39" id="s1581.e0" ontology_id="57045" text="TSG" type="GENE"/>
    <entity charOffset="120-126" id="s1581.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1581.e0" e2="s1581.e1" id="s1581.p0" relation="true"/>
  </sentence>
  <sentence id="s1582" text="ADAMTS18, located at 16q23.1, has been reported to be a critical TSG in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).">
    <entity charOffset="0-8" id="s1582.e0" ontology_id="170692" text="ADAMTS18" type="GENE"/>
    <entity charOffset="89-94" id="s1582.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1582.e0" e2="s1582.e1" id="s1582.p0" relation="true"/>
  </sentence>
  <sentence id="s1583" text="ADAMTS18, located at 16q23.1, has been reported to be a critical TSG in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).">
    <entity charOffset="0-8" id="s1583.e0" ontology_id="170692" text="ADAMTS18" type="GENE"/>
    <entity charOffset="140-171" id="s1583.e1" ontology_id="HP_0006770" text="clear cell renal cell carcinoma" type="HP"/>
    <pair e1="s1583.e0" e2="s1583.e1" id="s1583.p0" relation="true"/>
  </sentence>
  <sentence id="s1584" text="ADAMTS18, located at 16q23.1, has been reported to be a critical TSG in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).">
    <entity charOffset="65-68" id="s1584.e0" ontology_id="57045" text="TSG" type="GENE"/>
    <entity charOffset="140-171" id="s1584.e1" ontology_id="HP_0006770" text="clear cell renal cell carcinoma" type="HP"/>
    <pair e1="s1584.e0" e2="s1584.e1" id="s1584.p0" relation="true"/>
  </sentence>
  <sentence id="s1585" text="MSP was further performed for 101 ccRCC primary tumors and 20 adjacent normal tissues.">
    <entity charOffset="0-3" id="s1585.e0" ontology_id="89782" text="MSP" type="GENE"/>
    <entity charOffset="48-53" id="s1585.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1585.e0" e2="s1585.e1" id="s1585.p0" relation="true"/>
  </sentence>
  <sentence id="s1586" text="Furthermore, the methylation status of ADAMTS18 was not significantly associated with gender, age, location, tumor diameter, pathological stage, nuclear grade or short-term DFS in patients with ccRCC (p &amp;gt; 0.05).">
    <entity charOffset="39-47" id="s1586.e0" ontology_id="170692" text="ADAMTS18" type="GENE"/>
    <entity charOffset="109-114" id="s1586.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1586.e0" e2="s1586.e1" id="s1586.p0" relation="true"/>
  </sentence>
  <sentence id="s1587" text="The ADAMTS18 gene is often down-regulated by hypermethylation in ccRCC-derived cell lines and primary tumors, indicating its critical role as a TSG in ccRCC.">
    <entity charOffset="4-12" id="s1587.e0" ontology_id="170692" text="ADAMTS18" type="GENE"/>
    <entity charOffset="102-107" id="s1587.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1587.e0" e2="s1587.e1" id="s1587.p0" relation="true"/>
  </sentence>
  <sentence id="s1588" text="We conclude that ADAMTS18 gene hypermethylation may be involved in the tumorigenesis of ccRCC and may serve as a novel biomarker for this disease.">
    <entity charOffset="17-25" id="s1588.e0" ontology_id="170692" text="ADAMTS18" type="GENE"/>
    <entity charOffset="71-76" id="s1588.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1588.e0" e2="s1588.e1" id="s1588.p0" relation="true"/>
  </sentence>
  <sentence id="s1589" text="We observed the presence of the mutation at pH1047R of &lt;i&gt;PIK3CA&lt;/i&gt; gene in five samples of the tumour, while the remaining 15 samples did not show any mutation at &lt;i&gt;PIK3CA&lt;/i&gt; or any other investigated gene.">
    <entity charOffset="58-64" id="s1589.e0" ontology_id="5290" text="PIK3CA" type="GENE"/>
    <entity charOffset="97-103" id="s1589.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1589.e0" e2="s1589.e1" id="s1589.p0" relation="true"/>
  </sentence>
  <sentence id="s1590" text="There is a great need to develop novel RCC sampling strategies to overcome tumour heterogeneity prior to define precision oncology strategies">
    <entity charOffset="39-42" id="s1590.e0" ontology_id="7515" text="RCC" type="GENE"/>
    <entity charOffset="75-81" id="s1590.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1590.e0" e2="s1590.e1" id="s1590.p0" relation="true"/>
  </sentence>
  <sentence id="s1591" text="There is a great need to develop novel RCC sampling strategies to overcome tumour heterogeneity prior to define precision oncology strategies">
    <entity charOffset="39-42" id="s1591.e0" ontology_id="7515" text="RCC" type="GENE"/>
    <entity charOffset="82-95" id="s1591.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1591.e0" e2="s1591.e1" id="s1591.p0" relation="true"/>
  </sentence>
  <sentence id="s1592" text="Spinocerebellar ataxia type 5 (SCA5) is a neurodegenerative disease caused by mutations in the cytoskeletal protein -III-spectrin.">
    <entity charOffset="16-22" id="s1592.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="31-35" id="s1592.e1" ontology_id="6712" text="SCA5" type="GENE"/>
    <pair e1="s1592.e0" e2="s1592.e1" id="s1592.p0" relation="true"/>
  </sentence>
  <sentence id="s1593" text="Spinocerebellar ataxia type 5 (SCA5) is a neurodegenerative disease caused by mutations in the cytoskeletal protein -III-spectrin.">
    <entity charOffset="31-35" id="s1593.e0" ontology_id="6712" text="SCA5" type="GENE"/>
    <entity charOffset="42-67" id="s1593.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s1593.e0" e2="s1593.e1" id="s1593.p0" relation="true"/>
  </sentence>
  <sentence id="s1594" text="SMARCA4-deficient thoracic sarcoma is a recently proposed new entity of soft tissue sarcomas with an undifferentiated round cell morphology that is diagnostically challenging.">
    <entity charOffset="0-7" id="s1594.e0" ontology_id="6597" text="SMARCA4" type="GENE"/>
    <entity charOffset="27-34" id="s1594.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1594.e0" e2="s1594.e1" id="s1594.p0" relation="true"/>
  </sentence>
  <sentence id="s1595" text="Furthermore, in vitro inhibition of cancer-derived BMP4 noncanonical signals results in an increase of chemosensitivity in a colorectal cancer cell line.">
    <entity charOffset="36-42" id="s1595.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="51-55" id="s1595.e1" ontology_id="652" text="BMP4" type="GENE"/>
    <pair e1="s1595.e0" e2="s1595.e1" id="s1595.p0" relation="true"/>
  </sentence>
  <sentence id="s1596" text="Acad10 mice accumulate excess abdominal adipose tissue, develop an early inflammatory liver process, exhibit fasting rhabdomyolysis, and have abnormal skeletal muscle mitochondria.">
    <entity charOffset="0-6" id="s1596.e0" ontology_id="80724" text="Acad10" type="GENE"/>
    <entity charOffset="117-131" id="s1596.e1" ontology_id="HP_0003201" text="rhabdomyolysis" type="HP"/>
    <pair e1="s1596.e0" e2="s1596.e1" id="s1596.p0" relation="true"/>
  </sentence>
  <sentence id="s1597" text="Palatable foods (fat and sweet) induce hyperphagia, and facilitate the development of obesity.">
    <entity charOffset="17-20" id="s1597.e0" ontology_id="948" text="fat" type="GENE"/>
    <entity charOffset="39-50" id="s1597.e1" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <pair e1="s1597.e0" e2="s1597.e1" id="s1597.p0" relation="true"/>
  </sentence>
  <sentence id="s1598" text="Here we show that adipocyte OGT is essential for high fat diet-induced hyperphagia, but is dispensable for baseline food intake.">
    <entity charOffset="28-31" id="s1598.e0" ontology_id="8473" text="OGT" type="GENE"/>
    <entity charOffset="71-82" id="s1598.e1" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <pair e1="s1598.e0" e2="s1598.e1" id="s1598.p0" relation="true"/>
  </sentence>
  <sentence id="s1599" text="Adipocyte OGT stimulates hyperphagia by transcriptional activation of de novo lipid desaturation and accumulation of N-arachidonyl ethanolamine (AEA), an endogenous appetite-inducing cannabinoid (CB).">
    <entity charOffset="10-13" id="s1599.e0" ontology_id="8473" text="OGT" type="GENE"/>
    <entity charOffset="25-36" id="s1599.e1" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <pair e1="s1599.e0" e2="s1599.e1" id="s1599.p0" relation="true"/>
  </sentence>
  <sentence id="s1600" text="These findings define adipocyte OGT as a fat sensor that regulates peripheral lipid signals, and uncover an unexpected adipose-to-brain axis to induce hyperphagia and obesity">
    <entity charOffset="32-35" id="s1600.e0" ontology_id="8473" text="OGT" type="GENE"/>
    <entity charOffset="151-162" id="s1600.e1" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <pair e1="s1600.e0" e2="s1600.e1" id="s1600.p0" relation="true"/>
  </sentence>
  <sentence id="s1601" text="These findings define adipocyte OGT as a fat sensor that regulates peripheral lipid signals, and uncover an unexpected adipose-to-brain axis to induce hyperphagia and obesity">
    <entity charOffset="41-44" id="s1601.e0" ontology_id="948" text="fat" type="GENE"/>
    <entity charOffset="151-162" id="s1601.e1" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <pair e1="s1601.e0" e2="s1601.e1" id="s1601.p0" relation="true"/>
  </sentence>
  <sentence id="s1602" text="&lt;b&gt;Objective:&lt;/b&gt; To investigate the expression of granulocyte-colony stimulating factor receptor (G-CSFR) in a mouse model of colitis-associated cancer (CAC), and the roles of G-CSFR positive immune cells in the development of CAC.">
    <entity charOffset="101-105" id="s1602.e0" ontology_id="1436" text="CSFR" type="GENE"/>
    <entity charOffset="146-152" id="s1602.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1602.e0" e2="s1602.e1" id="s1602.p0" relation="true"/>
  </sentence>
  <sentence id="s1603" text="To investigate this mechanism, we developed a novel uterine sarcoma tissue-derived orthotopic and metastatic model in KSN nude mice using a green fluorescent protein stably expressed uterine sarcoma cell line, MES-SA.">
    <entity charOffset="60-67" id="s1603.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="127-131" id="s1603.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s1603.e0" e2="s1603.e1" id="s1603.p0" relation="false"/>
  </sentence>
  <sentence id="s1604" text="Microarray analysis between orthotopic tumors with high and low metastatic potentials revealed differential expression of genes related to cell proliferation and migration (TNNT1, COL1A2, and ZIC1).">
    <entity charOffset="39-45" id="s1604.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="173-178" id="s1604.e1" ontology_id="7138" text="TNNT1" type="GENE"/>
    <pair e1="s1604.e0" e2="s1604.e1" id="s1604.p0" relation="true"/>
  </sentence>
  <sentence id="s1605" text="Microarray analysis between orthotopic tumors with high and low metastatic potentials revealed differential expression of genes related to cell proliferation and migration (TNNT1, COL1A2, and ZIC1).">
    <entity charOffset="39-45" id="s1605.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="180-186" id="s1605.e1" ontology_id="1278" text="COL1A2" type="GENE"/>
    <pair e1="s1605.e0" e2="s1605.e1" id="s1605.p0" relation="true"/>
  </sentence>
  <sentence id="s1606" text="Microarray analysis between orthotopic tumors with high and low metastatic potentials revealed differential expression of genes related to cell proliferation and migration (TNNT1, COL1A2, and ZIC1).">
    <entity charOffset="39-45" id="s1606.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="192-196" id="s1606.e1" ontology_id="7545" text="ZIC1" type="GENE"/>
    <pair e1="s1606.e0" e2="s1606.e1" id="s1606.p0" relation="true"/>
  </sentence>
  <sentence id="s1607" text="The expression profile of ADAMTS1-20 in human breast carcinoma was undertaken by real-time PCR using RNA isolated from malignant tumors, nonneoplastic mammary tissue, and breast cancer cell lines to identify altered regulation that may have potential pathogenetic and prognostic significance.">
    <entity charOffset="26-33" id="s1607.e0" ontology_id="9510" text="ADAMTS1" type="GENE"/>
    <entity charOffset="46-62" id="s1607.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1607.e0" e2="s1607.e1" id="s1607.p0" relation="true"/>
  </sentence>
  <sentence id="s1608" text="The expression profile of ADAMTS1-20 in human breast carcinoma was undertaken by real-time PCR using RNA isolated from malignant tumors, nonneoplastic mammary tissue, and breast cancer cell lines to identify altered regulation that may have potential pathogenetic and prognostic significance.">
    <entity charOffset="26-33" id="s1608.e0" ontology_id="9510" text="ADAMTS1" type="GENE"/>
    <entity charOffset="129-135" id="s1608.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1608.e0" e2="s1608.e1" id="s1608.p0" relation="true"/>
  </sentence>
  <sentence id="s1609" text="The expression profile of ADAMTS1-20 in human breast carcinoma was undertaken by real-time PCR using RNA isolated from malignant tumors, nonneoplastic mammary tissue, and breast cancer cell lines to identify altered regulation that may have potential pathogenetic and prognostic significance.">
    <entity charOffset="26-33" id="s1609.e0" ontology_id="9510" text="ADAMTS1" type="GENE"/>
    <entity charOffset="178-184" id="s1609.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1609.e0" e2="s1609.e1" id="s1609.p0" relation="true"/>
  </sentence>
  <sentence id="s1610" text="Our studies show that seven of the ADAMTS genes (ADAMTS1, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor type or grade (Mann-Whitney U test, P &amp;lt; 0.0001 for each gene).">
    <entity charOffset="49-56" id="s1610.e0" ontology_id="9510" text="ADAMTS1" type="GENE"/>
    <entity charOffset="117-133" id="s1610.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1610.e0" e2="s1610.e1" id="s1610.p0" relation="true"/>
  </sentence>
  <sentence id="s1611" text="Our studies show that seven of the ADAMTS genes (ADAMTS1, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor type or grade (Mann-Whitney U test, P &amp;lt; 0.0001 for each gene).">
    <entity charOffset="49-56" id="s1611.e0" ontology_id="9510" text="ADAMTS1" type="GENE"/>
    <entity charOffset="201-214" id="s1611.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1611.e0" e2="s1611.e1" id="s1611.p0" relation="true"/>
  </sentence>
  <sentence id="s1612" text="Our studies show that seven of the ADAMTS genes (ADAMTS1, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor type or grade (Mann-Whitney U test, P &amp;lt; 0.0001 for each gene).">
    <entity charOffset="49-56" id="s1612.e0" ontology_id="9510" text="ADAMTS1" type="GENE"/>
    <entity charOffset="238-243" id="s1612.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1612.e0" e2="s1612.e1" id="s1612.p0" relation="true"/>
  </sentence>
  <sentence id="s1613" text="ADAMTS15 has emerged as being an independent predictor of survival, with RNA expression levels significantly lower (P = 0.007) in grade 3 breast carcinoma compared with grade 1 and 2 breast carcinoma">
    <entity charOffset="0-7" id="s1613.e0" ontology_id="9510" text="ADAMTS1" type="GENE"/>
    <entity charOffset="138-154" id="s1613.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1613.e0" e2="s1613.e1" id="s1613.p0" relation="true"/>
  </sentence>
  <sentence id="s1614" text="In addition to describing how to perform the EEG-ECG recordings, we also detail methods to quantify the resulting data for seizures, EEG spectral power, cardiac function, and heart rate variability, which we demonstrate in an example experiment using a mouse with epilepsy due to Kcna1 gene deletion.">
    <entity charOffset="123-131" id="s1614.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="280-285" id="s1614.e1" ontology_id="3736" text="Kcna1" type="GENE"/>
    <pair e1="s1614.e0" e2="s1614.e1" id="s1614.p0" relation="false"/>
  </sentence>
  <sentence id="s1615" text="In addition to describing how to perform the EEG-ECG recordings, we also detail methods to quantify the resulting data for seizures, EEG spectral power, cardiac function, and heart rate variability, which we demonstrate in an example experiment using a mouse with epilepsy due to Kcna1 gene deletion.">
    <entity charOffset="264-272" id="s1615.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="280-285" id="s1615.e1" ontology_id="3736" text="Kcna1" type="GENE"/>
    <pair e1="s1615.e0" e2="s1615.e1" id="s1615.p0" relation="true"/>
  </sentence>
  <sentence id="s1616" text="Genetic modification of a human prostate cancer cell line to induce miR-101 and suppress CENPF decreased cell migration and invasion.">
    <entity charOffset="41-47" id="s1616.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="89-94" id="s1616.e1" ontology_id="1063" text="CENPF" type="GENE"/>
    <pair e1="s1616.e0" e2="s1616.e1" id="s1616.p0" relation="true"/>
  </sentence>
  <sentence id="s1617" text="In this study, we evaluated the possible interaction between miR-146a and one of its putative targets ribonuclease L (RNASEL) in the risk of sporadic melanoma.">
    <entity charOffset="61-64" id="s1617.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="141-149" id="s1617.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1617.e0" e2="s1617.e1" id="s1617.p0" relation="true"/>
  </sentence>
  <sentence id="s1618" text="In this study, we evaluated the possible interaction between miR-146a and one of its putative targets ribonuclease L (RNASEL) in the risk of sporadic melanoma.">
    <entity charOffset="61-64" id="s1618.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="150-158" id="s1618.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1618.e0" e2="s1618.e1" id="s1618.p0" relation="true"/>
  </sentence>
  <sentence id="s1619" text="In this study, we evaluated the possible interaction between miR-146a and one of its putative targets ribonuclease L (RNASEL) in the risk of sporadic melanoma.">
    <entity charOffset="118-124" id="s1619.e0" ontology_id="6041" text="RNASEL" type="GENE"/>
    <entity charOffset="141-149" id="s1619.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1619.e0" e2="s1619.e1" id="s1619.p0" relation="true"/>
  </sentence>
  <sentence id="s1620" text="Polymorphisms rs2910164 in miR-146a and rs486907 in the RNASEL gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in nonmelanoma skin cancer.">
    <entity charOffset="27-30" id="s1620.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="200-208" id="s1620.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1620.e0" e2="s1620.e1" id="s1620.p0" relation="true"/>
  </sentence>
  <sentence id="s1621" text="The results reported in the present study suggest a sex-specific interaction between miR-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed">
    <entity charOffset="98-104" id="s1621.e0" ontology_id="6041" text="RNASEL" type="GENE"/>
    <entity charOffset="114-122" id="s1621.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1621.e0" e2="s1621.e1" id="s1621.p0" relation="true"/>
  </sentence>
  <sentence id="s1622" text="The results reported in the present study suggest a sex-specific interaction between miR-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed">
    <entity charOffset="98-104" id="s1622.e0" ontology_id="6041" text="RNASEL" type="GENE"/>
    <entity charOffset="128-134" id="s1622.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1622.e0" e2="s1622.e1" id="s1622.p0" relation="true"/>
  </sentence>
  <sentence id="s1623" text="Polo-like kinase 1 (Plk1) is overexpressed in a wide spectrum of human tumors, being frequently considered as an oncogene and an attractive cancer target.">
    <entity charOffset="20-24" id="s1623.e0" ontology_id="5347" text="Plk1" type="GENE"/>
    <entity charOffset="140-146" id="s1623.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1623.e0" e2="s1623.e1" id="s1623.p0" relation="true"/>
  </sentence>
  <sentence id="s1624" text="In vivo, Plk1 overexpression prevents the development of Kras-induced and Her2-induced mammary gland tumors, in the presence of increased rates of chromosome instability.">
    <entity charOffset="9-13" id="s1624.e0" ontology_id="5347" text="Plk1" type="GENE"/>
    <entity charOffset="101-107" id="s1624.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1624.e0" e2="s1624.e1" id="s1624.p0" relation="true"/>
  </sentence>
  <sentence id="s1625" text="In vivo, Plk1 overexpression prevents the development of Kras-induced and Her2-induced mammary gland tumors, in the presence of increased rates of chromosome instability.">
    <entity charOffset="57-61" id="s1625.e0" ontology_id="3845" text="Kras" type="GENE"/>
    <entity charOffset="101-107" id="s1625.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1625.e0" e2="s1625.e1" id="s1625.p0" relation="true"/>
  </sentence>
  <sentence id="s1626" text="In vivo, Plk1 overexpression prevents the development of Kras-induced and Her2-induced mammary gland tumors, in the presence of increased rates of chromosome instability.">
    <entity charOffset="74-78" id="s1626.e0" ontology_id="2064" text="Her2" type="GENE"/>
    <entity charOffset="101-107" id="s1626.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1626.e0" e2="s1626.e1" id="s1626.p0" relation="true"/>
  </sentence>
  <sentence id="s1627" text="In patients, Plk1 overexpression correlates with improved survival in specific breast cancer subtypes.">
    <entity charOffset="13-17" id="s1627.e0" ontology_id="5347" text="Plk1" type="GENE"/>
    <entity charOffset="86-92" id="s1627.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1627.e0" e2="s1627.e1" id="s1627.p0" relation="true"/>
  </sentence>
  <sentence id="s1628" text="Therefore, despite the therapeutic benefits of inhibiting Plk1 due to its essential role in tumor cell cycles, Plk1 overexpression has tumor-suppressive properties by perturbing mitotic progression and cytokinesis">
    <entity charOffset="58-62" id="s1628.e0" ontology_id="5347" text="Plk1" type="GENE"/>
    <entity charOffset="92-97" id="s1628.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1628.e0" e2="s1628.e1" id="s1628.p0" relation="true"/>
  </sentence>
  <sentence id="s1629" text="Two of these genes were independently mutated in more than one family with similar phenotypes, which substantiates their link to human disease (AKAP6 in intellectual disability and UBR4 in early dementia).">
    <entity charOffset="153-176" id="s1629.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="181-185" id="s1629.e1" ontology_id="23352" text="UBR4" type="GENE"/>
    <pair e1="s1629.e0" e2="s1629.e1" id="s1629.p0" relation="false"/>
  </sentence>
  <sentence id="s1630" text="There is growing evidence shown that microRNAs (miRNAs) are associated with cancer and can play a role in human cancers as oncogenes or tumor suppressor genes.">
    <entity charOffset="48-51" id="s1630.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="76-82" id="s1630.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1630.e0" e2="s1630.e1" id="s1630.p0" relation="true"/>
  </sentence>
  <sentence id="s1631" text="There is growing evidence shown that microRNAs (miRNAs) are associated with cancer and can play a role in human cancers as oncogenes or tumor suppressor genes.">
    <entity charOffset="48-51" id="s1631.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="136-141" id="s1631.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1631.e0" e2="s1631.e1" id="s1631.p0" relation="true"/>
  </sentence>
  <sentence id="s1632" text="MicroRNA-214 (miR-214) shows carcinogenesis in various tumor types, but little is known about biological functions of miR-214 in esophageal squamous cell carcinoma (ESCC).">
    <entity charOffset="14-17" id="s1632.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="55-60" id="s1632.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1632.e0" e2="s1632.e1" id="s1632.p0" relation="true"/>
  </sentence>
  <sentence id="s1633" text="MicroRNA-214 (miR-214) shows carcinogenesis in various tumor types, but little is known about biological functions of miR-214 in esophageal squamous cell carcinoma (ESCC).">
    <entity charOffset="14-17" id="s1633.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="140-163" id="s1633.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s1633.e0" e2="s1633.e1" id="s1633.p0" relation="true"/>
  </sentence>
  <sentence id="s1634" text="The results show miR-214 serve as a tumor promoter regulating cells migration, invasion and apoptosis in ESCC.">
    <entity charOffset="17-20" id="s1634.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="36-41" id="s1634.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1634.e0" e2="s1634.e1" id="s1634.p0" relation="true"/>
  </sentence>
  <sentence id="s1635" text="In summary, these results suggest that miR-214 serves as tumor promoter to promote proliferation, migration, invasion and inhibit apoptosis of ESCC cells by targeting LZTS1 via PI3K/AKT/mTOR signaling pathway.">
    <entity charOffset="39-42" id="s1635.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="57-62" id="s1635.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1635.e0" e2="s1635.e1" id="s1635.p0" relation="true"/>
  </sentence>
  <sentence id="s1636" text="In summary, these results suggest that miR-214 serves as tumor promoter to promote proliferation, migration, invasion and inhibit apoptosis of ESCC cells by targeting LZTS1 via PI3K/AKT/mTOR signaling pathway.">
    <entity charOffset="57-62" id="s1636.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="167-172" id="s1636.e1" ontology_id="11178" text="LZTS1" type="GENE"/>
    <pair e1="s1636.e0" e2="s1636.e1" id="s1636.p0" relation="true"/>
  </sentence>
  <sentence id="s1637" text="Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in TEKT1 which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.">
    <entity charOffset="60-65" id="s1637.e0" ontology_id="57728" text="WDR19" type="GENE"/>
    <entity charOffset="372-390" id="s1637.e1" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <pair e1="s1637.e0" e2="s1637.e1" id="s1637.p0" relation="false"/>
  </sentence>
  <sentence id="s1638" text="Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in TEKT1 which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.">
    <entity charOffset="60-65" id="s1638.e0" ontology_id="57728" text="WDR19" type="GENE"/>
    <entity charOffset="171-189" id="s1638.e1" ontology_id="HP_0006644" text="thoracic dysplasia" type="HP"/>
    <pair e1="s1638.e0" e2="s1638.e1" id="s1638.p0" relation="true"/>
  </sentence>
  <sentence id="s1639" text="Using preclinical models, we have recently found that ELK1, a transcriptional factor that activates downstream targets, including &lt;i&gt;c-fos&lt;/i&gt; proto-oncogene, induces bladder cancer outgrowth.">
    <entity charOffset="54-58" id="s1639.e0" ontology_id="2002" text="ELK1" type="GENE"/>
    <entity charOffset="175-181" id="s1639.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1639.e0" e2="s1639.e1" id="s1639.p0" relation="true"/>
  </sentence>
  <sentence id="s1640" text="Lymphovascular invasion was significantly (&lt;i&gt;P&lt;/i&gt; = 0.014) more often seen in phospho-ELK1(2+) tumors (80.0%) than in phospho-ELK1(0/1+) tumors (36.0%).">
    <entity charOffset="88-92" id="s1640.e0" ontology_id="2002" text="ELK1" type="GENE"/>
    <entity charOffset="97-103" id="s1640.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1640.e0" e2="s1640.e1" id="s1640.p0" relation="true"/>
  </sentence>
  <sentence id="s1641" text="There were no statistically significant associations between phospho-ELK1 expression and tumor grade, presence of concurrent carcinoma in situ or hydronephrosis, or pN status.">
    <entity charOffset="69-73" id="s1641.e0" ontology_id="2002" text="ELK1" type="GENE"/>
    <entity charOffset="146-160" id="s1641.e1" ontology_id="HP_0000126" text="hydronephrosis" type="HP"/>
    <pair e1="s1641.e0" e2="s1641.e1" id="s1641.p0" relation="true"/>
  </sentence>
  <sentence id="s1642" text="Kaplan-Meier and log-rank tests revealed that patients with phospho-ELK1(2+) tumor had marginally and significantly higher risks of disease progression (&lt;i&gt;P&lt;/i&gt; = 0.055) and cancer-specific mortality (&lt;i&gt;P&lt;/i&gt; = 0.008), respectively, compared to those with phospho-ELK1(0/1+) tumor.">
    <entity charOffset="68-72" id="s1642.e0" ontology_id="2002" text="ELK1" type="GENE"/>
    <entity charOffset="175-181" id="s1642.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1642.e0" e2="s1642.e1" id="s1642.p0" relation="true"/>
  </sentence>
  <sentence id="s1643" text="Kaplan-Meier and log-rank tests revealed that patients with phospho-ELK1(2+) tumor had marginally and significantly higher risks of disease progression (&lt;i&gt;P&lt;/i&gt; = 0.055) and cancer-specific mortality (&lt;i&gt;P&lt;/i&gt; = 0.008), respectively, compared to those with phospho-ELK1(0/1+) tumor.">
    <entity charOffset="68-72" id="s1643.e0" ontology_id="2002" text="ELK1" type="GENE"/>
    <entity charOffset="77-82" id="s1643.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1643.e0" e2="s1643.e1" id="s1643.p0" relation="true"/>
  </sentence>
  <sentence id="s1644" text="The current results thus support our previous observations in bladder cancer and further suggest that phospho-ELK1 overexpression serves as a predictor of poor prognosis in patients with UUTUC">
    <entity charOffset="70-76" id="s1644.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="110-114" id="s1644.e1" ontology_id="2002" text="ELK1" type="GENE"/>
    <pair e1="s1644.e0" e2="s1644.e1" id="s1644.p0" relation="true"/>
  </sentence>
  <sentence id="s1645" text="Subpopulation screening of the coding exons and flanking introns of SMPX was further performed for 338 Chinese patients with nonsydromic HL by Sanger sequencing, and another two potential causative substitutions (c.238C&amp;gt;A and c.55A&amp;gt;G) in SMPX were identified in additional sporadic cases of congenital deafness.">
    <entity charOffset="68-72" id="s1645.e0" ontology_id="23676" text="SMPX" type="GENE"/>
    <entity charOffset="279-287" id="s1645.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1645.e0" e2="s1645.e1" id="s1645.p0" relation="true"/>
  </sentence>
  <sentence id="s1646" text="Subpopulation screening of the coding exons and flanking introns of SMPX was further performed for 338 Chinese patients with nonsydromic HL by Sanger sequencing, and another two potential causative substitutions (c.238C&amp;gt;A and c.55A&amp;gt;G) in SMPX were identified in additional sporadic cases of congenital deafness.">
    <entity charOffset="68-72" id="s1646.e0" ontology_id="23676" text="SMPX" type="GENE"/>
    <entity charOffset="308-316" id="s1646.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1646.e0" e2="s1646.e1" id="s1646.p0" relation="true"/>
  </sentence>
  <sentence id="s1647" text="Collectively, this study is the first to report the role of SMPX in Chinese population and identify a novel frameshift mutation in SMPX that causes not only nonsyndromic late-onset progressive HL, but also congenital hearing impairment.">
    <entity charOffset="60-64" id="s1647.e0" ontology_id="23676" text="SMPX" type="GENE"/>
    <entity charOffset="217-235" id="s1647.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s1647.e0" e2="s1647.e1" id="s1647.p0" relation="true"/>
  </sentence>
  <sentence id="s1648" text="RNA sequencing transcriptome analysis revealed that inflammatory mediators such as tumor necrosis factor (TNF)- suppressed expression of R-spondin-1 (Rspo1, a critical growth factor for intestinal epithelial cells) in Sirt6-silenced YAMC cells &lt;i&gt;in vitro&lt;/i&gt;.">
    <entity charOffset="83-88" id="s1648.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="219-224" id="s1648.e1" ontology_id="51548" text="Sirt6" type="GENE"/>
    <pair e1="s1648.e0" e2="s1648.e1" id="s1648.p0" relation="true"/>
  </sentence>
  <sentence id="s1649" text="Homozygous and compound heterozygous mutations in C12orf57 have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.">
    <entity charOffset="50-58" id="s1649.e0" ontology_id="113246" text="C12orf57" type="GENE"/>
    <entity charOffset="138-161" id="s1649.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1649.e0" e2="s1649.e1" id="s1649.p0" relation="true"/>
  </sentence>
  <sentence id="s1650" text="Mutations of the sigma subunit of the heterotetrameric adaptor-related protein complex 2 (AP2) impair signalling of the calcium-sensing receptor (CaSR), and cause familial hypocalciuric hypercalcaemia type 3 (FHH3).">
    <entity charOffset="187-201" id="s1650.e0" ontology_id="HP_0003072" text="hypercalcaemia" type="HP"/>
    <entity charOffset="202-206" id="s1650.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s1650.e0" e2="s1650.e1" id="s1650.p0" relation="false"/>
  </sentence>
  <sentence id="s1651" text="Vestibular sensory-evoked potentials demonstrate severe to profound vestibular deficits in Dfnb31(neo/neo) and Dfnb31(wi/wi) mice.">
    <entity charOffset="59-67" id="s1651.e0" ontology_id="HP_0012829" text="profound" type="HP"/>
    <entity charOffset="125-129" id="s1651.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s1651.e0" e2="s1651.e1" id="s1651.p0" relation="true"/>
  </sentence>
  <sentence id="s1652" text="Multisystem proteinopathy (MSP), a newly proposed syndrome including inclusion body myopathy (IBM), PDB, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), is mainly caused by mutation in VCP gene.">
    <entity charOffset="105-128" id="s1652.e0" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <entity charOffset="209-212" id="s1652.e1" ontology_id="7415" text="VCP" type="GENE"/>
    <pair e1="s1652.e0" e2="s1652.e1" id="s1652.p0" relation="true"/>
  </sentence>
  <sentence id="s1653" text="In addition, polymorphisms in apoptosis-related genes such as RNF7, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and MICA variants are associated with HCV-related hepatocellular carcinoma.">
    <entity charOffset="68-73" id="s1653.e0" ontology_id="7287" text="TULP1" type="GENE"/>
    <entity charOffset="188-212" id="s1653.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1653.e0" e2="s1653.e1" id="s1653.p0" relation="false"/>
  </sentence>
  <sentence id="s1654" text="In addition, polymorphisms in apoptosis-related genes such as RNF7, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and MICA variants are associated with HCV-related hepatocellular carcinoma.">
    <entity charOffset="79-84" id="s1654.e0" ontology_id="10461" text="MERTK" type="GENE"/>
    <entity charOffset="188-212" id="s1654.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1654.e0" e2="s1654.e1" id="s1654.p0" relation="false"/>
  </sentence>
  <sentence id="s1655" text="In addition, polymorphisms in apoptosis-related genes such as RNF7, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and MICA variants are associated with HCV-related hepatocellular carcinoma.">
    <entity charOffset="131-137" id="s1655.e0" ontology_id="9681" text="DEPDC5" type="GENE"/>
    <entity charOffset="188-212" id="s1655.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1655.e0" e2="s1655.e1" id="s1655.p0" relation="true"/>
  </sentence>
  <sentence id="s1656" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="156-164" id="s1656.e0" ontology_id="55755" text="CDK5RAP2" type="GENE"/>
    <entity charOffset="331-343" id="s1656.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1656.e0" e2="s1656.e1" id="s1656.p0" relation="true"/>
  </sentence>
  <sentence id="s1657" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="173-177" id="s1657.e0" ontology_id="259266" text="ASPM" type="GENE"/>
    <entity charOffset="331-343" id="s1657.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1657.e0" e2="s1657.e1" id="s1657.p0" relation="true"/>
  </sentence>
  <sentence id="s1658" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="179-184" id="s1658.e0" ontology_id="55835" text="CENPJ" type="GENE"/>
    <entity charOffset="331-343" id="s1658.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1658.e0" e2="s1658.e1" id="s1658.p0" relation="true"/>
  </sentence>
  <sentence id="s1659" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="186-190" id="s1659.e0" ontology_id="6491" text="STIL" type="GENE"/>
    <entity charOffset="331-343" id="s1659.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1659.e0" e2="s1659.e1" id="s1659.p0" relation="true"/>
  </sentence>
  <sentence id="s1660" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="200-206" id="s1660.e0" ontology_id="22995" text="CEP152" type="GENE"/>
    <entity charOffset="331-343" id="s1660.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1660.e0" e2="s1660.e1" id="s1660.p0" relation="false"/>
  </sentence>
  <sentence id="s1661" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="228-233" id="s1661.e0" ontology_id="1062" text="CENPE" type="GENE"/>
    <entity charOffset="331-343" id="s1661.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1661.e0" e2="s1661.e1" id="s1661.p0" relation="true"/>
  </sentence>
  <sentence id="s1662" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="250-256" id="s1662.e0" ontology_id="23141" text="ANKLE2" type="GENE"/>
    <entity charOffset="331-343" id="s1662.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1662.e0" e2="s1662.e1" id="s1662.p0" relation="true"/>
  </sentence>
  <sentence id="s1663" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="258-261" id="s1663.e0" ontology_id="11113" text="CIT" type="GENE"/>
    <entity charOffset="331-343" id="s1663.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1663.e0" e2="s1663.e1" id="s1663.p0" relation="true"/>
  </sentence>
  <sentence id="s1664" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="266-271" id="s1664.e0" ontology_id="23001" text="WDFY3" type="GENE"/>
    <entity charOffset="331-343" id="s1664.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1664.e0" e2="s1664.e1" id="s1664.p0" relation="true"/>
  </sentence>
  <sentence id="s1665" text="There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (SOD1) and fused in sarcoma (FUS).">
    <entity charOffset="113-120" id="s1665.e0" ontology_id="203228" text="C9ORF72" type="GENE"/>
    <entity charOffset="217-224" id="s1665.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1665.e0" e2="s1665.e1" id="s1665.p0" relation="false"/>
  </sentence>
  <sentence id="s1666" text="There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (SOD1) and fused in sarcoma (FUS).">
    <entity charOffset="165-171" id="s1666.e0" ontology_id="23435" text="TARDBP" type="GENE"/>
    <entity charOffset="217-224" id="s1666.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1666.e0" e2="s1666.e1" id="s1666.p0" relation="true"/>
  </sentence>
  <sentence id="s1667" text="There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (SOD1) and fused in sarcoma (FUS).">
    <entity charOffset="217-224" id="s1667.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="226-229" id="s1667.e1" ontology_id="2521" text="FUS" type="GENE"/>
    <pair e1="s1667.e0" e2="s1667.e1" id="s1667.p0" relation="true"/>
  </sentence>
  <sentence id="s1668" text="Previous reports have identified SLC6A1 variants in patients with generalized epilepsies, such as myoclonic-atonic epilepsy and childhood absence epilepsy.">
    <entity charOffset="33-39" id="s1668.e0" ontology_id="6529" text="SLC6A1" type="GENE"/>
    <entity charOffset="115-123" id="s1668.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1668.e0" e2="s1668.e1" id="s1668.p0" relation="true"/>
  </sentence>
  <sentence id="s1669" text="The purpose of this study was to determine the incidence of SLC6A1 variants in 460 unselected epilepsy patients and to evaluate the impact of the identified variants on -aminobutyric acid (GABA)transport.">
    <entity charOffset="60-66" id="s1669.e0" ontology_id="6529" text="SLC6A1" type="GENE"/>
    <entity charOffset="94-102" id="s1669.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1669.e0" e2="s1669.e1" id="s1669.p0" relation="true"/>
  </sentence>
  <sentence id="s1670" text="These findings demonstrate that SLC6A1 is an important contributor to childhood epilepsy and that reduced GAT-1 function is a common consequence of epilepsy-causing SLC6A1 variants">
    <entity charOffset="32-38" id="s1670.e0" ontology_id="6529" text="SLC6A1" type="GENE"/>
    <entity charOffset="80-88" id="s1670.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1670.e0" e2="s1670.e1" id="s1670.p0" relation="true"/>
  </sentence>
  <sentence id="s1671" text="The studied CVD biomarkers include AXL receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (CRP), D-dimer, fibrinogen (Fib), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNF-) and troponins (Tns) on electrochemical transduction format.">
    <entity charOffset="35-38" id="s1671.e0" ontology_id="558" text="AXL" type="GENE"/>
    <entity charOffset="254-259" id="s1671.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1671.e0" e2="s1671.e1" id="s1671.p0" relation="true"/>
  </sentence>
  <sentence id="s1672" text="The studied CVD biomarkers include AXL receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (CRP), D-dimer, fibrinogen (Fib), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNF-) and troponins (Tns) on electrochemical transduction format.">
    <entity charOffset="115-118" id="s1672.e0" ontology_id="1401" text="CRP" type="GENE"/>
    <entity charOffset="254-259" id="s1672.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1672.e0" e2="s1672.e1" id="s1672.p0" relation="true"/>
  </sentence>
  <sentence id="s1673" text="The studied CVD biomarkers include AXL receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (CRP), D-dimer, fibrinogen (Fib), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNF-) and troponins (Tns) on electrochemical transduction format.">
    <entity charOffset="142-145" id="s1673.e0" ontology_id="2091" text="Fib" type="GENE"/>
    <entity charOffset="254-259" id="s1673.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1673.e0" e2="s1673.e1" id="s1673.p0" relation="true"/>
  </sentence>
  <sentence id="s1674" text="Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (car) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (ARC1, VPS33B).">
    <entity charOffset="114-128" id="s1674.e0" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <entity charOffset="184-187" id="s1674.e1" ontology_id="8996" text="ARC" type="GENE"/>
    <pair e1="s1674.e0" e2="s1674.e1" id="s1674.p0" relation="true"/>
  </sentence>
  <sentence id="s1675" text="While many downstream effectors of ATR have been established, the upstream regulators of ATR and the impact of such regulation on liver cancer remain unclear.">
    <entity charOffset="35-38" id="s1675.e0" ontology_id="84168" text="ATR" type="GENE"/>
    <entity charOffset="136-142" id="s1675.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1675.e0" e2="s1675.e1" id="s1675.p0" relation="false"/>
  </sentence>
  <sentence id="s1676" text="Here we demonstrate new functions for BRUCE in ATR activation in vitro and liver tumor suppression in vivo.">
    <entity charOffset="38-43" id="s1676.e0" ontology_id="57448" text="BRUCE" type="GENE"/>
    <entity charOffset="81-86" id="s1676.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1676.e0" e2="s1676.e1" id="s1676.p0" relation="true"/>
  </sentence>
  <sentence id="s1677" text="The in vivo impact of BRUCE loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.">
    <entity charOffset="12-18" id="s1677.e0" ontology_id="55364" text="impact" type="GENE"/>
    <entity charOffset="81-105" id="s1677.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1677.e0" e2="s1677.e1" id="s1677.p0" relation="true"/>
  </sentence>
  <sentence id="s1678" text="The in vivo impact of BRUCE loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.">
    <entity charOffset="22-27" id="s1678.e0" ontology_id="57448" text="BRUCE" type="GENE"/>
    <entity charOffset="81-105" id="s1678.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1678.e0" e2="s1678.e1" id="s1678.p0" relation="true"/>
  </sentence>
  <sentence id="s1679" text="Liver-specific knockout of murine Bruce impaired ATR activation and exacerbated inflammation, fibrosis and hepatocellular carcinoma, which exhibited a trabecular architecture, closely resembling human HCC.">
    <entity charOffset="49-52" id="s1679.e0" ontology_id="84168" text="ATR" type="GENE"/>
    <entity charOffset="107-131" id="s1679.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1679.e0" e2="s1679.e1" id="s1679.p0" relation="true"/>
  </sentence>
  <sentence id="s1680" text="Liver-specific knockout of murine Bruce impaired ATR activation and exacerbated inflammation, fibrosis and hepatocellular carcinoma, which exhibited a trabecular architecture, closely resembling human HCC.">
    <entity charOffset="107-131" id="s1680.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="201-204" id="s1680.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s1680.e0" e2="s1680.e1" id="s1680.p0" relation="true"/>
  </sentence>
  <sentence id="s1681" text="In humans, the clinical relevance of BRUCE downregulation in liver disease was found in hepatitis, cirrhosis and hepatocellular carcinoma specimens and deleterious somatic mutations of the Bruce gene was found in human hepatocellular carcinoma in TCGA database.">
    <entity charOffset="37-42" id="s1681.e0" ontology_id="57448" text="BRUCE" type="GENE"/>
    <entity charOffset="113-137" id="s1681.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1681.e0" e2="s1681.e1" id="s1681.p0" relation="true"/>
  </sentence>
  <sentence id="s1682" text="In humans, the clinical relevance of BRUCE downregulation in liver disease was found in hepatitis, cirrhosis and hepatocellular carcinoma specimens and deleterious somatic mutations of the Bruce gene was found in human hepatocellular carcinoma in TCGA database.">
    <entity charOffset="113-137" id="s1682.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="189-194" id="s1682.e1" ontology_id="57448" text="Bruce" type="GENE"/>
    <pair e1="s1682.e0" e2="s1682.e1" id="s1682.p0" relation="true"/>
  </sentence>
  <sentence id="s1683" text="Conclusion: These findings establish a new BRUCE-ATR signaling axis in accurate DNA replication and suppression of liver cancer in mice and humans and provides a clinically relevant HCC mouse model.">
    <entity charOffset="43-48" id="s1683.e0" ontology_id="57448" text="BRUCE" type="GENE"/>
    <entity charOffset="121-127" id="s1683.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1683.e0" e2="s1683.e1" id="s1683.p0" relation="true"/>
  </sentence>
  <sentence id="s1684" text="Conclusion: These findings establish a new BRUCE-ATR signaling axis in accurate DNA replication and suppression of liver cancer in mice and humans and provides a clinically relevant HCC mouse model.">
    <entity charOffset="49-52" id="s1684.e0" ontology_id="84168" text="ATR" type="GENE"/>
    <entity charOffset="121-127" id="s1684.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1684.e0" e2="s1684.e1" id="s1684.p0" relation="true"/>
  </sentence>
  <sentence id="s1685" text="Taking advantage of the homogeneous and heterogeneous electrochemical biosensors, a simple, sensitive, and selective electrochemical biosensor is constructed by combining entropy-driven amplification (EDA) with DNA walker.">
    <entity charOffset="40-53" id="s1685.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="84-90" id="s1685.e1" ontology_id="9516" text="simple" type="GENE"/>
    <pair e1="s1685.e0" e2="s1685.e1" id="s1685.p0" relation="true"/>
  </sentence>
  <sentence id="s1686" text="Three subtypes, &lt;i&gt;PTPN11- , NRAS-&lt;/i&gt;, and &lt;i&gt;KRAS&lt;/i&gt;-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.">
    <entity charOffset="29-33" id="s1686.e0" ontology_id="4893" text="NRAS" type="GENE"/>
    <entity charOffset="359-364" id="s1686.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1686.e0" e2="s1686.e1" id="s1686.p0" relation="true"/>
  </sentence>
  <sentence id="s1687" text="Three subtypes, &lt;i&gt;PTPN11- , NRAS-&lt;/i&gt;, and &lt;i&gt;KRAS&lt;/i&gt;-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.">
    <entity charOffset="47-51" id="s1687.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="359-364" id="s1687.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1687.e0" e2="s1687.e1" id="s1687.p0" relation="true"/>
  </sentence>
  <sentence id="s1688" text="COQ8A (ADCK3) is a mammalian UbiB protein associated with ubiquinone (CoQ) biosynthesis and an ataxia (ARCA2) through unclear means.">
    <entity charOffset="0-5" id="s1688.e0" ontology_id="56997" text="COQ8A" type="GENE"/>
    <entity charOffset="95-101" id="s1688.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1688.e0" e2="s1688.e1" id="s1688.p0" relation="true"/>
  </sentence>
  <sentence id="s1689" text="Recent evidence suggests that ARS genes may participate in a wide array of cellular processes, and may contribute to the pathology of autoimmune disease, cancer, and other diseases.">
    <entity charOffset="30-33" id="s1689.e0" ontology_id="57152" text="ARS" type="GENE"/>
    <entity charOffset="154-160" id="s1689.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1689.e0" e2="s1689.e1" id="s1689.p0" relation="true"/>
  </sentence>
  <sentence id="s1690" text="Several studies have suggested a role for the glutamyl prolyl tRNA synthetase (EPRS) in breast cancers, although none has identified any underlying mechanism about how EPRS contributes to carcinogenesis.">
    <entity charOffset="79-83" id="s1690.e0" ontology_id="2058" text="EPRS" type="GENE"/>
    <entity charOffset="95-101" id="s1690.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1690.e0" e2="s1690.e1" id="s1690.p0" relation="true"/>
  </sentence>
  <sentence id="s1691" text="Finally, we constructed a causal gene network based on over 2500 ER+ breast tumor samples to build up an EPRS-estrogen signaling pathway.">
    <entity charOffset="76-81" id="s1691.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="105-109" id="s1691.e1" ontology_id="2058" text="EPRS" type="GENE"/>
    <pair e1="s1691.e0" e2="s1691.e1" id="s1691.p0" relation="true"/>
  </sentence>
  <sentence id="s1692" text="EPRS and its regulated estrogenic gene network may offer a promising alternative approach to target ER+ breast cancers that are refractory to current anti-estrogens">
    <entity charOffset="0-4" id="s1692.e0" ontology_id="2058" text="EPRS" type="GENE"/>
    <entity charOffset="111-117" id="s1692.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1692.e0" e2="s1692.e1" id="s1692.p0" relation="true"/>
  </sentence>
  <sentence id="s1693" text="Furthermore, we detected association of rs58978565 near TNR (P = 2.3  10-8), rs28368872 near ATF7IP2 (P = 2.9  10-8) and rs142450006 near MMP9 (P = 0.0006) with progression to choroidal neovascularization but not geographic atrophy.">
    <entity charOffset="94-101" id="s1693.e0" ontology_id="80063" text="ATF7IP2" type="GENE"/>
    <entity charOffset="178-206" id="s1693.e1" ontology_id="HP_0011506" text="choroidal neovascularization" type="HP"/>
    <pair e1="s1693.e0" e2="s1693.e1" id="s1693.p0" relation="true"/>
  </sentence>
  <sentence id="s1694" text="For example, administration of 3-keto-HPR instead of fenretinide may be preferential if inhibition of SCD1 or DES1 activity is the goal (cancer), while MPR may be better for BCO1 modulation (carotenoid metabolism).">
    <entity charOffset="110-114" id="s1694.e0" ontology_id="8560" text="DES1" type="GENE"/>
    <entity charOffset="137-143" id="s1694.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1694.e0" e2="s1694.e1" id="s1694.p0" relation="true"/>
  </sentence>
  <sentence id="s1695" text="For example, administration of 3-keto-HPR instead of fenretinide may be preferential if inhibition of SCD1 or DES1 activity is the goal (cancer), while MPR may be better for BCO1 modulation (carotenoid metabolism).">
    <entity charOffset="137-143" id="s1695.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="174-178" id="s1695.e1" ontology_id="53630" text="BCO1" type="GENE"/>
    <pair e1="s1695.e0" e2="s1695.e1" id="s1695.p0" relation="true"/>
  </sentence>
  <sentence id="s1696" text="In the present study, we used a custom-made TES panel to identify the genetic defect of a four-generation Chinese family with bilateral pulverulent nuclear cataracts.">
    <entity charOffset="44-47" id="s1696.e0" ontology_id="26136" text="TES" type="GENE"/>
    <entity charOffset="156-164" id="s1696.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s1696.e0" e2="s1696.e1" id="s1696.p0" relation="true"/>
  </sentence>
  <sentence id="s1697" text="In the present study, we used a custom-made TES panel to identify the genetic defect of a four-generation Chinese family with bilateral pulverulent nuclear cataracts.">
    <entity charOffset="44-47" id="s1697.e0" ontology_id="26136" text="TES" type="GENE"/>
    <entity charOffset="126-135" id="s1697.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s1697.e0" e2="s1697.e1" id="s1697.p0" relation="true"/>
  </sentence>
  <sentence id="s1698" text="The results indicated two mutated driver pathways are important for the pathogenesis of MDS: pathway in cancer and in regulation of actin cytoskeleton.">
    <entity charOffset="88-91" id="s1698.e0" ontology_id="5048" text="MDS" type="GENE"/>
    <entity charOffset="104-110" id="s1698.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1698.e0" e2="s1698.e1" id="s1698.p0" relation="true"/>
  </sentence>
  <sentence id="s1699" text="Our findings support the recently proposed concept of 3'UTR-encoded &amp;quot;cryptic amyloidogenic elements.&amp;quot; Together with a previous report on an aggregation-prone REEP1 deletion variant in distal hereditary motor neuropathy, they also suggest that toxic gain of REEP1 function, rather than loss-of-function as relevant for HSP, specifically affects lower motor neurons.">
    <entity charOffset="168-173" id="s1699.e0" ontology_id="65055" text="REEP1" type="GENE"/>
    <entity charOffset="218-228" id="s1699.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1699.e0" e2="s1699.e1" id="s1699.p0" relation="true"/>
  </sentence>
  <sentence id="s1700" text="Over 140 disease-causing mutations have been described so far in GUCY2D, 88% of which cause autosomal recessive Leber congenital amaurosis (LCA) while heterozygous missense mutations cause autosomal dominant cone-rod degeneration (adCRD).">
    <entity charOffset="65-71" id="s1700.e0" ontology_id="3000" text="GUCY2D" type="GENE"/>
    <entity charOffset="92-111" id="s1700.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1700.e0" e2="s1700.e1" id="s1700.p0" relation="true"/>
  </sentence>
  <sentence id="s1701" text="Over 140 disease-causing mutations have been described so far in GUCY2D, 88% of which cause autosomal recessive Leber congenital amaurosis (LCA) while heterozygous missense mutations cause autosomal dominant cone-rod degeneration (adCRD).">
    <entity charOffset="92-111" id="s1701.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="140-143" id="s1701.e1" ontology_id="1211" text="LCA" type="GENE"/>
    <pair e1="s1701.e0" e2="s1701.e1" id="s1701.p0" relation="true"/>
  </sentence>
  <sentence id="s1702" text="Consistent with a conserved role for this gene in the cochlea, the genetic mapping data presented here support human TMIE as the gene affected at DFNB6, a non-syndromic hearing loss locus.">
    <entity charOffset="146-151" id="s1702.e0" ontology_id="9381" text="DFNB6" type="GENE"/>
    <entity charOffset="169-181" id="s1702.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1702.e0" e2="s1702.e1" id="s1702.p0" relation="true"/>
  </sentence>
  <sentence id="s1703" text="TBC1D24-related disorders include a wide phenotypic ranging from mild to lethal seizure disorders, non-syndromic deafness, and composite syndromes such as DOORS (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures).">
    <entity charOffset="0-7" id="s1703.e0" ontology_id="57465" text="TBC1D24" type="GENE"/>
    <entity charOffset="80-87" id="s1703.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s1703.e0" e2="s1703.e1" id="s1703.p0" relation="true"/>
  </sentence>
  <sentence id="s1704" text="TBC1D24-related disorders include a wide phenotypic ranging from mild to lethal seizure disorders, non-syndromic deafness, and composite syndromes such as DOORS (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures).">
    <entity charOffset="0-7" id="s1704.e0" ontology_id="57465" text="TBC1D24" type="GENE"/>
    <entity charOffset="113-121" id="s1704.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1704.e0" e2="s1704.e1" id="s1704.p0" relation="true"/>
  </sentence>
  <sentence id="s1705" text="Three predicted driver genes (CDKN2A, AKT1, RNF139) were found common in these three cancers by comparative analysis.">
    <entity charOffset="38-42" id="s1705.e0" ontology_id="207" text="AKT1" type="GENE"/>
    <entity charOffset="85-91" id="s1705.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1705.e0" e2="s1705.e1" id="s1705.p0" relation="true"/>
  </sentence>
  <sentence id="s1706" text="Three predicted driver genes (CDKN2A, AKT1, RNF139) were found common in these three cancers by comparative analysis.">
    <entity charOffset="44-50" id="s1706.e0" ontology_id="11236" text="RNF139" type="GENE"/>
    <entity charOffset="85-91" id="s1706.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1706.e0" e2="s1706.e1" id="s1706.p0" relation="true"/>
  </sentence>
  <sentence id="s1707" text="Mutations in the human TRNT1 gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the CCA (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.">
    <entity charOffset="23-28" id="s1707.e0" ontology_id="51095" text="TRNT1" type="GENE"/>
    <entity charOffset="336-355" id="s1707.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1707.e0" e2="s1707.e1" id="s1707.p0" relation="true"/>
  </sentence>
  <sentence id="s1708" text="Numerous studies have recently demonstrated that HDAC6 expression and activity are increased in kidney disease, such as autosomal dominant polycystic kidney disease (ADPKD), renal fibrosis, and acute kidney injury (AKI), among others.">
    <entity charOffset="49-54" id="s1708.e0" ontology_id="10013" text="HDAC6" type="GENE"/>
    <entity charOffset="174-188" id="s1708.e1" ontology_id="HP_0030760" text="renal fibrosis" type="HP"/>
    <pair e1="s1708.e0" e2="s1708.e1" id="s1708.p0" relation="true"/>
  </sentence>
  <sentence id="s1709" text="Here, we discuss the unique function of HDAC6 and recapitulate the alluring potential of its inhibitors in kidney diseases">
    <entity charOffset="40-45" id="s1709.e0" ontology_id="10013" text="HDAC6" type="GENE"/>
    <entity charOffset="107-121" id="s1709.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s1709.e0" e2="s1709.e1" id="s1709.p0" relation="true"/>
  </sentence>
  <sentence id="s1710" text="Cell surface carbohydrates are important for cell migration and invasion of prostate cancer (PCa).">
    <entity charOffset="85-91" id="s1710.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="93-96" id="s1710.e1" ontology_id="28982" text="PCa" type="GENE"/>
    <pair e1="s1710.e0" e2="s1710.e1" id="s1710.p0" relation="true"/>
  </sentence>
  <sentence id="s1711" text="Accordingly, the I-branching N-acetylglucosaminyltransferase (GCNT2) converts linear i-antigen to I-branching glycan, and its expression is associated with breast cancer progression.">
    <entity charOffset="62-67" id="s1711.e0" ontology_id="2651" text="GCNT2" type="GENE"/>
    <entity charOffset="163-169" id="s1711.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1711.e0" e2="s1711.e1" id="s1711.p0" relation="true"/>
  </sentence>
  <sentence id="s1712" text="Although clustering of missense mutations is often regarded as a hallmark of oncoproteins, we observed that a number of tumor suppressors, including FBXW7, VHL, and STK11, also showed such clustering.">
    <entity charOffset="120-125" id="s1712.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="149-154" id="s1712.e1" ontology_id="55294" text="FBXW7" type="GENE"/>
    <pair e1="s1712.e0" e2="s1712.e1" id="s1712.p0" relation="true"/>
  </sentence>
  <sentence id="s1713" text="Although clustering of missense mutations is often regarded as a hallmark of oncoproteins, we observed that a number of tumor suppressors, including FBXW7, VHL, and STK11, also showed such clustering.">
    <entity charOffset="120-125" id="s1713.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="156-159" id="s1713.e1" ontology_id="7428" text="VHL" type="GENE"/>
    <pair e1="s1713.e0" e2="s1713.e1" id="s1713.p0" relation="true"/>
  </sentence>
  <sentence id="s1714" text="Although clustering of missense mutations is often regarded as a hallmark of oncoproteins, we observed that a number of tumor suppressors, including FBXW7, VHL, and STK11, also showed such clustering.">
    <entity charOffset="120-125" id="s1714.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="165-170" id="s1714.e1" ontology_id="6794" text="STK11" type="GENE"/>
    <pair e1="s1714.e0" e2="s1714.e1" id="s1714.p0" relation="true"/>
  </sentence>
  <sentence id="s1715" text="Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) are epileptogenic neurodevelopmentalmalformations caused by mutations in mTOR pathway genes.">
    <entity charOffset="6-24" id="s1715.e0" ontology_id="HP_0002539" text="cortical dysplasia" type="HP"/>
    <entity charOffset="134-138" id="s1715.e1" ontology_id="2475" text="mTOR" type="GENE"/>
    <pair e1="s1715.e0" e2="s1715.e1" id="s1715.p0" relation="true"/>
  </sentence>
  <sentence id="s1716" text="Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) are epileptogenic neurodevelopmentalmalformations caused by mutations in mTOR pathway genes.">
    <entity charOffset="35-53" id="s1716.e0" ontology_id="HP_0007206" text="hemimegalencephaly" type="HP"/>
    <entity charOffset="55-58" id="s1716.e1" ontology_id="4321" text="HME" type="GENE"/>
    <pair e1="s1716.e0" e2="s1716.e1" id="s1716.p0" relation="true"/>
  </sentence>
  <sentence id="s1717" text="The AP4B1-associated phenotype has previously been assigned to spastic paraplegia-47.">
    <entity charOffset="4-9" id="s1717.e0" ontology_id="10717" text="AP4B1" type="GENE"/>
    <entity charOffset="63-81" id="s1717.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s1717.e0" e2="s1717.e1" id="s1717.p0" relation="true"/>
  </sentence>
  <sentence id="s1718" text="c.7253dupT in TEX15, encoding a DDR factor important in meiosis, associated with hereditary breast cancer (p=0.018) and likely represents a Northern Finnish founder mutation.">
    <entity charOffset="14-19" id="s1718.e0" ontology_id="56154" text="TEX15" type="GENE"/>
    <entity charOffset="99-105" id="s1718.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1718.e0" e2="s1718.e1" id="s1718.p0" relation="true"/>
  </sentence>
  <sentence id="s1719" text="A deletion (c.640_644del5) in RNF168, causative for recessive RIDDLE syndrome, had high prevalence in majority of the analyzed cohorts, but did not associate with breast cancer.">
    <entity charOffset="30-36" id="s1719.e0" ontology_id="165918" text="RNF168" type="GENE"/>
    <entity charOffset="170-176" id="s1719.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1719.e0" e2="s1719.e1" id="s1719.p0" relation="true"/>
  </sentence>
  <sentence id="s1720" text="In conclusion, truncating variants in TEX15 and FANCD2 are potential breast cancer risk factors, warranting further investigations in other populations.">
    <entity charOffset="38-43" id="s1720.e0" ontology_id="56154" text="TEX15" type="GENE"/>
    <entity charOffset="76-82" id="s1720.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1720.e0" e2="s1720.e1" id="s1720.p0" relation="true"/>
  </sentence>
  <sentence id="s1721" text="Our study provides further evidence for validating the role of PARS2 in the pathology of related infantile-onset encephalopathy, contributing to the phenotypic features of this condition, and providing clinical and molecular insight for the diagnosis of this disease entity">
    <entity charOffset="63-68" id="s1721.e0" ontology_id="25973" text="PARS2" type="GENE"/>
    <entity charOffset="113-127" id="s1721.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s1721.e0" e2="s1721.e1" id="s1721.p0" relation="true"/>
  </sentence>
  <sentence id="s1722" text="Mutations in the CPA6 gene have been identified in patients with temporal lobe epilepsy and febrile seizures.">
    <entity charOffset="17-21" id="s1722.e0" ontology_id="1548" text="CPA6" type="GENE"/>
    <entity charOffset="79-87" id="s1722.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1722.e0" e2="s1722.e1" id="s1722.p0" relation="true"/>
  </sentence>
  <sentence id="s1723" text="In the present study, we screened for CPA6 mutations in patients with juvenile myoclonic epilepsy and identified two novel missense mutations: Arg36His and Asn271Ser.">
    <entity charOffset="38-42" id="s1723.e0" ontology_id="1548" text="CPA6" type="GENE"/>
    <entity charOffset="89-97" id="s1723.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1723.e0" e2="s1723.e1" id="s1723.p0" relation="true"/>
  </sentence>
  <sentence id="s1724" text="We obtained cryo-electron microscopy structures of an activated filament that is allosterically induced by citrate (ACC-citrate), and an inactivated filament form that results from binding of the BRCT domains of the breast cancer type 1 susceptibility protein (BRCA1).">
    <entity charOffset="223-229" id="s1724.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="261-266" id="s1724.e1" ontology_id="672" text="BRCA1" type="GENE"/>
    <pair e1="s1724.e0" e2="s1724.e1" id="s1724.p0" relation="true"/>
  </sentence>
  <sentence id="s1725" text="The 1p breakpoint disrupts the 5' UTR of AHDC1, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.">
    <entity charOffset="41-46" id="s1725.e0" ontology_id="27245" text="AHDC1" type="GENE"/>
    <entity charOffset="477-491" id="s1725.e1" ontology_id="HP_0000750" text="language delay" type="HP"/>
    <pair e1="s1725.e0" e2="s1725.e1" id="s1725.p0" relation="true"/>
  </sentence>
  <sentence id="s1726" text="The 1p breakpoint disrupts the 5' UTR of AHDC1, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.">
    <entity charOffset="41-46" id="s1726.e0" ontology_id="27245" text="AHDC1" type="GENE"/>
    <entity charOffset="508-519" id="s1726.e1" ontology_id="HP_0010535" text="sleep apnea" type="HP"/>
    <pair e1="s1726.e0" e2="s1726.e1" id="s1726.p0" relation="true"/>
  </sentence>
  <sentence id="s1727" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s1727.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="77-82" id="s1727.e1" ontology_id="6334" text="SCN8A" type="GENE"/>
    <pair e1="s1727.e0" e2="s1727.e1" id="s1727.p0" relation="true"/>
  </sentence>
  <sentence id="s1728" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s1728.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="84-91" id="s1728.e1" ontology_id="773" text="CACNA1A" type="GENE"/>
    <pair e1="s1728.e0" e2="s1728.e1" id="s1728.p0" relation="true"/>
  </sentence>
  <sentence id="s1729" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s1729.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="93-99" id="s1729.e1" ontology_id="2562" text="GABRB3" type="GENE"/>
    <pair e1="s1729.e0" e2="s1729.e1" id="s1729.p0" relation="true"/>
  </sentence>
  <sentence id="s1730" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s1730.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="101-107" id="s1730.e1" ontology_id="2554" text="GABRA1" type="GENE"/>
    <pair e1="s1730.e0" e2="s1730.e1" id="s1730.p0" relation="true"/>
  </sentence>
  <sentence id="s1731" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s1731.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="109-115" id="s1731.e1" ontology_id="23096" text="IQSEC2" type="GENE"/>
    <pair e1="s1731.e0" e2="s1731.e1" id="s1731.p0" relation="true"/>
  </sentence>
  <sentence id="s1732" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s1732.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="123-127" id="s1732.e1" ontology_id="7444" text="VRK2" type="GENE"/>
    <pair e1="s1732.e0" e2="s1732.e1" id="s1732.p0" relation="true"/>
  </sentence>
  <sentence id="s1733" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s1733.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="129-135" id="s1733.e1" ontology_id="477" text="ATP1A2" type="GENE"/>
    <pair e1="s1733.e0" e2="s1733.e1" id="s1733.p0" relation="true"/>
  </sentence>
  <sentence id="s1734" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s1734.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="137-143" id="s1734.e1" ontology_id="57526" text="PCDH19" type="GENE"/>
    <pair e1="s1734.e0" e2="s1734.e1" id="s1734.p0" relation="true"/>
  </sentence>
  <sentence id="s1735" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s1735.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="145-151" id="s1735.e1" ontology_id="10479" text="SLC9A6" type="GENE"/>
    <pair e1="s1735.e0" e2="s1735.e1" id="s1735.p0" relation="true"/>
  </sentence>
  <sentence id="s1736" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s1736.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="156-160" id="s1736.e1" ontology_id="1106" text="CHD2" type="GENE"/>
    <pair e1="s1736.e0" e2="s1736.e1" id="s1736.p0" relation="true"/>
  </sentence>
  <sentence id="s1737" text="These results suggest (i) apparent allelic heterogeneity in CFB and genetic heterogeneity in SLC44A4 across different ethnic groups; (ii) shared ulcerative colitis genetic etiological factors among Asians; and finally (iii) re-exploration of GWAS findings together with high-density genotyping/sequencing and trans-ethnic fine mapping approaches may help identify shared and population-specific risk variants and enable to explain missing disease heritability">
    <entity charOffset="43-56" id="s1737.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="60-63" id="s1737.e1" ontology_id="629" text="CFB" type="GENE"/>
    <pair e1="s1737.e0" e2="s1737.e1" id="s1737.p0" relation="true"/>
  </sentence>
  <sentence id="s1738" text="These results suggest (i) apparent allelic heterogeneity in CFB and genetic heterogeneity in SLC44A4 across different ethnic groups; (ii) shared ulcerative colitis genetic etiological factors among Asians; and finally (iii) re-exploration of GWAS findings together with high-density genotyping/sequencing and trans-ethnic fine mapping approaches may help identify shared and population-specific risk variants and enable to explain missing disease heritability">
    <entity charOffset="43-56" id="s1738.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="93-100" id="s1738.e1" ontology_id="80736" text="SLC44A4" type="GENE"/>
    <pair e1="s1738.e0" e2="s1738.e1" id="s1738.p0" relation="true"/>
  </sentence>
  <sentence id="s1739" text="In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.">
    <entity charOffset="74-81" id="s1739.e0" ontology_id="5905" text="RanGAP1" type="GENE"/>
    <entity charOffset="235-243" id="s1739.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1739.e0" e2="s1739.e1" id="s1739.p0" relation="true"/>
  </sentence>
  <sentence id="s1740" text="In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.">
    <entity charOffset="132-138" id="s1740.e0" ontology_id="57122" text="NUP107" type="GENE"/>
    <entity charOffset="235-243" id="s1740.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1740.e0" e2="s1740.e1" id="s1740.p0" relation="true"/>
  </sentence>
  <sentence id="s1741" text="In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.">
    <entity charOffset="217-221" id="s1741.e0" ontology_id="6647" text="SOD1" type="GENE"/>
    <entity charOffset="235-243" id="s1741.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1741.e0" e2="s1741.e1" id="s1741.p0" relation="true"/>
  </sentence>
  <sentence id="s1742" text="The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention">
    <entity charOffset="112-115" id="s1742.e0" ontology_id="3483" text="ALS" type="GENE"/>
    <entity charOffset="147-155" id="s1742.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1742.e0" e2="s1742.e1" id="s1742.p0" relation="true"/>
  </sentence>
  <sentence id="s1743" text="The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention">
    <entity charOffset="124-128" id="s1743.e0" ontology_id="6647" text="SOD1" type="GENE"/>
    <entity charOffset="147-155" id="s1743.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1743.e0" e2="s1743.e1" id="s1743.p0" relation="true"/>
  </sentence>
  <sentence id="s1744" text="In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to WNT4, VEZT and FSHB genetic loci, respectively, are associated with risk for endometriosis in a Greek population.">
    <entity charOffset="133-137" id="s1744.e0" ontology_id="55591" text="VEZT" type="GENE"/>
    <entity charOffset="204-217" id="s1744.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1744.e0" e2="s1744.e1" id="s1744.p0" relation="true"/>
  </sentence>
  <sentence id="s1745" text="In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to WNT4, VEZT and FSHB genetic loci, respectively, are associated with risk for endometriosis in a Greek population.">
    <entity charOffset="142-146" id="s1745.e0" ontology_id="2488" text="FSHB" type="GENE"/>
    <entity charOffset="204-217" id="s1745.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1745.e0" e2="s1745.e1" id="s1745.p0" relation="true"/>
  </sentence>
  <sentence id="s1746" text="Notably, a significant difference in the distribution of the AG genotype and the minor allele A of FSHB rs11031006 SNP was found between the endometriosis patients and controls.">
    <entity charOffset="99-103" id="s1746.e0" ontology_id="2488" text="FSHB" type="GENE"/>
    <entity charOffset="141-154" id="s1746.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1746.e0" e2="s1746.e1" id="s1746.p0" relation="true"/>
  </sentence>
  <sentence id="s1747" text="We found a genetic association between rs11031006 (FSHB) SNP and endometriosis.">
    <entity charOffset="51-55" id="s1747.e0" ontology_id="2488" text="FSHB" type="GENE"/>
    <entity charOffset="65-78" id="s1747.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1747.e0" e2="s1747.e1" id="s1747.p0" relation="true"/>
  </sentence>
  <sentence id="s1748" text="WNT4 and VEZT genes constitute the most consistently associated genes with endometriosis.">
    <entity charOffset="0-4" id="s1748.e0" ontology_id="54361" text="WNT4" type="GENE"/>
    <entity charOffset="75-88" id="s1748.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1748.e0" e2="s1748.e1" id="s1748.p0" relation="true"/>
  </sentence>
  <sentence id="s1749" text="WNT4 and VEZT genes constitute the most consistently associated genes with endometriosis.">
    <entity charOffset="9-13" id="s1749.e0" ontology_id="55591" text="VEZT" type="GENE"/>
    <entity charOffset="75-88" id="s1749.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1749.e0" e2="s1749.e1" id="s1749.p0" relation="true"/>
  </sentence>
  <sentence id="s1750" text="In the present study, an association of rs7521902 (WNT4) and rs10859871 (VEZT) was confirmed in women with endometriosis at the genotypic but not the allelic level">
    <entity charOffset="51-55" id="s1750.e0" ontology_id="54361" text="WNT4" type="GENE"/>
    <entity charOffset="107-120" id="s1750.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1750.e0" e2="s1750.e1" id="s1750.p0" relation="true"/>
  </sentence>
  <sentence id="s1751" text="In the present study, an association of rs7521902 (WNT4) and rs10859871 (VEZT) was confirmed in women with endometriosis at the genotypic but not the allelic level">
    <entity charOffset="73-77" id="s1751.e0" ontology_id="55591" text="VEZT" type="GENE"/>
    <entity charOffset="107-120" id="s1751.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1751.e0" e2="s1751.e1" id="s1751.p0" relation="true"/>
  </sentence>
  <sentence id="s1752" text="Primary creatine disorders are inherited as autosomal recessive (mutations affecting GATM [for glycine-amidinotransferase, mitochondrial]) and GAMT genes) or X-linked (SLC6A8 gene) traits.">
    <entity charOffset="44-63" id="s1752.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="143-147" id="s1752.e1" ontology_id="2593" text="GAMT" type="GENE"/>
    <pair e1="s1752.e0" e2="s1752.e1" id="s1752.p0" relation="true"/>
  </sentence>
  <sentence id="s1753" text="Primary creatine disorders are inherited as autosomal recessive (mutations affecting GATM [for glycine-amidinotransferase, mitochondrial]) and GAMT genes) or X-linked (SLC6A8 gene) traits.">
    <entity charOffset="44-63" id="s1753.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="168-174" id="s1753.e1" ontology_id="6535" text="SLC6A8" type="GENE"/>
    <pair e1="s1753.e0" e2="s1753.e1" id="s1753.p0" relation="true"/>
  </sentence>
  <sentence id="s1754" text="Primary creatine disorders are inherited as autosomal recessive (mutations affecting GATM [for glycine-amidinotransferase, mitochondrial]) and GAMT genes) or X-linked (SLC6A8 gene) traits.">
    <entity charOffset="44-63" id="s1754.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="85-89" id="s1754.e1" ontology_id="2628" text="GATM" type="GENE"/>
    <pair e1="s1754.e0" e2="s1754.e1" id="s1754.p0" relation="true"/>
  </sentence>
  <sentence id="s1755" text="Primary ciliary dyskinesia (PCD) is clinically characterized by neonatal respiratory distress, chronic sinusitis, bronchiectasis and infertility, and situs inversus in 50% of the patients.">
    <entity charOffset="28-31" id="s1755.e0" ontology_id="352909" text="PCD" type="GENE"/>
    <entity charOffset="73-93" id="s1755.e1" ontology_id="HP_0002098" text="respiratory distress" type="HP"/>
    <pair e1="s1755.e0" e2="s1755.e1" id="s1755.p0" relation="true"/>
  </sentence>
  <sentence id="s1756" text="PCD is a result of mutations in genes encoding proteins involved in ciliary function, and is primarily inherited in an autosomal recessive fashion.">
    <entity charOffset="0-3" id="s1756.e0" ontology_id="352909" text="PCD" type="GENE"/>
    <entity charOffset="119-138" id="s1756.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1756.e0" e2="s1756.e1" id="s1756.p0" relation="true"/>
  </sentence>
  <sentence id="s1757" text="Diagnosis of PCD is often a challenging task due to its high clinical and genetic heterogeneities.">
    <entity charOffset="13-16" id="s1757.e0" ontology_id="352909" text="PCD" type="GENE"/>
    <entity charOffset="82-97" id="s1757.e1" ontology_id="HP_0001425" text="heterogeneities" type="HP"/>
    <pair e1="s1757.e0" e2="s1757.e1" id="s1757.p0" relation="true"/>
  </sentence>
  <sentence id="s1758" text="L371P mutation in MED17 is a founder mutation in the Caucasus Jewish community and that homozygosity for this mutation is associated with infantile cerebral and cerebellar atrophy with poor myelination">
    <entity charOffset="18-23" id="s1758.e0" ontology_id="9440" text="MED17" type="GENE"/>
    <entity charOffset="161-179" id="s1758.e1" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <pair e1="s1758.e0" e2="s1758.e1" id="s1758.p0" relation="true"/>
  </sentence>
  <sentence id="s1759" text="In the second example, Mdx mice, a model for Duchenne muscular dystrophy, were intravenously injected with AAV8-BGN.">
    <entity charOffset="54-72" id="s1759.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="112-115" id="s1759.e1" ontology_id="633" text="BGN" type="GENE"/>
    <pair e1="s1759.e0" e2="s1759.e1" id="s1759.p0" relation="true"/>
  </sentence>
  <sentence id="s1760" text="Like other macular degenerations, pathogenesis within the retinal pigment epithelium (RPE) appears to contribute to the loss of photoreceptors from the central retina.">
    <entity charOffset="11-32" id="s1760.e0" ontology_id="HP_0000608" text="macular degenerations" type="HP"/>
    <entity charOffset="86-89" id="s1760.e1" ontology_id="6120" text="RPE" type="GENE"/>
    <pair e1="s1760.e0" e2="s1760.e1" id="s1760.p0" relation="true"/>
  </sentence>
  <sentence id="s1761" text="Biallelic pathogenic variant in AHI1 gene can cause Joubert syndrome-related disorders with oculomotor apraxia characteristics.">
    <entity charOffset="32-36" id="s1761.e0" ontology_id="54806" text="AHI1" type="GENE"/>
    <entity charOffset="92-110" id="s1761.e1" ontology_id="HP_0000657" text="oculomotor apraxia" type="HP"/>
    <pair e1="s1761.e0" e2="s1761.e1" id="s1761.p0" relation="true"/>
  </sentence>
  <sentence id="s1762" text="Therefore, we concluded that AHI1 c.3257A&amp;gt;G and NEB c.914 A&amp;gt;G were potential causal variants in this strabismus pedigree.">
    <entity charOffset="29-33" id="s1762.e0" ontology_id="54806" text="AHI1" type="GENE"/>
    <entity charOffset="107-117" id="s1762.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s1762.e0" e2="s1762.e1" id="s1762.p0" relation="true"/>
  </sentence>
  <sentence id="s1763" text="Therefore, we concluded that AHI1 c.3257A&amp;gt;G and NEB c.914 A&amp;gt;G were potential causal variants in this strabismus pedigree.">
    <entity charOffset="51-54" id="s1763.e0" ontology_id="4703" text="NEB" type="GENE"/>
    <entity charOffset="107-117" id="s1763.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s1763.e0" e2="s1763.e1" id="s1763.p0" relation="true"/>
  </sentence>
  <sentence id="s1764" text="Here, we show that invasive breast tumors exhibit significant ADAM23-ITH and that this heterogeneity is critical for tumor growth and metastasis.">
    <entity charOffset="35-41" id="s1764.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="62-68" id="s1764.e1" ontology_id="10863" text="ADAM23" type="GENE"/>
    <pair e1="s1764.e0" e2="s1764.e1" id="s1764.p0" relation="true"/>
  </sentence>
  <sentence id="s1765" text="Here, we show that invasive breast tumors exhibit significant ADAM23-ITH and that this heterogeneity is critical for tumor growth and metastasis.">
    <entity charOffset="62-68" id="s1765.e0" ontology_id="10863" text="ADAM23" type="GENE"/>
    <entity charOffset="87-100" id="s1765.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1765.e0" e2="s1765.e1" id="s1765.p0" relation="true"/>
  </sentence>
  <sentence id="s1766" text="Here, we show that invasive breast tumors exhibit significant ADAM23-ITH and that this heterogeneity is critical for tumor growth and metastasis.">
    <entity charOffset="62-68" id="s1766.e0" ontology_id="10863" text="ADAM23" type="GENE"/>
    <entity charOffset="117-122" id="s1766.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1766.e0" e2="s1766.e1" id="s1766.p0" relation="true"/>
  </sentence>
  <sentence id="s1767" text="Rather, we observed that, in ADAM23-heterotypic environments, ADAM23-negative cells promote tumor growth and metastasis by enhancing the proliferation and invasion of adjacent A23-positive cells through the production ofLGI4 (Leucine-rich Glioma Inactivated 4) and nitric oxide (NO).">
    <entity charOffset="92-97" id="s1767.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="221-225" id="s1767.e1" ontology_id="163175" text="LGI4" type="GENE"/>
    <pair e1="s1767.e0" e2="s1767.e1" id="s1767.p0" relation="true"/>
  </sentence>
  <sentence id="s1768" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="176-180" id="s1768.e0" ontology_id="57724" text="EPG5" type="GENE"/>
    <entity charOffset="342-365" id="s1768.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1768.e0" e2="s1768.e1" id="s1768.p0" relation="false"/>
  </sentence>
  <sentence id="s1769" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="176-180" id="s1769.e0" ontology_id="57724" text="EPG5" type="GENE"/>
    <entity charOffset="406-424" id="s1769.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s1769.e0" e2="s1769.e1" id="s1769.p0" relation="true"/>
  </sentence>
  <sentence id="s1770" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="283-288" id="s1770.e0" ontology_id="57231" text="SNX14" type="GENE"/>
    <entity charOffset="320-337" id="s1770.e1" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <pair e1="s1770.e0" e2="s1770.e1" id="s1770.p0" relation="true"/>
  </sentence>
  <sentence id="s1771" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="283-288" id="s1771.e0" ontology_id="57231" text="SNX14" type="GENE"/>
    <entity charOffset="406-424" id="s1771.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s1771.e0" e2="s1771.e1" id="s1771.p0" relation="false"/>
  </sentence>
  <sentence id="s1772" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="320-337" id="s1772.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="426-431" id="s1772.e1" ontology_id="80208" text="SPG11" type="GENE"/>
    <pair e1="s1772.e0" e2="s1772.e1" id="s1772.p0" relation="true"/>
  </sentence>
  <sentence id="s1773" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="320-337" id="s1773.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="433-438" id="s1773.e1" ontology_id="23503" text="SPG15" type="GENE"/>
    <pair e1="s1773.e0" e2="s1773.e1" id="s1773.p0" relation="true"/>
  </sentence>
  <sentence id="s1774" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="320-337" id="s1774.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="443-448" id="s1774.e1" ontology_id="113612" text="SPG49" type="GENE"/>
    <pair e1="s1774.e0" e2="s1774.e1" id="s1774.p0" relation="true"/>
  </sentence>
  <sentence id="s1775" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="320-337" id="s1775.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="466-473" id="s1775.e1" ontology_id="23503" text="ZFYVE26" type="GENE"/>
    <pair e1="s1775.e0" e2="s1775.e1" id="s1775.p0" relation="true"/>
  </sentence>
  <sentence id="s1776" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="342-365" id="s1776.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="426-431" id="s1776.e1" ontology_id="80208" text="SPG11" type="GENE"/>
    <pair e1="s1776.e0" e2="s1776.e1" id="s1776.p0" relation="false"/>
  </sentence>
  <sentence id="s1777" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="342-365" id="s1777.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="433-438" id="s1777.e1" ontology_id="23503" text="SPG15" type="GENE"/>
    <pair e1="s1777.e0" e2="s1777.e1" id="s1777.p0" relation="false"/>
  </sentence>
  <sentence id="s1778" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="342-365" id="s1778.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="443-448" id="s1778.e1" ontology_id="113612" text="SPG49" type="GENE"/>
    <pair e1="s1778.e0" e2="s1778.e1" id="s1778.p0" relation="false"/>
  </sentence>
  <sentence id="s1779" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="342-365" id="s1779.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="466-473" id="s1779.e1" ontology_id="23503" text="ZFYVE26" type="GENE"/>
    <pair e1="s1779.e0" e2="s1779.e1" id="s1779.p0" relation="true"/>
  </sentence>
  <sentence id="s1780" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="342-365" id="s1780.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="478-484" id="s1780.e1" ontology_id="9895" text="TECPR2" type="GENE"/>
    <pair e1="s1780.e0" e2="s1780.e1" id="s1780.p0" relation="true"/>
  </sentence>
  <sentence id="s1781" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="406-424" id="s1781.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="466-473" id="s1781.e1" ontology_id="23503" text="ZFYVE26" type="GENE"/>
    <pair e1="s1781.e0" e2="s1781.e1" id="s1781.p0" relation="true"/>
  </sentence>
  <sentence id="s1782" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="406-424" id="s1782.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="478-484" id="s1782.e1" ontology_id="9895" text="TECPR2" type="GENE"/>
    <pair e1="s1782.e0" e2="s1782.e1" id="s1782.p0" relation="true"/>
  </sentence>
  <sentence id="s1783" text="Sushi repeat-containing protein X-linked 2 (SRPX2), a novel chondroitin sulfate proteoglycan, is overexpressed in human cancer.">
    <entity charOffset="44-49" id="s1783.e0" ontology_id="27286" text="SRPX2" type="GENE"/>
    <entity charOffset="120-126" id="s1783.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1783.e0" e2="s1783.e1" id="s1783.p0" relation="true"/>
  </sentence>
  <sentence id="s1784" text="While, the clinical significance and biological function of SRPX2 remain rarely known in hepatocellular carcinoma (HCC).">
    <entity charOffset="60-65" id="s1784.e0" ontology_id="27286" text="SRPX2" type="GENE"/>
    <entity charOffset="89-113" id="s1784.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1784.e0" e2="s1784.e1" id="s1784.p0" relation="true"/>
  </sentence>
  <sentence id="s1785" text="The positive expression of SRPX2 was prominently correlated with venous infiltration and advanced TNM tumor stage.">
    <entity charOffset="27-32" id="s1785.e0" ontology_id="27286" text="SRPX2" type="GENE"/>
    <entity charOffset="102-107" id="s1785.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1785.e0" e2="s1785.e1" id="s1785.p0" relation="true"/>
  </sentence>
  <sentence id="s1786" text="By exome sequencing, we identified three different bi-allelic truncating mutations in TANGO2 in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.">
    <entity charOffset="86-92" id="s1786.e0" ontology_id="128989" text="TANGO2" type="GENE"/>
    <entity charOffset="202-214" id="s1786.e1" ontology_id="HP_0001943" text="hypoglycemia" type="HP"/>
    <pair e1="s1786.e0" e2="s1786.e1" id="s1786.p0" relation="true"/>
  </sentence>
  <sentence id="s1787" text="By exome sequencing, we identified three different bi-allelic truncating mutations in TANGO2 in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.">
    <entity charOffset="86-92" id="s1787.e0" ontology_id="128989" text="TANGO2" type="GENE"/>
    <entity charOffset="216-230" id="s1787.e1" ontology_id="HP_0003201" text="rhabdomyolysis" type="HP"/>
    <pair e1="s1787.e0" e2="s1787.e1" id="s1787.p0" relation="true"/>
  </sentence>
  <sentence id="s1788" text="Typical ciliopathy phenotypes (curved body shape, retinal dystrophy, coloboma, and decreased cilia) in a CRISPR/Cas9-engineered zebrafish mutant model provide additional support for ARMC9 as a ciliopathy-associated gene.">
    <entity charOffset="50-67" id="s1788.e0" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <entity charOffset="182-187" id="s1788.e1" ontology_id="80210" text="ARMC9" type="GENE"/>
    <pair e1="s1788.e0" e2="s1788.e1" id="s1788.p0" relation="true"/>
  </sentence>
  <sentence id="s1789" text="Typical ciliopathy phenotypes (curved body shape, retinal dystrophy, coloboma, and decreased cilia) in a CRISPR/Cas9-engineered zebrafish mutant model provide additional support for ARMC9 as a ciliopathy-associated gene.">
    <entity charOffset="69-77" id="s1789.e0" ontology_id="HP_0000589" text="coloboma" type="HP"/>
    <entity charOffset="182-187" id="s1789.e1" ontology_id="80210" text="ARMC9" type="GENE"/>
    <pair e1="s1789.e0" e2="s1789.e1" id="s1789.p0" relation="true"/>
  </sentence>
  <sentence id="s1790" text="She manifested macrocephaly, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included GLI3, GCK, and CCM2.">
    <entity charOffset="15-27" id="s1790.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="200-203" id="s1790.e1" ontology_id="2735" text="GLI" type="GENE"/>
    <pair e1="s1790.e0" e2="s1790.e1" id="s1790.p0" relation="true"/>
  </sentence>
  <sentence id="s1791" text="She manifested macrocephaly, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included GLI3, GCK, and CCM2.">
    <entity charOffset="15-27" id="s1791.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="206-209" id="s1791.e1" ontology_id="5871" text="GCK" type="GENE"/>
    <pair e1="s1791.e0" e2="s1791.e1" id="s1791.p0" relation="true"/>
  </sentence>
  <sentence id="s1792" text="She manifested macrocephaly, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included GLI3, GCK, and CCM2.">
    <entity charOffset="66-85" id="s1792.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="206-209" id="s1792.e1" ontology_id="5871" text="GCK" type="GENE"/>
    <pair e1="s1792.e0" e2="s1792.e1" id="s1792.p0" relation="true"/>
  </sentence>
  <sentence id="s1793" text="We summarize the phenotypic extent of GLI2/3 syndromes in the literature and determine that these 2 syndromes manifest opposite features to a certain extent, such as midface hypoplasia or macrocephaly, and anterior or posterior side of polydactyly.">
    <entity charOffset="38-41" id="s1793.e0" ontology_id="2735" text="GLI" type="GENE"/>
    <entity charOffset="188-200" id="s1793.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s1793.e0" e2="s1793.e1" id="s1793.p0" relation="true"/>
  </sentence>
  <sentence id="s1794" text="The present study aimed to explore ARHGAP17 expression in cervical cancer and the possible function in tumor progression.">
    <entity charOffset="35-43" id="s1794.e0" ontology_id="55114" text="ARHGAP17" type="GENE"/>
    <entity charOffset="67-73" id="s1794.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1794.e0" e2="s1794.e1" id="s1794.p0" relation="true"/>
  </sentence>
  <sentence id="s1795" text="ARHGAP17 expression in cervical cancer cell lines was assessed by RT-PCR and Western blotting.">
    <entity charOffset="0-8" id="s1795.e0" ontology_id="55114" text="ARHGAP17" type="GENE"/>
    <entity charOffset="32-38" id="s1795.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1795.e0" e2="s1795.e1" id="s1795.p0" relation="true"/>
  </sentence>
  <sentence id="s1796" text="ARHGAP17 expression in cervical cancer tissues and normal tissues was assessed by immunohistochemistry.">
    <entity charOffset="0-8" id="s1796.e0" ontology_id="55114" text="ARHGAP17" type="GENE"/>
    <entity charOffset="32-38" id="s1796.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1796.e0" e2="s1796.e1" id="s1796.p0" relation="true"/>
  </sentence>
  <sentence id="s1797" text="Here, we showed lower expression of ARHGAP17 in cell lines and human cervical cancer samples.">
    <entity charOffset="36-44" id="s1797.e0" ontology_id="55114" text="ARHGAP17" type="GENE"/>
    <entity charOffset="78-84" id="s1797.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1797.e0" e2="s1797.e1" id="s1797.p0" relation="true"/>
  </sentence>
  <sentence id="s1798" text="Furthermore, the phosphorylation of AKT was enhanced in ARHGAP17 silencing cervical cancer cells.">
    <entity charOffset="36-39" id="s1798.e0" ontology_id="207" text="AKT" type="GENE"/>
    <entity charOffset="84-90" id="s1798.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1798.e0" e2="s1798.e1" id="s1798.p0" relation="true"/>
  </sentence>
  <sentence id="s1799" text="Furthermore, the phosphorylation of AKT was enhanced in ARHGAP17 silencing cervical cancer cells.">
    <entity charOffset="56-64" id="s1799.e0" ontology_id="55114" text="ARHGAP17" type="GENE"/>
    <entity charOffset="84-90" id="s1799.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1799.e0" e2="s1799.e1" id="s1799.p0" relation="true"/>
  </sentence>
  <sentence id="s1800" text="These results reveal that ARHGAP17 functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/AKT signaling and up-regulation of P21 and P27 expression">
    <entity charOffset="26-34" id="s1800.e0" ontology_id="55114" text="ARHGAP17" type="GENE"/>
    <entity charOffset="50-55" id="s1800.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1800.e0" e2="s1800.e1" id="s1800.p0" relation="true"/>
  </sentence>
  <sentence id="s1801" text="These results reveal that ARHGAP17 functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/AKT signaling and up-regulation of P21 and P27 expression">
    <entity charOffset="26-34" id="s1801.e0" ontology_id="55114" text="ARHGAP17" type="GENE"/>
    <entity charOffset="79-85" id="s1801.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1801.e0" e2="s1801.e1" id="s1801.p0" relation="true"/>
  </sentence>
  <sentence id="s1802" text="These results reveal that ARHGAP17 functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/AKT signaling and up-regulation of P21 and P27 expression">
    <entity charOffset="50-55" id="s1802.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="160-163" id="s1802.e1" ontology_id="207" text="AKT" type="GENE"/>
    <pair e1="s1802.e0" e2="s1802.e1" id="s1802.p0" relation="false"/>
  </sentence>
  <sentence id="s1803" text="Erbin(-/-) mice rapidly develop decompensated cardiac hypertrophy, and following severe pressure overload all Erbin(-/-) mice died from heart failure.">
    <entity charOffset="0-5" id="s1803.e0" ontology_id="55914" text="Erbin" type="GENE"/>
    <entity charOffset="136-149" id="s1803.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s1803.e0" e2="s1803.e1" id="s1803.p0" relation="true"/>
  </sentence>
  <sentence id="s1804" text="Although humans with X-linked hypophosphatemia (XLH) and the Hyp mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.">
    <entity charOffset="30-46" id="s1804.e0" ontology_id="HP_0002148" text="hypophosphatemia" type="HP"/>
    <entity charOffset="61-64" id="s1804.e1" ontology_id="5251" text="Hyp" type="GENE"/>
    <pair e1="s1804.e0" e2="s1804.e1" id="s1804.p0" relation="true"/>
  </sentence>
  <sentence id="s1805" text="Although humans with X-linked hypophosphatemia (XLH) and the Hyp mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.">
    <entity charOffset="61-64" id="s1805.e0" ontology_id="5251" text="Hyp" type="GENE"/>
    <entity charOffset="118-144" id="s1805.e1" ontology_id="HP_0002758" text="degenerative joint disease" type="HP"/>
    <pair e1="s1805.e0" e2="s1805.e1" id="s1805.p0" relation="true"/>
  </sentence>
  <sentence id="s1806" text="UCA1 knockdown significantly inhibited PTC cell viability, colony formation and the bromodomain containing 4 (BRD4) expression level invitro, and retarded PTC tumor growth invivo.">
    <entity charOffset="39-42" id="s1806.e0" ontology_id="8030" text="PTC" type="GENE"/>
    <entity charOffset="160-165" id="s1806.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1806.e0" e2="s1806.e1" id="s1806.p0" relation="true"/>
  </sentence>
  <sentence id="s1807" text="UCA1 knockdown significantly inhibited PTC cell viability, colony formation and the bromodomain containing 4 (BRD4) expression level invitro, and retarded PTC tumor growth invivo.">
    <entity charOffset="110-114" id="s1807.e0" ontology_id="23476" text="BRD4" type="GENE"/>
    <entity charOffset="160-165" id="s1807.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1807.e0" e2="s1807.e1" id="s1807.p0" relation="true"/>
  </sentence>
  <sentence id="s1808" text="In the previous study, microRNA (miR)204 inhibited thyroid cancer progression and was regulated by UCA1 in other types of cancer.">
    <entity charOffset="33-36" id="s1808.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="60-66" id="s1808.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1808.e0" e2="s1808.e1" id="s1808.p0" relation="true"/>
  </sentence>
  <sentence id="s1809" text="The Cripto-1 (CR-1) derived EGF-CFC family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.">
    <entity charOffset="4-12" id="s1809.e0" ontology_id="6997" text="Cripto-1" type="GENE"/>
    <entity charOffset="64-69" id="s1809.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1809.e0" e2="s1809.e1" id="s1809.p0" relation="true"/>
  </sentence>
  <sentence id="s1810" text="The Cripto-1 (CR-1) derived EGF-CFC family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.">
    <entity charOffset="14-16" id="s1810.e0" ontology_id="1604" text="CR" type="GENE"/>
    <entity charOffset="64-69" id="s1810.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1810.e0" e2="s1810.e1" id="s1810.p0" relation="true"/>
  </sentence>
  <sentence id="s1811" text="However, correlation between CR-1 and prostate cancer (PCa) remains still unclear.">
    <entity charOffset="47-53" id="s1811.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="55-58" id="s1811.e1" ontology_id="28982" text="PCa" type="GENE"/>
    <pair e1="s1811.e0" e2="s1811.e1" id="s1811.p0" relation="true"/>
  </sentence>
  <sentence id="s1812" text="Additionally, our results displayed that Licl had antitumor activity against PC-3 through the inhibition of Wnt/-catenin pathway.">
    <entity charOffset="54-59" id="s1812.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="77-79" id="s1812.e1" ontology_id="5420" text="PC" type="GENE"/>
    <pair e1="s1812.e0" e2="s1812.e1" id="s1812.p0" relation="true"/>
  </sentence>
  <sentence id="s1813" text="The aim of this study was to examine the Kif2a expression and its role in tumor progression, invasion and metastasis in squamous cell carcinoma of the oral tongue (SCCOT).">
    <entity charOffset="41-46" id="s1813.e0" ontology_id="3796" text="Kif2a" type="GENE"/>
    <entity charOffset="74-79" id="s1813.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1813.e0" e2="s1813.e1" id="s1813.p0" relation="true"/>
  </sentence>
  <sentence id="s1814" text="The immunohistochemistry showed that Kif2a expression was stronger in oral tongue cancer tissues than in paired adjacent tissues (P&amp;lt;0.01), and the higher expression of Kif2a was also significantly associated with lymph node metastasis (P&amp;lt;0.01), tumor clinical stage (P&amp;lt;0.01).">
    <entity charOffset="37-42" id="s1814.e0" ontology_id="3796" text="Kif2a" type="GENE"/>
    <entity charOffset="251-256" id="s1814.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1814.e0" e2="s1814.e1" id="s1814.p0" relation="true"/>
  </sentence>
  <sentence id="s1815" text="The immunohistochemistry showed that Kif2a expression was stronger in oral tongue cancer tissues than in paired adjacent tissues (P&amp;lt;0.01), and the higher expression of Kif2a was also significantly associated with lymph node metastasis (P&amp;lt;0.01), tumor clinical stage (P&amp;lt;0.01).">
    <entity charOffset="37-42" id="s1815.e0" ontology_id="3796" text="Kif2a" type="GENE"/>
    <entity charOffset="82-88" id="s1815.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1815.e0" e2="s1815.e1" id="s1815.p0" relation="true"/>
  </sentence>
  <sentence id="s1816" text="Nogo-A and Nogo-C are potent Nogos that are predominantly expressed in the central nervous system.">
    <entity charOffset="0-4" id="s1816.e0" ontology_id="57142" text="Nogo" type="GENE"/>
    <entity charOffset="75-82" id="s1816.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s1816.e0" e2="s1816.e1" id="s1816.p0" relation="true"/>
  </sentence>
  <sentence id="s1817" text="Downregulation of Gli1, Gli2, Gli3 and Kif7 was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.">
    <entity charOffset="24-28" id="s1817.e0" ontology_id="2736" text="Gli2" type="GENE"/>
    <entity charOffset="84-99" id="s1817.e1" ontology_id="HP_0100768" text="choriocarcinoma" type="HP"/>
    <pair e1="s1817.e0" e2="s1817.e1" id="s1817.p0" relation="true"/>
  </sentence>
  <sentence id="s1818" text="Downregulation of Gli1, Gli2, Gli3 and Kif7 was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.">
    <entity charOffset="30-34" id="s1818.e0" ontology_id="2737" text="Gli3" type="GENE"/>
    <entity charOffset="84-99" id="s1818.e1" ontology_id="HP_0100768" text="choriocarcinoma" type="HP"/>
    <pair e1="s1818.e0" e2="s1818.e1" id="s1818.p0" relation="true"/>
  </sentence>
  <sentence id="s1819" text="Ectopic expression of Kif7 in two choriocarcinoma cell lines JAR and JEG-3 led to a decrease in cell growth and increase in apoptosis demonstrated by MTT and TUNEL assays, respectively.">
    <entity charOffset="22-26" id="s1819.e0" ontology_id="374654" text="Kif7" type="GENE"/>
    <entity charOffset="34-49" id="s1819.e1" ontology_id="HP_0100768" text="choriocarcinoma" type="HP"/>
    <pair e1="s1819.e0" e2="s1819.e1" id="s1819.p0" relation="false"/>
  </sentence>
  <sentence id="s1820" text="Individuals with PTCHD1 deletion show symptoms of ADHD, sleep disruption, hypotonia, aggression, ASD, and ID.">
    <entity charOffset="17-23" id="s1820.e0" ontology_id="139411" text="PTCHD1" type="GENE"/>
    <entity charOffset="85-95" id="s1820.e1" ontology_id="HP_0000718" text="aggression" type="HP"/>
    <pair e1="s1820.e0" e2="s1820.e1" id="s1820.p0" relation="true"/>
  </sentence>
  <sentence id="s1821" text="TRN-restricted deletion of Ptchd1 leads to attention deficits and hyperactivity, both of which are rescued by pharmacological augmentation of SK channel activity.">
    <entity charOffset="0-3" id="s1821.e0" ontology_id="3842" text="TRN" type="GENE"/>
    <entity charOffset="66-79" id="s1821.e1" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <pair e1="s1821.e0" e2="s1821.e1" id="s1821.p0" relation="true"/>
  </sentence>
  <sentence id="s1822" text="TRN-restricted deletion of Ptchd1 leads to attention deficits and hyperactivity, both of which are rescued by pharmacological augmentation of SK channel activity.">
    <entity charOffset="27-33" id="s1822.e0" ontology_id="139411" text="Ptchd1" type="GENE"/>
    <entity charOffset="66-79" id="s1822.e1" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <pair e1="s1822.e0" e2="s1822.e1" id="s1822.p0" relation="true"/>
  </sentence>
  <sentence id="s1823" text="A growing number of studies has suggested that long non-coding RNAs (lncRNAs) exert essential roles in the development and progression of hepatocellular carcinoma (HCC).">
    <entity charOffset="138-162" id="s1823.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="164-167" id="s1823.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s1823.e0" e2="s1823.e1" id="s1823.p0" relation="true"/>
  </sentence>
  <sentence id="s1824" text="SBF2-AS1 knockdown could inhibit the proliferation of HCC cells and attenuate the development of HCC tumor invivo.">
    <entity charOffset="0-4" id="s1824.e0" ontology_id="81846" text="SBF2" type="GENE"/>
    <entity charOffset="101-106" id="s1824.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1824.e0" e2="s1824.e1" id="s1824.p0" relation="true"/>
  </sentence>
  <sentence id="s1825" text="SBF2-AS1 knockdown could inhibit the proliferation of HCC cells and attenuate the development of HCC tumor invivo.">
    <entity charOffset="54-57" id="s1825.e0" ontology_id="84668" text="HCC" type="GENE"/>
    <entity charOffset="101-106" id="s1825.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1825.e0" e2="s1825.e1" id="s1825.p0" relation="true"/>
  </sentence>
  <sentence id="s1826" text="In this study we present the first two cases from India of a rare inborn error of metabolism manifesting as dystonia and 3-methylglutaconic aciduria and a Leigh like lesions in the brain MRI associated with SERAC1 gene mutation, a phenotype characteristic of MEGDEL syndrome.">
    <entity charOffset="108-116" id="s1826.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="207-213" id="s1826.e1" ontology_id="84947" text="SERAC1" type="GENE"/>
    <pair e1="s1826.e0" e2="s1826.e1" id="s1826.p0" relation="true"/>
  </sentence>
  <sentence id="s1827" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.">
    <entity charOffset="92-111" id="s1827.e0" ontology_id="HP_0001999" text="facial dysmorphisms" type="HP"/>
    <entity charOffset="260-265" id="s1827.e1" ontology_id="372" text="ARCN1" type="GENE"/>
    <pair e1="s1827.e0" e2="s1827.e1" id="s1827.p0" relation="true"/>
  </sentence>
  <sentence id="s1828" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.">
    <entity charOffset="120-132" id="s1828.e0" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <entity charOffset="260-265" id="s1828.e1" ontology_id="372" text="ARCN1" type="GENE"/>
    <pair e1="s1828.e0" e2="s1828.e1" id="s1828.p0" relation="true"/>
  </sentence>
  <sentence id="s1829" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.">
    <entity charOffset="120-132" id="s1829.e0" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <entity charOffset="302-307" id="s1829.e1" ontology_id="5694" text="delta" type="GENE"/>
    <pair e1="s1829.e0" e2="s1829.e1" id="s1829.p0" relation="true"/>
  </sentence>
  <sentence id="s1830" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.">
    <entity charOffset="134-155" id="s1830.e0" ontology_id="HP_0008905" text="rhizomelic shortening" type="HP"/>
    <entity charOffset="260-265" id="s1830.e1" ontology_id="372" text="ARCN1" type="GENE"/>
    <pair e1="s1830.e0" e2="s1830.e1" id="s1830.p0" relation="true"/>
  </sentence>
  <sentence id="s1831" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.">
    <entity charOffset="185-189" id="s1831.e0" ontology_id="HP_0012825" text="mild" type="HP"/>
    <entity charOffset="260-265" id="s1831.e1" ontology_id="372" text="ARCN1" type="GENE"/>
    <pair e1="s1831.e0" e2="s1831.e1" id="s1831.p0" relation="true"/>
  </sentence>
  <sentence id="s1832" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.">
    <entity charOffset="185-189" id="s1832.e0" ontology_id="HP_0012825" text="mild" type="HP"/>
    <entity charOffset="302-307" id="s1832.e1" ontology_id="5694" text="delta" type="GENE"/>
    <pair e1="s1832.e0" e2="s1832.e1" id="s1832.p0" relation="false"/>
  </sentence>
  <sentence id="s1833" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.">
    <entity charOffset="190-209" id="s1833.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="260-265" id="s1833.e1" ontology_id="372" text="ARCN1" type="GENE"/>
    <pair e1="s1833.e0" e2="s1833.e1" id="s1833.p0" relation="true"/>
  </sentence>
  <sentence id="s1834" text="As a potential target for cancer treatment, the C-Myc high expresses abnormally in a variety of solid tumors and hematological malignancies in humans.">
    <entity charOffset="48-53" id="s1834.e0" ontology_id="4609" text="C-Myc" type="GENE"/>
    <entity charOffset="102-108" id="s1834.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1834.e0" e2="s1834.e1" id="s1834.p0" relation="true"/>
  </sentence>
  <sentence id="s1835" text="Furthermore, we identified the activity of nitric oxide synthase 2 (NOS2, also known as iNOS) originating from the glioma cells as a driving stimulus in the control of microglial caspase-3 activity.">
    <entity charOffset="88-92" id="s1835.e0" ontology_id="51477" text="iNOS" type="GENE"/>
    <entity charOffset="115-121" id="s1835.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1835.e0" e2="s1835.e1" id="s1835.p0" relation="true"/>
  </sentence>
  <sentence id="s1836" text="Repression of glioma NOS2 expression in vivo led to a reduction in both microglia recruitment and tumor expansion, whereas depletion of microglial caspase-3 gene promoted tumor growth.">
    <entity charOffset="14-20" id="s1836.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="21-25" id="s1836.e1" ontology_id="339345" text="NOS2" type="GENE"/>
    <pair e1="s1836.e0" e2="s1836.e1" id="s1836.p0" relation="true"/>
  </sentence>
  <sentence id="s1837" text="Repression of glioma NOS2 expression in vivo led to a reduction in both microglia recruitment and tumor expansion, whereas depletion of microglial caspase-3 gene promoted tumor growth.">
    <entity charOffset="21-25" id="s1837.e0" ontology_id="339345" text="NOS2" type="GENE"/>
    <entity charOffset="98-103" id="s1837.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1837.e0" e2="s1837.e1" id="s1837.p0" relation="true"/>
  </sentence>
  <sentence id="s1838" text="Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein Trx2 is a part of the microglial pro-tumoral activation pathway initiated by glioma cancer cells">
    <entity charOffset="129-133" id="s1838.e0" ontology_id="9757" text="Trx2" type="GENE"/>
    <entity charOffset="166-171" id="s1838.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1838.e0" e2="s1838.e1" id="s1838.p0" relation="true"/>
  </sentence>
  <sentence id="s1839" text="Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein Trx2 is a part of the microglial pro-tumoral activation pathway initiated by glioma cancer cells">
    <entity charOffset="129-133" id="s1839.e0" ontology_id="9757" text="Trx2" type="GENE"/>
    <entity charOffset="206-212" id="s1839.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1839.e0" e2="s1839.e1" id="s1839.p0" relation="true"/>
  </sentence>
  <sentence id="s1840" text="Results We demonstrated an association between six previously published single nucleotide polymorphisms (rs15869 [ BRCA2], rs1805389 [ LIG4], rs8079544 [ TP53], rs25489 [ XRCC1], rs1673041 [ POLD1], and rs11615 [ ERCC1]) and subsequent CNS tumors in survivors of childhood cancer.">
    <entity charOffset="213-218" id="s1840.e0" ontology_id="2067" text="ERCC1" type="GENE"/>
    <entity charOffset="273-279" id="s1840.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1840.e0" e2="s1840.e1" id="s1840.p0" relation="true"/>
  </sentence>
  <sentence id="s1841" text="Including genetic variants in a Final Model containing age at primary cancer, sex, and cranial radiation therapy dose yielded an area under the curve of 0.81 (95% CI, 0.76 to 0.86), which was superior ( P = .002) to the Clinical Model (area under the curve, 0.73; 95% CI, 0.66 to 0.80).">
    <entity charOffset="70-76" id="s1841.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="78-81" id="s1841.e1" ontology_id="55558" text="sex" type="GENE"/>
    <pair e1="s1841.e0" e2="s1841.e1" id="s1841.p0" relation="false"/>
  </sentence>
  <sentence id="s1842" text="We included 7 consecutive patients with LP with typical intracranial calcifications out of 16 patients with ECM1 mutations and investigated the semiologic features, ictal and interictal EEG findings, and long-term prognosis of epilepsy in this genodermatosis.">
    <entity charOffset="108-112" id="s1842.e0" ontology_id="1893" text="ECM1" type="GENE"/>
    <entity charOffset="227-235" id="s1842.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1842.e0" e2="s1842.e1" id="s1842.p0" relation="true"/>
  </sentence>
  <sentence id="s1843" text="The fat mass and obesity-associated (FTO) gene is tightly related to body weight and fat mass, and plays a pivotal role in regulating lipid accumulation in hepatocytes.">
    <entity charOffset="4-7" id="s1843.e0" ontology_id="948" text="fat" type="GENE"/>
    <entity charOffset="17-24" id="s1843.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1843.e0" e2="s1843.e1" id="s1843.p0" relation="true"/>
  </sentence>
  <sentence id="s1844" text="The fat mass and obesity-associated (FTO) gene is tightly related to body weight and fat mass, and plays a pivotal role in regulating lipid accumulation in hepatocytes.">
    <entity charOffset="17-24" id="s1844.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="37-40" id="s1844.e1" ontology_id="79068" text="FTO" type="GENE"/>
    <pair e1="s1844.e0" e2="s1844.e1" id="s1844.p0" relation="true"/>
  </sentence>
  <sentence id="s1845" text="Gabapentin (GBP; Neurontin) and pregabalin (PGB; Lyrica, S-(+)-3-isobutylgaba) are used clinically to treat several disorders associated with excessive or inappropriate excitability, including epilepsy; pain from diabetic neuropathy, postherpetic neuralgia, and fibromyalgia; and generalized anxiety disorder.">
    <entity charOffset="12-15" id="s1845.e0" ontology_id="3030" text="GBP" type="GENE"/>
    <entity charOffset="193-201" id="s1845.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1845.e0" e2="s1845.e1" id="s1845.p0" relation="true"/>
  </sentence>
  <sentence id="s1846" text="Gabapentin (GBP; Neurontin) and pregabalin (PGB; Lyrica, S-(+)-3-isobutylgaba) are used clinically to treat several disorders associated with excessive or inappropriate excitability, including epilepsy; pain from diabetic neuropathy, postherpetic neuralgia, and fibromyalgia; and generalized anxiety disorder.">
    <entity charOffset="12-15" id="s1846.e0" ontology_id="3030" text="GBP" type="GENE"/>
    <entity charOffset="222-232" id="s1846.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1846.e0" e2="s1846.e1" id="s1846.p0" relation="true"/>
  </sentence>
  <sentence id="s1847" text="In a family with post-lingual progressive non-syndromic deafness, whole-exome sequencing of genomic DNA from five hearing-impaired relatives revealed a single variant, p.Gly488Glu (rs145970949:G&amp;gt;A) in MYO3A, co-segregating with HL as an autosomal dominant trait.">
    <entity charOffset="56-64" id="s1847.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="204-209" id="s1847.e1" ontology_id="53904" text="MYO3A" type="GENE"/>
    <pair e1="s1847.e0" e2="s1847.e1" id="s1847.p0" relation="true"/>
  </sentence>
  <sentence id="s1848" text="TCS has a variable phenotype with typical clinical characteristics including downward-slant of palpebral fissure, malar hypoplasia, mandibular hypoplasia and microtia.">
    <entity charOffset="0-3" id="s1848.e0" ontology_id="6949" text="TCS" type="GENE"/>
    <entity charOffset="114-130" id="s1848.e1" ontology_id="HP_0000272" text="malar hypoplasia" type="HP"/>
    <pair e1="s1848.e0" e2="s1848.e1" id="s1848.p0" relation="true"/>
  </sentence>
  <sentence id="s1849" text="TCS has a variable phenotype with typical clinical characteristics including downward-slant of palpebral fissure, malar hypoplasia, mandibular hypoplasia and microtia.">
    <entity charOffset="0-3" id="s1849.e0" ontology_id="6949" text="TCS" type="GENE"/>
    <entity charOffset="132-153" id="s1849.e1" ontology_id="HP_0000347" text="mandibular hypoplasia" type="HP"/>
    <pair e1="s1849.e0" e2="s1849.e1" id="s1849.p0" relation="true"/>
  </sentence>
  <sentence id="s1850" text="We report a pair of siblings carrying a homozygous missense mutation p.P333L in EEF1A2 who exhibited global developmental delay, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood.">
    <entity charOffset="80-85" id="s1850.e0" ontology_id="1915" text="EEF1A" type="GENE"/>
    <entity charOffset="129-146" id="s1850.e1" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <pair e1="s1850.e0" e2="s1850.e1" id="s1850.p0" relation="true"/>
  </sentence>
  <sentence id="s1851" text="We report a pair of siblings carrying a homozygous missense mutation p.P333L in EEF1A2 who exhibited global developmental delay, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood.">
    <entity charOffset="80-85" id="s1851.e0" ontology_id="1915" text="EEF1A" type="GENE"/>
    <entity charOffset="175-183" id="s1851.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1851.e0" e2="s1851.e1" id="s1851.p0" relation="true"/>
  </sentence>
  <sentence id="s1852" text="EEF1A2-deficient zebrafish had skeletal muscle weakness, cardiac failure and small heads.">
    <entity charOffset="0-5" id="s1852.e0" ontology_id="1915" text="EEF1A" type="GENE"/>
    <entity charOffset="57-72" id="s1852.e1" ontology_id="HP_0001635" text="cardiac failure" type="HP"/>
    <pair e1="s1852.e0" e2="s1852.e1" id="s1852.p0" relation="true"/>
  </sentence>
  <sentence id="s1853" text="This rare condition is characterized by bilateral choanal atresia, hearing loss, cleft lip and/or palate, and other craniofacial dysmorphisms.">
    <entity charOffset="50-65" id="s1853.e0" ontology_id="HP_0000453" text="choanal atresia" type="HP"/>
    <entity charOffset="87-90" id="s1853.e1" ontology_id="23049" text="lip" type="GENE"/>
    <pair e1="s1853.e0" e2="s1853.e1" id="s1853.p0" relation="true"/>
  </sentence>
  <sentence id="s1854" text="Thirteen patients with GRM1-positive tumors were enrolled.">
    <entity charOffset="23-27" id="s1854.e0" ontology_id="2911" text="GRM1" type="GENE"/>
    <entity charOffset="37-43" id="s1854.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1854.e0" e2="s1854.e1" id="s1854.p0" relation="true"/>
  </sentence>
  <sentence id="s1855" text="Here, we sought to find lncRNAs differentially regulated in cancer cells resistant to either TNF-related apoptosis-inducing ligand (TRAIL) or the Mcl-1 inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.">
    <entity charOffset="60-66" id="s1855.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="132-137" id="s1855.e1" ontology_id="8743" text="TRAIL" type="GENE"/>
    <pair e1="s1855.e0" e2="s1855.e1" id="s1855.p0" relation="true"/>
  </sentence>
  <sentence id="s1856" text="Here, we sought to find lncRNAs differentially regulated in cancer cells resistant to either TNF-related apoptosis-inducing ligand (TRAIL) or the Mcl-1 inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.">
    <entity charOffset="60-66" id="s1856.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="146-151" id="s1856.e1" ontology_id="4170" text="Mcl-1" type="GENE"/>
    <pair e1="s1856.e0" e2="s1856.e1" id="s1856.p0" relation="true"/>
  </sentence>
  <sentence id="s1857" text="Additionally, c-Myc was demonstrated to drive OVAAL transcription, indicating a positive feedback loop between c-Myc and OVAAL in controlling tumor growth.">
    <entity charOffset="14-19" id="s1857.e0" ontology_id="4609" text="c-Myc" type="GENE"/>
    <entity charOffset="142-147" id="s1857.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1857.e0" e2="s1857.e1" id="s1857.p0" relation="true"/>
  </sentence>
  <sentence id="s1858" text="Taken together, these results reveal that OVAAL contributes to the survival of cancer cells through dual mechanisms controlling RAF/MEK/ERK signaling and p27-mediated cell senescence">
    <entity charOffset="79-85" id="s1858.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="154-157" id="s1858.e1" ontology_id="5715" text="p27" type="GENE"/>
    <pair e1="s1858.e0" e2="s1858.e1" id="s1858.p0" relation="true"/>
  </sentence>
  <sentence id="s1859" text="This review focuses on the molecular basis of the pathogenesis of cardiac abnormality due to PRKAG2 mutation and will provide current overviews of the mechanism of glycogen regulation by AMPK.">
    <entity charOffset="66-85" id="s1859.e0" ontology_id="HP_0001627" text="cardiac abnormality" type="HP"/>
    <entity charOffset="93-99" id="s1859.e1" ontology_id="51422" text="PRKAG2" type="GENE"/>
    <pair e1="s1859.e0" e2="s1859.e1" id="s1859.p0" relation="true"/>
  </sentence>
  <sentence id="s1860" text="Mutations in the gene encoding CCT (&lt;i&gt;PCYT1A&lt;/i&gt;) cause three distinct pathologies in humans: lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), and isolated retinal dystrophy.">
    <entity charOffset="40-42" id="s1860.e0" ontology_id="5420" text="PC" type="GENE"/>
    <entity charOffset="96-109" id="s1860.e1" ontology_id="HP_0009125" text="lipodystrophy" type="HP"/>
    <pair e1="s1860.e0" e2="s1860.e1" id="s1860.p0" relation="true"/>
  </sentence>
  <sentence id="s1861" text="The nonsense mutation and loss of protein of Rab23 has been associated with neural tube defect in mice and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.">
    <entity charOffset="45-50" id="s1861.e0" ontology_id="51715" text="Rab23" type="GENE"/>
    <entity charOffset="76-94" id="s1861.e1" ontology_id="HP_0045005" text="neural tube defect" type="HP"/>
    <pair e1="s1861.e0" e2="s1861.e1" id="s1861.p0" relation="true"/>
  </sentence>
  <sentence id="s1862" text="The nonsense mutation and loss of protein of Rab23 has been associated with neural tube defect in mice and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.">
    <entity charOffset="45-50" id="s1862.e0" ontology_id="51715" text="Rab23" type="GENE"/>
    <entity charOffset="211-216" id="s1862.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1862.e0" e2="s1862.e1" id="s1862.p0" relation="true"/>
  </sentence>
  <sentence id="s1863" text="The nonsense mutation and loss of protein of Rab23 has been associated with neural tube defect in mice and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.">
    <entity charOffset="98-102" id="s1863.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="211-216" id="s1863.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1863.e0" e2="s1863.e1" id="s1863.p0" relation="true"/>
  </sentence>
  <sentence id="s1864" text="In this review, we give a brief review on the functions of Rab23, summarize the involvement of Rab23 in genetic research, membrane trafficking, and potential autophagy pathway, especially focus on tumor promotion, disease pathogenesis, and discuss the possible underlying mechanisms that are regulated by Rab23">
    <entity charOffset="59-64" id="s1864.e0" ontology_id="51715" text="Rab23" type="GENE"/>
    <entity charOffset="197-202" id="s1864.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1864.e0" e2="s1864.e1" id="s1864.p0" relation="true"/>
  </sentence>
  <sentence id="s1865" text="Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell fate-specifying transcription factors including NEUROD1, HAND1, ZNF423 and REST.">
    <entity charOffset="18-23" id="s1865.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="163-170" id="s1865.e1" ontology_id="4760" text="NEUROD1" type="GENE"/>
    <pair e1="s1865.e0" e2="s1865.e1" id="s1865.p0" relation="true"/>
  </sentence>
  <sentence id="s1866" text="Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell fate-specifying transcription factors including NEUROD1, HAND1, ZNF423 and REST.">
    <entity charOffset="18-23" id="s1866.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="172-177" id="s1866.e1" ontology_id="9421" text="HAND1" type="GENE"/>
    <pair e1="s1866.e0" e2="s1866.e1" id="s1866.p0" relation="true"/>
  </sentence>
  <sentence id="s1867" text="Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell fate-specifying transcription factors including NEUROD1, HAND1, ZNF423 and REST.">
    <entity charOffset="18-23" id="s1867.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="179-185" id="s1867.e1" ontology_id="23090" text="ZNF423" type="GENE"/>
    <pair e1="s1867.e0" e2="s1867.e1" id="s1867.p0" relation="true"/>
  </sentence>
  <sentence id="s1868" text="Kindler syndrome is a rare, autosomal recessive genodermatosis, caused by mutations in the FERMT1 gene.">
    <entity charOffset="28-47" id="s1868.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="91-97" id="s1868.e1" ontology_id="55612" text="FERMT1" type="GENE"/>
    <pair e1="s1868.e0" e2="s1868.e1" id="s1868.p0" relation="true"/>
  </sentence>
  <sentence id="s1869" text="De novo heterozygous mutations in STXBP1/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.">
    <entity charOffset="34-40" id="s1869.e0" ontology_id="6812" text="STXBP1" type="GENE"/>
    <entity charOffset="72-98" id="s1869.e1" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <pair e1="s1869.e0" e2="s1869.e1" id="s1869.p0" relation="true"/>
  </sentence>
  <sentence id="s1870" text="De novo heterozygous mutations in STXBP1/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.">
    <entity charOffset="34-40" id="s1870.e0" ontology_id="6812" text="STXBP1" type="GENE"/>
    <entity charOffset="179-202" id="s1870.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1870.e0" e2="s1870.e1" id="s1870.p0" relation="true"/>
  </sentence>
  <sentence id="s1871" text="We characterized the cellular deficits for an allelic series of seven STXBP1 mutations and developed four mouse models that recapitulate the abnormal EEG activity and cognitive aspects of human STXBP1-encephalopathy.">
    <entity charOffset="70-76" id="s1871.e0" ontology_id="6812" text="STXBP1" type="GENE"/>
    <entity charOffset="201-215" id="s1871.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s1871.e0" e2="s1871.e1" id="s1871.p0" relation="true"/>
  </sentence>
  <sentence id="s1872" text="Together, these cellular studies suggest that impaired protein stability and STXBP1 haploinsufficiency explain STXBP1-encephalopathy and that, therefore, Stxbp1+/- mice provide a valid mouse model.">
    <entity charOffset="77-83" id="s1872.e0" ontology_id="6812" text="STXBP1" type="GENE"/>
    <entity charOffset="118-132" id="s1872.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s1872.e0" e2="s1872.e1" id="s1872.p0" relation="true"/>
  </sentence>
  <sentence id="s1873" text="Together, these cellular studies suggest that impaired protein stability and STXBP1 haploinsufficiency explain STXBP1-encephalopathy and that, therefore, Stxbp1+/- mice provide a valid mouse model.">
    <entity charOffset="118-132" id="s1873.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="154-160" id="s1873.e1" ontology_id="6812" text="Stxbp1" type="GENE"/>
    <pair e1="s1873.e0" e2="s1873.e1" id="s1873.p0" relation="true"/>
  </sentence>
  <sentence id="s1874" text="Simultaneous video and EEG recordings revealed that Stxbp1+/- mice with different genomic backgrounds recapitulate the seizure/spasm phenotype observed in humans, characterized by myoclonic jerks and spike-wave discharges that were suppressed by the antiepileptic drug levetiracetam.">
    <entity charOffset="52-58" id="s1874.e0" ontology_id="6812" text="Stxbp1" type="GENE"/>
    <entity charOffset="119-126" id="s1874.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s1874.e0" e2="s1874.e1" id="s1874.p0" relation="true"/>
  </sentence>
  <sentence id="s1875" text="Stxbp1+/- mice showed impaired cognitive performance, hyperactivity and anxiety-like behaviour, without altered social behaviour.">
    <entity charOffset="0-6" id="s1875.e0" ontology_id="6812" text="Stxbp1" type="GENE"/>
    <entity charOffset="54-67" id="s1875.e1" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <pair e1="s1875.e0" e2="s1875.e1" id="s1875.p0" relation="true"/>
  </sentence>
  <sentence id="s1876" text="Stxbp1+/- mice showed impaired cognitive performance, hyperactivity and anxiety-like behaviour, without altered social behaviour.">
    <entity charOffset="10-14" id="s1876.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="54-67" id="s1876.e1" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <pair e1="s1876.e0" e2="s1876.e1" id="s1876.p0" relation="true"/>
  </sentence>
  <sentence id="s1877" text="Taken together, these data demonstrate the construct, face and predictive validity of Stxbp1+/- mice and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of STXBP1-encephalopathy.">
    <entity charOffset="86-92" id="s1877.e0" ontology_id="6812" text="Stxbp1" type="GENE"/>
    <entity charOffset="232-246" id="s1877.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s1877.e0" e2="s1877.e1" id="s1877.p0" relation="true"/>
  </sentence>
  <sentence id="s1878" text="Taken together, these data demonstrate the construct, face and predictive validity of Stxbp1+/- mice and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of STXBP1-encephalopathy.">
    <entity charOffset="96-100" id="s1878.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="232-246" id="s1878.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s1878.e0" e2="s1878.e1" id="s1878.p0" relation="true"/>
  </sentence>
  <sentence id="s1879" text="Taken together, these data demonstrate the construct, face and predictive validity of Stxbp1+/- mice and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of STXBP1-encephalopathy.">
    <entity charOffset="225-231" id="s1879.e0" ontology_id="6812" text="STXBP1" type="GENE"/>
    <entity charOffset="232-246" id="s1879.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s1879.e0" e2="s1879.e1" id="s1879.p0" relation="true"/>
  </sentence>
  <sentence id="s1880" text="LMO1 is a high-risk neuroblastoma susceptibility gene, but how LMO1 cooperates with MYCN in neuroblastoma tumorigenesis is unclear.">
    <entity charOffset="0-4" id="s1880.e0" ontology_id="4004" text="LMO1" type="GENE"/>
    <entity charOffset="20-33" id="s1880.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1880.e0" e2="s1880.e1" id="s1880.p0" relation="true"/>
  </sentence>
  <sentence id="s1881" text="develop a novel zebrafish model that elucidates a mechanism by which LMO1 and MYCN synergistically initiate neuroblastoma and contribute to metastatic disease progression">
    <entity charOffset="69-73" id="s1881.e0" ontology_id="4004" text="LMO1" type="GENE"/>
    <entity charOffset="108-121" id="s1881.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1881.e0" e2="s1881.e1" id="s1881.p0" relation="true"/>
  </sentence>
  <sentence id="s1882" text="develop a novel zebrafish model that elucidates a mechanism by which LMO1 and MYCN synergistically initiate neuroblastoma and contribute to metastatic disease progression">
    <entity charOffset="78-82" id="s1882.e0" ontology_id="4613" text="MYCN" type="GENE"/>
    <entity charOffset="108-121" id="s1882.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1882.e0" e2="s1882.e1" id="s1882.p0" relation="true"/>
  </sentence>
  <sentence id="s1883" text="Although CHH and other skeletal dysplasias caused by mutations in RMRP or POP1 are commonly cited as ribosomal biogenesis disorders, recent studies question this assumption.">
    <entity charOffset="23-41" id="s1883.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="74-78" id="s1883.e1" ontology_id="11149" text="POP1" type="GENE"/>
    <pair e1="s1883.e0" e2="s1883.e1" id="s1883.p0" relation="true"/>
  </sentence>
  <sentence id="s1884" text="Homozygous recessive mutations in either EFEMP2 (encoding fibulin-4) or FBLN5 (encoding fibulin-5), critical genes for elastogenesis, lead to autosomal recessive cutis laxa types 1B and 1A, respectively.">
    <entity charOffset="72-77" id="s1884.e0" ontology_id="10516" text="FBLN5" type="GENE"/>
    <entity charOffset="142-161" id="s1884.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1884.e0" e2="s1884.e1" id="s1884.p0" relation="true"/>
  </sentence>
  <sentence id="s1885" text="Loss-of-function mutations of GNA11, which encodes G-protein subunit 11 (G11), a signaling partner for the calcium-sensing receptor (CaSR), result in familial hypocalciuric hypercalcemia type 2 (FHH2).">
    <entity charOffset="30-35" id="s1885.e0" ontology_id="2767" text="GNA11" type="GENE"/>
    <entity charOffset="175-188" id="s1885.e1" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <pair e1="s1885.e0" e2="s1885.e1" id="s1885.p0" relation="true"/>
  </sentence>
  <sentence id="s1886" text="Loss-of-function mutations of GNA11, which encodes G-protein subunit 11 (G11), a signaling partner for the calcium-sensing receptor (CaSR), result in familial hypocalciuric hypercalcemia type 2 (FHH2).">
    <entity charOffset="135-139" id="s1886.e0" ontology_id="846" text="CaSR" type="GENE"/>
    <entity charOffset="175-188" id="s1886.e1" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <pair e1="s1886.e0" e2="s1886.e1" id="s1886.p0" relation="true"/>
  </sentence>
  <sentence id="s1887" text="Loss-of-function mutations of GNA11, which encodes G-protein subunit 11 (G11), a signaling partner for the calcium-sensing receptor (CaSR), result in familial hypocalciuric hypercalcemia type 2 (FHH2).">
    <entity charOffset="175-188" id="s1887.e0" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <entity charOffset="197-201" id="s1887.e1" ontology_id="2767" text="FHH2" type="GENE"/>
    <pair e1="s1887.e0" e2="s1887.e1" id="s1887.p0" relation="true"/>
  </sentence>
  <sentence id="s1888" text="FHH2 is characterized by hypercalcemia, inappropriately normal or raised parathyroid hormone (PTH) concentrations, and normal or low urinary calcium excretion.">
    <entity charOffset="0-4" id="s1888.e0" ontology_id="2767" text="FHH2" type="GENE"/>
    <entity charOffset="25-38" id="s1888.e1" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <pair e1="s1888.e0" e2="s1888.e1" id="s1888.p0" relation="true"/>
  </sentence>
  <sentence id="s1889" text="FHH2 is characterized by hypercalcemia, inappropriately normal or raised parathyroid hormone (PTH) concentrations, and normal or low urinary calcium excretion.">
    <entity charOffset="25-38" id="s1889.e0" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <entity charOffset="94-97" id="s1889.e1" ontology_id="5741" text="PTH" type="GENE"/>
    <pair e1="s1889.e0" e2="s1889.e1" id="s1889.p0" relation="true"/>
  </sentence>
  <sentence id="s1890" text="Our results demonstrated that SelM may have an important role in protecting against oxidative damage in the brain of chicken, which might shed light on the role of SelM in human neurodegenerative disease.">
    <entity charOffset="94-100" id="s1890.e0" ontology_id="51438" text="damage" type="GENE"/>
    <entity charOffset="178-203" id="s1890.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s1890.e0" e2="s1890.e1" id="s1890.p0" relation="false"/>
  </sentence>
  <sentence id="s1891" text="The purpose of this study was to evaluate the association of the hepatic lipase (LIPC) rs493258 polymorphism and susceptibility to age-related macular degeneration (AMD).">
    <entity charOffset="81-85" id="s1891.e0" ontology_id="3990" text="LIPC" type="GENE"/>
    <entity charOffset="143-163" id="s1891.e1" ontology_id="HP_0000608" text="macular degeneration" type="HP"/>
    <pair e1="s1891.e0" e2="s1891.e1" id="s1891.p0" relation="true"/>
  </sentence>
  <sentence id="s1892" text="The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and MAP3K1) and glaucoma-related phenotypes (FNDC3B, LMX1B and LOXL1).">
    <entity charOffset="84-89" id="s1892.e0" ontology_id="4010" text="LMX1B" type="GENE"/>
    <entity charOffset="113-121" id="s1892.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s1892.e0" e2="s1892.e1" id="s1892.p0" relation="true"/>
  </sentence>
  <sentence id="s1893" text="The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and MAP3K1) and glaucoma-related phenotypes (FNDC3B, LMX1B and LOXL1).">
    <entity charOffset="91-96" id="s1893.e0" ontology_id="8091" text="HMGA2" type="GENE"/>
    <entity charOffset="113-121" id="s1893.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s1893.e0" e2="s1893.e1" id="s1893.p0" relation="true"/>
  </sentence>
  <sentence id="s1894" text="The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and MAP3K1) and glaucoma-related phenotypes (FNDC3B, LMX1B and LOXL1).">
    <entity charOffset="113-121" id="s1894.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="142-148" id="s1894.e1" ontology_id="64778" text="FNDC3B" type="GENE"/>
    <pair e1="s1894.e0" e2="s1894.e1" id="s1894.p0" relation="true"/>
  </sentence>
  <sentence id="s1895" text="In addition, FGF23 suppresses proximal tubular expression of 1-hydroxylase, the key enzyme responsible for vitamin D hormone production.">
    <entity charOffset="13-18" id="s1895.e0" ontology_id="8074" text="FGF23" type="GENE"/>
    <entity charOffset="30-38" id="s1895.e1" ontology_id="HP_0012840" text="proximal" type="HP"/>
    <pair e1="s1895.e0" e2="s1895.e1" id="s1895.p0" relation="true"/>
  </sentence>
  <sentence id="s1896" text="A mutation of Lrrc6 has been identified in human patients with primary ciliary dyskinesia (PCD).">
    <entity charOffset="14-19" id="s1896.e0" ontology_id="23639" text="Lrrc6" type="GENE"/>
    <entity charOffset="71-89" id="s1896.e1" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <pair e1="s1896.e0" e2="s1896.e1" id="s1896.p0" relation="true"/>
  </sentence>
  <sentence id="s1897" text="A mutation of Lrrc6 has been identified in human patients with primary ciliary dyskinesia (PCD).">
    <entity charOffset="71-89" id="s1897.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="91-94" id="s1897.e1" ontology_id="352909" text="PCD" type="GENE"/>
    <pair e1="s1897.e0" e2="s1897.e1" id="s1897.p0" relation="true"/>
  </sentence>
  <sentence id="s1898" text="Mutant mice lacking Lrrc6 show typical PCD defects such as hydrocephalus and laterality defects.">
    <entity charOffset="39-42" id="s1898.e0" ontology_id="352909" text="PCD" type="GENE"/>
    <entity charOffset="59-72" id="s1898.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s1898.e0" e2="s1898.e1" id="s1898.p0" relation="true"/>
  </sentence>
  <sentence id="s1899" text="Mutations in filamin A (FLNA) or ADP-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2) cause periventricular nodular heterotopia, but most patients with this malformation do not have a known aetiology.">
    <entity charOffset="24-28" id="s1899.e0" ontology_id="2316" text="FLNA" type="GENE"/>
    <entity charOffset="134-145" id="s1899.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s1899.e0" e2="s1899.e1" id="s1899.p0" relation="true"/>
  </sentence>
  <sentence id="s1900" text="Mutations in filamin A (FLNA) or ADP-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2) cause periventricular nodular heterotopia, but most patients with this malformation do not have a known aetiology.">
    <entity charOffset="33-36" id="s1900.e0" ontology_id="23038" text="ADP" type="GENE"/>
    <entity charOffset="134-145" id="s1900.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s1900.e0" e2="s1900.e1" id="s1900.p0" relation="true"/>
  </sentence>
  <sentence id="s1901" text="Mutations in filamin A (FLNA) or ADP-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2) cause periventricular nodular heterotopia, but most patients with this malformation do not have a known aetiology.">
    <entity charOffset="95-102" id="s1901.e0" ontology_id="10564" text="ARFGEF2" type="GENE"/>
    <entity charOffset="134-145" id="s1901.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s1901.e0" e2="s1901.e1" id="s1901.p0" relation="true"/>
  </sentence>
  <sentence id="s1902" text="Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (C6orf70) gene, mapping in the minimal critical deleted region.">
    <entity charOffset="191-210" id="s1902.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="299-306" id="s1902.e1" ontology_id="55780" text="C6orf70" type="GENE"/>
    <pair e1="s1902.e0" e2="s1902.e1" id="s1902.p0" relation="true"/>
  </sentence>
  <sentence id="s1903" text="Silencing of the contiguous Phf10 or Dll1 genes only produced slightly delayed migration but not periventricular nodular heterotopia.">
    <entity charOffset="28-33" id="s1903.e0" ontology_id="55274" text="Phf10" type="GENE"/>
    <entity charOffset="121-132" id="s1903.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s1903.e0" e2="s1903.e1" id="s1903.p0" relation="true"/>
  </sentence>
  <sentence id="s1904" text="Silencing of the contiguous Phf10 or Dll1 genes only produced slightly delayed migration but not periventricular nodular heterotopia.">
    <entity charOffset="37-41" id="s1904.e0" ontology_id="28514" text="Dll1" type="GENE"/>
    <entity charOffset="121-132" id="s1904.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s1904.e0" e2="s1904.e1" id="s1904.p0" relation="true"/>
  </sentence>
  <sentence id="s1905" text="Our data suggest that, of the genes within this minimal critical region, C6orf70 plays a major role in the control of neuronal migration and its haploinsufficiency or mutation causes periventricular nodular heterotopia.">
    <entity charOffset="73-80" id="s1905.e0" ontology_id="55780" text="C6orf70" type="GENE"/>
    <entity charOffset="207-218" id="s1905.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s1905.e0" e2="s1905.e1" id="s1905.p0" relation="true"/>
  </sentence>
  <sentence id="s1906" text="Several publications had illustrated the relationship of between CAV1 polymorphism and urinary cancer, but the results were not consistent.">
    <entity charOffset="65-69" id="s1906.e0" ontology_id="857" text="CAV1" type="GENE"/>
    <entity charOffset="95-101" id="s1906.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1906.e0" e2="s1906.e1" id="s1906.p0" relation="true"/>
  </sentence>
  <sentence id="s1907" text="Odds ratios (ORs) and 95% confidence intervals (CIs) were conducted to evaluate the overall strength of the associations in five genetic models, as well as in subgroup analyses, stratified by ethnicity, cancer type or source of control.">
    <entity charOffset="203-209" id="s1907.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="210-214" id="s1907.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s1907.e0" e2="s1907.e1" id="s1907.p0" relation="true"/>
  </sentence>
  <sentence id="s1908" text="Conclusion rs1049334 polymorphismof CAV1 upgrade the risk of urinary cancer, while rs1049337 and rs7804372 polymorphisms may act as a protector of urinary cancer.">
    <entity charOffset="36-40" id="s1908.e0" ontology_id="857" text="CAV1" type="GENE"/>
    <entity charOffset="69-75" id="s1908.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1908.e0" e2="s1908.e1" id="s1908.p0" relation="true"/>
  </sentence>
  <sentence id="s1909" text="In this work we investigated the role of forkhead box O1 (FoxO1) in the transcriptional regulation in macrophages, which affects the anti-tumor functions of tumor-associated macrophages (TAMs).">
    <entity charOffset="58-63" id="s1909.e0" ontology_id="2308" text="FoxO1" type="GENE"/>
    <entity charOffset="138-143" id="s1909.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1909.e0" e2="s1909.e1" id="s1909.p0" relation="true"/>
  </sentence>
  <sentence id="s1910" text="These results demonstrate that the protumoral property of TAMs is induced by the hypoxia-triggered FoxO1 deficiency, which could be a potential target of novel anti-tumor therapies">
    <entity charOffset="38-43" id="s1910.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="99-104" id="s1910.e1" ontology_id="2308" text="FoxO1" type="GENE"/>
    <pair e1="s1910.e0" e2="s1910.e1" id="s1910.p0" relation="false"/>
  </sentence>
  <sentence id="s1911" text="Furthermore, LHX3 is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).">
    <entity charOffset="13-17" id="s1911.e0" ontology_id="8022" text="LHX3" type="GENE"/>
    <entity charOffset="236-259" id="s1911.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s1911.e0" e2="s1911.e1" id="s1911.p0" relation="true"/>
  </sentence>
  <sentence id="s1912" text="Furthermore, LHX3 is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).">
    <entity charOffset="153-172" id="s1912.e0" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <entity charOffset="174-177" id="s1912.e1" ontology_id="113451" text="ADC" type="GENE"/>
    <pair e1="s1912.e0" e2="s1912.e1" id="s1912.p0" relation="true"/>
  </sentence>
  <sentence id="s1913" text="Our data confirm the genetic heterogeneity of childhood-onset pure HSP, with SPG4/SPAST and SPG3A/ATL1 being the most frequent forms.">
    <entity charOffset="29-42" id="s1913.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="98-102" id="s1913.e1" ontology_id="51062" text="ATL1" type="GENE"/>
    <pair e1="s1913.e0" e2="s1913.e1" id="s1913.p0" relation="true"/>
  </sentence>
  <sentence id="s1914" text="Our data confirm the genetic heterogeneity of childhood-onset pure HSP, with SPG4/SPAST and SPG3A/ATL1 being the most frequent forms.">
    <entity charOffset="29-42" id="s1914.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="82-87" id="s1914.e1" ontology_id="6683" text="SPAST" type="GENE"/>
    <pair e1="s1914.e0" e2="s1914.e1" id="s1914.p0" relation="true"/>
  </sentence>
  <sentence id="s1915" text="We identified eight hub genes which likely play important roles in obesity metabolism and identified microRNAs that significantly negatively correlated with hub genes.">
    <entity charOffset="20-23" id="s1915.e0" ontology_id="1993" text="hub" type="GENE"/>
    <entity charOffset="67-74" id="s1915.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1915.e0" e2="s1915.e1" id="s1915.p0" relation="true"/>
  </sentence>
  <sentence id="s1916" text="The results indicated that increased GPD1L in adipose tissue may have a significant therapeutic potential in reducing obesity and insulin resistance">
    <entity charOffset="37-42" id="s1916.e0" ontology_id="23171" text="GPD1L" type="GENE"/>
    <entity charOffset="118-125" id="s1916.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1916.e0" e2="s1916.e1" id="s1916.p0" relation="true"/>
  </sentence>
  <sentence id="s1917" text="Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="22-26" id="s1917.e0" ontology_id="1690" text="COCH" type="GENE"/>
    <entity charOffset="73-84" id="s1917.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s1917.e0" e2="s1917.e1" id="s1917.p0" relation="true"/>
  </sentence>
  <sentence id="s1918" text="Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="22-26" id="s1918.e0" ontology_id="1690" text="COCH" type="GENE"/>
    <entity charOffset="85-97" id="s1918.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1918.e0" e2="s1918.e1" id="s1918.p0" relation="true"/>
  </sentence>
  <sentence id="s1919" text="Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="22-26" id="s1919.e0" ontology_id="1690" text="COCH" type="GENE"/>
    <entity charOffset="102-124" id="s1919.e1" ontology_id="HP_0001751" text="vestibular dysfunction" type="HP"/>
    <pair e1="s1919.e0" e2="s1919.e1" id="s1919.p0" relation="true"/>
  </sentence>
  <sentence id="s1920" text="Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="48-53" id="s1920.e0" ontology_id="1690" text="DFNA9" type="GENE"/>
    <entity charOffset="73-84" id="s1920.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s1920.e0" e2="s1920.e1" id="s1920.p0" relation="true"/>
  </sentence>
  <sentence id="s1921" text="Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="48-53" id="s1921.e0" ontology_id="1690" text="DFNA9" type="GENE"/>
    <entity charOffset="102-124" id="s1921.e1" ontology_id="HP_0001751" text="vestibular dysfunction" type="HP"/>
    <pair e1="s1921.e0" e2="s1921.e1" id="s1921.p0" relation="true"/>
  </sentence>
  <sentence id="s1922" text="Here, we describe two brothers with congenital prelingual deafness and a homozygous nonsense c.292C&amp;gt;T(p.Arg98*) COCH variant, suggesting a loss-of-function effect.">
    <entity charOffset="58-66" id="s1922.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="115-119" id="s1922.e1" ontology_id="1690" text="COCH" type="GENE"/>
    <pair e1="s1922.e0" e2="s1922.e1" id="s1922.p0" relation="true"/>
  </sentence>
  <sentence id="s1923" text="This is the first report of autosomal recessive inheritance of cochlea-vestibular dysfunction caused by a pathogenic variant in the COCH gene.">
    <entity charOffset="28-59" id="s1923.e0" ontology_id="HP_0000007" text="autosomal recessive inheritance" type="HP"/>
    <entity charOffset="132-136" id="s1923.e1" ontology_id="1690" text="COCH" type="GENE"/>
    <pair e1="s1923.e0" e2="s1923.e1" id="s1923.p0" relation="true"/>
  </sentence>
  <sentence id="s1924" text="This is the first report of autosomal recessive inheritance of cochlea-vestibular dysfunction caused by a pathogenic variant in the COCH gene.">
    <entity charOffset="71-93" id="s1924.e0" ontology_id="HP_0001751" text="vestibular dysfunction" type="HP"/>
    <entity charOffset="132-136" id="s1924.e1" ontology_id="1690" text="COCH" type="GENE"/>
    <pair e1="s1924.e0" e2="s1924.e1" id="s1924.p0" relation="true"/>
  </sentence>
  <sentence id="s1925" text="An earlier onset of hearing impairment and vestibular dysfunction compared to the dominant hearing loss causing COCH variants is observed">
    <entity charOffset="91-103" id="s1925.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="112-116" id="s1925.e1" ontology_id="1690" text="COCH" type="GENE"/>
    <pair e1="s1925.e0" e2="s1925.e1" id="s1925.p0" relation="true"/>
  </sentence>
  <sentence id="s1926" text="Danon disease, an X-linked dominant cardioskeletal myopathy, is caused by primary deficiency of lysosome-associated membrane protein-2 (LAMP-2).">
    <entity charOffset="51-59" id="s1926.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="136-140" id="s1926.e1" ontology_id="27074" text="LAMP" type="GENE"/>
    <pair e1="s1926.e0" e2="s1926.e1" id="s1926.p0" relation="true"/>
  </sentence>
  <sentence id="s1927" text="The K&lt;sup&gt;+&lt;/sup&gt; channel KCNQ1 has been proposed as a tumor suppressor in colorectal cancer (CRC).">
    <entity charOffset="26-31" id="s1927.e0" ontology_id="3784" text="KCNQ1" type="GENE"/>
    <entity charOffset="86-92" id="s1927.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1927.e0" e2="s1927.e1" id="s1927.p0" relation="true"/>
  </sentence>
  <sentence id="s1928" text="Analysis of human primary CRC tumor patient databases showed a positive correlation between KCNQ1:KCNE3 channel complex expression and disease-free survival.">
    <entity charOffset="30-35" id="s1928.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="92-97" id="s1928.e1" ontology_id="3784" text="KCNQ1" type="GENE"/>
    <pair e1="s1928.e0" e2="s1928.e1" id="s1928.p0" relation="true"/>
  </sentence>
  <sentence id="s1929" text="We conclude that the KCNQ1 ion channel is a target gene and regulator of the Wnt/-catenin pathway, and its repression leads to CRC cell proliferation, EMT, and tumorigenesis">
    <entity charOffset="21-26" id="s1929.e0" ontology_id="3784" text="KCNQ1" type="GENE"/>
    <entity charOffset="161-166" id="s1929.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1929.e0" e2="s1929.e1" id="s1929.p0" relation="true"/>
  </sentence>
  <sentence id="s1930" text="We conclude that the KCNQ1 ion channel is a target gene and regulator of the Wnt/-catenin pathway, and its repression leads to CRC cell proliferation, EMT, and tumorigenesis">
    <entity charOffset="152-155" id="s1930.e0" ontology_id="3702" text="EMT" type="GENE"/>
    <entity charOffset="161-166" id="s1930.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1930.e0" e2="s1930.e1" id="s1930.p0" relation="true"/>
  </sentence>
  <sentence id="s1931" text="The aberrant activation of STAT3 contributes to several human diseases, particularly cancer.">
    <entity charOffset="27-32" id="s1931.e0" ontology_id="6774" text="STAT3" type="GENE"/>
    <entity charOffset="85-91" id="s1931.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1931.e0" e2="s1931.e1" id="s1931.p0" relation="true"/>
  </sentence>
  <sentence id="s1932" text="We hope that our study will stimulate further studies and a new targeted therapy and early medical intervention for YAP/TAZ could be a useful option for breast cancer cases complicated with LKB1 deficiency">
    <entity charOffset="160-166" id="s1932.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="190-194" id="s1932.e1" ontology_id="6794" text="LKB1" type="GENE"/>
    <pair e1="s1932.e0" e2="s1932.e1" id="s1932.p0" relation="true"/>
  </sentence>
  <sentence id="s1933" text="TAF12, NFYC, and RAD54L co-located on human chromosome 1p32-35.3 and mouse chromosome 4qD1-D3 were identified as oncogenes that are gained in tumors in both species and required for disease initiation and progression.">
    <entity charOffset="7-11" id="s1933.e0" ontology_id="4802" text="NFYC" type="GENE"/>
    <entity charOffset="142-148" id="s1933.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1933.e0" e2="s1933.e1" id="s1933.p0" relation="true"/>
  </sentence>
  <sentence id="s1934" text="TAF12, NFYC, and RAD54L co-located on human chromosome 1p32-35.3 and mouse chromosome 4qD1-D3 were identified as oncogenes that are gained in tumors in both species and required for disease initiation and progression.">
    <entity charOffset="17-23" id="s1934.e0" ontology_id="8438" text="RAD54L" type="GENE"/>
    <entity charOffset="142-148" id="s1934.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1934.e0" e2="s1934.e1" id="s1934.p0" relation="true"/>
  </sentence>
  <sentence id="s1935" text="Mendelian randomization analyses suggest causal inverse associations, independent of body mass index (BMI), between puberty timing and risks for breast and endometrial cancers in women and prostate cancer in men.">
    <entity charOffset="90-94" id="s1935.e0" ontology_id="2200" text="mass" type="GENE"/>
    <entity charOffset="168-174" id="s1935.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1935.e0" e2="s1935.e1" id="s1935.p0" relation="true"/>
  </sentence>
  <sentence id="s1936" text="To investigate genetic predispositions for MYCN-amplified neuroblastoma, we performed a meta-analysis of three genome-wide association studies totaling 615 MYCN-amplified high-risk neuroblastoma cases and 1869 MYCN-nonamplified non-high-risk neuroblastoma cases as controls using a fixed-effects model with inverse variance weighting.">
    <entity charOffset="43-47" id="s1936.e0" ontology_id="4613" text="MYCN" type="GENE"/>
    <entity charOffset="58-71" id="s1936.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1936.e0" e2="s1936.e1" id="s1936.p0" relation="true"/>
  </sentence>
  <sentence id="s1937" text="We identified a novel locus at 3p21.31 indexed by the single nucleotide polymorphism (SNP) rs80059929 (odds ratio [OR] = 2.95, 95% confidence interval [CI] = 2.17 to 4.02, Pmeta = 6.4710-12) associated with MYCN-amplified neuroblastoma, which was replicated in 127 MYCN-amplified cases and 254 non-high-risk controls (OR=2.30, 95% CI=1.12 to 4.69, Preplication = .02).">
    <entity charOffset="210-214" id="s1937.e0" ontology_id="4613" text="MYCN" type="GENE"/>
    <entity charOffset="225-238" id="s1937.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1937.e0" e2="s1937.e1" id="s1937.p0" relation="true"/>
  </sentence>
  <sentence id="s1938" text="To confirm this signal is exclusive to MYCN-amplified tumors, we performed a second meta-analysis comparing 728 MYCN-nonamplified high-risk patients to identical controls.">
    <entity charOffset="39-43" id="s1938.e0" ontology_id="4613" text="MYCN" type="GENE"/>
    <entity charOffset="54-60" id="s1938.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1938.e0" e2="s1938.e1" id="s1938.p0" relation="true"/>
  </sentence>
  <sentence id="s1939" text="Additionally, the previously reported LMO1 neuroblastoma risk locus was statistically significant only in patients with MYCN-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).">
    <entity charOffset="38-42" id="s1939.e0" ontology_id="4004" text="LMO1" type="GENE"/>
    <entity charOffset="43-56" id="s1939.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1939.e0" e2="s1939.e1" id="s1939.p0" relation="true"/>
  </sentence>
  <sentence id="s1940" text="Additionally, the previously reported LMO1 neuroblastoma risk locus was statistically significant only in patients with MYCN-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).">
    <entity charOffset="38-42" id="s1940.e0" ontology_id="4004" text="LMO1" type="GENE"/>
    <entity charOffset="148-154" id="s1940.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1940.e0" e2="s1940.e1" id="s1940.p0" relation="true"/>
  </sentence>
  <sentence id="s1941" text="Additionally, the previously reported LMO1 neuroblastoma risk locus was statistically significant only in patients with MYCN-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).">
    <entity charOffset="43-56" id="s1941.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="120-124" id="s1941.e1" ontology_id="4613" text="MYCN" type="GENE"/>
    <pair e1="s1941.e0" e2="s1941.e1" id="s1941.p0" relation="true"/>
  </sentence>
  <sentence id="s1942" text="Additionally, the previously reported LMO1 neuroblastoma risk locus was statistically significant only in patients with MYCN-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).">
    <entity charOffset="120-124" id="s1942.e0" ontology_id="4613" text="MYCN" type="GENE"/>
    <entity charOffset="148-154" id="s1942.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1942.e0" e2="s1942.e1" id="s1942.p0" relation="true"/>
  </sentence>
  <sentence id="s1943" text="Our results indicate that common genetic variation predisposes to different neuroblastoma genotypes, including the likelihood of somatic MYCN-amplification">
    <entity charOffset="76-89" id="s1943.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="137-141" id="s1943.e1" ontology_id="4613" text="MYCN" type="GENE"/>
    <pair e1="s1943.e0" e2="s1943.e1" id="s1943.p0" relation="true"/>
  </sentence>
  <sentence id="s1944" text="The gonadoblastoma gene, testis-specific protein Y-encoded (TSPY), on the Y chromosome and its X-homologue, TSPX, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.">
    <entity charOffset="4-18" id="s1944.e0" ontology_id="HP_0000150" text="gonadoblastoma" type="HP"/>
    <entity charOffset="108-112" id="s1944.e1" ontology_id="64061" text="TSPX" type="GENE"/>
    <pair e1="s1944.e0" e2="s1944.e1" id="s1944.p0" relation="true"/>
  </sentence>
  <sentence id="s1945" text="The gonadoblastoma gene, testis-specific protein Y-encoded (TSPY), on the Y chromosome and its X-homologue, TSPX, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.">
    <entity charOffset="60-64" id="s1945.e0" ontology_id="7258" text="TSPY" type="GENE"/>
    <entity charOffset="179-184" id="s1945.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1945.e0" e2="s1945.e1" id="s1945.p0" relation="true"/>
  </sentence>
  <sentence id="s1946" text="TSPY and TSPX co-localize with the endogenous AR, in the presence of ligand, on the promoters and differentially regulate the expression of the endogenous AR target genes in the androgen-responsive LNCaP prostate cancer cells.">
    <entity charOffset="0-4" id="s1946.e0" ontology_id="7258" text="TSPY" type="GENE"/>
    <entity charOffset="213-219" id="s1946.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1946.e0" e2="s1946.e1" id="s1946.p0" relation="true"/>
  </sentence>
  <sentence id="s1947" text="TSPY and TSPX co-localize with the endogenous AR, in the presence of ligand, on the promoters and differentially regulate the expression of the endogenous AR target genes in the androgen-responsive LNCaP prostate cancer cells.">
    <entity charOffset="9-13" id="s1947.e0" ontology_id="64061" text="TSPX" type="GENE"/>
    <entity charOffset="213-219" id="s1947.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1947.e0" e2="s1947.e1" id="s1947.p0" relation="true"/>
  </sentence>
  <sentence id="s1948" text="Hence, TSPY and TSPX exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate cancer but also likely contributing to sex differences in the health and diseases of man">
    <entity charOffset="80-82" id="s1948.e0" ontology_id="231" text="AR" type="GENE"/>
    <entity charOffset="260-266" id="s1948.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1948.e0" e2="s1948.e1" id="s1948.p0" relation="true"/>
  </sentence>
  <sentence id="s1949" text="Several advances have been made in the treatment of HER2-positive breast cancer, yet issues of resistance and poor response to therapy remains prevalent.">
    <entity charOffset="52-56" id="s1949.e0" ontology_id="2064" text="HER2" type="GENE"/>
    <entity charOffset="73-79" id="s1949.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1949.e0" e2="s1949.e1" id="s1949.p0" relation="true"/>
  </sentence>
  <sentence id="s1950" text="Our results provide evidence that sequence variants in human SIPA1L3 cause autosomal recessive isolated CC and give new insight into the molecular pathogenesis underlying human cataracts.">
    <entity charOffset="61-68" id="s1950.e0" ontology_id="23094" text="SIPA1L3" type="GENE"/>
    <entity charOffset="75-94" id="s1950.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1950.e0" e2="s1950.e1" id="s1950.p0" relation="true"/>
  </sentence>
  <sentence id="s1951" text="The phenotypic spectrum related to PEX10 mutations includes slowly progressive, syndromic recessive ataxia.">
    <entity charOffset="35-39" id="s1951.e0" ontology_id="5189" text="PEX1" type="GENE"/>
    <entity charOffset="100-106" id="s1951.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1951.e0" e2="s1951.e1" id="s1951.p0" relation="true"/>
  </sentence>
  <sentence id="s1952" text="The results imply that variants associated with prostate cancer can be identified through expressional change in the PEX6 gene, but not in the overlapped glycine N-methyltransferase gene which had been considered as a candidate gene.Further studies are required to understand their underlying mechanisms for the strong eQTLs for the SNHG5 and PEX6 genes">
    <entity charOffset="57-63" id="s1952.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="117-121" id="s1952.e1" ontology_id="5190" text="PEX6" type="GENE"/>
    <pair e1="s1952.e0" e2="s1952.e1" id="s1952.p0" relation="true"/>
  </sentence>
  <sentence id="s1953" text="Study of RetGC1 regulation in vitro and its association with fluorescently tagged GCAP in transfected cells showed that R822P substitution in the cyclase dimerization domain causing congenital early onset blindness disrupted RetGC1 ability to bind GCAP but did not eliminate its affinity for another photoreceptor-specific protein, retinal degeneration 3 (RD3).">
    <entity charOffset="82-86" id="s1953.e0" ontology_id="2978" text="GCAP" type="GENE"/>
    <entity charOffset="332-352" id="s1953.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1953.e0" e2="s1953.e1" id="s1953.p0" relation="false"/>
  </sentence>
  <sentence id="s1954" text="Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (ACO2) has been recently described as a neurodegenerative disease of autosomal recessive inheritance.">
    <entity charOffset="107-111" id="s1954.e0" ontology_id="50" text="ACO2" type="GENE"/>
    <entity charOffset="146-171" id="s1954.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s1954.e0" e2="s1954.e1" id="s1954.p0" relation="true"/>
  </sentence>
  <sentence id="s1955" text="In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, hypertelorism, low-set ears, upturned nose, and micrognathia), and multiple congenital malformations (including cerebral dysplasia, dislocation of the hip joint, and cryptorchidism).">
    <entity charOffset="152-165" id="s1955.e0" ontology_id="HP_0000316" text="hypertelorism" type="HP"/>
    <entity charOffset="303-306" id="s1955.e1" ontology_id="64399" text="hip" type="GENE"/>
    <pair e1="s1955.e0" e2="s1955.e1" id="s1955.p0" relation="true"/>
  </sentence>
  <sentence id="s1956" text="In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, hypertelorism, low-set ears, upturned nose, and micrognathia), and multiple congenital malformations (including cerebral dysplasia, dislocation of the hip joint, and cryptorchidism).">
    <entity charOffset="200-212" id="s1956.e0" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <entity charOffset="303-306" id="s1956.e1" ontology_id="64399" text="hip" type="GENE"/>
    <pair e1="s1956.e0" e2="s1956.e1" id="s1956.p0" relation="true"/>
  </sentence>
  <sentence id="s1957" text="However, in hepatocellular carcinoma (HCC), the characteristics and mechanism of IDO1 expression have not been well defined.">
    <entity charOffset="12-36" id="s1957.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="81-85" id="s1957.e1" ontology_id="3620" text="IDO1" type="GENE"/>
    <pair e1="s1957.e0" e2="s1957.e1" id="s1957.p0" relation="true"/>
  </sentence>
  <sentence id="s1958" text="However, in hepatocellular carcinoma (HCC), the characteristics and mechanism of IDO1 expression have not been well defined.">
    <entity charOffset="12-36" id="s1958.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="38-41" id="s1958.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s1958.e0" e2="s1958.e1" id="s1958.p0" relation="true"/>
  </sentence>
  <sentence id="s1959" text="In this study, IDO1 expression in tumor cells (T-IDO1) was frequently detected (109/112) by immunohistochemistry in formalin-fixed paraffin-embedded specimens from HCC patients, and the expression patterns were mostly focal (102/109).">
    <entity charOffset="15-19" id="s1959.e0" ontology_id="3620" text="IDO1" type="GENE"/>
    <entity charOffset="34-39" id="s1959.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1959.e0" e2="s1959.e1" id="s1959.p0" relation="true"/>
  </sentence>
  <sentence id="s1960" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s1960.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="106-109" id="s1960.e1" ontology_id="3952" text="LEP" type="GENE"/>
    <pair e1="s1960.e0" e2="s1960.e1" id="s1960.p0" relation="true"/>
  </sentence>
  <sentence id="s1961" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s1961.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="117-121" id="s1961.e1" ontology_id="5443" text="POMC" type="GENE"/>
    <pair e1="s1961.e0" e2="s1961.e1" id="s1961.p0" relation="true"/>
  </sentence>
  <sentence id="s1962" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s1962.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="123-128" id="s1962.e1" ontology_id="5122" text="PCSK1" type="GENE"/>
    <pair e1="s1962.e0" e2="s1962.e1" id="s1962.p0" relation="true"/>
  </sentence>
  <sentence id="s1963" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s1963.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="130-133" id="s1963.e1" ontology_id="79068" text="FTO" type="GENE"/>
    <pair e1="s1963.e0" e2="s1963.e1" id="s1963.p0" relation="true"/>
  </sentence>
  <sentence id="s1964" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s1964.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="147-153" id="s1964.e1" ontology_id="132789" text="GNPDA2" type="GENE"/>
    <pair e1="s1964.e0" e2="s1964.e1" id="s1964.p0" relation="true"/>
  </sentence>
  <sentence id="s1965" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s1965.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="155-161" id="s1965.e1" ontology_id="129787" text="TMEM18" type="GENE"/>
    <pair e1="s1965.e0" e2="s1965.e1" id="s1965.p0" relation="true"/>
  </sentence>
  <sentence id="s1966" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s1966.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="175-179" id="s1966.e1" ontology_id="627" text="BDNF" type="GENE"/>
    <pair e1="s1966.e0" e2="s1966.e1" id="s1966.p0" relation="true"/>
  </sentence>
  <sentence id="s1967" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s1967.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="181-185" id="s1967.e1" ontology_id="2119" text="ETV5" type="GENE"/>
    <pair e1="s1967.e0" e2="s1967.e1" id="s1967.p0" relation="true"/>
  </sentence>
  <sentence id="s1968" text="We therefore screened patients with hereditary PHPV, as well as bilateral optic nerve aplasia (ONA) or hypoplasia (ONH), for mutations in ATOH7.">
    <entity charOffset="64-73" id="s1968.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="138-143" id="s1968.e1" ontology_id="220202" text="ATOH7" type="GENE"/>
    <pair e1="s1968.e0" e2="s1968.e1" id="s1968.p0" relation="true"/>
  </sentence>
  <sentence id="s1969" text="We therefore screened patients with hereditary PHPV, as well as bilateral optic nerve aplasia (ONA) or hypoplasia (ONH), for mutations in ATOH7.">
    <entity charOffset="74-93" id="s1969.e0" ontology_id="HP_0012521" text="optic nerve aplasia" type="HP"/>
    <entity charOffset="138-143" id="s1969.e1" ontology_id="220202" text="ATOH7" type="GENE"/>
    <pair e1="s1969.e0" e2="s1969.e1" id="s1969.p0" relation="true"/>
  </sentence>
  <sentence id="s1970" text="We identified a homozygous ATOH7 mutation (N46H) in a large family with an autosomal recessive PHPV disease trait linked to 10q21, and a heterozygous variant (R65G, p.Arg65Gly) in one of five sporadic ONA patients.">
    <entity charOffset="27-32" id="s1970.e0" ontology_id="220202" text="ATOH7" type="GENE"/>
    <entity charOffset="75-94" id="s1970.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1970.e0" e2="s1970.e1" id="s1970.p0" relation="true"/>
  </sentence>
  <sentence id="s1971" text="We identified a homozygous ATOH7 mutation (N46H) in a large family with an autosomal recessive PHPV disease trait linked to 10q21, and a heterozygous variant (R65G, p.Arg65Gly) in one of five sporadic ONA patients.">
    <entity charOffset="27-32" id="s1971.e0" ontology_id="220202" text="ATOH7" type="GENE"/>
    <entity charOffset="192-200" id="s1971.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1971.e0" e2="s1971.e1" id="s1971.p0" relation="true"/>
  </sentence>
  <sentence id="s1972" text="This case-control study was aimed to evaluate the influence of cytochrome P450 family 17 subfamily A member 1 (CYP17A1) gene rs743572 polymorphism for the susceptibility to endometriosis.Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to genotype rs743572 polymorphism in 143 endometriosis patients and 148 healthy controls.">
    <entity charOffset="111-118" id="s1972.e0" ontology_id="1586" text="CYP17A1" type="GENE"/>
    <entity charOffset="173-186" id="s1972.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1972.e0" e2="s1972.e1" id="s1972.p0" relation="true"/>
  </sentence>
  <sentence id="s1973" text="Since microtubule severing is an important cellular mechanism of which malfunctions result in serious diseases such as spastic paraplegia, Alzheimer's disease and cell cycle related disorders, identification of KATNB1 transcriptional regulation is crucial in understanding the coordination of microtubule severing activity by different proteins in the cells.">
    <entity charOffset="127-137" id="s1973.e0" ontology_id="HP_0010550" text="paraplegia" type="HP"/>
    <entity charOffset="211-217" id="s1973.e1" ontology_id="10300" text="KATNB1" type="GENE"/>
    <pair e1="s1973.e0" e2="s1973.e1" id="s1973.p0" relation="true"/>
  </sentence>
  <sentence id="s1974" text="We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.">
    <entity charOffset="80-99" id="s1974.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="412-419" id="s1974.e1" ontology_id="1459" text="CSNK2A1" type="GENE"/>
    <pair e1="s1974.e0" e2="s1974.e1" id="s1974.p0" relation="true"/>
  </sentence>
  <sentence id="s1975" text="We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.">
    <entity charOffset="231-250" id="s1975.e0" ontology_id="HP_0000708" text="behavioral problems" type="HP"/>
    <entity charOffset="412-419" id="s1975.e1" ontology_id="1459" text="CSNK2A1" type="GENE"/>
    <pair e1="s1975.e0" e2="s1975.e1" id="s1975.p0" relation="true"/>
  </sentence>
  <sentence id="s1976" text="We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.">
    <entity charOffset="280-292" id="s1976.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="412-419" id="s1976.e1" ontology_id="1459" text="CSNK2A1" type="GENE"/>
    <pair e1="s1976.e0" e2="s1976.e1" id="s1976.p0" relation="true"/>
  </sentence>
  <sentence id="s1977" text="We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.">
    <entity charOffset="294-304" id="s1977.e0" ontology_id="HP_0001302" text="pachygyria" type="HP"/>
    <entity charOffset="412-419" id="s1977.e1" ontology_id="1459" text="CSNK2A1" type="GENE"/>
    <pair e1="s1977.e0" e2="s1977.e1" id="s1977.p0" relation="true"/>
  </sentence>
  <sentence id="s1978" text="Mutations in subunits of mitochondrial m-AAA proteases in the inner membrane cause neurodegeneration in spinocerebellar ataxia (SCA28) and hereditary spastic paraplegia (HSP7).">
    <entity charOffset="128-133" id="s1978.e0" ontology_id="10939" text="SCA28" type="GENE"/>
    <entity charOffset="150-168" id="s1978.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s1978.e0" e2="s1978.e1" id="s1978.p0" relation="true"/>
  </sentence>
  <sentence id="s1979" text="Further, exposure to the Notch signaling inhibitor and gene silencing studies showed that Notch signaling inhibition or silencing Nothc4/Dll3 decreased endothelial markers and function of tumor-derived endothelial cells under chemotherapy treatment, which may be through VEGFR3.">
    <entity charOffset="188-193" id="s1979.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="271-275" id="s1979.e1" ontology_id="7422" text="VEGF" type="GENE"/>
    <pair e1="s1979.e0" e2="s1979.e1" id="s1979.p0" relation="true"/>
  </sentence>
  <sentence id="s1980" text="Thus, our findings demonstrate that chemotherapy induces functional tumor-derived endothelial microvessels by mediating Notch signaling and VEGF signaling, and may provide new targets for anti-angiogenesis therapy in breast cancer">
    <entity charOffset="68-73" id="s1980.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="140-144" id="s1980.e1" ontology_id="7422" text="VEGF" type="GENE"/>
    <pair e1="s1980.e0" e2="s1980.e1" id="s1980.p0" relation="true"/>
  </sentence>
  <sentence id="s1981" text="This study aimed to investigate PAX2 expression in tamoxifen resistant (TAM-R) and tamoxifen sensitive (TAM-S) breast carcinoma patients and analyze its correlation with clinicopathological characteristics and survival.">
    <entity charOffset="32-36" id="s1981.e0" ontology_id="5076" text="PAX2" type="GENE"/>
    <entity charOffset="111-127" id="s1981.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1981.e0" e2="s1981.e1" id="s1981.p0" relation="true"/>
  </sentence>
  <sentence id="s1982" text="Immunohistochemical analysis was performed to evaluate PAX2 protein expression in 36 TAM-R and 36 TAM-S formalin-fixed paraffin-embedded (FFPE) breast tumor tissues.">
    <entity charOffset="55-59" id="s1982.e0" ontology_id="5076" text="PAX2" type="GENE"/>
    <entity charOffset="151-156" id="s1982.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1982.e0" e2="s1982.e1" id="s1982.p0" relation="true"/>
  </sentence>
  <sentence id="s1983" text="Our data suggested that high expression of PAX2 could be associated with better survival in estrogen receptor positive tamoxifen-treated breast carcinoma patients">
    <entity charOffset="43-47" id="s1983.e0" ontology_id="5076" text="PAX2" type="GENE"/>
    <entity charOffset="137-153" id="s1983.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1983.e0" e2="s1983.e1" id="s1983.p0" relation="true"/>
  </sentence>
  <sentence id="s1984" text="Deregulation of the phosphoinositide 3-kinase (PI3K) pathway contributes to the development and progression of tumors.">
    <entity charOffset="47-51" id="s1984.e0" ontology_id="5290" text="PI3K" type="GENE"/>
    <entity charOffset="111-117" id="s1984.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1984.e0" e2="s1984.e1" id="s1984.p0" relation="true"/>
  </sentence>
  <sentence id="s1985" text="Here, we determine that somatic mutations in PIK3CA (44%), PIK3R1 (17%), AKT3 (15%), and PTEN (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.">
    <entity charOffset="45-51" id="s1985.e0" ontology_id="5290" text="PIK3CA" type="GENE"/>
    <entity charOffset="144-150" id="s1985.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1985.e0" e2="s1985.e1" id="s1985.p0" relation="true"/>
  </sentence>
  <sentence id="s1986" text="Here, we determine that somatic mutations in PIK3CA (44%), PIK3R1 (17%), AKT3 (15%), and PTEN (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.">
    <entity charOffset="59-65" id="s1986.e0" ontology_id="5295" text="PIK3R1" type="GENE"/>
    <entity charOffset="144-150" id="s1986.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1986.e0" e2="s1986.e1" id="s1986.p0" relation="true"/>
  </sentence>
  <sentence id="s1987" text="Here, we determine that somatic mutations in PIK3CA (44%), PIK3R1 (17%), AKT3 (15%), and PTEN (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.">
    <entity charOffset="73-77" id="s1987.e0" ontology_id="10000" text="AKT3" type="GENE"/>
    <entity charOffset="144-150" id="s1987.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1987.e0" e2="s1987.e1" id="s1987.p0" relation="true"/>
  </sentence>
  <sentence id="s1988" text="Here, we determine that somatic mutations in PIK3CA (44%), PIK3R1 (17%), AKT3 (15%), and PTEN (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.">
    <entity charOffset="89-93" id="s1988.e0" ontology_id="5728" text="PTEN" type="GENE"/>
    <entity charOffset="144-150" id="s1988.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1988.e0" e2="s1988.e1" id="s1988.p0" relation="true"/>
  </sentence>
  <sentence id="s1989" text="Collectively, these findings advance our understanding of PI3K impactful mutations in breast cancer and have important implications for PI3K-targeted therapy in precision oncology">
    <entity charOffset="58-62" id="s1989.e0" ontology_id="5290" text="PI3K" type="GENE"/>
    <entity charOffset="93-99" id="s1989.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1989.e0" e2="s1989.e1" id="s1989.p0" relation="true"/>
  </sentence>
  <sentence id="s1990" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="82-87" id="s1990.e0" ontology_id="7407" text="VARS2" type="GENE"/>
    <entity charOffset="108-120" id="s1990.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1990.e0" e2="s1990.e1" id="s1990.p0" relation="true"/>
  </sentence>
  <sentence id="s1991" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="82-87" id="s1991.e0" ontology_id="7407" text="VARS2" type="GENE"/>
    <entity charOffset="125-133" id="s1991.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1991.e0" e2="s1991.e1" id="s1991.p0" relation="true"/>
  </sentence>
  <sentence id="s1992" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="82-87" id="s1992.e0" ontology_id="7407" text="VARS2" type="GENE"/>
    <entity charOffset="302-307" id="s1992.e1" ontology_id="HP_0025287" text="axial" type="HP"/>
    <pair e1="s1992.e0" e2="s1992.e1" id="s1992.p0" relation="true"/>
  </sentence>
  <sentence id="s1993" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="82-87" id="s1993.e0" ontology_id="7407" text="VARS2" type="GENE"/>
    <entity charOffset="177-190" id="s1993.e1" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <pair e1="s1993.e0" e2="s1993.e1" id="s1993.p0" relation="true"/>
  </sentence>
  <sentence id="s1994" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="108-120" id="s1994.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="210-213" id="s1994.e1" ontology_id="4345" text="MRC" type="GENE"/>
    <pair e1="s1994.e0" e2="s1994.e1" id="s1994.p0" relation="true"/>
  </sentence>
  <sentence id="s1995" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="108-120" id="s1995.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="264-269" id="s1995.e1" ontology_id="80222" text="TARS2" type="GENE"/>
    <pair e1="s1995.e0" e2="s1995.e1" id="s1995.p0" relation="true"/>
  </sentence>
  <sentence id="s1996" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="125-133" id="s1996.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="210-213" id="s1996.e1" ontology_id="4345" text="MRC" type="GENE"/>
    <pair e1="s1996.e0" e2="s1996.e1" id="s1996.p0" relation="true"/>
  </sentence>
  <sentence id="s1997" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="125-133" id="s1997.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="264-269" id="s1997.e1" ontology_id="80222" text="TARS2" type="GENE"/>
    <pair e1="s1997.e0" e2="s1997.e1" id="s1997.p0" relation="false"/>
  </sentence>
  <sentence id="s1998" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="177-190" id="s1998.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="210-213" id="s1998.e1" ontology_id="4345" text="MRC" type="GENE"/>
    <pair e1="s1998.e0" e2="s1998.e1" id="s1998.p0" relation="true"/>
  </sentence>
  <sentence id="s1999" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="264-269" id="s1999.e0" ontology_id="80222" text="TARS2" type="GENE"/>
    <entity charOffset="302-307" id="s1999.e1" ontology_id="HP_0025287" text="axial" type="HP"/>
    <pair e1="s1999.e0" e2="s1999.e1" id="s1999.p0" relation="true"/>
  </sentence>
  <sentence id="s2000" text="Expression of the corresponding wild-type transcripts in immortalized mutant fibroblasts rescued the biochemical impairment of mitochondrial respiration and yeast modeling of the VARS2 mutation confirmed its pathogenic role.">
    <entity charOffset="127-140" id="s2000.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="179-184" id="s2000.e1" ontology_id="7407" text="VARS2" type="GENE"/>
    <pair e1="s2000.e0" e2="s2000.e1" id="s2000.p0" relation="true"/>
  </sentence>
  <sentence id="s2001" text="Our study reports the first mutations in the VARS2 and TARS2 genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.">
    <entity charOffset="45-50" id="s2001.e0" ontology_id="7407" text="VARS2" type="GENE"/>
    <entity charOffset="187-203" id="s2001.e1" ontology_id="HP_0001298" text="encephalopathies" type="HP"/>
    <pair e1="s2001.e0" e2="s2001.e1" id="s2001.p0" relation="true"/>
  </sentence>
  <sentence id="s2002" text="Our study reports the first mutations in the VARS2 and TARS2 genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.">
    <entity charOffset="55-60" id="s2002.e0" ontology_id="80222" text="TARS2" type="GENE"/>
    <entity charOffset="187-203" id="s2002.e1" ontology_id="HP_0001298" text="encephalopathies" type="HP"/>
    <pair e1="s2002.e0" e2="s2002.e1" id="s2002.p0" relation="true"/>
  </sentence>
  <sentence id="s2003" text="De novo monoallelic mutations in the GNB1 gene, encoding a  subunit of heterotrimeric G proteins, cause a newly recognized disorder with the typical clinical picture of severe developmental delay/intellectual disability, hypotonia and extrapyramidal symptoms.">
    <entity charOffset="37-41" id="s2003.e0" ontology_id="2782" text="GNB1" type="GENE"/>
    <entity charOffset="177-196" id="s2003.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s2003.e0" e2="s2003.e1" id="s2003.p0" relation="true"/>
  </sentence>
  <sentence id="s2004" text="De novo monoallelic mutations in the GNB1 gene, encoding a  subunit of heterotrimeric G proteins, cause a newly recognized disorder with the typical clinical picture of severe developmental delay/intellectual disability, hypotonia and extrapyramidal symptoms.">
    <entity charOffset="37-41" id="s2004.e0" ontology_id="2782" text="GNB1" type="GENE"/>
    <entity charOffset="197-220" id="s2004.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2004.e0" e2="s2004.e1" id="s2004.p0" relation="true"/>
  </sentence>
  <sentence id="s2005" text="We describe another case of the condition with manifestations of cutaneous mastocytosis associated with a novel do novo mutation GNB1NM_001282539.1: c.230G&amp;gt;T; p.(Gly77Val).">
    <entity charOffset="65-87" id="s2005.e0" ontology_id="HP_0200151" text="cutaneous mastocytosis" type="HP"/>
    <entity charOffset="129-133" id="s2005.e1" ontology_id="2782" text="GNB1" type="GENE"/>
    <pair e1="s2005.e0" e2="s2005.e1" id="s2005.p0" relation="true"/>
  </sentence>
  <sentence id="s2006" text="Similarly, homozygous loss-of-function mutations in CYP26B1, one of the major RA-metabolizing enzymes, cause advanced bone age, premature epiphyseal fusion, and craniosynostosis.">
    <entity charOffset="52-59" id="s2006.e0" ontology_id="56603" text="CYP26B1" type="GENE"/>
    <entity charOffset="161-177" id="s2006.e1" ontology_id="HP_0001363" text="craniosynostosis" type="HP"/>
    <pair e1="s2006.e0" e2="s2006.e1" id="s2006.p0" relation="true"/>
  </sentence>
  <sentence id="s2007" text="Mutations in the COL4A5 gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in COL4A3 or COL4A4 are responsible for autosomal recessive Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.">
    <entity charOffset="17-23" id="s2007.e0" ontology_id="1287" text="COL4A5" type="GENE"/>
    <entity charOffset="151-170" id="s2007.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2007.e0" e2="s2007.e1" id="s2007.p0" relation="true"/>
  </sentence>
  <sentence id="s2008" text="Mutations in the COL4A5 gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in COL4A3 or COL4A4 are responsible for autosomal recessive Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.">
    <entity charOffset="124-130" id="s2008.e0" ontology_id="1286" text="COL4A4" type="GENE"/>
    <entity charOffset="151-170" id="s2008.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2008.e0" e2="s2008.e1" id="s2008.p0" relation="true"/>
  </sentence>
  <sentence id="s2009" text="This result suggests that COL4A3 and COL4A4 digenic mutations in cis mimicking an autosomal dominant inheritance should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown">
    <entity charOffset="65-68" id="s2009.e0" ontology_id="1154" text="cis" type="GENE"/>
    <entity charOffset="101-112" id="s2009.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s2009.e0" e2="s2009.e1" id="s2009.p0" relation="true"/>
  </sentence>
  <sentence id="s2010" text="The results also suggest that some schizophrenia-related alleles may be subject to cognitive tradeoffs involving both positive and negative effects on psychological phenotypes, which may help to explain the maintenance of psychiatric-disorder risk alleles in human populations">
    <entity charOffset="35-48" id="s2010.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="170-174" id="s2010.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s2010.e0" e2="s2010.e1" id="s2010.p0" relation="false"/>
  </sentence>
  <sentence id="s2011" text="The most significant association with childhood brain tumor risk was for IVS1-401G&amp;gt;C in the AICDA gene [odds ratio (OR) = 2.8; 95% confidence interval (95%CI) = 1.25-6.46]; the polymorphism *9276A&amp;gt;C of CASP14 was associated with decreased brain tumor risk (OR = 0.4; 95%CI = 0.19-0.95).">
    <entity charOffset="54-59" id="s2011.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="95-100" id="s2011.e1" ontology_id="57379" text="AICDA" type="GENE"/>
    <pair e1="s2011.e0" e2="s2011.e1" id="s2011.p0" relation="true"/>
  </sentence>
  <sentence id="s2012" text="We concluded that genetic polymorphisms in AICDA and CASP14 are associated with risk for brain tumor in Korean children.">
    <entity charOffset="43-48" id="s2012.e0" ontology_id="57379" text="AICDA" type="GENE"/>
    <entity charOffset="95-100" id="s2012.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2012.e0" e2="s2012.e1" id="s2012.p0" relation="true"/>
  </sentence>
  <sentence id="s2013" text="Clinical trials have revealed that inhibition of sonic Hedgehog (SHH) signaling or histone deacetylase (HDAC) holds promise as a treatment for liver cancer.">
    <entity charOffset="104-108" id="s2013.e0" ontology_id="9734" text="HDAC" type="GENE"/>
    <entity charOffset="149-155" id="s2013.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2013.e0" e2="s2013.e1" id="s2013.p0" relation="true"/>
  </sentence>
  <sentence id="s2014" text="The results revealed that the dual use of the SHH inhibitor and the HDAC inhibitor effectively synergized to inhibit proliferation, and promote apoptosis in liver cancer cells.">
    <entity charOffset="68-72" id="s2014.e0" ontology_id="9734" text="HDAC" type="GENE"/>
    <entity charOffset="163-169" id="s2014.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2014.e0" e2="s2014.e1" id="s2014.p0" relation="true"/>
  </sentence>
  <sentence id="s2015" text="Genetic variation in the TMC6/TMC8 region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.">
    <entity charOffset="25-29" id="s2015.e0" ontology_id="11322" text="TMC6" type="GENE"/>
    <entity charOffset="135-141" id="s2015.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2015.e0" e2="s2015.e1" id="s2015.p0" relation="true"/>
  </sentence>
  <sentence id="s2016" text="Genetic variation in the TMC6/TMC8 region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.">
    <entity charOffset="25-29" id="s2016.e0" ontology_id="11322" text="TMC6" type="GENE"/>
    <entity charOffset="89-124" id="s2016.e1" ontology_id="HP_0006739" text="squamous cell carcinoma of the skin" type="HP"/>
    <pair e1="s2016.e0" e2="s2016.e1" id="s2016.p0" relation="true"/>
  </sentence>
  <sentence id="s2017" text="Genetic variation in the TMC6/TMC8 region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.">
    <entity charOffset="30-34" id="s2017.e0" ontology_id="147138" text="TMC8" type="GENE"/>
    <entity charOffset="135-141" id="s2017.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2017.e0" e2="s2017.e1" id="s2017.p0" relation="true"/>
  </sentence>
  <sentence id="s2018" text="Genetic variation in the TMC6/TMC8 region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.">
    <entity charOffset="30-34" id="s2018.e0" ontology_id="147138" text="TMC8" type="GENE"/>
    <entity charOffset="89-124" id="s2018.e1" ontology_id="HP_0006739" text="squamous cell carcinoma of the skin" type="HP"/>
    <pair e1="s2018.e0" e2="s2018.e1" id="s2018.p0" relation="true"/>
  </sentence>
  <sentence id="s2019" text="Here, we have tested the hypothesis that the common TMC8 SNP rs7208422 is associated with high-risk HPV infection and risk of head and neck squamous cell carcinoma (HNSCC).">
    <entity charOffset="52-56" id="s2019.e0" ontology_id="147138" text="TMC8" type="GENE"/>
    <entity charOffset="140-163" id="s2019.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s2019.e0" e2="s2019.e1" id="s2019.p0" relation="true"/>
  </sentence>
  <sentence id="s2020" text="The Glis3 mutant mice have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of cancer.">
    <entity charOffset="4-9" id="s2020.e0" ontology_id="169792" text="Glis3" type="GENE"/>
    <entity charOffset="89-103" id="s2020.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s2020.e0" e2="s2020.e1" id="s2020.p0" relation="true"/>
  </sentence>
  <sentence id="s2021" text="The Glis3 mutant mice have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of cancer.">
    <entity charOffset="4-9" id="s2021.e0" ontology_id="169792" text="Glis3" type="GENE"/>
    <entity charOffset="150-156" id="s2021.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2021.e0" e2="s2021.e1" id="s2021.p0" relation="true"/>
  </sentence>
  <sentence id="s2022" text="The Glis3 mutant mice have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of cancer.">
    <entity charOffset="17-21" id="s2022.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="89-103" id="s2022.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s2022.e0" e2="s2022.e1" id="s2022.p0" relation="true"/>
  </sentence>
  <sentence id="s2023" text="Shh signalling from the prechordal plate and ventral midline of the diencephalon is required for appropriate division of the eyefield and forebrain, with mutation in a number of pathway components associated with Holoprosencephaly, a clinically heterogeneous developmental defect characterized by a failure of the early forebrain vesicle to divide into distinct halves.">
    <entity charOffset="0-3" id="s2023.e0" ontology_id="6469" text="Shh" type="GENE"/>
    <entity charOffset="245-258" id="s2023.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2023.e0" e2="s2023.e1" id="s2023.p0" relation="true"/>
  </sentence>
  <sentence id="s2024" text="In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast cancer risk and the expression of RCCD1 (joint p-value: 3.6x10-06) and DHODH (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for ANKLE1 (p-value: 9.3x10-05).">
    <entity charOffset="107-113" id="s2024.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="141-146" id="s2024.e1" ontology_id="91433" text="RCCD1" type="GENE"/>
    <pair e1="s2024.e0" e2="s2024.e1" id="s2024.p0" relation="true"/>
  </sentence>
  <sentence id="s2025" text="In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast cancer risk and the expression of RCCD1 (joint p-value: 3.6x10-06) and DHODH (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for ANKLE1 (p-value: 9.3x10-05).">
    <entity charOffset="107-113" id="s2025.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="178-183" id="s2025.e1" ontology_id="1723" text="DHODH" type="GENE"/>
    <pair e1="s2025.e0" e2="s2025.e1" id="s2025.p0" relation="true"/>
  </sentence>
  <sentence id="s2026" text="While genome-wide association studies (GWAS) have implicated RCCD1 and ANKLE1 in breast cancer risk, they have not identified the remaining three genes.">
    <entity charOffset="61-66" id="s2026.e0" ontology_id="91433" text="RCCD1" type="GENE"/>
    <entity charOffset="88-94" id="s2026.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2026.e0" e2="s2026.e1" id="s2026.p0" relation="true"/>
  </sentence>
  <sentence id="s2027" text="While genome-wide association studies (GWAS) have implicated RCCD1 and ANKLE1 in breast cancer risk, they have not identified the remaining three genes.">
    <entity charOffset="71-77" id="s2027.e0" ontology_id="126549" text="ANKLE1" type="GENE"/>
    <entity charOffset="88-94" id="s2027.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2027.e0" e2="s2027.e1" id="s2027.p0" relation="true"/>
  </sentence>
  <sentence id="s2028" text="Collectively, ICOSL supports the induction of durable, antigen-specific Th17/Th1-mediated immunity in vivo, establishing a vaccination platform to enhance CD4&lt;sup&gt;+&lt;/sup&gt; T cell-mediated antitumor immunity and providing a crucial component of an effective cancer vaccine">
    <entity charOffset="14-18" id="s2028.e0" ontology_id="1493" text="ICOS" type="GENE"/>
    <entity charOffset="256-262" id="s2028.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2028.e0" e2="s2028.e1" id="s2028.p0" relation="true"/>
  </sentence>
  <sentence id="s2029" text="Muscarinic acetylcholine receptor M3 (CHRM3) was reported as a key receptor in different cancer types.">
    <entity charOffset="38-43" id="s2029.e0" ontology_id="1131" text="CHRM3" type="GENE"/>
    <entity charOffset="89-95" id="s2029.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2029.e0" e2="s2029.e1" id="s2029.p0" relation="true"/>
  </sentence>
  <sentence id="s2030" text="&lt;i&gt;CHRM3&lt;/i&gt; is located at 1q42-43 which was reported to associate with bladder cancer.">
    <entity charOffset="3-8" id="s2030.e0" ontology_id="1131" text="CHRM3" type="GENE"/>
    <entity charOffset="80-86" id="s2030.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2030.e0" e2="s2030.e1" id="s2030.p0" relation="true"/>
  </sentence>
  <sentence id="s2031" text="Our study attempted to delineate whether genetic variants of &lt;i&gt;CHRM3&lt;/i&gt; contribute to bladder cancer in Chinese Han population in south Taiwan.">
    <entity charOffset="64-69" id="s2031.e0" ontology_id="1131" text="CHRM3" type="GENE"/>
    <entity charOffset="96-102" id="s2031.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2031.e0" e2="s2031.e1" id="s2031.p0" relation="true"/>
  </sentence>
  <sentence id="s2032" text="To our knowledge, this is the first genetic association study that reveals the genetic contribution of &lt;i&gt;CHRM3&lt;/i&gt; gene in bladder cancer etiology">
    <entity charOffset="106-111" id="s2032.e0" ontology_id="1131" text="CHRM3" type="GENE"/>
    <entity charOffset="132-138" id="s2032.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2032.e0" e2="s2032.e1" id="s2032.p0" relation="true"/>
  </sentence>
  <sentence id="s2033" text="Fuchs endothelial corneal dystrophy (FECD) is the most common late-onset, vision-threatening corneal dystrophy in the United States, affecting about 4% of the population.">
    <entity charOffset="18-35" id="s2033.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="37-41" id="s2033.e1" ontology_id="1296" text="FECD" type="GENE"/>
    <pair e1="s2033.e0" e2="s2033.e1" id="s2033.p0" relation="true"/>
  </sentence>
  <sentence id="s2034" text="Advanced FECD involves a thickening of the cornea from stromal edema and changes in Descemet membrane.">
    <entity charOffset="9-13" id="s2034.e0" ontology_id="1296" text="FECD" type="GENE"/>
    <entity charOffset="63-68" id="s2034.e1" ontology_id="HP_0000969" text="edema" type="HP"/>
    <pair e1="s2034.e0" e2="s2034.e1" id="s2034.p0" relation="true"/>
  </sentence>
  <sentence id="s2035" text="The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.">
    <entity charOffset="110-120" id="s2035.e0" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <entity charOffset="275-280" id="s2035.e1" ontology_id="6323" text="SCN1A" type="GENE"/>
    <pair e1="s2035.e0" e2="s2035.e1" id="s2035.p0" relation="true"/>
  </sentence>
  <sentence id="s2036" text="The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.">
    <entity charOffset="110-120" id="s2036.e0" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <entity charOffset="289-295" id="s2036.e1" ontology_id="2566" text="GABRG2" type="GENE"/>
    <pair e1="s2036.e0" e2="s2036.e1" id="s2036.p0" relation="true"/>
  </sentence>
  <sentence id="s2037" text="Genes for epileptic encephalopathies such as SLC2A1 were rediscovered in GGE, highlighting the biological continuum between different epilepsies.">
    <entity charOffset="45-51" id="s2037.e0" ontology_id="6513" text="SLC2A1" type="GENE"/>
    <entity charOffset="134-144" id="s2037.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s2037.e0" e2="s2037.e1" id="s2037.p0" relation="true"/>
  </sentence>
  <sentence id="s2038" text="The short-rib polydactyly syndromes (SRPS) are autosomal recessively inherited, genetically heterogeneous skeletal ciliopathies.">
    <entity charOffset="37-40" id="s2038.e0" ontology_id="10911" text="SRP" type="GENE"/>
    <entity charOffset="92-105" id="s2038.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2038.e0" e2="s2038.e1" id="s2038.p0" relation="true"/>
  </sentence>
  <sentence id="s2039" text="Here, we report that variants in TRAPPC12 result in progressive childhood encephalopathy.">
    <entity charOffset="33-41" id="s2039.e0" ontology_id="51112" text="TRAPPC12" type="GENE"/>
    <entity charOffset="74-88" id="s2039.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s2039.e0" e2="s2039.e1" id="s2039.p0" relation="true"/>
  </sentence>
  <sentence id="s2040" text="Specifically, ADHFE1, HAND2, and GNAO1 were hypermethylated and downregulated in colon cancer, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.">
    <entity charOffset="22-27" id="s2040.e0" ontology_id="9464" text="HAND2" type="GENE"/>
    <entity charOffset="87-93" id="s2040.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2040.e0" e2="s2040.e1" id="s2040.p0" relation="true"/>
  </sentence>
  <sentence id="s2041" text="Specifically, ADHFE1, HAND2, and GNAO1 were hypermethylated and downregulated in colon cancer, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.">
    <entity charOffset="33-38" id="s2041.e0" ontology_id="2775" text="GNAO1" type="GENE"/>
    <entity charOffset="87-93" id="s2041.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2041.e0" e2="s2041.e1" id="s2041.p0" relation="true"/>
  </sentence>
  <sentence id="s2042" text="The pH-sensing receptor ovarian cancer G protein-coupled receptor 1 (OGR1; GPR68) is expressed in the gut.">
    <entity charOffset="32-38" id="s2042.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="69-73" id="s2042.e1" ontology_id="8111" text="OGR1" type="GENE"/>
    <pair e1="s2042.e0" e2="s2042.e1" id="s2042.p0" relation="true"/>
  </sentence>
  <sentence id="s2043" text="The pH-sensing receptor ovarian cancer G protein-coupled receptor 1 (OGR1; GPR68) is expressed in the gut.">
    <entity charOffset="32-38" id="s2043.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="75-80" id="s2043.e1" ontology_id="8111" text="GPR68" type="GENE"/>
    <pair e1="s2043.e0" e2="s2043.e1" id="s2043.p0" relation="true"/>
  </sentence>
  <sentence id="s2044" text="Congenital hypogonadotrophic hypogonadism (CHH) is a challenging inherited endocrine disorder characterised by absent or incomplete pubertal development and infertility as a result of the low action/secretion of the hypothalamic gonadotrophin-releasing hormone (GnRH).">
    <entity charOffset="29-41" id="s2044.e0" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <entity charOffset="262-266" id="s2044.e1" ontology_id="2796" text="GnRH" type="GENE"/>
    <pair e1="s2044.e0" e2="s2044.e1" id="s2044.p0" relation="true"/>
  </sentence>
  <sentence id="s2045" text="Previously, a homozygous missense mutation in THOC6 in the Hutterite population was reported in association with syndromic intellectual disability.">
    <entity charOffset="46-51" id="s2045.e0" ontology_id="79228" text="THOC6" type="GENE"/>
    <entity charOffset="123-146" id="s2045.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2045.e0" e2="s2045.e1" id="s2045.p0" relation="true"/>
  </sentence>
  <sentence id="s2046" text="Our results expand the mutational and clinical spectrum of this rare disease, confirm that THOC6 is an intellectual disability causing gene, while providing insight into the importance of the THO complex in neurodevelopment">
    <entity charOffset="91-96" id="s2046.e0" ontology_id="79228" text="THOC6" type="GENE"/>
    <entity charOffset="103-126" id="s2046.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2046.e0" e2="s2046.e1" id="s2046.p0" relation="true"/>
  </sentence>
  <sentence id="s2047" text="Our study demonstrated that AURKA rs1047972 TT and (CC+CT) genotypes were significantly associated with an increased risk of gastric cancer.">
    <entity charOffset="65-69" id="s2047.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="135-141" id="s2047.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2047.e0" e2="s2047.e1" id="s2047.p0" relation="false"/>
  </sentence>
  <sentence id="s2048" text="Malfunction of mutant AIPL1 proteins triggers a severe form of Leber congenital amaurosis and leads to blindness.">
    <entity charOffset="22-27" id="s2048.e0" ontology_id="23746" text="AIPL1" type="GENE"/>
    <entity charOffset="103-112" id="s2048.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s2048.e0" e2="s2048.e1" id="s2048.p0" relation="true"/>
  </sentence>
  <sentence id="s2049" text="Up to now ATP2B2 has only been reported as a modifier, or in a digenic mechanism with CDH23 for hearing impairment in humans.">
    <entity charOffset="10-16" id="s2049.e0" ontology_id="493" text="ATP2B2" type="GENE"/>
    <entity charOffset="96-114" id="s2049.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s2049.e0" e2="s2049.e1" id="s2049.p0" relation="false"/>
  </sentence>
  <sentence id="s2050" text="Up to now ATP2B2 has only been reported as a modifier, or in a digenic mechanism with CDH23 for hearing impairment in humans.">
    <entity charOffset="86-91" id="s2050.e0" ontology_id="64072" text="CDH23" type="GENE"/>
    <entity charOffset="96-114" id="s2050.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s2050.e0" e2="s2050.e1" id="s2050.p0" relation="true"/>
  </sentence>
  <sentence id="s2051" text="Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2">
    <entity charOffset="11-30" id="s2051.e0" ontology_id="HP_0010984" text="digenic inheritance" type="HP"/>
    <entity charOffset="128-133" id="s2051.e1" ontology_id="64072" text="CDH23" type="GENE"/>
    <pair e1="s2051.e0" e2="s2051.e1" id="s2051.p0" relation="true"/>
  </sentence>
  <sentence id="s2052" text="Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2">
    <entity charOffset="42-60" id="s2052.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="128-133" id="s2052.e1" ontology_id="64072" text="CDH23" type="GENE"/>
    <pair e1="s2052.e0" e2="s2052.e1" id="s2052.p0" relation="true"/>
  </sentence>
  <sentence id="s2053" text="Friedreich's ataxia (FA) is an autosomal recessive disease caused by an intronic GAA triplet expansion in the FXN gene, leading to reduced expression of the mitochondrial protein frataxin.">
    <entity charOffset="13-19" id="s2053.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="81-84" id="s2053.e1" ontology_id="2548" text="GAA" type="GENE"/>
    <pair e1="s2053.e0" e2="s2053.e1" id="s2053.p0" relation="true"/>
  </sentence>
  <sentence id="s2054" text="Friedreich's ataxia (FA) is an autosomal recessive disease caused by an intronic GAA triplet expansion in the FXN gene, leading to reduced expression of the mitochondrial protein frataxin.">
    <entity charOffset="13-19" id="s2054.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="110-113" id="s2054.e1" ontology_id="2395" text="FXN" type="GENE"/>
    <pair e1="s2054.e0" e2="s2054.e1" id="s2054.p0" relation="true"/>
  </sentence>
  <sentence id="s2055" text="Friedreich's ataxia (FA) is an autosomal recessive disease caused by an intronic GAA triplet expansion in the FXN gene, leading to reduced expression of the mitochondrial protein frataxin.">
    <entity charOffset="31-50" id="s2055.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="110-113" id="s2055.e1" ontology_id="2395" text="FXN" type="GENE"/>
    <pair e1="s2055.e0" e2="s2055.e1" id="s2055.p0" relation="true"/>
  </sentence>
  <sentence id="s2056" text="TGFBR3-PLAG1 promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.">
    <entity charOffset="0-6" id="s2056.e0" ontology_id="7049" text="TGFBR3" type="GENE"/>
    <entity charOffset="24-29" id="s2056.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2056.e0" e2="s2056.e1" id="s2056.p0" relation="true"/>
  </sentence>
  <sentence id="s2057" text="TGFBR3-PLAG1 promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.">
    <entity charOffset="7-12" id="s2057.e0" ontology_id="5324" text="PLAG1" type="GENE"/>
    <entity charOffset="98-104" id="s2057.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2057.e0" e2="s2057.e1" id="s2057.p0" relation="true"/>
  </sentence>
  <sentence id="s2058" text="TGFBR3-PLAG1 promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.">
    <entity charOffset="7-12" id="s2058.e0" ontology_id="5324" text="PLAG1" type="GENE"/>
    <entity charOffset="24-29" id="s2058.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2058.e0" e2="s2058.e1" id="s2058.p0" relation="true"/>
  </sentence>
  <sentence id="s2059" text="Focal epilepsies, where seizures initiate in spatially limited networks, are the most frequent epilepsy type, accounting for two-thirds of patients.">
    <entity charOffset="95-103" id="s2059.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="104-108" id="s2059.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s2059.e0" e2="s2059.e1" id="s2059.p0" relation="true"/>
  </sentence>
  <sentence id="s2060" text="Brain somatic mutations in the gene encoding mTOR (MTOR) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.">
    <entity charOffset="45-49" id="s2060.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="92-110" id="s2060.e1" ontology_id="HP_0002539" text="cortical dysplasia" type="HP"/>
    <pair e1="s2060.e0" e2="s2060.e1" id="s2060.p0" relation="true"/>
  </sentence>
  <sentence id="s2061" text="Brain somatic mutations in the gene encoding mTOR (MTOR) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.">
    <entity charOffset="45-49" id="s2061.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="160-178" id="s2061.e1" ontology_id="HP_0007206" text="hemimegalencephaly" type="HP"/>
    <pair e1="s2061.e0" e2="s2061.e1" id="s2061.p0" relation="true"/>
  </sentence>
  <sentence id="s2062" text="Brain somatic mutations in the gene encoding mTOR (MTOR) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.">
    <entity charOffset="51-55" id="s2062.e0" ontology_id="2475" text="MTOR" type="GENE"/>
    <entity charOffset="92-110" id="s2062.e1" ontology_id="HP_0002539" text="cortical dysplasia" type="HP"/>
    <pair e1="s2062.e0" e2="s2062.e1" id="s2062.p0" relation="true"/>
  </sentence>
  <sentence id="s2063" text="In subgroup analysis, compared with PD patients with initial symptom of tremor and HCs, the minor allele frequency of NMD3 rs34016896 in PD patients with initial symptoms of rigidity/bradykinesia was significantly lower.">
    <entity charOffset="83-86" id="s2063.e0" ontology_id="54205" text="HCs" type="GENE"/>
    <entity charOffset="183-195" id="s2063.e1" ontology_id="HP_0002067" text="bradykinesia" type="HP"/>
    <pair e1="s2063.e0" e2="s2063.e1" id="s2063.p0" relation="true"/>
  </sentence>
  <sentence id="s2064" text="In subgroup analysis, compared with PD patients with initial symptom of tremor and HCs, the minor allele frequency of NMD3 rs34016896 in PD patients with initial symptoms of rigidity/bradykinesia was significantly lower.">
    <entity charOffset="92-97" id="s2064.e0" ontology_id="8013" text="minor" type="GENE"/>
    <entity charOffset="183-195" id="s2064.e1" ontology_id="HP_0002067" text="bradykinesia" type="HP"/>
    <pair e1="s2064.e0" e2="s2064.e1" id="s2064.p0" relation="true"/>
  </sentence>
  <sentence id="s2065" text="In subgroup analysis, compared with PD patients with initial symptom of tremor and HCs, the minor allele frequency of NMD3 rs34016896 in PD patients with initial symptoms of rigidity/bradykinesia was significantly lower.">
    <entity charOffset="118-122" id="s2065.e0" ontology_id="51068" text="NMD3" type="GENE"/>
    <entity charOffset="183-195" id="s2065.e1" ontology_id="HP_0002067" text="bradykinesia" type="HP"/>
    <pair e1="s2065.e0" e2="s2065.e1" id="s2065.p0" relation="true"/>
  </sentence>
  <sentence id="s2066" text="We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, CAPG, PFN1, SPTBN1, CFN1) associated with loss of BRCA1 function.">
    <entity charOffset="60-65" id="s2066.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="258-263" id="s2066.e1" ontology_id="672" text="BRCA1" type="GENE"/>
    <pair e1="s2066.e0" e2="s2066.e1" id="s2066.p0" relation="true"/>
  </sentence>
  <sentence id="s2067" text="We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, CAPG, PFN1, SPTBN1, CFN1) associated with loss of BRCA1 function.">
    <entity charOffset="60-65" id="s2067.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="208-212" id="s2067.e1" ontology_id="822" text="CAPG" type="GENE"/>
    <pair e1="s2067.e0" e2="s2067.e1" id="s2067.p0" relation="false"/>
  </sentence>
  <sentence id="s2068" text="We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, CAPG, PFN1, SPTBN1, CFN1) associated with loss of BRCA1 function.">
    <entity charOffset="60-65" id="s2068.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="220-226" id="s2068.e1" ontology_id="6711" text="SPTBN1" type="GENE"/>
    <pair e1="s2068.e0" e2="s2068.e1" id="s2068.p0" relation="true"/>
  </sentence>
  <sentence id="s2069" text="By immunohistochemistry of ovarian tumors with BRCA1(+/+) and BRCA1(null) status, we further verified our proteomic-based finding of elevated PFN1 expression associated with BRCA1 deficiency.">
    <entity charOffset="35-40" id="s2069.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="47-52" id="s2069.e1" ontology_id="672" text="BRCA1" type="GENE"/>
    <pair e1="s2069.e0" e2="s2069.e1" id="s2069.p0" relation="true"/>
  </sentence>
  <sentence id="s2070" text="By immunohistochemistry of ovarian tumors with BRCA1(+/+) and BRCA1(null) status, we further verified our proteomic-based finding of elevated PFN1 expression associated with BRCA1 deficiency.">
    <entity charOffset="35-40" id="s2070.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="142-146" id="s2070.e1" ontology_id="5216" text="PFN1" type="GENE"/>
    <pair e1="s2070.e0" e2="s2070.e1" id="s2070.p0" relation="true"/>
  </sentence>
  <sentence id="s2071" text="Finally, we established a causal link between PFN1 and BRCA1-induced changes in cell migration thus uncovering a novel mechanistic basis for BRCA1-dependent regulation of ovarian cancer cell migration.">
    <entity charOffset="46-50" id="s2071.e0" ontology_id="5216" text="PFN1" type="GENE"/>
    <entity charOffset="179-185" id="s2071.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2071.e0" e2="s2071.e1" id="s2071.p0" relation="true"/>
  </sentence>
  <sentence id="s2072" text="Finally, we established a causal link between PFN1 and BRCA1-induced changes in cell migration thus uncovering a novel mechanistic basis for BRCA1-dependent regulation of ovarian cancer cell migration.">
    <entity charOffset="55-60" id="s2072.e0" ontology_id="672" text="BRCA1" type="GENE"/>
    <entity charOffset="179-185" id="s2072.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2072.e0" e2="s2072.e1" id="s2072.p0" relation="true"/>
  </sentence>
  <sentence id="s2073" text="Mutations in Ankyrin repeat and sterile alpha motif domain containing 6 (ANKS6) play a causative role in renal cyst formation in the PKD/Mhm(cy/+) rat model of polycystic kidney disease and in nephronophthisis in humans.">
    <entity charOffset="73-78" id="s2073.e0" ontology_id="203286" text="ANKS6" type="GENE"/>
    <entity charOffset="105-115" id="s2073.e1" ontology_id="HP_0000107" text="renal cyst" type="HP"/>
    <pair e1="s2073.e0" e2="s2073.e1" id="s2073.p0" relation="true"/>
  </sentence>
  <sentence id="s2074" text="A network of protein partners of ANKS6 is emerging and their functional characterization provides important clues to understand the role of ANKS6 in renal biology and in mechanisms involved in the formation of renal cysts.">
    <entity charOffset="33-38" id="s2074.e0" ontology_id="203286" text="ANKS6" type="GENE"/>
    <entity charOffset="210-220" id="s2074.e1" ontology_id="HP_0000107" text="renal cyst" type="HP"/>
    <pair e1="s2074.e0" e2="s2074.e1" id="s2074.p0" relation="true"/>
  </sentence>
  <sentence id="s2075" text="Upregulated LINC00963 led to elevated expression of NACC1 through inhibiting miR-608, which consequently promoted melanoma malignant progression.">
    <entity charOffset="52-57" id="s2075.e0" ontology_id="112939" text="NACC1" type="GENE"/>
    <entity charOffset="114-122" id="s2075.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s2075.e0" e2="s2075.e1" id="s2075.p0" relation="true"/>
  </sentence>
  <sentence id="s2076" text="Upregulated LINC00963 led to elevated expression of NACC1 through inhibiting miR-608, which consequently promoted melanoma malignant progression.">
    <entity charOffset="77-80" id="s2076.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="114-122" id="s2076.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s2076.e0" e2="s2076.e1" id="s2076.p0" relation="true"/>
  </sentence>
  <sentence id="s2077" text="We recently reported that centrosomal protein 164 (CEP164) regulates both cilia and the DNA damage response in the autosomal recessive polycystic kidney disease nephronophthisis.">
    <entity charOffset="51-57" id="s2077.e0" ontology_id="22897" text="CEP164" type="GENE"/>
    <entity charOffset="115-134" id="s2077.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2077.e0" e2="s2077.e1" id="s2077.p0" relation="true"/>
  </sentence>
  <sentence id="s2078" text="Jeune asphyxiating thoracic dystrophy (JATD) is a skeletal dysplasia characterized by a small thoracic cage and a range of skeletal and extra-skeletal anomalies.">
    <entity charOffset="50-68" id="s2078.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="103-107" id="s2078.e1" ontology_id="168400" text="cage" type="GENE"/>
    <pair e1="s2078.e0" e2="s2078.e1" id="s2078.p0" relation="true"/>
  </sentence>
  <sentence id="s2079" text="Inhibition of the CEP120 ortholog in zebrafish produced pleiotropic phenotypes characteristic of cilia defects including abnormal body curvature, hydrocephalus, otolith defects and abnormal renal, head and craniofacial development.">
    <entity charOffset="18-24" id="s2079.e0" ontology_id="153241" text="CEP120" type="GENE"/>
    <entity charOffset="146-159" id="s2079.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s2079.e0" e2="s2079.e1" id="s2079.p0" relation="true"/>
  </sentence>
  <sentence id="s2080" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-112" id="s2080.e0" ontology_id="64131" text="XYLT1" type="GENE"/>
    <entity charOffset="234-250" id="s2080.e1" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <pair e1="s2080.e0" e2="s2080.e1" id="s2080.p0" relation="true"/>
  </sentence>
  <sentence id="s2081" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-112" id="s2081.e0" ontology_id="64131" text="XYLT1" type="GENE"/>
    <entity charOffset="252-262" id="s2081.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s2081.e0" e2="s2081.e1" id="s2081.p0" relation="true"/>
  </sentence>
  <sentence id="s2082" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-112" id="s2082.e0" ontology_id="64131" text="XYLT1" type="GENE"/>
    <entity charOffset="264-273" id="s2082.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s2082.e0" e2="s2082.e1" id="s2082.p0" relation="true"/>
  </sentence>
  <sentence id="s2083" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-112" id="s2083.e0" ontology_id="64131" text="XYLT1" type="GENE"/>
    <entity charOffset="286-294" id="s2083.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2083.e0" e2="s2083.e1" id="s2083.p0" relation="true"/>
  </sentence>
  <sentence id="s2084" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="114-119" id="s2084.e0" ontology_id="64132" text="XYLT2" type="GENE"/>
    <entity charOffset="275-284" id="s2084.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s2084.e0" e2="s2084.e1" id="s2084.p0" relation="true"/>
  </sentence>
  <sentence id="s2085" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="114-119" id="s2085.e0" ontology_id="64132" text="XYLT2" type="GENE"/>
    <entity charOffset="264-273" id="s2085.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s2085.e0" e2="s2085.e1" id="s2085.p0" relation="true"/>
  </sentence>
  <sentence id="s2086" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="114-119" id="s2086.e0" ontology_id="64132" text="XYLT2" type="GENE"/>
    <entity charOffset="286-294" id="s2086.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2086.e0" e2="s2086.e1" id="s2086.p0" relation="true"/>
  </sentence>
  <sentence id="s2087" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="114-119" id="s2087.e0" ontology_id="64132" text="XYLT2" type="GENE"/>
    <entity charOffset="333-351" id="s2087.e1" ontology_id="HP_0000541" text="retinal detachment" type="HP"/>
    <pair e1="s2087.e0" e2="s2087.e1" id="s2087.p0" relation="true"/>
  </sentence>
  <sentence id="s2088" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="121-128" id="s2088.e0" ontology_id="11285" text="B4GALT7" type="GENE"/>
    <entity charOffset="234-250" id="s2088.e1" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <pair e1="s2088.e0" e2="s2088.e1" id="s2088.p0" relation="true"/>
  </sentence>
  <sentence id="s2089" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="121-128" id="s2089.e0" ontology_id="11285" text="B4GALT7" type="GENE"/>
    <entity charOffset="275-284" id="s2089.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s2089.e0" e2="s2089.e1" id="s2089.p0" relation="true"/>
  </sentence>
  <sentence id="s2090" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="121-128" id="s2090.e0" ontology_id="11285" text="B4GALT7" type="GENE"/>
    <entity charOffset="252-262" id="s2090.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s2090.e0" e2="s2090.e1" id="s2090.p0" relation="true"/>
  </sentence>
  <sentence id="s2091" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="121-128" id="s2091.e0" ontology_id="11285" text="B4GALT7" type="GENE"/>
    <entity charOffset="264-273" id="s2091.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s2091.e0" e2="s2091.e1" id="s2091.p0" relation="true"/>
  </sentence>
  <sentence id="s2092" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="121-128" id="s2092.e0" ontology_id="11285" text="B4GALT7" type="GENE"/>
    <entity charOffset="286-294" id="s2092.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2092.e0" e2="s2092.e1" id="s2092.p0" relation="true"/>
  </sentence>
  <sentence id="s2093" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="121-128" id="s2093.e0" ontology_id="11285" text="B4GALT7" type="GENE"/>
    <entity charOffset="333-351" id="s2093.e1" ontology_id="HP_0000541" text="retinal detachment" type="HP"/>
    <pair e1="s2093.e0" e2="s2093.e1" id="s2093.p0" relation="true"/>
  </sentence>
  <sentence id="s2094" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="130-137" id="s2094.e0" ontology_id="126792" text="B3GALT6" type="GENE"/>
    <entity charOffset="234-250" id="s2094.e1" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <pair e1="s2094.e0" e2="s2094.e1" id="s2094.p0" relation="true"/>
  </sentence>
  <sentence id="s2095" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="130-137" id="s2095.e0" ontology_id="126792" text="B3GALT6" type="GENE"/>
    <entity charOffset="275-284" id="s2095.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s2095.e0" e2="s2095.e1" id="s2095.p0" relation="true"/>
  </sentence>
  <sentence id="s2096" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="130-137" id="s2096.e0" ontology_id="126792" text="B3GALT6" type="GENE"/>
    <entity charOffset="264-273" id="s2096.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s2096.e0" e2="s2096.e1" id="s2096.p0" relation="true"/>
  </sentence>
  <sentence id="s2097" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="130-137" id="s2097.e0" ontology_id="126792" text="B3GALT6" type="GENE"/>
    <entity charOffset="286-294" id="s2097.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2097.e0" e2="s2097.e1" id="s2097.p0" relation="true"/>
  </sentence>
  <sentence id="s2098" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="130-137" id="s2098.e0" ontology_id="126792" text="B3GALT6" type="GENE"/>
    <entity charOffset="333-351" id="s2098.e1" ontology_id="HP_0000541" text="retinal detachment" type="HP"/>
    <pair e1="s2098.e0" e2="s2098.e1" id="s2098.p0" relation="true"/>
  </sentence>
  <sentence id="s2099" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="143-149" id="s2099.e0" ontology_id="26229" text="B3GAT3" type="GENE"/>
    <entity charOffset="275-284" id="s2099.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s2099.e0" e2="s2099.e1" id="s2099.p0" relation="true"/>
  </sentence>
  <sentence id="s2100" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="143-149" id="s2100.e0" ontology_id="26229" text="B3GAT3" type="GENE"/>
    <entity charOffset="252-262" id="s2100.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s2100.e0" e2="s2100.e1" id="s2100.p0" relation="true"/>
  </sentence>
  <sentence id="s2101" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="143-149" id="s2101.e0" ontology_id="26229" text="B3GAT3" type="GENE"/>
    <entity charOffset="264-273" id="s2101.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s2101.e0" e2="s2101.e1" id="s2101.p0" relation="true"/>
  </sentence>
  <sentence id="s2102" text="The corneal clouding and cataracts in this patient may thus have been caused by her B4GALT7 mutation, but the colobomas are a novel phenotypic finding.">
    <entity charOffset="4-20" id="s2102.e0" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <entity charOffset="84-91" id="s2102.e1" ontology_id="11285" text="B4GALT7" type="GENE"/>
    <pair e1="s2102.e0" e2="s2102.e1" id="s2102.p0" relation="true"/>
  </sentence>
  <sentence id="s2103" text="The corneal clouding and cataracts in this patient may thus have been caused by her B4GALT7 mutation, but the colobomas are a novel phenotypic finding.">
    <entity charOffset="25-34" id="s2103.e0" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <entity charOffset="84-91" id="s2103.e1" ontology_id="11285" text="B4GALT7" type="GENE"/>
    <pair e1="s2103.e0" e2="s2103.e1" id="s2103.p0" relation="true"/>
  </sentence>
  <sentence id="s2104" text="Mitochondrial dysfunction and epithelial-to-mesenchymal transition (EMT) play important roles in cancer development and metastasis.">
    <entity charOffset="68-71" id="s2104.e0" ontology_id="3702" text="EMT" type="GENE"/>
    <entity charOffset="97-103" id="s2104.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2104.e0" e2="s2104.e1" id="s2104.p0" relation="true"/>
  </sentence>
  <sentence id="s2105" text="TUFM expression level was positively correlated with that of E-cadherin and decreased significantly during the progression of human lung cancer.">
    <entity charOffset="0-4" id="s2105.e0" ontology_id="7284" text="TUFM" type="GENE"/>
    <entity charOffset="137-143" id="s2105.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2105.e0" e2="s2105.e1" id="s2105.p0" relation="false"/>
  </sentence>
  <sentence id="s2106" text="Mechanistically, TUFM knockdown activated AMPK and phosphorylated GSK3 and increased the nuclear accumulation of -catenin, leading to the induction of EMT and increased migration and metastasis of A549 lung cancer cells.">
    <entity charOffset="17-21" id="s2106.e0" ontology_id="7284" text="TUFM" type="GENE"/>
    <entity charOffset="209-215" id="s2106.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2106.e0" e2="s2106.e1" id="s2106.p0" relation="true"/>
  </sentence>
  <sentence id="s2107" text="Although TUFM knockdown also induced EMT of MCF7 breast cancer cells, the underlying mechanism appeared somewhat different from that in lung cancer cells.">
    <entity charOffset="9-13" id="s2107.e0" ontology_id="7284" text="TUFM" type="GENE"/>
    <entity charOffset="56-62" id="s2107.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2107.e0" e2="s2107.e1" id="s2107.p0" relation="true"/>
  </sentence>
  <sentence id="s2108" text="Although TUFM knockdown also induced EMT of MCF7 breast cancer cells, the underlying mechanism appeared somewhat different from that in lung cancer cells.">
    <entity charOffset="37-40" id="s2108.e0" ontology_id="3702" text="EMT" type="GENE"/>
    <entity charOffset="56-62" id="s2108.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2108.e0" e2="s2108.e1" id="s2108.p0" relation="true"/>
  </sentence>
  <sentence id="s2109" text="Our work identifies TUFM as a novel regulator of EMT and suggests a molecular link between mitochondrial dysfunction and EMT induction.">
    <entity charOffset="20-24" id="s2109.e0" ontology_id="7284" text="TUFM" type="GENE"/>
    <entity charOffset="91-116" id="s2109.e1" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <pair e1="s2109.e0" e2="s2109.e1" id="s2109.p0" relation="true"/>
  </sentence>
  <sentence id="s2110" text="Our work identifies TUFM as a novel regulator of EMT and suggests a molecular link between mitochondrial dysfunction and EMT induction.">
    <entity charOffset="49-52" id="s2110.e0" ontology_id="3702" text="EMT" type="GENE"/>
    <entity charOffset="91-116" id="s2110.e1" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <pair e1="s2110.e0" e2="s2110.e1" id="s2110.p0" relation="true"/>
  </sentence>
  <sentence id="s2111" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s2111.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="101-108" id="s2111.e1" ontology_id="8404" text="SPARCL1" type="GENE"/>
    <pair e1="s2111.e0" e2="s2111.e1" id="s2111.p0" relation="true"/>
  </sentence>
  <sentence id="s2112" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s2112.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="124-128" id="s2112.e1" ontology_id="9055" text="PRC1" type="GENE"/>
    <pair e1="s2112.e0" e2="s2112.e1" id="s2112.p0" relation="true"/>
  </sentence>
  <sentence id="s2113" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s2113.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="130-135" id="s2113.e1" ontology_id="7153" text="TOP2A" type="GENE"/>
    <pair e1="s2113.e0" e2="s2113.e1" id="s2113.p0" relation="true"/>
  </sentence>
  <sentence id="s2114" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s2114.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="137-142" id="s2114.e1" ontology_id="27074" text="LAMP3" type="GENE"/>
    <pair e1="s2114.e0" e2="s2114.e1" id="s2114.p0" relation="true"/>
  </sentence>
  <sentence id="s2115" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s2115.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="144-150" id="s2115.e1" ontology_id="10112" text="KIF20A" type="GENE"/>
    <pair e1="s2115.e0" e2="s2115.e1" id="s2115.p0" relation="true"/>
  </sentence>
  <sentence id="s2116" text="Furthermore, gene ontology (GO) and co-expression analysis of these differentially expressed genes indicated that SPARCL1 may play a core role in cervical cancer development.">
    <entity charOffset="114-121" id="s2116.e0" ontology_id="8404" text="SPARCL1" type="GENE"/>
    <entity charOffset="155-161" id="s2116.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2116.e0" e2="s2116.e1" id="s2116.p0" relation="true"/>
  </sentence>
  <sentence id="s2117" text="Finally, we validated these observations by investigating SPARCL1 expression in cervical cancer tissue and serum samples.">
    <entity charOffset="58-65" id="s2117.e0" ontology_id="8404" text="SPARCL1" type="GENE"/>
    <entity charOffset="89-95" id="s2117.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2117.e0" e2="s2117.e1" id="s2117.p0" relation="true"/>
  </sentence>
  <sentence id="s2118" text="The diagnostic specificity of serum SPARCL1 in cervical cancer occurrence was also compared with other high incidence diseases.">
    <entity charOffset="36-43" id="s2118.e0" ontology_id="8404" text="SPARCL1" type="GENE"/>
    <entity charOffset="56-62" id="s2118.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2118.e0" e2="s2118.e1" id="s2118.p0" relation="true"/>
  </sentence>
  <sentence id="s2119" text="All of these data indicate that SPARCL1 may be a novel cancer predictive marker and a potential therapeutic target for tumor development and progression in cervical cancer">
    <entity charOffset="32-39" id="s2119.e0" ontology_id="8404" text="SPARCL1" type="GENE"/>
    <entity charOffset="55-61" id="s2119.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2119.e0" e2="s2119.e1" id="s2119.p0" relation="true"/>
  </sentence>
  <sentence id="s2120" text="All of these data indicate that SPARCL1 may be a novel cancer predictive marker and a potential therapeutic target for tumor development and progression in cervical cancer">
    <entity charOffset="32-39" id="s2120.e0" ontology_id="8404" text="SPARCL1" type="GENE"/>
    <entity charOffset="119-124" id="s2120.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2120.e0" e2="s2120.e1" id="s2120.p0" relation="true"/>
  </sentence>
  <sentence id="s2121" text="Here, we causally link a previously unreported missense mutation in TUBB2A (c.1249G&amp;gt;A, p.D417N), encoding one of the neuron-specific -tubulin isotype II, to a disorder characterized by progressive spastic paraplegia, peripheral sensory-motor polyneuropathy and ataxia.">
    <entity charOffset="68-74" id="s2121.e0" ontology_id="7280" text="TUBB2A" type="GENE"/>
    <entity charOffset="265-271" id="s2121.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s2121.e0" e2="s2121.e1" id="s2121.p0" relation="true"/>
  </sentence>
  <sentence id="s2122" text="We have previously identified a novel zinc finger protein, glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 (GZF1), whose expression was induced in the human neuroblastoma cell line TGW expressing RET by GDNF stimulation and was also detected in mouse metanephric kidney.">
    <entity charOffset="136-140" id="s2122.e0" ontology_id="64412" text="GZF1" type="GENE"/>
    <entity charOffset="185-198" id="s2122.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s2122.e0" e2="s2122.e1" id="s2122.p0" relation="true"/>
  </sentence>
  <sentence id="s2123" text="We have previously identified a novel zinc finger protein, glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 (GZF1), whose expression was induced in the human neuroblastoma cell line TGW expressing RET by GDNF stimulation and was also detected in mouse metanephric kidney.">
    <entity charOffset="185-198" id="s2123.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="231-235" id="s2123.e1" ontology_id="2668" text="GDNF" type="GENE"/>
    <pair e1="s2123.e0" e2="s2123.e1" id="s2123.p0" relation="true"/>
  </sentence>
  <sentence id="s2124" text="In addition, GZF1 expression was undetectable or very low in most cases of renal cell carcinomas and Wilms tumors.">
    <entity charOffset="13-17" id="s2124.e0" ontology_id="64412" text="GZF1" type="GENE"/>
    <entity charOffset="75-96" id="s2124.e1" ontology_id="HP_0005584" text="renal cell carcinomas" type="HP"/>
    <pair e1="s2124.e0" e2="s2124.e1" id="s2124.p0" relation="true"/>
  </sentence>
  <sentence id="s2125" text="In addition, GZF1 expression was undetectable or very low in most cases of renal cell carcinomas and Wilms tumors.">
    <entity charOffset="13-17" id="s2125.e0" ontology_id="64412" text="GZF1" type="GENE"/>
    <entity charOffset="107-113" id="s2125.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2125.e0" e2="s2125.e1" id="s2125.p0" relation="true"/>
  </sentence>
  <sentence id="s2126" text="Objective Hearing loss (HL) is the most common sensory-neural defect and the most heterogeneous trait in humans, with the involvement of &amp;gt;100 genes, which make a molecular diagnosis problematic.">
    <entity charOffset="24-26" id="s2126.e0" ontology_id="3155" text="HL" type="GENE"/>
    <entity charOffset="82-95" id="s2126.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2126.e0" e2="s2126.e1" id="s2126.p0" relation="true"/>
  </sentence>
  <sentence id="s2127" text="Results Clinical evaluations suggested autosomal recessive nonsyndromic HL.">
    <entity charOffset="39-58" id="s2127.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="72-74" id="s2127.e1" ontology_id="3155" text="HL" type="GENE"/>
    <pair e1="s2127.e0" e2="s2127.e1" id="s2127.p0" relation="true"/>
  </sentence>
  <sentence id="s2128" text="Overall, our findings establish RASSF4 as a tumor-suppressive hub in MM and provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.&lt;b&gt;Significance:&lt;/b&gt; These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.">
    <entity charOffset="44-49" id="s2128.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="62-65" id="s2128.e1" ontology_id="1993" text="hub" type="GENE"/>
    <pair e1="s2128.e0" e2="s2128.e1" id="s2128.p0" relation="true"/>
  </sentence>
  <sentence id="s2129" text="Overall, our findings establish RASSF4 as a tumor-suppressive hub in MM and provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.&lt;b&gt;Significance:&lt;/b&gt; These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.">
    <entity charOffset="44-49" id="s2129.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="138-142" id="s2129.e1" ontology_id="9734" text="HDAC" type="GENE"/>
    <pair e1="s2129.e0" e2="s2129.e1" id="s2129.p0" relation="true"/>
  </sentence>
  <sentence id="s2130" text="ANT1 is one of the nuclear genes responsible of autosomal dominant progressive external ophthalmoplegia (adPEO) with mitochondrial DNA multiple deletions.">
    <entity charOffset="0-4" id="s2130.e0" ontology_id="291" text="ANT1" type="GENE"/>
    <entity charOffset="67-78" id="s2130.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s2130.e0" e2="s2130.e1" id="s2130.p0" relation="true"/>
  </sentence>
  <sentence id="s2131" text="ANT1 is one of the nuclear genes responsible of autosomal dominant progressive external ophthalmoplegia (adPEO) with mitochondrial DNA multiple deletions.">
    <entity charOffset="0-4" id="s2131.e0" ontology_id="291" text="ANT1" type="GENE"/>
    <entity charOffset="88-103" id="s2131.e1" ontology_id="HP_0000602" text="ophthalmoplegia" type="HP"/>
    <pair e1="s2131.e0" e2="s2131.e1" id="s2131.p0" relation="true"/>
  </sentence>
  <sentence id="s2132" text="Further studies are needed to assess the prevalence of central neurological manifestations in ANT1 mitochondrial disease">
    <entity charOffset="55-62" id="s2132.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="94-98" id="s2132.e1" ontology_id="291" text="ANT1" type="GENE"/>
    <pair e1="s2132.e0" e2="s2132.e1" id="s2132.p0" relation="true"/>
  </sentence>
  <sentence id="s2133" text="Thus we conclude that the hearing loss in the family described in this report is caused by a novel missense mutation in GIPC3.">
    <entity charOffset="26-38" id="s2133.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="120-125" id="s2133.e1" ontology_id="126326" text="GIPC3" type="GENE"/>
    <pair e1="s2133.e0" e2="s2133.e1" id="s2133.p0" relation="true"/>
  </sentence>
  <sentence id="s2134" text="While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.">
    <entity charOffset="74-79" id="s2134.e0" ontology_id="55847" text="CISD1" type="GENE"/>
    <entity charOffset="203-209" id="s2134.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2134.e0" e2="s2134.e1" id="s2134.p0" relation="true"/>
  </sentence>
  <sentence id="s2135" text="While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.">
    <entity charOffset="81-89" id="s2135.e0" ontology_id="55847" text="mitoNEET" type="GENE"/>
    <entity charOffset="203-209" id="s2135.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2135.e0" e2="s2135.e1" id="s2135.p0" relation="false"/>
  </sentence>
  <sentence id="s2136" text="While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.">
    <entity charOffset="95-100" id="s2136.e0" ontology_id="493856" text="CISD2" type="GENE"/>
    <entity charOffset="203-209" id="s2136.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2136.e0" e2="s2136.e1" id="s2136.p0" relation="false"/>
  </sentence>
  <sentence id="s2137" text="While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.">
    <entity charOffset="102-107" id="s2137.e0" ontology_id="493856" text="NAF-1" type="GENE"/>
    <entity charOffset="203-209" id="s2137.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2137.e0" e2="s2137.e1" id="s2137.p0" relation="false"/>
  </sentence>
  <sentence id="s2138" text="Thus loss of ARPC1B produces a unique set of platelet abnormalities, and is associated with haematopoietic/immune symptoms affecting cell lineages where this isoform predominates.">
    <entity charOffset="13-19" id="s2138.e0" ontology_id="10095" text="ARPC1B" type="GENE"/>
    <entity charOffset="45-67" id="s2138.e1" ontology_id="HP_0001872" text="platelet abnormalities" type="HP"/>
    <pair e1="s2138.e0" e2="s2138.e1" id="s2138.p0" relation="true"/>
  </sentence>
  <sentence id="s2139" text="RAD51C and RAD51D have been defined as susceptibility genes for hereditary breast and ovarian cancer syndrome in several studies.">
    <entity charOffset="11-17" id="s2139.e0" ontology_id="5892" text="RAD51D" type="GENE"/>
    <entity charOffset="94-100" id="s2139.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2139.e0" e2="s2139.e1" id="s2139.p0" relation="true"/>
  </sentence>
  <sentence id="s2140" text="The RAD51C pathogenic variant c.404G&amp;gt;A was identified in a breast and ovarian cancer family (0.7%), while the RAD51D pathogenic variant c.694C&amp;gt;T was described in an ovarian cancer family (1.3%).">
    <entity charOffset="4-10" id="s2140.e0" ontology_id="5889" text="RAD51C" type="GENE"/>
    <entity charOffset="83-89" id="s2140.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2140.e0" e2="s2140.e1" id="s2140.p0" relation="true"/>
  </sentence>
  <sentence id="s2141" text="The RAD51C pathogenic variant c.404G&amp;gt;A was identified in a breast and ovarian cancer family (0.7%), while the RAD51D pathogenic variant c.694C&amp;gt;T was described in an ovarian cancer family (1.3%).">
    <entity charOffset="83-89" id="s2141.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="115-121" id="s2141.e1" ontology_id="5892" text="RAD51D" type="GENE"/>
    <pair e1="s2141.e0" e2="s2141.e1" id="s2141.p0" relation="true"/>
  </sentence>
  <sentence id="s2142" text="These results increase our knowledge about the RAD51C and RAD51D mutation spectrum and support the notion that these genes should be included in the gene panel testing performed on patients with hereditary breast and ovarian cancer syndrome">
    <entity charOffset="47-53" id="s2142.e0" ontology_id="5889" text="RAD51C" type="GENE"/>
    <entity charOffset="225-231" id="s2142.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2142.e0" e2="s2142.e1" id="s2142.p0" relation="true"/>
  </sentence>
  <sentence id="s2143" text="These results increase our knowledge about the RAD51C and RAD51D mutation spectrum and support the notion that these genes should be included in the gene panel testing performed on patients with hereditary breast and ovarian cancer syndrome">
    <entity charOffset="58-64" id="s2143.e0" ontology_id="5892" text="RAD51D" type="GENE"/>
    <entity charOffset="225-231" id="s2143.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2143.e0" e2="s2143.e1" id="s2143.p0" relation="true"/>
  </sentence>
  <sentence id="s2144" text="Fc-gamma receptor-IIb (FcRIIb) and its ligand are reported to be associated with obesity and type 2 diabetes mellitus (T2DM).">
    <entity charOffset="3-8" id="s2144.e0" ontology_id="9913" text="gamma" type="GENE"/>
    <entity charOffset="82-89" id="s2144.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s2144.e0" e2="s2144.e1" id="s2144.p0" relation="true"/>
  </sentence>
  <sentence id="s2145" text="Fc-gamma receptor-IIb (FcRIIb) and its ligand are reported to be associated with obesity and type 2 diabetes mellitus (T2DM).">
    <entity charOffset="82-89" id="s2145.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="94-98" id="s2145.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s2145.e0" e2="s2145.e1" id="s2145.p0" relation="true"/>
  </sentence>
  <sentence id="s2146" text="Chmp1A functions as a tumor suppressor gene and has been reported in pancreatic tumor cells.">
    <entity charOffset="0-6" id="s2146.e0" ontology_id="5119" text="Chmp1A" type="GENE"/>
    <entity charOffset="22-27" id="s2146.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2146.e0" e2="s2146.e1" id="s2146.p0" relation="true"/>
  </sentence>
  <sentence id="s2147" text="Here, we examined the expression level of Chmp1A in human RCC tissues and renal tumor cells by real-time quantitative RT-PCR and western blot.">
    <entity charOffset="42-48" id="s2147.e0" ontology_id="5119" text="Chmp1A" type="GENE"/>
    <entity charOffset="80-85" id="s2147.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2147.e0" e2="s2147.e1" id="s2147.p0" relation="true"/>
  </sentence>
  <sentence id="s2148" text="We found that the expression level of Chmp1A is significantly lower in RCC tissues and renal tumor cells compared with adjacent non-tumorous tissues and normal renal cells.">
    <entity charOffset="38-44" id="s2148.e0" ontology_id="5119" text="Chmp1A" type="GENE"/>
    <entity charOffset="93-98" id="s2148.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2148.e0" e2="s2148.e1" id="s2148.p0" relation="true"/>
  </sentence>
  <sentence id="s2149" text="Interestingly, overexpression of Chmp1A using a eukaryotic plasmid inhibited the proliferation of renal tumor cells in vitro and the growth of renal tumor in vivo.">
    <entity charOffset="33-39" id="s2149.e0" ontology_id="5119" text="Chmp1A" type="GENE"/>
    <entity charOffset="104-109" id="s2149.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2149.e0" e2="s2149.e1" id="s2149.p0" relation="true"/>
  </sentence>
  <sentence id="s2150" text="Thus, our results demonstrate that Chmp1A functions as a tumor suppressor gene in renal cells and may be a useful target for treatment of RCC">
    <entity charOffset="35-41" id="s2150.e0" ontology_id="5119" text="Chmp1A" type="GENE"/>
    <entity charOffset="57-62" id="s2150.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2150.e0" e2="s2150.e1" id="s2150.p0" relation="true"/>
  </sentence>
  <sentence id="s2151" text="The common Ser96Ala human genetic variant of HRC strongly correlates with life-threatening ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy.">
    <entity charOffset="45-48" id="s2151.e0" ontology_id="3270" text="HRC" type="GENE"/>
    <entity charOffset="91-114" id="s2151.e1" ontology_id="HP_0004308" text="ventricular arrhythmias" type="HP"/>
    <pair e1="s2151.e0" e2="s2151.e1" id="s2151.p0" relation="true"/>
  </sentence>
  <sentence id="s2152" text="In humans, CERKL mutations cause widespread retinal degeneration: early dysfunction and loss of rod and cone photoreceptors in the outer retina and, progressively, death of cells in the inner retina.">
    <entity charOffset="11-16" id="s2152.e0" ontology_id="375298" text="CERKL" type="GENE"/>
    <entity charOffset="44-64" id="s2152.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2152.e0" e2="s2152.e1" id="s2152.p0" relation="true"/>
  </sentence>
  <sentence id="s2153" text="Heterotaxy, a birth defect involving left-right patterning defects, and primary ciliary dyskinesia (PCD), a sinopulmonary disease with dyskinetic/immotile cilia in the airway are seemingly disparate diseases.">
    <entity charOffset="80-98" id="s2153.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="100-103" id="s2153.e1" ontology_id="352909" text="PCD" type="GENE"/>
    <pair e1="s2153.e0" e2="s2153.e1" id="s2153.p0" relation="false"/>
  </sentence>
  <sentence id="s2154" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="98-102" id="s2154.e0" ontology_id="1536" text="NOX2" type="GENE"/>
    <entity charOffset="227-232" id="s2154.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2154.e0" e2="s2154.e1" id="s2154.p0" relation="true"/>
  </sentence>
  <sentence id="s2155" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="112-116" id="s2155.e0" ontology_id="1535" text="Cyba" type="GENE"/>
    <entity charOffset="227-232" id="s2155.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2155.e0" e2="s2155.e1" id="s2155.p0" relation="true"/>
  </sentence>
  <sentence id="s2156" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="124-128" id="s2156.e0" ontology_id="653361" text="Ncf1" type="GENE"/>
    <entity charOffset="227-232" id="s2156.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2156.e0" e2="s2156.e1" id="s2156.p0" relation="true"/>
  </sentence>
  <sentence id="s2157" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="130-134" id="s2157.e0" ontology_id="4688" text="Ncf2" type="GENE"/>
    <entity charOffset="227-232" id="s2157.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2157.e0" e2="s2157.e1" id="s2157.p0" relation="true"/>
  </sentence>
  <sentence id="s2158" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="139-143" id="s2158.e0" ontology_id="4689" text="Ncf4" type="GENE"/>
    <entity charOffset="227-232" id="s2158.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2158.e0" e2="s2158.e1" id="s2158.p0" relation="true"/>
  </sentence>
  <sentence id="s2159" text="p.(Arg320His) mutation in the KCNC1 gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.">
    <entity charOffset="30-35" id="s2159.e0" ontology_id="3746" text="KCNC1" type="GENE"/>
    <entity charOffset="116-125" id="s2159.e1" ontology_id="HP_0001336" text="myoclonus" type="HP"/>
    <pair e1="s2159.e0" e2="s2159.e1" id="s2159.p0" relation="true"/>
  </sentence>
  <sentence id="s2160" text="p.(Arg320His) mutation in the KCNC1 gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.">
    <entity charOffset="30-35" id="s2160.e0" ontology_id="3746" text="KCNC1" type="GENE"/>
    <entity charOffset="219-227" id="s2160.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2160.e0" e2="s2160.e1" id="s2160.p0" relation="true"/>
  </sentence>
  <sentence id="s2161" text="As previously observed in the mutant mouse carrying a disrupted KCNC1 gene, these findings reveal that individuals with a KCNC1 loss-of-function variant can present intellectual disability without seizure and epilepsy">
    <entity charOffset="64-69" id="s2161.e0" ontology_id="3746" text="KCNC1" type="GENE"/>
    <entity charOffset="165-188" id="s2161.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2161.e0" e2="s2161.e1" id="s2161.p0" relation="true"/>
  </sentence>
  <sentence id="s2162" text="No significant associations were detected between these SNPs and schizophrenia in Han Chinese and the PGC data set.">
    <entity charOffset="65-78" id="s2162.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="102-105" id="s2162.e1" ontology_id="5225" text="PGC" type="GENE"/>
    <pair e1="s2162.e0" e2="s2162.e1" id="s2162.p0" relation="true"/>
  </sentence>
  <sentence id="s2163" text="However, we observed nominal significant associations of 2 SNPs in the NDUFS1 gene and 4 SNPs in the NDUFS2 gene with early onset schizophrenia (EOS), but none of these associations survived the Bonferroni correction.">
    <entity charOffset="71-77" id="s2163.e0" ontology_id="4719" text="NDUFS1" type="GENE"/>
    <entity charOffset="130-143" id="s2163.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2163.e0" e2="s2163.e1" id="s2163.p0" relation="true"/>
  </sentence>
  <sentence id="s2164" text="However, we observed nominal significant associations of 2 SNPs in the NDUFS1 gene and 4 SNPs in the NDUFS2 gene with early onset schizophrenia (EOS), but none of these associations survived the Bonferroni correction.">
    <entity charOffset="101-107" id="s2164.e0" ontology_id="4720" text="NDUFS2" type="GENE"/>
    <entity charOffset="130-143" id="s2164.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2164.e0" e2="s2164.e1" id="s2164.p0" relation="true"/>
  </sentence>
  <sentence id="s2165" text="We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1, and HIF-2) as targets for gene expression identification in 60 LARC cancer specimens.">
    <entity charOffset="67-71" id="s2165.e0" ontology_id="1806" text="DPYD" type="GENE"/>
    <entity charOffset="232-238" id="s2165.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2165.e0" e2="s2165.e1" id="s2165.p0" relation="true"/>
  </sentence>
  <sentence id="s2166" text="We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1, and HIF-2) as targets for gene expression identification in 60 LARC cancer specimens.">
    <entity charOffset="85-89" id="s2166.e0" ontology_id="1890" text="TYMP" type="GENE"/>
    <entity charOffset="232-238" id="s2166.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2166.e0" e2="s2166.e1" id="s2166.p0" relation="true"/>
  </sentence>
  <sentence id="s2167" text="We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1, and HIF-2) as targets for gene expression identification in 60 LARC cancer specimens.">
    <entity charOffset="148-153" id="s2167.e0" ontology_id="6513" text="GLUT1" type="GENE"/>
    <entity charOffset="232-238" id="s2167.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2167.e0" e2="s2167.e1" id="s2167.p0" relation="true"/>
  </sentence>
  <sentence id="s2168" text="After CCRT, 39 of 60 (65%) LARC patients were classified as responders (pathological tumor regression grade 2 ~ 4).">
    <entity charOffset="27-31" id="s2168.e0" ontology_id="6364" text="LARC" type="GENE"/>
    <entity charOffset="85-90" id="s2168.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2168.e0" e2="s2168.e1" id="s2168.p0" relation="true"/>
  </sentence>
  <sentence id="s2169" text="We aimed to identify the genetic cause of the devastating neurodegenerative disease amyotrophic lateral sclerosis (ALS) in a German family with two affected individuals, and to assess the prevalence of variants in the identified risk gene, FIG4, in a central European ALS cohort.">
    <entity charOffset="58-83" id="s2169.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="240-244" id="s2169.e1" ontology_id="9896" text="FIG4" type="GENE"/>
    <pair e1="s2169.e0" e2="s2169.e1" id="s2169.p0" relation="true"/>
  </sentence>
  <sentence id="s2170" text="Additionally, novel or rare heterozygous FIG4 missense variants predicted to be deleterious were detected in five sporadic ALS patients revealing an overall FIG4 variant frequency of 3% in our cohort.">
    <entity charOffset="41-45" id="s2170.e0" ontology_id="9896" text="FIG4" type="GENE"/>
    <entity charOffset="114-122" id="s2170.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2170.e0" e2="s2170.e1" id="s2170.p0" relation="true"/>
  </sentence>
  <sentence id="s2171" text="Additionally, novel or rare heterozygous FIG4 missense variants predicted to be deleterious were detected in five sporadic ALS patients revealing an overall FIG4 variant frequency of 3% in our cohort.">
    <entity charOffset="114-122" id="s2171.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="123-126" id="s2171.e1" ontology_id="3483" text="ALS" type="GENE"/>
    <pair e1="s2171.e0" e2="s2171.e1" id="s2171.p0" relation="true"/>
  </sentence>
  <sentence id="s2172" text="Four of six variants identified were previously associated with ALS or the motor and sensory neuropathy Charcot-Marie-Tooth disease type 4J (CMT4J), whereas two variants were novel.">
    <entity charOffset="93-103" id="s2172.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="141-146" id="s2172.e1" ontology_id="9896" text="CMT4J" type="GENE"/>
    <pair e1="s2172.e0" e2="s2172.e1" id="s2172.p0" relation="true"/>
  </sentence>
  <sentence id="s2173" text="Smad3, a major transcription factor in transforming growth factor- (TGF-) signaling, plays critical roles in both tumor-suppressive and pro-oncogenic functions.">
    <entity charOffset="0-5" id="s2173.e0" ontology_id="4088" text="Smad3" type="GENE"/>
    <entity charOffset="116-121" id="s2173.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2173.e0" e2="s2173.e1" id="s2173.p0" relation="true"/>
  </sentence>
  <sentence id="s2174" text="However, recent discoveries of Smad3-interacting molecules that preferentially bind phosphorylated Smad3 linker serine/threonine residues have shown a multitude of signal transductions that either enhance or suppress TGF- responses associated with Smad3 turnover or cancer progression.">
    <entity charOffset="31-36" id="s2174.e0" ontology_id="4088" text="Smad3" type="GENE"/>
    <entity charOffset="267-273" id="s2174.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2174.e0" e2="s2174.e1" id="s2174.p0" relation="true"/>
  </sentence>
  <sentence id="s2175" text="Recessive mutations in the secreted metalloprotease ADAMTS17 cause ectopia lentis and short stature in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.">
    <entity charOffset="52-60" id="s2175.e0" ontology_id="170691" text="ADAMTS17" type="GENE"/>
    <entity charOffset="67-81" id="s2175.e1" ontology_id="HP_0001083" text="ectopia lentis" type="HP"/>
    <pair e1="s2175.e0" e2="s2175.e1" id="s2175.p0" relation="true"/>
  </sentence>
  <sentence id="s2176" text="Recessive mutations in the secreted metalloprotease ADAMTS17 cause ectopia lentis and short stature in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.">
    <entity charOffset="52-60" id="s2176.e0" ontology_id="170691" text="ADAMTS17" type="GENE"/>
    <entity charOffset="169-177" id="s2176.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2176.e0" e2="s2176.e1" id="s2176.p0" relation="true"/>
  </sentence>
  <sentence id="s2177" text="We investigated the effects of heightened levels of COMT on dopamine-regulated motor behaviors and molecular alterations in a mouse model of dyskinesia.">
    <entity charOffset="52-56" id="s2177.e0" ontology_id="1312" text="COMT" type="GENE"/>
    <entity charOffset="141-151" id="s2177.e1" ontology_id="HP_0100660" text="dyskinesia" type="HP"/>
    <pair e1="s2177.e0" e2="s2177.e1" id="s2177.p0" relation="true"/>
  </sentence>
  <sentence id="s2178" text="l-DOPA-induced dyskinesia was exacerbated in TG mice without altering l-DOPA motor efficacy as determined by contralateral rotations or motor coordination.">
    <entity charOffset="15-25" id="s2178.e0" ontology_id="HP_0100660" text="dyskinesia" type="HP"/>
    <entity charOffset="48-52" id="s2178.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s2178.e0" e2="s2178.e1" id="s2178.p0" relation="true"/>
  </sentence>
  <sentence id="s2179" text="Our results demonstrate that human COMT overexpression confers a heightened susceptibility to l-DOPA-induced dyskinesia and alters molecular and neurochemical responses in the lesioned striatum of mice">
    <entity charOffset="35-39" id="s2179.e0" ontology_id="1312" text="COMT" type="GENE"/>
    <entity charOffset="109-119" id="s2179.e1" ontology_id="HP_0100660" text="dyskinesia" type="HP"/>
    <pair e1="s2179.e0" e2="s2179.e1" id="s2179.p0" relation="true"/>
  </sentence>
  <sentence id="s2180" text="TICs display resistance to frontline cancer treatment and retain the ability to repopulate a tumor after therapy, leading to cancer relapse.">
    <entity charOffset="0-3" id="s2180.e0" ontology_id="23550" text="TIC" type="GENE"/>
    <entity charOffset="93-98" id="s2180.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2180.e0" e2="s2180.e1" id="s2180.p0" relation="true"/>
  </sentence>
  <sentence id="s2181" text="TICs display resistance to frontline cancer treatment and retain the ability to repopulate a tumor after therapy, leading to cancer relapse.">
    <entity charOffset="0-3" id="s2181.e0" ontology_id="23550" text="TIC" type="GENE"/>
    <entity charOffset="37-43" id="s2181.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2181.e0" e2="s2181.e1" id="s2181.p0" relation="true"/>
  </sentence>
  <sentence id="s2182" text="Here we identify a novel mechanism of NOTCH regulation and TIC induction in breast cancer via the miR-106b-25 miRNA cluster.">
    <entity charOffset="59-62" id="s2182.e0" ontology_id="23550" text="TIC" type="GENE"/>
    <entity charOffset="83-89" id="s2182.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2182.e0" e2="s2182.e1" id="s2182.p0" relation="true"/>
  </sentence>
  <sentence id="s2183" text="We show that the miR-106b-25 cluster upregulates NOTCH1 in multiple breast cancer cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.">
    <entity charOffset="75-81" id="s2183.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="231-237" id="s2183.e1" ontology_id="23327" text="NEDD4L" type="GENE"/>
    <pair e1="s2183.e0" e2="s2183.e1" id="s2183.p0" relation="true"/>
  </sentence>
  <sentence id="s2184" text="We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.">
    <entity charOffset="37-43" id="s2184.e0" ontology_id="4851" text="NOTCH1" type="GENE"/>
    <entity charOffset="130-136" id="s2184.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2184.e0" e2="s2184.e1" id="s2184.p0" relation="true"/>
  </sentence>
  <sentence id="s2185" text="We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.">
    <entity charOffset="61-64" id="s2185.e0" ontology_id="23550" text="TIC" type="GENE"/>
    <entity charOffset="130-136" id="s2185.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2185.e0" e2="s2185.e1" id="s2185.p0" relation="true"/>
  </sentence>
  <sentence id="s2186" text="We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.">
    <entity charOffset="89-92" id="s2186.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="130-136" id="s2186.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2186.e0" e2="s2186.e1" id="s2186.p0" relation="true"/>
  </sentence>
  <sentence id="s2187" text="These data expand our knowledge of the mechanisms underlying NOTCH activation and TIC induction in breast cancer, and may provide new avenues for the development of therapies targeting this resistant subset of tumor cells">
    <entity charOffset="82-85" id="s2187.e0" ontology_id="23550" text="TIC" type="GENE"/>
    <entity charOffset="106-112" id="s2187.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2187.e0" e2="s2187.e1" id="s2187.p0" relation="true"/>
  </sentence>
  <sentence id="s2188" text="Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast cancer, including ATOH8, DMRT2, TBX15 and ZNF367.">
    <entity charOffset="96-102" id="s2188.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-119" id="s2188.e1" ontology_id="84913" text="ATOH8" type="GENE"/>
    <pair e1="s2188.e0" e2="s2188.e1" id="s2188.p0" relation="true"/>
  </sentence>
  <sentence id="s2189" text="Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast cancer, including ATOH8, DMRT2, TBX15 and ZNF367.">
    <entity charOffset="96-102" id="s2189.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="121-126" id="s2189.e1" ontology_id="10655" text="DMRT2" type="GENE"/>
    <pair e1="s2189.e0" e2="s2189.e1" id="s2189.p0" relation="true"/>
  </sentence>
  <sentence id="s2190" text="Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast cancer, including ATOH8, DMRT2, TBX15 and ZNF367.">
    <entity charOffset="96-102" id="s2190.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="128-133" id="s2190.e1" ontology_id="6913" text="TBX15" type="GENE"/>
    <pair e1="s2190.e0" e2="s2190.e1" id="s2190.p0" relation="true"/>
  </sentence>
  <sentence id="s2191" text="We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER(+) or ER(-)) and human ERBB2 (HER2(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade.">
    <entity charOffset="167-172" id="s2191.e0" ontology_id="2064" text="ERBB2" type="GENE"/>
    <entity charOffset="194-199" id="s2191.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2191.e0" e2="s2191.e1" id="s2191.p0" relation="true"/>
  </sentence>
  <sentence id="s2192" text="We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER(+) or ER(-)) and human ERBB2 (HER2(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade.">
    <entity charOffset="174-178" id="s2192.e0" ontology_id="2064" text="HER2" type="GENE"/>
    <entity charOffset="194-199" id="s2192.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2192.e0" e2="s2192.e1" id="s2192.p0" relation="true"/>
  </sentence>
  <sentence id="s2193" text="The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.">
    <entity charOffset="45-50" id="s2193.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="136-140" id="s2193.e1" ontology_id="2099" text="ESR1" type="GENE"/>
    <pair e1="s2193.e0" e2="s2193.e1" id="s2193.p0" relation="true"/>
  </sentence>
  <sentence id="s2194" text="The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.">
    <entity charOffset="45-50" id="s2194.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="142-147" id="s2194.e1" ontology_id="55005" text="RMND1" type="GENE"/>
    <pair e1="s2194.e0" e2="s2194.e1" id="s2194.p0" relation="true"/>
  </sentence>
  <sentence id="s2195" text="The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.">
    <entity charOffset="45-50" id="s2195.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="152-159" id="s2195.e1" ontology_id="80129" text="CCDC170" type="GENE"/>
    <pair e1="s2195.e0" e2="s2195.e1" id="s2195.p0" relation="true"/>
  </sentence>
  <sentence id="s2196" text="Genetic studies have identified a homozygous truncation mutation in Trak1 that causes hypertonia in mice.">
    <entity charOffset="68-73" id="s2196.e0" ontology_id="22906" text="Trak1" type="GENE"/>
    <entity charOffset="86-96" id="s2196.e1" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <pair e1="s2196.e0" e2="s2196.e1" id="s2196.p0" relation="true"/>
  </sentence>
  <sentence id="s2197" text="Moreover, elevated Trak1 protein expression is associated with several types of cancers and variants in Trak1 are linked to childhood absence epilepsy in humans.">
    <entity charOffset="19-24" id="s2197.e0" ontology_id="22906" text="Trak1" type="GENE"/>
    <entity charOffset="142-150" id="s2197.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2197.e0" e2="s2197.e1" id="s2197.p0" relation="true"/>
  </sentence>
  <sentence id="s2198" text="Biological activities of compounds 3-7 towards human cancer cells, COX-2, ROCK1, and JAK3 were evaluated">
    <entity charOffset="53-59" id="s2198.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-70" id="s2198.e1" ontology_id="1351" text="COX" type="GENE"/>
    <pair e1="s2198.e0" e2="s2198.e1" id="s2198.p0" relation="true"/>
  </sentence>
  <sentence id="s2199" text="Biological activities of compounds 3-7 towards human cancer cells, COX-2, ROCK1, and JAK3 were evaluated">
    <entity charOffset="53-59" id="s2199.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="85-89" id="s2199.e1" ontology_id="3718" text="JAK3" type="GENE"/>
    <pair e1="s2199.e0" e2="s2199.e1" id="s2199.p0" relation="true"/>
  </sentence>
  <sentence id="s2200" text="In this work, we functionally characterize two breast cancer associated genes, the proteasome 26S subunit ATPase 3 interacting protein (PSMC3IP) and the epithelial-stromal interaction 1 (EPSTI1), to explore their potential apoptotic role in breast cancer.">
    <entity charOffset="54-60" id="s2200.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="136-143" id="s2200.e1" ontology_id="29893" text="PSMC3IP" type="GENE"/>
    <pair e1="s2200.e0" e2="s2200.e1" id="s2200.p0" relation="true"/>
  </sentence>
  <sentence id="s2201" text="In this work, we functionally characterize two breast cancer associated genes, the proteasome 26S subunit ATPase 3 interacting protein (PSMC3IP) and the epithelial-stromal interaction 1 (EPSTI1), to explore their potential apoptotic role in breast cancer.">
    <entity charOffset="54-60" id="s2201.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="187-193" id="s2201.e1" ontology_id="94240" text="EPSTI1" type="GENE"/>
    <pair e1="s2201.e0" e2="s2201.e1" id="s2201.p0" relation="true"/>
  </sentence>
  <sentence id="s2202" text="Based on the generated interaction network, we examine several apoptotic markers to determine the effect of PSMC3IP and EPSTI1 gene expression modulation in two different human breast cancer cell lines to suggest potential molecular mechanisms to unveil their role in the disease.">
    <entity charOffset="108-115" id="s2202.e0" ontology_id="29893" text="PSMC3IP" type="GENE"/>
    <entity charOffset="184-190" id="s2202.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2202.e0" e2="s2202.e1" id="s2202.p0" relation="true"/>
  </sentence>
  <sentence id="s2203" text="Our results show that PSMC3IP and EPSTI1 are able to modulate the extrinsic apoptotic pathway in estrogen receptor positive and triple negative breast cancer cell lines, highlighting them as potential therapeutic targets.">
    <entity charOffset="22-29" id="s2203.e0" ontology_id="29893" text="PSMC3IP" type="GENE"/>
    <entity charOffset="151-157" id="s2203.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2203.e0" e2="s2203.e1" id="s2203.p0" relation="true"/>
  </sentence>
  <sentence id="s2204" text="Our results show that PSMC3IP and EPSTI1 are able to modulate the extrinsic apoptotic pathway in estrogen receptor positive and triple negative breast cancer cell lines, highlighting them as potential therapeutic targets.">
    <entity charOffset="34-40" id="s2204.e0" ontology_id="94240" text="EPSTI1" type="GENE"/>
    <entity charOffset="151-157" id="s2204.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2204.e0" e2="s2204.e1" id="s2204.p0" relation="true"/>
  </sentence>
  <sentence id="s2205" text="Here we demonstrate association of variants in the mitochondrial asparaginyl-tRNA synthetase NARS2 with human hearing loss and Leigh syndrome.">
    <entity charOffset="93-98" id="s2205.e0" ontology_id="79731" text="NARS2" type="GENE"/>
    <entity charOffset="110-122" id="s2205.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s2205.e0" e2="s2205.e1" id="s2205.p0" relation="true"/>
  </sentence>
  <sentence id="s2206" text="p.Asn381Ser also disrupts dimerization of NARS2, while the hearing loss p.Val213Phe variant has no effect on NARS2 oligomerization.">
    <entity charOffset="42-47" id="s2206.e0" ontology_id="79731" text="NARS2" type="GENE"/>
    <entity charOffset="59-71" id="s2206.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s2206.e0" e2="s2206.e1" id="s2206.p0" relation="true"/>
  </sentence>
  <sentence id="s2207" text="This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&amp;gt;G [p.(His 107 Arg)] mutation in &lt;i&gt;TUBA1A&lt;/i&gt; gene, and the clinical aspects and neuroimaging features of &amp;quot;lissencephaly syndrome&amp;quot; are summarized.">
    <entity charOffset="83-102" id="s2207.e0" ontology_id="HP_0001999" text="facial dysmorphisms" type="HP"/>
    <entity charOffset="208-211" id="s2207.e1" ontology_id="27" text="Arg" type="GENE"/>
    <pair e1="s2207.e0" e2="s2207.e1" id="s2207.p0" relation="true"/>
  </sentence>
  <sentence id="s2208" text="This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&amp;gt;G [p.(His 107 Arg)] mutation in &lt;i&gt;TUBA1A&lt;/i&gt; gene, and the clinical aspects and neuroimaging features of &amp;quot;lissencephaly syndrome&amp;quot; are summarized.">
    <entity charOffset="135-154" id="s2208.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="208-211" id="s2208.e1" ontology_id="27" text="Arg" type="GENE"/>
    <pair e1="s2208.e0" e2="s2208.e1" id="s2208.p0" relation="true"/>
  </sentence>
  <sentence id="s2209" text="Serine biosynthesis defects result from deficiencies in PGDH, PSAT, or PSP and have a broad phenotypic spectrum ranging from Neu-Laxova syndrome, a lethal multiple congenital anomaly disease at the severe end to a childhood disease with intellectual disability at the mild end, with infantile growth deficiency, and severe neurological manifestations as an intermediate phenotype.">
    <entity charOffset="56-60" id="s2209.e0" ontology_id="26227" text="PGDH" type="GENE"/>
    <entity charOffset="237-260" id="s2209.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2209.e0" e2="s2209.e1" id="s2209.p0" relation="true"/>
  </sentence>
  <sentence id="s2210" text="Serine biosynthesis defects result from deficiencies in PGDH, PSAT, or PSP and have a broad phenotypic spectrum ranging from Neu-Laxova syndrome, a lethal multiple congenital anomaly disease at the severe end to a childhood disease with intellectual disability at the mild end, with infantile growth deficiency, and severe neurological manifestations as an intermediate phenotype.">
    <entity charOffset="71-74" id="s2210.e0" ontology_id="140683" text="PSP" type="GENE"/>
    <entity charOffset="237-260" id="s2210.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2210.e0" e2="s2210.e1" id="s2210.p0" relation="true"/>
  </sentence>
  <sentence id="s2211" text="The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in PSAT1.">
    <entity charOffset="49-61" id="s2211.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="182-187" id="s2211.e1" ontology_id="29968" text="PSAT1" type="GENE"/>
    <pair e1="s2211.e0" e2="s2211.e1" id="s2211.p0" relation="true"/>
  </sentence>
  <sentence id="s2212" text="The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in PSAT1.">
    <entity charOffset="88-96" id="s2212.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="182-187" id="s2212.e1" ontology_id="29968" text="PSAT1" type="GENE"/>
    <pair e1="s2212.e0" e2="s2212.e1" id="s2212.p0" relation="true"/>
  </sentence>
  <sentence id="s2213" text="The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in PSAT1.">
    <entity charOffset="112-122" id="s2213.e0" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <entity charOffset="182-187" id="s2213.e1" ontology_id="29968" text="PSAT1" type="GENE"/>
    <pair e1="s2213.e0" e2="s2213.e1" id="s2213.p0" relation="true"/>
  </sentence>
  <sentence id="s2214" text="In a family with sensory neuropathy with loss of pain perception and destruction of the pedal skeleton we report a missense mutation in a highly conserved amino acid residue of atlastin GTPase 3 (ATL3), an endoplasmic reticulum-shaping GTPase.">
    <entity charOffset="25-35" id="s2214.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="196-200" id="s2214.e1" ontology_id="25923" text="ATL3" type="GENE"/>
    <pair e1="s2214.e0" e2="s2214.e1" id="s2214.p0" relation="true"/>
  </sentence>
  <sentence id="s2215" text="ATL3 is a paralogue of ATL1, a membrane curvature-generating molecule that is involved in spastic paraplegia and hereditary sensory neuropathy.">
    <entity charOffset="23-27" id="s2215.e0" ontology_id="51062" text="ATL1" type="GENE"/>
    <entity charOffset="132-142" id="s2215.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s2215.e0" e2="s2215.e1" id="s2215.p0" relation="true"/>
  </sentence>
  <sentence id="s2216" text="Succinate dehydrogenase subunit B and D (SDHB and SDHD) mutations represent the most frequent cause of hereditary pheochromocytoma and paraganglioma (PPGL).">
    <entity charOffset="41-45" id="s2216.e0" ontology_id="6390" text="SDHB" type="GENE"/>
    <entity charOffset="135-148" id="s2216.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s2216.e0" e2="s2216.e1" id="s2216.p0" relation="true"/>
  </sentence>
  <sentence id="s2217" text="In SDHB-related syndrome, PPGL maintenance seems to be reduced compared to SDHD (p = 0.04 vs 0.95) due to higher probability of tumor cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).">
    <entity charOffset="27-30" id="s2217.e0" ontology_id="6392" text="PGL" type="GENE"/>
    <entity charOffset="128-133" id="s2217.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2217.e0" e2="s2217.e1" id="s2217.p0" relation="true"/>
  </sentence>
  <sentence id="s2218" text="However, when SDHB-tumors give rise to metastases, metastatic cells are able to thrive with decreased probability of regression compared with SDHD counterparts (p = 0.17 vs 0.89).">
    <entity charOffset="14-18" id="s2218.e0" ontology_id="6390" text="SDHB" type="GENE"/>
    <entity charOffset="19-24" id="s2218.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2218.e0" e2="s2218.e1" id="s2218.p0" relation="true"/>
  </sentence>
  <sentence id="s2219" text="However, when SDHB-tumors give rise to metastases, metastatic cells are able to thrive with decreased probability of regression compared with SDHD counterparts (p = 0.17 vs 0.89).">
    <entity charOffset="19-24" id="s2219.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="142-146" id="s2219.e1" ontology_id="6392" text="SDHD" type="GENE"/>
    <pair e1="s2219.e0" e2="s2219.e1" id="s2219.p0" relation="true"/>
  </sentence>
  <sentence id="s2220" text="These findings align with data suggesting that SDHD-related PPGL require less genetic events for tumor initiation and maintenance compared to those related to SDHB, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues.">
    <entity charOffset="47-51" id="s2220.e0" ontology_id="6392" text="SDHD" type="GENE"/>
    <entity charOffset="97-102" id="s2220.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2220.e0" e2="s2220.e1" id="s2220.p0" relation="true"/>
  </sentence>
  <sentence id="s2221" text="These findings align with data suggesting that SDHD-related PPGL require less genetic events for tumor initiation and maintenance compared to those related to SDHB, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues.">
    <entity charOffset="97-102" id="s2221.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="159-163" id="s2221.e1" ontology_id="6390" text="SDHB" type="GENE"/>
    <pair e1="s2221.e0" e2="s2221.e1" id="s2221.p0" relation="true"/>
  </sentence>
  <sentence id="s2222" text="By contrast, the higher number of genetic abnormalities required for tumor initiation and maintenance in SDHB PPGL result in a lower penetrance of PGL, but when cells give rise to metastases they are assumed to be better adapted to sustain survival.">
    <entity charOffset="69-74" id="s2222.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="105-109" id="s2222.e1" ontology_id="6390" text="SDHB" type="GENE"/>
    <pair e1="s2222.e0" e2="s2222.e1" id="s2222.p0" relation="true"/>
  </sentence>
  <sentence id="s2223" text="In our study, the protein expression of Na&lt;sub&gt;V&lt;/sub&gt;1.3, Na&lt;sub&gt;V&lt;/sub&gt;1.6 and CaM was significantly increased in the tumor compared to control tissue, while the level of p-CaMKII/CaMKII was significantly decreased in the tumor group as determined by Western Blotting and immunohistochemistry.">
    <entity charOffset="81-84" id="s2223.e0" ontology_id="889" text="CaM" type="GENE"/>
    <entity charOffset="120-125" id="s2223.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2223.e0" e2="s2223.e1" id="s2223.p0" relation="true"/>
  </sentence>
  <sentence id="s2224" text="Furthermore, double-labeling immunofluorescence results showed that Na&lt;sub&gt;V&lt;/sub&gt;1.3/Na&lt;sub&gt;V&lt;/sub&gt;1.6 and CaM co-localization was significantly increased in the tumor group compared to control tissue.">
    <entity charOffset="108-111" id="s2224.e0" ontology_id="889" text="CaM" type="GENE"/>
    <entity charOffset="163-168" id="s2224.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2224.e0" e2="s2224.e1" id="s2224.p0" relation="true"/>
  </sentence>
  <sentence id="s2225" text="We found that KLK10 was significantly overexpressed in tissues of pancreatic intraepithelial neoplasia (PanIN) and PDAC from Pdx1-Cre; LSL-Kras&lt;sup&gt;G12D/+&lt;/sup&gt; mice (KC) and Pdx1-Cre; LSL-Kras&lt;sup&gt;G12D/+&lt;/sup&gt;; LSL-Trp53&lt;sup&gt;R172H/+&lt;/sup&gt; mice (KPC) by immunohistochemical analysis.">
    <entity charOffset="93-102" id="s2225.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="161-165" id="s2225.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s2225.e0" e2="s2225.e1" id="s2225.p0" relation="true"/>
  </sentence>
  <sentence id="s2226" text="Mutations in the membrane frizzled-related protein (MFRP/Mfrp) gene, specifically expressed in the retinal pigment epithelium (RPE) and ciliary body, cause nanophthalmia or posterior microphthalmia with retinitis pigmentosa in humans, and photoreceptor degeneration in mice.">
    <entity charOffset="52-56" id="s2226.e0" ontology_id="83552" text="MFRP" type="GENE"/>
    <entity charOffset="183-197" id="s2226.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s2226.e0" e2="s2226.e1" id="s2226.p0" relation="true"/>
  </sentence>
  <sentence id="s2227" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).">
    <entity charOffset="3-7" id="s2227.e0" ontology_id="83552" text="Mfrp" type="GENE"/>
    <entity charOffset="107-127" id="s2227.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2227.e0" e2="s2227.e1" id="s2227.p0" relation="true"/>
  </sentence>
  <sentence id="s2228" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).">
    <entity charOffset="107-127" id="s2228.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="171-176" id="s2228.e1" ontology_id="6121" text="Rpe65" type="GENE"/>
    <pair e1="s2228.e0" e2="s2228.e1" id="s2228.p0" relation="true"/>
  </sentence>
  <sentence id="s2229" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).">
    <entity charOffset="107-127" id="s2229.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="209-214" id="s2229.e1" ontology_id="5145" text="Pde6a" type="GENE"/>
    <pair e1="s2229.e0" e2="s2229.e1" id="s2229.p0" relation="true"/>
  </sentence>
  <sentence id="s2230" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).">
    <entity charOffset="107-127" id="s2230.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="216-222" id="s2230.e1" ontology_id="2979" text="Guca1b" type="GENE"/>
    <pair e1="s2230.e0" e2="s2230.e1" id="s2230.p0" relation="true"/>
  </sentence>
  <sentence id="s2231" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).">
    <entity charOffset="107-127" id="s2231.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="281-286" id="s2231.e1" ontology_id="25794" text="Fscn2" type="GENE"/>
    <pair e1="s2231.e0" e2="s2231.e1" id="s2231.p0" relation="true"/>
  </sentence>
  <sentence id="s2232" text="Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.">
    <entity charOffset="15-21" id="s2232.e0" ontology_id="646960" text="Prss56" type="GENE"/>
    <entity charOffset="80-94" id="s2232.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s2232.e0" e2="s2232.e1" id="s2232.p0" relation="true"/>
  </sentence>
  <sentence id="s2233" text="Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.">
    <entity charOffset="15-21" id="s2233.e0" ontology_id="646960" text="Prss56" type="GENE"/>
    <entity charOffset="60-68" id="s2233.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2233.e0" e2="s2233.e1" id="s2233.p0" relation="true"/>
  </sentence>
  <sentence id="s2234" text="Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.">
    <entity charOffset="15-21" id="s2234.e0" ontology_id="646960" text="Prss56" type="GENE"/>
    <entity charOffset="99-105" id="s2234.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s2234.e0" e2="s2234.e1" id="s2234.p0" relation="true"/>
  </sentence>
  <sentence id="s2235" text="Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.">
    <entity charOffset="60-68" id="s2235.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="125-129" id="s2235.e1" ontology_id="83552" text="Mfrp" type="GENE"/>
    <pair e1="s2235.e0" e2="s2235.e1" id="s2235.p0" relation="true"/>
  </sentence>
  <sentence id="s2236" text="Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.">
    <entity charOffset="99-105" id="s2236.e0" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <entity charOffset="125-129" id="s2236.e1" ontology_id="83552" text="Mfrp" type="GENE"/>
    <pair e1="s2236.e0" e2="s2236.e1" id="s2236.p0" relation="true"/>
  </sentence>
  <sentence id="s2237" text="Biallelic mutations in IBA57 cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset spastic paraplegia.">
    <entity charOffset="23-28" id="s2237.e0" ontology_id="200205" text="IBA57" type="GENE"/>
    <entity charOffset="117-140" id="s2237.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2237.e0" e2="s2237.e1" id="s2237.p0" relation="true"/>
  </sentence>
  <sentence id="s2238" text="Biallelic mutations in IBA57 cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset spastic paraplegia.">
    <entity charOffset="23-28" id="s2238.e0" ontology_id="200205" text="IBA57" type="GENE"/>
    <entity charOffset="161-179" id="s2238.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s2238.e0" e2="s2238.e1" id="s2238.p0" relation="true"/>
  </sentence>
  <sentence id="s2239" text="Gorlin syndrome is a rare multisystem inherited disorder which can predispose to basal cell carcinomas (BCCs), childhood medulloblastomas in addition to various developmental abnormalities; the majority of cases are due to mutations in the PTCH1 gene.">
    <entity charOffset="121-137" id="s2239.e0" ontology_id="HP_0002885" text="medulloblastomas" type="HP"/>
    <entity charOffset="240-245" id="s2239.e1" ontology_id="5727" text="PTCH1" type="GENE"/>
    <pair e1="s2239.e0" e2="s2239.e1" id="s2239.p0" relation="true"/>
  </sentence>
  <sentence id="s2240" text="Certain phenotypic features have been identified as being more prevalent in individuals with a SUFU mutation such as childhood medulloblastoma, infundibulocystic BCCs and trichoepitheliomas.">
    <entity charOffset="95-99" id="s2240.e0" ontology_id="51684" text="SUFU" type="GENE"/>
    <entity charOffset="127-142" id="s2240.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s2240.e0" e2="s2240.e1" id="s2240.p0" relation="true"/>
  </sentence>
  <sentence id="s2241" text="Certain phenotypic features have been identified as being more prevalent in individuals with a SUFU mutation such as childhood medulloblastoma, infundibulocystic BCCs and trichoepitheliomas.">
    <entity charOffset="95-99" id="s2241.e0" ontology_id="51684" text="SUFU" type="GENE"/>
    <entity charOffset="171-189" id="s2241.e1" ontology_id="HP_0025367" text="trichoepitheliomas" type="HP"/>
    <pair e1="s2241.e0" e2="s2241.e1" id="s2241.p0" relation="true"/>
  </sentence>
  <sentence id="s2242" text="Recently hamartomatous skin lesions have also been noted in families with childhood medulloblastoma, a &amp;quot;Gorlin like&amp;quot; phenotype and a SUFU mutation.">
    <entity charOffset="84-99" id="s2242.e0" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <entity charOffset="143-147" id="s2242.e1" ontology_id="51684" text="SUFU" type="GENE"/>
    <pair e1="s2242.e0" e2="s2242.e1" id="s2242.p0" relation="true"/>
  </sentence>
  <sentence id="s2243" text="Both RPE65 isomerase of the visual cycle and the rhodopsin visual pigment have recently been identified as critical players in mediating light-induced retinal degeneration.">
    <entity charOffset="137-142" id="s2243.e0" ontology_id="8740" text="light" type="GENE"/>
    <entity charOffset="151-171" id="s2243.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2243.e0" e2="s2243.e1" id="s2243.p0" relation="true"/>
  </sentence>
  <sentence id="s2244" text="The genes with the highest number of hypermethylated CpG sites in INRG M tumors are TERT, PCDHGA4, DLX5, and DLX6-AS1.">
    <entity charOffset="73-78" id="s2244.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="84-88" id="s2244.e1" ontology_id="7015" text="TERT" type="GENE"/>
    <pair e1="s2244.e0" e2="s2244.e1" id="s2244.p0" relation="true"/>
  </sentence>
  <sentence id="s2245" text="The genes with the highest number of hypermethylated CpG sites in INRG M tumors are TERT, PCDHGA4, DLX5, and DLX6-AS1.">
    <entity charOffset="73-78" id="s2245.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="109-113" id="s2245.e1" ontology_id="1750" text="DLX6" type="GENE"/>
    <pair e1="s2245.e0" e2="s2245.e1" id="s2245.p0" relation="false"/>
  </sentence>
  <sentence id="s2246" text="For validation, we used a set of independent tumors previously analyzed with the Illumina 27K methylation arrays, which confirmed the differentially methylated sites.">
    <entity charOffset="26-29" id="s2246.e0" ontology_id="6418" text="set" type="GENE"/>
    <entity charOffset="45-50" id="s2246.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2246.e0" e2="s2246.e1" id="s2246.p0" relation="true"/>
  </sentence>
  <sentence id="s2247" text="Mutations in the PCYT1A gene have been recently linked to two different phenotypes: one characterized by spondylometaphyseal dysplasia and cone-rod dystrophy (SMD-CRD) and the other by congenital lipodystrophy, severe fatty liver disease, and reduced HDL cholesterol without any retinal or skeletal involvement.">
    <entity charOffset="17-23" id="s2247.e0" ontology_id="5130" text="PCYT1A" type="GENE"/>
    <entity charOffset="105-134" id="s2247.e1" ontology_id="HP_0002657" text="spondylometaphyseal dysplasia" type="HP"/>
    <pair e1="s2247.e0" e2="s2247.e1" id="s2247.p0" relation="true"/>
  </sentence>
  <sentence id="s2248" text="Mutations in the PCYT1A gene have been recently linked to two different phenotypes: one characterized by spondylometaphyseal dysplasia and cone-rod dystrophy (SMD-CRD) and the other by congenital lipodystrophy, severe fatty liver disease, and reduced HDL cholesterol without any retinal or skeletal involvement.">
    <entity charOffset="17-23" id="s2248.e0" ontology_id="5130" text="PCYT1A" type="GENE"/>
    <entity charOffset="196-209" id="s2248.e1" ontology_id="HP_0009125" text="lipodystrophy" type="HP"/>
    <pair e1="s2248.e0" e2="s2248.e1" id="s2248.p0" relation="true"/>
  </sentence>
  <sentence id="s2249" text="This is the first report showing that the PCYT1A gene can be responsible for isolated forms of retinal dystrophy, particularly without any skeletal involvement, thus further expanding the phenotypic spectrum induced by mutations in this gene">
    <entity charOffset="42-48" id="s2249.e0" ontology_id="5130" text="PCYT1A" type="GENE"/>
    <entity charOffset="95-112" id="s2249.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s2249.e0" e2="s2249.e1" id="s2249.p0" relation="true"/>
  </sentence>
  <sentence id="s2250" text="Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (GPKOW) gene (NG_021310.2:g.6126G&amp;gt;A, NM_015698.4:c.331+5G&amp;gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by severe microcephaly and intrauterine growth restriction (IUGR).">
    <entity charOffset="88-93" id="s2250.e0" ontology_id="27238" text="GPKOW" type="GENE"/>
    <entity charOffset="301-313" id="s2250.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2250.e0" e2="s2250.e1" id="s2250.p0" relation="true"/>
  </sentence>
  <sentence id="s2251" text="Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (GPKOW) gene (NG_021310.2:g.6126G&amp;gt;A, NM_015698.4:c.331+5G&amp;gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by severe microcephaly and intrauterine growth restriction (IUGR).">
    <entity charOffset="88-93" id="s2251.e0" ontology_id="27238" text="GPKOW" type="GENE"/>
    <entity charOffset="318-349" id="s2251.e1" ontology_id="HP_0001511" text="intrauterine growth restriction" type="HP"/>
    <pair e1="s2251.e0" e2="s2251.e1" id="s2251.p0" relation="true"/>
  </sentence>
  <sentence id="s2252" text="Based on our and published data we propose that the GPKOW gene is essential for fetal development and when disrupted, leads to a severe, male-lethal phenotype characterised by microcephaly and IUGR">
    <entity charOffset="52-57" id="s2252.e0" ontology_id="27238" text="GPKOW" type="GENE"/>
    <entity charOffset="176-188" id="s2252.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2252.e0" e2="s2252.e1" id="s2252.p0" relation="true"/>
  </sentence>
  <sentence id="s2253" text="Based on our and published data we propose that the GPKOW gene is essential for fetal development and when disrupted, leads to a severe, male-lethal phenotype characterised by microcephaly and IUGR">
    <entity charOffset="154-158" id="s2253.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="176-188" id="s2253.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2253.e0" e2="s2253.e1" id="s2253.p0" relation="false"/>
  </sentence>
  <sentence id="s2254" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="112-118" id="s2254.e0" ontology_id="54757" text="FAM20A" type="GENE"/>
    <entity charOffset="158-173" id="s2254.e1" ontology_id="HP_0000787" text="nephrolithiasis" type="HP"/>
    <pair e1="s2254.e0" e2="s2254.e1" id="s2254.p0" relation="true"/>
  </sentence>
  <sentence id="s2255" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="112-118" id="s2255.e0" ontology_id="54757" text="FAM20A" type="GENE"/>
    <entity charOffset="218-239" id="s2255.e1" ontology_id="HP_0000169" text="gingival fibromatosis" type="HP"/>
    <pair e1="s2255.e0" e2="s2255.e1" id="s2255.p0" relation="true"/>
  </sentence>
  <sentence id="s2256" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="112-118" id="s2256.e0" ontology_id="54757" text="FAM20A" type="GENE"/>
    <entity charOffset="250-270" id="s2256.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s2256.e0" e2="s2256.e1" id="s2256.p0" relation="true"/>
  </sentence>
  <sentence id="s2257" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="112-118" id="s2257.e0" ontology_id="54757" text="FAM20A" type="GENE"/>
    <entity charOffset="282-292" id="s2257.e1" ontology_id="HP_0000668" text="hypodontia" type="HP"/>
    <pair e1="s2257.e0" e2="s2257.e1" id="s2257.p0" relation="true"/>
  </sentence>
  <sentence id="s2258" text="Very recently, SLX4 has been established as a new FA gene raising the question of its implication in breast cancer risk.">
    <entity charOffset="15-19" id="s2258.e0" ontology_id="84464" text="SLX4" type="GENE"/>
    <entity charOffset="108-114" id="s2258.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2258.e0" e2="s2258.e1" id="s2258.p0" relation="true"/>
  </sentence>
  <sentence id="s2259" text="This study aimed at answering this question sequencing the entire coding region of SLX4 in 526 familial breast cancer cases from Italy.">
    <entity charOffset="83-87" id="s2259.e0" ontology_id="84464" text="SLX4" type="GENE"/>
    <entity charOffset="111-117" id="s2259.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2259.e0" e2="s2259.e1" id="s2259.p0" relation="true"/>
  </sentence>
  <sentence id="s2260" text="Our results indicate that testing for SLX4 germline mutations is unlikely to be relevant for the identification of individuals at risk of breast cancer, at least in the Italian population">
    <entity charOffset="38-42" id="s2260.e0" ontology_id="84464" text="SLX4" type="GENE"/>
    <entity charOffset="145-151" id="s2260.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2260.e0" e2="s2260.e1" id="s2260.p0" relation="true"/>
  </sentence>
  <sentence id="s2261" text="Here we show, using whole-exome and cancer gene panel sequencing of 79 aGCTs from two independent cohorts, that truncating mutation of the histone lysine methyltransferase gene KMT2D (also known as MLL2) is a recurrent somatic event in aGCT.">
    <entity charOffset="36-42" id="s2261.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="198-202" id="s2261.e1" ontology_id="9757" text="MLL2" type="GENE"/>
    <pair e1="s2261.e0" e2="s2261.e1" id="s2261.p0" relation="true"/>
  </sentence>
  <sentence id="s2262" text="Moreover, Adenomatous polyposis coli 2 (APC2), a tumor suppressor and a negative regulator of Wnt signaling, was found to be the direct target of miR-3648.">
    <entity charOffset="49-54" id="s2262.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="146-149" id="s2262.e1" ontology_id="220972" text="miR" type="GENE"/>
    <pair e1="s2262.e0" e2="s2262.e1" id="s2262.p0" relation="true"/>
  </sentence>
  <sentence id="s2263" text="Exome sequencing of superior coloboma patients identified rare variants in a Bone Morphogenetic Protein (Bmp) receptor (BMPR1A) and T-box transcription factor (TBX2).">
    <entity charOffset="29-37" id="s2263.e0" ontology_id="HP_0000589" text="coloboma" type="HP"/>
    <entity charOffset="120-126" id="s2263.e1" ontology_id="657" text="BMPR1A" type="GENE"/>
    <pair e1="s2263.e0" e2="s2263.e1" id="s2263.p0" relation="true"/>
  </sentence>
  <sentence id="s2264" text="Exome sequencing of superior coloboma patients identified rare variants in a Bone Morphogenetic Protein (Bmp) receptor (BMPR1A) and T-box transcription factor (TBX2).">
    <entity charOffset="29-37" id="s2264.e0" ontology_id="HP_0000589" text="coloboma" type="HP"/>
    <entity charOffset="160-164" id="s2264.e1" ontology_id="6909" text="TBX2" type="GENE"/>
    <pair e1="s2264.e0" e2="s2264.e1" id="s2264.p0" relation="true"/>
  </sentence>
  <sentence id="s2265" text="We found that RFX5 is significantly upregulated in hepatocellular carcinoma (HCC) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.">
    <entity charOffset="14-18" id="s2265.e0" ontology_id="5993" text="RFX5" type="GENE"/>
    <entity charOffset="51-75" id="s2265.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2265.e0" e2="s2265.e1" id="s2265.p0" relation="true"/>
  </sentence>
  <sentence id="s2266" text="We found that RFX5 is significantly upregulated in hepatocellular carcinoma (HCC) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.">
    <entity charOffset="14-18" id="s2266.e0" ontology_id="5993" text="RFX5" type="GENE"/>
    <entity charOffset="82-88" id="s2266.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2266.e0" e2="s2266.e1" id="s2266.p0" relation="true"/>
  </sentence>
  <sentence id="s2267" text="We found that RFX5 is significantly upregulated in hepatocellular carcinoma (HCC) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.">
    <entity charOffset="14-18" id="s2267.e0" ontology_id="5993" text="RFX5" type="GENE"/>
    <entity charOffset="122-127" id="s2267.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2267.e0" e2="s2267.e1" id="s2267.p0" relation="true"/>
  </sentence>
  <sentence id="s2268" text="We performed exome sequencing in a large family affected by an autosomal-dominant form of mild syndromic ID with ptosis, growth retardation, and hypotonia, and we identified an inherited 2bp deletion causing a frameshift in BRPF1 (c.1052_1053del) in five affected family members.">
    <entity charOffset="113-119" id="s2268.e0" ontology_id="HP_0000508" text="ptosis" type="HP"/>
    <entity charOffset="225-230" id="s2268.e1" ontology_id="7862" text="BRPF1" type="GENE"/>
    <pair e1="s2268.e0" e2="s2268.e1" id="s2268.p0" relation="true"/>
  </sentence>
  <sentence id="s2269" text="We conclude that both genes contribute to the phenotypic severity of 3p25 deletion syndrome but that some specific features, such as ptosis and blepharophimosis, are mostly driven by BRPF1 haploinsufficiency">
    <entity charOffset="144-160" id="s2269.e0" ontology_id="HP_0000581" text="blepharophimosis" type="HP"/>
    <entity charOffset="183-188" id="s2269.e1" ontology_id="7862" text="BRPF1" type="GENE"/>
    <pair e1="s2269.e0" e2="s2269.e1" id="s2269.p0" relation="true"/>
  </sentence>
  <sentence id="s2270" text="Primary hyperoxaluria type 1 (PH1), a rare autosomal recessive disorder, is characterized by renal stones, nephrocalcinosis, and chronic kidney disease.">
    <entity charOffset="8-21" id="s2270.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="22-26" id="s2270.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s2270.e0" e2="s2270.e1" id="s2270.p0" relation="true"/>
  </sentence>
  <sentence id="s2271" text="Primary hyperoxaluria type 1 (PH1), a rare autosomal recessive disorder, is characterized by renal stones, nephrocalcinosis, and chronic kidney disease.">
    <entity charOffset="22-26" id="s2271.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="107-123" id="s2271.e1" ontology_id="HP_0000121" text="nephrocalcinosis" type="HP"/>
    <pair e1="s2271.e0" e2="s2271.e1" id="s2271.p0" relation="true"/>
  </sentence>
  <sentence id="s2272" text="In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins HSPB1 and HSPB8 and investigate the functional consequences of newly discovered variants.">
    <entity charOffset="54-60" id="s2272.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="142-147" id="s2272.e1" ontology_id="3315" text="HSPB1" type="GENE"/>
    <pair e1="s2272.e0" e2="s2272.e1" id="s2272.p0" relation="true"/>
  </sentence>
  <sentence id="s2273" text="In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins HSPB1 and HSPB8 and investigate the functional consequences of newly discovered variants.">
    <entity charOffset="78-88" id="s2273.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="142-147" id="s2273.e1" ontology_id="3315" text="HSPB1" type="GENE"/>
    <pair e1="s2273.e0" e2="s2273.e1" id="s2273.p0" relation="true"/>
  </sentence>
  <sentence id="s2274" text="In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins HSPB1 and HSPB8 and investigate the functional consequences of newly discovered variants.">
    <entity charOffset="78-88" id="s2274.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="152-157" id="s2274.e1" ontology_id="26353" text="HSPB8" type="GENE"/>
    <pair e1="s2274.e0" e2="s2274.e1" id="s2274.p0" relation="true"/>
  </sentence>
  <sentence id="s2275" text="Among 510 unrelated patients with distal motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and HSPB8 (four index patients/510; 0.8%) genes.">
    <entity charOffset="34-40" id="s2275.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="86-91" id="s2275.e1" ontology_id="3315" text="HSPB1" type="GENE"/>
    <pair e1="s2275.e0" e2="s2275.e1" id="s2275.p0" relation="true"/>
  </sentence>
  <sentence id="s2276" text="Among 510 unrelated patients with distal motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and HSPB8 (four index patients/510; 0.8%) genes.">
    <entity charOffset="47-57" id="s2276.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="86-91" id="s2276.e1" ontology_id="3315" text="HSPB1" type="GENE"/>
    <pair e1="s2276.e0" e2="s2276.e1" id="s2276.p0" relation="true"/>
  </sentence>
  <sentence id="s2277" text="We demonstrate that HSPB1 and HSPB8 mutations are a major cause of inherited motor axonal neuropathy.">
    <entity charOffset="20-25" id="s2277.e0" ontology_id="3315" text="HSPB1" type="GENE"/>
    <entity charOffset="90-100" id="s2277.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s2277.e0" e2="s2277.e1" id="s2277.p0" relation="true"/>
  </sentence>
  <sentence id="s2278" text="In this study, we aimed to assess the independent prognostic value of miR-361-3p in terms of overall survival (OS) and recurrence-free survival (RFS) in cervical cancer, as well as its possible regulative network.">
    <entity charOffset="70-73" id="s2278.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="162-168" id="s2278.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2278.e0" e2="s2278.e1" id="s2278.p0" relation="true"/>
  </sentence>
  <sentence id="s2279" text="Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of NUP214 and NUP98 in hematological neoplasms and overexpression of NUP88 in a variety of human cancers.">
    <entity charOffset="92-98" id="s2279.e0" ontology_id="8021" text="NUP214" type="GENE"/>
    <entity charOffset="126-135" id="s2279.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s2279.e0" e2="s2279.e1" id="s2279.p0" relation="true"/>
  </sentence>
  <sentence id="s2280" text="Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of NUP214 and NUP98 in hematological neoplasms and overexpression of NUP88 in a variety of human cancers.">
    <entity charOffset="103-108" id="s2280.e0" ontology_id="4928" text="NUP98" type="GENE"/>
    <entity charOffset="126-135" id="s2280.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s2280.e0" e2="s2280.e1" id="s2280.p0" relation="true"/>
  </sentence>
  <sentence id="s2281" text="Inherited mutations in NAA10, encoding the catalytic subunit of the major N-terminal acetylation complex NatA have been associated with diverse, syndromic X-linked recessive disorders, whereas de novo missense mutations have been reported in one male and one female individual with severe intellectual disability but otherwise unspecific phenotypes.">
    <entity charOffset="23-28" id="s2281.e0" ontology_id="8260" text="NAA10" type="GENE"/>
    <entity charOffset="289-312" id="s2281.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2281.e0" e2="s2281.e1" id="s2281.p0" relation="true"/>
  </sentence>
  <sentence id="s2282" text="The core phenotype of X-linked NAA10-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.">
    <entity charOffset="31-36" id="s2282.e0" ontology_id="8260" text="NAA10" type="GENE"/>
    <entity charOffset="148-171" id="s2282.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2282.e0" e2="s2282.e1" id="s2282.p0" relation="true"/>
  </sentence>
  <sentence id="s2283" text="The core phenotype of X-linked NAA10-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.">
    <entity charOffset="31-36" id="s2283.e0" ontology_id="8260" text="NAA10" type="GENE"/>
    <entity charOffset="173-197" id="s2283.e1" ontology_id="HP_0008897" text="postnatal growth failure" type="HP"/>
    <pair e1="s2283.e0" e2="s2283.e1" id="s2283.p0" relation="true"/>
  </sentence>
  <sentence id="s2284" text="The core phenotype of X-linked NAA10-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.">
    <entity charOffset="31-36" id="s2284.e0" ontology_id="8260" text="NAA10" type="GENE"/>
    <entity charOffset="210-222" id="s2284.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2284.e0" e2="s2284.e1" id="s2284.p0" relation="true"/>
  </sentence>
  <sentence id="s2285" text="Broad GNAS methylation abnormalities are also observed in most sporadic PHP1B (sporPHP1B) cases.">
    <entity charOffset="6-10" id="s2285.e0" ontology_id="2778" text="GNAS" type="GENE"/>
    <entity charOffset="63-71" id="s2285.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2285.e0" e2="s2285.e1" id="s2285.p0" relation="true"/>
  </sentence>
  <sentence id="s2286" text="We now investigated 23 Japanese sporPHP1B cases, who presented with hypocalcemia, hyperphosphatemia, elevated PTH levels, and occasionally with TSH elevations and mild AHO features.">
    <entity charOffset="68-80" id="s2286.e0" ontology_id="HP_0002901" text="hypocalcemia" type="HP"/>
    <entity charOffset="110-113" id="s2286.e1" ontology_id="5741" text="PTH" type="GENE"/>
    <pair e1="s2286.e0" e2="s2286.e1" id="s2286.p0" relation="true"/>
  </sentence>
  <sentence id="s2287" text="Cases were reviewed for consanguinity, sex, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).">
    <entity charOffset="39-42" id="s2287.e0" ontology_id="55558" text="sex" type="GENE"/>
    <entity charOffset="141-161" id="s2287.e1" ontology_id="HP_0011968" text="feeding difficulties" type="HP"/>
    <pair e1="s2287.e0" e2="s2287.e1" id="s2287.p0" relation="true"/>
  </sentence>
  <sentence id="s2288" text="Cases were reviewed for consanguinity, sex, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).">
    <entity charOffset="39-42" id="s2288.e0" ontology_id="55558" text="sex" type="GENE"/>
    <entity charOffset="389-407" id="s2288.e1" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <pair e1="s2288.e0" e2="s2288.e1" id="s2288.p0" relation="true"/>
  </sentence>
  <sentence id="s2289" text="To investigate the direct effects of this SNP in the heterogeneous cellular context of the brain, we generated humanized transgenic mice using a design that maximized the local transcriptional landscape of the human HTR1A gene while also controlling for effects of genomic insertion location.">
    <entity charOffset="53-66" id="s2289.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="216-221" id="s2289.e1" ontology_id="3350" text="HTR1A" type="GENE"/>
    <pair e1="s2289.e0" e2="s2289.e1" id="s2289.p0" relation="true"/>
  </sentence>
  <sentence id="s2290" text="De novo FOXP1 mutations have been associated with intellectual disability (ID), motor delay, autistic features and awide spectrum of speech difficulties.">
    <entity charOffset="8-13" id="s2290.e0" ontology_id="27086" text="FOXP1" type="GENE"/>
    <entity charOffset="50-73" id="s2290.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2290.e0" e2="s2290.e1" id="s2290.p0" relation="true"/>
  </sentence>
  <sentence id="s2291" text="De novo FOXP1 mutations have been associated with intellectual disability (ID), motor delay, autistic features and awide spectrum of speech difficulties.">
    <entity charOffset="8-13" id="s2291.e0" ontology_id="27086" text="FOXP1" type="GENE"/>
    <entity charOffset="80-91" id="s2291.e1" ontology_id="HP_0001270" text="motor delay" type="HP"/>
    <pair e1="s2291.e0" e2="s2291.e1" id="s2291.p0" relation="true"/>
  </sentence>
  <sentence id="s2292" text="De novo FOXP1 mutations have been associated with intellectual disability (ID), motor delay, autistic features and awide spectrum of speech difficulties.">
    <entity charOffset="8-13" id="s2292.e0" ontology_id="27086" text="FOXP1" type="GENE"/>
    <entity charOffset="134-153" id="s2292.e1" ontology_id="HP_0000750" text="speech difficulties" type="HP"/>
    <pair e1="s2292.e0" e2="s2292.e1" id="s2292.p0" relation="true"/>
  </sentence>
  <sentence id="s2293" text="By whole exome sequencing we identified a de novo splicing mutation in FOXP1 in a patient, initially diagnosed as C syndrome, who suffers from syndromic intellectual disability with trigonocephaly.">
    <entity charOffset="71-76" id="s2293.e0" ontology_id="27086" text="FOXP1" type="GENE"/>
    <entity charOffset="182-196" id="s2293.e1" ontology_id="HP_0000243" text="trigonocephaly" type="HP"/>
    <pair e1="s2293.e0" e2="s2293.e1" id="s2293.p0" relation="true"/>
  </sentence>
  <sentence id="s2294" text="The patient reported here shares speech difficulties, intellectual disability and autistic features with other FOXP1 syndrome patients, and thus the diagnosis for this patient should be changed.">
    <entity charOffset="33-52" id="s2294.e0" ontology_id="HP_0000750" text="speech difficulties" type="HP"/>
    <entity charOffset="111-116" id="s2294.e1" ontology_id="27086" text="FOXP1" type="GENE"/>
    <pair e1="s2294.e0" e2="s2294.e1" id="s2294.p0" relation="true"/>
  </sentence>
  <sentence id="s2295" text="The patient reported here shares speech difficulties, intellectual disability and autistic features with other FOXP1 syndrome patients, and thus the diagnosis for this patient should be changed.">
    <entity charOffset="54-77" id="s2295.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="111-116" id="s2295.e1" ontology_id="27086" text="FOXP1" type="GENE"/>
    <pair e1="s2295.e0" e2="s2295.e1" id="s2295.p0" relation="true"/>
  </sentence>
  <sentence id="s2296" text="Finally, since trigonocephaly has not been previously reported in FOXP1 syndrome, it remains to be proved whether it may be associated with the FOXP1 mutation">
    <entity charOffset="15-29" id="s2296.e0" ontology_id="HP_0000243" text="trigonocephaly" type="HP"/>
    <entity charOffset="66-71" id="s2296.e1" ontology_id="27086" text="FOXP1" type="GENE"/>
    <pair e1="s2296.e0" e2="s2296.e1" id="s2296.p0" relation="true"/>
  </sentence>
  <sentence id="s2297" text="Epithelial-stromal TGFBI dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (SCD) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.">
    <entity charOffset="19-24" id="s2297.e0" ontology_id="7045" text="TGFBI" type="GENE"/>
    <entity charOffset="157-176" id="s2297.e1" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <pair e1="s2297.e0" e2="s2297.e1" id="s2297.p0" relation="false"/>
  </sentence>
  <sentence id="s2298" text="Epithelial-stromal TGFBI dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (SCD) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.">
    <entity charOffset="19-24" id="s2298.e0" ontology_id="7045" text="TGFBI" type="GENE"/>
    <entity charOffset="46-63" id="s2298.e1" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <pair e1="s2298.e0" e2="s2298.e1" id="s2298.p0" relation="true"/>
  </sentence>
  <sentence id="s2299" text="Epithelial-stromal TGFBI dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (SCD) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.">
    <entity charOffset="46-63" id="s2299.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="96-99" id="s2299.e1" ontology_id="6584" text="SCD" type="GENE"/>
    <pair e1="s2299.e0" e2="s2299.e1" id="s2299.p0" relation="true"/>
  </sentence>
  <sentence id="s2300" text="Epithelial-stromal TGFBI dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (SCD) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.">
    <entity charOffset="96-99" id="s2300.e0" ontology_id="6584" text="SCD" type="GENE"/>
    <entity charOffset="157-176" id="s2300.e1" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <pair e1="s2300.e0" e2="s2300.e1" id="s2300.p0" relation="true"/>
  </sentence>
  <sentence id="s2301" text="Recessive mutations in WD repeat domain 62 (WDR62) cause microcephaly and a wide spectrum of severe brain malformations.">
    <entity charOffset="44-49" id="s2301.e0" ontology_id="284403" text="WDR62" type="GENE"/>
    <entity charOffset="57-69" id="s2301.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2301.e0" e2="s2301.e1" id="s2301.p0" relation="true"/>
  </sentence>
  <sentence id="s2302" text="As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).">
    <entity charOffset="90-103" id="s2302.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="236-240" id="s2302.e1" ontology_id="2915" text="GRM5" type="GENE"/>
    <pair e1="s2302.e0" e2="s2302.e1" id="s2302.p0" relation="true"/>
  </sentence>
  <sentence id="s2303" text="As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).">
    <entity charOffset="90-103" id="s2303.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="260-266" id="s2303.e1" ontology_id="2560" text="GABRB1" type="GENE"/>
    <pair e1="s2303.e0" e2="s2303.e1" id="s2303.p0" relation="true"/>
  </sentence>
  <sentence id="s2304" text="As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).">
    <entity charOffset="90-103" id="s2304.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="268-275" id="s2304.e1" ontology_id="11337" text="GABARAP" type="GENE"/>
    <pair e1="s2304.e0" e2="s2304.e1" id="s2304.p0" relation="true"/>
  </sentence>
  <sentence id="s2305" text="As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).">
    <entity charOffset="90-103" id="s2305.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="314-319" id="s2305.e1" ontology_id="3107" text="HLA-C" type="GENE"/>
    <pair e1="s2305.e0" e2="s2305.e1" id="s2305.p0" relation="true"/>
  </sentence>
  <sentence id="s2306" text="As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).">
    <entity charOffset="90-103" id="s2306.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="321-325" id="s2306.e1" ontology_id="266629" text="TAP2" type="GENE"/>
    <pair e1="s2306.e0" e2="s2306.e1" id="s2306.p0" relation="true"/>
  </sentence>
  <sentence id="s2307" text="As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).">
    <entity charOffset="90-103" id="s2307.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="327-335" id="s2307.e1" ontology_id="3009" text="HIST1H1B" type="GENE"/>
    <pair e1="s2307.e0" e2="s2307.e1" id="s2307.p0" relation="true"/>
  </sentence>
  <sentence id="s2308" text="Chronic hepatitis B virus (HBV) infection is partly responsible for hepatitis, fatty liver disease and hepatocellular carcinoma (HCC).">
    <entity charOffset="103-127" id="s2308.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="129-132" id="s2308.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s2308.e0" e2="s2308.e1" id="s2308.p0" relation="true"/>
  </sentence>
  <sentence id="s2309" text="In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&amp;lt;5  10&lt;sup&gt;-8&lt;/sup&gt;), implicating genes involved in sex steroid hormone pathways (FN1, CCDC170, ESR1, SYNE1 and FSHB).">
    <entity charOffset="111-124" id="s2309.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="232-236" id="s2309.e1" ontology_id="2099" text="ESR1" type="GENE"/>
    <pair e1="s2309.e0" e2="s2309.e1" id="s2309.p0" relation="true"/>
  </sentence>
  <sentence id="s2310" text="In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&amp;lt;5  10&lt;sup&gt;-8&lt;/sup&gt;), implicating genes involved in sex steroid hormone pathways (FN1, CCDC170, ESR1, SYNE1 and FSHB).">
    <entity charOffset="111-124" id="s2310.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="238-243" id="s2310.e1" ontology_id="23345" text="SYNE1" type="GENE"/>
    <pair e1="s2310.e0" e2="s2310.e1" id="s2310.p0" relation="false"/>
  </sentence>
  <sentence id="s2311" text="In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&amp;lt;5  10&lt;sup&gt;-8&lt;/sup&gt;), implicating genes involved in sex steroid hormone pathways (FN1, CCDC170, ESR1, SYNE1 and FSHB).">
    <entity charOffset="111-124" id="s2311.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="248-252" id="s2311.e1" ontology_id="2488" text="FSHB" type="GENE"/>
    <pair e1="s2311.e0" e2="s2311.e1" id="s2311.p0" relation="false"/>
  </sentence>
  <sentence id="s2312" text="Conditional analysis identified five secondary association signals, including two at the ESR1 locus, resulting in 19 independent single nucleotide polymorphisms (SNPs) robustly associated with endometriosis, which together explain up to 5.19% of variance in endometriosis.">
    <entity charOffset="89-93" id="s2312.e0" ontology_id="2099" text="ESR1" type="GENE"/>
    <entity charOffset="193-206" id="s2312.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2312.e0" e2="s2312.e1" id="s2312.p0" relation="true"/>
  </sentence>
  <sentence id="s2313" text="However, the impact of miR-145-3p (the passenger strand) on cancer cells is still ambiguous.">
    <entity charOffset="13-19" id="s2313.e0" ontology_id="55364" text="impact" type="GENE"/>
    <entity charOffset="60-66" id="s2313.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2313.e0" e2="s2313.e1" id="s2313.p0" relation="true"/>
  </sentence>
  <sentence id="s2314" text="Expression levels of miR-145-5p and miR-145-3p were markedly reduced in cancer tissues, and ectopic expression of these miRNAs inhibited cancer cell aggressiveness, suggesting that both miR-145-3p as well as miR-145-5p acted as antitumor miRNAs.">
    <entity charOffset="21-24" id="s2314.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="72-78" id="s2314.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2314.e0" e2="s2314.e1" id="s2314.p0" relation="true"/>
  </sentence>
  <sentence id="s2315" text="Taken together, both strands of miR-145, miR-145-5p and miR-145-3p are functional and play pivotal roles as antitumor miRNAs in lung SCC">
    <entity charOffset="32-35" id="s2315.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="112-117" id="s2315.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2315.e0" e2="s2315.e1" id="s2315.p0" relation="false"/>
  </sentence>
  <sentence id="s2316" text="On comparing Nesprin-2 and BRCA1 localization in the ovarian cancer cell lines SKOV-3 and Caov-3, Nesprin-2 and BRCA1 were localized to the NE envelope and the nucleus in SKOV-3, respectively, and to the cytoplasm in Caov-3 cells.">
    <entity charOffset="13-22" id="s2316.e0" ontology_id="23224" text="Nesprin-2" type="GENE"/>
    <entity charOffset="61-67" id="s2316.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2316.e0" e2="s2316.e1" id="s2316.p0" relation="true"/>
  </sentence>
  <sentence id="s2317" text="CYP21A2 defects result in congenital adrenal hyperplasia (CAH), an autosomal recessive disorder characterized by impaired adrenal steroidogenesis.">
    <entity charOffset="0-7" id="s2317.e0" ontology_id="1589" text="CYP21A2" type="GENE"/>
    <entity charOffset="37-56" id="s2317.e1" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <pair e1="s2317.e0" e2="s2317.e1" id="s2317.p0" relation="true"/>
  </sentence>
  <sentence id="s2318" text="This is the first study to investigate the effect of vitamin D receptor ( VDR) gene single-nucleotide polymorphisms on the clinicopathologic features of papillary thyroid cancer in Turkey.">
    <entity charOffset="74-77" id="s2318.e0" ontology_id="7421" text="VDR" type="GENE"/>
    <entity charOffset="171-177" id="s2318.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2318.e0" e2="s2318.e1" id="s2318.p0" relation="true"/>
  </sentence>
  <sentence id="s2319" text="VDR gene polymorphisms BsmI, ApaI, and TaqI did not differ between the papillary thyroid cancer group and control group (p&amp;gt;0.05, each).">
    <entity charOffset="0-3" id="s2319.e0" ontology_id="7421" text="VDR" type="GENE"/>
    <entity charOffset="89-95" id="s2319.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2319.e0" e2="s2319.e1" id="s2319.p0" relation="true"/>
  </sentence>
  <sentence id="s2320" text="VDR gene FokI T allele and TT genotype correlated with aggressiveness of papillary thyroid cancer; thus, FokI could be useful as a poor prognostic factor to assess the high risk of papillary thyroid cancer">
    <entity charOffset="0-3" id="s2320.e0" ontology_id="7421" text="VDR" type="GENE"/>
    <entity charOffset="91-97" id="s2320.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2320.e0" e2="s2320.e1" id="s2320.p0" relation="true"/>
  </sentence>
  <sentence id="s2321" text="VDR gene FokI T allele and TT genotype correlated with aggressiveness of papillary thyroid cancer; thus, FokI could be useful as a poor prognostic factor to assess the high risk of papillary thyroid cancer">
    <entity charOffset="0-3" id="s2321.e0" ontology_id="7421" text="VDR" type="GENE"/>
    <entity charOffset="55-69" id="s2321.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s2321.e0" e2="s2321.e1" id="s2321.p0" relation="true"/>
  </sentence>
  <sentence id="s2322" text="After 1year, because of worsening in spatial orientation and the onset of dressing apraxia, he was referred to our memory clinic.">
    <entity charOffset="38-45" id="s2322.e0" ontology_id="219793" text="spatial" type="GENE"/>
    <entity charOffset="84-91" id="s2322.e1" ontology_id="HP_0002186" text="apraxia" type="HP"/>
    <pair e1="s2322.e0" e2="s2322.e1" id="s2322.p0" relation="true"/>
  </sentence>
  <sentence id="s2323" text="Our results highlight the impact of age, BMI and HbA1c on epigenetic variation of candidate genes for obesity, type 2 diabetes and cancer in human adipose tissue.">
    <entity charOffset="26-32" id="s2323.e0" ontology_id="55364" text="impact" type="GENE"/>
    <entity charOffset="102-109" id="s2323.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s2323.e0" e2="s2323.e1" id="s2323.p0" relation="true"/>
  </sentence>
  <sentence id="s2324" text="Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (ALP), severe developmental delay, intellectual disability, and seizures.">
    <entity charOffset="16-33" id="s2324.e0" ontology_id="HP_0003155" text="hyperphosphatasia" type="HP"/>
    <entity charOffset="170-173" id="s2324.e1" ontology_id="80150" text="ALP" type="GENE"/>
    <pair e1="s2324.e0" e2="s2324.e1" id="s2324.p0" relation="true"/>
  </sentence>
  <sentence id="s2325" text="Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (ALP), severe developmental delay, intellectual disability, and seizures.">
    <entity charOffset="77-96" id="s2325.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="170-173" id="s2325.e1" ontology_id="80150" text="ALP" type="GENE"/>
    <pair e1="s2325.e0" e2="s2325.e1" id="s2325.p0" relation="true"/>
  </sentence>
  <sentence id="s2326" text="Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (ALP), severe developmental delay, intellectual disability, and seizures.">
    <entity charOffset="170-173" id="s2326.e0" ontology_id="80150" text="ALP" type="GENE"/>
    <entity charOffset="204-227" id="s2326.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2326.e0" e2="s2326.e1" id="s2326.p0" relation="true"/>
  </sentence>
  <sentence id="s2327" text="We performed whole-exome sequencing of a patient with severe intellectual disability, distinctive facial appearance, fragile nails, and persistent increased serum levels of ALP.">
    <entity charOffset="117-130" id="s2327.e0" ontology_id="HP_0001808" text="fragile nails" type="HP"/>
    <entity charOffset="173-176" id="s2327.e1" ontology_id="80150" text="ALP" type="GENE"/>
    <pair e1="s2327.e0" e2="s2327.e1" id="s2327.p0" relation="false"/>
  </sentence>
  <sentence id="s2328" text="Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.">
    <entity charOffset="49-53" id="s2328.e0" ontology_id="9487" text="PIGL" type="GENE"/>
    <entity charOffset="115-134" id="s2328.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2328.e0" e2="s2328.e1" id="s2328.p0" relation="true"/>
  </sentence>
  <sentence id="s2329" text="Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.">
    <entity charOffset="49-53" id="s2329.e0" ontology_id="9487" text="PIGL" type="GENE"/>
    <entity charOffset="246-269" id="s2329.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2329.e0" e2="s2329.e1" id="s2329.p0" relation="true"/>
  </sentence>
  <sentence id="s2330" text="Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.">
    <entity charOffset="49-53" id="s2330.e0" ontology_id="9487" text="PIGL" type="GENE"/>
    <entity charOffset="161-170" id="s2330.e1" ontology_id="HP_0000589" text="colobomas" type="HP"/>
    <pair e1="s2330.e0" e2="s2330.e1" id="s2330.p0" relation="true"/>
  </sentence>
  <sentence id="s2331" text="Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.">
    <entity charOffset="49-53" id="s2331.e0" ontology_id="9487" text="PIGL" type="GENE"/>
    <entity charOffset="172-196" id="s2331.e1" ontology_id="HP_0001627" text="congenital heart defects" type="HP"/>
    <pair e1="s2331.e0" e2="s2331.e1" id="s2331.p0" relation="true"/>
  </sentence>
  <sentence id="s2332" text="Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.">
    <entity charOffset="49-53" id="s2332.e0" ontology_id="9487" text="PIGL" type="GENE"/>
    <entity charOffset="210-219" id="s2332.e1" ontology_id="HP_0025279" text="migratory" type="HP"/>
    <pair e1="s2332.e0" e2="s2332.e1" id="s2332.p0" relation="true"/>
  </sentence>
  <sentence id="s2333" text="The tumor suppressor characteristics of cyclindependent kinase 10 (CDK10) in nasopharyngeal carcinoma and breast cancer have been previously demonstrated.">
    <entity charOffset="4-9" id="s2333.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="68-73" id="s2333.e1" ontology_id="8558" text="CDK10" type="GENE"/>
    <pair e1="s2333.e0" e2="s2333.e1" id="s2333.p0" relation="true"/>
  </sentence>
  <sentence id="s2334" text="In the present study the expression status of CDK10 and its prognostic significance in gastric cancer was determined, as well as its role in cell proliferation and invasion.">
    <entity charOffset="46-51" id="s2334.e0" ontology_id="8558" text="CDK10" type="GENE"/>
    <entity charOffset="95-101" id="s2334.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2334.e0" e2="s2334.e1" id="s2334.p0" relation="true"/>
  </sentence>
  <sentence id="s2335" text="Immunoblot analysis revealed that CDK10 protein expression was notably decreased in gastric cancer compared with normal tissues.">
    <entity charOffset="34-39" id="s2335.e0" ontology_id="8558" text="CDK10" type="GENE"/>
    <entity charOffset="92-98" id="s2335.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2335.e0" e2="s2335.e1" id="s2335.p0" relation="true"/>
  </sentence>
  <sentence id="s2336" text="Immunohistochemistry demonstrated that the loss of CDK10 expression, which was observed in 50.8% of primary gastric cancer tissues (n=128), significantly correlated with advanced tumor stage (P&amp;lt;0.001), frequent lymph node metastasis (P&amp;lt;0.001), distant metastasis (P=0.013), tumor differentiation (P=0.004) and unfavorable overall survival (P&amp;lt;0.001).">
    <entity charOffset="51-56" id="s2336.e0" ontology_id="8558" text="CDK10" type="GENE"/>
    <entity charOffset="116-122" id="s2336.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2336.e0" e2="s2336.e1" id="s2336.p0" relation="true"/>
  </sentence>
  <sentence id="s2337" text="To date, over 150 disease-associated variants in CRB1 have been described, resulting in a range of retinal disease phenotypes including Leber congenital amaurosis and retinitis pigmentosa.">
    <entity charOffset="49-53" id="s2337.e0" ontology_id="23418" text="CRB1" type="GENE"/>
    <entity charOffset="99-114" id="s2337.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s2337.e0" e2="s2337.e1" id="s2337.p0" relation="true"/>
  </sentence>
  <sentence id="s2338" text="Higher melanophilin level in prostate tissue of patients with a favorable PCa risk profile points out a tumor-suppressive effect.">
    <entity charOffset="74-77" id="s2338.e0" ontology_id="28982" text="PCa" type="GENE"/>
    <entity charOffset="104-109" id="s2338.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2338.e0" e2="s2338.e1" id="s2338.p0" relation="true"/>
  </sentence>
  <sentence id="s2339" text="CNGB3 encoding the beta subunit of the cyclic nucleotide-gated ion channel in cone photoreceptors is the major achromatopsia gene.">
    <entity charOffset="0-5" id="s2339.e0" ontology_id="54714" text="CNGB3" type="GENE"/>
    <entity charOffset="111-124" id="s2339.e1" ontology_id="HP_0011516" text="achromatopsia" type="HP"/>
    <pair e1="s2339.e0" e2="s2339.e1" id="s2339.p0" relation="true"/>
  </sentence>
  <sentence id="s2340" text="Here, we present a comprehensive spectrum of CNGB3 mutations and their prevalence in a cohort of 1074 independent families clinically diagnosed with achromatopsia.">
    <entity charOffset="45-50" id="s2340.e0" ontology_id="54714" text="CNGB3" type="GENE"/>
    <entity charOffset="149-162" id="s2340.e1" ontology_id="HP_0011516" text="achromatopsia" type="HP"/>
    <pair e1="s2340.e0" e2="s2340.e1" id="s2340.p0" relation="true"/>
  </sentence>
  <sentence id="s2341" text="However, the prevalence and spectrum of NKX2-5 mutations associated with sporadic DCM remain to be evaluated.">
    <entity charOffset="40-46" id="s2341.e0" ontology_id="1482" text="NKX2-5" type="GENE"/>
    <entity charOffset="73-81" id="s2341.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2341.e0" e2="s2341.e1" id="s2341.p0" relation="true"/>
  </sentence>
  <sentence id="s2342" text="In this study, the coding regions and flanking introns of the NKX2-5 gene, which encodes a cardiac transcription factor pivotal for cardiac development and structural remodeling, were sequenced in 210 unrelated patients with sporadic adult-onset DCM.">
    <entity charOffset="62-68" id="s2342.e0" ontology_id="1482" text="NKX2-5" type="GENE"/>
    <entity charOffset="225-233" id="s2342.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2342.e0" e2="s2342.e1" id="s2342.p0" relation="false"/>
  </sentence>
  <sentence id="s2343" text="As a result, two novel heterozygous NKX2-5 mutations, p.R139W and p.E167X, were identified in 2 unrelated patients with sporadic adult-onset DCM, with a mutational prevalence of approximately 0.95%.">
    <entity charOffset="36-42" id="s2343.e0" ontology_id="1482" text="NKX2-5" type="GENE"/>
    <entity charOffset="120-128" id="s2343.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2343.e0" e2="s2343.e1" id="s2343.p0" relation="true"/>
  </sentence>
  <sentence id="s2344" text="This study is the first to associate NKX2-5 loss-of-function mutations with enhanced susceptibility to sporadic DCM, which provides novel insight into the molecular etiology underpinning DCM, and suggests the potential implications for the genetic counseling and personalized treatment of the DCM patients">
    <entity charOffset="37-43" id="s2344.e0" ontology_id="1482" text="NKX2-5" type="GENE"/>
    <entity charOffset="103-111" id="s2344.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2344.e0" e2="s2344.e1" id="s2344.p0" relation="true"/>
  </sentence>
  <sentence id="s2345" text="The autosomal recessive disease propionic acidemia (PA) is an inborn error of metabolism with highly variable clinical manifestations, caused by a deficiency of propionyl-CoA carboxylase (PCC) enzyme, due to mutations in either PCCA or PCCB genes, which encode the alpha and beta subunits of the PCC enzyme, respectively.">
    <entity charOffset="4-23" id="s2345.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="228-232" id="s2345.e1" ontology_id="5095" text="PCCA" type="GENE"/>
    <pair e1="s2345.e0" e2="s2345.e1" id="s2345.p0" relation="true"/>
  </sentence>
  <sentence id="s2346" text="Owing to the lack of universal and specific tumor markers for neuroblastoma (NB), in this prospective study, we adopted an EpCAM-independent method to detect CTCs in the peripheral blood of NB patients.">
    <entity charOffset="44-49" id="s2346.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="123-128" id="s2346.e1" ontology_id="4072" text="EpCAM" type="GENE"/>
    <pair e1="s2346.e0" e2="s2346.e1" id="s2346.p0" relation="true"/>
  </sentence>
  <sentence id="s2347" text="Owing to the lack of universal and specific tumor markers for neuroblastoma (NB), in this prospective study, we adopted an EpCAM-independent method to detect CTCs in the peripheral blood of NB patients.">
    <entity charOffset="62-75" id="s2347.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="123-128" id="s2347.e1" ontology_id="4072" text="EpCAM" type="GENE"/>
    <pair e1="s2347.e0" e2="s2347.e1" id="s2347.p0" relation="true"/>
  </sentence>
  <sentence id="s2348" text="Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.">
    <entity charOffset="13-17" id="s2348.e0" ontology_id="859" text="CAV3" type="GENE"/>
    <entity charOffset="91-121" id="s2348.e1" ontology_id="HP_0006785" text="limb girdle muscular dystrophy" type="HP"/>
    <pair e1="s2348.e0" e2="s2348.e1" id="s2348.p0" relation="true"/>
  </sentence>
  <sentence id="s2349" text="Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.">
    <entity charOffset="13-17" id="s2349.e0" ontology_id="859" text="CAV3" type="GENE"/>
    <entity charOffset="165-171" id="s2349.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s2349.e0" e2="s2349.e1" id="s2349.p0" relation="true"/>
  </sentence>
  <sentence id="s2350" text="Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.">
    <entity charOffset="131-137" id="s2350.e0" ontology_id="859" text="LGMD1C" type="GENE"/>
    <entity charOffset="165-171" id="s2350.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s2350.e0" e2="s2350.e1" id="s2350.p0" relation="true"/>
  </sentence>
  <sentence id="s2351" text="This case series demonstrates that exercise intolerance, myalgia and rhabdomyolysis may be caused by CAV3 mutations and broadens the phenotypic spectrum of caveolinopathies.">
    <entity charOffset="69-83" id="s2351.e0" ontology_id="HP_0003201" text="rhabdomyolysis" type="HP"/>
    <entity charOffset="101-105" id="s2351.e1" ontology_id="859" text="CAV3" type="GENE"/>
    <pair e1="s2351.e0" e2="s2351.e1" id="s2351.p0" relation="true"/>
  </sentence>
  <sentence id="s2352" text="The expression of the ID2, PRELP and SMOC2 genes was compared between the endometrium of women without endometriosis in the proliferative phase of their menstrual cycle and the eutopic and ectopic endometrium of women with endometriosis in the proliferative phase.">
    <entity charOffset="27-32" id="s2352.e0" ontology_id="5549" text="PRELP" type="GENE"/>
    <entity charOffset="103-116" id="s2352.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2352.e0" e2="s2352.e1" id="s2352.p0" relation="true"/>
  </sentence>
  <sentence id="s2353" text="The expression of the ID2, PRELP and SMOC2 genes was compared between the endometrium of women without endometriosis in the proliferative phase of their menstrual cycle and the eutopic and ectopic endometrium of women with endometriosis in the proliferative phase.">
    <entity charOffset="37-42" id="s2353.e0" ontology_id="64094" text="SMOC2" type="GENE"/>
    <entity charOffset="103-116" id="s2353.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2353.e0" e2="s2353.e1" id="s2353.p0" relation="true"/>
  </sentence>
  <sentence id="s2354" text="The ID2 gene expression was increased in the most advanced stage of endometriosis and in ovarian endometriomas, the PRELP was more expressed in peritoneal lesions, and the SMOC2 was highly expressed in both peritoneal and endometrioma lesions.">
    <entity charOffset="68-81" id="s2354.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="172-177" id="s2354.e1" ontology_id="64094" text="SMOC2" type="GENE"/>
    <pair e1="s2354.e0" e2="s2354.e1" id="s2354.p0" relation="true"/>
  </sentence>
  <sentence id="s2355" text="Epidermal growth factor receptor (EGFR) mutation is prevalently expressed in lung adenocarcinoma cases and acts as one of the major driving oncogenes.">
    <entity charOffset="34-38" id="s2355.e0" ontology_id="1956" text="EGFR" type="GENE"/>
    <entity charOffset="77-96" id="s2355.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s2355.e0" e2="s2355.e1" id="s2355.p0" relation="true"/>
  </sentence>
  <sentence id="s2356" text="EGFR tyrosine kinase inhibitors (TKIs) have been used in patients with EGFR-mutant as an effective targeted therapy in lung adenocarcinoma, but drug resistance and tumor recurrence inevitably occurs.">
    <entity charOffset="0-4" id="s2356.e0" ontology_id="1956" text="EGFR" type="GENE"/>
    <entity charOffset="164-169" id="s2356.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2356.e0" e2="s2356.e1" id="s2356.p0" relation="true"/>
  </sentence>
  <sentence id="s2357" text="Recently, Yes-associate protein (YAP) has been reported to promote multiple cancer cell properties, such as promoting cell proliferation, epithelial-mesenchymal transition and drug resistance.">
    <entity charOffset="33-36" id="s2357.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="76-82" id="s2357.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2357.e0" e2="s2357.e1" id="s2357.p0" relation="true"/>
  </sentence>
  <sentence id="s2358" text="This study investigated the roles of YAP in TKI-resistant lung adenocarcinoma.">
    <entity charOffset="37-40" id="s2358.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="58-77" id="s2358.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s2358.e0" e2="s2358.e1" id="s2358.p0" relation="true"/>
  </sentence>
  <sentence id="s2359" text="With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.">
    <entity charOffset="13-16" id="s2359.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="119-124" id="s2359.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2359.e0" e2="s2359.e1" id="s2359.p0" relation="true"/>
  </sentence>
  <sentence id="s2360" text="With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.">
    <entity charOffset="13-16" id="s2360.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="234-240" id="s2360.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2360.e0" e2="s2360.e1" id="s2360.p0" relation="true"/>
  </sentence>
  <sentence id="s2361" text="With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.">
    <entity charOffset="166-170" id="s2361.e0" ontology_id="1956" text="EGFR" type="GENE"/>
    <entity charOffset="234-240" id="s2361.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2361.e0" e2="s2361.e1" id="s2361.p0" relation="true"/>
  </sentence>
  <sentence id="s2362" text="Progressive rod-cone degeneration (prcd) is a canine retinal disease that maps to the centromeric end of CFA9 in a region of synteny with the distal part of HSA17q.">
    <entity charOffset="35-39" id="s2362.e0" ontology_id="768206" text="prcd" type="GENE"/>
    <entity charOffset="53-68" id="s2362.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s2362.e0" e2="s2362.e1" id="s2362.p0" relation="true"/>
  </sentence>
  <sentence id="s2363" text="The transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1) has been linked to multiple neurological and psychiatric disorders including schizophrenia, but its involvement in the pathophysiology of these disorders is unclear.">
    <entity charOffset="75-80" id="s2363.e0" ontology_id="9913" text="gamma" type="GENE"/>
    <entity charOffset="187-200" id="s2363.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2363.e0" e2="s2363.e1" id="s2363.p0" relation="true"/>
  </sentence>
  <sentence id="s2364" text="The transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1) has been linked to multiple neurological and psychiatric disorders including schizophrenia, but its involvement in the pathophysiology of these disorders is unclear.">
    <entity charOffset="102-105" id="s2364.e0" ontology_id="5225" text="PGC" type="GENE"/>
    <entity charOffset="187-200" id="s2364.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2364.e0" e2="s2364.e1" id="s2364.p0" relation="true"/>
  </sentence>
  <sentence id="s2365" text="We measured the mRNA expression of PGC-1 and these transcripts in postmortem cortical tissue from control and schizophrenia patients and found a reduction in PGC-1-dependent transcripts without a change in PGC-1.">
    <entity charOffset="35-38" id="s2365.e0" ontology_id="5225" text="PGC" type="GENE"/>
    <entity charOffset="111-124" id="s2365.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2365.e0" e2="s2365.e1" id="s2365.p0" relation="true"/>
  </sentence>
  <sentence id="s2366" text="While control subjects with high PGC-1 expression exhibited high PV and Nefh expression, schizophrenia subjects with high PGC-1 expression did not, suggesting dissociation between PGC-1 expression and these targets in schizophrenia.">
    <entity charOffset="33-36" id="s2366.e0" ontology_id="5225" text="PGC" type="GENE"/>
    <entity charOffset="90-103" id="s2366.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2366.e0" e2="s2366.e1" id="s2366.p0" relation="true"/>
  </sentence>
  <sentence id="s2367" text="NRF-1 mRNA expression was reduced in schizophrenia, and its transcript levels predicted that of PGC-1-dependent targets in schizophrenia.">
    <entity charOffset="0-3" id="s2367.e0" ontology_id="55922" text="NRF" type="GENE"/>
    <entity charOffset="37-50" id="s2367.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2367.e0" e2="s2367.e1" id="s2367.p0" relation="true"/>
  </sentence>
  <sentence id="s2368" text="NRF-1 mRNA expression was reduced in schizophrenia, and its transcript levels predicted that of PGC-1-dependent targets in schizophrenia.">
    <entity charOffset="37-50" id="s2368.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="96-99" id="s2368.e1" ontology_id="5225" text="PGC" type="GENE"/>
    <pair e1="s2368.e0" e2="s2368.e1" id="s2368.p0" relation="true"/>
  </sentence>
  <sentence id="s2369" text="Interestingly, the positive correlation between PGC-1 and PV, Syt2, or Cplx1 expression was lost in schizophrenia patients with low NRF-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.">
    <entity charOffset="48-51" id="s2369.e0" ontology_id="5225" text="PGC" type="GENE"/>
    <entity charOffset="101-114" id="s2369.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2369.e0" e2="s2369.e1" id="s2369.p0" relation="true"/>
  </sentence>
  <sentence id="s2370" text="Interestingly, the positive correlation between PGC-1 and PV, Syt2, or Cplx1 expression was lost in schizophrenia patients with low NRF-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.">
    <entity charOffset="72-77" id="s2370.e0" ontology_id="10815" text="Cplx1" type="GENE"/>
    <entity charOffset="101-114" id="s2370.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2370.e0" e2="s2370.e1" id="s2370.p0" relation="true"/>
  </sentence>
  <sentence id="s2371" text="Interestingly, the positive correlation between PGC-1 and PV, Syt2, or Cplx1 expression was lost in schizophrenia patients with low NRF-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.">
    <entity charOffset="101-114" id="s2371.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="133-136" id="s2371.e1" ontology_id="55922" text="NRF" type="GENE"/>
    <pair e1="s2371.e0" e2="s2371.e1" id="s2371.p0" relation="true"/>
  </sentence>
  <sentence id="s2372" text="These data suggest that schizophrenia involves a disruption in PGC-1 and/or NRF-1-associated transcriptional programs in the cortex and that approaches to enhance the activity of PGC-1 or transcriptional regulators like NRF-1 should be considered with the goal of restoring normal gene programs and improving cortical function">
    <entity charOffset="24-37" id="s2372.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="63-66" id="s2372.e1" ontology_id="5225" text="PGC" type="GENE"/>
    <pair e1="s2372.e0" e2="s2372.e1" id="s2372.p0" relation="true"/>
  </sentence>
  <sentence id="s2373" text="These data suggest that schizophrenia involves a disruption in PGC-1 and/or NRF-1-associated transcriptional programs in the cortex and that approaches to enhance the activity of PGC-1 or transcriptional regulators like NRF-1 should be considered with the goal of restoring normal gene programs and improving cortical function">
    <entity charOffset="24-37" id="s2373.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="77-80" id="s2373.e1" ontology_id="55922" text="NRF" type="GENE"/>
    <pair e1="s2373.e0" e2="s2373.e1" id="s2373.p0" relation="true"/>
  </sentence>
  <sentence id="s2374" text="Mutations in SAMHD1 are implicated in cancer development and in a severe congenital inflammatory disease known as Aicardi-Goutires syndrome.">
    <entity charOffset="13-19" id="s2374.e0" ontology_id="25939" text="SAMHD1" type="GENE"/>
    <entity charOffset="38-44" id="s2374.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2374.e0" e2="s2374.e1" id="s2374.p0" relation="true"/>
  </sentence>
  <sentence id="s2375" text="The mechanism by which SAMHD1 protects against cancer and chronic inflammation is unknown.">
    <entity charOffset="23-29" id="s2375.e0" ontology_id="25939" text="SAMHD1" type="GENE"/>
    <entity charOffset="47-53" id="s2375.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2375.e0" e2="s2375.e1" id="s2375.p0" relation="true"/>
  </sentence>
  <sentence id="s2376" text="This includes the first two genes linked to recessively inherited isolated dystonia, that is, HPCA (hippocalcin) and COL6A3 (collagen VI alpha 3).">
    <entity charOffset="75-83" id="s2376.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="94-98" id="s2376.e1" ontology_id="773" text="HPCA" type="GENE"/>
    <pair e1="s2376.e0" e2="s2376.e1" id="s2376.p0" relation="true"/>
  </sentence>
  <sentence id="s2377" text="The novel myoclonus-dystonia genes KCTD17 and CACNA1B also implicate abnormal calcium signaling in dystonia.">
    <entity charOffset="20-28" id="s2377.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="46-53" id="s2377.e1" ontology_id="774" text="CACNA1B" type="GENE"/>
    <pair e1="s2377.e0" e2="s2377.e1" id="s2377.p0" relation="true"/>
  </sentence>
  <sentence id="s2378" text="Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex dystonias, for example those attributable to biallelic mutations in GCH1, TH, SPR, or to heterozygous TUBB4A mutations.">
    <entity charOffset="95-103" id="s2378.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="173-176" id="s2378.e1" ontology_id="6869" text="SPR" type="GENE"/>
    <pair e1="s2378.e0" e2="s2378.e1" id="s2378.p0" relation="true"/>
  </sentence>
  <sentence id="s2379" text="Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex dystonias, for example those attributable to biallelic mutations in GCH1, TH, SPR, or to heterozygous TUBB4A mutations.">
    <entity charOffset="95-103" id="s2379.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="197-203" id="s2379.e1" ontology_id="10382" text="TUBB4A" type="GENE"/>
    <pair e1="s2379.e0" e2="s2379.e1" id="s2379.p0" relation="true"/>
  </sentence>
  <sentence id="s2380" text="MESP2, HES7 and DUSP6 genes have been proved to be involved in the etiopathogenesis of congenital scoliosis (CS) in animal embryo studies, however, whether this association was detected in human CS patients also remains unknown.">
    <entity charOffset="7-11" id="s2380.e0" ontology_id="84667" text="HES7" type="GENE"/>
    <entity charOffset="98-107" id="s2380.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s2380.e0" e2="s2380.e1" id="s2380.p0" relation="true"/>
  </sentence>
  <sentence id="s2381" text="MESP2, HES7 and DUSP6 genes have been proved to be involved in the etiopathogenesis of congenital scoliosis (CS) in animal embryo studies, however, whether this association was detected in human CS patients also remains unknown.">
    <entity charOffset="16-21" id="s2381.e0" ontology_id="1848" text="DUSP6" type="GENE"/>
    <entity charOffset="98-107" id="s2381.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s2381.e0" e2="s2381.e1" id="s2381.p0" relation="true"/>
  </sentence>
  <sentence id="s2382" text="MESP2, HES7 and DUSP6 genes may not be involved in the etiopathogenesis of sporadic and non-syndromic CS in Chinese Han population">
    <entity charOffset="0-5" id="s2382.e0" ontology_id="145873" text="MESP2" type="GENE"/>
    <entity charOffset="75-83" id="s2382.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2382.e0" e2="s2382.e1" id="s2382.p0" relation="true"/>
  </sentence>
  <sentence id="s2383" text="MESP2, HES7 and DUSP6 genes may not be involved in the etiopathogenesis of sporadic and non-syndromic CS in Chinese Han population">
    <entity charOffset="16-21" id="s2383.e0" ontology_id="1848" text="DUSP6" type="GENE"/>
    <entity charOffset="75-83" id="s2383.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2383.e0" e2="s2383.e1" id="s2383.p0" relation="true"/>
  </sentence>
  <sentence id="s2384" text="Somatic defects at five loci, WT1, CTNNB1, WTX, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.">
    <entity charOffset="35-41" id="s2384.e0" ontology_id="1499" text="CTNNB1" type="GENE"/>
    <entity charOffset="109-114" id="s2384.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2384.e0" e2="s2384.e1" id="s2384.p0" relation="true"/>
  </sentence>
  <sentence id="s2385" text="Somatic defects at five loci, WT1, CTNNB1, WTX, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.">
    <entity charOffset="35-41" id="s2385.e0" ontology_id="1499" text="CTNNB1" type="GENE"/>
    <entity charOffset="147-153" id="s2385.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2385.e0" e2="s2385.e1" id="s2385.p0" relation="true"/>
  </sentence>
  <sentence id="s2386" text="Somatic defects at five loci, WT1, CTNNB1, WTX, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.">
    <entity charOffset="43-46" id="s2386.e0" ontology_id="139285" text="WTX" type="GENE"/>
    <entity charOffset="109-114" id="s2386.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2386.e0" e2="s2386.e1" id="s2386.p0" relation="true"/>
  </sentence>
  <sentence id="s2387" text="Somatic defects at five loci, WT1, CTNNB1, WTX, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.">
    <entity charOffset="43-46" id="s2387.e0" ontology_id="139285" text="WTX" type="GENE"/>
    <entity charOffset="147-153" id="s2387.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2387.e0" e2="s2387.e1" id="s2387.p0" relation="true"/>
  </sentence>
  <sentence id="s2388" text="We identified mutations of WTX in 32%, CTNNB1 in 15%, WT1 in 12% and TP53 in 5% of tumors.">
    <entity charOffset="39-45" id="s2388.e0" ontology_id="1499" text="CTNNB1" type="GENE"/>
    <entity charOffset="83-88" id="s2388.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2388.e0" e2="s2388.e1" id="s2388.p0" relation="true"/>
  </sentence>
  <sentence id="s2389" text="Group 1 tumors (63%) were defined as 11p15-mutant and WT1-normal; a third also had WTX mutations.">
    <entity charOffset="8-13" id="s2389.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="83-86" id="s2389.e1" ontology_id="139285" text="WTX" type="GENE"/>
    <pair e1="s2389.e0" e2="s2389.e1" id="s2389.p0" relation="false"/>
  </sentence>
  <sentence id="s2390" text="Here, we determine that non-canonical IKK-RelB pathway activation of KRAS-mutant tumor cells mediates MPE development and this is fueled by host-provided interleukin IL-1.">
    <entity charOffset="43-47" id="s2390.e0" ontology_id="5971" text="RelB" type="GENE"/>
    <entity charOffset="82-87" id="s2390.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2390.e0" e2="s2390.e1" id="s2390.p0" relation="true"/>
  </sentence>
  <sentence id="s2391" text="Indeed, IKK is required for the MPE-competence of KRAS-mutant tumor cells by activating non-canonical NF-B signaling.">
    <entity charOffset="51-55" id="s2391.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="63-68" id="s2391.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2391.e0" e2="s2391.e1" id="s2391.p0" relation="true"/>
  </sentence>
  <sentence id="s2392" text="Indeed, IKK is required for the MPE-competence of KRAS-mutant tumor cells by activating non-canonical NF-B signaling.">
    <entity charOffset="63-68" id="s2392.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="103-105" id="s2392.e1" ontology_id="23114" text="NF" type="GENE"/>
    <pair e1="s2392.e0" e2="s2392.e1" id="s2392.p0" relation="true"/>
  </sentence>
  <sentence id="s2393" text="Importantly, IL-1-mediated NF-B induction in KRAS-mutant tumor cells, as well as their resulting MPE-competence, can only be blocked by co-inhibition of both KRAS and IKK, a strategy that overcomes drug resistance to individual treatments.">
    <entity charOffset="28-30" id="s2393.e0" ontology_id="23114" text="NF" type="GENE"/>
    <entity charOffset="59-64" id="s2393.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2393.e0" e2="s2393.e1" id="s2393.p0" relation="true"/>
  </sentence>
  <sentence id="s2394" text="Importantly, IL-1-mediated NF-B induction in KRAS-mutant tumor cells, as well as their resulting MPE-competence, can only be blocked by co-inhibition of both KRAS and IKK, a strategy that overcomes drug resistance to individual treatments.">
    <entity charOffset="47-51" id="s2394.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="59-64" id="s2394.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2394.e0" e2="s2394.e1" id="s2394.p0" relation="true"/>
  </sentence>
  <sentence id="s2395" text="These experiments identify a role for mitofusins in directly regulating mitochondrial transport and offer important insight into the cell type specificity and molecular mechanisms of axonal degeneration in CMT2A and dominant optic atrophy">
    <entity charOffset="183-202" id="s2395.e0" ontology_id="HP_0040078" text="axonal degeneration" type="HP"/>
    <entity charOffset="206-211" id="s2395.e1" ontology_id="23095" text="CMT2A" type="GENE"/>
    <pair e1="s2395.e0" e2="s2395.e1" id="s2395.p0" relation="true"/>
  </sentence>
  <sentence id="s2396" text="In a consanguineous Saudi family segregating Usher syndrome type 1 (USH1), NGS of genes for Usher syndrome, deafness and retinal dystrophy and subsequent whole-exome sequencing each failed to identify a mutation.">
    <entity charOffset="60-64" id="s2396.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="108-116" id="s2396.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s2396.e0" e2="s2396.e1" id="s2396.p0" relation="true"/>
  </sentence>
  <sentence id="s2397" text="In a consanguineous Saudi family segregating Usher syndrome type 1 (USH1), NGS of genes for Usher syndrome, deafness and retinal dystrophy and subsequent whole-exome sequencing each failed to identify a mutation.">
    <entity charOffset="60-64" id="s2397.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="121-138" id="s2397.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s2397.e0" e2="s2397.e1" id="s2397.p0" relation="true"/>
  </sentence>
  <sentence id="s2398" text="Loss of ZBTB18 contributes to the aggressive phenotype of glioblastoma through regulation of poor prognosis-associated signatures.">
    <entity charOffset="8-14" id="s2398.e0" ontology_id="10472" text="ZBTB18" type="GENE"/>
    <entity charOffset="58-70" id="s2398.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s2398.e0" e2="s2398.e1" id="s2398.p0" relation="true"/>
  </sentence>
  <sentence id="s2399" text="Restitution of ZBTB18 expression reverses the phenotype and impairs tumor-forming ability.">
    <entity charOffset="15-21" id="s2399.e0" ontology_id="10472" text="ZBTB18" type="GENE"/>
    <entity charOffset="68-73" id="s2399.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2399.e0" e2="s2399.e1" id="s2399.p0" relation="true"/>
  </sentence>
  <sentence id="s2400" text="These results indicate that ZBTB18 functions as a tumor suppressor in GBM through the regulation of genes associated with phenotypically aggressive properties.&lt;b&gt;Implications:&lt;/b&gt; This study characterizes the role of the putative tumor suppressor ZBTB18 and its regulation by promoter hypermethylation, which appears to be a common mechanism to silence ZBTB18 in the mesenchymal subtype of GBM and provides a new mechanistic opportunity to specifically target this tumor subclass.">
    <entity charOffset="28-34" id="s2400.e0" ontology_id="10472" text="ZBTB18" type="GENE"/>
    <entity charOffset="50-55" id="s2400.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2400.e0" e2="s2400.e1" id="s2400.p0" relation="true"/>
  </sentence>
  <sentence id="s2401" text="Mutations in IFT172 lead to diseases ranging from isolated retinal degeneration to severe syndromic ciliopathies.">
    <entity charOffset="13-19" id="s2401.e0" ontology_id="26160" text="IFT172" type="GENE"/>
    <entity charOffset="59-79" id="s2401.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2401.e0" e2="s2401.e1" id="s2401.p0" relation="true"/>
  </sentence>
  <sentence id="s2402" text="In this study, we created a mouse model of IFT172-associated retinal degeneration to investigate the ocular disease mechanism.">
    <entity charOffset="43-49" id="s2402.e0" ontology_id="26160" text="IFT172" type="GENE"/>
    <entity charOffset="61-81" id="s2402.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2402.e0" e2="s2402.e1" id="s2402.p0" relation="true"/>
  </sentence>
  <sentence id="s2403" text="We investigated molecular mechanisms of degeneration and show that IFT172 protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, IFT139), aberrant light-driven translocation of alpha transducin and altered localization of glioma-associated oncogene family member 1 (GLI1).">
    <entity charOffset="67-73" id="s2403.e0" ontology_id="26160" text="IFT172" type="GENE"/>
    <entity charOffset="274-280" id="s2403.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2403.e0" e2="s2403.e1" id="s2403.p0" relation="true"/>
  </sentence>
  <sentence id="s2404" text="We investigated molecular mechanisms of degeneration and show that IFT172 protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, IFT139), aberrant light-driven translocation of alpha transducin and altered localization of glioma-associated oncogene family member 1 (GLI1).">
    <entity charOffset="274-280" id="s2404.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="318-322" id="s2404.e1" ontology_id="2735" text="GLI1" type="GENE"/>
    <pair e1="s2404.e0" e2="s2404.e1" id="s2404.p0" relation="true"/>
  </sentence>
  <sentence id="s2405" text="This mouse model exhibits key features of the retinal phenotype observed in patients with IFT172-associated blindness and can be used for in vivo testing of ciliopathy therapies">
    <entity charOffset="90-96" id="s2405.e0" ontology_id="26160" text="IFT172" type="GENE"/>
    <entity charOffset="108-117" id="s2405.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s2405.e0" e2="s2405.e1" id="s2405.p0" relation="true"/>
  </sentence>
  <sentence id="s2406" text="Age-related hearing impairment (ARHI), one of the most common sensory disorders, can be mitigated, but not cured or eliminated.">
    <entity charOffset="12-30" id="s2406.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="32-36" id="s2406.e1" ontology_id="9077" text="ARHI" type="GENE"/>
    <pair e1="s2406.e0" e2="s2406.e1" id="s2406.p0" relation="true"/>
  </sentence>
  <sentence id="s2407" text="The latter SNP lies just outside exon 8 and is highly correlated (r2 = 0.96) with the missense SNP rs5756795 in exon 7 of TRIOBP, a gene previously associated with prelingual nonsyndromic hearing loss.">
    <entity charOffset="122-128" id="s2407.e0" ontology_id="11078" text="TRIOBP" type="GENE"/>
    <entity charOffset="188-200" id="s2407.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s2407.e0" e2="s2407.e1" id="s2407.p0" relation="true"/>
  </sentence>
  <sentence id="s2408" text="We also tested variants within exons of 132 other previously-identified hearing loss genes, and identified two common additional significant SNPs: rs2877561 (synonymous change in ILDR1, p = 6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT (p = 0.00019) and speech discrimination score (SDS; p = 0.0019); and rs9493627 (missense change in EYA4, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and suggestive result for SDS (p = 0.081).">
    <entity charOffset="72-84" id="s2408.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="179-184" id="s2408.e1" ontology_id="286676" text="ILDR1" type="GENE"/>
    <pair e1="s2408.e0" e2="s2408.e1" id="s2408.p0" relation="true"/>
  </sentence>
  <sentence id="s2409" text="We also tested variants within exons of 132 other previously-identified hearing loss genes, and identified two common additional significant SNPs: rs2877561 (synonymous change in ILDR1, p = 6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT (p = 0.00019) and speech discrimination score (SDS; p = 0.0019); and rs9493627 (missense change in EYA4, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and suggestive result for SDS (p = 0.081).">
    <entity charOffset="72-84" id="s2409.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="381-385" id="s2409.e1" ontology_id="2070" text="EYA4" type="GENE"/>
    <pair e1="s2409.e0" e2="s2409.e1" id="s2409.p0" relation="true"/>
  </sentence>
  <sentence id="s2410" text="These data suggest a previously unrecognized mechanism by which EBNALP coactivates transcription through subverting of EP300 and thus affects the expression of LCL genes regulated by a broad range of host TFs.&lt;b&gt;IMPORTANCE&lt;/b&gt; Epstein-Barr virus was the first human DNA tumor virus discovered over 50 years ago.">
    <entity charOffset="119-124" id="s2410.e0" ontology_id="2033" text="EP300" type="GENE"/>
    <entity charOffset="270-275" id="s2410.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2410.e0" e2="s2410.e1" id="s2410.p0" relation="true"/>
  </sentence>
  <sentence id="s2411" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="22-26" id="s2411.e0" ontology_id="176" text="ACAN" type="GENE"/>
    <entity charOffset="68-86" id="s2411.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s2411.e0" e2="s2411.e1" id="s2411.p0" relation="true"/>
  </sentence>
  <sentence id="s2412" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="22-26" id="s2412.e0" ontology_id="176" text="ACAN" type="GENE"/>
    <entity charOffset="326-339" id="s2412.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2412.e0" e2="s2412.e1" id="s2412.p0" relation="true"/>
  </sentence>
  <sentence id="s2413" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="28-33" id="s2413.e0" ontology_id="2261" text="FGFR3" type="GENE"/>
    <entity charOffset="68-86" id="s2413.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s2413.e0" e2="s2413.e1" id="s2413.p0" relation="true"/>
  </sentence>
  <sentence id="s2414" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="28-33" id="s2414.e0" ontology_id="2261" text="FGFR3" type="GENE"/>
    <entity charOffset="326-339" id="s2414.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2414.e0" e2="s2414.e1" id="s2414.p0" relation="true"/>
  </sentence>
  <sentence id="s2415" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="35-39" id="s2415.e0" ontology_id="10641" text="NPR2" type="GENE"/>
    <entity charOffset="68-86" id="s2415.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s2415.e0" e2="s2415.e1" id="s2415.p0" relation="true"/>
  </sentence>
  <sentence id="s2416" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="45-49" id="s2416.e0" ontology_id="6473" text="SHOX" type="GENE"/>
    <entity charOffset="68-86" id="s2416.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s2416.e0" e2="s2416.e1" id="s2416.p0" relation="true"/>
  </sentence>
  <sentence id="s2417" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="45-49" id="s2417.e0" ontology_id="6473" text="SHOX" type="GENE"/>
    <entity charOffset="326-339" id="s2417.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2417.e0" e2="s2417.e1" id="s2417.p0" relation="false"/>
  </sentence>
  <sentence id="s2418" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="68-86" id="s2418.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="105-110" id="s2418.e1" ontology_id="2692" text="GHRHR" type="GENE"/>
    <pair e1="s2418.e0" e2="s2418.e1" id="s2418.p0" relation="true"/>
  </sentence>
  <sentence id="s2419" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="68-86" id="s2419.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="117-120" id="s2419.e1" ontology_id="2690" text="GHR" type="GENE"/>
    <pair e1="s2419.e0" e2="s2419.e1" id="s2419.p0" relation="true"/>
  </sentence>
  <sentence id="s2420" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="68-86" id="s2420.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="130-134" id="s2420.e1" ontology_id="3479" text="IGF1" type="GENE"/>
    <pair e1="s2420.e0" e2="s2420.e1" id="s2420.p0" relation="true"/>
  </sentence>
  <sentence id="s2421" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="68-86" id="s2421.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="136-142" id="s2421.e1" ontology_id="3483" text="IGFALS" type="GENE"/>
    <pair e1="s2421.e0" e2="s2421.e1" id="s2421.p0" relation="true"/>
  </sentence>
  <sentence id="s2422" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="68-86" id="s2422.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="112-114" id="s2422.e1" ontology_id="2688" text="GH" type="GENE"/>
    <pair e1="s2422.e0" e2="s2422.e1" id="s2422.p0" relation="true"/>
  </sentence>
  <sentence id="s2423" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="112-114" id="s2423.e0" ontology_id="2688" text="GH" type="GENE"/>
    <entity charOffset="326-339" id="s2423.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2423.e0" e2="s2423.e1" id="s2423.p0" relation="true"/>
  </sentence>
  <sentence id="s2424" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="117-120" id="s2424.e0" ontology_id="2690" text="GHR" type="GENE"/>
    <entity charOffset="326-339" id="s2424.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2424.e0" e2="s2424.e1" id="s2424.p0" relation="true"/>
  </sentence>
  <sentence id="s2425" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="122-128" id="s2425.e0" ontology_id="6777" text="STAT5B" type="GENE"/>
    <entity charOffset="326-339" id="s2425.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2425.e0" e2="s2425.e1" id="s2425.p0" relation="true"/>
  </sentence>
  <sentence id="s2426" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="130-134" id="s2426.e0" ontology_id="3479" text="IGF1" type="GENE"/>
    <entity charOffset="326-339" id="s2426.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2426.e0" e2="s2426.e1" id="s2426.p0" relation="true"/>
  </sentence>
  <sentence id="s2427" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="136-142" id="s2427.e0" ontology_id="3483" text="IGFALS" type="GENE"/>
    <entity charOffset="326-339" id="s2427.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2427.e0" e2="s2427.e1" id="s2427.p0" relation="true"/>
  </sentence>
  <sentence id="s2428" text="In mice, Sobp (also known as Jxc1) is critical for patterning of the organ of Corti; one of our patients has a subclinical cochlear hearing loss but no gross cochlear abnormalities.">
    <entity charOffset="9-13" id="s2428.e0" ontology_id="55084" text="Sobp" type="GENE"/>
    <entity charOffset="132-144" id="s2428.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s2428.e0" e2="s2428.e1" id="s2428.p0" relation="true"/>
  </sentence>
  <sentence id="s2429" text="Our study showed that targeted NGS is an effective tool for diagnosis of genetic deafness and that p.G141R in &lt;i&gt;ILDR1&lt;/i&gt; may be a relatively frequent mutation for DFNB42 in Chinese Hans">
    <entity charOffset="81-89" id="s2429.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="165-171" id="s2429.e1" ontology_id="286676" text="DFNB42" type="GENE"/>
    <pair e1="s2429.e0" e2="s2429.e1" id="s2429.p0" relation="true"/>
  </sentence>
  <sentence id="s2430" text="Ectodermal dysplasia-9 (ED-9) is a congenital condition characterized by hypotrichosis and nail dystrophy without other disorders, and Hoxc13 is a pathogenic gene for ED-9.">
    <entity charOffset="73-86" id="s2430.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="91-95" id="s2430.e1" ontology_id="51744" text="nail" type="GENE"/>
    <pair e1="s2430.e0" e2="s2430.e1" id="s2430.p0" relation="true"/>
  </sentence>
  <sentence id="s2431" text="Ectodermal dysplasia-9 (ED-9) is a congenital condition characterized by hypotrichosis and nail dystrophy without other disorders, and Hoxc13 is a pathogenic gene for ED-9.">
    <entity charOffset="73-86" id="s2431.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="135-141" id="s2431.e1" ontology_id="3229" text="Hoxc13" type="GENE"/>
    <pair e1="s2431.e0" e2="s2431.e1" id="s2431.p0" relation="true"/>
  </sentence>
  <sentence id="s2432" text="Furthermore, microRNA-22 targeted NRAS proto-oncogene, GTPase (NRAS) in breast cancer cells.">
    <entity charOffset="34-38" id="s2432.e0" ontology_id="4893" text="NRAS" type="GENE"/>
    <entity charOffset="79-85" id="s2432.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2432.e0" e2="s2432.e1" id="s2432.p0" relation="true"/>
  </sentence>
  <sentence id="s2433" text="Moreover, microRNA-22 sensitized breast cancer cells to paclitaxel by regulation of NRAS.">
    <entity charOffset="40-46" id="s2433.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="84-88" id="s2433.e1" ontology_id="4893" text="NRAS" type="GENE"/>
    <pair e1="s2433.e0" e2="s2433.e1" id="s2433.p0" relation="true"/>
  </sentence>
  <sentence id="s2434" text="RT-PCR analysis showed that the overall transcriptional activity of the main HS biosynthesis-involved genes (&lt;i&gt;EXT1&lt;/i&gt;, &lt;i&gt;EXT2&lt;/i&gt;, &lt;i&gt;NDST1&lt;/i&gt;, &lt;i&gt;NDST2&lt;/i&gt;, &lt;i&gt;GLCE&lt;/i&gt;, &lt;i&gt;HS2ST1&lt;/i&gt;, &lt;i&gt;HS3ST1&lt;/i&gt;, &lt;i&gt;HS3ST2&lt;/i&gt;, &lt;i&gt;HS6ST1&lt;/i&gt;, &lt;i&gt;HS6ST2&lt;/i&gt;, &lt;i&gt;SULF1&lt;/i&gt;, &lt;i&gt;SULF2&lt;/i&gt;, &lt;i&gt;HPSE&lt;/i&gt;) was decreased by 1.5-2-fold in Grade II-III glioma (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.01) and by 3-fold in Grade IV glioma (glioblastoma multiforme, GBM) (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05), as compared with the para-tumourous tissue.">
    <entity charOffset="282-286" id="s2434.e0" ontology_id="10855" text="HPSE" type="GENE"/>
    <entity charOffset="476-482" id="s2434.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s2434.e0" e2="s2434.e1" id="s2434.p0" relation="false"/>
  </sentence>
  <sentence id="s2435" text="Heparanase (&lt;i&gt;HPSE&lt;/i&gt;) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intratumoural heterogeneity of the presence of the HPSE protein.">
    <entity charOffset="15-19" id="s2435.e0" ontology_id="10855" text="HPSE" type="GENE"/>
    <entity charOffset="129-135" id="s2435.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s2435.e0" e2="s2435.e1" id="s2435.p0" relation="true"/>
  </sentence>
  <sentence id="s2436" text="Mutations in the KARS gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.">
    <entity charOffset="17-21" id="s2436.e0" ontology_id="3735" text="KARS" type="GENE"/>
    <entity charOffset="174-182" id="s2436.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s2436.e0" e2="s2436.e1" id="s2436.p0" relation="true"/>
  </sentence>
  <sentence id="s2437" text="Mutations in the KARS gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.">
    <entity charOffset="17-21" id="s2437.e0" ontology_id="3735" text="KARS" type="GENE"/>
    <entity charOffset="229-248" id="s2437.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s2437.e0" e2="s2437.e1" id="s2437.p0" relation="true"/>
  </sentence>
  <sentence id="s2438" text="Mutations in the KARS gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.">
    <entity charOffset="17-21" id="s2438.e0" ontology_id="3735" text="KARS" type="GENE"/>
    <entity charOffset="254-269" id="s2438.e1" ontology_id="HP_0003128" text="lactic acidosis" type="HP"/>
    <pair e1="s2438.e0" e2="s2438.e1" id="s2438.p0" relation="true"/>
  </sentence>
  <sentence id="s2439" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s2439.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="54-57" id="s2439.e1" ontology_id="472" text="ATM" type="GENE"/>
    <pair e1="s2439.e0" e2="s2439.e1" id="s2439.p0" relation="true"/>
  </sentence>
  <sentence id="s2440" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s2440.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="65-71" id="s2440.e1" ontology_id="5295" text="PIK3R1" type="GENE"/>
    <pair e1="s2440.e0" e2="s2440.e1" id="s2440.p0" relation="true"/>
  </sentence>
  <sentence id="s2441" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s2441.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="73-78" id="s2441.e1" ontology_id="5727" text="PTCH1" type="GENE"/>
    <pair e1="s2441.e0" e2="s2441.e1" id="s2441.p0" relation="true"/>
  </sentence>
  <sentence id="s2442" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s2442.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="80-84" id="s2442.e1" ontology_id="5728" text="PTEN" type="GENE"/>
    <pair e1="s2442.e0" e2="s2442.e1" id="s2442.p0" relation="true"/>
  </sentence>
  <sentence id="s2443" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s2443.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="86-90" id="s2443.e1" ontology_id="54790" text="TET2" type="GENE"/>
    <pair e1="s2443.e0" e2="s2443.e1" id="s2443.p0" relation="true"/>
  </sentence>
  <sentence id="s2444" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s2444.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="147-153" id="s2444.e1" ontology_id="1499" text="CTNNB1" type="GENE"/>
    <pair e1="s2444.e0" e2="s2444.e1" id="s2444.p0" relation="false"/>
  </sentence>
  <sentence id="s2445" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s2445.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="155-160" id="s2445.e1" ontology_id="2064" text="ERBB2" type="GENE"/>
    <pair e1="s2445.e0" e2="s2445.e1" id="s2445.p0" relation="false"/>
  </sentence>
  <sentence id="s2446" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s2446.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="187-191" id="s2446.e1" ontology_id="2475" text="MTOR" type="GENE"/>
    <pair e1="s2446.e0" e2="s2446.e1" id="s2446.p0" relation="true"/>
  </sentence>
  <sentence id="s2447" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s2447.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="193-199" id="s2447.e1" ontology_id="5156" text="PDGFRA" type="GENE"/>
    <pair e1="s2447.e0" e2="s2447.e1" id="s2447.p0" relation="false"/>
  </sentence>
  <sentence id="s2448" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s2448.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="210-216" id="s2448.e1" ontology_id="5781" text="PTPN11" type="GENE"/>
    <pair e1="s2448.e0" e2="s2448.e1" id="s2448.p0" relation="true"/>
  </sentence>
  <sentence id="s2449" text="We believe that this study will shed new light on fundamental aspects for understanding the molecular pathogenesis of endometrial cancer and may aid in the development of new targeted therapies.">
    <entity charOffset="41-46" id="s2449.e0" ontology_id="8740" text="light" type="GENE"/>
    <entity charOffset="130-136" id="s2449.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2449.e0" e2="s2449.e1" id="s2449.p0" relation="true"/>
  </sentence>
  <sentence id="s2450" text="Vegetarian and vegan diets have increased worldwide in the last decades, according to the knowledge that they might prevent coronary heart disease, cancer, and type 2 diabetes.">
    <entity charOffset="148-154" id="s2450.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="160-164" id="s2450.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s2450.e0" e2="s2450.e1" id="s2450.p0" relation="true"/>
  </sentence>
  <sentence id="s2451" text="Necropsy revealed extensive granulomatous pneumonia, from which Mtb was isolated and identified as a member of LAM3/F11 lineage; a common lineage found in humans in South Africa.">
    <entity charOffset="42-51" id="s2451.e0" ontology_id="HP_0002090" text="pneumonia" type="HP"/>
    <entity charOffset="64-67" id="s2451.e1" ontology_id="54892" text="Mtb" type="GENE"/>
    <pair e1="s2451.e0" e2="s2451.e1" id="s2451.p0" relation="true"/>
  </sentence>
  <sentence id="s2452" text="Herein, we report 3 patients with heterozygous constitutional CDK13 mutations, who were ascertained through exome analysis of children with intellectual disability and minor anomalies, who lacked cardiac anomalies.">
    <entity charOffset="62-67" id="s2452.e0" ontology_id="8621" text="CDK13" type="GENE"/>
    <entity charOffset="140-163" id="s2452.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2452.e0" e2="s2452.e1" id="s2452.p0" relation="true"/>
  </sentence>
  <sentence id="s2453" text="Herein, we report 3 patients with heterozygous constitutional CDK13 mutations, who were ascertained through exome analysis of children with intellectual disability and minor anomalies, who lacked cardiac anomalies.">
    <entity charOffset="62-67" id="s2453.e0" ontology_id="8621" text="CDK13" type="GENE"/>
    <entity charOffset="196-213" id="s2453.e1" ontology_id="HP_0001627" text="cardiac anomalies" type="HP"/>
    <pair e1="s2453.e0" e2="s2453.e1" id="s2453.p0" relation="true"/>
  </sentence>
  <sentence id="s2454" text="&lt;b&gt;Objective:&lt;/b&gt; To study the association between Thymidine Phosphorylase (TYMP) genetic variation and clinical outcomes and safety of postoperative colorectal cancer (CRC) patients.">
    <entity charOffset="76-80" id="s2454.e0" ontology_id="1890" text="TYMP" type="GENE"/>
    <entity charOffset="161-167" id="s2454.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2454.e0" e2="s2454.e1" id="s2454.p0" relation="true"/>
  </sentence>
  <sentence id="s2455" text="Additionally, of the 87 postoperative tissue specimens, the results showed that the expression of TYMP in cancer tissues of the patients with CT or TT genotypes were significantly higher than those of the wild type CC genotype patients (&lt;i&gt;P&lt;/i&gt;=0.019).">
    <entity charOffset="98-102" id="s2455.e0" ontology_id="1890" text="TYMP" type="GENE"/>
    <entity charOffset="106-112" id="s2455.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2455.e0" e2="s2455.e1" id="s2455.p0" relation="true"/>
  </sentence>
  <sentence id="s2456" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.">
    <entity charOffset="39-47" id="s2456.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="170-174" id="s2456.e1" ontology_id="6647" text="SOD1" type="GENE"/>
    <pair e1="s2456.e0" e2="s2456.e1" id="s2456.p0" relation="true"/>
  </sentence>
  <sentence id="s2457" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.">
    <entity charOffset="39-47" id="s2457.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="185-191" id="s2457.e1" ontology_id="23435" text="TARDBP" type="GENE"/>
    <pair e1="s2457.e0" e2="s2457.e1" id="s2457.p0" relation="true"/>
  </sentence>
  <sentence id="s2458" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.">
    <entity charOffset="39-47" id="s2458.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="193-196" id="s2458.e1" ontology_id="2521" text="FUS" type="GENE"/>
    <pair e1="s2458.e0" e2="s2458.e1" id="s2458.p0" relation="true"/>
  </sentence>
  <sentence id="s2459" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.">
    <entity charOffset="39-47" id="s2459.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="203-209" id="s2459.e1" ontology_id="25978" text="CHMP2B" type="GENE"/>
    <pair e1="s2459.e0" e2="s2459.e1" id="s2459.p0" relation="true"/>
  </sentence>
  <sentence id="s2460" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.">
    <entity charOffset="39-47" id="s2460.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="211-216" id="s2460.e1" ontology_id="6311" text="ATXN2" type="GENE"/>
    <pair e1="s2460.e0" e2="s2460.e1" id="s2460.p0" relation="true"/>
  </sentence>
  <sentence id="s2461" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.">
    <entity charOffset="39-47" id="s2461.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="218-223" id="s2461.e1" ontology_id="123606" text="NIPA1" type="GENE"/>
    <pair e1="s2461.e0" e2="s2461.e1" id="s2461.p0" relation="true"/>
  </sentence>
  <sentence id="s2462" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.">
    <entity charOffset="39-47" id="s2462.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="225-229" id="s2462.e1" ontology_id="6606" text="SMN1" type="GENE"/>
    <pair e1="s2462.e0" e2="s2462.e1" id="s2462.p0" relation="true"/>
  </sentence>
  <sentence id="s2463" text="Most of the available anticancer drugs are designed to act on specific targets by altering the activity of involved transporters and genes.">
    <entity charOffset="26-32" id="s2463.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="55-58" id="s2463.e1" ontology_id="11332" text="act" type="GENE"/>
    <pair e1="s2463.e0" e2="s2463.e1" id="s2463.p0" relation="true"/>
  </sentence>
  <sentence id="s2464" text="Crisponi syndrome (CS)/cold-induced sweating syndrome type 1 (CISS1) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.">
    <entity charOffset="54-58" id="s2464.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="251-271" id="s2464.e1" ontology_id="HP_0011968" text="feeding difficulties" type="HP"/>
    <pair e1="s2464.e0" e2="s2464.e1" id="s2464.p0" relation="true"/>
  </sentence>
  <sentence id="s2465" text="Crisponi syndrome (CS)/cold-induced sweating syndrome type 1 (CISS1) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.">
    <entity charOffset="62-67" id="s2465.e0" ontology_id="9244" text="CISS1" type="GENE"/>
    <entity charOffset="234-246" id="s2465.e1" ontology_id="HP_0001945" text="hyperthermia" type="HP"/>
    <pair e1="s2465.e0" e2="s2465.e1" id="s2465.p0" relation="true"/>
  </sentence>
  <sentence id="s2466" text="Crisponi syndrome (CS)/cold-induced sweating syndrome type 1 (CISS1) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.">
    <entity charOffset="62-67" id="s2466.e0" ontology_id="9244" text="CISS1" type="GENE"/>
    <entity charOffset="296-305" id="s2466.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s2466.e0" e2="s2466.e1" id="s2466.p0" relation="true"/>
  </sentence>
  <sentence id="s2467" text="Although these data further support the pathogenic role of KLHL7 mutations in a CS/CISS1-like phenotype, they do not explain all their clinical manifestations and highlight the high phenotypic heterogeneity associated with mutations in KLHL7.">
    <entity charOffset="59-64" id="s2467.e0" ontology_id="55975" text="KLHL7" type="GENE"/>
    <entity charOffset="193-206" id="s2467.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s2467.e0" e2="s2467.e1" id="s2467.p0" relation="true"/>
  </sentence>
  <sentence id="s2468" text="In this study, we enrolled 16individuals affected by tooth agenesis, prevalently hypodontia, and we carried out direct Sanger sequencing of paired box9(PAX9) and Msh homeobox1(MSX1) genes in 9subjects.">
    <entity charOffset="82-92" id="s2468.e0" ontology_id="HP_0000668" text="hypodontia" type="HP"/>
    <entity charOffset="155-159" id="s2468.e1" ontology_id="5083" text="PAX9" type="GENE"/>
    <pair e1="s2468.e0" e2="s2468.e1" id="s2468.p0" relation="true"/>
  </sentence>
  <sentence id="s2469" text="In this study, we enrolled 16individuals affected by tooth agenesis, prevalently hypodontia, and we carried out direct Sanger sequencing of paired box9(PAX9) and Msh homeobox1(MSX1) genes in 9subjects.">
    <entity charOffset="82-92" id="s2469.e0" ontology_id="HP_0000668" text="hypodontia" type="HP"/>
    <entity charOffset="165-168" id="s2469.e1" ontology_id="4488" text="Msh" type="GENE"/>
    <pair e1="s2469.e0" e2="s2469.e1" id="s2469.p0" relation="true"/>
  </sentence>
  <sentence id="s2470" text="Overall, our study confirmed the major role played by WNT10A in tooth agenesis and the genetic heterogeneity of this disease.">
    <entity charOffset="54-60" id="s2470.e0" ontology_id="80326" text="WNT10A" type="GENE"/>
    <entity charOffset="95-108" id="s2470.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s2470.e0" e2="s2470.e1" id="s2470.p0" relation="true"/>
  </sentence>
  <sentence id="s2471" text="Mutations in CRLF1 have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome type 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.">
    <entity charOffset="13-18" id="s2471.e0" ontology_id="9244" text="CRLF1" type="GENE"/>
    <entity charOffset="45-64" id="s2471.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2471.e0" e2="s2471.e1" id="s2471.p0" relation="true"/>
  </sentence>
  <sentence id="s2472" text="Mutations in CRLF1 have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome type 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.">
    <entity charOffset="13-18" id="s2472.e0" ontology_id="9244" text="CRLF1" type="GENE"/>
    <entity charOffset="186-206" id="s2472.e1" ontology_id="HP_0011968" text="feeding difficulties" type="HP"/>
    <pair e1="s2472.e0" e2="s2472.e1" id="s2472.p0" relation="true"/>
  </sentence>
  <sentence id="s2473" text="Mutations in CRLF1 have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome type 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.">
    <entity charOffset="45-64" id="s2473.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="108-112" id="s2473.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s2473.e0" e2="s2473.e1" id="s2473.p0" relation="true"/>
  </sentence>
  <sentence id="s2474" text="Mutations in CRLF1 have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome type 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.">
    <entity charOffset="108-112" id="s2474.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="186-206" id="s2474.e1" ontology_id="HP_0011968" text="feeding difficulties" type="HP"/>
    <pair e1="s2474.e0" e2="s2474.e1" id="s2474.p0" relation="true"/>
  </sentence>
  <sentence id="s2475" text="Growth abnormalities, motor dysfunction, hindlimb paralysis, muscle wasting, neurogenic atrophy, motor neuron degeneration, and loss of large-caliber axons in peripheral nerves occurred at an earlier age in &lt;i&gt;Scyl1&lt;/i&gt;/S&lt;i&gt;cyl3&lt;/i&gt; double-deficient mice than in &lt;i&gt;Scyl1&lt;/i&gt;-deficient mice.">
    <entity charOffset="61-75" id="s2475.e0" ontology_id="HP_0003202" text="muscle wasting" type="HP"/>
    <entity charOffset="210-215" id="s2475.e1" ontology_id="6357" text="Scyl1" type="GENE"/>
    <pair e1="s2475.e0" e2="s2475.e1" id="s2475.p0" relation="true"/>
  </sentence>
  <sentence id="s2476" text="Growth abnormalities, motor dysfunction, hindlimb paralysis, muscle wasting, neurogenic atrophy, motor neuron degeneration, and loss of large-caliber axons in peripheral nerves occurred at an earlier age in &lt;i&gt;Scyl1&lt;/i&gt;/S&lt;i&gt;cyl3&lt;/i&gt; double-deficient mice than in &lt;i&gt;Scyl1&lt;/i&gt;-deficient mice.">
    <entity charOffset="97-122" id="s2476.e0" ontology_id="HP_0007373" text="motor neuron degeneration" type="HP"/>
    <entity charOffset="210-215" id="s2476.e1" ontology_id="6357" text="Scyl1" type="GENE"/>
    <pair e1="s2476.e0" e2="s2476.e1" id="s2476.p0" relation="true"/>
  </sentence>
  <sentence id="s2477" text="Deficiency of the extracellular matrix molecule FRAS1, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (Fras1(bl/bl)) mice.">
    <entity charOffset="48-53" id="s2477.e0" ontology_id="80144" text="FRAS1" type="GENE"/>
    <entity charOffset="114-128" id="s2477.e1" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <pair e1="s2477.e0" e2="s2477.e1" id="s2477.p0" relation="true"/>
  </sentence>
  <sentence id="s2478" text="Deficiency of the extracellular matrix molecule FRAS1, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (Fras1(bl/bl)) mice.">
    <entity charOffset="104-113" id="s2478.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="187-191" id="s2478.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s2478.e0" e2="s2478.e1" id="s2478.p0" relation="true"/>
  </sentence>
  <sentence id="s2479" text="Deficiency of the extracellular matrix molecule FRAS1, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (Fras1(bl/bl)) mice.">
    <entity charOffset="114-128" id="s2479.e0" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <entity charOffset="187-191" id="s2479.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s2479.e0" e2="s2479.e1" id="s2479.p0" relation="true"/>
  </sentence>
  <sentence id="s2480" text="This prevented renal agenesis in Fras1(bl/bl) mice, permitting kidney development and postnatal survival.">
    <entity charOffset="15-29" id="s2480.e0" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <entity charOffset="33-38" id="s2480.e1" ontology_id="80144" text="Fras1" type="GENE"/>
    <pair e1="s2480.e0" e2="s2480.e1" id="s2480.p0" relation="true"/>
  </sentence>
  <sentence id="s2481" text="This prevented renal agenesis in Fras1(bl/bl) mice, permitting kidney development and postnatal survival.">
    <entity charOffset="15-29" id="s2481.e0" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <entity charOffset="46-50" id="s2481.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s2481.e0" e2="s2481.e1" id="s2481.p0" relation="true"/>
  </sentence>
  <sentence id="s2482" text="Developmental and epileptic encephalopathy with hypsarrhythmia is present in most patients with SLC35A2 variants, and is drug-resistant in the majority of cases.">
    <entity charOffset="28-42" id="s2482.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="96-103" id="s2482.e1" ontology_id="7355" text="SLC35A2" type="GENE"/>
    <pair e1="s2482.e0" e2="s2482.e1" id="s2482.p0" relation="true"/>
  </sentence>
  <sentence id="s2483" text="Developmental and epileptic encephalopathy with hypsarrhythmia is present in most patients with SLC35A2 variants, and is drug-resistant in the majority of cases.">
    <entity charOffset="48-62" id="s2483.e0" ontology_id="HP_0002521" text="hypsarrhythmia" type="HP"/>
    <entity charOffset="96-103" id="s2483.e1" ontology_id="7355" text="SLC35A2" type="GENE"/>
    <pair e1="s2483.e0" e2="s2483.e1" id="s2483.p0" relation="true"/>
  </sentence>
  <sentence id="s2484" text="The Nodal co-receptor Cripto is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.">
    <entity charOffset="4-9" id="s2484.e0" ontology_id="4838" text="Nodal" type="GENE"/>
    <entity charOffset="278-284" id="s2484.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2484.e0" e2="s2484.e1" id="s2484.p0" relation="true"/>
  </sentence>
  <sentence id="s2485" text="The Nodal co-receptor Cripto is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.">
    <entity charOffset="22-28" id="s2485.e0" ontology_id="6997" text="Cripto" type="GENE"/>
    <entity charOffset="278-284" id="s2485.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2485.e0" e2="s2485.e1" id="s2485.p0" relation="true"/>
  </sentence>
  <sentence id="s2486" text="Here we investigated methylation of the Cripto promoter in mouse germ cells and human germ cell cancer and correlated this with the level of CRIPTO protein expression.">
    <entity charOffset="96-102" id="s2486.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="141-147" id="s2486.e1" ontology_id="6997" text="CRIPTO" type="GENE"/>
    <pair e1="s2486.e0" e2="s2486.e1" id="s2486.p0" relation="true"/>
  </sentence>
  <sentence id="s2487" text="CRIPTO protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk sac tumor and seminomas.">
    <entity charOffset="0-6" id="s2487.e0" ontology_id="6997" text="CRIPTO" type="GENE"/>
    <entity charOffset="51-60" id="s2487.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s2487.e0" e2="s2487.e1" id="s2487.p0" relation="true"/>
  </sentence>
  <sentence id="s2488" text="CRIPTO protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk sac tumor and seminomas.">
    <entity charOffset="0-6" id="s2488.e0" ontology_id="6997" text="CRIPTO" type="GENE"/>
    <entity charOffset="110-115" id="s2488.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2488.e0" e2="s2488.e1" id="s2488.p0" relation="true"/>
  </sentence>
  <sentence id="s2489" text="Further, cleaved CRIPTO was detected in media from seminoma and embryonal carcinoma cell lines, suggesting that cleaved CRIPTO may provide diagnostic indication of germ cell cancer.">
    <entity charOffset="17-23" id="s2489.e0" ontology_id="6997" text="CRIPTO" type="GENE"/>
    <entity charOffset="174-180" id="s2489.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2489.e0" e2="s2489.e1" id="s2489.p0" relation="true"/>
  </sentence>
  <sentence id="s2490" text="Accordingly, CRIPTO was detectable in serum from 6/15 patients with embryonal carcinoma, 5/15 patients with seminoma, 4/5 patients with germ cell neoplasia in situ cells only and in 1/15 control patients.">
    <entity charOffset="13-19" id="s2490.e0" ontology_id="6997" text="CRIPTO" type="GENE"/>
    <entity charOffset="146-155" id="s2490.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s2490.e0" e2="s2490.e1" id="s2490.p0" relation="true"/>
  </sentence>
  <sentence id="s2491" text="These findings suggest that CRIPTO expression may be a useful serological marker for diagnostic and/or prognostic purposes during germ cell cancer management.">
    <entity charOffset="28-34" id="s2491.e0" ontology_id="6997" text="CRIPTO" type="GENE"/>
    <entity charOffset="140-146" id="s2491.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2491.e0" e2="s2491.e1" id="s2491.p0" relation="false"/>
  </sentence>
  <sentence id="s2492" text="We report the case of a patient with &lt;i&gt;PIGT&lt;/i&gt; mutations who experienced recurrent aseptic meningitis 121 times over 16 years before developing paroxysmal nocturnal haemoglobinuria (PNH).">
    <entity charOffset="40-44" id="s2492.e0" ontology_id="51604" text="PIGT" type="GENE"/>
    <entity charOffset="146-182" id="s2492.e1" ontology_id="HP_0004818" text="paroxysmal nocturnal haemoglobinuria" type="HP"/>
    <pair e1="s2492.e0" e2="s2492.e1" id="s2492.p0" relation="true"/>
  </sentence>
  <sentence id="s2493" text="Targeted expression of a human NGLY1 transgene to tissues involved in ecdysteroidogenesis, &lt;i&gt;e.g.&lt;/i&gt;, prothoracic gland, also partially rescues global developmental delay in mutant homozygotes.">
    <entity charOffset="31-36" id="s2493.e0" ontology_id="55768" text="NGLY1" type="GENE"/>
    <entity charOffset="153-172" id="s2493.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s2493.e0" e2="s2493.e1" id="s2493.p0" relation="true"/>
  </sentence>
  <sentence id="s2494" text="The most common and severe form, primary hyperoxaluria Type I, is due to the deficit of liver peroxisomal alanine/glyoxylate aminotransferase (AGT).">
    <entity charOffset="41-54" id="s2494.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="143-146" id="s2494.e1" ontology_id="189" text="AGT" type="GENE"/>
    <pair e1="s2494.e0" e2="s2494.e1" id="s2494.p0" relation="true"/>
  </sentence>
  <sentence id="s2495" text="Primary hyperoxaluria Type II and primary hyperoxaluria Type III are due to the deficit of glyoxylate reductase/hydroxypyruvate reductase (GRHPR) and 4-hydroxy-2-oxoglutarate aldolase (HOGA1), respectively.">
    <entity charOffset="8-21" id="s2495.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="139-144" id="s2495.e1" ontology_id="9380" text="GRHPR" type="GENE"/>
    <pair e1="s2495.e0" e2="s2495.e1" id="s2495.p0" relation="true"/>
  </sentence>
  <sentence id="s2496" text="Primary hyperoxaluria Type II and primary hyperoxaluria Type III are due to the deficit of glyoxylate reductase/hydroxypyruvate reductase (GRHPR) and 4-hydroxy-2-oxoglutarate aldolase (HOGA1), respectively.">
    <entity charOffset="8-21" id="s2496.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="185-190" id="s2496.e1" ontology_id="112817" text="HOGA1" type="GENE"/>
    <pair e1="s2496.e0" e2="s2496.e1" id="s2496.p0" relation="true"/>
  </sentence>
  <sentence id="s2497" text="Mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL) deficiency is an autosomal recessive disorder affecting the leucine catabolic pathway and ketone body synthesis, and is clinically characterized by metabolic crises with hypoketotic hypoglycemia, metabolic acidosis and hyperammonemia.">
    <entity charOffset="52-57" id="s2497.e0" ontology_id="3155" text="HMGCL" type="GENE"/>
    <entity charOffset="241-253" id="s2497.e1" ontology_id="HP_0001943" text="hypoglycemia" type="HP"/>
    <pair e1="s2497.e0" e2="s2497.e1" id="s2497.p0" relation="true"/>
  </sentence>
  <sentence id="s2498" text="Mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL) deficiency is an autosomal recessive disorder affecting the leucine catabolic pathway and ketone body synthesis, and is clinically characterized by metabolic crises with hypoketotic hypoglycemia, metabolic acidosis and hyperammonemia.">
    <entity charOffset="52-57" id="s2498.e0" ontology_id="3155" text="HMGCL" type="GENE"/>
    <entity charOffset="278-292" id="s2498.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s2498.e0" e2="s2498.e1" id="s2498.p0" relation="true"/>
  </sentence>
  <sentence id="s2499" text="This autosomal recessive disease is caused by mutations in the gene encoding barttin, BSND, an essential subunit of the ClC-K chloride channels expressed in renal and inner ear epithelia.">
    <entity charOffset="5-24" id="s2499.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="86-90" id="s2499.e1" ontology_id="7809" text="BSND" type="GENE"/>
    <pair e1="s2499.e0" e2="s2499.e1" id="s2499.p0" relation="true"/>
  </sentence>
  <sentence id="s2500" text="Previous work has demonstrated the effectiveness of inhibiting CHK1 with small-molecule inhibitors, but the role of CHK1 mediated DDR in medulloblastoma is unknown.">
    <entity charOffset="63-67" id="s2500.e0" ontology_id="1111" text="CHK1" type="GENE"/>
    <entity charOffset="137-152" id="s2500.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s2500.e0" e2="s2500.e1" id="s2500.p0" relation="true"/>
  </sentence>
  <sentence id="s2501" text="Overall, our results demonstrate that small-molecule inhibition of CHK1 in combination with, cisplatin, is more advantageous than either treatment alone, especially for Group 3 medulloblastoma, and therefore this combined therapeutic approach serves as an avenue for further investigation">
    <entity charOffset="67-71" id="s2501.e0" ontology_id="1111" text="CHK1" type="GENE"/>
    <entity charOffset="177-192" id="s2501.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s2501.e0" e2="s2501.e1" id="s2501.p0" relation="true"/>
  </sentence>
  <sentence id="s2502" text="We evaluated whether methylation of tumor-suppressor genes (TSGs) would classify non-muscle-invasive (NMI) bladder cancer subgroups and predict outcome.">
    <entity charOffset="102-105" id="s2502.e0" ontology_id="9111" text="NMI" type="GENE"/>
    <entity charOffset="115-121" id="s2502.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2502.e0" e2="s2502.e1" id="s2502.p0" relation="false"/>
  </sentence>
  <sentence id="s2503" text="A retrospective design included the following paraffin-embedded primary NMI tumor types (n = 251): pTa low grade (LG) (n = 79), pT1LG (n = 81), and pT1 high grade (HG) (n = 91).">
    <entity charOffset="72-75" id="s2503.e0" ontology_id="9111" text="NMI" type="GENE"/>
    <entity charOffset="76-81" id="s2503.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2503.e0" e2="s2503.e1" id="s2503.p0" relation="true"/>
  </sentence>
  <sentence id="s2504" text="A retrospective design included the following paraffin-embedded primary NMI tumor types (n = 251): pTa low grade (LG) (n = 79), pT1LG (n = 81), and pT1 high grade (HG) (n = 91).">
    <entity charOffset="76-81" id="s2504.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="99-102" id="s2504.e1" ontology_id="171558" text="pTa" type="GENE"/>
    <pair e1="s2504.e0" e2="s2504.e1" id="s2504.p0" relation="true"/>
  </sentence>
  <sentence id="s2505" text="Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="41-46" id="s2505.e0" ontology_id="23705" text="IGSF4" type="GENE"/>
    <entity charOffset="113-118" id="s2505.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2505.e0" e2="s2505.e1" id="s2505.p0" relation="true"/>
  </sentence>
  <sentence id="s2506" text="Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="56-62" id="s2506.e0" ontology_id="29108" text="PYCARD" type="GENE"/>
    <entity charOffset="113-118" id="s2506.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2506.e0" e2="s2506.e1" id="s2506.p0" relation="true"/>
  </sentence>
  <sentence id="s2507" text="Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="64-69" id="s2507.e0" ontology_id="1012" text="CDH13" type="GENE"/>
    <entity charOffset="113-118" id="s2507.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2507.e0" e2="s2507.e1" id="s2507.p0" relation="true"/>
  </sentence>
  <sentence id="s2508" text="Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="81-86" id="s2508.e0" ontology_id="140628" text="GATA5" type="GENE"/>
    <entity charOffset="113-118" id="s2508.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2508.e0" e2="s2508.e1" id="s2508.p0" relation="true"/>
  </sentence>
  <sentence id="s2509" text="Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="113-118" id="s2509.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="174-179" id="s2509.e1" ontology_id="6794" text="STK11" type="GENE"/>
    <pair e1="s2509.e0" e2="s2509.e1" id="s2509.p0" relation="false"/>
  </sentence>
  <sentence id="s2510" text="Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="113-118" id="s2510.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="154-158" id="s2510.e1" ontology_id="55743" text="CHFR" type="GENE"/>
    <pair e1="s2510.e0" e2="s2510.e1" id="s2510.p0" relation="true"/>
  </sentence>
  <sentence id="s2511" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="59-81" id="s2511.e0" ontology_id="HP_0007166" text="paroxysmal dyskinesias" type="HP"/>
    <entity charOffset="258-261" id="s2511.e1" ontology_id="773" text="FHM" type="GENE"/>
    <pair e1="s2511.e0" e2="s2511.e1" id="s2511.p0" relation="true"/>
  </sentence>
  <sentence id="s2512" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="83-86" id="s2512.e0" ontology_id="5587" text="PKD" type="GENE"/>
    <entity charOffset="129-137" id="s2512.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2512.e0" e2="s2512.e1" id="s2512.p0" relation="true"/>
  </sentence>
  <sentence id="s2513" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="129-137" id="s2513.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="258-261" id="s2513.e1" ontology_id="773" text="FHM" type="GENE"/>
    <pair e1="s2513.e0" e2="s2513.e1" id="s2513.p0" relation="true"/>
  </sentence>
  <sentence id="s2514" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="211-215" id="s2514.e0" ontology_id="112476" text="ICCA" type="GENE"/>
    <entity charOffset="319-327" id="s2514.e1" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <pair e1="s2514.e0" e2="s2514.e1" id="s2514.p0" relation="false"/>
  </sentence>
  <sentence id="s2515" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="211-215" id="s2515.e0" ontology_id="112476" text="ICCA" type="GENE"/>
    <entity charOffset="328-334" id="s2515.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s2515.e0" e2="s2515.e1" id="s2515.p0" relation="true"/>
  </sentence>
  <sentence id="s2516" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="258-261" id="s2516.e0" ontology_id="773" text="FHM" type="GENE"/>
    <entity charOffset="319-327" id="s2516.e1" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <pair e1="s2516.e0" e2="s2516.e1" id="s2516.p0" relation="true"/>
  </sentence>
  <sentence id="s2517" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="262-266" id="s2517.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="328-334" id="s2517.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s2517.e0" e2="s2517.e1" id="s2517.p0" relation="true"/>
  </sentence>
  <sentence id="s2518" text="OTUD6B encodes a member of the ovarian tumor domain (OTU)-containing subfamily of deubiquitinating enzymes.">
    <entity charOffset="0-6" id="s2518.e0" ontology_id="51633" text="OTUD6B" type="GENE"/>
    <entity charOffset="39-44" id="s2518.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2518.e0" e2="s2518.e1" id="s2518.p0" relation="true"/>
  </sentence>
  <sentence id="s2519" text="Herein, we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features.">
    <entity charOffset="51-57" id="s2519.e0" ontology_id="51633" text="OTUD6B" type="GENE"/>
    <entity charOffset="112-135" id="s2519.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2519.e0" e2="s2519.e1" id="s2519.p0" relation="true"/>
  </sentence>
  <sentence id="s2520" text="Chorea-acanthocytosis (ChAc), a neurodegenerative disease, results from loss-of-function-mutations of the chorein-encoding gene VPS13A.">
    <entity charOffset="23-27" id="s2520.e0" ontology_id="23230" text="ChAc" type="GENE"/>
    <entity charOffset="32-57" id="s2520.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s2520.e0" e2="s2520.e1" id="s2520.p0" relation="true"/>
  </sentence>
  <sentence id="s2521" text="Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.">
    <entity charOffset="72-78" id="s2521.e0" ontology_id="HP_0002072" text="chorea" type="HP"/>
    <entity charOffset="157-160" id="s2521.e1" ontology_id="23049" text="lip" type="GENE"/>
    <pair e1="s2521.e0" e2="s2521.e1" id="s2521.p0" relation="true"/>
  </sentence>
  <sentence id="s2522" text="Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.">
    <entity charOffset="157-160" id="s2522.e0" ontology_id="23049" text="lip" type="GENE"/>
    <entity charOffset="241-249" id="s2522.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s2522.e0" e2="s2522.e1" id="s2522.p0" relation="true"/>
  </sentence>
  <sentence id="s2523" text="Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.">
    <entity charOffset="157-160" id="s2523.e0" ontology_id="23049" text="lip" type="GENE"/>
    <entity charOffset="251-271" id="s2523.e1" ontology_id="HP_0100543" text="cognitive impairment" type="HP"/>
    <pair e1="s2523.e0" e2="s2523.e1" id="s2523.p0" relation="true"/>
  </sentence>
  <sentence id="s2524" text="Chorein, SGK1, ORAI1 and SOCE further confer survival of tumor cells.">
    <entity charOffset="9-13" id="s2524.e0" ontology_id="6446" text="SGK1" type="GENE"/>
    <entity charOffset="57-62" id="s2524.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2524.e0" e2="s2524.e1" id="s2524.p0" relation="true"/>
  </sentence>
  <sentence id="s2525" text="Chorein, SGK1, ORAI1 and SOCE further confer survival of tumor cells.">
    <entity charOffset="15-20" id="s2525.e0" ontology_id="84876" text="ORAI1" type="GENE"/>
    <entity charOffset="57-62" id="s2525.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2525.e0" e2="s2525.e1" id="s2525.p0" relation="true"/>
  </sentence>
  <sentence id="s2526" text="Disruption of Sema3C induced apoptosis of GSCs, but not NPCs or NSTCs, and suppressed tumor growth in orthotopic models of glioblastoma.">
    <entity charOffset="14-20" id="s2526.e0" ontology_id="10512" text="Sema3C" type="GENE"/>
    <entity charOffset="86-91" id="s2526.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2526.e0" e2="s2526.e1" id="s2526.p0" relation="true"/>
  </sentence>
  <sentence id="s2527" text="Disruption of Sema3C induced apoptosis of GSCs, but not NPCs or NSTCs, and suppressed tumor growth in orthotopic models of glioblastoma.">
    <entity charOffset="14-20" id="s2527.e0" ontology_id="10512" text="Sema3C" type="GENE"/>
    <entity charOffset="123-135" id="s2527.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s2527.e0" e2="s2527.e1" id="s2527.p0" relation="true"/>
  </sentence>
  <sentence id="s2528" text="Our study supports the targeting of Sema3C to break this GSC-specific autocrine/paracrine loop in order to improve glioblastoma treatment, potentially with a high therapeutic index.">
    <entity charOffset="36-42" id="s2528.e0" ontology_id="10512" text="Sema3C" type="GENE"/>
    <entity charOffset="115-127" id="s2528.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s2528.e0" e2="s2528.e1" id="s2528.p0" relation="true"/>
  </sentence>
  <sentence id="s2529" text="Here we identified six different de novo missense mutations in DHX30 in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.">
    <entity charOffset="63-68" id="s2529.e0" ontology_id="22907" text="DHX30" type="GENE"/>
    <entity charOffset="120-139" id="s2529.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s2529.e0" e2="s2529.e1" id="s2529.p0" relation="true"/>
  </sentence>
  <sentence id="s2530" text="Here we identified six different de novo missense mutations in DHX30 in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.">
    <entity charOffset="63-68" id="s2530.e0" ontology_id="22907" text="DHX30" type="GENE"/>
    <entity charOffset="147-170" id="s2530.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2530.e0" e2="s2530.e1" id="s2530.p0" relation="true"/>
  </sentence>
  <sentence id="s2531" text="Here we identified six different de novo missense mutations in DHX30 in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.">
    <entity charOffset="63-68" id="s2531.e0" ontology_id="22907" text="DHX30" type="GENE"/>
    <entity charOffset="184-201" id="s2531.e1" ontology_id="HP_0002167" text="speech impairment" type="HP"/>
    <pair e1="s2531.e0" e2="s2531.e1" id="s2531.p0" relation="true"/>
  </sentence>
  <sentence id="s2532" text="Here we identified six different de novo missense mutations in DHX30 in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.">
    <entity charOffset="63-68" id="s2532.e0" ontology_id="22907" text="DHX30" type="GENE"/>
    <entity charOffset="206-224" id="s2532.e1" ontology_id="HP_0001288" text="gait abnormalities" type="HP"/>
    <pair e1="s2532.e0" e2="s2532.e1" id="s2532.p0" relation="true"/>
  </sentence>
  <sentence id="s2533" text="Review of exome sequencing data of the proband and her unaffected son for 40 known genes causing congenital nonsyndromic cataracts revealed two variants, namely c.139G&amp;gt;A (p.Asp47Asn; D47N) in the &lt;i&gt;GJA8&lt;/i&gt; gene and c.2036C&amp;gt;T in the &lt;i&gt;FYCO1&lt;/i&gt; gene to be potentially pathogenic.">
    <entity charOffset="121-129" id="s2533.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="202-206" id="s2533.e1" ontology_id="2703" text="GJA8" type="GENE"/>
    <pair e1="s2533.e0" e2="s2533.e1" id="s2533.p0" relation="true"/>
  </sentence>
  <sentence id="s2534" text="The mutation c.139G&amp;gt;A in the &lt;i&gt;GJA8&lt;/i&gt; gene detected in the present study was also previously reported in Caucasian and Chinese families but with different phenotypes, i.e. nuclear and nuclear pulverulent cataracts.">
    <entity charOffset="35-39" id="s2534.e0" ontology_id="2703" text="GJA8" type="GENE"/>
    <entity charOffset="210-218" id="s2534.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s2534.e0" e2="s2534.e1" id="s2534.p0" relation="true"/>
  </sentence>
  <sentence id="s2535" text="Biallelic pathogenic variants in FBXL4 are associated with an encephalopathic mtDNA maintenance defect syndrome that is a multisystem disease characterized by lactic acidemia, developmental delay, and hypotonia.">
    <entity charOffset="33-38" id="s2535.e0" ontology_id="26235" text="FBXL4" type="GENE"/>
    <entity charOffset="159-174" id="s2535.e1" ontology_id="HP_0003128" text="lactic acidemia" type="HP"/>
    <pair e1="s2535.e0" e2="s2535.e1" id="s2535.p0" relation="true"/>
  </sentence>
  <sentence id="s2536" text="Biallelic pathogenic variants in FBXL4 are associated with an encephalopathic mtDNA maintenance defect syndrome that is a multisystem disease characterized by lactic acidemia, developmental delay, and hypotonia.">
    <entity charOffset="33-38" id="s2536.e0" ontology_id="26235" text="FBXL4" type="GENE"/>
    <entity charOffset="176-195" id="s2536.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s2536.e0" e2="s2536.e1" id="s2536.p0" relation="true"/>
  </sentence>
  <sentence id="s2537" text="The combination of sensorineural hearing loss and partial agenesis of the corpus callosum is a highly recognizable clinico-radiological entity that should prompt mutational analysis of the GPSM2 gene.">
    <entity charOffset="33-45" id="s2537.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="189-194" id="s2537.e1" ontology_id="29899" text="GPSM2" type="GENE"/>
    <pair e1="s2537.e0" e2="s2537.e1" id="s2537.p0" relation="true"/>
  </sentence>
  <sentence id="s2538" text="Knockdown of RIPK4 reduced cell migration and invasion via inhibition of Vimentin, MMP2 and Fibronectin expression in cervical cancer cells.">
    <entity charOffset="13-18" id="s2538.e0" ontology_id="54101" text="RIPK4" type="GENE"/>
    <entity charOffset="127-133" id="s2538.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2538.e0" e2="s2538.e1" id="s2538.p0" relation="true"/>
  </sentence>
  <sentence id="s2539" text="Molecular diagnosis is consistent with the genetic heterogeneity of the HPRT1 gene responsible for HGprt deficiency.">
    <entity charOffset="51-64" id="s2539.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="99-104" id="s2539.e1" ontology_id="3251" text="HGprt" type="GENE"/>
    <pair e1="s2539.e0" e2="s2539.e1" id="s2539.p0" relation="true"/>
  </sentence>
  <sentence id="s2540" text="Molecular diagnosis is consistent with the genetic heterogeneity of the HPRT1 gene responsible for HGprt deficiency.">
    <entity charOffset="51-64" id="s2540.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="72-77" id="s2540.e1" ontology_id="3251" text="HPRT1" type="GENE"/>
    <pair e1="s2540.e0" e2="s2540.e1" id="s2540.p0" relation="true"/>
  </sentence>
  <sentence id="s2541" text="Single large-scale mitochondrial DNA deletions disorders are classified into three main phenotypes with frequent clinical overlap: Pearson marrow-pancreas syndrome (PMS), Kearns-Sayre syndrome (KSS) and chronic progressive external ophtalmoplegia (PEO).">
    <entity charOffset="165-168" id="s2541.e0" ontology_id="5933" text="PMS" type="GENE"/>
    <entity charOffset="211-222" id="s2541.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s2541.e0" e2="s2541.e1" id="s2541.p0" relation="true"/>
  </sentence>
  <sentence id="s2542" text="We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (COPD; P=9.3  10(-4)), peripheral artery disease (PAD; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).">
    <entity charOffset="50-56" id="s2542.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="168-171" id="s2542.e1" ontology_id="79665" text="PAD" type="GENE"/>
    <pair e1="s2542.e0" e2="s2542.e1" id="s2542.p0" relation="true"/>
  </sentence>
  <sentence id="s2543" text="We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (COPD; P=9.3  10(-4)), peripheral artery disease (PAD; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).">
    <entity charOffset="118-122" id="s2543.e0" ontology_id="372" text="COPD" type="GENE"/>
    <entity charOffset="196-212" id="s2543.e1" ontology_id="HP_0004942" text="aortic aneurysms" type="HP"/>
    <pair e1="s2543.e0" e2="s2543.e1" id="s2543.p0" relation="true"/>
  </sentence>
  <sentence id="s2544" text="Although open hERG1 channels did not interact as strongly with &lt;sub&gt;1&lt;/sub&gt; integrins as did closed channels, current flow through hERG1 channels was necessary to activate the integrin-dependent phosphorylation of Tyr&lt;sup&gt;397&lt;/sup&gt; in focal adhesion kinase (FAK) in both normal and cancer cells.">
    <entity charOffset="259-262" id="s2544.e0" ontology_id="5747" text="FAK" type="GENE"/>
    <entity charOffset="283-289" id="s2544.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2544.e0" e2="s2544.e1" id="s2544.p0" relation="true"/>
  </sentence>
  <sentence id="s2545" text="Here, we identify tumor-associated calcium signal transducer 2 (TACSTD2), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with CLDN1 and OCLN and regulates their cellular localization.">
    <entity charOffset="18-23" id="s2545.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="180-184" id="s2545.e1" ontology_id="100506658" text="OCLN" type="GENE"/>
    <pair e1="s2545.e0" e2="s2545.e1" id="s2545.p0" relation="true"/>
  </sentence>
  <sentence id="s2546" text="To better understand the biological role of this factor, we generated Tmem70-deficient mice and found that the homozygous Tmem70-/- knockouts exhibited profound growth retardation and embryonic lethality at 9.5 days post coitum.">
    <entity charOffset="70-76" id="s2546.e0" ontology_id="54968" text="Tmem70" type="GENE"/>
    <entity charOffset="152-160" id="s2546.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s2546.e0" e2="s2546.e1" id="s2546.p0" relation="true"/>
  </sentence>
  <sentence id="s2547" text="We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia type 31 (SCA31) who had dystonia.">
    <entity charOffset="84-90" id="s2547.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="100-105" id="s2547.e1" ontology_id="146227" text="SCA31" type="GENE"/>
    <pair e1="s2547.e0" e2="s2547.e1" id="s2547.p0" relation="true"/>
  </sentence>
  <sentence id="s2548" text="And left hallux moved involuntarily toward the top surface of the foot at rest, that is dystonia.">
    <entity charOffset="74-78" id="s2548.e0" ontology_id="5978" text="rest" type="GENE"/>
    <entity charOffset="88-96" id="s2548.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s2548.e0" e2="s2548.e1" id="s2548.p0" relation="true"/>
  </sentence>
  <sentence id="s2549" text="Our case report support clinical heterogeneity of SCA31, and highlight the importance of considering this type in patients with dystonia and ataxia.">
    <entity charOffset="33-46" id="s2549.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="106-110" id="s2549.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s2549.e0" e2="s2549.e1" id="s2549.p0" relation="true"/>
  </sentence>
  <sentence id="s2550" text="Our case report support clinical heterogeneity of SCA31, and highlight the importance of considering this type in patients with dystonia and ataxia.">
    <entity charOffset="33-46" id="s2550.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="50-55" id="s2550.e1" ontology_id="146227" text="SCA31" type="GENE"/>
    <pair e1="s2550.e0" e2="s2550.e1" id="s2550.p0" relation="true"/>
  </sentence>
  <sentence id="s2551" text="Our case report support clinical heterogeneity of SCA31, and highlight the importance of considering this type in patients with dystonia and ataxia.">
    <entity charOffset="50-55" id="s2551.e0" ontology_id="146227" text="SCA31" type="GENE"/>
    <entity charOffset="141-147" id="s2551.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s2551.e0" e2="s2551.e1" id="s2551.p0" relation="true"/>
  </sentence>
  <sentence id="s2552" text="Our case report support clinical heterogeneity of SCA31, and highlight the importance of considering this type in patients with dystonia and ataxia.">
    <entity charOffset="50-55" id="s2552.e0" ontology_id="146227" text="SCA31" type="GENE"/>
    <entity charOffset="128-136" id="s2552.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s2552.e0" e2="s2552.e1" id="s2552.p0" relation="true"/>
  </sentence>
  <sentence id="s2553" text="Our case report support clinical heterogeneity of SCA31, and highlight the importance of considering this type in patients with dystonia and ataxia.">
    <entity charOffset="106-110" id="s2553.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="128-136" id="s2553.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s2553.e0" e2="s2553.e1" id="s2553.p0" relation="true"/>
  </sentence>
  <sentence id="s2554" text="Patients with the combination of dystonia and ataxia and a family history of a neurodegenerative disorder should be tested for SCA31.">
    <entity charOffset="33-41" id="s2554.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="127-132" id="s2554.e1" ontology_id="146227" text="SCA31" type="GENE"/>
    <pair e1="s2554.e0" e2="s2554.e1" id="s2554.p0" relation="true"/>
  </sentence>
  <sentence id="s2555" text="Mutations in CHCHD2 and CHCHD10 were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).">
    <entity charOffset="13-19" id="s2555.e0" ontology_id="51142" text="CHCHD2" type="GENE"/>
    <entity charOffset="78-104" id="s2555.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s2555.e0" e2="s2555.e1" id="s2555.p0" relation="true"/>
  </sentence>
  <sentence id="s2556" text="Mutations in CHCHD2 and CHCHD10 were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).">
    <entity charOffset="13-19" id="s2556.e0" ontology_id="51142" text="CHCHD2" type="GENE"/>
    <entity charOffset="171-194" id="s2556.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s2556.e0" e2="s2556.e1" id="s2556.p0" relation="true"/>
  </sentence>
  <sentence id="s2557" text="Mutations in CHCHD2 and CHCHD10 were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).">
    <entity charOffset="24-31" id="s2557.e0" ontology_id="400916" text="CHCHD10" type="GENE"/>
    <entity charOffset="171-194" id="s2557.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s2557.e0" e2="s2557.e1" id="s2557.p0" relation="true"/>
  </sentence>
  <sentence id="s2558" text="None of the patients showed CHCHD2 mutations, whereas 1 sporadic MM patient carried a homozygous Pro96Thr substitution in CHCHD10.">
    <entity charOffset="28-34" id="s2558.e0" ontology_id="51142" text="CHCHD2" type="GENE"/>
    <entity charOffset="56-64" id="s2558.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2558.e0" e2="s2558.e1" id="s2558.p0" relation="true"/>
  </sentence>
  <sentence id="s2559" text="None of the patients showed CHCHD2 mutations, whereas 1 sporadic MM patient carried a homozygous Pro96Thr substitution in CHCHD10.">
    <entity charOffset="56-64" id="s2559.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="122-129" id="s2559.e1" ontology_id="400916" text="CHCHD10" type="GENE"/>
    <pair e1="s2559.e0" e2="s2559.e1" id="s2559.p0" relation="true"/>
  </sentence>
  <sentence id="s2560" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="27-33" id="s2560.e0" ontology_id="1029" text="CDKN2A" type="GENE"/>
    <entity charOffset="213-218" id="s2560.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2560.e0" e2="s2560.e1" id="s2560.p0" relation="true"/>
  </sentence>
  <sentence id="s2561" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="35-40" id="s2561.e0" ontology_id="595" text="CCND1" type="GENE"/>
    <entity charOffset="213-218" id="s2561.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2561.e0" e2="s2561.e1" id="s2561.p0" relation="true"/>
  </sentence>
  <sentence id="s2562" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="49-53" id="s2562.e0" ontology_id="1956" text="EGFR" type="GENE"/>
    <entity charOffset="213-218" id="s2562.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2562.e0" e2="s2562.e1" id="s2562.p0" relation="true"/>
  </sentence>
  <sentence id="s2563" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="62-67" id="s2563.e0" ontology_id="2047" text="EPHB1" type="GENE"/>
    <entity charOffset="213-218" id="s2563.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2563.e0" e2="s2563.e1" id="s2563.p0" relation="true"/>
  </sentence>
  <sentence id="s2564" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="76-79" id="s2564.e0" ontology_id="3725" text="JUN" type="GENE"/>
    <entity charOffset="213-218" id="s2564.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2564.e0" e2="s2564.e1" id="s2564.p0" relation="true"/>
  </sentence>
  <sentence id="s2565" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="91-94" id="s2565.e0" ontology_id="5979" text="RET" type="GENE"/>
    <entity charOffset="213-218" id="s2565.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2565.e0" e2="s2565.e1" id="s2565.p0" relation="true"/>
  </sentence>
  <sentence id="s2566" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="148-151" id="s2566.e0" ontology_id="3815" text="KIT" type="GENE"/>
    <entity charOffset="213-218" id="s2566.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2566.e0" e2="s2566.e1" id="s2566.p0" relation="true"/>
  </sentence>
  <sentence id="s2567" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).">
    <entity charOffset="153-176" id="s2567.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="178-183" id="s2567.e1" ontology_id="10075" text="HUWE1" type="GENE"/>
    <pair e1="s2567.e0" e2="s2567.e1" id="s2567.p0" relation="true"/>
  </sentence>
  <sentence id="s2568" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).">
    <entity charOffset="153-176" id="s2568.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="185-190" id="s2568.e1" ontology_id="114787" text="GRIN1" type="GENE"/>
    <pair e1="s2568.e0" e2="s2568.e1" id="s2568.p0" relation="true"/>
  </sentence>
  <sentence id="s2569" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).">
    <entity charOffset="153-176" id="s2569.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="267-273" id="s2569.e1" ontology_id="9343" text="EFTUD2" type="GENE"/>
    <pair e1="s2569.e0" e2="s2569.e1" id="s2569.p0" relation="true"/>
  </sentence>
  <sentence id="s2570" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).">
    <entity charOffset="178-183" id="s2570.e0" ontology_id="10075" text="HUWE1" type="GENE"/>
    <entity charOffset="221-247" id="s2570.e1" ontology_id="HP_0005321" text="mandibulofacial dysostosis" type="HP"/>
    <pair e1="s2570.e0" e2="s2570.e1" id="s2570.p0" relation="true"/>
  </sentence>
  <sentence id="s2571" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).">
    <entity charOffset="178-183" id="s2571.e0" ontology_id="10075" text="HUWE1" type="GENE"/>
    <entity charOffset="253-265" id="s2571.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2571.e0" e2="s2571.e1" id="s2571.p0" relation="true"/>
  </sentence>
  <sentence id="s2572" text="Based on our findings we conclude that for new patients with Kabuki-like phenotypes it is possible to choose a specific molecular testing approach that has the highest detection rate for a given MLL2-Kabuki score, thus fostering more precise patient diagnosis and improved management in these genetically- and phenotypically heterogeneous clinical entities">
    <entity charOffset="195-199" id="s2572.e0" ontology_id="9757" text="MLL2" type="GENE"/>
    <entity charOffset="325-338" id="s2572.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2572.e0" e2="s2572.e1" id="s2572.p0" relation="true"/>
  </sentence>
  <sentence id="s2573" text="Mutations in the elongation of very long chain fatty acid 4 (ELOVL4) gene cause Stargardt macular dystrophy 3 (STGD3), a rare, juvenile-onset, autosomal dominant form of macular degeneration.">
    <entity charOffset="61-67" id="s2573.e0" ontology_id="6785" text="ELOVL4" type="GENE"/>
    <entity charOffset="90-107" id="s2573.e1" ontology_id="HP_0007754" text="macular dystrophy" type="HP"/>
    <pair e1="s2573.e0" e2="s2573.e1" id="s2573.p0" relation="true"/>
  </sentence>
  <sentence id="s2574" text="Mutations in the elongation of very long chain fatty acid 4 (ELOVL4) gene cause Stargardt macular dystrophy 3 (STGD3), a rare, juvenile-onset, autosomal dominant form of macular degeneration.">
    <entity charOffset="61-67" id="s2574.e0" ontology_id="6785" text="ELOVL4" type="GENE"/>
    <entity charOffset="170-190" id="s2574.e1" ontology_id="HP_0000608" text="macular degeneration" type="HP"/>
    <pair e1="s2574.e0" e2="s2574.e1" id="s2574.p0" relation="true"/>
  </sentence>
  <sentence id="s2575" text="Mutations in the elongation of very long chain fatty acid 4 (ELOVL4) gene cause Stargardt macular dystrophy 3 (STGD3), a rare, juvenile-onset, autosomal dominant form of macular degeneration.">
    <entity charOffset="90-107" id="s2575.e0" ontology_id="HP_0007754" text="macular dystrophy" type="HP"/>
    <entity charOffset="111-116" id="s2575.e1" ontology_id="6785" text="STGD3" type="GENE"/>
    <pair e1="s2575.e0" e2="s2575.e1" id="s2575.p0" relation="true"/>
  </sentence>
  <sentence id="s2576" text="Mutations in the elongation of very long chain fatty acid 4 (ELOVL4) gene cause Stargardt macular dystrophy 3 (STGD3), a rare, juvenile-onset, autosomal dominant form of macular degeneration.">
    <entity charOffset="111-116" id="s2576.e0" ontology_id="6785" text="STGD3" type="GENE"/>
    <entity charOffset="170-190" id="s2576.e1" ontology_id="HP_0000608" text="macular degeneration" type="HP"/>
    <pair e1="s2576.e0" e2="s2576.e1" id="s2576.p0" relation="true"/>
  </sentence>
  <sentence id="s2577" text="However, this reduction in PC-VLC-PUFA content in the all-cone retina had no impact on morphology or function and did not accelerate retinal degeneration in the R91W;Nrl-/-;Elovl4 mice.">
    <entity charOffset="27-29" id="s2577.e0" ontology_id="5420" text="PC" type="GENE"/>
    <entity charOffset="133-153" id="s2577.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2577.e0" e2="s2577.e1" id="s2577.p0" relation="true"/>
  </sentence>
  <sentence id="s2578" text="In OSCC samples, a high GLI3 expression was associated with tumour size but not with prognosis.">
    <entity charOffset="24-28" id="s2578.e0" ontology_id="2737" text="GLI3" type="GENE"/>
    <entity charOffset="60-66" id="s2578.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s2578.e0" e2="s2578.e1" id="s2578.p0" relation="true"/>
  </sentence>
  <sentence id="s2579" text="Both display heterotaxy, cardiopulmonary malformations and cystic kidneys, a syndrome also characteristic of mutations in Invs and Nphp3, the other known components of the IC.">
    <entity charOffset="59-73" id="s2579.e0" ontology_id="HP_0000107" text="cystic kidneys" type="HP"/>
    <entity charOffset="131-136" id="s2579.e1" ontology_id="27031" text="Nphp3" type="GENE"/>
    <pair e1="s2579.e0" e2="s2579.e1" id="s2579.p0" relation="true"/>
  </sentence>
  <sentence id="s2580" text="Our results reveal a novel genetic PMF-like mouse model and identify a tumor suppressor role for &lt;i&gt;NOL3&lt;/i&gt; in the pathogenesis of myeloid malignancies">
    <entity charOffset="35-38" id="s2580.e0" ontology_id="5933" text="PMF" type="GENE"/>
    <entity charOffset="71-76" id="s2580.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2580.e0" e2="s2580.e1" id="s2580.p0" relation="true"/>
  </sentence>
  <sentence id="s2581" text="BRWD3 is therefore a new gene implicated in the etiology of XLMR associated with macrocephaly and may cause disease by altering intracellular signaling pathways affecting cellular proliferation">
    <entity charOffset="0-5" id="s2581.e0" ontology_id="254065" text="BRWD3" type="GENE"/>
    <entity charOffset="81-93" id="s2581.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s2581.e0" e2="s2581.e1" id="s2581.p0" relation="true"/>
  </sentence>
  <sentence id="s2582" text="Hereditary angioedema (HAE), due to C1-inhibitor deficiency, is a rare autosomal dominant and potentially life-threatening disease characterised by recurrent oedema attacks of skin, mucosa and viscera.">
    <entity charOffset="11-21" id="s2582.e0" ontology_id="HP_0100665" text="angioedema" type="HP"/>
    <entity charOffset="36-38" id="s2582.e1" ontology_id="393" text="C1" type="GENE"/>
    <pair e1="s2582.e0" e2="s2582.e1" id="s2582.p0" relation="true"/>
  </sentence>
  <sentence id="s2583" text="Due to the rarity and the fact that symptoms of HAE imitate other forms of angioedema and other conditions, HAE may be misdiagnosed, especially in emergency settings.">
    <entity charOffset="26-30" id="s2583.e0" ontology_id="11198" text="fact" type="GENE"/>
    <entity charOffset="75-85" id="s2583.e1" ontology_id="HP_0100665" text="angioedema" type="HP"/>
    <pair e1="s2583.e0" e2="s2583.e1" id="s2583.p0" relation="true"/>
  </sentence>
  <sentence id="s2584" text="Rarely, patients with severe, salt-wasting CAH have deletions of CYP21A2 that extend into TNXB, resulting in a &amp;quot;contiguous gene syndrome&amp;quot; consisting of CAH and EDS.">
    <entity charOffset="65-72" id="s2584.e0" ontology_id="1589" text="CYP21A2" type="GENE"/>
    <entity charOffset="117-141" id="s2584.e1" ontology_id="HP_0001466" text="contiguous gene syndrome" type="HP"/>
    <pair e1="s2584.e0" e2="s2584.e1" id="s2584.p0" relation="true"/>
  </sentence>
  <sentence id="s2585" text="Rarely, patients with severe, salt-wasting CAH have deletions of CYP21A2 that extend into TNXB, resulting in a &amp;quot;contiguous gene syndrome&amp;quot; consisting of CAH and EDS.">
    <entity charOffset="90-94" id="s2585.e0" ontology_id="7148" text="TNXB" type="GENE"/>
    <entity charOffset="117-141" id="s2585.e1" ontology_id="HP_0001466" text="contiguous gene syndrome" type="HP"/>
    <pair e1="s2585.e0" e2="s2585.e1" id="s2585.p0" relation="true"/>
  </sentence>
  <sentence id="s2586" text="Reliable biomarkers for renal cell carcinoma (RCC) have yet to be determined.">
    <entity charOffset="24-44" id="s2586.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="46-49" id="s2586.e1" ontology_id="7515" text="RCC" type="GENE"/>
    <pair e1="s2586.e0" e2="s2586.e1" id="s2586.p0" relation="true"/>
  </sentence>
  <sentence id="s2587" text="Meningiomas may be classified as neurofibromin 2 (NF2)-associated and non-NF2 meningiomas depending on the presence or absence of molecular alterations in the &lt;i&gt;NF2&lt;/i&gt; gene.">
    <entity charOffset="50-53" id="s2587.e0" ontology_id="4771" text="NF2" type="GENE"/>
    <entity charOffset="78-89" id="s2587.e1" ontology_id="HP_0002858" text="meningiomas" type="HP"/>
    <pair e1="s2587.e0" e2="s2587.e1" id="s2587.p0" relation="true"/>
  </sentence>
  <sentence id="s2588" text="In humans, &lt;i&gt;NF2&lt;/i&gt; is the gene responsible for the disease neurofibromatosis type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.">
    <entity charOffset="14-17" id="s2588.e0" ontology_id="4771" text="NF2" type="GENE"/>
    <entity charOffset="131-137" id="s2588.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2588.e0" e2="s2588.e1" id="s2588.p0" relation="true"/>
  </sentence>
  <sentence id="s2589" text="In humans, &lt;i&gt;NF2&lt;/i&gt; is the gene responsible for the disease neurofibromatosis type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.">
    <entity charOffset="14-17" id="s2589.e0" ontology_id="4771" text="NF2" type="GENE"/>
    <entity charOffset="172-182" id="s2589.e1" ontology_id="HP_0002858" text="meningioma" type="HP"/>
    <pair e1="s2589.e0" e2="s2589.e1" id="s2589.p0" relation="true"/>
  </sentence>
  <sentence id="s2590" text="In humans, &lt;i&gt;NF2&lt;/i&gt; is the gene responsible for the disease neurofibromatosis type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.">
    <entity charOffset="80-84" id="s2590.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="131-137" id="s2590.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2590.e0" e2="s2590.e1" id="s2590.p0" relation="true"/>
  </sentence>
  <sentence id="s2591" text="In humans, &lt;i&gt;NF2&lt;/i&gt; is the gene responsible for the disease neurofibromatosis type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.">
    <entity charOffset="80-84" id="s2591.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="172-182" id="s2591.e1" ontology_id="HP_0002858" text="meningioma" type="HP"/>
    <pair e1="s2591.e0" e2="s2591.e1" id="s2591.p0" relation="true"/>
  </sentence>
  <sentence id="s2592" text="&lt;i&gt;Drosophila&lt;/i&gt; Fat is involved in PCP, tumor suppression and Hippo (Hpo) signaling, which is associated with Mer.">
    <entity charOffset="18-21" id="s2592.e0" ontology_id="948" text="Fat" type="GENE"/>
    <entity charOffset="42-47" id="s2592.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2592.e0" e2="s2592.e1" id="s2592.p0" relation="true"/>
  </sentence>
  <sentence id="s2593" text="Meesmann epithelial corneal dystrophy (MECD) is a rare autosomal dominant disorder caused by dominant-negative mutations within the KRT3 or KRT12 genes, which encode the cytoskeletal protein keratins K3 and K12, respectively.">
    <entity charOffset="20-37" id="s2593.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="140-145" id="s2593.e1" ontology_id="3859" text="KRT12" type="GENE"/>
    <pair e1="s2593.e0" e2="s2593.e1" id="s2593.p0" relation="true"/>
  </sentence>
  <sentence id="s2594" text="We present a 22-year old male with hypotonia, developmental delay, seizure disorder, and dysmorphic facial features who enrolled in our rare disease research center at 18 years of age, where exome sequencing revealed a novel, likely pathogenic variant in the OPHN1 gene.">
    <entity charOffset="46-65" id="s2594.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="259-264" id="s2594.e1" ontology_id="4983" text="OPHN1" type="GENE"/>
    <pair e1="s2594.e0" e2="s2594.e1" id="s2594.p0" relation="true"/>
  </sentence>
  <sentence id="s2595" text="We present a 22-year old male with hypotonia, developmental delay, seizure disorder, and dysmorphic facial features who enrolled in our rare disease research center at 18 years of age, where exome sequencing revealed a novel, likely pathogenic variant in the OPHN1 gene.">
    <entity charOffset="67-74" id="s2595.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="259-264" id="s2595.e1" ontology_id="4983" text="OPHN1" type="GENE"/>
    <pair e1="s2595.e0" e2="s2595.e1" id="s2595.p0" relation="true"/>
  </sentence>
  <sentence id="s2596" text="These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. hypoplastic scrotum, microphallus, cryptorchidism), which had been noted to be classic features of patients with OPHN1 variants.">
    <entity charOffset="152-179" id="s2596.e0" ontology_id="HP_0000119" text="genitourinary abnormalities" type="HP"/>
    <entity charOffset="299-304" id="s2596.e1" ontology_id="4983" text="OPHN1" type="GENE"/>
    <pair e1="s2596.e0" e2="s2596.e1" id="s2596.p0" relation="true"/>
  </sentence>
  <sentence id="s2597" text="These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. hypoplastic scrotum, microphallus, cryptorchidism), which had been noted to be classic features of patients with OPHN1 variants.">
    <entity charOffset="186-205" id="s2597.e0" ontology_id="HP_0000046" text="hypoplastic scrotum" type="HP"/>
    <entity charOffset="299-304" id="s2597.e1" ontology_id="4983" text="OPHN1" type="GENE"/>
    <pair e1="s2597.e0" e2="s2597.e1" id="s2597.p0" relation="true"/>
  </sentence>
  <sentence id="s2598" text="These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. hypoplastic scrotum, microphallus, cryptorchidism), which had been noted to be classic features of patients with OPHN1 variants.">
    <entity charOffset="207-219" id="s2598.e0" ontology_id="HP_0030260" text="microphallus" type="HP"/>
    <entity charOffset="299-304" id="s2598.e1" ontology_id="4983" text="OPHN1" type="GENE"/>
    <pair e1="s2598.e0" e2="s2598.e1" id="s2598.p0" relation="true"/>
  </sentence>
  <sentence id="s2599" text="Biallelic mutations in FKBP14 cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.">
    <entity charOffset="23-29" id="s2599.e0" ontology_id="55033" text="FKBP14" type="GENE"/>
    <entity charOffset="114-128" id="s2599.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s2599.e0" e2="s2599.e1" id="s2599.p0" relation="true"/>
  </sentence>
  <sentence id="s2600" text="Biallelic mutations in FKBP14 cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.">
    <entity charOffset="23-29" id="s2600.e0" ontology_id="55033" text="FKBP14" type="GENE"/>
    <entity charOffset="130-138" id="s2600.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s2600.e0" e2="s2600.e1" id="s2600.p0" relation="true"/>
  </sentence>
  <sentence id="s2601" text="Biallelic mutations in FKBP14 cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.">
    <entity charOffset="23-29" id="s2601.e0" ontology_id="55033" text="FKBP14" type="GENE"/>
    <entity charOffset="144-156" id="s2601.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s2601.e0" e2="s2601.e1" id="s2601.p0" relation="true"/>
  </sentence>
  <sentence id="s2602" text="We recently identified a 42-year-old man with severe kyphoscoliosis, restrictive/obstructive lung disease, short stature, mild hearing loss, decreased muscle mass, and a dissection of the celiac artery at age 41.">
    <entity charOffset="107-120" id="s2602.e0" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <entity charOffset="158-162" id="s2602.e1" ontology_id="2200" text="mass" type="GENE"/>
    <pair e1="s2602.e0" e2="s2602.e1" id="s2602.p0" relation="true"/>
  </sentence>
  <sentence id="s2603" text="We recently identified a 42-year-old man with severe kyphoscoliosis, restrictive/obstructive lung disease, short stature, mild hearing loss, decreased muscle mass, and a dissection of the celiac artery at age 41.">
    <entity charOffset="127-139" id="s2603.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="158-162" id="s2603.e1" ontology_id="2200" text="mass" type="GENE"/>
    <pair e1="s2603.e0" e2="s2603.e1" id="s2603.p0" relation="true"/>
  </sentence>
  <sentence id="s2604" text="KLLN is a p53 target gene with DNA binding function and represents a highly plausible candidate breast cancer predisposition gene.">
    <entity charOffset="0-4" id="s2604.e0" ontology_id="100144748" text="KLLN" type="GENE"/>
    <entity charOffset="103-109" id="s2604.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2604.e0" e2="s2604.e1" id="s2604.p0" relation="true"/>
  </sentence>
  <sentence id="s2605" text="A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for BRCA1 and BRCA2 mutations and in 1/84 sporadic breast cancer cases.">
    <entity charOffset="188-193" id="s2605.e0" ontology_id="672" text="BRCA1" type="GENE"/>
    <entity charOffset="242-248" id="s2605.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2605.e0" e2="s2605.e1" id="s2605.p0" relation="true"/>
  </sentence>
  <sentence id="s2606" text="A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for BRCA1 and BRCA2 mutations and in 1/84 sporadic breast cancer cases.">
    <entity charOffset="188-193" id="s2606.e0" ontology_id="672" text="BRCA1" type="GENE"/>
    <entity charOffset="226-234" id="s2606.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2606.e0" e2="s2606.e1" id="s2606.p0" relation="true"/>
  </sentence>
  <sentence id="s2607" text="A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for BRCA1 and BRCA2 mutations and in 1/84 sporadic breast cancer cases.">
    <entity charOffset="198-203" id="s2607.e0" ontology_id="675" text="BRCA2" type="GENE"/>
    <entity charOffset="242-248" id="s2607.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2607.e0" e2="s2607.e1" id="s2607.p0" relation="true"/>
  </sentence>
  <sentence id="s2608" text="A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for BRCA1 and BRCA2 mutations and in 1/84 sporadic breast cancer cases.">
    <entity charOffset="198-203" id="s2608.e0" ontology_id="675" text="BRCA2" type="GENE"/>
    <entity charOffset="226-234" id="s2608.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2608.e0" e2="s2608.e1" id="s2608.p0" relation="true"/>
  </sentence>
  <sentence id="s2609" text="However, the variant was also detected in 2/182 families with known BRCA1 or BRCA2 mutations and in 2/464 non-cancer controls.">
    <entity charOffset="68-73" id="s2609.e0" ontology_id="672" text="BRCA1" type="GENE"/>
    <entity charOffset="110-116" id="s2609.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2609.e0" e2="s2609.e1" id="s2609.p0" relation="true"/>
  </sentence>
  <sentence id="s2610" text="However, the variant was also detected in 2/182 families with known BRCA1 or BRCA2 mutations and in 2/464 non-cancer controls.">
    <entity charOffset="77-82" id="s2610.e0" ontology_id="675" text="BRCA2" type="GENE"/>
    <entity charOffset="110-116" id="s2610.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2610.e0" e2="s2610.e1" id="s2610.p0" relation="true"/>
  </sentence>
  <sentence id="s2611" text="Our data suggest that pathogenic mutations in KLLN are rare in breast cancer families and the c.339_340delAG variant does not represent a high-penetrance breast cancer risk allele">
    <entity charOffset="46-50" id="s2611.e0" ontology_id="100144748" text="KLLN" type="GENE"/>
    <entity charOffset="70-76" id="s2611.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2611.e0" e2="s2611.e1" id="s2611.p0" relation="true"/>
  </sentence>
  <sentence id="s2612" text="To address this gap, we performed a longitudinal exome-wide association study to identify susceptibility loci for obesity and MetS in a Japanese population.">
    <entity charOffset="16-19" id="s2612.e0" ontology_id="5921" text="gap" type="GENE"/>
    <entity charOffset="114-121" id="s2612.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s2612.e0" e2="s2612.e1" id="s2612.p0" relation="true"/>
  </sentence>
  <sentence id="s2613" text="The association of single nucleotide polymorphisms (SNPs) with body mass index (BMI) or the prevalence of obesity and MetS was examined in a generalized estimating equation model.">
    <entity charOffset="68-72" id="s2613.e0" ontology_id="2200" text="mass" type="GENE"/>
    <entity charOffset="106-113" id="s2613.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s2613.e0" e2="s2613.e1" id="s2613.p0" relation="true"/>
  </sentence>
  <sentence id="s2614" text="Consistent with a role in transition zone function, mutation of mouse Tmem231 disrupts the localization of proteins including Arl13b and Inpp5e to cilia, resulting in phenotypes characteristic of MKS such as polydactyly and kidney cysts.">
    <entity charOffset="70-77" id="s2614.e0" ontology_id="79583" text="Tmem231" type="GENE"/>
    <entity charOffset="208-219" id="s2614.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s2614.e0" e2="s2614.e1" id="s2614.p0" relation="true"/>
  </sentence>
  <sentence id="s2615" text="Consistent with a role in transition zone function, mutation of mouse Tmem231 disrupts the localization of proteins including Arl13b and Inpp5e to cilia, resulting in phenotypes characteristic of MKS such as polydactyly and kidney cysts.">
    <entity charOffset="126-132" id="s2615.e0" ontology_id="200894" text="Arl13b" type="GENE"/>
    <entity charOffset="208-219" id="s2615.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s2615.e0" e2="s2615.e1" id="s2615.p0" relation="true"/>
  </sentence>
  <sentence id="s2616" text="Consistent with a role in transition zone function, mutation of mouse Tmem231 disrupts the localization of proteins including Arl13b and Inpp5e to cilia, resulting in phenotypes characteristic of MKS such as polydactyly and kidney cysts.">
    <entity charOffset="137-143" id="s2616.e0" ontology_id="23203" text="Inpp5e" type="GENE"/>
    <entity charOffset="208-219" id="s2616.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s2616.e0" e2="s2616.e1" id="s2616.p0" relation="true"/>
  </sentence>
  <sentence id="s2617" text="Consistent with a role in transition zone function, mutation of mouse Tmem231 disrupts the localization of proteins including Arl13b and Inpp5e to cilia, resulting in phenotypes characteristic of MKS such as polydactyly and kidney cysts.">
    <entity charOffset="196-199" id="s2617.e0" ontology_id="54903" text="MKS" type="GENE"/>
    <entity charOffset="208-219" id="s2617.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s2617.e0" e2="s2617.e1" id="s2617.p0" relation="true"/>
  </sentence>
  <sentence id="s2618" text="CDCA7, a new member of the cell division cycle associated family of genes, is involved in embryonic development and dysregulated in various types of human cancer.">
    <entity charOffset="0-5" id="s2618.e0" ontology_id="83879" text="CDCA7" type="GENE"/>
    <entity charOffset="155-161" id="s2618.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2618.e0" e2="s2618.e1" id="s2618.p0" relation="true"/>
  </sentence>
  <sentence id="s2619" text="Furthermore, CDCA7 increased the expression of EZH2, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.">
    <entity charOffset="13-18" id="s2619.e0" ontology_id="83879" text="CDCA7" type="GENE"/>
    <entity charOffset="83-89" id="s2619.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2619.e0" e2="s2619.e1" id="s2619.p0" relation="true"/>
  </sentence>
  <sentence id="s2620" text="Furthermore, CDCA7 increased the expression of EZH2, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.">
    <entity charOffset="13-18" id="s2620.e0" ontology_id="83879" text="CDCA7" type="GENE"/>
    <entity charOffset="110-115" id="s2620.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2620.e0" e2="s2620.e1" id="s2620.p0" relation="true"/>
  </sentence>
  <sentence id="s2621" text="Furthermore, CDCA7 increased the expression of EZH2, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.">
    <entity charOffset="47-51" id="s2621.e0" ontology_id="2146" text="EZH2" type="GENE"/>
    <entity charOffset="83-89" id="s2621.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2621.e0" e2="s2621.e1" id="s2621.p0" relation="true"/>
  </sentence>
  <sentence id="s2622" text="XRCC4 is one of the essential proteins of this pathway and single-nucleotide polymorphisms (SNPs) of this gene are reported to be associated with cancer risks.">
    <entity charOffset="0-5" id="s2622.e0" ontology_id="7518" text="XRCC4" type="GENE"/>
    <entity charOffset="146-152" id="s2622.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2622.e0" e2="s2622.e1" id="s2622.p0" relation="true"/>
  </sentence>
  <sentence id="s2623" text="the Partner and localizer of BRCA2 (PALB2) gene and risk of breast cancer.">
    <entity charOffset="36-41" id="s2623.e0" ontology_id="79728" text="PALB2" type="GENE"/>
    <entity charOffset="67-73" id="s2623.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2623.e0" e2="s2623.e1" id="s2623.p0" relation="true"/>
  </sentence>
  <sentence id="s2624" text="the association between SNPs in the PALB2 gene and the susceptibility to breast cancer.">
    <entity charOffset="36-41" id="s2624.e0" ontology_id="79728" text="PALB2" type="GENE"/>
    <entity charOffset="80-86" id="s2624.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2624.e0" e2="s2624.e1" id="s2624.p0" relation="true"/>
  </sentence>
  <sentence id="s2625" text="This study investigated the role of potassium channel gene &lt;i&gt;(KCNQ5)&lt;/i&gt; polymorphisms in high myopia.">
    <entity charOffset="63-68" id="s2625.e0" ontology_id="56479" text="KCNQ5" type="GENE"/>
    <entity charOffset="96-102" id="s2625.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s2625.e0" e2="s2625.e1" id="s2625.p0" relation="true"/>
  </sentence>
  <sentence id="s2626" text="Five tag single-nucleotide polymorphisms (SNPs) of &lt;i&gt;KCNQ5&lt;/i&gt; were genotyped, and association testing with high myopia was conducted using logistic regression analysis adjusted for sex and age to give &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;asym&lt;/sub&gt; values, and multiple comparisons were corrected by permutation test to give &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;emp&lt;/sub&gt; values.">
    <entity charOffset="54-59" id="s2626.e0" ontology_id="56479" text="KCNQ5" type="GENE"/>
    <entity charOffset="114-120" id="s2626.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s2626.e0" e2="s2626.e1" id="s2626.p0" relation="true"/>
  </sentence>
  <sentence id="s2627" text="Five tag single-nucleotide polymorphisms (SNPs) of &lt;i&gt;KCNQ5&lt;/i&gt; were genotyped, and association testing with high myopia was conducted using logistic regression analysis adjusted for sex and age to give &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;asym&lt;/sub&gt; values, and multiple comparisons were corrected by permutation test to give &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;emp&lt;/sub&gt; values.">
    <entity charOffset="114-120" id="s2627.e0" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <entity charOffset="183-186" id="s2627.e1" ontology_id="55558" text="sex" type="GENE"/>
    <pair e1="s2627.e0" e2="s2627.e1" id="s2627.p0" relation="true"/>
  </sentence>
  <sentence id="s2628" text="The SNP rs7744813, previously shown to be associated with refractive error and myopia in two GWAS, showed an odds ratio of 0.75 (95% CI 0.63-0.90; &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;emp&lt;/sub&gt; = 0.0058) for the minor allele.">
    <entity charOffset="79-85" id="s2628.e0" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <entity charOffset="188-193" id="s2628.e1" ontology_id="8013" text="minor" type="GENE"/>
    <pair e1="s2628.e0" e2="s2628.e1" id="s2628.p0" relation="true"/>
  </sentence>
  <sentence id="s2629" text="Our data support the involvement of &lt;i&gt;KCNQ5&lt;/i&gt; gene polymorphisms in the genetic susceptibility to high myopia and further exploration of &lt;i&gt;KCNQ5&lt;/i&gt; as a risk factor for high myopia">
    <entity charOffset="39-44" id="s2629.e0" ontology_id="56479" text="KCNQ5" type="GENE"/>
    <entity charOffset="106-112" id="s2629.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s2629.e0" e2="s2629.e1" id="s2629.p0" relation="true"/>
  </sentence>
  <sentence id="s2630" text="Clinical features of affected individuals with LGD variants in NAA15 include variable levels of intellectual disability, delayed speech and motor milestones, and autism spectrum disorder.">
    <entity charOffset="63-68" id="s2630.e0" ontology_id="80155" text="NAA15" type="GENE"/>
    <entity charOffset="162-168" id="s2630.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s2630.e0" e2="s2630.e1" id="s2630.p0" relation="true"/>
  </sentence>
  <sentence id="s2631" text="Further supporting a mechanism of haploinsufficiency, individuals with copy-number variant (CNV) deletions involving NAA15 and surrounding genes can present with mild intellectual disability, mild dysmorphic features, motor delays, and decreased growth.">
    <entity charOffset="117-122" id="s2631.e0" ontology_id="80155" text="NAA15" type="GENE"/>
    <entity charOffset="167-190" id="s2631.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2631.e0" e2="s2631.e1" id="s2631.p0" relation="true"/>
  </sentence>
  <sentence id="s2632" text="Further supporting a mechanism of haploinsufficiency, individuals with copy-number variant (CNV) deletions involving NAA15 and surrounding genes can present with mild intellectual disability, mild dysmorphic features, motor delays, and decreased growth.">
    <entity charOffset="117-122" id="s2632.e0" ontology_id="80155" text="NAA15" type="GENE"/>
    <entity charOffset="218-230" id="s2632.e1" ontology_id="HP_0001270" text="motor delays" type="HP"/>
    <pair e1="s2632.e0" e2="s2632.e1" id="s2632.p0" relation="true"/>
  </sentence>
  <sentence id="s2633" text="Twenty-one genes showed single or cross-cancer associations, including novel associations of SDHA in melanoma and PALB2 in stomach adenocarcinoma.">
    <entity charOffset="40-46" id="s2633.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="93-97" id="s2633.e1" ontology_id="6389" text="SDHA" type="GENE"/>
    <pair e1="s2633.e0" e2="s2633.e1" id="s2633.p0" relation="true"/>
  </sentence>
  <sentence id="s2634" text="Twenty-one genes showed single or cross-cancer associations, including novel associations of SDHA in melanoma and PALB2 in stomach adenocarcinoma.">
    <entity charOffset="40-46" id="s2634.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-119" id="s2634.e1" ontology_id="79728" text="PALB2" type="GENE"/>
    <pair e1="s2634.e0" e2="s2634.e1" id="s2634.p0" relation="true"/>
  </sentence>
  <sentence id="s2635" text="Twenty-one genes showed single or cross-cancer associations, including novel associations of SDHA in melanoma and PALB2 in stomach adenocarcinoma.">
    <entity charOffset="101-109" id="s2635.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="114-119" id="s2635.e1" ontology_id="79728" text="PALB2" type="GENE"/>
    <pair e1="s2635.e0" e2="s2635.e1" id="s2635.p0" relation="true"/>
  </sentence>
  <sentence id="s2636" text="The 659 predisposition variants and 18 additional large deletions in tumor suppressors, including ATM, BRCA1, and NF1, showed low gene expression and frequent (43%) loss of heterozygosity or biallelic two-hit events.">
    <entity charOffset="69-74" id="s2636.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="98-101" id="s2636.e1" ontology_id="472" text="ATM" type="GENE"/>
    <pair e1="s2636.e0" e2="s2636.e1" id="s2636.p0" relation="true"/>
  </sentence>
  <sentence id="s2637" text="The 659 predisposition variants and 18 additional large deletions in tumor suppressors, including ATM, BRCA1, and NF1, showed low gene expression and frequent (43%) loss of heterozygosity or biallelic two-hit events.">
    <entity charOffset="69-74" id="s2637.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="103-108" id="s2637.e1" ontology_id="672" text="BRCA1" type="GENE"/>
    <pair e1="s2637.e0" e2="s2637.e1" id="s2637.p0" relation="true"/>
  </sentence>
  <sentence id="s2638" text="Williams-Beuren syndrome (WBS, no.OMIM 194050) is a rare multisystem genetic disorder caused by a microdeletion on chromosome7q11.23 and characterized by cardiovascular malformations, mental retardation, and a specific facial dysmorphism.">
    <entity charOffset="26-29" id="s2638.e0" ontology_id="2006" text="WBS" type="GENE"/>
    <entity charOffset="156-184" id="s2638.e1" ontology_id="HP_0030680" text="cardiovascular malformations" type="HP"/>
    <pair e1="s2638.e0" e2="s2638.e1" id="s2638.p0" relation="true"/>
  </sentence>
  <sentence id="s2639" text="Williams-Beuren syndrome (WBS, no.OMIM 194050) is a rare multisystem genetic disorder caused by a microdeletion on chromosome7q11.23 and characterized by cardiovascular malformations, mental retardation, and a specific facial dysmorphism.">
    <entity charOffset="26-29" id="s2639.e0" ontology_id="2006" text="WBS" type="GENE"/>
    <entity charOffset="221-239" id="s2639.e1" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <pair e1="s2639.e0" e2="s2639.e1" id="s2639.p0" relation="true"/>
  </sentence>
  <sentence id="s2640" text="The aim of this study was to look for genetic causes of Currarino Syndrome in sporadic patients after ruling out other causes, like chromosome aberrations, disease-causing variants in possible MNX1 cooperating transcription factors and aberrant methylation in the promoter of the MNX1 gene.">
    <entity charOffset="78-86" id="s2640.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="193-197" id="s2640.e1" ontology_id="3110" text="MNX1" type="GENE"/>
    <pair e1="s2640.e0" e2="s2640.e1" id="s2640.p0" relation="true"/>
  </sentence>
  <sentence id="s2641" text="Genetic analysis of a large Indian family with an autosomal dominant cataract phenotype allowed us to identify a novel cataract gene, CRYBA4.">
    <entity charOffset="69-77" id="s2641.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="134-140" id="s2641.e1" ontology_id="1413" text="CRYBA4" type="GENE"/>
    <pair e1="s2641.e0" e2="s2641.e1" id="s2641.p0" relation="true"/>
  </sentence>
  <sentence id="s2642" text="Considering that CRYBA4 associates with CRYBB2 and that the latter protein has been implicated in microphthalmia, mutational analysis of CRYBA4 was performed in 32 patients affected with microphthalmia (small eye).">
    <entity charOffset="40-46" id="s2642.e0" ontology_id="1415" text="CRYBB2" type="GENE"/>
    <entity charOffset="98-112" id="s2642.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s2642.e0" e2="s2642.e1" id="s2642.p0" relation="true"/>
  </sentence>
  <sentence id="s2643" text="This is the first report linking mutations in CRYBA4 to cataractogenesis and microphthalmia">
    <entity charOffset="46-52" id="s2643.e0" ontology_id="1413" text="CRYBA4" type="GENE"/>
    <entity charOffset="56-64" id="s2643.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s2643.e0" e2="s2643.e1" id="s2643.p0" relation="true"/>
  </sentence>
  <sentence id="s2644" text="miR-122, the expression of which is regulated by several transcription factors, such as HNF1A, was recently reported to be associated with type 2 diabetes (T2DM) and hepatocellular carcinoma.">
    <entity charOffset="0-3" id="s2644.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="166-190" id="s2644.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2644.e0" e2="s2644.e1" id="s2644.p0" relation="true"/>
  </sentence>
  <sentence id="s2645" text="miR-122, the expression of which is regulated by several transcription factors, such as HNF1A, was recently reported to be associated with type 2 diabetes (T2DM) and hepatocellular carcinoma.">
    <entity charOffset="88-93" id="s2645.e0" ontology_id="6927" text="HNF1A" type="GENE"/>
    <entity charOffset="166-190" id="s2645.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2645.e0" e2="s2645.e1" id="s2645.p0" relation="true"/>
  </sentence>
  <sentence id="s2646" text="Lower serum miR-122 is a unique feature of HNF1A-DM patients and might partially explain the increased risk for liver neoplasm and abnormal lipid metabolism in HNF1A-DM patients">
    <entity charOffset="12-15" id="s2646.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="118-126" id="s2646.e1" ontology_id="HP_0002664" text="neoplasm" type="HP"/>
    <pair e1="s2646.e0" e2="s2646.e1" id="s2646.p0" relation="true"/>
  </sentence>
  <sentence id="s2647" text="Lower serum miR-122 is a unique feature of HNF1A-DM patients and might partially explain the increased risk for liver neoplasm and abnormal lipid metabolism in HNF1A-DM patients">
    <entity charOffset="43-48" id="s2647.e0" ontology_id="6927" text="HNF1A" type="GENE"/>
    <entity charOffset="118-126" id="s2647.e1" ontology_id="HP_0002664" text="neoplasm" type="HP"/>
    <pair e1="s2647.e0" e2="s2647.e1" id="s2647.p0" relation="true"/>
  </sentence>
  <sentence id="s2648" text="Lower serum miR-122 is a unique feature of HNF1A-DM patients and might partially explain the increased risk for liver neoplasm and abnormal lipid metabolism in HNF1A-DM patients">
    <entity charOffset="49-51" id="s2648.e0" ontology_id="1760" text="DM" type="GENE"/>
    <entity charOffset="118-126" id="s2648.e1" ontology_id="HP_0002664" text="neoplasm" type="HP"/>
    <pair e1="s2648.e0" e2="s2648.e1" id="s2648.p0" relation="true"/>
  </sentence>
  <sentence id="s2649" text="In the present article, we review current evidence supporting the role of SPL in thymic egress, inflammation, and cancer.">
    <entity charOffset="74-77" id="s2649.e0" ontology_id="8879" text="SPL" type="GENE"/>
    <entity charOffset="114-120" id="s2649.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2649.e0" e2="s2649.e1" id="s2649.p0" relation="true"/>
  </sentence>
  <sentence id="s2650" text="These 294 differentially expressed genes and non-coding RNA transcripts provide here a set to specifically define skull base chordomas and to identify novel and potentially important targets for diagnosis, prognosis, and therapy of this cancer.">
    <entity charOffset="87-90" id="s2650.e0" ontology_id="6418" text="set" type="GENE"/>
    <entity charOffset="125-134" id="s2650.e1" ontology_id="HP_0010762" text="chordomas" type="HP"/>
    <pair e1="s2650.e0" e2="s2650.e1" id="s2650.p0" relation="false"/>
  </sentence>
  <sentence id="s2651" text="Therefore, quantification of glioma extracellular pH (pHe) is of crucial importance.">
    <entity charOffset="29-35" id="s2651.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="50-52" id="s2651.e1" ontology_id="5053" text="pH" type="GENE"/>
    <pair e1="s2651.e0" e2="s2651.e1" id="s2651.p0" relation="true"/>
  </sentence>
  <sentence id="s2652" text="This study is focused on the application of the YbHPDO3A (ytterbium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane) probe for in vivo glioma pHe quantification using chemical exchange saturation transfer (CEST)-MRI and its correlation with tumor metabolism assessed by immunohistochemistry.">
    <entity charOffset="142-148" id="s2652.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="149-151" id="s2652.e1" ontology_id="5053" text="pH" type="GENE"/>
    <pair e1="s2652.e0" e2="s2652.e1" id="s2652.p0" relation="true"/>
  </sentence>
  <sentence id="s2653" text="Blocking the expression of PAK1, DIAPH2, and RDX significantly inhibits breast cancer cell migration induced by let-7b repression.">
    <entity charOffset="27-31" id="s2653.e0" ontology_id="5585" text="PAK1" type="GENE"/>
    <entity charOffset="79-85" id="s2653.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2653.e0" e2="s2653.e1" id="s2653.p0" relation="true"/>
  </sentence>
  <sentence id="s2654" text="Blocking the expression of PAK1, DIAPH2, and RDX significantly inhibits breast cancer cell migration induced by let-7b repression.">
    <entity charOffset="33-39" id="s2654.e0" ontology_id="1730" text="DIAPH2" type="GENE"/>
    <entity charOffset="79-85" id="s2654.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2654.e0" e2="s2654.e1" id="s2654.p0" relation="true"/>
  </sentence>
  <sentence id="s2655" text="A previous study recently described two consanguineous families in which homozygous mutations of MCM9 were responsible for POI and short stature.">
    <entity charOffset="97-101" id="s2655.e0" ontology_id="254394" text="MCM9" type="GENE"/>
    <entity charOffset="131-144" id="s2655.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2655.e0" e2="s2655.e1" id="s2655.p0" relation="true"/>
  </sentence>
  <sentence id="s2656" text="Friedreich ataxia (FRDA) is the most frequent progressive autosomal recessive disorder associated with unstable expansion of GAA trinucleotide repeats in the first intron of the FXN gene, which encodes for the mitochondrial frataxin protein.">
    <entity charOffset="11-17" id="s2656.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="125-128" id="s2656.e1" ontology_id="2548" text="GAA" type="GENE"/>
    <pair e1="s2656.e0" e2="s2656.e1" id="s2656.p0" relation="true"/>
  </sentence>
  <sentence id="s2657" text="Friedreich ataxia (FRDA) is the most frequent progressive autosomal recessive disorder associated with unstable expansion of GAA trinucleotide repeats in the first intron of the FXN gene, which encodes for the mitochondrial frataxin protein.">
    <entity charOffset="11-17" id="s2657.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="178-181" id="s2657.e1" ontology_id="2395" text="FXN" type="GENE"/>
    <pair e1="s2657.e0" e2="s2657.e1" id="s2657.p0" relation="true"/>
  </sentence>
  <sentence id="s2658" text="The aim of the study was to understand the role of SLIT2-ROBO1/2-CDC42 signalling pathways in development of breast cancer (BC).">
    <entity charOffset="51-56" id="s2658.e0" ontology_id="6586" text="SLIT2" type="GENE"/>
    <entity charOffset="116-122" id="s2658.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2658.e0" e2="s2658.e1" id="s2658.p0" relation="true"/>
  </sentence>
  <sentence id="s2659" text="The aim of the study was to understand the role of SLIT2-ROBO1/2-CDC42 signalling pathways in development of breast cancer (BC).">
    <entity charOffset="57-62" id="s2659.e0" ontology_id="6091" text="ROBO1" type="GENE"/>
    <entity charOffset="116-122" id="s2659.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2659.e0" e2="s2659.e1" id="s2659.p0" relation="true"/>
  </sentence>
  <sentence id="s2660" text="Significantly, higher alteration of SLIT2 locus was observed in triple negative breast cancer (TNBC) over HER2 subtype (P = 0.0014).">
    <entity charOffset="36-41" id="s2660.e0" ontology_id="6586" text="SLIT2" type="GENE"/>
    <entity charOffset="87-93" id="s2660.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2660.e0" e2="s2660.e1" id="s2660.p0" relation="true"/>
  </sentence>
  <sentence id="s2661" text="Significantly, higher alteration of SLIT2 locus was observed in triple negative breast cancer (TNBC) over HER2 subtype (P = 0.0014).">
    <entity charOffset="87-93" id="s2661.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="106-110" id="s2661.e1" ontology_id="2064" text="HER2" type="GENE"/>
    <pair e1="s2661.e0" e2="s2661.e1" id="s2661.p0" relation="true"/>
  </sentence>
  <sentence id="s2662" text="Results indicate the importance of SLIT2-ROBO1-CDC42 signalling pathway in predicting tumour progression.">
    <entity charOffset="35-40" id="s2662.e0" ontology_id="6586" text="SLIT2" type="GENE"/>
    <entity charOffset="86-92" id="s2662.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s2662.e0" e2="s2662.e1" id="s2662.p0" relation="true"/>
  </sentence>
  <sentence id="s2663" text="Results indicate the importance of SLIT2-ROBO1-CDC42 signalling pathway in predicting tumour progression.">
    <entity charOffset="41-46" id="s2663.e0" ontology_id="6091" text="ROBO1" type="GENE"/>
    <entity charOffset="86-92" id="s2663.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s2663.e0" e2="s2663.e1" id="s2663.p0" relation="true"/>
  </sentence>
  <sentence id="s2664" text="Results indicate the importance of SLIT2-ROBO1-CDC42 signalling pathway in predicting tumour progression.">
    <entity charOffset="47-52" id="s2664.e0" ontology_id="998" text="CDC42" type="GENE"/>
    <entity charOffset="86-92" id="s2664.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s2664.e0" e2="s2664.e1" id="s2664.p0" relation="true"/>
  </sentence>
  <sentence id="s2665" text="An analysis approach combing supervised significant analysis of microarray (SAM), prediction analysis of microarray (PAM), and unsupervised hierarchical cluster methodologies statistically determined 211 upregulated and 78 downregulated genes between liver cancer and non-cancer liver tissues, and demonstrated &amp;gt; or = 93% accuracy in classifying the tissue samples.">
    <entity charOffset="117-120" id="s2665.e0" ontology_id="23077" text="PAM" type="GENE"/>
    <entity charOffset="257-263" id="s2665.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2665.e0" e2="s2665.e1" id="s2665.p0" relation="true"/>
  </sentence>
  <sentence id="s2666" text="Numerous genes found in this study were also differentially expressed in human HCC and many other human cancers including breast, prostate and lung cancers, etc., serving as tumor suppressors, promoters, prognostic markers or chemotherapy targets.">
    <entity charOffset="79-82" id="s2666.e0" ontology_id="84668" text="HCC" type="GENE"/>
    <entity charOffset="104-110" id="s2666.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2666.e0" e2="s2666.e1" id="s2666.p0" relation="true"/>
  </sentence>
  <sentence id="s2667" text="LETM1 protein was detected in 107 TNBC, 42 ductal carcinoma in situ (DCIS) and 65 adjacent non-tumor breast tissues using immunohistochemical (IHC) staining.">
    <entity charOffset="0-5" id="s2667.e0" ontology_id="3954" text="LETM1" type="GENE"/>
    <entity charOffset="95-100" id="s2667.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2667.e0" e2="s2667.e1" id="s2667.p0" relation="true"/>
  </sentence>
  <sentence id="s2668" text="In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="14-18" id="s2668.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="120-131" id="s2668.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s2668.e0" e2="s2668.e1" id="s2668.p0" relation="true"/>
  </sentence>
  <sentence id="s2669" text="In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="19-23" id="s2669.e0" ontology_id="60529" text="ALX4" type="GENE"/>
    <entity charOffset="120-131" id="s2669.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s2669.e0" e2="s2669.e1" id="s2669.p0" relation="true"/>
  </sentence>
  <sentence id="s2670" text="In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="19-23" id="s2670.e0" ontology_id="60529" text="ALX4" type="GENE"/>
    <entity charOffset="228-236" id="s2670.e1" ontology_id="HP_0001596" text="alopecia" type="HP"/>
    <pair e1="s2670.e0" e2="s2670.e1" id="s2670.p0" relation="true"/>
  </sentence>
  <sentence id="s2671" text="In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="19-23" id="s2671.e0" ontology_id="60529" text="ALX4" type="GENE"/>
    <entity charOffset="246-262" id="s2671.e1" ontology_id="HP_0001363" text="craniosynostosis" type="HP"/>
    <pair e1="s2671.e0" e2="s2671.e1" id="s2671.p0" relation="true"/>
  </sentence>
  <sentence id="s2672" text="In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="19-23" id="s2672.e0" ontology_id="60529" text="ALX4" type="GENE"/>
    <entity charOffset="264-277" id="s2672.e1" ontology_id="HP_0000316" text="hypertelorism" type="HP"/>
    <pair e1="s2672.e0" e2="s2672.e1" id="s2672.p0" relation="true"/>
  </sentence>
  <sentence id="s2673" text="By using exome and capillary sequencing, we here identify biallelic UBE3B mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.">
    <entity charOffset="68-73" id="s2673.e0" ontology_id="89910" text="UBE3B" type="GENE"/>
    <entity charOffset="286-310" id="s2673.e1" ontology_id="HP_0000252" text="small head circumference" type="HP"/>
    <pair e1="s2673.e0" e2="s2673.e1" id="s2673.p0" relation="true"/>
  </sentence>
  <sentence id="s2674" text="By using exome and capillary sequencing, we here identify biallelic UBE3B mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.">
    <entity charOffset="68-73" id="s2674.e0" ontology_id="89910" text="UBE3B" type="GENE"/>
    <entity charOffset="312-331" id="s2674.e1" ontology_id="HP_0001999" text="facial dysmorphisms" type="HP"/>
    <pair e1="s2674.e0" e2="s2674.e1" id="s2674.p0" relation="true"/>
  </sentence>
  <sentence id="s2675" text="Brain MRI showed diffuse leukoencephalopathy, suggesting CADASIL.">
    <entity charOffset="25-44" id="s2675.e0" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <entity charOffset="57-64" id="s2675.e1" ontology_id="4854" text="CADASIL" type="GENE"/>
    <pair e1="s2675.e0" e2="s2675.e1" id="s2675.p0" relation="true"/>
  </sentence>
  <sentence id="s2676" text="Induction of p53 by 5-Aza-dC was tested in vitro using cancer cells.">
    <entity charOffset="26-28" id="s2676.e0" ontology_id="1641" text="dC" type="GENE"/>
    <entity charOffset="55-61" id="s2676.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2676.e0" e2="s2676.e1" id="s2676.p0" relation="true"/>
  </sentence>
  <sentence id="s2677" text="Through genetic mapping of disease loci and whole-exome sequencing in four unrelated multiplex families presenting with severe AMC, we identified biallelic loss-of-function mutations in LGI4 (leucine-rich glioma-inactivated 4).">
    <entity charOffset="186-190" id="s2677.e0" ontology_id="163175" text="LGI4" type="GENE"/>
    <entity charOffset="205-211" id="s2677.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2677.e0" e2="s2677.e1" id="s2677.p0" relation="true"/>
  </sentence>
  <sentence id="s2678" text="This is consistent with previous studies reporting arthrogryposis in Lgi4-deficient mice due to peripheral hypomyelination.">
    <entity charOffset="51-65" id="s2678.e0" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <entity charOffset="69-73" id="s2678.e1" ontology_id="163175" text="Lgi4" type="GENE"/>
    <pair e1="s2678.e0" e2="s2678.e1" id="s2678.p0" relation="true"/>
  </sentence>
  <sentence id="s2679" text="Genetic reduction of Adcy1 also ameliorates autism-related symptoms including repetitive behaviour, defective social interaction and audiogenic seizures.">
    <entity charOffset="21-26" id="s2679.e0" ontology_id="107" text="Adcy1" type="GENE"/>
    <entity charOffset="44-50" id="s2679.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s2679.e0" e2="s2679.e1" id="s2679.p0" relation="true"/>
  </sentence>
  <sentence id="s2680" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s2680.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="31-36" id="s2680.e1" ontology_id="825" text="LGMD2" type="GENE"/>
    <pair e1="s2680.e0" e2="s2680.e1" id="s2680.p0" relation="true"/>
  </sentence>
  <sentence id="s2681" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s2681.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="208-214" id="s2681.e1" ontology_id="22954" text="TRIM32" type="GENE"/>
    <pair e1="s2681.e0" e2="s2681.e1" id="s2681.p0" relation="true"/>
  </sentence>
  <sentence id="s2682" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s2682.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="256-261" id="s2682.e1" ontology_id="10585" text="POMT1" type="GENE"/>
    <pair e1="s2682.e0" e2="s2682.e1" id="s2682.p0" relation="true"/>
  </sentence>
  <sentence id="s2683" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s2683.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="312-317" id="s2683.e1" ontology_id="29954" text="POMT2" type="GENE"/>
    <pair e1="s2683.e0" e2="s2683.e1" id="s2683.p0" relation="true"/>
  </sentence>
  <sentence id="s2684" text="Our data indicate that 5-hmC might serve as a metastasis marker for cancer and that the decreased expression of LSH is likely one of the mechanisms of genome instability underlying 5-hmC loss in cancer">
    <entity charOffset="68-74" id="s2684.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="112-115" id="s2684.e1" ontology_id="3070" text="LSH" type="GENE"/>
    <pair e1="s2684.e0" e2="s2684.e1" id="s2684.p0" relation="true"/>
  </sentence>
  <sentence id="s2685" text="It has been reported that functionally distinct cancer stem cells (CSCs) exist in human bladder cancer (BCa).">
    <entity charOffset="48-54" id="s2685.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="104-107" id="s2685.e1" ontology_id="29760" text="BCa" type="GENE"/>
    <pair e1="s2685.e0" e2="s2685.e1" id="s2685.p0" relation="true"/>
  </sentence>
  <sentence id="s2686" text="Using s as a reporter of Sox2 transcriptional expression, we demonstrated that Sox2-expressing cells mark a subpopulation of tumor cells that fuel the growth of established BCa.">
    <entity charOffset="125-130" id="s2686.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="173-176" id="s2686.e1" ontology_id="29760" text="BCa" type="GENE"/>
    <pair e1="s2686.e0" e2="s2686.e1" id="s2686.p0" relation="true"/>
  </sentence>
  <sentence id="s2687" text="KRT5 and KRT6 (KRT6A, KRT6B &amp;amp; KRT6C) gene expression was assessed in publically available serous ovarian cancer data sets, ovarian cancer cell lines and primary serous ovarian cancer cells.">
    <entity charOffset="0-4" id="s2687.e0" ontology_id="3852" text="KRT5" type="GENE"/>
    <entity charOffset="109-115" id="s2687.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2687.e0" e2="s2687.e1" id="s2687.p0" relation="true"/>
  </sentence>
  <sentence id="s2688" text="Survival analyses showed that high KRT5 mRNA in stage III/IV serous ovarian cancers was significantly associated with reduced progression-free (HR 1.38, P &amp;lt; 0.0001) and overall survival (HR 1.28, P = 0.013) whilst high KRT6 mRNA was only associated with reduced progression-free survival (HR 1.2, P = 0.031).">
    <entity charOffset="35-39" id="s2688.e0" ontology_id="3852" text="KRT5" type="GENE"/>
    <entity charOffset="76-82" id="s2688.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2688.e0" e2="s2688.e1" id="s2688.p0" relation="true"/>
  </sentence>
  <sentence id="s2689" text="Survival analyses showed that high KRT5 mRNA in stage III/IV serous ovarian cancers was significantly associated with reduced progression-free (HR 1.38, P &amp;lt; 0.0001) and overall survival (HR 1.28, P = 0.013) whilst high KRT6 mRNA was only associated with reduced progression-free survival (HR 1.2, P = 0.031).">
    <entity charOffset="76-82" id="s2689.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="222-226" id="s2689.e1" ontology_id="140807" text="KRT6" type="GENE"/>
    <pair e1="s2689.e0" e2="s2689.e1" id="s2689.p0" relation="true"/>
  </sentence>
  <sentence id="s2690" text="KRT5 but not KRT6C mRNA expression was increased in chemotherapy resistant primary serous ovarian cancer cells compared to chemotherapy sensitive cells.">
    <entity charOffset="13-17" id="s2690.e0" ontology_id="140807" text="KRT6" type="GENE"/>
    <entity charOffset="98-104" id="s2690.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2690.e0" e2="s2690.e1" id="s2690.p0" relation="false"/>
  </sentence>
  <sentence id="s2691" text="Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="71-76" id="s2691.e0" ontology_id="5594" text="MAPK1" type="GENE"/>
    <entity charOffset="144-163" id="s2691.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s2691.e0" e2="s2691.e1" id="s2691.p0" relation="true"/>
  </sentence>
  <sentence id="s2692" text="Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="78-83" id="s2692.e0" ontology_id="6774" text="STAT3" type="GENE"/>
    <entity charOffset="144-163" id="s2692.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s2692.e0" e2="s2692.e1" id="s2692.p0" relation="true"/>
  </sentence>
  <sentence id="s2693" text="Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="95-99" id="s2693.e0" ontology_id="3716" text="JAK1" type="GENE"/>
    <entity charOffset="144-163" id="s2693.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s2693.e0" e2="s2693.e1" id="s2693.p0" relation="true"/>
  </sentence>
  <sentence id="s2694" text="Patients with physical findings suggestive of Treacher Collins syndrome (TCS) or mandibulofacial dysostosis (MFD) and macrocytic anemia diagnostic of Diamond-Blackfan anemia (DBA) have been reported.">
    <entity charOffset="73-76" id="s2694.e0" ontology_id="6949" text="TCS" type="GENE"/>
    <entity charOffset="81-107" id="s2694.e1" ontology_id="HP_0005321" text="mandibulofacial dysostosis" type="HP"/>
    <pair e1="s2694.e0" e2="s2694.e1" id="s2694.p0" relation="true"/>
  </sentence>
  <sentence id="s2695" text="Patients with physical findings suggestive of Treacher Collins syndrome (TCS) or mandibulofacial dysostosis (MFD) and macrocytic anemia diagnostic of Diamond-Blackfan anemia (DBA) have been reported.">
    <entity charOffset="81-107" id="s2695.e0" ontology_id="HP_0005321" text="mandibulofacial dysostosis" type="HP"/>
    <entity charOffset="175-178" id="s2695.e1" ontology_id="6223" text="DBA" type="GENE"/>
    <pair e1="s2695.e0" e2="s2695.e1" id="s2695.p0" relation="true"/>
  </sentence>
  <sentence id="s2696" text="We conclude that the phenotype combining features of TCS with DBA is genetically heterogeneous.">
    <entity charOffset="53-56" id="s2696.e0" ontology_id="6949" text="TCS" type="GENE"/>
    <entity charOffset="81-94" id="s2696.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2696.e0" e2="s2696.e1" id="s2696.p0" relation="true"/>
  </sentence>
  <sentence id="s2697" text="We conclude that the phenotype combining features of TCS with DBA is genetically heterogeneous.">
    <entity charOffset="62-65" id="s2697.e0" ontology_id="6223" text="DBA" type="GENE"/>
    <entity charOffset="81-94" id="s2697.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2697.e0" e2="s2697.e1" id="s2697.p0" relation="true"/>
  </sentence>
  <sentence id="s2698" text="In vitro head and neck cancer studies have demonstrated that epidermal growth factor receptor kinase substrate 8 (Eps8) overexpression contributes to squamous carcinogenesis.">
    <entity charOffset="23-29" id="s2698.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-118" id="s2698.e1" ontology_id="2059" text="Eps8" type="GENE"/>
    <pair e1="s2698.e0" e2="s2698.e1" id="s2698.p0" relation="true"/>
  </sentence>
  <sentence id="s2699" text="In conclusion, our data offer in vivo support that, in HNSCCs, Eps8 is involved in tumor invasion but not necessarily the development of regional LN metastasis.">
    <entity charOffset="63-67" id="s2699.e0" ontology_id="2059" text="Eps8" type="GENE"/>
    <entity charOffset="83-88" id="s2699.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2699.e0" e2="s2699.e1" id="s2699.p0" relation="true"/>
  </sentence>
  <sentence id="s2700" text="A case with GABRB3 (C.905A&amp;gt;G) had seizure controlled for 3 mouths.">
    <entity charOffset="12-18" id="s2700.e0" ontology_id="2562" text="GABRB3" type="GENE"/>
    <entity charOffset="37-44" id="s2700.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s2700.e0" e2="s2700.e1" id="s2700.p0" relation="true"/>
  </sentence>
  <sentence id="s2701" text="Pedigree analysis in the Haflinger breed supports a simple recessive mode of inheritance and a genome-wide association study (N=23) identified a 1.5 Mb locus on ECA12 significantly associated with limbal SCC (P&lt;sub&gt;corrected&lt;/sub&gt; = 0.04).">
    <entity charOffset="69-88" id="s2701.e0" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <entity charOffset="206-209" id="s2701.e1" ontology_id="6317" text="SCC" type="GENE"/>
    <pair e1="s2701.e0" e2="s2701.e1" id="s2701.p0" relation="true"/>
  </sentence>
  <sentence id="s2702" text="Furthermore, in humans xeroderma pigmentosum complementation group E, a disease characterized by sun sensitivity and increased risk of cutaneous SCC and melanomas, is explained by mutations in DDB2.">
    <entity charOffset="145-148" id="s2702.e0" ontology_id="6317" text="SCC" type="GENE"/>
    <entity charOffset="153-162" id="s2702.e1" ontology_id="HP_0002861" text="melanomas" type="HP"/>
    <pair e1="s2702.e0" e2="s2702.e1" id="s2702.p0" relation="true"/>
  </sentence>
  <sentence id="s2703" text="Here, using a microarray screen, we found that knocking down DJ-1 in human neuroblastoma cells results in down-regulation of microRNA-221 (miR-221).">
    <entity charOffset="61-65" id="s2703.e0" ontology_id="11315" text="DJ-1" type="GENE"/>
    <entity charOffset="75-88" id="s2703.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s2703.e0" e2="s2703.e1" id="s2703.p0" relation="true"/>
  </sentence>
  <sentence id="s2704" text="Here, using a microarray screen, we found that knocking down DJ-1 in human neuroblastoma cells results in down-regulation of microRNA-221 (miR-221).">
    <entity charOffset="75-88" id="s2704.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="139-142" id="s2704.e1" ontology_id="220972" text="miR" type="GENE"/>
    <pair e1="s2704.e0" e2="s2704.e1" id="s2704.p0" relation="true"/>
  </sentence>
  <sentence id="s2705" text="Gap junction beta-1 (GJB1) gene mutations affecting the gap junction protein connexin32 (Cx32) cause the X-linked Charcot-Marie-Tooth disease (CMT1X), a common inherited neuropathy.">
    <entity charOffset="21-25" id="s2705.e0" ontology_id="2705" text="GJB1" type="GENE"/>
    <entity charOffset="170-180" id="s2705.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s2705.e0" e2="s2705.e1" id="s2705.p0" relation="true"/>
  </sentence>
  <sentence id="s2706" text="Mutations in the glucosylceramidase beta (GBA) gene are strongly associated with neurodegenerative diseases marked by protein aggregation.">
    <entity charOffset="42-45" id="s2706.e0" ontology_id="2629" text="GBA" type="GENE"/>
    <entity charOffset="81-106" id="s2706.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s2706.e0" e2="s2706.e1" id="s2706.p0" relation="true"/>
  </sentence>
  <sentence id="s2707" text="We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a FOXG1-like presentation.">
    <entity charOffset="60-72" id="s2707.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="187-192" id="s2707.e1" ontology_id="2290" text="FOXG1" type="GENE"/>
    <pair e1="s2707.e0" e2="s2707.e1" id="s2707.p0" relation="true"/>
  </sentence>
  <sentence id="s2708" text="We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a FOXG1-like presentation.">
    <entity charOffset="130-146" id="s2708.e0" ontology_id="HP_0002120" text="cortical atrophy" type="HP"/>
    <entity charOffset="187-192" id="s2708.e1" ontology_id="2290" text="FOXG1" type="GENE"/>
    <pair e1="s2708.e0" e2="s2708.e1" id="s2708.p0" relation="true"/>
  </sentence>
  <sentence id="s2709" text="The regulation of the post-mitotic neural survival activity of TLE1 depends critically on an interaction with FOXG1, a gene shown to be involved in a postnatal microcephaly syndrome.">
    <entity charOffset="63-67" id="s2709.e0" ontology_id="7088" text="TLE1" type="GENE"/>
    <entity charOffset="160-172" id="s2709.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2709.e0" e2="s2709.e1" id="s2709.p0" relation="false"/>
  </sentence>
  <sentence id="s2710" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.">
    <entity charOffset="93-96" id="s2710.e0" ontology_id="472" text="ATM" type="GENE"/>
    <entity charOffset="229-235" id="s2710.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2710.e0" e2="s2710.e1" id="s2710.p0" relation="true"/>
  </sentence>
  <sentence id="s2711" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.">
    <entity charOffset="101-106" id="s2711.e0" ontology_id="11200" text="CHEK2" type="GENE"/>
    <entity charOffset="229-235" id="s2711.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2711.e0" e2="s2711.e1" id="s2711.p0" relation="true"/>
  </sentence>
  <sentence id="s2712" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.">
    <entity charOffset="229-235" id="s2712.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="277-283" id="s2712.e1" ontology_id="5889" text="RAD51C" type="GENE"/>
    <pair e1="s2712.e0" e2="s2712.e1" id="s2712.p0" relation="true"/>
  </sentence>
  <sentence id="s2713" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.">
    <entity charOffset="229-235" id="s2713.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="285-291" id="s2713.e1" ontology_id="2177" text="FANCD2" type="GENE"/>
    <pair e1="s2713.e0" e2="s2713.e1" id="s2713.p0" relation="true"/>
  </sentence>
  <sentence id="s2714" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.">
    <entity charOffset="229-235" id="s2714.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="293-298" id="s2714.e1" ontology_id="55215" text="FANCI" type="GENE"/>
    <pair e1="s2714.e0" e2="s2714.e1" id="s2714.p0" relation="true"/>
  </sentence>
  <sentence id="s2715" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.">
    <entity charOffset="229-235" id="s2715.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="300-305" id="s2715.e1" ontology_id="9702" text="CEP57" type="GENE"/>
    <pair e1="s2715.e0" e2="s2715.e1" id="s2715.p0" relation="true"/>
  </sentence>
  <sentence id="s2716" text="Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian cancer and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &amp;quot;likely pathogenic&amp;quot; missense variants in ATM, BRIP1, CHEK2 and TP53.">
    <entity charOffset="121-127" id="s2716.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="269-272" id="s2716.e1" ontology_id="472" text="ATM" type="GENE"/>
    <pair e1="s2716.e0" e2="s2716.e1" id="s2716.p0" relation="true"/>
  </sentence>
  <sentence id="s2717" text="Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian cancer and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &amp;quot;likely pathogenic&amp;quot; missense variants in ATM, BRIP1, CHEK2 and TP53.">
    <entity charOffset="121-127" id="s2717.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="281-286" id="s2717.e1" ontology_id="11200" text="CHEK2" type="GENE"/>
    <pair e1="s2717.e0" e2="s2717.e1" id="s2717.p0" relation="true"/>
  </sentence>
  <sentence id="s2718" text="Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian cancer and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &amp;quot;likely pathogenic&amp;quot; missense variants in ATM, BRIP1, CHEK2 and TP53.">
    <entity charOffset="121-127" id="s2718.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="274-279" id="s2718.e1" ontology_id="64979" text="BRIP1" type="GENE"/>
    <pair e1="s2718.e0" e2="s2718.e1" id="s2718.p0" relation="true"/>
  </sentence>
  <sentence id="s2719" text="Homeobox A11 (HOXA11) is one of the hypermethylated genes in breast cancer and its function in breast tumorigenesis remains elusive.">
    <entity charOffset="14-20" id="s2719.e0" ontology_id="3207" text="HOXA11" type="GENE"/>
    <entity charOffset="68-74" id="s2719.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2719.e0" e2="s2719.e1" id="s2719.p0" relation="true"/>
  </sentence>
  <sentence id="s2720" text="Homeobox A11 (HOXA11) is one of the hypermethylated genes in breast cancer and its function in breast tumorigenesis remains elusive.">
    <entity charOffset="14-20" id="s2720.e0" ontology_id="3207" text="HOXA11" type="GENE"/>
    <entity charOffset="102-107" id="s2720.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2720.e0" e2="s2720.e1" id="s2720.p0" relation="true"/>
  </sentence>
  <sentence id="s2721" text="In this study, we analyzed the methylation status of HOXA11 in 264 paired breast cancer and normal tissue as well as in matched serum samples by MethyLight assay.">
    <entity charOffset="53-59" id="s2721.e0" ontology_id="3207" text="HOXA11" type="GENE"/>
    <entity charOffset="81-87" id="s2721.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2721.e0" e2="s2721.e1" id="s2721.p0" relation="true"/>
  </sentence>
  <sentence id="s2722" text="Further, the function of HOXA11 in breast tumorigenesis was analyzed by cell proliferation and migration assays.">
    <entity charOffset="25-31" id="s2722.e0" ontology_id="3207" text="HOXA11" type="GENE"/>
    <entity charOffset="42-47" id="s2722.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2722.e0" e2="s2722.e1" id="s2722.p0" relation="true"/>
  </sentence>
  <sentence id="s2723" text="We found that HOXA11 was hypermethylated in cancer tissues (45.08%), especially in invasive ductal carcinomas (P&amp;lt;0.001), patients with a family history of cancer (P=0.033), cases with metastatic lymph nodes (P=0.004) and P53 positive group (P=0.017).">
    <entity charOffset="14-20" id="s2723.e0" ontology_id="3207" text="HOXA11" type="GENE"/>
    <entity charOffset="44-50" id="s2723.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2723.e0" e2="s2723.e1" id="s2723.p0" relation="true"/>
  </sentence>
  <sentence id="s2724" text="These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-chat syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.">
    <entity charOffset="24-30" id="s2724.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="80-84" id="s2724.e1" ontology_id="1103" text="chat" type="GENE"/>
    <pair e1="s2724.e0" e2="s2724.e1" id="s2724.p0" relation="true"/>
  </sentence>
  <sentence id="s2725" text="Interestingly, REEP1 mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy type V (dHMN-V).">
    <entity charOffset="15-20" id="s2725.e0" ontology_id="65055" text="REEP1" type="GENE"/>
    <entity charOffset="124-142" id="s2725.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s2725.e0" e2="s2725.e1" id="s2725.p0" relation="true"/>
  </sentence>
  <sentence id="s2726" text="Interestingly, REEP1 mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy type V (dHMN-V).">
    <entity charOffset="124-142" id="s2726.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="188-192" id="s2726.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s2726.e0" e2="s2726.e1" id="s2726.p0" relation="true"/>
  </sentence>
  <sentence id="s2727" text="Interestingly, REEP1 mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy type V (dHMN-V).">
    <entity charOffset="177-187" id="s2727.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="188-192" id="s2727.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s2727.e0" e2="s2727.e1" id="s2727.p0" relation="true"/>
  </sentence>
  <sentence id="s2728" text="MDR rectal colonization occurs in 6.5% of haematological inpatients and predicts a 16% probability of MDRrel BSI, particularly during neutropenia, as well as a higher probability of unfavourable outcomes in CR-rel BSIs.">
    <entity charOffset="134-145" id="s2728.e0" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <entity charOffset="207-209" id="s2728.e1" ontology_id="1604" text="CR" type="GENE"/>
    <pair e1="s2728.e0" e2="s2728.e1" id="s2728.p0" relation="true"/>
  </sentence>
  <sentence id="s2729" text="Solute carrier family 34 member 2 (SLC34A2) is a well-known sodium-dependent phosphate transporter that has recently been linked to cancer development.">
    <entity charOffset="35-42" id="s2729.e0" ontology_id="10568" text="SLC34A2" type="GENE"/>
    <entity charOffset="132-138" id="s2729.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2729.e0" e2="s2729.e1" id="s2729.p0" relation="true"/>
  </sentence>
  <sentence id="s2730" text="Our results indicate that the protein expression level of dCK in pancreatic cancer tissue is a good predictor of PFS, and thus dCK may be the best biomarker of dFdC sensitivity in pancreatic cancer patients treated with dFdC, although other proteins would also contribute to dFdC-sensitivity at the cellular level in vivo and in vitro.">
    <entity charOffset="58-61" id="s2730.e0" ontology_id="1633" text="dCK" type="GENE"/>
    <entity charOffset="76-82" id="s2730.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2730.e0" e2="s2730.e1" id="s2730.p0" relation="true"/>
  </sentence>
  <sentence id="s2731" text="Here we describe the approaches and methods used to identify SMARCA4 mutations, which drive development of the rare ovarian cancer, small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), and point to the broader relevance of this paradigm for future research in rare cancers">
    <entity charOffset="61-68" id="s2731.e0" ontology_id="6597" text="SMARCA4" type="GENE"/>
    <entity charOffset="124-130" id="s2731.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2731.e0" e2="s2731.e1" id="s2731.p0" relation="true"/>
  </sentence>
  <sentence id="s2732" text="We show that morpholino-mediated inpp5k loss of function in the zebrafish results in shortened body axis, microphthalmia with disorganized lens, microcephaly, reduced touch-evoked motility, and highly disorganized myofibers.">
    <entity charOffset="33-39" id="s2732.e0" ontology_id="51763" text="inpp5k" type="GENE"/>
    <entity charOffset="106-120" id="s2732.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s2732.e0" e2="s2732.e1" id="s2732.p0" relation="true"/>
  </sentence>
  <sentence id="s2733" text="We show that morpholino-mediated inpp5k loss of function in the zebrafish results in shortened body axis, microphthalmia with disorganized lens, microcephaly, reduced touch-evoked motility, and highly disorganized myofibers.">
    <entity charOffset="33-39" id="s2733.e0" ontology_id="51763" text="inpp5k" type="GENE"/>
    <entity charOffset="145-157" id="s2733.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2733.e0" e2="s2733.e1" id="s2733.p0" relation="true"/>
  </sentence>
  <sentence id="s2734" text="Altogether these data demonstrate that mutations in INPP5K cause a congenital muscular dystrophy syndrome with short stature, cataracts, and intellectual disability">
    <entity charOffset="52-58" id="s2734.e0" ontology_id="51763" text="INPP5K" type="GENE"/>
    <entity charOffset="111-124" id="s2734.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2734.e0" e2="s2734.e1" id="s2734.p0" relation="true"/>
  </sentence>
  <sentence id="s2735" text="After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-art addresses pathways to improve small-cell lung cancer outcome such as the targeting of DNA damage repair mechanisms firstly anti-PARPs, inhibitory molecules of EZH2, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the MGMT promoter.">
    <entity charOffset="147-153" id="s2735.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="191-197" id="s2735.e1" ontology_id="51438" text="damage" type="GENE"/>
    <pair e1="s2735.e0" e2="s2735.e1" id="s2735.p0" relation="true"/>
  </sentence>
  <sentence id="s2736" text="After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-art addresses pathways to improve small-cell lung cancer outcome such as the targeting of DNA damage repair mechanisms firstly anti-PARPs, inhibitory molecules of EZH2, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the MGMT promoter.">
    <entity charOffset="147-153" id="s2736.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="260-264" id="s2736.e1" ontology_id="2146" text="EZH2" type="GENE"/>
    <pair e1="s2736.e0" e2="s2736.e1" id="s2736.p0" relation="true"/>
  </sentence>
  <sentence id="s2737" text="After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-art addresses pathways to improve small-cell lung cancer outcome such as the targeting of DNA damage repair mechanisms firstly anti-PARPs, inhibitory molecules of EZH2, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the MGMT promoter.">
    <entity charOffset="147-153" id="s2737.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="428-432" id="s2737.e1" ontology_id="4255" text="MGMT" type="GENE"/>
    <pair e1="s2737.e0" e2="s2737.e1" id="s2737.p0" relation="true"/>
  </sentence>
  <sentence id="s2738" text="An analysis of human SCLC specimens revealed that POU2F3 is expressed exclusively in variant SCLC tumors that lack expression of neuroendocrine markers and instead express markers of a chemosensory lineage known as tuft cells.">
    <entity charOffset="50-56" id="s2738.e0" ontology_id="25833" text="POU2F3" type="GENE"/>
    <entity charOffset="98-103" id="s2738.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2738.e0" e2="s2738.e1" id="s2738.p0" relation="true"/>
  </sentence>
  <sentence id="s2739" text="Moreover, we show that most SCLC tumors can be classified into one of three lineages based on the expression of POU2F3, ASCL1, or NEUROD1.">
    <entity charOffset="33-38" id="s2739.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="112-118" id="s2739.e1" ontology_id="25833" text="POU2F3" type="GENE"/>
    <pair e1="s2739.e0" e2="s2739.e1" id="s2739.p0" relation="true"/>
  </sentence>
  <sentence id="s2740" text="Epithelial-mesenchymal transition (EMT) is a process whereby epithelial cells assume mesenchymal characteristics to facilitate cancer metastasis.">
    <entity charOffset="35-38" id="s2740.e0" ontology_id="3702" text="EMT" type="GENE"/>
    <entity charOffset="127-133" id="s2740.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2740.e0" e2="s2740.e1" id="s2740.p0" relation="true"/>
  </sentence>
  <sentence id="s2741" text="However, EMT also contributes to the initiation and development of primary tumors.">
    <entity charOffset="9-12" id="s2741.e0" ontology_id="3702" text="EMT" type="GENE"/>
    <entity charOffset="75-81" id="s2741.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2741.e0" e2="s2741.e1" id="s2741.p0" relation="true"/>
  </sentence>
  <sentence id="s2742" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="21-34" id="s2742.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="237-241" id="s2742.e1" ontology_id="1535" text="CYBA" type="GENE"/>
    <pair e1="s2742.e0" e2="s2742.e1" id="s2742.p0" relation="true"/>
  </sentence>
  <sentence id="s2743" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="21-34" id="s2743.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="279-283" id="s2743.e1" ontology_id="4688" text="NCF2" type="GENE"/>
    <pair e1="s2743.e0" e2="s2743.e1" id="s2743.p0" relation="true"/>
  </sentence>
  <sentence id="s2744" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="21-34" id="s2744.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="303-307" id="s2744.e1" ontology_id="4689" text="NCF4" type="GENE"/>
    <pair e1="s2744.e0" e2="s2744.e1" id="s2744.p0" relation="true"/>
  </sentence>
  <sentence id="s2745" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="111-115" id="s2745.e0" ontology_id="1536" text="CYBB" type="GENE"/>
    <entity charOffset="176-195" id="s2745.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2745.e0" e2="s2745.e1" id="s2745.p0" relation="true"/>
  </sentence>
  <sentence id="s2746" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="176-195" id="s2746.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="279-283" id="s2746.e1" ontology_id="4688" text="NCF2" type="GENE"/>
    <pair e1="s2746.e0" e2="s2746.e1" id="s2746.p0" relation="true"/>
  </sentence>
  <sentence id="s2747" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="176-195" id="s2747.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="303-307" id="s2747.e1" ontology_id="4689" text="NCF4" type="GENE"/>
    <pair e1="s2747.e0" e2="s2747.e1" id="s2747.p0" relation="true"/>
  </sentence>
  <sentence id="s2748" text="We describe a multigenerational Saudi family with an autosomal dominant form of hypohidrotic ectodermal dysplasia in which positional mapping and exome sequencing identified a novel variant in KDF1 that fully segregates with the phenotype.">
    <entity charOffset="93-113" id="s2748.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="193-197" id="s2748.e1" ontology_id="126695" text="KDF1" type="GENE"/>
    <pair e1="s2748.e0" e2="s2748.e1" id="s2748.p0" relation="true"/>
  </sentence>
  <sentence id="s2749" text="In a unique case from a consanguineous union presenting with overgrowth, macrocephaly, retinal coloboma, large thumbs, severe varicose veins and learning disabilities, exome sequencing identified a homozygous nonsense FIBP variant.">
    <entity charOffset="73-85" id="s2749.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="218-222" id="s2749.e1" ontology_id="9158" text="FIBP" type="GENE"/>
    <pair e1="s2749.e0" e2="s2749.e1" id="s2749.p0" relation="true"/>
  </sentence>
  <sentence id="s2750" text="In a unique case from a consanguineous union presenting with overgrowth, macrocephaly, retinal coloboma, large thumbs, severe varicose veins and learning disabilities, exome sequencing identified a homozygous nonsense FIBP variant.">
    <entity charOffset="87-103" id="s2750.e0" ontology_id="HP_0000480" text="retinal coloboma" type="HP"/>
    <entity charOffset="218-222" id="s2750.e1" ontology_id="9158" text="FIBP" type="GENE"/>
    <pair e1="s2750.e0" e2="s2750.e1" id="s2750.p0" relation="true"/>
  </sentence>
  <sentence id="s2751" text="Spinocerebellar ataxia type 17 (SCA17) is caused by CAG repeat expansion in the TATA-box binding protein gene.">
    <entity charOffset="16-22" id="s2751.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="32-37" id="s2751.e1" ontology_id="6908" text="SCA17" type="GENE"/>
    <pair e1="s2751.e0" e2="s2751.e1" id="s2751.p0" relation="true"/>
  </sentence>
  <sentence id="s2752" text="The percentage of autosomal recessive forms due to mutations in BMP1, FKBP10, LEPRE1, SERPINF1, and WNT1 was unusually high (48%).">
    <entity charOffset="18-37" id="s2752.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="64-68" id="s2752.e1" ontology_id="649" text="BMP1" type="GENE"/>
    <pair e1="s2752.e0" e2="s2752.e1" id="s2752.p0" relation="true"/>
  </sentence>
  <sentence id="s2753" text="The percentage of autosomal recessive forms due to mutations in BMP1, FKBP10, LEPRE1, SERPINF1, and WNT1 was unusually high (48%).">
    <entity charOffset="18-37" id="s2753.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="70-76" id="s2753.e1" ontology_id="60681" text="FKBP10" type="GENE"/>
    <pair e1="s2753.e0" e2="s2753.e1" id="s2753.p0" relation="true"/>
  </sentence>
  <sentence id="s2754" text="The percentage of autosomal recessive forms due to mutations in BMP1, FKBP10, LEPRE1, SERPINF1, and WNT1 was unusually high (48%).">
    <entity charOffset="18-37" id="s2754.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="78-84" id="s2754.e1" ontology_id="64175" text="LEPRE1" type="GENE"/>
    <pair e1="s2754.e0" e2="s2754.e1" id="s2754.p0" relation="true"/>
  </sentence>
  <sentence id="s2755" text="The percentage of autosomal recessive forms due to mutations in BMP1, FKBP10, LEPRE1, SERPINF1, and WNT1 was unusually high (48%).">
    <entity charOffset="18-37" id="s2755.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="86-94" id="s2755.e1" ontology_id="5176" text="SERPINF1" type="GENE"/>
    <pair e1="s2755.e0" e2="s2755.e1" id="s2755.p0" relation="true"/>
  </sentence>
  <sentence id="s2756" text="The percentage of autosomal recessive forms due to mutations in BMP1, FKBP10, LEPRE1, SERPINF1, and WNT1 was unusually high (48%).">
    <entity charOffset="18-37" id="s2756.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="100-104" id="s2756.e1" ontology_id="7471" text="WNT1" type="GENE"/>
    <pair e1="s2756.e0" e2="s2756.e1" id="s2756.p0" relation="true"/>
  </sentence>
  <sentence id="s2757" text="Estrogens and estrogen receptors (ERs), such as ER and ER, prolactin (PRL) and prolactin receptor (PRLR) have been reported to be involved in the physiopathology of uterine cervical cancer (UCC).">
    <entity charOffset="72-75" id="s2757.e0" ontology_id="5617" text="PRL" type="GENE"/>
    <entity charOffset="184-190" id="s2757.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2757.e0" e2="s2757.e1" id="s2757.p0" relation="true"/>
  </sentence>
  <sentence id="s2758" text="The results revealed that ER, ER, PRLR and Ki67 expression levels were increased during the progression of cancer.">
    <entity charOffset="36-39" id="s2758.e0" ontology_id="5617" text="PRL" type="GENE"/>
    <entity charOffset="109-115" id="s2758.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2758.e0" e2="s2758.e1" id="s2758.p0" relation="true"/>
  </sentence>
  <sentence id="s2759" text="Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="16-20" id="s2759.e0" ontology_id="27130" text="INVS" type="GENE"/>
    <entity charOffset="70-89" id="s2759.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2759.e0" e2="s2759.e1" id="s2759.p0" relation="true"/>
  </sentence>
  <sentence id="s2760" text="Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="16-20" id="s2760.e0" ontology_id="27130" text="INVS" type="GENE"/>
    <entity charOffset="90-97" id="s2760.e1" ontology_id="HP_0011010" text="chronic" type="HP"/>
    <pair e1="s2760.e0" e2="s2760.e1" id="s2760.p0" relation="true"/>
  </sentence>
  <sentence id="s2761" text="Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="16-18" id="s2761.e0" ontology_id="7003" text="AA" type="GENE"/>
    <entity charOffset="90-97" id="s2761.e1" ontology_id="HP_0011010" text="chronic" type="HP"/>
    <pair e1="s2761.e0" e2="s2761.e1" id="s2761.p0" relation="true"/>
  </sentence>
  <sentence id="s2762" text="Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="16-20" id="s2762.e0" ontology_id="27130" text="INVS" type="GENE"/>
    <entity charOffset="117-128" id="s2762.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s2762.e0" e2="s2762.e1" id="s2762.p0" relation="true"/>
  </sentence>
  <sentence id="s2763" text="Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="50-54" id="s2763.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="117-128" id="s2763.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s2763.e0" e2="s2763.e1" id="s2763.p0" relation="true"/>
  </sentence>
  <sentence id="s2764" text="Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="59-64" id="s2764.e0" ontology_id="27130" text="NPHP2" type="GENE"/>
    <entity charOffset="90-97" id="s2764.e1" ontology_id="HP_0011010" text="chronic" type="HP"/>
    <pair e1="s2764.e0" e2="s2764.e1" id="s2764.p0" relation="true"/>
  </sentence>
  <sentence id="s2765" text="The zinc transporter SLC39A4 influences epithelial cell morphology and migration in various cancers; however, its role in regulating cell invasion and chemotherapeutic resistance in human lung cancer is not yet clear.">
    <entity charOffset="21-28" id="s2765.e0" ontology_id="55630" text="SLC39A4" type="GENE"/>
    <entity charOffset="92-98" id="s2765.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2765.e0" e2="s2765.e1" id="s2765.p0" relation="true"/>
  </sentence>
  <sentence id="s2766" text="Here, integrated analysis of gene expression in non-small cell lung cancer revealed that SLC39A4 expression is significantly correlated with increased tumour size and regional lymph node spread, as well as shorter overall survival (OS) and disease-free survival (DFS).">
    <entity charOffset="68-74" id="s2766.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="89-96" id="s2766.e1" ontology_id="55630" text="SLC39A4" type="GENE"/>
    <pair e1="s2766.e0" e2="s2766.e1" id="s2766.p0" relation="true"/>
  </sentence>
  <sentence id="s2767" text="SLC39A4 silencing by lentivirus-mediated shRNA blocked human lung cancer cell epithelial-mesenchymal transition and metastasis in vitro and in vivo, respectively.">
    <entity charOffset="0-7" id="s2767.e0" ontology_id="55630" text="SLC39A4" type="GENE"/>
    <entity charOffset="66-72" id="s2767.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2767.e0" e2="s2767.e1" id="s2767.p0" relation="true"/>
  </sentence>
  <sentence id="s2768" text="Moreover, SLC39A4 knockdown enhanced cancer cell sensitivity to cisplatin-induced death by inhibiting stemness in lung cancer cells.">
    <entity charOffset="10-17" id="s2768.e0" ontology_id="55630" text="SLC39A4" type="GENE"/>
    <entity charOffset="37-43" id="s2768.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2768.e0" e2="s2768.e1" id="s2768.p0" relation="true"/>
  </sentence>
  <sentence id="s2769" text="Collectively, these data suggest that SLC39A4 may be a novel therapeutic target and predictive marker of tumour metastasis in non-small cell lung cancer">
    <entity charOffset="38-45" id="s2769.e0" ontology_id="55630" text="SLC39A4" type="GENE"/>
    <entity charOffset="105-111" id="s2769.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s2769.e0" e2="s2769.e1" id="s2769.p0" relation="true"/>
  </sentence>
  <sentence id="s2770" text="Biallelic DNAJC12 mutations were described in children with hyperphenylalaninemia, neurodevelopmental delay, and dystonia.">
    <entity charOffset="10-17" id="s2770.e0" ontology_id="56521" text="DNAJC12" type="GENE"/>
    <entity charOffset="60-81" id="s2770.e1" ontology_id="HP_0004923" text="hyperphenylalaninemia" type="HP"/>
    <pair e1="s2770.e0" e2="s2770.e1" id="s2770.p0" relation="true"/>
  </sentence>
  <sentence id="s2771" text="Biallelic DNAJC12 mutations were described in children with hyperphenylalaninemia, neurodevelopmental delay, and dystonia.">
    <entity charOffset="10-17" id="s2771.e0" ontology_id="56521" text="DNAJC12" type="GENE"/>
    <entity charOffset="83-107" id="s2771.e1" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <pair e1="s2771.e0" e2="s2771.e1" id="s2771.p0" relation="true"/>
  </sentence>
  <sentence id="s2772" text="Biallelic DNAJC12 mutations were described in children with hyperphenylalaninemia, neurodevelopmental delay, and dystonia.">
    <entity charOffset="10-17" id="s2772.e0" ontology_id="56521" text="DNAJC12" type="GENE"/>
    <entity charOffset="113-121" id="s2772.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s2772.e0" e2="s2772.e1" id="s2772.p0" relation="true"/>
  </sentence>
  <sentence id="s2773" text="We identified DNAJC12 homozygous null variants (c.187A&amp;gt;T;p.K63* and c.79-2A&amp;gt;G;p.V27Wfs*14) in two kindreds with early-onset parkinsonism.">
    <entity charOffset="14-21" id="s2773.e0" ontology_id="56521" text="DNAJC12" type="GENE"/>
    <entity charOffset="130-142" id="s2773.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s2773.e0" e2="s2773.e1" id="s2773.p0" relation="true"/>
  </sentence>
  <sentence id="s2774" text="Our results suggest that DNAJC12 mutations (absent in 500 early-onset patients with Parkinson's disease) rarely cause dopa-responsive nonprogressive parkinsonism in adulthood, but broaden the clinical spectrum of DNAJC12 deficiency.">
    <entity charOffset="25-32" id="s2774.e0" ontology_id="56521" text="DNAJC12" type="GENE"/>
    <entity charOffset="149-161" id="s2774.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s2774.e0" e2="s2774.e1" id="s2774.p0" relation="true"/>
  </sentence>
  <sentence id="s2775" text="Our results suggest that DNAJC12 mutations (absent in 500 early-onset patients with Parkinson's disease) rarely cause dopa-responsive nonprogressive parkinsonism in adulthood, but broaden the clinical spectrum of DNAJC12 deficiency.">
    <entity charOffset="25-32" id="s2775.e0" ontology_id="56521" text="DNAJC12" type="GENE"/>
    <entity charOffset="134-148" id="s2775.e1" ontology_id="HP_0003680" text="nonprogressive" type="HP"/>
    <pair e1="s2775.e0" e2="s2775.e1" id="s2775.p0" relation="true"/>
  </sentence>
  <sentence id="s2776" text="Mutations of &lt;i&gt;MYO7A&lt;/i&gt;/&lt;i&gt;Myo7a&lt;/i&gt; have been implicated in inherited deafness in both humans and mice.">
    <entity charOffset="16-21" id="s2776.e0" ontology_id="4647" text="MYO7A" type="GENE"/>
    <entity charOffset="73-81" id="s2776.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s2776.e0" e2="s2776.e1" id="s2776.p0" relation="true"/>
  </sentence>
  <sentence id="s2777" text="Mutations of &lt;i&gt;MYO7A&lt;/i&gt;/&lt;i&gt;Myo7a&lt;/i&gt; have been implicated in inherited deafness in both humans and mice.">
    <entity charOffset="29-34" id="s2777.e0" ontology_id="4647" text="Myo7a" type="GENE"/>
    <entity charOffset="73-81" id="s2777.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s2777.e0" e2="s2777.e1" id="s2777.p0" relation="true"/>
  </sentence>
  <sentence id="s2778" text="This study also identified a de novo c.3015_3027dup frameshift mutation predicting p.Lys1010Glnfs*57 in NEFH from a CMT2 family with an atypical clinical symptom of prominent proximal weakness.">
    <entity charOffset="104-108" id="s2778.e0" ontology_id="4744" text="NEFH" type="GENE"/>
    <entity charOffset="175-183" id="s2778.e1" ontology_id="HP_0012840" text="proximal" type="HP"/>
    <pair e1="s2778.e0" e2="s2778.e1" id="s2778.p0" relation="true"/>
  </sentence>
  <sentence id="s2779" text="This study also identified a de novo c.3015_3027dup frameshift mutation predicting p.Lys1010Glnfs*57 in NEFH from a CMT2 family with an atypical clinical symptom of prominent proximal weakness.">
    <entity charOffset="116-120" id="s2779.e0" ontology_id="23095" text="CMT2" type="GENE"/>
    <entity charOffset="175-183" id="s2779.e1" ontology_id="HP_0012840" text="proximal" type="HP"/>
    <pair e1="s2779.e0" e2="s2779.e1" id="s2779.p0" relation="true"/>
  </sentence>
  <sentence id="s2780" text="Therefore, this study suggests that the stop loss and translational elongations by the 3' UTR of the NEFH mutations may be a relatively frequent genetic cause of axonal peripheral neuropathy with the specific characteristics of proximal dominant weakness">
    <entity charOffset="101-105" id="s2780.e0" ontology_id="4744" text="NEFH" type="GENE"/>
    <entity charOffset="228-236" id="s2780.e1" ontology_id="HP_0012840" text="proximal" type="HP"/>
    <pair e1="s2780.e0" e2="s2780.e1" id="s2780.p0" relation="true"/>
  </sentence>
  <sentence id="s2781" text="&lt;b&gt;Rationale:&lt;/b&gt; Oncogenic STAT3 signaling activation and 3p22-21.3 locus alteration are common in multiple tumors, especially carcinomas of the nasopharynx, esophagus and lung.">
    <entity charOffset="28-33" id="s2781.e0" ontology_id="6774" text="STAT3" type="GENE"/>
    <entity charOffset="109-115" id="s2781.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2781.e0" e2="s2781.e1" id="s2781.p0" relation="true"/>
  </sentence>
  <sentence id="s2782" text="&lt;i&gt;DLEC1&lt;/i&gt; was frequently downregulated in ESCC, lung and NPC cell lines and primary tumors, but was readily expressed in normal tissues and immortalized normal epithelial cells, with mutations rarely detected.">
    <entity charOffset="3-8" id="s2782.e0" ontology_id="9940" text="DLEC1" type="GENE"/>
    <entity charOffset="87-93" id="s2782.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2782.e0" e2="s2782.e1" id="s2782.p0" relation="true"/>
  </sentence>
  <sentence id="s2783" text="&lt;i&gt;DLEC1&lt;/i&gt; methylation was frequently detected in ESCC tumors and correlated with lymph node metastasis, tumor recurrence and progression, with &lt;i&gt;DLEC1&lt;/i&gt; as the most frequently methylated among the established 3p22.2 tumor suppressors (&lt;i&gt;RASSF1A, PLCD1&lt;/i&gt; and &lt;i&gt;ZMYND10/BLU&lt;/i&gt;).">
    <entity charOffset="3-8" id="s2783.e0" ontology_id="9940" text="DLEC1" type="GENE"/>
    <entity charOffset="57-63" id="s2783.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2783.e0" e2="s2783.e1" id="s2783.p0" relation="true"/>
  </sentence>
  <sentence id="s2784" text="Mutations in the Pejvakin (Pjvk) gene cause autosomal recessive hearing loss DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.">
    <entity charOffset="27-31" id="s2784.e0" ontology_id="494513" text="Pjvk" type="GENE"/>
    <entity charOffset="123-133" id="s2784.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s2784.e0" e2="s2784.e1" id="s2784.p0" relation="true"/>
  </sentence>
  <sentence id="s2785" text="In humans, recessive and dominant ALPL mutations cause hypophosphatasia (HPP), a metabolic bone disease with highly heterogeneous clinical manifestations, ranging from lethal perinatal hypomineralization to a relatively mild dental disease.">
    <entity charOffset="34-38" id="s2785.e0" ontology_id="249" text="ALPL" type="GENE"/>
    <entity charOffset="116-129" id="s2785.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2785.e0" e2="s2785.e1" id="s2785.p0" relation="true"/>
  </sentence>
  <sentence id="s2786" text="Lactate dehydrogenase-A (LDHA) can promote Warburg effect to produce lactate and Adenosine Triphosphate (ATP) in aerobic condition, which contributes to oncogenesis metastasis and drug resistance in various cancers.">
    <entity charOffset="25-29" id="s2786.e0" ontology_id="3939" text="LDHA" type="GENE"/>
    <entity charOffset="207-213" id="s2786.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2786.e0" e2="s2786.e1" id="s2786.p0" relation="true"/>
  </sentence>
  <sentence id="s2787" text="We determined that LDHA was over-expressed in GBC tumor tissues compared with normal tissues, which was also an independent prognostic factor for the overall survival of GBC patients by tissue microarrays analysis.">
    <entity charOffset="19-23" id="s2787.e0" ontology_id="3939" text="LDHA" type="GENE"/>
    <entity charOffset="50-55" id="s2787.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2787.e0" e2="s2787.e1" id="s2787.p0" relation="true"/>
  </sentence>
  <sentence id="s2788" text="The SNPs rs2124437 (RASGRP3), rs1335022 (GRIK2), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.">
    <entity charOffset="41-46" id="s2788.e0" ontology_id="2901" text="GRIK2" type="GENE"/>
    <entity charOffset="164-170" id="s2788.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2788.e0" e2="s2788.e1" id="s2788.p0" relation="true"/>
  </sentence>
  <sentence id="s2789" text="The SNPs rs2124437 (RASGRP3), rs1335022 (GRIK2), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.">
    <entity charOffset="102-106" id="s2789.e0" ontology_id="84708" text="LNX1" type="GENE"/>
    <entity charOffset="164-170" id="s2789.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2789.e0" e2="s2789.e1" id="s2789.p0" relation="true"/>
  </sentence>
  <sentence id="s2790" text="A significant association of the SNPs in oral cancer was observed in RASGRP3 AA (rs2124437) (p&amp;lt;0.000, OR 1.34, 95% confidence interval (CI) 1.01-1.76), GRIK2 TT (rs1335022) (p=0.008, OR 1.58, 95% CI 1.23-2.03), PREX2 CC (p=0.008, OR 1.56, 95% CI 1.15-2.1), and TT (p&amp;lt;0.000, OR 2.77, 1.68-4.57) genotypes, whereas the heterozygous genotypes showed higher frequencies in controls, i.e., GRIK2 CT (rs1335022) (p=0.029, OR 0.68, 95% CI 0.53-0.87) and PREX2 CT (p=0.004, OR 0.49, 95% CI 0.37-0.64), indicating protection.">
    <entity charOffset="46-52" id="s2790.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="69-76" id="s2790.e1" ontology_id="25780" text="RASGRP3" type="GENE"/>
    <pair e1="s2790.e0" e2="s2790.e1" id="s2790.p0" relation="true"/>
  </sentence>
  <sentence id="s2791" text="A significant association of the SNPs in oral cancer was observed in RASGRP3 AA (rs2124437) (p&amp;lt;0.000, OR 1.34, 95% confidence interval (CI) 1.01-1.76), GRIK2 TT (rs1335022) (p=0.008, OR 1.58, 95% CI 1.23-2.03), PREX2 CC (p=0.008, OR 1.56, 95% CI 1.15-2.1), and TT (p&amp;lt;0.000, OR 2.77, 1.68-4.57) genotypes, whereas the heterozygous genotypes showed higher frequencies in controls, i.e., GRIK2 CT (rs1335022) (p=0.029, OR 0.68, 95% CI 0.53-0.87) and PREX2 CT (p=0.004, OR 0.49, 95% CI 0.37-0.64), indicating protection.">
    <entity charOffset="46-52" id="s2791.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="158-163" id="s2791.e1" ontology_id="2901" text="GRIK2" type="GENE"/>
    <pair e1="s2791.e0" e2="s2791.e1" id="s2791.p0" relation="false"/>
  </sentence>
  <sentence id="s2792" text="A significant association of the SNPs in oral cancer was observed in RASGRP3 AA (rs2124437) (p&amp;lt;0.000, OR 1.34, 95% confidence interval (CI) 1.01-1.76), GRIK2 TT (rs1335022) (p=0.008, OR 1.58, 95% CI 1.23-2.03), PREX2 CC (p=0.008, OR 1.56, 95% CI 1.15-2.1), and TT (p&amp;lt;0.000, OR 2.77, 1.68-4.57) genotypes, whereas the heterozygous genotypes showed higher frequencies in controls, i.e., GRIK2 CT (rs1335022) (p=0.029, OR 0.68, 95% CI 0.53-0.87) and PREX2 CT (p=0.004, OR 0.49, 95% CI 0.37-0.64), indicating protection.">
    <entity charOffset="46-52" id="s2792.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="220-225" id="s2792.e1" ontology_id="80243" text="PREX2" type="GENE"/>
    <pair e1="s2792.e0" e2="s2792.e1" id="s2792.p0" relation="true"/>
  </sentence>
  <sentence id="s2793" text="Phosphatase and tensin homolog (PTEN) is a wellknown tumor suppressor and serves a vital role in cancer progression.">
    <entity charOffset="32-36" id="s2793.e0" ontology_id="5728" text="PTEN" type="GENE"/>
    <entity charOffset="98-104" id="s2793.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2793.e0" e2="s2793.e1" id="s2793.p0" relation="true"/>
  </sentence>
  <sentence id="s2794" text="Phosphatase and tensin homolog (PTEN) is a wellknown tumor suppressor and serves a vital role in cancer progression.">
    <entity charOffset="32-36" id="s2794.e0" ontology_id="5728" text="PTEN" type="GENE"/>
    <entity charOffset="54-59" id="s2794.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2794.e0" e2="s2794.e1" id="s2794.p0" relation="true"/>
  </sentence>
  <sentence id="s2795" text="DLX3 mutations have been found to be responsible for Tricho-Dento-Osseous (TDO) syndrome, characterized by kinky hair, thin-pitted enamel and increased bone density.">
    <entity charOffset="0-4" id="s2795.e0" ontology_id="1747" text="DLX3" type="GENE"/>
    <entity charOffset="142-164" id="s2795.e1" ontology_id="HP_0011001" text="increased bone density" type="HP"/>
    <pair e1="s2795.e0" e2="s2795.e1" id="s2795.p0" relation="true"/>
  </sentence>
  <sentence id="s2796" text="Here we show that the DLX3 mutation (c.533A&amp;gt;G; Q178R) attenuates osteogenic potential and senescence of bone mesenchymal stem cells (BMSCs) isolated from a TDO patient, providing a molecular explanation for abnormal increased bone density.">
    <entity charOffset="22-26" id="s2796.e0" ontology_id="1747" text="DLX3" type="GENE"/>
    <entity charOffset="220-242" id="s2796.e1" ontology_id="HP_0011001" text="increased bone density" type="HP"/>
    <pair e1="s2796.e0" e2="s2796.e1" id="s2796.p0" relation="true"/>
  </sentence>
  <sentence id="s2797" text="In contrast, SDH and FH act as tumor suppressors and genomic inactivation results in succinate and fumarate accumulation, respectively.">
    <entity charOffset="13-16" id="s2797.e0" ontology_id="1757" text="SDH" type="GENE"/>
    <entity charOffset="31-36" id="s2797.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2797.e0" e2="s2797.e1" id="s2797.p0" relation="true"/>
  </sentence>
  <sentence id="s2798" text="SDH deficiency may result from germline SDHA, SDHB, SDHC, or SDHD mutations and is found in autosomal-dominant familial paraganglioma/pheochromocytoma and Carney-Stratakis syndrome, describing the combination of paraganglioma and gastrointestinal stromal tumor (GIST).">
    <entity charOffset="0-3" id="s2798.e0" ontology_id="1757" text="SDH" type="GENE"/>
    <entity charOffset="255-260" id="s2798.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2798.e0" e2="s2798.e1" id="s2798.p0" relation="true"/>
  </sentence>
  <sentence id="s2799" text="SDH deficiency may result from germline SDHA, SDHB, SDHC, or SDHD mutations and is found in autosomal-dominant familial paraganglioma/pheochromocytoma and Carney-Stratakis syndrome, describing the combination of paraganglioma and gastrointestinal stromal tumor (GIST).">
    <entity charOffset="0-3" id="s2799.e0" ontology_id="1757" text="SDH" type="GENE"/>
    <entity charOffset="120-133" id="s2799.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s2799.e0" e2="s2799.e1" id="s2799.p0" relation="true"/>
  </sentence>
  <sentence id="s2800" text="In contrast, patients with the non-hereditary Carney triad, including paraganglioma, GIST, and pulmonary chondroma, usually lack germline SDH mutations and instead show epigenetic SDH complex inactivation through SDHC promoter methylation.">
    <entity charOffset="70-83" id="s2800.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="138-141" id="s2800.e1" ontology_id="1757" text="SDH" type="GENE"/>
    <pair e1="s2800.e0" e2="s2800.e1" id="s2800.p0" relation="true"/>
  </sentence>
  <sentence id="s2801" text="&lt;b&gt;Objective:&lt;/b&gt; To investigate the significance of Twist2 in glioma and whether it is involved in the malignant transformation of glioma by epithelial-mesenchymal transition (EMT).">
    <entity charOffset="53-59" id="s2801.e0" ontology_id="117581" text="Twist2" type="GENE"/>
    <entity charOffset="63-69" id="s2801.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2801.e0" e2="s2801.e1" id="s2801.p0" relation="true"/>
  </sentence>
  <sentence id="s2802" text="&lt;b&gt;Methods:&lt;/b&gt; Using immunohistochemical method detected the expression level of Twist2 in 60 cases of gliomas (including WHO grades ,  and , each for 20 cases) and 20 cases of non-tumor brain tissues.">
    <entity charOffset="82-88" id="s2802.e0" ontology_id="117581" text="Twist2" type="GENE"/>
    <entity charOffset="104-110" id="s2802.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2802.e0" e2="s2802.e1" id="s2802.p0" relation="true"/>
  </sentence>
  <sentence id="s2803" text="&lt;b&gt;Results:&lt;/b&gt; Immunohistochemistry results showed that the percentages of Twist2 expression in glioma was 90%(54/60) compared with 30%(6/20) in non-tumor brain tissues(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01).">
    <entity charOffset="76-82" id="s2803.e0" ontology_id="117581" text="Twist2" type="GENE"/>
    <entity charOffset="97-103" id="s2803.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2803.e0" e2="s2803.e1" id="s2803.p0" relation="true"/>
  </sentence>
  <sentence id="s2804" text="&lt;b&gt;Results:&lt;/b&gt; Immunohistochemistry results showed that the percentages of Twist2 expression in glioma was 90%(54/60) compared with 30%(6/20) in non-tumor brain tissues(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01).">
    <entity charOffset="76-82" id="s2804.e0" ontology_id="117581" text="Twist2" type="GENE"/>
    <entity charOffset="150-155" id="s2804.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2804.e0" e2="s2804.e1" id="s2804.p0" relation="true"/>
  </sentence>
  <sentence id="s2805" text="Real-time fluorescence quantitative PCR and Western blot showed that the expression level of Twist 2 in gliomas was significantly higher than that in para-cancerous tissues (&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01), and those in WHO grades  and  gliomas were significantly higher than that in WHO grade  glioma (&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01).">
    <entity charOffset="93-98" id="s2805.e0" ontology_id="7291" text="Twist" type="GENE"/>
    <entity charOffset="104-110" id="s2805.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2805.e0" e2="s2805.e1" id="s2805.p0" relation="true"/>
  </sentence>
  <sentence id="s2806" text="The expression of N-cadherin and vimentin was positively associated with Twist2 in glioma(&lt;i&gt;r&lt;/i&gt;=0.971, &lt;i&gt;P&lt;/i&gt;&amp;lt;0.01; &lt;i&gt;r&lt;/i&gt;=0.968, &lt;i&gt;P&lt;/i&gt;&amp;lt;0.01).">
    <entity charOffset="73-79" id="s2806.e0" ontology_id="117581" text="Twist2" type="GENE"/>
    <entity charOffset="83-89" id="s2806.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2806.e0" e2="s2806.e1" id="s2806.p0" relation="true"/>
  </sentence>
  <sentence id="s2807" text="Global-genome nucleotide excision repair (GG-NER) prevents ultraviolet (UV) light-induced skin cancer by removing mutagenic cyclobutane pyrimidine dimers (CPDs).">
    <entity charOffset="95-101" id="s2807.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="155-158" id="s2807.e1" ontology_id="9455" text="CPD" type="GENE"/>
    <pair e1="s2807.e0" e2="s2807.e1" id="s2807.p0" relation="true"/>
  </sentence>
  <sentence id="s2808" text="Superficial CD34-positive fibroblastic tumor is a recently described soft-tissue tumor entity.">
    <entity charOffset="12-16" id="s2808.e0" ontology_id="947" text="CD34" type="GENE"/>
    <entity charOffset="39-44" id="s2808.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2808.e0" e2="s2808.e1" id="s2808.p0" relation="true"/>
  </sentence>
  <sentence id="s2809" text="A 48 year-old-male presented with a gradually increasing soft-tissue mass in his right forearm of 2 years' duration, along with multiple subcutaneous soft-tissue nodular lesions, and reminiscent of lipomas over his body.">
    <entity charOffset="69-73" id="s2809.e0" ontology_id="2200" text="mass" type="GENE"/>
    <entity charOffset="198-205" id="s2809.e1" ontology_id="HP_0012032" text="lipomas" type="HP"/>
    <pair e1="s2809.e0" e2="s2809.e1" id="s2809.p0" relation="true"/>
  </sentence>
  <sentence id="s2810" text="By immunohistochemistry, the tumor cells were diffusely positive for CD34 while negative for cytokeratin (CK), pan CK (AE1/AE3), S100 protein, CD30, and CD31.">
    <entity charOffset="29-34" id="s2810.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="69-73" id="s2810.e1" ontology_id="947" text="CD34" type="GENE"/>
    <pair e1="s2810.e0" e2="s2810.e1" id="s2810.p0" relation="true"/>
  </sentence>
  <sentence id="s2811" text="Diagnosis of superficial CD34-positive fibroblastic tumor was offered.">
    <entity charOffset="25-29" id="s2811.e0" ontology_id="947" text="CD34" type="GENE"/>
    <entity charOffset="52-57" id="s2811.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2811.e0" e2="s2811.e1" id="s2811.p0" relation="true"/>
  </sentence>
  <sentence id="s2812" text="Fluorescence in situ hybridisation (FISH) targeting specific genes has been used as an ancillary method for differential diagnosis of melanocytic tumours, but most previous studies have focused on non-acral lesions which may have genetic alterations different from acral lesions.">
    <entity charOffset="36-40" id="s2812.e0" ontology_id="9644" text="FISH" type="GENE"/>
    <entity charOffset="146-153" id="s2812.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s2812.e0" e2="s2812.e1" id="s2812.p0" relation="false"/>
  </sentence>
  <sentence id="s2813" text="We evaluated use of multi-site FISH in the diagnosis of acral melanoma in a series of 82 acral melanocytic tumours.">
    <entity charOffset="31-35" id="s2813.e0" ontology_id="9644" text="FISH" type="GENE"/>
    <entity charOffset="107-114" id="s2813.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s2813.e0" e2="s2813.e1" id="s2813.p0" relation="true"/>
  </sentence>
  <sentence id="s2814" text="We evaluated use of multi-site FISH in the diagnosis of acral melanoma in a series of 82 acral melanocytic tumours.">
    <entity charOffset="31-35" id="s2814.e0" ontology_id="9644" text="FISH" type="GENE"/>
    <entity charOffset="56-61" id="s2814.e1" ontology_id="HP_0025292" text="acral" type="HP"/>
    <pair e1="s2814.e0" e2="s2814.e1" id="s2814.p0" relation="true"/>
  </sentence>
  <sentence id="s2815" text="Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-28" id="s2815.e0" ontology_id="221927" text="BRAT1" type="GENE"/>
    <entity charOffset="51-59" id="s2815.e1" ontology_id="HP_0002063" text="rigidity" type="HP"/>
    <pair e1="s2815.e0" e2="s2815.e1" id="s2815.p0" relation="true"/>
  </sentence>
  <sentence id="s2816" text="Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-28" id="s2816.e0" ontology_id="221927" text="BRAT1" type="GENE"/>
    <entity charOffset="64-74" id="s2816.e1" ontology_id="HP_0030651" text="multifocal" type="HP"/>
    <pair e1="s2816.e0" e2="s2816.e1" id="s2816.p0" relation="true"/>
  </sentence>
  <sentence id="s2817" text="Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-28" id="s2817.e0" ontology_id="221927" text="BRAT1" type="GENE"/>
    <entity charOffset="75-82" id="s2817.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s2817.e0" e2="s2817.e1" id="s2817.p0" relation="true"/>
  </sentence>
  <sentence id="s2818" text="Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-28" id="s2818.e0" ontology_id="221927" text="BRAT1" type="GENE"/>
    <entity charOffset="131-143" id="s2818.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2818.e0" e2="s2818.e1" id="s2818.p0" relation="true"/>
  </sentence>
  <sentence id="s2819" text="Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-28" id="s2819.e0" ontology_id="221927" text="BRAT1" type="GENE"/>
    <entity charOffset="145-155" id="s2819.e1" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <pair e1="s2819.e0" e2="s2819.e1" id="s2819.p0" relation="true"/>
  </sentence>
  <sentence id="s2820" text="Mildly affected individuals with BRAT1 mutations show that BRAT1 must be considered as a cause in childhood refractory epilepsy and microcephaly with survival beyond infancy.">
    <entity charOffset="33-38" id="s2820.e0" ontology_id="221927" text="BRAT1" type="GENE"/>
    <entity charOffset="132-144" id="s2820.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2820.e0" e2="s2820.e1" id="s2820.p0" relation="true"/>
  </sentence>
  <sentence id="s2821" text="Mildly affected individuals with BRAT1 mutations show that BRAT1 must be considered as a cause in childhood refractory epilepsy and microcephaly with survival beyond infancy.">
    <entity charOffset="33-38" id="s2821.e0" ontology_id="221927" text="BRAT1" type="GENE"/>
    <entity charOffset="119-127" id="s2821.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2821.e0" e2="s2821.e1" id="s2821.p0" relation="true"/>
  </sentence>
  <sentence id="s2822" text="Moreover, we demonstrated that pharmacological inhibition of 15-PGDH enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the ALDH1-positive subset in both human PDAC cells and tumor cells of Kras&lt;sup&gt;LSL-G12D/+&lt;/sup&gt;; Ptf1a&lt;sup&gt;Cre/+&lt;/sup&gt; (KC) mice.">
    <entity charOffset="64-68" id="s2822.e0" ontology_id="26227" text="PGDH" type="GENE"/>
    <entity charOffset="225-230" id="s2822.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2822.e0" e2="s2822.e1" id="s2822.p0" relation="true"/>
  </sentence>
  <sentence id="s2823" text="Moreover, we demonstrated that pharmacological inhibition of 15-PGDH enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the ALDH1-positive subset in both human PDAC cells and tumor cells of Kras&lt;sup&gt;LSL-G12D/+&lt;/sup&gt;; Ptf1a&lt;sup&gt;Cre/+&lt;/sup&gt; (KC) mice.">
    <entity charOffset="174-179" id="s2823.e0" ontology_id="216" text="ALDH1" type="GENE"/>
    <entity charOffset="225-230" id="s2823.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2823.e0" e2="s2823.e1" id="s2823.p0" relation="true"/>
  </sentence>
  <sentence id="s2824" text="Finally, ATRA replacement suppressed 15-PGDH inhibition-induced tumor progression in KC mice, and ATRA treatment attenuated Aldh1 activity in tumor cells isolated from the pancreas of 15-Pgdh&lt;sup&gt;-/-&lt;/sup&gt; KC mice.">
    <entity charOffset="40-44" id="s2824.e0" ontology_id="26227" text="PGDH" type="GENE"/>
    <entity charOffset="64-69" id="s2824.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2824.e0" e2="s2824.e1" id="s2824.p0" relation="true"/>
  </sentence>
  <sentence id="s2825" text="Finally, ATRA replacement suppressed 15-PGDH inhibition-induced tumor progression in KC mice, and ATRA treatment attenuated Aldh1 activity in tumor cells isolated from the pancreas of 15-Pgdh&lt;sup&gt;-/-&lt;/sup&gt; KC mice.">
    <entity charOffset="64-69" id="s2825.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="187-191" id="s2825.e1" ontology_id="26227" text="Pgdh" type="GENE"/>
    <pair e1="s2825.e0" e2="s2825.e1" id="s2825.p0" relation="true"/>
  </sentence>
  <sentence id="s2826" text="Finally, ATRA replacement suppressed 15-PGDH inhibition-induced tumor progression in KC mice, and ATRA treatment attenuated Aldh1 activity in tumor cells isolated from the pancreas of 15-Pgdh&lt;sup&gt;-/-&lt;/sup&gt; KC mice.">
    <entity charOffset="64-69" id="s2826.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="124-129" id="s2826.e1" ontology_id="216" text="Aldh1" type="GENE"/>
    <pair e1="s2826.e0" e2="s2826.e1" id="s2826.p0" relation="true"/>
  </sentence>
  <sentence id="s2827" text="These findings provide evidence that 15-PGDH inhibition enhances KRAS-driven tumor progression via ATRA depletion in the pancreas.">
    <entity charOffset="40-44" id="s2827.e0" ontology_id="26227" text="PGDH" type="GENE"/>
    <entity charOffset="77-82" id="s2827.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2827.e0" e2="s2827.e1" id="s2827.p0" relation="true"/>
  </sentence>
  <sentence id="s2828" text="These findings provide evidence that 15-PGDH inhibition enhances KRAS-driven tumor progression via ATRA depletion in the pancreas.">
    <entity charOffset="65-69" id="s2828.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="77-82" id="s2828.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2828.e0" e2="s2828.e1" id="s2828.p0" relation="true"/>
  </sentence>
  <sentence id="s2829" text="Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&amp;gt;A, DHFR 829C&amp;gt;T, MTHFR 677C&amp;gt;T, MTHFR 1298A&amp;gt;C, and ATIC 347C&amp;gt;G.">
    <entity charOffset="33-45" id="s2829.e0" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <entity charOffset="135-139" id="s2829.e1" ontology_id="1719" text="DHFR" type="GENE"/>
    <pair e1="s2829.e0" e2="s2829.e1" id="s2829.p0" relation="true"/>
  </sentence>
  <sentence id="s2830" text="Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&amp;gt;A, DHFR 829C&amp;gt;T, MTHFR 677C&amp;gt;T, MTHFR 1298A&amp;gt;C, and ATIC 347C&amp;gt;G.">
    <entity charOffset="33-45" id="s2830.e0" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <entity charOffset="151-156" id="s2830.e1" ontology_id="4524" text="MTHFR" type="GENE"/>
    <pair e1="s2830.e0" e2="s2830.e1" id="s2830.p0" relation="true"/>
  </sentence>
  <sentence id="s2831" text="Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&amp;gt;A, DHFR 829C&amp;gt;T, MTHFR 677C&amp;gt;T, MTHFR 1298A&amp;gt;C, and ATIC 347C&amp;gt;G.">
    <entity charOffset="33-45" id="s2831.e0" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <entity charOffset="190-194" id="s2831.e1" ontology_id="471" text="ATIC" type="GENE"/>
    <pair e1="s2831.e0" e2="s2831.e1" id="s2831.p0" relation="true"/>
  </sentence>
  <sentence id="s2832" text="Even though the role of single nucleotide polymorphisms of ATIC in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&amp;gt;G polymorphism may influence the levels of adenosine after MTX treatment, which may affect the histologic response of osteosarcoma.">
    <entity charOffset="59-63" id="s2832.e0" ontology_id="471" text="ATIC" type="GENE"/>
    <entity charOffset="269-281" id="s2832.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s2832.e0" e2="s2832.e1" id="s2832.p0" relation="true"/>
  </sentence>
  <sentence id="s2833" text="Even though the role of single nucleotide polymorphisms of ATIC in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&amp;gt;G polymorphism may influence the levels of adenosine after MTX treatment, which may affect the histologic response of osteosarcoma.">
    <entity charOffset="59-63" id="s2833.e0" ontology_id="471" text="ATIC" type="GENE"/>
    <entity charOffset="88-93" id="s2833.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2833.e0" e2="s2833.e1" id="s2833.p0" relation="true"/>
  </sentence>
  <sentence id="s2834" text="Even though the role of single nucleotide polymorphisms of ATIC in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&amp;gt;G polymorphism may influence the levels of adenosine after MTX treatment, which may affect the histologic response of osteosarcoma.">
    <entity charOffset="88-93" id="s2834.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="210-213" id="s2834.e1" ontology_id="4580" text="MTX" type="GENE"/>
    <pair e1="s2834.e0" e2="s2834.e1" id="s2834.p0" relation="true"/>
  </sentence>
  <sentence id="s2835" text="A recent syndromic condition with craniofacial dysmorphisms, comprising congenital ocular defect and neurodevelopmental delay named Helsmoortel-Van der Aa Syndrome (HVDAS) (OMIM#615873), has been described and molecularly defined, identifying pathogenic mutations in the ADNP gene (OMIM#611386) as biological cause.">
    <entity charOffset="101-125" id="s2835.e0" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <entity charOffset="271-275" id="s2835.e1" ontology_id="23394" text="ADNP" type="GENE"/>
    <pair e1="s2835.e0" e2="s2835.e1" id="s2835.p0" relation="true"/>
  </sentence>
  <sentence id="s2836" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="79-85" id="s2836.e0" ontology_id="55466" text="DNAJA4" type="GENE"/>
    <entity charOffset="261-277" id="s2836.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s2836.e0" e2="s2836.e1" id="s2836.p0" relation="true"/>
  </sentence>
  <sentence id="s2837" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="93-97" id="s2837.e0" ontology_id="79192" text="IRX1" type="GENE"/>
    <entity charOffset="261-277" id="s2837.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s2837.e0" e2="s2837.e1" id="s2837.p0" relation="true"/>
  </sentence>
  <sentence id="s2838" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="99-104" id="s2838.e0" ontology_id="353500" text="BMP8A" type="GENE"/>
    <entity charOffset="261-277" id="s2838.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s2838.e0" e2="s2838.e1" id="s2838.p0" relation="true"/>
  </sentence>
  <sentence id="s2839" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="106-111" id="s2839.e0" ontology_id="2626" text="GATA4" type="GENE"/>
    <entity charOffset="261-277" id="s2839.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s2839.e0" e2="s2839.e1" id="s2839.p0" relation="true"/>
  </sentence>
  <sentence id="s2840" text="Partial loss-of-function variants in the TREM2 immune receptor are associated with increased risk for Alzheimer's disease (AD) and other forms of neurodegenerative disease, but the molecular bases for these connections are unknown.">
    <entity charOffset="41-46" id="s2840.e0" ontology_id="54209" text="TREM2" type="GENE"/>
    <entity charOffset="146-171" id="s2840.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s2840.e0" e2="s2840.e1" id="s2840.p0" relation="true"/>
  </sentence>
  <sentence id="s2841" text="Excess accumulation of endogenous all-trans-retinal (atRAL) contributes to degeneration of the retinal pigment epithelium (RPE) and photoreceptor cells, and plays a role in the etiologies of age-related macular degeneration (AMD) and Stargardt's disease.">
    <entity charOffset="123-126" id="s2841.e0" ontology_id="6120" text="RPE" type="GENE"/>
    <entity charOffset="203-223" id="s2841.e1" ontology_id="HP_0000608" text="macular degeneration" type="HP"/>
    <pair e1="s2841.e0" e2="s2841.e1" id="s2841.p0" relation="true"/>
  </sentence>
  <sentence id="s2842" text="Therefore, we evaluated the roles of CSNK2A1, SIRT6, and phosphorylated SIRT6 and their relationships in breast carcinoma.">
    <entity charOffset="37-44" id="s2842.e0" ontology_id="1459" text="CSNK2A1" type="GENE"/>
    <entity charOffset="105-121" id="s2842.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s2842.e0" e2="s2842.e1" id="s2842.p0" relation="true"/>
  </sentence>
  <sentence id="s2843" text="Therefore, we evaluated the roles of CSNK2A1, SIRT6, and phosphorylated SIRT6 and their relationships in breast carcinoma.">
    <entity charOffset="46-51" id="s2843.e0" ontology_id="51548" text="SIRT6" type="GENE"/>
    <entity charOffset="105-121" id="s2843.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s2843.e0" e2="s2843.e1" id="s2843.p0" relation="true"/>
  </sentence>
  <sentence id="s2844" text="Inhibition of CSNK2A1 decreased the proliferative and invasive activity of cancer cells.">
    <entity charOffset="14-21" id="s2844.e0" ontology_id="1459" text="CSNK2A1" type="GENE"/>
    <entity charOffset="75-81" id="s2844.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2844.e0" e2="s2844.e1" id="s2844.p0" relation="true"/>
  </sentence>
  <sentence id="s2845" text="Knockdown of SIRT6 decreased the proliferation and invasiveness of cancer cells.">
    <entity charOffset="13-18" id="s2845.e0" ontology_id="51548" text="SIRT6" type="GENE"/>
    <entity charOffset="67-73" id="s2845.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2845.e0" e2="s2845.e1" id="s2845.p0" relation="true"/>
  </sentence>
  <sentence id="s2846" text="We found that miR-UL112-3p expression was significantly elevated in GBM, and its expression levels were highly associated with glioma size, differentiation, WHO stage and the overall and disease-free survival of patients.">
    <entity charOffset="14-17" id="s2846.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="127-133" id="s2846.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2846.e0" e2="s2846.e1" id="s2846.p0" relation="true"/>
  </sentence>
  <sentence id="s2847" text="This study identifies a set of candidate genes and their potential regulatory variants, and provides additional evidence showing the role of long-range chromatin interactions in prostate cancer etiology">
    <entity charOffset="24-27" id="s2847.e0" ontology_id="6418" text="set" type="GENE"/>
    <entity charOffset="187-193" id="s2847.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2847.e0" e2="s2847.e1" id="s2847.p0" relation="false"/>
  </sentence>
  <sentence id="s2848" text="Herein, we performed comparative quantitative proteomics on whole plasma sampled from patients with stable angina (NMI), acute myocardial infarction (MI), and healthy control subjects (Ctrl).">
    <entity charOffset="115-118" id="s2848.e0" ontology_id="9111" text="NMI" type="GENE"/>
    <entity charOffset="127-148" id="s2848.e1" ontology_id="HP_0001658" text="myocardial infarction" type="HP"/>
    <pair e1="s2848.e0" e2="s2848.e1" id="s2848.p0" relation="true"/>
  </sentence>
  <sentence id="s2849" text="It is caused by recessive mutations in &lt;i&gt;NBEAL2&lt;/i&gt;, resulting in macrothrombocytopenia and myelofibrosis.">
    <entity charOffset="42-48" id="s2849.e0" ontology_id="23218" text="NBEAL2" type="GENE"/>
    <entity charOffset="67-88" id="s2849.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s2849.e0" e2="s2849.e1" id="s2849.p0" relation="true"/>
  </sentence>
  <sentence id="s2850" text="The 18 new diagnoses made with WGS included structural and non-exonic sequence variants not detectable with whole-exome sequencing, and confirmed recent disease associations with the genes PIGG, RNU4ATAC, TRIO, and UNC13A.ConclusionWGS as a primary clinical test provided a higher diagnostic yield than conventional genetic testing in a clinically heterogeneous cohort">
    <entity charOffset="189-193" id="s2850.e0" ontology_id="54872" text="PIGG" type="GENE"/>
    <entity charOffset="348-361" id="s2850.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2850.e0" e2="s2850.e1" id="s2850.p0" relation="true"/>
  </sentence>
  <sentence id="s2851" text="The 18 new diagnoses made with WGS included structural and non-exonic sequence variants not detectable with whole-exome sequencing, and confirmed recent disease associations with the genes PIGG, RNU4ATAC, TRIO, and UNC13A.ConclusionWGS as a primary clinical test provided a higher diagnostic yield than conventional genetic testing in a clinically heterogeneous cohort">
    <entity charOffset="205-209" id="s2851.e0" ontology_id="7204" text="TRIO" type="GENE"/>
    <entity charOffset="348-361" id="s2851.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2851.e0" e2="s2851.e1" id="s2851.p0" relation="true"/>
  </sentence>
  <sentence id="s2852" text="However, mutation screening of these genes revealed two mutated alleles in only just over half of our MKS cohort (46 families), suggesting an even greater level of genetic heterogeneity.">
    <entity charOffset="102-105" id="s2852.e0" ontology_id="54903" text="MKS" type="GENE"/>
    <entity charOffset="172-185" id="s2852.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s2852.e0" e2="s2852.e1" id="s2852.p0" relation="true"/>
  </sentence>
  <sentence id="s2853" text="The fetus inherited an additional likely pathogenic novel missense change to a second MKS gene, CEP290; p.R2210C, suggesting oligogenic inheritance in this disorder">
    <entity charOffset="86-89" id="s2853.e0" ontology_id="54903" text="MKS" type="GENE"/>
    <entity charOffset="125-147" id="s2853.e1" ontology_id="HP_0010983" text="oligogenic inheritance" type="HP"/>
    <pair e1="s2853.e0" e2="s2853.e1" id="s2853.p0" relation="true"/>
  </sentence>
  <sentence id="s2854" text="Loss of GLIS3 function in humans and mice leads to the development of several pathologies, including neonatal diabetes and congenital hypothyroidism, polycystic kidney disease, and infertility.">
    <entity charOffset="8-13" id="s2854.e0" ontology_id="169792" text="GLIS3" type="GENE"/>
    <entity charOffset="134-148" id="s2854.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s2854.e0" e2="s2854.e1" id="s2854.p0" relation="true"/>
  </sentence>
  <sentence id="s2855" text="Single nucleotide polymorphisms in GLIS3 genes have been associated with increased risk of several diseases, including type 1 and type 2 diabetes, glaucoma, and neurological disorders.">
    <entity charOffset="35-40" id="s2855.e0" ontology_id="169792" text="GLIS3" type="GENE"/>
    <entity charOffset="147-155" id="s2855.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2855.e0" e2="s2855.e1" id="s2855.p0" relation="true"/>
  </sentence>
  <sentence id="s2856" text="The proband carried the two kinds of mutations and expressed various clinical manifestations of heart failure and had history of ventricular tachycardia, paraxial atrial fibrillation, pacemaker implantation, electrocardiogram showed right bundle branch block and echocardiography examination evidenced thickened interventricular septum (23.3 mm) and apex and reduced wall motion of these segments.">
    <entity charOffset="129-152" id="s2856.e0" ontology_id="HP_0004756" text="ventricular tachycardia" type="HP"/>
    <entity charOffset="350-354" id="s2856.e1" ontology_id="328" text="apex" type="GENE"/>
    <pair e1="s2856.e0" e2="s2856.e1" id="s2856.p0" relation="true"/>
  </sentence>
  <sentence id="s2857" text="Homozygous, loss of function variants in PROKR2 was initially implicated in autosomal recessive IGD; however, most IGD-associated PROKR2 variants are heterozygous.">
    <entity charOffset="41-47" id="s2857.e0" ontology_id="128674" text="PROKR2" type="GENE"/>
    <entity charOffset="76-95" id="s2857.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2857.e0" e2="s2857.e1" id="s2857.p0" relation="true"/>
  </sentence>
  <sentence id="s2858" text="However, only recently have genetic studies demonstrated sequence variation in HCN1 and HCN2 genes associated with human epilepsy.">
    <entity charOffset="88-92" id="s2858.e0" ontology_id="610" text="HCN2" type="GENE"/>
    <entity charOffset="121-129" id="s2858.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2858.e0" e2="s2858.e1" id="s2858.p0" relation="true"/>
  </sentence>
  <sentence id="s2859" text="These include a triple proline deletion in HCN2 that increases channel function and occurs more often in patients with febrile seizure syndromes.">
    <entity charOffset="43-47" id="s2859.e0" ontology_id="610" text="HCN2" type="GENE"/>
    <entity charOffset="127-134" id="s2859.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s2859.e0" e2="s2859.e1" id="s2859.p0" relation="true"/>
  </sentence>
  <sentence id="s2860" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).">
    <entity charOffset="160-167" id="s2860.e0" ontology_id="1836" text="SLC26A2" type="GENE"/>
    <entity charOffset="321-340" id="s2860.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2860.e0" e2="s2860.e1" id="s2860.p0" relation="true"/>
  </sentence>
  <sentence id="s2861" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).">
    <entity charOffset="244-251" id="s2861.e0" ontology_id="1811" text="SLC26A3" type="GENE"/>
    <entity charOffset="312-320" id="s2861.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s2861.e0" e2="s2861.e1" id="s2861.p0" relation="false"/>
  </sentence>
  <sentence id="s2862" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).">
    <entity charOffset="244-251" id="s2862.e0" ontology_id="1811" text="SLC26A3" type="GENE"/>
    <entity charOffset="321-340" id="s2862.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2862.e0" e2="s2862.e1" id="s2862.p0" relation="false"/>
  </sentence>
  <sentence id="s2863" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).">
    <entity charOffset="312-320" id="s2863.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="351-358" id="s2863.e1" ontology_id="5172" text="SLC26A4" type="GENE"/>
    <pair e1="s2863.e0" e2="s2863.e1" id="s2863.p0" relation="true"/>
  </sentence>
  <sentence id="s2864" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).">
    <entity charOffset="321-340" id="s2864.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="351-358" id="s2864.e1" ontology_id="5172" text="SLC26A4" type="GENE"/>
    <pair e1="s2864.e0" e2="s2864.e1" id="s2864.p0" relation="true"/>
  </sentence>
  <sentence id="s2865" text="To identify other possible transcriptional targets of PGC-1 in neural tissue, we conducted a microarray on neuroblastoma cells overexpressing PGC-1, mined results for genes with physiological relevance to interneurons, and measured cortical gene and protein expression of these genes in mice with underexpression and overexpression of PGC-1.">
    <entity charOffset="54-57" id="s2865.e0" ontology_id="5225" text="PGC" type="GENE"/>
    <entity charOffset="108-121" id="s2865.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s2865.e0" e2="s2865.e1" id="s2865.p0" relation="true"/>
  </sentence>
  <sentence id="s2866" text="Treacher Collins syndrome (TCS, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.">
    <entity charOffset="27-30" id="s2866.e0" ontology_id="6949" text="TCS" type="GENE"/>
    <entity charOffset="148-164" id="s2866.e1" ontology_id="HP_0000272" text="malar hypoplasia" type="HP"/>
    <pair e1="s2866.e0" e2="s2866.e1" id="s2866.p0" relation="true"/>
  </sentence>
  <sentence id="s2867" text="Treacher Collins syndrome (TCS, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.">
    <entity charOffset="27-30" id="s2867.e0" ontology_id="6949" text="TCS" type="GENE"/>
    <entity charOffset="244-252" id="s2867.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s2867.e0" e2="s2867.e1" id="s2867.p0" relation="true"/>
  </sentence>
  <sentence id="s2868" text="Here we describe three unrelated patients showing clinical features overlapping with TCS, but who in addition have developmental delay, microcephaly and a distinct facial gestalt.">
    <entity charOffset="85-88" id="s2868.e0" ontology_id="6949" text="TCS" type="GENE"/>
    <entity charOffset="136-148" id="s2868.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2868.e0" e2="s2868.e1" id="s2868.p0" relation="true"/>
  </sentence>
  <sentence id="s2869" text="Because of the distinct ear anomalies and the hearing loss a HOXA2 mutation was taken into account.">
    <entity charOffset="46-58" id="s2869.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="61-66" id="s2869.e1" ontology_id="3199" text="HOXA2" type="GENE"/>
    <pair e1="s2869.e0" e2="s2869.e1" id="s2869.p0" relation="true"/>
  </sentence>
  <sentence id="s2870" text="We and others have recently demonstrated that c-SRC is a key mediator of growth, invasion, and metastasis, and therefore represents a promising therapeutic target in thyroid cancer.">
    <entity charOffset="46-51" id="s2870.e0" ontology_id="6714" text="c-SRC" type="GENE"/>
    <entity charOffset="174-180" id="s2870.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2870.e0" e2="s2870.e1" id="s2870.p0" relation="true"/>
  </sentence>
  <sentence id="s2871" text="Consistently, SALL2 deficiency associates with neural tube defects and coloboma, a congenital eye disease.">
    <entity charOffset="14-19" id="s2871.e0" ontology_id="6297" text="SALL2" type="GENE"/>
    <entity charOffset="47-66" id="s2871.e1" ontology_id="HP_0045005" text="neural tube defects" type="HP"/>
    <pair e1="s2871.e0" e2="s2871.e1" id="s2871.p0" relation="true"/>
  </sentence>
  <sentence id="s2872" text="Consistently, SALL2 deficiency associates with neural tube defects and coloboma, a congenital eye disease.">
    <entity charOffset="14-19" id="s2872.e0" ontology_id="6297" text="SALL2" type="GENE"/>
    <entity charOffset="71-79" id="s2872.e1" ontology_id="HP_0000589" text="coloboma" type="HP"/>
    <pair e1="s2872.e0" e2="s2872.e1" id="s2872.p0" relation="true"/>
  </sentence>
  <sentence id="s2873" text="Relevant to cancer, clinical studies indicate that SALL2 is deregulated in various cancers and is a specific biomarker for Synovial Sarcoma.">
    <entity charOffset="12-18" id="s2873.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="51-56" id="s2873.e1" ontology_id="6297" text="SALL2" type="GENE"/>
    <pair e1="s2873.e0" e2="s2873.e1" id="s2873.p0" relation="true"/>
  </sentence>
  <sentence id="s2874" text="We specifically discuss the role of SALL2 in the regulation of cell proliferation and survival within the context of the identified target genes, its interaction with viral oncogenes, and its association with the TP53 tumor suppressor and MYC oncogene.">
    <entity charOffset="218-223" id="s2874.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="239-242" id="s2874.e1" ontology_id="4609" text="MYC" type="GENE"/>
    <pair e1="s2874.e0" e2="s2874.e1" id="s2874.p0" relation="true"/>
  </sentence>
  <sentence id="s2875" text="Special attention is given to p53-independent SALL2 regulation of pro-apoptotic genes BAX and PMAIP1, and the implication of these findings on the apoptotic response of cancer cells to therapy.">
    <entity charOffset="46-51" id="s2875.e0" ontology_id="6297" text="SALL2" type="GENE"/>
    <entity charOffset="169-175" id="s2875.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2875.e0" e2="s2875.e1" id="s2875.p0" relation="true"/>
  </sentence>
  <sentence id="s2876" text="Special attention is given to p53-independent SALL2 regulation of pro-apoptotic genes BAX and PMAIP1, and the implication of these findings on the apoptotic response of cancer cells to therapy.">
    <entity charOffset="94-100" id="s2876.e0" ontology_id="5366" text="PMAIP1" type="GENE"/>
    <entity charOffset="169-175" id="s2876.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2876.e0" e2="s2876.e1" id="s2876.p0" relation="true"/>
  </sentence>
  <sentence id="s2877" text="Analysis using Gene Set Enrichment Analysis (GSEA) software revealed significant enrichment for 197proteins from the CM of lung cancer samples in maternalplacental interface expression profiles for a midterm placenta with strong invasiveness relative to RNA expression profiles for a human fullterm placenta after delivery.">
    <entity charOffset="20-23" id="s2877.e0" ontology_id="6418" text="Set" type="GENE"/>
    <entity charOffset="129-135" id="s2877.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2877.e0" e2="s2877.e1" id="s2877.p0" relation="false"/>
  </sentence>
  <sentence id="s2878" text="In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.">
    <entity charOffset="18-23" id="s2878.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="44-48" id="s2878.e1" ontology_id="55294" text="FBW7" type="GENE"/>
    <pair e1="s2878.e0" e2="s2878.e1" id="s2878.p0" relation="true"/>
  </sentence>
  <sentence id="s2879" text="In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.">
    <entity charOffset="44-48" id="s2879.e0" ontology_id="55294" text="FBW7" type="GENE"/>
    <entity charOffset="66-72" id="s2879.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2879.e0" e2="s2879.e1" id="s2879.p0" relation="true"/>
  </sentence>
  <sentence id="s2880" text="Mechanistically, we find that stabilization of Brg1 in gastric cancer cells suppresses E-cadherin expression, subsequently promoting gastric cancer metastasis.">
    <entity charOffset="47-51" id="s2880.e0" ontology_id="6597" text="Brg1" type="GENE"/>
    <entity charOffset="63-69" id="s2880.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2880.e0" e2="s2880.e1" id="s2880.p0" relation="true"/>
  </sentence>
  <sentence id="s2881" text="Mechanistically, we find that stabilization of Brg1 in gastric cancer cells suppresses E-cadherin expression, subsequently promoting gastric cancer metastasis.">
    <entity charOffset="63-69" id="s2881.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="89-97" id="s2881.e1" ontology_id="1015" text="cadherin" type="GENE"/>
    <pair e1="s2881.e0" e2="s2881.e1" id="s2881.p0" relation="true"/>
  </sentence>
  <sentence id="s2882" text="Hence, this previously unknown FBW7/Brg1 signaling axis provides the molecular basis and the rationale to target Brg1 in FBW7-compromised human gastric cancers">
    <entity charOffset="36-40" id="s2882.e0" ontology_id="6597" text="Brg1" type="GENE"/>
    <entity charOffset="152-158" id="s2882.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2882.e0" e2="s2882.e1" id="s2882.p0" relation="false"/>
  </sentence>
  <sentence id="s2883" text="A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="43-46" id="s2883.e0" ontology_id="324" text="APC" type="GENE"/>
    <entity charOffset="127-133" id="s2883.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2883.e0" e2="s2883.e1" id="s2883.p0" relation="true"/>
  </sentence>
  <sentence id="s2884" text="A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="48-53" id="s2884.e0" ontology_id="1462" text="CSPG2" type="GENE"/>
    <entity charOffset="127-133" id="s2884.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2884.e0" e2="s2884.e1" id="s2884.p0" relation="true"/>
  </sentence>
  <sentence id="s2885" text="A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="68-73" id="s2885.e0" ontology_id="3205" text="HOXA9" type="GENE"/>
    <entity charOffset="127-133" id="s2885.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2885.e0" e2="s2885.e1" id="s2885.p0" relation="true"/>
  </sentence>
  <sentence id="s2886" text="A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="87-91" id="s2886.e0" ontology_id="3718" text="JAK3" type="GENE"/>
    <entity charOffset="127-133" id="s2886.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2886.e0" e2="s2886.e1" id="s2886.p0" relation="true"/>
  </sentence>
  <sentence id="s2887" text="A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="100-104" id="s2887.e0" ontology_id="6656" text="SOX1" type="GENE"/>
    <entity charOffset="127-133" id="s2887.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2887.e0" e2="s2887.e1" id="s2887.p0" relation="true"/>
  </sentence>
  <sentence id="s2888" text="Genome-wide association studies have identified loci at 15q25 (IREB2) and 4q22 (FAM13A), associated with lung cancer (LC) and chronic obstructive pulmonary disease (COPD).">
    <entity charOffset="63-68" id="s2888.e0" ontology_id="3658" text="IREB2" type="GENE"/>
    <entity charOffset="110-116" id="s2888.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2888.e0" e2="s2888.e1" id="s2888.p0" relation="true"/>
  </sentence>
  <sentence id="s2889" text="Genome-wide association studies have identified loci at 15q25 (IREB2) and 4q22 (FAM13A), associated with lung cancer (LC) and chronic obstructive pulmonary disease (COPD).">
    <entity charOffset="80-86" id="s2889.e0" ontology_id="10144" text="FAM13A" type="GENE"/>
    <entity charOffset="110-116" id="s2889.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2889.e0" e2="s2889.e1" id="s2889.p0" relation="true"/>
  </sentence>
  <sentence id="s2890" text="Further experiments demonstrated that the MYEOV ceRNA sequestered miR-30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.">
    <entity charOffset="42-47" id="s2890.e0" ontology_id="26579" text="MYEOV" type="GENE"/>
    <entity charOffset="200-205" id="s2890.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2890.e0" e2="s2890.e1" id="s2890.p0" relation="true"/>
  </sentence>
  <sentence id="s2891" text="Further experiments demonstrated that the MYEOV ceRNA sequestered miR-30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.">
    <entity charOffset="104-110" id="s2891.e0" ontology_id="7048" text="TGFBR2" type="GENE"/>
    <entity charOffset="200-205" id="s2891.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2891.e0" e2="s2891.e1" id="s2891.p0" relation="true"/>
  </sentence>
  <sentence id="s2892" text="Further experiments demonstrated that the MYEOV ceRNA sequestered miR-30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.">
    <entity charOffset="115-120" id="s2892.e0" ontology_id="9958" text="USP15" type="GENE"/>
    <entity charOffset="200-205" id="s2892.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2892.e0" e2="s2892.e1" id="s2892.p0" relation="false"/>
  </sentence>
  <sentence id="s2893" text="The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s2893.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="57-61" id="s2893.e1" ontology_id="11198" text="fact" type="GENE"/>
    <pair e1="s2893.e0" e2="s2893.e1" id="s2893.p0" relation="true"/>
  </sentence>
  <sentence id="s2894" text="The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s2894.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="143-147" id="s2894.e1" ontology_id="1813" text="DRD2" type="GENE"/>
    <pair e1="s2894.e0" e2="s2894.e1" id="s2894.p0" relation="true"/>
  </sentence>
  <sentence id="s2895" text="The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s2895.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="149-153" id="s2895.e1" ontology_id="1814" text="DRD3" type="GENE"/>
    <pair e1="s2895.e0" e2="s2895.e1" id="s2895.p0" relation="true"/>
  </sentence>
  <sentence id="s2896" text="The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s2896.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="155-163" id="s2896.e1" ontology_id="84152" text="DARPP-32" type="GENE"/>
    <pair e1="s2896.e0" e2="s2896.e1" id="s2896.p0" relation="true"/>
  </sentence>
  <sentence id="s2897" text="The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s2897.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="165-169" id="s2897.e1" ontology_id="627" text="BDNF" type="GENE"/>
    <pair e1="s2897.e0" e2="s2897.e1" id="s2897.p0" relation="true"/>
  </sentence>
  <sentence id="s2898" text="The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s2898.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="173-177" id="s2898.e1" ontology_id="1312" text="COMT" type="GENE"/>
    <pair e1="s2898.e0" e2="s2898.e1" id="s2898.p0" relation="true"/>
  </sentence>
  <sentence id="s2899" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).">
    <entity charOffset="32-45" id="s2899.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="203-209" id="s2899.e1" ontology_id="6511" text="SLC1A6" type="GENE"/>
    <pair e1="s2899.e0" e2="s2899.e1" id="s2899.p0" relation="true"/>
  </sentence>
  <sentence id="s2900" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).">
    <entity charOffset="32-45" id="s2900.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="211-217" id="s2900.e1" ontology_id="6506" text="SLC1A2" type="GENE"/>
    <pair e1="s2900.e0" e2="s2900.e1" id="s2900.p0" relation="true"/>
  </sentence>
  <sentence id="s2901" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).">
    <entity charOffset="32-45" id="s2901.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="218-223" id="s2901.e1" ontology_id="114787" text="GRIN1" type="GENE"/>
    <pair e1="s2901.e0" e2="s2901.e1" id="s2901.p0" relation="true"/>
  </sentence>
  <sentence id="s2902" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).">
    <entity charOffset="32-45" id="s2902.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="225-231" id="s2902.e1" ontology_id="2903" text="GRIN2A" type="GENE"/>
    <pair e1="s2902.e0" e2="s2902.e1" id="s2902.p0" relation="true"/>
  </sentence>
  <sentence id="s2903" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).">
    <entity charOffset="32-45" id="s2903.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="233-238" id="s2903.e1" ontology_id="2890" text="GRIA1" type="GENE"/>
    <pair e1="s2903.e0" e2="s2903.e1" id="s2903.p0" relation="true"/>
  </sentence>
  <sentence id="s2904" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).">
    <entity charOffset="32-45" id="s2904.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="253-259" id="s2904.e1" ontology_id="84062" text="DTNBP1" type="GENE"/>
    <pair e1="s2904.e0" e2="s2904.e1" id="s2904.p0" relation="true"/>
  </sentence>
  <sentence id="s2905" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).">
    <entity charOffset="32-45" id="s2905.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="275-279" id="s2905.e1" ontology_id="2913" text="GRM3" type="GENE"/>
    <pair e1="s2905.e0" e2="s2905.e1" id="s2905.p0" relation="true"/>
  </sentence>
  <sentence id="s2906" text="However, to the best of our knowledge, the role of EMX2 in human colorectal cancer (CRC) is still unclear.">
    <entity charOffset="51-55" id="s2906.e0" ontology_id="2018" text="EMX2" type="GENE"/>
    <entity charOffset="76-82" id="s2906.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2906.e0" e2="s2906.e1" id="s2906.p0" relation="true"/>
  </sentence>
  <sentence id="s2907" text="Overexpression of EMX2 significantly inhibited the proliferation in vitro and CRC tumor growth in nude mice.">
    <entity charOffset="18-22" id="s2907.e0" ontology_id="2018" text="EMX2" type="GENE"/>
    <entity charOffset="82-87" id="s2907.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2907.e0" e2="s2907.e1" id="s2907.p0" relation="true"/>
  </sentence>
  <sentence id="s2908" text="Taken together, our study demonstrates that EMX2 inhibits proliferation and tumorigenesis through inactivation of the Wnt/-catenin pathway in CRC cells.">
    <entity charOffset="44-48" id="s2908.e0" ontology_id="2018" text="EMX2" type="GENE"/>
    <entity charOffset="76-81" id="s2908.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2908.e0" e2="s2908.e1" id="s2908.p0" relation="true"/>
  </sentence>
  <sentence id="s2909" text="Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c mice, and mRNA levels of Mxra7 as well as several matrix-remodeling related genes (Mmp3, Mmp13, Ecm1, Timp1) were monitored with RT-PCR.">
    <entity charOffset="22-48" id="s2909.e0" ontology_id="HP_0011496" text="corneal neovascularization" type="HP"/>
    <entity charOffset="141-146" id="s2909.e1" ontology_id="439921" text="Mxra7" type="GENE"/>
    <pair e1="s2909.e0" e2="s2909.e1" id="s2909.p0" relation="true"/>
  </sentence>
  <sentence id="s2910" text="Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c mice, and mRNA levels of Mxra7 as well as several matrix-remodeling related genes (Mmp3, Mmp13, Ecm1, Timp1) were monitored with RT-PCR.">
    <entity charOffset="22-48" id="s2910.e0" ontology_id="HP_0011496" text="corneal neovascularization" type="HP"/>
    <entity charOffset="199-203" id="s2910.e1" ontology_id="4314" text="Mmp3" type="GENE"/>
    <pair e1="s2910.e0" e2="s2910.e1" id="s2910.p0" relation="true"/>
  </sentence>
  <sentence id="s2911" text="Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c mice, and mRNA levels of Mxra7 as well as several matrix-remodeling related genes (Mmp3, Mmp13, Ecm1, Timp1) were monitored with RT-PCR.">
    <entity charOffset="22-48" id="s2911.e0" ontology_id="HP_0011496" text="corneal neovascularization" type="HP"/>
    <entity charOffset="205-210" id="s2911.e1" ontology_id="4322" text="Mmp13" type="GENE"/>
    <pair e1="s2911.e0" e2="s2911.e1" id="s2911.p0" relation="true"/>
  </sentence>
  <sentence id="s2912" text="Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c mice, and mRNA levels of Mxra7 as well as several matrix-remodeling related genes (Mmp3, Mmp13, Ecm1, Timp1) were monitored with RT-PCR.">
    <entity charOffset="22-48" id="s2912.e0" ontology_id="HP_0011496" text="corneal neovascularization" type="HP"/>
    <entity charOffset="212-216" id="s2912.e1" ontology_id="1893" text="Ecm1" type="GENE"/>
    <pair e1="s2912.e0" e2="s2912.e1" id="s2912.p0" relation="true"/>
  </sentence>
  <sentence id="s2913" text="Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c mice, and mRNA levels of Mxra7 as well as several matrix-remodeling related genes (Mmp3, Mmp13, Ecm1, Timp1) were monitored with RT-PCR.">
    <entity charOffset="22-48" id="s2913.e0" ontology_id="HP_0011496" text="corneal neovascularization" type="HP"/>
    <entity charOffset="218-223" id="s2913.e1" ontology_id="7076" text="Timp1" type="GENE"/>
    <pair e1="s2913.e0" e2="s2913.e1" id="s2913.p0" relation="true"/>
  </sentence>
  <sentence id="s2914" text="This work provides a relevant hydrocephalus mouse model and demonstrates that &lt;i&gt;Mpdz&lt;/i&gt; is essential to maintain integrity of the ependyma">
    <entity charOffset="30-43" id="s2914.e0" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <entity charOffset="81-85" id="s2914.e1" ontology_id="84708" text="Mpdz" type="GENE"/>
    <pair e1="s2914.e0" e2="s2914.e1" id="s2914.p0" relation="true"/>
  </sentence>
  <sentence id="s2915" text="These mice displayed hypertension, hyperkalemia, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function WNK4.">
    <entity charOffset="21-33" id="s2915.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="165-169" id="s2915.e1" ontology_id="65266" text="WNK4" type="GENE"/>
    <pair e1="s2915.e0" e2="s2915.e1" id="s2915.p0" relation="true"/>
  </sentence>
  <sentence id="s2916" text="These mice displayed hypertension, hyperkalemia, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function WNK4.">
    <entity charOffset="35-47" id="s2916.e0" ontology_id="HP_0002153" text="hyperkalemia" type="HP"/>
    <entity charOffset="165-169" id="s2916.e1" ontology_id="65266" text="WNK4" type="GENE"/>
    <pair e1="s2916.e0" e2="s2916.e1" id="s2916.p0" relation="true"/>
  </sentence>
  <sentence id="s2917" text="We discover that proline catabolism via proline dehydrogenase (Prodh) supports growth of breast cancer cells in 3D culture.">
    <entity charOffset="63-68" id="s2917.e0" ontology_id="5625" text="Prodh" type="GENE"/>
    <entity charOffset="96-102" id="s2917.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2917.e0" e2="s2917.e1" id="s2917.p0" relation="true"/>
  </sentence>
  <sentence id="s2918" text="In particular, we find that PRODH expression and proline catabolism is increased in metastases compared to primary breast cancers of patients and mice.">
    <entity charOffset="28-33" id="s2918.e0" ontology_id="5625" text="PRODH" type="GENE"/>
    <entity charOffset="122-128" id="s2918.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2918.e0" e2="s2918.e1" id="s2918.p0" relation="true"/>
  </sentence>
  <sentence id="s2919" text="We describe a neurological disorder with epilepsy and prominent choreoathetosis caused by biallelic pathogenic variants in FRRS1L, which encodes an AMPA receptor outer-core protein.">
    <entity charOffset="41-49" id="s2919.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="123-129" id="s2919.e1" ontology_id="23732" text="FRRS1L" type="GENE"/>
    <pair e1="s2919.e0" e2="s2919.e1" id="s2919.p0" relation="true"/>
  </sentence>
  <sentence id="s2920" text="Expression of miR-17-92a miRNAs caused decreased cell proliferation, reduced activation of AKT and MAP kinases, delayed tumorigenicity and reduced tumor growth in animals.">
    <entity charOffset="91-94" id="s2920.e0" ontology_id="207" text="AKT" type="GENE"/>
    <entity charOffset="120-125" id="s2920.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2920.e0" e2="s2920.e1" id="s2920.p0" relation="true"/>
  </sentence>
  <sentence id="s2921" text="PRA is characterized by visual impairment due to degeneration of the photoreceptors in the retina, usually leading to blindness.">
    <entity charOffset="0-3" id="s2921.e0" ontology_id="6277" text="PRA" type="GENE"/>
    <entity charOffset="118-127" id="s2921.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s2921.e0" e2="s2921.e1" id="s2921.p0" relation="true"/>
  </sentence>
  <sentence id="s2922" text="PRA has been reported in dogs from more than 100 breeds and can be genetically heterogeneous both between and within breeds.">
    <entity charOffset="0-3" id="s2922.e0" ontology_id="6277" text="PRA" type="GENE"/>
    <entity charOffset="79-92" id="s2922.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2922.e0" e2="s2922.e1" id="s2922.p0" relation="true"/>
  </sentence>
  <sentence id="s2923" text="The study indicated genetic heterogeneity as the mutation was present in all PRA-affected individuals in one large family of Shelties, whereas some other cases in the studied Sheltie population were not associated with this CNGA1 mutation.">
    <entity charOffset="28-41" id="s2923.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="224-229" id="s2923.e1" ontology_id="1259" text="CNGA1" type="GENE"/>
    <pair e1="s2923.e0" e2="s2923.e1" id="s2923.p0" relation="true"/>
  </sentence>
  <sentence id="s2924" text="To this end, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-type (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against ATP13A2.">
    <entity charOffset="8-11" id="s2924.e0" ontology_id="2022" text="end" type="GENE"/>
    <entity charOffset="48-61" id="s2924.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s2924.e0" e2="s2924.e1" id="s2924.p0" relation="false"/>
  </sentence>
  <sentence id="s2925" text="To this end, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-type (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against ATP13A2.">
    <entity charOffset="35-43" id="s2925.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="100-104" id="s2925.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s2925.e0" e2="s2925.e1" id="s2925.p0" relation="true"/>
  </sentence>
  <sentence id="s2926" text="To this end, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-type (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against ATP13A2.">
    <entity charOffset="35-43" id="s2926.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="183-190" id="s2926.e1" ontology_id="23400" text="ATP13A2" type="GENE"/>
    <pair e1="s2926.e0" e2="s2926.e1" id="s2926.p0" relation="true"/>
  </sentence>
  <sentence id="s2927" text="To this end, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-type (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against ATP13A2.">
    <entity charOffset="48-61" id="s2927.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="183-190" id="s2927.e1" ontology_id="23400" text="ATP13A2" type="GENE"/>
    <pair e1="s2927.e0" e2="s2927.e1" id="s2927.p0" relation="true"/>
  </sentence>
  <sentence id="s2928" text="Reactive oxygen species (ROS) play a vital role in the pathogenesis of many cardiovascular diseases.">
    <entity charOffset="25-28" id="s2928.e0" ontology_id="6098" text="ROS" type="GENE"/>
    <entity charOffset="76-98" id="s2928.e1" ontology_id="HP_0001626" text="cardiovascular disease" type="HP"/>
    <pair e1="s2928.e0" e2="s2928.e1" id="s2928.p0" relation="true"/>
  </sentence>
  <sentence id="s2929" text="Promyelocytic leukemia (PML) is a pleiotropic tumor suppressor, but its role in tumor microenvironment regulation is poorly characterized.">
    <entity charOffset="24-27" id="s2929.e0" ontology_id="5371" text="PML" type="GENE"/>
    <entity charOffset="46-51" id="s2929.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2929.e0" e2="s2929.e1" id="s2929.p0" relation="true"/>
  </sentence>
  <sentence id="s2930" text="PML is frequently downregulated in many cancer types, including lung cancer.">
    <entity charOffset="0-3" id="s2930.e0" ontology_id="5371" text="PML" type="GENE"/>
    <entity charOffset="40-46" id="s2930.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2930.e0" e2="s2930.e1" id="s2930.p0" relation="true"/>
  </sentence>
  <sentence id="s2931" text="The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.">
    <entity charOffset="4-8" id="s2931.e0" ontology_id="10785" text="WDR4" type="GENE"/>
    <entity charOffset="265-271" id="s2931.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2931.e0" e2="s2931.e1" id="s2931.p0" relation="true"/>
  </sentence>
  <sentence id="s2932" text="The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.">
    <entity charOffset="9-12" id="s2932.e0" ontology_id="5371" text="PML" type="GENE"/>
    <entity charOffset="265-271" id="s2932.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2932.e0" e2="s2932.e1" id="s2932.p0" relation="true"/>
  </sentence>
  <sentence id="s2933" text="The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.">
    <entity charOffset="28-31" id="s2933.e0" ontology_id="6418" text="set" type="GENE"/>
    <entity charOffset="265-271" id="s2933.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2933.e0" e2="s2933.e1" id="s2933.p0" relation="false"/>
  </sentence>
  <sentence id="s2934" text="Our study identifies WDR4 as an oncoprotein that negatively regulates PML via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation">
    <entity charOffset="21-25" id="s2934.e0" ontology_id="10785" text="WDR4" type="GENE"/>
    <entity charOffset="180-185" id="s2934.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2934.e0" e2="s2934.e1" id="s2934.p0" relation="true"/>
  </sentence>
  <sentence id="s2935" text="Our study identifies WDR4 as an oncoprotein that negatively regulates PML via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation">
    <entity charOffset="21-25" id="s2935.e0" ontology_id="10785" text="WDR4" type="GENE"/>
    <entity charOffset="109-115" id="s2935.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2935.e0" e2="s2935.e1" id="s2935.p0" relation="true"/>
  </sentence>
  <sentence id="s2936" text="Our study identifies WDR4 as an oncoprotein that negatively regulates PML via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation">
    <entity charOffset="70-73" id="s2936.e0" ontology_id="5371" text="PML" type="GENE"/>
    <entity charOffset="109-115" id="s2936.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2936.e0" e2="s2936.e1" id="s2936.p0" relation="true"/>
  </sentence>
  <sentence id="s2937" text="Loss-of-function mutations of GATAD2B have recently been defined to cause a recognizable syndrome with intellectual disability (ID).">
    <entity charOffset="30-37" id="s2937.e0" ontology_id="57459" text="GATAD2B" type="GENE"/>
    <entity charOffset="103-126" id="s2937.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2937.e0" e2="s2937.e1" id="s2937.p0" relation="true"/>
  </sentence>
  <sentence id="s2938" text="We herein report an infant with feeding difficulty, developmental delay, hypotonia, and dysmorphic features including small palpebral fissures, telecanthus, sparse hair and eyebrow, cup-shaped ears, and clinodactyly.">
    <entity charOffset="118-142" id="s2938.e0" ontology_id="HP_0045025" text="small palpebral fissures" type="HP"/>
    <entity charOffset="193-197" id="s2938.e1" ontology_id="2058" text="ears" type="GENE"/>
    <pair e1="s2938.e0" e2="s2938.e1" id="s2938.p0" relation="true"/>
  </sentence>
  <sentence id="s2939" text="We herein report an infant with feeding difficulty, developmental delay, hypotonia, and dysmorphic features including small palpebral fissures, telecanthus, sparse hair and eyebrow, cup-shaped ears, and clinodactyly.">
    <entity charOffset="193-197" id="s2939.e0" ontology_id="2058" text="ears" type="GENE"/>
    <entity charOffset="203-215" id="s2939.e1" ontology_id="HP_0030084" text="clinodactyly" type="HP"/>
    <pair e1="s2939.e0" e2="s2939.e1" id="s2939.p0" relation="true"/>
  </sentence>
  <sentence id="s2940" text="X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene is an early onset and severe cause of blindness.">
    <entity charOffset="64-68" id="s2940.e0" ontology_id="6103" text="RPGR" type="GENE"/>
    <entity charOffset="112-121" id="s2940.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s2940.e0" e2="s2940.e1" id="s2940.p0" relation="true"/>
  </sentence>
  <sentence id="s2941" text="NEK2 overexpression promotes tumorigenesis and is associated with poor prognosis in several cancers.">
    <entity charOffset="0-4" id="s2941.e0" ontology_id="4751" text="NEK2" type="GENE"/>
    <entity charOffset="29-34" id="s2941.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2941.e0" e2="s2941.e1" id="s2941.p0" relation="true"/>
  </sentence>
  <sentence id="s2942" text="Increased NEK2 expression during the late pathological stage has been detected in the Oncomine liver dataset and hepatocellular carcinoma (HCC) specimens.">
    <entity charOffset="10-14" id="s2942.e0" ontology_id="4751" text="NEK2" type="GENE"/>
    <entity charOffset="113-137" id="s2942.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2942.e0" e2="s2942.e1" id="s2942.p0" relation="true"/>
  </sentence>
  <sentence id="s2943" text="Increased NEK2 expression during the late pathological stage has been detected in the Oncomine liver dataset and hepatocellular carcinoma (HCC) specimens.">
    <entity charOffset="113-137" id="s2943.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="139-142" id="s2943.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s2943.e0" e2="s2943.e1" id="s2943.p0" relation="true"/>
  </sentence>
  <sentence id="s2944" text="However, the precise roles and mechanisms of NEK2 in liver cancer progression remain largely unknown.">
    <entity charOffset="45-49" id="s2944.e0" ontology_id="4751" text="NEK2" type="GENE"/>
    <entity charOffset="59-65" id="s2944.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2944.e0" e2="s2944.e1" id="s2944.p0" relation="true"/>
  </sentence>
  <sentence id="s2945" text="Results from the current study showed that NEK2 mediates tumor growth, metastasis and angiogenesis in vivo.">
    <entity charOffset="43-47" id="s2945.e0" ontology_id="4751" text="NEK2" type="GENE"/>
    <entity charOffset="57-62" id="s2945.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2945.e0" e2="s2945.e1" id="s2945.p0" relation="true"/>
  </sentence>
  <sentence id="s2946" text="Moreover, NEK2 mediated liver cancer cell migration via pAKT/NF-B signaling and matrix metalloproteinase (MMP) activation.">
    <entity charOffset="10-14" id="s2946.e0" ontology_id="4751" text="NEK2" type="GENE"/>
    <entity charOffset="30-36" id="s2946.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2946.e0" e2="s2946.e1" id="s2946.p0" relation="true"/>
  </sentence>
  <sentence id="s2947" text="Moreover, NEK2 mediated liver cancer cell migration via pAKT/NF-B signaling and matrix metalloproteinase (MMP) activation.">
    <entity charOffset="30-36" id="s2947.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="57-60" id="s2947.e1" ontology_id="207" text="AKT" type="GENE"/>
    <pair e1="s2947.e0" e2="s2947.e1" id="s2947.p0" relation="true"/>
  </sentence>
  <sentence id="s2948" text="Moreover, NEK2 mediated liver cancer cell migration via pAKT/NF-B signaling and matrix metalloproteinase (MMP) activation.">
    <entity charOffset="30-36" id="s2948.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="61-63" id="s2948.e1" ontology_id="23114" text="NF" type="GENE"/>
    <pair e1="s2948.e0" e2="s2948.e1" id="s2948.p0" relation="true"/>
  </sentence>
  <sentence id="s2949" text="However, few reports exist on TNC expression in gastrointestinal stromal tumors (GISTs).">
    <entity charOffset="30-33" id="s2949.e0" ontology_id="3371" text="TNC" type="GENE"/>
    <entity charOffset="73-79" id="s2949.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2949.e0" e2="s2949.e1" id="s2949.p0" relation="true"/>
  </sentence>
  <sentence id="s2950" text="The TNC mRNA and protein levels were found to significantly downregulated in tumors without progression compared to those tumors which occurred tumor progression during the follow-up period (P&amp;lt;.05).">
    <entity charOffset="4-7" id="s2950.e0" ontology_id="3371" text="TNC" type="GENE"/>
    <entity charOffset="77-83" id="s2950.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2950.e0" e2="s2950.e1" id="s2950.p0" relation="true"/>
  </sentence>
  <sentence id="s2951" text="The TNC mRNA and protein levels were found to significantly downregulated in tumors without progression compared to those tumors which occurred tumor progression during the follow-up period (P&amp;lt;.05).">
    <entity charOffset="4-7" id="s2951.e0" ontology_id="3371" text="TNC" type="GENE"/>
    <entity charOffset="144-149" id="s2951.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2951.e0" e2="s2951.e1" id="s2951.p0" relation="true"/>
  </sentence>
  <sentence id="s2952" text="As for the prognostic analysis, it revealed that tumor size, mitotic count, surgical margins, multivisceral resection, and TNC expression were independent predictors of PFS for gastric GISTs (P&amp;lt;.05).">
    <entity charOffset="49-54" id="s2952.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="123-126" id="s2952.e1" ontology_id="3371" text="TNC" type="GENE"/>
    <pair e1="s2952.e0" e2="s2952.e1" id="s2952.p0" relation="true"/>
  </sentence>
  <sentence id="s2953" text="Primary ciliary dyskinesia (PCD) is a clinical rare peculiar disorder, mainly featured by respiratory infection, tympanitis, nasosinusitis, and male infertility.">
    <entity charOffset="8-26" id="s2953.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="28-31" id="s2953.e1" ontology_id="352909" text="PCD" type="GENE"/>
    <pair e1="s2953.e0" e2="s2953.e1" id="s2953.p0" relation="true"/>
  </sentence>
  <sentence id="s2954" text="The authors report here a brief summary of findings from 12 lines of genetically engineered mice that presented with autosomal recessive congenital hydrocephalus.">
    <entity charOffset="92-96" id="s2954.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="148-161" id="s2954.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s2954.e0" e2="s2954.e1" id="s2954.p0" relation="true"/>
  </sentence>
  <sentence id="s2955" text="The authors report here a brief summary of findings from 12 lines of genetically engineered mice that presented with autosomal recessive congenital hydrocephalus.">
    <entity charOffset="92-96" id="s2955.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="117-136" id="s2955.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2955.e0" e2="s2955.e1" id="s2955.p0" relation="true"/>
  </sentence>
  <sentence id="s2956" text="A hypomorphic variant in CCDC22 was previously reported in association with a familial case of syndromic X-linked intellectual disability, which shows phenotypic overlap with RSS/3C syndrome.">
    <entity charOffset="25-31" id="s2956.e0" ontology_id="28952" text="CCDC22" type="GENE"/>
    <entity charOffset="114-137" id="s2956.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2956.e0" e2="s2956.e1" id="s2956.p0" relation="true"/>
  </sentence>
  <sentence id="s2957" text="In particular, the TMEM132D, SPTA1 and VPS13B genes were commonly mutated in both early and late stage tumors, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.">
    <entity charOffset="29-34" id="s2957.e0" ontology_id="6708" text="SPTA1" type="GENE"/>
    <entity charOffset="103-109" id="s2957.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2957.e0" e2="s2957.e1" id="s2957.p0" relation="true"/>
  </sentence>
  <sentence id="s2958" text="In particular, the TMEM132D, SPTA1 and VPS13B genes were commonly mutated in both early and late stage tumors, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.">
    <entity charOffset="39-45" id="s2958.e0" ontology_id="157680" text="VPS13B" type="GENE"/>
    <entity charOffset="103-109" id="s2958.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2958.e0" e2="s2958.e1" id="s2958.p0" relation="true"/>
  </sentence>
  <sentence id="s2959" text="We found that the expression of Sgo1 mRNA was relatively low in normal tissues, but was upregulated in 82% of hepatocellular carcinoma (HCC), and correlated with elevated alpha-fetoprotein and early disease onset of HCC.">
    <entity charOffset="32-36" id="s2959.e0" ontology_id="151648" text="Sgo1" type="GENE"/>
    <entity charOffset="110-134" id="s2959.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2959.e0" e2="s2959.e1" id="s2959.p0" relation="true"/>
  </sentence>
  <sentence id="s2960" text="We found that the expression of Sgo1 mRNA was relatively low in normal tissues, but was upregulated in 82% of hepatocellular carcinoma (HCC), and correlated with elevated alpha-fetoprotein and early disease onset of HCC.">
    <entity charOffset="110-134" id="s2960.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="136-139" id="s2960.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s2960.e0" e2="s2960.e1" id="s2960.p0" relation="true"/>
  </sentence>
  <sentence id="s2961" text="Recent studies have suggested possible therapeutic targets for some patients with early-onset glaucoma based on the molecular and cellular events caused by MYOC, OPTN and TBK1 mutations.">
    <entity charOffset="94-102" id="s2961.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="156-160" id="s2961.e1" ontology_id="4653" text="MYOC" type="GENE"/>
    <pair e1="s2961.e0" e2="s2961.e1" id="s2961.p0" relation="true"/>
  </sentence>
  <sentence id="s2962" text="Recent studies have suggested possible therapeutic targets for some patients with early-onset glaucoma based on the molecular and cellular events caused by MYOC, OPTN and TBK1 mutations.">
    <entity charOffset="94-102" id="s2962.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="171-175" id="s2962.e1" ontology_id="29110" text="TBK1" type="GENE"/>
    <pair e1="s2962.e0" e2="s2962.e1" id="s2962.p0" relation="true"/>
  </sentence>
  <sentence id="s2963" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s2963.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="136-141" id="s2963.e1" ontology_id="19" text="ABCA1" type="GENE"/>
    <pair e1="s2963.e0" e2="s2963.e1" id="s2963.p0" relation="true"/>
  </sentence>
  <sentence id="s2964" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s2964.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="143-148" id="s2964.e1" ontology_id="60312" text="AFAP1" type="GENE"/>
    <pair e1="s2964.e0" e2="s2964.e1" id="s2964.p0" relation="true"/>
  </sentence>
  <sentence id="s2965" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s2965.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="150-154" id="s2965.e1" ontology_id="2762" text="GMDS" type="GENE"/>
    <pair e1="s2965.e0" e2="s2965.e1" id="s2965.p0" relation="true"/>
  </sentence>
  <sentence id="s2966" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s2966.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="156-160" id="s2966.e1" ontology_id="5373" text="PMM2" type="GENE"/>
    <pair e1="s2966.e0" e2="s2966.e1" id="s2966.p0" relation="true"/>
  </sentence>
  <sentence id="s2967" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s2967.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="170-176" id="s2967.e1" ontology_id="64778" text="FNDC3B" type="GENE"/>
    <pair e1="s2967.e0" e2="s2967.e1" id="s2967.p0" relation="true"/>
  </sentence>
  <sentence id="s2968" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s2968.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="194-199" id="s2968.e1" ontology_id="2296" text="FOXC1" type="GENE"/>
    <pair e1="s2968.e0" e2="s2968.e1" id="s2968.p0" relation="true"/>
  </sentence>
  <sentence id="s2969" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s2969.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="201-206" id="s2969.e1" ontology_id="6311" text="ATXN2" type="GENE"/>
    <pair e1="s2969.e0" e2="s2969.e1" id="s2969.p0" relation="true"/>
  </sentence>
  <sentence id="s2970" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s2970.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="255-260" id="s2970.e1" ontology_id="54749" text="EPDR1" type="GENE"/>
    <pair e1="s2970.e0" e2="s2970.e1" id="s2970.p0" relation="false"/>
  </sentence>
  <sentence id="s2971" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s2971.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="275-281" id="s2971.e1" ontology_id="10979" text="FERMT2" type="GENE"/>
    <pair e1="s2971.e0" e2="s2971.e1" id="s2971.p0" relation="true"/>
  </sentence>
  <sentence id="s2972" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s2972.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="283-287" id="s2972.e1" ontology_id="8818" text="DPM2" type="GENE"/>
    <pair e1="s2972.e0" e2="s2972.e1" id="s2972.p0" relation="true"/>
  </sentence>
  <sentence id="s2973" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s2973.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="338-345" id="s2973.e1" ontology_id="773" text="CACNA1A" type="GENE"/>
    <pair e1="s2973.e0" e2="s2973.e1" id="s2973.p0" relation="true"/>
  </sentence>
  <sentence id="s2974" text="In total sixteen genomic regions have been associated with POAG (including the normal tension glaucoma (NTG) subgroup), 8 with PACG and 2 with XFS.">
    <entity charOffset="94-102" id="s2974.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="104-107" id="s2974.e1" ontology_id="9968" text="NTG" type="GENE"/>
    <pair e1="s2974.e0" e2="s2974.e1" id="s2974.p0" relation="true"/>
  </sentence>
  <sentence id="s2975" text="Recent studies reported germline variants in POT1 in melanoma families.">
    <entity charOffset="45-49" id="s2975.e0" ontology_id="25913" text="POT1" type="GENE"/>
    <entity charOffset="53-61" id="s2975.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s2975.e0" e2="s2975.e1" id="s2975.p0" relation="true"/>
  </sentence>
  <sentence id="s2976" text="So, in conclusion, melanoma associated POT1 germline variants seem to be rare.">
    <entity charOffset="19-27" id="s2976.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="39-43" id="s2976.e1" ontology_id="25913" text="POT1" type="GENE"/>
    <pair e1="s2976.e0" e2="s2976.e1" id="s2976.p0" relation="true"/>
  </sentence>
  <sentence id="s2977" text="The classical mammalian isoforms of PLD are PLD1 and PLD2, and the levels of both mRNA were higher at the primary tumor sites than in normal kidney tissues.">
    <entity charOffset="44-48" id="s2977.e0" ontology_id="5589" text="PLD1" type="GENE"/>
    <entity charOffset="114-119" id="s2977.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2977.e0" e2="s2977.e1" id="s2977.p0" relation="true"/>
  </sentence>
  <sentence id="s2978" text="Notably, shRNA-mediated knockdown of PLD2 suppressed the growth and invasion of tumors in nude mouse xenograft models.">
    <entity charOffset="80-85" id="s2978.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="90-94" id="s2978.e1" ontology_id="54820" text="nude" type="GENE"/>
    <pair e1="s2978.e0" e2="s2978.e1" id="s2978.p0" relation="true"/>
  </sentence>
  <sentence id="s2979" text="As for genes relating to the tumor invasion of PLD2, we found that angiogenin (ANG) was positively regulated by PLD2.">
    <entity charOffset="29-34" id="s2979.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="47-51" id="s2979.e1" ontology_id="5338" text="PLD2" type="GENE"/>
    <pair e1="s2979.e0" e2="s2979.e1" id="s2979.p0" relation="true"/>
  </sentence>
  <sentence id="s2980" text="In fact, the expression levels of ANG were elevated in tumor tissues as compared with normal kidney and the inhibition of ANG activity with a neutralizing antibody significantly suppressed tumor invasion.">
    <entity charOffset="34-37" id="s2980.e0" ontology_id="283" text="ANG" type="GENE"/>
    <entity charOffset="55-60" id="s2980.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2980.e0" e2="s2980.e1" id="s2980.p0" relation="true"/>
  </sentence>
  <sentence id="s2981" text="We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="44-48" id="s2981.e0" ontology_id="1123" text="CHN1" type="GENE"/>
    <entity charOffset="125-151" id="s2981.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s2981.e0" e2="s2981.e1" id="s2981.p0" relation="true"/>
  </sentence>
  <sentence id="s2982" text="We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="50-54" id="s2982.e0" ontology_id="4190" text="MDH1" type="GENE"/>
    <entity charOffset="125-151" id="s2982.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s2982.e0" e2="s2982.e1" id="s2982.p0" relation="true"/>
  </sentence>
  <sentence id="s2983" text="We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="56-60" id="s2983.e0" ontology_id="5121" text="PCP4" type="GENE"/>
    <entity charOffset="125-151" id="s2983.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s2983.e0" e2="s2983.e1" id="s2983.p0" relation="true"/>
  </sentence>
  <sentence id="s2984" text="We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="68-75" id="s2984.e0" ontology_id="6563" text="SLC14A1" type="GENE"/>
    <entity charOffset="125-151" id="s2984.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s2984.e0" e2="s2984.e1" id="s2984.p0" relation="false"/>
  </sentence>
  <sentence id="s2985" text="We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="77-83" id="s2985.e0" ontology_id="6616" text="SNAP25" type="GENE"/>
    <entity charOffset="125-151" id="s2985.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s2985.e0" e2="s2985.e1" id="s2985.p0" relation="true"/>
  </sentence>
  <sentence id="s2986" text="We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="88-93" id="s2986.e0" ontology_id="7447" text="VSNL1" type="GENE"/>
    <entity charOffset="125-151" id="s2986.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s2986.e0" e2="s2986.e1" id="s2986.p0" relation="true"/>
  </sentence>
  <sentence id="s2987" text="Ectodysplasin-A2 (EDA-A2) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (XEDAR).">
    <entity charOffset="18-24" id="s2987.e0" ontology_id="1896" text="EDA-A2" type="GENE"/>
    <entity charOffset="63-68" id="s2987.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2987.e0" e2="s2987.e1" id="s2987.p0" relation="true"/>
  </sentence>
  <sentence id="s2988" text="Ectodysplasin-A2 (EDA-A2) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (XEDAR).">
    <entity charOffset="63-68" id="s2988.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="151-156" id="s2988.e1" ontology_id="60401" text="XEDAR" type="GENE"/>
    <pair e1="s2988.e0" e2="s2988.e1" id="s2988.p0" relation="true"/>
  </sentence>
  <sentence id="s2989" text="Ectodysplasin-A2 (EDA-A2) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (XEDAR).">
    <entity charOffset="120-140" id="s2989.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="151-156" id="s2989.e1" ontology_id="60401" text="XEDAR" type="GENE"/>
    <pair e1="s2989.e0" e2="s2989.e1" id="s2989.p0" relation="true"/>
  </sentence>
  <sentence id="s2990" text="Limb girdle muscular dystrophy type 2G (LGMD2G) is caused by mutations in the telethonin gene.">
    <entity charOffset="12-30" id="s2990.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="41-47" id="s2990.e1" ontology_id="8557" text="LGMD2G" type="GENE"/>
    <pair e1="s2990.e0" e2="s2990.e1" id="s2990.p0" relation="true"/>
  </sentence>
  <sentence id="s2991" text="Limb girdle muscular dystrophy type 2G (LGMD2G) is caused by mutations in the telethonin gene.">
    <entity charOffset="12-30" id="s2991.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="79-89" id="s2991.e1" ontology_id="8557" text="telethonin" type="GENE"/>
    <pair e1="s2991.e0" e2="s2991.e1" id="s2991.p0" relation="true"/>
  </sentence>
  <sentence id="s2992" text="Sjgren-Larsson syndrome (SLS) is a rare autosomal recessive disorder characterized by ichthyosis, spasticity and intellectual disability.">
    <entity charOffset="26-29" id="s2992.e0" ontology_id="224" text="SLS" type="GENE"/>
    <entity charOffset="99-109" id="s2992.e1" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <pair e1="s2992.e0" e2="s2992.e1" id="s2992.p0" relation="false"/>
  </sentence>
  <sentence id="s2993" text="We report a case of ALK-positive renal cell carcinoma coincident with Hodgkin lymphoma.">
    <entity charOffset="20-23" id="s2993.e0" ontology_id="238" text="ALK" type="GENE"/>
    <entity charOffset="33-53" id="s2993.e1" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <pair e1="s2993.e0" e2="s2993.e1" id="s2993.p0" relation="true"/>
  </sentence>
  <sentence id="s2994" text="The variety of growth patterns and cell features led us to speculate a possibility of ALK-positive renal cell carcinoma (ALK+RCC).">
    <entity charOffset="86-89" id="s2994.e0" ontology_id="238" text="ALK" type="GENE"/>
    <entity charOffset="99-119" id="s2994.e1" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <pair e1="s2994.e0" e2="s2994.e1" id="s2994.p0" relation="true"/>
  </sentence>
  <sentence id="s2995" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s2995.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="173-176" id="s2995.e1" ontology_id="10054" text="ARX" type="GENE"/>
    <pair e1="s2995.e0" e2="s2995.e1" id="s2995.p0" relation="true"/>
  </sentence>
  <sentence id="s2996" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s2996.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="247-253" id="s2996.e1" ontology_id="6812" text="STXBP1" type="GENE"/>
    <pair e1="s2996.e0" e2="s2996.e1" id="s2996.p0" relation="true"/>
  </sentence>
  <sentence id="s2997" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s2997.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="292-300" id="s2997.e1" ontology_id="79751" text="SLC25A22" type="GENE"/>
    <pair e1="s2997.e0" e2="s2997.e1" id="s2997.p0" relation="true"/>
  </sentence>
  <sentence id="s2998" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s2998.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="333-339" id="s2998.e1" ontology_id="6709" text="SPTAN1" type="GENE"/>
    <pair e1="s2998.e0" e2="s2998.e1" id="s2998.p0" relation="true"/>
  </sentence>
  <sentence id="s2999" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s2999.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="464-468" id="s2999.e1" ontology_id="11284" text="PNKP" type="GENE"/>
    <pair e1="s2999.e0" e2="s2999.e1" id="s2999.p0" relation="true"/>
  </sentence>
  <sentence id="s3000" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s3000.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="495-499" id="s3000.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s3000.e0" e2="s3000.e1" id="s3000.p0" relation="true"/>
  </sentence>
  <sentence id="s3001" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s3001.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="512-517" id="s3001.e1" ontology_id="6323" text="SCN1A" type="GENE"/>
    <pair e1="s3001.e0" e2="s3001.e1" id="s3001.p0" relation="true"/>
  </sentence>
  <sentence id="s3002" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s3002.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="591-595" id="s3002.e1" ontology_id="55163" text="PNPO" type="GENE"/>
    <pair e1="s3002.e0" e2="s3002.e1" id="s3002.p0" relation="true"/>
  </sentence>
  <sentence id="s3003" text="These clinical and imaging findings are unlike that of any recognized severe forms of microcephaly which is believed to be a new microcephalic primordial dwarfism (MPD) with developmental brain malformations with most probably autosomal recessive inheritance based on consanguinity and similarly affected male and female sibs">
    <entity charOffset="86-98" id="s3003.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="164-167" id="s3003.e1" ontology_id="4597" text="MPD" type="GENE"/>
    <pair e1="s3003.e0" e2="s3003.e1" id="s3003.p0" relation="true"/>
  </sentence>
  <sentence id="s3004" text="These clinical and imaging findings are unlike that of any recognized severe forms of microcephaly which is believed to be a new microcephalic primordial dwarfism (MPD) with developmental brain malformations with most probably autosomal recessive inheritance based on consanguinity and similarly affected male and female sibs">
    <entity charOffset="164-167" id="s3004.e0" ontology_id="4597" text="MPD" type="GENE"/>
    <entity charOffset="247-258" id="s3004.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s3004.e0" e2="s3004.e1" id="s3004.p0" relation="true"/>
  </sentence>
  <sentence id="s3005" text="The patients were classified according to the presence of significant coronary atherosclerosis (CAS) and history of myocardial infarction (MI).">
    <entity charOffset="96-99" id="s3005.e0" ontology_id="9564" text="CAS" type="GENE"/>
    <entity charOffset="116-137" id="s3005.e1" ontology_id="HP_0001658" text="myocardial infarction" type="HP"/>
    <pair e1="s3005.e0" e2="s3005.e1" id="s3005.p0" relation="true"/>
  </sentence>
  <sentence id="s3006" text="Corticosteroid-binding globulin (SERPINA6) deficiency is an extremely rare hereditary disorder characterized by reduced corticosteroid-binding capacity with normal or low plasma corticosteroid-binding globulin concentration, and normal or low basal cortisol levels associated with hypo-/hypertension and muscle fatigue.">
    <entity charOffset="33-41" id="s3006.e0" ontology_id="866" text="SERPINA6" type="GENE"/>
    <entity charOffset="287-299" id="s3006.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s3006.e0" e2="s3006.e1" id="s3006.p0" relation="true"/>
  </sentence>
  <sentence id="s3007" text="LncRNA &lt;i&gt;pancEts-1&lt;/i&gt; promoted the growth, invasion, and metastasis of neuroblastoma cells &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt; Mechanistically, &lt;i&gt;pancEts-1&lt;/i&gt; bound to hnRNPK to facilitate its physical interaction with -catenin, whereas hnRNPK stabilized the -catenin by inhibiting proteasome-mediated degradation, resulting in transcriptional alteration of target genes associated with neuroblastoma progression.">
    <entity charOffset="73-86" id="s3007.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="171-177" id="s3007.e1" ontology_id="3190" text="hnRNPK" type="GENE"/>
    <pair e1="s3007.e0" e2="s3007.e1" id="s3007.p0" relation="true"/>
  </sentence>
  <sentence id="s3008" text="Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, ORC4, ORC6, CDT1, and CDC6.">
    <entity charOffset="45-58" id="s3008.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="211-215" id="s3008.e1" ontology_id="10166" text="ORC1" type="GENE"/>
    <pair e1="s3008.e0" e2="s3008.e1" id="s3008.p0" relation="true"/>
  </sentence>
  <sentence id="s3009" text="Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, ORC4, ORC6, CDT1, and CDC6.">
    <entity charOffset="45-58" id="s3009.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="229-233" id="s3009.e1" ontology_id="81620" text="CDT1" type="GENE"/>
    <pair e1="s3009.e0" e2="s3009.e1" id="s3009.p0" relation="true"/>
  </sentence>
  <sentence id="s3010" text="Multiple mitochondrial dysfunction syndrome 1 (MMDS1) arises as a result of the missense mutation in NFU1, an Fe/S cluster scaffold protein, which substitutes a glycine near the Fe/S cluster-binding pocket to a cysteine (p.Gly208Cys).">
    <entity charOffset="9-34" id="s3010.e0" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <entity charOffset="110-112" id="s3010.e1" ontology_id="2960" text="Fe" type="GENE"/>
    <pair e1="s3010.e0" e2="s3010.e1" id="s3010.p0" relation="true"/>
  </sentence>
  <sentence id="s3011" text="T cell-related encephalopathy (CRES) syndrome may occur concomitantly.">
    <entity charOffset="15-29" id="s3011.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="31-35" id="s3011.e1" ontology_id="10047" text="CRES" type="GENE"/>
    <pair e1="s3011.e0" e2="s3011.e1" id="s3011.p0" relation="true"/>
  </sentence>
  <sentence id="s3012" text="We show that maternal COL24A1 variants have a significant genome-wide interaction with maternal pre-pregnancy overweight/obesity on PTB risk, with rs11161721 (P&lt;sub&gt;G  E&lt;/sub&gt;=1.8  10&lt;sup&gt;-8&lt;/sup&gt;; empirical P&lt;sub&gt;G  E&lt;/sub&gt;=1.2  10&lt;sup&gt;-8&lt;/sup&gt;) as the top hit.">
    <entity charOffset="22-29" id="s3012.e0" ontology_id="255631" text="COL24A1" type="GENE"/>
    <entity charOffset="121-128" id="s3012.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3012.e0" e2="s3012.e1" id="s3012.p0" relation="true"/>
  </sentence>
  <sentence id="s3013" text="Subsequent FISH analysis with region-specific YAC clones was used to relate the phenotypic findings such as bilateral split hand formation, specific cardiac and kidney anomalies, microtia, and hypoplastic thorax more exactly to the partial trisomy of the segment 4q26-qter">
    <entity charOffset="11-15" id="s3013.e0" ontology_id="9644" text="FISH" type="GENE"/>
    <entity charOffset="108-117" id="s3013.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s3013.e0" e2="s3013.e1" id="s3013.p0" relation="true"/>
  </sentence>
  <sentence id="s3014" text="Therefore, our findings firstly suggested that miR-34a could modulate the susceptibility of gastric cancer cell to luteolin via targeting HK1, potentially benefiting GC patients' treatment in the future">
    <entity charOffset="47-50" id="s3014.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="100-106" id="s3014.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3014.e0" e2="s3014.e1" id="s3014.p0" relation="true"/>
  </sentence>
  <sentence id="s3015" text="However, little information is currently available on the skeletal abnormalities of PRS and the potential contribution of PAX2 mutations.">
    <entity charOffset="58-80" id="s3015.e0" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <entity charOffset="122-126" id="s3015.e1" ontology_id="5076" text="PAX2" type="GENE"/>
    <pair e1="s3015.e0" e2="s3015.e1" id="s3015.p0" relation="true"/>
  </sentence>
  <sentence id="s3016" text="This case unravels a previously unrecognized phenotype of camptodactyly due to a significant skeletal deformity of PRS with a heterogeneous PAX2 mutation of hexanucleotide duplication.">
    <entity charOffset="58-71" id="s3016.e0" ontology_id="HP_0012385" text="camptodactyly" type="HP"/>
    <entity charOffset="140-144" id="s3016.e1" ontology_id="5076" text="PAX2" type="GENE"/>
    <pair e1="s3016.e0" e2="s3016.e1" id="s3016.p0" relation="true"/>
  </sentence>
  <sentence id="s3017" text="Functional studies have elucidated the role of the mammalian target of rapamycin (mTOR) pathway in breast carcinogenesis, but to date, there is a paucity of data on its contribution to breast cancer risk in women of African ancestry.">
    <entity charOffset="82-86" id="s3017.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="192-198" id="s3017.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3017.e0" e2="s3017.e1" id="s3017.p0" relation="true"/>
  </sentence>
  <sentence id="s3018" text="We examined 47628 SNPs in 61 mTOR pathway genes in the genome wide association study of breast cancer in the African Diaspora study (The Root consortium), which included 3686 participants (1657 cases).">
    <entity charOffset="29-33" id="s3018.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="95-101" id="s3018.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3018.e0" e2="s3018.e1" id="s3018.p0" relation="true"/>
  </sentence>
  <sentence id="s3019" text="PRKAG3 (Padj = 0.0018) and RPS6KA3 (Padj = 0.061) were the leading genes for the associations with overall breast cancer risk and ER- breast cancer risk, respectively.">
    <entity charOffset="27-34" id="s3019.e0" ontology_id="6197" text="RPS6KA3" type="GENE"/>
    <entity charOffset="114-120" id="s3019.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3019.e0" e2="s3019.e1" id="s3019.p0" relation="true"/>
  </sentence>
  <sentence id="s3020" text="These results provide new insights on the biological relevance of the mTOR pathway in breast cancer progression and underscore the need for more genetic epidemiology studies of breast cancer in the African Diaspora">
    <entity charOffset="70-74" id="s3020.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="93-99" id="s3020.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3020.e0" e2="s3020.e1" id="s3020.p0" relation="true"/>
  </sentence>
  <sentence id="s3021" text="Although the expression pattern and functions of the CaSR in the colonic microenvironment are far from being completely understood, evidence has been accumulating that the CaSR might play a protective role against both colonic inflammation and colorectal cancer.">
    <entity charOffset="53-57" id="s3021.e0" ontology_id="846" text="CaSR" type="GENE"/>
    <entity charOffset="255-261" id="s3021.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3021.e0" e2="s3021.e1" id="s3021.p0" relation="true"/>
  </sentence>
  <sentence id="s3022" text="For example, CaSR agonists such as dipeptides have been suggested to reduce colonic inflammation, while dietary calcium was shown to reduce the risk of colorectal cancer.">
    <entity charOffset="13-17" id="s3022.e0" ontology_id="846" text="CaSR" type="GENE"/>
    <entity charOffset="163-169" id="s3022.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3022.e0" e2="s3022.e1" id="s3022.p0" relation="true"/>
  </sentence>
  <sentence id="s3023" text="This dual anti-inflammatory and anti-tumourigenic role of the CaSR makes it especially interesting in colitis-associated colorectal cancer.">
    <entity charOffset="62-66" id="s3023.e0" ontology_id="846" text="CaSR" type="GENE"/>
    <entity charOffset="132-138" id="s3023.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3023.e0" e2="s3023.e1" id="s3023.p0" relation="true"/>
  </sentence>
  <sentence id="s3024" text="In this review, we describe the clinical and experimental evidence for the role of the CaSR in colonic inflammation and colorectal cancer, the intracellular signalling pathways which are putatively involved in these actions, and the possibilities to exploit these actions of the CaSR for future therapies of colonic inflammation and cancer">
    <entity charOffset="87-91" id="s3024.e0" ontology_id="846" text="CaSR" type="GENE"/>
    <entity charOffset="131-137" id="s3024.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3024.e0" e2="s3024.e1" id="s3024.p0" relation="false"/>
  </sentence>
  <sentence id="s3025" text="In human, PDC deficiency leads to severe neurodevelopmental delay and progressive neurodegeneration.">
    <entity charOffset="10-13" id="s3025.e0" ontology_id="25953" text="PDC" type="GENE"/>
    <entity charOffset="41-65" id="s3025.e1" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <pair e1="s3025.e0" e2="s3025.e1" id="s3025.p0" relation="true"/>
  </sentence>
  <sentence id="s3026" text="Independently, another group has recently observed SRD5A3 mutations in several families with a type 1 congenital disorder of glycosylation (CDG type Ix, OMIM 212067), mental retardation, cerebellar ataxia and eye disorders.">
    <entity charOffset="51-57" id="s3026.e0" ontology_id="79644" text="SRD5A3" type="GENE"/>
    <entity charOffset="187-204" id="s3026.e1" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <pair e1="s3026.e0" e2="s3026.e1" id="s3026.p0" relation="true"/>
  </sentence>
  <sentence id="s3027" text="The expression level of lncRNA FEZF-AS1 and FEZF1 was determined by the quantitative Real-time PCR in 160 cases of NSCLC tissues and their adjacent non-tumour tissues.">
    <entity charOffset="44-49" id="s3027.e0" ontology_id="389549" text="FEZF1" type="GENE"/>
    <entity charOffset="152-158" id="s3027.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3027.e0" e2="s3027.e1" id="s3027.p0" relation="true"/>
  </sentence>
  <sentence id="s3028" text="By GEPIA database analysis, we also found that the expression of lncRNA FEZF-AS1 and FEZF1 were significantly higher in tumour tissues than those of the adjacent non-cancerous tissues in 969 NSCLC patients (P&amp;lt;0.05), and lncRNA FEZF-AS1 was positively correlated with FEZF1 (r=0.90, P&amp;lt;0.001).">
    <entity charOffset="85-90" id="s3028.e0" ontology_id="389549" text="FEZF1" type="GENE"/>
    <entity charOffset="166-172" id="s3028.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3028.e0" e2="s3028.e1" id="s3028.p0" relation="true"/>
  </sentence>
  <sentence id="s3029" text="In the framework of this heterogeneity, we report the clinical description of a neonate, first child of consanguineous parents, who had osteoclast-rich osteopetrosis and bone marrow failure in early life, but no other usual classical features of infantile malignant OPT, such as visual or hearing impairments.">
    <entity charOffset="266-269" id="s3029.e0" ontology_id="51430" text="OPT" type="GENE"/>
    <entity charOffset="289-308" id="s3029.e1" ontology_id="HP_0000365" text="hearing impairments" type="HP"/>
    <pair e1="s3029.e0" e2="s3029.e1" id="s3029.p0" relation="true"/>
  </sentence>
  <sentence id="s3030" text="ASXL1 (additional sex combs like 1) is a gene that is mutated in a number of hematological neoplasms.">
    <entity charOffset="0-5" id="s3030.e0" ontology_id="171023" text="ASXL1" type="GENE"/>
    <entity charOffset="91-100" id="s3030.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s3030.e0" e2="s3030.e1" id="s3030.p0" relation="true"/>
  </sentence>
  <sentence id="s3031" text="In addition, we investigated the impact of proofreading capabilities of different DNA polymerases on ASXL1 c.1934dupG somatic mutation using conventional Sanger sequencing, another common method for ASXL1 genotyping.">
    <entity charOffset="101-106" id="s3031.e0" ontology_id="171023" text="ASXL1" type="GENE"/>
    <entity charOffset="118-134" id="s3031.e1" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <pair e1="s3031.e0" e2="s3031.e1" id="s3031.p0" relation="true"/>
  </sentence>
  <sentence id="s3032" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="64-69" id="s3032.e0" ontology_id="171023" text="ASXL1" type="GENE"/>
    <entity charOffset="121-130" id="s3032.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s3032.e0" e2="s3032.e1" id="s3032.p0" relation="true"/>
  </sentence>
  <sentence id="s3033" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="64-69" id="s3033.e0" ontology_id="171023" text="ASXL1" type="GENE"/>
    <entity charOffset="86-102" id="s3033.e1" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <pair e1="s3033.e0" e2="s3033.e1" id="s3033.p0" relation="true"/>
  </sentence>
  <sentence id="s3034" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="86-102" id="s3034.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="141-144" id="s3034.e1" ontology_id="5048" text="MDS" type="GENE"/>
    <pair e1="s3034.e0" e2="s3034.e1" id="s3034.p0" relation="true"/>
  </sentence>
  <sentence id="s3035" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="86-102" id="s3035.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="151-154" id="s3035.e1" ontology_id="83886" text="MPN" type="GENE"/>
    <pair e1="s3035.e0" e2="s3035.e1" id="s3035.p0" relation="true"/>
  </sentence>
  <sentence id="s3036" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="86-102" id="s3036.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="223-227" id="s3036.e1" ontology_id="2146" text="EZH2" type="GENE"/>
    <pair e1="s3036.e0" e2="s3036.e1" id="s3036.p0" relation="true"/>
  </sentence>
  <sentence id="s3037" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="86-102" id="s3037.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="229-233" id="s3037.e1" ontology_id="3418" text="IDH2" type="GENE"/>
    <pair e1="s3037.e0" e2="s3037.e1" id="s3037.p0" relation="true"/>
  </sentence>
  <sentence id="s3038" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="121-130" id="s3038.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="151-154" id="s3038.e1" ontology_id="83886" text="MPN" type="GENE"/>
    <pair e1="s3038.e0" e2="s3038.e1" id="s3038.p0" relation="true"/>
  </sentence>
  <sentence id="s3039" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="121-130" id="s3039.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="217-221" id="s3039.e1" ontology_id="54790" text="TET2" type="GENE"/>
    <pair e1="s3039.e0" e2="s3039.e1" id="s3039.p0" relation="true"/>
  </sentence>
  <sentence id="s3040" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="121-130" id="s3040.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="229-233" id="s3040.e1" ontology_id="3418" text="IDH2" type="GENE"/>
    <pair e1="s3040.e0" e2="s3040.e1" id="s3040.p0" relation="false"/>
  </sentence>
  <sentence id="s3041" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="121-130" id="s3041.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="235-240" id="s3041.e1" ontology_id="861" text="RUNX1" type="GENE"/>
    <pair e1="s3041.e0" e2="s3041.e1" id="s3041.p0" relation="true"/>
  </sentence>
  <sentence id="s3042" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="121-130" id="s3042.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="242-246" id="s3042.e1" ontology_id="4893" text="NRAS" type="GENE"/>
    <pair e1="s3042.e0" e2="s3042.e1" id="s3042.p0" relation="true"/>
  </sentence>
  <sentence id="s3043" text="Transcription factors (TFs) are major cell fate regulators frequently involved in cancer, particularly in leukemia.">
    <entity charOffset="14-18" id="s3043.e0" ontology_id="11198" text="fact" type="GENE"/>
    <entity charOffset="82-88" id="s3043.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3043.e0" e2="s3043.e1" id="s3043.p0" relation="true"/>
  </sentence>
  <sentence id="s3044" text="In humans, &lt;i&gt;GFI1&lt;/i&gt; mutations are associated with severe congenital neutropenia.">
    <entity charOffset="14-18" id="s3044.e0" ontology_id="2672" text="GFI1" type="GENE"/>
    <entity charOffset="71-82" id="s3044.e1" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <pair e1="s3044.e0" e2="s3044.e1" id="s3044.p0" relation="true"/>
  </sentence>
  <sentence id="s3045" text="In keeping with this key role in cell fate, &lt;i&gt;GFI1B&lt;/i&gt; is emerging as a gene involved in cancer, which also includes solid tumors.">
    <entity charOffset="38-42" id="s3045.e0" ontology_id="89885" text="fate" type="GENE"/>
    <entity charOffset="91-97" id="s3045.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3045.e0" e2="s3045.e1" id="s3045.p0" relation="true"/>
  </sentence>
  <sentence id="s3046" text="In keeping with this key role in cell fate, &lt;i&gt;GFI1B&lt;/i&gt; is emerging as a gene involved in cancer, which also includes solid tumors.">
    <entity charOffset="38-42" id="s3046.e0" ontology_id="89885" text="fate" type="GENE"/>
    <entity charOffset="125-131" id="s3046.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3046.e0" e2="s3046.e1" id="s3046.p0" relation="true"/>
  </sentence>
  <sentence id="s3047" text="In keeping with this key role in cell fate, &lt;i&gt;GFI1B&lt;/i&gt; is emerging as a gene involved in cancer, which also includes solid tumors.">
    <entity charOffset="47-52" id="s3047.e0" ontology_id="8328" text="GFI1B" type="GENE"/>
    <entity charOffset="91-97" id="s3047.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3047.e0" e2="s3047.e1" id="s3047.p0" relation="true"/>
  </sentence>
  <sentence id="s3048" text="In keeping with this key role in cell fate, &lt;i&gt;GFI1B&lt;/i&gt; is emerging as a gene involved in cancer, which also includes solid tumors.">
    <entity charOffset="47-52" id="s3048.e0" ontology_id="8328" text="GFI1B" type="GENE"/>
    <entity charOffset="125-131" id="s3048.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3048.e0" e2="s3048.e1" id="s3048.p0" relation="true"/>
  </sentence>
  <sentence id="s3049" text="In fact, abnormal activation of &lt;i&gt;GFI1B&lt;/i&gt; and &lt;i&gt;GFI1&lt;/i&gt; has been related to human medulloblastoma and is also likely to be relevant in blood malignancies.">
    <entity charOffset="35-40" id="s3049.e0" ontology_id="8328" text="GFI1B" type="GENE"/>
    <entity charOffset="87-102" id="s3049.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s3049.e0" e2="s3049.e1" id="s3049.p0" relation="true"/>
  </sentence>
  <sentence id="s3050" text="In fact, abnormal activation of &lt;i&gt;GFI1B&lt;/i&gt; and &lt;i&gt;GFI1&lt;/i&gt; has been related to human medulloblastoma and is also likely to be relevant in blood malignancies.">
    <entity charOffset="52-56" id="s3050.e0" ontology_id="2672" text="GFI1" type="GENE"/>
    <entity charOffset="87-102" id="s3050.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s3050.e0" e2="s3050.e1" id="s3050.p0" relation="true"/>
  </sentence>
  <sentence id="s3051" text="When stratified by tumor histology, three SNPs (ENO1 rs2274971A&amp;gt;G, PFKM rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="19-24" id="s3051.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="48-52" id="s3051.e1" ontology_id="2023" text="ENO1" type="GENE"/>
    <pair e1="s3051.e0" e2="s3051.e1" id="s3051.p0" relation="true"/>
  </sentence>
  <sentence id="s3052" text="When stratified by tumor histology, three SNPs (ENO1 rs2274971A&amp;gt;G, PFKM rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="19-24" id="s3052.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="72-76" id="s3052.e1" ontology_id="5213" text="PFKM" type="GENE"/>
    <pair e1="s3052.e0" e2="s3052.e1" id="s3052.p0" relation="true"/>
  </sentence>
  <sentence id="s3053" text="When stratified by tumor histology, three SNPs (ENO1 rs2274971A&amp;gt;G, PFKM rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="48-52" id="s3053.e0" ontology_id="2023" text="ENO1" type="GENE"/>
    <entity charOffset="182-205" id="s3053.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3053.e0" e2="s3053.e1" id="s3053.p0" relation="true"/>
  </sentence>
  <sentence id="s3054" text="When stratified by tumor histology, three SNPs (ENO1 rs2274971A&amp;gt;G, PFKM rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="72-76" id="s3054.e0" ontology_id="5213" text="PFKM" type="GENE"/>
    <entity charOffset="182-205" id="s3054.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3054.e0" e2="s3054.e1" id="s3054.p0" relation="true"/>
  </sentence>
  <sentence id="s3055" text="When stratified by tumor histology, three SNPs (ENO1 rs2274971A&amp;gt;G, PFKM rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="182-205" id="s3055.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="215-219" id="s3055.e1" ontology_id="5214" text="PFKP" type="GENE"/>
    <pair e1="s3055.e0" e2="s3055.e1" id="s3055.p0" relation="false"/>
  </sentence>
  <sentence id="s3056" text="Missense mutations in the human GPI biosynthesis enzyme pigv are associated with a multiple congenital malformation syndrome with a high frequency of Hirschsprung disease and renal anomalies.">
    <entity charOffset="32-35" id="s3056.e0" ontology_id="10007" text="GPI" type="GENE"/>
    <entity charOffset="175-190" id="s3056.e1" ontology_id="HP_0000077" text="renal anomalies" type="HP"/>
    <pair e1="s3056.e0" e2="s3056.e1" id="s3056.p0" relation="true"/>
  </sentence>
  <sentence id="s3057" text="In this study, we found that HIC1 acted as a tumor suppressor and that its expression was downregulated in UM.">
    <entity charOffset="29-33" id="s3057.e0" ontology_id="3090" text="HIC1" type="GENE"/>
    <entity charOffset="45-50" id="s3057.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3057.e0" e2="s3057.e1" id="s3057.p0" relation="true"/>
  </sentence>
  <sentence id="s3058" text="Taken together, our studies of UM reveal a critical role of HIC1 in the regulation of tumorigenesis, at least partly through its downstream target, lncRNA-numb, and provide a potential therapeutic target for UM">
    <entity charOffset="60-64" id="s3058.e0" ontology_id="3090" text="HIC1" type="GENE"/>
    <entity charOffset="86-91" id="s3058.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3058.e0" e2="s3058.e1" id="s3058.p0" relation="true"/>
  </sentence>
  <sentence id="s3059" text="In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and basal ganglia calcification suggestive of Aicardi-Goutires syndrome, who carries the same Arg822Gln mutation in IFIH1 previously associated with SMS.">
    <entity charOffset="97-124" id="s3059.e0" ontology_id="HP_0002135" text="basal ganglia calcification" type="HP"/>
    <entity charOffset="210-215" id="s3059.e1" ontology_id="64135" text="IFIH1" type="GENE"/>
    <pair e1="s3059.e0" e2="s3059.e1" id="s3059.p0" relation="true"/>
  </sentence>
  <sentence id="s3060" text="In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and basal ganglia calcification suggestive of Aicardi-Goutires syndrome, who carries the same Arg822Gln mutation in IFIH1 previously associated with SMS.">
    <entity charOffset="97-124" id="s3060.e0" ontology_id="HP_0002135" text="basal ganglia calcification" type="HP"/>
    <entity charOffset="243-246" id="s3060.e1" ontology_id="10743" text="SMS" type="GENE"/>
    <pair e1="s3060.e0" e2="s3060.e1" id="s3060.p0" relation="true"/>
  </sentence>
  <sentence id="s3061" text="Before and after eight weeks daily treatment with six capsules of F&amp;amp;amp;V juice concentrate or placebo, peripheral blood gene expression (microarray, quantitative polymerase chain reaction (qPCR)), plasma tumour necrosis factor (TNF) (enzyme-linked immunosorbent assay (ELISA)), body composition (Dual-energy X-ray absorptiometry (DEXA)) and lipid profiles were assessed.">
    <entity charOffset="209-215" id="s3061.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="233-236" id="s3061.e1" ontology_id="7124" text="TNF" type="GENE"/>
    <pair e1="s3061.e0" e2="s3061.e1" id="s3061.p0" relation="true"/>
  </sentence>
  <sentence id="s3062" text="His facial features included a high anterior hairline, small eyes with narrowed palpebral fissures, a bulbous nasal tip with a short columella, and a large mouth with a thin upper vermilion, and small chin.">
    <entity charOffset="116-119" id="s3062.e0" ontology_id="81533" text="tip" type="GENE"/>
    <entity charOffset="127-142" id="s3062.e1" ontology_id="HP_0002000" text="short columella" type="HP"/>
    <pair e1="s3062.e0" e2="s3062.e1" id="s3062.p0" relation="false"/>
  </sentence>
  <sentence id="s3063" text="His facial features included a high anterior hairline, small eyes with narrowed palpebral fissures, a bulbous nasal tip with a short columella, and a large mouth with a thin upper vermilion, and small chin.">
    <entity charOffset="116-119" id="s3063.e0" ontology_id="81533" text="tip" type="GENE"/>
    <entity charOffset="150-161" id="s3063.e1" ontology_id="HP_0000154" text="large mouth" type="HP"/>
    <pair e1="s3063.e0" e2="s3063.e1" id="s3063.p0" relation="true"/>
  </sentence>
  <sentence id="s3064" text="De novo missense and frameshift mutations and deletions involving TBL1XR1 have been described in patients with intellectual disability and autism, but without any of the dysmorphic findings or malformations associated with Pierpont syndrome, implying a mutation-specific mechanism for the pathogenicity of p.Tyr446Cys.">
    <entity charOffset="66-73" id="s3064.e0" ontology_id="79718" text="TBL1XR1" type="GENE"/>
    <entity charOffset="111-134" id="s3064.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3064.e0" e2="s3064.e1" id="s3064.p0" relation="true"/>
  </sentence>
  <sentence id="s3065" text="His distinctive facial and digital features are further evidence that p.Tyr446Cys results in a clinically recognizable, syndromic form of intellectual disability in contrast to other TBL1XR1 mutations">
    <entity charOffset="138-161" id="s3065.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="183-190" id="s3065.e1" ontology_id="79718" text="TBL1XR1" type="GENE"/>
    <pair e1="s3065.e0" e2="s3065.e1" id="s3065.p0" relation="true"/>
  </sentence>
  <sentence id="s3066" text="This study is the first to associate a component of the RAR pathway with renal agenesis in humans">
    <entity charOffset="56-59" id="s3066.e0" ontology_id="10966" text="RAR" type="GENE"/>
    <entity charOffset="73-87" id="s3066.e1" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <pair e1="s3066.e0" e2="s3066.e1" id="s3066.p0" relation="true"/>
  </sentence>
  <sentence id="s3067" text="Here, we report mutations in PYCR2, which encodes an enzyme in the proline biosynthesis pathway, as the cause of a unique syndrome characterized by postnatal microcephaly, hypomyelination, and reduced cerebral white-matter volume.">
    <entity charOffset="29-34" id="s3067.e0" ontology_id="29920" text="PYCR2" type="GENE"/>
    <entity charOffset="172-187" id="s3067.e1" ontology_id="HP_0003429" text="hypomyelination" type="HP"/>
    <pair e1="s3067.e0" e2="s3067.e1" id="s3067.p0" relation="true"/>
  </sentence>
  <sentence id="s3068" text="Morpholino-based knockdown of a zebrafish PYCR2 ortholog, pycr1b, recapitulated the human microcephaly phenotype, which was rescued by wild-type human PYCR2 mRNA, but not by mutant mRNAs, further supporting the pathogenicity of the identified variants.">
    <entity charOffset="42-47" id="s3068.e0" ontology_id="29920" text="PYCR2" type="GENE"/>
    <entity charOffset="90-102" id="s3068.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3068.e0" e2="s3068.e1" id="s3068.p0" relation="false"/>
  </sentence>
  <sentence id="s3069" text="GATA3, a critical transcription factor involved in the development of the mammary gland, also plays important roles in mammary tumorigenesis by regulating transcription in coordination with two essential DNA repair factors, PARP1 and BRCA1.">
    <entity charOffset="127-132" id="s3069.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="224-229" id="s3069.e1" ontology_id="142" text="PARP1" type="GENE"/>
    <pair e1="s3069.e0" e2="s3069.e1" id="s3069.p0" relation="true"/>
  </sentence>
  <sentence id="s3070" text="However, whether and how GATA3 participates in the process of DNA repair, which is often associated with tumorigenesis, has not been investigated.">
    <entity charOffset="25-30" id="s3070.e0" ontology_id="2625" text="GATA3" type="GENE"/>
    <entity charOffset="105-110" id="s3070.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3070.e0" e2="s3070.e1" id="s3070.p0" relation="false"/>
  </sentence>
  <sentence id="s3071" text="In addition, through data mining analysis, we observed an extremely strong correlation between the expression levels of GATA3 and CtIP in paratumors, but the correlation turned insignificant in mammary tumors.">
    <entity charOffset="120-125" id="s3071.e0" ontology_id="2625" text="GATA3" type="GENE"/>
    <entity charOffset="142-148" id="s3071.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3071.e0" e2="s3071.e1" id="s3071.p0" relation="true"/>
  </sentence>
  <sentence id="s3072" text="Using vectors encoding GATA3 with mutations frequently occurring in mammary tumors, we found that several mutations on GATA3 led to a dysregulation of CtIP, and therefore HR repair.">
    <entity charOffset="76-82" id="s3072.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="151-155" id="s3072.e1" ontology_id="5932" text="CtIP" type="GENE"/>
    <pair e1="s3072.e0" e2="s3072.e1" id="s3072.p0" relation="true"/>
  </sentence>
  <sentence id="s3073" text="In summary, our data delineates the regulatory mechanisms of GATA3 in DNA DSB repair and strongly suggests that it might act as a tumor suppressor by promoting CtIP expression and HR to stabilize genomes">
    <entity charOffset="61-66" id="s3073.e0" ontology_id="2625" text="GATA3" type="GENE"/>
    <entity charOffset="130-135" id="s3073.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3073.e0" e2="s3073.e1" id="s3073.p0" relation="true"/>
  </sentence>
  <sentence id="s3074" text="In summary, our data delineates the regulatory mechanisms of GATA3 in DNA DSB repair and strongly suggests that it might act as a tumor suppressor by promoting CtIP expression and HR to stabilize genomes">
    <entity charOffset="130-135" id="s3074.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="160-164" id="s3074.e1" ontology_id="5932" text="CtIP" type="GENE"/>
    <pair e1="s3074.e0" e2="s3074.e1" id="s3074.p0" relation="true"/>
  </sentence>
  <sentence id="s3075" text="Altered ERCC1 expression or function is closely associated with cancer development and progression.">
    <entity charOffset="8-13" id="s3075.e0" ontology_id="2067" text="ERCC1" type="GENE"/>
    <entity charOffset="64-70" id="s3075.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3075.e0" e2="s3075.e1" id="s3075.p0" relation="true"/>
  </sentence>
  <sentence id="s3076" text="This study determined the association of ERCC1 expression with survivin expression, clinicopathological characteristics, and survival of esophageal squamous cell carcinoma (ESCC) patients after postoperative concurrent chemoradiotherapy.Tissue specimens from 102 resected ESCC patients were acquired for immunohistochemical analysis of ERCC1 and survivin protein expression.ERCC1 expression was detected in 62.7% of ESCC tissues and in 9.8% of normal squamous epithelium tissues (P&amp;lt;.01), while survivin expression was detected in 60.8% of ESCC tissues and in 19.6% of normal squamous epithelia (P&amp;lt;.01).">
    <entity charOffset="41-46" id="s3076.e0" ontology_id="2067" text="ERCC1" type="GENE"/>
    <entity charOffset="148-171" id="s3076.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3076.e0" e2="s3076.e1" id="s3076.p0" relation="true"/>
  </sentence>
  <sentence id="s3077" text="This study determined the association of ERCC1 expression with survivin expression, clinicopathological characteristics, and survival of esophageal squamous cell carcinoma (ESCC) patients after postoperative concurrent chemoradiotherapy.Tissue specimens from 102 resected ESCC patients were acquired for immunohistochemical analysis of ERCC1 and survivin protein expression.ERCC1 expression was detected in 62.7% of ESCC tissues and in 9.8% of normal squamous epithelium tissues (P&amp;lt;.01), while survivin expression was detected in 60.8% of ESCC tissues and in 19.6% of normal squamous epithelia (P&amp;lt;.01).">
    <entity charOffset="63-71" id="s3077.e0" ontology_id="332" text="survivin" type="GENE"/>
    <entity charOffset="148-171" id="s3077.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3077.e0" e2="s3077.e1" id="s3077.p0" relation="true"/>
  </sentence>
  <sentence id="s3078" text="Using homozygosity mapping followed by exome sequencing, we identified a Thr224Asn mutation in the VPS45 gene in infants from consanguineous families who suffered from life-threatening neutropenia, which was refractory to granulocyte CSF, from defective platelet aggregation and myelofibrosis.">
    <entity charOffset="99-104" id="s3078.e0" ontology_id="11311" text="VPS45" type="GENE"/>
    <entity charOffset="185-196" id="s3078.e1" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <pair e1="s3078.e0" e2="s3078.e1" id="s3078.p0" relation="true"/>
  </sentence>
  <sentence id="s3079" text="This is the first report of a Vps45-related disease in humans, manifesting by neutropenia, thrombasthenia, myelofibrosis, and progressive bone marrow failure">
    <entity charOffset="30-35" id="s3079.e0" ontology_id="11311" text="Vps45" type="GENE"/>
    <entity charOffset="78-89" id="s3079.e1" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <pair e1="s3079.e0" e2="s3079.e1" id="s3079.p0" relation="true"/>
  </sentence>
  <sentence id="s3080" text="We presented the significant clinical heterogeneity among three Chinese late-onset MADD patients with similar ETFDH genotype by collecting clinical information, muscle histology, and genetic analysis.">
    <entity charOffset="38-51" id="s3080.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="110-115" id="s3080.e1" ontology_id="2110" text="ETFDH" type="GENE"/>
    <pair e1="s3080.e0" e2="s3080.e1" id="s3080.p0" relation="true"/>
  </sentence>
  <sentence id="s3081" text="To decipher a mechanism for this, we previously generated a mathematical model of how estrogen-mediated upregulation of the transcription factor, E2F6, upregulates the ovarian cancer stem/initiating cell marker, c-Kit, by epigenetic silencing the tumor suppressor miR-193a, and a competing endogenous (ceRNA) mechanism.">
    <entity charOffset="176-182" id="s3081.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="212-217" id="s3081.e1" ontology_id="3815" text="c-Kit" type="GENE"/>
    <pair e1="s3081.e0" e2="s3081.e1" id="s3081.p0" relation="true"/>
  </sentence>
  <sentence id="s3082" text="Interestingly, ChIP-PCR and bisulphite pyrosequencing showed that E2F6 also epigenetically suppresses miR-193a, through recruitment of EZH2, and by a complex ceRNA mechanism in ovarian cancer cell lines.">
    <entity charOffset="135-139" id="s3082.e0" ontology_id="2146" text="EZH2" type="GENE"/>
    <entity charOffset="185-191" id="s3082.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3082.e0" e2="s3082.e1" id="s3082.p0" relation="true"/>
  </sentence>
  <sentence id="s3083" text="In a previous report, we described the clinical and radiographical features of three related subjects with the disease and suggest that due to the unusual combination of limb defects and to its phenotypic similarity with the limb malformative pattern induced by disrupting the Hoxd13 gene in mouse, the triphalangeal thumb-brachyectrodactyly syndrome might be caused by mutations in a HOX gene.">
    <entity charOffset="277-283" id="s3083.e0" ontology_id="3239" text="Hoxd13" type="GENE"/>
    <entity charOffset="303-322" id="s3083.e1" ontology_id="HP_0001199" text="triphalangeal thumb" type="HP"/>
    <pair e1="s3083.e0" e2="s3083.e1" id="s3083.p0" relation="true"/>
  </sentence>
  <sentence id="s3084" text="Our objective was to determine molecular phenotypes of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): TAC1 (characterised by immune receptors &lt;i&gt;IL33R&lt;/i&gt;, &lt;i&gt;CCR3&lt;/i&gt; and &lt;i&gt;TSLPR&lt;/i&gt;), TAC2 (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and TAC3 (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).">
    <entity charOffset="495-499" id="s3084.e0" ontology_id="6863" text="TAC1" type="GENE"/>
    <entity charOffset="616-622" id="s3084.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3084.e0" e2="s3084.e1" id="s3084.p0" relation="true"/>
  </sentence>
  <sentence id="s3085" text="Our objective was to determine molecular phenotypes of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): TAC1 (characterised by immune receptors &lt;i&gt;IL33R&lt;/i&gt;, &lt;i&gt;CCR3&lt;/i&gt; and &lt;i&gt;TSLPR&lt;/i&gt;), TAC2 (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and TAC3 (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).">
    <entity charOffset="580-584" id="s3085.e0" ontology_id="6863" text="TAC2" type="GENE"/>
    <entity charOffset="616-622" id="s3085.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3085.e0" e2="s3085.e1" id="s3085.p0" relation="true"/>
  </sentence>
  <sentence id="s3086" text="Our objective was to determine molecular phenotypes of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): TAC1 (characterised by immune receptors &lt;i&gt;IL33R&lt;/i&gt;, &lt;i&gt;CCR3&lt;/i&gt; and &lt;i&gt;TSLPR&lt;/i&gt;), TAC2 (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and TAC3 (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).">
    <entity charOffset="616-622" id="s3086.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="681-685" id="s3086.e1" ontology_id="6866" text="TAC3" type="GENE"/>
    <pair e1="s3086.e0" e2="s3086.e1" id="s3086.p0" relation="false"/>
  </sentence>
  <sentence id="s3087" text="TAC2 showed the highest sputum neutrophilia, serum C-reactive protein levels and prevalence of eczema.">
    <entity charOffset="0-4" id="s3087.e0" ontology_id="6863" text="TAC2" type="GENE"/>
    <entity charOffset="31-43" id="s3087.e1" ontology_id="HP_0011897" text="neutrophilia" type="HP"/>
    <pair e1="s3087.e0" e2="s3087.e1" id="s3087.p0" relation="true"/>
  </sentence>
  <sentence id="s3088" text="Here, integrative genomic analysis identified MYST3 as a potential oncogene target that is frequently amplified in breast cancer.">
    <entity charOffset="46-51" id="s3088.e0" ontology_id="7994" text="MYST3" type="GENE"/>
    <entity charOffset="122-128" id="s3088.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3088.e0" e2="s3088.e1" id="s3088.p0" relation="true"/>
  </sentence>
  <sentence id="s3089" text="We found that MYST3 was amplified in 11% and/or overexpressed in 15% of breast tumors, and overexpression of MYST3 correlated with worse clinical outcome in estrogen receptor+ (ER+) breast cancers.">
    <entity charOffset="14-19" id="s3089.e0" ontology_id="7994" text="MYST3" type="GENE"/>
    <entity charOffset="79-85" id="s3089.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3089.e0" e2="s3089.e1" id="s3089.p0" relation="true"/>
  </sentence>
  <sentence id="s3090" text="Interestingly, MYST3 depletion drastically inhibited proliferation in MYST3-high, ER+ breast cancer cells, but not in benign breast epithelial cells or in MYST3-low breast cancer cells.">
    <entity charOffset="15-20" id="s3090.e0" ontology_id="7994" text="MYST3" type="GENE"/>
    <entity charOffset="93-99" id="s3090.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3090.e0" e2="s3090.e1" id="s3090.p0" relation="true"/>
  </sentence>
  <sentence id="s3091" text="We investigated the impact of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (AURKB) and geminin (GMNN), on disease progression in neuroblastomas.">
    <entity charOffset="20-26" id="s3091.e0" ontology_id="55364" text="impact" type="GENE"/>
    <entity charOffset="147-161" id="s3091.e1" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <pair e1="s3091.e0" e2="s3091.e1" id="s3091.p0" relation="true"/>
  </sentence>
  <sentence id="s3092" text="We investigated the impact of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (AURKB) and geminin (GMNN), on disease progression in neuroblastomas.">
    <entity charOffset="94-99" id="s3092.e0" ontology_id="9212" text="AURKB" type="GENE"/>
    <entity charOffset="147-161" id="s3092.e1" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <pair e1="s3092.e0" e2="s3092.e1" id="s3092.p0" relation="true"/>
  </sentence>
  <sentence id="s3093" text="We investigated the impact of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (AURKB) and geminin (GMNN), on disease progression in neuroblastomas.">
    <entity charOffset="114-118" id="s3093.e0" ontology_id="51053" text="GMNN" type="GENE"/>
    <entity charOffset="147-161" id="s3093.e1" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <pair e1="s3093.e0" e2="s3093.e1" id="s3093.p0" relation="true"/>
  </sentence>
  <sentence id="s3094" text="The expression of AURKB and GMNN was studied by immunostaining 84 neuroblastomas.">
    <entity charOffset="18-23" id="s3094.e0" ontology_id="9212" text="AURKB" type="GENE"/>
    <entity charOffset="66-80" id="s3094.e1" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <pair e1="s3094.e0" e2="s3094.e1" id="s3094.p0" relation="true"/>
  </sentence>
  <sentence id="s3095" text="The expression of AURKB and GMNN was studied by immunostaining 84 neuroblastomas.">
    <entity charOffset="28-32" id="s3095.e0" ontology_id="51053" text="GMNN" type="GENE"/>
    <entity charOffset="66-80" id="s3095.e1" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <pair e1="s3095.e0" e2="s3095.e1" id="s3095.p0" relation="true"/>
  </sentence>
  <sentence id="s3096" text="The PI for both markers was significantly higher in neuroblastomas from patients with unfavorable clinical (high-risk group, advanced stage, age 18 months at presentation, primary abdominal compared to extra-abdominal sites), biological (MYCN amplification, 1p deletion, 17q gain), and pathological (undifferentiated or poorly differentiated status, high mitosis-karyorrhexis index, [MKI], unfavorable histology) factors.">
    <entity charOffset="52-66" id="s3096.e0" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <entity charOffset="239-243" id="s3096.e1" ontology_id="4613" text="MYCN" type="GENE"/>
    <pair e1="s3096.e0" e2="s3096.e1" id="s3096.p0" relation="true"/>
  </sentence>
  <sentence id="s3097" text="Recent studies have revealed severe cases of microcephaly resulting from human mutations in the NDE1 gene, which is involved in the regulation of cytoplasmic dynein.">
    <entity charOffset="45-57" id="s3097.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="96-100" id="s3097.e1" ontology_id="54820" text="NDE1" type="GENE"/>
    <pair e1="s3097.e0" e2="s3097.e1" id="s3097.p0" relation="true"/>
  </sentence>
  <sentence id="s3098" text="These results reveal that the severity of NDE1-associated microcephaly results not from defects in mitosis, but rather the inability of neural progenitors to ever reach this stage">
    <entity charOffset="42-46" id="s3098.e0" ontology_id="54820" text="NDE1" type="GENE"/>
    <entity charOffset="58-70" id="s3098.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3098.e0" e2="s3098.e1" id="s3098.p0" relation="true"/>
  </sentence>
  <sentence id="s3099" text="Remarkably, variable expressivity of the human phenotype can be recapitulated in Cwc27 mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.">
    <entity charOffset="12-33" id="s3099.e0" ontology_id="HP_0003828" text="variable expressivity" type="HP"/>
    <entity charOffset="81-86" id="s3099.e1" ontology_id="10283" text="Cwc27" type="GENE"/>
    <pair e1="s3099.e0" e2="s3099.e1" id="s3099.p0" relation="true"/>
  </sentence>
  <sentence id="s3100" text="Remarkably, variable expressivity of the human phenotype can be recapitulated in Cwc27 mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.">
    <entity charOffset="12-33" id="s3100.e0" ontology_id="HP_0003828" text="variable expressivity" type="HP"/>
    <entity charOffset="192-196" id="s3100.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s3100.e0" e2="s3100.e1" id="s3100.p0" relation="true"/>
  </sentence>
  <sentence id="s3101" text="Remarkably, variable expressivity of the human phenotype can be recapitulated in Cwc27 mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.">
    <entity charOffset="192-196" id="s3101.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="266-286" id="s3101.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s3101.e0" e2="s3101.e1" id="s3101.p0" relation="true"/>
  </sentence>
  <sentence id="s3102" text="The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="4-9" id="s3102.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="63-68" id="s3102.e1" ontology_id="54768" text="HYDIN" type="GENE"/>
    <pair e1="s3102.e0" e2="s3102.e1" id="s3102.p0" relation="true"/>
  </sentence>
  <sentence id="s3103" text="The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="4-9" id="s3103.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="70-74" id="s3103.e1" ontology_id="3845" text="KRAS" type="GENE"/>
    <pair e1="s3103.e0" e2="s3103.e1" id="s3103.p0" relation="true"/>
  </sentence>
  <sentence id="s3104" text="The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="4-9" id="s3104.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="80-84" id="s3104.e1" ontology_id="5728" text="PTEN" type="GENE"/>
    <pair e1="s3104.e0" e2="s3104.e1" id="s3104.p0" relation="true"/>
  </sentence>
  <sentence id="s3105" text="The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="63-68" id="s3105.e0" ontology_id="54768" text="HYDIN" type="GENE"/>
    <entity charOffset="133-139" id="s3105.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3105.e0" e2="s3105.e1" id="s3105.p0" relation="true"/>
  </sentence>
  <sentence id="s3106" text="The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="70-74" id="s3106.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="133-139" id="s3106.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3106.e0" e2="s3106.e1" id="s3106.p0" relation="true"/>
  </sentence>
  <sentence id="s3107" text="The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="80-84" id="s3107.e0" ontology_id="5728" text="PTEN" type="GENE"/>
    <entity charOffset="133-139" id="s3107.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3107.e0" e2="s3107.e1" id="s3107.p0" relation="true"/>
  </sentence>
  <sentence id="s3108" text="We use the BMI- and obesity-associated FTO locus as a subject as it poses an illustrative example on the value of these resources.">
    <entity charOffset="20-27" id="s3108.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="39-42" id="s3108.e1" ontology_id="79068" text="FTO" type="GENE"/>
    <pair e1="s3108.e0" e2="s3108.e1" id="s3108.p0" relation="true"/>
  </sentence>
  <sentence id="s3109" text="Polo-Like Kinase 1 (PLK1), a serine-threonine kinase that is often overexpressed across multiple tumor types, is one of the key regulators of CIN and is considered as a potential therapeutic target.">
    <entity charOffset="20-24" id="s3109.e0" ontology_id="5347" text="PLK1" type="GENE"/>
    <entity charOffset="97-102" id="s3109.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3109.e0" e2="s3109.e1" id="s3109.p0" relation="true"/>
  </sentence>
  <sentence id="s3110" text="Rather than directly inhibiting PLK1, we found that inhibition of PP2A causes selective lethality to PLK1-overexpressing breast, pancreatic, ovarian, glioblastoma, and prostate cancer cells.">
    <entity charOffset="32-36" id="s3110.e0" ontology_id="5347" text="PLK1" type="GENE"/>
    <entity charOffset="150-162" id="s3110.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s3110.e0" e2="s3110.e1" id="s3110.p0" relation="true"/>
  </sentence>
  <sentence id="s3111" text="Rather than directly inhibiting PLK1, we found that inhibition of PP2A causes selective lethality to PLK1-overexpressing breast, pancreatic, ovarian, glioblastoma, and prostate cancer cells.">
    <entity charOffset="32-36" id="s3111.e0" ontology_id="5347" text="PLK1" type="GENE"/>
    <entity charOffset="177-183" id="s3111.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3111.e0" e2="s3111.e1" id="s3111.p0" relation="true"/>
  </sentence>
  <sentence id="s3112" text="Tumor proliferation promoted by the regulation of miRNA expression can be regulated in thyroid cancer by upregulating transforming growth factor-1 (TGF-1), which is thought to interact with Pard3.">
    <entity charOffset="50-53" id="s3112.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="95-101" id="s3112.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3112.e0" e2="s3112.e1" id="s3112.p0" relation="true"/>
  </sentence>
  <sentence id="s3113" text="Tumor proliferation promoted by the regulation of miRNA expression can be regulated in thyroid cancer by upregulating transforming growth factor-1 (TGF-1), which is thought to interact with Pard3.">
    <entity charOffset="95-101" id="s3113.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="192-197" id="s3113.e1" ontology_id="56288" text="Pard3" type="GENE"/>
    <pair e1="s3113.e0" e2="s3113.e1" id="s3113.p0" relation="true"/>
  </sentence>
  <sentence id="s3114" text="When compared with adjacent non-tumor tissues, we found that miR-483 was upregulated and Pard3 was downregulated in 80 thyroid tumor samples.">
    <entity charOffset="32-37" id="s3114.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="89-94" id="s3114.e1" ontology_id="56288" text="Pard3" type="GENE"/>
    <pair e1="s3114.e0" e2="s3114.e1" id="s3114.p0" relation="true"/>
  </sentence>
  <sentence id="s3115" text="When compared with adjacent non-tumor tissues, we found that miR-483 was upregulated and Pard3 was downregulated in 80 thyroid tumor samples.">
    <entity charOffset="32-37" id="s3115.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="61-64" id="s3115.e1" ontology_id="220972" text="miR" type="GENE"/>
    <pair e1="s3115.e0" e2="s3115.e1" id="s3115.p0" relation="true"/>
  </sentence>
  <sentence id="s3116" text="Our previous studies reported gastric cancer cells are insensitive to TRAIL.">
    <entity charOffset="38-44" id="s3116.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="70-75" id="s3116.e1" ontology_id="8743" text="TRAIL" type="GENE"/>
    <pair e1="s3116.e0" e2="s3116.e1" id="s3116.p0" relation="true"/>
  </sentence>
  <sentence id="s3117" text="However, whether -elemene could enhance anti-cancer effects of TRAIL on gastric cancer cells is unknown.">
    <entity charOffset="46-52" id="s3117.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="64-69" id="s3117.e1" ontology_id="8743" text="TRAIL" type="GENE"/>
    <pair e1="s3117.e0" e2="s3117.e1" id="s3117.p0" relation="true"/>
  </sentence>
  <sentence id="s3118" text="In our present study, -elemene prevented gastric cancer cell viability in dose-dependent manner, and when combined with TRAIL, obviously inhibited proliferation and promoted apoptosis in gastric cancer cells.">
    <entity charOffset="50-56" id="s3118.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="121-126" id="s3118.e1" ontology_id="8743" text="TRAIL" type="GENE"/>
    <pair e1="s3118.e0" e2="s3118.e1" id="s3118.p0" relation="true"/>
  </sentence>
  <sentence id="s3119" text="Our results suggest that -elemene increases the sensitivity of gastric cancer cells to TRAIL partially by promoting the formation of DISC in lipid rafts">
    <entity charOffset="72-78" id="s3119.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="88-93" id="s3119.e1" ontology_id="8743" text="TRAIL" type="GENE"/>
    <pair e1="s3119.e0" e2="s3119.e1" id="s3119.p0" relation="true"/>
  </sentence>
  <sentence id="s3120" text="&lt;i&gt;Background:&lt;/i&gt; YAP/TAZ have been reported to be highly expressed in malignant tumors.">
    <entity charOffset="19-22" id="s3120.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="82-88" id="s3120.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3120.e0" e2="s3120.e1" id="s3120.p0" relation="true"/>
  </sentence>
  <sentence id="s3121" text="&lt;i&gt;Background:&lt;/i&gt; YAP/TAZ have been reported to be highly expressed in malignant tumors.">
    <entity charOffset="23-26" id="s3121.e0" ontology_id="25937" text="TAZ" type="GENE"/>
    <entity charOffset="82-88" id="s3121.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3121.e0" e2="s3121.e1" id="s3121.p0" relation="true"/>
  </sentence>
  <sentence id="s3122" text="This research was aimed to study the expression of TAZ/YAP protein in malignant melanoma and to investigate its relationship to the clinicopathology and prognosis of patients with malignant melanoma.">
    <entity charOffset="51-54" id="s3122.e0" ontology_id="25937" text="TAZ" type="GENE"/>
    <entity charOffset="70-88" id="s3122.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3122.e0" e2="s3122.e1" id="s3122.p0" relation="true"/>
  </sentence>
  <sentence id="s3123" text="This research was aimed to study the expression of TAZ/YAP protein in malignant melanoma and to investigate its relationship to the clinicopathology and prognosis of patients with malignant melanoma.">
    <entity charOffset="55-58" id="s3123.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="70-88" id="s3123.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3123.e0" e2="s3123.e1" id="s3123.p0" relation="true"/>
  </sentence>
  <sentence id="s3124" text="Relationship between TAZ/YAP and clinical data of malignant melanoma were analyzed.">
    <entity charOffset="21-24" id="s3124.e0" ontology_id="25937" text="TAZ" type="GENE"/>
    <entity charOffset="50-68" id="s3124.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3124.e0" e2="s3124.e1" id="s3124.p0" relation="false"/>
  </sentence>
  <sentence id="s3125" text="Relationship between TAZ/YAP and clinical data of malignant melanoma were analyzed.">
    <entity charOffset="25-28" id="s3125.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="50-68" id="s3125.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3125.e0" e2="s3125.e1" id="s3125.p0" relation="true"/>
  </sentence>
  <sentence id="s3126" text="&lt;i&gt;Results:&lt;/i&gt; The number of positive cells of TAZ and YAP in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &amp;lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &amp;lt;0.05), and increased with TNM staging.">
    <entity charOffset="48-51" id="s3126.e0" ontology_id="25937" text="TAZ" type="GENE"/>
    <entity charOffset="63-81" id="s3126.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3126.e0" e2="s3126.e1" id="s3126.p0" relation="true"/>
  </sentence>
  <sentence id="s3127" text="&lt;i&gt;Results:&lt;/i&gt; The number of positive cells of TAZ and YAP in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &amp;lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &amp;lt;0.05), and increased with TNM staging.">
    <entity charOffset="56-59" id="s3127.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="63-81" id="s3127.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3127.e0" e2="s3127.e1" id="s3127.p0" relation="true"/>
  </sentence>
  <sentence id="s3128" text="&lt;i&gt;Results:&lt;/i&gt; The number of positive cells of TAZ and YAP in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &amp;lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &amp;lt;0.05), and increased with TNM staging.">
    <entity charOffset="63-81" id="s3128.e0" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <entity charOffset="430-433" id="s3128.e1" ontology_id="10178" text="TNM" type="GENE"/>
    <pair e1="s3128.e0" e2="s3128.e1" id="s3128.p0" relation="true"/>
  </sentence>
  <sentence id="s3129" text="High expression of TAZ/YAP significantly reduced the postoperative survival rate in patients with malignant melanoma.">
    <entity charOffset="19-22" id="s3129.e0" ontology_id="25937" text="TAZ" type="GENE"/>
    <entity charOffset="98-116" id="s3129.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3129.e0" e2="s3129.e1" id="s3129.p0" relation="true"/>
  </sentence>
  <sentence id="s3130" text="High expression of TAZ/YAP significantly reduced the postoperative survival rate in patients with malignant melanoma.">
    <entity charOffset="23-26" id="s3130.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="98-116" id="s3130.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3130.e0" e2="s3130.e1" id="s3130.p0" relation="true"/>
  </sentence>
  <sentence id="s3131" text="&lt;i&gt;Conclusion:&lt;/i&gt; TAZ/YAP is highly expressed in malignant melanoma tumor tissues.">
    <entity charOffset="19-22" id="s3131.e0" ontology_id="25937" text="TAZ" type="GENE"/>
    <entity charOffset="50-68" id="s3131.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3131.e0" e2="s3131.e1" id="s3131.p0" relation="true"/>
  </sentence>
  <sentence id="s3132" text="&lt;i&gt;Conclusion:&lt;/i&gt; TAZ/YAP is highly expressed in malignant melanoma tumor tissues.">
    <entity charOffset="19-22" id="s3132.e0" ontology_id="25937" text="TAZ" type="GENE"/>
    <entity charOffset="69-74" id="s3132.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3132.e0" e2="s3132.e1" id="s3132.p0" relation="true"/>
  </sentence>
  <sentence id="s3133" text="&lt;i&gt;Conclusion:&lt;/i&gt; TAZ/YAP is highly expressed in malignant melanoma tumor tissues.">
    <entity charOffset="23-26" id="s3133.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="50-68" id="s3133.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3133.e0" e2="s3133.e1" id="s3133.p0" relation="true"/>
  </sentence>
  <sentence id="s3134" text="&lt;i&gt;Conclusion:&lt;/i&gt; TAZ/YAP is highly expressed in malignant melanoma tumor tissues.">
    <entity charOffset="23-26" id="s3134.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="69-74" id="s3134.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3134.e0" e2="s3134.e1" id="s3134.p0" relation="true"/>
  </sentence>
  <sentence id="s3135" text="The high expression of TAZ/YAP promotes the progression of malignant melanoma and affects the postoperative survival of patients">
    <entity charOffset="23-26" id="s3135.e0" ontology_id="25937" text="TAZ" type="GENE"/>
    <entity charOffset="59-77" id="s3135.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3135.e0" e2="s3135.e1" id="s3135.p0" relation="true"/>
  </sentence>
  <sentence id="s3136" text="The high expression of TAZ/YAP promotes the progression of malignant melanoma and affects the postoperative survival of patients">
    <entity charOffset="27-30" id="s3136.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="59-77" id="s3136.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3136.e0" e2="s3136.e1" id="s3136.p0" relation="true"/>
  </sentence>
  <sentence id="s3137" text="Few studies have examined the roles of CRELD1 and GATA4 in cardiac abnormalities or their association with pulmonary artery histopathology.">
    <entity charOffset="50-55" id="s3137.e0" ontology_id="2626" text="GATA4" type="GENE"/>
    <entity charOffset="59-80" id="s3137.e1" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <pair e1="s3137.e0" e2="s3137.e1" id="s3137.p0" relation="true"/>
  </sentence>
  <sentence id="s3138" text="Children with DS have an elevated risk of pulmonary arterial hypertension (PAH).">
    <entity charOffset="42-73" id="s3138.e0" ontology_id="HP_0002092" text="pulmonary arterial hypertension" type="HP"/>
    <entity charOffset="75-78" id="s3138.e1" ontology_id="5053" text="PAH" type="GENE"/>
    <pair e1="s3138.e0" e2="s3138.e1" id="s3138.p0" relation="true"/>
  </sentence>
  <sentence id="s3139" text="Addition of exogenous SLURP1 (6XHis-tagged, E. coli expressed and partially purified using Ni-ion columns) significantly suppressed the tumor necrosis factor- (TNF-)-stimulated human umbilical cord vascular endothelial cell (HUVEC) tube formation.">
    <entity charOffset="136-141" id="s3139.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="234-238" id="s3139.e1" ontology_id="51175" text="tube" type="GENE"/>
    <pair e1="s3139.e0" e2="s3139.e1" id="s3139.p0" relation="true"/>
  </sentence>
  <sentence id="s3140" text="Therefore, we performed this preliminary clinical study to investigate the possible association between 2 adipokines, C1q/tumor necrosis factor-related protein-3 and -5 (CTRP-3 and CTRP-5), with lung function and other markers of inflammation in COPD.">
    <entity charOffset="122-127" id="s3140.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="246-250" id="s3140.e1" ontology_id="372" text="COPD" type="GENE"/>
    <pair e1="s3140.e0" e2="s3140.e1" id="s3140.p0" relation="true"/>
  </sentence>
  <sentence id="s3141" text="Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of distal renal tubular acidosis, analyzing the prevalence of genetic defects in SLC4A1, ATP6V0A4, and ATP6V1B1 genes and the clinical phenotype.">
    <entity charOffset="88-117" id="s3141.e0" ontology_id="HP_0008341" text="distal renal tubular acidosis" type="HP"/>
    <entity charOffset="166-172" id="s3141.e1" ontology_id="6521" text="SLC4A1" type="GENE"/>
    <pair e1="s3141.e0" e2="s3141.e1" id="s3141.p0" relation="true"/>
  </sentence>
  <sentence id="s3142" text="Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of distal renal tubular acidosis, analyzing the prevalence of genetic defects in SLC4A1, ATP6V0A4, and ATP6V1B1 genes and the clinical phenotype.">
    <entity charOffset="88-117" id="s3142.e0" ontology_id="HP_0008341" text="distal renal tubular acidosis" type="HP"/>
    <entity charOffset="174-182" id="s3142.e1" ontology_id="50617" text="ATP6V0A4" type="GENE"/>
    <pair e1="s3142.e0" e2="s3142.e1" id="s3142.p0" relation="true"/>
  </sentence>
  <sentence id="s3143" text="Their phosphorylation activity has also linked them to the development of neurodegenerative diseases like Alzheimer's disease, amyotrophic lateral sclerosis or spinocerebellar ataxia type 11.">
    <entity charOffset="176-182" id="s3143.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="183-187" id="s3143.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s3143.e0" e2="s3143.e1" id="s3143.p0" relation="true"/>
  </sentence>
  <sentence id="s3144" text="The final analysis of all this information led us to propose TTBK1 as a new target for the treatment of neurodegenerative diseases and its selective inhibitors as potential effective drugs for the treatment of these severe unmet disorders">
    <entity charOffset="61-66" id="s3144.e0" ontology_id="84630" text="TTBK1" type="GENE"/>
    <entity charOffset="104-130" id="s3144.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s3144.e0" e2="s3144.e1" id="s3144.p0" relation="true"/>
  </sentence>
  <sentence id="s3145" text="In the case of GC, in fact, several cytological and molecular works have already demonstrated GJ to be an interesting biological material for improving clinicopathologic and prognostic knowledge of this cancer.">
    <entity charOffset="15-17" id="s3145.e0" ontology_id="2638" text="GC" type="GENE"/>
    <entity charOffset="203-209" id="s3145.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3145.e0" e2="s3145.e1" id="s3145.p0" relation="true"/>
  </sentence>
  <sentence id="s3146" text="In 2003, a new syndrome was described in the Sephardi Jewish population, named progressive cerebello-cerebral atrophy (PCCA) based on the typical neuroradiological findings.">
    <entity charOffset="101-117" id="s3146.e0" ontology_id="HP_0002059" text="cerebral atrophy" type="HP"/>
    <entity charOffset="119-123" id="s3146.e1" ontology_id="5095" text="PCCA" type="GENE"/>
    <pair e1="s3146.e0" e2="s3146.e1" id="s3146.p0" relation="true"/>
  </sentence>
  <sentence id="s3147" text="The tumors were characterized by immunohistochemistry for pituitary hormones, cytokeratins, Pit-1, and the neuronal markers NeuN, neurofilaments (NFP), and MAP2.">
    <entity charOffset="4-10" id="s3147.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="92-97" id="s3147.e1" ontology_id="6574" text="Pit-1" type="GENE"/>
    <pair e1="s3147.e0" e2="s3147.e1" id="s3147.p0" relation="true"/>
  </sentence>
  <sentence id="s3148" text="The tumors were characterized by immunohistochemistry for pituitary hormones, cytokeratins, Pit-1, and the neuronal markers NeuN, neurofilaments (NFP), and MAP2.">
    <entity charOffset="4-10" id="s3148.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="124-128" id="s3148.e1" ontology_id="146713" text="NeuN" type="GENE"/>
    <pair e1="s3148.e0" e2="s3148.e1" id="s3148.p0" relation="true"/>
  </sentence>
  <sentence id="s3149" text="Double-labeling immunohistochemistry for Pit-1/GH, Pit-1/NFP, Pit-1/MAP2, and NeuN/GH was performed in 9/10 tumors.">
    <entity charOffset="41-46" id="s3149.e0" ontology_id="6574" text="Pit-1" type="GENE"/>
    <entity charOffset="108-114" id="s3149.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3149.e0" e2="s3149.e1" id="s3149.p0" relation="true"/>
  </sentence>
  <sentence id="s3150" text="Correlation analysis using microarray data from (TRAMP  PWK/PhJ) F2 prostate tumors identified 35 metastasis-associated transcripts within the two loci.">
    <entity charOffset="49-54" id="s3150.e0" ontology_id="8718" text="TRAMP" type="GENE"/>
    <entity charOffset="78-84" id="s3150.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3150.e0" e2="s3150.e1" id="s3150.p0" relation="true"/>
  </sentence>
  <sentence id="s3151" text="A protective effect was observed for the fetal NOG1 SNP on cleft palate only, opposite in direction to the effect on CLO.">
    <entity charOffset="47-51" id="s3151.e0" ontology_id="23560" text="NOG1" type="GENE"/>
    <entity charOffset="59-71" id="s3151.e1" ontology_id="HP_0000175" text="cleft palate" type="HP"/>
    <pair e1="s3151.e0" e2="s3151.e1" id="s3151.p0" relation="true"/>
  </sentence>
  <sentence id="s3152" text="This study investigates the soluble factors released by tumor-associated dendritic cells (TADCs) responsible for increasing cancer stem cell (CSC) properties, cell mobility, and epithelial-to-mesenchymal transition (EMT).">
    <entity charOffset="124-130" id="s3152.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="216-219" id="s3152.e1" ontology_id="3702" text="EMT" type="GENE"/>
    <pair e1="s3152.e0" e2="s3152.e1" id="s3152.p0" relation="true"/>
  </sentence>
  <sentence id="s3153" text="Dendritic cells (DCs) of colon cancer patients were collected for phenotype and CXCL1 expression by flow cytometry and Luminex assays.">
    <entity charOffset="31-37" id="s3153.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="80-85" id="s3153.e1" ontology_id="2919" text="CXCL1" type="GENE"/>
    <pair e1="s3153.e0" e2="s3153.e1" id="s3153.p0" relation="true"/>
  </sentence>
  <sentence id="s3154" text="The transcriptome of CXCL1-treated cancer cells was established by next generation sequencing.">
    <entity charOffset="21-26" id="s3154.e0" ontology_id="2919" text="CXCL1" type="GENE"/>
    <entity charOffset="35-41" id="s3154.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3154.e0" e2="s3154.e1" id="s3154.p0" relation="true"/>
  </sentence>
  <sentence id="s3155" text="The enhanced CXCL1 expression in DCs is also noted in mice transplanted with colon cancer cells.">
    <entity charOffset="13-18" id="s3155.e0" ontology_id="2919" text="CXCL1" type="GENE"/>
    <entity charOffset="83-89" id="s3155.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3155.e0" e2="s3155.e1" id="s3155.p0" relation="true"/>
  </sentence>
  <sentence id="s3156" text="Concurrently, CXCL1 displays a specific microRNA (miR) upregulated by the prototypical colon cancer onco-miR miR-105.">
    <entity charOffset="14-19" id="s3156.e0" ontology_id="2919" text="CXCL1" type="GENE"/>
    <entity charOffset="93-99" id="s3156.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3156.e0" e2="s3156.e1" id="s3156.p0" relation="true"/>
  </sentence>
  <sentence id="s3157" text="Concurrently, CXCL1 displays a specific microRNA (miR) upregulated by the prototypical colon cancer onco-miR miR-105.">
    <entity charOffset="50-53" id="s3157.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="93-99" id="s3157.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3157.e0" e2="s3157.e1" id="s3157.p0" relation="true"/>
  </sentence>
  <sentence id="s3158" text="Analysis of publicly available data reveals CXCL1-driven oncogenes and miR-105 have a negative prognostic impact on the outcome of colon cancer.">
    <entity charOffset="44-49" id="s3158.e0" ontology_id="2919" text="CXCL1" type="GENE"/>
    <entity charOffset="137-143" id="s3158.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3158.e0" e2="s3158.e1" id="s3158.p0" relation="true"/>
  </sentence>
  <sentence id="s3159" text="Analysis of publicly available data reveals CXCL1-driven oncogenes and miR-105 have a negative prognostic impact on the outcome of colon cancer.">
    <entity charOffset="71-74" id="s3159.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="137-143" id="s3159.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3159.e0" e2="s3159.e1" id="s3159.p0" relation="true"/>
  </sentence>
  <sentence id="s3160" text="Recently, a missense mutation (R7S) in yet another member of this family, HSPB3, was found to cause an axonal motor neuropathy (distal hereditary motor neuropathy type 2C, dHMN2C).">
    <entity charOffset="74-79" id="s3160.e0" ontology_id="8988" text="HSPB3" type="GENE"/>
    <entity charOffset="116-126" id="s3160.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s3160.e0" e2="s3160.e1" id="s3160.p0" relation="true"/>
  </sentence>
  <sentence id="s3161" text="WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (PSEN1, PSEN2), lysosomal (CTSF, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.">
    <entity charOffset="111-116" id="s3161.e0" ontology_id="5663" text="PSEN1" type="GENE"/>
    <entity charOffset="329-337" id="s3161.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3161.e0" e2="s3161.e1" id="s3161.p0" relation="true"/>
  </sentence>
  <sentence id="s3162" text="WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (PSEN1, PSEN2), lysosomal (CTSF, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.">
    <entity charOffset="118-123" id="s3162.e0" ontology_id="5664" text="PSEN2" type="GENE"/>
    <entity charOffset="329-337" id="s3162.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3162.e0" e2="s3162.e1" id="s3162.p0" relation="true"/>
  </sentence>
  <sentence id="s3163" text="WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (PSEN1, PSEN2), lysosomal (CTSF, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.">
    <entity charOffset="137-141" id="s3163.e0" ontology_id="8722" text="CTSF" type="GENE"/>
    <entity charOffset="329-337" id="s3163.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3163.e0" e2="s3163.e1" id="s3163.p0" relation="false"/>
  </sentence>
  <sentence id="s3164" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="97-101" id="s3164.e0" ontology_id="1041" text="CDSN" type="GENE"/>
    <entity charOffset="221-240" id="s3164.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3164.e0" e2="s3164.e1" id="s3164.p0" relation="false"/>
  </sentence>
  <sentence id="s3165" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="97-101" id="s3165.e0" ontology_id="1041" text="CDSN" type="GENE"/>
    <entity charOffset="155-168" id="s3165.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s3165.e0" e2="s3165.e1" id="s3165.p0" relation="true"/>
  </sentence>
  <sentence id="s3166" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="103-109" id="s3166.e0" ontology_id="147495" text="APCDD1" type="GENE"/>
    <entity charOffset="155-168" id="s3166.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s3166.e0" e2="s3166.e1" id="s3166.p0" relation="true"/>
  </sentence>
  <sentence id="s3167" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="114-119" id="s3167.e0" ontology_id="6635" text="SNRPE" type="GENE"/>
    <entity charOffset="221-240" id="s3167.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3167.e0" e2="s3167.e1" id="s3167.p0" relation="false"/>
  </sentence>
  <sentence id="s3168" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="114-119" id="s3168.e0" ontology_id="6635" text="SNRPE" type="GENE"/>
    <entity charOffset="155-168" id="s3168.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s3168.e0" e2="s3168.e1" id="s3168.p0" relation="true"/>
  </sentence>
  <sentence id="s3169" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="155-168" id="s3169.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="192-196" id="s3169.e1" ontology_id="147409" text="DSG4" type="GENE"/>
    <pair e1="s3169.e0" e2="s3169.e1" id="s3169.p0" relation="true"/>
  </sentence>
  <sentence id="s3170" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="155-168" id="s3170.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="198-202" id="s3170.e1" ontology_id="200879" text="LIPH" type="GENE"/>
    <pair e1="s3170.e0" e2="s3170.e1" id="s3170.p0" relation="true"/>
  </sentence>
  <sentence id="s3171" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="155-168" id="s3171.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="207-212" id="s3171.e1" ontology_id="10161" text="LPAR6" type="GENE"/>
    <pair e1="s3171.e0" e2="s3171.e1" id="s3171.p0" relation="false"/>
  </sentence>
  <sentence id="s3172" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="192-196" id="s3172.e0" ontology_id="147409" text="DSG4" type="GENE"/>
    <entity charOffset="221-240" id="s3172.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3172.e0" e2="s3172.e1" id="s3172.p0" relation="true"/>
  </sentence>
  <sentence id="s3173" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="198-202" id="s3173.e0" ontology_id="200879" text="LIPH" type="GENE"/>
    <entity charOffset="221-240" id="s3173.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3173.e0" e2="s3173.e1" id="s3173.p0" relation="false"/>
  </sentence>
  <sentence id="s3174" text="Peripheral neuropathy (PNP) remains one of the most frequent side-effects experienced by patients who receive these novel agents.">
    <entity charOffset="11-21" id="s3174.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="23-26" id="s3174.e1" ontology_id="5539" text="PNP" type="GENE"/>
    <pair e1="s3174.e0" e2="s3174.e1" id="s3174.p0" relation="true"/>
  </sentence>
  <sentence id="s3175" text="A growing body of literature indicates that YY1 is overexpressed in multiple cancer types and that increased YY1 levels correlate with poor clinical outcomes in many cancers.">
    <entity charOffset="77-83" id="s3175.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="84-88" id="s3175.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s3175.e0" e2="s3175.e1" id="s3175.p0" relation="true"/>
  </sentence>
  <sentence id="s3176" text="This review highlights recent advances in our understanding of regulatory insights involving YY1 function in a range of cancer types.">
    <entity charOffset="120-126" id="s3176.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="127-131" id="s3176.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s3176.e0" e2="s3176.e1" id="s3176.p0" relation="true"/>
  </sentence>
  <sentence id="s3177" text="For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.">
    <entity charOffset="28-33" id="s3177.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="251-254" id="s3177.e1" ontology_id="6098" text="ROS" type="GENE"/>
    <pair e1="s3177.e0" e2="s3177.e1" id="s3177.p0" relation="true"/>
  </sentence>
  <sentence id="s3178" text="For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.">
    <entity charOffset="28-33" id="s3178.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="436-441" id="s3178.e1" ontology_id="10859" text="miR-7" type="GENE"/>
    <pair e1="s3178.e0" e2="s3178.e1" id="s3178.p0" relation="true"/>
  </sentence>
  <sentence id="s3179" text="On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor BRCA1, increased Bax transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of SOX2 overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.">
    <entity charOffset="19-24" id="s3179.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="103-108" id="s3179.e1" ontology_id="672" text="BRCA1" type="GENE"/>
    <pair e1="s3179.e0" e2="s3179.e1" id="s3179.p0" relation="true"/>
  </sentence>
  <sentence id="s3180" text="On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor BRCA1, increased Bax transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of SOX2 overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.">
    <entity charOffset="19-24" id="s3180.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="120-123" id="s3180.e1" ontology_id="581" text="Bax" type="GENE"/>
    <pair e1="s3180.e0" e2="s3180.e1" id="s3180.p0" relation="true"/>
  </sentence>
  <sentence id="s3181" text="On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor BRCA1, increased Bax transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of SOX2 overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.">
    <entity charOffset="19-24" id="s3181.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="358-362" id="s3181.e1" ontology_id="6657" text="SOX2" type="GENE"/>
    <pair e1="s3181.e0" e2="s3181.e1" id="s3181.p0" relation="true"/>
  </sentence>
  <sentence id="s3182" text="YY1 expression is associated with that of cancer stem cell markers SOX2, BMI1 and OCT4 across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.">
    <entity charOffset="42-48" id="s3182.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-71" id="s3182.e1" ontology_id="6657" text="SOX2" type="GENE"/>
    <pair e1="s3182.e0" e2="s3182.e1" id="s3182.p0" relation="true"/>
  </sentence>
  <sentence id="s3183" text="YY1 expression is associated with that of cancer stem cell markers SOX2, BMI1 and OCT4 across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.">
    <entity charOffset="42-48" id="s3183.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="73-77" id="s3183.e1" ontology_id="648" text="BMI1" type="GENE"/>
    <pair e1="s3183.e0" e2="s3183.e1" id="s3183.p0" relation="true"/>
  </sentence>
  <sentence id="s3184" text="Intraepithelial neoplasia in FGPs, referred to as FGP with dysplasia, is often seen in patients with familial adenomatous polyposis (FAP).">
    <entity charOffset="16-25" id="s3184.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="133-136" id="s3184.e1" ontology_id="2191" text="FAP" type="GENE"/>
    <pair e1="s3184.e0" e2="s3184.e1" id="s3184.p0" relation="true"/>
  </sentence>
  <sentence id="s3185" text="In the present case, a sporadic FGP with LGD did not develop into invasive carcinoma, but contained foci of HGD 14 years after diagnosis.">
    <entity charOffset="23-31" id="s3185.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="108-111" id="s3185.e1" ontology_id="3081" text="HGD" type="GENE"/>
    <pair e1="s3185.e0" e2="s3185.e1" id="s3185.p0" relation="true"/>
  </sentence>
  <sentence id="s3186" text="The pathological diagnosis of the resected specimen was FGP with HGD mixed in LGD, with no invasive carcinoma.">
    <entity charOffset="65-68" id="s3186.e0" ontology_id="3081" text="HGD" type="GENE"/>
    <entity charOffset="100-109" id="s3186.e1" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <pair e1="s3186.e0" e2="s3186.e1" id="s3186.p0" relation="true"/>
  </sentence>
  <sentence id="s3187" text="We find that SWELL1-mediated VRAC is augmented in hypertrophic murine and human adipocytes in the setting of obesity.">
    <entity charOffset="13-19" id="s3187.e0" ontology_id="56262" text="SWELL1" type="GENE"/>
    <entity charOffset="109-116" id="s3187.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3187.e0" e2="s3187.e1" id="s3187.p0" relation="true"/>
  </sentence>
  <sentence id="s3188" text="Molecular genetic tests for episodic ataxia type 2 (EA2) usually target only the specific calcium channel gene (&lt;i&gt;CACNA1A&lt;/i&gt;) that is known to cause EA2.">
    <entity charOffset="28-36" id="s3188.e0" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <entity charOffset="44-48" id="s3188.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s3188.e0" e2="s3188.e1" id="s3188.p0" relation="true"/>
  </sentence>
  <sentence id="s3189" text="The trio was studied by whole-exome sequencing to identify candidate genes responsible for causing the complex EA/seizure phenotype.">
    <entity charOffset="4-8" id="s3189.e0" ontology_id="7204" text="trio" type="GENE"/>
    <entity charOffset="114-121" id="s3189.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s3189.e0" e2="s3189.e1" id="s3189.p0" relation="true"/>
  </sentence>
  <sentence id="s3190" text="We identified a recurrent de novo ATAD3A c.1582C&amp;gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.">
    <entity charOffset="34-40" id="s3190.e0" ontology_id="55210" text="ATAD3A" type="GENE"/>
    <entity charOffset="170-189" id="s3190.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s3190.e0" e2="s3190.e1" id="s3190.p0" relation="true"/>
  </sentence>
  <sentence id="s3191" text="We identified a recurrent de novo ATAD3A c.1582C&amp;gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.">
    <entity charOffset="34-40" id="s3191.e0" ontology_id="55210" text="ATAD3A" type="GENE"/>
    <entity charOffset="202-215" id="s3191.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s3191.e0" e2="s3191.e1" id="s3191.p0" relation="true"/>
  </sentence>
  <sentence id="s3192" text="We identified a recurrent de novo ATAD3A c.1582C&amp;gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.">
    <entity charOffset="34-40" id="s3192.e0" ontology_id="55210" text="ATAD3A" type="GENE"/>
    <entity charOffset="224-234" id="s3192.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s3192.e0" e2="s3192.e1" id="s3192.p0" relation="true"/>
  </sentence>
  <sentence id="s3193" text="We identified a recurrent de novo ATAD3A c.1582C&amp;gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.">
    <entity charOffset="34-40" id="s3193.e0" ontology_id="55210" text="ATAD3A" type="GENE"/>
    <entity charOffset="253-267" id="s3193.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s3193.e0" e2="s3193.e1" id="s3193.p0" relation="true"/>
  </sentence>
  <sentence id="s3194" text="Hepatocyte growth factor (HGF)/c-MET signaling plays an important role in cell proliferation, survival, migration and motility of cancer cells.">
    <entity charOffset="26-29" id="s3194.e0" ontology_id="3569" text="HGF" type="GENE"/>
    <entity charOffset="130-136" id="s3194.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3194.e0" e2="s3194.e1" id="s3194.p0" relation="true"/>
  </sentence>
  <sentence id="s3195" text="The scope of the present review is to recapitulate and review the evidence of SPINT2 participation in cancer development and progression, exploring the clinical, biological and functional descriptions of the involvement of this protein in diverse neoplasias.">
    <entity charOffset="78-84" id="s3195.e0" ontology_id="10653" text="SPINT2" type="GENE"/>
    <entity charOffset="102-108" id="s3195.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3195.e0" e2="s3195.e1" id="s3195.p0" relation="true"/>
  </sentence>
  <sentence id="s3196" text="The scope of the present review is to recapitulate and review the evidence of SPINT2 participation in cancer development and progression, exploring the clinical, biological and functional descriptions of the involvement of this protein in diverse neoplasias.">
    <entity charOffset="78-84" id="s3196.e0" ontology_id="10653" text="SPINT2" type="GENE"/>
    <entity charOffset="247-257" id="s3196.e1" ontology_id="HP_0002664" text="neoplasias" type="HP"/>
    <pair e1="s3196.e0" e2="s3196.e1" id="s3196.p0" relation="true"/>
  </sentence>
  <sentence id="s3197" text="Most studies are in agreement as to the belief that, in a large range of human cancers, the SPINT2 gene promoter is frequently methylated, resulting in the epigenetic silence of this gene.">
    <entity charOffset="79-85" id="s3197.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="92-98" id="s3197.e1" ontology_id="10653" text="SPINT2" type="GENE"/>
    <pair e1="s3197.e0" e2="s3197.e1" id="s3197.p0" relation="true"/>
  </sentence>
  <sentence id="s3198" text="In sum, the SPINT2 gene is epigenetically silenced or downregulated in human cancers, altering the balance of HGF activation/inhibition ratio, which contributes to cancer development and progression">
    <entity charOffset="12-18" id="s3198.e0" ontology_id="10653" text="SPINT2" type="GENE"/>
    <entity charOffset="77-83" id="s3198.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3198.e0" e2="s3198.e1" id="s3198.p0" relation="true"/>
  </sentence>
  <sentence id="s3199" text="Using a new conditional allele, we first show that Eif4a3 haploinsufficiency phenocopies aberrant neurogenesis and microcephaly of Magoh and Rbm8a mutant mice.">
    <entity charOffset="51-57" id="s3199.e0" ontology_id="9775" text="Eif4a3" type="GENE"/>
    <entity charOffset="115-127" id="s3199.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3199.e0" e2="s3199.e1" id="s3199.p0" relation="true"/>
  </sentence>
  <sentence id="s3200" text="We show that craniosynostosis, which has not been previously reported in association with KAT6B mutations, may be part of the genitopatellar/Say Barber Biesecker Young Simpson spectrum.">
    <entity charOffset="13-29" id="s3200.e0" ontology_id="HP_0001363" text="craniosynostosis" type="HP"/>
    <entity charOffset="90-95" id="s3200.e1" ontology_id="23522" text="KAT6B" type="GENE"/>
    <pair e1="s3200.e0" e2="s3200.e1" id="s3200.p0" relation="true"/>
  </sentence>
  <sentence id="s3201" text="Here we report that UBE3A ubiquitylates and triggers degradation of the tumor-suppressive sirtuin SIRT6 in hepatocellular carcinoma.">
    <entity charOffset="20-25" id="s3201.e0" ontology_id="7337" text="UBE3A" type="GENE"/>
    <entity charOffset="72-77" id="s3201.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3201.e0" e2="s3201.e1" id="s3201.p0" relation="true"/>
  </sentence>
  <sentence id="s3202" text="Here we report that UBE3A ubiquitylates and triggers degradation of the tumor-suppressive sirtuin SIRT6 in hepatocellular carcinoma.">
    <entity charOffset="20-25" id="s3202.e0" ontology_id="7337" text="UBE3A" type="GENE"/>
    <entity charOffset="107-131" id="s3202.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3202.e0" e2="s3202.e1" id="s3202.p0" relation="false"/>
  </sentence>
  <sentence id="s3203" text="Here we report that UBE3A ubiquitylates and triggers degradation of the tumor-suppressive sirtuin SIRT6 in hepatocellular carcinoma.">
    <entity charOffset="72-77" id="s3203.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="98-103" id="s3203.e1" ontology_id="51548" text="SIRT6" type="GENE"/>
    <pair e1="s3203.e0" e2="s3203.e1" id="s3203.p0" relation="true"/>
  </sentence>
  <sentence id="s3204" text="Here we report that UBE3A ubiquitylates and triggers degradation of the tumor-suppressive sirtuin SIRT6 in hepatocellular carcinoma.">
    <entity charOffset="98-103" id="s3204.e0" ontology_id="51548" text="SIRT6" type="GENE"/>
    <entity charOffset="107-131" id="s3204.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3204.e0" e2="s3204.e1" id="s3204.p0" relation="true"/>
  </sentence>
  <sentence id="s3205" text="In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.">
    <entity charOffset="19-43" id="s3205.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="118-123" id="s3205.e1" ontology_id="7337" text="UBE3A" type="GENE"/>
    <pair e1="s3205.e0" e2="s3205.e1" id="s3205.p0" relation="true"/>
  </sentence>
  <sentence id="s3206" text="In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.">
    <entity charOffset="19-43" id="s3206.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="94-99" id="s3206.e1" ontology_id="302" text="ANXA2" type="GENE"/>
    <pair e1="s3206.e0" e2="s3206.e1" id="s3206.p0" relation="true"/>
  </sentence>
  <sentence id="s3207" text="In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.">
    <entity charOffset="94-99" id="s3207.e0" ontology_id="302" text="ANXA2" type="GENE"/>
    <entity charOffset="133-138" id="s3207.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3207.e0" e2="s3207.e1" id="s3207.p0" relation="true"/>
  </sentence>
  <sentence id="s3208" text="In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.">
    <entity charOffset="118-123" id="s3208.e0" ontology_id="7337" text="UBE3A" type="GENE"/>
    <entity charOffset="133-138" id="s3208.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3208.e0" e2="s3208.e1" id="s3208.p0" relation="true"/>
  </sentence>
  <sentence id="s3209" text="Furthermore, in clinical specimens, increased UBE3A levels correlated with reduced SIRT6 levels and elevated ANXA2 levels in increasing tumor grades.">
    <entity charOffset="46-51" id="s3209.e0" ontology_id="7337" text="UBE3A" type="GENE"/>
    <entity charOffset="136-141" id="s3209.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3209.e0" e2="s3209.e1" id="s3209.p0" relation="true"/>
  </sentence>
  <sentence id="s3210" text="Furthermore, in clinical specimens, increased UBE3A levels correlated with reduced SIRT6 levels and elevated ANXA2 levels in increasing tumor grades.">
    <entity charOffset="83-88" id="s3210.e0" ontology_id="51548" text="SIRT6" type="GENE"/>
    <entity charOffset="136-141" id="s3210.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3210.e0" e2="s3210.e1" id="s3210.p0" relation="true"/>
  </sentence>
  <sentence id="s3211" text="Furthermore, in clinical specimens, increased UBE3A levels correlated with reduced SIRT6 levels and elevated ANXA2 levels in increasing tumor grades.">
    <entity charOffset="109-114" id="s3211.e0" ontology_id="302" text="ANXA2" type="GENE"/>
    <entity charOffset="136-141" id="s3211.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3211.e0" e2="s3211.e1" id="s3211.p0" relation="true"/>
  </sentence>
  <sentence id="s3212" text="Overall, our findings show how the tumor suppressor SIRT6 is regulated in hepatocellular carcinoma and establish the mechanism underlying UBE3A-mediated tumorigenesis in this disease.&lt;b&gt;Significance:&lt;/b&gt; These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.">
    <entity charOffset="35-40" id="s3212.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="138-143" id="s3212.e1" ontology_id="7337" text="UBE3A" type="GENE"/>
    <pair e1="s3212.e0" e2="s3212.e1" id="s3212.p0" relation="true"/>
  </sentence>
  <sentence id="s3213" text="Overall, our findings show how the tumor suppressor SIRT6 is regulated in hepatocellular carcinoma and establish the mechanism underlying UBE3A-mediated tumorigenesis in this disease.&lt;b&gt;Significance:&lt;/b&gt; These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.">
    <entity charOffset="52-57" id="s3213.e0" ontology_id="51548" text="SIRT6" type="GENE"/>
    <entity charOffset="74-98" id="s3213.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3213.e0" e2="s3213.e1" id="s3213.p0" relation="true"/>
  </sentence>
  <sentence id="s3214" text="Corresponding implicated genes, such as TNNI3K, ErbB3, MKL2, MTNR1B and PRKD1, may explain the associations between reproductive factors and heart failure.">
    <entity charOffset="40-46" id="s3214.e0" ontology_id="51086" text="TNNI3K" type="GENE"/>
    <entity charOffset="141-154" id="s3214.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s3214.e0" e2="s3214.e1" id="s3214.p0" relation="true"/>
  </sentence>
  <sentence id="s3215" text="Corresponding implicated genes, such as TNNI3K, ErbB3, MKL2, MTNR1B and PRKD1, may explain the associations between reproductive factors and heart failure.">
    <entity charOffset="61-67" id="s3215.e0" ontology_id="4544" text="MTNR1B" type="GENE"/>
    <entity charOffset="141-154" id="s3215.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s3215.e0" e2="s3215.e1" id="s3215.p0" relation="true"/>
  </sentence>
  <sentence id="s3216" text="Corresponding implicated genes, such as TNNI3K, ErbB3, MKL2, MTNR1B and PRKD1, may explain the associations between reproductive factors and heart failure.">
    <entity charOffset="72-77" id="s3216.e0" ontology_id="5587" text="PRKD1" type="GENE"/>
    <entity charOffset="141-154" id="s3216.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s3216.e0" e2="s3216.e1" id="s3216.p0" relation="true"/>
  </sentence>
  <sentence id="s3217" text="The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor HLXB9 that interacts with NONO/p54NRB, a survival factor.">
    <entity charOffset="48-54" id="s3217.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="207-212" id="s3217.e1" ontology_id="3110" text="HLXB9" type="GENE"/>
    <pair e1="s3217.e0" e2="s3217.e1" id="s3217.p0" relation="true"/>
  </sentence>
  <sentence id="s3218" text="Also, two somatic heterozygous NONO mutations were found in endocrine-related tumors, p.H146R (parathyroid) and p.R293H (small intestine neuroendocrine tumor).">
    <entity charOffset="31-35" id="s3218.e0" ontology_id="4841" text="NONO" type="GENE"/>
    <entity charOffset="78-84" id="s3218.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3218.e0" e2="s3218.e1" id="s3218.p0" relation="true"/>
  </sentence>
  <sentence id="s3219" text="Our studies implicate therapeutic strategies for either reducing -cell proliferation in insulinomas or alleviating normal -cell deficiency in diabetes through the modulation of HLXB9 phosphorylation">
    <entity charOffset="89-100" id="s3219.e0" ontology_id="HP_0012197" text="insulinomas" type="HP"/>
    <entity charOffset="179-184" id="s3219.e1" ontology_id="3110" text="HLXB9" type="GENE"/>
    <pair e1="s3219.e0" e2="s3219.e1" id="s3219.p0" relation="true"/>
  </sentence>
  <sentence id="s3220" text="In a large Scottish pedigree, a balanced translocation t (1;11)(q42.1;q14.3) disrupting the DISC1 and DISC2 genes segregates with major mental illness, including schizophrenia and depression.">
    <entity charOffset="92-97" id="s3220.e0" ontology_id="27185" text="DISC1" type="GENE"/>
    <entity charOffset="162-175" id="s3220.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s3220.e0" e2="s3220.e1" id="s3220.p0" relation="true"/>
  </sentence>
  <sentence id="s3221" text="A frame-shift carboxyl-terminal deletion was reported in DISC1 in an American family with schizophrenia, but subsequently found in two controls.">
    <entity charOffset="57-62" id="s3221.e0" ontology_id="27185" text="DISC1" type="GENE"/>
    <entity charOffset="90-103" id="s3221.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s3221.e0" e2="s3221.e1" id="s3221.p0" relation="false"/>
  </sentence>
  <sentence id="s3222" text="To discover additional risk loci, we performed a GWAS of 123 sporadic HSCR patients and 432 unaffected controls using a large-scale platform with coverage of over 1 million polymorphic markers.">
    <entity charOffset="61-69" id="s3222.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="70-74" id="s3222.e1" ontology_id="1910" text="HSCR" type="GENE"/>
    <pair e1="s3222.e0" e2="s3222.e1" id="s3222.p0" relation="true"/>
  </sentence>
  <sentence id="s3223" text="We find NF1 mutations in neuroblastoma cell lines and in primary tumors.">
    <entity charOffset="3-7" id="s3223.e0" ontology_id="81501" text="find" type="GENE"/>
    <entity charOffset="25-38" id="s3223.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s3223.e0" e2="s3223.e1" id="s3223.p0" relation="true"/>
  </sentence>
  <sentence id="s3224" text="Our study aimed to investigate the relationship between single nucleotide polymorphisms (SNPs) of claudin 10 (CLDN10) (rs1325774, rs7333503, rs3751334) and breast cancer and the clinical characteristics of patients.A total of 104 patients with breast cancer and 118 healthy controls were recruited in our study between 2013 and 2015.">
    <entity charOffset="110-116" id="s3224.e0" ontology_id="9071" text="CLDN10" type="GENE"/>
    <entity charOffset="163-169" id="s3224.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3224.e0" e2="s3224.e1" id="s3224.p0" relation="true"/>
  </sentence>
  <sentence id="s3225" text="The expression level of CLDN10 was reduced in breast cancer tissues compared with normal breast tissues according to the analysis of The Cancer Genome Atlas (TCGA) data through GEPIA.Our results suggest that the polymorphism of rs1325774 associate with increase the breast cancer risk.">
    <entity charOffset="24-30" id="s3225.e0" ontology_id="9071" text="CLDN10" type="GENE"/>
    <entity charOffset="53-59" id="s3225.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3225.e0" e2="s3225.e1" id="s3225.p0" relation="true"/>
  </sentence>
  <sentence id="s3226" text="This report identifies the implication of IFT57 in human pathology and highlights the first description of a ciliary transport defect in OFDS, extending the genetic heterogeneity of this subgroup of ciliopathies">
    <entity charOffset="42-47" id="s3226.e0" ontology_id="55081" text="IFT57" type="GENE"/>
    <entity charOffset="165-178" id="s3226.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s3226.e0" e2="s3226.e1" id="s3226.p0" relation="true"/>
  </sentence>
  <sentence id="s3227" text="Recessively inherited, pathogenic defects in LonP1 have been previously reported to underlie cerebral, ocular, dental, auricular and skeletal anomalies (CODAS) syndrome, a complex multisystemic and developmental disorder.">
    <entity charOffset="45-50" id="s3227.e0" ontology_id="9361" text="LonP1" type="GENE"/>
    <entity charOffset="133-151" id="s3227.e1" ontology_id="HP_0000924" text="skeletal anomalies" type="HP"/>
    <pair e1="s3227.e0" e2="s3227.e1" id="s3227.p0" relation="true"/>
  </sentence>
  <sentence id="s3228" text="We have applied whole exome sequencing to a patient with congenital lactic acidosis, muscle weakness, profound deficiencies in mitochondrial oxidative phosphorylation associated with loss of mtDNA copy number and MRI abnormalities consistent with Leigh syndrome, identifying biallelic variants in the LONP1 (NM_004793.3) gene; c.1693T&amp;gt;C predicting p.(Tyr565His) and c.2197G&amp;gt;A predicting p.(Glu733Lys); no evidence of the classical skeletal or dental defects observed in CODAS syndrome patients were noted in our patient.">
    <entity charOffset="75-83" id="s3228.e0" ontology_id="HP_0001941" text="acidosis" type="HP"/>
    <entity charOffset="301-306" id="s3228.e1" ontology_id="9361" text="LONP1" type="GENE"/>
    <pair e1="s3228.e0" e2="s3228.e1" id="s3228.p0" relation="true"/>
  </sentence>
  <sentence id="s3229" text="Among these genes, mutations in VCP gene involve in inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).">
    <entity charOffset="32-35" id="s3229.e0" ontology_id="7415" text="VCP" type="GENE"/>
    <entity charOffset="187-193" id="s3229.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s3229.e0" e2="s3229.e1" id="s3229.p0" relation="false"/>
  </sentence>
  <sentence id="s3230" text="Primary ciliary dyskinesia (PCD) can manifest in the neonatal period with severe respiratory distress.">
    <entity charOffset="8-26" id="s3230.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="28-31" id="s3230.e1" ontology_id="352909" text="PCD" type="GENE"/>
    <pair e1="s3230.e0" e2="s3230.e1" id="s3230.p0" relation="true"/>
  </sentence>
  <sentence id="s3231" text="Their expression changes were further validated in U2OS osteosarcoma cell lines and hOB normal cell lines through quantitative PCR (qPCR) and consistent result with microarray analysis was obtained.">
    <entity charOffset="53-55" id="s3231.e0" ontology_id="4281" text="OS" type="GENE"/>
    <entity charOffset="56-68" id="s3231.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s3231.e0" e2="s3231.e1" id="s3231.p0" relation="true"/>
  </sentence>
  <sentence id="s3232" text="We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.">
    <entity charOffset="18-22" id="s3232.e0" ontology_id="25972" text="UNCL" type="GENE"/>
    <entity charOffset="279-284" id="s3232.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3232.e0" e2="s3232.e1" id="s3232.p0" relation="true"/>
  </sentence>
  <sentence id="s3233" text="We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.">
    <entity charOffset="23-29" id="s3233.e0" ontology_id="9723" text="Sema3E" type="GENE"/>
    <entity charOffset="279-284" id="s3233.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3233.e0" e2="s3233.e1" id="s3233.p0" relation="true"/>
  </sentence>
  <sentence id="s3234" text="We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.">
    <entity charOffset="47-51" id="s3234.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="279-284" id="s3234.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3234.e0" e2="s3234.e1" id="s3234.p0" relation="false"/>
  </sentence>
  <sentence id="s3235" text="We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.">
    <entity charOffset="52-58" id="s3235.e0" ontology_id="9723" text="sema3E" type="GENE"/>
    <entity charOffset="279-284" id="s3235.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3235.e0" e2="s3235.e1" id="s3235.p0" relation="false"/>
  </sentence>
  <sentence id="s3236" text="To investigate the role of MEGF10 variants with putative transcription regulatory function in the etiology of autism, we performed a family-based association study in 410 Chinese Han trios.">
    <entity charOffset="27-33" id="s3236.e0" ontology_id="84466" text="MEGF10" type="GENE"/>
    <entity charOffset="110-116" id="s3236.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s3236.e0" e2="s3236.e1" id="s3236.p0" relation="true"/>
  </sentence>
  <sentence id="s3237" text="Alterations in mTOR signaling are involved both in cancer progression and in osteoclast differentiation.">
    <entity charOffset="15-19" id="s3237.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="51-57" id="s3237.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3237.e0" e2="s3237.e1" id="s3237.p0" relation="true"/>
  </sentence>
  <sentence id="s3238" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s3238.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="78-83" id="s3238.e1" ontology_id="6310" text="ATXN1" type="GENE"/>
    <pair e1="s3238.e0" e2="s3238.e1" id="s3238.p0" relation="true"/>
  </sentence>
  <sentence id="s3239" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s3239.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="118-121" id="s3239.e1" ontology_id="6908" text="TBP" type="GENE"/>
    <pair e1="s3239.e0" e2="s3239.e1" id="s3239.p0" relation="true"/>
  </sentence>
  <sentence id="s3240" text="Clinical comparisons showed that ataxias due to channelopathies had a significantly earlier age at onset with an average of 24.6 years, versus 40.9 years for polyglutamine expansion spinocerebellar ataxias and 37.8 years for SPG7-related forms (P = 0.001).">
    <entity charOffset="33-40" id="s3240.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="225-229" id="s3240.e1" ontology_id="6687" text="SPG7" type="GENE"/>
    <pair e1="s3240.e0" e2="s3240.e1" id="s3240.p0" relation="true"/>
  </sentence>
  <sentence id="s3241" text="Similar differences were found among a single gene group, comparing 23 patients with CACNA1A expansions (spinocerebellar ataxia 6) to 22 patients with CACNA1A point mutations, which had lower average age at onset (25.2 versus 47.3 years) with longer disease duration (18.7 versus 10.9), but lower severity indexes (0.39 versus 0.44), indicating slower progression of the disease.">
    <entity charOffset="85-92" id="s3241.e0" ontology_id="773" text="CACNA1A" type="GENE"/>
    <entity charOffset="121-127" id="s3241.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3241.e0" e2="s3241.e1" id="s3241.p0" relation="true"/>
  </sentence>
  <sentence id="s3242" text="In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and SPG7 as major ataxia genes.">
    <entity charOffset="138-145" id="s3242.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="161-168" id="s3242.e1" ontology_id="773" text="CACNA1A" type="GENE"/>
    <pair e1="s3242.e0" e2="s3242.e1" id="s3242.p0" relation="true"/>
  </sentence>
  <sentence id="s3243" text="In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and SPG7 as major ataxia genes.">
    <entity charOffset="138-145" id="s3243.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="173-177" id="s3243.e1" ontology_id="6687" text="SPG7" type="GENE"/>
    <pair e1="s3243.e0" e2="s3243.e1" id="s3243.p0" relation="true"/>
  </sentence>
  <sentence id="s3244" text="In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and SPG7 as major ataxia genes.">
    <entity charOffset="161-168" id="s3244.e0" ontology_id="773" text="CACNA1A" type="GENE"/>
    <entity charOffset="187-193" id="s3244.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3244.e0" e2="s3244.e1" id="s3244.p0" relation="true"/>
  </sentence>
  <sentence id="s3245" text="LIMKs and SSH promote cancer cell invasion and metastasis and represent novel anti-cancer targets.">
    <entity charOffset="0-3" id="s3245.e0" ontology_id="10611" text="LIM" type="GENE"/>
    <entity charOffset="22-28" id="s3245.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3245.e0" e2="s3245.e1" id="s3245.p0" relation="true"/>
  </sentence>
  <sentence id="s3246" text="We show that active cofilin, LIMK1, LIMK2, and SSH1 are overexpressed in human CRC and are associated with tumor progression parameters.">
    <entity charOffset="29-32" id="s3246.e0" ontology_id="10611" text="LIM" type="GENE"/>
    <entity charOffset="107-112" id="s3246.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3246.e0" e2="s3246.e1" id="s3246.p0" relation="true"/>
  </sentence>
  <sentence id="s3247" text="In addition, immunofluorescence analysis showed increased expression of active cofilin, LIMK1, LIMK2, and SSH1 in HT29 colon cancer cells resistant to 5-fluorouracil compared to parental HT29 cells.">
    <entity charOffset="88-91" id="s3247.e0" ontology_id="10611" text="LIM" type="GENE"/>
    <entity charOffset="125-131" id="s3247.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3247.e0" e2="s3247.e1" id="s3247.p0" relation="true"/>
  </sentence>
  <sentence id="s3248" text="In addition, immunofluorescence analysis showed increased expression of active cofilin, LIMK1, LIMK2, and SSH1 in HT29 colon cancer cells resistant to 5-fluorouracil compared to parental HT29 cells.">
    <entity charOffset="106-110" id="s3248.e0" ontology_id="54434" text="SSH1" type="GENE"/>
    <entity charOffset="125-131" id="s3248.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3248.e0" e2="s3248.e1" id="s3248.p0" relation="true"/>
  </sentence>
  <sentence id="s3249" text="Our results suggest that F-actin regulators LIMK/cofilin pathway and SSH1 are associated with CRC progression and chemoresistance representing promising tumor biomarkers and therapeutic targets in CRC">
    <entity charOffset="69-73" id="s3249.e0" ontology_id="54434" text="SSH1" type="GENE"/>
    <entity charOffset="153-158" id="s3249.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3249.e0" e2="s3249.e1" id="s3249.p0" relation="true"/>
  </sentence>
  <sentence id="s3250" text="We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the HBS1L gene characterized by facial dysmorphism, severe growth restriction, axial hypotonia, global developmental delay and retinal pigmentary deposits.">
    <entity charOffset="108-113" id="s3250.e0" ontology_id="10767" text="HBS1L" type="GENE"/>
    <entity charOffset="136-154" id="s3250.e1" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <pair e1="s3250.e0" e2="s3250.e1" id="s3250.p0" relation="true"/>
  </sentence>
  <sentence id="s3251" text="We also describe a mouse model harboring a knockdown mutation in the murine Hbs1l gene that shared several of the phenotypic elements observed in the Hbs1L-deficient human including facial dysmorphism, growth restriction and retinal deposits.">
    <entity charOffset="76-81" id="s3251.e0" ontology_id="10767" text="Hbs1l" type="GENE"/>
    <entity charOffset="182-200" id="s3251.e1" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <pair e1="s3251.e0" e2="s3251.e1" id="s3251.p0" relation="true"/>
  </sentence>
  <sentence id="s3252" text="We also describe a mouse model harboring a knockdown mutation in the murine Hbs1l gene that shared several of the phenotypic elements observed in the Hbs1L-deficient human including facial dysmorphism, growth restriction and retinal deposits.">
    <entity charOffset="150-155" id="s3252.e0" ontology_id="10767" text="Hbs1L" type="GENE"/>
    <entity charOffset="182-200" id="s3252.e1" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <pair e1="s3252.e0" e2="s3252.e1" id="s3252.p0" relation="false"/>
  </sentence>
  <sentence id="s3253" text="The mutations in both LIPH and LPAR6/P2RY5 are responsible for autosomal recessive woolly hair with or without hypotrichosis (ARWH/HT).">
    <entity charOffset="22-26" id="s3253.e0" ontology_id="200879" text="LIPH" type="GENE"/>
    <entity charOffset="111-124" id="s3253.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s3253.e0" e2="s3253.e1" id="s3253.p0" relation="true"/>
  </sentence>
  <sentence id="s3254" text="The mutations in both LIPH and LPAR6/P2RY5 are responsible for autosomal recessive woolly hair with or without hypotrichosis (ARWH/HT).">
    <entity charOffset="22-26" id="s3254.e0" ontology_id="200879" text="LIPH" type="GENE"/>
    <entity charOffset="63-82" id="s3254.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3254.e0" e2="s3254.e1" id="s3254.p0" relation="true"/>
  </sentence>
  <sentence id="s3255" text="The main objective of this study is to provide a brief version of the Spanish translation of the PIP, across a sample consisting of 465 main familial caregivers (85.2% female, n = 396) between 27 and 67 years old ([Formula: see text] = 44.13; SD = 5.35) of paediatric patients between 9 and 18 years old ([Formula: see text] = 12.10, SD = 2.20; 56.8% men, n = 264) diagnosed with diabetes mellitus type I (20.9% of the sample; n = 97), short stature (32.5% of the sample; n = 151), or a chronic respiratory disease (asthma, cystic fibrosis, bronchiolitis obliterans and bronchiectasis) (46.6% of the sample; n = 217).">
    <entity charOffset="97-100" id="s3255.e0" ontology_id="5304" text="PIP" type="GENE"/>
    <entity charOffset="436-449" id="s3255.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s3255.e0" e2="s3255.e1" id="s3255.p0" relation="false"/>
  </sentence>
  <sentence id="s3256" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="173-178" id="s3256.e0" ontology_id="120892" text="LRRK2" type="GENE"/>
    <entity charOffset="280-299" id="s3256.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3256.e0" e2="s3256.e1" id="s3256.p0" relation="false"/>
  </sentence>
  <sentence id="s3257" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="180-184" id="s3257.e0" ontology_id="6622" text="SNCA" type="GENE"/>
    <entity charOffset="280-299" id="s3257.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3257.e0" e2="s3257.e1" id="s3257.p0" relation="true"/>
  </sentence>
  <sentence id="s3258" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="186-191" id="s3258.e0" ontology_id="55737" text="VPS35" type="GENE"/>
    <entity charOffset="280-299" id="s3258.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3258.e0" e2="s3258.e1" id="s3258.p0" relation="true"/>
  </sentence>
  <sentence id="s3259" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="193-197" id="s3259.e0" ontology_id="2643" text="GCH1" type="GENE"/>
    <entity charOffset="280-299" id="s3259.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3259.e0" e2="s3259.e1" id="s3259.p0" relation="false"/>
  </sentence>
  <sentence id="s3260" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="199-204" id="s3260.e0" ontology_id="6311" text="ATXN2" type="GENE"/>
    <entity charOffset="280-299" id="s3260.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3260.e0" e2="s3260.e1" id="s3260.p0" relation="false"/>
  </sentence>
  <sentence id="s3261" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="206-213" id="s3261.e0" ontology_id="23317" text="DNAJC13" type="GENE"/>
    <entity charOffset="280-299" id="s3261.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3261.e0" e2="s3261.e1" id="s3261.p0" relation="true"/>
  </sentence>
  <sentence id="s3262" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="215-222" id="s3262.e0" ontology_id="29058" text="TMEM230" type="GENE"/>
    <entity charOffset="280-299" id="s3262.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3262.e0" e2="s3262.e1" id="s3262.p0" relation="false"/>
  </sentence>
  <sentence id="s3263" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="232-237" id="s3263.e0" ontology_id="27429" text="HTRA2" type="GENE"/>
    <entity charOffset="280-299" id="s3263.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3263.e0" e2="s3263.e1" id="s3263.p0" relation="true"/>
  </sentence>
  <sentence id="s3264" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="239-243" id="s3264.e0" ontology_id="79608" text="RIC3" type="GENE"/>
    <entity charOffset="280-299" id="s3264.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3264.e0" e2="s3264.e1" id="s3264.p0" relation="true"/>
  </sentence>
  <sentence id="s3265" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="245-251" id="s3265.e0" ontology_id="1981" text="EIF4G1" type="GENE"/>
    <entity charOffset="280-299" id="s3265.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3265.e0" e2="s3265.e1" id="s3265.p0" relation="true"/>
  </sentence>
  <sentence id="s3266" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="260-266" id="s3266.e0" ontology_id="51142" text="CHCHD2" type="GENE"/>
    <entity charOffset="280-299" id="s3266.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3266.e0" e2="s3266.e1" id="s3266.p0" relation="false"/>
  </sentence>
  <sentence id="s3267" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="272-275" id="s3267.e0" ontology_id="2629" text="GBA" type="GENE"/>
    <entity charOffset="280-299" id="s3267.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3267.e0" e2="s3267.e1" id="s3267.p0" relation="false"/>
  </sentence>
  <sentence id="s3268" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="280-299" id="s3268.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="318-322" id="s3268.e1" ontology_id="5071" text="PRKN" type="GENE"/>
    <pair e1="s3268.e0" e2="s3268.e1" id="s3268.p0" relation="true"/>
  </sentence>
  <sentence id="s3269" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="280-299" id="s3269.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="324-329" id="s3269.e1" ontology_id="65018" text="PINK1" type="GENE"/>
    <pair e1="s3269.e0" e2="s3269.e1" id="s3269.p0" relation="true"/>
  </sentence>
  <sentence id="s3270" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="280-299" id="s3270.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="336-343" id="s3270.e1" ontology_id="23400" text="ATP13A2" type="GENE"/>
    <pair e1="s3270.e0" e2="s3270.e1" id="s3270.p0" relation="true"/>
  </sentence>
  <sentence id="s3271" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="280-299" id="s3271.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="353-358" id="s3271.e1" ontology_id="25793" text="FBXO7" type="GENE"/>
    <pair e1="s3271.e0" e2="s3271.e1" id="s3271.p0" relation="true"/>
  </sentence>
  <sentence id="s3272" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="280-299" id="s3272.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="360-366" id="s3272.e1" ontology_id="9829" text="DNAJC6" type="GENE"/>
    <pair e1="s3272.e0" e2="s3272.e1" id="s3272.p0" relation="true"/>
  </sentence>
  <sentence id="s3273" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="280-299" id="s3273.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="368-373" id="s3273.e1" ontology_id="8867" text="SYNJ1" type="GENE"/>
    <pair e1="s3273.e0" e2="s3273.e1" id="s3273.p0" relation="true"/>
  </sentence>
  <sentence id="s3274" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="280-299" id="s3274.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="382-388" id="s3274.e1" ontology_id="54832" text="VPS13C" type="GENE"/>
    <pair e1="s3274.e0" e2="s3274.e1" id="s3274.p0" relation="true"/>
  </sentence>
  <sentence id="s3275" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="280-299" id="s3275.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="390-395" id="s3275.e1" ontology_id="5420" text="PODXL" type="GENE"/>
    <pair e1="s3275.e0" e2="s3275.e1" id="s3275.p0" relation="true"/>
  </sentence>
  <sentence id="s3276" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="280-299" id="s3276.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="401-407" id="s3276.e1" ontology_id="391356" text="PTRHD1" type="GENE"/>
    <pair e1="s3276.e0" e2="s3276.e1" id="s3276.p0" relation="true"/>
  </sentence>
  <sentence id="s3277" text="Duplication in LMNB1 encoding lamin B1 causes autosomal dominant leukodystrophy and mutations in LMNB2 encoding lamin B2 are associated with acquired partial lipodystrophy.">
    <entity charOffset="15-20" id="s3277.e0" ontology_id="4001" text="LMNB1" type="GENE"/>
    <entity charOffset="65-79" id="s3277.e1" ontology_id="HP_0002415" text="leukodystrophy" type="HP"/>
    <pair e1="s3277.e0" e2="s3277.e1" id="s3277.p0" relation="true"/>
  </sentence>
  <sentence id="s3278" text="Duplication in LMNB1 encoding lamin B1 causes autosomal dominant leukodystrophy and mutations in LMNB2 encoding lamin B2 are associated with acquired partial lipodystrophy.">
    <entity charOffset="65-79" id="s3278.e0" ontology_id="HP_0002415" text="leukodystrophy" type="HP"/>
    <entity charOffset="97-102" id="s3278.e1" ontology_id="84823" text="LMNB2" type="GENE"/>
    <pair e1="s3278.e0" e2="s3278.e1" id="s3278.p0" relation="true"/>
  </sentence>
  <sentence id="s3279" text="In this study, we found that tumor suppressor candidate3(TUSC3) was downregulated in temozolomide-resistant U87MG cells(U87MG-res cells) and its restoration sensitized U87MG-res cells to temozolomide.">
    <entity charOffset="29-34" id="s3279.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="59-64" id="s3279.e1" ontology_id="7991" text="TUSC3" type="GENE"/>
    <pair e1="s3279.e0" e2="s3279.e1" id="s3279.p0" relation="true"/>
  </sentence>
  <sentence id="s3280" text="miR132 was upregulated in the U87MG-res cells and its overexpression induced temozolomide resistance and the formation of cancer stem cell phenotypes in the U87MG cells.">
    <entity charOffset="0-3" id="s3280.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="123-129" id="s3280.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3280.e0" e2="s3280.e1" id="s3280.p0" relation="true"/>
  </sentence>
  <sentence id="s3281" text="Thus, our data indicate that miR-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting TUSC3 in glioblastoma">
    <entity charOffset="29-32" id="s3281.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="99-105" id="s3281.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3281.e0" e2="s3281.e1" id="s3281.p0" relation="true"/>
  </sentence>
  <sentence id="s3282" text="Thus, our data indicate that miR-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting TUSC3 in glioblastoma">
    <entity charOffset="99-105" id="s3282.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="140-145" id="s3282.e1" ontology_id="7991" text="TUSC3" type="GENE"/>
    <pair e1="s3282.e0" e2="s3282.e1" id="s3282.p0" relation="true"/>
  </sentence>
  <sentence id="s3283" text="We hypothesized that newly identified genetic risk factors for the general African American population could also impact laboratory biomarkers known to contribute to the clinical disease expression of SCA, including variants influencing the white blood cell count and the development of albuminuria and abnormal glomerular filtration rate.">
    <entity charOffset="114-120" id="s3283.e0" ontology_id="55364" text="impact" type="GENE"/>
    <entity charOffset="287-298" id="s3283.e1" ontology_id="HP_0012592" text="albuminuria" type="HP"/>
    <pair e1="s3283.e0" e2="s3283.e1" id="s3283.p0" relation="false"/>
  </sentence>
  <sentence id="s3284" text="To investigate the mechanism by which the -crystallin mutations Cryaa-R49C and Cryab-R120G lead to cataract formation, we determined whether these mutations cause an altered expression of specific transcripts in the lens at an early postnatal age by RNA-seq analysis.">
    <entity charOffset="80-85" id="s3284.e0" ontology_id="1410" text="Cryab" type="GENE"/>
    <entity charOffset="100-108" id="s3284.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s3284.e0" e2="s3284.e1" id="s3284.p0" relation="true"/>
  </sentence>
  <sentence id="s3285" text="Taken together, these findings offer additional insight into the early transcriptional changes caused by Cryaa and Cryab mutations associated with autosomal dominant human cataracts, and indicate that the transcript levels of certain genes are affected by the expression of mutant -crystallin in vivo">
    <entity charOffset="105-110" id="s3285.e0" ontology_id="1409" text="Cryaa" type="GENE"/>
    <entity charOffset="172-181" id="s3285.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s3285.e0" e2="s3285.e1" id="s3285.p0" relation="true"/>
  </sentence>
  <sentence id="s3286" text="Taken together, these findings offer additional insight into the early transcriptional changes caused by Cryaa and Cryab mutations associated with autosomal dominant human cataracts, and indicate that the transcript levels of certain genes are affected by the expression of mutant -crystallin in vivo">
    <entity charOffset="115-120" id="s3286.e0" ontology_id="1410" text="Cryab" type="GENE"/>
    <entity charOffset="172-181" id="s3286.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s3286.e0" e2="s3286.e1" id="s3286.p0" relation="true"/>
  </sentence>
  <sentence id="s3287" text="However, the underlying mechanisms involved in hepatocellular carcinoma (HCC) progression remain poorly understood.">
    <entity charOffset="47-71" id="s3287.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="73-76" id="s3287.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s3287.e0" e2="s3287.e1" id="s3287.p0" relation="true"/>
  </sentence>
  <sentence id="s3288" text="Surprisingly, germline variants in SAMD9 or SAMD9L were present in 17% of primary MDS patients, and these variants were routinely lost in the tumor cells by chromosomal deletions (e.g., monosomy 7) or copy number neutral loss of heterozygosity (CN-LOH).">
    <entity charOffset="35-40" id="s3288.e0" ontology_id="54809" text="SAMD9" type="GENE"/>
    <entity charOffset="142-147" id="s3288.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3288.e0" e2="s3288.e1" id="s3288.p0" relation="true"/>
  </sentence>
  <sentence id="s3289" text="Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease.">
    <entity charOffset="31-34" id="s3289.e0" ontology_id="3483" text="ALS" type="GENE"/>
    <entity charOffset="47-72" id="s3289.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s3289.e0" e2="s3289.e1" id="s3289.p0" relation="true"/>
  </sentence>
  <sentence id="s3290" text="The Aicardi-Goutires syndrome (AGS) was first described in 1984, and over the following years was defined by the clinical and radiological features of an early onset, severe, neurologic disorder with intracranial calcification, leukoencephalopathy, and cerebral atrophy, usually associated with a cerebrospinal fluid (CSF) pleocytosis and elevated CSF interferon  activity.">
    <entity charOffset="32-35" id="s3290.e0" ontology_id="182" text="AGS" type="GENE"/>
    <entity charOffset="201-227" id="s3290.e1" ontology_id="HP_0002514" text="intracranial calcification" type="HP"/>
    <pair e1="s3290.e0" e2="s3290.e1" id="s3290.p0" relation="true"/>
  </sentence>
  <sentence id="s3291" text="The Aicardi-Goutires syndrome (AGS) was first described in 1984, and over the following years was defined by the clinical and radiological features of an early onset, severe, neurologic disorder with intracranial calcification, leukoencephalopathy, and cerebral atrophy, usually associated with a cerebrospinal fluid (CSF) pleocytosis and elevated CSF interferon  activity.">
    <entity charOffset="32-35" id="s3291.e0" ontology_id="182" text="AGS" type="GENE"/>
    <entity charOffset="254-270" id="s3291.e1" ontology_id="HP_0002059" text="cerebral atrophy" type="HP"/>
    <pair e1="s3291.e0" e2="s3291.e1" id="s3291.p0" relation="true"/>
  </sentence>
  <sentence id="s3292" text="Wnt transgenic mice provide convincing evidence that Wnt signaling is involved in breast cancer initiation and progression, which is further strengthened by observations on human clinical breast cancer patients and studies on in vitro cultured human breast cancer cells.">
    <entity charOffset="15-19" id="s3292.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="89-95" id="s3292.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3292.e0" e2="s3292.e1" id="s3292.p0" relation="true"/>
  </sentence>
  <sentence id="s3293" text="Objective clinical response was 19% (one confirmed partial response (PR) in small cell lung cancer (SCLC) and two unconfirmed); stable disease (SD) was 6% for a disease control rate (DCR) of 25%.">
    <entity charOffset="92-98" id="s3293.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="183-186" id="s3293.e1" ontology_id="51181" text="DCR" type="GENE"/>
    <pair e1="s3293.e0" e2="s3293.e1" id="s3293.p0" relation="true"/>
  </sentence>
  <sentence id="s3294" text="Genetic discoveries have established the importance of SETX for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia type 2 (AOA2) (OMIM: 606002), which is the third most common form of recessive ataxia, after Friedreich's ataxia and Ataxia-Telangiectasia.">
    <entity charOffset="55-59" id="s3294.e0" ontology_id="23064" text="SETX" type="GENE"/>
    <entity charOffset="237-243" id="s3294.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3294.e0" e2="s3294.e1" id="s3294.p0" relation="true"/>
  </sentence>
  <sentence id="s3295" text="Genetic discoveries have established the importance of SETX for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia type 2 (AOA2) (OMIM: 606002), which is the third most common form of recessive ataxia, after Friedreich's ataxia and Ataxia-Telangiectasia.">
    <entity charOffset="158-162" id="s3295.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="237-243" id="s3295.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3295.e0" e2="s3295.e1" id="s3295.p0" relation="true"/>
  </sentence>
  <sentence id="s3296" text="Genetic discoveries have established the importance of SETX for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia type 2 (AOA2) (OMIM: 606002), which is the third most common form of recessive ataxia, after Friedreich's ataxia and Ataxia-Telangiectasia.">
    <entity charOffset="166-170" id="s3296.e0" ontology_id="23064" text="AOA2" type="GENE"/>
    <entity charOffset="237-243" id="s3296.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3296.e0" e2="s3296.e1" id="s3296.p0" relation="true"/>
  </sentence>
  <sentence id="s3297" text="While we do not yet know which SETX activities are most critical to neurodegeneration, our evolving understanding of SETX function will undoubtedly be crucial for not only understanding the role of SETX in ALS and ataxia disease pathogenesis, but also for delineating the mechanistic biology of fundamentally important molecular processes in the cell">
    <entity charOffset="31-35" id="s3297.e0" ontology_id="23064" text="SETX" type="GENE"/>
    <entity charOffset="214-220" id="s3297.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3297.e0" e2="s3297.e1" id="s3297.p0" relation="true"/>
  </sentence>
  <sentence id="s3298" text="Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (MIM 146255) under the acronym HDR.">
    <entity charOffset="31-49" id="s3298.e0" ontology_id="HP_0000829" text="hypoparathyroidism" type="HP"/>
    <entity charOffset="163-166" id="s3298.e1" ontology_id="2625" text="HDR" type="GENE"/>
    <pair e1="s3298.e0" e2="s3298.e1" id="s3298.p0" relation="true"/>
  </sentence>
  <sentence id="s3299" text="Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (MIM 146255) under the acronym HDR.">
    <entity charOffset="65-80" id="s3299.e0" ontology_id="HP_0000110" text="renal dysplasia" type="HP"/>
    <entity charOffset="163-166" id="s3299.e1" ontology_id="2625" text="HDR" type="GENE"/>
    <pair e1="s3299.e0" e2="s3299.e1" id="s3299.p0" relation="true"/>
  </sentence>
  <sentence id="s3300" text="Hemizygosity of the distal region, designated HDR1, can cause hypoparathyroidism and in addition sensorineuronal deafness and renal dysplasia/insufficiency or a subset of this triad">
    <entity charOffset="46-49" id="s3300.e0" ontology_id="2625" text="HDR" type="GENE"/>
    <entity charOffset="126-141" id="s3300.e1" ontology_id="HP_0000110" text="renal dysplasia" type="HP"/>
    <pair e1="s3300.e0" e2="s3300.e1" id="s3300.p0" relation="true"/>
  </sentence>
  <sentence id="s3301" text="A heterozygous nonsense variant was identified in dapper, antagonist of beta-catenin, 1 (DACT1) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.">
    <entity charOffset="50-56" id="s3301.e0" ontology_id="51339" text="dapper" type="GENE"/>
    <entity charOffset="228-241" id="s3301.e1" ontology_id="HP_0000598" text="ear anomalies" type="HP"/>
    <pair e1="s3301.e0" e2="s3301.e1" id="s3301.p0" relation="true"/>
  </sentence>
  <sentence id="s3302" text="A heterozygous nonsense variant was identified in dapper, antagonist of beta-catenin, 1 (DACT1) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.">
    <entity charOffset="72-84" id="s3302.e0" ontology_id="1499" text="beta-catenin" type="GENE"/>
    <entity charOffset="146-162" id="s3302.e1" ontology_id="HP_0002023" text="imperforate anus" type="HP"/>
    <pair e1="s3302.e0" e2="s3302.e1" id="s3302.p0" relation="true"/>
  </sentence>
  <sentence id="s3303" text="A heterozygous nonsense variant was identified in dapper, antagonist of beta-catenin, 1 (DACT1) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.">
    <entity charOffset="72-84" id="s3303.e0" ontology_id="1499" text="beta-catenin" type="GENE"/>
    <entity charOffset="228-241" id="s3303.e1" ontology_id="HP_0000598" text="ear anomalies" type="HP"/>
    <pair e1="s3303.e0" e2="s3303.e1" id="s3303.p0" relation="true"/>
  </sentence>
  <sentence id="s3304" text="A heterozygous nonsense variant was identified in dapper, antagonist of beta-catenin, 1 (DACT1) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.">
    <entity charOffset="89-94" id="s3304.e0" ontology_id="51339" text="DACT1" type="GENE"/>
    <entity charOffset="146-162" id="s3304.e1" ontology_id="HP_0002023" text="imperforate anus" type="HP"/>
    <pair e1="s3304.e0" e2="s3304.e1" id="s3304.p0" relation="true"/>
  </sentence>
  <sentence id="s3305" text="A heterozygous nonsense variant was identified in dapper, antagonist of beta-catenin, 1 (DACT1) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.">
    <entity charOffset="89-94" id="s3305.e0" ontology_id="51339" text="DACT1" type="GENE"/>
    <entity charOffset="228-241" id="s3305.e1" ontology_id="HP_0000598" text="ear anomalies" type="HP"/>
    <pair e1="s3305.e0" e2="s3305.e1" id="s3305.p0" relation="true"/>
  </sentence>
  <sentence id="s3306" text="The DACT1 c.1256G&amp;gt;A;p.Trp419&lt;sup&gt;*&lt;/sup&gt; variant segregated appropriately in the family consistent with an autosomal dominant mode of inheritance.">
    <entity charOffset="4-9" id="s3306.e0" ontology_id="51339" text="DACT1" type="GENE"/>
    <entity charOffset="129-148" id="s3306.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s3306.e0" e2="s3306.e1" id="s3306.p0" relation="true"/>
  </sentence>
  <sentence id="s3307" text="DACT1 is a member of the Wnt-signaling pathway, and mice homozygous for null alleles display multiple congenital anomalies including absent anus with blind-ending colon and genitourinary malformations.">
    <entity charOffset="0-5" id="s3307.e0" ontology_id="51339" text="DACT1" type="GENE"/>
    <entity charOffset="133-144" id="s3307.e1" ontology_id="HP_0002023" text="absent anus" type="HP"/>
    <pair e1="s3307.e0" e2="s3307.e1" id="s3307.p0" relation="true"/>
  </sentence>
  <sentence id="s3308" text="DACT1 is a member of the Wnt-signaling pathway, and mice homozygous for null alleles display multiple congenital anomalies including absent anus with blind-ending colon and genitourinary malformations.">
    <entity charOffset="52-56" id="s3308.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="133-144" id="s3308.e1" ontology_id="HP_0002023" text="absent anus" type="HP"/>
    <pair e1="s3308.e0" e2="s3308.e1" id="s3308.p0" relation="false"/>
  </sentence>
  <sentence id="s3309" text="To examine if CRC patients have altered decorin levels, expression of decorin and its target genes, Met and vascular endothelial growth factor A (VEGFA), were analyzed in their tumors.">
    <entity charOffset="100-103" id="s3309.e0" ontology_id="4233" text="Met" type="GENE"/>
    <entity charOffset="177-183" id="s3309.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3309.e0" e2="s3309.e1" id="s3309.p0" relation="true"/>
  </sentence>
  <sentence id="s3310" text="Compared to normal tissues, decorin expression was reduced in CRC patients' tumors, while there were increased Met and VEGFA levels.">
    <entity charOffset="76-82" id="s3310.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="119-124" id="s3310.e1" ontology_id="7422" text="VEGFA" type="GENE"/>
    <pair e1="s3310.e0" e2="s3310.e1" id="s3310.p0" relation="true"/>
  </sentence>
  <sentence id="s3311" text="Mutations in a proline-rich-repeat region (PRR) of UBQLN2 cause amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD); however, neither the normal functions of the PRR nor impacts of ALS-associated mutations within it are well understood.">
    <entity charOffset="43-46" id="s3311.e0" ontology_id="10159" text="PRR" type="GENE"/>
    <entity charOffset="100-123" id="s3311.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s3311.e0" e2="s3311.e1" id="s3311.p0" relation="true"/>
  </sentence>
  <sentence id="s3312" text="Mutations in a proline-rich-repeat region (PRR) of UBQLN2 cause amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD); however, neither the normal functions of the PRR nor impacts of ALS-associated mutations within it are well understood.">
    <entity charOffset="51-57" id="s3312.e0" ontology_id="29978" text="UBQLN2" type="GENE"/>
    <entity charOffset="100-123" id="s3312.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s3312.e0" e2="s3312.e1" id="s3312.p0" relation="true"/>
  </sentence>
  <sentence id="s3313" text="Mutations in a proline-rich-repeat region (PRR) of UBQLN2 cause amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD); however, neither the normal functions of the PRR nor impacts of ALS-associated mutations within it are well understood.">
    <entity charOffset="95-98" id="s3313.e0" ontology_id="3483" text="ALS" type="GENE"/>
    <entity charOffset="100-123" id="s3313.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s3313.e0" e2="s3313.e1" id="s3313.p0" relation="false"/>
  </sentence>
  <sentence id="s3314" text="PAK3-related intellectual disability is caused by mutations in the gene encoding the p21-activated kinase (PAK) protein.">
    <entity charOffset="0-4" id="s3314.e0" ontology_id="8874" text="PAK3" type="GENE"/>
    <entity charOffset="13-36" id="s3314.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3314.e0" e2="s3314.e1" id="s3314.p0" relation="true"/>
  </sentence>
  <sentence id="s3315" text="The authors report a patient with a novel PAK3 mutation, who presented with intellectual disability, severe automutilation, and epilepsy.">
    <entity charOffset="42-46" id="s3315.e0" ontology_id="8874" text="PAK3" type="GENE"/>
    <entity charOffset="128-136" id="s3315.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3315.e0" e2="s3315.e1" id="s3315.p0" relation="true"/>
  </sentence>
  <sentence id="s3316" text="This is the first case of PAK3-related intellectual disability presenting with severe self-injury with improvement following treatment.">
    <entity charOffset="26-30" id="s3316.e0" ontology_id="8874" text="PAK3" type="GENE"/>
    <entity charOffset="39-62" id="s3316.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3316.e0" e2="s3316.e1" id="s3316.p0" relation="true"/>
  </sentence>
  <sentence id="s3317" text="Spinal muscular atrophy (SMA) is a lethal autosomal recessive neurological disease characterized by selective degeneration of motor neurons in the spinal cord.">
    <entity charOffset="25-28" id="s3317.e0" ontology_id="6606" text="SMA" type="GENE"/>
    <entity charOffset="42-61" id="s3317.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3317.e0" e2="s3317.e1" id="s3317.p0" relation="true"/>
  </sentence>
  <sentence id="s3318" text="We also highlight NCKAP1 as another compelling candidate in a large family with autosomal dominant mild intellectual disability that fully segregates with a heterozygous truncating variant.">
    <entity charOffset="18-24" id="s3318.e0" ontology_id="10787" text="NCKAP1" type="GENE"/>
    <entity charOffset="104-127" id="s3318.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3318.e0" e2="s3318.e1" id="s3318.p0" relation="true"/>
  </sentence>
  <sentence id="s3319" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s3319.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="143-148" id="s3319.e1" ontology_id="4913" text="NTHL1" type="GENE"/>
    <pair e1="s3319.e0" e2="s3319.e1" id="s3319.p0" relation="true"/>
  </sentence>
  <sentence id="s3320" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s3320.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="150-155" id="s3320.e1" ontology_id="6224" text="RPS20" type="GENE"/>
    <pair e1="s3320.e0" e2="s3320.e1" id="s3320.p0" relation="true"/>
  </sentence>
  <sentence id="s3321" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s3321.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="164-168" id="s3321.e1" ontology_id="22909" text="FAN1" type="GENE"/>
    <pair e1="s3321.e0" e2="s3321.e1" id="s3321.p0" relation="true"/>
  </sentence>
  <sentence id="s3322" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s3322.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="182-186" id="s3322.e1" ontology_id="9184" text="BUB3" type="GENE"/>
    <pair e1="s3322.e0" e2="s3322.e1" id="s3322.p0" relation="true"/>
  </sentence>
  <sentence id="s3323" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s3323.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="188-192" id="s3323.e1" ontology_id="4040" text="LRP6" type="GENE"/>
    <pair e1="s3323.e0" e2="s3323.e1" id="s3323.p0" relation="true"/>
  </sentence>
  <sentence id="s3324" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s3324.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="198-204" id="s3324.e1" ontology_id="5782" text="PTPN12" type="GENE"/>
    <pair e1="s3324.e0" e2="s3324.e1" id="s3324.p0" relation="true"/>
  </sentence>
  <sentence id="s3325" text="Pyridoxine-dependent epilepsy (PDE) is a rare disease characterized by mutations in the lysine degradation gene &lt;i&gt;ALDH7A1&lt;/i&gt; leading to recurrent neonatal seizures, which are uniquely alleviated by high doses of pyridoxine or pyridoxal 5'-phosphate (vitamin B6 vitamers).">
    <entity charOffset="31-34" id="s3325.e0" ontology_id="501" text="PDE" type="GENE"/>
    <entity charOffset="157-165" id="s3325.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s3325.e0" e2="s3325.e1" id="s3325.p0" relation="true"/>
  </sentence>
  <sentence id="s3326" text="Impaired lysine degradation with accumulation of PDE biomarkers, B6 deficiency, and low -aminobutyric acid levels were observed in the &lt;i&gt;aldh7a1&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; larvae, which may play a significant role in the seizure phenotype and PDE pathogenesis.">
    <entity charOffset="49-52" id="s3326.e0" ontology_id="501" text="PDE" type="GENE"/>
    <entity charOffset="214-221" id="s3326.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s3326.e0" e2="s3326.e1" id="s3326.p0" relation="true"/>
  </sentence>
  <sentence id="s3327" text="Impaired lysine degradation with accumulation of PDE biomarkers, B6 deficiency, and low -aminobutyric acid levels were observed in the &lt;i&gt;aldh7a1&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; larvae, which may play a significant role in the seizure phenotype and PDE pathogenesis.">
    <entity charOffset="139-146" id="s3327.e0" ontology_id="501" text="aldh7a1" type="GENE"/>
    <entity charOffset="214-221" id="s3327.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s3327.e0" e2="s3327.e1" id="s3327.p0" relation="true"/>
  </sentence>
  <sentence id="s3328" text="ATP13A2 mutations are rare cause of autosomal recessive juvenile-onset Parkinson disease.">
    <entity charOffset="0-7" id="s3328.e0" ontology_id="23400" text="ATP13A2" type="GENE"/>
    <entity charOffset="36-55" id="s3328.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3328.e0" e2="s3328.e1" id="s3328.p0" relation="true"/>
  </sentence>
  <sentence id="s3329" text="Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and MAPK3, and enrichment of our PSD proteome.">
    <entity charOffset="26-29" id="s3329.e0" ontology_id="6418" text="set" type="GENE"/>
    <entity charOffset="99-112" id="s3329.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s3329.e0" e2="s3329.e1" id="s3329.p0" relation="false"/>
  </sentence>
  <sentence id="s3330" text="Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and MAPK3, and enrichment of our PSD proteome.">
    <entity charOffset="99-112" id="s3330.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="196-204" id="s3330.e1" ontology_id="3008" text="HIST1H1E" type="GENE"/>
    <pair e1="s3330.e0" e2="s3330.e1" id="s3330.p0" relation="true"/>
  </sentence>
  <sentence id="s3331" text="The importance of Akt actions in human physiology is strengthened by the rarity of modifying mutations in their genes and by the devastating impact caused by these mutations on growth and development and in disorders such as cancer.">
    <entity charOffset="18-21" id="s3331.e0" ontology_id="207" text="Akt" type="GENE"/>
    <entity charOffset="225-231" id="s3331.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3331.e0" e2="s3331.e1" id="s3331.p0" relation="true"/>
  </sentence>
  <sentence id="s3332" text="By trio exome sequencing we now identified a novel, homozygous 2kb deletion, partially affecting exon 12 in an adult female with the typical facial gestalt of 3MC syndrome and hearing loss, but without the main feature cleft lip/palate, and without intellectual disability, or short stature.">
    <entity charOffset="3-7" id="s3332.e0" ontology_id="7204" text="trio" type="GENE"/>
    <entity charOffset="176-188" id="s3332.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3332.e0" e2="s3332.e1" id="s3332.p0" relation="true"/>
  </sentence>
  <sentence id="s3333" text="In Japan, 26 mutations in the ATP2A2 gene in 7 pedigrees and 19 sporadic cases with DD have been reported, among which one pedigree and one sporadic case were accompanied by neuropsychiatric symptoms.">
    <entity charOffset="30-36" id="s3333.e0" ontology_id="488" text="ATP2A2" type="GENE"/>
    <entity charOffset="64-72" id="s3333.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3333.e0" e2="s3333.e1" id="s3333.p0" relation="true"/>
  </sentence>
  <sentence id="s3334" text="Zinc finger protein 687 (ZNF687), identified as a C2H2 zinc finger protein, has been found to be mutated and upregulated in giant cell tumor of bone and acute myeloid leukemia, suggesting an oncogenic role for ZNF687 in cancer.">
    <entity charOffset="25-31" id="s3334.e0" ontology_id="57592" text="ZNF687" type="GENE"/>
    <entity charOffset="135-140" id="s3334.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3334.e0" e2="s3334.e1" id="s3334.p0" relation="true"/>
  </sentence>
  <sentence id="s3335" text="Herein, we report that ZNF687 was markedly upregulated in hepatocellular carcinoma (HCC) cell lines and HCC tissues, and was significantly correlated with relapse-free survival in HCC.">
    <entity charOffset="23-29" id="s3335.e0" ontology_id="57592" text="ZNF687" type="GENE"/>
    <entity charOffset="58-82" id="s3335.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3335.e0" e2="s3335.e1" id="s3335.p0" relation="true"/>
  </sentence>
  <sentence id="s3336" text="ZNF687 overexpression greatly enhanced HCC cell capability for tumorsphere formation, invasion and chemoresistance in vitro, whereas inhibiting ZNF687 reduced these capabilities and inhibited HCC cell tumorigenic capability in vivo.">
    <entity charOffset="0-6" id="s3336.e0" ontology_id="57592" text="ZNF687" type="GENE"/>
    <entity charOffset="63-68" id="s3336.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3336.e0" e2="s3336.e1" id="s3336.p0" relation="true"/>
  </sentence>
  <sentence id="s3337" text="ZNF687 overexpression greatly enhanced HCC cell capability for tumorsphere formation, invasion and chemoresistance in vitro, whereas inhibiting ZNF687 reduced these capabilities and inhibited HCC cell tumorigenic capability in vivo.">
    <entity charOffset="39-42" id="s3337.e0" ontology_id="84668" text="HCC" type="GENE"/>
    <entity charOffset="63-68" id="s3337.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3337.e0" e2="s3337.e1" id="s3337.p0" relation="true"/>
  </sentence>
  <sentence id="s3338" text="Importantly, extreme limiting dilution analysis revealed that even 1  10&lt;sup&gt;2&lt;/sup&gt; ZNF687-transduced cells could form tumors in vivo, indicating that ZNF687 contributes to HCC recurrence.">
    <entity charOffset="86-92" id="s3338.e0" ontology_id="57592" text="ZNF687" type="GENE"/>
    <entity charOffset="121-126" id="s3338.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3338.e0" e2="s3338.e1" id="s3338.p0" relation="true"/>
  </sentence>
  <sentence id="s3339" text="Importantly, extreme limiting dilution analysis revealed that even 1  10&lt;sup&gt;2&lt;/sup&gt; ZNF687-transduced cells could form tumors in vivo, indicating that ZNF687 contributes to HCC recurrence.">
    <entity charOffset="121-126" id="s3339.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="175-178" id="s3339.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s3339.e0" e2="s3339.e1" id="s3339.p0" relation="true"/>
  </sentence>
  <sentence id="s3340" text="Further in vitro and in vivo results demonstrated that ALDOA was associated with proliferation and metastasis of pancreatic cancer cells.">
    <entity charOffset="55-60" id="s3340.e0" ontology_id="226" text="ALDOA" type="GENE"/>
    <entity charOffset="124-130" id="s3340.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3340.e0" e2="s3340.e1" id="s3340.p0" relation="true"/>
  </sentence>
  <sentence id="s3341" text="Mechanistically, the role of ALDOA in pancreatic cancer might attribute to its regulation of c-Myc, HIF1 and NRF2 (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.">
    <entity charOffset="29-34" id="s3341.e0" ontology_id="226" text="ALDOA" type="GENE"/>
    <entity charOffset="49-55" id="s3341.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3341.e0" e2="s3341.e1" id="s3341.p0" relation="true"/>
  </sentence>
  <sentence id="s3342" text="Here, we report that hypoxia-inducible factor (HIF-1) and cancer-associated fibroblasts (CAFs)-secreted TGF-2 converge to activate the expression of hedgehog transcription factor GLI2 in CSCs, resulting in increased stemness/dedifferentiation and intrinsic resistance to chemotherapy.">
    <entity charOffset="59-65" id="s3342.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="181-185" id="s3342.e1" ontology_id="2736" text="GLI2" type="GENE"/>
    <pair e1="s3342.e0" e2="s3342.e1" id="s3342.p0" relation="true"/>
  </sentence>
  <sentence id="s3343" text="Importantly, high expression levels of HIF-1/TGF-2/GLI2 correlated robustly with the patient relapse following chemotherapy, highlighting a potential biomarker and therapeutic target for chemoresistance in colorectal cancer.">
    <entity charOffset="53-57" id="s3343.e0" ontology_id="2736" text="GLI2" type="GENE"/>
    <entity charOffset="219-225" id="s3343.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3343.e0" e2="s3343.e1" id="s3343.p0" relation="true"/>
  </sentence>
  <sentence id="s3344" text="RESULTS Overexpression of LINC00665 in patients with HCC was significantly associated with gender, tumor grade, stage, and tumor cell type.">
    <entity charOffset="53-56" id="s3344.e0" ontology_id="84668" text="HCC" type="GENE"/>
    <entity charOffset="99-104" id="s3344.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3344.e0" e2="s3344.e1" id="s3344.p0" relation="true"/>
  </sentence>
  <sentence id="s3345" text="However, the ectopic expression of FSHR was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine tumours).">
    <entity charOffset="35-39" id="s3345.e0" ontology_id="2492" text="FSHR" type="GENE"/>
    <entity charOffset="192-199" id="s3345.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s3345.e0" e2="s3345.e1" id="s3345.p0" relation="true"/>
  </sentence>
  <sentence id="s3346" text="However, the ectopic expression of FSHR was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine tumours).">
    <entity charOffset="35-39" id="s3346.e0" ontology_id="2492" text="FSHR" type="GENE"/>
    <entity charOffset="73-78" id="s3346.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3346.e0" e2="s3346.e1" id="s3346.p0" relation="true"/>
  </sentence>
  <sentence id="s3347" text="The possible involvement of FSHR in tumor progression and the use of FSHR examination for diagnostic purposes is also reviewed.">
    <entity charOffset="28-32" id="s3347.e0" ontology_id="2492" text="FSHR" type="GENE"/>
    <entity charOffset="36-41" id="s3347.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3347.e0" e2="s3347.e1" id="s3347.p0" relation="true"/>
  </sentence>
  <sentence id="s3348" text="All three and two patients with NKX2.1 variants had hypothyroidism and developmental delay, respectively.">
    <entity charOffset="32-38" id="s3348.e0" ontology_id="7080" text="NKX2.1" type="GENE"/>
    <entity charOffset="52-66" id="s3348.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s3348.e0" e2="s3348.e1" id="s3348.p0" relation="true"/>
  </sentence>
  <sentence id="s3349" text="All three and two patients with NKX2.1 variants had hypothyroidism and developmental delay, respectively.">
    <entity charOffset="32-38" id="s3349.e0" ontology_id="7080" text="NKX2.1" type="GENE"/>
    <entity charOffset="71-90" id="s3349.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s3349.e0" e2="s3349.e1" id="s3349.p0" relation="false"/>
  </sentence>
  <sentence id="s3350" text="Similarly, SEPT4 has lymphoid and non-lymphoid forms; SEPT2 has lymphoid and central nervous system (CNS) forms; and SEPT6 and SEPT9 are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.">
    <entity charOffset="54-59" id="s3350.e0" ontology_id="23157" text="SEPT2" type="GENE"/>
    <entity charOffset="77-84" id="s3350.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s3350.e0" e2="s3350.e1" id="s3350.p0" relation="true"/>
  </sentence>
  <sentence id="s3351" text="Similarly, SEPT4 has lymphoid and non-lymphoid forms; SEPT2 has lymphoid and central nervous system (CNS) forms; and SEPT6 and SEPT9 are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.">
    <entity charOffset="77-84" id="s3351.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="117-122" id="s3351.e1" ontology_id="23157" text="SEPT6" type="GENE"/>
    <pair e1="s3351.e0" e2="s3351.e1" id="s3351.p0" relation="true"/>
  </sentence>
  <sentence id="s3352" text="Similarly, SEPT4 has lymphoid and non-lymphoid forms; SEPT2 has lymphoid and central nervous system (CNS) forms; and SEPT6 and SEPT9 are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.">
    <entity charOffset="77-84" id="s3352.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="127-132" id="s3352.e1" ontology_id="10801" text="SEPT9" type="GENE"/>
    <pair e1="s3352.e0" e2="s3352.e1" id="s3352.p0" relation="true"/>
  </sentence>
  <sentence id="s3353" text="Overexpression of LOXL2 and SERPINH1 was observed in clinical specimens of lung cancer and fibrotic lesions.">
    <entity charOffset="18-23" id="s3353.e0" ontology_id="4017" text="LOXL2" type="GENE"/>
    <entity charOffset="80-86" id="s3353.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3353.e0" e2="s3353.e1" id="s3353.p0" relation="true"/>
  </sentence>
  <sentence id="s3354" text="Downregulation of miR-29a caused overexpression of LOXL2 and SERPINH1 in lung cancer and IPF, suggesting that these genes are involved in the pathogenesis of these two diseases">
    <entity charOffset="51-56" id="s3354.e0" ontology_id="4017" text="LOXL2" type="GENE"/>
    <entity charOffset="78-84" id="s3354.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3354.e0" e2="s3354.e1" id="s3354.p0" relation="true"/>
  </sentence>
  <sentence id="s3355" text="The reported enamel abnormality in LAMA3 mutation carriers could be attributed to a half dose effect of the laminin 3 chain (haploinsufficiency)">
    <entity charOffset="13-31" id="s3355.e0" ontology_id="HP_0000682" text="enamel abnormality" type="HP"/>
    <entity charOffset="35-40" id="s3355.e1" ontology_id="3910" text="LAMA3" type="GENE"/>
    <pair e1="s3355.e0" e2="s3355.e1" id="s3355.p0" relation="true"/>
  </sentence>
  <sentence id="s3356" text="Low-density lipoprotein receptor-related protein 4 (LRP4) is a multi-functional protein implicated in bone, kidney and neurological diseases including Cenani-Lenz syndactyly (CLS), sclerosteosis, osteoporosis, congenital myasthenic syndrome and myasthenia gravis.">
    <entity charOffset="52-56" id="s3356.e0" ontology_id="4038" text="LRP4" type="GENE"/>
    <entity charOffset="163-173" id="s3356.e1" ontology_id="HP_0001159" text="syndactyly" type="HP"/>
    <pair e1="s3356.e0" e2="s3356.e1" id="s3356.p0" relation="true"/>
  </sentence>
  <sentence id="s3357" text="This study supports heterogeneity for CDPX1-like phenotypes and sorting these out will help to define the biological pathway and genetic contributors">
    <entity charOffset="20-33" id="s3357.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="38-43" id="s3357.e1" ontology_id="415" text="CDPX1" type="GENE"/>
    <pair e1="s3357.e0" e2="s3357.e1" id="s3357.p0" relation="true"/>
  </sentence>
  <sentence id="s3358" text="BACKGROUND Previous research found that ALG3 is associated with cervical cancer, but the role of ALG3 in breast cancer was still unknown.">
    <entity charOffset="40-44" id="s3358.e0" ontology_id="10195" text="ALG3" type="GENE"/>
    <entity charOffset="73-79" id="s3358.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3358.e0" e2="s3358.e1" id="s3358.p0" relation="true"/>
  </sentence>
  <sentence id="s3359" text="MATERIAL AND METHODS The expression of ALG3 in breast carcinoma tissues was determined by immunochemistry.">
    <entity charOffset="39-43" id="s3359.e0" ontology_id="10195" text="ALG3" type="GENE"/>
    <entity charOffset="47-63" id="s3359.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s3359.e0" e2="s3359.e1" id="s3359.p0" relation="true"/>
  </sentence>
  <sentence id="s3360" text="ALG3 expression was significantly increased in cancer samples with advanced stages (stage III/IV) compared with those in the early stages of disease (stage I/II) (p&amp;lt;0.05).">
    <entity charOffset="0-4" id="s3360.e0" ontology_id="10195" text="ALG3" type="GENE"/>
    <entity charOffset="47-53" id="s3360.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3360.e0" e2="s3360.e1" id="s3360.p0" relation="true"/>
  </sentence>
  <sentence id="s3361" text="The staining intensity of ALG3 was significantly correlated to the tumor grade (grades 2-3 versus 1, p&amp;lt;0.05).">
    <entity charOffset="26-30" id="s3361.e0" ontology_id="10195" text="ALG3" type="GENE"/>
    <entity charOffset="67-72" id="s3361.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3361.e0" e2="s3361.e1" id="s3361.p0" relation="true"/>
  </sentence>
  <sentence id="s3362" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="30-35" id="s3362.e0" ontology_id="27034" text="ACAD8" type="GENE"/>
    <entity charOffset="401-415" id="s3362.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s3362.e0" e2="s3362.e1" id="s3362.p0" relation="true"/>
  </sentence>
  <sentence id="s3363" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="30-35" id="s3363.e0" ontology_id="27034" text="ACAD8" type="GENE"/>
    <entity charOffset="417-425" id="s3363.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3363.e0" e2="s3363.e1" id="s3363.p0" relation="false"/>
  </sentence>
  <sentence id="s3364" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="30-35" id="s3364.e0" ontology_id="27034" text="ACAD8" type="GENE"/>
    <entity charOffset="431-443" id="s3364.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3364.e0" e2="s3364.e1" id="s3364.p0" relation="true"/>
  </sentence>
  <sentence id="s3365" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="85-91" id="s3365.e0" ontology_id="36" text="ACADSB" type="GENE"/>
    <entity charOffset="417-425" id="s3365.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3365.e0" e2="s3365.e1" id="s3365.p0" relation="true"/>
  </sentence>
  <sentence id="s3366" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="85-91" id="s3366.e0" ontology_id="36" text="ACADSB" type="GENE"/>
    <entity charOffset="431-443" id="s3366.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3366.e0" e2="s3366.e1" id="s3366.p0" relation="true"/>
  </sentence>
  <sentence id="s3367" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="129-133" id="s3367.e0" ontology_id="35" text="SCAD" type="GENE"/>
    <entity charOffset="417-425" id="s3367.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3367.e0" e2="s3367.e1" id="s3367.p0" relation="true"/>
  </sentence>
  <sentence id="s3368" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="129-133" id="s3368.e0" ontology_id="35" text="SCAD" type="GENE"/>
    <entity charOffset="431-443" id="s3368.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3368.e0" e2="s3368.e1" id="s3368.p0" relation="false"/>
  </sentence>
  <sentence id="s3369" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="148-151" id="s3369.e0" ontology_id="549" text="AUH" type="GENE"/>
    <entity charOffset="401-415" id="s3369.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s3369.e0" e2="s3369.e1" id="s3369.p0" relation="true"/>
  </sentence>
  <sentence id="s3370" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="148-151" id="s3370.e0" ontology_id="549" text="AUH" type="GENE"/>
    <entity charOffset="431-443" id="s3370.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3370.e0" e2="s3370.e1" id="s3370.p0" relation="false"/>
  </sentence>
  <sentence id="s3371" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="192-197" id="s3371.e0" ontology_id="1717" text="DHCR7" type="GENE"/>
    <entity charOffset="401-415" id="s3371.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s3371.e0" e2="s3371.e1" id="s3371.p0" relation="true"/>
  </sentence>
  <sentence id="s3372" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="192-197" id="s3372.e0" ontology_id="1717" text="DHCR7" type="GENE"/>
    <entity charOffset="417-425" id="s3372.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3372.e0" e2="s3372.e1" id="s3372.p0" relation="true"/>
  </sentence>
  <sentence id="s3373" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="192-197" id="s3373.e0" ontology_id="1717" text="DHCR7" type="GENE"/>
    <entity charOffset="431-443" id="s3373.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3373.e0" e2="s3373.e1" id="s3373.p0" relation="true"/>
  </sentence>
  <sentence id="s3374" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="228-234" id="s3374.e0" ontology_id="3158" text="HMGCS2" type="GENE"/>
    <entity charOffset="417-425" id="s3374.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3374.e0" e2="s3374.e1" id="s3374.p0" relation="true"/>
  </sentence>
  <sentence id="s3375" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="228-234" id="s3375.e0" ontology_id="3158" text="HMGCS2" type="GENE"/>
    <entity charOffset="431-443" id="s3375.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3375.e0" e2="s3375.e1" id="s3375.p0" relation="true"/>
  </sentence>
  <sentence id="s3376" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="291-299" id="s3376.e0" ontology_id="3028" text="HSD17B10" type="GENE"/>
    <entity charOffset="401-415" id="s3376.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s3376.e0" e2="s3376.e1" id="s3376.p0" relation="false"/>
  </sentence>
  <sentence id="s3377" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="353-359" id="s3377.e0" ontology_id="55033" text="FKBP14" type="GENE"/>
    <entity charOffset="401-415" id="s3377.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s3377.e0" e2="s3377.e1" id="s3377.p0" relation="true"/>
  </sentence>
  <sentence id="s3378" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="353-359" id="s3378.e0" ontology_id="55033" text="FKBP14" type="GENE"/>
    <entity charOffset="417-425" id="s3378.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3378.e0" e2="s3378.e1" id="s3378.p0" relation="true"/>
  </sentence>
  <sentence id="s3379" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="353-359" id="s3379.e0" ontology_id="55033" text="FKBP14" type="GENE"/>
    <entity charOffset="431-443" id="s3379.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3379.e0" e2="s3379.e1" id="s3379.p0" relation="true"/>
  </sentence>
  <sentence id="s3380" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="417-425" id="s3380.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="457-462" id="s3380.e1" ontology_id="79641" text="ROGDI" type="GENE"/>
    <pair e1="s3380.e0" e2="s3380.e1" id="s3380.p0" relation="false"/>
  </sentence>
  <sentence id="s3381" text="Homozygous null mutation of tumor suppressor &lt;i&gt;WWOX/Wwox&lt;/i&gt; gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, mice and rats.">
    <entity charOffset="28-33" id="s3381.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="53-57" id="s3381.e1" ontology_id="51741" text="Wwox" type="GENE"/>
    <pair e1="s3381.e0" e2="s3381.e1" id="s3381.p0" relation="true"/>
  </sentence>
  <sentence id="s3382" text="Homozygous null mutation of tumor suppressor &lt;i&gt;WWOX/Wwox&lt;/i&gt; gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, mice and rats.">
    <entity charOffset="28-33" id="s3382.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="163-167" id="s3382.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s3382.e0" e2="s3382.e1" id="s3382.p0" relation="true"/>
  </sentence>
  <sentence id="s3383" text="&lt;i&gt;In vitro&lt;/i&gt; analysis revealed that knockdown of WWOX protein in neuroblastoma cells results in aggregation of TRAPPC6A, TIAF1, amyloid , and Tau in a sequential manner.">
    <entity charOffset="52-56" id="s3383.e0" ontology_id="51741" text="WWOX" type="GENE"/>
    <entity charOffset="68-81" id="s3383.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s3383.e0" e2="s3383.e1" id="s3383.p0" relation="true"/>
  </sentence>
  <sentence id="s3384" text="&lt;i&gt;In vitro&lt;/i&gt; analysis revealed that knockdown of WWOX protein in neuroblastoma cells results in aggregation of TRAPPC6A, TIAF1, amyloid , and Tau in a sequential manner.">
    <entity charOffset="68-81" id="s3384.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="125-130" id="s3384.e1" ontology_id="9220" text="TIAF1" type="GENE"/>
    <pair e1="s3384.e0" e2="s3384.e1" id="s3384.p0" relation="true"/>
  </sentence>
  <sentence id="s3385" text="Down-regulation of PLZF has been found in various tumor cell lines.">
    <entity charOffset="19-23" id="s3385.e0" ontology_id="7704" text="PLZF" type="GENE"/>
    <entity charOffset="50-55" id="s3385.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3385.e0" e2="s3385.e1" id="s3385.p0" relation="false"/>
  </sentence>
  <sentence id="s3386" text="There has been virtually no tissue study on the expression of PLZF in prostate cancer (PCa).">
    <entity charOffset="79-85" id="s3386.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="87-90" id="s3386.e1" ontology_id="28982" text="PCa" type="GENE"/>
    <pair e1="s3386.e0" e2="s3386.e1" id="s3386.p0" relation="true"/>
  </sentence>
  <sentence id="s3387" text="This study aimed to investigate the expression of PLZF by immunohistochemistry in different grade as well as metastatic PCa and to correlate the alteration of PLZF expression with PCa aggressiveness.">
    <entity charOffset="50-54" id="s3387.e0" ontology_id="7704" text="PLZF" type="GENE"/>
    <entity charOffset="184-198" id="s3387.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s3387.e0" e2="s3387.e1" id="s3387.p0" relation="true"/>
  </sentence>
  <sentence id="s3388" text="These data demonstrated that down-regulation of PLZF is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for PCa aggressiveness and metastasis in the personalized care of PCa.">
    <entity charOffset="48-52" id="s3388.e0" ontology_id="7704" text="PLZF" type="GENE"/>
    <entity charOffset="91-96" id="s3388.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3388.e0" e2="s3388.e1" id="s3388.p0" relation="false"/>
  </sentence>
  <sentence id="s3389" text="These data demonstrated that down-regulation of PLZF is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for PCa aggressiveness and metastasis in the personalized care of PCa.">
    <entity charOffset="48-52" id="s3389.e0" ontology_id="7704" text="PLZF" type="GENE"/>
    <entity charOffset="224-238" id="s3389.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s3389.e0" e2="s3389.e1" id="s3389.p0" relation="true"/>
  </sentence>
  <sentence id="s3390" text="These data demonstrated that down-regulation of PLZF is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for PCa aggressiveness and metastasis in the personalized care of PCa.">
    <entity charOffset="91-96" id="s3390.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="220-223" id="s3390.e1" ontology_id="28982" text="PCa" type="GENE"/>
    <pair e1="s3390.e0" e2="s3390.e1" id="s3390.p0" relation="true"/>
  </sentence>
  <sentence id="s3391" text="These data demonstrated that down-regulation of PLZF is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for PCa aggressiveness and metastasis in the personalized care of PCa.">
    <entity charOffset="220-223" id="s3391.e0" ontology_id="28982" text="PCa" type="GENE"/>
    <entity charOffset="224-238" id="s3391.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s3391.e0" e2="s3391.e1" id="s3391.p0" relation="true"/>
  </sentence>
  <sentence id="s3392" text="Abnormalities in nucleic acid processing are associated with the development of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).">
    <entity charOffset="111-114" id="s3392.e0" ontology_id="3483" text="ALS" type="GENE"/>
    <entity charOffset="120-143" id="s3392.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s3392.e0" e2="s3392.e1" id="s3392.p0" relation="true"/>
  </sentence>
  <sentence id="s3393" text="Mutations in &lt;i&gt;Matrin 3&lt;/i&gt; (&lt;i&gt;MATR3&lt;/i&gt;), a poorly understood DNA- and RNA-binding protein, cause familial ALS/FTD, and MATR3 pathology is a feature of sporadic disease, suggesting that MATR3 dysfunction is integrally linked to ALS pathogenesis.">
    <entity charOffset="33-38" id="s3393.e0" ontology_id="9782" text="MATR3" type="GENE"/>
    <entity charOffset="155-163" id="s3393.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3393.e0" e2="s3393.e1" id="s3393.p0" relation="true"/>
  </sentence>
  <sentence id="s3394" text="Mutations in &lt;i&gt;Matrin 3&lt;/i&gt; (&lt;i&gt;MATR3&lt;/i&gt;), a poorly understood DNA- and RNA-binding protein, cause familial ALS/FTD, and MATR3 pathology is a feature of sporadic disease, suggesting that MATR3 dysfunction is integrally linked to ALS pathogenesis.">
    <entity charOffset="110-113" id="s3394.e0" ontology_id="3483" text="ALS" type="GENE"/>
    <entity charOffset="155-163" id="s3394.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3394.e0" e2="s3394.e1" id="s3394.p0" relation="true"/>
  </sentence>
  <sentence id="s3395" text="Peroxisome biogenesis disorders (PBD) are a heterogeneous group of disorders due to PEX genes mutations, with a broad clinical spectrum comprising severe neonatal disease to mild presentation.">
    <entity charOffset="44-57" id="s3395.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="84-87" id="s3395.e1" ontology_id="5251" text="PEX" type="GENE"/>
    <pair e1="s3395.e0" e2="s3395.e1" id="s3395.p0" relation="true"/>
  </sentence>
  <sentence id="s3396" text="MicroRNA-200a (miR-200a) is frequently downregulated in most cancer types and plays an important role in carcinogenesis and cancer progression.">
    <entity charOffset="15-18" id="s3396.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="61-67" id="s3396.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3396.e0" e2="s3396.e1" id="s3396.p0" relation="true"/>
  </sentence>
  <sentence id="s3397" text="In this study, we determined that miR-200a was downregulated in hepatocellular carcinoma (HCC) tissues and cell lines, consistent with the results of our previous study.">
    <entity charOffset="34-37" id="s3397.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="64-88" id="s3397.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3397.e0" e2="s3397.e1" id="s3397.p0" relation="true"/>
  </sentence>
  <sentence id="s3398" text="In this study, we determined that miR-200a was downregulated in hepatocellular carcinoma (HCC) tissues and cell lines, consistent with the results of our previous study.">
    <entity charOffset="64-88" id="s3398.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="90-93" id="s3398.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s3398.e0" e2="s3398.e1" id="s3398.p0" relation="true"/>
  </sentence>
  <sentence id="s3399" text="Taken together, these data provide novel information for comprehending the tumor-suppressive role of miR-200a in HCC pathogenesis through inhibition of GAB1 translation">
    <entity charOffset="75-80" id="s3399.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="101-104" id="s3399.e1" ontology_id="220972" text="miR" type="GENE"/>
    <pair e1="s3399.e0" e2="s3399.e1" id="s3399.p0" relation="true"/>
  </sentence>
  <sentence id="s3400" text="Taken together, these data provide novel information for comprehending the tumor-suppressive role of miR-200a in HCC pathogenesis through inhibition of GAB1 translation">
    <entity charOffset="75-80" id="s3400.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="113-116" id="s3400.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s3400.e0" e2="s3400.e1" id="s3400.p0" relation="true"/>
  </sentence>
  <sentence id="s3401" text="The ability of OX40 to promote proliferation and differentiation of activated T cells fueled present attempts to modulate this immune checkpoint to reinforce antitumor immunity.">
    <entity charOffset="15-19" id="s3401.e0" ontology_id="7293" text="OX40" type="GENE"/>
    <entity charOffset="162-167" id="s3401.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3401.e0" e2="s3401.e1" id="s3401.p0" relation="true"/>
  </sentence>
  <sentence id="s3402" text="The data presented thus not only identify the yet unknown involvement of OX40/OX40L in ALL pathophysiology and NK cell immunosurveillance but also point to the necessity to thoroughly consider the consequences of modulating the OX40/OX40L molecule system beyond its effects on T cells when developing OX40-targeting approaches for cancer immunotherapy">
    <entity charOffset="73-77" id="s3402.e0" ontology_id="7293" text="OX40" type="GENE"/>
    <entity charOffset="331-337" id="s3402.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3402.e0" e2="s3402.e1" id="s3402.p0" relation="true"/>
  </sentence>
  <sentence id="s3403" text="Mutations in PINK1, a mitochondrially targeted serine/threonine kinase, cause autosomal recessive Parkinson's disease (PD).">
    <entity charOffset="13-18" id="s3403.e0" ontology_id="65018" text="PINK1" type="GENE"/>
    <entity charOffset="78-97" id="s3403.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3403.e0" e2="s3403.e1" id="s3403.p0" relation="true"/>
  </sentence>
  <sentence id="s3404" text="We show that signaling through herpes virus entry mediator (HVEM), a member of the tumor necrosis factor (TNF) receptor superfamily, in ILC3 is important for host defense against oral infection with the bacterial pathogen Yersinia enterocolitica.">
    <entity charOffset="60-64" id="s3404.e0" ontology_id="8764" text="HVEM" type="GENE"/>
    <entity charOffset="83-88" id="s3404.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3404.e0" e2="s3404.e1" id="s3404.p0" relation="true"/>
  </sentence>
  <sentence id="s3405" text="Introduction Despite some new treatment possibilities, the improvement in survival rate for hepatocellular carcinoma (HCC) patients is still poor due to late diagnosis.">
    <entity charOffset="92-116" id="s3405.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="118-121" id="s3405.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s3405.e0" e2="s3405.e1" id="s3405.p0" relation="true"/>
  </sentence>
  <sentence id="s3406" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="152-160" id="s3406.e0" ontology_id="2817" text="Glypican" type="GENE"/>
    <entity charOffset="189-212" id="s3406.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3406.e0" e2="s3406.e1" id="s3406.p0" relation="false"/>
  </sentence>
  <sentence id="s3407" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="182-186" id="s3407.e0" ontology_id="1476" text="CSTB" type="GENE"/>
    <entity charOffset="189-212" id="s3407.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3407.e0" e2="s3407.e1" id="s3407.p0" relation="true"/>
  </sentence>
  <sentence id="s3408" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="189-212" id="s3408.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="261-264" id="s3408.e1" ontology_id="3569" text="HGF" type="GENE"/>
    <pair e1="s3408.e0" e2="s3408.e1" id="s3408.p0" relation="true"/>
  </sentence>
  <sentence id="s3409" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="224-229" id="s3409.e0" ontology_id="6317" text="SCCA1" type="GENE"/>
    <entity charOffset="279-285" id="s3409.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3409.e0" e2="s3409.e1" id="s3409.p0" relation="true"/>
  </sentence>
  <sentence id="s3410" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="279-285" id="s3410.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="298-301" id="s3410.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s3410.e0" e2="s3410.e1" id="s3410.p0" relation="true"/>
  </sentence>
  <sentence id="s3411" text="Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="47-52" id="s3411.e0" ontology_id="8443" text="GNPAT" type="GENE"/>
    <entity charOffset="198-206" id="s3411.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3411.e0" e2="s3411.e1" id="s3411.p0" relation="true"/>
  </sentence>
  <sentence id="s3412" text="Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="54-59" id="s3412.e0" ontology_id="7341" text="SUMO1" type="GENE"/>
    <entity charOffset="198-206" id="s3412.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3412.e0" e2="s3412.e1" id="s3412.p0" relation="true"/>
  </sentence>
  <sentence id="s3413" text="Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="61-67" id="s3413.e0" ontology_id="10653" text="SPINT2" type="GENE"/>
    <entity charOffset="198-206" id="s3413.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3413.e0" e2="s3413.e1" id="s3413.p0" relation="true"/>
  </sentence>
  <sentence id="s3414" text="Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="185-189" id="s3414.e0" ontology_id="673" text="BRAF" type="GENE"/>
    <entity charOffset="198-206" id="s3414.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3414.e0" e2="s3414.e1" id="s3414.p0" relation="true"/>
  </sentence>
  <sentence id="s3415" text="Our findings indicate that GNPAT, SUMO1, SPINT2, FLI1, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control">
    <entity charOffset="34-39" id="s3415.e0" ontology_id="7341" text="SUMO1" type="GENE"/>
    <entity charOffset="136-144" id="s3415.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3415.e0" e2="s3415.e1" id="s3415.p0" relation="true"/>
  </sentence>
  <sentence id="s3416" text="Our findings indicate that GNPAT, SUMO1, SPINT2, FLI1, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control">
    <entity charOffset="41-47" id="s3416.e0" ontology_id="10653" text="SPINT2" type="GENE"/>
    <entity charOffset="136-144" id="s3416.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3416.e0" e2="s3416.e1" id="s3416.p0" relation="true"/>
  </sentence>
  <sentence id="s3417" text="Our findings indicate that GNPAT, SUMO1, SPINT2, FLI1, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control">
    <entity charOffset="59-63" id="s3417.e0" ontology_id="6756" text="SSX1" type="GENE"/>
    <entity charOffset="136-144" id="s3417.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3417.e0" e2="s3417.e1" id="s3417.p0" relation="true"/>
  </sentence>
  <sentence id="s3418" text="We conducted a cis-expression quantitative trait loci (cis-eQTL) analysis using normal or tumor breast transcriptome data from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), The Cancer Genome Atlas (TCGA), and the Genotype-Tissue Expression (GTEx) project.">
    <entity charOffset="15-18" id="s3418.e0" ontology_id="1154" text="cis" type="GENE"/>
    <entity charOffset="90-95" id="s3418.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3418.e0" e2="s3418.e1" id="s3418.p0" relation="true"/>
  </sentence>
  <sentence id="s3419" text="Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that DCLRE1B, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.">
    <entity charOffset="52-58" id="s3419.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="111-117" id="s3419.e1" ontology_id="10884" text="MRPS30" type="GENE"/>
    <pair e1="s3419.e0" e2="s3419.e1" id="s3419.p0" relation="true"/>
  </sentence>
  <sentence id="s3420" text="Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that DCLRE1B, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.">
    <entity charOffset="52-58" id="s3420.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="123-128" id="s3420.e1" ontology_id="83734" text="ATG10" type="GENE"/>
    <pair e1="s3420.e0" e2="s3420.e1" id="s3420.p0" relation="true"/>
  </sentence>
  <sentence id="s3421" text="Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that DCLRE1B, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.">
    <entity charOffset="111-117" id="s3421.e0" ontology_id="10884" text="MRPS30" type="GENE"/>
    <entity charOffset="159-164" id="s3421.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3421.e0" e2="s3421.e1" id="s3421.p0" relation="true"/>
  </sentence>
  <sentence id="s3422" text="PDSS2 is a putative tumor suppressor, and promoter hypermethylation is a key regulatory mechanism in HCC.">
    <entity charOffset="0-5" id="s3422.e0" ontology_id="57107" text="PDSS2" type="GENE"/>
    <entity charOffset="20-25" id="s3422.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3422.e0" e2="s3422.e1" id="s3422.p0" relation="true"/>
  </sentence>
  <sentence id="s3423" text="Mutations in UBQLN2 have been associated with rare cases of X-linked juvenile and adult forms of amyotrophic lateral sclerosis (ALS) and ALS linked to frontotemporal dementia (FTD).">
    <entity charOffset="13-19" id="s3423.e0" ontology_id="29978" text="UBQLN2" type="GENE"/>
    <entity charOffset="151-174" id="s3423.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s3423.e0" e2="s3423.e1" id="s3423.p0" relation="true"/>
  </sentence>
  <sentence id="s3424" text="A novel missense mutation (c.1462G&amp;gt;A, p.Ala488Thr, A488T) adjacent to this hotspot UBQLN2 domain was identified in a sporadic case of ALS.">
    <entity charOffset="86-92" id="s3424.e0" ontology_id="29978" text="UBQLN2" type="GENE"/>
    <entity charOffset="120-128" id="s3424.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3424.e0" e2="s3424.e1" id="s3424.p0" relation="true"/>
  </sentence>
  <sentence id="s3425" text="Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.">
    <entity charOffset="64-83" id="s3425.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="85-89" id="s3425.e1" ontology_id="5837" text="PYGM" type="GENE"/>
    <pair e1="s3425.e0" e2="s3425.e1" id="s3425.p0" relation="true"/>
  </sentence>
  <sentence id="s3426" text="Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.">
    <entity charOffset="64-83" id="s3426.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="129-135" id="s3426.e1" ontology_id="6535" text="SLC6A8" type="GENE"/>
    <pair e1="s3426.e0" e2="s3426.e1" id="s3426.p0" relation="true"/>
  </sentence>
  <sentence id="s3427" text="We hypothesized that heterozygous variants in PRDM5 and ZNF469 predispose to the development of isolated keratoconus.">
    <entity charOffset="46-51" id="s3427.e0" ontology_id="11107" text="PRDM5" type="GENE"/>
    <entity charOffset="105-116" id="s3427.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s3427.e0" e2="s3427.e1" id="s3427.p0" relation="true"/>
  </sentence>
  <sentence id="s3428" text="We hypothesized that heterozygous variants in PRDM5 and ZNF469 predispose to the development of isolated keratoconus.">
    <entity charOffset="56-62" id="s3428.e0" ontology_id="84627" text="ZNF469" type="GENE"/>
    <entity charOffset="105-116" id="s3428.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s3428.e0" e2="s3428.e1" id="s3428.p0" relation="true"/>
  </sentence>
  <sentence id="s3429" text="We found a significant enrichment of potentially pathologic heterozygous alleles in ZNF469 associated with the development of keratoconus (P = 0.00102) resulting in a relative risk of 12.0.">
    <entity charOffset="84-90" id="s3429.e0" ontology_id="84627" text="ZNF469" type="GENE"/>
    <entity charOffset="126-137" id="s3429.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s3429.e0" e2="s3429.e1" id="s3429.p0" relation="true"/>
  </sentence>
  <sentence id="s3430" text="This enrichment of rare potentially pathogenic alleles in ZNF469 in 12.5% of keratoconus patients represents a significant mutational load and highlights ZNF469 as the most significant genetic factor responsible for keratoconus identified to date.">
    <entity charOffset="58-64" id="s3430.e0" ontology_id="84627" text="ZNF469" type="GENE"/>
    <entity charOffset="77-88" id="s3430.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s3430.e0" e2="s3430.e1" id="s3430.p0" relation="true"/>
  </sentence>
  <sentence id="s3431" text="Integration of cell culture genomes, transcriptomes and tumour phenotypes with functional studies and human data reveals additional widespread effects of oncogenic dosage variation on cell morphology and plasticity, histopathology and clinical outcome, with the highest Kras&lt;sup&gt;MUT&lt;/sup&gt; levels underlying aggressive undifferentiated phenotypes.">
    <entity charOffset="56-62" id="s3431.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="270-274" id="s3431.e1" ontology_id="3845" text="Kras" type="GENE"/>
    <pair e1="s3431.e0" e2="s3431.e1" id="s3431.p0" relation="true"/>
  </sentence>
  <sentence id="s3432" text="Mechanistically, different oncogenic gains and dosages evolve along distinct evolutionary routes, licensed by defined allelic states and/or combinations of hallmark tumour suppressor alterations (Cdkn2a, Trp53, Tgf-pathway).">
    <entity charOffset="165-171" id="s3432.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="196-202" id="s3432.e1" ontology_id="1029" text="Cdkn2a" type="GENE"/>
    <pair e1="s3432.e0" e2="s3432.e1" id="s3432.p0" relation="true"/>
  </sentence>
  <sentence id="s3433" text="Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (ACTH)-independent macronodular adrenal hyperplasia, is a rare type of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.">
    <entity charOffset="21-40" id="s3433.e0" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <entity charOffset="141-145" id="s3433.e1" ontology_id="5443" text="ACTH" type="GENE"/>
    <pair e1="s3433.e0" e2="s3433.e1" id="s3433.p0" relation="true"/>
  </sentence>
  <sentence id="s3434" text="Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (ACTH)-independent macronodular adrenal hyperplasia, is a rare type of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.">
    <entity charOffset="21-40" id="s3434.e0" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <entity charOffset="203-207" id="s3434.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s3434.e0" e2="s3434.e1" id="s3434.p0" relation="true"/>
  </sentence>
  <sentence id="s3435" text="Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (ACTH)-independent macronodular adrenal hyperplasia, is a rare type of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.">
    <entity charOffset="75-84" id="s3435.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="141-145" id="s3435.e1" ontology_id="5443" text="ACTH" type="GENE"/>
    <pair e1="s3435.e0" e2="s3435.e1" id="s3435.p0" relation="true"/>
  </sentence>
  <sentence id="s3436" text="In addition, haploid clone of tumor DNA was confirmed by germline mutation and somaticmutation, which suggested the pathogenic mechanism of &amp;quot;two-hit-model.&amp;quot; ARMC5 was the causative gene of AIMAH pedigrees.">
    <entity charOffset="30-35" id="s3436.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="167-172" id="s3436.e1" ontology_id="79798" text="ARMC5" type="GENE"/>
    <pair e1="s3436.e0" e2="s3436.e1" id="s3436.p0" relation="true"/>
  </sentence>
  <sentence id="s3437" text="Extensive IDS gene deletions were identified in four patients; using DNA microarray analysis two patients showed the loss of the entire AFF2 gene, and epilepsy developed in only one of them.">
    <entity charOffset="136-140" id="s3437.e0" ontology_id="2334" text="AFF2" type="GENE"/>
    <entity charOffset="151-159" id="s3437.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3437.e0" e2="s3437.e1" id="s3437.p0" relation="false"/>
  </sentence>
  <sentence id="s3438" text="Wide allelic heterogeneity was noted, with large gene alterations (e.g. IDS/IDSP1 gene inversions, partial to extensive IDS deletions, and one chimeric IDS-IDSP1 allele) that occurred at higher frequencies than previously reported (36% vs 18.9-29%).">
    <entity charOffset="13-26" id="s3438.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="72-75" id="s3438.e1" ontology_id="3423" text="IDS" type="GENE"/>
    <pair e1="s3438.e0" e2="s3438.e1" id="s3438.p0" relation="true"/>
  </sentence>
  <sentence id="s3439" text="Our findings suggest a wide allelic heterogeneity in Mexican MPSII patients; DNA microarray analysis contributes to further delineation of the resulting phenotype for IDS and neighboring loci deletions">
    <entity charOffset="36-49" id="s3439.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="167-170" id="s3439.e1" ontology_id="3423" text="IDS" type="GENE"/>
    <pair e1="s3439.e0" e2="s3439.e1" id="s3439.p0" relation="true"/>
  </sentence>
  <sentence id="s3440" text="Norepinephrine transporter (NET) transfection leads to significant uptake of iodine-131-labeled metaiodobenzylguanidine (&lt;sup&gt;131&lt;/sup&gt;I-MIBG) in non-neuroendocrine tumors.">
    <entity charOffset="28-31" id="s3440.e0" ontology_id="2004" text="NET" type="GENE"/>
    <entity charOffset="165-171" id="s3440.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3440.e0" e2="s3440.e1" id="s3440.p0" relation="true"/>
  </sentence>
  <sentence id="s3441" text="We evaluated the uptake and efflux of &lt;sup&gt;131&lt;/sup&gt;I-MIBG both in vitro and in vivo in mice bearing transfected tumors.">
    <entity charOffset="88-92" id="s3441.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="113-119" id="s3441.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3441.e0" e2="s3441.e1" id="s3441.p0" relation="true"/>
  </sentence>
  <sentence id="s3442" text="In vivo experiments were performed in nude mice bearing transfected tumors; results revealed that NET-VMAT2-coexpressing tumors had longer &lt;sup&gt;131&lt;/sup&gt;I-MIBG retention time than NET-expressing tumors.">
    <entity charOffset="38-42" id="s3442.e0" ontology_id="54820" text="nude" type="GENE"/>
    <entity charOffset="68-74" id="s3442.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3442.e0" e2="s3442.e1" id="s3442.p0" relation="true"/>
  </sentence>
  <sentence id="s3443" text="In vivo experiments were performed in nude mice bearing transfected tumors; results revealed that NET-VMAT2-coexpressing tumors had longer &lt;sup&gt;131&lt;/sup&gt;I-MIBG retention time than NET-expressing tumors.">
    <entity charOffset="68-74" id="s3443.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="98-101" id="s3443.e1" ontology_id="2004" text="NET" type="GENE"/>
    <pair e1="s3443.e0" e2="s3443.e1" id="s3443.p0" relation="true"/>
  </sentence>
  <sentence id="s3444" text="Meanwhile, NET-VMAT2-coexpressing and NET-expressing tumors displayed 0.54% and 0.19%, respectively, of the injected dose per gram of tissue 24 h after &lt;sup&gt;131&lt;/sup&gt;I-MIBG administration.">
    <entity charOffset="11-14" id="s3444.e0" ontology_id="2004" text="NET" type="GENE"/>
    <entity charOffset="53-59" id="s3444.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3444.e0" e2="s3444.e1" id="s3444.p0" relation="true"/>
  </sentence>
  <sentence id="s3445" text="Meanwhile, NET-VMAT2-coexpressing and NET-expressing tumors displayed 0.54% and 0.19%, respectively, of the injected dose per gram of tissue 24 h after &lt;sup&gt;131&lt;/sup&gt;I-MIBG administration.">
    <entity charOffset="15-20" id="s3445.e0" ontology_id="6571" text="VMAT2" type="GENE"/>
    <entity charOffset="53-59" id="s3445.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3445.e0" e2="s3445.e1" id="s3445.p0" relation="true"/>
  </sentence>
  <sentence id="s3446" text="&lt;b&gt;Result:&lt;/b&gt; Three mutant genes (PTPN11 gene in chromosome 12, RIT1 gene in chromosome 1 and RAF1 gene in chromosome 3) in five cases all had been reported to be related to hypertrophic cardiomyopathy.">
    <entity charOffset="35-41" id="s3446.e0" ontology_id="5781" text="PTPN11" type="GENE"/>
    <entity charOffset="188-202" id="s3446.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s3446.e0" e2="s3446.e1" id="s3446.p0" relation="true"/>
  </sentence>
  <sentence id="s3447" text="&lt;b&gt;Result:&lt;/b&gt; Three mutant genes (PTPN11 gene in chromosome 12, RIT1 gene in chromosome 1 and RAF1 gene in chromosome 3) in five cases all had been reported to be related to hypertrophic cardiomyopathy.">
    <entity charOffset="65-69" id="s3447.e0" ontology_id="6016" text="RIT1" type="GENE"/>
    <entity charOffset="188-202" id="s3447.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s3447.e0" e2="s3447.e1" id="s3447.p0" relation="true"/>
  </sentence>
  <sentence id="s3448" text="&lt;b&gt;Result:&lt;/b&gt; Three mutant genes (PTPN11 gene in chromosome 12, RIT1 gene in chromosome 1 and RAF1 gene in chromosome 3) in five cases all had been reported to be related to hypertrophic cardiomyopathy.">
    <entity charOffset="95-99" id="s3448.e0" ontology_id="5894" text="RAF1" type="GENE"/>
    <entity charOffset="188-202" id="s3448.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s3448.e0" e2="s3448.e1" id="s3448.p0" relation="true"/>
  </sentence>
  <sentence id="s3449" text="The reported hypertrophic cardiomyopathy relevant genes MYPN, MYH6 and MYBP3 had also been found in case 1 and 2.">
    <entity charOffset="26-40" id="s3449.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="56-60" id="s3449.e1" ontology_id="84665" text="MYPN" type="GENE"/>
    <pair e1="s3449.e0" e2="s3449.e1" id="s3449.p0" relation="true"/>
  </sentence>
  <sentence id="s3450" text="Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3hub genes (FTH1, GRM1 and DDIT3).">
    <entity charOffset="79-85" id="s3450.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="305-308" id="s3450.e1" ontology_id="1993" text="hub" type="GENE"/>
    <pair e1="s3450.e0" e2="s3450.e1" id="s3450.p0" relation="false"/>
  </sentence>
  <sentence id="s3451" text="Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3hub genes (FTH1, GRM1 and DDIT3).">
    <entity charOffset="79-85" id="s3451.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="316-320" id="s3451.e1" ontology_id="2495" text="FTH1" type="GENE"/>
    <pair e1="s3451.e0" e2="s3451.e1" id="s3451.p0" relation="true"/>
  </sentence>
  <sentence id="s3452" text="Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3hub genes (FTH1, GRM1 and DDIT3).">
    <entity charOffset="79-85" id="s3452.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="331-336" id="s3452.e1" ontology_id="1649" text="DDIT3" type="GENE"/>
    <pair e1="s3452.e0" e2="s3452.e1" id="s3452.p0" relation="false"/>
  </sentence>
  <sentence id="s3453" text="As a result, patients with LAD suffer from severe bacterial infections and impaired wound healing, accompanied by neutrophilia.">
    <entity charOffset="27-30" id="s3453.e0" ontology_id="1738" text="LAD" type="GENE"/>
    <entity charOffset="114-126" id="s3453.e1" ontology_id="HP_0011897" text="neutrophilia" type="HP"/>
    <pair e1="s3453.e0" e2="s3453.e1" id="s3453.p0" relation="true"/>
  </sentence>
  <sentence id="s3454" text="But the role of MFAP5 in breast cancer remains unclear.">
    <entity charOffset="16-21" id="s3454.e0" ontology_id="8076" text="MFAP5" type="GENE"/>
    <entity charOffset="32-38" id="s3454.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3454.e0" e2="s3454.e1" id="s3454.p0" relation="true"/>
  </sentence>
  <sentence id="s3455" text="Functionally, MFAP5 overexpression accelerated breast cancer cell proliferation and migration, while an opposite effect was observed when MFAP5 was knocked down.">
    <entity charOffset="14-19" id="s3455.e0" ontology_id="8076" text="MFAP5" type="GENE"/>
    <entity charOffset="54-60" id="s3455.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3455.e0" e2="s3455.e1" id="s3455.p0" relation="true"/>
  </sentence>
  <sentence id="s3456" text="These findings may provide a better understanding about the mechanism of breast cancer and suggest that MFAP5 may be a potential prognostic biomarker and therapeutic target for breast cancer, especially for bone metastasis of breast cancer">
    <entity charOffset="80-86" id="s3456.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="104-109" id="s3456.e1" ontology_id="8076" text="MFAP5" type="GENE"/>
    <pair e1="s3456.e0" e2="s3456.e1" id="s3456.p0" relation="true"/>
  </sentence>
  <sentence id="s3457" text="In the gene expression and network-level information, we revealed significant alterations of molecules related to HIF1 and metabolic pathways in the hypoxic-conditioned lung cancer cells.">
    <entity charOffset="114-118" id="s3457.e0" ontology_id="3091" text="HIF1" type="GENE"/>
    <entity charOffset="174-180" id="s3457.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3457.e0" e2="s3457.e1" id="s3457.p0" relation="true"/>
  </sentence>
  <sentence id="s3458" text="We also observed that GBE1 and HK2 are downstream of HIF1 pathway important in hypoxia-conditioned lung cancer cell.">
    <entity charOffset="22-26" id="s3458.e0" ontology_id="2632" text="GBE1" type="GENE"/>
    <entity charOffset="104-110" id="s3458.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3458.e0" e2="s3458.e1" id="s3458.p0" relation="true"/>
  </sentence>
  <sentence id="s3459" text="We also observed that GBE1 and HK2 are downstream of HIF1 pathway important in hypoxia-conditioned lung cancer cell.">
    <entity charOffset="53-57" id="s3459.e0" ontology_id="3091" text="HIF1" type="GENE"/>
    <entity charOffset="104-110" id="s3459.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3459.e0" e2="s3459.e1" id="s3459.p0" relation="true"/>
  </sentence>
  <sentence id="s3460" text="Furthermore, we used publicly available datasets to validate that the late-stage lung adenocarcinoma patients showed higher expression HK2 and GBE1 than early-stage ones.">
    <entity charOffset="81-100" id="s3460.e0" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <entity charOffset="143-147" id="s3460.e1" ontology_id="2632" text="GBE1" type="GENE"/>
    <pair e1="s3460.e0" e2="s3460.e1" id="s3460.p0" relation="true"/>
  </sentence>
  <sentence id="s3461" text="In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (RPL9), RPL5, RPS20, RPL23, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE">
    <entity charOffset="177-181" id="s3461.e0" ontology_id="6133" text="RPL9" type="GENE"/>
    <entity charOffset="208-213" id="s3461.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3461.e0" e2="s3461.e1" id="s3461.p0" relation="false"/>
  </sentence>
  <sentence id="s3462" text="In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (RPL9), RPL5, RPS20, RPL23, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE">
    <entity charOffset="184-188" id="s3462.e0" ontology_id="6125" text="RPL5" type="GENE"/>
    <entity charOffset="208-213" id="s3462.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3462.e0" e2="s3462.e1" id="s3462.p0" relation="true"/>
  </sentence>
  <sentence id="s3463" text="In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (RPL9), RPL5, RPS20, RPL23, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE">
    <entity charOffset="190-195" id="s3463.e0" ontology_id="6224" text="RPS20" type="GENE"/>
    <entity charOffset="208-213" id="s3463.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3463.e0" e2="s3463.e1" id="s3463.p0" relation="false"/>
  </sentence>
  <sentence id="s3464" text="In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (RPL9), RPL5, RPS20, RPL23, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE">
    <entity charOffset="197-202" id="s3464.e0" ontology_id="9349" text="RPL23" type="GENE"/>
    <entity charOffset="208-213" id="s3464.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3464.e0" e2="s3464.e1" id="s3464.p0" relation="true"/>
  </sentence>
  <sentence id="s3465" text="The sisters reported here display the distinguishing clinical features of WABS: pre- and post-natal growth restriction, microcephaly, intellectual disability, sensorineural hearing loss with cochlear abnormalities, and facial dysmorphic features.">
    <entity charOffset="74-78" id="s3465.e0" ontology_id="1663" text="WABS" type="GENE"/>
    <entity charOffset="120-132" id="s3465.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3465.e0" e2="s3465.e1" id="s3465.p0" relation="true"/>
  </sentence>
  <sentence id="s3466" text="Schwartz-Jampel syndrome type 1 (SJS1) is a rare autosomal recessive disease caused by mutations in the gene heparan sulfate proteoglycan 2 (HSPG2; also known as basement membranespecific heparin sulfate).">
    <entity charOffset="49-68" id="s3466.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="141-146" id="s3466.e1" ontology_id="3339" text="HSPG2" type="GENE"/>
    <pair e1="s3466.e0" e2="s3466.e1" id="s3466.p0" relation="true"/>
  </sentence>
  <sentence id="s3467" text="The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.">
    <entity charOffset="46-50" id="s3467.e0" ontology_id="3339" text="SJS1" type="GENE"/>
    <entity charOffset="60-73" id="s3467.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s3467.e0" e2="s3467.e1" id="s3467.p0" relation="true"/>
  </sentence>
  <sentence id="s3468" text="The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.">
    <entity charOffset="46-50" id="s3468.e0" ontology_id="3339" text="SJS1" type="GENE"/>
    <entity charOffset="81-93" id="s3468.e1" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <pair e1="s3468.e0" e2="s3468.e1" id="s3468.p0" relation="true"/>
  </sentence>
  <sentence id="s3469" text="The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.">
    <entity charOffset="46-50" id="s3469.e0" ontology_id="3339" text="SJS1" type="GENE"/>
    <entity charOffset="114-122" id="s3469.e1" ontology_id="HP_0002486" text="myotonia" type="HP"/>
    <pair e1="s3469.e0" e2="s3469.e1" id="s3469.p0" relation="true"/>
  </sentence>
  <sentence id="s3470" text="In ALDH&lt;sup&gt;+&lt;/sup&gt;CD24&lt;sup&gt;-&lt;/sup&gt;CD44&lt;sup&gt;+&lt;/sup&gt; BCSCs, we identified P4HA2, PTGR1 and RAB40B as potential prognostic markers, which were virtually related to the status of BCSCs and tumor growth in TNBC cells">
    <entity charOffset="80-85" id="s3470.e0" ontology_id="22949" text="PTGR1" type="GENE"/>
    <entity charOffset="186-191" id="s3470.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3470.e0" e2="s3470.e1" id="s3470.p0" relation="true"/>
  </sentence>
  <sentence id="s3471" text="Missense mutations in SCN2A (p.Leu1342Pro) and KCNQ2 (p.Ala306Thr) were found in two patients with no history of epilepsy before the onset of ISs.">
    <entity charOffset="22-27" id="s3471.e0" ontology_id="6326" text="SCN2A" type="GENE"/>
    <entity charOffset="113-121" id="s3471.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3471.e0" e2="s3471.e1" id="s3471.p0" relation="true"/>
  </sentence>
  <sentence id="s3472" text="The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="12-16" id="s3472.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="190-209" id="s3472.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s3472.e0" e2="s3472.e1" id="s3472.p0" relation="false"/>
  </sentence>
  <sentence id="s3473" text="The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="100-106" id="s3473.e0" ontology_id="51010" text="EXOSC3" type="GENE"/>
    <entity charOffset="190-209" id="s3473.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s3473.e0" e2="s3473.e1" id="s3473.p0" relation="true"/>
  </sentence>
  <sentence id="s3474" text="The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="100-106" id="s3474.e0" ontology_id="51010" text="EXOSC3" type="GENE"/>
    <entity charOffset="222-240" id="s3474.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s3474.e0" e2="s3474.e1" id="s3474.p0" relation="true"/>
  </sentence>
  <sentence id="s3475" text="The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="110-118" id="s3475.e0" ontology_id="91137" text="SLC25A46" type="GENE"/>
    <entity charOffset="190-209" id="s3475.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s3475.e0" e2="s3475.e1" id="s3475.p0" relation="true"/>
  </sentence>
  <sentence id="s3476" text="The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="110-118" id="s3476.e0" ontology_id="91137" text="SLC25A46" type="GENE"/>
    <entity charOffset="222-240" id="s3476.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s3476.e0" e2="s3476.e1" id="s3476.p0" relation="true"/>
  </sentence>
  <sentence id="s3477" text="The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="110-118" id="s3477.e0" ontology_id="91137" text="SLC25A46" type="GENE"/>
    <entity charOffset="286-299" id="s3477.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s3477.e0" e2="s3477.e1" id="s3477.p0" relation="true"/>
  </sentence>
  <sentence id="s3478" text="The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="136-139" id="s3478.e0" ontology_id="6606" text="SMA" type="GENE"/>
    <entity charOffset="258-270" id="s3478.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3478.e0" e2="s3478.e1" id="s3478.p0" relation="true"/>
  </sentence>
  <sentence id="s3479" text="The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="136-139" id="s3479.e0" ontology_id="6606" text="SMA" type="GENE"/>
    <entity charOffset="286-299" id="s3479.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s3479.e0" e2="s3479.e1" id="s3479.p0" relation="true"/>
  </sentence>
  <sentence id="s3480" text="Mutations with milder presentation (homozygous p.D132A/EXOSC3 or VRK1) may display additionally signs of upper motor neuron impairment, dystonia or ataxia and die at age between 5 and 18 years.">
    <entity charOffset="55-61" id="s3480.e0" ontology_id="51010" text="EXOSC3" type="GENE"/>
    <entity charOffset="148-154" id="s3480.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3480.e0" e2="s3480.e1" id="s3480.p0" relation="true"/>
  </sentence>
  <sentence id="s3481" text="Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.">
    <entity charOffset="23-28" id="s3481.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="196-199" id="s3481.e1" ontology_id="2108" text="EMA" type="GENE"/>
    <pair e1="s3481.e0" e2="s3481.e1" id="s3481.p0" relation="false"/>
  </sentence>
  <sentence id="s3482" text="Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.">
    <entity charOffset="23-28" id="s3482.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="204-209" id="s3482.e1" ontology_id="6752" text="SSTR2" type="GENE"/>
    <pair e1="s3482.e0" e2="s3482.e1" id="s3482.p0" relation="true"/>
  </sentence>
  <sentence id="s3483" text="Reported susceptibility SNPs for narcolepsy in the Japanese population, CPT1B (carnitine palmitoyltransferase 1B), TRA@ (T-cell receptor alpha) and P2RY11 (purinergic receptor P2Y, G-protein coupled, 11), were found to explain 0.8% of narcolepsy onset (P&lt;sub&gt;whole genome without HLA-DQB1*06:02&lt;/sub&gt;=9.74  10&lt;sup&gt;-2&lt;/sup&gt;).">
    <entity charOffset="33-43" id="s3483.e0" ontology_id="HP_0030050" text="narcolepsy" type="HP"/>
    <entity charOffset="72-77" id="s3483.e1" ontology_id="1375" text="CPT1B" type="GENE"/>
    <pair e1="s3483.e0" e2="s3483.e1" id="s3483.p0" relation="true"/>
  </sentence>
  <sentence id="s3484" text="In addition, splicing variants of CIZ1 mRNA is associated with a variety of cancers and Alzheimer's disease, and mutations of the CIZ1 gene lead to cervical dystonia.">
    <entity charOffset="34-38" id="s3484.e0" ontology_id="25792" text="CIZ1" type="GENE"/>
    <entity charOffset="148-165" id="s3484.e1" ontology_id="HP_0000473" text="cervical dystonia" type="HP"/>
    <pair e1="s3484.e0" e2="s3484.e1" id="s3484.p0" relation="true"/>
  </sentence>
  <sentence id="s3485" text="A putative tumor suppressor BLU mapped on the chromosomal 3p21 region, is frequently lost in human tumors including nasopharyngeal carcinoma (NPC).">
    <entity charOffset="11-16" id="s3485.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="28-31" id="s3485.e1" ontology_id="51364" text="BLU" type="GENE"/>
    <pair e1="s3485.e0" e2="s3485.e1" id="s3485.p0" relation="true"/>
  </sentence>
  <sentence id="s3486" text="To explore the underlying mechanism of tumor suppression by BLU, its potential to promote apoptosis induced by TRAIL, an effector molecule elaborated by natural killer-T (NKT) cells was investigated.">
    <entity charOffset="39-44" id="s3486.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="111-116" id="s3486.e1" ontology_id="8743" text="TRAIL" type="GENE"/>
    <pair e1="s3486.e0" e2="s3486.e1" id="s3486.p0" relation="true"/>
  </sentence>
  <sentence id="s3487" text="In conclusion, BLU suppressed tumor formation by strengthening the antitumor immunity">
    <entity charOffset="15-18" id="s3487.e0" ontology_id="51364" text="BLU" type="GENE"/>
    <entity charOffset="30-35" id="s3487.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3487.e0" e2="s3487.e1" id="s3487.p0" relation="true"/>
  </sentence>
  <sentence id="s3488" text="Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (DCTN4), retinoic acid early transcript 1E (RAET1E), and V-akt murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal meningitis.">
    <entity charOffset="159-164" id="s3488.e0" ontology_id="51164" text="DCTN4" type="GENE"/>
    <entity charOffset="341-351" id="s3488.e1" ontology_id="HP_0001287" text="meningitis" type="HP"/>
    <pair e1="s3488.e0" e2="s3488.e1" id="s3488.p0" relation="true"/>
  </sentence>
  <sentence id="s3489" text="Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (DCTN4), retinoic acid early transcript 1E (RAET1E), and V-akt murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal meningitis.">
    <entity charOffset="202-208" id="s3489.e0" ontology_id="135250" text="RAET1E" type="GENE"/>
    <entity charOffset="341-351" id="s3489.e1" ontology_id="HP_0001287" text="meningitis" type="HP"/>
    <pair e1="s3489.e0" e2="s3489.e1" id="s3489.p0" relation="true"/>
  </sentence>
  <sentence id="s3490" text="Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (DCTN4), retinoic acid early transcript 1E (RAET1E), and V-akt murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal meningitis.">
    <entity charOffset="217-220" id="s3490.e0" ontology_id="207" text="akt" type="GENE"/>
    <entity charOffset="341-351" id="s3490.e1" ontology_id="HP_0001287" text="meningitis" type="HP"/>
    <pair e1="s3490.e0" e2="s3490.e1" id="s3490.p0" relation="true"/>
  </sentence>
  <sentence id="s3491" text="No clinical replication cohort is available, so we validated the role of one of these targets, AKT3, in a pneumococcal meningitis mouse model.">
    <entity charOffset="95-99" id="s3491.e0" ontology_id="10000" text="AKT3" type="GENE"/>
    <entity charOffset="119-129" id="s3491.e1" ontology_id="HP_0001287" text="meningitis" type="HP"/>
    <pair e1="s3491.e0" e2="s3491.e1" id="s3491.p0" relation="true"/>
  </sentence>
  <sentence id="s3492" text="Here we identify a set of genes that is highly expressed in breast cancer bone metastasis and activated by ZEB1.">
    <entity charOffset="67-73" id="s3492.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="107-111" id="s3492.e1" ontology_id="6935" text="ZEB1" type="GENE"/>
    <pair e1="s3492.e0" e2="s3492.e1" id="s3492.p0" relation="true"/>
  </sentence>
  <sentence id="s3493" text="We here demonstrate that the expression of ZEB1 and BMP-inhibitors is correlated with bone metastasis, but not with brain or lung metastasis of breast cancer patients.">
    <entity charOffset="43-47" id="s3493.e0" ontology_id="6935" text="ZEB1" type="GENE"/>
    <entity charOffset="151-157" id="s3493.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3493.e0" e2="s3493.e1" id="s3493.p0" relation="false"/>
  </sentence>
  <sentence id="s3494" text="Identifying the central and peripheral vestibular mechanisms responsible for pathology can aid in management of SRC.">
    <entity charOffset="28-38" id="s3494.e0" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <entity charOffset="112-115" id="s3494.e1" ontology_id="6714" text="SRC" type="GENE"/>
    <pair e1="s3494.e0" e2="s3494.e1" id="s3494.p0" relation="true"/>
  </sentence>
  <sentence id="s3495" text="5-20% of melanoma families have germline mutations in the CDKN2A gene.">
    <entity charOffset="9-17" id="s3495.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="58-64" id="s3495.e1" ontology_id="1029" text="CDKN2A" type="GENE"/>
    <pair e1="s3495.e0" e2="s3495.e1" id="s3495.p0" relation="true"/>
  </sentence>
  <sentence id="s3496" text="In a few (non-Swedish) melanoma families, mutations in other genes have been found, including CDK4, TERT, POT1, ACD and TERF2IP.">
    <entity charOffset="23-31" id="s3496.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="106-110" id="s3496.e1" ontology_id="25913" text="POT1" type="GENE"/>
    <pair e1="s3496.e0" e2="s3496.e1" id="s3496.p0" relation="true"/>
  </sentence>
  <sentence id="s3497" text="In a few (non-Swedish) melanoma families, mutations in other genes have been found, including CDK4, TERT, POT1, ACD and TERF2IP.">
    <entity charOffset="23-31" id="s3497.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="112-115" id="s3497.e1" ontology_id="65057" text="ACD" type="GENE"/>
    <pair e1="s3497.e0" e2="s3497.e1" id="s3497.p0" relation="true"/>
  </sentence>
  <sentence id="s3498" text="In some families with multiple cases of uveal and cutaneous melanoma (including a few Swedish families), mutations in the BAP1 gene have been found.">
    <entity charOffset="60-68" id="s3498.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="122-126" id="s3498.e1" ontology_id="154043" text="BAP1" type="GENE"/>
    <pair e1="s3498.e0" e2="s3498.e1" id="s3498.p0" relation="true"/>
  </sentence>
  <sentence id="s3499" text="In genes that regulate cellular pigmentation pathways, including MC1R, ASIP, IRF4, TYR, TYRP1 and OCA, there are different common variants that determine complexion traits, and those variants are also associated with different risks of melanoma.">
    <entity charOffset="71-75" id="s3499.e0" ontology_id="56288" text="ASIP" type="GENE"/>
    <entity charOffset="236-244" id="s3499.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3499.e0" e2="s3499.e1" id="s3499.p0" relation="true"/>
  </sentence>
  <sentence id="s3500" text="In genes that regulate cellular pigmentation pathways, including MC1R, ASIP, IRF4, TYR, TYRP1 and OCA, there are different common variants that determine complexion traits, and those variants are also associated with different risks of melanoma.">
    <entity charOffset="77-81" id="s3500.e0" ontology_id="3662" text="IRF4" type="GENE"/>
    <entity charOffset="236-244" id="s3500.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3500.e0" e2="s3500.e1" id="s3500.p0" relation="false"/>
  </sentence>
  <sentence id="s3501" text="In genes that regulate cellular pigmentation pathways, including MC1R, ASIP, IRF4, TYR, TYRP1 and OCA, there are different common variants that determine complexion traits, and those variants are also associated with different risks of melanoma.">
    <entity charOffset="165-171" id="s3501.e0" ontology_id="55929" text="traits" type="GENE"/>
    <entity charOffset="236-244" id="s3501.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3501.e0" e2="s3501.e1" id="s3501.p0" relation="true"/>
  </sentence>
  <sentence id="s3502" text="Individuals with known mutations in tumor suppressor genes such as CDKN2A and BAP1 require, in addition, follow up for other cancers">
    <entity charOffset="36-41" id="s3502.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="78-82" id="s3502.e1" ontology_id="154043" text="BAP1" type="GENE"/>
    <pair e1="s3502.e0" e2="s3502.e1" id="s3502.p0" relation="true"/>
  </sentence>
  <sentence id="s3503" text="BACKGROUND Latent transforming growth factor b binding protein 2 (LTBP2) is proven to be associated with ECM and involved in the advancement of several kinds of cancer.">
    <entity charOffset="66-71" id="s3503.e0" ontology_id="4053" text="LTBP2" type="GENE"/>
    <entity charOffset="161-167" id="s3503.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3503.e0" e2="s3503.e1" id="s3503.p0" relation="true"/>
  </sentence>
  <sentence id="s3504" text="BACKGROUND Latent transforming growth factor b binding protein 2 (LTBP2) is proven to be associated with ECM and involved in the advancement of several kinds of cancer.">
    <entity charOffset="105-108" id="s3504.e0" ontology_id="22915" text="ECM" type="GENE"/>
    <entity charOffset="161-167" id="s3504.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3504.e0" e2="s3504.e1" id="s3504.p0" relation="true"/>
  </sentence>
  <sentence id="s3505" text="Vitamin-B&lt;sub&gt;6&lt;/sub&gt;-dependent epilepsies are a heterogenous group of treatable disorders due to mutations in several genes (&lt;i&gt;ALDH7A1, PNPO, ALPL&lt;/i&gt; or &lt;i&gt;ALDH4A1&lt;/i&gt;).">
    <entity charOffset="32-42" id="s3505.e0" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <entity charOffset="138-142" id="s3505.e1" ontology_id="55163" text="PNPO" type="GENE"/>
    <pair e1="s3505.e0" e2="s3505.e1" id="s3505.p0" relation="true"/>
  </sentence>
  <sentence id="s3506" text="In neonatal seizures, defects in &lt;i&gt;ALDH7A1 and PNPO&lt;/i&gt; explain a major fraction of cases.">
    <entity charOffset="12-20" id="s3506.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="48-52" id="s3506.e1" ontology_id="55163" text="PNPO" type="GENE"/>
    <pair e1="s3506.e0" e2="s3506.e1" id="s3506.p0" relation="true"/>
  </sentence>
  <sentence id="s3507" text="Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in STAC3 as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).">
    <entity charOffset="79-84" id="s3507.e0" ontology_id="246329" text="STAC3" type="GENE"/>
    <entity charOffset="209-221" id="s3507.e1" ontology_id="HP_0000175" text="cleft palate" type="HP"/>
    <pair e1="s3507.e0" e2="s3507.e1" id="s3507.p0" relation="true"/>
  </sentence>
  <sentence id="s3508" text="Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in STAC3 as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).">
    <entity charOffset="79-84" id="s3508.e0" ontology_id="246329" text="STAC3" type="GENE"/>
    <entity charOffset="223-236" id="s3508.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s3508.e0" e2="s3508.e1" id="s3508.p0" relation="true"/>
  </sentence>
  <sentence id="s3509" text="Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in STAC3 as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).">
    <entity charOffset="79-84" id="s3509.e0" ontology_id="246329" text="STAC3" type="GENE"/>
    <entity charOffset="238-244" id="s3509.e1" ontology_id="HP_0000508" text="ptosis" type="HP"/>
    <pair e1="s3509.e0" e2="s3509.e1" id="s3509.p0" relation="true"/>
  </sentence>
  <sentence id="s3510" text="Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in STAC3 as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).">
    <entity charOffset="79-84" id="s3510.e0" ontology_id="246329" text="STAC3" type="GENE"/>
    <entity charOffset="246-260" id="s3510.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s3510.e0" e2="s3510.e1" id="s3510.p0" relation="true"/>
  </sentence>
  <sentence id="s3511" text="Mutations affecting human COG1, COG2 and COG4-COG8 cause monogenic forms of inherited, autosomal recessive CDGs.">
    <entity charOffset="26-30" id="s3511.e0" ontology_id="9382" text="COG1" type="GENE"/>
    <entity charOffset="87-106" id="s3511.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3511.e0" e2="s3511.e1" id="s3511.p0" relation="true"/>
  </sentence>
  <sentence id="s3512" text="Mutations affecting human COG1, COG2 and COG4-COG8 cause monogenic forms of inherited, autosomal recessive CDGs.">
    <entity charOffset="32-36" id="s3512.e0" ontology_id="22796" text="COG2" type="GENE"/>
    <entity charOffset="87-106" id="s3512.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3512.e0" e2="s3512.e1" id="s3512.p0" relation="true"/>
  </sentence>
  <sentence id="s3513" text="Mutations affecting human COG1, COG2 and COG4-COG8 cause monogenic forms of inherited, autosomal recessive CDGs.">
    <entity charOffset="41-45" id="s3513.e0" ontology_id="25839" text="COG4" type="GENE"/>
    <entity charOffset="87-106" id="s3513.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3513.e0" e2="s3513.e1" id="s3513.p0" relation="true"/>
  </sentence>
  <sentence id="s3514" text="Mutations affecting human COG1, COG2 and COG4-COG8 cause monogenic forms of inherited, autosomal recessive CDGs.">
    <entity charOffset="46-50" id="s3514.e0" ontology_id="84342" text="COG8" type="GENE"/>
    <entity charOffset="87-106" id="s3514.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3514.e0" e2="s3514.e1" id="s3514.p0" relation="true"/>
  </sentence>
  <sentence id="s3515" text="Minichromosome maintenance protein 5 (MCM5) has been suggested overexpressed in cervical cancer, but the clinical value and biological function of MCM5 in cervical cancer is still unknown.">
    <entity charOffset="38-42" id="s3515.e0" ontology_id="4174" text="MCM5" type="GENE"/>
    <entity charOffset="89-95" id="s3515.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3515.e0" e2="s3515.e1" id="s3515.p0" relation="true"/>
  </sentence>
  <sentence id="s3516" text="In our study, MCM5 mRNA and protein were significantly overexpressed in cervical cancer tissues and cell lines compared with normal cervical tissues and cell lines, and were obviously increased in cervical adenocarcinoma tissues and cell lines in comparison to cervical squamous cell carcinoma tissues and cell lines.">
    <entity charOffset="14-18" id="s3516.e0" ontology_id="4174" text="MCM5" type="GENE"/>
    <entity charOffset="81-87" id="s3516.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3516.e0" e2="s3516.e1" id="s3516.p0" relation="false"/>
  </sentence>
  <sentence id="s3517" text="In our study, MCM5 mRNA and protein were significantly overexpressed in cervical cancer tissues and cell lines compared with normal cervical tissues and cell lines, and were obviously increased in cervical adenocarcinoma tissues and cell lines in comparison to cervical squamous cell carcinoma tissues and cell lines.">
    <entity charOffset="14-18" id="s3517.e0" ontology_id="4174" text="MCM5" type="GENE"/>
    <entity charOffset="270-293" id="s3517.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3517.e0" e2="s3517.e1" id="s3517.p0" relation="true"/>
  </sentence>
  <sentence id="s3518" text="We tried to elucidate the role of three 3p21.3 TSGs: DLEC1, ITGA9 and MLH1, in non-small cell lung cancer (NSCLC).">
    <entity charOffset="53-58" id="s3518.e0" ontology_id="9940" text="DLEC1" type="GENE"/>
    <entity charOffset="99-105" id="s3518.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3518.e0" e2="s3518.e1" id="s3518.p0" relation="true"/>
  </sentence>
  <sentence id="s3519" text="We tried to elucidate the role of three 3p21.3 TSGs: DLEC1, ITGA9 and MLH1, in non-small cell lung cancer (NSCLC).">
    <entity charOffset="60-65" id="s3519.e0" ontology_id="3680" text="ITGA9" type="GENE"/>
    <entity charOffset="99-105" id="s3519.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3519.e0" e2="s3519.e1" id="s3519.p0" relation="true"/>
  </sentence>
  <sentence id="s3520" text="We tried to elucidate the role of three 3p21.3 TSGs: DLEC1, ITGA9 and MLH1, in non-small cell lung cancer (NSCLC).">
    <entity charOffset="70-74" id="s3520.e0" ontology_id="4292" text="MLH1" type="GENE"/>
    <entity charOffset="99-105" id="s3520.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3520.e0" e2="s3520.e1" id="s3520.p0" relation="true"/>
  </sentence>
  <sentence id="s3521" text="In case of DLEC1 and ITGA9, expression levels were decreased in 71-78% of tumor samples and significantly different between tumor and normal tissues (P=0.0001).">
    <entity charOffset="11-16" id="s3521.e0" ontology_id="9940" text="DLEC1" type="GENE"/>
    <entity charOffset="75-80" id="s3521.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3521.e0" e2="s3521.e1" id="s3521.p0" relation="true"/>
  </sentence>
  <sentence id="s3522" text="ITGA9 could also be regarded as a diagnostic marker differentiating NSCLC subtypes, as its expression level was significantly lower in squamous cell carcinoma (P=0.001).">
    <entity charOffset="0-5" id="s3522.e0" ontology_id="3680" text="ITGA9" type="GENE"/>
    <entity charOffset="135-158" id="s3522.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3522.e0" e2="s3522.e1" id="s3522.p0" relation="true"/>
  </sentence>
  <sentence id="s3523" text="The presented workflow employed three different peptide microarray formats to discover and resolve the epitopes of human autoantibodies and revealed two potentially new autoantigens: MAP3K7 in multiple sclerosis and NRXN1 in narcolepsy.">
    <entity charOffset="183-189" id="s3523.e0" ontology_id="6885" text="MAP3K7" type="GENE"/>
    <entity charOffset="225-235" id="s3523.e1" ontology_id="HP_0030050" text="narcolepsy" type="HP"/>
    <pair e1="s3523.e0" e2="s3523.e1" id="s3523.p0" relation="true"/>
  </sentence>
  <sentence id="s3524" text="PMM2-CDG is an autosomal recessive disease with a large phenotypic spectrum, and is associated with mutations in the &lt;i&gt;PMM2&lt;/i&gt; gene.">
    <entity charOffset="0-4" id="s3524.e0" ontology_id="5373" text="PMM2" type="GENE"/>
    <entity charOffset="15-34" id="s3524.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3524.e0" e2="s3524.e1" id="s3524.p0" relation="true"/>
  </sentence>
  <sentence id="s3525" text="Recently, autosomal recessive loss-of-function mutations in EXPH5 (encoding exophilin-5, also known as Slac2-b, a protein involved in intracellular vesicle transport) were identified in a new mechanobullous disease resembling a form of epidermolysis bullosa simplex (EBS).">
    <entity charOffset="10-29" id="s3525.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="103-110" id="s3525.e1" ontology_id="23086" text="Slac2-b" type="GENE"/>
    <pair e1="s3525.e0" e2="s3525.e1" id="s3525.p0" relation="true"/>
  </sentence>
  <sentence id="s3526" text="This case represents the third pedigree with EXPH5 mutations resulting in inherited skin fragility.">
    <entity charOffset="45-50" id="s3526.e0" ontology_id="23086" text="EXPH5" type="GENE"/>
    <entity charOffset="84-98" id="s3526.e1" ontology_id="HP_0001030" text="skin fragility" type="HP"/>
    <pair e1="s3526.e0" e2="s3526.e1" id="s3526.p0" relation="true"/>
  </sentence>
  <sentence id="s3527" text="Epilepsy with mental retardation limited to females (EFMR) is a syndrome characterized by early onset heat-sensitive epilepsy of infancy or early childhood and generally limited to females, which previously reported that the cadherin gene superfamily subtype protocadherin 19 (PCDH19) gene is its pathogenic gene.">
    <entity charOffset="117-125" id="s3527.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="225-233" id="s3527.e1" ontology_id="1015" text="cadherin" type="GENE"/>
    <pair e1="s3527.e0" e2="s3527.e1" id="s3527.p0" relation="true"/>
  </sentence>
  <sentence id="s3528" text="Cognitive impairment or autism-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo PCDH19 gene mutations were found in their epilepsy gene chip sequencing.">
    <entity charOffset="24-30" id="s3528.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="189-195" id="s3528.e1" ontology_id="57526" text="PCDH19" type="GENE"/>
    <pair e1="s3528.e0" e2="s3528.e1" id="s3528.p0" relation="true"/>
  </sentence>
  <sentence id="s3529" text="Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the SERPINB7 gene.">
    <entity charOffset="51-70" id="s3529.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="147-155" id="s3529.e1" ontology_id="8710" text="SERPINB7" type="GENE"/>
    <pair e1="s3529.e0" e2="s3529.e1" id="s3529.p0" relation="true"/>
  </sentence>
  <sentence id="s3530" text="Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the SERPINB7 gene.">
    <entity charOffset="79-103" id="s3530.e0" ontology_id="HP_0000982" text="palmoplantar keratoderma" type="HP"/>
    <entity charOffset="147-155" id="s3530.e1" ontology_id="8710" text="SERPINB7" type="GENE"/>
    <pair e1="s3530.e0" e2="s3530.e1" id="s3530.p0" relation="true"/>
  </sentence>
  <sentence id="s3531" text="Gastrointestinal stromal tumors (GISTs) are the most common type of mesenchymal tumor of the digestive tract.">
    <entity charOffset="25-31" id="s3531.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="60-64" id="s3531.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s3531.e0" e2="s3531.e1" id="s3531.p0" relation="true"/>
  </sentence>
  <sentence id="s3532" text="Dysregulated miRNAs are involved in various types of human disease, including cancer.">
    <entity charOffset="13-16" id="s3532.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="78-84" id="s3532.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3532.e0" e2="s3532.e1" id="s3532.p0" relation="true"/>
  </sentence>
  <sentence id="s3533" text="Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="38-42" id="s3533.e0" ontology_id="3481" text="IGF2" type="GENE"/>
    <entity charOffset="72-78" id="s3533.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3533.e0" e2="s3533.e1" id="s3533.p0" relation="true"/>
  </sentence>
  <sentence id="s3534" text="Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="43-46" id="s3534.e0" ontology_id="91833" text="DMR" type="GENE"/>
    <entity charOffset="72-78" id="s3534.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3534.e0" e2="s3534.e1" id="s3534.p0" relation="true"/>
  </sentence>
  <sentence id="s3535" text="Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="72-78" id="s3535.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="107-113" id="s3535.e1" ontology_id="9077" text="DIRAS3" type="GENE"/>
    <pair e1="s3535.e0" e2="s3535.e1" id="s3535.p0" relation="true"/>
  </sentence>
  <sentence id="s3536" text="Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="72-78" id="s3536.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="126-131" id="s3536.e1" ontology_id="2887" text="GRB10" type="GENE"/>
    <pair e1="s3536.e0" e2="s3536.e1" id="s3536.p0" relation="true"/>
  </sentence>
  <sentence id="s3537" text="This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, DDX3X, and MGA), the JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, and EP300).">
    <entity charOffset="133-138" id="s3537.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="158-163" id="s3537.e1" ontology_id="1654" text="DDX3X" type="GENE"/>
    <pair e1="s3537.e0" e2="s3537.e1" id="s3537.p0" relation="true"/>
  </sentence>
  <sentence id="s3538" text="This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, DDX3X, and MGA), the JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, and EP300).">
    <entity charOffset="133-138" id="s3538.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="169-172" id="s3538.e1" ontology_id="8972" text="MGA" type="GENE"/>
    <pair e1="s3538.e0" e2="s3538.e1" id="s3538.p0" relation="true"/>
  </sentence>
  <sentence id="s3539" text="This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, DDX3X, and MGA), the JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, and EP300).">
    <entity charOffset="133-138" id="s3539.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="223-228" id="s3539.e1" ontology_id="8085" text="KMT2D" type="GENE"/>
    <pair e1="s3539.e0" e2="s3539.e1" id="s3539.p0" relation="true"/>
  </sentence>
  <sentence id="s3540" text="This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, DDX3X, and MGA), the JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, and EP300).">
    <entity charOffset="133-138" id="s3540.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="230-234" id="s3540.e1" ontology_id="54880" text="BCOR" type="GENE"/>
    <pair e1="s3540.e0" e2="s3540.e1" id="s3540.p0" relation="true"/>
  </sentence>
  <sentence id="s3541" text="This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, DDX3X, and MGA), the JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, and EP300).">
    <entity charOffset="133-138" id="s3541.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="236-242" id="s3541.e1" ontology_id="8289" text="ARID1A" type="GENE"/>
    <pair e1="s3541.e0" e2="s3541.e1" id="s3541.p0" relation="false"/>
  </sentence>
  <sentence id="s3542" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="61-71" id="s3542.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="144-148" id="s3542.e1" ontology_id="9381" text="OTOF" type="GENE"/>
    <pair e1="s3542.e0" e2="s3542.e1" id="s3542.p0" relation="true"/>
  </sentence>
  <sentence id="s3543" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="61-71" id="s3543.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="215-219" id="s3543.e1" ontology_id="494513" text="PJVK" type="GENE"/>
    <pair e1="s3543.e0" e2="s3543.e1" id="s3543.p0" relation="true"/>
  </sentence>
  <sentence id="s3544" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="61-71" id="s3544.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="351-357" id="s3544.e1" ontology_id="81624" text="DIAPH3" type="GENE"/>
    <pair e1="s3544.e0" e2="s3544.e1" id="s3544.p0" relation="true"/>
  </sentence>
  <sentence id="s3545" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="110-118" id="s3545.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="144-148" id="s3545.e1" ontology_id="9381" text="OTOF" type="GENE"/>
    <pair e1="s3545.e0" e2="s3545.e1" id="s3545.p0" relation="false"/>
  </sentence>
  <sentence id="s3546" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="110-118" id="s3546.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="215-219" id="s3546.e1" ontology_id="494513" text="PJVK" type="GENE"/>
    <pair e1="s3546.e0" e2="s3546.e1" id="s3546.p0" relation="true"/>
  </sentence>
  <sentence id="s3547" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="144-148" id="s3547.e0" ontology_id="9381" text="OTOF" type="GENE"/>
    <entity charOffset="264-275" id="s3547.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s3547.e0" e2="s3547.e1" id="s3547.p0" relation="false"/>
  </sentence>
  <sentence id="s3548" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="215-219" id="s3548.e0" ontology_id="494513" text="PJVK" type="GENE"/>
    <entity charOffset="264-275" id="s3548.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s3548.e0" e2="s3548.e1" id="s3548.p0" relation="true"/>
  </sentence>
  <sentence id="s3549" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="264-275" id="s3549.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="351-357" id="s3549.e1" ontology_id="81624" text="DIAPH3" type="GENE"/>
    <pair e1="s3549.e0" e2="s3549.e1" id="s3549.p0" relation="true"/>
  </sentence>
  <sentence id="s3550" text="OTOF gene mutations exert a significant role in auditory neuropathy.">
    <entity charOffset="0-4" id="s3550.e0" ontology_id="9381" text="OTOF" type="GENE"/>
    <entity charOffset="57-67" id="s3550.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s3550.e0" e2="s3550.e1" id="s3550.p0" relation="true"/>
  </sentence>
  <sentence id="s3551" text="Thus, the present study aimed to investigate molecular changes in the OTOF gene in patients with auditory neuropathy, and to develop a DNA chip for the molecular diagnosis of auditory neuropathy using mass spectrometry for genotyping.">
    <entity charOffset="70-74" id="s3551.e0" ontology_id="9381" text="OTOF" type="GENE"/>
    <entity charOffset="106-116" id="s3551.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s3551.e0" e2="s3551.e1" id="s3551.p0" relation="true"/>
  </sentence>
  <sentence id="s3552" text="Genetic alterations were investigated in 47patients with hearing loss and clinical diagnosis of auditory neuropathy, and the c.35delG mutation in the GJB2 gene was identified in three homozygous patients, and the heterozygous parents of one of these cases.">
    <entity charOffset="58-70" id="s3552.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="151-155" id="s3552.e1" ontology_id="2706" text="GJB2" type="GENE"/>
    <pair e1="s3552.e0" e2="s3552.e1" id="s3552.p0" relation="true"/>
  </sentence>
  <sentence id="s3553" text="Genetic alterations were investigated in 47patients with hearing loss and clinical diagnosis of auditory neuropathy, and the c.35delG mutation in the GJB2 gene was identified in three homozygous patients, and the heterozygous parents of one of these cases.">
    <entity charOffset="106-116" id="s3553.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="151-155" id="s3553.e1" ontology_id="2706" text="GJB2" type="GENE"/>
    <pair e1="s3553.e0" e2="s3553.e1" id="s3553.p0" relation="true"/>
  </sentence>
  <sentence id="s3554" text="Several candidate genes for obesity and T2D (e.g., IRS1 and VEGFA) were differentially expressed in discordant twins.">
    <entity charOffset="28-35" id="s3554.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="51-55" id="s3554.e1" ontology_id="3667" text="IRS1" type="GENE"/>
    <pair e1="s3554.e0" e2="s3554.e1" id="s3554.p0" relation="false"/>
  </sentence>
  <sentence id="s3555" text="The DFNB79 locus harbors TPRN mutations in which have been reported in a few families with deafness.">
    <entity charOffset="4-10" id="s3555.e0" ontology_id="286262" text="DFNB79" type="GENE"/>
    <entity charOffset="91-99" id="s3555.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s3555.e0" e2="s3555.e1" id="s3555.p0" relation="true"/>
  </sentence>
  <sentence id="s3556" text="The DFNB79 locus harbors TPRN mutations in which have been reported in a few families with deafness.">
    <entity charOffset="25-29" id="s3556.e0" ontology_id="286262" text="TPRN" type="GENE"/>
    <entity charOffset="91-99" id="s3556.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s3556.e0" e2="s3556.e1" id="s3556.p0" relation="true"/>
  </sentence>
  <sentence id="s3557" text="Four frameshift mutations in TPRN have been described to cause severe or severe-to-profound hearing loss in Moroccan and Pakistani families, and a single frameshift mutation was associated with progressive hearing loss in deaf individuals in a Dutch family.">
    <entity charOffset="29-33" id="s3557.e0" ontology_id="286262" text="TPRN" type="GENE"/>
    <entity charOffset="83-91" id="s3557.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s3557.e0" e2="s3557.e1" id="s3557.p0" relation="true"/>
  </sentence>
  <sentence id="s3558" text="Four frameshift mutations in TPRN have been described to cause severe or severe-to-profound hearing loss in Moroccan and Pakistani families, and a single frameshift mutation was associated with progressive hearing loss in deaf individuals in a Dutch family.">
    <entity charOffset="29-33" id="s3558.e0" ontology_id="286262" text="TPRN" type="GENE"/>
    <entity charOffset="92-104" id="s3558.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3558.e0" e2="s3558.e1" id="s3558.p0" relation="true"/>
  </sentence>
  <sentence id="s3559" text="Four frameshift mutations in TPRN have been described to cause severe or severe-to-profound hearing loss in Moroccan and Pakistani families, and a single frameshift mutation was associated with progressive hearing loss in deaf individuals in a Dutch family.">
    <entity charOffset="29-33" id="s3559.e0" ontology_id="286262" text="TPRN" type="GENE"/>
    <entity charOffset="194-205" id="s3559.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s3559.e0" e2="s3559.e1" id="s3559.p0" relation="true"/>
  </sentence>
  <sentence id="s3560" text="The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="21-26" id="s3560.e0" ontology_id="5631" text="PRPS1" type="GENE"/>
    <entity charOffset="70-80" id="s3560.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s3560.e0" e2="s3560.e1" id="s3560.p0" relation="false"/>
  </sentence>
  <sentence id="s3561" text="The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="21-26" id="s3561.e0" ontology_id="5631" text="PRPS1" type="GENE"/>
    <entity charOffset="160-166" id="s3561.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3561.e0" e2="s3561.e1" id="s3561.p0" relation="true"/>
  </sentence>
  <sentence id="s3562" text="The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="70-80" id="s3562.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="117-121" id="s3562.e1" ontology_id="5414" text="Arts" type="GENE"/>
    <pair e1="s3562.e0" e2="s3562.e1" id="s3562.p0" relation="false"/>
  </sentence>
  <sentence id="s3563" text="The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="81-85" id="s3563.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="160-166" id="s3563.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3563.e0" e2="s3563.e1" id="s3563.p0" relation="true"/>
  </sentence>
  <sentence id="s3564" text="The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="89-94" id="s3564.e0" ontology_id="5631" text="CMTX5" type="GENE"/>
    <entity charOffset="141-149" id="s3564.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s3564.e0" e2="s3564.e1" id="s3564.p0" relation="false"/>
  </sentence>
  <sentence id="s3565" text="The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="89-94" id="s3565.e0" ontology_id="5631" text="CMTX5" type="GENE"/>
    <entity charOffset="160-166" id="s3565.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3565.e0" e2="s3565.e1" id="s3565.p0" relation="true"/>
  </sentence>
  <sentence id="s3566" text="Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding TYMP in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases.">
    <entity charOffset="123-141" id="s3566.e0" ontology_id="HP_0002204" text="pulmonary embolism" type="HP"/>
    <entity charOffset="157-161" id="s3566.e1" ontology_id="1890" text="TYMP" type="GENE"/>
    <pair e1="s3566.e0" e2="s3566.e1" id="s3566.p0" relation="true"/>
  </sentence>
  <sentence id="s3567" text="Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding TYMP in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases.">
    <entity charOffset="157-161" id="s3567.e0" ontology_id="1890" text="TYMP" type="GENE"/>
    <entity charOffset="233-256" id="s3567.e1" ontology_id="HP_0001626" text="cardiovascular diseases" type="HP"/>
    <pair e1="s3567.e0" e2="s3567.e1" id="s3567.p0" relation="true"/>
  </sentence>
  <sentence id="s3568" text="A total of nine non-coding variants on 11q13.5 predispose men to prostate cancer (PrCa). rs200331695 within the EMSY intron is associated with aggressive PrCa and two high linkage disequilibrium (LD) groups of single-nucleotide polymorphisms (SNPs) in the intergenic region are associated with PrCa death.">
    <entity charOffset="58-61" id="s3568.e0" ontology_id="8178" text="men" type="GENE"/>
    <entity charOffset="74-80" id="s3568.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3568.e0" e2="s3568.e1" id="s3568.p0" relation="true"/>
  </sentence>
  <sentence id="s3569" text="The results were validated in a second tumor set (n=41), in lymphoblastoid cell lines (LCLs) (n=38), and using the GTEx Portal.">
    <entity charOffset="39-44" id="s3569.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="45-48" id="s3569.e1" ontology_id="6418" text="set" type="GENE"/>
    <pair e1="s3569.e0" e2="s3569.e1" id="s3569.p0" relation="true"/>
  </sentence>
  <sentence id="s3570" text="The findings indicate the functionality of the PrCa death-predisposing SNPs rs143975731, rs12277366, rs2155225, and rs2155222 as DGAT2 regulators in prostate tumors.">
    <entity charOffset="129-134" id="s3570.e0" ontology_id="84649" text="DGAT2" type="GENE"/>
    <entity charOffset="158-164" id="s3570.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3570.e0" e2="s3570.e1" id="s3570.p0" relation="true"/>
  </sentence>
  <sentence id="s3571" text="The mechanistic target of rapamycin (mTOR) is an established therapeutic target in renal cell carcinoma (RCC).">
    <entity charOffset="37-41" id="s3571.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="83-103" id="s3571.e1" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <pair e1="s3571.e0" e2="s3571.e1" id="s3571.p0" relation="true"/>
  </sentence>
  <sentence id="s3572" text="The mechanistic target of rapamycin (mTOR) is an established therapeutic target in renal cell carcinoma (RCC).">
    <entity charOffset="83-103" id="s3572.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="105-108" id="s3572.e1" ontology_id="7515" text="RCC" type="GENE"/>
    <pair e1="s3572.e0" e2="s3572.e1" id="s3572.p0" relation="true"/>
  </sentence>
  <sentence id="s3573" text="We identified six patients with metastatic RCC who initially responded to mTOR inhibitor therapy and then progressed, and had pre-treatment and post-treatment tumor samples available for analysis.">
    <entity charOffset="74-78" id="s3573.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="159-164" id="s3573.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3573.e0" e2="s3573.e1" id="s3573.p0" relation="true"/>
  </sentence>
  <sentence id="s3574" text="Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated EIF3E-RSPO2 and PTPRK-RSPO3 chromosome rearrangements in vivo.">
    <entity charOffset="123-129" id="s3574.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="141-146" id="s3574.e1" ontology_id="3646" text="EIF3E" type="GENE"/>
    <pair e1="s3574.e0" e2="s3574.e1" id="s3574.p0" relation="true"/>
  </sentence>
  <sentence id="s3575" text="Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated EIF3E-RSPO2 and PTPRK-RSPO3 chromosome rearrangements in vivo.">
    <entity charOffset="123-129" id="s3575.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="147-152" id="s3575.e1" ontology_id="340419" text="RSPO2" type="GENE"/>
    <pair e1="s3575.e0" e2="s3575.e1" id="s3575.p0" relation="true"/>
  </sentence>
  <sentence id="s3576" text="Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated EIF3E-RSPO2 and PTPRK-RSPO3 chromosome rearrangements in vivo.">
    <entity charOffset="123-129" id="s3576.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="163-168" id="s3576.e1" ontology_id="84870" text="RSPO3" type="GENE"/>
    <pair e1="s3576.e0" e2="s3576.e1" id="s3576.p0" relation="true"/>
  </sentence>
  <sentence id="s3577" text="We show that both Rspo2 and Rspo3 fusion events are sufficient to initiate hyperplasia and tumour development in vivo, without additional cooperating genetic events.">
    <entity charOffset="18-23" id="s3577.e0" ontology_id="340419" text="Rspo2" type="GENE"/>
    <entity charOffset="91-97" id="s3577.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3577.e0" e2="s3577.e1" id="s3577.p0" relation="true"/>
  </sentence>
  <sentence id="s3578" text="Altogether, our study provides direct evidence that endogenous Rspo2 and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers">
    <entity charOffset="63-68" id="s3578.e0" ontology_id="340419" text="Rspo2" type="GENE"/>
    <entity charOffset="131-137" id="s3578.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3578.e0" e2="s3578.e1" id="s3578.p0" relation="true"/>
  </sentence>
  <sentence id="s3579" text="Altogether, our study provides direct evidence that endogenous Rspo2 and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers">
    <entity charOffset="73-78" id="s3579.e0" ontology_id="84870" text="Rspo3" type="GENE"/>
    <entity charOffset="228-234" id="s3579.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3579.e0" e2="s3579.e1" id="s3579.p0" relation="true"/>
  </sentence>
  <sentence id="s3580" text="Altogether, our study provides direct evidence that endogenous Rspo2 and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers">
    <entity charOffset="73-78" id="s3580.e0" ontology_id="84870" text="Rspo3" type="GENE"/>
    <entity charOffset="131-137" id="s3580.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3580.e0" e2="s3580.e1" id="s3580.p0" relation="true"/>
  </sentence>
  <sentence id="s3581" text="Importantly, in regard to early gastric cancer and submucosal tumors (SMTs) of the stomach, ESD and full thickness resection (FTR) can excise these lesions &lt;i&gt;en-bloc&lt;/i&gt; and endoscopic suturing is now used to close large defects and perforations.">
    <entity charOffset="62-68" id="s3581.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="234-237" id="s3581.e1" ontology_id="5187" text="per" type="GENE"/>
    <pair e1="s3581.e0" e2="s3581.e1" id="s3581.p0" relation="true"/>
  </sentence>
  <sentence id="s3582" text="Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease, characterized genetically by a disproportionately large contribution of rare genetic variation.">
    <entity charOffset="31-34" id="s3582.e0" ontology_id="3483" text="ALS" type="GENE"/>
    <entity charOffset="49-74" id="s3582.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s3582.e0" e2="s3582.e1" id="s3582.p0" relation="true"/>
  </sentence>
  <sentence id="s3583" text="&lt;i&gt;GPX2&lt;/i&gt; and &lt;i&gt;TXNRD3&lt;/i&gt; showed a higher expression and &lt;i&gt;GPX3&lt;/i&gt;, &lt;i&gt;SELENOP&lt;/i&gt;, &lt;i&gt;SELENOS&lt;/i&gt;, and &lt;i&gt;SEPHS2&lt;/i&gt; exhibited a lower expression in the disease tissue from adenomas and both cancer groups (&lt;i&gt;p&lt;/i&gt;-values from 0.023 to &amp;lt;0.001).">
    <entity charOffset="77-84" id="s3583.e0" ontology_id="6414" text="SELENOP" type="GENE"/>
    <entity charOffset="198-204" id="s3583.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3583.e0" e2="s3583.e1" id="s3583.p0" relation="true"/>
  </sentence>
  <sentence id="s3584" text="Myelodysplastic syndromes (MDS) in children and adolescents are a rare heterogeneous group of clonal stem cell disorders.">
    <entity charOffset="27-30" id="s3584.e0" ontology_id="5048" text="MDS" type="GENE"/>
    <entity charOffset="71-84" id="s3584.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3584.e0" e2="s3584.e1" id="s3584.p0" relation="true"/>
  </sentence>
  <sentence id="s3585" text="The roles of STX3 in human breast cancer remains elusive.">
    <entity charOffset="13-17" id="s3585.e0" ontology_id="6809" text="STX3" type="GENE"/>
    <entity charOffset="34-40" id="s3585.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3585.e0" e2="s3585.e1" id="s3585.p0" relation="true"/>
  </sentence>
  <sentence id="s3586" text="Here we report that STX3 acts as an oncogenic protein in human breast cancer.">
    <entity charOffset="20-24" id="s3586.e0" ontology_id="6809" text="STX3" type="GENE"/>
    <entity charOffset="70-76" id="s3586.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3586.e0" e2="s3586.e1" id="s3586.p0" relation="true"/>
  </sentence>
  <sentence id="s3587" text="We analyzed the expression of STX3 in 148 patients with breast cancer.">
    <entity charOffset="30-34" id="s3587.e0" ontology_id="6809" text="STX3" type="GENE"/>
    <entity charOffset="63-69" id="s3587.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3587.e0" e2="s3587.e1" id="s3587.p0" relation="true"/>
  </sentence>
  <sentence id="s3588" text="The mRNA and protein levels of STX3 are significantly up-regulated in human breast cancer compared with matched adjacent non-cancer tissues.">
    <entity charOffset="31-35" id="s3588.e0" ontology_id="6809" text="STX3" type="GENE"/>
    <entity charOffset="83-89" id="s3588.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3588.e0" e2="s3588.e1" id="s3588.p0" relation="true"/>
  </sentence>
  <sentence id="s3589" text="Lentivirus-mediated knockdown of STX3 represses in vitro proliferation and colony formation and in vivo growth of breast cancer cells, whereas STX3 overexpression promotes the growth of breast cancer cells in vitro and in vivo.">
    <entity charOffset="33-37" id="s3589.e0" ontology_id="6809" text="STX3" type="GENE"/>
    <entity charOffset="121-127" id="s3589.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3589.e0" e2="s3589.e1" id="s3589.p0" relation="true"/>
  </sentence>
  <sentence id="s3590" text="We find that STX3 promotes the proliferation of breast cancer cells by increasing the activation of the Akt-mTOR signaling, and Akt inhibitor Ipatasertib or MK-2206 represses STX3 effects on the growth of breast cancer cells.">
    <entity charOffset="13-17" id="s3590.e0" ontology_id="6809" text="STX3" type="GENE"/>
    <entity charOffset="55-61" id="s3590.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3590.e0" e2="s3590.e1" id="s3590.p0" relation="true"/>
  </sentence>
  <sentence id="s3591" text="Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-Akt-mTOR signaling">
    <entity charOffset="11-15" id="s3591.e0" ontology_id="6809" text="STX3" type="GENE"/>
    <entity charOffset="46-52" id="s3591.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3591.e0" e2="s3591.e1" id="s3591.p0" relation="true"/>
  </sentence>
  <sentence id="s3592" text="Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-Akt-mTOR signaling">
    <entity charOffset="46-52" id="s3592.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="77-81" id="s3592.e1" ontology_id="5728" text="PTEN" type="GENE"/>
    <pair e1="s3592.e0" e2="s3592.e1" id="s3592.p0" relation="false"/>
  </sentence>
  <sentence id="s3593" text="Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-Akt-mTOR signaling">
    <entity charOffset="46-52" id="s3593.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="82-86" id="s3593.e1" ontology_id="5290" text="PI3K" type="GENE"/>
    <pair e1="s3593.e0" e2="s3593.e1" id="s3593.p0" relation="true"/>
  </sentence>
  <sentence id="s3594" text="However, HoFH is clinically heterogeneous, reflecting residual low-density lipoprotein receptor (LDLR) activity.">
    <entity charOffset="28-41" id="s3594.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="97-101" id="s3594.e1" ontology_id="3949" text="LDLR" type="GENE"/>
    <pair e1="s3594.e0" e2="s3594.e1" id="s3594.p0" relation="true"/>
  </sentence>
  <sentence id="s3595" text="Here, we show that TILs from mice deleted in protocadherin-18 had enhanced antitumor activity and that coblockade of PD-1 and protocadherin-18 in wild-type mice significantly enhanced TIL effector phase function.">
    <entity charOffset="29-33" id="s3595.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="79-84" id="s3595.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3595.e0" e2="s3595.e1" id="s3595.p0" relation="true"/>
  </sentence>
  <sentence id="s3596" text="The bilateral retinal cherry red spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with TTC19 mutations.">
    <entity charOffset="4-13" id="s3596.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="174-179" id="s3596.e1" ontology_id="54902" text="TTC19" type="GENE"/>
    <pair e1="s3596.e0" e2="s3596.e1" id="s3596.p0" relation="true"/>
  </sentence>
  <sentence id="s3597" text="The bilateral retinal cherry red spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with TTC19 mutations.">
    <entity charOffset="29-32" id="s3597.e0" ontology_id="8444" text="red" type="GENE"/>
    <entity charOffset="43-60" id="s3597.e1" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <pair e1="s3597.e0" e2="s3597.e1" id="s3597.p0" relation="true"/>
  </sentence>
  <sentence id="s3598" text="The bilateral retinal cherry red spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with TTC19 mutations.">
    <entity charOffset="43-60" id="s3598.e0" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <entity charOffset="174-179" id="s3598.e1" ontology_id="54902" text="TTC19" type="GENE"/>
    <pair e1="s3598.e0" e2="s3598.e1" id="s3598.p0" relation="true"/>
  </sentence>
  <sentence id="s3599" text="We performed a clinical, neurophysiological (in vivo electroencephalography-auditory-evoked related potentials) and genetic (whole-exome sequencing) follow-up analysis of two families with known deleterious NLGN4X gene mutations (either truncating or overexpressing) present in individuals with ASD and/or with intellectual disability (ID).">
    <entity charOffset="207-213" id="s3599.e0" ontology_id="57502" text="NLGN4X" type="GENE"/>
    <entity charOffset="311-334" id="s3599.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3599.e0" e2="s3599.e1" id="s3599.p0" relation="true"/>
  </sentence>
  <sentence id="s3600" text="Recently, defects of ZBTB20, a BTB and zinc finger domain containing transcriptional repressor, have been implicated in a wide range of neurodevelopmental disorders, including intellectual disability and autism.">
    <entity charOffset="21-27" id="s3600.e0" ontology_id="26137" text="ZBTB20" type="GENE"/>
    <entity charOffset="176-199" id="s3600.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3600.e0" e2="s3600.e1" id="s3600.p0" relation="true"/>
  </sentence>
  <sentence id="s3601" text="Recently, defects of ZBTB20, a BTB and zinc finger domain containing transcriptional repressor, have been implicated in a wide range of neurodevelopmental disorders, including intellectual disability and autism.">
    <entity charOffset="21-27" id="s3601.e0" ontology_id="26137" text="ZBTB20" type="GENE"/>
    <entity charOffset="204-210" id="s3601.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s3601.e0" e2="s3601.e1" id="s3601.p0" relation="true"/>
  </sentence>
  <sentence id="s3602" text="Two ZBTB20 single nucleotide variants, located at the N-terminal and central regions of the protein and potentially conferring autism risk, altered dendritic spine morphology.">
    <entity charOffset="4-10" id="s3602.e0" ontology_id="26137" text="ZBTB20" type="GENE"/>
    <entity charOffset="127-133" id="s3602.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s3602.e0" e2="s3602.e1" id="s3602.p0" relation="true"/>
  </sentence>
  <sentence id="s3603" text="In contrast, a single nucleotide variant identified in patients with intellectual disability and located at the C-terminus of ZBTB20 affected dendritic arborization and dendritic length but had no effect on dendritic spine morphology.">
    <entity charOffset="69-92" id="s3603.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="126-132" id="s3603.e1" ontology_id="26137" text="ZBTB20" type="GENE"/>
    <pair e1="s3603.e0" e2="s3603.e1" id="s3603.p0" relation="true"/>
  </sentence>
  <sentence id="s3604" text="Genetic workup confirmed the clinical diagnosis of camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome CACP syndrome and also revealed a rare mutation in the causative gene">
    <entity charOffset="51-64" id="s3604.e0" ontology_id="HP_0012385" text="camptodactyly" type="HP"/>
    <entity charOffset="101-105" id="s3604.e1" ontology_id="10216" text="CACP" type="GENE"/>
    <pair e1="s3604.e0" e2="s3604.e1" id="s3604.p0" relation="true"/>
  </sentence>
  <sentence id="s3605" text="Deficits in miRNA biogenesis have been linked to neurological deficits in humans, and widespread changes in miRNA levels occur in epilepsy, traumatic brain injury, and in response to less dramatic brain insults in rodent models.">
    <entity charOffset="12-15" id="s3605.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="130-138" id="s3605.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3605.e0" e2="s3605.e1" id="s3605.p0" relation="true"/>
  </sentence>
  <sentence id="s3606" text="Recently, microdeletions encompassing &lt;i&gt;MIR137HG&lt;/i&gt;, the host gene which encodes the miRNA miR-137, have been linked to autism and intellectual disability, and genome wide association studies have linked this locus to schizophrenia.">
    <entity charOffset="87-90" id="s3606.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="122-128" id="s3606.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s3606.e0" e2="s3606.e1" id="s3606.p0" relation="true"/>
  </sentence>
  <sentence id="s3607" text="Recently, microdeletions encompassing &lt;i&gt;MIR137HG&lt;/i&gt;, the host gene which encodes the miRNA miR-137, have been linked to autism and intellectual disability, and genome wide association studies have linked this locus to schizophrenia.">
    <entity charOffset="87-90" id="s3607.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="133-156" id="s3607.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3607.e0" e2="s3607.e1" id="s3607.p0" relation="true"/>
  </sentence>
  <sentence id="s3608" text="Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment of glioblastoma (GBM).">
    <entity charOffset="44-47" id="s3608.e0" ontology_id="57379" text="aid" type="GENE"/>
    <entity charOffset="95-107" id="s3608.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s3608.e0" e2="s3608.e1" id="s3608.p0" relation="true"/>
  </sentence>
  <sentence id="s3609" text="The plasma concentrations of LRG1, CRP, and C9 showed significant positive correlations with tumor size (R2 = 0.534, 0.495, and 0.452, respectively)">
    <entity charOffset="29-33" id="s3609.e0" ontology_id="116844" text="LRG1" type="GENE"/>
    <entity charOffset="93-98" id="s3609.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3609.e0" e2="s3609.e1" id="s3609.p0" relation="true"/>
  </sentence>
  <sentence id="s3610" text="The plasma concentrations of LRG1, CRP, and C9 showed significant positive correlations with tumor size (R2 = 0.534, 0.495, and 0.452, respectively)">
    <entity charOffset="35-38" id="s3610.e0" ontology_id="1401" text="CRP" type="GENE"/>
    <entity charOffset="93-98" id="s3610.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3610.e0" e2="s3610.e1" id="s3610.p0" relation="true"/>
  </sentence>
  <sentence id="s3611" text="Hepatocellular carcinoma (HCC) is an aggressive and deadly cancer.">
    <entity charOffset="26-29" id="s3611.e0" ontology_id="84668" text="HCC" type="GENE"/>
    <entity charOffset="59-65" id="s3611.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3611.e0" e2="s3611.e1" id="s3611.p0" relation="true"/>
  </sentence>
  <sentence id="s3612" text="Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by Edn1-Ednra in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, albuminuria, and glomerulosclerosis">
    <entity charOffset="102-106" id="s3612.e0" ontology_id="1906" text="Edn1" type="GENE"/>
    <entity charOffset="305-316" id="s3612.e1" ontology_id="HP_0012592" text="albuminuria" type="HP"/>
    <pair e1="s3612.e0" e2="s3612.e1" id="s3612.p0" relation="true"/>
  </sentence>
  <sentence id="s3613" text="The deleted in colorectal cancer (DCC) gene encodes the netrin-1 (NTN1) receptor DCC, a transmembrane protein required for the guidance of commissural axons.">
    <entity charOffset="26-32" id="s3613.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="66-70" id="s3613.e1" ontology_id="9423" text="NTN1" type="GENE"/>
    <pair e1="s3613.e0" e2="s3613.e1" id="s3613.p0" relation="true"/>
  </sentence>
  <sentence id="s3614" text="Germline DCC mutations disrupt the development of predominantly commissural tracts in the central nervous system (CNS) and cause a spectrum of neurological disorders.">
    <entity charOffset="9-12" id="s3614.e0" ontology_id="1630" text="DCC" type="GENE"/>
    <entity charOffset="90-97" id="s3614.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s3614.e0" e2="s3614.e1" id="s3614.p0" relation="true"/>
  </sentence>
  <sentence id="s3615" text="It is a genetic disorder caused by a mutation in the dysferlin gene (DYSF) with an autosomal recessive mode of inheritance.">
    <entity charOffset="69-73" id="s3615.e0" ontology_id="8291" text="DYSF" type="GENE"/>
    <entity charOffset="103-122" id="s3615.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s3615.e0" e2="s3615.e1" id="s3615.p0" relation="true"/>
  </sentence>
  <sentence id="s3616" text="In this article, we report a case of Limb-girdle muscular dystrophy type 2B with a rare homozygous duplication c.164dupA, p.(Ile57Hisfs*8) (rs863225020) in DYSF in a Saudi patient.">
    <entity charOffset="49-67" id="s3616.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="156-160" id="s3616.e1" ontology_id="8291" text="DYSF" type="GENE"/>
    <pair e1="s3616.e0" e2="s3616.e1" id="s3616.p0" relation="true"/>
  </sentence>
  <sentence id="s3617" text="Our results therefore confirm the KCNC3R423H allele as causative for SCA13, through a dominant negative effect on KCNC3WT and links with EGFR that account for dominant inheritance, congenital onset, and disease pathology">
    <entity charOffset="34-39" id="s3617.e0" ontology_id="3748" text="KCNC3" type="GENE"/>
    <entity charOffset="168-179" id="s3617.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s3617.e0" e2="s3617.e1" id="s3617.p0" relation="true"/>
  </sentence>
  <sentence id="s3618" text="Besides, previous evidence suggested that AHI1 expression was changed in schizophrenia patients.">
    <entity charOffset="42-46" id="s3618.e0" ontology_id="54806" text="AHI1" type="GENE"/>
    <entity charOffset="73-86" id="s3618.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s3618.e0" e2="s3618.e1" id="s3618.p0" relation="true"/>
  </sentence>
  <sentence id="s3619" text="Furthermore, association signal between AHI1 variants and schizophrenia has been reported in several European samples.">
    <entity charOffset="40-44" id="s3619.e0" ontology_id="54806" text="AHI1" type="GENE"/>
    <entity charOffset="58-71" id="s3619.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s3619.e0" e2="s3619.e1" id="s3619.p0" relation="true"/>
  </sentence>
  <sentence id="s3620" text="These results suggested that AHI1 is likely a risk gene for schizophrenia, at least in European populations.">
    <entity charOffset="29-33" id="s3620.e0" ontology_id="54806" text="AHI1" type="GENE"/>
    <entity charOffset="60-73" id="s3620.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s3620.e0" e2="s3620.e1" id="s3620.p0" relation="true"/>
  </sentence>
  <sentence id="s3621" text="Pathogenic mutations have been identified in the TIMM8A (DDP) and DNAJC19 (TIMM14) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.">
    <entity charOffset="49-55" id="s3621.e0" ontology_id="1678" text="TIMM8A" type="GENE"/>
    <entity charOffset="186-192" id="s3621.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3621.e0" e2="s3621.e1" id="s3621.p0" relation="true"/>
  </sentence>
  <sentence id="s3622" text="Pathogenic mutations have been identified in the TIMM8A (DDP) and DNAJC19 (TIMM14) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.">
    <entity charOffset="57-60" id="s3622.e0" ontology_id="1678" text="DDP" type="GENE"/>
    <entity charOffset="186-192" id="s3622.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3622.e0" e2="s3622.e1" id="s3622.p0" relation="true"/>
  </sentence>
  <sentence id="s3623" text="Pathogenic mutations have been identified in the TIMM8A (DDP) and DNAJC19 (TIMM14) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.">
    <entity charOffset="66-73" id="s3623.e0" ontology_id="131118" text="DNAJC19" type="GENE"/>
    <entity charOffset="186-192" id="s3623.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3623.e0" e2="s3623.e1" id="s3623.p0" relation="true"/>
  </sentence>
  <sentence id="s3624" text="Pathogenic mutations have been identified in the TIMM8A (DDP) and DNAJC19 (TIMM14) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.">
    <entity charOffset="75-81" id="s3624.e0" ontology_id="131118" text="TIMM14" type="GENE"/>
    <entity charOffset="186-192" id="s3624.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3624.e0" e2="s3624.e1" id="s3624.p0" relation="true"/>
  </sentence>
  <sentence id="s3625" text="Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor ZEB1, while had no effect on Snail, Slug or Twist.">
    <entity charOffset="112-118" id="s3625.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="268-272" id="s3625.e1" ontology_id="6591" text="Slug" type="GENE"/>
    <pair e1="s3625.e0" e2="s3625.e1" id="s3625.p0" relation="true"/>
  </sentence>
  <sentence id="s3626" text="In vivo multispectral fluorescent imaging, the EGFP-EGF1 conjugated nanoparticles showed significantly higher accumulation in tumor tissues than non-conjugated ones.">
    <entity charOffset="52-56" id="s3626.e0" ontology_id="85476" text="EGF1" type="GENE"/>
    <entity charOffset="126-131" id="s3626.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3626.e0" e2="s3626.e1" id="s3626.p0" relation="true"/>
  </sentence>
  <sentence id="s3627" text="Tumor tissue slides further presented that EGFP-EGF1 conjugated nanoparticles showed significantly higher accumulation in tumor vasculature than non-conjugated ones.">
    <entity charOffset="48-52" id="s3627.e0" ontology_id="85476" text="EGF1" type="GENE"/>
    <entity charOffset="122-127" id="s3627.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3627.e0" e2="s3627.e1" id="s3627.p0" relation="true"/>
  </sentence>
  <sentence id="s3628" text="These promising results indicated that PDT enhanced EGFP-EGF1modified PEG-PLGA nanoparticle accumulation in tumor vaculature.">
    <entity charOffset="57-61" id="s3628.e0" ontology_id="85476" text="EGF1" type="GENE"/>
    <entity charOffset="108-113" id="s3628.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3628.e0" e2="s3628.e1" id="s3628.p0" relation="true"/>
  </sentence>
  <sentence id="s3629" text="A combination of both EGFP-EGF1 modification and PDT provided a positive feed-back target effect to tumor vessels and might have a great potential for tumor therapy">
    <entity charOffset="27-31" id="s3629.e0" ontology_id="85476" text="EGF1" type="GENE"/>
    <entity charOffset="100-105" id="s3629.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3629.e0" e2="s3629.e1" id="s3629.p0" relation="true"/>
  </sentence>
  <sentence id="s3630" text="Here we show that a series of transcription factors, including C/EBP, GCM1, and GATA1, could act as potential modulators of histone methylation in tumor cells.">
    <entity charOffset="71-75" id="s3630.e0" ontology_id="8521" text="GCM1" type="GENE"/>
    <entity charOffset="148-153" id="s3630.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3630.e0" e2="s3630.e1" id="s3630.p0" relation="true"/>
  </sentence>
  <sentence id="s3631" text="Here we show that a series of transcription factors, including C/EBP, GCM1, and GATA1, could act as potential modulators of histone methylation in tumor cells.">
    <entity charOffset="81-86" id="s3631.e0" ontology_id="2623" text="GATA1" type="GENE"/>
    <entity charOffset="148-153" id="s3631.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3631.e0" e2="s3631.e1" id="s3631.p0" relation="true"/>
  </sentence>
  <sentence id="s3632" text="Here, we report two novel GUCA1A (the gene for guanylate cyclase activating protein 1) mutations identified in unrelated Spanish families affected by autosomal dominant retinal degeneration (adRD) with cone and rod involvement.">
    <entity charOffset="26-32" id="s3632.e0" ontology_id="2978" text="GUCA1A" type="GENE"/>
    <entity charOffset="169-189" id="s3632.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s3632.e0" e2="s3632.e1" id="s3632.p0" relation="true"/>
  </sentence>
  <sentence id="s3633" text="The expression of DLL4 in nonsmall cell lung cancer (NSCLC) remains unclear.">
    <entity charOffset="18-22" id="s3633.e0" ontology_id="54567" text="DLL4" type="GENE"/>
    <entity charOffset="46-52" id="s3633.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3633.e0" e2="s3633.e1" id="s3633.p0" relation="false"/>
  </sentence>
  <sentence id="s3634" text="Therefore, DLL4 expression was detected in clinical specimens using quantum dots (QDs)immunohistochemistry (IHC) and lung cancer cell lines by quantitative realtime polymerase chain reaction.">
    <entity charOffset="11-15" id="s3634.e0" ontology_id="54567" text="DLL4" type="GENE"/>
    <entity charOffset="123-129" id="s3634.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3634.e0" e2="s3634.e1" id="s3634.p0" relation="true"/>
  </sentence>
  <sentence id="s3635" text="The protein levels of DLL4 were decreased in the tumor tissues of NSCLC patients and lung cancer cell lines.">
    <entity charOffset="22-26" id="s3635.e0" ontology_id="54567" text="DLL4" type="GENE"/>
    <entity charOffset="90-96" id="s3635.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3635.e0" e2="s3635.e1" id="s3635.p0" relation="true"/>
  </sentence>
  <sentence id="s3636" text="The protein levels of DLL4 were decreased in the tumor tissues of NSCLC patients and lung cancer cell lines.">
    <entity charOffset="22-26" id="s3636.e0" ontology_id="54567" text="DLL4" type="GENE"/>
    <entity charOffset="49-54" id="s3636.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3636.e0" e2="s3636.e1" id="s3636.p0" relation="true"/>
  </sentence>
  <sentence id="s3637" text="Adolescent idiopathic scoliosis (AIS) and pectus excavatum (PE) are common pediatric musculoskeletal disorders.">
    <entity charOffset="22-31" id="s3637.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="33-36" id="s3637.e1" ontology_id="231" text="AIS" type="GENE"/>
    <pair e1="s3637.e0" e2="s3637.e1" id="s3637.p0" relation="true"/>
  </sentence>
  <sentence id="s3638" text="Silencing expression of CCND1, JUN and SPP1 in the human oral cancer cell line OECM-1 confirmed that those genes play essential roles in oral cancer cell invasion.">
    <entity charOffset="24-29" id="s3638.e0" ontology_id="595" text="CCND1" type="GENE"/>
    <entity charOffset="62-68" id="s3638.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3638.e0" e2="s3638.e1" id="s3638.p0" relation="true"/>
  </sentence>
  <sentence id="s3639" text="Silencing expression of CCND1, JUN and SPP1 in the human oral cancer cell line OECM-1 confirmed that those genes play essential roles in oral cancer cell invasion.">
    <entity charOffset="31-34" id="s3639.e0" ontology_id="3725" text="JUN" type="GENE"/>
    <entity charOffset="62-68" id="s3639.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3639.e0" e2="s3639.e1" id="s3639.p0" relation="true"/>
  </sentence>
  <sentence id="s3640" text="Silencing expression of CCND1, JUN and SPP1 in the human oral cancer cell line OECM-1 confirmed that those genes play essential roles in oral cancer cell invasion.">
    <entity charOffset="39-43" id="s3640.e0" ontology_id="30827" text="SPP1" type="GENE"/>
    <entity charOffset="62-68" id="s3640.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3640.e0" e2="s3640.e1" id="s3640.p0" relation="true"/>
  </sentence>
  <sentence id="s3641" text="Our study identified a unique gene signature - CCND1, JUN and SPP1 - which may be involved in oral cancer lymph node metastasis">
    <entity charOffset="47-52" id="s3641.e0" ontology_id="595" text="CCND1" type="GENE"/>
    <entity charOffset="99-105" id="s3641.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3641.e0" e2="s3641.e1" id="s3641.p0" relation="true"/>
  </sentence>
  <sentence id="s3642" text="Our study identified a unique gene signature - CCND1, JUN and SPP1 - which may be involved in oral cancer lymph node metastasis">
    <entity charOffset="54-57" id="s3642.e0" ontology_id="3725" text="JUN" type="GENE"/>
    <entity charOffset="99-105" id="s3642.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3642.e0" e2="s3642.e1" id="s3642.p0" relation="true"/>
  </sentence>
  <sentence id="s3643" text="Our study identified a unique gene signature - CCND1, JUN and SPP1 - which may be involved in oral cancer lymph node metastasis">
    <entity charOffset="62-66" id="s3643.e0" ontology_id="30827" text="SPP1" type="GENE"/>
    <entity charOffset="99-105" id="s3643.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3643.e0" e2="s3643.e1" id="s3643.p0" relation="true"/>
  </sentence>
  <sentence id="s3644" text="Inhibitory immune receptors, such as NLRP12, dampen inflammation and are important for resolving inflammation, but their role in obesity is unknown.">
    <entity charOffset="37-43" id="s3644.e0" ontology_id="91662" text="NLRP12" type="GENE"/>
    <entity charOffset="129-136" id="s3644.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3644.e0" e2="s3644.e1" id="s3644.p0" relation="false"/>
  </sentence>
  <sentence id="s3645" text="We show that obesity in humans correlates with reduced expression of adipose tissue NLRP12.">
    <entity charOffset="13-20" id="s3645.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="84-90" id="s3645.e1" ontology_id="91662" text="NLRP12" type="GENE"/>
    <pair e1="s3645.e0" e2="s3645.e1" id="s3645.p0" relation="true"/>
  </sentence>
  <sentence id="s3646" text="Co-housing with wild-type animals, antibiotic treatment, or germ-free condition was sufficient to restrain inflammation, obesity, and insulin tolerance in Nlrp12&lt;sup&gt;-/-&lt;/sup&gt; mice, implicating the microbiota.">
    <entity charOffset="121-128" id="s3646.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="155-161" id="s3646.e1" ontology_id="91662" text="Nlrp12" type="GENE"/>
    <pair e1="s3646.e0" e2="s3646.e1" id="s3646.p0" relation="true"/>
  </sentence>
  <sentence id="s3647" text="HFD-fed Nlrp12&lt;sup&gt;-/-&lt;/sup&gt; mice display dysbiosis marked by increased obesity-associated Erysipelotrichaceae, but reduced Lachnospiraceae family and the associated enzymes required for short-chain fatty acid (SCFA) synthesis.">
    <entity charOffset="8-14" id="s3647.e0" ontology_id="91662" text="Nlrp12" type="GENE"/>
    <entity charOffset="72-79" id="s3647.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3647.e0" e2="s3647.e1" id="s3647.p0" relation="true"/>
  </sentence>
  <sentence id="s3648" text="These findings reveal that Nlrp12 reduces HFD-induced obesity by maintaining beneficial microbiota">
    <entity charOffset="27-33" id="s3648.e0" ontology_id="91662" text="Nlrp12" type="GENE"/>
    <entity charOffset="54-61" id="s3648.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3648.e0" e2="s3648.e1" id="s3648.p0" relation="true"/>
  </sentence>
  <sentence id="s3649" text="The presence of minor loss-of-function variants in WFS1 predicted isolated diabetes, isolated deafness, or isolated congenital cataracts without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).">
    <entity charOffset="51-55" id="s3649.e0" ontology_id="7466" text="WFS1" type="GENE"/>
    <entity charOffset="94-102" id="s3649.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s3649.e0" e2="s3649.e1" id="s3649.p0" relation="true"/>
  </sentence>
  <sentence id="s3650" text="The presence of minor loss-of-function variants in WFS1 predicted isolated diabetes, isolated deafness, or isolated congenital cataracts without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).">
    <entity charOffset="51-55" id="s3650.e0" ontology_id="7466" text="WFS1" type="GENE"/>
    <entity charOffset="127-136" id="s3650.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s3650.e0" e2="s3650.e1" id="s3650.p0" relation="true"/>
  </sentence>
  <sentence id="s3651" text="A major susceptibility locus, HIVAN1, was previously mapped to chromosome 3A1-A3 in a cross between TgFVB and CAST/EiJ (CAST) strains, and introgression of a 51.9 Mb segment encompassing HIVAN1 from CAST into TgFVB resulted in accelerated development of nephropathy.">
    <entity charOffset="110-114" id="s3651.e0" ontology_id="10849" text="CAST" type="GENE"/>
    <entity charOffset="254-265" id="s3651.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s3651.e0" e2="s3651.e1" id="s3651.p0" relation="true"/>
  </sentence>
  <sentence id="s3652" text="Of these, Frem1, Foxo1, and Setd7 have been implicated in the pathogenesis of nephropathy.">
    <entity charOffset="17-22" id="s3652.e0" ontology_id="2308" text="Foxo1" type="GENE"/>
    <entity charOffset="78-89" id="s3652.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s3652.e0" e2="s3652.e1" id="s3652.p0" relation="true"/>
  </sentence>
  <sentence id="s3653" text="We report a new (fifth) patient with the cblJ disorder who presented at 7 days of age with poor feeding, hypotonia, methylmalonic aciduria, and elevated plasma homocysteine and harbored the mutations c.1667_1668delAG [p.Glu556Glyfs*27] and c.1295G&amp;gt;A [p.Arg432Gln] in the &lt;i&gt;ABCD4&lt;/i&gt; gene.">
    <entity charOffset="116-138" id="s3653.e0" ontology_id="HP_0012120" text="methylmalonic aciduria" type="HP"/>
    <entity charOffset="277-282" id="s3653.e1" ontology_id="5826" text="ABCD4" type="GENE"/>
    <pair e1="s3653.e0" e2="s3653.e1" id="s3653.p0" relation="true"/>
  </sentence>
  <sentence id="s3654" text="The sterile alpha motif (SAM) domain of the protein ANKS6, a protein-protein interaction domain, is responsible for autosomal dominant polycystic kidney disease.">
    <entity charOffset="52-57" id="s3654.e0" ontology_id="203286" text="ANKS6" type="GENE"/>
    <entity charOffset="146-160" id="s3654.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s3654.e0" e2="s3654.e1" id="s3654.p0" relation="true"/>
  </sentence>
  <sentence id="s3655" text="Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing GM-CSF (to amplify immune responses) successfully blocks the outgrowth of an implantable cancer (Lewis lung carcinoma; LLC) and lung tumors generated in mice using a combination of a mutagen followed by chronic pulmonary inflammation.">
    <entity charOffset="141-147" id="s3655.e0" ontology_id="1437" text="GM-CSF" type="GENE"/>
    <entity charOffset="230-236" id="s3655.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3655.e0" e2="s3655.e1" id="s3655.p0" relation="true"/>
  </sentence>
  <sentence id="s3656" text="Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing GM-CSF (to amplify immune responses) successfully blocks the outgrowth of an implantable cancer (Lewis lung carcinoma; LLC) and lung tumors generated in mice using a combination of a mutagen followed by chronic pulmonary inflammation.">
    <entity charOffset="230-236" id="s3656.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="294-298" id="s3656.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s3656.e0" e2="s3656.e1" id="s3656.p0" relation="true"/>
  </sentence>
  <sentence id="s3657" text="Examination of tumor-infiltrating immune cells from mice vaccinated with the GM-CSF-expressing exosomes showed robust tumor-reactive CD8&lt;sup&gt;+&lt;/sup&gt; T effector responses, Th1 cytokine responses, and higher CD8&lt;sup&gt;+&lt;/sup&gt; T effector/CD4&lt;sup&gt;+&lt;/sup&gt;CD25&lt;sup&gt;+&lt;/sup&gt;Foxp3&lt;sup&gt;+&lt;/sup&gt; T regulatory cell ratio in the tumors.">
    <entity charOffset="77-83" id="s3657.e0" ontology_id="1437" text="GM-CSF" type="GENE"/>
    <entity charOffset="313-319" id="s3657.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3657.e0" e2="s3657.e1" id="s3657.p0" relation="true"/>
  </sentence>
  <sentence id="s3658" text="Deleted in lung and esophageal cancer 1 (DLEC1) is a tumor suppressor gene with reduced transcriptional activity and promoter hypermethylation in various cancers, including colorectal cancer.">
    <entity charOffset="31-37" id="s3658.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="41-46" id="s3658.e1" ontology_id="9940" text="DLEC1" type="GENE"/>
    <pair e1="s3658.e0" e2="s3658.e1" id="s3658.p0" relation="true"/>
  </sentence>
  <sentence id="s3659" text="Deleted in lung and esophageal cancer 1 (DLEC1) is a tumor suppressor gene with reduced transcriptional activity and promoter hypermethylation in various cancers, including colorectal cancer.">
    <entity charOffset="41-46" id="s3659.e0" ontology_id="9940" text="DLEC1" type="GENE"/>
    <entity charOffset="53-58" id="s3659.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3659.e0" e2="s3659.e1" id="s3659.p0" relation="true"/>
  </sentence>
  <sentence id="s3660" text="Here we find, launching from Drosophila models of amyotrophic lateral sclerosis and frontotemporal dementia, that TDP-43 impairs the induction of multiple key stress genes required to protect from disease by reducing the recruitment of the chromatin remodeler Chd1 to chromatin.">
    <entity charOffset="84-107" id="s3660.e0" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <entity charOffset="260-264" id="s3660.e1" ontology_id="1105" text="Chd1" type="GENE"/>
    <pair e1="s3660.e0" e2="s3660.e1" id="s3660.p0" relation="true"/>
  </sentence>
  <sentence id="s3661" text="For instance, mutations in both BFSP1 and BFSP2 cause cataract in humans.">
    <entity charOffset="32-37" id="s3661.e0" ontology_id="631" text="BFSP1" type="GENE"/>
    <entity charOffset="54-62" id="s3661.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s3661.e0" e2="s3661.e1" id="s3661.p0" relation="true"/>
  </sentence>
  <sentence id="s3662" text="For instance, mutations in both BFSP1 and BFSP2 cause cataract in humans.">
    <entity charOffset="42-47" id="s3662.e0" ontology_id="8419" text="BFSP2" type="GENE"/>
    <entity charOffset="54-62" id="s3662.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s3662.e0" e2="s3662.e1" id="s3662.p0" relation="true"/>
  </sentence>
  <sentence id="s3663" text="In the case-control analysis, the rs9607195 A&amp;gt;G on intergenic area 250kb away from the ISX gene and the rs12738007 A&amp;gt;G on the intron of the MECR gene were the most strongly associated SNPs with the risk of schizophrenia (P=6.210(-8) , OR=0.50 and P=3.710(-7) , OR=2.39, respectively).">
    <entity charOffset="147-151" id="s3663.e0" ontology_id="51102" text="MECR" type="GENE"/>
    <entity charOffset="213-226" id="s3663.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s3663.e0" e2="s3663.e1" id="s3663.p0" relation="true"/>
  </sentence>
  <sentence id="s3664" text="In subsequent fine-mapping analysis, 6 SNPs of MECR were genotyped with 310 schizophrenia patients and 604 control subjects.">
    <entity charOffset="47-51" id="s3664.e0" ontology_id="51102" text="MECR" type="GENE"/>
    <entity charOffset="76-89" id="s3664.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s3664.e0" e2="s3664.e1" id="s3664.p0" relation="false"/>
  </sentence>
  <sentence id="s3665" text="Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, SLC2A1, BIRC5, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.">
    <entity charOffset="47-53" id="s3665.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="88-94" id="s3665.e1" ontology_id="6513" text="SLC2A1" type="GENE"/>
    <pair e1="s3665.e0" e2="s3665.e1" id="s3665.p0" relation="true"/>
  </sentence>
  <sentence id="s3666" text="Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, SLC2A1, BIRC5, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.">
    <entity charOffset="47-53" id="s3666.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="107-112" id="s3666.e1" ontology_id="991" text="CDC20" type="GENE"/>
    <pair e1="s3666.e0" e2="s3666.e1" id="s3666.p0" relation="true"/>
  </sentence>
  <sentence id="s3667" text="Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including KRAS and inactivation of tumor suppressors, such as TP53, SMAD4 and CDKN2A.">
    <entity charOffset="151-157" id="s3667.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="227-232" id="s3667.e1" ontology_id="4089" text="SMAD4" type="GENE"/>
    <pair e1="s3667.e0" e2="s3667.e1" id="s3667.p0" relation="true"/>
  </sentence>
  <sentence id="s3668" text="Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including KRAS and inactivation of tumor suppressors, such as TP53, SMAD4 and CDKN2A.">
    <entity charOffset="169-173" id="s3668.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="194-199" id="s3668.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3668.e0" e2="s3668.e1" id="s3668.p0" relation="true"/>
  </sentence>
  <sentence id="s3669" text="Therefore, there is a great need for the development of safe and effective nanoparticles for better tumor-specific delivery of anti-cancer therapeutics.">
    <entity charOffset="22-27" id="s3669.e0" ontology_id="122042" text="great" type="GENE"/>
    <entity charOffset="132-138" id="s3669.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3669.e0" e2="s3669.e1" id="s3669.p0" relation="true"/>
  </sentence>
  <sentence id="s3670" text="We show that tumour cells specifically induce Notch2 activity in mesenchymal stromal cells (MSCs) required for the transcription of the complement factor C1q.">
    <entity charOffset="13-19" id="s3670.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="46-52" id="s3670.e1" ontology_id="4853" text="Notch2" type="GENE"/>
    <pair e1="s3670.e0" e2="s3670.e1" id="s3670.p0" relation="true"/>
  </sentence>
  <sentence id="s3671" text="Notch2 activation in the microenvironment is a pre-requisite for the activation of canonical Wnt signalling in tumour cells">
    <entity charOffset="0-6" id="s3671.e0" ontology_id="4853" text="Notch2" type="GENE"/>
    <entity charOffset="111-117" id="s3671.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3671.e0" e2="s3671.e1" id="s3671.p0" relation="true"/>
  </sentence>
  <sentence id="s3672" text="Posterior microphthalmos (PM) is a relatively infrequent type of microphthalmos where posterior segment is predominantly affected with normal anterior segment measurements.">
    <entity charOffset="10-24" id="s3672.e0" ontology_id="HP_0000568" text="microphthalmos" type="HP"/>
    <entity charOffset="57-61" id="s3672.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s3672.e0" e2="s3672.e1" id="s3672.p0" relation="true"/>
  </sentence>
  <sentence id="s3673" text="We here report that (-)-epigallocatechin gallate (EGCG) inhibited programmed cell death ligand 1 (PD-L1) expression in nonsmall-cell lung cancer cells, induced by both interferon (IFN)- and epidermal growth factor (EGF).">
    <entity charOffset="139-145" id="s3673.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="217-220" id="s3673.e1" ontology_id="1950" text="EGF" type="GENE"/>
    <pair e1="s3673.e0" e2="s3673.e1" id="s3673.p0" relation="true"/>
  </sentence>
  <sentence id="s3674" text="Furthermore, 0.3% GTE in drinking water reduced the average number of tumors per mouse from 4.1  0.5 to 2.6  0.4 and the percentage of PD-L1 positive cells from 9.6% to 2.9%, a decrease of 70%, in lung tumors of A/J mice given a single intraperitoneal injection of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).">
    <entity charOffset="70-76" id="s3674.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="218-222" id="s3674.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s3674.e0" e2="s3674.e1" id="s3674.p0" relation="false"/>
  </sentence>
  <sentence id="s3675" text="We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="33-36" id="s3675.e0" ontology_id="324" text="APC" type="GENE"/>
    <entity charOffset="120-126" id="s3675.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3675.e0" e2="s3675.e1" id="s3675.p0" relation="true"/>
  </sentence>
  <sentence id="s3676" text="We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="50-54" id="s3676.e0" ontology_id="2778" text="GNAS" type="GENE"/>
    <entity charOffset="120-126" id="s3676.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3676.e0" e2="s3676.e1" id="s3676.p0" relation="true"/>
  </sentence>
  <sentence id="s3677" text="We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="62-67" id="s3677.e0" ontology_id="4089" text="SMAD4" type="GENE"/>
    <entity charOffset="120-126" id="s3677.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3677.e0" e2="s3677.e1" id="s3677.p0" relation="true"/>
  </sentence>
  <sentence id="s3678" text="We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="80-86" id="s3678.e0" ontology_id="5290" text="PIK3CA" type="GENE"/>
    <entity charOffset="120-126" id="s3678.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3678.e0" e2="s3678.e1" id="s3678.p0" relation="true"/>
  </sentence>
  <sentence id="s3679" text="Five HGCAs harbored either mono-allelic (four HGCAs) or bi-allelic (one HGCA) SMAD4 mutation or 18q loss that had been known as early carcinoma-specific changes.">
    <entity charOffset="78-83" id="s3679.e0" ontology_id="4089" text="SMAD4" type="GENE"/>
    <entity charOffset="134-143" id="s3679.e1" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <pair e1="s3679.e0" e2="s3679.e1" id="s3679.p0" relation="true"/>
  </sentence>
  <sentence id="s3680" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s3680.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="81-85" id="s3680.e1" ontology_id="3845" text="KRAS" type="GENE"/>
    <pair e1="s3680.e0" e2="s3680.e1" id="s3680.p0" relation="true"/>
  </sentence>
  <sentence id="s3681" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s3681.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="96-100" id="s3681.e1" ontology_id="2778" text="GNAS" type="GENE"/>
    <pair e1="s3681.e0" e2="s3681.e1" id="s3681.p0" relation="true"/>
  </sentence>
  <sentence id="s3682" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s3682.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="190-195" id="s3682.e1" ontology_id="196528" text="ARID2" type="GENE"/>
    <pair e1="s3682.e0" e2="s3682.e1" id="s3682.p0" relation="true"/>
  </sentence>
  <sentence id="s3683" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s3683.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="151-155" id="s3683.e1" ontology_id="2475" text="MTOR" type="GENE"/>
    <pair e1="s3683.e0" e2="s3683.e1" id="s3683.p0" relation="false"/>
  </sentence>
  <sentence id="s3684" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s3684.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="157-163" id="s3684.e1" ontology_id="91" text="ACVR1B" type="GENE"/>
    <pair e1="s3684.e0" e2="s3684.e1" id="s3684.p0" relation="true"/>
  </sentence>
  <sentence id="s3685" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s3685.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="171-174" id="s3685.e1" ontology_id="472" text="ATM" type="GENE"/>
    <pair e1="s3685.e0" e2="s3685.e1" id="s3685.p0" relation="true"/>
  </sentence>
  <sentence id="s3686" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s3686.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="176-181" id="s3686.e1" ontology_id="23019" text="CNOT1" type="GENE"/>
    <pair e1="s3686.e0" e2="s3686.e1" id="s3686.p0" relation="true"/>
  </sentence>
  <sentence id="s3687" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s3687.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="197-200" id="s3687.e1" ontology_id="5979" text="RET" type="GENE"/>
    <pair e1="s3687.e0" e2="s3687.e1" id="s3687.p0" relation="true"/>
  </sentence>
  <sentence id="s3688" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s3688.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="205-211" id="s3688.e1" ontology_id="6416" text="MAP2K4" type="GENE"/>
    <pair e1="s3688.e0" e2="s3688.e1" id="s3688.p0" relation="true"/>
  </sentence>
  <sentence id="s3689" text="Intravascular lithotripsy (IVL) with the Shockwave system has recently been evaluated as a familiar angioplasty-balloon-based but effective technique for the management of arterial calcification.">
    <entity charOffset="27-30" id="s3689.e0" ontology_id="3713" text="IVL" type="GENE"/>
    <entity charOffset="173-195" id="s3689.e1" ontology_id="HP_0003207" text="arterial calcification" type="HP"/>
    <pair e1="s3689.e0" e2="s3689.e1" id="s3689.p0" relation="true"/>
  </sentence>
  <sentence id="s3690" text="The mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy index (RVHI), pulmonary vascular remodeling, serum tumor necrosis factor  (TNF), and interleukin-6 (IL-6) were higher either in SI or in TI 28 and 35 days after the first MCT injection.">
    <entity charOffset="51-74" id="s3690.e0" ontology_id="HP_0001714" text="ventricular hypertrophy" type="HP"/>
    <entity charOffset="248-251" id="s3690.e1" ontology_id="27349" text="MCT" type="GENE"/>
    <pair e1="s3690.e0" e2="s3690.e1" id="s3690.p0" relation="false"/>
  </sentence>
  <sentence id="s3691" text="The mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy index (RVHI), pulmonary vascular remodeling, serum tumor necrosis factor  (TNF), and interleukin-6 (IL-6) were higher either in SI or in TI 28 and 35 days after the first MCT injection.">
    <entity charOffset="126-131" id="s3691.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="248-251" id="s3691.e1" ontology_id="27349" text="MCT" type="GENE"/>
    <pair e1="s3691.e0" e2="s3691.e1" id="s3691.p0" relation="true"/>
  </sentence>
  <sentence id="s3692" text="We describe an infant with the phenotype of a congenital muscular dystrophy, with borderline microcephaly, hypotonia, camptodactyly, severe motor delay, and elevated creatine kinase.">
    <entity charOffset="36-40" id="s3692.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="118-131" id="s3692.e1" ontology_id="HP_0012385" text="camptodactyly" type="HP"/>
    <pair e1="s3692.e0" e2="s3692.e1" id="s3692.p0" relation="false"/>
  </sentence>
  <sentence id="s3693" text="Neurofibromatosis type 2 (NF2) is a tumor-forming disease of the nervous system caused by deletion or by loss-of-function mutations in NF2, encoding the tumor suppressing protein neurofibromin 2 (also known as schwannomin or merlin).">
    <entity charOffset="36-41" id="s3693.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="225-231" id="s3693.e1" ontology_id="4771" text="merlin" type="GENE"/>
    <pair e1="s3693.e0" e2="s3693.e1" id="s3693.p0" relation="true"/>
  </sentence>
  <sentence id="s3694" text="The correlation of the tumor-suppressive function and conformation (open or closed) of neurofibromin 2 has been subject to much speculation, often based on extrapolation from other ERM proteins, and controversy.">
    <entity charOffset="23-28" id="s3694.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="181-184" id="s3694.e1" ontology_id="2119" text="ERM" type="GENE"/>
    <pair e1="s3694.e0" e2="s3694.e1" id="s3694.p0" relation="true"/>
  </sentence>
  <sentence id="s3695" text="These data suggest AMPD2-related PCH as a potentially treatable early-onset neurodegenerative disease.">
    <entity charOffset="19-24" id="s3695.e0" ontology_id="271" text="AMPD2" type="GENE"/>
    <entity charOffset="76-101" id="s3695.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s3695.e0" e2="s3695.e1" id="s3695.p0" relation="true"/>
  </sentence>
  <sentence id="s3696" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).">
    <entity charOffset="103-108" id="s3696.e0" ontology_id="5937" text="RBMS1" type="GENE"/>
    <entity charOffset="186-193" id="s3696.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3696.e0" e2="s3696.e1" id="s3696.p0" relation="true"/>
  </sentence>
  <sentence id="s3697" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).">
    <entity charOffset="159-164" id="s3697.e0" ontology_id="9784" text="SNX17" type="GENE"/>
    <entity charOffset="186-193" id="s3697.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3697.e0" e2="s3697.e1" id="s3697.p0" relation="true"/>
  </sentence>
  <sentence id="s3698" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).">
    <entity charOffset="173-179" id="s3698.e0" ontology_id="79672" text="FN3KRP" type="GENE"/>
    <entity charOffset="186-193" id="s3698.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3698.e0" e2="s3698.e1" id="s3698.p0" relation="true"/>
  </sentence>
  <sentence id="s3699" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).">
    <entity charOffset="186-193" id="s3699.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="200-204" id="s3699.e1" ontology_id="5443" text="POMC" type="GENE"/>
    <pair e1="s3699.e0" e2="s3699.e1" id="s3699.p0" relation="true"/>
  </sentence>
  <sentence id="s3700" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).">
    <entity charOffset="186-193" id="s3700.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="206-211" id="s3700.e1" ontology_id="80315" text="CPEB4" type="GENE"/>
    <pair e1="s3700.e0" e2="s3700.e1" id="s3700.p0" relation="true"/>
  </sentence>
  <sentence id="s3701" text="Single-gene variant analysis showed significant associations of the TT genotype of CYP1A1 and the rare GG genotype of ERCC2 with bladder cancer susceptibility (OR=1.34, 95% CI 1.22-1.40, P&amp;lt;0.0001).">
    <entity charOffset="83-89" id="s3701.e0" ontology_id="1543" text="CYP1A1" type="GENE"/>
    <entity charOffset="137-143" id="s3701.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3701.e0" e2="s3701.e1" id="s3701.p0" relation="true"/>
  </sentence>
  <sentence id="s3702" text="Single-gene variant analysis showed significant associations of the TT genotype of CYP1A1 and the rare GG genotype of ERCC2 with bladder cancer susceptibility (OR=1.34, 95% CI 1.22-1.40, P&amp;lt;0.0001).">
    <entity charOffset="118-123" id="s3702.e0" ontology_id="2068" text="ERCC2" type="GENE"/>
    <entity charOffset="137-143" id="s3702.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3702.e0" e2="s3702.e1" id="s3702.p0" relation="true"/>
  </sentence>
  <sentence id="s3703" text="Although Sur8 has been shown to be a scaffold protein of the Ras-ERK pathway, its interaction with other signaling pathways and its involvement in tumor malignancy has not been reported.">
    <entity charOffset="65-68" id="s3703.e0" ontology_id="2048" text="ERK" type="GENE"/>
    <entity charOffset="147-152" id="s3703.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3703.e0" e2="s3703.e1" id="s3703.p0" relation="true"/>
  </sentence>
  <sentence id="s3704" text="At surgery, the mass was located within the epineurium, could be bluntly dissected from the nerve fascicles, and was suspected to be a schwannoma.">
    <entity charOffset="16-20" id="s3704.e0" ontology_id="2200" text="mass" type="GENE"/>
    <entity charOffset="135-145" id="s3704.e1" ontology_id="HP_0100008" text="schwannoma" type="HP"/>
    <pair e1="s3704.e0" e2="s3704.e1" id="s3704.p0" relation="true"/>
  </sentence>
  <sentence id="s3705" text="Fluorescence in situ hybridization, with a break-apart probe strategy, demonstrated FUS rearrangement, consistent in this morphological context with the low-grade fibromyxoid sarcoma-associated FUS-CREB3L2 or FUS-CREB3L1 fusions.">
    <entity charOffset="84-87" id="s3705.e0" ontology_id="2521" text="FUS" type="GENE"/>
    <entity charOffset="175-182" id="s3705.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s3705.e0" e2="s3705.e1" id="s3705.p0" relation="true"/>
  </sentence>
  <sentence id="s3706" text="The association replicated in the UK Biobank sample (odds ratio = 1.25, &lt;i&gt;P&lt;/i&gt; = 6.8  10&lt;sup&gt;-14&lt;/sup&gt;), and the effect is independent of known erectile dysfunction risk factors, including body mass index (BMI).">
    <entity charOffset="147-167" id="s3706.e0" ontology_id="HP_0000802" text="erectile dysfunction" type="HP"/>
    <entity charOffset="197-201" id="s3706.e1" ontology_id="2200" text="mass" type="GENE"/>
    <pair e1="s3706.e0" e2="s3706.e1" id="s3706.p0" relation="true"/>
  </sentence>
  <sentence id="s3707" text="Mutations in the ubiquitously expressed pre-mRNA processing factors 3, 8, and 31 (PRPF3, PRPF8, and PRPF31) cause nonsyndromic dominant retinitis pigmentosa in humans, an inherited retinal degeneration.">
    <entity charOffset="82-87" id="s3707.e0" ontology_id="9129" text="PRPF3" type="GENE"/>
    <entity charOffset="181-201" id="s3707.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s3707.e0" e2="s3707.e1" id="s3707.p0" relation="true"/>
  </sentence>
  <sentence id="s3708" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="111-116" id="s3708.e0" ontology_id="538" text="ATP7A" type="GENE"/>
    <entity charOffset="508-520" id="s3708.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s3708.e0" e2="s3708.e1" id="s3708.p0" relation="true"/>
  </sentence>
  <sentence id="s3709" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="111-116" id="s3709.e0" ontology_id="538" text="ATP7A" type="GENE"/>
    <entity charOffset="548-557" id="s3709.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s3709.e0" e2="s3709.e1" id="s3709.p0" relation="true"/>
  </sentence>
  <sentence id="s3710" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="230-234" id="s3710.e0" ontology_id="91949" text="COG7" type="GENE"/>
    <entity charOffset="508-520" id="s3710.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s3710.e0" e2="s3710.e1" id="s3710.p0" relation="true"/>
  </sentence>
  <sentence id="s3711" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="230-234" id="s3711.e0" ontology_id="91949" text="COG7" type="GENE"/>
    <entity charOffset="548-557" id="s3711.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s3711.e0" e2="s3711.e1" id="s3711.p0" relation="false"/>
  </sentence>
  <sentence id="s3712" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s3712.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="590-593" id="s3712.e1" ontology_id="3267" text="Rab" type="GENE"/>
    <pair e1="s3712.e0" e2="s3712.e1" id="s3712.p0" relation="false"/>
  </sentence>
  <sentence id="s3713" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s3713.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="608-612" id="s3713.e1" ontology_id="54453" text="RIN2" type="GENE"/>
    <pair e1="s3713.e0" e2="s3713.e1" id="s3713.p0" relation="true"/>
  </sentence>
  <sentence id="s3714" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s3714.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="694-700" id="s3714.e1" ontology_id="6888" text="TALDO1" type="GENE"/>
    <pair e1="s3714.e0" e2="s3714.e1" id="s3714.p0" relation="false"/>
  </sentence>
  <sentence id="s3715" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s3715.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="768-772" id="s3715.e1" ontology_id="5870" text="RAB6" type="GENE"/>
    <pair e1="s3715.e0" e2="s3715.e1" id="s3715.p0" relation="false"/>
  </sentence>
  <sentence id="s3716" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s3716.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="786-791" id="s3716.e1" ontology_id="92344" text="GORAB" type="GENE"/>
    <pair e1="s3716.e0" e2="s3716.e1" id="s3716.p0" relation="true"/>
  </sentence>
  <sentence id="s3717" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s3717.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="795-803" id="s3717.e1" ontology_id="92344" text="SCYL1BP1" type="GENE"/>
    <pair e1="s3717.e0" e2="s3717.e1" id="s3717.p0" relation="false"/>
  </sentence>
  <sentence id="s3718" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s3718.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1000-1004" id="s3718.e1" ontology_id="3265" text="HRAS" type="GENE"/>
    <pair e1="s3718.e0" e2="s3718.e1" id="s3718.p0" relation="true"/>
  </sentence>
  <sentence id="s3719" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s3719.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1155-1159" id="s3719.e1" ontology_id="6655" text="SOS2" type="GENE"/>
    <pair e1="s3719.e0" e2="s3719.e1" id="s3719.p0" relation="false"/>
  </sentence>
  <sentence id="s3720" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s3720.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1200-1205" id="s3720.e1" ontology_id="8036" text="SHOC2" type="GENE"/>
    <pair e1="s3720.e0" e2="s3720.e1" id="s3720.p0" relation="true"/>
  </sentence>
  <sentence id="s3721" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s3721.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1208-1212" id="s3721.e1" ontology_id="4893" text="NRAS" type="GENE"/>
    <pair e1="s3721.e0" e2="s3721.e1" id="s3721.p0" relation="true"/>
  </sentence>
  <sentence id="s3722" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s3722.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1295-1299" id="s3722.e1" ontology_id="5894" text="RAF1" type="GENE"/>
    <pair e1="s3722.e0" e2="s3722.e1" id="s3722.p0" relation="false"/>
  </sentence>
  <sentence id="s3723" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3723.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="590-593" id="s3723.e1" ontology_id="3267" text="Rab" type="GENE"/>
    <pair e1="s3723.e0" e2="s3723.e1" id="s3723.p0" relation="true"/>
  </sentence>
  <sentence id="s3724" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3724.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="608-612" id="s3724.e1" ontology_id="54453" text="RIN2" type="GENE"/>
    <pair e1="s3724.e0" e2="s3724.e1" id="s3724.p0" relation="true"/>
  </sentence>
  <sentence id="s3725" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3725.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="694-700" id="s3725.e1" ontology_id="6888" text="TALDO1" type="GENE"/>
    <pair e1="s3725.e0" e2="s3725.e1" id="s3725.p0" relation="true"/>
  </sentence>
  <sentence id="s3726" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3726.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="768-772" id="s3726.e1" ontology_id="5870" text="RAB6" type="GENE"/>
    <pair e1="s3726.e0" e2="s3726.e1" id="s3726.p0" relation="false"/>
  </sentence>
  <sentence id="s3727" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3727.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="795-803" id="s3727.e1" ontology_id="92344" text="SCYL1BP1" type="GENE"/>
    <pair e1="s3727.e0" e2="s3727.e1" id="s3727.p0" relation="true"/>
  </sentence>
  <sentence id="s3728" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3728.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="953-959" id="s3728.e1" ontology_id="5781" text="PTPN11" type="GENE"/>
    <pair e1="s3728.e0" e2="s3728.e1" id="s3728.p0" relation="false"/>
  </sentence>
  <sentence id="s3729" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3729.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="971-975" id="s3729.e1" ontology_id="3265" text="HRas" type="GENE"/>
    <pair e1="s3729.e0" e2="s3729.e1" id="s3729.p0" relation="true"/>
  </sentence>
  <sentence id="s3730" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3730.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1000-1004" id="s3730.e1" ontology_id="3265" text="HRAS" type="GENE"/>
    <pair e1="s3730.e0" e2="s3730.e1" id="s3730.p0" relation="false"/>
  </sentence>
  <sentence id="s3731" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3731.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1054-1058" id="s3731.e1" ontology_id="673" text="BRAF" type="GENE"/>
    <pair e1="s3731.e0" e2="s3731.e1" id="s3731.p0" relation="false"/>
  </sentence>
  <sentence id="s3732" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3732.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1069-1073" id="s3732.e1" ontology_id="3845" text="KRAS" type="GENE"/>
    <pair e1="s3732.e0" e2="s3732.e1" id="s3732.p0" relation="false"/>
  </sentence>
  <sentence id="s3733" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3733.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1155-1159" id="s3733.e1" ontology_id="6655" text="SOS2" type="GENE"/>
    <pair e1="s3733.e0" e2="s3733.e1" id="s3733.p0" relation="false"/>
  </sentence>
  <sentence id="s3734" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s3734.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1208-1212" id="s3734.e1" ontology_id="4893" text="NRAS" type="GENE"/>
    <pair e1="s3734.e0" e2="s3734.e1" id="s3734.p0" relation="true"/>
  </sentence>
  <sentence id="s3735" text="According to the Ottawa Heart Genomics Study genome-wide association study, a recent research identified that Q688 spastic paraplegia 7 (SPG7) variant is associated with CAD as it bypasses the regulation of tyrosine phosphorylation of AFG3L2 and enhances the processing and maturation of SPG7 protein.">
    <entity charOffset="115-133" id="s3735.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="235-241" id="s3735.e1" ontology_id="10939" text="AFG3L2" type="GENE"/>
    <pair e1="s3735.e0" e2="s3735.e1" id="s3735.p0" relation="true"/>
  </sentence>
  <sentence id="s3736" text="The deafness genes GJB3, CRYM, GRHL2, DFNA5, and ATP6B1 were expressed in marmoset cochleae in patterns different from those in mouse cochleae.">
    <entity charOffset="4-12" id="s3736.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="19-23" id="s3736.e1" ontology_id="2707" text="GJB3" type="GENE"/>
    <pair e1="s3736.e0" e2="s3736.e1" id="s3736.p0" relation="true"/>
  </sentence>
  <sentence id="s3737" text="The deafness genes GJB3, CRYM, GRHL2, DFNA5, and ATP6B1 were expressed in marmoset cochleae in patterns different from those in mouse cochleae.">
    <entity charOffset="4-12" id="s3737.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="31-36" id="s3737.e1" ontology_id="79977" text="GRHL2" type="GENE"/>
    <pair e1="s3737.e0" e2="s3737.e1" id="s3737.p0" relation="true"/>
  </sentence>
  <sentence id="s3738" text="The deafness genes GJB3, CRYM, GRHL2, DFNA5, and ATP6B1 were expressed in marmoset cochleae in patterns different from those in mouse cochleae.">
    <entity charOffset="4-12" id="s3738.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="49-55" id="s3738.e1" ontology_id="525" text="ATP6B1" type="GENE"/>
    <pair e1="s3738.e0" e2="s3738.e1" id="s3738.p0" relation="true"/>
  </sentence>
  <sentence id="s3739" text="We first develop a doxycycline-inducible cell line expressing GFP-tagged cytoplasmic TDP-43 protein (iGFP-NLSm) as a cell-based system to screen and identify seeding activity of human brain-derived pathological TDP-43 isolated from sporadic FTLD-TDP and familial cases with Granulin (FTLD-TDP-GRN) or C9orf72 repeat expansion mutations (FTLD-TDP-C9+).">
    <entity charOffset="232-240" id="s3739.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="301-308" id="s3739.e1" ontology_id="203228" text="C9orf72" type="GENE"/>
    <pair e1="s3739.e0" e2="s3739.e1" id="s3739.p0" relation="true"/>
  </sentence>
  <sentence id="s3740" text="Circulating soluble corin has been found to be associated with various cardiovascular diseases, such as hypertension, heart failure, myocardial infarction, preeclampsia, and stroke.">
    <entity charOffset="20-25" id="s3740.e0" ontology_id="10699" text="corin" type="GENE"/>
    <entity charOffset="133-154" id="s3740.e1" ontology_id="HP_0001658" text="myocardial infarction" type="HP"/>
    <pair e1="s3740.e0" e2="s3740.e1" id="s3740.p0" relation="true"/>
  </sentence>
  <sentence id="s3741" text="Through gene set enrichment analysis and bi-clustering, we also found that most of the differential expressed lncRNAs were closely associated with mitochondrial functions (e.g. mitochondrion organization, P=3.2110&lt;sup&gt;-17&lt;/sup&gt;; mitochondrial ATP synthesis coupled electron transport, P=1.7310&lt;sup&gt;-19&lt;/sup&gt; and mitochondrial membrane organization, P=4.0410&lt;sup&gt;-8&lt;/sup&gt;).">
    <entity charOffset="13-16" id="s3741.e0" ontology_id="6418" text="set" type="GENE"/>
    <entity charOffset="147-160" id="s3741.e1" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <pair e1="s3741.e0" e2="s3741.e1" id="s3741.p0" relation="true"/>
  </sentence>
  <sentence id="s3742" text="The MATR3 gene is mutated in a form of distal myopathy and amyotrophic lateral sclerosis (ALS).">
    <entity charOffset="4-9" id="s3742.e0" ontology_id="9782" text="MATR3" type="GENE"/>
    <entity charOffset="39-45" id="s3742.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s3742.e0" e2="s3742.e1" id="s3742.p0" relation="true"/>
  </sentence>
  <sentence id="s3743" text="The MATR3 gene is mutated in a form of distal myopathy and amyotrophic lateral sclerosis (ALS).">
    <entity charOffset="4-9" id="s3743.e0" ontology_id="9782" text="MATR3" type="GENE"/>
    <entity charOffset="46-54" id="s3743.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3743.e0" e2="s3743.e1" id="s3743.p0" relation="true"/>
  </sentence>
  <sentence id="s3744" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="38-44" id="s3744.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="159-165" id="s3744.e1" ontology_id="54949" text="SDHAF2" type="GENE"/>
    <pair e1="s3744.e0" e2="s3744.e1" id="s3744.p0" relation="true"/>
  </sentence>
  <sentence id="s3745" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="38-44" id="s3745.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="167-171" id="s3745.e1" ontology_id="6389" text="SDHA" type="GENE"/>
    <pair e1="s3745.e0" e2="s3745.e1" id="s3745.p0" relation="true"/>
  </sentence>
  <sentence id="s3746" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="38-44" id="s3746.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="173-177" id="s3746.e1" ontology_id="6390" text="SDHB" type="GENE"/>
    <pair e1="s3746.e0" e2="s3746.e1" id="s3746.p0" relation="true"/>
  </sentence>
  <sentence id="s3747" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="46-62" id="s3747.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="144-147" id="s3747.e1" ontology_id="5979" text="RET" type="GENE"/>
    <pair e1="s3747.e0" e2="s3747.e1" id="s3747.p0" relation="true"/>
  </sentence>
  <sentence id="s3748" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="46-62" id="s3748.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="159-165" id="s3748.e1" ontology_id="54949" text="SDHAF2" type="GENE"/>
    <pair e1="s3748.e0" e2="s3748.e1" id="s3748.p0" relation="true"/>
  </sentence>
  <sentence id="s3749" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="46-62" id="s3749.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="167-171" id="s3749.e1" ontology_id="6389" text="SDHA" type="GENE"/>
    <pair e1="s3749.e0" e2="s3749.e1" id="s3749.p0" relation="true"/>
  </sentence>
  <sentence id="s3750" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="46-62" id="s3750.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="173-177" id="s3750.e1" ontology_id="6390" text="SDHB" type="GENE"/>
    <pair e1="s3750.e0" e2="s3750.e1" id="s3750.p0" relation="true"/>
  </sentence>
  <sentence id="s3751" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="46-62" id="s3751.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="179-183" id="s3751.e1" ontology_id="6391" text="SDHC" type="GENE"/>
    <pair e1="s3751.e0" e2="s3751.e1" id="s3751.p0" relation="true"/>
  </sentence>
  <sentence id="s3752" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="46-62" id="s3752.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="185-189" id="s3752.e1" ontology_id="6392" text="SDHD" type="GENE"/>
    <pair e1="s3752.e0" e2="s3752.e1" id="s3752.p0" relation="true"/>
  </sentence>
  <sentence id="s3753" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="68-81" id="s3753.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="167-171" id="s3753.e1" ontology_id="6389" text="SDHA" type="GENE"/>
    <pair e1="s3753.e0" e2="s3753.e1" id="s3753.p0" relation="true"/>
  </sentence>
  <sentence id="s3754" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="68-81" id="s3754.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="173-177" id="s3754.e1" ontology_id="6390" text="SDHB" type="GENE"/>
    <pair e1="s3754.e0" e2="s3754.e1" id="s3754.p0" relation="true"/>
  </sentence>
  <sentence id="s3755" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="68-81" id="s3755.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="179-183" id="s3755.e1" ontology_id="6391" text="SDHC" type="GENE"/>
    <pair e1="s3755.e0" e2="s3755.e1" id="s3755.p0" relation="true"/>
  </sentence>
  <sentence id="s3756" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="68-81" id="s3756.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="191-198" id="s3756.e1" ontology_id="55654" text="TMEM127" type="GENE"/>
    <pair e1="s3756.e0" e2="s3756.e1" id="s3756.p0" relation="true"/>
  </sentence>
  <sentence id="s3757" text="Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.">
    <entity charOffset="75-82" id="s3757.e0" ontology_id="5528" text="PPP2R5D" type="GENE"/>
    <entity charOffset="130-153" id="s3757.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3757.e0" e2="s3757.e1" id="s3757.p0" relation="true"/>
  </sentence>
  <sentence id="s3758" text="Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.">
    <entity charOffset="75-82" id="s3758.e0" ontology_id="5528" text="PPP2R5D" type="GENE"/>
    <entity charOffset="212-218" id="s3758.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s3758.e0" e2="s3758.e1" id="s3758.p0" relation="true"/>
  </sentence>
  <sentence id="s3759" text="Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.">
    <entity charOffset="75-82" id="s3759.e0" ontology_id="5528" text="PPP2R5D" type="GENE"/>
    <entity charOffset="238-250" id="s3759.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s3759.e0" e2="s3759.e1" id="s3759.p0" relation="true"/>
  </sentence>
  <sentence id="s3760" text="Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.">
    <entity charOffset="75-82" id="s3760.e0" ontology_id="5528" text="PPP2R5D" type="GENE"/>
    <entity charOffset="263-271" id="s3760.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s3760.e0" e2="s3760.e1" id="s3760.p0" relation="true"/>
  </sentence>
  <sentence id="s3761" text="Our current study found that phosphoserine aminotransferase 1 (PSAT1), an enzyme catalyzing serine biosynthesis, was significantly up-regulated in non-small cell lung cancer (NSCLC) and was involved in the regulation of E2F activity.">
    <entity charOffset="63-68" id="s3761.e0" ontology_id="29968" text="PSAT1" type="GENE"/>
    <entity charOffset="167-173" id="s3761.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3761.e0" e2="s3761.e1" id="s3761.p0" relation="true"/>
  </sentence>
  <sentence id="s3762" text="Loss- and gain-of-function experiments demonstrated that PSAT1 promoted cell cycle progression, cell proliferation and tumorigenesis.">
    <entity charOffset="57-62" id="s3762.e0" ontology_id="29968" text="PSAT1" type="GENE"/>
    <entity charOffset="119-124" id="s3762.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3762.e0" e2="s3762.e1" id="s3762.p0" relation="true"/>
  </sentence>
  <sentence id="s3763" text="Correlation analysis showed that PSAT1 expression positively correlated with the levels of phosphorylated GSK-3, cyclin D1 and phosphorylated Rb in NSCLC primary tumors.">
    <entity charOffset="33-38" id="s3763.e0" ontology_id="29968" text="PSAT1" type="GENE"/>
    <entity charOffset="163-168" id="s3763.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3763.e0" e2="s3763.e1" id="s3763.p0" relation="true"/>
  </sentence>
  <sentence id="s3764" text="A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, CHRNA4, was in a focal (frontal lobe)-onset syndrome.">
    <entity charOffset="99-107" id="s3764.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="194-198" id="s3764.e1" ontology_id="84335" text="lobe" type="GENE"/>
    <pair e1="s3764.e0" e2="s3764.e1" id="s3764.p0" relation="true"/>
  </sentence>
  <sentence id="s3765" text="A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, CHRNA4, was in a focal (frontal lobe)-onset syndrome.">
    <entity charOffset="136-144" id="s3765.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="162-168" id="s3765.e1" ontology_id="1137" text="CHRNA4" type="GENE"/>
    <pair e1="s3765.e0" e2="s3765.e1" id="s3765.p0" relation="true"/>
  </sentence>
  <sentence id="s3766" text="The reason why CHRNA4 causes focal-onset seizures is unknown.">
    <entity charOffset="15-21" id="s3766.e0" ontology_id="1137" text="CHRNA4" type="GENE"/>
    <entity charOffset="41-49" id="s3766.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s3766.e0" e2="s3766.e1" id="s3766.p0" relation="true"/>
  </sentence>
  <sentence id="s3767" text="Recently, the second focal (temporal lobe)-onset epilepsy gene, LGI1 (unknown function), was discovered.">
    <entity charOffset="49-57" id="s3767.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="64-68" id="s3767.e1" ontology_id="9211" text="LGI1" type="GENE"/>
    <pair e1="s3767.e0" e2="s3767.e1" id="s3767.p0" relation="true"/>
  </sentence>
  <sentence id="s3768" text="CHRNA4 led the way to mutation identifications in 15 ion channel genes, most causing primarily generalized epilepsies.">
    <entity charOffset="0-6" id="s3768.e0" ontology_id="1137" text="CHRNA4" type="GENE"/>
    <entity charOffset="107-117" id="s3768.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s3768.e0" e2="s3768.e1" id="s3768.p0" relation="true"/>
  </sentence>
  <sentence id="s3769" text="Mutations in the EFHC1 gene (unknown function) occur in other rare JME families, and yet in other families, associations are present between JME (or other generalized epilepsies) and single nucleotide polymorphisms in the BRD2 gene (unknown function) and the malic enzyme 2 (ME2) gene.">
    <entity charOffset="17-22" id="s3769.e0" ontology_id="114327" text="EFHC1" type="GENE"/>
    <entity charOffset="167-177" id="s3769.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s3769.e0" e2="s3769.e1" id="s3769.p0" relation="true"/>
  </sentence>
  <sentence id="s3770" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s3770.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="462-468" id="s3770.e1" ontology_id="2566" text="GABRG2" type="GENE"/>
    <pair e1="s3770.e0" e2="s3770.e1" id="s3770.p0" relation="true"/>
  </sentence>
  <sentence id="s3771" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s3771.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="470-476" id="s3771.e1" ontology_id="2904" text="GRIN2B" type="GENE"/>
    <pair e1="s3771.e0" e2="s3771.e1" id="s3771.p0" relation="true"/>
  </sentence>
  <sentence id="s3772" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s3772.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="478-483" id="s3772.e1" ontology_id="3785" text="KCNQ2" type="GENE"/>
    <pair e1="s3772.e0" e2="s3772.e1" id="s3772.p0" relation="true"/>
  </sentence>
  <sentence id="s3773" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s3773.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="485-490" id="s3773.e1" ontology_id="4204" text="MECP2" type="GENE"/>
    <pair e1="s3773.e0" e2="s3773.e1" id="s3773.p0" relation="true"/>
  </sentence>
  <sentence id="s3774" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s3774.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="492-498" id="s3774.e1" ontology_id="57526" text="PCDH19" type="GENE"/>
    <pair e1="s3774.e0" e2="s3774.e1" id="s3774.p0" relation="true"/>
  </sentence>
  <sentence id="s3775" text="Importantly, the role of CtBP1 overexpression in adult tissues in promoting the progression of multiple cancer types through their ability to modulate the transcription of developmental genes ectopically is explored.">
    <entity charOffset="25-30" id="s3775.e0" ontology_id="1487" text="CtBP1" type="GENE"/>
    <entity charOffset="104-110" id="s3775.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3775.e0" e2="s3775.e1" id="s3775.p0" relation="true"/>
  </sentence>
  <sentence id="s3776" text="CtBP1 overexpression is known to be protumorigenic and affects the regulation of gene networks associated with &amp;quot;cancer hallmarks&amp;quot; and malignant behavior, including increased cell survival, proliferation, migration, invasion, and the epithelial-mesenchymal transition.">
    <entity charOffset="0-5" id="s3776.e0" ontology_id="1487" text="CtBP1" type="GENE"/>
    <entity charOffset="117-123" id="s3776.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3776.e0" e2="s3776.e1" id="s3776.p0" relation="true"/>
  </sentence>
  <sentence id="s3777" text="CtBP1 overexpression is known to be protumorigenic and affects the regulation of gene networks associated with &amp;quot;cancer hallmarks&amp;quot; and malignant behavior, including increased cell survival, proliferation, migration, invasion, and the epithelial-mesenchymal transition.">
    <entity charOffset="0-5" id="s3777.e0" ontology_id="1487" text="CtBP1" type="GENE"/>
    <entity charOffset="39-44" id="s3777.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3777.e0" e2="s3777.e1" id="s3777.p0" relation="true"/>
  </sentence>
  <sentence id="s3778" text="As a transcriptional regulator of broad developmental processes capable of promoting malignant growth in adult tissues, therapeutically targeting the CtBP1 corepressor has the potential to be an effective method for the treatment of diverse tumor types.">
    <entity charOffset="150-155" id="s3778.e0" ontology_id="1487" text="CtBP1" type="GENE"/>
    <entity charOffset="241-246" id="s3778.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3778.e0" e2="s3778.e1" id="s3778.p0" relation="true"/>
  </sentence>
  <sentence id="s3779" text="Fanconi anemia (FA) is a rare disease characterized by bone marrow failure, developmental abnormalities, and increased cancer risk that is caused by defective repair of DNA interstrand crosslinks (ICLs).">
    <entity charOffset="16-18" id="s3779.e0" ontology_id="2395" text="FA" type="GENE"/>
    <entity charOffset="119-125" id="s3779.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3779.e0" e2="s3779.e1" id="s3779.p0" relation="true"/>
  </sentence>
  <sentence id="s3780" text="Progressive retinal atrophy (PRA) in dogs, the canine equivalent of retinitis pigmentosa (RP) in humans, is characterised by vision loss due to degeneration of the photoreceptor cells in the retina, eventually leading to complete blindness.">
    <entity charOffset="12-27" id="s3780.e0" ontology_id="HP_0001105" text="retinal atrophy" type="HP"/>
    <entity charOffset="29-32" id="s3780.e1" ontology_id="6277" text="PRA" type="GENE"/>
    <pair e1="s3780.e0" e2="s3780.e1" id="s3780.p0" relation="true"/>
  </sentence>
  <sentence id="s3781" text="Progressive retinal atrophy (PRA) in dogs, the canine equivalent of retinitis pigmentosa (RP) in humans, is characterised by vision loss due to degeneration of the photoreceptor cells in the retina, eventually leading to complete blindness.">
    <entity charOffset="29-32" id="s3781.e0" ontology_id="6277" text="PRA" type="GENE"/>
    <entity charOffset="230-239" id="s3781.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s3781.e0" e2="s3781.e1" id="s3781.p0" relation="true"/>
  </sentence>
  <sentence id="s3782" text="Mutations in the PGAP2 gene cause hyperphosphatasia mental retardation syndrome-3.">
    <entity charOffset="17-22" id="s3782.e0" ontology_id="27315" text="PGAP2" type="GENE"/>
    <entity charOffset="34-51" id="s3782.e1" ontology_id="HP_0003155" text="hyperphosphatasia" type="HP"/>
    <pair e1="s3782.e0" e2="s3782.e1" id="s3782.p0" relation="true"/>
  </sentence>
  <sentence id="s3783" text="The genetic diagnosis is difficult owing to the large genetic heterogeneity of the 6p21.3 region, which contains the CYP21A2 gene, especially with respect to the use of new-generation techniques of sequencing.">
    <entity charOffset="62-75" id="s3783.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="117-124" id="s3783.e1" ontology_id="1589" text="CYP21A2" type="GENE"/>
    <pair e1="s3783.e0" e2="s3783.e1" id="s3783.p0" relation="true"/>
  </sentence>
  <sentence id="s3784" text="By real-time PCR and analysis of GEO database, we determined the up-regulated expression of miR-135b-5p in pancreatic cancer tissues and cell lines.">
    <entity charOffset="92-95" id="s3784.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="118-124" id="s3784.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3784.e0" e2="s3784.e1" id="s3784.p0" relation="true"/>
  </sentence>
  <sentence id="s3785" text="Functionally, Transwell assays indicated that miR-135b-5p was a promoter for migration and invasion of pancreatic cancer cells.">
    <entity charOffset="46-49" id="s3785.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="114-120" id="s3785.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3785.e0" e2="s3785.e1" id="s3785.p0" relation="true"/>
  </sentence>
  <sentence id="s3786" text="Additionally, immunohistochemistry staining and Western blot showed that highly expressed miR-135b-5p accelerated EMT process of pancreatic cancer cells.">
    <entity charOffset="90-93" id="s3786.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="140-146" id="s3786.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3786.e0" e2="s3786.e1" id="s3786.p0" relation="true"/>
  </sentence>
  <sentence id="s3787" text="Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of miR-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the tumor cells migration, invasion and EMT.">
    <entity charOffset="146-149" id="s3787.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="172-178" id="s3787.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3787.e0" e2="s3787.e1" id="s3787.p0" relation="true"/>
  </sentence>
  <sentence id="s3788" text="Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of miR-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the tumor cells migration, invasion and EMT.">
    <entity charOffset="146-149" id="s3788.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="240-245" id="s3788.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3788.e0" e2="s3788.e1" id="s3788.p0" relation="true"/>
  </sentence>
  <sentence id="s3789" text="Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of miR-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the tumor cells migration, invasion and EMT.">
    <entity charOffset="240-245" id="s3789.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="276-279" id="s3789.e1" ontology_id="3702" text="EMT" type="GENE"/>
    <pair e1="s3789.e0" e2="s3789.e1" id="s3789.p0" relation="true"/>
  </sentence>
  <sentence id="s3790" text="In conclusion, miR-135b-5p, maybe a novel therapeutic target for pancreatic cancer, promoted migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2">
    <entity charOffset="15-18" id="s3790.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="76-82" id="s3790.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3790.e0" e2="s3790.e1" id="s3790.p0" relation="true"/>
  </sentence>
  <sentence id="s3791" text="Similar to the human phenotype, &lt;i&gt;Lima1&lt;/i&gt;-deficient mice displayed reduced cholesterol absorption and were resistant to diet-induced hypercholesterolemia.">
    <entity charOffset="35-40" id="s3791.e0" ontology_id="51474" text="Lima1" type="GENE"/>
    <entity charOffset="136-156" id="s3791.e1" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <pair e1="s3791.e0" e2="s3791.e1" id="s3791.p0" relation="true"/>
  </sentence>
  <sentence id="s3792" text="Transplantation of rod photoreceptors, derived either from neonatal retinae or pluripotent stem cells (PSCs), can restore rod-mediated visual function in murine models of inherited blindness.">
    <entity charOffset="19-22" id="s3792.e0" ontology_id="9735" text="rod" type="GENE"/>
    <entity charOffset="181-190" id="s3792.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s3792.e0" e2="s3792.e1" id="s3792.p0" relation="true"/>
  </sentence>
  <sentence id="s3793" text="The human Shwachman-Diamond syndrome (SDS) is an autosomal recessive disease caused by mutations in a highly conserved ribosome assembly factor SBDS.">
    <entity charOffset="49-68" id="s3793.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="144-148" id="s3793.e1" ontology_id="51119" text="SBDS" type="GENE"/>
    <pair e1="s3793.e0" e2="s3793.e1" id="s3793.p0" relation="true"/>
  </sentence>
  <sentence id="s3794" text="We further identified a reciprocal connection of HKDC1 to the clock in the primary tumor, which is lost in the metastatic cells.">
    <entity charOffset="49-54" id="s3794.e0" ontology_id="80201" text="HKDC1" type="GENE"/>
    <entity charOffset="83-88" id="s3794.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3794.e0" e2="s3794.e1" id="s3794.p0" relation="true"/>
  </sentence>
  <sentence id="s3795" text="Joubert syndrome exhibits genetic heterogeneity, with mutations identified in more than 30 genes, including INPP5E, a gene encoding inositol polyphosphate 5-phosphatase E, which is important in the development and stability of the primary cilium.">
    <entity charOffset="34-47" id="s3795.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="108-114" id="s3795.e1" ontology_id="23203" text="INPP5E" type="GENE"/>
    <pair e1="s3795.e0" e2="s3795.e1" id="s3795.p0" relation="true"/>
  </sentence>
  <sentence id="s3796" text="A pathogenic R474Q mutation of LGI1, which does not exceptionallyaffect either the secretion or the ADAM22 binding, is located in the LGI1-LGI1 interface and disrupts the higher-order assembly of the LGI1-ADAM22 complex in vitro and in a mouse model for familial epilepsy.">
    <entity charOffset="31-35" id="s3796.e0" ontology_id="9211" text="LGI1" type="GENE"/>
    <entity charOffset="264-272" id="s3796.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3796.e0" e2="s3796.e1" id="s3796.p0" relation="true"/>
  </sentence>
  <sentence id="s3797" text="A pathogenic R474Q mutation of LGI1, which does not exceptionallyaffect either the secretion or the ADAM22 binding, is located in the LGI1-LGI1 interface and disrupts the higher-order assembly of the LGI1-ADAM22 complex in vitro and in a mouse model for familial epilepsy.">
    <entity charOffset="101-107" id="s3797.e0" ontology_id="53616" text="ADAM22" type="GENE"/>
    <entity charOffset="264-272" id="s3797.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3797.e0" e2="s3797.e1" id="s3797.p0" relation="true"/>
  </sentence>
  <sentence id="s3798" text="Haplotype GAT for GRM6 markers rs2067011-rs2645339-rs762724 showed significance (P=0.0239), but such association did not remain significant after multiple testing corrections.ConclusionsOur data suggested that genetic variants in GRM6 are associated with high myopia.">
    <entity charOffset="18-22" id="s3798.e0" ontology_id="2916" text="GRM6" type="GENE"/>
    <entity charOffset="260-266" id="s3798.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s3798.e0" e2="s3798.e1" id="s3798.p0" relation="true"/>
  </sentence>
  <sentence id="s3799" text="The mechanism of GRM6 in the development of high myopia need to be further investigated.">
    <entity charOffset="17-21" id="s3799.e0" ontology_id="2916" text="GRM6" type="GENE"/>
    <entity charOffset="49-55" id="s3799.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s3799.e0" e2="s3799.e1" id="s3799.p0" relation="true"/>
  </sentence>
  <sentence id="s3800" text="The molecular chaperone Hsp90 is overexpressed in prostate cancer (PCa) and is responsible for the folding, stabilization and maturation of multiple oncoproteins, which are implicated in PCa progression.">
    <entity charOffset="24-29" id="s3800.e0" ontology_id="3320" text="Hsp90" type="GENE"/>
    <entity charOffset="59-65" id="s3800.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3800.e0" e2="s3800.e1" id="s3800.p0" relation="true"/>
  </sentence>
  <sentence id="s3801" text="The molecular chaperone Hsp90 is overexpressed in prostate cancer (PCa) and is responsible for the folding, stabilization and maturation of multiple oncoproteins, which are implicated in PCa progression.">
    <entity charOffset="59-65" id="s3801.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-70" id="s3801.e1" ontology_id="28982" text="PCa" type="GENE"/>
    <pair e1="s3801.e0" e2="s3801.e1" id="s3801.p0" relation="true"/>
  </sentence>
  <sentence id="s3802" text="This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="64-69" id="s3802.e0" ontology_id="5017" text="OVOL1" type="GENE"/>
    <entity charOffset="199-205" id="s3802.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3802.e0" e2="s3802.e1" id="s3802.p0" relation="true"/>
  </sentence>
  <sentence id="s3803" text="This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="64-69" id="s3803.e0" ontology_id="5017" text="OVOL1" type="GENE"/>
    <entity charOffset="216-239" id="s3803.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3803.e0" e2="s3803.e1" id="s3803.p0" relation="true"/>
  </sentence>
  <sentence id="s3804" text="This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="70-75" id="s3804.e0" ontology_id="58495" text="OVOL2" type="GENE"/>
    <entity charOffset="199-205" id="s3804.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3804.e0" e2="s3804.e1" id="s3804.p0" relation="true"/>
  </sentence>
  <sentence id="s3805" text="This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="70-75" id="s3805.e0" ontology_id="58495" text="OVOL2" type="GENE"/>
    <entity charOffset="244-262" id="s3805.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3805.e0" e2="s3805.e1" id="s3805.p0" relation="true"/>
  </sentence>
  <sentence id="s3806" text="Across the years the CCNs have been increasingly implicated in the development of obesity, diabetes and its complications.">
    <entity charOffset="21-25" id="s3806.e0" ontology_id="81669" text="CCNs" type="GENE"/>
    <entity charOffset="82-89" id="s3806.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3806.e0" e2="s3806.e1" id="s3806.p0" relation="true"/>
  </sentence>
  <sentence id="s3807" text="Key steps where CCNs may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where CCN2 inhibits fat cell differentiation in vitro and CCN3 may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.">
    <entity charOffset="16-20" id="s3807.e0" ontology_id="81669" text="CCNs" type="GENE"/>
    <entity charOffset="71-78" id="s3807.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3807.e0" e2="s3807.e1" id="s3807.p0" relation="true"/>
  </sentence>
  <sentence id="s3808" text="Key steps where CCNs may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where CCN2 inhibits fat cell differentiation in vitro and CCN3 may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.">
    <entity charOffset="71-78" id="s3808.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="109-113" id="s3808.e1" ontology_id="1490" text="CCN2" type="GENE"/>
    <pair e1="s3808.e0" e2="s3808.e1" id="s3808.p0" relation="true"/>
  </sentence>
  <sentence id="s3809" text="Key steps where CCNs may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where CCN2 inhibits fat cell differentiation in vitro and CCN3 may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.">
    <entity charOffset="71-78" id="s3809.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="123-126" id="s3809.e1" ontology_id="948" text="fat" type="GENE"/>
    <pair e1="s3809.e0" e2="s3809.e1" id="s3809.p0" relation="true"/>
  </sentence>
  <sentence id="s3810" text="Key steps where CCNs may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where CCN2 inhibits fat cell differentiation in vitro and CCN3 may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.">
    <entity charOffset="71-78" id="s3810.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="161-165" id="s3810.e1" ontology_id="5361" text="CCN3" type="GENE"/>
    <pair e1="s3810.e0" e2="s3810.e1" id="s3810.p0" relation="true"/>
  </sentence>
  <sentence id="s3811" text="Taken together, we show here that mutations leading either to BCL11B haploinsufficiency or to a truncated BCL11B protein clinically cause a non-syndromic neurodevelopmental delay.">
    <entity charOffset="62-68" id="s3811.e0" ontology_id="64919" text="BCL11B" type="GENE"/>
    <entity charOffset="159-178" id="s3811.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s3811.e0" e2="s3811.e1" id="s3811.p0" relation="true"/>
  </sentence>
  <sentence id="s3812" text="TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="28-33" id="s3812.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="67-70" id="s3812.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s3812.e0" e2="s3812.e1" id="s3812.p0" relation="true"/>
  </sentence>
  <sentence id="s3813" text="TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="28-33" id="s3813.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="307-310" id="s3813.e1" ontology_id="3702" text="EMT" type="GENE"/>
    <pair e1="s3813.e0" e2="s3813.e1" id="s3813.p0" relation="false"/>
  </sentence>
  <sentence id="s3814" text="TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="28-33" id="s3814.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="334-342" id="s3814.e1" ontology_id="1015" text="cadherin" type="GENE"/>
    <pair e1="s3814.e0" e2="s3814.e1" id="s3814.p0" relation="false"/>
  </sentence>
  <sentence id="s3815" text="TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="28-33" id="s3815.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="379-383" id="s3815.e1" ontology_id="6591" text="Slug" type="GENE"/>
    <pair e1="s3815.e0" e2="s3815.e1" id="s3815.p0" relation="true"/>
  </sentence>
  <sentence id="s3816" text="For individual RP patients, our study may help to predict time-courses for Pde6a-related retinal degeneration and thereby facilitate the definition of a window-of-opportunity for clinical interventions.">
    <entity charOffset="75-80" id="s3816.e0" ontology_id="5145" text="Pde6a" type="GENE"/>
    <entity charOffset="89-109" id="s3816.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s3816.e0" e2="s3816.e1" id="s3816.p0" relation="true"/>
  </sentence>
  <sentence id="s3817" text="Some aspects of the disease are now well known, such as nephrocalcinosis and craniosynostosis, related to the natural course of the disease, which persisted despite the ERT.">
    <entity charOffset="56-72" id="s3817.e0" ontology_id="HP_0000121" text="nephrocalcinosis" type="HP"/>
    <entity charOffset="169-172" id="s3817.e1" ontology_id="1999" text="ERT" type="GENE"/>
    <pair e1="s3817.e0" e2="s3817.e1" id="s3817.p0" relation="false"/>
  </sentence>
  <sentence id="s3818" text="Some aspects of the disease are now well known, such as nephrocalcinosis and craniosynostosis, related to the natural course of the disease, which persisted despite the ERT.">
    <entity charOffset="77-93" id="s3818.e0" ontology_id="HP_0001363" text="craniosynostosis" type="HP"/>
    <entity charOffset="169-172" id="s3818.e1" ontology_id="1999" text="ERT" type="GENE"/>
    <pair e1="s3818.e0" e2="s3818.e1" id="s3818.p0" relation="false"/>
  </sentence>
  <sentence id="s3819" text="BMPR1B is known to be responsible for autosomal dominant brachydactyly and autosomal recessive acromesomelic chondrodysplasia.">
    <entity charOffset="0-6" id="s3819.e0" ontology_id="658" text="BMPR1B" type="GENE"/>
    <entity charOffset="57-70" id="s3819.e1" ontology_id="HP_0001156" text="brachydactyly" type="HP"/>
    <pair e1="s3819.e0" e2="s3819.e1" id="s3819.p0" relation="true"/>
  </sentence>
  <sentence id="s3820" text="BMPR1B is known to be responsible for autosomal dominant brachydactyly and autosomal recessive acromesomelic chondrodysplasia.">
    <entity charOffset="0-6" id="s3820.e0" ontology_id="658" text="BMPR1B" type="GENE"/>
    <entity charOffset="75-94" id="s3820.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3820.e0" e2="s3820.e1" id="s3820.p0" relation="true"/>
  </sentence>
  <sentence id="s3821" text="This study establishes PYROXD1 variants as a cause of early-onset myopathy and uses biospecimens and cell lines, yeast, and zebrafish models to elucidate the fundamental role of PYROXD1 in skeletal muscle.">
    <entity charOffset="23-30" id="s3821.e0" ontology_id="79912" text="PYROXD1" type="GENE"/>
    <entity charOffset="66-74" id="s3821.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3821.e0" e2="s3821.e1" id="s3821.p0" relation="true"/>
  </sentence>
  <sentence id="s3822" text="We characterize variants in the oxidoreductase PYROXD1 as a cause of early-onset myopathy with distinctive histopathology and introduce altered redox regulation as a primary cause of congenital muscle disease">
    <entity charOffset="47-54" id="s3822.e0" ontology_id="79912" text="PYROXD1" type="GENE"/>
    <entity charOffset="81-89" id="s3822.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3822.e0" e2="s3822.e1" id="s3822.p0" relation="true"/>
  </sentence>
  <sentence id="s3823" text="Mutations of FIG4 result in the inherited disorders Charcot-Marie-Tooth disease type 4J, Yunis-Varn syndrome, and polymicrogyria with seizures.">
    <entity charOffset="13-17" id="s3823.e0" ontology_id="9896" text="FIG4" type="GENE"/>
    <entity charOffset="135-143" id="s3823.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s3823.e0" e2="s3823.e1" id="s3823.p0" relation="true"/>
  </sentence>
  <sentence id="s3824" text="Conversely, Tsc1 loss led to the early-onset death of cochlear hair cells and consequently accelerated hearing loss.">
    <entity charOffset="12-16" id="s3824.e0" ontology_id="7248" text="Tsc1" type="GENE"/>
    <entity charOffset="103-115" id="s3824.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3824.e0" e2="s3824.e1" id="s3824.p0" relation="true"/>
  </sentence>
  <sentence id="s3825" text="C1QBP deficiency represents an important mitochondrial disorder associated with a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio)myopathy and late-onset progressive external ophthalmoplegia">
    <entity charOffset="0-5" id="s3825.e0" ontology_id="708" text="C1QBP" type="GENE"/>
    <entity charOffset="160-168" id="s3825.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3825.e0" e2="s3825.e1" id="s3825.p0" relation="true"/>
  </sentence>
  <sentence id="s3826" text="C1QBP deficiency represents an important mitochondrial disorder associated with a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio)myopathy and late-onset progressive external ophthalmoplegia">
    <entity charOffset="0-5" id="s3826.e0" ontology_id="708" text="C1QBP" type="GENE"/>
    <entity charOffset="184-195" id="s3826.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s3826.e0" e2="s3826.e1" id="s3826.p0" relation="true"/>
  </sentence>
  <sentence id="s3827" text="We thus provide evidence that PCP signaling can act in a context dependent manner to promote breast cancer progression.">
    <entity charOffset="30-33" id="s3827.e0" ontology_id="54858" text="PCP" type="GENE"/>
    <entity charOffset="100-106" id="s3827.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3827.e0" e2="s3827.e1" id="s3827.p0" relation="true"/>
  </sentence>
  <sentence id="s3828" text="We thus provide evidence that PCP signaling can act in a context dependent manner to promote breast cancer progression.">
    <entity charOffset="48-51" id="s3828.e0" ontology_id="11332" text="act" type="GENE"/>
    <entity charOffset="100-106" id="s3828.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3828.e0" e2="s3828.e1" id="s3828.p0" relation="true"/>
  </sentence>
  <sentence id="s3829" text="The mutational analysis of the whole mitochondrial DNA revealed the presence of m.1555A&amp;gt;G mutation in MT-RNR1 gene associated to the m.8527A&amp;gt;G (p.M&amp;gt;V) and the m.8392C&amp;gt;T (p.136P&amp;gt;S) variations in the mitochondrial MT-ATP6 gene in patient1 and his family members with variable phenotype including hearing impairment.">
    <entity charOffset="227-234" id="s3829.e0" ontology_id="100287745" text="MT-ATP6" type="GENE"/>
    <entity charOffset="309-327" id="s3829.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s3829.e0" e2="s3829.e1" id="s3829.p0" relation="true"/>
  </sentence>
  <sentence id="s3830" text="Prostate cancer (PCa) is one of the most common types of cancer in the urinary system in men.">
    <entity charOffset="9-15" id="s3830.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="17-20" id="s3830.e1" ontology_id="28982" text="PCa" type="GENE"/>
    <pair e1="s3830.e0" e2="s3830.e1" id="s3830.p0" relation="true"/>
  </sentence>
  <sentence id="s3831" text="These tumors often exhibit a plasmablastic morphology, a finding which prompted our interest in looking for ALK fusions in plasma cell neoplasms.">
    <entity charOffset="6-12" id="s3831.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="108-111" id="s3831.e1" ontology_id="238" text="ALK" type="GENE"/>
    <pair e1="s3831.e0" e2="s3831.e1" id="s3831.p0" relation="true"/>
  </sentence>
  <sentence id="s3832" text="These tumors often exhibit a plasmablastic morphology, a finding which prompted our interest in looking for ALK fusions in plasma cell neoplasms.">
    <entity charOffset="108-111" id="s3832.e0" ontology_id="238" text="ALK" type="GENE"/>
    <entity charOffset="135-144" id="s3832.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s3832.e0" e2="s3832.e1" id="s3832.p0" relation="true"/>
  </sentence>
  <sentence id="s3833" text="Biallelic loss-of-function mutations in TYROBP and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).">
    <entity charOffset="40-46" id="s3833.e0" ontology_id="7305" text="TYROBP" type="GENE"/>
    <entity charOffset="105-128" id="s3833.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s3833.e0" e2="s3833.e1" id="s3833.p0" relation="true"/>
  </sentence>
  <sentence id="s3834" text="Biallelic loss-of-function mutations in TYROBP and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).">
    <entity charOffset="40-46" id="s3834.e0" ontology_id="7305" text="TYROBP" type="GENE"/>
    <entity charOffset="211-230" id="s3834.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s3834.e0" e2="s3834.e1" id="s3834.p0" relation="true"/>
  </sentence>
  <sentence id="s3835" text="Bcl2-associated athanogene 3 (BAG3) mutations have been reported to cause the myofibrillar myopathy (MFM) which shows progressive limb muscle weakness, respiratory failure, and cardiomyopathy.">
    <entity charOffset="30-34" id="s3835.e0" ontology_id="9531" text="BAG3" type="GENE"/>
    <entity charOffset="91-99" id="s3835.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3835.e0" e2="s3835.e1" id="s3835.p0" relation="true"/>
  </sentence>
  <sentence id="s3836" text="We found BAG3 mutation in one patient with neuropathy, myopathy and rigid spine syndrome, and performed electrophysiological study, whole body MRI and muscle biopsy on the patient.">
    <entity charOffset="9-13" id="s3836.e0" ontology_id="9531" text="BAG3" type="GENE"/>
    <entity charOffset="55-63" id="s3836.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3836.e0" e2="s3836.e1" id="s3836.p0" relation="true"/>
  </sentence>
  <sentence id="s3837" text="She showed an axonal sensory-motor polyneuropathy like Charcot-Marie-Tooth disease (CMT), myopathy, rigid spine and respiratory dysfunction; however, she did not show any cardiomyopathy, which is a common symptom in BAG3 mutation.">
    <entity charOffset="35-49" id="s3837.e0" ontology_id="HP_0001271" text="polyneuropathy" type="HP"/>
    <entity charOffset="216-220" id="s3837.e1" ontology_id="9531" text="BAG3" type="GENE"/>
    <pair e1="s3837.e0" e2="s3837.e1" id="s3837.p0" relation="true"/>
  </sentence>
  <sentence id="s3838" text="We described a BAG3 mutation patient with atypical phenotype of CMT and myopathy, and those are expected to broaden the clinical spectrum of the disease and help to diagnose it">
    <entity charOffset="15-19" id="s3838.e0" ontology_id="9531" text="BAG3" type="GENE"/>
    <entity charOffset="72-80" id="s3838.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3838.e0" e2="s3838.e1" id="s3838.p0" relation="true"/>
  </sentence>
  <sentence id="s3839" text="Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.">
    <entity charOffset="28-33" id="s3839.e0" ontology_id="23590" text="PDSS1" type="GENE"/>
    <entity charOffset="120-133" id="s3839.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3839.e0" e2="s3839.e1" id="s3839.p0" relation="true"/>
  </sentence>
  <sentence id="s3840" text="Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.">
    <entity charOffset="42-46" id="s3840.e0" ontology_id="27235" text="COQ2" type="GENE"/>
    <entity charOffset="120-133" id="s3840.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3840.e0" e2="s3840.e1" id="s3840.p0" relation="true"/>
  </sentence>
  <sentence id="s3841" text="Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.">
    <entity charOffset="54-58" id="s3841.e0" ontology_id="51004" text="COQ6" type="GENE"/>
    <entity charOffset="120-133" id="s3841.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3841.e0" e2="s3841.e1" id="s3841.p0" relation="true"/>
  </sentence>
  <sentence id="s3842" text="We have previously identified a role for the secreted serine protease PRSS56 in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and myopia, highlighting its importance in refractive development.">
    <entity charOffset="70-76" id="s3842.e0" ontology_id="646960" text="PRSS56" type="GENE"/>
    <entity charOffset="171-180" id="s3842.e1" ontology_id="HP_0000540" text="hyperopia" type="HP"/>
    <pair e1="s3842.e0" e2="s3842.e1" id="s3842.p0" relation="true"/>
  </sentence>
  <sentence id="s3843" text="Here, we use a combination of genetic mouse models to demonstrate that Prss56 mutations leading to reduced ocular size and hyperopia act via a loss of function mechanism.">
    <entity charOffset="71-77" id="s3843.e0" ontology_id="646960" text="Prss56" type="GENE"/>
    <entity charOffset="123-132" id="s3843.e1" ontology_id="HP_0000540" text="hyperopia" type="HP"/>
    <pair e1="s3843.e0" e2="s3843.e1" id="s3843.p0" relation="true"/>
  </sentence>
  <sentence id="s3844" text="Overall, our findings identify PRSS56 as a potential therapeutic target for modulating ocular growth aimed at preventing or slowing down myopia, which is reaching epidemic proportions">
    <entity charOffset="31-37" id="s3844.e0" ontology_id="646960" text="PRSS56" type="GENE"/>
    <entity charOffset="137-143" id="s3844.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s3844.e0" e2="s3844.e1" id="s3844.p0" relation="true"/>
  </sentence>
  <sentence id="s3845" text="Their seizures started within the first day and could not be controlled by pyridoxine or pyridoxal-5'-phosphate (PLP) completely.">
    <entity charOffset="6-14" id="s3845.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="113-116" id="s3845.e1" ontology_id="5354" text="PLP" type="GENE"/>
    <pair e1="s3845.e0" e2="s3845.e1" id="s3845.p0" relation="true"/>
  </sentence>
  <sentence id="s3846" text="With particular relevance for muscle physiology, mutations in TRIM32 are associated with autosomal recessive Limb-Girdle Muscular Dystrophy 2H, a muscle-wasting disease with variable clinical spectrum ranging from almost asymptomatic to wheelchair-bound patients.">
    <entity charOffset="62-68" id="s3846.e0" ontology_id="22954" text="TRIM32" type="GENE"/>
    <entity charOffset="89-108" id="s3846.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3846.e0" e2="s3846.e1" id="s3846.p0" relation="true"/>
  </sentence>
  <sentence id="s3847" text="Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic disease caused by expansion of a stem cell that harbors a somatic mutation in &lt;i&gt;PIGA&lt;/i&gt; PIGA mutant blood cells are deficient in the complement regulator proteins CD55 and CD59, making them susceptible to intravascular hemolysis due to a failure to regulate the APC on erythrocytes.">
    <entity charOffset="126-142" id="s3847.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="332-335" id="s3847.e1" ontology_id="324" text="APC" type="GENE"/>
    <pair e1="s3847.e0" e2="s3847.e1" id="s3847.p0" relation="true"/>
  </sentence>
  <sentence id="s3848" text="Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic disease caused by expansion of a stem cell that harbors a somatic mutation in &lt;i&gt;PIGA&lt;/i&gt; PIGA mutant blood cells are deficient in the complement regulator proteins CD55 and CD59, making them susceptible to intravascular hemolysis due to a failure to regulate the APC on erythrocytes.">
    <entity charOffset="126-142" id="s3848.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="149-153" id="s3848.e1" ontology_id="5277" text="PIGA" type="GENE"/>
    <pair e1="s3848.e0" e2="s3848.e1" id="s3848.p0" relation="true"/>
  </sentence>
  <sentence id="s3849" text="the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the light sensitivity and adaptation in intact rods; 2. functional differences between GCAP1 and GCAP2 in intact rod photoreceptors; and 3. whether GCAP mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies">
    <entity charOffset="75-80" id="s3849.e0" ontology_id="8740" text="light" type="GENE"/>
    <entity charOffset="267-282" id="s3849.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s3849.e0" e2="s3849.e1" id="s3849.p0" relation="true"/>
  </sentence>
  <sentence id="s3850" text="the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the light sensitivity and adaptation in intact rods; 2. functional differences between GCAP1 and GCAP2 in intact rod photoreceptors; and 3. whether GCAP mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies">
    <entity charOffset="158-163" id="s3850.e0" ontology_id="2978" text="GCAP1" type="GENE"/>
    <entity charOffset="267-282" id="s3850.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s3850.e0" e2="s3850.e1" id="s3850.p0" relation="true"/>
  </sentence>
  <sentence id="s3851" text="the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the light sensitivity and adaptation in intact rods; 2. functional differences between GCAP1 and GCAP2 in intact rod photoreceptors; and 3. whether GCAP mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies">
    <entity charOffset="168-173" id="s3851.e0" ontology_id="2979" text="GCAP2" type="GENE"/>
    <entity charOffset="267-282" id="s3851.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s3851.e0" e2="s3851.e1" id="s3851.p0" relation="true"/>
  </sentence>
  <sentence id="s3852" text="the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the light sensitivity and adaptation in intact rods; 2. functional differences between GCAP1 and GCAP2 in intact rod photoreceptors; and 3. whether GCAP mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies">
    <entity charOffset="219-223" id="s3852.e0" ontology_id="2978" text="GCAP" type="GENE"/>
    <entity charOffset="267-282" id="s3852.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s3852.e0" e2="s3852.e1" id="s3852.p0" relation="true"/>
  </sentence>
  <sentence id="s3853" text="Our data support ARV1 deficiency as a cause of autosomal recessive epileptic encephalopathy">
    <entity charOffset="17-21" id="s3853.e0" ontology_id="64801" text="ARV1" type="GENE"/>
    <entity charOffset="47-66" id="s3853.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3853.e0" e2="s3853.e1" id="s3853.p0" relation="true"/>
  </sentence>
  <sentence id="s3854" text="The major question to be solved is the genetic basis of bilateral adrenal hyperplasia (BAH).">
    <entity charOffset="66-85" id="s3854.e0" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <entity charOffset="87-90" id="s3854.e1" ontology_id="444" text="BAH" type="GENE"/>
    <pair e1="s3854.e0" e2="s3854.e1" id="s3854.p0" relation="true"/>
  </sentence>
  <sentence id="s3855" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.">
    <entity charOffset="58-77" id="s3855.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="226-233" id="s3855.e1" ontology_id="1302" text="COL11A2" type="GENE"/>
    <pair e1="s3855.e0" e2="s3855.e1" id="s3855.p0" relation="true"/>
  </sentence>
  <sentence id="s3856" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.">
    <entity charOffset="58-77" id="s3856.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="248-254" id="s3856.e1" ontology_id="222662" text="DFNB67" type="GENE"/>
    <pair e1="s3856.e0" e2="s3856.e1" id="s3856.p0" relation="true"/>
  </sentence>
  <sentence id="s3857" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.">
    <entity charOffset="91-103" id="s3857.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="226-233" id="s3857.e1" ontology_id="1302" text="COL11A2" type="GENE"/>
    <pair e1="s3857.e0" e2="s3857.e1" id="s3857.p0" relation="true"/>
  </sentence>
  <sentence id="s3858" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.">
    <entity charOffset="91-103" id="s3858.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="248-254" id="s3858.e1" ontology_id="222662" text="DFNB67" type="GENE"/>
    <pair e1="s3858.e0" e2="s3858.e1" id="s3858.p0" relation="true"/>
  </sentence>
  <sentence id="s3859" text="Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &amp;quot;hurry scurry&amp;quot; mouse and in two DFNB67-linked families from Pakistan.">
    <entity charOffset="22-28" id="s3859.e0" ontology_id="1302" text="DFNB53" type="GENE"/>
    <entity charOffset="90-96" id="s3859.e1" ontology_id="HP_0012032" text="lipoma" type="HP"/>
    <pair e1="s3859.e0" e2="s3859.e1" id="s3859.p0" relation="true"/>
  </sentence>
  <sentence id="s3860" text="Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &amp;quot;hurry scurry&amp;quot; mouse and in two DFNB67-linked families from Pakistan.">
    <entity charOffset="90-96" id="s3860.e0" ontology_id="HP_0012032" text="lipoma" type="HP"/>
    <entity charOffset="97-102" id="s3860.e1" ontology_id="8091" text="HMGIC" type="GENE"/>
    <pair e1="s3860.e0" e2="s3860.e1" id="s3860.p0" relation="true"/>
  </sentence>
  <sentence id="s3861" text="Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &amp;quot;hurry scurry&amp;quot; mouse and in two DFNB67-linked families from Pakistan.">
    <entity charOffset="90-96" id="s3861.e0" ontology_id="HP_0012032" text="lipoma" type="HP"/>
    <entity charOffset="151-160" id="s3861.e1" ontology_id="7106" text="tetraspan" type="GENE"/>
    <pair e1="s3861.e0" e2="s3861.e1" id="s3861.p0" relation="true"/>
  </sentence>
  <sentence id="s3862" text="Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &amp;quot;hurry scurry&amp;quot; mouse and in two DFNB67-linked families from Pakistan.">
    <entity charOffset="90-96" id="s3862.e0" ontology_id="HP_0012032" text="lipoma" type="HP"/>
    <entity charOffset="204-208" id="s3862.e1" ontology_id="222662" text="TMHS" type="GENE"/>
    <pair e1="s3862.e0" e2="s3862.e1" id="s3862.p0" relation="true"/>
  </sentence>
  <sentence id="s3863" text="Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &amp;quot;hurry scurry&amp;quot; mouse and in two DFNB67-linked families from Pakistan.">
    <entity charOffset="90-96" id="s3863.e0" ontology_id="HP_0012032" text="lipoma" type="HP"/>
    <entity charOffset="304-310" id="s3863.e1" ontology_id="222662" text="DFNB67" type="GENE"/>
    <pair e1="s3863.e0" e2="s3863.e1" id="s3863.p0" relation="true"/>
  </sentence>
  <sentence id="s3864" text="Thus, the geographic imbalance in colorectal cancer, in part, may reflect chronic exposure to ST-producing organisms that restore GUCY2C signaling silenced by hormone loss during transformation.">
    <entity charOffset="45-51" id="s3864.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="130-136" id="s3864.e1" ontology_id="2984" text="GUCY2C" type="GENE"/>
    <pair e1="s3864.e0" e2="s3864.e1" id="s3864.p0" relation="true"/>
  </sentence>
  <sentence id="s3865" text="Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF) are rare tumors with distinct sets of morphological features, both characterized by MUC4 immunoreactivity.">
    <entity charOffset="22-29" id="s3865.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="168-172" id="s3865.e1" ontology_id="4585" text="MUC4" type="GENE"/>
    <pair e1="s3865.e0" e2="s3865.e1" id="s3865.p0" relation="true"/>
  </sentence>
  <sentence id="s3866" text="In the largest study of hybrid LGFMS-SEF tumors to date, all cases exhibited FUS rearrangements, a similar genetic profile to LGFMS.">
    <entity charOffset="41-47" id="s3866.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="77-80" id="s3866.e1" ontology_id="2521" text="FUS" type="GENE"/>
    <pair e1="s3866.e0" e2="s3866.e1" id="s3866.p0" relation="true"/>
  </sentence>
  <sentence id="s3867" text="Fusion gene detection using a next-generation sequencing-based anchored multiplex PCR technique (Archer FusionPlex Sarcoma Panel) was performed on both the primary renal tumor that showed the morphology of a LGFMS, and a cervical metastasis that showed the morphology of SEF.">
    <entity charOffset="170-175" id="s3867.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="271-274" id="s3867.e1" ontology_id="54756" text="SEF" type="GENE"/>
    <pair e1="s3867.e0" e2="s3867.e1" id="s3867.p0" relation="true"/>
  </sentence>
  <sentence id="s3868" text="We show that hypermethylation of p16/Ink4a and p19/Arf in CNT- and asbestos-induced inflammatory lesions precedes mesothelioma; this results in silencing of Cdkn2a (Ink4a/Arf) and loss of p16 and p19 protein, consistent with epigenetic alterations playing a gatekeeper role in cancer.">
    <entity charOffset="157-163" id="s3868.e0" ontology_id="1029" text="Cdkn2a" type="GENE"/>
    <entity charOffset="277-283" id="s3868.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3868.e0" e2="s3868.e1" id="s3868.p0" relation="true"/>
  </sentence>
  <sentence id="s3869" text="B cell-associated protein 31 (BAP31) was shown to participate in the apoptosis, and to be an immunotherapy target and a, prognostic factor for cancer, but its role in CRC has not been elucidated.">
    <entity charOffset="30-35" id="s3869.e0" ontology_id="10134" text="BAP31" type="GENE"/>
    <entity charOffset="143-149" id="s3869.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3869.e0" e2="s3869.e1" id="s3869.p0" relation="true"/>
  </sentence>
  <sentence id="s3870" text="Gain-of-function mutations in iRHOM2 underlie Tylosis with oesophageal cancer (TOC), characterized by palmoplantar thickening, upregulate K16 with robust downregulation of its type II keratin binding partner, K6.">
    <entity charOffset="30-36" id="s3870.e0" ontology_id="79651" text="iRHOM2" type="GENE"/>
    <entity charOffset="71-77" id="s3870.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3870.e0" e2="s3870.e1" id="s3870.p0" relation="true"/>
  </sentence>
  <sentence id="s3871" text="Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disease that is caused by mutations in the &lt;i&gt;SACS&lt;/i&gt; gene.">
    <entity charOffset="28-34" id="s3871.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="59-65" id="s3871.e1" ontology_id="26278" text="ARSACS" type="GENE"/>
    <pair e1="s3871.e0" e2="s3871.e1" id="s3871.p0" relation="true"/>
  </sentence>
  <sentence id="s3872" text="Levels of serum CysC might become elevated regardless of renal function, and CysC-eGFR might become unpredictable during the active phase of tumors.">
    <entity charOffset="82-86" id="s3872.e0" ontology_id="1956" text="eGFR" type="GENE"/>
    <entity charOffset="141-146" id="s3872.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3872.e0" e2="s3872.e1" id="s3872.p0" relation="true"/>
  </sentence>
  <sentence id="s3873" text="The second most frequently mutated gene, histone methyltransferase &lt;i&gt;SETD2&lt;/i&gt;, has known roles in multiple cancers, but has not previously been strongly implicated in osteosarcoma.">
    <entity charOffset="70-75" id="s3873.e0" ontology_id="29072" text="SETD2" type="GENE"/>
    <entity charOffset="169-181" id="s3873.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s3873.e0" e2="s3873.e1" id="s3873.p0" relation="true"/>
  </sentence>
  <sentence id="s3874" text="The second most frequently mutated gene, histone methyltransferase &lt;i&gt;SETD2&lt;/i&gt;, has known roles in multiple cancers, but has not previously been strongly implicated in osteosarcoma.">
    <entity charOffset="70-75" id="s3874.e0" ontology_id="29072" text="SETD2" type="GENE"/>
    <entity charOffset="109-115" id="s3874.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3874.e0" e2="s3874.e1" id="s3874.p0" relation="true"/>
  </sentence>
  <sentence id="s3875" text="This study points to the likely importance of histone modifications in osteosarcoma and highlights the strong genetic similarities between human and dog osteosarcoma, suggesting that canine osteosarcoma may serve as an excellent model for developing treatment strategies in both species.&lt;b&gt;Significance:&lt;/b&gt; Canine osteosarcoma genomics identify SETD2 as a possible oncogenic driver of osteosarcoma, and findings establish the canine model as a useful comparative model for the corresponding human disease.">
    <entity charOffset="71-83" id="s3875.e0" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <entity charOffset="346-351" id="s3875.e1" ontology_id="29072" text="SETD2" type="GENE"/>
    <pair e1="s3875.e0" e2="s3875.e1" id="s3875.p0" relation="true"/>
  </sentence>
  <sentence id="s3876" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="0-3" id="s3876.e0" ontology_id="1536" text="CGD" type="GENE"/>
    <entity charOffset="161-180" id="s3876.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3876.e0" e2="s3876.e1" id="s3876.p0" relation="true"/>
  </sentence>
  <sentence id="s3877" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="21-34" id="s3877.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="111-115" id="s3877.e1" ontology_id="1536" text="CYBB" type="GENE"/>
    <pair e1="s3877.e0" e2="s3877.e1" id="s3877.p0" relation="true"/>
  </sentence>
  <sentence id="s3878" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="21-34" id="s3878.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="228-232" id="s3878.e1" ontology_id="653361" text="NCF1" type="GENE"/>
    <pair e1="s3878.e0" e2="s3878.e1" id="s3878.p0" relation="true"/>
  </sentence>
  <sentence id="s3879" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="21-34" id="s3879.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="234-238" id="s3879.e1" ontology_id="4688" text="NCF2" type="GENE"/>
    <pair e1="s3879.e0" e2="s3879.e1" id="s3879.p0" relation="false"/>
  </sentence>
  <sentence id="s3880" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="111-115" id="s3880.e0" ontology_id="1536" text="CYBB" type="GENE"/>
    <entity charOffset="161-180" id="s3880.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3880.e0" e2="s3880.e1" id="s3880.p0" relation="true"/>
  </sentence>
  <sentence id="s3881" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="161-180" id="s3881.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="234-238" id="s3881.e1" ontology_id="4688" text="NCF2" type="GENE"/>
    <pair e1="s3881.e0" e2="s3881.e1" id="s3881.p0" relation="true"/>
  </sentence>
  <sentence id="s3882" text="Triple-negative breast cancer (TNBC), lacking the steroid hormone receptors ER and PR and the oncoprotein HER2, is characterized by its aggressive pattern and insensitivity to endocrine and HER2-directed therapy.">
    <entity charOffset="23-29" id="s3882.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="106-110" id="s3882.e1" ontology_id="2064" text="HER2" type="GENE"/>
    <pair e1="s3882.e0" e2="s3882.e1" id="s3882.p0" relation="true"/>
  </sentence>
  <sentence id="s3883" text="KLK4 protein is localized in the cytoplasm of tumor and stroma cells.">
    <entity charOffset="0-4" id="s3883.e0" ontology_id="9622" text="KLK4" type="GENE"/>
    <entity charOffset="46-51" id="s3883.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3883.e0" e2="s3883.e1" id="s3883.p0" relation="true"/>
  </sentence>
  <sentence id="s3884" text="In this patient cohort, elevated stroma cell KLK4 expression, but not tumor cell KLK4 expression, is predictive for poor disease-free survival by univariate analysis (hazard ratio: 2.26, p=0.001) and multivariable analysis (hazard ratio: 2.12, p&amp;lt;0.01).">
    <entity charOffset="45-49" id="s3884.e0" ontology_id="9622" text="KLK4" type="GENE"/>
    <entity charOffset="70-75" id="s3884.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3884.e0" e2="s3884.e1" id="s3884.p0" relation="true"/>
  </sentence>
  <sentence id="s3885" text="Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).">
    <entity charOffset="60-64" id="s3885.e0" ontology_id="27125" text="AFF4" type="GENE"/>
    <entity charOffset="272-285" id="s3885.e1" ontology_id="HP_0000280" text="coarse facies" type="HP"/>
    <pair e1="s3885.e0" e2="s3885.e1" id="s3885.p0" relation="true"/>
  </sentence>
  <sentence id="s3886" text="Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).">
    <entity charOffset="60-64" id="s3886.e0" ontology_id="27125" text="AFF4" type="GENE"/>
    <entity charOffset="314-321" id="s3886.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3886.e0" e2="s3886.e1" id="s3886.p0" relation="true"/>
  </sentence>
  <sentence id="s3887" text="Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).">
    <entity charOffset="60-64" id="s3887.e0" ontology_id="27125" text="AFF4" type="GENE"/>
    <entity charOffset="361-374" id="s3887.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s3887.e0" e2="s3887.e1" id="s3887.p0" relation="false"/>
  </sentence>
  <sentence id="s3888" text="These results revealed that mutations in CCDC114 are a cause of ciliary dysmotility and PCD and further demonstrate the utility of exome sequencing to identify genetic causes in heterogeneous recessive disorders">
    <entity charOffset="41-48" id="s3888.e0" ontology_id="93233" text="CCDC114" type="GENE"/>
    <entity charOffset="178-191" id="s3888.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3888.e0" e2="s3888.e1" id="s3888.p0" relation="true"/>
  </sentence>
  <sentence id="s3889" text="These results revealed that mutations in CCDC114 are a cause of ciliary dysmotility and PCD and further demonstrate the utility of exome sequencing to identify genetic causes in heterogeneous recessive disorders">
    <entity charOffset="88-91" id="s3889.e0" ontology_id="352909" text="PCD" type="GENE"/>
    <entity charOffset="178-191" id="s3889.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3889.e0" e2="s3889.e1" id="s3889.p0" relation="true"/>
  </sentence>
  <sentence id="s3890" text="Prion proteins (PRNP and PRND), known mostly for its involvement in neurodegenerative spongiform encephalopathies, have been recently demonstrated to be involved in resistance to apoptosis, tumorigenesis, proliferation, and metastasis.">
    <entity charOffset="16-20" id="s3890.e0" ontology_id="5621" text="PRNP" type="GENE"/>
    <entity charOffset="97-113" id="s3890.e1" ontology_id="HP_0001298" text="encephalopathies" type="HP"/>
    <pair e1="s3890.e0" e2="s3890.e1" id="s3890.p0" relation="true"/>
  </sentence>
  <sentence id="s3891" text="Prion proteins (PRNP and PRND), known mostly for its involvement in neurodegenerative spongiform encephalopathies, have been recently demonstrated to be involved in resistance to apoptosis, tumorigenesis, proliferation, and metastasis.">
    <entity charOffset="25-29" id="s3891.e0" ontology_id="23627" text="PRND" type="GENE"/>
    <entity charOffset="97-113" id="s3891.e1" ontology_id="HP_0001298" text="encephalopathies" type="HP"/>
    <pair e1="s3891.e0" e2="s3891.e1" id="s3891.p0" relation="true"/>
  </sentence>
  <sentence id="s3892" text="PRNP and PRND are significantly over-expressed in osteosarcoma.">
    <entity charOffset="9-13" id="s3892.e0" ontology_id="23627" text="PRND" type="GENE"/>
    <entity charOffset="50-62" id="s3892.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s3892.e0" e2="s3892.e1" id="s3892.p0" relation="true"/>
  </sentence>
  <sentence id="s3893" text="PRNP and PRND appear involved with some important genes related to tumorigenesis and apoptosis.">
    <entity charOffset="0-4" id="s3893.e0" ontology_id="5621" text="PRNP" type="GENE"/>
    <entity charOffset="67-72" id="s3893.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3893.e0" e2="s3893.e1" id="s3893.p0" relation="true"/>
  </sentence>
  <sentence id="s3894" text="Alazami syndrome (AS) (MIM# 615071) is an autosomal recessive microcephalic primordial dwarfism (PD) with recognizable facial features and severe intellectual disability due to depletion or loss of function variants in LARP7.">
    <entity charOffset="42-61" id="s3894.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="219-224" id="s3894.e1" ontology_id="51574" text="LARP7" type="GENE"/>
    <pair e1="s3894.e0" e2="s3894.e1" id="s3894.p0" relation="true"/>
  </sentence>
  <sentence id="s3895" text="Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of TMPRSS7(P=0.0024; odds ratio, 0.37), rs2292661 of PDIA5 (P=0.0054; odds ratio, 0.35) and rs191885206 of CYP4F12 (P=0.0082; odds ratio, 2.60)] were related(P&amp;lt;0.01) to ischemic stroke.">
    <entity charOffset="68-71" id="s3895.e0" ontology_id="55558" text="sex" type="GENE"/>
    <entity charOffset="94-106" id="s3895.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s3895.e0" e2="s3895.e1" id="s3895.p0" relation="true"/>
  </sentence>
  <sentence id="s3896" text="Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of TMPRSS7(P=0.0024; odds ratio, 0.37), rs2292661 of PDIA5 (P=0.0054; odds ratio, 0.35) and rs191885206 of CYP4F12 (P=0.0082; odds ratio, 2.60)] were related(P&amp;lt;0.01) to ischemic stroke.">
    <entity charOffset="94-106" id="s3896.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="225-232" id="s3896.e1" ontology_id="344805" text="TMPRSS7" type="GENE"/>
    <pair e1="s3896.e0" e2="s3896.e1" id="s3896.p0" relation="true"/>
  </sentence>
  <sentence id="s3897" text="Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of TMPRSS7(P=0.0024; odds ratio, 0.37), rs2292661 of PDIA5 (P=0.0054; odds ratio, 0.35) and rs191885206 of CYP4F12 (P=0.0082; odds ratio, 2.60)] were related(P&amp;lt;0.01) to ischemic stroke.">
    <entity charOffset="94-106" id="s3897.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="276-281" id="s3897.e1" ontology_id="10954" text="PDIA5" type="GENE"/>
    <pair e1="s3897.e0" e2="s3897.e1" id="s3897.p0" relation="true"/>
  </sentence>
  <sentence id="s3898" text="Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of TMPRSS7(P=0.0024; odds ratio, 0.37), rs2292661 of PDIA5 (P=0.0054; odds ratio, 0.35) and rs191885206 of CYP4F12 (P=0.0082; odds ratio, 2.60)] were related(P&amp;lt;0.01) to ischemic stroke.">
    <entity charOffset="94-106" id="s3898.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="330-337" id="s3898.e1" ontology_id="66002" text="CYP4F12" type="GENE"/>
    <pair e1="s3898.e0" e2="s3898.e1" id="s3898.p0" relation="true"/>
  </sentence>
  <sentence id="s3899" text="Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension revealed that rs138533962 of STYK1 (P&amp;lt;1.0x10-23; odds ratio, 111.3) was significantly (P&amp;lt;2.60x10-4) associated with ICH and that rs117564807 of COL17A1 (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&amp;lt;0.0010) associated with SAH.">
    <entity charOffset="94-106" id="s3899.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="347-350" id="s3899.e1" ontology_id="6296" text="SAH" type="GENE"/>
    <pair e1="s3899.e0" e2="s3899.e1" id="s3899.p0" relation="false"/>
  </sentence>
  <sentence id="s3900" text="Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension revealed that rs138533962 of STYK1 (P&amp;lt;1.0x10-23; odds ratio, 111.3) was significantly (P&amp;lt;2.60x10-4) associated with ICH and that rs117564807 of COL17A1 (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&amp;lt;0.0010) associated with SAH.">
    <entity charOffset="94-106" id="s3900.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="136-141" id="s3900.e1" ontology_id="55359" text="STYK1" type="GENE"/>
    <pair e1="s3900.e0" e2="s3900.e1" id="s3900.p0" relation="true"/>
  </sentence>
  <sentence id="s3901" text="Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension revealed that rs138533962 of STYK1 (P&amp;lt;1.0x10-23; odds ratio, 111.3) was significantly (P&amp;lt;2.60x10-4) associated with ICH and that rs117564807 of COL17A1 (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&amp;lt;0.0010) associated with SAH.">
    <entity charOffset="94-106" id="s3901.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="257-264" id="s3901.e1" ontology_id="1308" text="COL17A1" type="GENE"/>
    <pair e1="s3901.e0" e2="s3901.e1" id="s3901.p0" relation="true"/>
  </sentence>
  <sentence id="s3902" text="We identified the first de novo variant in KCNMA1 (c.2984A&amp;gt;G (p.(N995S)))-encoding the BK channel-that causes epilepsy, but not paroxysmal dyskinesia, in two independent families.">
    <entity charOffset="43-49" id="s3902.e0" ontology_id="3778" text="KCNMA1" type="GENE"/>
    <entity charOffset="116-124" id="s3902.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3902.e0" e2="s3902.e1" id="s3902.p0" relation="true"/>
  </sentence>
  <sentence id="s3903" text="While mutations in TMEM165 are known to cause human 'congenital disorders of glycosylation', a recessive autosomal metabolic disease, the potential association of this protein with human cancer development has not been explored to date.">
    <entity charOffset="19-26" id="s3903.e0" ontology_id="55858" text="TMEM165" type="GENE"/>
    <entity charOffset="187-193" id="s3903.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3903.e0" e2="s3903.e1" id="s3903.p0" relation="true"/>
  </sentence>
  <sentence id="s3904" text="In the present study, we revealed that TMEM165 is overexpressed in HCC and its depletion weakens the invasive activity of cancer cells through suppression of matrix metalloproteinase2 (MMP2) expression.">
    <entity charOffset="39-46" id="s3904.e0" ontology_id="55858" text="TMEM165" type="GENE"/>
    <entity charOffset="122-128" id="s3904.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3904.e0" e2="s3904.e1" id="s3904.p0" relation="true"/>
  </sentence>
  <sentence id="s3905" text="The 2016 revised World Health Organization (WHO) classification of lymphoid neoplasms included the category of high-grade B cell lymphomas (HGBLs) with combined MYC and BCL2 and/or BCL6 rearrangements (double-hit, DH).">
    <entity charOffset="76-85" id="s3905.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="161-164" id="s3905.e1" ontology_id="4609" text="MYC" type="GENE"/>
    <pair e1="s3905.e0" e2="s3905.e1" id="s3905.p0" relation="true"/>
  </sentence>
  <sentence id="s3906" text="The 2016 revised World Health Organization (WHO) classification of lymphoid neoplasms included the category of high-grade B cell lymphomas (HGBLs) with combined MYC and BCL2 and/or BCL6 rearrangements (double-hit, DH).">
    <entity charOffset="76-85" id="s3906.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="169-173" id="s3906.e1" ontology_id="596" text="BCL2" type="GENE"/>
    <pair e1="s3906.e0" e2="s3906.e1" id="s3906.p0" relation="true"/>
  </sentence>
  <sentence id="s3907" text="The significance of the ubiquitin-proteasome system (UPS) for protein degradation has been highlighted in the context of neurodegenerative diseases, including retinal dystrophies.">
    <entity charOffset="53-56" id="s3907.e0" ontology_id="3145" text="UPS" type="GENE"/>
    <entity charOffset="159-178" id="s3907.e1" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <pair e1="s3907.e0" e2="s3907.e1" id="s3907.p0" relation="true"/>
  </sentence>
  <sentence id="s3908" text="The encoded protein, complexin 1, is crucially involved in neuronal synaptic regulation, and homozygous Cplx1 knockout mice have the earliest known onset of ataxia seen in a mouse model.">
    <entity charOffset="104-109" id="s3908.e0" ontology_id="10815" text="Cplx1" type="GENE"/>
    <entity charOffset="157-163" id="s3908.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3908.e0" e2="s3908.e1" id="s3908.p0" relation="true"/>
  </sentence>
  <sentence id="s3909" text="Recently, a homozygous truncating variant in CPLX1 was suggested to be causative for migrating epilepsy and structural brain abnormalities.">
    <entity charOffset="45-50" id="s3909.e0" ontology_id="10815" text="CPLX1" type="GENE"/>
    <entity charOffset="95-103" id="s3909.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3909.e0" e2="s3909.e1" id="s3909.p0" relation="true"/>
  </sentence>
  <sentence id="s3910" text="However, the currently limited knowledge on CPLX1 suggests that loss of complexin 1 function may lead to a complex but variable clinical phenotype, and our findings encourage further investigations of CPLX1 in patients with ID, developmental delay and myoclonic epilepsy to unravel the phenotypic spectrum of carriers of CPLX1 variants">
    <entity charOffset="44-49" id="s3910.e0" ontology_id="10815" text="CPLX1" type="GENE"/>
    <entity charOffset="228-247" id="s3910.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s3910.e0" e2="s3910.e1" id="s3910.p0" relation="true"/>
  </sentence>
  <sentence id="s3911" text="However, the currently limited knowledge on CPLX1 suggests that loss of complexin 1 function may lead to a complex but variable clinical phenotype, and our findings encourage further investigations of CPLX1 in patients with ID, developmental delay and myoclonic epilepsy to unravel the phenotypic spectrum of carriers of CPLX1 variants">
    <entity charOffset="44-49" id="s3911.e0" ontology_id="10815" text="CPLX1" type="GENE"/>
    <entity charOffset="262-270" id="s3911.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3911.e0" e2="s3911.e1" id="s3911.p0" relation="true"/>
  </sentence>
  <sentence id="s3912" text="Defects in Membrane Frizzled-related Protein (MFRP) cause autosomal recessive retinitis pigmentosa (RP).">
    <entity charOffset="46-50" id="s3912.e0" ontology_id="83552" text="MFRP" type="GENE"/>
    <entity charOffset="58-77" id="s3912.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3912.e0" e2="s3912.e1" id="s3912.p0" relation="true"/>
  </sentence>
  <sentence id="s3913" text="Cystinosis is an autosomal recessive lysosomal storage disease caused by mutations in CTNS.">
    <entity charOffset="17-36" id="s3913.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="86-90" id="s3913.e1" ontology_id="1497" text="CTNS" type="GENE"/>
    <pair e1="s3913.e0" e2="s3913.e1" id="s3913.p0" relation="true"/>
  </sentence>
  <sentence id="s3914" text="Here, we hypothesize that PYCR1 might be a novel prognostic biomarker and therapeutic target for breast cancer.">
    <entity charOffset="26-31" id="s3914.e0" ontology_id="5831" text="PYCR1" type="GENE"/>
    <entity charOffset="104-110" id="s3914.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3914.e0" e2="s3914.e1" id="s3914.p0" relation="true"/>
  </sentence>
  <sentence id="s3915" text="In this study, breast cancer tissue samples were obtained from Zhejiang University (ZJU set).">
    <entity charOffset="22-28" id="s3915.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="88-91" id="s3915.e1" ontology_id="6418" text="set" type="GENE"/>
    <pair e1="s3915.e0" e2="s3915.e1" id="s3915.p0" relation="true"/>
  </sentence>
  <sentence id="s3916" text="The prognostic significance and performance of PYCR1 mRNA were validated on 13 worldwide independent microarray data sets, composed of 2500 assessable breast cancer cases.">
    <entity charOffset="47-52" id="s3916.e0" ontology_id="5831" text="PYCR1" type="GENE"/>
    <entity charOffset="158-164" id="s3916.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3916.e0" e2="s3916.e1" id="s3916.p0" relation="true"/>
  </sentence>
  <sentence id="s3917" text="The prognostic significance and performance of PYCR1 mRNA were validated on 13 worldwide independent microarray data sets, composed of 2500 assessable breast cancer cases.">
    <entity charOffset="117-120" id="s3917.e0" ontology_id="6418" text="set" type="GENE"/>
    <entity charOffset="158-164" id="s3917.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3917.e0" e2="s3917.e1" id="s3917.p0" relation="true"/>
  </sentence>
  <sentence id="s3918" text="Our findings revealed that both PYCR1 mRNA and protein expression were significantly associated with tumor size, grade and invasive molecular subtypes of breast cancers.">
    <entity charOffset="32-37" id="s3918.e0" ontology_id="5831" text="PYCR1" type="GENE"/>
    <entity charOffset="161-167" id="s3918.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3918.e0" e2="s3918.e1" id="s3918.p0" relation="true"/>
  </sentence>
  <sentence id="s3919" text="Our findings revealed that both PYCR1 mRNA and protein expression were significantly associated with tumor size, grade and invasive molecular subtypes of breast cancers.">
    <entity charOffset="32-37" id="s3919.e0" ontology_id="5831" text="PYCR1" type="GENE"/>
    <entity charOffset="101-106" id="s3919.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3919.e0" e2="s3919.e1" id="s3919.p0" relation="true"/>
  </sentence>
  <sentence id="s3920" text="Further population study also validated that chemotherapy significantly improved survival in early-stage breast cancer patients with low PYCR1 expression levels.">
    <entity charOffset="112-118" id="s3920.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="137-142" id="s3920.e1" ontology_id="5831" text="PYCR1" type="GENE"/>
    <pair e1="s3920.e0" e2="s3920.e1" id="s3920.p0" relation="true"/>
  </sentence>
  <sentence id="s3921" text="Therefore, PYCR1 might serve as a prognostic biomaker for either ER-positive or ER-negative breast cancer subtypes and can also be a potential target for breast cancer therapy">
    <entity charOffset="11-16" id="s3921.e0" ontology_id="5831" text="PYCR1" type="GENE"/>
    <entity charOffset="99-105" id="s3921.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3921.e0" e2="s3921.e1" id="s3921.p0" relation="true"/>
  </sentence>
  <sentence id="s3922" text="LCA is predominantly inherited as an autosomal recessive trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults.">
    <entity charOffset="0-3" id="s3922.e0" ontology_id="1211" text="LCA" type="GENE"/>
    <entity charOffset="37-56" id="s3922.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3922.e0" e2="s3922.e1" id="s3922.p0" relation="true"/>
  </sentence>
  <sentence id="s3923" text="LCA is predominantly inherited as an autosomal recessive trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults.">
    <entity charOffset="0-3" id="s3923.e0" ontology_id="1211" text="LCA" type="GENE"/>
    <entity charOffset="92-111" id="s3923.e1" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <pair e1="s3923.e0" e2="s3923.e1" id="s3923.p0" relation="true"/>
  </sentence>
  <sentence id="s3924" text="Here we have studied eleven consanguineous LCA and one autosomal recessive RP (arRP) south Indian families to know the prevalence of mutations in known genes and also to know the involvement of novel loci, if any.">
    <entity charOffset="43-46" id="s3924.e0" ontology_id="1211" text="LCA" type="GENE"/>
    <entity charOffset="55-74" id="s3924.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3924.e0" e2="s3924.e1" id="s3924.p0" relation="false"/>
  </sentence>
  <sentence id="s3925" text="Amyotrophic lateral sclerosis (ALS) is the major adult-onset motor neuron disease, and is clinically, pathologically, and genetically associated with frontotemporal dementia, the second cause of dementia in the elderly.">
    <entity charOffset="31-34" id="s3925.e0" ontology_id="3483" text="ALS" type="GENE"/>
    <entity charOffset="150-173" id="s3925.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s3925.e0" e2="s3925.e1" id="s3925.p0" relation="true"/>
  </sentence>
  <sentence id="s3926" text="Here, we reported a sporadic PVOD patient evidenced by pathology and EIF2AK4 biallelic mutation.">
    <entity charOffset="20-28" id="s3926.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="69-76" id="s3926.e1" ontology_id="440275" text="EIF2AK4" type="GENE"/>
    <pair e1="s3926.e0" e2="s3926.e1" id="s3926.p0" relation="true"/>
  </sentence>
  <sentence id="s3927" text="Germline CHEK2 mutations confer increased cancer risk, for breast and other types, which is variable depending on the specific mutation.">
    <entity charOffset="9-14" id="s3927.e0" ontology_id="11200" text="CHEK2" type="GENE"/>
    <entity charOffset="42-48" id="s3927.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3927.e0" e2="s3927.e1" id="s3927.p0" relation="false"/>
  </sentence>
  <sentence id="s3928" text="Patients with HCP show &amp;lt;50% of normal activity and those with the rare autosomal recessive harderoporphyria accumulate harderoporphyrinogen, an intermediate porphyrin of the CPOX reaction.">
    <entity charOffset="14-17" id="s3928.e0" ontology_id="259" text="HCP" type="GENE"/>
    <entity charOffset="74-93" id="s3928.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3928.e0" e2="s3928.e1" id="s3928.p0" relation="true"/>
  </sentence>
  <sentence id="s3929" text="PHF8 knockdown inhibits proliferation and promotes the apoptosis of ALL cells invitro as well as attenuates tumor growth invivo.">
    <entity charOffset="0-4" id="s3929.e0" ontology_id="23133" text="PHF8" type="GENE"/>
    <entity charOffset="109-114" id="s3929.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3929.e0" e2="s3929.e1" id="s3929.p0" relation="true"/>
  </sentence>
  <sentence id="s3930" text="The membrane-type frizzled-related protein (MFRP) is the only gene so far reported implicated in autosomal recessive, non-syndromic and syndromic forms of PM.">
    <entity charOffset="44-48" id="s3930.e0" ontology_id="83552" text="MFRP" type="GENE"/>
    <entity charOffset="97-116" id="s3930.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3930.e0" e2="s3930.e1" id="s3930.p0" relation="true"/>
  </sentence>
  <sentence id="s3931" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="114-119" id="s3931.e0" ontology_id="338917" text="CHX10" type="GENE"/>
    <entity charOffset="236-250" id="s3931.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s3931.e0" e2="s3931.e1" id="s3931.p0" relation="false"/>
  </sentence>
  <sentence id="s3932" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="121-125" id="s3932.e0" ontology_id="9968" text="OPA1" type="GENE"/>
    <entity charOffset="236-250" id="s3932.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s3932.e0" e2="s3932.e1" id="s3932.p0" relation="true"/>
  </sentence>
  <sentence id="s3933" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="127-131" id="s3933.e0" ontology_id="4286" text="MITF" type="GENE"/>
    <entity charOffset="236-250" id="s3933.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s3933.e0" e2="s3933.e1" id="s3933.p0" relation="true"/>
  </sentence>
  <sentence id="s3934" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="139-145" id="s3934.e0" ontology_id="1414" text="CRYBB1" type="GENE"/>
    <entity charOffset="236-250" id="s3934.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s3934.e0" e2="s3934.e1" id="s3934.p0" relation="true"/>
  </sentence>
  <sentence id="s3935" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="152-158" id="s3935.e0" ontology_id="1413" text="CRYBA4" type="GENE"/>
    <entity charOffset="236-250" id="s3935.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s3935.e0" e2="s3935.e1" id="s3935.p0" relation="true"/>
  </sentence>
  <sentence id="s3936" text="MATERIAL AND METHODS We analyzed BC microarray studies GSE37751, GSE7390, and GSE21653 to investigate the expression of FGF5 gene between BC patients and their normal counterparts and the relationship between FGF5 expression and age, tumor size, histopathological grading, estrogen receptors, clinical risk group according to St Gallen criteria, clinical risk group according to NPI criteria, clinical risk group according to Veridex signature, distant metastasis-free survival (DMFS), time to distant metastasis (TDM), disease-free survival (DFS), and overall survival (OS) of BC patients.">
    <entity charOffset="120-124" id="s3936.e0" ontology_id="2250" text="FGF5" type="GENE"/>
    <entity charOffset="234-239" id="s3936.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3936.e0" e2="s3936.e1" id="s3936.p0" relation="true"/>
  </sentence>
  <sentence id="s3937" text="BC patients in the FGF5 low-expression group were correlated with better clinical characteristics, including tumor size, histopathological grading, estrogen receptors, clinical risk group according to St Gallen criteria, NPI criteria and Veridex signature, DMFS, TDM, and DFS compared with those in the FGF5 high-expression cohort.">
    <entity charOffset="19-23" id="s3937.e0" ontology_id="2250" text="FGF5" type="GENE"/>
    <entity charOffset="109-114" id="s3937.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3937.e0" e2="s3937.e1" id="s3937.p0" relation="true"/>
  </sentence>
  <sentence id="s3938" text="The results showed that the concentration of inflammatory cytokines [interleukin 1 (IL1) and tumor necrosis factor  (TNF-)], myeloperoxidase (MPO) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (TLR4), nuclear factor B (NF-B, p65), phosphorylated p65 (p-p65), inhibitor B (IB), and phosphorylated IB (p-IB), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-B, IL1, interleukin 6 (IL6), and TNF-, were significantly upregulated in the LPS group compared to the PBS group.">
    <entity charOffset="95-100" id="s3938.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="233-237" id="s3938.e1" ontology_id="7099" text="TLR4" type="GENE"/>
    <pair e1="s3938.e0" e2="s3938.e1" id="s3938.p0" relation="false"/>
  </sentence>
  <sentence id="s3939" text="FGF23 excess induces hypophosphatemia via impaired phosphate reabsorption in the renal proximal tubules and decreased phosphate absorption in the intestines.">
    <entity charOffset="0-5" id="s3939.e0" ontology_id="8074" text="FGF23" type="GENE"/>
    <entity charOffset="21-37" id="s3939.e1" ontology_id="HP_0002148" text="hypophosphatemia" type="HP"/>
    <pair e1="s3939.e0" e2="s3939.e1" id="s3939.p0" relation="true"/>
  </sentence>
  <sentence id="s3940" text="Among these diseases, X-linked hypophosphatemia (XLH), which is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (PHEX) gene, is the most prevalent form of genetic FGF23-related hypophosphatemic rickets.">
    <entity charOffset="31-47" id="s3940.e0" ontology_id="HP_0002148" text="hypophosphatemia" type="HP"/>
    <entity charOffset="208-213" id="s3940.e1" ontology_id="8074" text="FGF23" type="GENE"/>
    <pair e1="s3940.e0" e2="s3940.e1" id="s3940.p0" relation="true"/>
  </sentence>
  <sentence id="s3941" text="Among these diseases, X-linked hypophosphatemia (XLH), which is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (PHEX) gene, is the most prevalent form of genetic FGF23-related hypophosphatemic rickets.">
    <entity charOffset="31-47" id="s3941.e0" ontology_id="HP_0002148" text="hypophosphatemia" type="HP"/>
    <entity charOffset="158-162" id="s3941.e1" ontology_id="5251" text="PHEX" type="GENE"/>
    <pair e1="s3941.e0" e2="s3941.e1" id="s3941.p0" relation="true"/>
  </sentence>
  <sentence id="s3942" text="Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, MCD) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of developmental delay, seizures, cardiomyopathy and acidosis.">
    <entity charOffset="52-55" id="s3942.e0" ontology_id="23417" text="MCD" type="GENE"/>
    <entity charOffset="189-197" id="s3942.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s3942.e0" e2="s3942.e1" id="s3942.p0" relation="true"/>
  </sentence>
  <sentence id="s3943" text="Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, MCD) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of developmental delay, seizures, cardiomyopathy and acidosis.">
    <entity charOffset="52-55" id="s3943.e0" ontology_id="23417" text="MCD" type="GENE"/>
    <entity charOffset="199-213" id="s3943.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s3943.e0" e2="s3943.e1" id="s3943.p0" relation="true"/>
  </sentence>
  <sentence id="s3944" text="The RS-MC was also validated against measurements and simulations in heterogeneous phantoms created by placing lung or bone slabs in a water phantom.">
    <entity charOffset="4-6" id="s3944.e0" ontology_id="5308" text="RS" type="GENE"/>
    <entity charOffset="69-82" id="s3944.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3944.e0" e2="s3944.e1" id="s3944.p0" relation="true"/>
  </sentence>
  <sentence id="s3945" text="We identified 52 variants contributing to obesity in 2% of cases including multiple novel variants in GNAS, which were sometimes found with accelerated growth rather than short stature as described previously.">
    <entity charOffset="102-106" id="s3945.e0" ontology_id="2778" text="GNAS" type="GENE"/>
    <entity charOffset="171-184" id="s3945.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s3945.e0" e2="s3945.e1" id="s3945.p0" relation="true"/>
  </sentence>
  <sentence id="s3946" text="Further validation in cohorts with severe obesity and engineering the variants in model organisms will be needed to explore whether human variants in ANGPTL6 and other genes that lead to obesity when deleted in mice, do contribute to obesity.">
    <entity charOffset="42-49" id="s3946.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="150-157" id="s3946.e1" ontology_id="83854" text="ANGPTL6" type="GENE"/>
    <pair e1="s3946.e0" e2="s3946.e1" id="s3946.p0" relation="true"/>
  </sentence>
  <sentence id="s3947" text="Further validation in cohorts with severe obesity and engineering the variants in model organisms will be needed to explore whether human variants in ANGPTL6 and other genes that lead to obesity when deleted in mice, do contribute to obesity.">
    <entity charOffset="42-49" id="s3947.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="211-215" id="s3947.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s3947.e0" e2="s3947.e1" id="s3947.p0" relation="true"/>
  </sentence>
  <sentence id="s3948" text="The condition was initially termed MACS syndrome (macrocephaly, alopecia, cutis laxa, and scoliosis), based on the clinical features of the first identified family; however, with the expansion of the clinical phenotype in additional families, it was subsequently coined RIN2 syndrome.">
    <entity charOffset="90-99" id="s3948.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="270-274" id="s3948.e1" ontology_id="54453" text="RIN2" type="GENE"/>
    <pair e1="s3948.e0" e2="s3948.e1" id="s3948.p0" relation="true"/>
  </sentence>
  <sentence id="s3949" text="Patients with RIN2 syndrome present phenotypic overlap with other conditions, including EDS (especially the dermatosparaxis and kyphoscoliosis subtypes).">
    <entity charOffset="14-18" id="s3949.e0" ontology_id="54453" text="RIN2" type="GENE"/>
    <entity charOffset="133-142" id="s3949.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s3949.e0" e2="s3949.e1" id="s3949.p0" relation="true"/>
  </sentence>
  <sentence id="s3950" text="Besides the hallmark features, this patient also presents problems not previously associated with RIN2 syndrome, including cervical vertebral fusion, mild hearing loss, and colonic fibrosis.">
    <entity charOffset="98-102" id="s3950.e0" ontology_id="54453" text="RIN2" type="GENE"/>
    <entity charOffset="123-148" id="s3950.e1" ontology_id="HP_0002949" text="cervical vertebral fusion" type="HP"/>
    <pair e1="s3950.e0" e2="s3950.e1" id="s3950.p0" relation="true"/>
  </sentence>
  <sentence id="s3951" text="Fragile X syndrome (FXS), the leading cause of inherited forms of mental retardation and autism, is caused by the transcriptional silencing of fmr1 encoding the fragile X mental retardation protein (FMRP).">
    <entity charOffset="89-95" id="s3951.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="143-147" id="s3951.e1" ontology_id="2332" text="fmr1" type="GENE"/>
    <pair e1="s3951.e0" e2="s3951.e1" id="s3951.p0" relation="true"/>
  </sentence>
  <sentence id="s3952" text="Fragile X syndrome (FXS), the leading cause of inherited forms of mental retardation and autism, is caused by the transcriptional silencing of fmr1 encoding the fragile X mental retardation protein (FMRP).">
    <entity charOffset="89-95" id="s3952.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="199-203" id="s3952.e1" ontology_id="2332" text="FMRP" type="GENE"/>
    <pair e1="s3952.e0" e2="s3952.e1" id="s3952.p0" relation="true"/>
  </sentence>
  <sentence id="s3953" text="Patients with KCNK9 imprinting syndrome demonstrate congenital hypotonia, variable cleft palate, normal MRIs and EEGs, delayed development, and feeding problems.">
    <entity charOffset="14-19" id="s3953.e0" ontology_id="51305" text="KCNK9" type="GENE"/>
    <entity charOffset="83-95" id="s3953.e1" ontology_id="HP_0000175" text="cleft palate" type="HP"/>
    <pair e1="s3953.e0" e2="s3953.e1" id="s3953.p0" relation="true"/>
  </sentence>
  <sentence id="s3954" text="In clinical practices, the therapeutic outcomes and prognosis of hepatocellular carcinoma (HCC) patients with different tumor numbers after surgery are very different; however, the underlying mechanisms of the tumorigenesis and development of HCC with different tumor numbers are still not well understood.">
    <entity charOffset="91-94" id="s3954.e0" ontology_id="84668" text="HCC" type="GENE"/>
    <entity charOffset="120-125" id="s3954.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3954.e0" e2="s3954.e1" id="s3954.p0" relation="false"/>
  </sentence>
  <sentence id="s3955" text="These information revealed that there might be different molecular mechanisms of the tumorigenesis and development of the HCC with single and multiple lesions.">
    <entity charOffset="85-90" id="s3955.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="122-125" id="s3955.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s3955.e0" e2="s3955.e1" id="s3955.p0" relation="true"/>
  </sentence>
  <sentence id="s3956" text="Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving RORA in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.">
    <entity charOffset="308-312" id="s3956.e0" ontology_id="6095" text="RORA" type="GENE"/>
    <entity charOffset="362-386" id="s3956.e1" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <pair e1="s3956.e0" e2="s3956.e1" id="s3956.p0" relation="true"/>
  </sentence>
  <sentence id="s3957" text="Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving RORA in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.">
    <entity charOffset="308-312" id="s3957.e0" ontology_id="6095" text="RORA" type="GENE"/>
    <entity charOffset="450-467" id="s3957.e1" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <pair e1="s3957.e0" e2="s3957.e1" id="s3957.p0" relation="true"/>
  </sentence>
  <sentence id="s3958" text="The clinical presentation was severe, early-onset, progressive SMA-like motor neuronopathy, cerebellar atrophy, and in one affected individual, congenital fractures of the long bones.">
    <entity charOffset="63-66" id="s3958.e0" ontology_id="6606" text="SMA" type="GENE"/>
    <entity charOffset="92-110" id="s3958.e1" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <pair e1="s3958.e0" e2="s3958.e1" id="s3958.p0" relation="true"/>
  </sentence>
  <sentence id="s3959" text="In summary, we show that variants in EXOSC9 result in a neurological syndrome combining cerebellar atrophy and spinal motoneuronopathy, thus expanding the list of human exosomopathies">
    <entity charOffset="37-43" id="s3959.e0" ontology_id="5393" text="EXOSC9" type="GENE"/>
    <entity charOffset="88-106" id="s3959.e1" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <pair e1="s3959.e0" e2="s3959.e1" id="s3959.p0" relation="true"/>
  </sentence>
  <sentence id="s3960" text="Additionally, despite GDAP1 affecting mitochondrial functionality, and hence being of great importance to cellular function, the GDAP1associated Charcot-Marie-Tooth disease is mainly characterized by axonal degeneration.">
    <entity charOffset="22-27" id="s3960.e0" ontology_id="54332" text="GDAP1" type="GENE"/>
    <entity charOffset="201-220" id="s3960.e1" ontology_id="HP_0040078" text="axonal degeneration" type="HP"/>
    <pair e1="s3960.e0" e2="s3960.e1" id="s3960.p0" relation="true"/>
  </sentence>
  <sentence id="s3961" text="Gastric stump cancer (GSC) is a carcinoma arising from the remnant stomach following gastric surgery for benign or malignant disease, and is more common in men.">
    <entity charOffset="22-25" id="s3961.e0" ontology_id="145258" text="GSC" type="GENE"/>
    <entity charOffset="32-41" id="s3961.e1" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <pair e1="s3961.e0" e2="s3961.e1" id="s3961.p0" relation="true"/>
  </sentence>
  <sentence id="s3962" text="Here, we examined the effects of UBE2T on the progression of gastric cancer.">
    <entity charOffset="33-38" id="s3962.e0" ontology_id="29089" text="UBE2T" type="GENE"/>
    <entity charOffset="69-75" id="s3962.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3962.e0" e2="s3962.e1" id="s3962.p0" relation="true"/>
  </sentence>
  <sentence id="s3963" text="UBE2T was highly expressed in gastric tumors and gastric cancer cells.">
    <entity charOffset="0-5" id="s3963.e0" ontology_id="29089" text="UBE2T" type="GENE"/>
    <entity charOffset="38-44" id="s3963.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3963.e0" e2="s3963.e1" id="s3963.p0" relation="true"/>
  </sentence>
  <sentence id="s3964" text="Suppression of UBE2T also attenuated the invasive and metastatic abilities of gastric cancer cells by altering expression of epithelial-mesenchymal transition (EMT)-related factors.">
    <entity charOffset="15-20" id="s3964.e0" ontology_id="29089" text="UBE2T" type="GENE"/>
    <entity charOffset="86-92" id="s3964.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3964.e0" e2="s3964.e1" id="s3964.p0" relation="false"/>
  </sentence>
  <sentence id="s3965" text="Suppression of UBE2T also attenuated the invasive and metastatic abilities of gastric cancer cells by altering expression of epithelial-mesenchymal transition (EMT)-related factors.">
    <entity charOffset="86-92" id="s3965.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="160-163" id="s3965.e1" ontology_id="3702" text="EMT" type="GENE"/>
    <pair e1="s3965.e0" e2="s3965.e1" id="s3965.p0" relation="false"/>
  </sentence>
  <sentence id="s3966" text="A xenograft model in which nude mice were injected with UBE2T knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.">
    <entity charOffset="56-61" id="s3966.e0" ontology_id="29089" text="UBE2T" type="GENE"/>
    <entity charOffset="86-92" id="s3966.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3966.e0" e2="s3966.e1" id="s3966.p0" relation="true"/>
  </sentence>
  <sentence id="s3967" text="A xenograft model in which nude mice were injected with UBE2T knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.">
    <entity charOffset="56-61" id="s3967.e0" ontology_id="29089" text="UBE2T" type="GENE"/>
    <entity charOffset="150-155" id="s3967.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3967.e0" e2="s3967.e1" id="s3967.p0" relation="true"/>
  </sentence>
  <sentence id="s3968" text="These results suggest that UBE2T plays a critical role in gastric cancer, and that it may serve as a useful prognostic biomarker and therapeutic target in gastric cancer patients">
    <entity charOffset="27-32" id="s3968.e0" ontology_id="29089" text="UBE2T" type="GENE"/>
    <entity charOffset="66-72" id="s3968.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3968.e0" e2="s3968.e1" id="s3968.p0" relation="true"/>
  </sentence>
  <sentence id="s3969" text="We investigated glioma-associated oncogene protein-1 (Gli-1) expression in human esophageal carcinoma tissue and the inhibition of cyclopamine on EC9706 esophageal carcinoma cell growth.">
    <entity charOffset="16-22" id="s3969.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="54-57" id="s3969.e1" ontology_id="2735" text="Gli" type="GENE"/>
    <pair e1="s3969.e0" e2="s3969.e1" id="s3969.p0" relation="true"/>
  </sentence>
  <sentence id="s3970" text="MATERIAL AND METHODS Gli-1 in tumor tissue was measured by immunohistochemistry (IHC).">
    <entity charOffset="21-24" id="s3970.e0" ontology_id="2735" text="Gli" type="GENE"/>
    <entity charOffset="30-35" id="s3970.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3970.e0" e2="s3970.e1" id="s3970.p0" relation="true"/>
  </sentence>
  <sentence id="s3971" text="Despite their clinical heterogeneity, which remains an open question, laminopathies are commonly caused by mutations in the LMNA gene, encoding the nuclear proteins Lamin A and C.">
    <entity charOffset="23-36" id="s3971.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="124-128" id="s3971.e1" ontology_id="4000" text="LMNA" type="GENE"/>
    <pair e1="s3971.e0" e2="s3971.e1" id="s3971.p0" relation="true"/>
  </sentence>
  <sentence id="s3972" text="Individuals had microcephaly, developmental delay, epilepsy, and recessive mutations in TRIT1.">
    <entity charOffset="16-28" id="s3972.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="88-93" id="s3972.e1" ontology_id="54802" text="TRIT1" type="GENE"/>
    <pair e1="s3972.e0" e2="s3972.e1" id="s3972.p0" relation="true"/>
  </sentence>
  <sentence id="s3973" text="Individuals had microcephaly, developmental delay, epilepsy, and recessive mutations in TRIT1.">
    <entity charOffset="30-49" id="s3973.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="88-93" id="s3973.e1" ontology_id="54802" text="TRIT1" type="GENE"/>
    <pair e1="s3973.e0" e2="s3973.e1" id="s3973.p0" relation="true"/>
  </sentence>
  <sentence id="s3974" text="Diamond-Blackfan anemia (DBA), an inherited bone marrow failure syndrome characterized by anemia that usually presents before the first birthday or in early childhood, is associated with birth defects and an increased risk of cancer.">
    <entity charOffset="25-28" id="s3974.e0" ontology_id="6223" text="DBA" type="GENE"/>
    <entity charOffset="226-232" id="s3974.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3974.e0" e2="s3974.e1" id="s3974.p0" relation="true"/>
  </sentence>
  <sentence id="s3975" text="MIR22HG is an lncRNA that contributes to the initiation and progression of many human cancers, including hepatocellular carcinoma (HCC).">
    <entity charOffset="105-129" id="s3975.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="131-134" id="s3975.e1" ontology_id="84668" text="HCC" type="GENE"/>
    <pair e1="s3975.e0" e2="s3975.e1" id="s3975.p0" relation="true"/>
  </sentence>
  <sentence id="s3976" text="The sonic Hedgehog/GLI signaling pathway (HH) is critical for maintaining tissue polarity in development and contributes to tumor stemness.">
    <entity charOffset="19-22" id="s3976.e0" ontology_id="2735" text="GLI" type="GENE"/>
    <entity charOffset="124-129" id="s3976.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3976.e0" e2="s3976.e1" id="s3976.p0" relation="true"/>
  </sentence>
  <sentence id="s3977" text="Important factors GLI1 and GLI2 were always expressed, only exceptionally one of them was lowered, suggesting the functionality of HH in all tumors tested.">
    <entity charOffset="18-21" id="s3977.e0" ontology_id="2735" text="GLI" type="GENE"/>
    <entity charOffset="141-146" id="s3977.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3977.e0" e2="s3977.e1" id="s3977.p0" relation="true"/>
  </sentence>
  <sentence id="s3978" text="By comparing the Src-induced AR-cistrome and/or transcriptome in LNCaP to those in CRPC and LuCaP35.1 tumors, we identified an 11-gene Src-regulated CRPC signature consisting of AR-dependent, AR binding site (ARBS)-associated genes whose expression is altered by DHT in LNCaP[Src527F] but not in LNCaP cells.">
    <entity charOffset="17-20" id="s3978.e0" ontology_id="6714" text="Src" type="GENE"/>
    <entity charOffset="102-108" id="s3978.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3978.e0" e2="s3978.e1" id="s3978.p0" relation="true"/>
  </sentence>
  <sentence id="s3979" text="By comparing the Src-induced AR-cistrome and/or transcriptome in LNCaP to those in CRPC and LuCaP35.1 tumors, we identified an 11-gene Src-regulated CRPC signature consisting of AR-dependent, AR binding site (ARBS)-associated genes whose expression is altered by DHT in LNCaP[Src527F] but not in LNCaP cells.">
    <entity charOffset="29-31" id="s3979.e0" ontology_id="231" text="AR" type="GENE"/>
    <entity charOffset="102-108" id="s3979.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3979.e0" e2="s3979.e1" id="s3979.p0" relation="true"/>
  </sentence>
  <sentence id="s3980" text="In the present review, 22loci of glaucoma are presented, including the relevant genes (myocilin, interleukin20 receptor subunit B, optineurin, ankyrin repeat and SOCS boxcontaining protein 10, WD repeatcontaining protein 36, EGFcontaining fibulinlike extracellular matrix protein 1, neurotrophin 4, TANKbinding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor  binding protein 2 and TEK tyrosine kinase endothelial) and 74other genes (including tolllike receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortinlike kinase 1, RE repeatsencoding gene, retinitis pigmentosa GTPase regulatorinteracting protein, lysyl oxidaselike protein 1, heatshock 70kDa protein 1A, baculoviral IAP repeatcontaining protein 6, 5,10methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos1) that are more closely associated with glaucoma.">
    <entity charOffset="34-42" id="s3980.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="165-169" id="s3980.e1" ontology_id="1154" text="SOCS" type="GENE"/>
    <pair e1="s3980.e0" e2="s3980.e1" id="s3980.p0" relation="true"/>
  </sentence>
  <sentence id="s3981" text="In the present review, 22loci of glaucoma are presented, including the relevant genes (myocilin, interleukin20 receptor subunit B, optineurin, ankyrin repeat and SOCS boxcontaining protein 10, WD repeatcontaining protein 36, EGFcontaining fibulinlike extracellular matrix protein 1, neurotrophin 4, TANKbinding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor  binding protein 2 and TEK tyrosine kinase endothelial) and 74other genes (including tolllike receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortinlike kinase 1, RE repeatsencoding gene, retinitis pigmentosa GTPase regulatorinteracting protein, lysyl oxidaselike protein 1, heatshock 70kDa protein 1A, baculoviral IAP repeatcontaining protein 6, 5,10methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos1) that are more closely associated with glaucoma.">
    <entity charOffset="34-42" id="s3981.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="746-749" id="s3981.e1" ontology_id="961" text="IAP" type="GENE"/>
    <pair e1="s3981.e0" e2="s3981.e1" id="s3981.p0" relation="true"/>
  </sentence>
  <sentence id="s3982" text="Mutation in FLNA causes a wide spectrum of disease including skeletal dysplasia, neuronal migration abnormality, cardiovascular malformation, intellectual disability and intestinal obstruction.">
    <entity charOffset="12-16" id="s3982.e0" ontology_id="2316" text="FLNA" type="GENE"/>
    <entity charOffset="61-79" id="s3982.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s3982.e0" e2="s3982.e1" id="s3982.p0" relation="true"/>
  </sentence>
  <sentence id="s3983" text="Mutation in FLNA causes a wide spectrum of disease including skeletal dysplasia, neuronal migration abnormality, cardiovascular malformation, intellectual disability and intestinal obstruction.">
    <entity charOffset="12-16" id="s3983.e0" ontology_id="2316" text="FLNA" type="GENE"/>
    <entity charOffset="142-165" id="s3983.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3983.e0" e2="s3983.e1" id="s3983.p0" relation="true"/>
  </sentence>
  <sentence id="s3984" text="Mutation in FLNA causes a wide spectrum of disease including skeletal dysplasia, neuronal migration abnormality, cardiovascular malformation, intellectual disability and intestinal obstruction.">
    <entity charOffset="12-16" id="s3984.e0" ontology_id="2316" text="FLNA" type="GENE"/>
    <entity charOffset="170-192" id="s3984.e1" ontology_id="HP_0005214" text="intestinal obstruction" type="HP"/>
    <pair e1="s3984.e0" e2="s3984.e1" id="s3984.p0" relation="true"/>
  </sentence>
  <sentence id="s3985" text="Reviewing the emerging dataset, we underline this unanticipated phenotypic consequence of pathogenic FLNA mutation-associated pulmonary disease.Conclusion: From the emerging data, we suggest that while reviewing complex cases with a sustained oxygen requirement against a clincial background of cardiac concerns or intestinal obstruction to have a high index of suspicion for FLNA related pathology and to instigate early MRI brain scan and FLNA mutation analysis.">
    <entity charOffset="101-105" id="s3985.e0" ontology_id="2316" text="FLNA" type="GENE"/>
    <entity charOffset="315-337" id="s3985.e1" ontology_id="HP_0005214" text="intestinal obstruction" type="HP"/>
    <pair e1="s3985.e0" e2="s3985.e1" id="s3985.p0" relation="true"/>
  </sentence>
  <sentence id="s3986" text="The expression of CD133, ALDH1 and Lgr5 was found to be positive in 55.6, 47.2 and 78.9% of the primary tumour samples, respectively.">
    <entity charOffset="25-30" id="s3986.e0" ontology_id="216" text="ALDH1" type="GENE"/>
    <entity charOffset="104-110" id="s3986.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3986.e0" e2="s3986.e1" id="s3986.p0" relation="true"/>
  </sentence>
  <sentence id="s3987" text="The expression of CD133, ALDH1 and Lgr5 was found to be positive in 55.6, 47.2 and 78.9% of the primary tumour samples, respectively.">
    <entity charOffset="35-39" id="s3987.e0" ontology_id="8549" text="Lgr5" type="GENE"/>
    <entity charOffset="104-110" id="s3987.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3987.e0" e2="s3987.e1" id="s3987.p0" relation="true"/>
  </sentence>
  <sentence id="s3988" text="In the present study, individual driver genes for each type of cancer were identified using integrated analysis of multiple microarray data.">
    <entity charOffset="55-59" id="s3988.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="63-69" id="s3988.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3988.e0" e2="s3988.e1" id="s3988.p0" relation="true"/>
  </sentence>
  <sentence id="s3989" text="Survival analysis revealed that the expression of MCM2, MMP2, COL1A1 and JUN was associated with the prognosis of the aforementioned gynecological cancer types.">
    <entity charOffset="50-54" id="s3989.e0" ontology_id="4176" text="MCM2" type="GENE"/>
    <entity charOffset="147-153" id="s3989.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3989.e0" e2="s3989.e1" id="s3989.p0" relation="true"/>
  </sentence>
  <sentence id="s3990" text="Survival analysis revealed that the expression of MCM2, MMP2, COL1A1 and JUN was associated with the prognosis of the aforementioned gynecological cancer types.">
    <entity charOffset="56-60" id="s3990.e0" ontology_id="4313" text="MMP2" type="GENE"/>
    <entity charOffset="147-153" id="s3990.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3990.e0" e2="s3990.e1" id="s3990.p0" relation="true"/>
  </sentence>
  <sentence id="s3991" text="Survival analysis revealed that the expression of MCM2, MMP2, COL1A1 and JUN was associated with the prognosis of the aforementioned gynecological cancer types.">
    <entity charOffset="62-68" id="s3991.e0" ontology_id="1277" text="COL1A1" type="GENE"/>
    <entity charOffset="147-153" id="s3991.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3991.e0" e2="s3991.e1" id="s3991.p0" relation="true"/>
  </sentence>
  <sentence id="s3992" text="Survival analysis revealed that the expression of MCM2, MMP2, COL1A1 and JUN was associated with the prognosis of the aforementioned gynecological cancer types.">
    <entity charOffset="73-76" id="s3992.e0" ontology_id="3725" text="JUN" type="GENE"/>
    <entity charOffset="147-153" id="s3992.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3992.e0" e2="s3992.e1" id="s3992.p0" relation="true"/>
  </sentence>
  <sentence id="s3993" text="In conclusion, the present study demonstrated a connection model across three types of gynecological cancer, which was useful in identifying potential diagnostic markers and novel therapeutic targets, in addition to in aiding the prediction of the development of cancer as it progresses">
    <entity charOffset="78-82" id="s3993.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="101-107" id="s3993.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3993.e0" e2="s3993.e1" id="s3993.p0" relation="false"/>
  </sentence>
  <sentence id="s3994" text="In the single-locus analysis, two variants, the NBS1 rs1805794 (OR 1.42, 95% CI 1.15-1.76, P = 0.001), and RAD54L rs1048771 (OR 1.61, 95% CI 1.17-2.22, P = 0.002) were significantly associated with glioma risk.">
    <entity charOffset="48-52" id="s3994.e0" ontology_id="9048" text="NBS1" type="GENE"/>
    <entity charOffset="198-204" id="s3994.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s3994.e0" e2="s3994.e1" id="s3994.p0" relation="true"/>
  </sentence>
  <sentence id="s3995" text="In the single-locus analysis, two variants, the NBS1 rs1805794 (OR 1.42, 95% CI 1.15-1.76, P = 0.001), and RAD54L rs1048771 (OR 1.61, 95% CI 1.17-2.22, P = 0.002) were significantly associated with glioma risk.">
    <entity charOffset="107-113" id="s3995.e0" ontology_id="8438" text="RAD54L" type="GENE"/>
    <entity charOffset="198-204" id="s3995.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s3995.e0" e2="s3995.e1" id="s3995.p0" relation="true"/>
  </sentence>
  <sentence id="s3996" text="Moreover, results from our real-time quantitative polymerase chain reaction (qPCR) using 72 normal liver tissues adjacent to the tumors showed that SERPINA6 expression was significantly different among different genotypes of this variant (GG versus CC: P = 0.032; Group test: P = 0.060).">
    <entity charOffset="129-135" id="s3996.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="148-156" id="s3996.e1" ontology_id="866" text="SERPINA6" type="GENE"/>
    <pair e1="s3996.e0" e2="s3996.e1" id="s3996.p0" relation="true"/>
  </sentence>
  <sentence id="s3997" text="Limb girdle muscular dystrophy type 2I (LGMD2I) is a progressive disorder caused by mutations in the FuKutin-Related Protein gene (FKRP).">
    <entity charOffset="12-30" id="s3997.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="131-135" id="s3997.e1" ontology_id="79147" text="FKRP" type="GENE"/>
    <pair e1="s3997.e0" e2="s3997.e1" id="s3997.p0" relation="true"/>
  </sentence>
  <sentence id="s3998" text="LGMD2I displays clinical heterogeneity with onset of severe symptoms in early childhood to mild calf and thigh hypertrophy in the second or third decade.">
    <entity charOffset="0-6" id="s3998.e0" ontology_id="79147" text="LGMD2I" type="GENE"/>
    <entity charOffset="25-38" id="s3998.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s3998.e0" e2="s3998.e1" id="s3998.p0" relation="true"/>
  </sentence>
  <sentence id="s3999" text="Knockout of genes encoding metabotropic glutamate receptor 5 (mGluR5) or its endogenous regulators, such as Norbin, induce a schizophrenia-like phenotype in rodents, suggesting dysregulation of mGluR5 in schizophrenia.">
    <entity charOffset="62-68" id="s3999.e0" ontology_id="2915" text="mGluR5" type="GENE"/>
    <entity charOffset="125-138" id="s3999.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s3999.e0" e2="s3999.e1" id="s3999.p0" relation="true"/>
  </sentence>
  <sentence id="s4000" text="We assessed mGluR5 mRNA and protein levels in the dorsolateral prefrontal cortex (DLPFC) using a large cohort of schizophrenia and control subjects (n = 37/group), and additionally measured protein levels of recently discovered mGluR5 endogenous regulators, Norbin (neurochondrin), Tamalin (GRASP-1), and Preso1 (FRMPD4), which regulate mGluR5 localization, internalization and signaling.">
    <entity charOffset="113-126" id="s4000.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="291-298" id="s4000.e1" ontology_id="56850" text="GRASP-1" type="GENE"/>
    <pair e1="s4000.e0" e2="s4000.e1" id="s4000.p0" relation="true"/>
  </sentence>
  <sentence id="s4001" text="We assessed mGluR5 mRNA and protein levels in the dorsolateral prefrontal cortex (DLPFC) using a large cohort of schizophrenia and control subjects (n = 37/group), and additionally measured protein levels of recently discovered mGluR5 endogenous regulators, Norbin (neurochondrin), Tamalin (GRASP-1), and Preso1 (FRMPD4), which regulate mGluR5 localization, internalization and signaling.">
    <entity charOffset="113-126" id="s4001.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="313-319" id="s4001.e1" ontology_id="9758" text="FRMPD4" type="GENE"/>
    <pair e1="s4001.e0" e2="s4001.e1" id="s4001.p0" relation="false"/>
  </sentence>
  <sentence id="s4002" text="mGluR5 protein was significantly associated with mGluR5 mRNA and mGluR5 endogenous regulators in control subjects, but these associations were lost in schizophrenia subjects.">
    <entity charOffset="0-6" id="s4002.e0" ontology_id="2915" text="mGluR5" type="GENE"/>
    <entity charOffset="151-164" id="s4002.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4002.e0" e2="s4002.e1" id="s4002.p0" relation="true"/>
  </sentence>
  <sentence id="s4003" text="The results from our study provide compelling evidence that mGluR5 regulation is altered in schizophrenia, likely contributing to the altered glutamatergic signaling that is associated with the disorder">
    <entity charOffset="60-66" id="s4003.e0" ontology_id="2915" text="mGluR5" type="GENE"/>
    <entity charOffset="92-105" id="s4003.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4003.e0" e2="s4003.e1" id="s4003.p0" relation="false"/>
  </sentence>
  <sentence id="s4004" text="Whereas Klf13 heterozygote mice have no detectable cardiac defects, loss of a Klf13 allele in Tbx5 heterozygote mice significantly increases the penetrance of TBX5-dependent cardiac abnormalities including atrial, atrial-ventricular and ventricular septal defects.">
    <entity charOffset="8-13" id="s4004.e0" ontology_id="51621" text="Klf13" type="GENE"/>
    <entity charOffset="174-195" id="s4004.e1" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <pair e1="s4004.e0" e2="s4004.e1" id="s4004.p0" relation="true"/>
  </sentence>
  <sentence id="s4005" text="Whereas Klf13 heterozygote mice have no detectable cardiac defects, loss of a Klf13 allele in Tbx5 heterozygote mice significantly increases the penetrance of TBX5-dependent cardiac abnormalities including atrial, atrial-ventricular and ventricular septal defects.">
    <entity charOffset="94-98" id="s4005.e0" ontology_id="6910" text="Tbx5" type="GENE"/>
    <entity charOffset="174-195" id="s4005.e1" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <pair e1="s4005.e0" e2="s4005.e1" id="s4005.p0" relation="true"/>
  </sentence>
  <sentence id="s4006" text="Whereas Klf13 heterozygote mice have no detectable cardiac defects, loss of a Klf13 allele in Tbx5 heterozygote mice significantly increases the penetrance of TBX5-dependent cardiac abnormalities including atrial, atrial-ventricular and ventricular septal defects.">
    <entity charOffset="159-163" id="s4006.e0" ontology_id="6910" text="TBX5" type="GENE"/>
    <entity charOffset="174-195" id="s4006.e1" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <pair e1="s4006.e0" e2="s4006.e1" id="s4006.p0" relation="true"/>
  </sentence>
  <sentence id="s4007" text="Mutations in the MID1 gene have been associated with the X-linked form of Opitz Syndrome, a developmental disorder characterized by midline defects and intellectual disability.">
    <entity charOffset="17-21" id="s4007.e0" ontology_id="4281" text="MID1" type="GENE"/>
    <entity charOffset="152-175" id="s4007.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4007.e0" e2="s4007.e1" id="s4007.p0" relation="true"/>
  </sentence>
  <sentence id="s4008" text="SASS6 upregulation in colon cancer was also revealed in the Cancer Genome Atlas (TCGA) data and was shown to be an independent predictor of poor survival (multivariate analysis: hazard ratio, 2.805; 95% confidence interval, 1.2447.512; P=0.0112).">
    <entity charOffset="0-5" id="s4008.e0" ontology_id="163786" text="SASS6" type="GENE"/>
    <entity charOffset="28-34" id="s4008.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4008.e0" e2="s4008.e1" id="s4008.p0" relation="true"/>
  </sentence>
  <sentence id="s4009" text="Finally, further analysis of the TCGA data demonstrated SASS6 upregulation in a modest manner in 8 of 11 cancer types other than colon cancer, and SASS6 upregulation was found to be associated with a poor survival outcome in patients with kidney renal cell carcinoma and lung adenocarcinoma.">
    <entity charOffset="56-61" id="s4009.e0" ontology_id="163786" text="SASS6" type="GENE"/>
    <entity charOffset="105-111" id="s4009.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4009.e0" e2="s4009.e1" id="s4009.p0" relation="true"/>
  </sentence>
  <sentence id="s4010" text="Finally, further analysis of the TCGA data demonstrated SASS6 upregulation in a modest manner in 8 of 11 cancer types other than colon cancer, and SASS6 upregulation was found to be associated with a poor survival outcome in patients with kidney renal cell carcinoma and lung adenocarcinoma.">
    <entity charOffset="56-61" id="s4010.e0" ontology_id="163786" text="SASS6" type="GENE"/>
    <entity charOffset="271-290" id="s4010.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s4010.e0" e2="s4010.e1" id="s4010.p0" relation="true"/>
  </sentence>
  <sentence id="s4011" text="Our present findings revealed that the upregulation of SASS6 expression is involved in the pathogenesis of CRC and is associated with a poor prognosis among patients with colon cancer.">
    <entity charOffset="55-60" id="s4011.e0" ontology_id="163786" text="SASS6" type="GENE"/>
    <entity charOffset="177-183" id="s4011.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4011.e0" e2="s4011.e1" id="s4011.p0" relation="true"/>
  </sentence>
  <sentence id="s4012" text="Squamous cell carcinoma (SCC) can progress to malignant metastatic cancer, including an aggressive subtype known as spindle cell carcinoma (spSCC). spSCC formation involves epithelial-to-mesenchymal transition (EMT), yet the molecular basis of this event remains unknown.">
    <entity charOffset="25-28" id="s4012.e0" ontology_id="6317" text="SCC" type="GENE"/>
    <entity charOffset="67-73" id="s4012.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4012.e0" e2="s4012.e1" id="s4012.p0" relation="true"/>
  </sentence>
  <sentence id="s4013" text="spSCC tumours arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo EMT to generate spSCC.">
    <entity charOffset="2-5" id="s4013.e0" ontology_id="6317" text="SCC" type="GENE"/>
    <entity charOffset="6-13" id="s4013.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s4013.e0" e2="s4013.e1" id="s4013.p0" relation="true"/>
  </sentence>
  <sentence id="s4014" text="spSCC tumours arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo EMT to generate spSCC.">
    <entity charOffset="2-5" id="s4014.e0" ontology_id="6317" text="SCC" type="GENE"/>
    <entity charOffset="67-73" id="s4014.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4014.e0" e2="s4014.e1" id="s4014.p0" relation="true"/>
  </sentence>
  <sentence id="s4015" text="spSCC tumours arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo EMT to generate spSCC.">
    <entity charOffset="6-13" id="s4015.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="110-113" id="s4015.e1" ontology_id="3702" text="EMT" type="GENE"/>
    <pair e1="s4015.e0" e2="s4015.e1" id="s4015.p0" relation="true"/>
  </sentence>
  <sentence id="s4016" text="PAH in children is much more heterogeneous than in adults, and can be associated with several genetic syndromes, congenital heart disease, pulmonary disease, and vascular disease.">
    <entity charOffset="0-3" id="s4016.e0" ontology_id="5053" text="PAH" type="GENE"/>
    <entity charOffset="29-42" id="s4016.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4016.e0" e2="s4016.e1" id="s4016.p0" relation="true"/>
  </sentence>
  <sentence id="s4017" text="We genotyped 7 potentially functional polymorphisms in CASP3, CASP7, CASP8, CASP9, CASP10 genes in 362 HCC patients of receiving surgical resection of HCC tumor.">
    <entity charOffset="55-59" id="s4017.e0" ontology_id="10491" text="CASP" type="GENE"/>
    <entity charOffset="155-160" id="s4017.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4017.e0" e2="s4017.e1" id="s4017.p0" relation="true"/>
  </sentence>
  <sentence id="s4018" text="We genotyped 7 potentially functional polymorphisms in CASP3, CASP7, CASP8, CASP9, CASP10 genes in 362 HCC patients of receiving surgical resection of HCC tumor.">
    <entity charOffset="103-106" id="s4018.e0" ontology_id="84668" text="HCC" type="GENE"/>
    <entity charOffset="155-160" id="s4018.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4018.e0" e2="s4018.e1" id="s4018.p0" relation="true"/>
  </sentence>
  <sentence id="s4019" text="In cancer, elevated XIAP expression has been associated with malignancy, poor prognosis, and treatment resistance.">
    <entity charOffset="3-9" id="s4019.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="20-24" id="s4019.e1" ontology_id="331" text="XIAP" type="GENE"/>
    <pair e1="s4019.e0" e2="s4019.e1" id="s4019.p0" relation="true"/>
  </sentence>
  <sentence id="s4020" text="XIAP has previously been proposed to promote tumor growth through suppression of autophagy.">
    <entity charOffset="0-4" id="s4020.e0" ontology_id="331" text="XIAP" type="GENE"/>
    <entity charOffset="45-50" id="s4020.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4020.e0" e2="s4020.e1" id="s4020.p0" relation="true"/>
  </sentence>
  <sentence id="s4021" text="In this study, we examined the expression of XIAP and p62, two critical mediators of autophagy, in breast and colon cancer.">
    <entity charOffset="45-49" id="s4021.e0" ontology_id="331" text="XIAP" type="GENE"/>
    <entity charOffset="116-122" id="s4021.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4021.e0" e2="s4021.e1" id="s4021.p0" relation="true"/>
  </sentence>
  <sentence id="s4022" text="We observed a negative correlation between XIAP and p62 expression in normal and cancer tissues of breast and colon, and that the ratio of XIAP and p62 expression determines the cancer phenotype.">
    <entity charOffset="43-47" id="s4022.e0" ontology_id="331" text="XIAP" type="GENE"/>
    <entity charOffset="81-87" id="s4022.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4022.e0" e2="s4022.e1" id="s4022.p0" relation="true"/>
  </sentence>
  <sentence id="s4023" text="Mutations in COL4A1 have been reported in schizencephaly and porencephaly combined with microbleeds or calcifications, often associated with ocular and renal abnormalities, myopathy, elevated creatine kinase levels and haemolytic anaemia.">
    <entity charOffset="13-19" id="s4023.e0" ontology_id="1282" text="COL4A1" type="GENE"/>
    <entity charOffset="42-56" id="s4023.e1" ontology_id="HP_0010636" text="schizencephaly" type="HP"/>
    <pair e1="s4023.e0" e2="s4023.e1" id="s4023.p0" relation="true"/>
  </sentence>
  <sentence id="s4024" text="Mutations in COL4A1 have been reported in schizencephaly and porencephaly combined with microbleeds or calcifications, often associated with ocular and renal abnormalities, myopathy, elevated creatine kinase levels and haemolytic anaemia.">
    <entity charOffset="13-19" id="s4024.e0" ontology_id="1282" text="COL4A1" type="GENE"/>
    <entity charOffset="173-181" id="s4024.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4024.e0" e2="s4024.e1" id="s4024.p0" relation="true"/>
  </sentence>
  <sentence id="s4025" text="In this study, we aimed to clarify the phenotypic spectrum of COL4A1/A2 mutations in the context of cortical malformations that include schizencephaly, polymicrogyria and/or heterotopia">
    <entity charOffset="62-68" id="s4025.e0" ontology_id="1282" text="COL4A1" type="GENE"/>
    <entity charOffset="152-166" id="s4025.e1" ontology_id="HP_0002126" text="polymicrogyria" type="HP"/>
    <pair e1="s4025.e0" e2="s4025.e1" id="s4025.p0" relation="true"/>
  </sentence>
  <sentence id="s4026" text="The colonic expression of D2HGDH is decreased in ulcerative colitis (UC) patients at baseline who progress to cancer.">
    <entity charOffset="26-32" id="s4026.e0" ontology_id="728294" text="D2HGDH" type="GENE"/>
    <entity charOffset="110-116" id="s4026.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4026.e0" e2="s4026.e1" id="s4026.p0" relation="true"/>
  </sentence>
  <sentence id="s4027" text="Our study identifies urine D2HG and tissue D2HGDH expression as biomarkers to identify patients at risk for progressing from colitis to cancer.">
    <entity charOffset="43-49" id="s4027.e0" ontology_id="728294" text="D2HGDH" type="GENE"/>
    <entity charOffset="136-142" id="s4027.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4027.e0" e2="s4027.e1" id="s4027.p0" relation="true"/>
  </sentence>
  <sentence id="s4028" text="Craniofrontonasal syndrome (CFNS) is a very rare genetic disorder with variable clinical phenotypes, including brachycephaly, hypertelorism, and a bifid nasal tip.">
    <entity charOffset="28-32" id="s4028.e0" ontology_id="1947" text="CFNS" type="GENE"/>
    <entity charOffset="111-124" id="s4028.e1" ontology_id="HP_0000248" text="brachycephaly" type="HP"/>
    <pair e1="s4028.e0" e2="s4028.e1" id="s4028.p0" relation="true"/>
  </sentence>
  <sentence id="s4029" text="Craniofrontonasal syndrome (CFNS) is a very rare genetic disorder with variable clinical phenotypes, including brachycephaly, hypertelorism, and a bifid nasal tip.">
    <entity charOffset="28-32" id="s4029.e0" ontology_id="1947" text="CFNS" type="GENE"/>
    <entity charOffset="126-139" id="s4029.e1" ontology_id="HP_0000316" text="hypertelorism" type="HP"/>
    <pair e1="s4029.e0" e2="s4029.e1" id="s4029.p0" relation="true"/>
  </sentence>
  <sentence id="s4030" text="Duchenne muscular dystrophy (DMD) is characterized by a severe and progressive destruction of muscle fibers associated with altered Ca&lt;sup&gt;2+&lt;/sup&gt; homeostasis.">
    <entity charOffset="9-27" id="s4030.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="29-32" id="s4030.e1" ontology_id="1756" text="DMD" type="GENE"/>
    <pair e1="s4030.e0" e2="s4030.e1" id="s4030.p0" relation="true"/>
  </sentence>
  <sentence id="s4031" text="Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease of the cerebellum caused by a polyglutamine-repeat expansion in the protein ATXN1.">
    <entity charOffset="16-22" id="s4031.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="31-35" id="s4031.e1" ontology_id="6310" text="SCA1" type="GENE"/>
    <pair e1="s4031.e0" e2="s4031.e1" id="s4031.p0" relation="true"/>
  </sentence>
  <sentence id="s4032" text="Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease of the cerebellum caused by a polyglutamine-repeat expansion in the protein ATXN1.">
    <entity charOffset="16-22" id="s4032.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="165-170" id="s4032.e1" ontology_id="6310" text="ATXN1" type="GENE"/>
    <pair e1="s4032.e0" e2="s4032.e1" id="s4032.p0" relation="true"/>
  </sentence>
  <sentence id="s4033" text="PAX6 expression and molecular mechanisms by which PAX6 modifies the migration capacity of breast cancer cells">
    <entity charOffset="0-4" id="s4033.e0" ontology_id="5080" text="PAX6" type="GENE"/>
    <entity charOffset="97-103" id="s4033.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4033.e0" e2="s4033.e1" id="s4033.p0" relation="true"/>
  </sentence>
  <sentence id="s4034" text="The genetic study by panels of known genes associated with tubulointerstitial disease allowed us to discover autosomal dominant distal renal tubular acidosis associated with a de novo mutation in exon 14 of the SLC4A1 gene, which would have been impossible to diagnose clinically due to the advanced nature of the kidney disease when it was discovered">
    <entity charOffset="128-134" id="s4034.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="211-217" id="s4034.e1" ontology_id="6521" text="SLC4A1" type="GENE"/>
    <pair e1="s4034.e0" e2="s4034.e1" id="s4034.p0" relation="true"/>
  </sentence>
  <sentence id="s4035" text="The genetic study by panels of known genes associated with tubulointerstitial disease allowed us to discover autosomal dominant distal renal tubular acidosis associated with a de novo mutation in exon 14 of the SLC4A1 gene, which would have been impossible to diagnose clinically due to the advanced nature of the kidney disease when it was discovered">
    <entity charOffset="135-157" id="s4035.e0" ontology_id="HP_0001947" text="renal tubular acidosis" type="HP"/>
    <entity charOffset="211-217" id="s4035.e1" ontology_id="6521" text="SLC4A1" type="GENE"/>
    <pair e1="s4035.e0" e2="s4035.e1" id="s4035.p0" relation="true"/>
  </sentence>
  <sentence id="s4036" text="Functional studies support intraocular pressure-related influences of FMNL2 and LMX1B, with certain Lmx1b mutations causing high IOP and glaucoma resembling POAG in mice.">
    <entity charOffset="70-75" id="s4036.e0" ontology_id="114793" text="FMNL2" type="GENE"/>
    <entity charOffset="137-145" id="s4036.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s4036.e0" e2="s4036.e1" id="s4036.p0" relation="true"/>
  </sentence>
  <sentence id="s4037" text="Aberrant expression of the sodium channel gene (SCN5A) has been proposed to disrupt cardiac action potential and cause human cardiac arrhythmias, but the mechanisms of SCN5A gene regulation and dysregulation still remain largely unexplored.">
    <entity charOffset="48-53" id="s4037.e0" ontology_id="6331" text="SCN5A" type="GENE"/>
    <entity charOffset="125-144" id="s4037.e1" ontology_id="HP_0011675" text="cardiac arrhythmias" type="HP"/>
    <pair e1="s4037.e0" e2="s4037.e1" id="s4037.p0" relation="true"/>
  </sentence>
  <sentence id="s4038" text="This study aimed to evaluate the interactions between single nucleotide polymorphisms of ERCC6 (rs1917799) and ERCC8 (rs158572 and rs158916) in gastric cancer and its precancerous diseases.">
    <entity charOffset="89-94" id="s4038.e0" ontology_id="2074" text="ERCC6" type="GENE"/>
    <entity charOffset="152-158" id="s4038.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4038.e0" e2="s4038.e1" id="s4038.p0" relation="true"/>
  </sentence>
  <sentence id="s4039" text="This study aimed to evaluate the interactions between single nucleotide polymorphisms of ERCC6 (rs1917799) and ERCC8 (rs158572 and rs158916) in gastric cancer and its precancerous diseases.">
    <entity charOffset="111-116" id="s4039.e0" ontology_id="1161" text="ERCC8" type="GENE"/>
    <entity charOffset="152-158" id="s4039.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4039.e0" e2="s4039.e1" id="s4039.p0" relation="true"/>
  </sentence>
  <sentence id="s4040" text="ERCC6 rs1917799 also showed a significant interaction with ERCC8 rs158916 to reduce gastric cancer risk.">
    <entity charOffset="0-5" id="s4040.e0" ontology_id="2074" text="ERCC6" type="GENE"/>
    <entity charOffset="92-98" id="s4040.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4040.e0" e2="s4040.e1" id="s4040.p0" relation="true"/>
  </sentence>
  <sentence id="s4041" text="The expressions of ERCC6, ERCC8 and ERCC6-ERCC8 combination have similarities that higher positivity was observed in chronic superficial gastritis compared with chronic atrophic gastritis and gastric cancer.">
    <entity charOffset="19-24" id="s4041.e0" ontology_id="2074" text="ERCC6" type="GENE"/>
    <entity charOffset="200-206" id="s4041.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4041.e0" e2="s4041.e1" id="s4041.p0" relation="true"/>
  </sentence>
  <sentence id="s4042" text="The expressions of ERCC6, ERCC8 and ERCC6-ERCC8 combination have similarities that higher positivity was observed in chronic superficial gastritis compared with chronic atrophic gastritis and gastric cancer.">
    <entity charOffset="26-31" id="s4042.e0" ontology_id="1161" text="ERCC8" type="GENE"/>
    <entity charOffset="200-206" id="s4042.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4042.e0" e2="s4042.e1" id="s4042.p0" relation="false"/>
  </sentence>
  <sentence id="s4043" text="ABHD12 mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.">
    <entity charOffset="0-6" id="s4043.e0" ontology_id="26090" text="ABHD12" type="GENE"/>
    <entity charOffset="78-90" id="s4043.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4043.e0" e2="s4043.e1" id="s4043.p0" relation="true"/>
  </sentence>
  <sentence id="s4044" text="ABHD12 mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.">
    <entity charOffset="0-6" id="s4044.e0" ontology_id="26090" text="ABHD12" type="GENE"/>
    <entity charOffset="138-146" id="s4044.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s4044.e0" e2="s4044.e1" id="s4044.p0" relation="true"/>
  </sentence>
  <sentence id="s4045" text="Of these five genes, the brain expressed CDK5R1 gene constitutes a good candidate for the developmental delay, while the RHOT1 gene, involved in mitochondrial trafficking, might underlie the hypotonia and the excessive fatigue">
    <entity charOffset="41-47" id="s4045.e0" ontology_id="8851" text="CDK5R1" type="GENE"/>
    <entity charOffset="90-109" id="s4045.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s4045.e0" e2="s4045.e1" id="s4045.p0" relation="true"/>
  </sentence>
  <sentence id="s4046" text="Of these five genes, the brain expressed CDK5R1 gene constitutes a good candidate for the developmental delay, while the RHOT1 gene, involved in mitochondrial trafficking, might underlie the hypotonia and the excessive fatigue">
    <entity charOffset="90-109" id="s4046.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="121-126" id="s4046.e1" ontology_id="55288" text="RHOT1" type="GENE"/>
    <pair e1="s4046.e0" e2="s4046.e1" id="s4046.p0" relation="true"/>
  </sentence>
  <sentence id="s4047" text="A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/TSHR signaling in the development of PTCs.">
    <entity charOffset="82-96" id="s4047.e0" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <entity charOffset="279-283" id="s4047.e1" ontology_id="7253" text="TSHR" type="GENE"/>
    <pair e1="s4047.e0" e2="s4047.e1" id="s4047.p0" relation="true"/>
  </sentence>
  <sentence id="s4048" text="A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/TSHR signaling in the development of PTCs.">
    <entity charOffset="82-96" id="s4048.e0" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <entity charOffset="316-319" id="s4048.e1" ontology_id="8030" text="PTC" type="GENE"/>
    <pair e1="s4048.e0" e2="s4048.e1" id="s4048.p0" relation="true"/>
  </sentence>
  <sentence id="s4049" text="BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and Kmt2c (90%) mutations by exome sequencing, similar to human MIBC.">
    <entity charOffset="4-10" id="s4049.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="127-132" id="s4049.e1" ontology_id="8085" text="Kmt2d" type="GENE"/>
    <pair e1="s4049.e0" e2="s4049.e1" id="s4049.p0" relation="true"/>
  </sentence>
  <sentence id="s4050" text="BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and Kmt2c (90%) mutations by exome sequencing, similar to human MIBC.">
    <entity charOffset="53-59" id="s4050.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="127-132" id="s4050.e1" ontology_id="8085" text="Kmt2d" type="GENE"/>
    <pair e1="s4050.e0" e2="s4050.e1" id="s4050.p0" relation="true"/>
  </sentence>
  <sentence id="s4051" text="BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and Kmt2c (90%) mutations by exome sequencing, similar to human MIBC.">
    <entity charOffset="53-59" id="s4051.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="144-149" id="s4051.e1" ontology_id="58508" text="Kmt2c" type="GENE"/>
    <pair e1="s4051.e0" e2="s4051.e1" id="s4051.p0" relation="true"/>
  </sentence>
  <sentence id="s4052" text="Here, we report that TRIP13 is highly overexpressed in multiple lung adenocarcinoma cell lines and tumor tissues.">
    <entity charOffset="21-27" id="s4052.e0" ontology_id="9319" text="TRIP13" type="GENE"/>
    <entity charOffset="64-83" id="s4052.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s4052.e0" e2="s4052.e1" id="s4052.p0" relation="true"/>
  </sentence>
  <sentence id="s4053" text="Clinically, TRIP13 expression is positively associated with tumor size, T-stage, and N-stage, and Kaplan-Meier analysis revealed that heightened TRIP13 expression is associated with lower overall survival.">
    <entity charOffset="12-18" id="s4053.e0" ontology_id="9319" text="TRIP13" type="GENE"/>
    <entity charOffset="60-65" id="s4053.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4053.e0" e2="s4053.e1" id="s4053.p0" relation="true"/>
  </sentence>
  <sentence id="s4054" text="TRIP13 promotes lung adenocarcinoma cell proliferation, clonogenicity, and migration while inhibiting apoptosis and G2/M phase shift invitro.">
    <entity charOffset="0-6" id="s4054.e0" ontology_id="9319" text="TRIP13" type="GENE"/>
    <entity charOffset="16-35" id="s4054.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s4054.e0" e2="s4054.e1" id="s4054.p0" relation="true"/>
  </sentence>
  <sentence id="s4055" text="Accordingly, TRIP13-silenced xenograft tumors displayed significant growth inhibition invivo.">
    <entity charOffset="13-19" id="s4055.e0" ontology_id="9319" text="TRIP13" type="GENE"/>
    <entity charOffset="39-44" id="s4055.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4055.e0" e2="s4055.e1" id="s4055.p0" relation="true"/>
  </sentence>
  <sentence id="s4056" text="In conclusion, heightened TRIP13 expression appears to promote lung adenocarcinoma tumor progression and displays potential as a therapeutic target or biomarker for lung adenocarcinoma">
    <entity charOffset="26-32" id="s4056.e0" ontology_id="9319" text="TRIP13" type="GENE"/>
    <entity charOffset="63-82" id="s4056.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s4056.e0" e2="s4056.e1" id="s4056.p0" relation="true"/>
  </sentence>
  <sentence id="s4057" text="In conclusion, heightened TRIP13 expression appears to promote lung adenocarcinoma tumor progression and displays potential as a therapeutic target or biomarker for lung adenocarcinoma">
    <entity charOffset="26-32" id="s4057.e0" ontology_id="9319" text="TRIP13" type="GENE"/>
    <entity charOffset="83-88" id="s4057.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4057.e0" e2="s4057.e1" id="s4057.p0" relation="true"/>
  </sentence>
  <sentence id="s4058" text="Bartter syndrome type 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (&lt;i&gt;CLCNKB&lt;/i&gt;), which encodes the ClC-Kb chloride channel involved in NaCl reabsorption in the renal tubule.">
    <entity charOffset="40-53" id="s4058.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="159-165" id="s4058.e1" ontology_id="1188" text="CLCNKB" type="GENE"/>
    <pair e1="s4058.e0" e2="s4058.e1" id="s4058.p0" relation="true"/>
  </sentence>
  <sentence id="s4059" text="Bartter syndrome type 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (&lt;i&gt;CLCNKB&lt;/i&gt;), which encodes the ClC-Kb chloride channel involved in NaCl reabsorption in the renal tubule.">
    <entity charOffset="40-53" id="s4059.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="190-193" id="s4059.e1" ontology_id="23529" text="ClC" type="GENE"/>
    <pair e1="s4059.e0" e2="s4059.e1" id="s4059.p0" relation="true"/>
  </sentence>
  <sentence id="s4060" text="Our findings imply that microcephaly is a variable phenotype in WDR73-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease">
    <entity charOffset="64-69" id="s4060.e0" ontology_id="84942" text="WDR73" type="GENE"/>
    <entity charOffset="134-157" id="s4060.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4060.e0" e2="s4060.e1" id="s4060.p0" relation="true"/>
  </sentence>
  <sentence id="s4061" text="Our findings imply that microcephaly is a variable phenotype in WDR73-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease">
    <entity charOffset="64-69" id="s4061.e0" ontology_id="84942" text="WDR73" type="GENE"/>
    <entity charOffset="162-183" id="s4061.e1" ontology_id="HP_0001321" text="cerebellar hypoplasia" type="HP"/>
    <pair e1="s4061.e0" e2="s4061.e1" id="s4061.p0" relation="true"/>
  </sentence>
  <sentence id="s4062" text="Two rare pathogenic variants were identified in the COL15A1 gene: one in a sporadic case and another was found to segregate in a family with six affected individuals with CD.">
    <entity charOffset="52-59" id="s4062.e0" ontology_id="1306" text="COL15A1" type="GENE"/>
    <entity charOffset="75-83" id="s4062.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4062.e0" e2="s4062.e1" id="s4062.p0" relation="true"/>
  </sentence>
  <sentence id="s4063" text="Mutations in heat shock transcription factor 4 (HSF4) have been associated with cataract; however, the mechanisms regarding how mutations in HSF4 cause cataract are still obscure.">
    <entity charOffset="48-52" id="s4063.e0" ontology_id="3299" text="HSF4" type="GENE"/>
    <entity charOffset="80-88" id="s4063.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s4063.e0" e2="s4063.e1" id="s4063.p0" relation="true"/>
  </sentence>
  <sentence id="s4064" text="The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(SCC) of the tongue: the vascular endothelial growth factor(VEGF)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(CCR7); neuropilin(NRP)1 and NRP2; and semaphorin 3E(SEMA3E).">
    <entity charOffset="119-142" id="s4064.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="144-147" id="s4064.e1" ontology_id="6317" text="SCC" type="GENE"/>
    <pair e1="s4064.e0" e2="s4064.e1" id="s4064.p0" relation="true"/>
  </sentence>
  <sentence id="s4065" text="The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(SCC) of the tongue: the vascular endothelial growth factor(VEGF)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(CCR7); neuropilin(NRP)1 and NRP2; and semaphorin 3E(SEMA3E).">
    <entity charOffset="119-142" id="s4065.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="204-208" id="s4065.e1" ontology_id="7422" text="VEGF" type="GENE"/>
    <pair e1="s4065.e0" e2="s4065.e1" id="s4065.p0" relation="true"/>
  </sentence>
  <sentence id="s4066" text="The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(SCC) of the tongue: the vascular endothelial growth factor(VEGF)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(CCR7); neuropilin(NRP)1 and NRP2; and semaphorin 3E(SEMA3E).">
    <entity charOffset="119-142" id="s4066.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="339-343" id="s4066.e1" ontology_id="1236" text="CCR7" type="GENE"/>
    <pair e1="s4066.e0" e2="s4066.e1" id="s4066.p0" relation="true"/>
  </sentence>
  <sentence id="s4067" text="The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(SCC) of the tongue: the vascular endothelial growth factor(VEGF)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(CCR7); neuropilin(NRP)1 and NRP2; and semaphorin 3E(SEMA3E).">
    <entity charOffset="119-142" id="s4067.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="358-361" id="s4067.e1" ontology_id="4673" text="NRP" type="GENE"/>
    <pair e1="s4067.e0" e2="s4067.e1" id="s4067.p0" relation="true"/>
  </sentence>
  <sentence id="s4068" text="The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(SCC) of the tongue: the vascular endothelial growth factor(VEGF)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(CCR7); neuropilin(NRP)1 and NRP2; and semaphorin 3E(SEMA3E).">
    <entity charOffset="119-142" id="s4068.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="393-399" id="s4068.e1" ontology_id="9723" text="SEMA3E" type="GENE"/>
    <pair e1="s4068.e0" e2="s4068.e1" id="s4068.p0" relation="true"/>
  </sentence>
  <sentence id="s4069" text="Subsequent quantitative PCR experiments confirmed that PRDX4, CKS2, MAGED2, and an EST (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.">
    <entity charOffset="55-60" id="s4069.e0" ontology_id="10549" text="PRDX4" type="GENE"/>
    <entity charOffset="172-178" id="s4069.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4069.e0" e2="s4069.e1" id="s4069.p0" relation="true"/>
  </sentence>
  <sentence id="s4070" text="Subsequent quantitative PCR experiments confirmed that PRDX4, CKS2, MAGED2, and an EST (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.">
    <entity charOffset="68-74" id="s4070.e0" ontology_id="10916" text="MAGED2" type="GENE"/>
    <entity charOffset="172-178" id="s4070.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4070.e0" e2="s4070.e1" id="s4070.p0" relation="true"/>
  </sentence>
  <sentence id="s4071" text="Subsequent quantitative PCR experiments confirmed that PRDX4, CKS2, MAGED2, and an EST (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.">
    <entity charOffset="83-86" id="s4071.e0" ontology_id="1326" text="EST" type="GENE"/>
    <entity charOffset="172-178" id="s4071.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4071.e0" e2="s4071.e1" id="s4071.p0" relation="true"/>
  </sentence>
  <sentence id="s4072" text="We investigated this issue by analyzing the expression patterns of APP, APP-processing secretases, and APP metabolites in mitochondria separated from human neuroblastoma SH-SY5Y cells and those expressing Swedish mutant APP.">
    <entity charOffset="67-70" id="s4072.e0" ontology_id="351" text="APP" type="GENE"/>
    <entity charOffset="156-169" id="s4072.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s4072.e0" e2="s4072.e1" id="s4072.p0" relation="true"/>
  </sentence>
  <sentence id="s4073" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="236-250" id="s4073.e0" ontology_id="HP_0002311" text="incoordination" type="HP"/>
    <entity charOffset="307-310" id="s4073.e1" ontology_id="6531" text="DAT" type="GENE"/>
    <pair e1="s4073.e0" e2="s4073.e1" id="s4073.p0" relation="true"/>
  </sentence>
  <sentence id="s4074" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="236-250" id="s4074.e0" ontology_id="HP_0002311" text="incoordination" type="HP"/>
    <entity charOffset="312-317" id="s4074.e1" ontology_id="4010" text="LMX1B" type="GENE"/>
    <pair e1="s4074.e0" e2="s4074.e1" id="s4074.p0" relation="false"/>
  </sentence>
  <sentence id="s4075" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="255-265" id="s4075.e0" ontology_id="HP_0000733" text="stereotypy" type="HP"/>
    <entity charOffset="307-310" id="s4075.e1" ontology_id="6531" text="DAT" type="GENE"/>
    <pair e1="s4075.e0" e2="s4075.e1" id="s4075.p0" relation="true"/>
  </sentence>
  <sentence id="s4076" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="255-265" id="s4076.e0" ontology_id="HP_0000733" text="stereotypy" type="HP"/>
    <entity charOffset="312-317" id="s4076.e1" ontology_id="4010" text="LMX1B" type="GENE"/>
    <pair e1="s4076.e0" e2="s4076.e1" id="s4076.p0" relation="true"/>
  </sentence>
  <sentence id="s4077" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="255-265" id="s4077.e0" ontology_id="HP_0000733" text="stereotypy" type="HP"/>
    <entity charOffset="319-324" id="s4077.e1" ontology_id="4929" text="Nurr1" type="GENE"/>
    <pair e1="s4077.e0" e2="s4077.e1" id="s4077.p0" relation="false"/>
  </sentence>
  <sentence id="s4078" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="255-265" id="s4078.e0" ontology_id="HP_0000733" text="stereotypy" type="HP"/>
    <entity charOffset="326-331" id="s4078.e1" ontology_id="5309" text="Pitx3" type="GENE"/>
    <pair e1="s4078.e0" e2="s4078.e1" id="s4078.p0" relation="false"/>
  </sentence>
  <sentence id="s4079" text="The neurophenotype of these GFAP.HMOX1&lt;sup&gt;8.5-19m&lt;/sup&gt; mice is highly consistent with parkinsonism and differs dramatically from the schizophrenia-like features previously documented in younger GFAP.HMOX1&lt;sup&gt;0-12m&lt;/sup&gt; mice.">
    <entity charOffset="57-61" id="s4079.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="88-100" id="s4079.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s4079.e0" e2="s4079.e1" id="s4079.p0" relation="true"/>
  </sentence>
  <sentence id="s4080" text="Finally, we show that PCP genes &lt;i&gt;VANGL2&lt;/i&gt; and &lt;i&gt;SCRIB&lt;/i&gt; are significantly downregulated in lung tissue from patients with emphysema.">
    <entity charOffset="22-25" id="s4080.e0" ontology_id="54858" text="PCP" type="GENE"/>
    <entity charOffset="129-138" id="s4080.e1" ontology_id="HP_0002097" text="emphysema" type="HP"/>
    <pair e1="s4080.e0" e2="s4080.e1" id="s4080.p0" relation="true"/>
  </sentence>
  <sentence id="s4081" text="Schnyder corneal dystrophy (SCD) is a rare autosomal dominant disease in humans, characterized by abnormal deposition of cholesterol and phospholipids in cornea caused by mutations in the UbiA prenyltransferase domain containing 1 (UBIAD1) gene.">
    <entity charOffset="9-26" id="s4081.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="232-238" id="s4081.e1" ontology_id="29914" text="UBIAD1" type="GENE"/>
    <pair e1="s4081.e0" e2="s4081.e1" id="s4081.p0" relation="true"/>
  </sentence>
  <sentence id="s4082" text="Patients with autosomal dominant vibratory urticaria have localized hives and systemic manifestations in response to dermal vibration, with coincident degranulation of mast cells and increased histamine levels in serum.">
    <entity charOffset="43-52" id="s4082.e0" ontology_id="HP_0001025" text="urticaria" type="HP"/>
    <entity charOffset="168-172" id="s4082.e1" ontology_id="51324" text="mast" type="GENE"/>
    <pair e1="s4082.e0" e2="s4082.e1" id="s4082.p0" relation="true"/>
  </sentence>
  <sentence id="s4083" text="We identified a previously unknown missense substitution in ADGRE2 (also known as EMR2), which was predicted to result in the replacement of cysteine with tyrosine at amino acid position 492 (p.C492Y), as the only nonsynonymous variant cosegregating with vibratory urticaria in two large kindreds.">
    <entity charOffset="60-66" id="s4083.e0" ontology_id="30817" text="ADGRE2" type="GENE"/>
    <entity charOffset="265-274" id="s4083.e1" ontology_id="HP_0001025" text="urticaria" type="HP"/>
    <pair e1="s4083.e0" e2="s4083.e1" id="s4083.p0" relation="true"/>
  </sentence>
  <sentence id="s4084" text="Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, HLA-DQB1), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, OR52N2-TRIM5).">
    <entity charOffset="20-26" id="s4084.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="86-94" id="s4084.e1" ontology_id="3119" text="HLA-DQB1" type="GENE"/>
    <pair e1="s4084.e0" e2="s4084.e1" id="s4084.p0" relation="true"/>
  </sentence>
  <sentence id="s4085" text="Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, HLA-DQB1), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, OR52N2-TRIM5).">
    <entity charOffset="20-26" id="s4085.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="150-156" id="s4085.e1" ontology_id="390077" text="OR52N2" type="GENE"/>
    <pair e1="s4085.e0" e2="s4085.e1" id="s4085.p0" relation="true"/>
  </sentence>
  <sentence id="s4086" text="Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L).">
    <entity charOffset="5-11" id="s4086.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="68-72" id="s4086.e1" ontology_id="11321" text="GPN1" type="GENE"/>
    <pair e1="s4086.e0" e2="s4086.e1" id="s4086.p0" relation="true"/>
  </sentence>
  <sentence id="s4087" text="Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L).">
    <entity charOffset="5-11" id="s4087.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="97-102" id="s4087.e1" ontology_id="10319" text="LAMC3" type="GENE"/>
    <pair e1="s4087.e0" e2="s4087.e1" id="s4087.p0" relation="true"/>
  </sentence>
  <sentence id="s4088" text="Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L).">
    <entity charOffset="5-11" id="s4088.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="159-165" id="s4088.e1" ontology_id="1030" text="CDKN2B" type="GENE"/>
    <pair e1="s4088.e0" e2="s4088.e1" id="s4088.p0" relation="true"/>
  </sentence>
  <sentence id="s4089" text="Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L).">
    <entity charOffset="5-11" id="s4089.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="196-203" id="s4089.e1" ontology_id="81037" text="CLPTM1L" type="GENE"/>
    <pair e1="s4089.e0" e2="s4089.e1" id="s4089.p0" relation="true"/>
  </sentence>
  <sentence id="s4090" text="We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic cancer predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), BRCA2 (3), MSH2 (1), MSH6 (1)].">
    <entity charOffset="149-155" id="s4090.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="261-266" id="s4090.e1" ontology_id="675" text="BRCA2" type="GENE"/>
    <pair e1="s4090.e0" e2="s4090.e1" id="s4090.p0" relation="true"/>
  </sentence>
  <sentence id="s4091" text="We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic cancer predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), BRCA2 (3), MSH2 (1), MSH6 (1)].">
    <entity charOffset="149-155" id="s4091.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="272-276" id="s4091.e1" ontology_id="4436" text="MSH2" type="GENE"/>
    <pair e1="s4091.e0" e2="s4091.e1" id="s4091.p0" relation="true"/>
  </sentence>
  <sentence id="s4092" text="We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic cancer predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), BRCA2 (3), MSH2 (1), MSH6 (1)].">
    <entity charOffset="149-155" id="s4092.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="282-286" id="s4092.e1" ontology_id="2956" text="MSH6" type="GENE"/>
    <pair e1="s4092.e0" e2="s4092.e1" id="s4092.p0" relation="true"/>
  </sentence>
  <sentence id="s4093" text="The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="27-30" id="s4093.e0" ontology_id="4693" text="NDP" type="GENE"/>
    <entity charOffset="133-145" id="s4093.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s4093.e0" e2="s4093.e1" id="s4093.p0" relation="true"/>
  </sentence>
  <sentence id="s4094" text="The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="27-30" id="s4094.e0" ontology_id="4693" text="NDP" type="GENE"/>
    <entity charOffset="176-184" id="s4094.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4094.e0" e2="s4094.e1" id="s4094.p0" relation="true"/>
  </sentence>
  <sentence id="s4095" text="The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="70-75" id="s4095.e0" ontology_id="80258" text="EFHC2" type="GENE"/>
    <entity charOffset="147-170" id="s4095.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4095.e0" e2="s4095.e1" id="s4095.p0" relation="true"/>
  </sentence>
  <sentence id="s4096" text="The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="70-75" id="s4096.e0" ontology_id="80258" text="EFHC2" type="GENE"/>
    <entity charOffset="176-184" id="s4096.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4096.e0" e2="s4096.e1" id="s4096.p0" relation="true"/>
  </sentence>
  <sentence id="s4097" text="This familial study demonstrates that a deficiency in one of two MAO genes may not lead to psychomotor delay, and deletion of EFHC2 may not cause epilepsy.">
    <entity charOffset="126-131" id="s4097.e0" ontology_id="80258" text="EFHC2" type="GENE"/>
    <entity charOffset="146-154" id="s4097.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4097.e0" e2="s4097.e1" id="s4097.p0" relation="true"/>
  </sentence>
  <sentence id="s4098" text="Since this is an atypical but previously described rare presentation of PHP1b, we reemphasize STX16 deletions and PHP1b as a rare cause for early onset obesity and macrosomia.">
    <entity charOffset="72-75" id="s4098.e0" ontology_id="6658" text="PHP" type="GENE"/>
    <entity charOffset="164-174" id="s4098.e1" ontology_id="HP_0001520" text="macrosomia" type="HP"/>
    <pair e1="s4098.e0" e2="s4098.e1" id="s4098.p0" relation="true"/>
  </sentence>
  <sentence id="s4099" text="Since this is an atypical but previously described rare presentation of PHP1b, we reemphasize STX16 deletions and PHP1b as a rare cause for early onset obesity and macrosomia.">
    <entity charOffset="72-75" id="s4099.e0" ontology_id="6658" text="PHP" type="GENE"/>
    <entity charOffset="152-159" id="s4099.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4099.e0" e2="s4099.e1" id="s4099.p0" relation="true"/>
  </sentence>
  <sentence id="s4100" text="Since this is an atypical but previously described rare presentation of PHP1b, we reemphasize STX16 deletions and PHP1b as a rare cause for early onset obesity and macrosomia.">
    <entity charOffset="94-99" id="s4100.e0" ontology_id="8675" text="STX16" type="GENE"/>
    <entity charOffset="164-174" id="s4100.e1" ontology_id="HP_0001520" text="macrosomia" type="HP"/>
    <pair e1="s4100.e0" e2="s4100.e1" id="s4100.p0" relation="true"/>
  </sentence>
  <sentence id="s4101" text="Here, we identified three families with mutations in ADD3, encoding for adducin-, with intellectual disability, microcephaly, cataracts and skeletal defects.">
    <entity charOffset="53-57" id="s4101.e0" ontology_id="120" text="ADD3" type="GENE"/>
    <entity charOffset="127-136" id="s4101.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s4101.e0" e2="s4101.e1" id="s4101.p0" relation="true"/>
  </sentence>
  <sentence id="s4102" text="In one of the families with additional cardiomyopathy and steroid-resistant nephrotic syndrome (SRNS), we found a homozygous variant in KAT2B, encoding the lysine acetyltransferase 2B, with impact on KAT2B protein levels in patient fibroblasts, suggesting that this second mutation might contribute to the increased disease spectrum.">
    <entity charOffset="39-53" id="s4102.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="136-141" id="s4102.e1" ontology_id="8850" text="KAT2B" type="GENE"/>
    <pair e1="s4102.e0" e2="s4102.e1" id="s4102.p0" relation="true"/>
  </sentence>
  <sentence id="s4103" text="Colorectal cancer cell lines with CHFR methylation demonstrated increased sensitivity to irinotecan.">
    <entity charOffset="11-17" id="s4103.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="34-38" id="s4103.e1" ontology_id="55743" text="CHFR" type="GENE"/>
    <pair e1="s4103.e0" e2="s4103.e1" id="s4103.p0" relation="true"/>
  </sentence>
  <sentence id="s4104" text="The autosomal recessive neurodegenerative disease spinal muscular atrophy (SMA) results from low levels of survival motor neuron (SMN) protein; however, it is unclear how reduced SMN promotes SMA development.">
    <entity charOffset="4-23" id="s4104.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="75-78" id="s4104.e1" ontology_id="6606" text="SMA" type="GENE"/>
    <pair e1="s4104.e0" e2="s4104.e1" id="s4104.p0" relation="true"/>
  </sentence>
  <sentence id="s4105" text="The autosomal recessive neurodegenerative disease spinal muscular atrophy (SMA) results from low levels of survival motor neuron (SMN) protein; however, it is unclear how reduced SMN promotes SMA development.">
    <entity charOffset="24-49" id="s4105.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="130-133" id="s4105.e1" ontology_id="6638" text="SMN" type="GENE"/>
    <pair e1="s4105.e0" e2="s4105.e1" id="s4105.p0" relation="true"/>
  </sentence>
  <sentence id="s4106" text="Aberrant expression of different family members of the Eph/ephrin system, which comprises the Eph receptors (Ephs) and their ligands (ephrins), has been implicated in various malignancies including breast cancer.">
    <entity charOffset="55-58" id="s4106.e0" ontology_id="2041" text="Eph" type="GENE"/>
    <entity charOffset="205-211" id="s4106.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4106.e0" e2="s4106.e1" id="s4106.p0" relation="true"/>
  </sentence>
  <sentence id="s4107" text="This review reflects the existing Eph/ephrin literature while focusing on breast cancer heterogeneity.">
    <entity charOffset="34-37" id="s4107.e0" ontology_id="2041" text="Eph" type="GENE"/>
    <entity charOffset="88-101" id="s4107.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s4107.e0" e2="s4107.e1" id="s4107.p0" relation="true"/>
  </sentence>
  <sentence id="s4108" text="Hormone positive, HER2 positive and triple negative breast cancer (TNBC) cell lines, xenografts/mutant animal models and patient samples are examined separately as, in humans, they represent entities with differences in prognosis and treatment.">
    <entity charOffset="18-22" id="s4108.e0" ontology_id="2064" text="HER2" type="GENE"/>
    <entity charOffset="59-65" id="s4108.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4108.e0" e2="s4108.e1" id="s4108.p0" relation="true"/>
  </sentence>
  <sentence id="s4109" text="EphA2, EphB4 and EphB6 are the members most extensively studied in breast cancer.">
    <entity charOffset="0-3" id="s4109.e0" ontology_id="2041" text="Eph" type="GENE"/>
    <entity charOffset="74-80" id="s4109.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4109.e0" e2="s4109.e1" id="s4109.p0" relation="true"/>
  </sentence>
  <sentence id="s4110" text="Existing research points to the potential use of various Eph/ephrin members as biomarkers for assessing prognosis and selecting the most suitable therapeutic strategies in variable clinical scenarios, also for overcoming drug resistance, in the era of breast cancer heterogeneity">
    <entity charOffset="148-151" id="s4110.e0" ontology_id="2099" text="era" type="GENE"/>
    <entity charOffset="259-265" id="s4110.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4110.e0" e2="s4110.e1" id="s4110.p0" relation="true"/>
  </sentence>
  <sentence id="s4111" text="Further, high IRAK1 expression level was correlated with higher tumor stage, lymph node metastasis, myometrial invasion, and lower survival rate.">
    <entity charOffset="14-19" id="s4111.e0" ontology_id="3654" text="IRAK1" type="GENE"/>
    <entity charOffset="64-69" id="s4111.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4111.e0" e2="s4111.e1" id="s4111.p0" relation="true"/>
  </sentence>
  <sentence id="s4112" text="These collective data indicated that IRAK1 overexpression promotes EC tumorigenesis by activating mitotic cell cycle and cell division pathways, and IRAK1 may serve as a promising therapeutic strategy for EC">
    <entity charOffset="37-42" id="s4112.e0" ontology_id="3654" text="IRAK1" type="GENE"/>
    <entity charOffset="70-75" id="s4112.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4112.e0" e2="s4112.e1" id="s4112.p0" relation="true"/>
  </sentence>
  <sentence id="s4113" text="More importantly, overexpression of MRPL33-L could increase tumorigenic potential of hnRNPK-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.">
    <entity charOffset="36-42" id="s4113.e0" ontology_id="9553" text="MRPL33" type="GENE"/>
    <entity charOffset="101-107" id="s4113.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4113.e0" e2="s4113.e1" id="s4113.p0" relation="true"/>
  </sentence>
  <sentence id="s4114" text="More importantly, overexpression of MRPL33-L could increase tumorigenic potential of hnRNPK-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.">
    <entity charOffset="60-65" id="s4114.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="85-91" id="s4114.e1" ontology_id="3190" text="hnRNPK" type="GENE"/>
    <pair e1="s4114.e0" e2="s4114.e1" id="s4114.p0" relation="true"/>
  </sentence>
  <sentence id="s4115" text="More importantly, overexpression of MRPL33-L could increase tumorigenic potential of hnRNPK-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.">
    <entity charOffset="85-91" id="s4115.e0" ontology_id="3190" text="hnRNPK" type="GENE"/>
    <entity charOffset="101-107" id="s4115.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4115.e0" e2="s4115.e1" id="s4115.p0" relation="true"/>
  </sentence>
  <sentence id="s4116" text="Finally, we found that inclusion of MRPL33 exon 3 was promoted in human colorectal cancer tissues and this was correlated with hnRNPK levels.">
    <entity charOffset="36-42" id="s4116.e0" ontology_id="9553" text="MRPL33" type="GENE"/>
    <entity charOffset="83-89" id="s4116.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4116.e0" e2="s4116.e1" id="s4116.p0" relation="true"/>
  </sentence>
  <sentence id="s4117" text="Finally, we found that inclusion of MRPL33 exon 3 was promoted in human colorectal cancer tissues and this was correlated with hnRNPK levels.">
    <entity charOffset="83-89" id="s4117.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="127-133" id="s4117.e1" ontology_id="3190" text="hnRNPK" type="GENE"/>
    <pair e1="s4117.e0" e2="s4117.e1" id="s4117.p0" relation="true"/>
  </sentence>
  <sentence id="s4118" text="In summary, our findings underscore the biological significance of MRPL33-L and hnRNPK in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells">
    <entity charOffset="67-73" id="s4118.e0" ontology_id="9553" text="MRPL33" type="GENE"/>
    <entity charOffset="94-99" id="s4118.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4118.e0" e2="s4118.e1" id="s4118.p0" relation="true"/>
  </sentence>
  <sentence id="s4119" text="In summary, our findings underscore the biological significance of MRPL33-L and hnRNPK in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells">
    <entity charOffset="80-86" id="s4119.e0" ontology_id="3190" text="hnRNPK" type="GENE"/>
    <entity charOffset="187-193" id="s4119.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4119.e0" e2="s4119.e1" id="s4119.p0" relation="true"/>
  </sentence>
  <sentence id="s4120" text="In summary, our findings underscore the biological significance of MRPL33-L and hnRNPK in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells">
    <entity charOffset="80-86" id="s4120.e0" ontology_id="3190" text="hnRNPK" type="GENE"/>
    <entity charOffset="94-99" id="s4120.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4120.e0" e2="s4120.e1" id="s4120.p0" relation="true"/>
  </sentence>
  <sentence id="s4121" text="Glutaric aciduria type I (GA-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).">
    <entity charOffset="26-28" id="s4121.e0" ontology_id="27165" text="GA" type="GENE"/>
    <entity charOffset="42-58" id="s4121.e1" ontology_id="HP_0001992" text="organic aciduria" type="HP"/>
    <pair e1="s4121.e0" e2="s4121.e1" id="s4121.p0" relation="true"/>
  </sentence>
  <sentence id="s4122" text="Disruption of PHF21A has previously been implicated in the causation of intellectual disability (but not aniridia).">
    <entity charOffset="14-20" id="s4122.e0" ontology_id="51317" text="PHF21A" type="GENE"/>
    <entity charOffset="72-95" id="s4122.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4122.e0" e2="s4122.e1" id="s4122.p0" relation="true"/>
  </sentence>
  <sentence id="s4123" text="In functional assays performed with RNA knockdown, loss of STEAP3 attenuated aggressive phenotypes in glioma cells, including cell proliferation, invasion, and sphere formation in vitro and tumor growth in vivo.">
    <entity charOffset="59-65" id="s4123.e0" ontology_id="55240" text="STEAP3" type="GENE"/>
    <entity charOffset="190-195" id="s4123.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4123.e0" e2="s4123.e1" id="s4123.p0" relation="true"/>
  </sentence>
  <sentence id="s4124" text="The correlations between the expressions of CTHRC1 with clinicopathologic features,E-cadherin and Vimentin expression were analyzed.&lt;b&gt;Result:&lt;/b&gt;CTHRC1 protein expression levels in papillary thyroid carcinoma tissue were significantly higher than those in adjacent normal thyroid tissue and benign disease(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01);CTHRC1 expression was significantly correlated with lymph node metastases(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.05).">
    <entity charOffset="44-50" id="s4124.e0" ontology_id="115908" text="CTHRC1" type="GENE"/>
    <entity charOffset="182-209" id="s4124.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s4124.e0" e2="s4124.e1" id="s4124.p0" relation="true"/>
  </sentence>
  <sentence id="s4125" text="In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, SLC39A5, LEPREL1 and LRPAP1, in a cohort of 187 independent Chinese patients with high myopia.">
    <entity charOffset="122-129" id="s4125.e0" ontology_id="283375" text="SLC39A5" type="GENE"/>
    <entity charOffset="209-215" id="s4125.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s4125.e0" e2="s4125.e1" id="s4125.p0" relation="true"/>
  </sentence>
  <sentence id="s4126" text="In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, SLC39A5, LEPREL1 and LRPAP1, in a cohort of 187 independent Chinese patients with high myopia.">
    <entity charOffset="131-138" id="s4126.e0" ontology_id="55214" text="LEPREL1" type="GENE"/>
    <entity charOffset="209-215" id="s4126.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s4126.e0" e2="s4126.e1" id="s4126.p0" relation="false"/>
  </sentence>
  <sentence id="s4127" text="In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, SLC39A5, LEPREL1 and LRPAP1, in a cohort of 187 independent Chinese patients with high myopia.">
    <entity charOffset="143-149" id="s4127.e0" ontology_id="4043" text="LRPAP1" type="GENE"/>
    <entity charOffset="209-215" id="s4127.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s4127.e0" e2="s4127.e1" id="s4127.p0" relation="true"/>
  </sentence>
  <sentence id="s4128" text="The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases ataxia-telangiectasia mutated (ATM) and ATM and Rad3-related (ATR), and proteins with BRCA1 COOH-terminal (BRCT) domains.">
    <entity charOffset="107-113" id="s4128.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="169-172" id="s4128.e1" ontology_id="84168" text="ATR" type="GENE"/>
    <pair e1="s4128.e0" e2="s4128.e1" id="s4128.p0" relation="true"/>
  </sentence>
  <sentence id="s4129" text="The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases ataxia-telangiectasia mutated (ATM) and ATM and Rad3-related (ATR), and proteins with BRCA1 COOH-terminal (BRCT) domains.">
    <entity charOffset="107-113" id="s4129.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="193-198" id="s4129.e1" ontology_id="672" text="BRCA1" type="GENE"/>
    <pair e1="s4129.e0" e2="s4129.e1" id="s4129.p0" relation="true"/>
  </sentence>
  <sentence id="s4130" text="Single marker-based association tests for corneal astigmatism identified four genome-wide significant loci (P&amp;lt;510&lt;sup&gt;-8&lt;/sup&gt;) near the genes ZC3H11B (1q41), LINC00340 (6p22.3), HERC2/OCA2 (15q13.1) and NPLOC4/TSPAN10 (17q25.3).">
    <entity charOffset="50-61" id="s4130.e0" ontology_id="HP_0000483" text="astigmatism" type="HP"/>
    <entity charOffset="212-218" id="s4130.e1" ontology_id="55666" text="NPLOC4" type="GENE"/>
    <pair e1="s4130.e0" e2="s4130.e1" id="s4130.p0" relation="true"/>
  </sentence>
  <sentence id="s4131" text="Three of these loci also demonstrated genome-wide significant association with refractive astigmatism: LINC00340, HERC2/OCA2 and NPLOC4/TSPAN10.">
    <entity charOffset="90-101" id="s4131.e0" ontology_id="HP_0000483" text="astigmatism" type="HP"/>
    <entity charOffset="114-119" id="s4131.e1" ontology_id="8924" text="HERC2" type="GENE"/>
    <pair e1="s4131.e0" e2="s4131.e1" id="s4131.p0" relation="true"/>
  </sentence>
  <sentence id="s4132" text="Three of these loci also demonstrated genome-wide significant association with refractive astigmatism: LINC00340, HERC2/OCA2 and NPLOC4/TSPAN10.">
    <entity charOffset="90-101" id="s4132.e0" ontology_id="HP_0000483" text="astigmatism" type="HP"/>
    <entity charOffset="129-135" id="s4132.e1" ontology_id="55666" text="NPLOC4" type="GENE"/>
    <pair e1="s4132.e0" e2="s4132.e1" id="s4132.p0" relation="true"/>
  </sentence>
  <sentence id="s4133" text="These loci have previously demonstrated association with axial length (ZC3H11B), myopia (NPLOC4), spherical equivalent refractive error (LINC00340) and eye colour (HERC2).">
    <entity charOffset="81-87" id="s4133.e0" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <entity charOffset="164-169" id="s4133.e1" ontology_id="8924" text="HERC2" type="GENE"/>
    <pair e1="s4133.e0" e2="s4133.e1" id="s4133.p0" relation="true"/>
  </sentence>
  <sentence id="s4134" text="Importantly, cardiac ANKRD1 has been shown to be highly induced in various cardiomyopathies and in heart failure, although it is still unclear what impact this may have on the pathophysiology of heart failure.">
    <entity charOffset="21-27" id="s4134.e0" ontology_id="27063" text="ANKRD1" type="GENE"/>
    <entity charOffset="99-112" id="s4134.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s4134.e0" e2="s4134.e1" id="s4134.p0" relation="true"/>
  </sentence>
  <sentence id="s4135" text="CMG2 mRNA was measured in 121 tumor samples of soft tissue sarcoma patients using quantitative real-time PCR.">
    <entity charOffset="0-4" id="s4135.e0" ontology_id="118429" text="CMG2" type="GENE"/>
    <entity charOffset="30-35" id="s4135.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4135.e0" e2="s4135.e1" id="s4135.p0" relation="true"/>
  </sentence>
  <sentence id="s4136" text="CMG2 protein was evaluated in 52 tumor samples by ELISA.">
    <entity charOffset="0-4" id="s4136.e0" ontology_id="118429" text="CMG2" type="GENE"/>
    <entity charOffset="33-38" id="s4136.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4136.e0" e2="s4136.e1" id="s4136.p0" relation="true"/>
  </sentence>
  <sentence id="s4137" text="Low CMG2 mRNA expression was correlated with a worsened patients' disease-specific survival in Kaplan-Meier analyses (mean patient survival was 25 vs. 96 months; &lt;i&gt;p&lt;/i&gt; = 0.013), especially in high-stage tumors.">
    <entity charOffset="4-8" id="s4137.e0" ontology_id="118429" text="CMG2" type="GENE"/>
    <entity charOffset="206-211" id="s4137.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4137.e0" e2="s4137.e1" id="s4137.p0" relation="true"/>
  </sentence>
  <sentence id="s4138" text="A decreased CMG2 expression is a negative prognostic factor for soft tissue sarcoma patients.">
    <entity charOffset="12-16" id="s4138.e0" ontology_id="118429" text="CMG2" type="GENE"/>
    <entity charOffset="76-83" id="s4138.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s4138.e0" e2="s4138.e1" id="s4138.p0" relation="true"/>
  </sentence>
  <sentence id="s4139" text="CMG2 may be an interesting candidate gene for the further exploration of soft tissue sarcoma genesis and progression">
    <entity charOffset="0-4" id="s4139.e0" ontology_id="118429" text="CMG2" type="GENE"/>
    <entity charOffset="85-92" id="s4139.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s4139.e0" e2="s4139.e1" id="s4139.p0" relation="true"/>
  </sentence>
  <sentence id="s4140" text="In this study, we found that LASS2 protein level was positively related to InternationalFederationof Gynecology and Obstetrics (FIGO) stage and LASS2-negative tumors showed significant association with longer disease-free survival (DFS) and overall survival (OS) in ovarian cancer patients.">
    <entity charOffset="29-34" id="s4140.e0" ontology_id="29956" text="LASS2" type="GENE"/>
    <entity charOffset="161-167" id="s4140.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4140.e0" e2="s4140.e1" id="s4140.p0" relation="true"/>
  </sentence>
  <sentence id="s4141" text="In this study, we found that LASS2 protein level was positively related to InternationalFederationof Gynecology and Obstetrics (FIGO) stage and LASS2-negative tumors showed significant association with longer disease-free survival (DFS) and overall survival (OS) in ovarian cancer patients.">
    <entity charOffset="29-34" id="s4141.e0" ontology_id="29956" text="LASS2" type="GENE"/>
    <entity charOffset="276-282" id="s4141.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4141.e0" e2="s4141.e1" id="s4141.p0" relation="true"/>
  </sentence>
  <sentence id="s4142" text="The heterogeneous expression of LASS2 had been exhibited in diverse ovarian cancer cells.">
    <entity charOffset="4-17" id="s4142.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="32-37" id="s4142.e1" ontology_id="29956" text="LASS2" type="GENE"/>
    <pair e1="s4142.e0" e2="s4142.e1" id="s4142.p0" relation="true"/>
  </sentence>
  <sentence id="s4143" text="The heterogeneous expression of LASS2 had been exhibited in diverse ovarian cancer cells.">
    <entity charOffset="32-37" id="s4143.e0" ontology_id="29956" text="LASS2" type="GENE"/>
    <entity charOffset="76-82" id="s4143.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4143.e0" e2="s4143.e1" id="s4143.p0" relation="true"/>
  </sentence>
  <sentence id="s4144" text="A significantly lower messenger RNA (mRNA) and protein level of LASS2 was seen in 3AO cell compared with those in other types of ovarian cancer cells.">
    <entity charOffset="64-69" id="s4144.e0" ontology_id="29956" text="LASS2" type="GENE"/>
    <entity charOffset="137-143" id="s4144.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4144.e0" e2="s4144.e1" id="s4144.p0" relation="true"/>
  </sentence>
  <sentence id="s4145" text="The oncogenic capacity of LASS2 in ovarian cancer may be mediated by increased expression of YAP/TAZ.">
    <entity charOffset="26-31" id="s4145.e0" ontology_id="29956" text="LASS2" type="GENE"/>
    <entity charOffset="43-49" id="s4145.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4145.e0" e2="s4145.e1" id="s4145.p0" relation="true"/>
  </sentence>
  <sentence id="s4146" text="Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).">
    <entity charOffset="17-22" id="s4146.e0" ontology_id="3798" text="KIF5A" type="GENE"/>
    <entity charOffset="73-91" id="s4146.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s4146.e0" e2="s4146.e1" id="s4146.p0" relation="true"/>
  </sentence>
  <sentence id="s4147" text="Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).">
    <entity charOffset="17-22" id="s4147.e0" ontology_id="3798" text="KIF5A" type="GENE"/>
    <entity charOffset="139-149" id="s4147.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s4147.e0" e2="s4147.e1" id="s4147.p0" relation="true"/>
  </sentence>
  <sentence id="s4148" text="Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).">
    <entity charOffset="128-138" id="s4148.e0" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <entity charOffset="150-154" id="s4148.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s4148.e0" e2="s4148.e1" id="s4148.p0" relation="true"/>
  </sentence>
  <sentence id="s4149" text="Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).">
    <entity charOffset="128-138" id="s4149.e0" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <entity charOffset="158-162" id="s4149.e1" ontology_id="23095" text="CMT2" type="GENE"/>
    <pair e1="s4149.e0" e2="s4149.e1" id="s4149.p0" relation="true"/>
  </sentence>
  <sentence id="s4150" text="Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).">
    <entity charOffset="139-149" id="s4150.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="158-162" id="s4150.e1" ontology_id="23095" text="CMT2" type="GENE"/>
    <pair e1="s4150.e0" e2="s4150.e1" id="s4150.p0" relation="true"/>
  </sentence>
  <sentence id="s4151" text="Backgorund: Sanjad-Sakati syndrome (SSS) is a rare autosomal recessive disease caused by a deletion mutation (155-166del) in exon 3 of the TBCE gene on chromosome 1q42-43.">
    <entity charOffset="51-70" id="s4151.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="139-143" id="s4151.e1" ontology_id="6905" text="TBCE" type="GENE"/>
    <pair e1="s4151.e0" e2="s4151.e1" id="s4151.p0" relation="true"/>
  </sentence>
  <sentence id="s4152" text="DICER1 is an RNase III endoribonuclease central to miRNA biogenesis, and germline &lt;i&gt;DICER1&lt;/i&gt; mutations result in a cancer predisposition syndrome, associated with an increased risk of many tumor types.">
    <entity charOffset="0-6" id="s4152.e0" ontology_id="23405" text="DICER1" type="GENE"/>
    <entity charOffset="118-124" id="s4152.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4152.e0" e2="s4152.e1" id="s4152.p0" relation="true"/>
  </sentence>
  <sentence id="s4153" text="DICER1 is an RNase III endoribonuclease central to miRNA biogenesis, and germline &lt;i&gt;DICER1&lt;/i&gt; mutations result in a cancer predisposition syndrome, associated with an increased risk of many tumor types.">
    <entity charOffset="0-6" id="s4153.e0" ontology_id="23405" text="DICER1" type="GENE"/>
    <entity charOffset="192-197" id="s4153.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4153.e0" e2="s4153.e1" id="s4153.p0" relation="true"/>
  </sentence>
  <sentence id="s4154" text="Angiosarcomas in &lt;i&gt;aP2-Cre;Dicer1&lt;sup&gt;Flox/-&lt;/sup&gt;&lt;/i&gt; mice histologically and genetically resemble human angiosarcoma.">
    <entity charOffset="5-12" id="s4154.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="28-34" id="s4154.e1" ontology_id="23405" text="Dicer1" type="GENE"/>
    <pair e1="s4154.e0" e2="s4154.e1" id="s4154.p0" relation="true"/>
  </sentence>
  <sentence id="s4155" text="Angiosarcomas in &lt;i&gt;aP2-Cre;Dicer1&lt;sup&gt;Flox/-&lt;/sup&gt;&lt;/i&gt; mice histologically and genetically resemble human angiosarcoma.">
    <entity charOffset="28-34" id="s4155.e0" ontology_id="23405" text="Dicer1" type="GENE"/>
    <entity charOffset="107-119" id="s4155.e1" ontology_id="HP_0200058" text="angiosarcoma" type="HP"/>
    <pair e1="s4155.e0" e2="s4155.e1" id="s4155.p0" relation="true"/>
  </sentence>
  <sentence id="s4156" text="These studies illustrate that Dicer1 can function as a traditional loss-of-function tumor suppressor gene, and they provide a fully penetrant animal model for the study of angiosarcoma development and metastasis.">
    <entity charOffset="30-36" id="s4156.e0" ontology_id="23405" text="Dicer1" type="GENE"/>
    <entity charOffset="172-184" id="s4156.e1" ontology_id="HP_0200058" text="angiosarcoma" type="HP"/>
    <pair e1="s4156.e0" e2="s4156.e1" id="s4156.p0" relation="true"/>
  </sentence>
  <sentence id="s4157" text="The original tumor harbors mutations in PBRM1, while the second harbors mutations in KDM5C.">
    <entity charOffset="13-18" id="s4157.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="40-45" id="s4157.e1" ontology_id="55193" text="PBRM1" type="GENE"/>
    <pair e1="s4157.e0" e2="s4157.e1" id="s4157.p0" relation="true"/>
  </sentence>
  <sentence id="s4158" text="In this study, we reported the identification of Calcium Binding Protein 39-Like (CAB39L) as a novel regulator of tumor metabolism in GC.">
    <entity charOffset="82-88" id="s4158.e0" ontology_id="81617" text="CAB39L" type="GENE"/>
    <entity charOffset="114-119" id="s4158.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4158.e0" e2="s4158.e1" id="s4158.p0" relation="true"/>
  </sentence>
  <sentence id="s4159" text="LKB1-AMPK activation in GC cell lines was tumor suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the CAB39L-silenced cells.">
    <entity charOffset="0-4" id="s4159.e0" ontology_id="6794" text="LKB1" type="GENE"/>
    <entity charOffset="42-47" id="s4159.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4159.e0" e2="s4159.e1" id="s4159.p0" relation="true"/>
  </sentence>
  <sentence id="s4160" text="LKB1-AMPK activation in GC cell lines was tumor suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the CAB39L-silenced cells.">
    <entity charOffset="5-9" id="s4160.e0" ontology_id="5563" text="AMPK" type="GENE"/>
    <entity charOffset="42-47" id="s4160.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4160.e0" e2="s4160.e1" id="s4160.p0" relation="true"/>
  </sentence>
  <sentence id="s4161" text="LKB1-AMPK activation in GC cell lines was tumor suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the CAB39L-silenced cells.">
    <entity charOffset="42-47" id="s4161.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="126-132" id="s4161.e1" ontology_id="81617" text="CAB39L" type="GENE"/>
    <pair e1="s4161.e0" e2="s4161.e1" id="s4161.p0" relation="false"/>
  </sentence>
  <sentence id="s4162" text="Moreover, knockdown of LKB1 reversed growth inhibitory effect of CAB39L, indicating that tumor suppression by CAB39L depended on LKB1-AMPK.">
    <entity charOffset="23-27" id="s4162.e0" ontology_id="6794" text="LKB1" type="GENE"/>
    <entity charOffset="89-94" id="s4162.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4162.e0" e2="s4162.e1" id="s4162.p0" relation="true"/>
  </sentence>
  <sentence id="s4163" text="Moreover, knockdown of LKB1 reversed growth inhibitory effect of CAB39L, indicating that tumor suppression by CAB39L depended on LKB1-AMPK.">
    <entity charOffset="89-94" id="s4163.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="134-138" id="s4163.e1" ontology_id="5563" text="AMPK" type="GENE"/>
    <pair e1="s4163.e0" e2="s4163.e1" id="s4163.p0" relation="true"/>
  </sentence>
  <sentence id="s4164" text="Our data demonstrate that CAB39L is a novel tumor suppressor which suppresses tumorigenesis by promoting LKB1-AMPK-PGC1 axis, thereby preventing a metabolic shift that drives carcinogenesis.">
    <entity charOffset="26-32" id="s4164.e0" ontology_id="81617" text="CAB39L" type="GENE"/>
    <entity charOffset="44-49" id="s4164.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4164.e0" e2="s4164.e1" id="s4164.p0" relation="true"/>
  </sentence>
  <sentence id="s4165" text="Our data demonstrate that CAB39L is a novel tumor suppressor which suppresses tumorigenesis by promoting LKB1-AMPK-PGC1 axis, thereby preventing a metabolic shift that drives carcinogenesis.">
    <entity charOffset="44-49" id="s4165.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="105-109" id="s4165.e1" ontology_id="6794" text="LKB1" type="GENE"/>
    <pair e1="s4165.e0" e2="s4165.e1" id="s4165.p0" relation="true"/>
  </sentence>
  <sentence id="s4166" text="of UNC5C gene (one of the netrin-1 receptors) in colorectal cancer patients of Kashmiri population (North India).">
    <entity charOffset="3-8" id="s4166.e0" ontology_id="8633" text="UNC5C" type="GENE"/>
    <entity charOffset="60-66" id="s4166.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4166.e0" e2="s4166.e1" id="s4166.p0" relation="true"/>
  </sentence>
  <sentence id="s4167" text="Results: UNC5C promoter hypermethylation was significantly found to be associated with colorectal cancer cases">
    <entity charOffset="9-14" id="s4167.e0" ontology_id="8633" text="UNC5C" type="GENE"/>
    <entity charOffset="98-104" id="s4167.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4167.e0" e2="s4167.e1" id="s4167.p0" relation="true"/>
  </sentence>
  <sentence id="s4168" text="One hundred and forty-eight CTLA4 mutation carriers have been reported; patients showed hypogammaglobulinemia, recurrent infectious diseases, various autoimmune diseases, and lymphocytic infiltration into multiple organs.">
    <entity charOffset="28-33" id="s4168.e0" ontology_id="1493" text="CTLA4" type="GENE"/>
    <entity charOffset="88-109" id="s4168.e1" ontology_id="HP_0004313" text="hypogammaglobulinemia" type="HP"/>
    <pair e1="s4168.e0" e2="s4168.e1" id="s4168.p0" relation="true"/>
  </sentence>
  <sentence id="s4169" text="We also functionally characterized two CaBP4 mutants that are associated with a congenital variant of human night blindness and other closely related nonstationary retinal diseases.">
    <entity charOffset="39-44" id="s4169.e0" ontology_id="57010" text="CaBP4" type="GENE"/>
    <entity charOffset="114-123" id="s4169.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s4169.e0" e2="s4169.e1" id="s4169.p0" relation="true"/>
  </sentence>
  <sentence id="s4170" text="We also functionally characterized two CaBP4 mutants that are associated with a congenital variant of human night blindness and other closely related nonstationary retinal diseases.">
    <entity charOffset="39-44" id="s4170.e0" ontology_id="57010" text="CaBP4" type="GENE"/>
    <entity charOffset="164-180" id="s4170.e1" ontology_id="HP_0000479" text="retinal diseases" type="HP"/>
    <pair e1="s4170.e0" e2="s4170.e1" id="s4170.p0" relation="true"/>
  </sentence>
  <sentence id="s4171" text="Bartter syndrome (BS) is a hereditary condition transmitted as an autosomal recessive (Bartter type 1 to 4) or dominant trait (Bartter type 5).">
    <entity charOffset="66-85" id="s4171.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="95-99" id="s4171.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s4171.e0" e2="s4171.e1" id="s4171.p0" relation="true"/>
  </sentence>
  <sentence id="s4172" text="Here we presented a case (BS type ) of a 17 years old female presented with polyhydramnios, polyuria, nephrocalcinosis and hypokalemia, which was alleviated after treatment with celecoxib and vitamin D(3).">
    <entity charOffset="29-33" id="s4172.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="77-91" id="s4172.e1" ontology_id="HP_0001561" text="polyhydramnios" type="HP"/>
    <pair e1="s4172.e0" e2="s4172.e1" id="s4172.p0" relation="true"/>
  </sentence>
  <sentence id="s4173" text="Here we presented a case (BS type ) of a 17 years old female presented with polyhydramnios, polyuria, nephrocalcinosis and hypokalemia, which was alleviated after treatment with celecoxib and vitamin D(3).">
    <entity charOffset="29-33" id="s4173.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="93-101" id="s4173.e1" ontology_id="HP_0000103" text="polyuria" type="HP"/>
    <pair e1="s4173.e0" e2="s4173.e1" id="s4173.p0" relation="true"/>
  </sentence>
  <sentence id="s4174" text="We demonstrate the presence of either biallelic loss of Hippo pathway tumor suppressor genes (TSG) and/or evidence of alteration of Hippo pathway genes in 85% of samples.">
    <entity charOffset="70-75" id="s4174.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="94-97" id="s4174.e1" ontology_id="57045" text="TSG" type="GENE"/>
    <pair e1="s4174.e0" e2="s4174.e1" id="s4174.p0" relation="true"/>
  </sentence>
  <sentence id="s4175" text="Moreover, the novel mutation, p.R414C, adds up to the literature for the infantile-onset form of autosomal recessive ataxia associated with SPTBN2.">
    <entity charOffset="97-116" id="s4175.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="140-146" id="s4175.e1" ontology_id="6712" text="SPTBN2" type="GENE"/>
    <pair e1="s4175.e0" e2="s4175.e1" id="s4175.p0" relation="true"/>
  </sentence>
  <sentence id="s4176" text="Moreover, the novel mutation, p.R414C, adds up to the literature for the infantile-onset form of autosomal recessive ataxia associated with SPTBN2.">
    <entity charOffset="117-123" id="s4176.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="140-146" id="s4176.e1" ontology_id="6712" text="SPTBN2" type="GENE"/>
    <pair e1="s4176.e0" e2="s4176.e1" id="s4176.p0" relation="true"/>
  </sentence>
  <sentence id="s4177" text="The Rb tumor suppressor gene performs a critical role in controlling cell proliferation and tumorigenesis; it recruits HDAC1 protein into the E2F complexes to repress transcription.">
    <entity charOffset="7-12" id="s4177.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="119-124" id="s4177.e1" ontology_id="3065" text="HDAC1" type="GENE"/>
    <pair e1="s4177.e0" e2="s4177.e1" id="s4177.p0" relation="true"/>
  </sentence>
  <sentence id="s4178" text="In this study, we demonstrate that SNIP1, RB and HDAC1 were significantly expressed in same lung cancer tissues in a tissue microarray (TMA) containing 300 non-small cell lung cancers (NSCLC).">
    <entity charOffset="35-40" id="s4178.e0" ontology_id="79753" text="SNIP1" type="GENE"/>
    <entity charOffset="97-103" id="s4178.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4178.e0" e2="s4178.e1" id="s4178.p0" relation="true"/>
  </sentence>
  <sentence id="s4179" text="In this study, we demonstrate that SNIP1, RB and HDAC1 were significantly expressed in same lung cancer tissues in a tissue microarray (TMA) containing 300 non-small cell lung cancers (NSCLC).">
    <entity charOffset="49-54" id="s4179.e0" ontology_id="3065" text="HDAC1" type="GENE"/>
    <entity charOffset="97-103" id="s4179.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4179.e0" e2="s4179.e1" id="s4179.p0" relation="true"/>
  </sentence>
  <sentence id="s4180" text="High expression level of SNIP1 in tumor patients was significantly correlated with poor prognosis in NSCLC (log-rank P for OS = 0.01, log-rank P for DFS = 0.001).">
    <entity charOffset="25-30" id="s4180.e0" ontology_id="79753" text="SNIP1" type="GENE"/>
    <entity charOffset="34-39" id="s4180.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4180.e0" e2="s4180.e1" id="s4180.p0" relation="true"/>
  </sentence>
  <sentence id="s4181" text="Knockdown of SNIP1 reduced colony formation ability of lung cancer cells.">
    <entity charOffset="13-18" id="s4181.e0" ontology_id="79753" text="SNIP1" type="GENE"/>
    <entity charOffset="60-66" id="s4181.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4181.e0" e2="s4181.e1" id="s4181.p0" relation="true"/>
  </sentence>
  <sentence id="s4182" text="These findings may indicate the involvement of SNIP1 in progression of lung cancer by regulating the RB/HDAC1 interaction">
    <entity charOffset="47-52" id="s4182.e0" ontology_id="79753" text="SNIP1" type="GENE"/>
    <entity charOffset="76-82" id="s4182.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4182.e0" e2="s4182.e1" id="s4182.p0" relation="true"/>
  </sentence>
  <sentence id="s4183" text="These findings may indicate the involvement of SNIP1 in progression of lung cancer by regulating the RB/HDAC1 interaction">
    <entity charOffset="76-82" id="s4183.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="104-109" id="s4183.e1" ontology_id="3065" text="HDAC1" type="GENE"/>
    <pair e1="s4183.e0" e2="s4183.e1" id="s4183.p0" relation="true"/>
  </sentence>
  <sentence id="s4184" text="3-Methylglutaconic aciduria is associated with variants in genes encoding mitochondrial inner membrane organizing determinants, including TAZ, DNAJC19, SERAC1 and QIL1/MIC13">
    <entity charOffset="74-87" id="s4184.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="138-141" id="s4184.e1" ontology_id="25937" text="TAZ" type="GENE"/>
    <pair e1="s4184.e0" e2="s4184.e1" id="s4184.p0" relation="true"/>
  </sentence>
  <sentence id="s4185" text="3-Methylglutaconic aciduria is associated with variants in genes encoding mitochondrial inner membrane organizing determinants, including TAZ, DNAJC19, SERAC1 and QIL1/MIC13">
    <entity charOffset="74-87" id="s4185.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="143-150" id="s4185.e1" ontology_id="131118" text="DNAJC19" type="GENE"/>
    <pair e1="s4185.e0" e2="s4185.e1" id="s4185.p0" relation="true"/>
  </sentence>
  <sentence id="s4186" text="3-Methylglutaconic aciduria is associated with variants in genes encoding mitochondrial inner membrane organizing determinants, including TAZ, DNAJC19, SERAC1 and QIL1/MIC13">
    <entity charOffset="74-87" id="s4186.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="152-158" id="s4186.e1" ontology_id="84947" text="SERAC1" type="GENE"/>
    <pair e1="s4186.e0" e2="s4186.e1" id="s4186.p0" relation="true"/>
  </sentence>
  <sentence id="s4187" text="Additional plasma and 52 brain tissues obtained from patients with gliomas were used to validate the association rate of serum amyloid A1 (SAA1) in different grades of gliomas and its distribution in tumors.">
    <entity charOffset="67-74" id="s4187.e0" ontology_id="HP_0009733" text="gliomas" type="HP"/>
    <entity charOffset="139-143" id="s4187.e1" ontology_id="6288" text="SAA1" type="GENE"/>
    <pair e1="s4187.e0" e2="s4187.e1" id="s4187.p0" relation="true"/>
  </sentence>
  <sentence id="s4188" text="Additional plasma and 52 brain tissues obtained from patients with gliomas were used to validate the association rate of serum amyloid A1 (SAA1) in different grades of gliomas and its distribution in tumors.">
    <entity charOffset="139-143" id="s4188.e0" ontology_id="6288" text="SAA1" type="GENE"/>
    <entity charOffset="200-205" id="s4188.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4188.e0" e2="s4188.e1" id="s4188.p0" relation="true"/>
  </sentence>
  <sentence id="s4189" text="Microarray database analysis further validated the coefficient of SAA1 levels in gliomas.">
    <entity charOffset="66-70" id="s4189.e0" ontology_id="6288" text="SAA1" type="GENE"/>
    <entity charOffset="81-88" id="s4189.e1" ontology_id="HP_0009733" text="gliomas" type="HP"/>
    <pair e1="s4189.e0" e2="s4189.e1" id="s4189.p0" relation="true"/>
  </sentence>
  <sentence id="s4190" text="Magnetic resonance imaging and tumor region-specific microarray analysis identified a correlation between SAA1 and GBM cell infiltration in patients.">
    <entity charOffset="31-36" id="s4190.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="106-110" id="s4190.e1" ontology_id="6288" text="SAA1" type="GENE"/>
    <pair e1="s4190.e0" e2="s4190.e1" id="s4190.p0" relation="true"/>
  </sentence>
  <sentence id="s4191" text="In summary, our results demonstrate that SAA1 in combination with integrin V and 3 can serve as an indicator of high glioblastoma risk.">
    <entity charOffset="41-45" id="s4191.e0" ontology_id="6288" text="SAA1" type="GENE"/>
    <entity charOffset="119-131" id="s4191.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s4191.e0" e2="s4191.e1" id="s4191.p0" relation="true"/>
  </sentence>
  <sentence id="s4192" text="cDNA-encoded FLAG-tagged human wildtype ATP6V0A2 (&lt;i&gt;a&lt;/i&gt;2) and ATP6V0A4 (&lt;i&gt;a&lt;/i&gt;4) subunits and their mutants, &lt;i&gt;a&lt;/i&gt;2&lt;sup&gt;P405L&lt;/sup&gt; (causing cutis laxa), and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;R449H&lt;/sup&gt; and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;G820R&lt;/sup&gt; (causing renal tubular acidosis, dRTA), were transiently expressed in HEK 293 cells.">
    <entity charOffset="40-48" id="s4192.e0" ontology_id="23545" text="ATP6V0A2" type="GENE"/>
    <entity charOffset="231-253" id="s4192.e1" ontology_id="HP_0001947" text="renal tubular acidosis" type="HP"/>
    <pair e1="s4192.e0" e2="s4192.e1" id="s4192.p0" relation="true"/>
  </sentence>
  <sentence id="s4193" text="cDNA-encoded FLAG-tagged human wildtype ATP6V0A2 (&lt;i&gt;a&lt;/i&gt;2) and ATP6V0A4 (&lt;i&gt;a&lt;/i&gt;4) subunits and their mutants, &lt;i&gt;a&lt;/i&gt;2&lt;sup&gt;P405L&lt;/sup&gt; (causing cutis laxa), and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;R449H&lt;/sup&gt; and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;G820R&lt;/sup&gt; (causing renal tubular acidosis, dRTA), were transiently expressed in HEK 293 cells.">
    <entity charOffset="65-73" id="s4193.e0" ontology_id="50617" text="ATP6V0A4" type="GENE"/>
    <entity charOffset="231-253" id="s4193.e1" ontology_id="HP_0001947" text="renal tubular acidosis" type="HP"/>
    <pair e1="s4193.e0" e2="s4193.e1" id="s4193.p0" relation="true"/>
  </sentence>
  <sentence id="s4194" text="cDNA-encoded FLAG-tagged human wildtype ATP6V0A2 (&lt;i&gt;a&lt;/i&gt;2) and ATP6V0A4 (&lt;i&gt;a&lt;/i&gt;4) subunits and their mutants, &lt;i&gt;a&lt;/i&gt;2&lt;sup&gt;P405L&lt;/sup&gt; (causing cutis laxa), and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;R449H&lt;/sup&gt; and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;G820R&lt;/sup&gt; (causing renal tubular acidosis, dRTA), were transiently expressed in HEK 293 cells.">
    <entity charOffset="231-253" id="s4194.e0" ontology_id="HP_0001947" text="renal tubular acidosis" type="HP"/>
    <entity charOffset="292-295" id="s4194.e1" ontology_id="2042" text="HEK" type="GENE"/>
    <pair e1="s4194.e0" e2="s4194.e1" id="s4194.p0" relation="true"/>
  </sentence>
  <sentence id="s4195" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="43-55" id="s4195.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="317-320" id="s4195.e1" ontology_id="23049" text="lip" type="GENE"/>
    <pair e1="s4195.e0" e2="s4195.e1" id="s4195.p0" relation="true"/>
  </sentence>
  <sentence id="s4196" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="97-103" id="s4196.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="317-320" id="s4196.e1" ontology_id="23049" text="lip" type="GENE"/>
    <pair e1="s4196.e0" e2="s4196.e1" id="s4196.p0" relation="true"/>
  </sentence>
  <sentence id="s4197" text="Our findings expand the clinical phenotype and further demonstrate the clinical heterogeneity related to PTRH2 variants">
    <entity charOffset="80-93" id="s4197.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="105-110" id="s4197.e1" ontology_id="51651" text="PTRH2" type="GENE"/>
    <pair e1="s4197.e0" e2="s4197.e1" id="s4197.p0" relation="true"/>
  </sentence>
  <sentence id="s4198" text="Although p53R2 has been linked to human cancer, its role in cervical cancer remains unknown.">
    <entity charOffset="9-12" id="s4198.e0" ontology_id="7157" text="p53" type="GENE"/>
    <entity charOffset="40-46" id="s4198.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4198.e0" e2="s4198.e1" id="s4198.p0" relation="true"/>
  </sentence>
  <sentence id="s4199" text="p53R2 expression is significantly upregulated at both mRNA and protein levels in cervical cancer cells and tissues, compared with that in matched normal cervical cells and tissues, respectively.">
    <entity charOffset="0-3" id="s4199.e0" ontology_id="7157" text="p53" type="GENE"/>
    <entity charOffset="90-96" id="s4199.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4199.e0" e2="s4199.e1" id="s4199.p0" relation="true"/>
  </sentence>
  <sentence id="s4200" text="Patients with high p53R2 expression have a shorter overall survival (OS) and disease-free survival (DFS). p53R2 is an independent factor for predicting OS and DFS of cervical cancer patients.">
    <entity charOffset="19-22" id="s4200.e0" ontology_id="7157" text="p53" type="GENE"/>
    <entity charOffset="175-181" id="s4200.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4200.e0" e2="s4200.e1" id="s4200.p0" relation="true"/>
  </sentence>
  <sentence id="s4201" text="We further show that p53R2 is important for oncogenic growth, migration and invasion in cervical cancer cells.">
    <entity charOffset="21-24" id="s4201.e0" ontology_id="7157" text="p53" type="GENE"/>
    <entity charOffset="97-103" id="s4201.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4201.e0" e2="s4201.e1" id="s4201.p0" relation="true"/>
  </sentence>
  <sentence id="s4202" text="In conclusion, our study demonstrates for the first time that p53R2 protein is overexpressed in early-stage cervical cancer and unravels some unconventional oncogenic functions of p53R2. p53R2 may be a useful prognostic biomarker and therapeutic target for cervical cancer">
    <entity charOffset="62-65" id="s4202.e0" ontology_id="7157" text="p53" type="GENE"/>
    <entity charOffset="117-123" id="s4202.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4202.e0" e2="s4202.e1" id="s4202.p0" relation="true"/>
  </sentence>
  <sentence id="s4203" text="IGSF1 (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and macroorchidism.">
    <entity charOffset="0-5" id="s4203.e0" ontology_id="3547" text="IGSF1" type="GENE"/>
    <entity charOffset="83-97" id="s4203.e1" ontology_id="HP_0000053" text="macroorchidism" type="HP"/>
    <pair e1="s4203.e0" e2="s4203.e1" id="s4203.p0" relation="true"/>
  </sentence>
  <sentence id="s4204" text="Based on a patient with a full deletion of IGSF1 clinically followed from neonate to adulthood, we investigated a common pituitary origin for hypothyroidism and macroorchidism, and the role of IGSF1 as regulator of pituitary hormone secretion.">
    <entity charOffset="43-48" id="s4204.e0" ontology_id="3547" text="IGSF1" type="GENE"/>
    <entity charOffset="142-156" id="s4204.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s4204.e0" e2="s4204.e1" id="s4204.p0" relation="true"/>
  </sentence>
  <sentence id="s4205" text="Based on a patient with a full deletion of IGSF1 clinically followed from neonate to adulthood, we investigated a common pituitary origin for hypothyroidism and macroorchidism, and the role of IGSF1 as regulator of pituitary hormone secretion.">
    <entity charOffset="43-48" id="s4205.e0" ontology_id="3547" text="IGSF1" type="GENE"/>
    <entity charOffset="161-175" id="s4205.e1" ontology_id="HP_0000053" text="macroorchidism" type="HP"/>
    <pair e1="s4205.e0" e2="s4205.e1" id="s4205.p0" relation="true"/>
  </sentence>
  <sentence id="s4206" text="In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and macroorchidism in IGSF1 deficiency are identified, revealing IGSF1 as an important regulator of TGF/Activin pathways in the pituitary">
    <entity charOffset="59-66" id="s4206.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="104-109" id="s4206.e1" ontology_id="3547" text="IGSF1" type="GENE"/>
    <pair e1="s4206.e0" e2="s4206.e1" id="s4206.p0" relation="true"/>
  </sentence>
  <sentence id="s4207" text="In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and macroorchidism in IGSF1 deficiency are identified, revealing IGSF1 as an important regulator of TGF/Activin pathways in the pituitary">
    <entity charOffset="67-81" id="s4207.e0" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <entity charOffset="104-109" id="s4207.e1" ontology_id="3547" text="IGSF1" type="GENE"/>
    <pair e1="s4207.e0" e2="s4207.e1" id="s4207.p0" relation="true"/>
  </sentence>
  <sentence id="s4208" text="The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.">
    <entity charOffset="26-34" id="s4208.e0" ontology_id="91137" text="SLC25A46" type="GENE"/>
    <entity charOffset="238-244" id="s4208.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4208.e0" e2="s4208.e1" id="s4208.p0" relation="true"/>
  </sentence>
  <sentence id="s4209" text="The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.">
    <entity charOffset="157-170" id="s4209.e0" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <entity charOffset="192-196" id="s4209.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s4209.e0" e2="s4209.e1" id="s4209.p0" relation="true"/>
  </sentence>
  <sentence id="s4210" text="Mutant mice manifest the main clinical features identified in patients, including ataxia, optic atrophy and cerebellar hypoplasia, which were completely rescued by expression of the human ortholog.">
    <entity charOffset="7-11" id="s4210.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="108-129" id="s4210.e1" ontology_id="HP_0001321" text="cerebellar hypoplasia" type="HP"/>
    <pair e1="s4210.e0" e2="s4210.e1" id="s4210.p0" relation="true"/>
  </sentence>
  <sentence id="s4211" text="The dystrobrevin-binding protein 1 (DTNBP1) gene is a candidate risk factor for schizophrenia and has been associated with cognitive ability in both patient populations and healthy controls.">
    <entity charOffset="36-42" id="s4211.e0" ontology_id="84062" text="DTNBP1" type="GENE"/>
    <entity charOffset="80-93" id="s4211.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4211.e0" e2="s4211.e1" id="s4211.p0" relation="true"/>
  </sentence>
  <sentence id="s4212" text="DTNBP1 encodes dysbindin protein, which is localized to synaptic sites and is reduced in the prefrontal cortex and hippocampus of patients with schizophrenia, indicating a potential role in schizophrenia etiology.">
    <entity charOffset="0-6" id="s4212.e0" ontology_id="84062" text="DTNBP1" type="GENE"/>
    <entity charOffset="144-157" id="s4212.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4212.e0" e2="s4212.e1" id="s4212.p0" relation="true"/>
  </sentence>
  <sentence id="s4213" text="First-line IVF is a good option in case of no operated deeply infiltrating endometriosis associated infertility.">
    <entity charOffset="11-14" id="s4213.e0" ontology_id="6331" text="IVF" type="GENE"/>
    <entity charOffset="75-88" id="s4213.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s4213.e0" e2="s4213.e1" id="s4213.p0" relation="true"/>
  </sentence>
  <sentence id="s4214" text="In addition, p-BS/GS can occur as a result of other inherited diseases such as cystic fibrosis, autosomal dominant hypocalcemia, Dent disease, or congenital chloride diarrhea (CCD).">
    <entity charOffset="115-127" id="s4214.e0" ontology_id="HP_0002901" text="hypocalcemia" type="HP"/>
    <entity charOffset="176-179" id="s4214.e1" ontology_id="860" text="CCD" type="GENE"/>
    <pair e1="s4214.e0" e2="s4214.e1" id="s4214.p0" relation="true"/>
  </sentence>
  <sentence id="s4215" text="Insufficient signaling through one or more of these metabolite-sensing GPCRs likely contributes to human diseases such as asthma, food allergies, type 1 and type 2 diabetes, hepatic steatosis, cardiovascular disease, and inflammatory bowel diseases">
    <entity charOffset="146-150" id="s4215.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="182-191" id="s4215.e1" ontology_id="HP_0001397" text="steatosis" type="HP"/>
    <pair e1="s4215.e0" e2="s4215.e1" id="s4215.p0" relation="true"/>
  </sentence>
  <sentence id="s4216" text="Insufficient signaling through one or more of these metabolite-sensing GPCRs likely contributes to human diseases such as asthma, food allergies, type 1 and type 2 diabetes, hepatic steatosis, cardiovascular disease, and inflammatory bowel diseases">
    <entity charOffset="146-150" id="s4216.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="193-215" id="s4216.e1" ontology_id="HP_0001626" text="cardiovascular disease" type="HP"/>
    <pair e1="s4216.e0" e2="s4216.e1" id="s4216.p0" relation="true"/>
  </sentence>
  <sentence id="s4217" text="Applied to ~10,000 tumor exomes the approach identifies known and putative CPGs - including the chromatin modifier NSD1 -that contribute to cancer through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH).">
    <entity charOffset="19-24" id="s4217.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="115-119" id="s4217.e1" ontology_id="64324" text="NSD1" type="GENE"/>
    <pair e1="s4217.e0" e2="s4217.e1" id="s4217.p0" relation="true"/>
  </sentence>
  <sentence id="s4218" text="Applied to ~10,000 tumor exomes the approach identifies known and putative CPGs - including the chromatin modifier NSD1 -that contribute to cancer through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH).">
    <entity charOffset="115-119" id="s4218.e0" ontology_id="64324" text="NSD1" type="GENE"/>
    <entity charOffset="141-147" id="s4218.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4218.e0" e2="s4218.e1" id="s4218.p0" relation="true"/>
  </sentence>
  <sentence id="s4219" text="Pulmonary arterial hypertension (PAH) is a progressive disease characterised by increased pulmonary vascular resistance and pulmonary artery remodelling as result of increased vascular tone and vascular cell proliferation, respectively.">
    <entity charOffset="33-36" id="s4219.e0" ontology_id="5053" text="PAH" type="GENE"/>
    <entity charOffset="80-119" id="s4219.e1" ontology_id="HP_0005317" text="increased pulmonary vascular resistance" type="HP"/>
    <pair e1="s4219.e0" e2="s4219.e1" id="s4219.p0" relation="true"/>
  </sentence>
  <sentence id="s4220" text="However, the associations between RAD50 germline mutations and the survival and risk of breast cancer have not been fully elucidated.">
    <entity charOffset="34-39" id="s4220.e0" ontology_id="10111" text="RAD50" type="GENE"/>
    <entity charOffset="95-101" id="s4220.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4220.e0" e2="s4220.e1" id="s4220.p0" relation="true"/>
  </sentence>
  <sentence id="s4221" text="Here, we aimed to investigate the clinical impact of RAD50 germline mutations in a large cohort of unselected breast cancer patients.">
    <entity charOffset="53-58" id="s4221.e0" ontology_id="10111" text="RAD50" type="GENE"/>
    <entity charOffset="117-123" id="s4221.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4221.e0" e2="s4221.e1" id="s4221.p0" relation="true"/>
  </sentence>
  <sentence id="s4222" text="In our study, RAD50 germline mutations were determined using next-generation sequencing in 7657 consecutive unselected breast cancer patients without BRCA1/2 mutations.">
    <entity charOffset="14-19" id="s4222.e0" ontology_id="10111" text="RAD50" type="GENE"/>
    <entity charOffset="126-132" id="s4222.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4222.e0" e2="s4222.e1" id="s4222.p0" relation="true"/>
  </sentence>
  <sentence id="s4223" text="Our study suggested that RAD50 germline mutations are not associated with an increased risk of breast cancer, but patients with RAD50 germline mutations have unfavourable survival compared to patients without these mutations">
    <entity charOffset="25-30" id="s4223.e0" ontology_id="10111" text="RAD50" type="GENE"/>
    <entity charOffset="102-108" id="s4223.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4223.e0" e2="s4223.e1" id="s4223.p0" relation="true"/>
  </sentence>
  <sentence id="s4224" text="In summary, our results reveal that rare loss-of-function variants in GABRA3 increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern">
    <entity charOffset="70-76" id="s4224.e0" ontology_id="2556" text="GABRA3" type="GENE"/>
    <entity charOffset="158-177" id="s4224.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s4224.e0" e2="s4224.e1" id="s4224.p0" relation="true"/>
  </sentence>
  <sentence id="s4225" text="In summary, our results reveal that rare loss-of-function variants in GABRA3 increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern">
    <entity charOffset="70-76" id="s4225.e0" ontology_id="2556" text="GABRA3" type="GENE"/>
    <entity charOffset="124-132" id="s4225.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4225.e0" e2="s4225.e1" id="s4225.p0" relation="true"/>
  </sentence>
  <sentence id="s4226" text="We previously found that spinal cord and muscle, organs involved in either ALS or distal myopathy, have relatively lower levels of Matrin 3 compared to the brain and other peripheral organs in the murine system.">
    <entity charOffset="75-78" id="s4226.e0" ontology_id="3483" text="ALS" type="GENE"/>
    <entity charOffset="89-97" id="s4226.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4226.e0" e2="s4226.e1" id="s4226.p0" relation="true"/>
  </sentence>
  <sentence id="s4227" text="CONCLUSIONS Our findings indicate that resveratrol induces apoptosis via HIF-1/ROS/p53 signaling in prostate cancer cells and may be a useful therapeutic agent against prostate cancer">
    <entity charOffset="80-83" id="s4227.e0" ontology_id="6098" text="ROS" type="GENE"/>
    <entity charOffset="110-116" id="s4227.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4227.e0" e2="s4227.e1" id="s4227.p0" relation="true"/>
  </sentence>
  <sentence id="s4228" text="BACKGROUND RET rearrangements have been reported in 30% of papillary thyroid carcinomas and 1-2% of non-small cell lung cancer (NSCLC).">
    <entity charOffset="11-14" id="s4228.e0" ontology_id="5979" text="RET" type="GENE"/>
    <entity charOffset="59-87" id="s4228.e1" ontology_id="HP_0002895" text="papillary thyroid carcinomas" type="HP"/>
    <pair e1="s4228.e0" e2="s4228.e1" id="s4228.p0" relation="true"/>
  </sentence>
  <sentence id="s4229" text="In this investigation we assessed the positivity rate of RET gene rearrangement in primary and metastatic non-small cell lung cancer and explored their relationships.">
    <entity charOffset="57-60" id="s4229.e0" ontology_id="5979" text="RET" type="GENE"/>
    <entity charOffset="126-132" id="s4229.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4229.e0" e2="s4229.e1" id="s4229.p0" relation="true"/>
  </sentence>
  <sentence id="s4230" text="The RET rearrangement uniformity in metastatic lymph nodes and tumor specimens were contrasted and the relationships between RET rearrangement and patients' clinical features were investigated.">
    <entity charOffset="4-7" id="s4230.e0" ontology_id="5979" text="RET" type="GENE"/>
    <entity charOffset="63-68" id="s4230.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4230.e0" e2="s4230.e1" id="s4230.p0" relation="true"/>
  </sentence>
  <sentence id="s4231" text="Among the 246 paired cases, 3 (1.22%) cases of primary tumor had identified RET rearrangement and 2 (0.81%) cases of metastases had identified RET rearrangement.">
    <entity charOffset="55-60" id="s4231.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="76-79" id="s4231.e1" ontology_id="5979" text="RET" type="GENE"/>
    <pair e1="s4231.e0" e2="s4231.e1" id="s4231.p0" relation="true"/>
  </sentence>
  <sentence id="s4232" text="CONCLUSIONS The results of this research indicate that the metastases of non-small cell lung cancer can predict RET rearrangement of the primary tumor tissue in the majority of cases.">
    <entity charOffset="93-99" id="s4232.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="112-115" id="s4232.e1" ontology_id="5979" text="RET" type="GENE"/>
    <pair e1="s4232.e0" e2="s4232.e1" id="s4232.p0" relation="true"/>
  </sentence>
  <sentence id="s4233" text="CONCLUSIONS The results of this research indicate that the metastases of non-small cell lung cancer can predict RET rearrangement of the primary tumor tissue in the majority of cases.">
    <entity charOffset="112-115" id="s4233.e0" ontology_id="5979" text="RET" type="GENE"/>
    <entity charOffset="145-150" id="s4233.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4233.e0" e2="s4233.e1" id="s4233.p0" relation="true"/>
  </sentence>
  <sentence id="s4234" text="Testing for RET rearrangement in metastases can be used as an alternative to testing of primary tumor tissue if it is inaccessible">
    <entity charOffset="12-15" id="s4234.e0" ontology_id="5979" text="RET" type="GENE"/>
    <entity charOffset="96-101" id="s4234.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4234.e0" e2="s4234.e1" id="s4234.p0" relation="true"/>
  </sentence>
  <sentence id="s4235" text="We further replicated pleiotropic associations of GYS2 in a childhood obesity study (n=482) and in a gestational diabetes study (n=1710), respectively.">
    <entity charOffset="50-54" id="s4235.e0" ontology_id="2998" text="GYS2" type="GENE"/>
    <entity charOffset="70-77" id="s4235.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4235.e0" e2="s4235.e1" id="s4235.p0" relation="true"/>
  </sentence>
  <sentence id="s4236" text="Here we have investigated the effects of depletion of TNFAIP8 on the mRNA, microRNA and protein expression profiles in prostate and breast cancers and melanoma.">
    <entity charOffset="54-61" id="s4236.e0" ontology_id="25816" text="TNFAIP8" type="GENE"/>
    <entity charOffset="151-159" id="s4236.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4236.e0" e2="s4236.e1" id="s4236.p0" relation="true"/>
  </sentence>
  <sentence id="s4237" text="Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s4237.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="189-194" id="s4237.e1" ontology_id="2042" text="EPHA3" type="GENE"/>
    <pair e1="s4237.e0" e2="s4237.e1" id="s4237.p0" relation="true"/>
  </sentence>
  <sentence id="s4238" text="Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s4238.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="226-231" id="s4238.e1" ontology_id="33" text="ACADL" type="GENE"/>
    <pair e1="s4238.e0" e2="s4238.e1" id="s4238.p0" relation="true"/>
  </sentence>
  <sentence id="s4239" text="Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s4239.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="294-297" id="s4239.e1" ontology_id="4233" text="MET" type="GENE"/>
    <pair e1="s4239.e0" e2="s4239.e1" id="s4239.p0" relation="true"/>
  </sentence>
  <sentence id="s4240" text="Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s4240.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="306-310" id="s4240.e1" ontology_id="3845" text="KRAS" type="GENE"/>
    <pair e1="s4240.e0" e2="s4240.e1" id="s4240.p0" relation="true"/>
  </sentence>
  <sentence id="s4241" text="Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s4241.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="319-324" id="s4241.e1" ontology_id="26578" text="OSTF1" type="GENE"/>
    <pair e1="s4241.e0" e2="s4241.e1" id="s4241.p0" relation="true"/>
  </sentence>
  <sentence id="s4242" text="TNFAIP8-centric molecules were found to be predominately implicated in the hypoxia-inducible factor-1 (HIF-1) signaling pathway, and cancer and development signaling networks.">
    <entity charOffset="0-7" id="s4242.e0" ontology_id="25816" text="TNFAIP8" type="GENE"/>
    <entity charOffset="135-141" id="s4242.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4242.e0" e2="s4242.e1" id="s4242.p0" relation="true"/>
  </sentence>
  <sentence id="s4243" text="Thus TNFAIP8 seems to regulate the cell survival and cancer progression processes in a multifaceted manner.">
    <entity charOffset="5-12" id="s4243.e0" ontology_id="25816" text="TNFAIP8" type="GENE"/>
    <entity charOffset="53-59" id="s4243.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4243.e0" e2="s4243.e1" id="s4243.p0" relation="true"/>
  </sentence>
  <sentence id="s4244" text="We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.">
    <entity charOffset="54-59" id="s4244.e0" ontology_id="724066" text="ATXN8" type="GENE"/>
    <entity charOffset="201-209" id="s4244.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4244.e0" e2="s4244.e1" id="s4244.p0" relation="true"/>
  </sentence>
  <sentence id="s4245" text="We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.">
    <entity charOffset="69-76" id="s4245.e0" ontology_id="5521" text="PPP2R2B" type="GENE"/>
    <entity charOffset="201-209" id="s4245.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4245.e0" e2="s4245.e1" id="s4245.p0" relation="true"/>
  </sentence>
  <sentence id="s4246" text="We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.">
    <entity charOffset="78-83" id="s4246.e0" ontology_id="10528" text="NOP56" type="GENE"/>
    <entity charOffset="201-209" id="s4246.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4246.e0" e2="s4246.e1" id="s4246.p0" relation="true"/>
  </sentence>
  <sentence id="s4247" text="We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.">
    <entity charOffset="85-89" id="s4247.e0" ontology_id="1760" text="DMPK" type="GENE"/>
    <entity charOffset="201-209" id="s4247.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4247.e0" e2="s4247.e1" id="s4247.p0" relation="true"/>
  </sentence>
  <sentence id="s4248" text="We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.">
    <entity charOffset="95-99" id="s4248.e0" ontology_id="57338" text="JPH3" type="GENE"/>
    <entity charOffset="201-209" id="s4248.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4248.e0" e2="s4248.e1" id="s4248.p0" relation="true"/>
  </sentence>
  <sentence id="s4249" text="Cyclooxygenase (COX)-2 is upregulated in hepatocellular carcinoma (HCC).">
    <entity charOffset="16-19" id="s4249.e0" ontology_id="1351" text="COX" type="GENE"/>
    <entity charOffset="41-65" id="s4249.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s4249.e0" e2="s4249.e1" id="s4249.p0" relation="true"/>
  </sentence>
  <sentence id="s4250" text="In conclusion, this study demonstrated for the first time that enhanced COX-2 expression in hepatocytes is sufficient to induce HCC through inducing promoter hypermethylation by reducing TET1, silencing tumor-suppressive genes and activating key oncogenic pathways.">
    <entity charOffset="72-75" id="s4250.e0" ontology_id="1351" text="COX" type="GENE"/>
    <entity charOffset="203-208" id="s4250.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4250.e0" e2="s4250.e1" id="s4250.p0" relation="true"/>
  </sentence>
  <sentence id="s4251" text="This mutation was also found in a second unrelated family with the same clinical phenotype, while no germline or somatic &lt;i&gt;MAFA&lt;/i&gt; mutations were identified in nine patients with sporadic insulinomatosis.">
    <entity charOffset="124-128" id="s4251.e0" ontology_id="10219" text="MAFA" type="GENE"/>
    <entity charOffset="181-189" id="s4251.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4251.e0" e2="s4251.e1" id="s4251.p0" relation="true"/>
  </sentence>
  <sentence id="s4252" text="This study investigated the TGFBI gene mutation types in outpatients clinically diagnosed with granular corneal dystrophy (GCD) prior to phototherapeutic keratectomy (PTK), also calculated the mutation rate of subjects with normal corneas, but positive family history.">
    <entity charOffset="28-33" id="s4252.e0" ontology_id="7045" text="TGFBI" type="GENE"/>
    <entity charOffset="104-121" id="s4252.e1" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <pair e1="s4252.e0" e2="s4252.e1" id="s4252.p0" relation="true"/>
  </sentence>
  <sentence id="s4253" text="In this study, we expand the genotype-phenotype repertoire of SCA13 by describing the novel KCNC3 deletion p.Pro583_Pro585del highlighting the allelic heterogeneity observed in SCA13 patients.">
    <entity charOffset="62-67" id="s4253.e0" ontology_id="3748" text="SCA13" type="GENE"/>
    <entity charOffset="151-164" id="s4253.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s4253.e0" e2="s4253.e1" id="s4253.p0" relation="true"/>
  </sentence>
  <sentence id="s4254" text="In this study, we expand the genotype-phenotype repertoire of SCA13 by describing the novel KCNC3 deletion p.Pro583_Pro585del highlighting the allelic heterogeneity observed in SCA13 patients.">
    <entity charOffset="92-97" id="s4254.e0" ontology_id="3748" text="KCNC3" type="GENE"/>
    <entity charOffset="151-164" id="s4254.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s4254.e0" e2="s4254.e1" id="s4254.p0" relation="true"/>
  </sentence>
  <sentence id="s4255" text="We characterize adult-onset, progressive clinical symptoms of two afflicted kindred and introduce the symptom of profound spasticity not previously associated with the SCA13 phenotype.">
    <entity charOffset="122-132" id="s4255.e0" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <entity charOffset="168-173" id="s4255.e1" ontology_id="3748" text="SCA13" type="GENE"/>
    <pair e1="s4255.e0" e2="s4255.e1" id="s4255.p0" relation="true"/>
  </sentence>
  <sentence id="s4256" text="Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.">
    <entity charOffset="8-26" id="s4256.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="28-31" id="s4256.e1" ontology_id="352909" text="PCD" type="GENE"/>
    <pair e1="s4256.e0" e2="s4256.e1" id="s4256.p0" relation="true"/>
  </sentence>
  <sentence id="s4257" text="Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.">
    <entity charOffset="28-31" id="s4257.e0" ontology_id="352909" text="PCD" type="GENE"/>
    <entity charOffset="198-209" id="s4257.e1" ontology_id="HP_0030853" text="heterotaxia" type="HP"/>
    <pair e1="s4257.e0" e2="s4257.e1" id="s4257.p0" relation="true"/>
  </sentence>
  <sentence id="s4258" text="Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.">
    <entity charOffset="28-31" id="s4258.e0" ontology_id="352909" text="PCD" type="GENE"/>
    <entity charOffset="214-237" id="s4258.e1" ontology_id="HP_0012206" text="abnormal sperm motility" type="HP"/>
    <pair e1="s4258.e0" e2="s4258.e1" id="s4258.p0" relation="true"/>
  </sentence>
  <sentence id="s4259" text="Mutations in four genes (LDLR, APOB, PCSK9 and LDLRAP1) account for the majority of cases with familial hypercholesterolemia.">
    <entity charOffset="25-29" id="s4259.e0" ontology_id="3949" text="LDLR" type="GENE"/>
    <entity charOffset="104-124" id="s4259.e1" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <pair e1="s4259.e0" e2="s4259.e1" id="s4259.p0" relation="true"/>
  </sentence>
  <sentence id="s4260" text="Mutations in four genes (LDLR, APOB, PCSK9 and LDLRAP1) account for the majority of cases with familial hypercholesterolemia.">
    <entity charOffset="31-35" id="s4260.e0" ontology_id="338" text="APOB" type="GENE"/>
    <entity charOffset="104-124" id="s4260.e1" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <pair e1="s4260.e0" e2="s4260.e1" id="s4260.p0" relation="true"/>
  </sentence>
  <sentence id="s4261" text="Mutations in four genes (LDLR, APOB, PCSK9 and LDLRAP1) account for the majority of cases with familial hypercholesterolemia.">
    <entity charOffset="37-42" id="s4261.e0" ontology_id="255738" text="PCSK9" type="GENE"/>
    <entity charOffset="104-124" id="s4261.e1" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <pair e1="s4261.e0" e2="s4261.e1" id="s4261.p0" relation="true"/>
  </sentence>
  <sentence id="s4262" text="Nearly 80 genes involved in lipid metabolism (encoding structural components of lipoproteins, lipoprotein receptors and related proteins, enzymes, lipid transporters, lipid transfer proteins, and activators or inhibitors of protein function and gene transcription) with single nucleotide variants (SNVs) that are recognized to be associated with hypercholesterolemia and serum lipid traits in genome-wide association studies and candidate gene studies were identified.">
    <entity charOffset="346-366" id="s4262.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="383-389" id="s4262.e1" ontology_id="55929" text="traits" type="GENE"/>
    <pair e1="s4262.e0" e2="s4262.e1" id="s4262.p0" relation="true"/>
  </sentence>
  <sentence id="s4263" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="92-97" id="s4263.e0" ontology_id="87" text="ACTN1" type="GENE"/>
    <entity charOffset="346-365" id="s4263.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4263.e0" e2="s4263.e1" id="s4263.p0" relation="false"/>
  </sentence>
  <sentence id="s4264" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="92-97" id="s4264.e0" ontology_id="87" text="ACTN1" type="GENE"/>
    <entity charOffset="462-483" id="s4264.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s4264.e0" e2="s4264.e1" id="s4264.p0" relation="true"/>
  </sentence>
  <sentence id="s4265" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="99-104" id="s4265.e0" ontology_id="8816" text="DCAF5" type="GENE"/>
    <entity charOffset="346-365" id="s4265.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4265.e0" e2="s4265.e1" id="s4265.p0" relation="false"/>
  </sentence>
  <sentence id="s4266" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="99-104" id="s4266.e0" ontology_id="8816" text="DCAF5" type="GENE"/>
    <entity charOffset="462-483" id="s4266.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s4266.e0" e2="s4266.e1" id="s4266.p0" relation="true"/>
  </sentence>
  <sentence id="s4267" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="106-110" id="s4267.e0" ontology_id="55218" text="EXD2" type="GENE"/>
    <entity charOffset="462-483" id="s4267.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s4267.e0" e2="s4267.e1" id="s4267.p0" relation="true"/>
  </sentence>
  <sentence id="s4268" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="112-119" id="s4268.e0" ontology_id="57452" text="GALNTL1" type="GENE"/>
    <entity charOffset="346-365" id="s4268.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4268.e0" e2="s4268.e1" id="s4268.p0" relation="false"/>
  </sentence>
  <sentence id="s4269" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="112-119" id="s4269.e0" ontology_id="57452" text="GALNTL1" type="GENE"/>
    <entity charOffset="462-483" id="s4269.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s4269.e0" e2="s4269.e1" id="s4269.p0" relation="false"/>
  </sentence>
  <sentence id="s4270" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="126-133" id="s4270.e0" ontology_id="55334" text="SLC39A9" type="GENE"/>
    <entity charOffset="346-365" id="s4270.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4270.e0" e2="s4270.e1" id="s4270.p0" relation="false"/>
  </sentence>
  <sentence id="s4271" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="135-142" id="s4271.e0" ontology_id="400224" text="PLEKHD1" type="GENE"/>
    <entity charOffset="346-365" id="s4271.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4271.e0" e2="s4271.e1" id="s4271.p0" relation="false"/>
  </sentence>
  <sentence id="s4272" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="135-142" id="s4272.e0" ontology_id="400224" text="PLEKHD1" type="GENE"/>
    <entity charOffset="462-483" id="s4272.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s4272.e0" e2="s4272.e1" id="s4272.p0" relation="false"/>
  </sentence>
  <sentence id="s4273" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="144-151" id="s4273.e0" ontology_id="56936" text="CCDC177" type="GENE"/>
    <entity charOffset="462-483" id="s4273.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s4273.e0" e2="s4273.e1" id="s4273.p0" relation="true"/>
  </sentence>
  <sentence id="s4274" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="153-161" id="s4274.e0" ontology_id="9766" text="KIAA0247" type="GENE"/>
    <entity charOffset="462-483" id="s4274.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s4274.e0" e2="s4274.e1" id="s4274.p0" relation="false"/>
  </sentence>
  <sentence id="s4275" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="177-182" id="s4275.e0" ontology_id="6430" text="SRSF5" type="GENE"/>
    <entity charOffset="346-365" id="s4275.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4275.e0" e2="s4275.e1" id="s4275.p0" relation="true"/>
  </sentence>
  <sentence id="s4276" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="184-191" id="s4276.e0" ontology_id="6554" text="SLC10A1" type="GENE"/>
    <entity charOffset="346-365" id="s4276.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4276.e0" e2="s4276.e1" id="s4276.p0" relation="false"/>
  </sentence>
  <sentence id="s4277" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="184-191" id="s4277.e0" ontology_id="6554" text="SLC10A1" type="GENE"/>
    <entity charOffset="462-483" id="s4277.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s4277.e0" e2="s4277.e1" id="s4277.p0" relation="false"/>
  </sentence>
  <sentence id="s4278" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="193-198" id="s4278.e0" ontology_id="64093" text="SMOC1" type="GENE"/>
    <entity charOffset="462-483" id="s4278.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s4278.e0" e2="s4278.e1" id="s4278.p0" relation="true"/>
  </sentence>
  <sentence id="s4279" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="208-214" id="s4279.e0" ontology_id="8747" text="ADAM21" type="GENE"/>
    <entity charOffset="346-365" id="s4279.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4279.e0" e2="s4279.e1" id="s4279.p0" relation="false"/>
  </sentence>
  <sentence id="s4280" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="218-223" id="s4280.e0" ontology_id="51241" text="COX16" type="GENE"/>
    <entity charOffset="346-365" id="s4280.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4280.e0" e2="s4280.e1" id="s4280.p0" relation="false"/>
  </sentence>
  <sentence id="s4281" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="225-232" id="s4281.e0" ontology_id="55333" text="SYNJ2BP" type="GENE"/>
    <entity charOffset="346-365" id="s4281.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4281.e0" e2="s4281.e1" id="s4281.p0" relation="false"/>
  </sentence>
  <sentence id="s4282" text="Our case presented the specific characteristics: macrocephaly, midline cleft-lip, cleft palate, polydactyly of both hands and feet but without occipitoschisis, considered as the pathognomonic sign of the syndrome.">
    <entity charOffset="49-61" id="s4282.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="77-80" id="s4282.e1" ontology_id="23049" text="lip" type="GENE"/>
    <pair e1="s4282.e0" e2="s4282.e1" id="s4282.p0" relation="false"/>
  </sentence>
  <sentence id="s4283" text="In the leiomyomas with 12q rearrangements, both HMGA2 and PLAG1 were expressed whereas in the tumors with 8q aberrations, only PLAG1 was expressed.">
    <entity charOffset="58-63" id="s4283.e0" ontology_id="5324" text="PLAG1" type="GENE"/>
    <entity charOffset="94-99" id="s4283.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4283.e0" e2="s4283.e1" id="s4283.p0" relation="true"/>
  </sentence>
  <sentence id="s4284" text="In two tumors with 12q rearrangements, RPSAP52 on 12q14.3 was fused with non-coding RNA (accession number XR_944195) from 14q32.2 or ZFP36L1 from14q24.1.">
    <entity charOffset="7-12" id="s4284.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="133-140" id="s4284.e1" ontology_id="677" text="ZFP36L1" type="GENE"/>
    <pair e1="s4284.e0" e2="s4284.e1" id="s4284.p0" relation="true"/>
  </sentence>
  <sentence id="s4285" text="We recently found that DDHD2 is a principal triglyceride hydrolase in the central nervous system (CNS) and that genetic deletion of this enzyme in mice leads to ectopic lipid droplet (LD) accumulation in neurons throughout the brain.">
    <entity charOffset="23-28" id="s4285.e0" ontology_id="23259" text="DDHD2" type="GENE"/>
    <entity charOffset="74-81" id="s4285.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s4285.e0" e2="s4285.e1" id="s4285.p0" relation="true"/>
  </sentence>
  <sentence id="s4286" text="We confirmed the association between DGCR2 and schizophrenia through individual genotyping of 1,400 subjects.">
    <entity charOffset="37-42" id="s4286.e0" ontology_id="9993" text="DGCR2" type="GENE"/>
    <entity charOffset="47-60" id="s4286.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4286.e0" e2="s4286.e1" id="s4286.p0" relation="true"/>
  </sentence>
  <sentence id="s4287" text="In a gene expression analysis the risk allele of a coding SNP associated with schizophrenia was found to be associated with a reduced expression of DGCR2.">
    <entity charOffset="78-91" id="s4287.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="148-153" id="s4287.e1" ontology_id="9993" text="DGCR2" type="GENE"/>
    <pair e1="s4287.e0" e2="s4287.e1" id="s4287.p0" relation="true"/>
  </sentence>
  <sentence id="s4288" text="The genetic and functional evidences here reported suggest a possible role of the DGCR2 gene in the pathology of schizophrenia and also in the therapeutic effects of antipsychotic drugs">
    <entity charOffset="82-87" id="s4288.e0" ontology_id="9993" text="DGCR2" type="GENE"/>
    <entity charOffset="113-126" id="s4288.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4288.e0" e2="s4288.e1" id="s4288.p0" relation="true"/>
  </sentence>
  <sentence id="s4289" text="Mechanical compression induced miR-9 downregulation by DNMT3A-dependent promoter methylation in the MDA-MB-231 and BT-474 breast cancer cell lines and in cancer-associated fibroblasts.">
    <entity charOffset="31-34" id="s4289.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="129-135" id="s4289.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4289.e0" e2="s4289.e1" id="s4289.p0" relation="true"/>
  </sentence>
  <sentence id="s4290" text="Mechanical compression induced miR-9 downregulation by DNMT3A-dependent promoter methylation in the MDA-MB-231 and BT-474 breast cancer cell lines and in cancer-associated fibroblasts.">
    <entity charOffset="55-61" id="s4290.e0" ontology_id="1788" text="DNMT3A" type="GENE"/>
    <entity charOffset="129-135" id="s4290.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4290.e0" e2="s4290.e1" id="s4290.p0" relation="true"/>
  </sentence>
  <sentence id="s4291" text="Mechanical compression induced miR-9 downregulation by DNMT3A-dependent promoter methylation in the MDA-MB-231 and BT-474 breast cancer cell lines and in cancer-associated fibroblasts.">
    <entity charOffset="115-117" id="s4291.e0" ontology_id="696" text="BT" type="GENE"/>
    <entity charOffset="129-135" id="s4291.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4291.e0" e2="s4291.e1" id="s4291.p0" relation="true"/>
  </sentence>
  <sentence id="s4292" text="This paper deals with the molecular investigation of Waardenburg syndrome (WS) in a sample of 49 clinically diagnosed probands (most from southeastern Brazil), 24 of them having the type 1 (WS1) variant (10 familial and 14 isolated cases) and 25 being affected by the type 2 (WS2) variant (five familial and 20 isolated cases).">
    <entity charOffset="182-186" id="s4292.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="223-237" id="s4292.e1" ontology_id="HP_0003745" text="isolated cases" type="HP"/>
    <pair e1="s4292.e0" e2="s4292.e1" id="s4292.p0" relation="true"/>
  </sentence>
  <sentence id="s4293" text="Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the KATNB1 gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.">
    <entity charOffset="106-112" id="s4293.e0" ontology_id="10300" text="KATNB1" type="GENE"/>
    <entity charOffset="198-210" id="s4293.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s4293.e0" e2="s4293.e1" id="s4293.p0" relation="true"/>
  </sentence>
  <sentence id="s4294" text="Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the KATNB1 gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.">
    <entity charOffset="106-112" id="s4294.e0" ontology_id="10300" text="KATNB1" type="GENE"/>
    <entity charOffset="212-225" id="s4294.e1" ontology_id="HP_0001339" text="lissencephaly" type="HP"/>
    <pair e1="s4294.e0" e2="s4294.e1" id="s4294.p0" relation="true"/>
  </sentence>
  <sentence id="s4295" text="Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the KATNB1 gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.">
    <entity charOffset="106-112" id="s4295.e0" ontology_id="10300" text="KATNB1" type="GENE"/>
    <entity charOffset="227-240" id="s4295.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s4295.e0" e2="s4295.e1" id="s4295.p0" relation="true"/>
  </sentence>
  <sentence id="s4296" text="Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the KATNB1 gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.">
    <entity charOffset="106-112" id="s4296.e0" ontology_id="10300" text="KATNB1" type="GENE"/>
    <entity charOffset="262-282" id="s4296.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s4296.e0" e2="s4296.e1" id="s4296.p0" relation="true"/>
  </sentence>
  <sentence id="s4297" text="Homozygous and compound heterozygous mutations in KATNB1 have very recently been described as a cause of microcephaly with brain malformations and seizures.">
    <entity charOffset="50-56" id="s4297.e0" ontology_id="10300" text="KATNB1" type="GENE"/>
    <entity charOffset="105-117" id="s4297.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s4297.e0" e2="s4297.e1" id="s4297.p0" relation="true"/>
  </sentence>
  <sentence id="s4298" text="Homozygous and compound heterozygous mutations in KATNB1 have very recently been described as a cause of microcephaly with brain malformations and seizures.">
    <entity charOffset="50-56" id="s4298.e0" ontology_id="10300" text="KATNB1" type="GENE"/>
    <entity charOffset="147-155" id="s4298.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s4298.e0" e2="s4298.e1" id="s4298.p0" relation="true"/>
  </sentence>
  <sentence id="s4299" text="Interestingly, de novo loss-of-function and missense variants in KDM5B were identified in patients with intellectual disability (ID) and autism spectrum disorder (ASD) but also in unaffected individuals.">
    <entity charOffset="65-70" id="s4299.e0" ontology_id="10765" text="KDM5B" type="GENE"/>
    <entity charOffset="137-143" id="s4299.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s4299.e0" e2="s4299.e1" id="s4299.p0" relation="true"/>
  </sentence>
  <sentence id="s4300" text="The c.808+1G&amp;gt;A variant was identified in a boy with mild ID and autism traits and is associated with a significant reduced KDM5B mRNA expression without alteration of its H3K4me3 pattern.">
    <entity charOffset="71-77" id="s4300.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="130-135" id="s4300.e1" ontology_id="10765" text="KDM5B" type="GENE"/>
    <pair e1="s4300.e0" e2="s4300.e1" id="s4300.p0" relation="true"/>
  </sentence>
  <sentence id="s4301" text="Our data reinforces the recent observation that the KDM5B haploinsufficiency is not a mechanism involved in intellectual disability and that KDM5B disorder associated with LOF variants is a recessive disorder.">
    <entity charOffset="52-57" id="s4301.e0" ontology_id="10765" text="KDM5B" type="GENE"/>
    <entity charOffset="108-131" id="s4301.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4301.e0" e2="s4301.e1" id="s4301.p0" relation="true"/>
  </sentence>
  <sentence id="s4302" text="Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="25-32" id="s4302.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="41-45" id="s4302.e1" ontology_id="2475" text="mTOR" type="GENE"/>
    <pair e1="s4302.e0" e2="s4302.e1" id="s4302.p0" relation="true"/>
  </sentence>
  <sentence id="s4303" text="Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="25-32" id="s4303.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="104-108" id="s4303.e1" ontology_id="4830" text="NME1" type="GENE"/>
    <pair e1="s4303.e0" e2="s4303.e1" id="s4303.p0" relation="true"/>
  </sentence>
  <sentence id="s4304" text="Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="25-32" id="s4304.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="113-117" id="s4304.e1" ontology_id="4831" text="NME2" type="GENE"/>
    <pair e1="s4304.e0" e2="s4304.e1" id="s4304.p0" relation="true"/>
  </sentence>
  <sentence id="s4305" text="Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="53-77" id="s4305.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="104-108" id="s4305.e1" ontology_id="4830" text="NME1" type="GENE"/>
    <pair e1="s4305.e0" e2="s4305.e1" id="s4305.p0" relation="true"/>
  </sentence>
  <sentence id="s4306" text="Conversely, expression of the putative histidine phosphatase LHPP was downregulated specifically in the tumours.">
    <entity charOffset="61-65" id="s4306.e0" ontology_id="64077" text="LHPP" type="GENE"/>
    <entity charOffset="104-111" id="s4306.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s4306.e0" e2="s4306.e1" id="s4306.p0" relation="true"/>
  </sentence>
  <sentence id="s4307" text="Sustained, hepatic expression of LHPP in the hepatocellular carcinoma mouse model reduced tumour burden and prevented the loss of liver function.">
    <entity charOffset="33-37" id="s4307.e0" ontology_id="64077" text="LHPP" type="GENE"/>
    <entity charOffset="45-69" id="s4307.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s4307.e0" e2="s4307.e1" id="s4307.p0" relation="true"/>
  </sentence>
  <sentence id="s4308" text="Sustained, hepatic expression of LHPP in the hepatocellular carcinoma mouse model reduced tumour burden and prevented the loss of liver function.">
    <entity charOffset="33-37" id="s4308.e0" ontology_id="64077" text="LHPP" type="GENE"/>
    <entity charOffset="90-96" id="s4308.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4308.e0" e2="s4308.e1" id="s4308.p0" relation="true"/>
  </sentence>
  <sentence id="s4309" text="Finally, in patients with hepatocellular carcinoma, low expression of LHPP correlated with increased tumour severity and reduced overall survival.">
    <entity charOffset="70-74" id="s4309.e0" ontology_id="64077" text="LHPP" type="GENE"/>
    <entity charOffset="101-107" id="s4309.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4309.e0" e2="s4309.e1" id="s4309.p0" relation="false"/>
  </sentence>
  <sentence id="s4310" text="Thus, LHPP is a protein histidine phosphatase and tumour suppressor, suggesting that deregulated histidine phosphorylation is oncogenic">
    <entity charOffset="6-10" id="s4310.e0" ontology_id="64077" text="LHPP" type="GENE"/>
    <entity charOffset="50-56" id="s4310.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4310.e0" e2="s4310.e1" id="s4310.p0" relation="true"/>
  </sentence>
  <sentence id="s4311" text="OGFOD1 knockdown in MDA-MB-231 breast cancer cells significantly impeded cell proliferation and resulted in the accumulation of G1 and G2/M cells by decreasing the mRNA levels of G1/S transition- and G2/M-related transcription factors and their target genes.">
    <entity charOffset="0-6" id="s4311.e0" ontology_id="55239" text="OGFOD1" type="GENE"/>
    <entity charOffset="38-44" id="s4311.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4311.e0" e2="s4311.e1" id="s4311.p0" relation="true"/>
  </sentence>
  <sentence id="s4312" text="We also confirmed that OGFOD1 is highly expressed in breast cancer tissues by bioinformatic analysis and immunohistochemistry.">
    <entity charOffset="23-29" id="s4312.e0" ontology_id="55239" text="OGFOD1" type="GENE"/>
    <entity charOffset="60-66" id="s4312.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4312.e0" e2="s4312.e1" id="s4312.p0" relation="true"/>
  </sentence>
  <sentence id="s4313" text="Thus, we propose that OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer.">
    <entity charOffset="22-28" id="s4313.e0" ontology_id="55239" text="OGFOD1" type="GENE"/>
    <entity charOffset="52-58" id="s4313.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4313.e0" e2="s4313.e1" id="s4313.p0" relation="true"/>
  </sentence>
  <sentence id="s4314" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.">
    <entity charOffset="201-207" id="s4314.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="221-226" id="s4314.e1" ontology_id="5599" text="MAPK8" type="GENE"/>
    <pair e1="s4314.e0" e2="s4314.e1" id="s4314.p0" relation="true"/>
  </sentence>
  <sentence id="s4315" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.">
    <entity charOffset="201-207" id="s4315.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="236-243" id="s4315.e1" ontology_id="7786" text="MAP3K12" type="GENE"/>
    <pair e1="s4315.e0" e2="s4315.e1" id="s4315.p0" relation="true"/>
  </sentence>
  <sentence id="s4316" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.">
    <entity charOffset="201-207" id="s4316.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="245-250" id="s4316.e1" ontology_id="5595" text="MAPK3" type="GENE"/>
    <pair e1="s4316.e0" e2="s4316.e1" id="s4316.p0" relation="true"/>
  </sentence>
  <sentence id="s4317" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.">
    <entity charOffset="201-207" id="s4317.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="259-264" id="s4317.e1" ontology_id="5598" text="MAPK7" type="GENE"/>
    <pair e1="s4317.e0" e2="s4317.e1" id="s4317.p0" relation="true"/>
  </sentence>
  <sentence id="s4318" text="The cause was identified in only 7 patients and included methylmalonic aciduria, meningoencephalitis, perinatal hypoxic-ischemic injury, large genomic deletion on chromosome 7q21, translocase of inner mitochondrial membrane 8 homolog A (TIMM8A) mutation (Mohr-Tranebjaerg syndrome), and chromosome 2 open reading frame 37 (C2orf37) mutation (Woodhouse-Sakati syndrome).">
    <entity charOffset="57-79" id="s4318.e0" ontology_id="HP_0012120" text="methylmalonic aciduria" type="HP"/>
    <entity charOffset="237-243" id="s4318.e1" ontology_id="1678" text="TIMM8A" type="GENE"/>
    <pair e1="s4318.e0" e2="s4318.e1" id="s4318.p0" relation="true"/>
  </sentence>
  <sentence id="s4319" text="The cause was identified in only 7 patients and included methylmalonic aciduria, meningoencephalitis, perinatal hypoxic-ischemic injury, large genomic deletion on chromosome 7q21, translocase of inner mitochondrial membrane 8 homolog A (TIMM8A) mutation (Mohr-Tranebjaerg syndrome), and chromosome 2 open reading frame 37 (C2orf37) mutation (Woodhouse-Sakati syndrome).">
    <entity charOffset="57-79" id="s4319.e0" ontology_id="HP_0012120" text="methylmalonic aciduria" type="HP"/>
    <entity charOffset="323-330" id="s4319.e1" ontology_id="80067" text="C2orf37" type="GENE"/>
    <pair e1="s4319.e0" e2="s4319.e1" id="s4319.p0" relation="true"/>
  </sentence>
  <sentence id="s4320" text="A large, complex, and robust gene network containing well-known lung cancer-related genes, including EGFR and TERT, was identified from combined gene lists for lung adenocarcinoma.">
    <entity charOffset="69-75" id="s4320.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="101-105" id="s4320.e1" ontology_id="1956" text="EGFR" type="GENE"/>
    <pair e1="s4320.e0" e2="s4320.e1" id="s4320.p0" relation="true"/>
  </sentence>
  <sentence id="s4321" text="A large, complex, and robust gene network containing well-known lung cancer-related genes, including EGFR and TERT, was identified from combined gene lists for lung adenocarcinoma.">
    <entity charOffset="110-114" id="s4321.e0" ontology_id="7015" text="TERT" type="GENE"/>
    <entity charOffset="160-179" id="s4321.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s4321.e0" e2="s4321.e1" id="s4321.p0" relation="true"/>
  </sentence>
  <sentence id="s4322" text="Here we found that perilipin-1 (PLIN1) mRNA expression is significantly downregulated in human breast cancer.">
    <entity charOffset="32-37" id="s4322.e0" ontology_id="5346" text="PLIN1" type="GENE"/>
    <entity charOffset="102-108" id="s4322.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4322.e0" e2="s4322.e1" id="s4322.p0" relation="true"/>
  </sentence>
  <sentence id="s4323" text="Further Cox proportional hazard models analysis revealed that the reduced expression of PLIN1 is an independent predictor of overall survival in estrogen receptor positive (p &amp;lt; 0.0001, HR = 0.87, 95% CI = 0.81-0.92, N = 3,600) and luminal A-subtype (p = 0.02, HR = 0.88, 95% CI = 0.78-0.98, N = 1,469) breast cancer patients.">
    <entity charOffset="88-93" id="s4323.e0" ontology_id="5346" text="PLIN1" type="GENE"/>
    <entity charOffset="312-318" id="s4323.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4323.e0" e2="s4323.e1" id="s4323.p0" relation="true"/>
  </sentence>
  <sentence id="s4324" text="We also demonstrated that the exogenous expression of PLIN1 in human breast cancer MCF-7 and MDA-MB-231 cells significantly inhibits cell proliferation, migration, invasion and in vivo tumorigenesis in mice.">
    <entity charOffset="54-59" id="s4324.e0" ontology_id="5346" text="PLIN1" type="GENE"/>
    <entity charOffset="76-82" id="s4324.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4324.e0" e2="s4324.e1" id="s4324.p0" relation="true"/>
  </sentence>
  <sentence id="s4325" text="Together, these data provide novel insights into a prognostic significance of PLIN1 in human breast cancer and reveal a potentially new gene therapy target for breast cancer">
    <entity charOffset="78-83" id="s4325.e0" ontology_id="5346" text="PLIN1" type="GENE"/>
    <entity charOffset="100-106" id="s4325.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4325.e0" e2="s4325.e1" id="s4325.p0" relation="true"/>
  </sentence>
  <sentence id="s4326" text="We investigated the impact of these polymorphisms on the clinical outcome of 103 patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with a platinum compound, fluorouracil and cetuximab as palliative first-line therapy.">
    <entity charOffset="20-26" id="s4326.e0" ontology_id="55364" text="impact" type="GENE"/>
    <entity charOffset="119-142" id="s4326.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s4326.e0" e2="s4326.e1" id="s4326.p0" relation="true"/>
  </sentence>
  <sentence id="s4327" text="Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&amp;gt;C, p.V378L) KCNB1 mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.">
    <entity charOffset="93-98" id="s4327.e0" ontology_id="3745" text="KCNB1" type="GENE"/>
    <entity charOffset="133-152" id="s4327.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s4327.e0" e2="s4327.e1" id="s4327.p0" relation="true"/>
  </sentence>
  <sentence id="s4328" text="Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&amp;gt;C, p.V378L) KCNB1 mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.">
    <entity charOffset="93-98" id="s4328.e0" ontology_id="3745" text="KCNB1" type="GENE"/>
    <entity charOffset="154-177" id="s4328.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4328.e0" e2="s4328.e1" id="s4328.p0" relation="true"/>
  </sentence>
  <sentence id="s4329" text="We present a case of a patient with long-standing hyperpigmented macules and erythematous papules over his chest, abdomen, back and arms, suggestive of Dowling-Degos disease (DDD).">
    <entity charOffset="50-72" id="s4329.e0" ontology_id="HP_0001034" text="hyperpigmented macules" type="HP"/>
    <entity charOffset="132-136" id="s4329.e1" ontology_id="57498" text="arms" type="GENE"/>
    <pair e1="s4329.e0" e2="s4329.e1" id="s4329.p0" relation="false"/>
  </sentence>
  <sentence id="s4330" text="Although mutations in the gene encoding tricellulin are known to cause deafness in humans (DFNB49) and mice, the influence of its systemic deletion in vivo remains unknown.">
    <entity charOffset="71-79" id="s4330.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="91-97" id="s4330.e1" ontology_id="153562" text="DFNB49" type="GENE"/>
    <pair e1="s4330.e0" e2="s4330.e1" id="s4330.p0" relation="true"/>
  </sentence>
  <sentence id="s4331" text="When we generated tricellulin-knockout mice (Tric(-/-)), we found an early-onset rapidly progressive hearing loss associated with the degeneration of hair cells (HCs); however, their body size and overall appearance were normal.">
    <entity charOffset="45-49" id="s4331.e0" ontology_id="153562" text="Tric" type="GENE"/>
    <entity charOffset="89-100" id="s4331.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s4331.e0" e2="s4331.e1" id="s4331.p0" relation="true"/>
  </sentence>
  <sentence id="s4332" text="When we generated tricellulin-knockout mice (Tric(-/-)), we found an early-onset rapidly progressive hearing loss associated with the degeneration of hair cells (HCs); however, their body size and overall appearance were normal.">
    <entity charOffset="45-49" id="s4332.e0" ontology_id="153562" text="Tric" type="GENE"/>
    <entity charOffset="101-113" id="s4332.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4332.e0" e2="s4332.e1" id="s4332.p0" relation="true"/>
  </sentence>
  <sentence id="s4333" text="Spinocerebellar ataxia type 11 (SCA11) is a rare, dominantly inherited human ataxia characterized by atrophy of Purkinje neurons in the cerebellum.">
    <entity charOffset="16-22" id="s4333.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="32-37" id="s4333.e1" ontology_id="146057" text="SCA11" type="GENE"/>
    <pair e1="s4333.e0" e2="s4333.e1" id="s4333.p0" relation="true"/>
  </sentence>
  <sentence id="s4334" text="Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the cardinal features include primary microcephaly and profound global developmental delay.">
    <entity charOffset="185-193" id="s4334.e0" ontology_id="22900" text="cardinal" type="GENE"/>
    <entity charOffset="236-244" id="s4334.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s4334.e0" e2="s4334.e1" id="s4334.p0" relation="true"/>
  </sentence>
  <sentence id="s4335" text="Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the cardinal features include primary microcephaly and profound global developmental delay.">
    <entity charOffset="185-193" id="s4335.e0" ontology_id="22900" text="cardinal" type="GENE"/>
    <entity charOffset="252-271" id="s4335.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s4335.e0" e2="s4335.e1" id="s4335.p0" relation="true"/>
  </sentence>
  <sentence id="s4336" text="However, the biological function and mechanism of TPI1 in cancer remain largely unknown.">
    <entity charOffset="50-54" id="s4336.e0" ontology_id="7167" text="TPI1" type="GENE"/>
    <entity charOffset="58-64" id="s4336.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4336.e0" e2="s4336.e1" id="s4336.p0" relation="true"/>
  </sentence>
  <sentence id="s4337" text="In this study, we have found that TPI1 expression was greatly decreased in clinical HCC samples, positively correlated with overall survival, and negatively associated with histological differentiation, tumor size and organ metastasis.">
    <entity charOffset="84-87" id="s4337.e0" ontology_id="84668" text="HCC" type="GENE"/>
    <entity charOffset="203-208" id="s4337.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4337.e0" e2="s4337.e1" id="s4337.p0" relation="true"/>
  </sentence>
  <sentence id="s4338" text="Moreover, overexpression of TPI1 led to slowed tumor growth and decreased tumor weight invivo.">
    <entity charOffset="28-32" id="s4338.e0" ontology_id="7167" text="TPI1" type="GENE"/>
    <entity charOffset="47-52" id="s4338.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4338.e0" e2="s4338.e1" id="s4338.p0" relation="true"/>
  </sentence>
  <sentence id="s4339" text="Therefore, our data suggested that TPI1 functioned as a tumor suppressor in HCC and might serve as a potential therapeutic target for the treatment of HCC">
    <entity charOffset="35-39" id="s4339.e0" ontology_id="7167" text="TPI1" type="GENE"/>
    <entity charOffset="56-61" id="s4339.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4339.e0" e2="s4339.e1" id="s4339.p0" relation="true"/>
  </sentence>
  <sentence id="s4340" text="We also found that multiple cancers are genetically correlated with non-cancer traits including smoking, psychiatric diseases and metabolic characteristics.">
    <entity charOffset="28-34" id="s4340.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="79-85" id="s4340.e1" ontology_id="55929" text="traits" type="GENE"/>
    <pair e1="s4340.e0" e2="s4340.e1" id="s4340.p0" relation="true"/>
  </sentence>
  <sentence id="s4341" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="85-91" id="s4341.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="127-131" id="s4341.e1" ontology_id="7015" text="TERT" type="GENE"/>
    <pair e1="s4341.e0" e2="s4341.e1" id="s4341.p0" relation="true"/>
  </sentence>
  <sentence id="s4342" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="85-91" id="s4342.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="160-163" id="s4342.e1" ontology_id="472" text="ATM" type="GENE"/>
    <pair e1="s4342.e0" e2="s4342.e1" id="s4342.p0" relation="true"/>
  </sentence>
  <sentence id="s4343" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="85-91" id="s4343.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="337-342" id="s4343.e1" ontology_id="9687" text="GREB1" type="GENE"/>
    <pair e1="s4343.e0" e2="s4343.e1" id="s4343.p0" relation="true"/>
  </sentence>
  <sentence id="s4344" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="85-91" id="s4344.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="354-358" id="s4344.e1" ontology_id="84515" text="MCM8" type="GENE"/>
    <pair e1="s4344.e0" e2="s4344.e1" id="s4344.p0" relation="true"/>
  </sentence>
  <sentence id="s4345" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="160-163" id="s4345.e0" ontology_id="472" text="ATM" type="GENE"/>
    <entity charOffset="296-302" id="s4345.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4345.e0" e2="s4345.e1" id="s4345.p0" relation="false"/>
  </sentence>
  <sentence id="s4346" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="296-302" id="s4346.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="337-342" id="s4346.e1" ontology_id="9687" text="GREB1" type="GENE"/>
    <pair e1="s4346.e0" e2="s4346.e1" id="s4346.p0" relation="true"/>
  </sentence>
  <sentence id="s4347" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="296-302" id="s4347.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="354-358" id="s4347.e1" ontology_id="84515" text="MCM8" type="GENE"/>
    <pair e1="s4347.e0" e2="s4347.e1" id="s4347.p0" relation="true"/>
  </sentence>
  <sentence id="s4348" text="In the present case, magnetic resonance imaging (MRI) obtained during infancy revealed symmetric lesions in the substantia nigra of a patient with Leigh syndrome with an NDUFA1 mutation; lesions of the bilateral putamen and brainstem were subsequently observed.">
    <entity charOffset="170-176" id="s4348.e0" ontology_id="4694" text="NDUFA1" type="GENE"/>
    <entity charOffset="202-211" id="s4348.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s4348.e0" e2="s4348.e1" id="s4348.p0" relation="true"/>
  </sentence>
  <sentence id="s4349" text="We provide functional evidence to support the pathogenicity of these TMEM126B variants, including evidence of founder effects for both variants, and establish defects within this gene as a cause of complex I deficiency in association with either pure myopathy in adulthood or, in one individual, a severe multisystem presentation (chronic renal failure andcardiomyopathy) in infancy.">
    <entity charOffset="69-77" id="s4349.e0" ontology_id="55863" text="TMEM126B" type="GENE"/>
    <entity charOffset="339-352" id="s4349.e1" ontology_id="HP_0000083" text="renal failure" type="HP"/>
    <pair e1="s4349.e0" e2="s4349.e1" id="s4349.p0" relation="true"/>
  </sentence>
  <sentence id="s4350" text="Tbx3, a member of the T-box family of transcription factors, contributes directly to tumor formation, migration, and invasion.">
    <entity charOffset="0-4" id="s4350.e0" ontology_id="6926" text="Tbx3" type="GENE"/>
    <entity charOffset="85-90" id="s4350.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4350.e0" e2="s4350.e1" id="s4350.p0" relation="true"/>
  </sentence>
  <sentence id="s4351" text="Tbx3 expression was positively associated with multiple tumor nodes, venous infiltration, and advanced TNM tumor stage.">
    <entity charOffset="0-4" id="s4351.e0" ontology_id="6926" text="Tbx3" type="GENE"/>
    <entity charOffset="56-61" id="s4351.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4351.e0" e2="s4351.e1" id="s4351.p0" relation="true"/>
  </sentence>
  <sentence id="s4352" text="Tbx3 expression was positively associated with multiple tumor nodes, venous infiltration, and advanced TNM tumor stage.">
    <entity charOffset="56-61" id="s4352.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="103-106" id="s4352.e1" ontology_id="10178" text="TNM" type="GENE"/>
    <pair e1="s4352.e0" e2="s4352.e1" id="s4352.p0" relation="true"/>
  </sentence>
  <sentence id="s4353" text="There is increasing evidence of a clinical, neuropathological and genetic overlap between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).">
    <entity charOffset="90-113" id="s4353.e0" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <entity charOffset="155-158" id="s4353.e1" ontology_id="3483" text="ALS" type="GENE"/>
    <pair e1="s4353.e0" e2="s4353.e1" id="s4353.p0" relation="true"/>
  </sentence>
  <sentence id="s4354" text="A better understanding of Preb gene expression, during the pathogenesis of hepatic insulin resistance, could ultimately provide new avenues for therapies for metabolic syndrome, obesity, and type-2 diabetes mellitus, disorders whose worldwide incidences are increasing drastically">
    <entity charOffset="26-30" id="s4354.e0" ontology_id="10113" text="Preb" type="GENE"/>
    <entity charOffset="178-185" id="s4354.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4354.e0" e2="s4354.e1" id="s4354.p0" relation="true"/>
  </sentence>
  <sentence id="s4355" text="Using whole-exome sequencing, we identified biallelic mutations in seizure threshold 2 (SZT2) in both affected children.">
    <entity charOffset="67-74" id="s4355.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="88-92" id="s4355.e1" ontology_id="23334" text="SZT2" type="GENE"/>
    <pair e1="s4355.e0" e2="s4355.e1" id="s4355.p0" relation="true"/>
  </sentence>
  <sentence id="s4356" text="Although the molecular role of the peroxisomal protein SZT2 in neuronal excitability and brain development remains to be defined, Szt2 has been shown to influence seizure threshold and epileptogenesis in mice, consistent with our findings in humans.">
    <entity charOffset="55-59" id="s4356.e0" ontology_id="23334" text="SZT2" type="GENE"/>
    <entity charOffset="163-170" id="s4356.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s4356.e0" e2="s4356.e1" id="s4356.p0" relation="true"/>
  </sentence>
  <sentence id="s4357" text="Although the molecular role of the peroxisomal protein SZT2 in neuronal excitability and brain development remains to be defined, Szt2 has been shown to influence seizure threshold and epileptogenesis in mice, consistent with our findings in humans.">
    <entity charOffset="130-134" id="s4357.e0" ontology_id="23334" text="Szt2" type="GENE"/>
    <entity charOffset="163-170" id="s4357.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s4357.e0" e2="s4357.e1" id="s4357.p0" relation="true"/>
  </sentence>
  <sentence id="s4358" text="We conclude that mutations in SZT2 cause a severe type of autosomal-recessive infantile encephalopathy with intractable seizures and distinct neuroradiological anomalies.">
    <entity charOffset="30-34" id="s4358.e0" ontology_id="23334" text="SZT2" type="GENE"/>
    <entity charOffset="88-102" id="s4358.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s4358.e0" e2="s4358.e1" id="s4358.p0" relation="true"/>
  </sentence>
  <sentence id="s4359" text="We conclude that mutations in SZT2 cause a severe type of autosomal-recessive infantile encephalopathy with intractable seizures and distinct neuroradiological anomalies.">
    <entity charOffset="30-34" id="s4359.e0" ontology_id="23334" text="SZT2" type="GENE"/>
    <entity charOffset="120-127" id="s4359.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s4359.e0" e2="s4359.e1" id="s4359.p0" relation="true"/>
  </sentence>
  <sentence id="s4360" text="We conclude that mutations in SZT2 cause a severe type of autosomal-recessive infantile encephalopathy with intractable seizures and distinct neuroradiological anomalies.">
    <entity charOffset="50-54" id="s4360.e0" ontology_id="6445" text="type" type="GENE"/>
    <entity charOffset="120-127" id="s4360.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s4360.e0" e2="s4360.e1" id="s4360.p0" relation="true"/>
  </sentence>
  <sentence id="s4361" text="Here, we found that cervical cancer cells undergo massive death by SIRT1 knockdown, but this effect is reversed by SIRT1 restoration.">
    <entity charOffset="29-35" id="s4361.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-72" id="s4361.e1" ontology_id="23411" text="SIRT1" type="GENE"/>
    <pair e1="s4361.e0" e2="s4361.e1" id="s4361.p0" relation="true"/>
  </sentence>
  <sentence id="s4362" text="Interestingly, pyroptotic death signaling in SIRT1-knocked-down cells was transmitted to nave cervical cancer cells, which was mediated by extracellular vesicles carrying AIM2 inflammasome proteins.">
    <entity charOffset="45-50" id="s4362.e0" ontology_id="23411" text="SIRT1" type="GENE"/>
    <entity charOffset="104-110" id="s4362.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4362.e0" e2="s4362.e1" id="s4362.p0" relation="true"/>
  </sentence>
  <sentence id="s4363" text="Interestingly, pyroptotic death signaling in SIRT1-knocked-down cells was transmitted to nave cervical cancer cells, which was mediated by extracellular vesicles carrying AIM2 inflammasome proteins.">
    <entity charOffset="104-110" id="s4363.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="172-176" id="s4363.e1" ontology_id="9447" text="AIM2" type="GENE"/>
    <pair e1="s4363.e0" e2="s4363.e1" id="s4363.p0" relation="true"/>
  </sentence>
  <sentence id="s4364" text="Immunohistochemical analyses showed that SIRT1 expression correlated with poor clinical outcomes in cervical cancer.">
    <entity charOffset="41-46" id="s4364.e0" ontology_id="23411" text="SIRT1" type="GENE"/>
    <entity charOffset="109-115" id="s4364.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4364.e0" e2="s4364.e1" id="s4364.p0" relation="true"/>
  </sentence>
  <sentence id="s4365" text="In conclusion, SIRT1 enabled HPV-infected cervical cancer cells to continue growing by nullifying AIM2 inflammasome-mediated immunity.">
    <entity charOffset="15-20" id="s4365.e0" ontology_id="23411" text="SIRT1" type="GENE"/>
    <entity charOffset="51-57" id="s4365.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4365.e0" e2="s4365.e1" id="s4365.p0" relation="true"/>
  </sentence>
  <sentence id="s4366" text="Without SIRT1, cervical cancer cells could no longer survive because of the derepression of the AIM2 inflammasome.">
    <entity charOffset="8-13" id="s4366.e0" ontology_id="23411" text="SIRT1" type="GENE"/>
    <entity charOffset="24-30" id="s4366.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4366.e0" e2="s4366.e1" id="s4366.p0" relation="true"/>
  </sentence>
  <sentence id="s4367" text="Clinicopathologic features such as menarche age, body mass index, personal cancer history, grade, and histologic type were compared between the 2 groups.">
    <entity charOffset="75-81" id="s4367.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="113-117" id="s4367.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s4367.e0" e2="s4367.e1" id="s4367.p0" relation="true"/>
  </sentence>
  <sentence id="s4368" text="Univariate (Pearson Chi-squared test, Fisher exact test, T test, Wilcoxon rank sum test, logistic regression) statistics and stepwise multivariate logistic regression were used to identify factors associated with PFH in the analysis.Among young patients with EC, the PFH group had younger age-of-onset age of endometrial cancer (40 years) (odds ratio [OR] = 2.21, 95% confidence interval [95% CI]: 1.01-4.82) than the NFH group.">
    <entity charOffset="74-78" id="s4368.e0" ontology_id="8792" text="rank" type="GENE"/>
    <entity charOffset="321-327" id="s4368.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4368.e0" e2="s4368.e1" id="s4368.p0" relation="true"/>
  </sentence>
  <sentence id="s4369" text="Colorectal, lung, endometrial, breast, and hepatocellular carcinoma accounted for 58.6% of all cancer types among 1st- and 2nd-degree relatives.">
    <entity charOffset="43-67" id="s4369.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="102-106" id="s4369.e1" ontology_id="6445" text="type" type="GENE"/>
    <pair e1="s4369.e0" e2="s4369.e1" id="s4369.p0" relation="true"/>
  </sentence>
  <sentence id="s4370" text="Our study identifies GLIS3 as a key regulator of TSH/TSHR-mediated thyroid hormone biosynthesis and proliferation of thyroid follicular cells and uncovers a mechanism by which GLIS3 deficiency causes neonatal hypothyroidism and prevents goiter development">
    <entity charOffset="21-26" id="s4370.e0" ontology_id="169792" text="GLIS3" type="GENE"/>
    <entity charOffset="209-223" id="s4370.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s4370.e0" e2="s4370.e1" id="s4370.p0" relation="true"/>
  </sentence>
  <sentence id="s4371" text="Appraisal of the present case against previously reported patients indicate that EXPH5 mutations result in a distinctive skin fragility phenotype, with minimal blistering compared with other forms of basal EBS">
    <entity charOffset="81-86" id="s4371.e0" ontology_id="23086" text="EXPH5" type="GENE"/>
    <entity charOffset="121-135" id="s4371.e1" ontology_id="HP_0001030" text="skin fragility" type="HP"/>
    <pair e1="s4371.e0" e2="s4371.e1" id="s4371.p0" relation="true"/>
  </sentence>
  <sentence id="s4372" text="In this study, we investigated the expression of JIP3 in temporal lobe epilepsy (TLE) and in a kainic acid (KA)-induced mouse model of epileptic seizures, and determined whether down-regulation of JIP3 can decrease susceptibility to seizures and neuron damage induced by KA.">
    <entity charOffset="49-53" id="s4372.e0" ontology_id="23162" text="JIP3" type="GENE"/>
    <entity charOffset="71-79" id="s4372.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4372.e0" e2="s4372.e1" id="s4372.p0" relation="true"/>
  </sentence>
  <sentence id="s4373" text="We found that JIP3 was markedly increased in TLE patients and a mouse model of epileptic seizures; mice underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first seizure and decreased seizure duration response to the epileptogenic properties of KA.">
    <entity charOffset="14-18" id="s4373.e0" ontology_id="23162" text="JIP3" type="GENE"/>
    <entity charOffset="213-220" id="s4373.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s4373.e0" e2="s4373.e1" id="s4373.p0" relation="true"/>
  </sentence>
  <sentence id="s4374" text="Subsequently, a decreased activation of JNK following seizure induction was observed in mice underexpressing JIP3, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.">
    <entity charOffset="40-43" id="s4374.e0" ontology_id="5599" text="JNK" type="GENE"/>
    <entity charOffset="54-61" id="s4374.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s4374.e0" e2="s4374.e1" id="s4374.p0" relation="true"/>
  </sentence>
  <sentence id="s4375" text="Subsequently, a decreased activation of JNK following seizure induction was observed in mice underexpressing JIP3, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.">
    <entity charOffset="54-61" id="s4375.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="109-113" id="s4375.e1" ontology_id="23162" text="JIP3" type="GENE"/>
    <pair e1="s4375.e0" e2="s4375.e1" id="s4375.p0" relation="true"/>
  </sentence>
  <sentence id="s4376" text="Subsequently, a decreased activation of JNK following seizure induction was observed in mice underexpressing JIP3, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.">
    <entity charOffset="54-61" id="s4376.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="88-92" id="s4376.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s4376.e0" e2="s4376.e1" id="s4376.p0" relation="true"/>
  </sentence>
  <sentence id="s4377" text="We also found that mice underexpressing JIP3 exhibited a delayed pentylenetetrazole (PTZ)-induced kindling seizure process">
    <entity charOffset="19-23" id="s4377.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="107-114" id="s4377.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s4377.e0" e2="s4377.e1" id="s4377.p0" relation="true"/>
  </sentence>
  <sentence id="s4378" text="We also found that mice underexpressing JIP3 exhibited a delayed pentylenetetrazole (PTZ)-induced kindling seizure process">
    <entity charOffset="40-44" id="s4378.e0" ontology_id="23162" text="JIP3" type="GENE"/>
    <entity charOffset="107-114" id="s4378.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s4378.e0" e2="s4378.e1" id="s4378.p0" relation="true"/>
  </sentence>
  <sentence id="s4379" text="Cerebral, ocular, dental, auricular, skeletal (CODAS) syndrome is a rare autosomal recessive multisystem disorder caused by mutations in LONP1.">
    <entity charOffset="73-92" id="s4379.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="137-142" id="s4379.e1" ontology_id="9361" text="LONP1" type="GENE"/>
    <pair e1="s4379.e0" e2="s4379.e1" id="s4379.p0" relation="true"/>
  </sentence>
  <sentence id="s4380" text="We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital bilateral cataracts, spasticity, hypotonia with motor regression and progressive cerebellar atrophy with hyperintensity of the cerebellar cortex on T2-weighted images.">
    <entity charOffset="196-214" id="s4380.e0" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <entity charOffset="263-265" id="s4380.e1" ontology_id="292" text="T2" type="GENE"/>
    <pair e1="s4380.e0" e2="s4380.e1" id="s4380.p0" relation="true"/>
  </sentence>
  <sentence id="s4381" text="Here, we investigated whether synonymous changes could affect expression of the potassium voltage-gated channel subfamily H member 2 (&lt;i&gt;KCNH2&lt;/i&gt;) gene, encoding the human ether-a-go-go-related gene (hERG) ion channel, which is linked to hereditary cardiac arrhythmia.">
    <entity charOffset="201-205" id="s4381.e0" ontology_id="3757" text="hERG" type="GENE"/>
    <entity charOffset="250-268" id="s4381.e1" ontology_id="HP_0011675" text="cardiac arrhythmia" type="HP"/>
    <pair e1="s4381.e0" e2="s4381.e1" id="s4381.p0" relation="true"/>
  </sentence>
  <sentence id="s4382" text="Urofacial syndrome (UFS) is an autosomal recessive disease with severe dysfunctional urination including urinary incontinence (UI).">
    <entity charOffset="20-23" id="s4382.e0" ontology_id="60495" text="UFS" type="GENE"/>
    <entity charOffset="31-50" id="s4382.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4382.e0" e2="s4382.e1" id="s4382.p0" relation="true"/>
  </sentence>
  <sentence id="s4383" text="Ltd), a vascular endothelial growth factor receptor 2 (VEGFR-2) tyrosine kinase inhibitor, has been proven to be safe and to significantly prolong survival in advanced chemotherapy-refractory gastric cancer.">
    <entity charOffset="17-20" id="s4383.e0" ontology_id="2022" text="end" type="GENE"/>
    <entity charOffset="200-206" id="s4383.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4383.e0" e2="s4383.e1" id="s4383.p0" relation="false"/>
  </sentence>
  <sentence id="s4384" text="Four established melanoma susceptibility genes achieved nominal statistical significance, MC1R (p=.0014), MITF (p=.0165) BRCA2 (p=.0206), and MTAP (p=.0393).">
    <entity charOffset="17-25" id="s4384.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="108-112" id="s4384.e1" ontology_id="4286" text="MITF" type="GENE"/>
    <pair e1="s4384.e0" e2="s4384.e1" id="s4384.p0" relation="true"/>
  </sentence>
  <sentence id="s4385" text="Four established melanoma susceptibility genes achieved nominal statistical significance, MC1R (p=.0014), MITF (p=.0165) BRCA2 (p=.0206), and MTAP (p=.0393).">
    <entity charOffset="17-25" id="s4385.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="125-130" id="s4385.e1" ontology_id="675" text="BRCA2" type="GENE"/>
    <pair e1="s4385.e0" e2="s4385.e1" id="s4385.p0" relation="true"/>
  </sentence>
  <sentence id="s4386" text="We also observed a suggestive association for FANCA (p=.002), a gene previously implicated in melanoma survival.">
    <entity charOffset="46-51" id="s4386.e0" ontology_id="2175" text="FANCA" type="GENE"/>
    <entity charOffset="96-104" id="s4386.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4386.e0" e2="s4386.e1" id="s4386.p0" relation="true"/>
  </sentence>
  <sentence id="s4387" text="We confirmed that this nonsense MYO6 mutation segregated with deafness in this family.">
    <entity charOffset="32-36" id="s4387.e0" ontology_id="4646" text="MYO6" type="GENE"/>
    <entity charOffset="62-70" id="s4387.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s4387.e0" e2="s4387.e1" id="s4387.p0" relation="true"/>
  </sentence>
  <sentence id="s4388" text="In conclusion, we described a novel nonsense MYO6 mutation that was responsible for the hearing loss in a Brazilian family.">
    <entity charOffset="45-49" id="s4388.e0" ontology_id="4646" text="MYO6" type="GENE"/>
    <entity charOffset="88-100" id="s4388.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4388.e0" e2="s4388.e1" id="s4388.p0" relation="true"/>
  </sentence>
  <sentence id="s4389" text="ZC4H2 is a small nuclear protein associated with intellectual disability and neural development in humans.">
    <entity charOffset="0-5" id="s4389.e0" ontology_id="55906" text="ZC4H2" type="GENE"/>
    <entity charOffset="49-72" id="s4389.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4389.e0" e2="s4389.e1" id="s4389.p0" relation="true"/>
  </sentence>
  <sentence id="s4390" text="We show here that HDAC11 depletion in MYCN-driven neuroblastoma cell lines strongly induces cell death, mostly mediated by apoptotic programs.">
    <entity charOffset="18-24" id="s4390.e0" ontology_id="79885" text="HDAC11" type="GENE"/>
    <entity charOffset="50-63" id="s4390.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s4390.e0" e2="s4390.e1" id="s4390.p0" relation="true"/>
  </sentence>
  <sentence id="s4391" text="Our study identified a group of cell cycle-promoting genes regulated by HDAC11, being both predictors of unfavorable patient outcome and essential for tumor cell viability.">
    <entity charOffset="72-78" id="s4391.e0" ontology_id="79885" text="HDAC11" type="GENE"/>
    <entity charOffset="151-156" id="s4391.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4391.e0" e2="s4391.e1" id="s4391.p0" relation="true"/>
  </sentence>
  <sentence id="s4392" text="Mutations in GJB2 or GJB6 and the mitochondrial A7445G mutation, known to be the major causes of diverse Inherited Palmoplantar Keratodermas -hearing loss syndromes were not detected by Sanger sequencing.">
    <entity charOffset="21-25" id="s4392.e0" ontology_id="10804" text="GJB6" type="GENE"/>
    <entity charOffset="142-154" id="s4392.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4392.e0" e2="s4392.e1" id="s4392.p0" relation="true"/>
  </sentence>
  <sentence id="s4393" text="Treatment of tumor cells with the inhibitor GSK2830371 increases phosphorylation of Wip1 substrates and causes growth inhibition in both hematopoietic tumor cell lines and Wip1-amplified breast tumor cells harboring wild-type TP53.">
    <entity charOffset="13-18" id="s4393.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="84-88" id="s4393.e1" ontology_id="8493" text="Wip1" type="GENE"/>
    <pair e1="s4393.e0" e2="s4393.e1" id="s4393.p0" relation="true"/>
  </sentence>
  <sentence id="s4394" text="Although ABCD1 is responsible for X-linked adrenoleukodystrophy (X-ALD), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.">
    <entity charOffset="9-14" id="s4394.e0" ontology_id="215" text="ABCD1" type="GENE"/>
    <entity charOffset="233-250" id="s4394.e1" ontology_id="HP_0001410" text="liver dysfunction" type="HP"/>
    <pair e1="s4394.e0" e2="s4394.e1" id="s4394.p0" relation="true"/>
  </sentence>
  <sentence id="s4395" text="Although ABCD1 is responsible for X-linked adrenoleukodystrophy (X-ALD), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.">
    <entity charOffset="9-14" id="s4395.e0" ontology_id="215" text="ABCD1" type="GENE"/>
    <entity charOffset="252-263" id="s4395.e1" ontology_id="HP_0001396" text="cholestasis" type="HP"/>
    <pair e1="s4395.e0" e2="s4395.e1" id="s4395.p0" relation="false"/>
  </sentence>
  <sentence id="s4396" text="Although ABCD1 is responsible for X-linked adrenoleukodystrophy (X-ALD), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.">
    <entity charOffset="43-63" id="s4396.e0" ontology_id="215" text="adrenoleukodystrophy" type="GENE"/>
    <entity charOffset="252-263" id="s4396.e1" ontology_id="HP_0001396" text="cholestasis" type="HP"/>
    <pair e1="s4396.e0" e2="s4396.e1" id="s4396.p0" relation="false"/>
  </sentence>
  <sentence id="s4397" text="Lastly, a syndromic form of PCD with retinal degeneration results in normal ciliary ultrastructure through mutations in the RPGR gene.">
    <entity charOffset="37-57" id="s4397.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="124-128" id="s4397.e1" ontology_id="6103" text="RPGR" type="GENE"/>
    <pair e1="s4397.e0" e2="s4397.e1" id="s4397.p0" relation="true"/>
  </sentence>
  <sentence id="s4398" text="Mutations and post-translational modifications of PLN may lead to dilated cardiomyopathy (DCM) and heart failure.">
    <entity charOffset="50-53" id="s4398.e0" ontology_id="5350" text="PLN" type="GENE"/>
    <entity charOffset="99-112" id="s4398.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s4398.e0" e2="s4398.e1" id="s4398.p0" relation="true"/>
  </sentence>
  <sentence id="s4399" text="Here we find that a lymphocyte lineage-restricted transcription factor, Spi-B, is frequently expressed in human lung cancer tissues.">
    <entity charOffset="72-77" id="s4399.e0" ontology_id="6689" text="Spi-B" type="GENE"/>
    <entity charOffset="117-123" id="s4399.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4399.e0" e2="s4399.e1" id="s4399.p0" relation="true"/>
  </sentence>
  <sentence id="s4400" text="The Spi-B-expressing cancer cells coexpressed vimentin but repressed E-cadherin and exhibited invasive behavior.">
    <entity charOffset="21-27" id="s4400.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="71-79" id="s4400.e1" ontology_id="1015" text="cadherin" type="GENE"/>
    <pair e1="s4400.e0" e2="s4400.e1" id="s4400.p0" relation="true"/>
  </sentence>
  <sentence id="s4401" text="Increased Spi-B expression was associated with tumor grade, lymphatic metastasis, and short overall survival.">
    <entity charOffset="10-15" id="s4401.e0" ontology_id="6689" text="Spi-B" type="GENE"/>
    <entity charOffset="47-52" id="s4401.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4401.e0" e2="s4401.e1" id="s4401.p0" relation="true"/>
  </sentence>
  <sentence id="s4402" text="These data suggest that Spi-B participates in mesenchymal invasion, linking epithelial cancer metastasis with a lymphatic transcriptional program.">
    <entity charOffset="24-29" id="s4402.e0" ontology_id="6689" text="Spi-B" type="GENE"/>
    <entity charOffset="87-93" id="s4402.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4402.e0" e2="s4402.e1" id="s4402.p0" relation="true"/>
  </sentence>
  <sentence id="s4403" text="Candidate markers were further characterized for concentration- and time-dependent responses to the BET inhibitor ABBV-075 in vitro and in vivo HEXIM1 was found to be the only gene that exhibited robust and consistent modulation by BET inhibitors across multiple cancer indications and surrogate tissues.">
    <entity charOffset="100-103" id="s4403.e0" ontology_id="92737" text="BET" type="GENE"/>
    <entity charOffset="263-269" id="s4403.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4403.e0" e2="s4403.e1" id="s4403.p0" relation="true"/>
  </sentence>
  <sentence id="s4404" text="Candidate markers were further characterized for concentration- and time-dependent responses to the BET inhibitor ABBV-075 in vitro and in vivo HEXIM1 was found to be the only gene that exhibited robust and consistent modulation by BET inhibitors across multiple cancer indications and surrogate tissues.">
    <entity charOffset="144-150" id="s4404.e0" ontology_id="10614" text="HEXIM1" type="GENE"/>
    <entity charOffset="263-269" id="s4404.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4404.e0" e2="s4404.e1" id="s4404.p0" relation="true"/>
  </sentence>
  <sentence id="s4405" text="Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="16-24" id="s4405.e0" ontology_id="5274" text="SERPINI1" type="GENE"/>
    <entity charOffset="105-111" id="s4405.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4405.e0" e2="s4405.e1" id="s4405.p0" relation="true"/>
  </sentence>
  <sentence id="s4406" text="Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="16-24" id="s4406.e0" ontology_id="5274" text="SERPINI1" type="GENE"/>
    <entity charOffset="137-143" id="s4406.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4406.e0" e2="s4406.e1" id="s4406.p0" relation="true"/>
  </sentence>
  <sentence id="s4407" text="Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="26-33" id="s4407.e0" ontology_id="219654" text="ZCCHC24" type="GENE"/>
    <entity charOffset="105-111" id="s4407.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4407.e0" e2="s4407.e1" id="s4407.p0" relation="true"/>
  </sentence>
  <sentence id="s4408" text="Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="39-45" id="s4408.e0" ontology_id="23613" text="ZMYND8" type="GENE"/>
    <entity charOffset="105-111" id="s4408.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4408.e0" e2="s4408.e1" id="s4408.p0" relation="true"/>
  </sentence>
  <sentence id="s4409" text="Significant downregulation of c-Myc, a well-publicized target of BET inhibitors, was largely restricted to hematologic cancer cell lines.">
    <entity charOffset="30-35" id="s4409.e0" ontology_id="4609" text="c-Myc" type="GENE"/>
    <entity charOffset="119-125" id="s4409.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4409.e0" e2="s4409.e1" id="s4409.p0" relation="true"/>
  </sentence>
  <sentence id="s4410" text="Significant downregulation of c-Myc, a well-publicized target of BET inhibitors, was largely restricted to hematologic cancer cell lines.">
    <entity charOffset="65-68" id="s4410.e0" ontology_id="92737" text="BET" type="GENE"/>
    <entity charOffset="119-125" id="s4410.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4410.e0" e2="s4410.e1" id="s4410.p0" relation="true"/>
  </sentence>
  <sentence id="s4411" text="Until recently, four loci (DFN2, DFN3, DFN4, and DFN6) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.">
    <entity charOffset="27-31" id="s4411.e0" ontology_id="5631" text="DFN2" type="GENE"/>
    <entity charOffset="100-112" id="s4411.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4411.e0" e2="s4411.e1" id="s4411.p0" relation="true"/>
  </sentence>
  <sentence id="s4412" text="Until recently, four loci (DFN2, DFN3, DFN4, and DFN6) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.">
    <entity charOffset="49-53" id="s4412.e0" ontology_id="23676" text="DFN6" type="GENE"/>
    <entity charOffset="100-112" id="s4412.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4412.e0" e2="s4412.e1" id="s4412.p0" relation="true"/>
  </sentence>
  <sentence id="s4413" text="In addition to the POU3F4 gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, PRPS1, has recently been identified to be the causative gene of DFNX1 (DFN2).">
    <entity charOffset="19-25" id="s4413.e0" ontology_id="5456" text="POU3F4" type="GENE"/>
    <entity charOffset="101-113" id="s4413.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4413.e0" e2="s4413.e1" id="s4413.p0" relation="true"/>
  </sentence>
  <sentence id="s4414" text="In addition to the POU3F4 gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, PRPS1, has recently been identified to be the causative gene of DFNX1 (DFN2).">
    <entity charOffset="101-113" id="s4414.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="201-205" id="s4414.e1" ontology_id="5631" text="DFN2" type="GENE"/>
    <pair e1="s4414.e0" e2="s4414.e1" id="s4414.p0" relation="true"/>
  </sentence>
  <sentence id="s4415" text="In addition to the POU3F4 gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, PRPS1, has recently been identified to be the causative gene of DFNX1 (DFN2).">
    <entity charOffset="101-113" id="s4415.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="130-135" id="s4415.e1" ontology_id="5631" text="PRPS1" type="GENE"/>
    <pair e1="s4415.e0" e2="s4415.e1" id="s4415.p0" relation="true"/>
  </sentence>
  <sentence id="s4416" text="In addition to the POU3F4 gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, PRPS1, has recently been identified to be the causative gene of DFNX1 (DFN2).">
    <entity charOffset="101-113" id="s4416.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="194-199" id="s4416.e1" ontology_id="5631" text="DFNX1" type="GENE"/>
    <pair e1="s4416.e0" e2="s4416.e1" id="s4416.p0" relation="true"/>
  </sentence>
  <sentence id="s4417" text="Bone morphogenetic protein7(BMP7), a member of the BMP family of signaling molecules, has been implicated in various types of cancer, particularly prostate cancer and breast cancer.">
    <entity charOffset="30-34" id="s4417.e0" ontology_id="655" text="BMP7" type="GENE"/>
    <entity charOffset="128-134" id="s4417.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4417.e0" e2="s4417.e1" id="s4417.p0" relation="true"/>
  </sentence>
  <sentence id="s4418" text="80.5% of luminal-type tumours developed bone metastasis as opposed to 41.7% of basal and 55.6% of HER2-like tumours.">
    <entity charOffset="23-30" id="s4418.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="101-105" id="s4418.e1" ontology_id="2064" text="HER2" type="GENE"/>
    <pair e1="s4418.e0" e2="s4418.e1" id="s4418.p0" relation="false"/>
  </sentence>
  <sentence id="s4419" text="The expression levels of the up-regulated genes (NAT1, BBS1 and PH-4) were also found to be correlated to epithelial to mesenchymal transition status of the tumour.">
    <entity charOffset="49-53" id="s4419.e0" ontology_id="1982" text="NAT1" type="GENE"/>
    <entity charOffset="157-163" id="s4419.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4419.e0" e2="s4419.e1" id="s4419.p0" relation="true"/>
  </sentence>
  <sentence id="s4420" text="The expression levels of the up-regulated genes (NAT1, BBS1 and PH-4) were also found to be correlated to epithelial to mesenchymal transition status of the tumour.">
    <entity charOffset="55-59" id="s4420.e0" ontology_id="582" text="BBS1" type="GENE"/>
    <entity charOffset="157-163" id="s4420.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4420.e0" e2="s4420.e1" id="s4420.p0" relation="true"/>
  </sentence>
  <sentence id="s4421" text="LTBP4 was identified as a genetic modifier of muscular dystrophy in mice and humans.">
    <entity charOffset="0-5" id="s4421.e0" ontology_id="8425" text="LTBP4" type="GENE"/>
    <entity charOffset="46-64" id="s4421.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s4421.e0" e2="s4421.e1" id="s4421.p0" relation="true"/>
  </sentence>
  <sentence id="s4422" text="An in-frame insertion polymorphism in the murine Ltbp4 gene associates with partial protection against muscular dystrophy.">
    <entity charOffset="49-54" id="s4422.e0" ontology_id="8425" text="Ltbp4" type="GENE"/>
    <entity charOffset="103-121" id="s4422.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s4422.e0" e2="s4422.e1" id="s4422.p0" relation="true"/>
  </sentence>
  <sentence id="s4423" text="In humans, nonsynonymous single nucleotide polymorphisms in LTBP4 associate with prolonged ambulation in Duchenne muscular dystrophy.">
    <entity charOffset="60-65" id="s4423.e0" ontology_id="8425" text="LTBP4" type="GENE"/>
    <entity charOffset="114-132" id="s4423.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s4423.e0" e2="s4423.e1" id="s4423.p0" relation="true"/>
  </sentence>
  <sentence id="s4424" text="In order to assess the effects of LTBP4 in muscular dystrophy, LTBP4 overexpressing mice were bred to mdx mice, a model of Duchenne muscular dystrophy.">
    <entity charOffset="34-39" id="s4424.e0" ontology_id="8425" text="LTBP4" type="GENE"/>
    <entity charOffset="43-61" id="s4424.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s4424.e0" e2="s4424.e1" id="s4424.p0" relation="true"/>
  </sentence>
  <sentence id="s4425" text="In order to assess the effects of LTBP4 in muscular dystrophy, LTBP4 overexpressing mice were bred to mdx mice, a model of Duchenne muscular dystrophy.">
    <entity charOffset="43-61" id="s4425.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="84-88" id="s4425.e1" ontology_id="23581" text="mice" type="GENE"/>
    <pair e1="s4425.e0" e2="s4425.e1" id="s4425.p0" relation="false"/>
  </sentence>
  <sentence id="s4426" text="Several myotubularins have been genetically linked to human diseases: MTM1 is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth (CMT) neuropathies.">
    <entity charOffset="104-112" id="s4426.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="171-177" id="s4426.e1" ontology_id="64419" text="MTMR14" type="GENE"/>
    <pair e1="s4426.e0" e2="s4426.e1" id="s4426.p0" relation="true"/>
  </sentence>
  <sentence id="s4427" text="a small fraction of the breast cancer burden, mutations in the BRCA1 and BRCA2 genes are known to confer a high">
    <entity charOffset="31-37" id="s4427.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="63-68" id="s4427.e1" ontology_id="672" text="BRCA1" type="GENE"/>
    <pair e1="s4427.e0" e2="s4427.e1" id="s4427.p0" relation="true"/>
  </sentence>
  <sentence id="s4428" text="a small fraction of the breast cancer burden, mutations in the BRCA1 and BRCA2 genes are known to confer a high">
    <entity charOffset="31-37" id="s4428.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="73-78" id="s4428.e1" ontology_id="675" text="BRCA2" type="GENE"/>
    <pair e1="s4428.e0" e2="s4428.e1" id="s4428.p0" relation="true"/>
  </sentence>
  <sentence id="s4429" text="studies have shown that mutations in the CHEK2 gene are involved in breast cancer susceptibility due to its impact">
    <entity charOffset="41-46" id="s4429.e0" ontology_id="11200" text="CHEK2" type="GENE"/>
    <entity charOffset="75-81" id="s4429.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4429.e0" e2="s4429.e1" id="s4429.p0" relation="true"/>
  </sentence>
  <sentence id="s4430" text="germline mutations in CHEK2 gene (c.1100delC, R145W and I157T) in breast cancers in Rwanda.">
    <entity charOffset="22-27" id="s4430.e0" ontology_id="11200" text="CHEK2" type="GENE"/>
    <entity charOffset="73-79" id="s4430.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4430.e0" e2="s4430.e1" id="s4430.p0" relation="true"/>
  </sentence>
  <sentence id="s4431" text="Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.">
    <entity charOffset="49-55" id="s4431.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="132-137" id="s4431.e1" ontology_id="64979" text="BRIP1" type="GENE"/>
    <pair e1="s4431.e0" e2="s4431.e1" id="s4431.p0" relation="true"/>
  </sentence>
  <sentence id="s4432" text="Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.">
    <entity charOffset="49-55" id="s4432.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="273-278" id="s4432.e1" ontology_id="2068" text="ERCC2" type="GENE"/>
    <pair e1="s4432.e0" e2="s4432.e1" id="s4432.p0" relation="true"/>
  </sentence>
  <sentence id="s4433" text="Cystinuria is a heterogeneous, rare but important cause of inherited kidney stone disease due to mutations in 2 genes: SLC3A1 and SLC7A9.">
    <entity charOffset="16-29" id="s4433.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="130-136" id="s4433.e1" ontology_id="11136" text="SLC7A9" type="GENE"/>
    <pair e1="s4433.e0" e2="s4433.e1" id="s4433.p0" relation="true"/>
  </sentence>
  <sentence id="s4434" text="We report 83 patients affected by cystinuria: 44 presented prenatally with a HEC (HEC group) and 39 with a classical postnatal form (CC group).">
    <entity charOffset="34-44" id="s4434.e0" ontology_id="HP_0003131" text="cystinuria" type="HP"/>
    <entity charOffset="77-80" id="s4434.e1" ontology_id="10403" text="HEC" type="GENE"/>
    <pair e1="s4434.e0" e2="s4434.e1" id="s4434.p0" relation="true"/>
  </sentence>
  <sentence id="s4435" text="This study shows a relationship between genotype and the clinical form of cystinuria, suggesting that only the patients with the most severe mutations presented with an HEC.">
    <entity charOffset="74-84" id="s4435.e0" ontology_id="HP_0003131" text="cystinuria" type="HP"/>
    <entity charOffset="169-172" id="s4435.e1" ontology_id="10403" text="HEC" type="GENE"/>
    <pair e1="s4435.e0" e2="s4435.e1" id="s4435.p0" relation="true"/>
  </sentence>
  <sentence id="s4436" text="PM were loaded with a siRNA against AKT2, an important oncogene involved in breast cancer tumorigenesis, with a special role in CSC malignancy.">
    <entity charOffset="36-40" id="s4436.e0" ontology_id="208" text="AKT2" type="GENE"/>
    <entity charOffset="83-89" id="s4436.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4436.e0" e2="s4436.e1" id="s4436.p0" relation="true"/>
  </sentence>
  <sentence id="s4437" text="PM were loaded with a siRNA against AKT2, an important oncogene involved in breast cancer tumorigenesis, with a special role in CSC malignancy.">
    <entity charOffset="36-40" id="s4437.e0" ontology_id="208" text="AKT2" type="GENE"/>
    <entity charOffset="90-95" id="s4437.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4437.e0" e2="s4437.e1" id="s4437.p0" relation="true"/>
  </sentence>
  <sentence id="s4438" text="Efficacy of siAKT2-PM was validated in CSC isolated from two breast cancer cell lines: MCF-7 and Triple Negative MDA-MB-231 corresponding to an aggressive subtype of breast cancer.">
    <entity charOffset="14-18" id="s4438.e0" ontology_id="208" text="AKT2" type="GENE"/>
    <entity charOffset="68-74" id="s4438.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4438.e0" e2="s4438.e1" id="s4438.p0" relation="true"/>
  </sentence>
  <sentence id="s4439" text="These results prompt AKT2 inhibition as a powerful therapeutic target against CSC and pave the way to the appearance of more effective nanomedicine-based gene therapies aimed to prevent CSC-related tumor recurrence">
    <entity charOffset="21-25" id="s4439.e0" ontology_id="208" text="AKT2" type="GENE"/>
    <entity charOffset="198-203" id="s4439.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4439.e0" e2="s4439.e1" id="s4439.p0" relation="true"/>
  </sentence>
  <sentence id="s4440" text="These studies suggest that compound 4d behaves well in lowering body weight and maintaining energy expenditure without a chance of hyperglycaemia, 4d has strong clinical potential as an efficient GLP-1/GCGR agonist in the prevention and treatment of obesity and dyslipidemia">
    <entity charOffset="196-199" id="s4440.e0" ontology_id="342096" text="GLP" type="GENE"/>
    <entity charOffset="250-257" id="s4440.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4440.e0" e2="s4440.e1" id="s4440.p0" relation="true"/>
  </sentence>
  <sentence id="s4441" text="Finally, we reveal that papillary craniopharyngioma (PCP), a benign human pituitary tumour harbouring &lt;i&gt;BRAF p.V600E&lt;/i&gt; also contains Sox2&lt;sup&gt;+&lt;/sup&gt; cells with sustained proliferative capacity and disrupted pituitary differentiation.">
    <entity charOffset="53-56" id="s4441.e0" ontology_id="54858" text="PCP" type="GENE"/>
    <entity charOffset="84-90" id="s4441.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4441.e0" e2="s4441.e1" id="s4441.p0" relation="true"/>
  </sentence>
  <sentence id="s4442" text="ALG2 mutation results in a heterogeneous phenotype and care should be taken in categorization and treatment of these patients.">
    <entity charOffset="0-4" id="s4442.e0" ontology_id="85365" text="ALG2" type="GENE"/>
    <entity charOffset="27-40" id="s4442.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4442.e0" e2="s4442.e1" id="s4442.p0" relation="true"/>
  </sentence>
  <sentence id="s4443" text="We conducted further optimization of dual enzymatic inhibitions towards FGFR1 and DDR2, two important kinases in lung squamous cell carcinoma.">
    <entity charOffset="82-86" id="s4443.e0" ontology_id="4921" text="DDR2" type="GENE"/>
    <entity charOffset="118-141" id="s4443.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s4443.e0" e2="s4443.e1" id="s4443.p0" relation="true"/>
  </sentence>
  <sentence id="s4444" text="Familial hypercholesterolemia (FH) is mostly caused by low-density lipoprotein receptor (LDLR) mutations and results in an increased risk of early-onset cardiovascular disease due to marked elevation of LDL cholesterol (LDL-C) in blood.">
    <entity charOffset="9-29" id="s4444.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="89-93" id="s4444.e1" ontology_id="3949" text="LDLR" type="GENE"/>
    <pair e1="s4444.e0" e2="s4444.e1" id="s4444.p0" relation="true"/>
  </sentence>
  <sentence id="s4445" text="Statins are the first line of lipid-lowering drugs for treating FH and other types of hypercholesterolemia, but new approaches are emerging, in particular PCSK9 antibodies, which are now being tested in clinical trials.">
    <entity charOffset="86-106" id="s4445.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="155-160" id="s4445.e1" ontology_id="255738" text="PCSK9" type="GENE"/>
    <pair e1="s4445.e0" e2="s4445.e1" id="s4445.p0" relation="true"/>
  </sentence>
  <sentence id="s4446" text="Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without MYCN amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.">
    <entity charOffset="57-71" id="s4446.e0" ontology_id="HP_0000243" text="trigonocephaly" type="HP"/>
    <entity charOffset="242-246" id="s4446.e1" ontology_id="4613" text="MYCN" type="GENE"/>
    <pair e1="s4446.e0" e2="s4446.e1" id="s4446.p0" relation="true"/>
  </sentence>
  <sentence id="s4447" text="Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without MYCN amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.">
    <entity charOffset="114-126" id="s4447.e0" ontology_id="HP_0000601" text="hypotelorism" type="HP"/>
    <entity charOffset="242-246" id="s4447.e1" ontology_id="4613" text="MYCN" type="GENE"/>
    <pair e1="s4447.e0" e2="s4447.e1" id="s4447.p0" relation="true"/>
  </sentence>
  <sentence id="s4448" text="Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without MYCN amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.">
    <entity charOffset="158-170" id="s4448.e0" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <entity charOffset="242-246" id="s4448.e1" ontology_id="4613" text="MYCN" type="GENE"/>
    <pair e1="s4448.e0" e2="s4448.e1" id="s4448.p0" relation="false"/>
  </sentence>
  <sentence id="s4449" text="Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without MYCN amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.">
    <entity charOffset="183-199" id="s4449.e0" ontology_id="HP_0000286" text="epicanthal folds" type="HP"/>
    <entity charOffset="242-246" id="s4449.e1" ontology_id="4613" text="MYCN" type="GENE"/>
    <pair e1="s4449.e0" e2="s4449.e1" id="s4449.p0" relation="false"/>
  </sentence>
  <sentence id="s4450" text="Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without MYCN amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.">
    <entity charOffset="220-233" id="s4450.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="242-246" id="s4450.e1" ontology_id="4613" text="MYCN" type="GENE"/>
    <pair e1="s4450.e0" e2="s4450.e1" id="s4450.p0" relation="true"/>
  </sentence>
  <sentence id="s4451" text="Human-induced neuronal progenitor cells (iNPCs) carrying dominant and recessive GARS mutations showed alterations of mitochondrial proteins, which were more prominent in iNPCs with dominant, neuropathy-causing mutations.">
    <entity charOffset="80-84" id="s4451.e0" ontology_id="2617" text="GARS" type="GENE"/>
    <entity charOffset="191-201" id="s4451.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s4451.e0" e2="s4451.e1" id="s4451.p0" relation="true"/>
  </sentence>
  <sentence id="s4452" text="Our data suggest that altered mitochondria-associated endoplasmic reticulum (ER) membranes (MAM) may be important disease mechanisms leading to neuropathy in this condition">
    <entity charOffset="92-95" id="s4452.e0" ontology_id="6445" text="MAM" type="GENE"/>
    <entity charOffset="144-154" id="s4452.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s4452.e0" e2="s4452.e1" id="s4452.p0" relation="true"/>
  </sentence>
  <sentence id="s4453" text="Basic immunological assessments have confirmed that this strain of human CD3 EDG-replaced mice are entirely immune competent, and we have also demonstrated that a bispecific antibody that simultaneously binds to human CD3 and a tumor-associated antigen (e.g. ERBB2 or GPC3) can be evaluated in human CD3 EDG-replaced mice engrafted with tumors.">
    <entity charOffset="228-233" id="s4453.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="268-272" id="s4453.e1" ontology_id="2719" text="GPC3" type="GENE"/>
    <pair e1="s4453.e0" e2="s4453.e1" id="s4453.p0" relation="true"/>
  </sentence>
  <sentence id="s4454" text="Mutations in human ADAMTSL4, encoding an ADAMTS-like protein which has been implicated in fibrillin microfibril biogenesis, cause ectopia lentis (EL) and EL et pupillae.">
    <entity charOffset="19-27" id="s4454.e0" ontology_id="54507" text="ADAMTSL4" type="GENE"/>
    <entity charOffset="130-144" id="s4454.e1" ontology_id="HP_0001083" text="ectopia lentis" type="HP"/>
    <pair e1="s4454.e0" e2="s4454.e1" id="s4454.p0" relation="true"/>
  </sentence>
  <sentence id="s4455" text="PhIP-induced skin tumors were subjected to mutation screening, which identified genetic changes in Hras (7/40, 17.5%) and Tp53 (2/40, 5%), but not in Ctnnb1, a commonly mutated gene in PhIP-induced colon tumors.">
    <entity charOffset="0-4" id="s4455.e0" ontology_id="55023" text="PhIP" type="GENE"/>
    <entity charOffset="18-24" id="s4455.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4455.e0" e2="s4455.e1" id="s4455.p0" relation="true"/>
  </sentence>
  <sentence id="s4456" text="PhIP-induced skin tumors were subjected to mutation screening, which identified genetic changes in Hras (7/40, 17.5%) and Tp53 (2/40, 5%), but not in Ctnnb1, a commonly mutated gene in PhIP-induced colon tumors.">
    <entity charOffset="18-24" id="s4456.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="99-103" id="s4456.e1" ontology_id="3265" text="Hras" type="GENE"/>
    <pair e1="s4456.e0" e2="s4456.e1" id="s4456.p0" relation="true"/>
  </sentence>
  <sentence id="s4457" text="PhIP-induced skin tumors were subjected to mutation screening, which identified genetic changes in Hras (7/40, 17.5%) and Tp53 (2/40, 5%), but not in Ctnnb1, a commonly mutated gene in PhIP-induced colon tumors.">
    <entity charOffset="18-24" id="s4457.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="150-156" id="s4457.e1" ontology_id="1499" text="Ctnnb1" type="GENE"/>
    <pair e1="s4457.e0" e2="s4457.e1" id="s4457.p0" relation="true"/>
  </sentence>
  <sentence id="s4458" text="Despite the absence of Ctnnb1 mutations, -catenin was overexpressed in nuclear and plasma membrane fractions from PhIP-induced skin tumors, coinciding with loss of p120-catenin from the plasma membrane, and the appearance of multiple p120-catenin-associated bands in the nuclear extracts.">
    <entity charOffset="23-29" id="s4458.e0" ontology_id="1499" text="Ctnnb1" type="GENE"/>
    <entity charOffset="133-139" id="s4458.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4458.e0" e2="s4458.e1" id="s4458.p0" relation="true"/>
  </sentence>
  <sentence id="s4459" text="Despite the absence of Ctnnb1 mutations, -catenin was overexpressed in nuclear and plasma membrane fractions from PhIP-induced skin tumors, coinciding with loss of p120-catenin from the plasma membrane, and the appearance of multiple p120-catenin-associated bands in the nuclear extracts.">
    <entity charOffset="115-119" id="s4459.e0" ontology_id="55023" text="PhIP" type="GENE"/>
    <entity charOffset="133-139" id="s4459.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4459.e0" e2="s4459.e1" id="s4459.p0" relation="true"/>
  </sentence>
  <sentence id="s4460" text="Real-time RT-PCR revealed that p120-catenin isoforms 1 and 4 were upregulated in PhIP-induced skin tumors, whereas p120-catenin isoform 3 was expressed uniformly, compared with adjacent normal-looking tissue.">
    <entity charOffset="81-85" id="s4460.e0" ontology_id="55023" text="PhIP" type="GENE"/>
    <entity charOffset="99-105" id="s4460.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4460.e0" e2="s4460.e1" id="s4460.p0" relation="true"/>
  </sentence>
  <sentence id="s4461" text="Co-immunoprecipitation experiments identified associations of -catenin with p120-catenin isoforms in PhIP-induced skin tumors and human cancer cell lines.">
    <entity charOffset="102-106" id="s4461.e0" ontology_id="55023" text="PhIP" type="GENE"/>
    <entity charOffset="120-126" id="s4461.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4461.e0" e2="s4461.e1" id="s4461.p0" relation="true"/>
  </sentence>
  <sentence id="s4462" text="Co-immunoprecipitation experiments identified associations of -catenin with p120-catenin isoforms in PhIP-induced skin tumors and human cancer cell lines.">
    <entity charOffset="102-106" id="s4462.e0" ontology_id="55023" text="PhIP" type="GENE"/>
    <entity charOffset="137-143" id="s4462.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4462.e0" e2="s4462.e1" id="s4462.p0" relation="true"/>
  </sentence>
  <sentence id="s4463" text="In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or OTX2 being the most common.">
    <entity charOffset="27-39" id="s4463.e0" ontology_id="HP_0000528" text="anophthalmia" type="HP"/>
    <entity charOffset="206-210" id="s4463.e1" ontology_id="5015" text="OTX2" type="GENE"/>
    <pair e1="s4463.e0" e2="s4463.e1" id="s4463.p0" relation="true"/>
  </sentence>
  <sentence id="s4464" text="In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or OTX2 being the most common.">
    <entity charOffset="50-64" id="s4464.e0" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <entity charOffset="206-210" id="s4464.e1" ontology_id="5015" text="OTX2" type="GENE"/>
    <pair e1="s4464.e0" e2="s4464.e1" id="s4464.p0" relation="true"/>
  </sentence>
  <sentence id="s4465" text="After its downregulation in neuroblastoma cells and in brains of Tspan3-deficient mice, ADAM10 and APP levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.">
    <entity charOffset="28-41" id="s4465.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="88-94" id="s4465.e1" ontology_id="102" text="ADAM10" type="GENE"/>
    <pair e1="s4465.e0" e2="s4465.e1" id="s4465.p0" relation="true"/>
  </sentence>
  <sentence id="s4466" text="After its downregulation in neuroblastoma cells and in brains of Tspan3-deficient mice, ADAM10 and APP levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.">
    <entity charOffset="28-41" id="s4466.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="99-102" id="s4466.e1" ontology_id="351" text="APP" type="GENE"/>
    <pair e1="s4466.e0" e2="s4466.e1" id="s4466.p0" relation="true"/>
  </sentence>
  <sentence id="s4467" text="After its downregulation in neuroblastoma cells and in brains of Tspan3-deficient mice, ADAM10 and APP levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.">
    <entity charOffset="28-41" id="s4467.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="65-71" id="s4467.e1" ontology_id="10099" text="Tspan3" type="GENE"/>
    <pair e1="s4467.e0" e2="s4467.e1" id="s4467.p0" relation="true"/>
  </sentence>
  <sentence id="s4468" text="Deregulated monoubiquitination of histone H2B (H2Bub1), mainly catalyzed by E3 ubiquitin-protein ligase RNF20/RNF40 complex, may play an important role in cancer.">
    <entity charOffset="104-109" id="s4468.e0" ontology_id="56254" text="RNF20" type="GENE"/>
    <entity charOffset="155-161" id="s4468.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4468.e0" e2="s4468.e1" id="s4468.p0" relation="true"/>
  </sentence>
  <sentence id="s4469" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s4469.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="109-114" id="s4469.e1" ontology_id="896" text="CCND3" type="GENE"/>
    <pair e1="s4469.e0" e2="s4469.e1" id="s4469.p0" relation="true"/>
  </sentence>
  <sentence id="s4470" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s4470.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="131-135" id="s4470.e1" ontology_id="596" text="Bcl2" type="GENE"/>
    <pair e1="s4470.e0" e2="s4470.e1" id="s4470.p0" relation="true"/>
  </sentence>
  <sentence id="s4471" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s4471.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="154-157" id="s4471.e1" ontology_id="90427" text="BMF" type="GENE"/>
    <pair e1="s4471.e0" e2="s4471.e1" id="s4471.p0" relation="true"/>
  </sentence>
  <sentence id="s4472" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s4472.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="169-172" id="s4472.e1" ontology_id="4609" text="Myc" type="GENE"/>
    <pair e1="s4472.e0" e2="s4472.e1" id="s4472.p0" relation="true"/>
  </sentence>
  <sentence id="s4473" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s4473.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="277-285" id="s4473.e1" ontology_id="1015" text="cadherin" type="GENE"/>
    <pair e1="s4473.e0" e2="s4473.e1" id="s4473.p0" relation="false"/>
  </sentence>
  <sentence id="s4474" text="Moreover, RNF20 knockdown dramatically suppresses terminal squamous differentiation of cultured bronchial epithelial cells, and significantly enhances proliferation, migration, invasion, and cisplatin resistance of lung cancer cells.">
    <entity charOffset="10-15" id="s4474.e0" ontology_id="56254" text="RNF20" type="GENE"/>
    <entity charOffset="220-226" id="s4474.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4474.e0" e2="s4474.e1" id="s4474.p0" relation="true"/>
  </sentence>
  <sentence id="s4475" text="Consistent with our description of this pathway and the phenotype of patients with FGD1 mutations, mice with a targeted deletion of Mlk3 displayed multiple skeletal defects, including dental abnormalities, deficient calvarial mineralization, and reduced bone mass.">
    <entity charOffset="99-103" id="s4475.e0" ontology_id="23581" text="mice" type="GENE"/>
    <entity charOffset="184-204" id="s4475.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s4475.e0" e2="s4475.e1" id="s4475.p0" relation="true"/>
  </sentence>
  <sentence id="s4476" text="Very recently, PUS7 mutations were reported to cause intellectual disability with growth retardation.">
    <entity charOffset="15-19" id="s4476.e0" ontology_id="54517" text="PUS7" type="GENE"/>
    <entity charOffset="53-76" id="s4476.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4476.e0" e2="s4476.e1" id="s4476.p0" relation="true"/>
  </sentence>
  <sentence id="s4477" text="We describe two families in which two different homozygous PUS7 mutations (missense and frameshift deletion) segregate with a phenotype comprising intellectual disability and progressive microcephaly.">
    <entity charOffset="59-63" id="s4477.e0" ontology_id="54517" text="PUS7" type="GENE"/>
    <entity charOffset="147-170" id="s4477.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4477.e0" e2="s4477.e1" id="s4477.p0" relation="true"/>
  </sentence>
  <sentence id="s4478" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="12-17" id="s4478.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="147-151" id="s4478.e1" ontology_id="6389" text="SDHA" type="GENE"/>
    <pair e1="s4478.e0" e2="s4478.e1" id="s4478.p0" relation="true"/>
  </sentence>
  <sentence id="s4479" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="12-17" id="s4479.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="153-157" id="s4479.e1" ontology_id="6390" text="SDHB" type="GENE"/>
    <pair e1="s4479.e0" e2="s4479.e1" id="s4479.p0" relation="true"/>
  </sentence>
  <sentence id="s4480" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="12-17" id="s4480.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="165-169" id="s4480.e1" ontology_id="6392" text="SDHD" type="GENE"/>
    <pair e1="s4480.e0" e2="s4480.e1" id="s4480.p0" relation="true"/>
  </sentence>
  <sentence id="s4481" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="147-151" id="s4481.e0" ontology_id="6389" text="SDHA" type="GENE"/>
    <entity charOffset="255-268" id="s4481.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s4481.e0" e2="s4481.e1" id="s4481.p0" relation="true"/>
  </sentence>
  <sentence id="s4482" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="147-151" id="s4482.e0" ontology_id="6389" text="SDHA" type="GENE"/>
    <entity charOffset="269-286" id="s4482.e1" ontology_id="HP_0002666" text="pheochromocytomas" type="HP"/>
    <pair e1="s4482.e0" e2="s4482.e1" id="s4482.p0" relation="true"/>
  </sentence>
  <sentence id="s4483" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="159-163" id="s4483.e0" ontology_id="6391" text="SDHC" type="GENE"/>
    <entity charOffset="269-286" id="s4483.e1" ontology_id="HP_0002666" text="pheochromocytomas" type="HP"/>
    <pair e1="s4483.e0" e2="s4483.e1" id="s4483.p0" relation="true"/>
  </sentence>
  <sentence id="s4484" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="159-163" id="s4484.e0" ontology_id="6391" text="SDHC" type="GENE"/>
    <entity charOffset="307-328" id="s4484.e1" ontology_id="HP_0005584" text="renal cell carcinomas" type="HP"/>
    <pair e1="s4484.e0" e2="s4484.e1" id="s4484.p0" relation="true"/>
  </sentence>
  <sentence id="s4485" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="165-169" id="s4485.e0" ontology_id="6392" text="SDHD" type="GENE"/>
    <entity charOffset="255-268" id="s4485.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s4485.e0" e2="s4485.e1" id="s4485.p0" relation="true"/>
  </sentence>
  <sentence id="s4486" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="165-169" id="s4486.e0" ontology_id="6392" text="SDHD" type="GENE"/>
    <entity charOffset="269-286" id="s4486.e1" ontology_id="HP_0002666" text="pheochromocytomas" type="HP"/>
    <pair e1="s4486.e0" e2="s4486.e1" id="s4486.p0" relation="true"/>
  </sentence>
  <sentence id="s4487" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="165-169" id="s4487.e0" ontology_id="6392" text="SDHD" type="GENE"/>
    <entity charOffset="307-328" id="s4487.e1" ontology_id="HP_0005584" text="renal cell carcinomas" type="HP"/>
    <pair e1="s4487.e0" e2="s4487.e1" id="s4487.p0" relation="true"/>
  </sentence>
  <sentence id="s4488" text="We identified 30 new blood pressure- or hypertension-associated genetic regions in the general population, including 3 rare missense variants in RBM47, COL21A1 and RRAS with larger effects (&amp;gt;1.5 mm Hg/allele) than common variants.">
    <entity charOffset="40-52" id="s4488.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="145-150" id="s4488.e1" ontology_id="54502" text="RBM47" type="GENE"/>
    <pair e1="s4488.e0" e2="s4488.e1" id="s4488.p0" relation="true"/>
  </sentence>
  <sentence id="s4489" text="We identified 30 new blood pressure- or hypertension-associated genetic regions in the general population, including 3 rare missense variants in RBM47, COL21A1 and RRAS with larger effects (&amp;gt;1.5 mm Hg/allele) than common variants.">
    <entity charOffset="40-52" id="s4489.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="152-159" id="s4489.e1" ontology_id="81578" text="COL21A1" type="GENE"/>
    <pair e1="s4489.e0" e2="s4489.e1" id="s4489.p0" relation="true"/>
  </sentence>
  <sentence id="s4490" text="We identified 30 new blood pressure- or hypertension-associated genetic regions in the general population, including 3 rare missense variants in RBM47, COL21A1 and RRAS with larger effects (&amp;gt;1.5 mm Hg/allele) than common variants.">
    <entity charOffset="40-52" id="s4490.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="164-168" id="s4490.e1" ontology_id="6237" text="RRAS" type="GENE"/>
    <pair e1="s4490.e0" e2="s4490.e1" id="s4490.p0" relation="true"/>
  </sentence>
  <sentence id="s4491" text="Our data extend the spectrum of allelic variation underlying blood pressure traits and hypertension, provide new insights into the pathophysiology of hypertension and indicate new targets for clinical intervention">
    <entity charOffset="76-82" id="s4491.e0" ontology_id="55929" text="traits" type="GENE"/>
    <entity charOffset="87-99" id="s4491.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s4491.e0" e2="s4491.e1" id="s4491.p0" relation="true"/>
  </sentence>
  <sentence id="s4492" text="Three loci with high mutation frequencies, the 138665410 FOXL2 gene variant, the 23862952 MYH6 gene variant, and the 71098693 HYDIN gene variant were found to be significantly associated with sporadic ASD (P&amp;lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&amp;lt;510^-4).">
    <entity charOffset="90-94" id="s4492.e0" ontology_id="4624" text="MYH6" type="GENE"/>
    <entity charOffset="192-200" id="s4492.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4492.e0" e2="s4492.e1" id="s4492.p0" relation="true"/>
  </sentence>
  <sentence id="s4493" text="Three loci with high mutation frequencies, the 138665410 FOXL2 gene variant, the 23862952 MYH6 gene variant, and the 71098693 HYDIN gene variant were found to be significantly associated with sporadic ASD (P&amp;lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&amp;lt;510^-4).">
    <entity charOffset="126-131" id="s4493.e0" ontology_id="54768" text="HYDIN" type="GENE"/>
    <entity charOffset="192-200" id="s4493.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4493.e0" e2="s4493.e1" id="s4493.p0" relation="true"/>
  </sentence>
  <sentence id="s4494" text="CONCLUSIONS This was the first study that demonstrated variants in FOXL2 and HYDIN associated with sporadic ASD, and supported the use of WES and bioinformatics analysis to identify disease-associated mutations">
    <entity charOffset="67-72" id="s4494.e0" ontology_id="668" text="FOXL2" type="GENE"/>
    <entity charOffset="99-107" id="s4494.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4494.e0" e2="s4494.e1" id="s4494.p0" relation="true"/>
  </sentence>
  <sentence id="s4495" text="CONCLUSIONS This was the first study that demonstrated variants in FOXL2 and HYDIN associated with sporadic ASD, and supported the use of WES and bioinformatics analysis to identify disease-associated mutations">
    <entity charOffset="77-82" id="s4495.e0" ontology_id="54768" text="HYDIN" type="GENE"/>
    <entity charOffset="99-107" id="s4495.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4495.e0" e2="s4495.e1" id="s4495.p0" relation="true"/>
  </sentence>
  <sentence id="s4496" text="We suspected PVOD from CT characteristics and pulmonary edema after PAH-targeted vasodilator therapy, and then started oral imatinib treatment.">
    <entity charOffset="46-61" id="s4496.e0" ontology_id="HP_0100598" text="pulmonary edema" type="HP"/>
    <entity charOffset="68-71" id="s4496.e1" ontology_id="5053" text="PAH" type="GENE"/>
    <pair e1="s4496.e0" e2="s4496.e1" id="s4496.p0" relation="true"/>
  </sentence>
  <sentence id="s4497" text="Animal models of viral-associated blood-brain barrier (BBB) disruption and experimental cerebral malaria (ECM) have identified perforin as critical for inducing pathologic central nervous system CNS vascular permeability.">
    <entity charOffset="106-109" id="s4497.e0" ontology_id="22915" text="ECM" type="GENE"/>
    <entity charOffset="172-179" id="s4497.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s4497.e0" e2="s4497.e1" id="s4497.p0" relation="true"/>
  </sentence>
  <sentence id="s4498" text="The current study aims to investigate the biological roles and clinical significance of HCRP1 in human gastric cancer.">
    <entity charOffset="88-93" id="s4498.e0" ontology_id="137492" text="HCRP1" type="GENE"/>
    <entity charOffset="111-117" id="s4498.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4498.e0" e2="s4498.e1" id="s4498.p0" relation="true"/>
  </sentence>
  <sentence id="s4499" text="HCRP1 downregulation was found in 57 of 137 human gastric cancer samples and correlated with advanced TNM stage, positive nodal status, and relapse.">
    <entity charOffset="0-5" id="s4499.e0" ontology_id="137492" text="HCRP1" type="GENE"/>
    <entity charOffset="58-64" id="s4499.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4499.e0" e2="s4499.e1" id="s4499.p0" relation="true"/>
  </sentence>
  <sentence id="s4500" text="In conclusion, our results suggest that HCRP1 downregulation might serve as an indicator for poor prognosis in gastric cancer patients.">
    <entity charOffset="40-45" id="s4500.e0" ontology_id="137492" text="HCRP1" type="GENE"/>
    <entity charOffset="119-125" id="s4500.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4500.e0" e2="s4500.e1" id="s4500.p0" relation="true"/>
  </sentence>
  <sentence id="s4501" text="To better understand the molecular changes in the AH content under such conditions, we analyzed the miRNA profiles of AH samples from patients with POAG and XFG compared to non-glaucoma controls.">
    <entity charOffset="100-103" id="s4501.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="177-185" id="s4501.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s4501.e0" e2="s4501.e1" id="s4501.p0" relation="true"/>
  </sentence>
  <sentence id="s4502" text="Pathway analysis revealed that these miRNAs are involved in potential glaucoma pathways, including focal adhesion, tight junctions, and TGF- signaling.">
    <entity charOffset="37-40" id="s4502.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="70-78" id="s4502.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s4502.e0" e2="s4502.e1" id="s4502.p0" relation="true"/>
  </sentence>
</document>
